PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	BREWTON, RG; WRIGHT, DW; MAYNE, R				BREWTON, RG; WRIGHT, DW; MAYNE, R			STRUCTURAL AND FUNCTIONAL COMPARISON OF TYPE-IX COLLAGEN-PROTEOGLYCAN FROM CHICKEN CARTILAGE AND VITREOUS-HUMOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROITIN SULFATE CHAIN(S); HYALINE CARTILAGE; II COLLAGEN; CONTAINS; GLYCOSAMINOGLYCANS; ANTIBODIES; PROTEINS; FIBRILS; FORMS	Type IX collagen-proteoglycan is a major component of hyaline cartilages where it is located on the surface of the collagen fibrils so that a collagenous domain of the molecule (called COL3) and a non-collagenous domain (called NC4) project at periodic distances away from the surface of the fibril. Type IX collagen-proteoglycan is also present on the surface of the collagen fibrils of the adult chicken vitreous but, unlike cartilage, lacks the NC4 domain and possesses a very long chondroitin sulfate chain which provides an extensive coat to the fibril. A monoclonal antibody (called 4D6) is described which will distinguish cartilage from vitreous type IX collagen. To form the epitope for 4D6 two peptides called C2 and C5 derived, respectively, from the alpha-1(IX) and alpha-3(IX) chains are required. Further analysis shows that specificity for 4D6 resides only in the C2 peptide from cartilage and not in C5. These results are entirely consistent with recent evidence that there are two promoters for transcription of the alpha-1(IX) chain which will result in an alpha-1(IX) chain in which the NC4 domain is either present or absent and that expression of these two promoters has tissue specificity (Nishimura, I., Muragaki, Y., and Olsen, B. R. (1989) J. Biol. Chem. 264, 20033-20041). In addition, the function of type IX collagen in cartilage and vitreous may differ with the long chondroitin sulfate chains of vitreous type IX collagen being responsible for the gel-like matrix of this tissue.	UNIV ALABAMA,DEPT CELL BIOL,UAB STN,BOX 302,BIRMINGHAM,AL 35294	University of Alabama System; University of Alabama Birmingham			Wright, David/F-1209-2013	Wright, David/0000-0002-7145-9105	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM030481] Funding Source: NIH RePORTER; NIADDK NIH HHS [AM 30481] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AYAD S, 1989, BIOCHEM J, V262, P753, DOI 10.1042/bj2620753; AYAD S, 1984, BIOCHEM J, V218, P835, DOI 10.1042/bj2180835; BALAZS EA, 1984, EYE A, V1, P533; BRUCKNER P, 1985, P NATL ACAD SCI USA, V82, P2608, DOI 10.1073/pnas.82.9.2608; EYRE DR, 1987, FEBS LETT, V220, P337, DOI 10.1016/0014-5793(87)80842-6; FITCH JM, 1988, DEV BIOL, V128, P396, DOI 10.1016/0012-1606(88)90301-6; FITCH JM, 1989, DEVELOPMENT, V105, P85; HUBER S, 1986, J BIOL CHEM, V261, P5965; IRWIN MH, 1985, J CELL BIOL, V101, P814, DOI 10.1083/jcb.101.3.814; IRWIN MH, 1986, J BIOL CHEM, V261, P6281; KONOMI H, 1986, J BIOL CHEM, V261, P6742; LINSENMAYER TF, 1990, INVEST OPHTH VIS SCI, V31, P1271; LINSENMAYER TF, 1991, IN PRESS DEVELOPMENT; MAYNE R, 1985, J CELL BIOCHEM, V27, P133, DOI 10.1002/jcb.240270207; MAYNE R, 1989, ARTHRITIS RHEUM, V32, P241, DOI 10.1002/anr.1780320302; MAYNE R, 1986, ANN NY ACAD SCI, V460, P38; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; MURAGAKI Y, 1990, P NATL ACAD SCI USA, V87, P2400, DOI 10.1073/pnas.87.7.2400; NINOMIYA Y, 1984, P NATL ACAD SCI-BIOL, V81, P3014, DOI 10.1073/pnas.81.10.3014; NINOMIYA Y, 1991, EXTRACELLULAR MATRIX, P79; NISHIMURA I, 1989, J BIOL CHEM, V264, P20033; PODELL DN, 1978, BIOCHEM BIOPH RES CO, V81, P176, DOI 10.1016/0006-291X(78)91646-7; REESE CA, 1982, BIOCHEMISTRY-US, V21, P826, DOI 10.1021/bi00534a002; REESE CA, 1981, BIOCHEMISTRY-US, V20, P5443, DOI 10.1021/bi00522a014; SHIMOKOMAKI M, 1990, ANN NY ACAD SCI, V580, P1, DOI 10.1111/j.1749-6632.1990.tb17912.x; SMITH GN, 1978, DEV BIOL, V62, P65, DOI 10.1016/0012-1606(78)90093-3; SVOBODA KK, 1988, P NATL ACAD SCI USA, V85, P7496, DOI 10.1073/pnas.85.20.7496; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Van der Rest M, 1987, STRUCTURE FUNCTION C, P195; VANDERREST M, 1988, J BIOL CHEM, V263, P1615; VANDERREST M, 1985, J BIOL CHEM, V260, P220; VASIOS G, 1988, J BIOL CHEM, V263, P2324; VAUGHAN L, 1985, J BIOL CHEM, V260, P4758; VAUGHAN L, 1988, J CELL BIOL, V106, P991, DOI 10.1083/jcb.106.3.991; WRIGHT DW, 1988, J ULTRA MOL STRUCT R, V100, P224, DOI 10.1016/0889-1605(88)90039-0; YADA T, 1990, J BIOL CHEM, V265, P6992	36	64	67	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4752	4757						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002024				2022-12-25	WOS:A1991FC21700016
J	BALDINI, G; HOHMAN, R; CHARRON, MJ; LODISH, HF				BALDINI, G; HOHMAN, R; CHARRON, MJ; LODISH, HF			INSULIN AND NONHYDROLYZABLE GTP ANALOGS INDUCE TRANSLOCATION OF GLUT-4 TO THE PLASMA-MEMBRANE IN ALPHA-TOXIN-PERMEABILIZED RAT ADIPOSE-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							RESPONSIVE GLUCOSE TRANSPORTER; ADRENAL CHROMAFFIN CELLS; 3T3-L1 ADIPOCYTES; CATECHOLAMINE SECRETION; GUANINE-NUCLEOTIDES; MESSENGER-RNA; G-PROTEINS; CLONING; TISSUES; SEQUENCE	Rat adipose cells treated with Staphylococcus aureus alpha-toxin are permeable and retain their ability to respond to insulin after hormone treatment. The GLUT 4 glucose transporter isoform, specific to fat and muscle cells, is translocated normally from low density microsomes to the plasma membrane in permeabilized cells. Addition of guanosine 5'-O-(3-thiotriphosphate), guanylyl imidodiphosphate, or guanylyl beta, gamma-methylenediphosphate to permeabilized adipocytes induces an insulin-like translocation of GLUT 4 to the plasma membrane; GTP or adenosine 5'-(beta, gamma-imino)triphosphate has no effect. No translocation of GLUT 4 is observed when GTP analogs are added to intact adipocytes. These results suggest the involvement of a GTP-binding protein in insulin-triggered recruitment of GLUT 4 to the cell surface.	NIAID,BETHESDA,MD 20892; MIT,DEPT BIOL,CAMBRIDGE,MA 02139	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Massachusetts Institute of Technology (MIT)	BALDINI, G (corresponding author), WHITEHEAD INST BIOMED RES,CAMBRIDGE,MA 02142, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL041484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK008101] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL41484] Funding Source: Medline; NIDDK NIH HHS [DK08101] Funding Source: Medline; NIGMS NIH HHS [GM40916] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALI H, 1989, J IMMUNOL, V143, P2626; BADER MF, 1989, J BIOL CHEM, V264, P16426; BARROWMAN MM, 1986, NATURE, V319, P504, DOI 10.1038/319504a0; BIBER JW, 1986, J BIOL CHEM, V261, P6180; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; BIRNBAUM MJ, 1986, P NATL ACAD SCI USA, V83, P5784, DOI 10.1073/pnas.83.16.5784; BITTNER MA, 1986, J BIOL CHEM, V261, P182; BOURNE HR, 1988, CELL, V53, P669, DOI 10.1016/0092-8674(88)90081-5; CHARRON MJ, 1989, P NATL ACAD SCI USA, V86, P2535, DOI 10.1073/pnas.86.8.2535; CHARRON MJ, 1990, J BIOL CHEM, V265, P7994; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; FLIER JS, 1987, J CLIN INVEST, V79, P657, DOI 10.1172/JCI112864; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; FUKUMOTO H, 1989, J BIOL CHEM, V264, P7776; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; GREEN N, 1982, CELL, V28, P477, DOI 10.1016/0092-8674(82)90202-1; HOHMAN RJ, 1988, P NATL ACAD SCI USA, V85, P1624, DOI 10.1073/pnas.85.5.1624; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; KAESTNER KH, 1989, P NATL ACAD SCI USA, V86, P3150, DOI 10.1073/pnas.86.9.3150; KAHN BB, 1989, J CLIN INVEST, V84, P404, DOI 10.1172/JCI114180; KELLY KL, 1989, J BIOL CHEM, V264, P12754; KLIP A, 1987, J BIOL CHEM, V262, P9141; MELANCON P, 1987, CELL, V51, P1053, DOI 10.1016/0092-8674(87)90591-5; MICK GJ, 1988, J BIOL CHEM, V263, P10667; MOLLARD GFV, 1990, P NATL ACAD SCI USA, V87, P1988; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; NADIN CY, 1989, J CELL BIOL, V109, P2801, DOI 10.1083/jcb.109.6.2801; RODBELL M, 1964, J BIOL CHEM, V239, P375; SIMPSON IA, 1986, ANNU REV BIOCHEM, V55, P1059, DOI 10.1146/annurev.biochem.55.1.1059; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; SUZUKI K, 1980, P NATL ACAD SCI-BIOL, V77, P2542, DOI 10.1073/pnas.77.5.2542; THORENS B, 1988, CELL, V55, P281, DOI 10.1016/0092-8674(88)90051-7; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VALLAR L, 1987, J BIOL CHEM, V262, P5049; WEBER TM, 1988, RECEPTOR BIOCH METHO, P171; WHEELER TJ, 1982, BIOCHEM BIOPH RES CO, V105, P89, DOI 10.1016/S0006-291X(82)80014-4; ZORZANO A, 1989, J BIOL CHEM, V264, P12358	40	147	148	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4037	4040						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999400				2022-12-25	WOS:A1991FA69400004
J	KILEDJIAN, M; KADESCH, T				KILEDJIAN, M; KADESCH, T			POSTTRANSCRIPTIONAL REGULATION OF THE HUMAN LIVER BONE KIDNEY ALKALINE-PHOSPHATASE GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; INFANTILE HYPOPHOSPHATASIA; HYBRIDIZATION PROBES; SKIN FIBROBLASTS; STABILIZATION; EXPRESSION; SEQUENCES; CELLS; CDNA; TRANSPORT	Osteoblasts express high levels of liver/bone/kidney alkaline phosphatase (LBK AP), an enzyme critical for bone formation. Other tissues and cell types generally express much lower levels of LBK AP and correspondingly lower levels of mRNA. In light of our early observations that the human LBK AP promoter is expressed equally when transfected into a variety of different cells, we have carried out a detailed study of LBK AP gene expression in Saos-2 cells which are osteoblast-derived and express high levels of LBK AP mRNA, and in HepG2 hepatoblastoma cells which express LBK AP mRNA at levels which are approximately 1000-fold lower. Our results indicate that both of these cells utilize the same promoter sequences to initiate transcription of their LBK AP genes at roughly the same rates. Moreover, the stability of cytoplasmic LBK AP mRNA is equal in both cell types. The lack of any apparent buildup of unspliced precursor mRNA in the nucleus of HepG2 cells leads us to the conclusion that splicing (and nuclear export) is equivalent. It is therefore likely that differential expression is controlled at a very early step post-transcription, possibly by sequences that destabilize the nascent RNA in HepG2 cells. We reason that these destabilizing sequences are located in the gene's introns because of a transfected LBK AP minigene, comprised of the full length cDNA and flanking sequences, is expressed efficiently in both cell types.	UNIV PENN,SCH MED,DEPT HUMAN GENET,PHILADELPHIA,PA 19104	University of Pennsylvania	KILEDJIAN, M (corresponding author), UNIV PENN,SCH MED,HOWARD HUGHES MED INST,PHILADELPHIA,PA 19104, USA.							[Anonymous], METABOLIC BASIS INHE; BRAWERMAN G, 1989, CELL, V57, P9, DOI 10.1016/0092-8674(89)90166-9; BRAWERMAN G, 1987, CELL, V48, P5, DOI 10.1016/0092-8674(87)90346-1; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHRETIEN S, 1988, P NATL ACAD SCI USA, V85, P6, DOI 10.1073/pnas.85.1.6; DANI C, 1984, P NATL ACAD SCI-BIOL, V81, P7046, DOI 10.1073/pnas.81.22.7046; DANOVITCH SH, 1968, NEW ENGL J MED, V278, P1253, DOI 10.1056/NEJM196806062782303; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; Fogh J., 1975, HUMAN TUMOR CELLS IN, VVolume 1, P115, DOI [10.1007/978-1-4757-1647-4_5, DOI 10.1007/978-1-4757-1647-4_5]; GAY DA, 1987, CELL, V50, P671, DOI 10.1016/0092-8674(87)90325-4; GOLDSTEIN DJ, 1982, CLIN CHIM ACTA, V125, P63, DOI 10.1016/0009-8981(82)90046-8; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HARRIS H, 1981, HARVEY LECT, V76, P95; JONES TR, 1987, MOL CELL BIOL, V7, P4513, DOI 10.1128/MCB.7.12.4513; KADESCH T, 1986, MOL CELL BIOL, V6, P2593, DOI 10.1128/MCB.6.7.2593; KHALILI K, 1984, J MOL BIOL, V180, P1007, DOI 10.1016/0022-2836(84)90268-7; KILEDJIAN M, 1990, NUCLEIC ACIDS RES, V18, P957, DOI 10.1093/nar/18.4.957; KISHI F, 1989, NUCLEIC ACIDS RES, V17, P2129, DOI 10.1093/nar/17.5.2129; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; LEPPARD KN, 1989, EMBO J, V8, P2329, DOI 10.1002/j.1460-2075.1989.tb08360.x; LEVITT N, 1989, GENE DEV, V3, P1019, DOI 10.1101/gad.3.7.1019; Maniatis T., 1982, MOL CLONING; MATSUURA S, 1990, BIOCHEM BIOPH RES CO, V168, P993, DOI 10.1016/0006-291X(90)91127-E; McComb Jr RB, 1979, ALKALINE PHOSPHATASE, DOI 10.1007/978-1-4613-2970-1_4; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MUELLER HD, 1983, J LAB CLIN MED, V102, P24; NORDSTROM JL, 1986, BIOCHIM BIOPHYS ACTA, V867, P152, DOI 10.1016/0167-4781(86)90075-8; PILDER S, 1986, MOL CELL BIOL, V6, P470, DOI 10.1128/MCB.6.2.470; RAGHOW R, 1987, TRENDS BIOCHEM SCI, V12, P358, DOI 10.1016/0968-0004(87)90165-4; Robison R, 1923, BIOCHEM J, V17, P286, DOI 10.1042/bj0170286; RODAN SB, 1987, CANCER RES, V47, P4961; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; STEWART CJ, 1987, MOL CELL BIOL, V7, P1156, DOI 10.1128/MCB.7.3.1156; SUGGS SV, 1981, P NATL ACAD SCI-BIOL, V78, P6613, DOI 10.1073/pnas.78.11.6613; TAUB R, 1984, CELL, V36, P339, DOI 10.1016/0092-8674(84)90227-7; WEBER B, 1989, MOL CELL BIOL, V9, P769, DOI 10.1128/MCB.9.2.769; WEISS MJ, 1989, AM J HUM GENET, V44, P686; WEISS MJ, 1986, P NATL ACAD SCI USA, V83, P7182, DOI 10.1073/pnas.83.19.7182; WEISS MJ, 1988, J BIOL CHEM, V263, P12002; WEISS MJ, 1988, P NATL ACAD SCI USA, V85, P7666, DOI 10.1073/pnas.85.20.7666; WEISS MJ, 1989, THESIS U PENNSYLVANI; WHYTE MP, 1987, CALCIFIED TISSUE INT, V40, P244, DOI 10.1007/BF02555256; Wuthier R.E., 1985, CHEM BIOL MINERALIZE, P113	43	57	58	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4207	4213						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999414				2022-12-25	WOS:A1991FA69400032
J	XU, SY; SCHILDKRAUT, I				XU, SY; SCHILDKRAUT, I			ISOLATION OF BAMHI VARIANTS WITH REDUCED CLEAVAGE ACTIVITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ECORI ENDONUCLEASE; DNA; REPRESSOR; AFFINITY; BINDING; SITE	Derivation of the bamhIR sequence (Brooks, J. E., Nathan, P. D., Landry, D., Sznyter, L. A., Waite-Rees, P., Ives, C. C., Mazzola, L. M., Slatko, B. E., and Benner, J. S. (1991) Nucleic Acids Res., in press), the gene coding for BamHI endonuclease, has facilitated construction of an Escherichia coli strain that overproduces BamHI endonuclease (W.E. Jack, L. Greenough, L. F. Dorner, S.Y.Xu, T. Strezelecka, A. K. Aggarwal, and I. Schildkraut, submitted for publication). As expected, low-level constitutive expression of the bamhIR gene in E. coli from the P(tac) promotor construct is lethal to the host unless the bamHIM gene, which encodes the BamHI methylase, is also expressed within the cell. We identified four classes of BamHI endonuclease variants deficient in catalysis by selecting for survival of a host deficient for bamHIM gene, transformed with mutagenized copies of the bamhIR gene, and then screening the surviving cell extracts for DNA cleavage and binding activities. Class I variants (G56S, G91S/T153I, T114I, G130R, E135K, T153I, T157I, G194D) displayed 0.1-1% of the wild-type cleavage activity; class II variant (D94N) lacked cleavage activity but retained wild-type DNA binding specificity; class III variants (E77K, E113K) lacked cleavage activity but bound DNA more tightly; class IV variants (G56D, G90D, G91S, R122H, R155H) lacked both binding and cleavage activities. Variants with residual cleavage activities induced the E. coli SOS response and thus are presumed to cleave chromosomal DNA in vivo. We conclude that Glu77, Asp94, and Glu113 residues are essential for BamHI catalytic function.	NEW ENGLAND BIOLABS INC,BEVERLY,MA 01915									BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; BROOKS JE, 1989, NUCLEIC ACIDS RES, V17, P979, DOI 10.1093/nar/17.3.979; BROOKS JE, 1990, IN PRESS NUCLEIC ACI; BROSIUS J, 1984, GENE, V27, P151, DOI 10.1016/0378-1119(84)90136-7; DERBYSHIRE V, 1988, SCIENCE, V240, P199, DOI 10.1126/science.2832946; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HEITMAN J, 1990, PROTEINS, V7, P185, DOI 10.1002/prot.340070207; JENJACOBSON L, 1986, CELL, V45, P619, DOI 10.1016/0092-8674(86)90294-1; KENYON CJ, 1980, P NATL ACAD SCI-BIOL, V77, P2819, DOI 10.1073/pnas.77.5.2819; KING K, 1989, J BIOL CHEM, V264, P11807; LEVITT M, 1978, BIOCHEMISTRY-US, V17, P4277, DOI 10.1021/bi00613a026; LIN SY, 1975, CELL, V4, P107, DOI 10.1016/0092-8674(75)90116-6; Maniatis T., 1982, MOL CLONING; Miller J.H., 1972, EXPT MOL GENETICS; NARDONE G, 1987, GENE AMPLIFICATION A, P147; NELSON HCM, 1985, CELL, V42, P549, DOI 10.1016/0092-8674(85)90112-6; ROBERTS RJ, 1977, NATURE, V256, P82; ROSENBERG JM, 1987, GENE AMPLIFICATION A, P103; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Silhavy T.J., 1984, EXPT GENE FUSIONS; TERRY BJ, 1987, GENE AMPLIFICATION A, P103; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687	22	86	91	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4425	4429						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999426				2022-12-25	WOS:A1991FA69400063
J	REYNOLDS, DS; GURLEY, DS; AUSTEN, KF; SERAFIN, WE				REYNOLDS, DS; GURLEY, DS; AUSTEN, KF; SERAFIN, WE			CLONING OF THE CDNA AND GENE OF MOUSE MAST-CELL PROTEASE-6 - TRANSCRIPTION BY PROGENITOR MAST-CELLS AND MAST-CELLS OF THE CONNECTIVE-TISSUE SUBCLASS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXIC LYMPHOCYTE-T; CHYMOTRYPSIN-LIKE PROTEINASE; SERINE PROTEASES; MOLECULAR-CLONING; TRICHINELLA-SPIRALIS; MESSENGER-RNA; W/WV MICE; TRYPTASE; SEQUENCES; DIFFERENTIATION	The cDNA and gene for mouse mast cell protease-6 (MMCP-6) have been sequenced and show MMCP-6 to be translated as a prepro-enzyme with a 21-amino acid hydrophobic leader peptide, a 10-amino acid activation peptide, and a 245-amino acid mature enzyme. The mature form of the enzyme has 73% amino acid sequence identity with human and dog mast cell tryptases. The MMCP-6 gene includes 6 exons, with a total span of 1.8 kilobases. A 208-base pair intron was defined which separates the 5'-untranslated sequence of MMCP-6 from the translation initiation codon, thereby presenting a gene organization which distinguishes tryptic serine proteases from chymotryptic serine proteases of the mast cell secretory granule. By RNA blot analysis with a gene-specific probe, MMCP-6 has a unique subclass distribution in being transcribed in mouse connective tissue mast cells but undetectable in mucosal mast cells. MMCP-6 is the first serine protease of any class to be shown to be significantly transcribed in progenitor, bone marrow-derived mast cells, which can reconstitute both mucosal mast cell and connective tissue mast cell populations in mast cell-deficient mice.	HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02115 USA; BRIGHAM & WOMENS HOSP, DEPT RHEUMATOL & IMMUNOL, BOSTON, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital					NATIONAL CANCER INSTITUTE [T32CA009141] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR035907] Funding Source: NIH RePORTER; NCI NIH HHS [CA-09141] Funding Source: Medline; NHLBI NIH HHS [HL-36110] Funding Source: Medline; NIAMS NIH HHS [AR-35907] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALIZADEH H, 1982, INT J PARASITOL, V12, P65, DOI 10.1016/0020-7519(82)90097-2; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BUVINGER WE, 1989, J BIOL CHEM, V264, P1195; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CORDEN J, 1980, SCIENCE, V209, P1406, DOI 10.1126/science.6251548; CRAIK CS, 1984, J BIOL CHEM, V259, P4255; DAVIDSON S, 1990, J BIOL CHEM, V265, P12324; de Haen C, 1975, J Mol Biol, V92, P225, DOI 10.1016/0022-2836(75)90225-9; FURIE B, 1982, J BIOL CHEM, V257, P3875; FURITSU T, 1989, P NATL ACAD SCI USA, V86, P10039, DOI 10.1073/pnas.86.24.10039; GELIEBTER J, 1986, P NATL ACAD SCI USA, V83, P3371, DOI 10.1073/pnas.83.10.3371; GERSHENFELD HK, 1986, SCIENCE, V232, P854, DOI 10.1126/science.2422755; GRUBER BL, 1989, J CLIN INVEST, V84, P1657, DOI 10.1172/JCI114344; GUYGRAND D, 1984, J EXP MED, V160, P12, DOI 10.1084/jem.160.1.12; HARTLEY BS, 1970, PHILOS T ROY SOC B, V257, P77, DOI 10.1098/rstb.1970.0010; IRANI AA, 1986, P NATL ACAD SCI USA, V83, P4464, DOI 10.1073/pnas.83.12.4464; JENNE D, 1988, P NATL ACAD SCI USA, V85, P4814, DOI 10.1073/pnas.85.13.4814; JENNE D, 1988, J IMMUNOL, V140, P318; LOBE CG, 1986, SCIENCE, V232, P858, DOI 10.1126/science.3518058; LOBE CG, 1988, BIOCHEMISTRY-US, V27, P6941, DOI 10.1021/bi00418a040; MAIZEL JV, 1981, P NATL ACAD SCI-BIOL, V78, P7665, DOI 10.1073/pnas.78.12.7665; MILLER JS, 1989, J CLIN INVEST, V84, P1188, DOI 10.1172/JCI114284; MITCHELL LA, 1983, PARASITE IMMUNOL, V5, P1, DOI 10.1111/j.1365-3024.1983.tb00718.x; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; NEWLANDS GFJ, 1987, IMMUNOLOGY, V62, P629; OTSU K, 1987, J EXP MED, V165, P615, DOI 10.1084/jem.165.3.615; RAZIN E, 1984, J IMMUNOL, V132, P1479; REYNOLDS DS, 1989, J BIOL CHEM, V264, P20094; REYNOLDS DS, 1988, J BIOL CHEM, V263, P12783; REYNOLDS DS, 1990, P NATL ACAD SCI USA, V87, P3230, DOI 10.1073/pnas.87.8.3230; SCHECHTER NM, 1986, J IMMUNOL, V137, P962; SCHWARTZ LB, 1983, J IMMUNOL, V130, P1891; SCHWARTZ LB, 1985, J IMMUNOL, V134, P526; SEKIZAWA K, 1989, J CLIN INVEST, V83, P175, DOI 10.1172/JCI113855; SERAFIN WE, 1991, J BIOL CHEM, V266, P1934; SERAFIN WE, 1990, J BIOL CHEM, V265, P423; SERAFIN WE, 1987, J IMMUNOL, V139, P3771; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPIEGELMAN BM, 1983, J BIOL CHEM, V258, P83; STEITZ TA, 1969, J MOL BIOL, V46, P337, DOI 10.1016/0022-2836(69)90426-4; STOFLET ES, 1988, SCIENCE, V239, P491, DOI 10.1126/science.3340835; TANTRAVAHI RV, 1986, P NATL ACAD SCI USA, V83, P9207, DOI 10.1073/pnas.83.23.9207; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TRONG HL, 1987, BIOCHEMISTRY-US, V26, P6988; TRONG HL, 1989, BIOCHEMISTRY-US, V28, P391; VANDERSLICE P, 1989, BIOCHEMISTRY-US, V28, P4148, DOI 10.1021/bi00436a004; VANDERSLICE P, 1990, P NATL ACAD SCI USA, V87, P3811, DOI 10.1073/pnas.87.10.3811; VONHEIJNE G, 1984, J MOL BIOL, V173, P243, DOI 10.1016/0022-2836(84)90192-X; Wise R J, 1984, Mol Biol Med, V2, P307; WONG WW, 1985, P NATL ACAD SCI USA, V82, P7711, DOI 10.1073/pnas.82.22.7711; WOODBURY RG, 1978, BIOCHEMISTRY-US, V17, P811, DOI 10.1021/bi00598a010; YURT R, 1977, J EXP MED, V146, P1405, DOI 10.1084/jem.146.5.1405; YURT RW, 1977, J BIOL CHEM, V252, P518	55	181	183	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3847	3853						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995638				2022-12-25	WOS:A1991EY68200075
J	KATOH, T; FUJISAWA, H				KATOH, T; FUJISAWA, H			AUTOACTIVATION OF CALMODULIN-DEPENDENT PROTEIN KINASE-II BY AUTOPHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; TRYPTOPHAN 5-MONOOXYGENASE; RAT-BRAIN; PURIFICATION; ACTIVATION; MECHANISM; THREONINE-286; EXPRESSION; GENERATION; SUBUNIT	Autophosphorylation of calmodulin (CaM)-dependent protein kinase II (CaM-kinase II) under limiting conditions (2-mu-M ATP) decreased progressively with increasing concentrations of a substrate, Pro-Leu-Ala-Arg-Thr-Leu-Ser-Val-Ala-Gly-Leu-Pro-Gly-Lys-Lys (syntide-2), suggesting a competition between the substrate and the autophosphorylation site(s) of the enzyme. The rate and extent of the generation of Ca2+/CaM-independent activity of the enzyme by autophosphorylation were also decreased by the presence of syntide-2. The syntide-2 phosphorylation in the presence of Ca2+/CaM under the limiting conditions reached a steady state, after a lag, when the Ca2+/CaM-independent activity reached a plateau. A linear relationship was observed between the activities in the presence and absence of Ca2+/CaM of the enzyme which had undergone various degrees of autophosphorylation, and the extrapolation of activity in the absence of Ca2+/CaM to zero gave 15-20% of the maximum activity. The steady-state rate of syntide-2 phosphorylation in the presence of Ca2+/CaM by the enzyme that had not undergone prior autophosphorylation was decreased by high concentrations of syntide-2 which suppressed autophosphorylation as well as the generation of Ca2+/CaM-independent activity. These results suggest that although the nonautophosphorylated enzyme possesses a basal low level of Ca2+/CaM-dependent activity, autophosphorylation is required for full activation.	ASAHIKAWA MED COLL,DEPT BIOCHEM,ASAHIKAWA 078,JAPAN	Asahikawa Medical College								BENNETT MK, 1983, J BIOL CHEM, V258, P2735; BENNETT MK, 1987, P NATL ACAD SCI USA, V84, P1794, DOI 10.1073/pnas.84.7.1794; BULLEIT RF, 1988, NEURON, V1, P63, DOI 10.1016/0896-6273(88)90210-3; FONG YL, 1989, J BIOL CHEM, V264, P16759; GOLDENRING JR, 1983, J BIOL CHEM, V258, P2632; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; HANSON PI, 1989, NEURON, V3, P59, DOI 10.1016/0896-6273(89)90115-3; HASHIMOTO Y, 1987, ARCH BIOCHEM BIOPHYS, V252, P418, DOI 10.1016/0003-9861(87)90048-8; HASHIMOTO Y, 1987, J BIOL CHEM, V262, P8051; KAMESHITA I, 1989, ANAL BIOCHEM, V183, P139, DOI 10.1016/0003-2697(89)90181-4; KATOH T, 1991, IN PRESS BIOCH BIOPH; KENNEDY MB, 1981, P NATL ACAD SCI-BIOL, V78, P1293, DOI 10.1073/pnas.78.2.1293; KURET J, 1984, BIOCHEMISTRY-US, V23, P5495, DOI 10.1021/bi00318a018; KURET J, 1985, J BIOL CHEM, V260, P6427; KWIATKOWSKI AP, 1988, J BIOL CHEM, V263, P6484; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI Y, 1986, P NATL ACAD SCI USA, V83, P4253, DOI 10.1073/pnas.83.12.4253; LEVINE H, 1987, BIOCHEM BIOPH RES CO, V148, P1104, DOI 10.1016/S0006-291X(87)80246-2; LIN CR, 1987, P NATL ACAD SCI USA, V84, P5962, DOI 10.1073/pnas.84.16.5962; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; SCHWORER CM, 1986, J BIOL CHEM, V261, P8581; SHIELDS SM, 1984, J NEUROCHEM, V43, P1599, DOI 10.1111/j.1471-4159.1984.tb06084.x; SHOELSON SE, 1989, J BIOL CHEM, V264, P7831; THIEL G, 1988, P NATL ACAD SCI USA, V85, P6337, DOI 10.1073/pnas.85.17.6337; TOBIMATSU T, 1989, J BIOL CHEM, V264, P17907; TOBIMATSU T, 1988, J BIOL CHEM, V263, P16082; YAMAUCHI T, 1983, EUR J BIOCHEM, V132, P15, DOI 10.1111/j.1432-1033.1983.tb07319.x; YAMAUCHI T, 1981, FEBS LETT, V129, P117, DOI 10.1016/0014-5793(81)80769-7; YAMAUCHI T, 1985, BIOCHEM BIOPH RES CO, V129, P213, DOI 10.1016/0006-291X(85)91424-X; YAZAWA M, 1980, J BIOCHEM, V87, P1313, DOI 10.1093/oxfordjournals.jbchem.a132869	30	40	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3039	3044						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993676				2022-12-25	WOS:A1991EX60000057
J	LEACH, KL; RUFF, VA; WRIGHT, TM; PESSIN, MS; RABEN, DM				LEACH, KL; RUFF, VA; WRIGHT, TM; PESSIN, MS; RABEN, DM			DISSOCIATION OF PROTEIN-KINASE-C ACTIVATION AND SN-1,2-DIACYLGLYCEROL FORMATION - COMPARISON OF PHOSPHATIDYLINOSITOL-DERIVED AND PHOSPHATIDYLCHOLINE-DERIVED DIGLYCERIDES IN ALPHA-THROMBIN-STIMULATED FIBROBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-SPECIES ANALYSIS; CULTURED FIBROBLASTS; PHORBOL ESTERS; BRAIN; PHOSPHORYLATION; DIACYLGLYCEROL; CELLS; PURIFICATION; HEPATOCYTES; SPECIFICITY	Diacylglycerols (DAGs) derived from phosphatidylcholine (PC) hydrolysis have been shown to activate protein kinase C (PKC) in vitro, but it is not known whether this event occurs in response to DAGs generated via agonist-induced PC hydrolysis in intact cells. In this report we have addressed this question directly, using alpha-thrombin stimulation of IIC9 fibroblasts. PKC activation in intact cells was assessed in two ways, by measuring: 1) PKC membrane association as determined by kinase activity and Western blot analysis and 2) the phosphorylation of an endogenous PKC substrate, an 80-kDa protein. Treatment with 500 ng/ml alpha-thrombin has been shown to stimulate both phosphoinositide and PC hydrolysis, whereas treatment with 100 pg/ml alpha-thrombin stimulates only PC breakdown. Using these two conditions, we show that DAG produced from phosphoinositide, but not PC hydrolysis, is associated with the activation of PKC.	JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PHYSIOL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROSCI,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	LEACH, KL (corresponding author), UPJOHN CO,DEPT CELL BIOL,301 HENRIETTA ST,KALAMAZOO,MI 49007, USA.			Pessin, Melissa/0000-0003-3990-6494	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [K12AM001298] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039086] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL39086] Funding Source: Medline; NIADDK NIH HHS [AM01298] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AUGERT G, 1989, J BIOL CHEM, V264, P2574; Bell R M, 1986, Methods Enzymol, V124, P353; BLACKSHEAR PJ, 1986, J BIOL CHEM, V261, P1459; BOCCKINO SB, 1985, J BIOL CHEM, V260, P4201; BONNER TI, 1986, NUCLEIC ACIDS RES, V14, P1009, DOI 10.1093/nar/14.2.1009; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNS DJ, 1990, J BIOL CHEM, V265, P12044; ERUSALIMSKY JD, 1988, J BIOL CHEM, V263, P19188; EXTON JH, 1990, J BIOL CHEM, V265, P1; GO M, 1987, BIOCHEM BIOPH RES CO, V144, P598; GONZATTIHACES MI, 1986, J BIOL CHEM, V261, P5266; GRAFF JM, 1989, SCIENCE, V246, P503, DOI 10.1126/science.2814478; HIDAKA H, 1990, CELL, V61, P1113; HUANG FL, 1987, BIOCHEM BIOPH RES CO, V149, P946, DOI 10.1016/0006-291X(87)90500-6; HUANG KP, 1988, J BIOL CHEM, V263, P14839; IRVING HR, 1987, J BIOL CHEM, V262, P3440; ISHIKAWA F, 1986, JPN J CANCER RES, V77, P1183; JAKEN S, 1987, P NATL ACAD SCI USA, V84, P4418, DOI 10.1073/pnas.84.13.4418; KENNERLY DA, 1987, J BIOL CHEM, V262, P16305; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARRODERA P, 1990, CELL, V61, P1113, DOI 10.1016/0092-8674(90)90074-O; LEACH KL, 1988, J BIOL CHEM, V263, P13223; LEACH KL, 1989, INOSITOL LIPIDS CELL, P179; LEE MH, 1986, J BIOL CHEM, V261, P4867; LOW DA, 1982, NATURE, V298, P476, DOI 10.1038/298476a0; MARAIS RM, 1989, EUR J BIOCHEM, V182, P129, DOI 10.1111/j.1432-1033.1989.tb14809.x; MARTIN TFJ, 1990, J BIOL CHEM, V265, P7623; MORI T, 1982, J BIOCHEM, V91, P427, DOI 10.1093/oxfordjournals.jbchem.a133714; NANBERG E, 1990, J CELL PHYSIOL, V143, P232, DOI 10.1002/jcp.1041430206; NIEDEL J E, 1986, P47; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; OHNO S, 1988, CELL, V53, P731, DOI 10.1016/0092-8674(88)90091-8; OPELECH SL, 1989, TENDS BIOCH SCI, V14, P28; PESSIN MS, 1990, J BIOL CHEM, V265, P7959; PESSIN MS, 1989, J BIOL CHEM, V264, P8729; PFEFFER LM, 1990, P NATL ACAD SCI USA, V87, P6537, DOI 10.1073/pnas.87.17.6537; RODRIGUEZPENA A, 1986, EMBO J, V5, P77, DOI 10.1002/j.1460-2075.1986.tb04180.x; ROSCOFF PM, 1988, CELL, V54, P73; ROZENGURT E, 1986, SCIENCE, V234, P160; SEKIGUCHI K, 1987, BIOCHEM BIOPH RES CO, V145, P797, DOI 10.1016/0006-291X(87)91035-7; SILVKA SR, 1988, J BIOL CHEM, V263, P12242; STUMPO DJ, 1989, P NATL ACAD SCI USA, V86, P4012, DOI 10.1073/pnas.86.11.4012; WHETTON AD, 1988, P NATL ACAD SCI USA, V85, P3284, DOI 10.1073/pnas.85.10.3284; WRIGHT TM, 1990, BIOCHEM J, V267, P501, DOI 10.1042/bj2670501; WRIGHT TM, 1988, J BIOL CHEM, V263, P9374	45	128	129	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3215	3221						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993695				2022-12-25	WOS:A1991EX60000082
J	MANZELLA, JM; RYCHLIK, W; RHOADS, RE; HERSHEY, JWB; BLACKSHEAR, PJ				MANZELLA, JM; RYCHLIK, W; RHOADS, RE; HERSHEY, JWB; BLACKSHEAR, PJ			INSULIN INDUCTION OF ORNITHINE DECARBOXYLASE - IMPORTANCE OF MESSENGER-RNA SECONDARY STRUCTURE AND PHOSPHORYLATION OF EUKARYOTIC INITIATION FACTOR-EIF-4B AND FACTOR-EIF-4E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAP-BINDING PROTEIN; KINASE ACTIVITIES; HEPATOMA-CELLS; EXPRESSION; GENE; PURIFICATION; TRANSLATION; FIBROBLASTS; POLYAMINES; LIVER	We investigated the possibility that insulin could stimulate translation of ornithine decarboxylase (ODC) mRNA in a murine fibroblast cell line that expresses large numbers of human insulin receptors (HIR 3.5 cells). Within 3 h after exposure to 70 nM insulin, ODC enzyme activity increased approximately 50-fold and mRNA accumulation 3-fold in the HIR 3.5 cells but not in normal fibroblasts. Pretreatment of cells with cycloheximide completely inhibited insulin-stimulated ODC expression; actinomycin D partially inhibited this effect. To determine the influence of the 5'-untranslated region (5'UTR) of ODC mRNA on insulin-regulated ODC expression, plasmids were constructed which contained sequences from the 5'UTR of a rat ODC mRNA interposed between the ferritin promoter and the coding region of the human growth hormone gene. These constructions were then expressed transiently in HIR 3.5 cells. Insulin stimulated a 2-4-fold change in growth hormone accumulation in the medium of cells transiently expressing plasmids containing the entire 5'UTR of ODC mRNA or just the 5'-most 115 bases, a G/C-rich conserved sequence predicted to form a stem-loop structure and shown previously to be responsible for constitutive inhibition of translation. There was a direct correlation between the extent of insulin stimulation and the predicted secondary structure of the added 5'UTR sequences. To determine whether this effect might be due to insulin activation of initiation factors responsible for melting mRNA secondary structure, we examined the effect of insulin on the phosphorylation states of two such factors, eucaryotic initiation factors eIF-4B and eIF-4E. Insulin stimulated the phosphorylation of both initiation factors; this stimulation was evident at 15 min and maximal by 60 min. These results suggest a potential general mechanism by which insulin could preferentially stimulate translation of mRNAs whose 5'UTRs exhibit significant secondary structure by activating initiation factors involved in melting such secondary structures.	DUKE UNIV,MED CTR,HOWARD HUGHES MED INST LABS,BOX 3897,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT MED,DIV ENDOCRINOL METAB & GENET,DIABET & METAB SECT,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT BIOCHEM,DURHAM,NC 27710; UNIV KENTUCKY,DEPT BIOCHEM,LEXINGTON,KY 40536; UNIV CALIF DAVIS,SCH MED,DEPT BIOL CHEM,DAVIS,CA 95616	Duke University; Duke University; Duke University; University of Kentucky; University of California System; University of California Davis			Blackshear, Perry J./C-6206-2019	Blackshear, Perry J./0000-0002-9561-8529	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007184] Funding Source: NIH RePORTER; NIGMS NIH HHS [5T32 GM07184, GM20818] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLACKSHEAR PJ, 1984, ENDOCRINOLOGY, V114, P141, DOI 10.1210/endo-114-1-141; BLACKSHEAR PJ, 1987, MOL ENDOCRINOL, V1, P44, DOI 10.1210/mend-1-1-44; BONNEAU AM, 1987, J BIOL CHEM, V262, P11134; BRABANT M, 1988, P NATL ACAD SCI USA, V85, P2200, DOI 10.1073/pnas.85.7.2200; DEBENEDETTI A, 1990, P NATL ACAD SCI USA, V87, P8212, DOI 10.1073/pnas.87.21.8212; DUNCAN R, 1987, J BIOL CHEM, V262, P380; GRENS A, 1990, J BIOL CHEM, V265, P11810; HENTZE MW, 1987, SCIENCE, V238, P1570, DOI 10.1126/science.3685996; HERSHEY JWB, 1989, J BIOL CHEM, V264, P20823; HOVIS JG, 1986, J BIOL CHEM, V261, P380; Jagus R, 1981, Prog Nucleic Acid Res Mol Biol, V25, P127, DOI 10.1016/S0079-6603(08)60484-5; JOSHIBARVE S, 1990, J BIOL CHEM, V265, P2979; KASPAR RL, 1990, J BIOL CHEM, V265, P3619; KLAUSNER RD, 1989, SCIENCE, V246, P870, DOI 10.1126/science.2683086; KOZAK M, 1988, MOL CELL BIOL, V8, P2737, DOI 10.1128/MCB.8.7.2737; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LAWSON TG, 1989, BIOCHEMISTRY-US, V28, P4729, DOI 10.1021/bi00437a033; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; LEVENSON RM, 1989, J BIOL CHEM, V264, P11904; LOBAUGH LA, 1990, J BIOL CHEM, V265, P18393; LUMENG L, 1979, BIOCHIM BIOPHYS ACTA, V587, P556, DOI 10.1016/0304-4165(79)90008-4; LYONS RT, 1980, J BIOL CHEM, V255, P6330; MANZELLA JM, 1990, J BIOL CHEM, V265, P11817; MEYER LJ, 1982, BIOCHEMISTRY-US, V21, P4212; MORLEY SJ, 1990, J BIOL CHEM, V265, P10611; MOSHIER JA, 1990, J BIOL CHEM, V265, P4884; NAIRN AC, 1987, J BIOL CHEM, V262, P7273; PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249; POTTER VR, 1984, IN VITRO CELL DEV B, V20, P723; RAY BK, 1985, J BIOL CHEM, V260, P7651; RHOADS RE, 1988, TRENDS BIOCHEM SCI, V13, P52, DOI 10.1016/0968-0004(88)90028-X; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; RYCHLIK W, 1986, J BIOL CHEM, V261, P71; SPACH DH, 1986, J BIOL CHEM, V261, P2750; STANDAERT ML, 1988, FASEB J, V2, P2453, DOI 10.1096/fasebj.2.9.3286349; STUMPO DJ, 1986, P NATL ACAD SCI USA, V83, P9453, DOI 10.1073/pnas.83.24.9453; STUMPO DJ, 1988, MOL CELL BIOL DIABET, V3, P1; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TOMITA Y, 1981, EXP CELL RES, V135, P363, DOI 10.1016/0014-4827(81)90172-5; TUAZON PT, 1990, J BIOL CHEM, V265, P10617; WEBB NR, 1984, BIOCHEMISTRY-US, V23, P177, DOI 10.1021/bi00297a001; WEN L, 1989, J BIOL CHEM, V264, P9016; WHITTAKER J, 1987, P NATL ACAD SCI USA, V84, P5237, DOI 10.1073/pnas.84.15.5237; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	44	166	169	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2383	2389						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989989				2022-12-25	WOS:A1991EV51500057
J	TAKASU, N; ASAWA, T; KOMIYA, I; NAGASAWA, Y; YAMADA, T				TAKASU, N; ASAWA, T; KOMIYA, I; NAGASAWA, Y; YAMADA, T			ALLOXAN-INDUCED DNA STRAND BREAKS IN PANCREATIC-ISLETS - EVIDENCE FOR H2O2 AS AN INTERMEDIATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(ADP-RIBOSE) SYNTHETASE; HYDROGEN-PEROXIDE; STREPTOZOTOCIN; CELLS	Alloxan exhibits the most potent diabetogenicity and has been used for induction of experimental diabetes mellitus. Understanding the mechanisms of action of the typical diabetogenic agent is important for elucidating the causes of diabetes. Okamoto (Okamoto, H. (1985) BioEssays 2, 15-21) proposed a model in which DNA fragmentation plays an important role for the development of diabetes. This DNA fragmentation is supposed to result from the accumulation of superoxide or hydroxyl radicals. However, direct evidence for this accumulation is lacking. Using rat pancreatic islets, we demonstrated that alloxan stimulated H2O2 generation, which induced DNA strand breaks. These findings support Okamoto's proposal that alloxan induces diabetes through the following biochemical events: alloxan --> H2O2 generation --> DNA strand breaks --> diabetes mellitus. Perhaps this report constitutes the first demonstration of alloxan-stimulated H2O2 generation which could conceivably act as an intermediate for alloxan-induced DNA strand breaks.			TAKASU, N (corresponding author), SHINSHU UNIV,SCH MED,DEPT GERONTOL ENDOCRINOL & METAB,ASAHI 3-1-1,MATSUMOTO,NAGANO 390,JAPAN.							AGARWAL MK, 1980, FEBS LETT, V120, P1, DOI 10.1016/0014-5793(80)81031-3; FISZERSZAFARZ B, 1981, ANAL BIOCHEM, V110, P165, DOI 10.1016/0003-2697(81)90130-5; HEIKKILA RE, 1976, BIOCHEM PHARMACOL, V25, P1085, DOI 10.1016/0006-2952(76)90502-5; HOFFMANN ME, 1984, BIOCHIM BIOPHYS ACTA, V781, P234, DOI 10.1016/0167-4781(84)90088-5; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; OKAMOTO H, 1985, BIOESSAYS, V2, P15, DOI 10.1002/bies.950020106; Renold A.E., 1988, DIABETES ANN, P592; RERUP C C, 1970, Pharmacological Reviews, V22, P485; TAKASU N, 1989, J ENDOCRINOL, V120, P503, DOI 10.1677/joe.0.1200503; UCHIGATA Y, 1982, J BIOL CHEM, V257, P6084; YAMAMOTO H, 1981, BIOCHEM BIOPH RES CO, V103, P1014, DOI 10.1016/0006-291X(81)90910-4; YAMAMOTO H, 1981, NATURE, V294, P284, DOI 10.1038/294284a0	12	76	78	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2112	2114						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989973				2022-12-25	WOS:A1991EV51500018
J	PICKING, WD; ODOM, OW; TSALKOVA, T; SERDYUK, I; HARDESTY, B				PICKING, WD; ODOM, OW; TSALKOVA, T; SERDYUK, I; HARDESTY, B			THE CONFORMATION OF NASCENT POLYLYSINE AND POLYPHENYLALANINE PEPTIDES ON RIBOSOMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RIBOSOMES; BACILLUS-SUBTILIS; RIBONUCLEIC-ACIDS; BINDING-SITE; TRANSFER-RNA; ERYTHROMYCIN; SUBUNIT	Polypeptide synthesis using either phenylalanine or lysine was initiated on Escherichia coli ribosomes; then the position and conformation of the nascent peptide were monitored by fluorescence techniques. To this end, fluorophores had been attached to the amino terminus of each nascent peptide, and major differences were observed as chain extension occurred. Polyphenylalanine appeared to build up as a hydrophobic mass adjacent to the peptidyl transferase center while polylysine apparently was extended directly from the ribosome into the surrounding solution. An explanation for these differences may be provided by the physical and chemical properties of each polypeptide. These properties may be responsible for the route by which each peptide exits the peptidyl transferase center as demonstrated by the different sensitivity of each to inhibition by erythromycin.	UNIV TEXAS, DEPT CHEM & BIOCHEM, AUSTIN, TX 78712 USA; ACAD SCI USSR, INST PROT RES, PUSHCHINO, USSR; UNIV TEXAS, CLAYTON FDN RES, AUSTIN, TX 78712 USA	University of Texas System; University of Texas Austin; Russian Academy of Sciences; University of Texas System; University of Texas Austin								AREVALO MA, 1988, J BIOL CHEM, V263, P58; BERGEMANN K, 1983, J BIOL CHEM, V258, P5105; BERNABEU C, 1980, P NATL ACAD SCI USA, V77, P3111; BLOBEL G, 1970, J CELL BIOL, V45, P130, DOI 10.1083/jcb.45.1.130; HARDESTY B, 1971, METHOD ENZYMOL, V20, P316; HARTMAN R, 1974, J MOL BIOL, V90, P415, DOI 10.1016/0022-2836(74)90225-3; JOHNSON AE, 1976, BIOCHEMISTRY-US, V15, P569, DOI 10.1021/bi00648a018; KRAMER GA, 1975, EUR J BIOCHEM, V53, P471, DOI 10.1111/j.1432-1033.1975.tb04088.x; LIM VI, 1986, J MOL BIOL, V188, P565, DOI 10.1016/S0022-2836(86)80006-7; MALKIN LI, 1967, J MOL BIOL, V26, P329, DOI 10.1016/0022-2836(67)90301-4; ODOM OW, 1988, METHOD ENZYMOL, V164, P174; ODOM OW, 1984, BIOCHEMISTRY-US, V23, P5069, DOI 10.1021/bi00316a037; ODOM OW, 1980, BIOCHEMISTRY-US, V19, P5947, DOI 10.1021/bi00567a001; OTAKA T, 1975, P NATL ACAD SCI USA, V72, P2649, DOI 10.1073/pnas.72.7.2649; Rappoport S, 1974, Methods Enzymol, V29, P685; RYABOVA LA, 1988, FEBS LETT, V226, P255, DOI 10.1016/0014-5793(88)81434-0; RYCHLIK W, 1983, BIOCHEMISTRY-US, V22, P85, DOI 10.1021/bi00270a012; SHARP PM, 1988, NUCLEIC ACIDS RES, V16, P8207, DOI 10.1093/nar/16.17.8207; SMITH WP, 1978, P NATL ACAD SCI USA, V75, P5922, DOI 10.1073/pnas.75.12.5922; TAI PC, 1974, BIOCHEMISTRY-US, V13, P4653, DOI 10.1021/bi00719a029; VASQUEZ D, 1979, MOL BIOL BIOCH BIOPH, V30, P1; VAZQUEZ D, 1966, BIOCHIM BIOPHYS ACTA, V114, P289, DOI 10.1016/0005-2787(66)90310-8; VINCE R, 1976, ANTIMICROB AGENTS CH, V9, P131, DOI 10.1128/AAC.9.1.131; WURMBACH P, 1979, P NATL ACAD SCI USA, V76, P2143, DOI 10.1073/pnas.76.5.2143; YONATH A, 1987, SCIENCE, V236, P813, DOI 10.1126/science.3576200	25	29	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1534	1542						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1988435				2022-12-25	WOS:A1991EU49700030
J	ROUQUIER, S; VERDIER, JM; IOVANNA, J; DAGORN, JC; GIORGI, D				ROUQUIER, S; VERDIER, JM; IOVANNA, J; DAGORN, JC; GIORGI, D			RAT PANCREATIC STONE PROTEIN MESSENGER-RNA - ABUNDANT EXPRESSION IN MATURE EXOCRINE CELLS, REGULATION BY FOOD CONTENT, AND SEQUENCE IDENTITY WITH THE ENDOCRINE REG TRANSCRIPT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC CALCIFYING PANCREATITIS; GEL-ELECTROPHORESIS; CRYSTAL-GROWTH; HYBRIDIZATION; PURIFICATION; SIMILARITY; INHIBITORS; JUICE	We used a cDNA encoding the human pancreatic stone protein (PSP-S), the secretory inhibitor of CaCO3 crystal growth, as a probe for cloning rat PSP-S mesenger RNA. Overlapping clones gave a mRNA sequence of 783 nucleotides encoding a preprotein of 165 amino acids including a prepeptide of 21 amino acids. Rat and human PSP-S showed 70% identity, and the mature proteins had the same length. PSP-S mRNA concentration was measured in the pancreas of rats adapted to diets containing 15, 25, or 70% protein. Compared with the 15% protein diet, concentration increased 3 and 12 times with the diets with 25 and 70% protein, respectively, which is 3 times higher than for serine proteases. A complete sequence identity was observed between the rat PSP-S transcript and the reg mRNA described by Terazono et al. (Terazono, K., Yamamoto, H., Takasawa, S., Shiga, K., Yonemura, Y., Tochino, Y., and Okamoto, H. (1988) J. Biol. Chem. 263, 2111-2114), which is expressed in regenerating pancreatic islets but not in mature islets. A specific role of the reg protein in islet regeneration was suggested. We found that PSP-S (reg) mRNA concentration was indeed increased in isolated regenerating islets. Yet, a transient increase was also observed in exocrine tissue during the initial phase of regeneration following pancreatectomy or acute pancreatitis, suggesting increased expression during cell dedifferentiation. It is concluded that, in mature pancreas, expression of the reg/PSP-S gene occurs primarily in acinar cells. The gene product, which encodes a secretory protein inhibiting CaCO3 crystal growth in juice, is unlikely to play a specific role in islet regeneration.	INSERM, U315, 46 BLVD GAYE, F-13258 MARSEILLE 09, FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm)			Iovanna, Juan/M-9805-2017	Iovanna, Juan/0000-0003-1822-2237; VERDIER, Jean-Michel/0000-0002-7252-1556				ADRICH Z, 1989, COMP BIOCHEM PHYS B, V93, P793, DOI 10.1016/0305-0491(89)90047-3; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BAILEY JM, 1976, ANAL BIOCHEM, V70, P75, DOI 10.1016/S0003-2697(76)80049-8; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BERNARD JP, 1991, IN PRESS PANCREAS; CALVO EL, 1991, IN PRESS PANCREAS; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DECARO A, 1988, BIOCHIMIE, V70, P1209, DOI 10.1016/0300-9084(88)90186-1; Elsasser H P, 1986, Pancreas, V1, P421, DOI 10.1097/00006676-198609000-00006; FEINBERG A, 1908, ANAL BIOCHEM, V132, P6; FOGLIA V. G., 1947, REV SOC ARGENTINA BIOL, V23, P107; GEROLAMI A, 1989, GASTROENTEROLOGY, V96, P881; GIORGI D, 1985, BIOCHEM BIOPH RES CO, V127, P937, DOI 10.1016/S0006-291X(85)80034-6; GIORGI D, 1984, EMBO J, V3, P1521, DOI 10.1002/j.1460-2075.1984.tb02005.x; GIORGI D, 1989, J CLIN INVEST, V84, P100, DOI 10.1172/JCI114128; GOAD WB, 1982, NUCLEIC ACIDS RES, V10, P247, DOI 10.1093/nar/10.1.247; HAY DI, 1979, INORG PERSPECT BIOL, V2, P271; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; LANKISCH PG, 1974, SCAND J GASTROENTERO, V9, P725; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; MACDONALD RJ, 1980, NATURE, V287, P117, DOI 10.1038/287117a0; MONTALTO G, 1986, BIOCHEM J, V238, P227, DOI 10.1042/bj2380227; MULTIGNER L, 1987, DIGESTION, V38, P43; MULTIGNER L, 1985, GASTROENTEROLOGY, V89, P387, DOI 10.1016/0016-5085(85)90341-5; NAKAGAWA Y, 1983, J BIOL CHEM, V258, P2594; PICTET RL, 1972, DEV BIOL, V29, P436, DOI 10.1016/0012-1606(72)90083-8; PROVANSALCHEYLAN M, 1989, PANCREAS, V4, P680, DOI 10.1097/00006676-198912000-00005; REBOUD JP, 1962, BIOCHIM BIOPHYS ACTA, V58, P326, DOI 10.1016/0006-3002(62)91016-8; ROUQUIER S, 1989, BIOCHEM J, V264, P621, DOI 10.1042/bj2640621; SANGER F, 1977, P NATL ACAD SCI USA, V80, P726; SARLES H, 1973, DIGESTION, V9, P389, DOI 10.1159/000197468; SARLES H, 1974, GASTROENTEROLOGY, V66, P604, DOI 10.1016/s0016-5085(74)80050-8; STEWART TA, 1989, BIOCHEM J, V260, P622, DOI 10.1042/bj2600622; TERAZONO K, 1988, J BIOL CHEM, V263, P2111; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; ULLRICH A, 1977, SCIENCE, V196, P1313, DOI 10.1126/science.325648; WATANABE T, 1990, J BIOL CHEM, V265, P7432; WHITE BA, 1982, J BIOL CHEM, V257, P8569; YONEMURA Y, 1984, DIABETES, V33, P401, DOI 10.2337/diabetes.33.4.401	40	61	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					786	791						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985964				2022-12-25	WOS:A1991ET17700020
J	BEYER, WF; FRIDOVICH, I				BEYER, WF; FRIDOVICH, I			INVIVO COMPETITION BETWEEN IRON AND MANGANESE FOR OCCUPANCY OF THE ACTIVE-SITE REGION OF THE MANGANESE-SUPEROXIDE DISMUTASE OF ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SEQUENCE; BACTEROIDES-FRAGILIS; STREPTOCOCCUS-MUTANS; ANAEROBIC INDUCTION; CIRCULAR-DICHROISM; CONTAINING ENZYME; 2.4-A RESOLUTION; PROTEIN; ZINC; RECONSTITUTION	Three forms of the dimeric manganese superoxide dismutase (MnSOD) were isolated from aerobically grown Escherichia coli which contained 2 Mn, 1 Mn and 1 Fe, or 2 Fe, respectively. These are designated Mn2-MnSOD, Mn,Fe-MnSOD, and Fe2-MnSOD. Substitution of iron in place of manganese, eliminated catalytic activity, decreased the isoelectric point, and increased the native electrophoretic anodic mobility, although circular dichroism, high performance liquid chromatography gel exclusion chromatography, and sedimentation equilibrium revealed no gross changes in conformation. Moreover, replacement of iron by manganese restored enzymatic activity. Fe2-MnSOD and the iron-superoxide (FeSOD) of E. coli exhibit distinct optical absorption spectra. These data indicate that the active site environments of E. coli MnSOD and FeSOD must differ. They also indicate that competition between iron and manganese for nascent MnSOD polypeptide chains occurs in vivo, and copurification of these variably substituted MnSODs can explain the substoichiometric manganese contents and the variable specific activities which have been reported for this enzyme.			BEYER, WF (corresponding author), DUKE UNIV, MED CTR, DEPT BIOCHEM, DURHAM, NC 27710 USA.							AMANO A, 1990, J BACTERIOL, V172, P1457, DOI 10.1128/jb.172.3.1457-1463.1990; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BEYER WF, 1989, BIOCHEMISTRY-US, V28, P4403, DOI 10.1021/bi00436a042; BEYER WF, 1987, BIOCHEMISTRY-US, V26, P1251, DOI 10.1021/bi00379a008; BJERRUM MJ, 1987, BIOCHIM BIOPHYS ACTA, V915, P225, DOI 10.1016/0167-4838(87)90304-9; BORDERS CL, 1989, ARCH BIOCHEM BIOPHYS, V268, P74, DOI 10.1016/0003-9861(89)90566-3; BRITTON L, 1978, ARCH BIOCHEM BIOPHYS, V191, P198, DOI 10.1016/0003-9861(78)90082-6; CARLIOZ A, 1988, J BIOL CHEM, V263, P1555; CHAN VWF, 1990, ARCH BIOCHEM BIOPHYS, V279, P195, DOI 10.1016/0003-9861(90)90481-D; CHEN YH, 1971, BIOCHEM BIOPH RES CO, V44, P1285, DOI 10.1016/S0006-291X(71)80225-5; CLARE DA, 1984, J BIOL CHEM, V259, P5932; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; DIGUISEPPI J, 1984, CRC CR REV TOXICOL, V12, P315, DOI 10.3109/10408448409044213; DOOLEY DM, 1986, INORG CHEM, V25, P4761, DOI 10.1021/ic00246a035; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GOODIN DB, 1983, THESIS U CALIFORNIA; GREGORY EM, 1985, ARCH BIOCHEM BIOPHYS, V238, P83, DOI 10.1016/0003-9861(85)90143-2; GREGORY EM, 1983, ARCH BIOCHEM BIOPHYS, V220, P293, DOI 10.1016/0003-9861(83)90413-7; HASSAN HM, 1987, J BIOL CHEM, V262, P17173; KEELE BB, 1970, J BIOL CHEM, V245, P6176; KELLER C, 1975, MTP INT REV SCIENC 2, V7, P1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWRENCE GD, 1979, BIOCHEMISTRY-US, V18, P3045, DOI 10.1021/bi00581a021; LEGENDRE N, 1988, BIOTECHNIQUES, V6, P154; MARTIN ME, 1986, J BIOL CHEM, V261, P9361; MARTIN ME, 1984, J BACTERIOL, V159, P745, DOI 10.1128/JB.159.2.745-749.1984; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; McCord JM, 1977, SUPEROXIDE SUPEROXID, P129; MEIER B, 1982, J BIOL CHEM, V257, P3977; MOODY CS, 1984, J BIOL CHEM, V259, P2821; OSE DE, 1976, J BIOL CHEM, V251, P1217; OSE DE, 1979, ARCH BIOCHEM BIOPHYS, V194, P360, DOI 10.1016/0003-9861(79)90628-3; OZOLS J, 1990, METHOD ENZYMOL, V182, P587; PARKER MW, 1988, FEBS LETT, V229, P377, DOI 10.1016/0014-5793(88)81160-8; PARKER MW, 1988, J MOL BIOL, V199, P649, DOI 10.1016/0022-2836(88)90308-7; PENNINGTON CD, 1986, J BACTERIOL, V166, P528, DOI 10.1128/jb.166.2.528-532.1986; PRIVALLE CT, 1988, J BIOL CHEM, V263, P4274; PRIVALLE CT, 1989, J BIOL CHEM, V264, P2758; PUGH SYR, 1985, J BACTERIOL, V162, P196, DOI 10.1128/JB.162.1.196-202.1985; RINGE D, 1983, P NATL ACAD SCI-BIOL, V80, P3879, DOI 10.1073/pnas.80.13.3879; SCHININA ME, 1987, FEBS LETT, V221, P87, DOI 10.1016/0014-5793(87)80357-5; SLYKHOUSE TO, 1976, J BIOL CHEM, V251, P5472; STALLINGS WC, 1983, P NATL ACAD SCI-BIOL, V80, P3884, DOI 10.1073/pnas.80.13.3884; STALLINGS WC, 1985, J BIOL CHEM, V260, P6424; STALLINGS WC, 1984, J BIOL CHEM, V259, P695; STEINMAN HM, 1978, J BIOL CHEM, V253, P8708; TAKEDA Y, 1986, NUCLEIC ACIDS RES, V14, P4577, DOI 10.1093/nar/14.11.4577; TWILFER H, 1980, CHEM BIOCH ASPECTS S, P168; VILLAFRANCA JJ, 1976, FEBS LETT, V62, P230, DOI 10.1016/0014-5793(76)80059-2; YAMAKURA F, 1980, J BIOCHEM-TOKYO, V88, P191; YANG JT, 1986, METHOD ENZYMOL, V130, P208; YOST FJ, 1973, J BIOL CHEM, V248, P4905; GEL FILTRATION THEOR, P32	54	109	111	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					303	308						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985901				2022-12-25	WOS:A1991EQ33900045
J	HIRST, MC; PORTEOUS, DJ				HIRST, MC; PORTEOUS, DJ			MOLECULAR-CLONING OF A REARRANGED HRAS1 ONCOGENE IN CHROMOSOME MEDIATED GENE-TRANSFER ASSOCIATED WITH ELEVATED TUMORIGENICITY	ONCOGENE			English	Note							DNA-SEQUENCE ANALYSIS; TELOMERIC DNA; HAMSTER-CELLS; TUMOR DNAS; APRT LOCUS; BCR GENE; TRANSLOCATION; FRAGMENTS; REPEAT; UNIQUE	We describe the molecular cloning of the rearranged HRASI oncogene found in association with the increased tumorigenic potential of the chromosome mediated gene transfectant E65.5. The rearrangement occurs immediately 3' to the c-Ha-ras coding region, removing the variable numbered tandem repeat (VNTR) but not altering the HRASI transcription unit. The novel 3' DNA sequence contains a short open reading frame but shows no homology to any previously cloned elements. Sequence analysis identifies a number of short DNA motifs consistent with the activity of an aberrant recombinogenic mechanism.	WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND	University of Edinburgh			Porteous, David/AAA-3446-2021; Porteous, David J/C-7289-2013	Porteous, David/0000-0003-1249-6106; Porteous, David J/0000-0003-1249-6106; Hirst, Mark/0000-0003-3851-9740				ALLSHIRE RC, 1988, NATURE, V332, P656, DOI 10.1038/332656a0; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BICKMORE W, 1988, NUCLEIC ACIDS RES, V16, P51, DOI 10.1093/nar/16.1.51; BISHOP JM, 1986, TRENDS GENET, V1, P245; BODRUG SE, 1987, SCIENCE, V237, P1620, DOI 10.1126/science.3629260; BOEHM T, 1988, EMBO J, V7, P385, DOI 10.1002/j.1460-2075.1988.tb02825.x; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; DEININGER PL, 1981, J MOL BIOL, V151, P17, DOI 10.1016/0022-2836(81)90219-9; DEKLEIN A, 1986, NUCLEIC ACIDS RES, V14, P7071, DOI 10.1093/nar/14.17.7071; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRISCHAUF AM, 1983, J MOL BIOL, V170, P827, DOI 10.1016/S0022-2836(83)80190-9; GOSDEN JR, 1987, CYTOGENET CELL GENET, V45, P44, DOI 10.1159/000132429; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; HEISTERKAMP N, 1985, NATURE, V317, P559, DOI 10.1038/317559b0; HELMS C, 1985, DNA-J MOLEC CELL BIO, V4, P39, DOI 10.1089/dna.1985.4.39; HENDERSON E, 1987, CELL, V51, P899, DOI 10.1016/0092-8674(87)90577-0; HOPE TJ, 1986, SCIENCE, V231, P1141, DOI 10.1126/science.3003919; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KRONTIRIS TG, 1981, P NATL ACAD SCI-BIOL, V78, P1181, DOI 10.1073/pnas.78.2.1181; KRONTIRIS TG, 1985, NATURE, V313, P369, DOI 10.1038/313369a0; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573; Maniatis T., 1982, MOL CLONING; MORTEN JEN, 1987, ANTICANCER RES, V7, P573; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NALBANTOGLU J, 1988, J MOL BIOL, V200, P449, DOI 10.1016/0022-2836(88)90535-9; NALBANTOGLU J, 1987, MOL CELL BIOL, V7, P1445, DOI 10.1128/MCB.7.4.1445; PICOLLI SP, 1984, NATURE, V310, P327; PORTEOUS DJ, 1985, SOMAT CELL MOLEC GEN, V11, P445, DOI 10.1007/BF01534838; PORTEOUS DJ, 1986, INT J CANCER, V38, P603, DOI 10.1002/ijc.2910380422; PORTEOUS DJ, 1906, MOL CELL BIOL, V6, P2223; ROGERS J, 1985, NATURE, V317, P559, DOI 10.1038/317559a0; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; SHIH C, 1981, NATURE, V290, P261, DOI 10.1038/290261a0; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; SHUANGYOUNG X, 1986, GENE ANAL TECH, V3, P90; STEINMETZ M, 1986, CELL, V44, P895, DOI 10.1016/0092-8674(86)90012-7; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; VANDERFELTZ MJM, 1989, NUCLEIC ACIDS RES, V17, P1, DOI 10.1093/nar/17.1.1; VANIN EF, 1983, CELL, V35, P701, DOI 10.1016/0092-8674(83)90103-4; VARMUS HE, 1984, ANNU REV GENET, V18, P553; VIERA J, 1982, GENE, V19, P259; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7; WYMAN AR, 1985, P NATL ACAD SCI USA, V82, P2880, DOI 10.1073/pnas.82.9.2880	47	3	3	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1991	6	1					153	157						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY039	1992442				2022-12-25	WOS:A1991EY03900022
J	KIDO, H; FUKUTOMI, A; KATUNUMA, N				KIDO, H; FUKUTOMI, A; KATUNUMA, N			A NOVEL MEMBRANE-BOUND SERINE ESTERASE IN HUMAN LYMPHOCYTES-T4+ IMMUNOLOGICALLY REACTIVE WITH ANTIBODY INHIBITING SYNCYTIA INDUCED BY HIV-1 - PURIFICATION AND CHARACTERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV TOKUSHIMA,INST ENZYME RES,DIV ENZYME CHEM,TOKUSHIMA 770,JAPAN	Tokushima University								AUERSWALD EA, 1988, BIOL CHEM H-S, V369, P27; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; FRUTH U, 1987, EUR J IMMUNOL, V17, P1625, DOI 10.1002/eji.1830171116; GEBHARD W, 1988, BIOL CHEM H-S, V369, P19; GERSHENFELD HK, 1988, P NATL ACAD SCI USA, V85, P1184, DOI 10.1073/pnas.85.4.1184; GOUDSMIT J, 1988, P NATL ACAD SCI USA, V85, P4478, DOI 10.1073/pnas.85.12.4478; GURGO C, 1988, VIROLOGY, V164, P531, DOI 10.1016/0042-6822(88)90568-5; HATTORI T, 1989, FEBS LETT, V248, P48, DOI 10.1016/0014-5793(89)80429-6; HILDRETH JEK, 1989, SCIENCE, V244, P1075, DOI 10.1126/science.2543075; HILLMAN K, 1990, J IMMUNOL, V144, P2131; HOLMES KL, 1985, P NATL ACAD SCI USA, V82, P7706, DOI 10.1073/pnas.82.22.7706; HOMSY J, 1989, SCIENCE, V244, P1357, DOI 10.1126/science.2786647; KATUNUMA N, 1975, EUR J BIOCHEM, V52, P37, DOI 10.1111/j.1432-1033.1975.tb03970.x; KATUNUMA N, 1988, J CELL BIOCHEM, V38, P291, DOI 10.1002/jcb.240380408; KIDO H, 1988, J BIOL CHEM, V263, P18104; KIDO H, 1985, ARCH BIOCHEM BIOPHYS, V239, P436, DOI 10.1016/0003-9861(85)90709-X; KIKUKAWA R, 1986, J VIROL, V57, P1159, DOI 10.1128/JVI.57.3.1159-1162.1986; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; Koito A, 1989, Int Immunol, V1, P613, DOI 10.1093/intimm/1.6.613; KRAHENBUHL O, 1988, J IMMUNOL, V141, P3471; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LERNMARK A, 1976, J CELL BIOL, V71, P606, DOI 10.1083/jcb.71.2.606; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; MASSON D, 1987, CELL, V49, P679, DOI 10.1016/0092-8674(87)90544-7; MATSUSHITA S, 1988, J VIROL, V62, P2107, DOI 10.1128/JVI.62.6.2107-2114.1988; MCDOUGAL JS, 1986, SCIENCE, V231, P382, DOI 10.1126/science.3001934; MCKEATING JA, 1990, NATURE, V343, P659, DOI 10.1038/343659a0; MILSOM DW, 1972, BIOCHEM J, V128, P331, DOI 10.1042/bj1280331; PALKER TJ, 1988, P NATL ACAD SCI USA, V85, P1932, DOI 10.1073/pnas.85.6.1932; PASTERNACK MS, 1985, NATURE, V314, P743, DOI 10.1038/314743a0; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; RICE RH, 1971, J BIOL CHEM, V246, P831; RUSCHE JR, 1988, P NATL ACAD SCI USA, V85, P3198, DOI 10.1073/pnas.85.9.3198; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Strobel H W, 1978, Methods Enzymol, V52, P89; VALENTIN A, 1990, J IMMUNOL, V144, P934; WACHTER E, 1981, H-S Z PHYSIOL CHEM, V362, P1351, DOI 10.1515/bchm2.1981.362.2.1351; Wharton DC., 1967, METHOD ENZYMOL, P245; WILLEY RL, 1986, P NATL ACAD SCI USA, V83, P5038, DOI 10.1073/pnas.83.14.5038; YOUNG JDE, 1986, CELL, V47, P183, DOI 10.1016/0092-8674(86)90441-1; [No title captured]	42	69	73	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1990	265	35					21979	21985						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM456	1979328				2022-12-25	WOS:A1990EM45600091
J	YAMAGUCHI, M; RUTLEDGE, LJ; GARBERS, DL				YAMAGUCHI, M; RUTLEDGE, LJ; GARBERS, DL			THE PRIMARY STRUCTURE OF THE RAT GUANYLYL CYCLASE-A ATRIAL-NATRIURETIC-PEPTIDE RECEPTOR GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									VANDERBILT UNIV, MED CTR, SCH MED, DEPT PHARMACOL, NASHVILLE, TN 37232 USA; VANDERBILT UNIV, MED CTR, SCH MED, DEPT MOLEC PHYSIOL & BIOPHYS, NASHVILLE, TN 37232 USA	Vanderbilt University; Vanderbilt University	YAMAGUCHI, M (corresponding author), VANDERBILT UNIV, MED CTR, SCH MED, HOWARD HUGHES MED INST, NASHVILLE, TN 37232 USA.							ANANDSRIVASTAVA MB, 1990, J BIOL CHEM, V265, P8566; ANANDSRIVASTAVA MB, 1987, J BIOL CHEM, V262, P4931; ANDERSON SK, 1985, MOL CELL BIOL, V5, P1122, DOI 10.1128/MCB.5.5.1122; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; CHANG M, 1989, NATURE, V341, P68, DOI 10.1038/341068a0; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; CHINKERS M, 1989, SCIENCE, V245, P1392, DOI 10.1126/science.2571188; CHRIVIA JC, 1988, J BIOL CHEM, V263, P5739; COLLINS J, 1980, COLD SPRING HARB SYM, V45, P409, DOI 10.1101/SQB.1981.045.01.055; CROSS M, 1990, EMBO J, V9, P1283, DOI 10.1002/j.1460-2075.1990.tb08237.x; DORN A, 1987, P NATL ACAD SCI USA, V84, P6249, DOI 10.1073/pnas.84.17.6249; FULLER F, 1988, J BIOL CHEM, V263, P9395; GARBERS DL, 1989, ANNU REV BIOCHEM, V58, P719, DOI 10.1146/annurev.bi.58.070189.003443; GLAICHENHAUS N, 1987, CELL, V50, P1081, DOI 10.1016/0092-8674(87)90174-7; HIRATA M, 1989, BIOCHIM BIOPHYS ACTA, V1010, P346, DOI 10.1016/0167-4889(89)90060-8; INAGAMI T, 1989, J BIOL CHEM, V264, P3043; KARIYA Y, 1987, GENE, V53, P1, DOI 10.1016/0378-1119(87)90087-4; KIMURA H, 1975, P NATL ACAD SCI USA, V72, P1965, DOI 10.1073/pnas.72.5.1965; KOESLING D, 1990, FEBS LETT, V266, P128, DOI 10.1016/0014-5793(90)81523-Q; KOESLING D, 1988, FEBS LETT, V239, P29, DOI 10.1016/0014-5793(88)80539-8; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; LIU B, 1989, BIOCHEMISTRY-US, V28, P5599, DOI 10.1021/bi00439a039; LOWE DG, 1989, EMBO J, V8, P1377, DOI 10.1002/j.1460-2075.1989.tb03518.x; LOWE DG, 1990, IN PRESS GENOMICS; MAACK T, 1987, SCIENCE, V238, P675, DOI 10.1126/science.2823385; MATSUSHIME H, 1986, MOL CELL BIOL, V6, P3000, DOI 10.1128/MCB.6.8.3000; MCKNIGHT S, 1986, CELL, V46, P795, DOI 10.1016/0092-8674(86)90061-9; MCKNIGHT SL, 1982, SCIENCE, V217, P316, DOI 10.1126/science.6283634; NAKANE M, 1988, BIOCHEM BIOPH RES CO, V157, P1139, DOI 10.1016/S0006-291X(88)80992-6; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; SCHULZ S, 1989, CELL, V58, P1155, DOI 10.1016/0092-8674(89)90513-8; SEINO S, 1989, P NATL ACAD SCI USA, V86, P114, DOI 10.1073/pnas.86.1.114; SEMBA K, 1985, P NATL ACAD SCI USA, V82, P6497, DOI 10.1073/pnas.82.19.6497; SHIMOMURA H, 1986, J BIOL CHEM, V261, P5778; SINGH S, 1988, NATURE, V334, P708, DOI 10.1038/334708a0; SMALE ST, 1990, P NATL ACAD SCI USA, V87, P4509, DOI 10.1073/pnas.87.12.4509; THORPE DS, 1989, J BIOL CHEM, V264, P6545; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027; ULLU E, 1984, NATURE, V312, P171, DOI 10.1038/312171a0	40	76	79	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1990	265	33					20414	20420						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ525	1978722				2022-12-25	WOS:A1990EJ52500058
J	GIRARD, TJ; EDDY, R; WESSELSCHMIDT, RL; MACPHAIL, LA; LIKERT, KM; BYERS, MG; SHOWS, TB; BROZE, GJ				GIRARD, TJ; EDDY, R; WESSELSCHMIDT, RL; MACPHAIL, LA; LIKERT, KM; BYERS, MG; SHOWS, TB; BROZE, GJ			STRUCTURE OF THE HUMAN LIPOPROTEIN-ASSOCIATED COAGULATION INHIBITOR GENE - INTRO EXON GENE ORGANIZATION AND LOCALIZATION OF THE GENE TO CHROMOSOME-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE FACTOR; FACTOR-VII; EXTRINSIC PATHWAY; FACTOR-XA; INSITU HYBRIDIZATION; BINDING-PROTEIN; HUMAN GENOME; FACTOR-IX; ACTIVATION; DNA	Lipoprotein-associated coagulation inhibitor (LACI) is a multivalent, Kunitz-type proteinase inhibitor which appears to play an important role in the regulation of hemostasis. LACI directly inhibits factor Xa, and, in a Xa-dependent fashion, also inhibits the factor VIIa-tissue factor catalytic complex. Hybridization of a LACI cDNA probe to DNA isolated from a panel of human-mouse somatic cell hybrids containing different human chromosomes localized the human LACI gene to chromosome 2. In situ hybridization to metaphase chromosomes further mapped the gene to the region 2q31 --> 2q32.1. Exons of the human LACI gene were cloned from genomic or chromosome 2-specific phage libraries and sequenced, including approximately 500 base pairs of 5' upstream DNA. The 5' DNA did not contain a prototypical TATAA box or CCAAT sequence, and attempts to identify a unique site for the initiation of transcription were unsuccessful in that primer extension and S1 nuclease protection analysis indicate multiple transcription initiation sites for LACI messages. Comparing the gene sequence with LACI cDNA sequences indicates that the gene contains nine exons and that alternative splicing can occur, resulting in the absence of exon 2 in the 5' untranslated region of some messages. The three Kunitz domains in LACI are encoded on separate exons. Introns which interrupt coding sequences all occur in the same codon phase interrupting the first and second bases of the codon triplets. The data are consistent with LACI evolving by a combination of gene segment duplications and exon shuffling.	WASHINGTON UNIV,JEWISH HOSP ST LOUIS,MED CTR,DIV HEMATOL ONCOL,216 S KINGSHIGHWAY,ST LOUIS,MO 63110; NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT HUMAN GENET,BUFFALO,NY 14263	Barnes-Jewish Hospital; Washington University (WUSTL); Roswell Park Cancer Institute					NHLBI NIH HHS [HL 34462] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034462] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BOORSTEIN WR, 1989, METHOD ENZYMOL, V65, P357; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BROZE GJ, 1980, J BIOL CHEM, V255, P1242; BROZE GJ, 1988, BLOOD, V71, P335; BROZE GJ, 1987, BLOOD, V69, P150; CARSON SD, 1981, FEBS LETT, V132, P37, DOI 10.1016/0014-5793(81)80422-X; CORDEN J, 1980, SCIENCE, V209, P1406, DOI 10.1126/science.6251548; CREIGHTON TE, 1987, J MOL BIOL, V194, P11, DOI 10.1016/0022-2836(87)90711-X; DURAND DB, 1988, MOL CELL BIOL, V8, P1715, DOI 10.1128/MCB.8.4.1715; GIRARD TJ, 1989, THROMB RES, V55, P37, DOI 10.1016/0049-3848(89)90454-4; GIRARD TJ, 1989, NATURE, V338, P518, DOI 10.1038/338518a0; HOHN PA, 1989, J BIOL CHEM, V264, P13412; HUBBARD AR, 1987, THROMB RES, V46, P527, DOI 10.1016/0049-3848(87)90154-X; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KINGSTON IB, 1986, BIOCHEM J, V233, P443, DOI 10.1042/bj2330443; LEE W, 1987, NATURE, V325, P368, DOI 10.1038/325368a0; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MYERS RM, 1986, SCIENCE, V232, P613, DOI 10.1126/science.3457470; NAKAI H, 1986, CYTOGENET CELL GENET, V43, P215, DOI 10.1159/000132324; NAYLOR SL, 1983, J EXP MED, V57, P1020; NEMERSON Y, 1966, BIOCHEMISTRY-US, V5, P601, DOI 10.1021/bi00866a029; NOVOTNY WF, 1988, BLOOD, V72, P2020; NOVOTNY WF, 1989, J BIOL CHEM, V264, P18832; NOVOTNY WF, 1989, BLOOD S, V74, pA209; OSTERUD B, 1977, P NATL ACAD SCI USA, V74, P5260, DOI 10.1073/pnas.74.12.5260; RANA SV, 1988, BLOOD, V71, P259; RAPAPORT SI, 1989, BLOOD, V73, P359; SANDERS NL, 1985, BLOOD, V66, P204; SANDSET PM, 1988, THROMB RES, V50, P803, DOI 10.1016/0049-3848(88)90340-4; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; SHOWS T, 1984, SOMAT CELL MOLEC GEN, V10, P315, DOI 10.1007/BF01535253; SHOWS TB, 1983, ISOZYMES-CURR T BIOL, V10, P323; SHOWS TB, 1978, CYTOGENET CELL GENET, V21, P99, DOI 10.1159/000130882; SHOWS TB, 1982, ADV HUM GENET, V12, P341; SILVERBERG SA, 1977, J BIOL CHEM, V252, P8481; SINGH H, 1988, CELL, V52, P415, DOI 10.1016/S0092-8674(88)80034-5; VETR H, 1989, FEBS LETT, V245, P137, DOI 10.1016/0014-5793(89)80207-8; WARNCRAMER BJ, 1989, THROMB HAEMOSTASIS, V61, P101; WUN TC, 1988, J BIOL CHEM, V263, P6001; YOSHIKAI S, 1990, GENE, V87, P257, DOI 10.1016/0378-1119(90)90310-N; ZABEL BU, 1983, P NATL ACAD SCI-BIOL, V80, P6932, DOI 10.1073/pnas.80.22.6932; ZUR M, 1980, J BIOL CHEM, V255, P5703	45	63	68	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					5036	5041						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002045				2022-12-25	WOS:A1991FC21700055
J	KRAMER, RM; ROBERTS, EF; MANETTA, J; PUTNAM, JE				KRAMER, RM; ROBERTS, EF; MANETTA, J; PUTNAM, JE			THE CA2+-SENSITIVE CYTOSOLIC PHOSPHOLIPASE-A2 IS A 100-KDA PROTEIN IN HUMAN MONOBLAST U937 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PLATELET PHOSPHOLIPASE-A2; ARACHIDONIC-ACID; KINASE-C; ACTIVATING FACTOR; MESANGIAL CELLS; CALCIUM; IDENTIFICATION; DIACYLGLYCEROL; PURIFICATION; RELEASE	Human monoblast U937 cells contain a soluble phospholipase A2 (PLA2) that is activated over the range of 150-600 nM Ca2+ and is stable only at neutral pH. We have purified this PLA2 over 34,000-fold to near homogeneity using sequential ion exchange, hydrophobic interaction, and gel filtration chromatography steps. The protein has a M(r) of approximately 100,000 (by sodium dodecyl sulfate-polyacrylamide gel electrophoresis) and an isoelectric point of 5.1. Four lines of evidence indicate that this 100-kDa polypeptide represents the PLA2. (i) The intensity of staining of the 100-kDa protein was proportional to the degree of purification of PLA2 activity, (ii) the relative staining intensity of the 100-kDa protein precisely paralleled the elution profile of PLA2 activity during chromatography steps, (iii) the PLA2 activity recovered from a nondenaturing gel (> 60% of the total activity applied) coincided exactly with the major high molecular weight protein detected by silver staining, and (iv) monoclonal antibodies against the 100-kDa protein immunoprecipitated the PLA2. We conclude that the cytosolic PLA2 isolated from U937 cells represents a novel, high molecular weight PLA2 responding to physiological (intracellular) changes in Ca2+ concentration and therefore may play a critical role in cellular signal transduction processes and the biosynthesis of lipid mediators.			KRAMER, RM (corresponding author), ELI LILLY & CO, LILLY RES LAB, LILLY CORP CTR, BIOCHEM RES, INDIANAPOLIS, IN 46285 USA.							AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; AXELROD J, 1990, BIOCHEM SOC T, V18, P503, DOI 10.1042/bst0180503; BALSINDE J, 1990, J IMMUNOL, V144, P4298; BONVENTRE JV, 1988, J CLIN INVEST, V82, P168, DOI 10.1172/JCI113566; BROOKS RC, 1989, J BIOL CHEM, V264, P20147; BURCH RM, 1989, MOL NEUROBIOL, V3, P155, DOI 10.1007/BF02935629; BURCH RM, 1988, FEBS LETT, V234, P283, DOI 10.1016/0014-5793(88)80099-1; CLARK JD, 1990, P NATL ACAD SCI USA, V87, P7708, DOI 10.1073/pnas.87.19.7708; DENNIS EA, 1987, BIO-TECHNOL, V5, P1294, DOI 10.1038/nbt1287-1294; Dennis EA, 1983, ENZYMES, P307; DIEZ E, 1990, J BIOL CHEM, V265, P14654; GASSAMADIAGNE A, 1989, J BIOL CHEM, V264, P9470; Goding J., 1986, MONOCLONAL ANTIBODIE, P108; GRONICH JH, 1988, J BIOL CHEM, V263, P16645; HALENDA SP, 1989, BIOCHEMISTRY-US, V28, P7356, DOI 10.1021/bi00444a031; HAZEN SL, 1990, J BIOL CHEM, V265, P10622; IRVINE RF, 1982, BIOCHEM J, V204, P3, DOI 10.1042/bj2040003; Kramer R M, 1990, Adv Exp Med Biol, V275, P35; KRAMER RM, 1989, J BIOL CHEM, V264, P5768; KRAMER RM, 1991, METHOD ENZYMOL, V197, P373; KRAMER RM, 1987, BIOCHEM J, V248, P779, DOI 10.1042/bj2480779; KRAMER RM, 1988, BIOCHIM BIOPHYS ACTA, V959, P269, DOI 10.1016/0005-2760(88)90200-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LESLIE CC, 1988, BIOCHIM BIOPHYS ACTA, V963, P476, DOI 10.1016/0005-2760(88)90316-5; LOEB LA, 1986, J BIOL CHEM, V261, P467; PARKER J, 1987, J BIOL CHEM, V262, P5385; SNYDER F, 1989, P SOC EXP BIOL MED, V190, P125; SUGA K, 1990, J BIOL CHEM, V265, P12363; VANDENBOSCH H, 1980, BIOCHIM BIOPHYS ACTA, V604, P191; WAITE M, 1987, PHOSPHOLIPASES, P111; WIJKANDER J, 1989, FEBS LETT, V244, P51, DOI 10.1016/0014-5793(89)81160-3; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2	32	424	446	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					5268	5272						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002059				2022-12-25	WOS:A1991FC21700085
J	LEVEILLARD, T; KASSAVETIS, GA; GEIDUSCHEK, EP				LEVEILLARD, T; KASSAVETIS, GA; GEIDUSCHEK, EP			SACCHAROMYCES-CEREVISIAE TRANSCRIPTION FACTOR-IIIB AND FACTOR-IIIC BEND THE DNA OF A TRANSFER RNAGLN GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRATION HOST FACTOR; POLYMERASE-III; ELECTRON-MICROSCOPY; FACTOR-TAU; BINDING; COMPLEXES; ELECTROPHORESIS; REPRESSOR; OPERATOR; SITE	The ability of Saccharomyces cerevisiae transcription factors IIIC and IIIB to bend DNA at their binding sites in a tRNA(Gln) gene has been analyzed by two methods that are based on the anomalous electrophoretic mobility of bent DNA in a tight gel network. Both transcription factors bend DNA, TFIIIB more than TFIIIC. The effective centers of the transcription factor IIIB- and IIIC-induced bends are not in helical phase.	UNIV CALIF SAN DIEGO,CTR MOLEC GENET,LA JOLLA,CA 92093	University of California System; University of California San Diego	LEVEILLARD, T (corresponding author), UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093, USA.		Léveillard, Thierry/AAR-1804-2020	Léveillard, Thierry/0000-0001-5692-8770				BARTHOLOMEW B, 1990, EMBO J, V9, P2197, DOI 10.1002/j.1460-2075.1990.tb07389.x; BAZETTJONES DP, 1989, MOL CELL BIOL, V9, P336, DOI 10.1128/MCB.9.1.336; BEDROSIAN DL, 1990, VIROLOGY, V174, P557; BRAUN BR, 1989, P NATL ACAD SCI USA, V86, P2530, DOI 10.1073/pnas.86.8.2530; CROTHERS DM, 1991, IN PRESS METHODS ENZ; GABRIELSEN OS, 1989, J BIOL CHEM, V264, P7505; GARTENBERG MR, 1990, P NATL ACAD SCI USA, V87, P6034, DOI 10.1073/pnas.87.16.6034; GEIDUSCHEK EP, 1988, ANNU REV BIOCHEM, V57, P873, DOI 10.1146/annurev.bi.57.070188.004301; HATFULL GF, 1987, CELL, V49, P103, DOI 10.1016/0092-8674(87)90760-4; HOGAN ME, 1989, P NATL ACAD SCI USA, V86, P9273, DOI 10.1073/pnas.86.23.9273; KASSAVETIS GA, 1989, MOL CELL BIOL, V9, P2551, DOI 10.1128/MCB.9.6.2551; KASSAVETIS GA, 1990, CELL, V60, P235, DOI 10.1016/0092-8674(90)90739-2; KIM J, 1989, GENE, V85, P15, DOI 10.1016/0378-1119(89)90459-9; KLEKAMP MS, 1986, J BIOL CHEM, V261, P2819; KOO HS, 1990, BIOCHEMISTRY-US, V29, P4227, DOI 10.1021/bi00469a027; KOUDELKA GB, 1988, P NATL ACAD SCI USA, V85, P4633, DOI 10.1073/pnas.85.13.4633; LEVENE SD, 1989, SCIENCE, V245, P396, DOI 10.1126/science.2756426; LLOUBES R, 1988, J MOL BIOL, V204, P1049, DOI 10.1016/0022-2836(88)90062-9; LUMPKIN OJ, 1982, BIOPOLYMERS, V21, P2315, DOI 10.1002/bip.360211116; MOSKALUK C, 1988, P NATL ACAD SCI USA, V85, P1826, DOI 10.1073/pnas.85.6.1826; PARSONS MC, 1990, J BIOL CHEM, V265, P5095; PRENTKI P, 1987, NUCLEIC ACIDS RES, V15, P10060, DOI 10.1093/nar/15.23.10060; PRENTKI P, 1987, EMBO J, V6, P2479, DOI 10.1002/j.1460-2075.1987.tb02529.x; ROBERTSON CA, 1988, J BIOL CHEM, V263, P3554; ROJO F, 1990, J MOL BIOL, V211, P713, DOI 10.1016/0022-2836(90)90072-T; RUET A, 1984, EMBO J, V3, P343, DOI 10.1002/j.1460-2075.1984.tb01809.x; SCHROTH GP, 1989, NATURE, V340, P487, DOI 10.1038/340487a0; SCHULTZ P, 1989, EMBO J, V8, P3815, DOI 10.1002/j.1460-2075.1989.tb08559.x; SHARP SJ, 1985, CRC CR REV BIOCH MOL, V19, P107, DOI 10.3109/10409238509082541; STILLMAN DJ, 1985, J MOL BIOL, V185, P451, DOI 10.1016/0022-2836(85)90417-6; SUCK D, 1988, NATURE, V332, P464, DOI 10.1038/332464a0; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; TRAVERS AA, 1989, ANNU REV BIOCHEM, V58, P427, DOI 10.1146/annurev.biochem.58.1.427; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0; ZINKEL SS, 1987, NATURE, V328, P178, DOI 10.1038/328178a0; ZWIEB C, 1990, NUCLEIC ACIDS RES, V18, P583, DOI 10.1093/nar/18.3.583	36	49	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					5162	5168						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002052				2022-12-25	WOS:A1991FC21700072
J	WASHBURN, WN; DENNIS, EA				WASHBURN, WN; DENNIS, EA			SUICIDE-INHIBITORY BIFUNCTIONALLY LINKED SUBSTRATES (SIBLINKS) AS PHOSPHOLIPASE-A2 INHIBITORS - MECHANISTIC IMPLICATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORCINE PANCREATIC PHOSPHOLIPASE-A2; COBRA VENOM PHOSPHOLIPASE-A2; ACTIVATION; AGGREGATION; CATALYSIS	Novel phospholipids that function as mechanism-based inhibitors for phospholipase A2 (PLA2) are described. PLA2-catalyzed hydrolysis of the sn-2 ester of these suicide-inhibitory bifunctionally linked substrates (SIBLINKS) followed by a cyclization reaction generates a cyclic anhydride at the active site of the enzyme which leads to inhibition. Structure/activity relationships for the SIBLINKS substituents in the sn-1 and sn-2 position are delineated. Time courses and efficiency of SIBLINKS inhibition are reported and compared for extracellular PLA2s obtained from Naja naja naja, porcine pancreas, bee venom, Crotalus atrox and Crotalus adamanteus. SIBLINKS-inhibited PLA2s cannot process either monomeric or micellar substrates consistent with inhibition at the catalytic site. Some SIBLINKS efficiently inactivate 1 mol of N. naja naja and C. adamanteus PLA2/6-10 mol of SIBLINKS hydrolyzed. Inhibition of N. naja naja PLA2 can be reversed by hydroxylamine, suggesting that a tyrosine residue is acylated.			WASHBURN, WN (corresponding author), UNIV CALIF SAN DIEGO, DEPT CHEM, LA JOLLA, CA 92093 USA.		Dennis, Edward A./M-5554-2019	Dennis, Edward A./0000-0003-3738-3140				CHO WW, 1988, J BIOL CHEM, V263, P11237; DARKE P, 1982, THESIS U CALIF, P79; DAVIDSON FF, 1990, BIOCHIM BIOPHYS ACTA, V1037, P7, DOI 10.1016/0167-4838(90)90095-W; DEBOSE CD, 1985, BIOCHEMISTRY-US, V24, P1298, DOI 10.1021/bi00327a005; Deems R.A., 1981, Methods in Enzymology, V71, P703; DEEMS RA, 1975, J BIOL CHEM, V250, P9013; DENNIS EA, 1987, BIO-TECHNOL, V5, P1294, DOI 10.1038/nbt1287-1294; DENNIS EA, 1990, J MOL EVOL, V31, P228; Dennis EA, 1983, ENZYMES, P307; FIFE TH, 1965, J AM CHEM SOC, V87, P4597, DOI 10.1021/ja00948a035; HAZLETT TL, 1985, TOXICON, V23, P457, DOI 10.1016/0041-0101(85)90029-7; Heinrikson R.L., 1982, P131; HEINRIKSON RL, 1977, J BIOL CHEM, V252, P4913; JAIN MK, 1989, BIOCHIM BIOPHYS ACTA, V1002, P127, DOI 10.1016/0005-2760(89)90281-6; Kirby A.J., 1980, ADV PHYS ORG CHEM, V17, P183; MOBILIO D, 1989, ANNU REP MED CHEM, V24, P157; Nieuwenhuizen W, 1974, Methods Enzymol, V32, P147; PLUCKTHUN A, 1985, J BIOL CHEM, V260, P1099; ROBERTS MF, 1977, J BIOL CHEM, V252, P6011; ROBERTS MF, 1977, P NATL ACAD SCI USA, V74, P1950, DOI 10.1073/pnas.74.5.1950; ROMERO G, 1987, J BIOL CHEM, V262, P13476; Taft R.W., 1956, STERIC EFFECTS ORGAN, P591; TOMASSELLI AG, 1989, J BIOL CHEM, V264, P10041; WAITE M, 1987, PHOSPHOLIPASES, P155; WASHBURN WN, 1990, J AM CHEM SOC, V112, P2042, DOI 10.1021/ja00161a083; WASHBURN WN, 1990, J AM CHEM SOC, V112, P2040, DOI 10.1021/ja00161a082; WELLS MA, 1973, BIOCHEMISTRY-US, V12, P108; WILSON IB, 1950, J BIOL CHEM, V186, P781	28	19	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					5042	5048						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002046				2022-12-25	WOS:A1991FC21700056
J	WILLIAMS, WV; KIEBEREMMONS, T; VONFELDT, J; GREENE, MI; WEINER, DB				WILLIAMS, WV; KIEBEREMMONS, T; VONFELDT, J; GREENE, MI; WEINER, DB			DESIGN OF BIOACTIVE PEPTIDES BASED ON ANTIBODY HYPERVARIABLE REGION STRUCTURES - DEVELOPMENT OF CONFORMATIONALLY CONSTRAINED AND DIMERIC PEPTIDES WITH ENHANCED AFFINITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL STRUCTURE; MAMMALIAN REOVIRUS; ANTIGEN COMPLEX; CELL RECEPTORS; BINDING; NEURAMINIDASE; ATTACHMENT; INHIBITION; SEQUENCE; IDIOTYPE	The variable regions of antibody molecules bind antigens with high affinity and specificity. This binding is imparted largely by the hypervariable portions of the variable region. Hypervariable regions typically fold into reverse turn or loop structures. Peptides derived from antibody hypervariable region sequences can bind antigens with similar specificity, albeit with markedly lower affinity. In this study, cyclic and dimeric peptide analogs of an anti-idiotypic/antireceptor antibody hypervariable region were developed. This antibody (87.92.6) binds to reovirus type 3 receptors on cells as well as to a neutralizing anti-reovirus type 3 monoclonal antibody (9B.G5). The cyclic peptides were utilized to probe the optimal conformation for binding to both the receptor and 9B.G5. By dimerizing or constraining the conformation of these peptides, higher affinity binding was produced. By utilizing several different cyclic peptides, the optimal conformation for binding was established. The conformationally optimized cyclic peptide possessed > 40-fold higher affinity for the receptor and the idiotype than the linear analog. This study suggests that conformationally constrained and dimeric peptides derived from antibody hypervariable loop sequences can bind antigens (including receptors) with reasonable affinity.	UNIV PENN, SCH MED, DEPT PATHOL & LAB MED, PHILADELPHIA, PA 19104 USA; WISTAR INST, PHILADELPHIA, PA 19104 USA; CHILDRENS HOSP PENN, PHILADELPHIA, PA 19104 USA	University of Pennsylvania; The Wistar Institute; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	WILLIAMS, WV (corresponding author), UNIV PENN, SCH MED, DEPT MED, PHILADELPHIA, PA 19104 USA.		Weiner, David B/H-8579-2014	Williams, William/0000-0003-3611-9284				AMIT AG, 1986, SCIENCE, V233, P747, DOI 10.1126/science.2426778; ARRHENIUS T, 1989, VACCINES 89; BRUCK C, 1986, P NATL ACAD SCI USA, V83, P6578, DOI 10.1073/pnas.83.17.6578; COHEN J, 1990, IN PRESS ANN NY ACAD; COHEN JA, 1990, P NATL ACAD SCI USA, V87, P4922, DOI 10.1073/pnas.87.13.4922; COLMAN PM, 1987, NATURE, V326, P358, DOI 10.1038/326358a0; DARMAN PS, 1985, BIOCHEM BIOPH RES CO, V127, P656, DOI 10.1016/S0006-291X(85)80211-4; DUTTA AS, 1989, BIOCHEM BIOPH RES CO, V159, P1114, DOI 10.1016/0006-291X(89)92224-9; DUTTA AS, 1990, J MED CHEM, V33, P2560, DOI 10.1021/jm00171a034; GENTSCH JR, 1985, J VIROL, V56, P356, DOI 10.1128/JVI.56.2.356-364.1985; GOUDSMIT J, 1988, AIDS, V2, P157; KANG CY, 1988, SCIENCE, V240, P1034, DOI 10.1126/science.3368787; KAUFFMAN RS, 1983, J IMMUNOL, V131, P2539; Kieber-Emmons T, 1987, Int Rev Immunol, V2, P339, DOI 10.3109/08830188709044761; KIEBEREMMONS T, 1989, BIOCHIM BIOPHYS ACTA, V989, P281; KIEBEREMMONS T, 1986, IMMUNOL REV, V90, P29; KIEBEREMMONS T, 1987, MONOGR ALLERGY, V22, P126; NOSEWORTHY JH, 1983, J IMMUNOL, V131, P2533; NOVOTNY J, 1986, J MOL BIOL, V189, P715, DOI 10.1016/0022-2836(86)90502-4; PACITTI A, 1990, J BIOL CHEM COMMUN, P666; PADLAN EA, 1989, P NATL ACAD SCI USA, V86, P5938, DOI 10.1073/pnas.86.15.5938; POLJAK RJ, 1974, P NATL ACAD SCI USA, V71, P3440, DOI 10.1073/pnas.71.9.3440; SEGAL DM, 1974, P NATL ACAD SCI USA, V71, P4298, DOI 10.1073/pnas.71.11.4298; SHERIFF S, 1987, P NATL ACAD SCI USA, V84, P8075, DOI 10.1073/pnas.84.22.8075; STANFIELD RL, 1990, SCIENCE, V248, P712, DOI 10.1126/science.2333521; TAUB R, 1989, J BIOL CHEM, V264, P259; TRAN VT, 1985, SCIENCE, V228, P492, DOI 10.1126/science.2858917; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216; WILLIAMS WV, 1988, P NATL ACAD SCI USA, V85, P6488, DOI 10.1073/pnas.85.17.6488; WILLIAMS WV, 1989, P NATL ACAD SCI USA, V86, P5537, DOI 10.1073/pnas.86.14.5537; Zavala F., 1988, Vaccines 88. New chemical and genetic approaches to vaccination: prevention of AIDS and other viral, bacterial and parasitic diseases., P61	31	108	117	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					5182	5190						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002053				2022-12-25	WOS:A1991FC21700075
J	KRAUSE, G; HOLMGREN, A				KRAUSE, G; HOLMGREN, A			SUBSTITUTION OF THE CONSERVED TRYPTOPHAN-31 IN ESCHERICHIA-COLI THIOREDOXIN BY SITE-DIRECTED MUTAGENESIS AND STRUCTURE-FUNCTION ANALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T7 DEOXYRIBONUCLEIC-ACID; PHAGE-T7 DNA-POLYMERASE; REDUCED THIOREDOXIN; NUCLEOTIDE-SEQUENCE; MUTANT THIOREDOXINS; TRXA GENE; CLONING; PROTEIN; REDUCTION; GLUTAREDOXIN	All prokaryotic and eukaryotic thioredoxins contain a conserved tryptophan residue, exposed at the active site disulfide/dithiol. The role of this W31 in Escherichia coli thioredoxin (Trx) was studied by site-directed mutagenesis. Four mutant Trx with W31Y, W31F, W31H, and W31A replacements were characterized. Very low tryptophan fluorescence emission from the remaining W28 was observed in all mutant Trx; reduction resulted in large, but variable increases (up to 11-fold) of fluorescence, to levels higher than in native or denatured wild-type Trx, demonstrating a previously postulated change involving W28. All W31 mutant Trx were good substrates for E. coli thioredoxin reductase. Compared with wild type, the apparent K(m) values were increased less than 2-fold for the W31A, W31H, and W31F Trx and the W31Y Trx showed even slightly higher catalytic efficiency (k(cat)/K(m) value). Functions of reduced Trx with ribonucleotide reductase and in reduction of insulin disulfides were more strongly influenced by the W31 replacements, in particular at low pH for A and H residues. T7 DNA polymerase activity generated by T7 gene 5 protein and reduced Trx was lowered by large factors for W31Y, W31A, or W31H compared with W31F or the wild-type protein. The in vivo function of Trx was studied by using pUC118-trxA expression in an E. coli trxA- background. The trxA genes with W31Y and W31F substitutions restored, fully and partly, the methionine sulfoxide utilization of a trxA-, metE- test strain; W31A and W31H mutations resulted in no growth. Propagation of M13 was moderately impeded by W31Y and W31F or severely by W31A and W31H replacements. Growth of a phage T3/7 hybrid was possible only with the W31Y and W31F substitutions reflecting the in vitro results for T7 DNA polymerase.	KAROLINSKA INST, DEPT PHYSIOL CHEM, BOX 60400, S-10401 STOCKHOLM 60, SWEDEN	Karolinska Institutet			Krause, Günter/A-1858-2012	Krause, Günter/0000-0003-3905-0921				ADLER S, 1983, J BIOL CHEM, V258, P6956; BENNETT CF, 1988, NATURE, V334, P268, DOI 10.1038/334268a0; BERGLUND O, 1970, J BIOL CHEM, V245, P6030; CHAMBERLIN M, 1974, J VIROL, V14, P509, DOI 10.1128/JVI.14.3.509-516.1974; DYSON HJ, 1989, BIOCHEMISTRY-US, V28, P7074, DOI 10.1021/bi00443a044; DYSON HJ, 1988, FEBS LETT, V228, P254, DOI 10.1016/0014-5793(88)80010-3; DYSON HJ, 1990, BIOCHEMISTRY-US, V29, P4129, DOI 10.1021/bi00469a016; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; EKLUND H, 1984, EMBO J, V3, P1443, DOI 10.1002/j.1460-2075.1984.tb01994.x; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GLEASON FK, 1990, BIOCHEMISTRY-US, V29, P3701, DOI 10.1021/bi00467a016; GLEASON FK, 1988, FEMS MICROBIOL LETT, V54, P271, DOI 10.1111/j.1574-6968.1988.tb02747.x; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; HOLMGREN A, 1984, METHOD ENZYMOL, V107, P295; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1972, J BIOL CHEM, V247, P1992; HOLMGREN A, 1975, P NATL ACAD SCI USA, V72, P2305, DOI 10.1073/pnas.72.6.2305; HOLMGREN A, 1968, EUR J BIOCHEM, V6, P475, DOI 10.1111/j.1432-1033.1968.tb00470.x; HOLMGREN A, 1967, EUR J BIOCHEM, V2, P187, DOI 10.1111/j.1432-1033.1967.tb00125.x; HOLMGREN A, 1981, BIOCHEMISTRY-US, V20, P3204, DOI 10.1021/bi00514a033; HOLMGREN A, 1979, J BIOL CHEM, V254, P9113; HOLMGREN A, 1970, Journal of Molecular Biology, V54, P387, DOI 10.1016/0022-2836(70)90437-7; HOLMGREN A, 1982, J BIOL CHEM, V257, P6926; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; HOLMGREN A, 1981, J BIOL CHEM, V256, P3118; HOLMGREN A, 1976, P NATL ACAD SCI USA, V73, P2275, DOI 10.1073/pnas.73.7.2275; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; HOLMGREN A, 1978, J BIOL CHEM, V253, P430; Holmgren A., 1986, THIOREDOXIN GLUTARED; HOOG JO, 1984, BIOSCIENCE REP, V4, P917, DOI 10.1007/BF01116889; HUBER HE, 1986, J BIOL CHEM, V261, P5006; JONES SW, 1988, J BIOL CHEM, V263, P9607; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; LANGSETMO K, 1989, BIOCHEMISTRY-US, V28, P3211, DOI 10.1021/bi00434a015; LIM CJ, 1985, J BACTERIOL, V163, P311, DOI 10.1128/JB.163.1.311-316.1985; LIM CJ, 1986, J BACTERIOL, V168, P1258, DOI 10.1128/jb.168.3.1258-1264.1986; LIM CJ, 1988, BIOCHEMISTRY-US, V27, P1401, DOI 10.1021/bi00405a002; LIM CJ, 1985, J BACTERIOL, V161, P799, DOI 10.1128/JB.161.2.799-802.1985; LUNN CA, 1984, J BIOL CHEM, V259, P469; Maniatis T., 1982, MOL CLONING; MARK DF, 1976, P NATL ACAD SCI USA, V73, P780, DOI 10.1073/pnas.73.3.780; MEROLA F, 1989, BIOCHEMISTRY-US, V28, P3383, DOI 10.1021/bi00434a038; MOORE EC, 1964, J BIOL CHEM, V239, P3453; NORDSTROM B, 1981, J BIOL CHEM, V256, P3112; REUTIMANN H, 1985, P NATL ACAD SCI USA, V82, P6783, DOI 10.1073/pnas.82.20.6783; REUTIMANN H, 1981, J BIOL CHEM, V256, P6796; RUSSEL M, 1985, J BACTERIOL, V163, P238, DOI 10.1128/JB.163.1.238-242.1985; RUSSEL M, 1988, P NATL ACAD SCI USA, V85, P990, DOI 10.1073/pnas.85.4.990; RUSSEL M, 1985, P NATL ACAD SCI USA, V82, P29, DOI 10.1073/pnas.82.1.29; RUSSEL M, 1986, J BIOL CHEM, V261, P4997; SLABY I, 1989, J BIOL CHEM, V264, P16502; SLABY I, 1979, BIOCHEMISTRY-US, V18, P5584, DOI 10.1021/bi00592a010; SPECTOR A, 1988, J BIOL CHEM, V263, P4984; STRYER L, 1967, BIOCHEMISTRY-US, V6, P1016, DOI 10.1021/bi00856a009; TABOR S, 1987, J BIOL CHEM, V262, P16212; Thelander L, 1978, Methods Enzymol, V51, P227; VANDEYAR MA, 1988, GENE, V65, P129, DOI 10.1016/0378-1119(88)90425-8; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; WALLACE BJ, 1984, GENE, V32, P399, DOI 10.1016/0378-1119(84)90015-5; Williams CH., 1976, ENZYMES, P89; WOLLMAN EE, 1988, J BIOL CHEM, V263, P15506; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	62	97	98	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4056	4066						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999401				2022-12-25	WOS:A1991FA69400009
J	ARAKI, E; MURAKAMI, T; SHIROTANI, T; KANAI, F; SHINOHARA, Y; SHIMADA, F; MORI, M; SHICHIRI, M; EBINA, Y				ARAKI, E; MURAKAMI, T; SHIROTANI, T; KANAI, F; SHINOHARA, Y; SHIMADA, F; MORI, M; SHICHIRI, M; EBINA, Y			A CLUSTER OF 4 SP1 BINDING-SITES REQUIRED FOR EFFICIENT EXPRESSION OF THE HUMAN INSULIN-RECEPTOR GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE DOMAIN; MAMMALIAN-CELLS; PROMOTER REGION; PROTEIN-KINASE; POINT MUTATION; RESISTANCE; TRANSCRIPTION; ANTIBODY; SEQUENCE; CLONING	Fragments of 5'-flanking sequences of the human insulin receptor gene were analyzed in transient expression assays after transfection of cell lines with an improved low background chloramphenicol acetyltransferase vector system pSVOOCAT (Araki, E., Shimada, F., Shichiri, M., Mori, M., and Ebina, Y. (1988) Nucleic Acids Res. 16, 1627). Transfection of chimeric chloramphenicol acetyltransferase plasmids containing various deletions and insertions of the promoter of HIR gene into CHO and COS cells indicated that the region between -629 and -1 (initiator ATG is +1) is sufficient for maximal promoter activity. The DNA element of the cluster of four G-C boxes (-593 to -618) enhanced the transcription, examined by the low background pSVOOCAT vector system in vivo. DNase I footprinting and gel retardation experiments using partially purified LacZ-Sp1 hybrid proteins showed that the transcription factor Sp1 can bind to the cluster of the four G-C boxes of the promoter. Thus, the efficient expression of the human insulin receptor gene possibly requires the binding of transcriptional factor Sp1 to four G-C boxes located -593 to -618 base pairs upstream of the ATG translation initiation codon.	UNIV TOKUSHIMA,INST ENZYME RES,DEPT ENZYME GENET,KURAMOTO CHO,TOKUSHIMA 770,JAPAN; UNIV TOKUSHIMA,FAC PHARMACEUT SCI,TOKUSHIMA 770,JAPAN; KUMAMOTO UNIV,SCH MED,DEPT METABOL MED,KUMAMOTO 860,JAPAN; KUMAMOTO UNIV,SCH MED,INST MED GENET,KUMAMOTO 860,JAPAN; CHIBA UNIV,SCH MED,DEPT INTERNAL MED 2,CHIBA 280,JAPAN	Tokushima University; Tokushima University; Kumamoto University; Kumamoto University; Chiba University								ACCILI D, 1989, EMBO J, V8, P2509, DOI 10.1002/j.1460-2075.1989.tb08388.x; ARAKI E, 1987, J BIOL CHEM, V262, P16186; ARAKI E, 1988, NUCLEIC ACIDS RES, V16, P1627, DOI 10.1093/nar/16.4.1627; ARAKI E, 1988, DIABETES S2, V37, P8; CHOU CK, 1987, J BIOL CHEM, V262, P1842; CZECH MP, 1985, ANNU REV PHYSIOL, V47, P357, DOI 10.1146/annurev.ph.47.030185.002041; DISTEL RJ, 1987, CELL, V49, P835, DOI 10.1016/0092-8674(87)90621-0; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; EBINA Y, 1987, P NATL ACAD SCI USA, V84, P704, DOI 10.1073/pnas.84.3.704; FEHLMANN M, 1982, P NATL ACAD SCI-BIOL, V79, P5921, DOI 10.1073/pnas.79.19.5921; GAVIN JR, 1974, P NATL ACAD SCI USA, V71, P84, DOI 10.1073/pnas.71.1.84; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; KADONAGA JT, 1987, CELL, V51, P1078; KADOWAKI T, 1988, SCIENCE, V240, P787, DOI 10.1126/science.2834824; KAGEYAMA R, 1988, P NATL ACAD SCI USA, V85, P5016, DOI 10.1073/pnas.85.14.5016; KAGEYAMA R, 1989, CELL, V59, P815, DOI 10.1016/0092-8674(89)90605-3; KAHN CR, 1985, ANNU REV MED, V36, P429; KASUGA M, 1983, P NATL ACAD SCI-BIOL, V80, P2137, DOI 10.1073/pnas.80.8.2137; KASUGA M, 1981, P NATL ACAD SCI-BIOL, V78, P6917, DOI 10.1073/pnas.78.11.6917; KLINKHAMER MP, 1989, EMBO J, V8, P2503, DOI 10.1002/j.1460-2075.1989.tb08387.x; KOBAYASHI M, 1988, BIOCHEM BIOPH RES CO, V153, P657, DOI 10.1016/S0006-291X(88)81145-8; KOLTERMAN OG, 1981, J CLIN INVEST, V68, P957, DOI 10.1172/JCI110350; LANGNER KD, 1986, P NATL ACAD SCI USA, V83, P1598, DOI 10.1073/pnas.83.6.1598; MAMULA PW, 1988, DIABETES, V37, P1241, DOI 10.2337/diabetes.37.9.1241; MORGAN DO, 1987, P NATL ACAD SCI USA, V84, P41, DOI 10.1073/pnas.84.1.41; MUGGEO M, 1979, ENDOCRINOLOGY, V104, P1393, DOI 10.1210/endo-104-5-1393; MURAKAMI T, 1990, MOL CELL BIOL, V10, P1180, DOI 10.1128/MCB.10.3.1180; NISHIDA Y, 1986, BIOCHEM BIOPH RES CO, V141, P474, DOI 10.1016/S0006-291X(86)80197-8; ODAWARA M, 1989, SCIENCE, V245, P66, DOI 10.1126/science.2544998; OJAMAA K, 1988, MOL ENDOCRINOL, V2, P242, DOI 10.1210/mend-2-3-242; OKAYAMA H, 1983, MOL CELL BIOL, V3, P280, DOI 10.1128/MCB.3.2.280; PETRUZZELLI L, 1986, P NATL ACAD SCI USA, V83, P4710, DOI 10.1073/pnas.83.13.4710; ROSEN OM, 1987, SCIENCE, V237, P1452, DOI 10.1126/science.2442814; ROSENFELD PJ, 1987, MOL CELL BIOL, V7, P875, DOI 10.1128/MCB.7.2.875; ROTH RA, 1983, SCIENCE, V219, P299, DOI 10.1126/science.6849137; SEINO S, 1989, P NATL ACAD SCI USA, V86, P114, DOI 10.1073/pnas.86.1.114; SHIMADA F, 1990, LANCET, V335, P1179, DOI 10.1016/0140-6736(90)92695-E; SIBLEY E, 1989, P NATL ACAD SCI USA, V86, P9732, DOI 10.1073/pnas.86.24.9732; TAIRA M, 1989, SCIENCE, V245, P63, DOI 10.1126/science.2544997; TEWARI DS, 1989, J BIOL CHEM, V264, P16238; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; YOSHIMASA Y, 1988, SCIENCE, V240, P784, DOI 10.1126/science.3283938	44	80	82	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3944	3948						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995641				2022-12-25	WOS:A1991EY68200088
J	HAIECH, J; KILHOFFER, MC; LUKAS, TJ; CRAIG, TA; ROBERTS, DM; WATTERSON, DM				HAIECH, J; KILHOFFER, MC; LUKAS, TJ; CRAIG, TA; ROBERTS, DM; WATTERSON, DM			RESTORATION OF THE CALCIUM-BINDING ACTIVITY OF MUTANT CALMODULINS TOWARD NORMAL BY THE PRESENCE OF A CALMODULIN BINDING STRUCTURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT CHAIN KINASE; NUCLEAR MAGNETIC-RESONANCE; SITE-SPECIFIC MUTAGENESIS; MYOSIN; PARAMECIUM; PROTEINS; H-1-NMR; DOMAINS; HELIX	The altered calcium binding activity of calmodulins (CaM) with point mutations can be restored toward that of wild type CaMs by the formation of a complex between CaM and a CaM binding sequence. Three different site-specific mutations resulted in selective effects on the apparent stoichiometry and affinity of CaM for calcium, with maintenance of the ability to activate myosin light chain kinase. The effects on calcium binding, however, were suppressed when the mutant CaMs were complexed with RS20, a peptide analog of a myosin light chain kinase CaM binding site. The mutations included: 1) a Glu --> Ala mutation at two phylogenetically conserved calcium ligands in the second (E67A-CaM) and fourth (E140A-CaM) sites; and 2) a Ser --> Phe mutation at residue 101 (S101F-CaM) which affects ion channel regulation. The mutant CaMs bind 4 calciums in the absence of magnesium, but two sites have approximately 60- to 300-fold weaker binding than wild-type CaM (SYNCAM CaM). E67A-CaM and E140A-CaM bound only two calciums and S101F-CaM bound 4 calciums in the presence of magnesium. E67A-CaM and E140A-CaM recovered the ability to bind 4 calcium ions in the presence of the RS20 CaM binding peptide. These results are consistent with models in which the calcium binding activity of CaM within a supramolecular complex is different from purified CaM and raise the possibility that the selective functional effects of in vivo mutations in the calcium binding sites of CaM might be partially due to the ability of some CaM binding proteins to select and utilize CaM conformations with calcium ligation structures different from the so-called canonical EF-hand.	UNIV LOUIS PASTEUR, BIOPHYS LAB, F-67401 ILLKIRCH GRAFFENSTADEN, FRANCE; UNIV TENNESSEE, DEPT BIOCHEM, KNOXVILLE, TN 37996 USA; VANDERBILT UNIV, DEPT PHARMACOL, NASHVILLE, TN 37232 USA	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Tennessee System; University of Tennessee Knoxville; Vanderbilt University	HAIECH, J (corresponding author), CNRS, LCB, BP 71, F-13277 MARSEILLE, FRANCE.		haiech, jacques J/F-2890-2010	haiech, jacques/0000-0003-2908-8053; Watterson, Daniel/0000-0001-7605-5866	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030861] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM30861] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOGUTA G, 1988, BIOPHYS CHEM, V31, P133, DOI 10.1016/0301-4622(88)80017-6; CHABBERT M, 1990, BIOPHYS J, V57, pA425; CRAIG TA, 1987, J BIOL CHEM, V262, P3278; HAIECH J, 1990, ADV EXP MED BIOL, V269, P43; HAIECH J, 1981, BIOCHEMISTRY-US, V20, P3890, DOI 10.1021/bi00516a035; HAIECH J, 1988, CALCIUM CALCIUM BIND, P191; HEINRICHSEN R, 1990, J CELL BIOL, V111, P2537; KILHOFFER MC, 1988, J BIOL CHEM, V263, P17023; KLEVIT RE, 1984, EUR J BIOCHEM, V139, P109, DOI 10.1111/j.1432-1033.1984.tb07983.x; LUKAS TJ, 1986, BIOCHEMISTRY-US, V25, P1458, DOI 10.1021/bi00354a041; LUKAS TJ, 1989, P NATL ACAD SCI USA, V86, P7331, DOI 10.1073/pnas.86.19.7331; OLWIN BB, 1985, BIOCHEMISTRY-US, V24, P8081, DOI 10.1021/bi00348a037; OLWIN BB, 1984, J BIOL CHEM, V259, P949; ROBERTS DM, 1985, BIOCHEMISTRY-US, V24, P5090, DOI 10.1021/bi00340a020; SCHAEFER WH, 1987, P NATL ACAD SCI USA, V84, P3931, DOI 10.1073/pnas.84.11.3931; SEAMON KB, 1980, BIOCHEMISTRY-US, V19, P207, DOI 10.1021/bi00542a031; SEEHOLZER SH, 1989, BIOCHEMISTRY-US, V28, P4011, DOI 10.1021/bi00435a057; SHOEMAKER MO, 1990, J CELL BIOL, V111, P1107, DOI 10.1083/jcb.111.3.1107; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; SUTOO D, 1989, JPN J PHARMACOL, V50, P217, DOI 10.1254/jjp.50.217; TAKIO K, 1986, BIOCHEMISTRY-US, V25, P8049, DOI 10.1021/bi00372a038; TSAI MD, 1987, BIOCHEMISTRY-US, V26, P3635, DOI 10.1021/bi00386a057; WEBER PC, 1989, PROTEIN-STRUCT FUNCT, V6, P69	23	103	105	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3427	3431						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995606				2022-12-25	WOS:A1991EY68200016
J	MORLOCK, KR; MCLAUGHLIN, JJ; LIN, YP; CARMAN, GM				MORLOCK, KR; MCLAUGHLIN, JJ; LIN, YP; CARMAN, GM			PHOSPHATIDATE PHOSPHATASE FROM SACCHAROMYCES-CEREVISIAE - ISOLATION OF 45-KDA AND 104-KDA FORMS OF THE ENZYME THAT ARE DIFFERENTIALLY REGULATED BY INOSITOL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CDP-DIACYLGLYCEROL SYNTHASE; SODIUM DODECYL-SULFATE; PHOSPHOLIPID BIOSYNTHESIS; PHOSPHATIDYLSERINE SYNTHASE; GEL-ELECTROPHORESIS; PHOSPHATIDYLINOSITOL SYNTHASE; COORDINATE REGULATION; MEMBRANE-PROTEINS; PURIFICATION; YEAST	Immunoblot analysis of cell extracts using antibodies specific for the 91-kDa form of membrane-associated phosphatidate phosphatase from Saccharomyces cerevisiae (Lin, Y.-P., and Carman, G. M. (1989) J. Biol. Chem. 264, 8641-8645) revealed the existence of a 45-kDa form of the enzyme. Immunoblot analysis also showed that the 91-kDa form of the enzyme was a proteolytic product of a 104-kDa enzyme. The mitochondrial fraction contained the 45-kDa enzyme, whereas the microsomal fraction contained the 45- and 104-kDa enzymes. In vivo labeling experiments showed that the 104-kDa form of phosphatidate phosphatase was not a precursor of the 45-kDa form of the enzyme. The 45- and 104-kDa forms of phosphatidate phosphatase were purified and characterized. The enzymological properties of both enzymes were similar. However, the phosphatidate phosphatase 45- and 104-kDa proteins differed with respect to their isoelectric points and peptide fragments resulting from V8 proteolysis and cyanogen bromide cleavage. The expression of the phosphatidate phosphatase 45- and 104-kDa enzymes were regulated differentially in cells supplemented with inositol. The addition of inositol to the growth medium resulted in the induction of the phosphatidate phosphatase 45-kDa enzyme. The expression of the 104-kDa enzyme was not affected by inositol. Both forms of phosphatidate phosphatase were induced when cells entered the stationary phase of growth.	RUTGERS STATE UNIV, COOK COLL, NEW JERSEY AGR EXPT STN, DEPT FOOD SCI, NEW BRUNSWICK, NJ 08903 USA	Rutgers State University New Brunswick					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028140] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-28140] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABDELLATIE AA, 1984, CAN J BIOCHEM CELL B, V62, P170, DOI 10.1139/o84-024; AMES GFL, 1976, BIOCHEMISTRY-US, V15, P616, DOI 10.1021/bi00648a026; ATKINSON K, 1980, J BIOL CHEM, V255, P6653; ATKINSON KD, 1980, J BACTERIOL, V141, P558, DOI 10.1128/JB.141.2.558-564.1980; BAILIS AM, 1987, MOL CELL BIOL, V7, P167, DOI 10.1128/MCB.7.1.167; BELENDIUK G, 1978, J BIOL CHEM, V253, P4555; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRINDLEY DN, 1984, PROG LIPID RES, V23, P115, DOI 10.1016/0163-7827(84)90001-8; CARMAN GM, 1989, ANNU REV BIOCHEM, V58, P635, DOI 10.1146/annurev.biochem.58.1.635; CARSON MA, 1984, J BIOL CHEM, V259, P6267; CARSON MA, 1982, J BIOL CHEM, V257, P8115; CHRISTIANSEN K, 1979, BIOCHIM BIOPHYS ACTA, V574, P448, DOI 10.1016/0005-2760(79)90241-8; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; CULBERTSON MR, 1975, GENETICS, V80, P23; DAWSON RMC, 1986, DATA BIOCH RES, P384; DEAN N, 1990, J CELL BIOL, V111, P369, DOI 10.1083/jcb.111.2.369; DEEMS RA, 1975, J BIOL CHEM, V250, P9013; EXTON JH, 1990, J BIOL CHEM, V265, P1; FISCHL AS, 1986, J BIOL CHEM, V261, P3178; FISCHL AS, 1983, J BACTERIOL, V154, P304, DOI 10.1128/JB.154.1.304-311.1983; GREENBERG ML, 1982, GENETICS, V100, P19; HAID A, 1983, METHOD ENZYMOL, V96, P192; HENRY SA, 1977, J BACTERIOL, V130, P472, DOI 10.1128/JB.130.1.472-484.1977; HOMANN MJ, 1987, J BACTERIOL, V169, P533, DOI 10.1128/jb.169.2.533-539.1987; HOMANN MJ, 1985, J BACTERIOL, V163, P1265, DOI 10.1128/JB.163.3.1265-1266.1985; HOSAKA K, 1984, BIOCHIM BIOPHYS ACTA, V796, P110; JONES EW, 1991, METHOD ENZYMOL, V194, P428; KELLEY MJ, 1987, J BIOL CHEM, V262, P14563; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; KLIG LS, 1985, J BACTERIOL, V162, P1135, DOI 10.1128/JB.162.3.1135-1141.1985; KLIG LS, 1988, J BACTERIOL, V170, P1878, DOI 10.1128/jb.170.4.1878-1886.1988; KOUL O, 1987, ARCH BIOCHEM BIOPHYS, V253, P453, DOI 10.1016/0003-9861(87)90199-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEGENDRE L, 1989, LIFE SCI R, V44, P49; LIN YP, 1989, J BIOL CHEM, V264, P8641; LIN YP, 1990, J BIOL CHEM, V265, P166; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; OHASHI A, 1982, J BIOL CHEM, V257, P3042; OLMSTED JB, 1981, J BIOL CHEM, V256, P1955; PAPPU AS, 1983, NEUROCHEM RES, V8, P1565, DOI 10.1007/BF00964158; POOLE MA, 1986, J BACTERIOL, V168, P668, DOI 10.1128/jb.168.2.668-672.1986; RIEZMAN H, 1983, EMBO J, V2, P2161, DOI 10.1002/j.1460-2075.1983.tb01717.x; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; WAECHTER CJ, 1973, ARCH BIOCHEM BIOPHYS, V158, P401, DOI 10.1016/0003-9861(73)90637-1; WAECHTER CJ, 1971, J BACTERIOL, V105, P837, DOI 10.1128/JB.105.3.837-843.1971; WALSH JP, 1986, J BIOL CHEM, V261, P6239; YAMASHITA S, 1980, EUR J BIOCHEM, V104, P611, DOI 10.1111/j.1432-1033.1980.tb04465.x; YAMASHITA S, 1982, EUR J BIOCHEM, V128, P589	48	62	63	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3586	3593						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995619				2022-12-25	WOS:A1991EY68200039
J	JAMAL, Z; MARTIN, A; GOMEZMUNOZ, A; BRINDLEY, DN				JAMAL, Z; MARTIN, A; GOMEZMUNOZ, A; BRINDLEY, DN			PLASMA-MEMBRANE FRACTIONS FROM RAT-LIVER CONTAIN A PHOSPHATIDATE PHOSPHOHYDROLASE DISTINCT FROM THAT IN THE ENDOPLASMIC-RETICULUM AND CYTOSOL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBCELLULAR-DISTRIBUTION; GLYCEROLIPID SYNTHESIS; PARTIAL-PURIFICATION; SIGNAL TRANSDUCTION; ARGININE RESIDUES; PHOSPHOLIPASE-C; ADIPOSE-TISSUE; CYCLIC-AMP; HEPATOCYTES; TRANSLOCATION	Assays for two distinct phosphatidate phosphohydrolase activities were established based upon a differential inhibition by N-ethylmaleimide (NEM). The activity that is insensitive to this reagent in rat liver is predominantly in the plasma membrane fraction, whereas the NEM-sensitive activity is in the cytosolic and microsomal fractions. The NEM-insensitive activity is further distinguished from the NEM-sensitive phosphohydrolase by: (a) being relatively stable to heat; (b) not being inhibited by phenylglyoxal, butane-2,3-dione, cyclohexane-1,2-dione, 2,4-dinitrofluorobenzene, 7-chloro-4-nitrobenz-2-oxa-1,3-diazole, and diethyl pyrocarbonate; (c) being inhibited by NaF and phosphatidylcholine; and (d) not being stimulated by Mg2+. The NEM-insensitive activity was specific for phosphatidate. Both phosphohydrolase activities could be inhibited by chlorpromazine, propranolol, sphingosine, and spermine. The NEM-sensitive phosphatidate phosphohydrolase activity was increased by incubating hepatocytes for 12 h with glucagon and dexamethasone, and this effect was antagonized by insulin. The NEM-sensitive phosphohydrolase is concluded to be involved in glycerolipid synthesis. The activity of the NEM-insensitive phosphohydrolase was not altered by preincubation of rat hepatocytes in the short or long term with vasopressin, glucagon, insulin, triiodothyronine, or dexamethasone, but it might by modulated indirectly by sphingosine. The NEM-insensitive enzyme of the plasma membranes could be involved in signal transduction via the agonist-stimulated degradation of phosphatidylcholine through the phospholipase D pathway.	DEPT BIOCHEM,328 HERITAGE MED RES CTR,EDMONTON T6G 2S2,ALBERTA,CANADA; LIPID & LIPOPROTEIN RES GRP,EDMONTON T6G 2S2,ALBERTA,CANADA					GOMEZ MUNOZ, ANTONIO/0000-0002-2539-016X				ABDELLATIE AA, 1984, CAN J BIOCHEM CELL B, V62, P170, DOI 10.1139/o84-024; ARVIDSON GA, 1968, EUR J BIOCHEM, V4, P478, DOI 10.1111/j.1432-1033.1968.tb00237.x; BELSHAM GJ, 1980, BIOCHEM J, V192, P457, DOI 10.1042/bj1920457; BERGERON JJ, 1973, J CELL BIOL, V59, P73, DOI 10.1083/jcb.59.1.73; BILLAH MM, 1989, J BIOL CHEM, V264, P17069; BILLAH MM, 1990, BIOCHEM J, V269, P281, DOI 10.1042/bj2690281; BOCCKINO SB, 1987, J BIOL CHEM, V262, P15309; BOWLEY M, 1977, BIOCHEM J, V165, P447, DOI 10.1042/bj1650447; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRINDLEY DN, 1984, PROG LIPID RES, V23, P115, DOI 10.1016/0163-7827(84)90001-8; BRINDLEY DN, 1987, CRC SERIES ENZYME BI, V1, P1; BUTTERWITH SC, 1984, BIOCHEM J, V220, P825, DOI 10.1042/bj2200825; BUTTERWITH SC, 1984, BIOCHEM J, V222, P487, DOI 10.1042/bj2220487; CASCALES C, 1984, BIOCHEM J, V219, P911, DOI 10.1042/bj2190911; COLEMAN R, 1968, BIOCHIM BIOPHYS ACTA, V163, P111; EICHBERG J, 1974, BIOCHEM BIOPH RES CO, V60, P1460, DOI 10.1016/0006-291X(74)90362-3; FREEMAN M, 1989, BIOCHEM J, V263, P589, DOI 10.1042/bj2630589; GOMEZMUNOZ A, 1989, BIOCHEM J, V262, P417, DOI 10.1042/bj2620417; HADVARY P, 1988, BIOCHEM J, V256, P357, DOI 10.1042/bj2560357; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; HOPEWELL R, 1985, BIOCHEM J, V232, P485, DOI 10.1042/bj2320485; HOSAKA K, 1975, J BIOCHEM-TOKYO, V77, P501, DOI 10.1093/oxfordjournals.jbchem.a130751; HUBBARD AL, 1983, J CELL BIOL, V96, P217, DOI 10.1083/jcb.96.1.217; IDE H, 1989, ARCH BIOCHEM BIOPHYS, V271, P177, DOI 10.1016/0003-9861(89)90268-3; JAUHIAINEN M, 1986, J BIOL CHEM, V261, P7032; JOHNSTON JM, 1967, LIPIDS, V2, P14, DOI 10.1007/BF02531994; KELLY SJ, 1975, BIOCHEMISTRY-US, V14, P4983, DOI 10.1021/bi00693a030; KENT C, 1976, BIOCHIM BIOPHYS ACTA, V436, P377, DOI 10.1016/0005-2736(76)90201-7; LAMB RG, 1987, BIOCHIM BIOPHYS ACTA, V921, P67, DOI 10.1016/0005-2760(87)90171-8; LAMB RG, 1982, TOXICOL APPL PHARM, V63, P216, DOI 10.1016/0041-008X(82)90044-8; LAVIE Y, 1990, J BIOL CHEM, V265, P3868; LAWSON N, 1981, BIOCHEM J, V200, P285, DOI 10.1042/bj2000285; LEWIS RNAH, 1986, ARCH BIOCHEM BIOPHYS, V247, P201, DOI 10.1016/0003-9861(86)90549-7; LOFFELHOLZ K, 1989, BIOCHEM PHARMACOL, V38, P1543, DOI 10.1016/0006-2952(89)90299-2; MARTIN A, 1987, BIOCHEM J, V245, P347, DOI 10.1042/bj2450347; MARTIN A, 1986, BIOCHIM BIOPHYS ACTA, V876, P581, DOI 10.1016/0005-2760(86)90047-0; MARTINSANZ P, 1985, FEBS LETT, V179, P262, DOI 10.1016/0014-5793(85)80531-7; MERRILL AH, 1989, BIOCHIM BIOPHYS ACTA, V1010, P131, DOI 10.1016/0167-4889(89)90152-3; MULLMANN TJ, 1990, J IMMUNOL, V144, P1901; MURAYAMA T, 1987, J BIOL CHEM, V262, P5522; NEWBY AC, 1975, BIOCHEM J, V146, P625, DOI 10.1042/bj1460625; PATTHY L, 1975, J BIOL CHEM, V250, P557; PATTHY L, 1975, J BIOL CHEM, V250, P565; PITTNER RA, 1985, BIOCHEM J, V230, P525, DOI 10.1042/bj2300525; PITTNER RA, 1986, FEBS LETT, V207, P42, DOI 10.1016/0014-5793(86)80009-6; ROSSI F, 1990, BIOCHEM BIOPH RES CO, V168, P320, DOI 10.1016/0006-291X(90)91711-Z; RUSSELL SM, 1979, BIOCHEM J, V181, P7, DOI 10.1042/bj1810007; SAGGERSON ED, 1969, BIOCHEM J, V115, P405, DOI 10.1042/bj1150405; SEDGWICK B, 1965, BIOCHIM BIOPHYS ACTA, V106, P63, DOI 10.1016/0005-2760(65)90096-2; SHEPHARD EH, 1969, BIOCHEM J, V113, P429, DOI 10.1042/bj1130429; SMITH ME, 1967, EUR J BIOCHEM, V3, P70, DOI 10.1111/j.1432-1033.1967.tb19499.x; STURTON RG, 1978, BIOCHEM J, V171, P263, DOI 10.1042/bj1710263; TAYLOR SJ, 1986, BIOCHEM J, V239, P275, DOI 10.1042/bj2390275; VANCE JE, 1990, J BIOL CHEM, V265, P7248; WALTON PA, 1989, BIOCHEM J, V261, P673, DOI 10.1042/bj2610673; WALTON PA, 1985, ANAL BIOCHEM, V151, P479, DOI 10.1016/0003-2697(85)90208-8; Wharton DC., 1967, METHOD ENZYMOL, P245; WILGRAM GF, 1963, J BIOL CHEM, V238, P2615; WISHER MH, 1975, BIOCHEM J, V146, P375, DOI 10.1042/bj1460375; WURSTER N, 1971, BIOCHIM BIOPHYS ACTA, V248, P282, DOI 10.1016/0005-2760(71)90016-6	60	248	252	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2988	2996						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993672				2022-12-25	WOS:A1991EX60000051
J	BOTBOL, V; SCORNIK, OA				BOTBOL, V; SCORNIK, OA			MEASUREMENT OF INSTANT RATES OF PROTEIN-DEGRADATION IN THE LIVERS OF INTACT MICE BY THE ACCUMULATION OF BESTATIN-INDUCED PEPTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHESIS IN-VIVO; INTRACELLULAR DEGRADATION; ABNORMAL PROTEINS; RETICULOCYTES; STARVATION; INVIVO; GROWTH; FIBROBLASTS; INHIBITION; AUTOPHAGY	Bestatin induces the accumulation of di- and tripeptide intermediates in cellular protein breakdown. In liver, a single set of bestatin-sensitive cytosolic peptidases are involved in the degradation to amino acids of the major classes of cellular proteins. Accumulation of bestatin-induced peptides, in isolated hepatocytes, is proportional to the rate of protein degradation (Botbol, V., and Scornik, O. A. (1989) J. Biol. Chem. 264, 13504-13509). Injection of 1 mg of bestatin into mice results in detectable amounts of hepatic intermediates in 15 min. We propose to use the accumulation of these peptides as a relative measurement of liver protein degradation. There is at present no other way to determine transient changes in protein breakdown in the tissues of intact animals. As an example of the applications of this procedure, we present the effects of a single meal on hepatic protein metabolism. Protein synthesis was estimated by the incorporation into liver protein of a massive dose of radioactive leucine (Scornik, O. A. (1974) J. Biol. Chem. 249, 3876-3883) and degradation of long-lived or short-lived proteins by the accumulation of bestatin-induced peptides, labeled in carboxy-C of their Leu or Arg moieties, 1 day or 1 h beforehand. A single meal resulted in an 18% increase in liver protein in 8 h, a 45% increase in the rate of hepatic protein synthesis, and a 3-fold decrease in the rate of breakdown of long-lived proteins. Short-lived proteins were not affected. To establish the efficiency with which bestatin-induced peptides accumulate in the livers of fasting mice, we compared them with the disappearance, in 1 day, of protein-bound C-14-guanidino-Arg residues, labeled by previous injection of C-14-bicarbonate (Swick, R. W., and Ip, M. M. (1974) J. Biol. Chem. 249, 6836-6841). From this comparison, we estimated that bestatin-induced Leu-labeled intermediates, accumulating in 15 min, represented 39% of the hepatic proteins degraded in that interval. For Arg-labeled intermediates the value was 55%. Correcting for these efficiencies, we estimate that in 4 h a meal decreased the rate of degradation for long-lived Arg-labeled proteins from 2.02 to 0.73% h. For Leu-labeled proteins the estimated rates were 1.76 and 0.66%/h, respectively. Although a transient slowdown of liver protein degradation after a single meal had been suggested before, this is the first time that acute changes such as this can be determined directly in intact animals. This novel procedure should be of use to establish the relative importance of nutrients and hormones in the regulation of hepatic protein turnover.			BOTBOL, V (corresponding author), DARTMOUTH COLL,HITCHCOCK MED CTR,DARTMOUTH MED SCH,DEPT BIOCHEM,HANOVER,NH 03756, USA.				NIADDK NIH HHS [AM13336] Funding Source: Medline	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMENTA JS, 1978, J CELL PHYSIOL, V94, P77, DOI 10.1002/jcp.1040940110; ASHFORD TP, 1962, J CELL BIOL, V12, P198, DOI 10.1083/jcb.12.1.198; Ballard F J, 1977, Essays Biochem, V13, P1; BALLARD FJ, 1987, LYSOSOMES THEIR ROLE, P285; BOTBOL V, 1979, P NATL ACAD SCI USA, V76, P710, DOI 10.1073/pnas.76.2.710; BOTBOL V, 1983, J BIOL CHEM, V258, P1942; BOTBOL V, 1989, J BIOL CHEM, V264, P13504; BOTBOL V, 1979, J BIOL CHEM, V254, P1254; BOTBOL V, 1985, INTRACELLULAR PROTEI, P573; CIECHANOVER A, 1984, CELL, V37, P57, DOI 10.1016/0092-8674(84)90300-3; CONDE RD, 1976, BIOCHEM J, V158, P385, DOI 10.1042/bj1580385; DE DUVE CHRISTIAN, 1963, SCI AMER, V208, P64; DETER RL, 1967, J CELL BIOL, V33, P437, DOI 10.1083/jcb.33.2.437; ETLINGER JD, 1977, P NATL ACAD SCI USA, V74, P54, DOI 10.1073/pnas.74.1.54; FISHMAN B, 1969, P NATL ACAD SCI USA, V64, P677, DOI 10.1073/pnas.64.2.677; GARLICK PJ, 1973, BIOCHEM J, V136, P935, DOI 10.1042/bj1360935; HERSHKO A, 1982, ANNU REV BIOCHEM, V51, P335, DOI 10.1146/annurev.bi.51.070182.002003; HUTSON NJ, 1982, P NATL ACAD SCI-BIOL, V79, P1737, DOI 10.1073/pnas.79.6.1737; Khairallah E. A., 1978, Protein turnover and lysosome function, P89; KNOWLES SE, 1976, BIOCHEM J, V156, P609, DOI 10.1042/bj1560609; Marzella L, 1987, LYSOSOMES THEIR ROLE, P319; MCNURLAN MA, 1989, DIABETES METAB REV, V5, P165, DOI 10.1002/dmr.5610050206; MORTIMORE GE, 1989, DIABETES METAB REV, V5, P49, DOI 10.1002/dmr.5610050105; MORTIMORE GE, 1976, LYSOSOM BIOL PATHOL, P157; NOVIKOFF AB, 1964, FED PROC, V23, P1010; OBLED C, 1975, ANN BIOL ANIM BIOCH, V15, P73, DOI 10.1051/rnd:19750108; PETERS T, 1972, J BIOL CHEM, V247, P3858; PFEIFER U, 1978, J CELL BIOL, V78, P152, DOI 10.1083/jcb.78.1.152; PFEIFER U, 1977, VIRCHOWS ARCH B, V24, P109; PFEIFER U, 1973, VIRCHOWS ARCH B, V12, P195; Pfeifer U., 1987, LYSOSOMES THEIR ROLE, P3; POTTER VR, 1968, FED PROC, V27, P1238; Rechsteiner M., 1988, UBIQUITIN; RICHMOND JE, 1963, AM J PHYSIOL, V205, P848, DOI 10.1152/ajplegacy.1963.205.5.848; ROSEN H, 1957, ARCH BIOCHEM BIOPHYS, V67, P10, DOI 10.1016/0003-9861(57)90241-2; SCORNIK OA, 1976, J BIOL CHEM, V251, P2891; SCORNIK OA, 1974, J BIOL CHEM, V249, P3876; SCORNIK OA, 1987, LYSOSOMES THEIR ROLE, P445; Seglen P O, 1980, Ann N Y Acad Sci, V349, P1, DOI 10.1111/j.1749-6632.1980.tb29510.x; SEGLEN PO, 1981, ACTA BIOL MED GER, V40, P1587; SEGLEN PO, 1987, LYSOSOMES THEIR ROLE, P371; SWICK RW, 1974, J BIOL CHEM, V249, P6836; TAKITA T, 1977, J MED CHEM, V20, P510; WARBURTON MJ, 1977, P NATL ACAD SCI USA, V74, P2427, DOI 10.1073/pnas.74.6.2427; WATGERLOW JC, 1978, PROTGEIN TURNOVER MA	45	35	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2151	2157						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989975				2022-12-25	WOS:A1991EV51500024
J	PAPINI, E; SANTUCCI, A; SCHIAVO, G; DOMENIGHINI, M; NERI, P; RAPPUOLI, R; MONTECUCCO, C				PAPINI, E; SANTUCCI, A; SCHIAVO, G; DOMENIGHINI, M; NERI, P; RAPPUOLI, R; MONTECUCCO, C			TYROSINE-65 IS PHOTOLABELED BY 8-AZIDOADENINE AND 8-AZIDOADENOSINE AT THE NAD BINDING-SITE OF DIPHTHERIA-TOXIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AERUGINOSA EXOTOXIN-A; PSEUDOMONAS-AERUGINOSA; ACTIVE-SITE; NUCLEOTIDE-SEQUENCE; PEPTIDE-BONDS; CYTOCHROME-C; FRAGMENT; ACID; TRYPTOPHANYL; HOMOLOGY	8-Azidoadenine and 8-azidoadenosine, two photoactivatable derivatives of adenine and adenosine, are competitive inhibitors of diphtheria toxin of similar potency with respect to their parent compounds. On irradiation, the two tritium-labeled photoactivatable azidoadenines bind covalently and specifically to an enzymic fragment of diphtheria toxin that is known to bind to NAD. This photolabeling is protected by the enzyme substrate NAD. The radiolabeled protein was fragmented, and the radioactive fragments were sequenced. Tyr-65 is labeled specifically by both photoreagents, and its labeling was reduced strongly when NAD was present during irradiation. Labeling is also reduced strongly by adenine, adenosine, and nicotinamide. These results suggest that Tyr-65 is at the NAD binding site of diphtheria toxin and that the competitive inhibitors adenine, adenosine, and nicotinamide bind to the same portion of the catalytic center of the toxin.	UNIV PADUA, IST PATOL GEN, I-35121 PADUA, ITALY; UNIV SIENA, DIPARTMENTO CHIM, I-53100 SIENA, ITALY; SCLAVO SPA, CTR RIC, I-53100 SIENA, ITALY	University of Padua; University of Siena	PAPINI, E (corresponding author), UNIV PADUA, CNR, CTR BIOMEMBRANE, VIA TRIESTE 75, I-35121 PADUA, ITALY.		Santucci, Annalisa/K-1932-2018; Papini, Emanuele/AAE-6961-2022	Santucci, Annalisa/0000-0001-6976-9086; Papini, Emanuele/0000-0001-6033-4473; Schiavo, Giampietro/0000-0002-4319-8745				ALLURED VS, 1986, P NATL ACAD SCI USA, V83, P1320, DOI 10.1073/pnas.83.5.1320; Bayley H, 1977, Methods Enzymol, V46, P69; BAYLEY H, 1983, PHOTOGENERATED REAGE, P1; BRANDHUBER BJ, 1988, PROTEINS, V3, P146, DOI 10.1002/prot.340030303; CARROLL SF, 1984, P NATL ACAD SCI-BIOL, V81, P3307, DOI 10.1073/pnas.81.11.3307; CARROLL SF, 1987, J BIOL CHEM, V262, P8707; CARROLL SF, 1988, MOL MICROBIOL, V2, P293, DOI 10.1111/j.1365-2958.1988.tb00031.x; CARROLL SF, 1988, METHOD ENZYMOL, V165, P218; Collier RJ, 1982, ADP RIBOSYLATION REA, P575; DRAZIN R, 1971, J BIOL CHEM, V246, P1504; FONTANA A, 1981, BIOCHEMISTRY-US, V20, P6997, DOI 10.1021/bi00527a034; GIRAUDAT J, 1986, P NATL ACAD SCI USA, V83, P2719, DOI 10.1073/pnas.83.8.2719; GREENFIELD L, 1983, P NATL ACAD SCI-BIOL, V80, P6853, DOI 10.1073/pnas.80.22.6853; HOPPE J, 1983, J BIOL CHEM, V258, P2882; KADENBACH B, 1983, ANAL BIOCHEM, V129, P517, DOI 10.1016/0003-2697(83)90586-9; KANDEL J, 1974, J BIOL CHEM, V249, P2088; KANTARDJIEFF K, 1989, J BIOL CHEM, V264, P10402; LISCHWE MA, 1977, J BIOL CHEM, V252, P4976; MALIARIK MJ, 1988, J BIOL CHEM, V263, P11274; MARTENSON RE, 1977, BIOCHEMISTRY-US, V16, P216, DOI 10.1021/bi00621a009; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MONTECUCCO C, 1990, IN PRESS STRUCTURE R; Montecucco C., 1988, METHOD ENZYMOL, V165, P347; PAPINI E, 1987, EUR J BIOCHEM, V169, P637, DOI 10.1111/j.1432-1033.1987.tb13655.x; PAPINI E, 1989, J BIOL CHEM, V264, P12385; PAPINI E, 1990, TOXICON, V28, P631, DOI 10.1016/0041-0101(90)90251-2; PAPPENHEIMER AM, 1977, ANNU REV BIOCHEM, V46, P69, DOI 10.1146/annurev.bi.46.070177.000441; RANKIN PW, 1989, J BIOL CHEM, V264, P4312; RAPPUOLI R, 1983, J CHROMATOGR, V268, P543, DOI 10.1016/S0021-9673(01)95457-3; RAPPUOLI R, 1990, IN PRESS STRUCTURE R; RATTI G, 1983, NUCLEIC ACIDS RES, V11, P6589, DOI 10.1093/nar/11.19.6589; ROSS AH, 1982, J BIOL CHEM, V257, P4152; TWETEN RK, 1985, J BIOL CHEM, V260, P392; ZHAO JM, 1988, BIOCHEMISTRY-US, V27, P3398, DOI 10.1021/bi00409a041	34	22	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2494	2498						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1990001				2022-12-25	WOS:A1991EV51500073
J	MEIER, KE; LICCIARDI, KA; HAYSTEAD, TAJ; KREBS, EG				MEIER, KE; LICCIARDI, KA; HAYSTEAD, TAJ; KREBS, EG			ACTIVATION OF MESSENGER-INDEPENDENT PROTEIN-KINASES IN WILD-TYPE AND PHORBOL ESTER-RESISTANT EL4 THYMOMA CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL PROTEIN-S6; PHOSPHORYLATION; TYROSINE; STAUROSPORINE; INHIBITION; PRODUCT; GENE	Phorbol esters, acting via activation of the protein kinase C family of protein serine/threonine kinases, are able to exert profound effects on various cellular functions. In this study, we used the EL4 thymoma cell line to study the potential role of "downstream" protein serine/threonine kinases in cellular responses to phorbol esters. In wild-type EL4 cells, addition of phorbol ester caused a rapid activation of kinase activity toward RRLSSLRA (S6P). This increased activity was maintained for at least 15 min but diminished to control levels by 60 min. Activation of a myelin basic protein (MBP) kinase was also seen in response to phorbol ester. In a variant EL4 cell line in which phorbol ester does not induce interleukin 2 transcription, phorbol ester failed to activate either the S6P kinase or MBP kinase. Partial purification of the activated S6P and MBP kinases from wild-type cells showed that they represent separate enzymes that are distinct from protein kinase C. Although the variant cells had reduced levels of protein kinase C as compared with the wild-type cells, the amount of membrane-bound enzyme increased in response to phorbol 12-myristate 13-acetate in both wild-type and variant cells. Treatment of intact cells with phorbol ester resulted in phosphorylation of some of the same protein substrates in both cell lines. Okadaic acid, a phosphatase inhibitor, increased S6P and MBP kinase activities in both wild-type and variant cells. Thus, phorbol ester failed to activate the S6P and MBP kinases in the variant cells even though these cells express activatable protein kinase C, S6P kinase, and MBP kinase. Two protein kinase inhibitors, staurosporine and H-7, inhibited the activity of all three kinases in vitro, while a peptide inhibitor (PKC 19-31) showed specificity for protein kinase C. In summary, these results suggest that activation of messenger-independent protein kinases may be critical for certain protein kinase C-dependent responses.			MEIER, KE (corresponding author), UNIV WASHINGTON,DEPT PHARMACOL,SL-15,SEATTLE,WA 98195, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM042508] Funding Source: NIH RePORTER; NIGMS NIH HHS [P01 GM42508] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHN NG, 1990, J BIOL CHEM, V265, P11487; AHN NG, 1990, J BIOL CHEM, V265, P11495; AHN NG, 1991, IN PRESS J BIOL CHEM; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; BISHOP R, 1983, BIOCHEM BIOPH RES CO, V115, P536, DOI 10.1016/S0006-291X(83)80178-8; BLENIS J, 1984, P NATL ACAD SCI-BIOL, V81, P6408, DOI 10.1073/pnas.81.20.6408; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; GILMORE T, 1983, NATURE, V306, P487, DOI 10.1038/306487a0; GUERRIN M, 1990, BIOCHEM BIOPH RES CO, V166, P687, DOI 10.1016/0006-291X(90)90864-J; HANEKOM C, 1989, BIOCHEM J, V262, P449, DOI 10.1042/bj2620449; HARRISON JR, 1987, J BIOL CHEM, V262, P234; HAYSTEAD TAJ, 1990, J BIOL CHEM, V265, P16571; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; KAZLAUSKAS A, 1988, J CELL BIOL, V106, P1395, DOI 10.1083/jcb.106.4.1395; KLARLUND JK, 1990, J BIOL CHEM, V265, P227; KRAMER CM, 1986, CANCER RES, V46, P3040; KUENZEL EA, 1987, J BIOL CHEM, V262, P9136; LANE PJL, 1990, LIGANDS RECEPTORS SI, P117; MAKOWSKE M, 1988, J BIOL CHEM, V263, P3402; MEIER KE, 1990, J BIOL CHEM, V265, P4635; NEL AE, 1990, J IMMUNOL, V144, P2683; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; PELECH SL, 1987, J BIOL CHEM, V262, P11598; PETERSON M, 1990, CLIN RES, V35, pA152; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; SANDO JJ, 1982, CANCER RES, V42, P1676; SCHATER E, 1986, ENZYMES, V17, P21; SCOTT JD, 1986, P NATL ACAD SCI USA, V83, P1613, DOI 10.1073/pnas.83.6.1613; SERFLING E, 1989, EMBO J, V8, P465, DOI 10.1002/j.1460-2075.1989.tb03399.x; SMITH CD, 1988, BIOCHEM BIOPH RES CO, V156, P1250, DOI 10.1016/S0006-291X(88)80767-8; SOMMERCORN J, 1988, ADV POST TRANSLATION, P403; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; TREVILLYAN JM, 1984, J BIOL CHEM, V259, P897	36	63	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1914	1920						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1988454				2022-12-25	WOS:A1991EU49700083
J	SEEDORF, U; ASSMANN, G				SEEDORF, U; ASSMANN, G			CLONING, EXPRESSION, AND NUCLEOTIDE-SEQUENCE OF RAT-LIVER STEROL CARRIER PROTEIN-2 CDNAS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-TRANSFER PROTEIN; PHOSPHOLIPID TRANSFER PROTEIN; BOVINE LIVER; CHOLESTEROL; PURIFICATION; DNA; ACID; BIOSYNTHESIS; PEROXISOMES; CONVERSION	The structure and expression of rat sterol carrier protein 2 (SCP2) were studied by cloning and sequencing SCP2 cDNAs and by hybridizing the SCP2 cDNA to RNA from a variety of rat tissues. Initial screening of a rat liver cDNA library with an oligonucleotide probe derived from the rat SCP2 protein sequence revealed an 825-base pair cDNA clone coding for the complete SCP2 protein sequence. Our results suggest that rat liver SCP2 is 143 amino acid residues long, including a 20-amino acid residue prepeptide (pre-SCP2). Using the rat SCP2 cDNA as a probe for Northern blot hybridization analyses under high stringency conditions with rat liver poly(A) RNA, four mRNA species differing in their sizes and levels of expression are detected. The lengths of the corresponding mRNAs are 0.8, 1.4, 2.1, and 2.7 kilobases (kb), respectively. In all other tissues analyzed mRNAs hybridizing to the SCP2 cDNA probe were detected in levels much lower than in the liver. In these tissues the vast majority of the expressed SCP2 mRNAs consists of the 0.8-kb mRNA. Results from Southern blotting hybridization analyses with rat genomic DNA suggest that the four different mRNA species are products of a single gene. Extensive screening of rat liver cDNA libraries using rat liver SCP2 cDNA probes led to the isolation of 10 additional clones, all of them containing cDNA insertions longer than 0.8 kb. Restriction mapping and nucleotide sequencing analyses of these cDNAs indicate that eight extend upstream of the SCP2 cDNA, and two extend 5' as well as 3'. Translation of the sequence extending most upstream suggests that this cDNA is a nearly full-length cDNA coding for a protein of 547 amino acids (SCP(x)). SCP(x) contains a 404-amino acid amino-terminal extension as compared with pre-SCP2 whereas its carboxyl-terminal part is identical with pre-SCP2. Sequencing of the 3' extension cDNAs suggests that polyadenylation had occurred 651 nucleotides downstream as compared with the remaining cDNAs. A probe from this region hybridizes to the 1.4- and 2.7-kb mRNAs. From our data we conclude that the 1.4- and 2.7-kb mRNA species are generated by alternative polyadenylation of the 0.8- and 2.1-kb mRNAs contain an approximately 1300-nucleotide extension upstream of the 0.8- and 1.4-kb mRNAs, suggesting differential splicing of the primary SCP2 gene transcript leading to expression of pre-SCP2 and SCP(x) from a single gene.	UNIV MUNSTER,ZENT LAB,INST KLIN CHEM,W-4400 MUNSTER,GERMANY; UNIV MUNSTER,ZENT LAB,MED LAB,W-4400 MUNSTER,GERMANY	University of Munster; University of Munster	SEEDORF, U (corresponding author), UNIV MUNSTER,INST ARTERIOSKLEROSEFORSCH,W-4400 MUNSTER,GERMANY.							APPELKVIST EL, 1987, BIOSCIENCE REP, V7, P853, DOI 10.1007/BF01119476; BASU J, 1988, BIOCHIM BIOPHYS ACTA, V959, P134, DOI 10.1016/0005-2760(88)90024-0; BJORKHEM I, 1985, NEW COMPREHENSIVE BI, V12, P231; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BLOJ B, 1978, FEBS LETT, V96, P87, DOI 10.1016/0014-5793(78)81068-0; BLOJ B, 1977, J BIOL CHEM, V252, P1613; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; CHANDERBHAN R, 1983, BIOCHEM BIOPH RES CO, V117, P702, DOI 10.1016/0006-291X(83)91654-6; CHANDERBHAN R, 1982, J BIOL CHEM, V257, P8928; CHESTERTON CJ, 1968, J BIOL CHEM, V243, P1147; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COLBEAU A, 1971, BIOCHIM BIOPHYS ACTA, V249, P462, DOI 10.1016/0005-2736(71)90123-4; CRAIN RC, 1980, BIOCHEMISTRY-US, V19, P1433, DOI 10.1021/bi00548a026; DILELLA AG, 1987, METHOD ENZYMOL, V152, P447; FASMAN GD, 1980, ANN NY ACAD SCI, V348, P147; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GAVEY KL, 1981, J BIOL CHEM, V256, P2993; GOLDBERG DA, 1980, P NATL ACAD SCI-BIOL, V77, P5794, DOI 10.1073/pnas.77.10.5794; Gros E., 1967, METHOD ENZYMOL, V11, P238; IMBRIEMILLIGAN C, 1989, J BIOL CHEM, V264, P16793; LIDSTROMOLSSON B, 1986, BIOCHEM J, V238, P879, DOI 10.1042/bj2380879; Maniatis T, 1982, MOL CLONING LABORATO; MESSING J, 1981, NUCLEIC ACIDS RES, V9, P309, DOI 10.1093/nar/9.2.309; MORRIS HR, 1988, BIOCHEM BIOPH RES CO, V154, P476, DOI 10.1016/0006-291X(88)90711-5; NOLAND BJ, 1980, J BIOL CHEM, V255, P4282; PASTUSZYN A, 1987, J BIOL CHEM, V262, P13219; POORTHUIS BJHM, 1981, BIOCHIM BIOPHYS ACTA, V665, P256, DOI 10.1016/0005-2760(81)90010-2; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TANAKA T, 1984, ENDOCRINOLOGY, V114, P533, DOI 10.1210/endo-114-2-533; TEERLINK T, 1984, BIOCHIM BIOPHYS ACTA, V793, P251, DOI 10.1016/0005-2760(84)90327-8; THOMPSON SL, 1987, J BIOL CHEM, V262, P17420; TRZASKOS JM, 1983, BIOCHIM BIOPHYS ACTA, V751, P52, DOI 10.1016/0005-2760(83)90256-4; TRZECIAK WH, 1987, J BIOL CHEM, V262, P3713; TSUNEOKA M, 1988, J BIOCHEM-TOKYO, V104, P560, DOI 10.1093/oxfordjournals.jbchem.a122510; VAHOUNY GV, 1984, BIOCHEM BIOPH RES CO, V122, P509, DOI 10.1016/S0006-291X(84)80062-5; VAHOUNY GV, 1983, J BIOL CHEM, V258, P1731; VANAMERONGEN A, 1985, CHEM PHYS LIPIDS, V38, P195, DOI 10.1016/0009-3084(85)90067-2; VANAMERONGEN A, 1987, BIOCHIM BIOPHYS ACTA, V919, P149, DOI 10.1016/0005-2760(87)90201-3; WALKER MD, 1983, NATURE, V306, P557, DOI 10.1038/306557a0; WESTERMAN J, 1985, BIOCHEM BIOPH RES CO, V127, P333, DOI 10.1016/S0006-291X(85)80163-7; ZILVERSMIT DB, 1976, METHODS MEMBRANE BIO, P211	42	103	106	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					630	636						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985920				2022-12-25	WOS:A1991EQ33900091
J	SHEPEL, LA; GORSKI, J				SHEPEL, LA; GORSKI, J			RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISMS IN THE RAT N-RAS AND RETINOBLASTOMA GENES - THEIR IDENTIFICATION AND CHARACTERIZATION	ONCOGENE			English	Article									UNIV WISCONSIN,DEPT BIOCHEM,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD008192, R37HD008192] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA018110] Funding Source: NIH RePORTER; NCI NIH HHS [CA18110] Funding Source: Medline; NICHD NIH HHS [HD08192] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		CLIFTON KH, 1956, ANAT REC, V125, P65, DOI 10.1002/ar.1091250106; CZERNILOFSKY AP, 1980, NATURE, V287, P198, DOI 10.1038/287198a0; DEVARE SG, 1983, P NATL ACAD SCI-BIOL, V80, P731, DOI 10.1073/pnas.80.3.731; DURRIN LK, 1985, ENDOCRINOLOGY, V117, P2098, DOI 10.1210/endo-117-5-2098; ELLIS RW, 1980, J VIROL, V36, P408, DOI 10.1128/JVI.36.2.408-420.1980; ELLIS RW, 1981, NATURE, V292, P506, DOI 10.1038/292506a0; ESCOT C, 1986, P NATL ACAD SCI USA, V83, P4843; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FUJIMOTO M, 1987, J NEURO-ONCOL, V5, P151, DOI 10.1007/BF02571303; GOFF SP, 1980, CELL, V22, P777, DOI 10.1016/0092-8674(80)90554-1; GREEN MR, 1989, CELL, V56, P1, DOI 10.1016/0092-8674(89)90975-6; HAMPE A, 1984, P NATL ACAD SCI-BIOL, V81, P85, DOI 10.1073/pnas.81.1.85; HANSEN MF, 1988, CELL, V53, P172, DOI 10.1016/0092-8674(88)90376-5; HOLTZMAN S, 1979, CANCER RES, V39, P779; KITYAMA H, 1989, CELL, V556, P77; KRONTIRIS TG, 1985, NATURE, V313, P369, DOI 10.1038/313369a0; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LEE EYHP, 1988, SCIENCE, V241, P218, DOI 10.1126/science.3388033; LINGHAM RB, 1988, MOL ENDOCRINOL, V2, P230, DOI 10.1210/mend-2-3-230; LLOYD RV, 1983, AM J PATHOL, V113, P198; LOOSEMITCHELL DS, 1988, MOL ENDOCRINOL, V2, P926; MAKI Y, 1987, P NATL ACAD SCI USA, V84, P2848, DOI 10.1073/pnas.84.9.2848; MALKOVA J, 1977, NEOPLASMA, V24, P277; MARX JL, 1983, SCIENCE, V222, P602, DOI 10.1126/science.6635658; MIDDLETONPRICE H, 1988, ANN HUM GENET, V52, P189, DOI 10.1111/j.1469-1809.1988.tb01096.x; MURPHY LJ, 1987, ENDOCRINOLOGY, V120, P1882, DOI 10.1210/endo-120-5-1882; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SHENONG GLC, 1982, CELL, V31, P443, DOI 10.1016/0092-8674(82)90137-4; SHEPEL L A, 1988, Biofactors, V1, P71; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPANDIDOS DA, 1984, ANTICANCER RES, V4, P269; STONE JP, 1979, CANCER RES, V39, P773; SUMI C, 1984, JNCI-J NATL CANCER I, V73, P1229; TANG A, 1988, SCIENCE, V242, P263, DOI 10.1126/science.3175651; TAPAROWSKY E, 1983, CELL, V34, P581, DOI 10.1016/0092-8674(83)90390-2; TRAVERS MT, 1987, FEBS LETT, V211, P27, DOI 10.1016/0014-5793(87)81267-X; VANBEVEREN C, 1983, CELL, V32, P1241, DOI 10.1016/0092-8674(83)90306-9; VENNSTROM B, 1980, J VIROL, V36, P575; WICKLUND JA, 1982, ENDOCRINOLOGY, V111, P1140; WIKLUND J, 1981, ENDOCRINOLOGY, V109, P1708, DOI 10.1210/endo-109-5-1708; WIKLUND J, 1981, ENDOCRINOLOGY, V109, P1700, DOI 10.1210/endo-109-5-1700	45	4	4	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1990	5	11					1675	1682						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EL401	1980008				2022-12-25	WOS:A1990EL40100010
J	BROWN, PJ; LEE, AB; NORMAN, MG; PRESKY, DH; SCHONBRUNN, A				BROWN, PJ; LEE, AB; NORMAN, MG; PRESKY, DH; SCHONBRUNN, A			IDENTIFICATION OF SOMATOSTATIN RECEPTORS BY COVALENT LABELING WITH A NOVEL PHOTOREACTIVE SOMATOSTATIN ANALOG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV TEXAS,SCH MED,DEPT PHARMACOL,HOUSTON,TX 77225	University of Texas System					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032234, F32DK007613] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 32234, DK07613] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BRUNO JF, 1989, ENDOCRINOLOGY, V124, P831, DOI 10.1210/endo-124-2-831; CAPRIOLI RM, 1988, INT J MASS SPECTROM, V86, P187, DOI 10.1016/0168-1176(88)80063-6; CAPRIOLI RM, 1986, ANAL CHEM, V58, P2949, DOI 10.1021/ac00127a012; COTRONEO P, 1988, EUR J BIOCHEM, V174, P219, DOI 10.1111/j.1432-1033.1988.tb14085.x; DORFLINGER LJ, 1983, ENDOCRINOLOGY, V113, P1541, DOI 10.1210/endo-113-5-1541; FISCHER JB, 1988, J BIOL CHEM, V263, P2808; KIMURA N, 1989, BIOCHEM BIOPH RES CO, V160, P72, DOI 10.1016/0006-291X(89)91622-7; KIMURA N, 1989, J BIOL CHEM, V264, P7033; KOCH BD, 1988, J BIOL CHEM, V263, P216; KOCH BD, 1985, J BIOL CHEM, V260, P3138; KOCH BD, 1988, J BIOL CHEM, V263, P226; KOCH BD, 1984, ENDOCRINOLOGY, V114, P1784, DOI 10.1210/endo-114-5-1784; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEWIS DL, 1986, P NATL ACAD SCI USA, V83, P9035, DOI 10.1073/pnas.83.23.9035; LEWIS LD, 1987, ENDOCRINOLOGY, V121, P486, DOI 10.1210/endo-121-2-486; MAHAN LC, 1987, SOMATOSTATIN BASIC C, P137; MEYERS CA, 1980, P NATL ACAD SCI-BIOL, V77, P577, DOI 10.1073/pnas.77.1.577; MOLLARD P, 1988, ENDOCRINOLOGY, V123, P721, DOI 10.1210/endo-123-2-721; MURTHY KK, 1989, ENDOCRINOLOGY, V125, P948, DOI 10.1210/endo-125-2-948; NELSON TY, 1987, J BIOL CHEM, V262, P2608; NUTT RF, 1983, INT J PEPT PROT RES, V21, P66; PRESKY DH, 1988, MOL PHARMACOL, V34, P651; REICHLIN S, 1983, NEW ENGL J MED, V309, P1495, DOI 10.1056/NEJM198312153092406; REICHLIN S, 1983, NEW ENGL J MED, V309, P1556, DOI 10.1056/NEJM198312223092506; REUBI JC, 1982, REGUL PEPTIDES, V4, P141, DOI 10.1016/0167-0115(82)90081-7; RICHARDSON UI, 1981, ENDOCRINOLOGY, V108, P281, DOI 10.1210/endo-108-1-281; ROSENTHAL W, 1988, EMBO J, V7, P1627, DOI 10.1002/j.1460-2075.1988.tb02989.x; SAKAMOTO C, 1988, J BIOL CHEM, V263, P14441; SCHONBRUNN A, 1978, J BIOL CHEM, V253, P6473; SCHONBRUNN A, 1983, ENDOCRINOLOGY, V113, P1559, DOI 10.1210/endo-113-5-1559; Schonbrunn A., 1987, SOMATOSTATIN BASIC C, P121; SRIKANT CB, 1983, LIFE SCI, V33, P201, DOI 10.1016/0024-3205(83)90414-9; SRIKANT CB, 1981, P NATL ACAD SCI-BIOL, V78, P3930, DOI 10.1073/pnas.78.6.3930; SRIKANT CB, 1989, 1ST ANN M END SOC SE, V103; SRIKANT CB, 1987, SOMATOSTATIN BASIC C, P89; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; SWOPE SL, 1984, P NATL ACAD SCI-BIOL, V81, P1822, DOI 10.1073/pnas.81.6.1822; THERMOS K, 1988, MOL PHARMACOL, V33, P370; THERMOS K, 1989, NEUROSCIENCE, V31, P131, DOI 10.1016/0306-4522(89)90035-3; VALE W, 1978, METABOLISM, V27, P1391, DOI 10.1016/0026-0495(78)90081-1; VIGUERIE N, 1988, AM J PHYSIOL, V255, pG113, DOI 10.1152/ajpgi.1988.255.1.G113; YAJIMA Y, 1986, J BIOL CHEM, V261, P2684; YATANI A, 1987, MOL ENDOCRINOL, V1, P283, DOI 10.1210/mend-1-4-283	43	31	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1990	265	29					17995	18004						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC766	1976633				2022-12-25	WOS:A1990EC76600096
J	CERDAN, S; KUNNECKE, B; SEELIG, J				CERDAN, S; KUNNECKE, B; SEELIG, J			CEREBRAL METABOLISM OF [1,2-C-13(2)]ACETATE AS DETECTED BY INVIVO AND INVITRO C-13 NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV BASEL,BIOCTR,KLINGELBERGSTR 70,CH-4056 BASEL,SWITZERLAND; CSIC,INST INVEST BIOMED,E-28029 MADRID,SPAIN	University of Basel; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM)				Cerdan, Sebastian/0000-0001-9965-0270				BADARGOFFER RS, 1990, BIOCHEM J, V266, P133, DOI 10.1042/bj2660133; BALAZS R, 1970, BIOCHEM J, V116, P445; BARANY M, 1985, MAGNET RESON MED, V2, P289, DOI 10.1002/mrm.1910020312; BEHAR KL, 1985, J NEUROCHEM, V44, P1045, DOI 10.1111/j.1471-4159.1985.tb08723.x; BEHAR KL, 1986, MAGNET RESON MED, V3, P911, DOI 10.1002/mrm.1910030611; BEHAR KL, 1983, P NATL ACAD SCI-BIOL, V80, P4945, DOI 10.1073/pnas.80.16.4945; BERL S, 1968, J NEUROCHEM, V15, P131, DOI 10.1111/j.1471-4159.1968.tb06184.x; BERL S, 1961, J NEUROCHEM, V7, P186, DOI 10.1111/j.1471-4159.1961.tb13503.x; BERL S, 1970, J NEUROCHEM, V17, P1009, DOI 10.1111/j.1471-4159.1970.tb02254.x; BERL S, 1962, J BIOL CHEM, V237, P2562; Berl S., 1983, GLUTAMINE GLUTAMATE, P205; BRAINARD JR, 1989, J NEUROCHEM, V53, P1285, DOI 10.1111/j.1471-4159.1989.tb07426.x; CERDAN S, 1985, FEBS LETT, V187, P167, DOI 10.1016/0014-5793(85)81235-7; CERDAN S, 1988, J BIOL CHEM, V263, P11664; CERDAN S, 1986, MAGNET RESON MED, V3, P432, DOI 10.1002/mrm.1910030308; CHENG SC, 1973, ARCH BIOCHEM BIOPHYS, V151, P501; COHEN SM, 1987, BIOCHEMISTRY-US, V26, P573, DOI 10.1021/bi00376a032; CROSS TA, 1985, J MAGN RESON, V62, P87, DOI 10.1016/0022-2364(85)90298-7; CROSS TA, 1984, BIOCHEMISTRY-US, V23, P6398, DOI 10.1021/bi00321a018; FRIEDMANN B, 1971, ARCH BIOCHEM BIOPHYS, V143, P566; GARFINKEL D, 1966, J BIOL CHEM, V41, P3918; HANSTOCK CC, 1988, P NATL ACAD SCI USA, V85, P1821, DOI 10.1073/pnas.85.6.1821; HERTZ L, 1983, GLUTAMINE GLUTAMATE, P327; HILBERMAN M, 1984, J CEREBR BLOOD F MET, V4, P334, DOI 10.1038/jcbfm.1984.50; LAJTHA A, 1959, J NEUROCHEM, V3, P322, DOI 10.1111/j.1471-4159.1959.tb12638.x; LONDON RE, 1975, J AM CHEM SOC, V97, P3565, DOI 10.1021/ja00846a001; LONDON RE, 1988, PROGR NMR SPECT, V20, P237; MALLOY CR, 1987, FEBS LETT, V212, P58, DOI 10.1016/0014-5793(87)81556-9; MALLOY CR, 1988, J BIOL CHEM, V263, P6964; McIlwain H., 1971, BIOCH CENTRAL NERVOU; METCALFE JC, 1971, NATURE, V233, P199, DOI 10.1038/233199a0; NORENBERG MD, 1979, J HISTOCHEM CYTOCHEM, V27, P756, DOI 10.1177/27.3.39099; Olendorf W., 1973, AM J PHYSIOL, V224, P1450; OLENDORF WH, 1976, AM J PHYSIOL, V230, P94; PAHLWOSTL C, 1987, BIOL CHEM H-S, V368, P205, DOI 10.1515/bchm3.1987.368.1.205; PAHLWOSTL C, 1986, BIOCHEMISTRY-US, V25, P6799, DOI 10.1021/bi00370a011; PARDRIDGE WM, 1983, PHYSIOL REV, V63, P1481, DOI 10.1152/physrev.1983.63.4.1481; PATEL MS, 1974, J NEUROCHEM, V22, P717, DOI 10.1111/j.1471-4159.1974.tb04285.x; PEREZSALA D, 1987, BIOCHEM J, V241, P491, DOI 10.1042/bj2410491; PETROFF OAC, 1985, NEUROLOGY, V35, P781, DOI 10.1212/WNL.35.6.781; PRICHARD JW, 1983, P NATL ACAD SCI-BIOL, V80, P2748, DOI 10.1073/pnas.80.9.2748; PRICHARD JW, 1986, ANNU REV NEUROSCI, V9, P61; RUDERMAN NB, 1974, BIOCHEM J, V138, P1; SCHOOLMAN M, 1987, POLIT THEORY, V15, P205, DOI 10.1177/0090591787015002003; SHERRY AD, 1988, BIOCHEM J, V254, P593, DOI 10.1042/bj2540593; STRISOWER EH, 1952, J BIOL CHEM, V198, P115; VANDENBE.CJ, 1971, BIOCHEM J, V123, P211, DOI 10.1042/bj1230211; VANDENBERG CJ, 1969, BIOCHEM J, V113, P281, DOI 10.1042/bj1130281; WALKER TE, 1982, J BIOL CHEM, V257, P1189; YU ACH, 1983, J NEUROCHEM, V41, P1484, DOI 10.1111/j.1471-4159.1983.tb00849.x	50	296	301	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 5	1990	265	22					12916	12926						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR201	1973931				2022-12-25	WOS:A1990DR20100030
J	MARSHALL, S; BACOTE, V; TRAXINGER, RR				MARSHALL, S; BACOTE, V; TRAXINGER, RR			DISCOVERY OF A METABOLIC PATHWAY MEDIATING GLUCOSE-INDUCED DESENSITIZATION OF THE GLUCOSE-TRANSPORT SYSTEM - ROLE OF HEXOSAMINE BIOSYNTHESIS IN THE INDUCTION OF INSULIN RESISTANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT ADIPOSE CELL; PRIMARY CULTURED ADIPOCYTES; PLASMA-MEMBRANE; FAT-CELLS; MECHANISM; TRANSLOCATION; DEPLETION; SITE	Based on our previous finding that desensitization of the insulin-responsive glucose transport system (GTS) requires three components, glucose, insulin, and glutamine, we postulated that the routing of incoming glucose through the hexosamine biosynthesis pathway plays a key role in the development of insulin resistance in primary cultured adipocytes. Two approaches were used to test this hypothesis. First, we assessed whether glucose-induced desensitization of the GTS could be prevented by glutamine analogs that irreversibly inactivate glutamine-requiring enzymes, such as glutamine:fructose-6-phosphate amidotransferase (GFAT) the first and the rate-limiting enzyme in hexosamine biosynthesis. Both O-diazoacetyl-L-serine (azaserine) and 6-diazo-5-oxonorleucine inhibited desensitization in 18-h treated cells without affecting maximal insulin responsiveness in control cells. Moreover, close agreement was seen between the ability of azaserine to prevent desensitization of the GTS in intact adipocytes (70% inhibition, ED50 = 1.1-mu-M), its ability to inactivate GFAT in intact adipocytes (64% inhibition, ED50 = 1.0-mu-M) and its ability to inactivate GFAT activity in a cytosolic adipocyte preparation (ED50 = 1.3-mu-M). From these results we concluded that a glutamine amidotransferase is involved in the induction of insulin resistance. As a second approach, we determined whether glucosamine, an agent known to preferentially enter the hexosamine pathway at a point distal to enzymatic amidation by GFAT, could induce cellular insulin resistance. When adipocytes were exposed to various concentrations of glucosamine for 5 h, progressive desensitization of the GTS was observed (ED50 = 0.36 mM) that culminated in a 40-50% loss of insulin responsiveness. Moreover, we estimated that glucosamine is at least 40 times more potent than glucose in mediating desensitization, since glucosamine entered adipocytes at only one-quarter of the glucose uptake rate, yet induced desensitization at an extracellular dose 10 times lower than glucose. In addition, we found that glucosamine-induced desensitization did not require glutamine and was unaffected by azaserine treatment. Thus, we conclude that glucosamine enters the hexosamine-desensitization pathway at a point distal to GFAT amidation. Overall, these studies indicate that a unique metabolic pathway exists in adipocytes that mediates desensitization of the insulin-responsive GTS, and reveal that an early step in this pathway involves the conversion of fructose 6-phosphate to glucosamine 6-phosphate by the first and rate-limiting enzyme of the hexosamine pathway, glutamine:fructose-6-phosphate amidotransferase.			MARSHALL, S (corresponding author), UNIV TENNESSEE,CTR HLTH SCI,DEPT BIOCHEM,800 MADISON AVE,MEMPHIS,TN 38163, USA.				NIDDK NIH HHS [DK38754, DK08206] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK008206, R01DK038754] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BADET B, 1987, BIOCHEMISTRY-US, V26, P1940, DOI 10.1021/bi00381a023; BEKESI JG, 1969, J BIOL CHEM, V244, P5663; BEUTLER HO, 1983, METHOD ENZYMAT AN, V2, P331; CORY JG, 1986, TXB BIOCH CLIN CORRE, P489; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; CUSHMAN SW, 1931, ADIPOCYTE OBESITY CE, P105; DELGIACCO R, 1964, J BIOL CHEM, V239, P2400; FERRANNINI E, 1988, PATHOGENESIS NONINSU, P201; FLIER JS, 1983, ANNU REV MED, V34, P145, DOI 10.1146/annurev.me.34.020183.001045; GARVEY WT, 1987, J BIOL CHEM, V262, P189; GARVEY WT, 1988, PATHOGENESIS NONINSU, P171; HASSELL JR, 1986, ANNU REV BIOCHEM, V55, P539, DOI 10.1146/annurev.bi.55.070186.002543; HISSIN PJ, 1982, J CLIN INVEST, V70, P780, DOI 10.1172/JCI110674; HISSIN PJ, 1982, DIABETES, V31, P589, DOI 10.2337/diabetes.31.7.589; KAHN CR, 1978, METABOLISM, V27, P1893; KARNIELI E, 1981, J BIOL CHEM, V256, P4772; KONO T, 1982, J BIOL CHEM, V257, P942; KONO T, 1981, J BIOL CHEM, V256, P6400; KORNFELD S, 1966, EXP CELL RES, V41, P592, DOI 10.1016/S0014-4827(66)80109-X; MARSHALL S, 1984, J BIOL CHEM, V259, P6376; MARSHALL S, 1983, DIABETES, V32, P319, DOI 10.2337/diab.32.4.319; MOLNAR J, 1964, J BIOL CHEM, V239, P3157; OLEFSKY JM, 1989, ENDOCRINOLOGY, P1369; RODBELL M, 1964, J BIOL CHEM, V239, P375; Schauer R., 1982, ADV CARBOHYD CHEM BI, V40, P132; SCHWARTZ NB, 1986, TXB BIOCH CLIN CORRE, P329; SHAFRIR E, 1987, ENDOCRINOL METAB, P1043; SMITH U, 1988, PATHOGENESIS NONINSU, P221; SUZUKI K, 1980, P NATL ACAD SCI-BIOL, V77, P2542, DOI 10.1073/pnas.77.5.2542; TRAXINGER RR, 1989, J BIOL CHEM, V264, P8156; TRAXINGER RR, 1989, J BIOL CHEM, V264, P20910; TRAXINGER RR, 1990, BIOCHEM INT, V22, P607; WHITESELL RR, 1979, J BIOL CHEM, V254, P5276; YUTEH B, 1982, ADV CARBOHY CHEM BIO, V40, P235; ZUBAY G, 1988, BIOCHEMISTRY-US, P806	35	804	829	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4706	4712						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002019				2022-12-25	WOS:A1991FC21700009
J	WIEMANN, S; KINZEL, V; PYERIN, W				WIEMANN, S; KINZEL, V; PYERIN, W			ISOFORM C-BETA-2, AN UNUSUAL FORM OF THE BOVINE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN-KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I REGULATORY SUBUNIT; MOLECULAR-CLONING; CDNA CLONE; C-ALPHA; MUSCLE; SEQUENCES; TRANSLATION; INVITRO; SYSTEM; BRAIN	The catalytic (C) subunit is the phosphorylating component of the cAMP-dependent protein kinase, a key element in a multitude of hormonally controlled cellular functions. The C-subunit, thought to be a solitary protein until several years ago, is now known to be a group of isoforms comprising as yet C-alpha, C-beta, and C-gamma. We report here the isolation of a full-length cDNA clone coding for a hitherto undiscovered isoform of the bovine C-subunit. The end parts of the 5'-coding region and the 5'-noncoding region of this 3365-base pair clone are unique, whereas the rest of the coding region and the 3'-noncoding region are identical to those of isoform C-beta. The clone has therefore been named C-beta-2. The deduced amino acid sequence of C-beta-2 has a length of 397 amino acid residues and a calculated molecular mass of 46.1 kDa, thus being some 6 kDa higher than that of any known C-subunit. In vitro translation of clone C-beta-2 resulted in a single 46-kDa protein. The unique amino-terminal sequence of C-beta-2 lacks the usual myristoylation site of C-subunits. It contains a stretch of hydrophobic residues (residues 7-19) and a stretch which may fold into an amphiphilic alpha-helix (residues 16-27) conceivably serving targeting functions. The existence of isoform C-beta-2 is confirmed by: (i) the isolation of a second independent C-beta-2 clone, (ii) the development of products of expected size and sequence upon amplification from total RNA of various bovine tissues with the polymerase chain reaction using C-beta-2-specific primers, and (iii) Northern blots probed with a cDNA fragment containing exclusively C-beta-2 sequence. C-beta-2 mRNA has a size of 4.4 kilobases and is expressed in various bovine tissues, mainly in heart and brain. Both the size and tissue distribution are indistinguishable from those of C-beta mRNA, thus explaining the failure of previous investigations to distinguish it from C-beta-2. Southern blotting and polymerase chain reaction with genomic DNA indicate that intron sequence(s) exist at the C-beta-2/C-beta deviation site (bases 267/268). The deviation site is equivalent to the exon 1/exon 2 splice site of the mouse C-subunit. Since splice sites are highly conserved and since not a single mutation is found downstream of the deviation site, it is tempting to suppose that C-beta-2 and C-beta are coded by one gene which possesses two alternatively spliced exons 1.	GERMAN CANC RES CTR,INST EXPTL PATHOL,W-6900 HEIDELBERG 1,GERMANY	Helmholtz Association; German Cancer Research Center (DKFZ)			Wiemann, Stefan/E-4424-2013	Wiemann, Stefan/0000-0003-4683-3174				ADAVANI SR, 1987, EUR J BIOCHEM, V167, P221, DOI 10.1111/j.1432-1033.1987.tb13326.x; BEEBE SJ, 1990, MOL ENDOCRINOL, V4, P465, DOI 10.1210/mend-4-3-465; CARR SA, 1982, P NATL ACAD SCI-BIOL, V79, P6128, DOI 10.1073/pnas.79.20.6128; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHRIVIA JC, 1988, J BIOL CHEM, V263, P5739; CLEGG CH, 1988, P NATL ACAD SCI USA, V85, P3703, DOI 10.1073/pnas.85.11.3703; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GAGELMANN M, 1980, P NATL ACAD SCI-BIOL, V77, P2492, DOI 10.1073/pnas.77.5.2492; GRANTHAM R, 1981, NUCLEIC ACIDS RES, V9, pR43; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; HOTZ A, 1989, FEBS LETT, V256, P115, DOI 10.1016/0014-5793(89)81729-6; HOTZ A, 1989, BIOCHEM BIOPH RES CO, V160, P596, DOI 10.1016/0006-291X(89)92474-1; JAHNSEN T, 1986, J BIOL CHEM, V261, P2352; KAISER ET, 1987, TRENDS BIOCHEM SCI, V12, P305, DOI 10.1016/0968-0004(87)90147-2; KINZEL V, 1987, ARCH BIOCHEM BIOPHYS, V253, P341, DOI 10.1016/0003-9861(87)90187-1; KUBLER D, 1979, H-S Z PHYSIOL CHEM, V360, P1421, DOI 10.1515/bchm2.1979.360.2.1421; LEE DC, 1983, P NATL ACAD SCI-BIOL, V80, P3608, DOI 10.1073/pnas.80.12.3608; MALDONADO F, 1988, NUCLEIC ACIDS RES, V16, P8189, DOI 10.1093/nar/16.16.8189; Maniatis T., 1982, MOL CLONING; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; ROBERTS BE, 1973, P NATL ACAD SCI USA, V70, P2330, DOI 10.1073/pnas.70.8.2330; ROTH JS, 1990, CANCER RES, V50, P1675; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHMIDT MFG, 1989, BIOCHIM BIOPHYS ACTA, V988, P411, DOI 10.1016/0304-4157(89)90013-0; SCOTT JD, 1987, P NATL ACAD SCI USA, V84, P5192, DOI 10.1073/pnas.84.15.5192; SHOWERS MO, 1986, J BIOL CHEM, V261, P6288; STUEBER D, 1984, EMBO J, V3, P3143, DOI 10.1002/j.1460-2075.1984.tb02271.x; TAYLOR SS, 1988, COLD SPRING HARB SYM, V53, P121, DOI 10.1101/SQB.1988.053.01.018; UHLER MD, 1986, J BIOL CHEM, V261, P5360; UHLER MD, 1986, P NATL ACAD SCI USA, V83, P1300, DOI 10.1073/pnas.83.5.1300; WALSH DA, 1968, J BIOL CHEM, V243, P3763	34	65	68	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					5140	5146						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002051				2022-12-25	WOS:A1991FC21700069
J	BROOKER, RJ				BROOKER, RJ			AN ANALYSIS OF LACTOSE PERMEASE SUGAR SPECIFICITY MUTATIONS WHICH ALSO AFFECT THE COUPLING BETWEEN PROTON AND LACTOSE TRANSPORT .1. VAL177 AND VAL177/ASN319 PERMEASES FACILITATE PROTON UNIPORT AND SUGAR UNIPORT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; LAC PERMEASE; ACTIVE-TRANSPORT; CARRIER PROTEIN; CATION SPECIFICITY; PLASMA-MEMBRANE; MUTANTS; HISTIDINE-322; COTRANSPORT; MALTOSE	The sugar specificity mutants of the lactose permease containing Val177 or Val177/Asn319 were analyzed with regard to their ability to couple H+ and sugar co-transport. Both mutants were able to transport lactose downhill to a significant degree. The Val177 mutant was partially defective in the active accumulation of galactosides, whereas the Val177/Asn319 mutant was completely defective in the uphill accumulation of sugars. With regard to coupling, the Val177 mutant was shown to catalyze the uncoupled transport of H+ to a substantial degree. This led to a decrease in the H+ electrochemical gradient under aerobic conditions and also resulted in faster H+ uptake when a transient H+ electrochemical gradient was generated under anaerobic conditions. Interestingly, galactosides were shown to diminish the rate of uncoupled H+ transport in the Val177 strain. The Val177/Asn319 strain also catalyzed uncoupled H+ transport, but to a lesser degree than the single Val177 mutant. In addition, the Val177/Asn319 mutant was shown to transport galactosides with or without H+. The observed H+/lactose stoichiometry was 0.30 in the double mutant compared to 0.98 in the wild-type strain. When an H+ electrochemical gradient was generated across the membrane, the Val177/Asn319 mutant permease was shown to facilitate an extremely rapid net H+ leak if nonmetabolizable galactosides had been equilibrated across the membrane. The mechanism of this leak is consistent with a circular pathway involving H+/galactoside influx and uncoupled galactoside efflux. The magnitude of the H+ leak in the presence of nonmetabolizable galactosides was so great in the double mutant that low concentrations of certain galactosides (i.e. 0.5 mM thiodigalactoside) resulted in a complete inhibition of growth. These results are discussed with regard to the possibility that cation and sugar binding to the lactose permease may involve a direct physical coupling at a common recognition site.	UNIV MINNESOTA,INST ADV STUDIES BIOL PROC TECHNOL,ST PAUL,MN 55108	University of Minnesota System; University of Minnesota Twin Cities	BROOKER, RJ (corresponding author), UNIV MINNESOTA,DEPT GENET & CELL BIOL,ST PAUL,MN 55108, USA.				NIAID NIH HHS [AI24204] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024204] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BEYREUTHER K, 1982, METHODS PROTEIN SEQU, P139; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BOOTH IR, 1979, BIOCHEM J, V182, P687, DOI 10.1042/bj1820687; BOTFIELD MC, 1988, J BIOL CHEM, V263, P12909; BOYER PD, 1988, TRENDS BIOCHEM SCI, V13, P5, DOI 10.1016/0968-0004(88)90005-9; BROOKER RJ, 1985, P NATL ACAD SCI USA, V82, P3959, DOI 10.1073/pnas.82.12.3959; BROOKER RJ, 1989, J BIOL CHEM, V264, P8135; BROOKER RJ, 1985, J BIOL CHEM, V260, P6181; BROOKER RJ, 1990, J BIOL CHEM, V265, P4155; BUCHEL DE, 1980, NATURE, V283, P541, DOI 10.1038/283541a0; CARRASCO N, 1986, BIOCHEMISTRY-US, V25, P4486, DOI 10.1021/bi00364a004; CRANE RK, 1977, REV PHYSIOL BIOCH P, V78, P99, DOI 10.1007/BFb0027722; CRANE RK, 1962, FED PROC, V21, P891; CRANE RK, 1960, PHYSIOL REV, V40, P784; EDDY AA, 1971, BIOCHEM J, V122, P701, DOI 10.1042/bj1220701; FELLE H, 1980, BIOCHEMISTRY-US, V19, P3585, DOI 10.1021/bi00556a026; FOSTER DL, 1983, J BIOL CHEM, V258, P31; FOX CF, 1965, P NATL ACAD SCI USA, V54, P891, DOI 10.1073/pnas.54.3.891; FRANCO PJ, 1989, J BIOL CHEM, V264, P15988; Gabrovec S, 1974, ARHEOLO KI VESTNIK, V25, P287; KABACK HR, 1986, ANNU REV BIOPHYS BIO, V15, P279; KING SC, 1989, J BIOL CHEM, V264, P7390; KING SC, 1989, BIOCHIM BIOPHYS ACTA, V982, P253, DOI 10.1016/0005-2736(89)90062-X; KING SC, 1990, J BIOL CHEM, V265, P9645; KOMOR E, 1973, FEBS LETT, V38, P16, DOI 10.1016/0014-5793(73)80501-0; Mandel M, 1970, J MOL BIOL, V53, P154; MARKGRAF M, 1985, MOL GEN GENET, V198, P473, DOI 10.1007/BF00332941; MENICK DR, 1985, BIOCHEM BIOPH RES CO, V132, P162, DOI 10.1016/0006-291X(85)91002-2; MENICK DR, 1987, BIOCHEMISTRY-US, V26, P6638, DOI 10.1021/bi00395a012; Miller J. H., 1972, EXPT MOL GENETICS, P433; Mitchell P., 1963, BIOCHEM SOC SYMP, V22, P142; PUTTNER IB, 1986, BIOCHEMISTRY-US, V25, P4483; QUIOCHO FA, 1986, ANNU REV BIOCHEM, V55, P287, DOI 10.1146/annurev.bi.55.070186.001443; RICKENBERG HV, 1956, ANN I PASTEUR PARIS, V91, P829; ROEPE PD, 1990, RES MICROBIOL, V141, P290, DOI 10.1016/0923-2508(90)90003-9; SLAYMAN CL, 1974, P NATL ACAD SCI USA, V71, P1935, DOI 10.1073/pnas.71.5.1935; TEATHER RM, 1978, MOL GEN GENET, V159, P239, DOI 10.1007/BF00268260; TEATHER RM, 1980, EUR J BIOCHEM, V108, P223, DOI 10.1111/j.1432-1033.1980.tb04715.x; TSUCHIYA T, 1980, MEMBRANE BIOCHEM, V3, P131, DOI 10.3109/09687688009063881; VOGEL H, 1985, EMBO J, V4, P3625, DOI 10.1002/j.1460-2075.1985.tb04126.x; WEST I, 1972, J BIOENERG, V3, P445, DOI 10.1007/BF01516082; WEST IC, 1973, BIOCHEM J, V132, P587, DOI 10.1042/bj1320587; WEST IC, 1970, BIOCHEM BIOPH RES CO, V41, P655, DOI 10.1016/0006-291X(70)90063-X; WILSON DM, 1981, BIOCHIM BIOPHYS ACTA, V649, P377, DOI 10.1016/0005-2736(81)90427-2; WILSON DM, 1980, FEBS LETT, V117, P37; WILSON TH, 1970, BIOCHEM BIOPH RES CO, V40, P1409; WILSON TH, 1983, CELL MEMBR METH REV, V1, P1; WILSON TH, 1972, BIOCHIM BIOPHYS ACTA, V255, P786; WILSON TH, 1980, ANN NY ACAD SCI, V341, P465; WRIGHT JK, 1986, ANNU REV BIOCHEM, V55, P225	50	45	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4131	4138						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999407				2022-12-25	WOS:A1991FA69400020
J	DALMAN, FC; SCHERRER, LC; TAYLOR, LP; AKIL, H; PRATT, WB				DALMAN, FC; SCHERRER, LC; TAYLOR, LP; AKIL, H; PRATT, WB			LOCALIZATION OF THE 90-KDA HEAT-SHOCK PROTEIN-BINDING SITE WITHIN THE HORMONE-BINDING DOMAIN OF THE GLUCOCORTICOID RECEPTOR BY PEPTIDE COMPETITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROID-BINDING; DNA-BINDING; DEXAMETHASONE 21-MESYLATE; COMPLEMENTARY-DNA; NUCLEAR RECEPTORS; RETINOIC ACID; AMINO-ACID; PROGESTERONE RECEPTORS; MONOCLONAL-ANTIBODY; RAT-LIVER	In this work, we used two approaches to localize the 90-kDa heat shock protein (hsp90)-binding site within the hormone-binding domain of the glucocorticoid receptor. In the first approach, derivatives of the glucocorticoid receptor deleted for increasing portions of the COOH terminus were translated in rabbit reticulocyte lysate, and the [S-35]methionine-labeled translation products were immunoadsorbed with the 8D3 monoclonal antibody against hsp90. The data suggest that a segment from amino acids 604 to 659 (mouse) of the receptor is required for hsp90 binding. We have recently shown that the internal deletion mutant of the mouse receptor (DELTA-574-632) binds hsp90, although the complex is somewhat unstable (Housley, P. R., Sanchez, E. R., Danielsen, M., Ringold, G. M., and Pratt, W. B. (1990) J. Biol. Chem. 265, 12778-12781). The two observations indicate that amino acids 574-659 are involved in forming a stable receptor-hsp90 complex and that region 632-659 is especially important. To test this hypothesis directly, we synthesized three peptides corresponding to segments in region 624-665 and three peptides spanning the highly conserved sequence at amino acids 582-617, and we then tested the ability of the peptides to compete for the association of hsp90 with the L cell glucocorticoid receptor. In this assay, the immunopurified hsp90-free mouse receptor is incubated with rabbit reticulocyte lysate, which directs the association of rabbit hsp90 with the mouse receptor, simultaneously converting the receptor to the steroid binding state. All three peptides spanning region 624-665 and a peptide corresponding to segment 587-606 inhibited both hsp90 association with the receptor and reconstitution of steroid binding capacity. The data from all of the approaches support a two-site model for the hsp90-binding site in which the critical contact site occurs in region 632-659, which contains a short proline-containing hydrophobic segment and adjacent dipole-plus-cysteine motif that are conserved among all of the hsp90-binding receptors in the super-family. A second hsp90 contact site is predicted in region 574-632, which contains the only highly conserved amino acid sequence in the receptor superfamily outside of the DNA-binding domain.	UNIV MICHIGAN, SCH MED, DEPT PHARMACOL, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, SCH MED, MENTAL HLTH RES INST, ANN ARBOR, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan					NATIONAL CANCER INSTITUTE [R01CA028010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK031573, R01DK031573] Funding Source: NIH RePORTER; NCI NIH HHS [CA28010] Funding Source: Medline; NIDDK NIH HHS [DK31573] Funding Source: Medline; NIMH NIH HHS [MH 42251] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; BAKER AR, 1988, P NATL ACAD SCI USA, V85, P3294, DOI 10.1073/pnas.85.10.3294; BRESNICK EH, 1990, BIOCHEMISTRY-US, V29, P520, DOI 10.1021/bi00454a028; BRESNICK EH, 1988, J STEROID BIOCHEM, V30, P267, DOI 10.1016/0022-4731(88)90104-5; BRESNICK EH, 1989, J BIOL CHEM, V264, P4992; CARLSTEDTDUKE J, 1988, J BIOL CHEM, V263, P6842; CASANOVA J, 1984, J BIOL CHEM, V259, P2084; CHANG CS, 1988, SCIENCE, V240, P324, DOI 10.1126/science.3353726; DALMAN FC, 1989, J BIOL CHEM, V264, P19815; DALMAN FC, 1990, J BIOL CHEM, V265, P3615; DANIELSEN M, 1986, EMBO J, V5, P2513, DOI 10.1002/j.1460-2075.1986.tb04529.x; DENIS M, 1988, J BIOL CHEM, V263, P18520; DENIS M, 1988, NATURE, V333, P686, DOI 10.1038/333686a0; DENIS M, 1987, J BIOL CHEM, V262, P11803; EHRHART JC, 1988, ONCOGENE, V3, P595; GAMETCHU B, 1984, ENDOCRINOLOGY, V114, P274, DOI 10.1210/endo-114-1-274; GASC JM, 1989, EXP CELL RES, V181, P492, DOI 10.1016/0014-4827(89)90106-7; GEHRING U, 1985, FEBS LETT, V179, P138, DOI 10.1016/0014-5793(85)80208-8; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; GREENE GL, 1986, SCIENCE, V231, P1150, DOI 10.1126/science.3753802; HAUSSLER MR, 1988, RECENT PROG HORM RES, V44, P263; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; HOUSLEY PR, 1990, J BIOL CHEM, V265, P12778; HOUSLEY PR, 1985, J BIOL CHEM, V260, P3810; HOWARD KJ, 1990, J BIOL CHEM, V265, P11928; LOPEZ S, 1990, J BIOL CHEM, V265, P16039; LUBAHN DB, 1988, SCIENCE, V240, P327, DOI 10.1126/science.3353727; MENDEL DB, 1988, J BIOL CHEM, V263, P6695; MENDEL DB, 1986, J BIOL CHEM, V261, P3758; MESHINCHI S, 1990, J BIOL CHEM, V265, P4863; MESHINCHI S, 1990, J BIOL CHEM, V265, P11643; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; MILLER NR, 1988, J BIOL CHEM, V263, P15217; MILLER PA, 1988, ENDOCRINOLOGY, V122, P2990, DOI 10.1210/endo-122-6-2990; MISRAHI M, 1987, BIOCHEM BIOPH RES CO, V143, P740, DOI 10.1016/0006-291X(87)91416-1; NEMOTO T, 1990, BIOCHEMISTRY-US, V29, P1880, DOI 10.1021/bi00459a031; NERVI C, 1989, P NATL ACAD SCI USA, V86, P5854, DOI 10.1073/pnas.86.15.5854; OKRET S, 1985, BIOCHEMISTRY-US, V24, P6581, DOI 10.1021/bi00344a041; PERDEW GH, 1988, J BIOL CHEM, V263, P13802; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; PRATT WB, 1987, J CELL BIOCHEM, V35, P51, DOI 10.1002/jcb.240350105; PRATT WB, 1988, J BIOL CHEM, V263, P267; RUSCONI S, 1987, EMBO J, V6, P1309, DOI 10.1002/j.1460-2075.1987.tb02369.x; SAMUELS HH, 1974, J CLIN INVEST, V54, P853, DOI 10.1172/JCI107825; SANCHEZ ER, 1985, J BIOL CHEM, V260, P2398; SANCHEZ ER, 1987, J BIOL CHEM, V262, P6986; SANCHEZ ER, 1990, J BIOL CHEM, V265, P20123; SCHERRER LC, 1990, J BIOL CHEM, V265, P21397; SIMONS SS, 1987, J BIOL CHEM, V262, P9676; SIMONS SS, 1990, J BIOL CHEM, V265, P1938; SIMONS SS, 1989, J BIOL CHEM, V264, P14493; SISTARE FD, 1987, MOL ENDOCRINOL, V1, P648, DOI 10.1210/mend-1-9-648; SMITH DF, 1990, MOL ENDOCRINOL, V4, P1704, DOI 10.1210/mend-4-11-1704; SMITH LI, 1988, BIOCHEMISTRY-US, V27, P3747, DOI 10.1021/bi00410a034; SPINDLER BJ, 1975, J BIOL CHEM, V250, P4113; WALTERS MR, 1985, ENDOCR REV, V6, P512, DOI 10.1210/edrv-6-4-512; WALTERS SN, 1986, ARCH BIOCHEM BIOPHYS, V246, P366, DOI 10.1016/0003-9861(86)90481-9; WATSON SJ, 1983, P NATL ACAD SCI-BIOL, V80, P891, DOI 10.1073/pnas.80.3.891; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0	61	151	152	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3482	3490						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995612				2022-12-25	WOS:A1991EY68200025
J	FABRE, E; NICAUD, JM; LOPEZ, MC; GAILLARDIN, C				FABRE, E; NICAUD, JM; LOPEZ, MC; GAILLARDIN, C			ROLE OF THE PROREGION IN THE PRODUCTION AND SECRETION OF THE YARROWIA-LIPOLYTICA ALKALINE EXTRACELLULAR PROTEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-LYTIC PROTEASE; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; DIPEPTIDYL AMINOPEPTIDASE; ENDOPLASMIC-RETICULUM; NEUTRAL PROTEASE; PRO-SEQUENCE; YEAST; PROTEINS; GLYCOSYLATION	The yeast Yarrowia lipolytica secretes an alkaline extracellular protease (AEP). It is first synthesized as a precursor comprising a putative signal peptide, a stretch of 10 X-Ala or X-Pro sequences that are substrates for a dipeptidyl aminopeptidase, a large proregion that contains a glycosylation site and two LysArg sites that can be cleaved by a KEX2-like endoprotease and finally the mature protease itself. A defect in the XPR6 (KEX2-like) gene results in the secretion of an inactive proenzyme (Matoba, S., and Ogrydziak, D. M. (1989) J. Biol. Chem. 264, 6037-6043), showing that the proregion inhibits protease activity. To determine whether the proregion plays an additional role in protease secretion, we have generated deletions and point mutations in the corresponding region of the structural gene. In this paper we examine the effects of these mutations on AEP secretion and maturation and show that the proregion is essential for its secretion. All deletions affecting the proregion resulted in the intracellular accumulation of unprocessed precursors. Deletion of the glycosylation site in the proregion resulted in the production of an unglycosylated precursor that was secreted and matured correctly at 18-degrees-C but accumulated in the cells at 28-degrees-C. From these results, we propose that the AEP prosequence plays an additional essential role in guiding the proper folding of the protein into a conformation compatible with secretion.	CNRS,INRA,CTR BIOTECHNOL AGR IND,INST NATL AGRON,GENET LAB,F-78850 THIVERVAL GRIGNON,FRANCE	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay			Nicaud, jean marc/G-4204-2016; NICAUD, Jean-marc/ABA-9076-2021	Nicaud, jean marc/0000-0002-6679-972X; FABRE, Emmanuelle/0000-0002-0009-4604				BRAKE AJ, 1984, P NATL ACAD SCI-BIOL, V81, P4642, DOI 10.1073/pnas.81.15.4642; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; BUSSEY H, 1988, YEAST, V4, P17, DOI 10.1002/yea.320040103; CARTER P, 1985, NUCLEIC ACIDS RES, V13, P4431, DOI 10.1093/nar/13.12.4431; DAGERT M, 1979, GENE, V6, P23, DOI 10.1016/0378-1119(79)90082-9; DAVIDOW LS, 1987, J BACTERIOL, V169, P4621, DOI 10.1128/jb.169.10.4621-4629.1987; DAVIS RW, 1980, ADV BACTERIAL GENET, P116; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; DOCHERTY K, 1982, ANNU REV PHYSIOL, V44, P625, DOI 10.1146/annurev.ph.44.030182.003205; EFIMOV VA, 1983, NUCLEIC ACIDS RES, V11, P8369, DOI 10.1093/nar/11.23.8369; ERNST JF, 1988, DNA-J MOLEC CELL BIO, V7, P355, DOI 10.1089/dna.1.1988.7.355; FELDMAN RI, 1987, J BIOL CHEM, V262, P9332; FERRONOVICK S, 1984, J CELL BIOL, V98, P44, DOI 10.1083/jcb.98.1.44; Franke A.E., 1988, DEV IND MICROBIOL, V29, P43; GAILLARDIN C, 1985, CURR GENET, V10, P49, DOI 10.1007/BF00418493; GAILLARDIN C, 1987, CURR GENET, V11, P369, DOI 10.1007/BF00378179; HESLOT H, 1990, 2ND P SSM INT C MICR, P27; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; HOLMES DS, 1981, ANAL BIOCHEM, V114, P193, DOI 10.1016/0003-2697(81)90473-5; IKEMURA H, 1988, J BIOL CHEM, V263, P12959; IKEMURA H, 1987, J BIOL CHEM, V262, P7859; JAMES M, 1988, YEAST, V4, pS441; JULIUS D, 1983, CELL, V32, P839, DOI 10.1016/0092-8674(83)90070-3; JULIUS D, 1984, CELL, V36, P309, DOI 10.1016/0092-8674(84)90224-1; KALETTA C, 1989, J BACTERIOL, V171, P1597, DOI 10.1128/jb.171.3.1597-1601.1989; KOK J, 1985, APPL ENVIRON MICROB, V50, P94, DOI 10.1128/AEM.50.1.94-101.1985; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATOBA S, 1988, MOL CELL BIOL, V8, P4904, DOI 10.1128/MCB.8.11.4904; MATOBA S, 1989, J BIOL CHEM, V264, P6037; MILLER JH, 1972, MOL CLONING LABORATO, P431; MIZUNAGA T, 1988, J BIOCHEM-TOKYO, V103, P321, DOI 10.1093/oxfordjournals.jbchem.a122268; NAKAYAMA A, 1987, J BIOTECHNOL, V5, P171, DOI 10.1016/0168-1656(87)90014-9; NICAUD JM, 1989, CURR GENET, V16, P253, DOI 10.1007/BF00422111; NICAUD JM, 1989, J BIOTECHNOL, V12, P285, DOI 10.1016/0168-1656(89)90048-5; NOVICK P, 1981, CELL, V25, P461, DOI 10.1016/0092-8674(81)90064-7; OGRYDZIAK DM, 1977, BIOCHIM BIOPHYS ACTA, V497, P525, DOI 10.1016/0304-4165(77)90209-4; OGRYDZIAK DM, 1977, GENETICS, V87, P621; PARK SH, 1988, SCIENCE, V239, P1033, DOI 10.1126/science.3278378; PUGSLEY A, 1989, PROTEIN TARGETING, P20; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHULKE N, 1988, J BIOL CHEM, V263, P8832; SILEN JL, 1989, J BACTERIOL, V171, P1320, DOI 10.1128/jb.171.3.1320-1325.1989; SILEN JL, 1989, NATURE, V341, P462, DOI 10.1038/341462a0; SILEN JL, 1988, GENE, V69, P237, DOI 10.1016/0378-1119(88)90434-9; STOLLER TJ, 1989, J CELL BIOL, V108, P1647, DOI 10.1083/jcb.108.5.1647; TOBE ST, 1976, AGR BIOL CHEM TOKYO, V40, P1037; VALLS LA, 1987, CELL, V48, P887, DOI 10.1016/0092-8674(87)90085-7; VASANTHA N, 1984, J BACTERIOL, V159, P811, DOI 10.1128/JB.159.3.811-819.1984; WANDERSMAN C, 1989, MOL MICROBIOL, V3, P1825, DOI 10.1111/j.1365-2958.1989.tb00169.x; ZHU XL, 1989, NATURE, V339, P483, DOI 10.1038/339483a0	50	58	65	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3782	3790						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995632				2022-12-25	WOS:A1991EY68200067
J	FLOTOW, H; ROACH, PJ				FLOTOW, H; ROACH, PJ			ROLE OF ACIDIC RESIDUES AS SUBSTRATE DETERMINANTS FOR CASEIN KINASE-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE PHOSPHORYLASE-KINASE; PROTEIN-KINASE; GLYCOGEN-SYNTHASE; RABBIT MUSCLE; CYCLIC-AMP; SPECIFICITY	Sites phosphorylated by casein kinase I have been characterized by the presence of acidic amino acids NH2-terminal to the modified residue. Recently, phosphoserine was shown to be a particularly effective determinant for casein kinase I action when present in the motif -S(P)-X-X-S- (Flotow, H., Graves, P. R., Wang, A., Fiol, C. J., Roeske, R. W., and Roach, P. J. (1990) J. Biol. Chem. 265, 14264-14269). Nonetheless, nonphosphorylated substrates for casein kinase I are well documented. In this study, we examined the efficacy of Asp and Glu residues as determinants of casein kinase I action using synthetic peptide substrates. Peptides with runs of Asp residues in the motif D(n)-X-X-S- were substrates for casein kinase I. Peptides with n = 3 or 4 were the most effective substrates, much better than n = 2. The peptide with n = 1, a single Asp residue, was a very poor substrate. A block of 4 Glu residues was a little less effective as a substrate determinant than 4 Asp residues in an otherwise identical peptide. The most effective substrate, with the motif -D-D-D-D-X-X-S-, was specific for casein kinase I and was not detectably phosphorylated by cyclic AMP-dependent protein kinase, casein kinase II, glycogen synthase kinase 3, or phosphorylase kinase and thus will be useful for the specific assay of casein kinase I. This peptide was nonetheless significantly worse as a substrate than peptides in which casein kinase I action was determined by phosphoserine in the -3 position. Still, the fact that Asp or Glu residues can specify a casein kinase I substrate suggests that acidic character has a role in substrate selection by this protein kinase.	INDIANA UNIV,SCH MED,DEPT BIOCHEM & MOLEC BIOL,INDIANAPOLIS,IN 46223	Indiana University System; Indiana University-Purdue University Indianapolis					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK027221, P60DK020542, R37DK027221] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-20542, DK-27221] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AGOSTINIS P, 1989, FEBS LETT, V259, P75, DOI 10.1016/0014-5793(89)81498-X; AHMAD Z, 1986, ARCH BIOCHEM BIOPHYS, V250, P329, DOI 10.1016/0003-9861(86)90734-4; COHEN P, 1973, EUR J BIOCHEM, V34, P1, DOI 10.1111/j.1432-1033.1973.tb02721.x; DEPAOLIROACH AA, 1979, J BIOL CHEM, V254, P4212; DEPAOLIROACH AA, 1981, J BIOL CHEM, V256, P8955; DONELLADEANA A, 1985, BIOCHIM BIOPHYS ACTA, V829, P180, DOI 10.1016/0167-4838(85)90187-6; FIOL CJ, 1990, J BIOL CHEM, V265, P6061; FISCHER EDMOND H., 1958, JOUR BIOL CHEM, V231, P65; FLOTOW H, 1989, J BIOL CHEM, V264, P9126; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; KITAS EA, 1990, BIOCHEM BIOPH RES CO, V170, P635, DOI 10.1016/0006-291X(90)92139-Q; KUENZEL EA, 1985, P NATL ACAD SCI USA, V82, P737, DOI 10.1073/pnas.82.3.737; KUENZEL EA, 1987, J BIOL CHEM, V262, P9136; MARIN O, 1986, EUR J BIOCHEM, V160, P239, DOI 10.1111/j.1432-1033.1986.tb09962.x; MEGGIO F, 1979, FEBS LETT, V106, P76, DOI 10.1016/0014-5793(79)80698-5; PINNA LA, 1991, IN PRESS BIOCH BIOPH; PINNA LA, 1990, PEPT PROT PHOSPH, P145; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; TUAZON PT, 1979, EUR J BIOCHEM, V94, P497, DOI 10.1111/j.1432-1033.1979.tb12918.x; TUAZON PT, 1991, ADV 2ND MESSENGER PH, V23	21	139	140	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3724	3727						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995625				2022-12-25	WOS:A1991EY68200058
J	NILSSON, IM; VONHEIJNE, G				NILSSON, IM; VONHEIJNE, G			A DENOVO DESIGNED SIGNAL PEPTIDE CLEAVAGE CASSETTE FUNCTIONS INVIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYTOPIC MEMBRANE-PROTEIN; COLI LEADER PEPTIDASE; ESCHERICHIA-COLI; SEQUENCE; DOMAIN; MUTAGENESIS; SITES; TRANSLOCATION; TOPOLOGY; GENE	Leader peptidase (Lep) is a membrane-bound enzyme of the Escherichia coli inner membrane that serves to remove signal peptides from exported proteins. Statistical and experimental studies of known signal peptides have defined a short C-terminal region that seems to provide the information for correct cleavage by Lep. Based on the patterns of conserved amino acids found in this region, we have designed a signal peptide "cleavage cassette." This cassette is processed at the expected site when introduced after an uncleaved signal peptide. Furthermore, processing is blocked in the predicted manner when the (-3,-1)-rule for signal peptide cleavage is violated. This suggests that current understanding of the sequence requirements for signal peptide cleavage is sufficiently advanced to be used in, e.g. protein engineering applications.			NILSSON, IM (corresponding author), KAROLINSKA INST,CTR BIOTECHNOL,NOVUM,DEPT MOLEC BIOL,S-14152 HUDDINGE,SWEDEN.		von Heijne, Gunnar/F-5576-2011; von Heijne, Gunnar/AAH-9389-2019; Nilsson, IngMarie/H-2887-2012	von Heijne, Gunnar/0000-0002-4490-8569; 				BELTZER JP, 1989, FEBS LETT, V253, P93, DOI 10.1016/0014-5793(89)80937-8; BILGIN N, 1990, EMBO J, V9, P2717, DOI 10.1002/j.1460-2075.1990.tb07458.x; BRUCH MD, 1989, BIOCHEMISTRY-US, V28, P8554, DOI 10.1021/bi00447a043; DALBEY RE, 1987, SCIENCE, V235, P783, DOI 10.1126/science.3544218; DALBEY RE, 1986, J BIOL CHEM, V261, P3844; FIKES JD, 1990, J BIOL CHEM, V265, P3417; FOLZ RJ, 1988, J BIOL CHEM, V263, P2070; GEISSELSODER J, 1987, BIOTECHNIQUES, V5, P786; JOHNSTON S, 1985, GENE, V34, P137, DOI 10.1016/0378-1119(85)90121-0; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; MOORE KE, 1987, J BIOL CHEM, V262, P8806; NOTWEHR SF, 1989, J BIOL CHEM, V264, P3979; SANMILLAN JL, 1989, J BACTERIOL, V171, P5536, DOI 10.1128/jb.171.10.5536-5541.1989; VONHEIJNE G, 1988, P NATL ACAD SCI USA, V85, P3363; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; VONHEIJNE G, 1986, J MOL BIOL, V192, P287, DOI 10.1016/0022-2836(86)90365-7; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; WOLFE PB, 1983, J BIOL CHEM, V258, P2073; WOLFE PB, 1982, J BIOL CHEM, V257, P7898; YAMAMOTO Y, 1989, BIOCHEMISTRY-US, V28, P2728, DOI 10.1021/bi00432a054	22	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3408	3410						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995603				2022-12-25	WOS:A1991EY68200012
J	CRIPPA, MP; NICKOL, JM; BUSTIN, M				CRIPPA, MP; NICKOL, JM; BUSTIN, M			DEVELOPMENTAL-CHANGES IN THE EXPRESSION OF HIGH MOBILITY GROUP CHROMOSOMAL-PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							BINDING-SITES; CDNA; DNA; SEQUENCE; HMG-14; GENES; HMG1	The high mobility group (HMG) chromosomal proteins may modulate the structure of distinct regions in chromatin, thereby affecting processes such as development and differentiation. Here we report that the levels of the HMG chromosomal proteins and their mRNAs change significantly during erythropoiesis. Erythroid cells from 5-day chicken embryos contain 2.5-10 times more HMG mRNAs than cells from 14-day embryos, whereas circulating cells from adult animals are devoid of HMG and most other mRNAs. Nuclear run-off experiments and Northern analysis of RNA from various developmental stages and from Percoll-fractionated cells indicate that the genes are transcribed in early cells of either the primitive or definitive erythroid lineage. The rate of synthesis of the various HMGs changes during erythropoiesis; in erythroid cells from 7-day embryos the ratio of HMG-14b or HMG-17 to HMG-14a is, respectively, 8 and 10 times lower than in 9-day erythroids. HMG-14a, the major chicken HMG-14 species, is synthesized mainly in primitive cells, while HMG-14b is preferentially synthesized in definitive cells. Thus, the change from primitive to definitive erythroid lineage during embryogenesis is accompanied by a change in the expression of HMG chromosomal proteins. Conceivably, these changes may affect the structure of certain regions in chromatin; however, it is not presently clear whether the switch in HMG protein gene expression is a consequence or a prerequisite for proper differentiation.	NCI,MOLEC CARCINOGENESIS LAB,BLDG 37,RM 3D12,BETHESDA,MD 20892; NIDDKD,MOLEC BIOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)			Bustin, Michael/G-6155-2015; crippa, massimo/J-6514-2016	crippa, massimo/0000-0003-3214-9670; Bustin, Michael/0000-0002-5147-7242				ALBANESE I, 1980, NUCLEIC ACIDS RES, V8, P2787, DOI 10.1093/nar/8.12.2787; AUSUBEL FM, 1990, CURRENT PROTOCOLS MO; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; BUSTIN M, 1990, BIOCHIM BIOPHYS ACTA, V1049, P231, DOI 10.1016/0167-4781(90)90092-G; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CRIPPA MP, 1990, IN PRESS J MOL BIOL; DODGSON JB, 1988, GENE AMST, V6, P287; HAMADA H, 1985, BIOCHEMISTRY-US, V24, P1428, DOI 10.1021/bi00327a022; ISACKSON PJ, 1979, J BIOL CHEM, V254, P5569; Johns EW, 1982, HMG CHROMOSOMAL PROT; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDSMAN D, 1987, NUCLEIC ACIDS RES, V15, P6750, DOI 10.1093/nar/15.16.6750; LEE KLD, 1987, NUCLEIC ACIDS RES, V15, P5051, DOI 10.1093/nar/15.13.5051; LOIS R, 1989, BIOCHEMISTRY-US, V28, P2281, DOI 10.1021/bi00431a046; NEELIN JM, 1964, CAN J BIOCHEM PHYS, V42, P1743, DOI 10.1139/o64-185; PAONESSA G, 1987, NUCLEIC ACIDS RES, V15, P9077, DOI 10.1093/nar/15.21.9077; PASH JM, 1990, J BIOL CHEM, V265, P4197; SCHROTER H, 1982, EUR J BIOCHEM, V127, P429, DOI 10.1111/j.1432-1033.1982.tb06890.x; SRIKANTHA T, 1988, J BIOL CHEM, V263, P13500; SRIKANTHA T, 1989, J MOL BIOL, V211, P49; WEISBROD S, 1980, CELL, V19, P289, DOI 10.1016/0092-8674(80)90410-9	21	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2712	2714						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993650				2022-12-25	WOS:A1991EX60000009
J	HIRABAYASHI, J; KUSUNOKI, T; KASAI, K				HIRABAYASHI, J; KUSUNOKI, T; KASAI, K			COMPLETE PRIMARY STRUCTURE OF A GALACTOSE-SPECIFIC LECTIN FROM THE VENOM OF THE RATTLESNAKE CROTALUS-ATROX - HOMOLOGIES WITH CA2+-DEPENDENT-TYPE LECTINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; CARBOHYDRATE-RECOGNITION DOMAINS; URCHIN ANTHOCIDARIS-CRASSISPINA; BINDING LECTIN; CARTILAGE PROTEOGLYCAN; CELOMIC FLUID; SNAKE-VENOMS; PROTEIN; RECEPTOR; CDNA	The complete primary structure of a galactose-specific lectin contained in the venom of the rattlesnake, Crotalus atrox, was determined. The lectin is composed of two covalently linked, identical subunits, each consisting of 135 amino acid residues. Under physiological conditions the lectin proved to be highly aggregated. The venom lectin contained 9 half-cystines, 8 of which formed four intrasubunit disulfide bridges (Cys3-Cys-14, Cys31-Cys131, Cys38-Cys133, and Cys106-Cys123), while Cys86 was involved in an intersubunit disulfide bridge. Because of the high content of disulfide bridges, the intact lectin was extremely resistant to tryptic digestion. The determined amino acid sequence was found to be homologous with those of the so-called carbohydrate recognition domains of Ca2+-dependent-type lectins in animal. Among them, 8 amino acid residues (Cys31, Gly69, Trp92, Pro97, Cys106, Asp120, Cys123, and Cys131) were completely conserved. Leu40, Trp67, and Trp81 were also well conserved. The rattlesnake venom lectin showed high hemagglutinating activity. These results, together with the occurrence of similar lectins in crotalid venoms, suggest that these lectins have evolved in order to make the venom a more effective weapon to capture prey animals.			HIRABAYASHI, J (corresponding author), TEIKYO UNIV, FAC PHARMACEUT SCI, DEPT BIOL CHEM, SAGAMIKO, KANAGAWA 19901, JAPAN.							ABBOTT WM, 1988, BIOCHEM J, V252, P283, DOI 10.1042/bj2520283; ARBBRANDT K, 1987, P NATL ACAD SCI USA, V84, P6859; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang C.C., 1979, SNAKE VENOMS, P309; CHERAYIL BJ, 1989, J EXP MED, V170, P1959, DOI 10.1084/jem.170.6.1959; CLERCH LB, 1988, BIOCHEMISTRY-US, V27, P692, DOI 10.1021/bi00402a030; DAYHOFF MO, 1983, METHOD ENZYMOL, V91, P524; DOEGE K, 1986, J BIOL CHEM, V261, P8108; DRICKAMER K, 1981, J BIOL CHEM, V256, P5827; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; DRICKAMER K, 1986, J BIOL CHEM, V261, P6878; DRICKAMER K, 1984, J BIOL CHEM, V259, P770; DRICKAMER K, 1989, CIBA F S, V145, P46; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FLOROS J, 1986, J BIOL CHEM, V261, P9029; FUHLENDORFF J, 1987, BIOCHEMISTRY-US, V26, P6757, DOI 10.1021/bi00395a027; GARTNER TK, 1984, BIOCHEM J, V224, P301, DOI 10.1042/bj2240301; GARTNER TK, 1980, FEBS LETT, V117, P13, DOI 10.1016/0014-5793(80)80902-1; GIGA Y, 1987, J BIOL CHEM, V262, P6197; GIGA Y, 1985, BIOCHEMISTRY-US, V24, P4461, DOI 10.1021/bi00337a030; HERMODSON MA, 1973, BIOCHEMISTRY-US, V12, P3146, DOI 10.1021/bi00741a002; HIRABAYASHI J, 1988, J BIOCHEM-TOKYO, V104, P1; HIRABAYASHI J, 1987, J BIOCHEM-TOKYO, V101, P775, DOI 10.1093/jb/101.3.775; HOYLE GW, 1988, J BIOL CHEM, V263, P7487; JIA SH, 1988, J BIOL CHEM, V263, P6009; Kasai K., 1990, ADV LECTIN RES, V3, P10; KIKUTANI H, 1986, CELL, V47, P657, DOI 10.1016/0092-8674(86)90508-8; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKY LA, 1989, CELL, V56, P1045, DOI 10.1016/0092-8674(89)90637-5; LEE RT, 1989, BIOCHEMISTRY-US, V28, P8351, DOI 10.1021/bi00447a013; LOMONTE B, 1990, TOXICON, V28, P75, DOI 10.1016/0041-0101(90)90008-U; MURAMOTO K, 1986, BIOCHIM BIOPHYS ACTA, V874, P285, DOI 10.1016/0167-4838(86)90027-0; NOWAK TP, 1976, BIOCHEM BIOPH RES CO, V68, P650, DOI 10.1016/0006-291X(76)91195-5; OGILVIE ML, 1986, J BIOCHEM, V100, P1425, DOI 10.1093/oxfordjournals.jbchem.a121848; OGILVIE ML, 1989, THROMB HAEMOSTASIS, V62, P704; OGILVIE ML, 1984, J HERPETOL, V18, P285, DOI 10.2307/1564082; OHSAKA A, 1979, HDB EXPT PHARM, V252, P480; OHYAMA Y, 1986, BIOCHEM BIOPH RES CO, V134, P51, DOI 10.1016/0006-291X(86)90525-5; QUIOCHO FA, 1986, ANNU REV BIOCHEM, V55, P287, DOI 10.1146/annurev.bi.55.070186.001443; SAKAKURA Y, IN PRESS J BIOL CHEM; SUZUKI T, 1990, J BIOL CHEM, V265, P1274; TAKAHASHI H, 1985, J BIOL CHEM, V260, P2228; WOO HJ, 1990, J BIOL CHEM, V265, P7097; YAMAMOTO K, 1977, ANAL BIOCHEM, V79, P83, DOI 10.1016/0003-2697(77)90381-5	46	92	96	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2320	2326						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989986				2022-12-25	WOS:A1991EV51500048
J	MURASUGI, A; TANAKA, S; KOMIYAMA, N; IWATA, N; KINO, K; TSUNOO, H; SAKUMA, S				MURASUGI, A; TANAKA, S; KOMIYAMA, N; IWATA, N; KINO, K; TSUNOO, H; SAKUMA, S			MOLECULAR-CLONING OF A CDNA AND A GENE ENCODING AN IMMUNOMODULATORY PROTEIN, LING ZHI-8, FROM A FUNGUS, GANODERMA-LUCIDUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; GLOBIN GENE; TRANSCRIPTIONAL INITIATION; SACCHAROMYCES-CEREVISIAE; FLAMMULINA-VELTIPES; SECONDARY STRUCTURE; CODON USAGE; BASE-PAIRS; SEQUENCE; REGION	A large amount of the novel immunomodulatory protein Ling Zhi-8 (LZ-8) is synthesized in the mycelia of Ganoderma lucidum (Kino, K., Yamashita, A., Yamaoka, K., Watanabe, J., Tanaka, S., Ko, K., Shimizu, K., and Tsunoo, H. (1989) J. Biol. Chem 264, 472-478). A cDNA and a gene for LZ-8 were isolated and characterized. The mixed oligonucleotide probes for LZ-8 cDNA were designed from the results of protein sequencing (Tanaka, S., Ko, K., Kino, K., Tsuchiya, K., Yamashita, A., Murasugi, A., Sakuma, S., and Tsunoo, H. (1989) J. Biol. Chem. 264, 16372-16377) and were used for screening the mycelial cDNA library. The nucleotide sequence of the cloned cDNA confirms the amino acid sequence of LZ-8 that was previously determined by protein sequencing. The clones containing the LZ-8 gene (lz-8) were obtained from the mycelial genomic DNA library using the cDNA probe. Two CCAAT-like sequences and one TATA box were found at the upstream region of the postulated transcription initiation site of lz-8. A small intron (61 nucleotides long) divided lz-8 into two exons at the 5'-untranslated region. The other characteristic sequences were also found around the postulated transcription initiation site and around the poly(A) additional site.	MEIJI INST HLTH SCI,DIV BIOCHEM GENET,ODAWARA,KANAGAWA 250,JAPAN		MURASUGI, A (corresponding author), MEIJI INST HLTH SCI,DIV MOLEC ONCOL,ODAWARA,KANAGAWA 250,JAPAN.		Murasugi, Akira/Q-8763-2019					Battey, 1986, BASIC METHODS MOL BI; BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; BRAKE AJ, 1983, MOL CELL BIOL, V3, P1440, DOI 10.1128/MCB.3.8.1440; BROWN JWS, 1986, NUCLEIC ACIDS RES, V14, P9549, DOI 10.1093/nar/14.24.9549; CASEY JL, 1988, SCIENCE, V240, P924, DOI 10.1126/science.2452485; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CONNER BJ, 1983, P NATL ACAD SCI-BIOL, V80, P278, DOI 10.1073/pnas.80.1.278; DEANJOHNSON M, 1989, J BIOL CHEM, V264, P1274; DELAPENA P, 1987, CELL, V50, P613, DOI 10.1016/0092-8674(87)90034-1; DILELLA AG, 1987, METHOD ENZYMOL, V152, P447; DRUMMOND DR, 1985, NUCLEIC ACIDS RES, V13, P7375, DOI 10.1093/nar/13.20.7375; DRYGAS ME, 1989, J BIOL CHEM, V264, P17897; FRAYNE EG, 1986, NUCLEIC ACIDS RES, V14, P4113, DOI 10.1093/nar/14.10.4113; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GRUSS P, 1980, NATURE, V286, P634, DOI 10.1038/286634a0; GUAN KL, 1989, J BIOL CHEM, V264, P17764; Gurr SJ, 1987, GENE STRUCTURE EUKAR, P93; HAGENBUCHLE O, 1984, CELL, V38, P737, DOI 10.1016/0092-8674(84)90269-1; HAHN S, 1985, P NATL ACAD SCI USA, V82, P8562, DOI 10.1073/pnas.82.24.8562; HAMER DH, 1979, CELL, V18, P1299, DOI 10.1016/0092-8674(79)90240-X; HAMILTON R, 1987, NUCLEIC ACIDS RES, V15, P3581, DOI 10.1093/nar/15.8.3581; HIRANO S, 1987, J BIOCHEM-TOKYO, V102, P445, DOI 10.1093/oxfordjournals.jbchem.a122073; IKEMURA T, 1982, COLD SPRING HARB SYM, V47, P1087, DOI 10.1101/SQB.1983.047.01.123; IKUTA S, 1987, NUCLEIC ACIDS RES, V15, P797, DOI 10.1093/nar/15.2.797; KINO K, 1989, J BIOL CHEM, V264, P472; KLIGMAN D, 1988, TRENDS BIOCHEM SCI, V13, P437, DOI 10.1016/0968-0004(88)90218-6; Krainer AR, 1988, TRANSCRIPTION SPLICI, P131; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANGFORD CJ, 1983, CELL, V33, P519, DOI 10.1016/0092-8674(83)90433-6; LAUER J, 1980, CELL, V20, P119, DOI 10.1016/0092-8674(80)90240-8; LIM HM, 1988, GENE ANAL TECH, V5, P32, DOI 10.1016/0735-0651(88)90024-6; Maniatis T., 1982, MOL CLONING; MCDEVITT MA, 1984, CELL, V37, P993, DOI 10.1016/0092-8674(84)90433-1; MULLNER EW, 1988, CELL, V53, P815, DOI 10.1016/0092-8674(88)90098-0; NOGI Y, 1983, NUCLEIC ACIDS RES, V11, P8555, DOI 10.1093/nar/11.24.8555; NUNBERG JH, 1984, MOL CELL BIOL, V4, P2306, DOI 10.1128/MCB.4.11.2306; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; PERBAL B, 1985, PRACTICAL GUIDE MOL, P221; PESOLE G, 1988, NUCLEIC ACIDS RES, V16, P1715, DOI 10.1093/nar/16.5.1715; PRIBYL TM, 1988, MOL CELL BIOL, V8, P5369, DOI 10.1128/MCB.8.12.5369; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STRUHL K, 1987, CELL, V49, P295, DOI 10.1016/0092-8674(87)90277-7; TANAKA S, 1989, J BIOL CHEM, V264, P16372; TAUB RA, 1983, NATURE, V304, P172, DOI 10.1038/304172a0; TSUDA M, 1979, J BIOCHEM-TOKYO, V86, P1463, DOI 10.1093/oxfordjournals.jbchem.a132664; UHLENBECK OC, 1971, J MOL BIOL, V57, P217, DOI 10.1016/0022-2836(71)90342-1; WHITELAW E, 1986, EMBO J, V5, P2915, DOI 10.1002/j.1460-2075.1986.tb04587.x; WOYCHIK RP, 1984, P NATL ACAD SCI-BIOL, V81, P3944, DOI 10.1073/pnas.81.13.3944; YATOHGO T, 1988, AGR BIOL CHEM TOKYO, V52, P1485; ZARET KS, 1984, J MOL BIOL, V176, P107	52	46	62	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2486	2493						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1990000				2022-12-25	WOS:A1991EV51500072
J	HIRAKAWA, T; MARUYAMA, K; KOHL, NE; KODAMA, T; RULEY, HE				HIRAKAWA, T; MARUYAMA, K; KOHL, NE; KODAMA, T; RULEY, HE			MASSIVE ACCUMULATION OF NEUTRAL LIPIDS IN CELLS CONDITIONALLY TRANSFORMED BY AN ACTIVATED H-RAS ONCOGENE	ONCOGENE			English	Article							LOW-DENSITY LIPOPROTEIN; DIFFERENTIATION-DEPENDENT GENE; DEVELOPMENTAL PROGRAM; ADIPOCYTE DIFFERENTIATION; GLUCOCORTICOID REGULATION; PROTEIN GAP; BINDING; FIBROBLASTS; GROWTH; MICROINJECTION	Phenotypic consequences of ras oncogene expression were studied in cells conditionally transformed by T24 H-ras and a temperature-sensitive SV40 large T antigen (tsA58). Previous studies have demonstrated that transformation of REF52 cells by ras and SV40 large T antigen requires continuous T antigen expression. Thus, tsA58/T24 H-ras transformants ceased growing when transferred to a restrictive temperature for T antigen expression. Inhibition of cell growth was accompanied by massive accumulations of cholesterol esters, triglycerides and a third lipid species, identified as glycerol ethers on the basis of mobility on TLC. Cholesterol esters were derived from serum lipoproteins, and appeared to accumulate because LDL receptor expression and activity did not decline in growth arrested cells. Triglycerides and glycerol ethers were products of cell metabolism. The process lacked features characteristic of adipocyte differentiation, but may suggest mechanisms important in diseases, such as atherosclerosis, that involve abnormal accumulations of neutral lipids. Accumulating lipid species may also include metabolites induced by ras that accumulate in growth-arrested cells.	MIT,CTR CANC,CAMBRIDGE,MA 02139; MIT,DEPT BIOL,CAMBRIDGE,MA 02139; AJINOMOTO CO INC,CENT RES LABS,KAWASAKI,KANAGAWA 210,JAPAN; DYNAX RES INST,PALO ALTO,CA 94304; MERCK SHARP & DOHME LTD,W POINT,PA 19486	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Ajinomoto Co Inc; Merck & Company					NATIONAL CANCER INSTITUTE [R01CA040602] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA40602] Funding Source: Medline; PHS HHS [14051] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ADARI H, 1988, SCIENCE, V240, P518, DOI 10.1126/science.2833817; ALONSO T, 1988, P NATL ACAD SCI USA, V85, P4271, DOI 10.1073/pnas.85.12.4271; BALMAIN A, 1984, NATURE, V307, P658, DOI 10.1038/307658a0; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; CALES C, 1988, NATURE, V332, P548, DOI 10.1038/332548a0; CHAPMAN AB, 1984, J BIOL CHEM, V259, P5548; CHAPMAN AB, 1985, J CELL BIOL, V101, P1227, DOI 10.1083/jcb.101.4.1227; DOTTO GP, 1985, NATURE, V318, P472; FERAMISCO JR, 1984, CELL, V38, P109, DOI 10.1016/0092-8674(84)90531-2; FLEISCHMAN LF, 1986, SCIENCE, V231, P407, DOI 10.1126/science.3001936; FRANZA BR, 1986, CELL, V44, P409, DOI 10.1016/0092-8674(86)90462-9; GARRELS JI, 1989, J BIOL CHEM, V264, P5283; GOLDFARB M, 1982, NATURE, V296, P404, DOI 10.1038/296404a0; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; GOLDSTEIN JL, 1975, J BIOL CHEM, V250, P8487; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; HIRAKAWA T, 1988, P NATL ACAD SCI USA, V85, P1519, DOI 10.1073/pnas.85.5.1519; HUNT CR, 1986, P NATL ACAD SCI USA, V83, P3786, DOI 10.1073/pnas.83.11.3786; Kates M., 1972, LAB TECH BIOCH MOL B, V3, P268, DOI [10.1016/S0075-7535(08)70544-8, DOI 10.1016/S0075-7535(08)70544-8]; KIMES BW, 1976, EXP CELL RES, V98, P349, DOI 10.1016/0014-4827(76)90446-8; KOHL NE, 1987, ONCOGENE, V2, P41; LACAL JC, 1987, NATURE, V330, P269, DOI 10.1038/330269a0; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LOGAN J, 1981, VIROLOGY, V115, P419, DOI 10.1016/0042-6822(81)90126-4; MARUYAMA K, 1987, ONCOGENE, V1, P361; McClure DB, 1982, COLD SPRING HARBOR C, V9, P345; MELANCON P, 1987, CELL, V51, P1053, DOI 10.1016/0092-8674(87)90591-5; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; PREISS J, 1986, J BIOL CHEM, V261, P8587; RIDLEY AJ, 1988, EMBO J, V7, P1635, DOI 10.1002/j.1460-2075.1988.tb02990.x; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; SAGER R, 1982, P NATL ACAD SCI-BIOL, V79, P480, DOI 10.1073/pnas.79.2.480; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; SEGE RD, 1986, MOL CELL BIOL, V6, P3268, DOI 10.1128/MCB.6.9.3268; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; STACEY DW, 1984, NATURE, V310, P508, DOI 10.1038/310508a0; SUKUMAR S, 1988, SCIENCE, V240, P524, DOI 10.1126/science.3282307; WEBER KA, 1988, NATURE, V332, P553; WION KL, 1987, SCIENCE, V235, P1638, DOI 10.1126/science.3823907; WOLFMAN A, 1987, NATURE, V325, P359, DOI 10.1038/325359a0; YU CL, 1988, CELL, V52, P63, DOI 10.1016/0092-8674(88)90531-4	48	26	26	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1991	6	2					289	295						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ134	2000221				2022-12-25	WOS:A1991FZ13400015
J	BREMS, DN; BROWN, PL; NAKAGAWA, SH; TAGER, HS				BREMS, DN; BROWN, PL; NAKAGAWA, SH; TAGER, HS			THE CONFORMATIONAL STABILITY AND FLEXIBILITY OF INSULIN WITH AN ADDITIONAL INTRAMOLECULAR CROSS-LINK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR INTERACTIONS; SELF-ASSOCIATION; SIDE-CHAIN; MAIN CHAIN; EXCHANGE; BINDING; PH	The conformational stability and flexibility of insulin containing a cross-link between the alpha-amino group of the A-chain to the epsilon-amino group of Lys29 of the B-chain was examined. The cross-link varied in length from 2 to 12 carbon atoms. The conformational stability was determined by guanidine hydrochloride-induced equilibrium denaturation and flexibility was assessed by H2O/D2O amide exchange. The cross-link has substantial effects on both conformational stability and flexibility which depend on its length. In general, the addition of a cross-link enhances conformational stability and decreases flexibility. The optimal length for enhanced stability and decreased flexibility was the 6-carbon link. For the 6-carbon link the Gibbs free energy of unfolding was 8.0 kcal/mol compared to 4.5 kcal/mol for insulin, and the amide exchange rate decreased by at least 3-fold. A very short cross-link (i.e. the 2-carbon link) caused conformational strain that was detectable by a lack of stabilization in the Gibbs free energy of unfolding and enhancement in the amide exchange rate compared to insulin. The effect of the cross-link length on insulin hydrodynamic properties is discussed relative to previously obtained receptor binding results.	UNIV CHICAGO,DEPT BIOCHEM & MOLEC BIOL,CHICAGO,IL 60637	University of Chicago	BREMS, DN (corresponding author), ELI LILLY INT CORP,DEPT PARENTERAL RES & DEV,INDIANAPOLIS,IN 46285, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK018347, R01DK018347, P60DK020595] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK20595, DK18347] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; BRANDENB.D, 1973, H-S Z PHYSIOL CHEM, V354, P613, DOI 10.1515/bchm2.1973.354.1.613; BRANDENBURG D, 1973, H-S Z PHYSIOL CHEM, V354, P1521; BRANDENBURG D, 1972, H-S Z PHYSIOL CHEM, V353, P869, DOI 10.1515/bchm2.1972.353.1.869; BRANDENBURG D, 1972, 12TH P EUR PEPT S, P270; BROWN H, 1955, BIOCHEM J, V60, P556, DOI 10.1042/bj0600556; CHOTHIA C, 1983, NATURE, V302, P500, DOI 10.1038/302500a0; COLEMAN DL, 1969, CR TRAV LAB CARLSB, V37, P1; CREIGHTON TE, 1984, PROTEINS, P321; CUTFIELD J, 1981, H-S Z PHYSIOL CHEM, V362, P755, DOI 10.1515/bchm2.1981.362.1.755; DODSON EJ, 1979, CAN J BIOCHEM CELL B, V57, P469, DOI 10.1139/o79-060; DODSON GG, 1980, INSULIN CHEM STRUCTU, P17; ENGLANDER JJ, 1979, ANAL BIOCHEM, V92, P517, DOI 10.1016/0003-2697(79)90693-6; ENGLANDER SW, 1972, ANNU REV BIOCHEM, V41, P903, DOI 10.1146/annurev.bi.41.070172.004351; FLORY PJ, 1956, J AM CHEM SOC, V78, P5222, DOI 10.1021/ja01601a025; FREDERICQ E, 1956, ARCH BIOCHEM BIOPHYS, V65, P218, DOI 10.1016/0003-9861(56)90189-8; FREYCHET P, 1974, DIABETOLOGIA, V10, P1, DOI 10.1007/BF00421406; GLIEMANN J, 1974, DIABETOLOGIA, V10, P105, DOI 10.1007/BF01219665; GOLDMAN J, 1974, BIOCHEMISTRY-US, V13, P4566, DOI 10.1021/bi00719a015; HVIDT AASE, 1955, COMPT REND TRAV LAB CARLSBERG SER CHIM, V29, P385; JEFFREY PD, 1966, BIOCHEMISTRY-US, V5, P489, DOI 10.1021/bi00866a014; JEFFREY PD, 1976, BIOCHEMISTRY-US, V15, P4660, DOI 10.1021/bi00666a018; LINDSAY DG, 1972, FEBS LETT, V21, P105, DOI 10.1016/0014-5793(72)80175-3; MARKUSSEN J, 1985, INT J PEPT PROT RES, V26, P70; MIRMIRA RG, 1989, J BIOL CHEM, V264, P6349; NAKAGAWA SH, 1987, J BIOL CHEM, V262, P12054; NAKAGAWA SH, 1986, J BIOL CHEM, V261, P7332; NAKAGAWA SH, 1989, J BIOL CHEM, V264, P272; Pace C N, 1986, Methods Enzymol, V131, P266; PEKAR AH, 1972, BIOCHEMISTRY-US, V11, P4013, DOI 10.1021/bi00772a001; POCKER Y, 1980, BIOCHEMISTRY-US, V19, P5043, DOI 10.1021/bi00563a017; POCKER Y, 1981, BIOCHEMISTRY-US, V20, P4354, DOI 10.1021/bi00518a019; PRAISSMAN M, 1968, BIOCHEMISTRY-US, V7, P2431, DOI 10.1021/bi00846a052; SAUNDERS D, 1982, H-S Z PHYSIOL CHEM, V363, P655; SCHELLMAN JOHN A., 1958, COMPT REND TRAV LAB CARLSBERG SER CHIM, V30, P415; WILLUMSEN L, 1971, CR TRAV LAB CARLSB, V38, P223; 1976, SCI SINICA, V19, P351	37	16	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1611	1615						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1988440				2022-12-25	WOS:A1991EU49700041
J	BELTZER, JP; FIEDLER, K; FUHRER, C; GEFFEN, I; HANDSCHIN, C; WESSELS, HP; SPIESS, M				BELTZER, JP; FIEDLER, K; FUHRER, C; GEFFEN, I; HANDSCHIN, C; WESSELS, HP; SPIESS, M			CHARGED RESIDUES ARE MAJOR DETERMINANTS OF THE TRANSMEMBRANE ORIENTATION OF A SIGNAL-ANCHOR SEQUENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ASIALOGLYCOPROTEIN RECEPTOR; ENDOPLASMIC-RETICULUM MEMBRANE; STOP TRANSFER SEQUENCE; STRUCTURAL REQUIREMENTS; MICROSOMAL MEMBRANE; PROTEIN INSERTION; TRANSLOCATION; DOMAIN; MECHANISMS; TOPOLOGY	Uncleaved signal-anchor sequences of membrane proteins inserted into the endoplasmic reticulum initiate the translocation of either the amino-terminal or the carboxyl-terminal polypeptide segment across the bilayer. Which topology is acquired is not determined by the apolar segment of the signal but rather by the hydrophilic sequences flanking it. To study the role of charged residues in determining the membrane topology, the insertion of mutants of the asialoglycoprotein receptor H1, a single-spanning protein with a cytoplasmic amino terminus, was analyzed in transfected COS-7 cells. When the charged amino acids flanking the hydrophobic signal were mutated to residues of opposite charge, half the polypeptides inserted with the inverted orientation. When, in addition, the aminoterminal domain of the mutant protein was truncated, approximately 90% of the polypeptides acquired the inverted topology. The transmembrane orientation appears to be primarily determined by the charges flanking the signal sequence but is modulated by the domains to be translocated.	UNIV BASEL,BIOCTR,DEPT BIOCHEM,KLINGELBERGSTR 70,CH-4056 BASEL,SWITZERLAND	University of Basel				Fuhrer, Christian/0000-0001-8216-8883; Fiedler, Klaus/0000-0001-9398-1116; Spiess, Martin/0000-0001-7139-0550				ADAMS GA, 1985, CELL, V41, P1007, DOI 10.1016/S0092-8674(85)80081-7; AUDIGIER Y, 1987, P NATL ACAD SCI USA, V84, P5783, DOI 10.1073/pnas.84.16.5783; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; DAVIS NG, 1985, CELL, V41, P607, DOI 10.1016/S0092-8674(85)80033-7; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; FINIDORI J, 1987, J CELL BIOL, V104, P1705, DOI 10.1083/jcb.104.6.1705; GAROFF H, 1985, ANNU REV CELL BIOL, V1, P403, DOI 10.1146/annurev.cb.01.110185.002155; GILMORE R, 1985, CELL, V42, P497, DOI 10.1016/0092-8674(85)90107-2; HAEUPTLE MT, 1989, J CELL BIOL, V108, P1227, DOI 10.1083/jcb.108.4.1227; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; KAISER CA, 1987, SCIENCE, V235, P312, DOI 10.1126/science.3541205; KOPITO RR, 1985, NATURE, V316, P234, DOI 10.1038/316234a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIPP J, 1989, J CELL BIOL, V109, P2013, DOI 10.1083/jcb.109.5.2013; MONIER S, 1988, J CELL BIOL, V107, P457, DOI 10.1083/jcb.107.2.457; OVCHINNIKOV YA, 1982, FEBS LETT, V148, P179, DOI 10.1016/0014-5793(82)80805-3; PARKS GD, 1989, J CELL BIOL, V109, P2023, DOI 10.1083/jcb.109.5.2023; ROTHMAN RE, 1988, J BIOL CHEM, V263, P10470; SABATINI DD, 1982, J CELL BIOL, V92, P1, DOI 10.1083/jcb.92.1.1; SAKAGUCHI M, 1987, EMBO J, V6, P2425, DOI 10.1002/j.1460-2075.1987.tb02521.x; SCHNEIDER C, 1984, NATURE, V311, P675, DOI 10.1038/311675b0; SCHWARTZ AL, 1983, J BIOL CHEM, V258, P1249; SHIA MA, 1989, P NATL ACAD SCI USA, V86, P1158, DOI 10.1073/pnas.86.4.1158; SPIESS M, 1987, EMBO J, V6, P2683, DOI 10.1002/j.1460-2075.1987.tb02560.x; SPIESS M, 1989, J BIOL CHEM, V264, P19117; SPIESS M, 1985, J BIOL CHEM, V260, P1979; SPIESS M, 1986, CELL, V44, P177, DOI 10.1016/0092-8674(86)90496-4; SZCZESNASKORUPA E, 1989, J CELL BIOL, V108, P1237, DOI 10.1083/jcb.108.4.1237; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VERNER K, 1988, SCIENCE, V241, P1307, DOI 10.1126/science.2842866; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; WESSELS HP, 1988, CELL, V55, P61, DOI 10.1016/0092-8674(88)90009-8; WICKNER WT, 1985, SCIENCE, V230, P400, DOI 10.1126/science.4048938; ZERIAL M, 1987, CELL, V48, P147, DOI 10.1016/0092-8674(87)90365-5	39	119	121	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					973	978						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985975				2022-12-25	WOS:A1991ET17700048
J	GARABEDIAN, TE; YOUNT, RG				GARABEDIAN, TE; YOUNT, RG			DIRECT PHOTOAFFINITY-LABELING OF GIZZARD MYOSIN WITH [H-3] URIDINE-DIPHOSPHATE PLACES GLU(185) OF THE HEAVY-CHAIN AT THE ACTIVE-SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VANADATE-DEPENDENT MODIFICATION; SMOOTH-MUSCLE MYOSIN; COLI DNA-POLYMERASE; AMINO-ACID-SEQUENCE; ESCHERICHIA-COLI; SKELETAL MYOSIN; CROSS-LINKING; ADENOSINE-TRIPHOSPHATASE; COMPLETE NUCLEOTIDE; DIPHTHERIA-TOXIN	The active site of chicken gizzard myosin was labeled by direct photoaffinity labeling with [H-3]UDP. [H-3] UDP was stably trapped at the active site by addition of vanadate (V(i)) and Co2+. The extraordinary stability of the myosin.Co2+.[H-3]UDP.V(i) complex (t 1/2 > 5 days at 0-degrees-C) allowed it to be purified free of extraneous [H-3]UDP before irradiation began. Upon UV irradiation, > 60% of the trapped [H-3]UDP was photoincorporated into the active site. Only the 200-kDa heavy chain was labeled, confirming earlier results (Maruta, H., and Korn, E. (1981) J. Biol. Chem. 256, 499-502) using [H-3]UTP. Extensive tryptic digestion of photo-labeled myosin subfragment 1 followed by high performance liquid chromatography separations and removal of nucleotide phosphates by treatment with alkaline phosphatase allowed two labeled peptides to be isolated. Sequencing of the labeled peptides and radioactive counting showed that Glu185 was the residue labeled. Since UDP is a "zero-length" cross-linker, Glu185 is located at the purine-binding pocket of the active site of smooth myosin and adjacent to the glycine-rich loop which binds the polyphosphate portion of ATP. This Glu residue is conserved in smooth and nonmuscle myosins and is the same residue identified previously by [H-3]UTP photolabeling in Acanthamoeba myosin II (Atkinson, M. A., Robinson, E. A., Appella, E., and Korn, E. D. (1986) J. Biol. Chem. 261, 1844-1848).	WASHINGTON STATE UNIV,INST BIOL CHEM,DEPT BIOCHEM & BIOPHYS,PULLMAN,WA 99164; WASHINGTON STATE UNIV,DEPT CHEM,PULLMAN,WA 99164	Washington State University; Washington State University					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK005195, R01DK005195] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 05195] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABRAHAM KI, 1984, BIOCHEMISTRY-US, V23, P1176, DOI 10.1021/bi00301a023; ATKINSON MAL, 1986, J BIOL CHEM, V261, P1844; BANKS GR, 1986, BIOCHEMISTRY-US, V25, P5882, DOI 10.1021/bi00368a007; BISWAS SB, 1984, J BIOL CHEM, V259, P7990; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARROLL SF, 1987, J BIOL CHEM, V262, P8707; CARROLL SF, 1985, P NATL ACAD SCI USA, V82, P7237, DOI 10.1073/pnas.82.21.7237; COLE D G, 1989, Biophysical Journal, V55, p77A; COLE DG, 1990, J BIOL CHEM, V265, P22537; CREMO CR, 1988, BIOCHEMISTRY-US, V27, P8415, DOI 10.1021/bi00422a018; CREMO CR, 1989, J BIOL CHEM, V264, P6608; EBASHI S, 1976, J BIOCHEM-TOKYO, V79, P229, DOI 10.1093/oxfordjournals.jbchem.a131052; GOODNO CC, 1982, METHOD ENZYMOL, V85, P116; GOODNO CC, 1979, P NATL ACAD SCI USA, V76, P2620, DOI 10.1073/pnas.76.6.2620; GRAMMER JC, 1988, BIOCHEMISTRY-US, V27, P8408, DOI 10.1021/bi00422a017; HAMMER JA, 1987, J CELL BIOL, V105, P913, DOI 10.1083/jcb.105.2.913; HILLEL Z, 1978, BIOCHEMISTRY-US, V17, P2954, DOI 10.1021/bi00608a003; JUNG G, 1987, P NATL ACAD SCI USA, V84, P6720, DOI 10.1073/pnas.84.19.6720; KARN J, 1983, P NATL ACAD SCI-BIOL, V80, P4253, DOI 10.1073/pnas.80.14.4253; KIERDASZUK B, 1988, BIOCHEMISTRY-US, V27, P4952, DOI 10.1021/bi00413a054; LINSE K, 1988, J BIOL CHEM, V263, P15205; MAHMOOD R, 1989, BIOCHEMISTRY-US, V28, P3989, DOI 10.1021/bi00435a054; MARUTA H, 1981, J BIOL CHEM, V256, P499; MOLINA MI, 1987, J BIOL CHEM, V262, P6478; MURAKAMI N, 1990, J BIOL CHEM, V265, P1041; NATH JP, 1986, BIOCHEM BIOPH RES CO, V135, P1135, DOI 10.1016/0006-291X(86)91046-6; OKAMOTO Y, 1985, P NATL ACAD SCI USA, V82, P1575, DOI 10.1073/pnas.82.6.1575; OKAMOTO Y, 1986, NATURE, V324, P78, DOI 10.1038/324078a0; PANDEY VN, 1987, BIOCHEMISTRY-US, V26, P7744, DOI 10.1021/bi00398a031; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; Reid T.W., 1971, ENZYMES, V4, P373; Saenger W., 1984, PRINCIPLES NUCL ACID, P51; SEIDEL JC, 1980, J BIOL CHEM, V255, P4355; SHOHET RV, 1989, P NATL ACAD SCI USA, V86, P7726, DOI 10.1073/pnas.86.20.7726; SMITH KC, 1969, BIOCHEM BIOPH RES CO, V34, P354, DOI 10.1016/0006-291X(69)90840-7; STREHLER EE, 1986, J MOL BIOL, V190, P291, DOI 10.1016/0022-2836(86)90003-3; SUTOH K, 1986, P NATL ACAD SCI USA, V83, P212, DOI 10.1073/pnas.83.2.212; SUTOH K, 1987, BIOCHEMISTRY-US, V26, P7648, DOI 10.1021/bi00398a018; SZILAGYI L, 1979, BIOCHEM BIOPH RES CO, V87, P936, DOI 10.1016/0006-291X(79)92047-3; TONG SW, 1983, J BIOL CHEM, V258, P3100; WANG SY, 1976, PHOTOCHEM PHOTOBIOL, P1; WARRICK HM, 1987, ANNU REV CELL BIOL, V3, P379, DOI 10.1146/annurev.cb.03.110187.002115; WARRICK HM, 1986, P NATL ACAD SCI USA, V83, P9433, DOI 10.1073/pnas.83.24.9433; WASSENBERG DR, 1987, J BIOL CHEM, V262, P10741; WELLS JA, 1979, BIOCHEMISTRY-US, V18, P4800, DOI 10.1021/bi00589a006; YANAGISAWA M, 1987, J MOL BIOL, V198, P143, DOI 10.1016/0022-2836(87)90302-0; YOUNT RG, 1987, PERSPECTIVES BIOL EN, P67; YUE VT, 1977, BIOCHEMISTRY-US, V16, P4678, DOI 10.1021/bi00640a023	48	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1990	265	36					22547	22553						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP556	1979981				2022-12-25	WOS:A1990EP55600076
J	CRAWFORD, CR; NG, CYC; BELT, JA				CRAWFORD, CR; NG, CYC; BELT, JA			ISOLATION AND CHARACTERIZATION OF AN L1210 CELL-LINE RETAINING THE SODIUM-DEPENDENT CARRIER CIF AS ITS SOLE NUCLEOSIDE TRANSPORT ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									ST JUDE CHILDRENS RES HOSP, DEPT BIOCHEM & CLIN PHARMACOL, MEMPHIS, TN 38101 USA	St Jude Children's Research Hospital					NATIONAL CANCER INSTITUTE [R01CA033362, P30CA021765] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA33362, P30 CA21765] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BELT JA, 1983, MOL PHARMACOL, V24, P479; BELT JA, 1988, J BIOL CHEM, V263, P13819; BELT JA, 1985, BIOCHEM J, V232, P681, DOI 10.1042/bj2320681; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BLOCH A, 1967, BIOCHIM BIOPHYS ACTA, V138, P10, DOI 10.1016/0005-2787(67)90581-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASS CE, 1974, BIOCHIM BIOPHYS ACTA, V345, P1, DOI 10.1016/0005-2736(74)90239-9; Cleland W W, 1979, Methods Enzymol, V63, P103; CRAWFORD CR, 1990, J BIOL CHEM, V265, P9732; DAGNINO L, 1987, P AM ASSOC CANC RES, V28, P15; DAGNINO L, 1988, THESIS U ALBERTA CAN; DARNOWSKI JW, 1987, CANCER RES, V47, P2614; HOGUE DL, 1990, BIOCHEM CELL BIOL, V68, P199, DOI 10.1139/o90-026; JAKOBS ES, 1986, BIOCHEM BIOPH RES CO, V140, P1028, DOI 10.1016/0006-291X(86)90738-2; JARVIS SM, 1989, BIOCHIM BIOPHYS ACTA, V979, P132, DOI 10.1016/0005-2736(89)90533-6; JARVIS SM, 1988, ADENOSINE RECEPTORS, P113; KANG GJ, 1984, CANCER RES, V44, P461; LEE CW, 1988, BIOCHIM BIOPHYS ACTA, V942, P139, DOI 10.1016/0005-2736(88)90283-0; LEHIR M, 1984, PFLUG ARCH EUR J PHY, V401, P58, DOI 10.1007/BF00581533; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MEYER WH, 1986, CANCER RES, V46, P4896; MOMPARLER RL, 1968, J BIOL CHEM, V243, P4298; MONTGOMERY JA, 1984, NUCLEOS NUCLEOT, P19; PATERSON ARP, 1987, TOPICS PERSPECTIVES, P89; PATERSON ARP, 1986, MEMBRANE TRANSPORT A, P309; PAUL B, 1975, J MED CHEM, V18, P968, DOI 10.1021/jm00244a003; PLAGEMANN PGW, 1989, BIOCHIM BIOPHYS ACTA, V1010, P7, DOI 10.1016/0167-4889(89)90177-8; PLAGEMANN PGW, 1984, BIOCHIM BIOPHYS ACTA, V773, P39, DOI 10.1016/0005-2736(84)90548-0; PLAGEMANN PGW, 1988, BIOCHIM BIOPHYS ACTA, V947, P405, DOI 10.1016/0304-4157(88)90002-0; PLAGEMANN PGW, 1985, CANCER RES, V45, P6418; PLAGEMANN PGW, 1989, BIOCHIM BIOPHYS ACTA, V981, P315, DOI 10.1016/0005-2736(89)90043-6; ROSS EM, 1977, J BIOL CHEM, V252, P5761; SCHWENK M, 1984, BIOCHIM BIOPHYS ACTA, V805, P370, DOI 10.1016/0167-4889(84)90020-X; SPECTOR R, 1984, J NEUROCHEM, V42, P1048, DOI 10.1111/j.1471-4159.1984.tb12709.x; VIJAYALAKSHMI D, 1988, J BIOL CHEM, V263, P19419; YOUNG JD, 1984, J BIOL CHEM, V259, P8363	36	34	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1990	265	23					13730	13734						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DU275	1974252				2022-12-25	WOS:A1990DU27500053
J	WOEHLE, DL; LUEDDECKE, BA; LUDDEN, PW				WOEHLE, DL; LUEDDECKE, BA; LUDDEN, PW			ATP-DEPENDENT AND NAD-DEPENDENT MODIFICATION OF GLUTAMINE-SYNTHETASE FROM RHODOSPIRILLUM-RUBRUM INVITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV WISCONSIN, CTR STUDY NITROGEN FIXAT, MADISON, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	WOEHLE, DL (corresponding author), UNIV WISCONSIN, DEPT BIOCHEM, MADISON, WI 53706 USA.							ALEF K, 1981, Z NATURFORSCH C, V36, P246; ANGUS CW, 1988, FASEB J, V2, pA1343; BURTON ZF, 1981, ARCH BIOCHEM BIOPHYS, V211, P507, DOI 10.1016/0003-9861(81)90484-7; BURTON ZF, 1980, ARCH BIOCHEM BIOPHYS, V205, P478, DOI 10.1016/0003-9861(80)90130-7; CASSEL D, 1978, P NATL ACAD SCI USA, V75, P2669, DOI 10.1073/pnas.75.6.2669; COLOMBO G, 1986, J BIOL CHEM, V261, P587; EDMONDS C, 1989, BIOCHEM J, V261, P113, DOI 10.1042/bj2610113; ENGELHARDT H, 1982, ARCH MICROBIOL, V133, P202, DOI 10.1007/BF00415001; FALK G, 1982, ARCH MICROBIOL, V132, P251, DOI 10.1007/BF00407960; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; HONJO T, 1968, J BIOL CHEM, V243, P3553; IGLEWSKI BH, 1975, P NATL ACAD SCI USA, V72, P2284, DOI 10.1073/pnas.72.6.2284; JOHANSSON BC, 1977, EUR J BIOCHEM, V81, P365, DOI 10.1111/j.1432-1033.1977.tb11960.x; JOUANNEAU Y, 1989, BIOCHEMISTRY-US, V28, P6524, DOI 10.1021/bi00441a054; KANEMOTO RH, 1987, J BACTERIOL, V169, P3035, DOI 10.1128/jb.169.7.3035-3043.1987; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI J, 1987, J BACTERIOL, V169, P231, DOI 10.1128/jb.169.1.231-237.1987; LOWERY RG, 1986, J BACTERIOL, V166, P513, DOI 10.1128/jb.166.2.513-518.1986; LOWERY RG, 1988, J BIOL CHEM, V263, P16714; LUDDEN PW, 1989, CURR TOP CELL REGUL, V30, P23; LUDDEN PW, 1978, BIOCHEM J, V175, P251, DOI 10.1042/bj1750251; MICHALSKI WP, 1983, BIOCHIM BIOPHYS ACTA, V743, P136, DOI 10.1016/0167-4838(83)90427-2; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; MOSS J, 1984, J BIOL CHEM, V259, P5100; NORDLUND S, 1985, J BACTERIOL, V161, P13, DOI 10.1128/JB.161.1.13-17.1985; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; ORMEROD JG, 1961, ARCH BIOCHEM BIOPHYS, V94, P449, DOI 10.1016/0003-9861(61)90073-X; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; POPE MR, 1985, P NATL ACAD SCI USA, V82, P3173, DOI 10.1073/pnas.82.10.3173; RHEE SG, 1985, METHOD ENZYMOL, V113, P213; ROBERTS GP, 1980, J BACTERIOL, V144, P210, DOI 10.1128/JB.144.1.210-216.1980; SAARI LL, 1986, J BIOL CHEM, V261, P4973; Shapiro B., 1970, METHOD ENZYMOL, V17A, P910, DOI 10.1016/0076-6879(71)17305-3; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SOLIMAN A, 1981, ACTA CHEM SCAND B, V35, P63, DOI 10.3891/acta.chem.scand.35b-0063; SOLIMAN A, 1989, BIOCHIM BIOPHYS ACTA, V994, P138, DOI 10.1016/0167-4838(89)90152-0; SON HS, 1987, J BIOL CHEM, V262, P8690; STADTMAN ER, 1979, ANAL BIOCHEM, V95, P275, DOI 10.1016/0003-2697(79)90217-3; STECK G, 1980, ANAL BIOCHEM, V107, P21, DOI 10.1016/0003-2697(80)90486-8; STREICHER SL, 1980, J BACTERIOL, V142, P69, DOI 10.1128/JB.142.1.69-78.1980; TANUMA S, 1988, J BIOL CHEM, V263, P5485; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TYLER B, 1978, ANNU REV BIOCHEM, V47, P1127, DOI 10.1146/annurev.bi.47.070178.005403; Vaitukaitis J L, 1981, Methods Enzymol, V73, P46; WEST RE, 1986, BIOCHEMISTRY-US, V25, P8057, DOI 10.1021/bi00372a039; WEST RE, 1985, J BIOL CHEM, V260, P4428; WIELCKENS K, 1981, EUR J BIOCHEM, V117, P69; YOCH DC, 1983, J BACTERIOL, V154, P632, DOI 10.1128/JB.154.2.632-639.1983; ZUMFT WG, 1978, ARCH MICROBIOL, V117, P53, DOI 10.1007/BF00689351	49	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	1990	265	23					13741	13749						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DU275	1974253				2022-12-25	WOS:A1990DU27500055
J	ALTIERI, DC; AGBANYO, FR; PLESCIA, J; GINSBERG, MH; EDGINGTON, TS; PLOW, EF				ALTIERI, DC; AGBANYO, FR; PLESCIA, J; GINSBERG, MH; EDGINGTON, TS; PLOW, EF			A UNIQUE RECOGNITION SITE MEDIATES THE INTERACTION OF FIBRINOGEN WITH THE LEUKOCYTE INTEGRIN MAC-1 (CD11B CD18)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note									SCRIPPS CLIN & RES FDN,RES INST,COMM VASC BIOL,LA JOLLA,CA 92037	Scripps Research Institute	ALTIERI, DC (corresponding author), SCRIPPS CLIN & RES FDN,RES INST,DEPT IMMUNOL IMM-17,10666 N TORREY PINES RD,LA JOLLA,CA 92037, USA.				NHLBI NIH HHS [HL-16411, HL-38292, HL-28235] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL016411, R01HL038292, R01HL028235] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTIERI DC, 1986, J CLIN INVEST, V78, P968, DOI 10.1172/JCI112687; ALTIERI DC, 1988, J CELL BIOL, V107, P1893, DOI 10.1083/jcb.107.5.1893; BUDZYNSK.AZ, 1974, J BIOL CHEM, V249, P2294; CHERESH DA, 1989, CELL, V58, P945, DOI 10.1016/0092-8674(89)90946-X; CHERESH DA, 1987, P NATL ACAD SCI USA, V84, P6471, DOI 10.1073/pnas.84.18.6471; COLVIN RB, 1975, J IMMUNOL, V114, P377; COLVIN RB, 1975, J EXP MED, V142, P1377, DOI 10.1084/jem.142.6.1377; DEJANA E, 1987, J CELL BIOL, V104, P1403, DOI 10.1083/jcb.104.5.1403; DOOLITTLE RF, 1979, NATURE, V280, P464, DOI 10.1038/280464a0; DSOUZA SE, 1988, J BIOL CHEM, V263, P3943; DSOUZA SE, 1988, SCIENCE, V242, P91, DOI 10.1126/science.3262922; FAIR DS, 1981, J BIOL CHEM, V256, P8018; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; FURLAN M, 1975, BIOCHIM BIOPHYS ACTA, V400, P95, DOI 10.1016/0005-2795(75)90130-0; GECZY CL, 1983, J IMMUNOL, V130, P2743; GERRITY RG, 1981, AM J PATHOL, V103, P191; GERRITY RG, 1981, AM J PATHOL, V103, P181; GOWN AM, 1986, AM J PATHOL, V125, P191; GUSTAFSON EJ, 1989, J CELL BIOL, V109, P377, DOI 10.1083/jcb.109.1.377; HATTLER BG, 1973, CELL IMMUNOL, V9, P289, DOI 10.1016/0008-8749(73)90080-4; HAWIGER J, 1982, P NATL ACAD SCI-BIOL, V79, P2068, DOI 10.1073/pnas.79.6.2068; HOGG N, 1983, J EXP MED, V157, P473, DOI 10.1084/jem.157.2.473; HOPPER KE, 1981, J IMMUNOL, V126, P1052; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; KLOCZEWIAK M, 1984, BIOCHEMISTRY-US, V23, P1767, DOI 10.1021/bi00303a028; MADRID FS, 1983, J EXP MED, V158, P1785; MARGUERIE GA, 1979, J BIOL CHEM, V254, P5357; MATSUEDA GR, 1988, FASEB J, V2, P6480; PACKHAM MA, 1969, J LAB CLIN MED, V73, P686; PIZZO SV, 1972, J BIOL CHEM, V247, P636; PIZZO SV, 1973, J BIOL CHEM, V248, P4584; PLOW EF, 1986, P NATL ACAD SCI USA, V83, P6002, DOI 10.1073/pnas.83.16.6002; PLOW EF, 1984, J BIOL CHEM, V259, P5388; PLOW EF, 1985, P NATL ACAD SCI USA, V82, P8057, DOI 10.1073/pnas.82.23.8057; PYTELA R, 1986, SCIENCE, V231, P1559, DOI 10.1126/science.2420006; RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SANTORO SA, 1987, CELL, V48, P867, DOI 10.1016/0092-8674(87)90083-3; SHELLEY WB, 1977, NATURE, V270, P343, DOI 10.1038/270343a0; SHERMAN LA, 1977, J EXP MED, V145, P76, DOI 10.1084/jem.145.1.76; TREZZINI C, 1988, BIOCHEM BIOPH RES CO, V156, P477, DOI 10.1016/S0006-291X(88)80866-0; WRIGHT SD, 1988, P NATL ACAD SCI USA, V85, P7734, DOI 10.1073/pnas.85.20.7734	42	165	170	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 25	1990	265	21					12119	12122						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DP458	1973686				2022-12-25	WOS:A1990DP45800003
J	BILLHEIMER, JT; CROMLEY, DA; KEMPNER, ES				BILLHEIMER, JT; CROMLEY, DA; KEMPNER, ES			THE FUNCTIONAL SIZE OF ACYL-COENZYME-A (COA) - CHOLESTEROL ACYLTRANSFERASE AND ACYL-COA HYDROLASE AS DETERMINED BY RADIATION INACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									NIAMSD,PHYS BIOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	BILLHEIMER, JT (corresponding author), DUPONT CO,DIV MED PROD,WILMINGTON,DE 19880, USA.							ANDERSON AD, 1971, J NEUROCHEM, V18, P1179, DOI 10.1111/j.1471-4159.1971.tb00216.x; BERGE RK, 1980, SCAND J CLIN LAB INV, V40, P271, DOI 10.3109/00365518009095578; BERGE RK, 1981, INT J BIOCHEM, V13, P1157, DOI 10.1016/0020-711X(81)90208-1; BILLHEIMER JT, 1981, ANAL BIOCHEM, V111, P331, DOI 10.1016/0003-2697(81)90570-4; BILLHEIMER JT, 1983, J LIPID RES, V24, P1646; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cleary M P, 1984, Horm Metab Res, V16 Suppl 1, P43; DOOLITTLE GM, 1982, BIOCHEMISTRY-US, V21, P674, DOI 10.1021/bi00533a014; ERICKSON SK, 1983, FED PROC, V42, P1787; HARMON JT, 1985, METHOD ENZYMOL, V117, P65; KEMPNER ES, 1985, GROWTH MATURATION FA, V3, P157; KREIBICH G, 1978, J CELL BIOL, V77, P464, DOI 10.1083/jcb.77.2.464; LICHTENSTEIN AH, 1980, J BIOL CHEM, V255, P9098; LICHTENSTEIN AH, 1983, BIOCHIM BIOPHYS ACTA, V751, P340, DOI 10.1016/0005-2760(83)90292-8; MCINTYRE JO, 1985, ANAL BIOCHEM, V147, P468, DOI 10.1016/0003-2697(85)90300-8; MUKHERJEE S, 1958, J BIOL CHEM, V230, P91; Olive C, 1975, Methods Enzymol, V41, P196; REINHART MP, 1987, J BIOL CHEM, V262, P9649; SANJANWALA M, 1987, ARCH BIOCHEM BIOPHYS, V258, P299, DOI 10.1016/0003-9861(87)90348-1; SUCKLING KE, 1985, J LIPID RES, V26, P647; SUCKLING KE, 1982, BIOCHIM BIOPHYS ACTA, V710, P154, DOI 10.1016/0005-2760(82)90145-X; TASVANI D, 1985, FED PROC, V44, P1601	22	33	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	1990	265	15					8632	8635						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD976	1971274				2022-12-25	WOS:A1990DD97600047
J	HASHIMOTO, K; YONESAKI, T				HASHIMOTO, K; YONESAKI, T			THE CHARACTERIZATION OF A COMPLEX OF 3 BACTERIOPHAGE-T4 RECOMBINATION PROTEINS, UVSX PROTEIN, UVSY PROTEIN, AND GENE-32 PROTEIN, ON SINGLE-STRANDED-DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENETIC-RECOMBINATION; PURIFICATION	Three recombination proteins of bacteriophage T4, uvsX, uvsY, and gene 32 proteins, were examined for the formation of a complex with short single-stranded DNA (ssDNA) molecules containing either 24 or 69 nucleotides. Gel-shift assays revealed that either the uvsX or uvsY protein, when present alone, formed a stable complex only with the 69-mer, while the gene 32 protein bound stably to both ssDNAs. However, a characteristic stable complex formed on the 24-mer when both the uvsX and uvsY proteins were present, and the uvsY protein bound to this DNA in the presence of the gene 32 protein. Isolation of the complexes by centrifugation through a glycerol gradient revealed their protein constituents and showed that the uvsX protein-uvsY protein-24-mer ssDNA complex formed even in the presence of excess gene 32 protein. The possible biological significance of these protein-DNA complexes is discussed.	KYOTO UNIV,FAC SCI,DEPT BOT,KYOTO 606,JAPAN	Kyoto University								COX MM, 1987, ANNU REV BIOCHEM, V56, P229, DOI 10.1146/annurev.bi.56.070187.001305; FORMOSA T, 1983, P NATL ACAD SCI-BIOL, V80, P2442, DOI 10.1073/pnas.80.9.2442; FORMOSA T, 1984, COLD SPRING HARB SYM, V49, P363, DOI 10.1101/SQB.1984.049.01.043; FORMOSA T, 1986, J BIOL CHEM, V261, P6107; GRIFFITH J, 1985, J BIOL CHEM, V260, P4484; HARRIS LD, 1987, J BIOL CHEM, V262, P9285; RADDING CM, 1982, ANNU REV GENET, V16, P405, DOI 10.1146/annurev.ge.16.120182.002201; WILLIAMS KR, 1983, BACTERIOPHAGE T4, P82; YONESAKI T, 1989, J BIOL CHEM, V264, P7814; YONESAKI T, 1988, MOL GEN GENET, V213, P548, DOI 10.1007/BF00339630; YONESAKI T, 1985, EMBO J, V4, P3321, DOI 10.1002/j.1460-2075.1985.tb04083.x	11	30	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4883	4888						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002035				2022-12-25	WOS:A1991FC21700034
J	MCDERMOTT, PJ; CARL, LL; CONNER, KJ; ALLO, SN				MCDERMOTT, PJ; CARL, LL; CONNER, KJ; ALLO, SN			TRANSCRIPTIONAL REGULATION OF RIBOSOMAL-RNA SYNTHESIS DURING GROWTH OF CARDIAC MYOCYTES IN CULTURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN KINASE-C; RAT-HEART; MYOCARDIAL HYPERTROPHY; RDNA TRANSCRIPTION; POLYMERASE-I; MUSCLE; CELLS; DEGRADATION; GENES; LIVER	The mechanism(s) by which rRNA accumulates during the growth of cardiac myocytes was investigated. The rates of rDNA transcription were measured in contracting myocytes and compared with nonbeating myocytes depolarized with 50 mM KCl. After 3 days of contraction the absolute rate of rDNA transcription was accelerated by 2-fold as measured by incorporation of [H-3]UTP into the external transcribed spacer of preribosomal RNA. Corresponding increases in transcription were observed in isolated nuclei of contracting myocytes as measured by either hybridization of run-on transcripts of preribosomal RNA or activity of RNA polymerase I. The extent to which transcription was stimulated in contracting myocytes accounted for the previously observed acceleration of rRNA synthesis rates. The steady-state levels of preribosomal RNA relative to rRNA were unchanged in contracting myocytes, but the total amount of preribosomal RNA was 1.3-fold greater as a result of increased rRNA content. The increase of preribosomal RNA in proportion to rRNA in contracting myocytes demonstrated that the rate of preribosomal RNA processing was unchanged and that rRNA synthesis is regulated by an accelerated rate of rDNA transcription.	GEISINGER MED CLIN,JANET WEIS CTR RES,DANVILLE,PA 17822	Geisinger Medical Center								ASHFORD AJ, 1986, J BIOL CHEM, V261, P4059; BATEMAN E, 1986, CELL, V47, P445, DOI 10.1016/0092-8674(86)90601-X; BELENGUER P, 1989, NUCLEIC ACIDS RES, V17, P6625; BELL SP, 1988, SCIENCE, V241, P1192, DOI 10.1126/science.3413483; BLAUSTEIN MP, 1988, J CARDIOVASC PHAR S5, V12, pS56; BOWMAN LH, 1987, DEV BIOL, V119, P152, DOI 10.1016/0012-1606(87)90217-X; CAMACHO JA, 1990, AM J PHYSIOL, V258, pC86, DOI 10.1152/ajpcell.1990.258.1.C86; CASSIDY BG, 1987, MOL CELL BIOL, V7, P2388, DOI 10.1128/MCB.7.7.2388; CESARONE CF, 1979, ANAL BIOCHEM, V100, P188, DOI 10.1016/0003-2697(79)90131-3; CUTILLETTA AF, 1978, J MOL CELL CARDIOL, V10, P677, DOI 10.1016/0022-2828(78)90403-0; DUBUS I, 1990, CIRC RES, V66, P867, DOI 10.1161/01.RES.66.3.867; Hadjiolov A.A., 1976, Progress Biophys Molec Biol, V31, P95; HENRICH CJ, 1988, J MOL CELL CARDIOL, V20, P1081, DOI 10.1016/0022-2828(88)90588-3; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; JACOBS FA, 1985, EUR J BIOCHEM, V150, P255, DOI 10.1111/j.1432-1033.1985.tb09015.x; KENT RL, 1989, CIRC RES, V64, P74, DOI 10.1161/01.RES.64.1.74; KOMURO I, 1990, J BIOL CHEM, V265, P3595; KRAUTER KS, 1979, J MOL BIOL, V134, P727, DOI 10.1016/0022-2836(79)90482-0; LARDEUX BR, 1987, J BIOL CHEM, V262, P14507; LONG CS, 1989, J CLIN INVEST, V83, P1078, DOI 10.1172/JCI113951; MANN DL, 1989, CIRC RES, V64, P1079, DOI 10.1161/01.RES.64.6.1079; MCDERMOTT PJ, 1989, CIRC RES, V64, P542, DOI 10.1161/01.RES.64.3.542; MCDERMOTT PJ, 1989, J BIOL CHEM, V264, P18220; MCKNIGHT GS, 1979, J BIOL CHEM, V254, P9050; MORGAN HE, 1987, ANNU REV PHYSIOL, V49, P533; MORRIS CE, 1990, J MEMBRANE BIOL, V113, P93, DOI 10.1007/BF01872883; PETERSON CJ, 1989, CIRC RES, V64, P360, DOI 10.1161/01.RES.64.2.360; RICHTER EA, 1987, FEBS LETT, V217, P232, DOI 10.1016/0014-5793(87)80669-5; ROCHASINGH KJ, 1989, CIRCULATION S2, V80, P93; ROSSI A, 1984, EUR HEART J, V5, P155, DOI 10.1093/eurheartj/5.suppl_F.155; ROTHBLUM LI, 1982, GENE, V17, P75, DOI 10.1016/0378-1119(82)90102-0; SCHREIBER SS, 1969, AM J PHYSIOL, V271, P1305; SIEHL D, 1985, AM J PHYSIOL, V248, pC309, DOI 10.1152/ajpcell.1985.248.3.C309; SIMPSON PC, 1988, AM J CARDIOL, V62, pG13; SMITH SD, 1990, NUCLEIC ACIDS RES, V18, P1677, DOI 10.1093/nar/18.7.1677; SOLLNERWEBB B, 1986, ANNU REV BIOCHEM, V55, P801, DOI 10.1146/annurev.bi.55.070186.004101; TOWER J, 1987, CELL, V50, P873, DOI 10.1016/0092-8674(87)90514-9; TSURUGI K, 1979, EUR J BIOCHEM, V101, P205, DOI 10.1111/j.1432-1033.1979.tb04233.x; VEINOTDREBOT LM, 1988, J MOL BIOL, V199, P107, DOI 10.1016/0022-2836(88)90382-8; VERGARA J, 1985, P NATL ACAD SCI USA, V82, P6352, DOI 10.1073/pnas.82.18.6352; VONHARSDORF R, 1989, CIRC RES, V65, P494, DOI 10.1161/01.RES.65.2.494; WARNER JR, 1977, J MOL BIOL, V115, P315, DOI 10.1016/0022-2836(77)90157-7; WATSON G, 1988, MOL CELL BIOL, V8, P2117, DOI 10.1128/MCB.8.5.2117; WATSON PA, 1989, AM J PHYSIOL, V256, pC1257, DOI 10.1152/ajpcell.1989.256.6.C1257; WOLF S, 1980, BIOCHEMISTRY-US, V19, P3484, DOI 10.1021/bi00556a012; ZAHRADKA P, 1988, EUR J BIOCHEM, V171, P37, DOI 10.1111/j.1432-1033.1988.tb13755.x; ZHANG H, 1988, P NATL ACAD SCI USA, V85, P1060, DOI 10.1073/pnas.85.4.1060	47	44	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4409	4416						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999424				2022-12-25	WOS:A1991FA69400061
J	DAHLMANWRIGHT, K; WRIGHT, A; GUSTAFSSON, JA; CARLSTEDTDUKE, J				DAHLMANWRIGHT, K; WRIGHT, A; GUSTAFSSON, JA; CARLSTEDTDUKE, J			INTERACTION OF THE GLUCOCORTICOID RECEPTOR DNA-BINDING DOMAIN WITH DNA AS A DIMER IS MEDIATED BY A SHORT SEGMENT OF 5 AMINO-ACIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGET GENE SPECIFICITY; HORMONE RECEPTOR; THYROID-HORMONE; RESPONSIVE ELEMENT; ESTROGEN-RECEPTOR; ZINC FINGER; PROTEINS; TRANSCRIPTION; EXPRESSION; INDUCTION	We have previously shown that protein-protein interactions mediate cooperative binding of the glucocorticoid receptor DNA-binding domain to a glucocorticoid response element (Dahlman-Wright, K., Siltala-Roos, H., Carlstedt-Duke, J., and Gustafsson, J.-A. (1990) J. Biol. Chem. 265, 14030-14035). The cooperativity of DNA binding is lost when the distance between the two half-sites constituting a glucocorticoid responsive element is altered or when their relative orientation is changed. We show here that mutations in the responsive element which interfere with cooperative DNA binding by the glucocorticoid receptor DNA-binding domain in vitro also abolish transactivation by the full length glucocorticoid receptor in vivo. We also identify a short segment in the proximity of one of the bound zinc ions that is required for cooperative binding of the glucocorticoid receptor DNA-binding domain to a glucocorticoid response element. We suggest that this segment is involved in dimer formation of the native glucocorticoid receptor and that it is important for correct positioning of the dimeric molecule on the double helix of DNA.	KAROLINSKA INST,HUDDINGE UNIV HOSP F60,NOVUM,CTR BIOTECHNOL,S-14186 HUDDINGE,SWEDEN	Karolinska Institutet	DAHLMANWRIGHT, K (corresponding author), KAROLINSKA INST,HUDDINGE UNIV HOSP F60,NOVUM,DEPT MED NUTR,S-14186 HUDDINGE,SWEDEN.		Wright, Anthony PH/J-8187-2015					BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; DAHLMAN K, 1989, J BIOL CHEM, V264, P804; DAHLMANWRIGHT K, 1990, J BIOL CHEM, V265, P14030; DANESCH U, 1987, EMBO J, V6, P625, DOI 10.1002/j.1460-2075.1987.tb04800.x; DANIELSEN M, 1989, CELL, V57, P1131, DOI 10.1016/0092-8674(89)90050-0; DENIS M, 1987, J BIOL CHEM, V262, P11803; ERIKSSON P, 1990, J BIOL CHEM, V265, P3535; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FAWELL SE, 1990, CELL, V60, P953, DOI 10.1016/0092-8674(90)90343-D; FREEDMAN LP, 1988, NATURE, V334, P543, DOI 10.1038/334543a0; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; GREEN JBA, 1988, MOL GEN GENET, V215, P100, DOI 10.1007/BF00331310; GREEN S, 1987, NATURE, V325, P75, DOI 10.1038/325075a0; GREEN S, 1988, EMBO J, V7, P3037, DOI 10.1002/j.1460-2075.1988.tb03168.x; GREEN S, 1988, TRENDS GENET, V4, P309, DOI 10.1016/0168-9525(88)90108-4; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; HARD T, 1990, SCIENCE, V249, P157, DOI 10.1126/science.2115209; HARD T, 1990, BIOCHEMISTRY-US, V29, P5358; HOECK W, 1989, J BIOL CHEM, V264, P14396; JANTZEN HM, 1987, CELL, V49, P29, DOI 10.1016/0092-8674(87)90752-5; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; MADER S, 1989, NATURE, V338, P271, DOI 10.1038/338271a0; OKRET S, 1985, BIOCHEMISTRY-US, V24, P6581, DOI 10.1021/bi00344a041; OMALLEY B, 1990, MOL ENDOCRINOL, V4, P363, DOI 10.1210/mend-4-3-363; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHMID W, 1989, EMBO J, V8, P2257, DOI 10.1002/j.1460-2075.1989.tb08350.x; TSAI SY, 1989, CELL, V57, P443, DOI 10.1016/0092-8674(89)90919-7; TSAI SY, 1988, CELL, V55, P361, DOI 10.1016/0092-8674(88)90059-1; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; WRANGE O, 1989, J BIOL CHEM, V264, P5253; WRIGHT APH, 1990, J BIOL CHEM, V265, P14763; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209	38	183	184	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3107	3112						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993683				2022-12-25	WOS:A1991EX60000066
J	LAMPHEAR, BJ; PANNIERS, R				LAMPHEAR, BJ; PANNIERS, R			HEAT-SHOCK IMPAIRS THE INTERACTION OF CAP-BINDING PROTEIN COMPLEX WITH 5' MESSENGER-RNA CAP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE-CHAIN INITIATION; NUCLEOTIDE-EXCHANGE FACTOR; ASCITES TUMOR-CELLS; HELA-CELLS; PHYSIOLOGICAL STRESSES; TRANSLATIONAL CONTROL; POLIOVIRUS RNA; EHRLICH CELLS; FACTOR-II; INHIBITION	Cell-free protein synthesizing systems prepared from heat-shocked Ehrlich cells retain the inhibition of translation that is seen at the cellular level. Recently, we showed that a highly purified cap-binding protein complex composed of the p220 and p28 subunits of eukaryotic initiation factor 4F, in a 1:1 molar ratio, restores protein synthesis in these cell-free translation systems (Lamphear, B. J., and Panniers, R. (1990) J. Biol. Chem. 265, 5333-5336). Here we have estimated the amount of cap-binding complex in cell extracts that can restore protein synthesis in heat-shocked cells. We find reduced restoring activity in heat-shocked cell extracts. Further, less cap-binding complex can be purified by 7-methyl-guanosine triphosphate Sepharose affinity chromatography from heat-shocked cell extracts, and we conclude that heat shock impairs the binding of complex to 5' mRNA cap. We have ruled out proteolysis and competitive inhibitors as mediators of this impairment. However we cannot distinguish between two possible explanations: (i) reduced association of p220 with p28 or (ii) a noncompetitive inhibitor blocks complex binding to cap. We have also examined the affect of heat shock on the phosphorylation state of two forms of p28, p220.p28 complex and p28 free of p220. Both forms have reduced levels of phosphorylation during heat shock. The significance of these changes is discussed.	UNIV ROCHESTER, CTR CANC, ROCHESTER, NY 14642 USA; UNIV ROCHESTER, DEPT BIOCHEM, ROCHESTER, NY 14642 USA	University of Rochester; University of Rochester								BIENZ M, 1982, CELL, V29, P811, DOI 10.1016/0092-8674(82)90443-3; BOND U, 1988, EMBO J, V7, P3509, DOI 10.1002/j.1460-2075.1988.tb03227.x; BONNEAU AM, 1987, J BIOL CHEM, V262, P11134; CRAIG EA, 1985, CRC CR REV BIOCH MOL, V18, P239, DOI 10.3109/10409238509085135; DEBENEDETTI A, 1982, J BIOL CHEM, V261, P15800; DUNCAN R, 1984, J BIOL CHEM, V259, P1882; DUNCAN R, 1987, J BIOL CHEM, V262, P380; ETCHISON D, 1990, J BIOL CHEM, V265, P7492; ETCHISON D, 1982, J BIOL CHEM, V257, P4806; GRIFO JA, 1983, J BIOL CHEM, V258, P5804; HERMAN RC, 1989, TRENDS BIOCHEM SCI, V14, P219, DOI 10.1016/0968-0004(89)90030-3; HICKEY ED, 1982, BIOCHEMISTRY-US, V21, P1513, DOI 10.1021/bi00536a008; HOLMGREN R, 1981, P NATL ACAD SCI-BIOL, V78, P3775, DOI 10.1073/pnas.78.6.3775; KASPAR RL, 1990, J BIOL CHEM, V265, P3619; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPHEAR BJ, 1990, J BIOL CHEM, V265, P5333; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; MAROTO FG, 1988, J BIOL CHEM, V263, P15720; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; MUNOZ A, 1984, VIROLOGY, V137, P150, DOI 10.1016/0042-6822(84)90018-7; OCHOA S, 1983, ARCH BIOCHEM BIOPHYS, V223, P325, DOI 10.1016/0003-9861(83)90598-2; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PAIN VM, 1986, BIOCHEM J, V235, P625, DOI 10.1042/bj2350625; PANNIERS LRV, 1981, J CELL SCI, V48, P259; PANNIERS R, 1985, J BIOL CHEM, V260, P9648; PANNIERS R, 1984, EUR J BIOCHEM, V140, P209, DOI 10.1111/j.1432-1033.1984.tb08088.x; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; PELLETIER J, 1989, J VIROL, V63, P441, DOI 10.1128/JVI.63.1.441-444.1989; RAY BK, 1983, P NATL ACAD SCI-BIOL, V80, P663, DOI 10.1073/pnas.80.3.663; RHOADS RE, 1988, TRENDS BIOCHEM SCI, V13, P52, DOI 10.1016/0968-0004(88)90028-X; ROWLANDS AG, 1988, J BIOL CHEM, V263, P5526; ROWLANDS AG, 1988, EUR J BIOCHEM, V175, P93, DOI 10.1111/j.1432-1033.1988.tb14170.x; SARKAR G, 1984, BIOCHIM BIOPHYS ACTA, V783, P122, DOI 10.1016/0167-4781(84)90003-4; SCORSONE KA, 1987, J BIOL CHEM, V262, P14538; SONENBERG N, 1987, ADV VIRUS RES, V33, P175, DOI 10.1016/S0065-3527(08)60318-8; TRACHSEL H, 1980, P NATL ACAD SCI-BIOL, V77, P770, DOI 10.1073/pnas.77.2.770; YOST HJ, 1988, SCIENCE, V242, P1544, DOI 10.1126/science.3201243	37	88	88	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2789	2794						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993658				2022-12-25	WOS:A1991EX60000022
J	LOEBER, G; INFANTE, AA; MAURERFOGY, I; KRYSTEK, E; DWORKIN, MB				LOEBER, G; INFANTE, AA; MAURERFOGY, I; KRYSTEK, E; DWORKIN, MB			HUMAN NAD+-DEPENDENT MITOCHONDRIAL MALIC ENZYME - CDNA CLONING, PRIMARY STRUCTURE, AND EXPRESSION IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; TUMOR MITOCHONDRIA; ADRENAL-CORTEX; RAT-LIVER; PURIFICATION; SEQUENCES; CELLS; IDENTIFICATION; GLUTAMINE; PROTEINS	Mitochondrial NAD+-dependent malic enzyme (EC 1.1.1.40) is expressed in rapidly proliferating cells and tumor cells, where it is probably linked to the conversion of amino acid carbon to pyruvate. In this paper, we report the cDNA cloning, amino acid sequence, and expression in Escherichia coli of functional human NAD+-dependent mitochondrial malic enzyme. The cDNA is 1,923 base pairs long and contains an open reading frame coding for a 584-amino acid protein. The molecular mass is 65.4 kDa for the unprocessed precursor protein. Comparison of the amino acid sequence of the human protein with the published NADP+-dependent mammalian cytosolic or plant chloroplast malic enzymes reveals highly conserved regions interrupted with long stretches of amino acids without significant homology. Expression of the processed protein in E. coli yielded an enzyme with the same kinetic and allosteric properties as malic enzyme purified from human cells.			LOEBER, G (corresponding author), ERNST BOEHRINGER INST ARZNEIMITTELFORSCH,DR BOEHRINGERGASSE 5-11,A-1121 VIENNA,AUSTRIA.							ALLISON DS, 1986, P NATL ACAD SCI USA, V83, P9011, DOI 10.1073/pnas.83.23.9011; BAGCHI S, 1987, J BIOL CHEM, V262, P1558; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; Bodo G, 1981, Methods Enzymol, V78, P69; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOZIN B, 1985, BIOCHEMISTRY-US, V24, P5581, DOI 10.1021/bi00341a044; DWORKIN MB, 1990, DEV BIOL, V138, P177, DOI 10.1016/0012-1606(90)90187-N; DWORKINRASTL E, 1983, GENE, V21, P237, DOI 10.1016/0378-1119(83)90007-0; FRAENKEL R, 1975, CURR TOP CELL REGUL, V9, P157; KHYSEANDERSON J, 1984, J BIOCHEM BIOPH METH, V10, P203; KOABAYSHI K, 1989, J BIOL CHEM, V264, P3200; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIGUORI M, 1989, ADV MYOCHEM, V2, P203; LIN RC, 1974, J BIOL CHEM, V249, P3867; MAGNUSON MA, 1986, J BIOL CHEM, V261, P1183; MANDELLA RD, 1975, J BIOL CHEM, V250, P5877; MONONEN I, 1984, BIOCHIM BIOPHYS ACTA, V788, P364, DOI 10.1016/0167-4838(84)90050-5; MOREADITH RW, 1984, J BIOL CHEM, V259, P6215; MOREADITH RW, 1984, J BIOL CHEM, V259, P6222; NAGEL WO, 1980, J BIOL CHEM, V255, P3849; NAGEL WO, 1982, J BIOL CHEM, V257, P2405; POULOSE AJ, 1983, ARCH BIOCHEM BIOPHYS, V220, P652, DOI 10.1016/0003-9861(83)90459-9; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; ROTHERMEL BA, 1989, J BIOL CHEM, V264, P19587; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAUER LA, 1973, BIOCHEM BIOPH RES CO, V50, P524, DOI 10.1016/0006-291X(73)90871-1; SAUER LA, 1980, J BIOL CHEM, V255, P3844; SAUER LA, 1979, BIOCHEM J, V184, P185, DOI 10.1042/bj1840185; SAUER LA, 1978, CANCER RES, V38, P1751; SCRUTTON NS, 1990, NATURE, V343, P38, DOI 10.1038/343038a0; SIMPSON ER, 1969, ARCH BIOCHEM BIOPHYS, V129, P384, DOI 10.1016/0003-9861(69)90190-8; TARONI F, 1988, INT J BIOCHEM, V20, P857, DOI 10.1016/0020-711X(88)90075-4; TARONI F, 1988, BIOCHIM BIOPHYS ACTA, V916, P446; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; WALTER MH, 1988, P NATL ACAD SCI USA, V85, P5546, DOI 10.1073/pnas.85.15.5546; WICE BM, 1981, J BIOL CHEM, V256, P7812; WIERENGA RK, 1985, BIOCHEMISTRY-US, V24, P1346, DOI 10.1021/bi00327a012; ZOLNIEROWICZ S, 1988, BIOCHEM MED METAB B, V39, P208, DOI 10.1016/0885-4505(88)90078-3	40	87	92	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3016	3021						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993674				2022-12-25	WOS:A1991EX60000054
J	ANDERSSON, C; MOSIALOU, E; ADANG, AEP; MULDER, GJ; VANDERGEN, A; MORGENSTERN, R				ANDERSSON, C; MOSIALOU, E; ADANG, AEP; MULDER, GJ; VANDERGEN, A; MORGENSTERN, R			STUDIES ON THE ACTIVITY AND ACTIVATION OF RAT-LIVER MICROSOMAL GLUTATHIONE TRANSFERASE WITH A SERIES OF GLUTATHIONE ANALOGS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-TRANSFERASE; SUBSTRATE-SPECIFICITY; PURIFICATION; MOIETY	The substrate specificity of rat liver microsomal glutathione transferase toward glutathione has been examined in a systematic manner. Out of a glycyl-modified and eight gamma-glutamyl-modified glutathione analogues, it was found that four (glutaryl-L-Cys-Gly, alpha-L-Glu-L-Cys-Gly, alpha-D-Glu-L-Cys-Gly, and gamma-L-Glu-L-Cys-beta-Ala) function as substrates. The kinetic parameters for three of these substrates (the alpha-D-Glu-L-Cys-Gly analogue gave very low activity) were compared with those of GSH with both unactivated and the N-ethylmaleimide-activated microsomal glutathione transferase. The alpha-L-Glu-L-Cys-Gly analogue is similar to GSH in that it has a higher k(cat) (6.9 versus 0.6 s-1) value with the activated enzyme compared with the unactivated enzyme but displays a high K(m) (6 versus 11 mM) with both forms. Glutaryl-L-Cys-Gly, in contrast, exhibited a similar k(cat) (8.9 versus 6.7 s-1) with the N-ethylmaleimide-treated enzyme but retains a higher K(M) value (50 versus 15 mM). Thus, the alpha-amino group of the glutamyl residue in GSH is important for the activity of the activated microsomal glutathione transferase. These observations were quantitated by analyzing the changes in the Gibbs free energy of binding calculated from the changes in k(cat)/K(m) values, comparing the analogues of GSH and each other. It is estimated that the binding energy of the alpha-amino group of the glutamyl residue in GSH contributes 9.7 kJ/mol to catalysis by the activated enzyme, whereas the corresponding value for the unactivated enzyme is 3.2 kj/mol. The importance of the acidic functions in glutathione is also evident as shown by the lack of activity with 4-aminobutyric acid-L-Cys-Gly and the low k(cat)/K(m) values with gamma-L-Glu-L-Cys-beta-Ala (0.03 and 0.01 mM-1 s-1 for unactivated and activated enzyme, respectively). Utilization of binding energy from a correctly positioned carboxyl group in the glycine residue (10 and 17 kJ/mol for unactivated and activated enzyme, respectively) therefore also appears to be required for optimal activity and activation. A conformational change in the microsomal glutathione transferase upon treatment with N-ethylmaleimide or trypsin, which allows utilization of binding energy from the alpha-amino group of GSH as well as the glycine carboxyl in catalysis, is suggested to account for at least part of the activation of the enzyme.	KAROLINSKA INST,DEPT TOXIKOL,BOX 60400,S-10401 STOCKHOLM 60,SWEDEN; UNIV LEIDEN,DEPT ORGAN CHEM,LEIDEN,NETHERLANDS; UNIV STOCKHOLM,DEPT BIOCHEM,WALLENBERGLAB,S-10691 STOCKHOLM,SWEDEN; UNIV LEIDEN,CTR BIOPHARMACEUT SCI,LEIDEN,NETHERLANDS	Karolinska Institutet; Leiden University; Leiden University - Excl LUMC; Stockholm University; Leiden University; Leiden University - Excl LUMC			Morgenstern, Ralf/GZH-0158-2022					ADANG AEP, 1988, BIOCHEM J, V255, P715; ADANG AEP, 1988, BIOCHEM J, V255, P721; ADANG AEP, 1989, BIOCHEM J, V264, P759, DOI 10.1042/bj2640759; Chasseaud L F, 1979, Adv Cancer Res, V29, P175, DOI 10.1016/S0065-230X(08)60848-9; Fersht A., 1985, ENZYME STRUCTURE MEC; HABIG WH, 1974, J BIOL CHEM, V249, P7130; KOHN MC, 1979, COMPUT BIOMED RES, V12, P461, DOI 10.1016/0010-4809(79)90032-6; Mannervik B, 1985, Adv Enzymol Relat Areas Mol Biol, V57, P357; MORGENSTERN R, 1979, BIOCHEM BIOPH RES CO, V87, P657, DOI 10.1016/0006-291X(79)92009-6; MORGENSTERN R, 1989, BIOCHEM J, V260, P577, DOI 10.1042/bj2600577; MORGENSTERN R, 1984, BIOCHEM PHARMACOL, V33, P3609, DOI 10.1016/0006-2952(84)90145-X; MORGENSTERN R, 1982, EUR J BIOCHEM, V128, P243; MORGENSTERN R, 1983, EUR J BIOCHEM, V134, P591, DOI 10.1111/j.1432-1033.1983.tb07607.x; MORGENSTERN R, 1988, J BIOL CHEM, V263, P6671; Morgenstern R, 1985, REV BIOCHEM TOXICOL, V7, P67; MORGENSTERN R, 1988, GLUTATHIONE CONJUGAT, P157; MOSIALOU E, 1989, ARCH BIOCHEM BIOPHYS, V275, P289, DOI 10.1016/0003-9861(89)90375-5; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4	18	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2076	2079						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989971				2022-12-25	WOS:A1991EV51500013
J	ASTERMARK, J; BJORK, I; OHLIN, AK; STENFLO, J				ASTERMARK, J; BJORK, I; OHLIN, AK; STENFLO, J			STRUCTURAL REQUIREMENTS FOR CA2+ BINDING TO THE GAMMA-CARBOXYGLUTAMIC ACID AND EPIDERMAL GROWTH FACTOR-LIKE REGIONS OF FACTOR-IX - STUDIES USING INTACT DOMAINS ISOLATED FROM CONTROLLED PROTEOLYTIC DIGESTS OF BOVINE FACTOR-IX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-HYDROXYASPARTIC ACID; BLOOD-COAGULATION FACTOR; HUMAN PROTEIN-C; HUMAN FACTOR-VII; FACTOR-X; CALCIUM-BINDING; NUCLEOTIDE-SEQUENCE; PHOSPHOLIPID-BINDING; MONOCLONAL-ANTIBODY; HUMAN-PROTHROMBIN	Blood coagulation factor IX is composed of discrete domains with an NH2-terminal vitamin K-dependent gamma-carboxyglutamic acid (Gla)-containing region, followed by two domains that are homologous with the epidermal growth factor (EGF) precursor and a COOH-terminal serine protease part. Calcium ions bind to the Gla-containing region and to the NH2-terminal EGF-like domain. To be able to determine the structure and function of the Gla- and EGF-like domains, we have devised a method for cleaving factor IX under controlled conditions and isolating the intact domains in high yield, either separately or linked together. The Ca2+ and Mg2+ binding properties of these fragments were examined by monitoring the metal ion-induced changes in intrinsic protein fluorescence. A fragment, consisting of the Gla region linked to the two EGF-like domains, bound Ca2+ in a manner that was indistinguishable from that of the intact molecule, indicating a native conformation. The Ca2+ affinity of the isolated Gla region was lower, suggesting that the EGF-like domains function as a scaffold for the folding of the Gla region. The Gla-independent high affinity metal ion binding site in the NH2-terminal EGF-like domain was shown to bind Ca2+ but not Mg2+. A comparison with similar studies of factor X (Persson, E., Bjork, I., and Stenflo, J. (1991) J. Biol. Chem. 266, 2444-2452) suggests that the Ca2+-induced fluorescence quenching is due to an altered environment primarily around the tryptophan residue in position 42.	UNIV LUND,MALMO GEN HOSP,DEPT CLIN CHEM,S-21401 MALMO,SWEDEN; SWEDISH UNIV AGR SCI,CTR BIOMED,DEPT VET MED CHEM,S-75123 UPPSALA,SWEDEN	Lund University; Swedish University of Agricultural Sciences								BAJAJ SP, 1982, J BIOL CHEM, V257, P3726; BAJAJ SP, 1985, J BIOL CHEM, V260, P1574; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; DEGEN SJF, 1987, BIOCHEMISTRY-US, V26, P6165, DOI 10.1021/bi00393a033; DRAKENBERG T, 1983, P NATL ACAD SCI-BIOL, V80, P1802, DOI 10.1073/pnas.80.7.1802; ENFIELD DL, 1975, P NATL ACAD SCI USA, V72, P16, DOI 10.1073/pnas.72.1.16; ESMON NL, 1983, J BIOL CHEM, V258, P5548; FERNLUND P, 1983, J BIOL CHEM, V258, P2509; FERNLUND P, 1982, J BIOL CHEM, V257, P2170; FERNLUND P, 1980, VITAMIN K METABOLISM, P166; FOSTER DC, 1985, P NATL ACAD SCI USA, V82, P4673, DOI 10.1073/pnas.82.14.4673; FUJIKAWA K, 1974, BIOCHEMISTRY-US, V13, P4508, DOI 10.1021/bi00719a006; FUJIKAWA K, 1973, BIOCHEMISTRY-US, V12, P4938, DOI 10.1021/bi00748a019; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; GREEN PM, 1989, EMBO J, V8, P1067, DOI 10.1002/j.1460-2075.1989.tb03474.x; HANDFORD PA, 1990, EMBO J, V9, P475, DOI 10.1002/j.1460-2075.1990.tb08133.x; HASE S, 1990, J BIOL CHEM, V265, P1858; HASE S, 1988, J BIOCHEM-TOKYO, V104, P867, DOI 10.1093/oxfordjournals.jbchem.a122571; HEIMARK RL, 1983, BIOCHEM BIOPH RES CO, V111, P723, DOI 10.1016/0006-291X(83)90365-0; HOJRUP P, 1987, BIOCHEM J, V245, P887, DOI 10.1042/bj2450887; HUANG LH, 1989, BIOCHEM BIOPH RES CO, V160, P133, DOI 10.1016/0006-291X(89)91631-8; JACKSON CM, 1980, ANNU REV BIOCHEM, V49, P765, DOI 10.1146/annurev.bi.49.070180.004001; JOHNSON AE, 1983, J BIOL CHEM, V258, P5554; KATAYAMA K, 1979, P NATL ACAD SCI USA, V262, P7605; KISIEL W, 1976, BIOCHEMISTRY-US, V15, P4901, DOI 10.1021/bi00667a023; LEYTUS SP, 1986, BIOCHEMISTRY-US, V25, P5098, DOI 10.1021/bi00366a018; LIEBMAN HA, 1987, J BIOL CHEM, V262, P7605; LIN SW, 1990, J BIOL CHEM, V265, P144; Magnusson S, 1975, PROTEASES BIOL CONTR, V2, P123; Maizel JV, 1971, METHOD VIROL, V5, P179; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MCCORD DM, 1990, J BIOL CHEM, V265, P10250; MCMULLEN BA, 1983, BIOCHEM BIOPH RES CO, V115, P8, DOI 10.1016/0006-291X(83)90961-0; MORITA T, 1985, J BIOL CHEM, V260, P2583; MORITA T, 1985, BIOCHEM BIOPH RES CO, V130, P841, DOI 10.1016/0006-291X(85)90493-0; MORITA T, 1986, J BIOL CHEM, V261, P4015; MORITA T, 1984, J BIOL CHEM, V259, P5698; MORITA T, 1980, 8TH STEENB S MAD, P124; NISHIMURA H, 1989, J BIOL CHEM, V264, P20320; OHARA PJ, 1987, P NATL ACAD SCI USA, V84, P5158, DOI 10.1073/pnas.84.15.5158; OHLIN AK, 1987, J BIOL CHEM, V262, P13798; OHLIN AK, 1988, J BIOL CHEM, V263, P7411; OHLIN AK, 1990, BIOCHEMISTRY-US, V29, P644; OHLIN AK, 1988, J BIOL CHEM, V263, P19240; PERSSON E, 1989, J BIOL CHEM, V264, P16897; PERSSON E, 1991, J BIOL CHEM, V266, P2444; PLUTZKY J, 1986, P NATL ACAD SCI USA, V83, P546, DOI 10.1073/pnas.83.3.546; POLLOCK JS, 1988, J BIOL CHEM, V263, P14216; REES DJG, 1988, EMBO J, V7, P2053, DOI 10.1002/j.1460-2075.1988.tb03045.x; RYAN J, 1989, J BIOL CHEM, V264, P20283; SKOGEN WF, 1983, BIOCHEM BIOPH RES CO, V111, P14, DOI 10.1016/S0006-291X(83)80110-7; SORIANOGARCIA M, 1989, BIOCHEMISTRY-US, V28, P6805, DOI 10.1021/bi00443a004; STENFLO J, 1977, ANNU REV BIOCHEM, V46, P157, DOI 10.1146/annurev.bi.46.070177.001105; STERN DM, 1983, P NATL ACAD SCI-BIOL, V80, P4119, DOI 10.1073/pnas.80.13.4119; SUGO T, 1984, J BIOL CHEM, V259, P5705; THOMPSON AR, 1986, BLOOD, V67, P565; TULINSKY A, 1988, J MOL BIOL, V202, P885, DOI 10.1016/0022-2836(88)90565-7; YOSHITAKE S, 1985, BIOCHEMISTRY-US, V24, P3736, DOI 10.1021/bi00335a049	59	63	65	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2430	2437						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989994				2022-12-25	WOS:A1991EV51500064
J	THOMPSON, JP; SIMKEVICH, CP; HOLNESS, MA; KANG, AH; RAGHOW, R				THOMPSON, JP; SIMKEVICH, CP; HOLNESS, MA; KANG, AH; RAGHOW, R			INVITRO METHYLATION OF THE PROMOTER AND ENHANCER OF PRO-ALPHA-1(I) COLLAGEN GENE LEADS TO ITS TRANSCRIPTIONAL INACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROUS-SARCOMA VIRUS; CHICK-EMBRYO FIBROBLASTS; LIVER EPITHELIAL-CELLS; 1ST INTRON CONTRIBUTE; MESSENGER-RNA LEVELS; DNA METHYLATION; REGULATORY ELEMENTS; CALCITONIN GENE; HUMAN CANCERS; 3T3 CELLS	We created pCOL/KT, a plasmid construct in which the promoter/enhancer of human Pro-alpha-1(I) gene is linked to the chloramphenicol acetyl transferase reporter gene. The Pro-alpha-1(I) promoter/enhancer in pCOL-KT was methylated in vitro and tested for transcriptional activity by transient expression analysis. Methylation of the construct with bacterial methylases reduced transcriptional activity about 25-fold. Site-specific methylation of eight potential canonical sites of eukaryotic methylation within the promoter greatly reduced transcriptional activity. Chromatin conformation of the transfected pCOL-KT DNA was analyzed by nuclease sensitivity. Although both methylated and unmethylated transfected DNA had increased susceptibility to DNase I compared with the endogenous gene, the methylated transfected DNA showed increased resistance to nuclease when compared with unmethylated transfected DNA, indicating that the methylation of the DNA alters the chromatin conformation. We also tested the ability of a human rhabdomyosarcoma cell line that does not express type I collagen to support transcription from an exogenously added Pro-alpha-1(I) promoter/enhancer. The transformed cell line is able to support transcription from the Pro-alpha-1(I) promoter/enhancer. Treatment of the transformed cell line with 5-azacytidine, a potent inhibitor of DNA methylation, resulted in transcriptional activation of the Pro-alpha-1(I) gene. These findings, along with the extreme methylation sensitivity of the Pro-alpha-1(I) promoter and enhancer, suggest that DNA methylation may be an important mechanism of transcriptional inactivation of interstitial collagen genes.	VET AFFAIRS MED CTR,RES SERV,1030 JEFFERSON AVE,MEMPHIS,TN 38104; UNIV TENNESSEE,CTR HLTH SCI,DEPT MED,MEMPHIS,TN 38163; UNIV TENNESSEE,CTR HLTH SCI,DEPT PHARMACOL,MEMPHIS,TN 38163	US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center					NIAMS NIH HHS [AR39166] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR039166] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ADAMS SL, 1977, P NATL ACAD SCI USA, V74, P3399, DOI 10.1073/pnas.74.8.3399; ALITALO K, 1982, J BIOL CHEM, V257, P9016; AVVEDIMENTO E, 1981, NUCLEIC ACIDS RES, V9, P1123, DOI 10.1093/nar/9.5.1123; BARSH GS, 1984, J BIOL CHEM, V259, P4906; BAYLIN SB, 1986, CANCER RES, V46, P2917; BAYLIN SB, 1987, BLOOD, V70, P412; BECKER PB, 1987, CELL, V51, P435, DOI 10.1016/0092-8674(87)90639-8; BORNSTEIN P, 1987, P NATL ACAD SCI USA, V84, P8869, DOI 10.1073/pnas.84.24.8869; CELANO P, 1989, BIOTECHNIQUES, V7, P942; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOE I, 1987, J BIOL CHEM, V262, P5408; COMB M, 1990, NUCLEIC ACIDS RES, V18, P3975, DOI 10.1093/nar/18.13.3975; DEBUSTROS A, 1988, P NATL ACAD SCI USA, V85, P5693; DOERFLER W, 1984, CURR TOP MICROBIOL, V108, P79; DOERFLER W, 1983, ANNU REV BIOCHEM, V52, P93, DOI 10.1146/annurev.bi.52.070183.000521; Doerfler W, 1985, Prog Clin Biol Res, V198, P133; EHRLICH M, 1981, SCIENCE, V212, P1350, DOI 10.1126/science.6262918; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; FEINBERG AP, 1983, BIOCHEM BIOPH RES CO, V111, P47, DOI 10.1016/S0006-291X(83)80115-6; GOELZ SE, 1985, SCIENCE, V228, P187, DOI 10.1126/science.2579435; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAESSMANN M, 1983, P NATL ACAD SCI-BIOL, V80, P6470, DOI 10.1073/pnas.80.21.6470; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GREENBERG ME, 1988, CURRENT PROTOCOLS MO; HATA RI, 1977, P NATL ACAD SCI USA, V74, P2933, DOI 10.1073/pnas.74.7.2933; HERBOMEL P, 1984, CELL, V39, P653, DOI 10.1016/0092-8674(84)90472-0; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; KAUTIAINEN TL, 1986, J BIOL CHEM, V261, P1594; KESHET I, 1986, CELL, V44, P535, DOI 10.1016/0092-8674(86)90263-1; KESHET I, 1985, P NATL ACAD SCI USA, V82, P2560, DOI 10.1073/pnas.82.9.2560; KRUCZEK I, 1982, EMBO J, V1, P409, DOI 10.1002/j.1460-2075.1982.tb01183.x; LANGNER KD, 1984, P NATL ACAD SCI-BIOL, V81, P2950, DOI 10.1073/pnas.81.10.2950; MAJMUDAR G, 1988, J BIOL CHEM, V263, P5555; MARSILIO E, 1984, J BIOL CHEM, V259, P1401; MCKEON C, 1982, CELL, V29, P203, DOI 10.1016/0092-8674(82)90104-0; PARKER BA, 1979, J VIROL, V31, P360, DOI 10.1128/JVI.31.2.360-369.1979; PARKER MI, 1982, NUCLEIC ACIDS RES, V10, P5879, DOI 10.1093/nar/10.19.5879; PARKER ML, 1980, NUCLEIC ACIDS RES, V13, P2823; PAUI U, 1987, P NATL ACAD SCI USA, V85, P16; PETERKOFSKY B, 1986, J BIOL CHEM, V261, P6818; RAGHOW R, 1989, MOL CELL BIOCHEM, V86, P5; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; REUE K, 1988, J BIOL CHEM, V263, P6857; RIGGS AD, 1983, ADV CANCER RES, V40, P1, DOI 10.1016/S0065-230X(08)60678-8; RIPPE RA, 1989, MOL CELL BIOL, V9, P2224, DOI 10.1128/MCB.9.5.2224; ROWE DW, 1978, BIOCHEMISTRY-US, V17, P1581, DOI 10.1021/bi00602a001; SANDMEYER S, 1981, J BIOL CHEM, V256, P5022; SANDMEYER S, 1981, CANCER RES, V41, P830; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SMITH BD, 1980, BIOCHEMISTRY-US, V19, P1820, DOI 10.1021/bi00550a014; SMITH BD, 1988, BIOCHEM J, V253, P269, DOI 10.1042/bj2530269; SMITH BD, 1979, IN VITRO, V152, P455; STEIN R, 1983, P NATL ACAD SCI-BIOL, V80, P2422, DOI 10.1073/pnas.80.9.2422; SZYF M, 1989, P NATL ACAD SCI USA, V86, P6853, DOI 10.1073/pnas.86.18.6853; THOMPSON JP, 1986, P NATL ACAD SCI USA, V83, P7688, DOI 10.1073/pnas.83.20.7688	56	59	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2549	2556						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1990005				2022-12-25	WOS:A1991EV51500082
J	SOZZI, G; PIEROTTI, MA; MIOZZO, M; DONGHI, R; RADICE, P; DEBENEDETTI, V; GRIECO, M; SANTORO, M; FUSCO, A; VECCHIO, G; MATHEW, CGP; PONDER, BAJ; SPURR, NK; DELLAPORTA, G				SOZZI, G; PIEROTTI, MA; MIOZZO, M; DONGHI, R; RADICE, P; DEBENEDETTI, V; GRIECO, M; SANTORO, M; FUSCO, A; VECCHIO, G; MATHEW, CGP; PONDER, BAJ; SPURR, NK; DELLAPORTA, G			REFINED LOCALIZATION TO CONTIGUOUS REGIONS ON CHROMOSOME-10Q OF THE 2 GENES (H4 AND RET) THAT FORM THE ONCOGENIC SEQUENCE PTC	ONCOGENE			English	Note							THYROID PAPILLARY CARCINOMAS; HUMAN-MOUSE HYBRIDS; PROTO-ONCOGENE; ASSIGNMENT; ACTIVATION	In this report we confirm the localization of the human RET proto-oncogene to chromosome 10q11.2, both by Southern blot analysis of a panel of human-rodent somatic cell hybrids and by in situ hybridization on human metaphase chromosomes. Previously, we had assigned to the same chromosome region the gene termed H4. In about 25% of papillary thyroid carcinomas, this gene was shown to rearrange with RET to give rise to the transforming sequence PTC. The analysis of different cell hybrids containing subfragments of chromosome 10, in conjunction with pulse field gel electrophoresis, established that H4 is mapped distally to RET at a distance not less than 280 kb. These findings suggest that intrachromosomal rearrangements are responsible for PTC activation in papillary thyroid carcinomas.	IST NAZL TUMORI,DIV ONCOL SPERIMENTALE A,VIA G VENEZIAN,I-20133 MILAN,ITALY; NAPLES UNIV,FAC MED & CHIRURG 2,CNR,CTR ENDOCRINOL & ONCOL SPERIMENTALE,I-80131 NAPLES,ITALY; GUYS HOSP,PEDIAT RES UNIT,LONDON SE1 9RT,ENGLAND; INST CANC RES,CANC RES CAMPAIGN,HUMAN CANC GENET RES GRP,SUTTON SM2 5PX,SURREY,ENGLAND; UNIV CAMBRIDGE,DEPT PATHOL,CAMBRIDGE,ENGLAND; CLARE HALL LABS,IMPERIAL CANC RES FUND,S MIMMS EN6 3LID,HERTS,ENGLAND	Fondazione IRCCS Istituto Nazionale Tumori Milan; Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II; Guy's & St Thomas' NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Cambridge			Mathew, Christopher G/G-3434-2015; Radice, Paolo/O-3119-2013; sozzi, gabriella/G-8259-2011	Mathew, Christopher G/0000-0003-4178-1838; Radice, Paolo/0000-0001-6298-4111; sozzi, gabriella/0000-0001-9360-6914; Grieco, Michele/0000-0002-4212-7814; Fusco, Alfredo/0000-0003-3332-5197; Pierotti, Marco Alessandro/0000-0002-7431-8332; Miozzo, Monica/0000-0002-6523-4575				ANAND R, 1986, TRENDS GENET, V2, P278, DOI 10.1016/0168-9525(86)90269-6; BAI Y, 1982, ANN HUM GENET, V46, P337, DOI 10.1111/j.1469-1809.1982.tb01584.x; BONGARZONE I, 1989, ONCOGENE, V4, P1457; DONGHI R, 1989, ONCOGENE, V4, P521; EDWARDS YH, 1985, ANN HUM GENET, V49, P101, DOI 10.1111/j.1469-1809.1985.tb01681.x; FUSCO A, 1987, NATURE, V328, P170, DOI 10.1038/328170a0; GRIECO M, 1990, CELL, V60, P557, DOI 10.1016/0092-8674(90)90659-3; ISHIZAKA Y, 1989, ONCOGENE, V4, P1519; JONES EA, 1976, SOMAT CELL GENET, V2, P483, DOI 10.1007/BF01542686; MATHEW CGP, 1990, ANN HUM GENET, V54, P121, DOI 10.1111/j.1469-1809.1990.tb00368.x; MAYALL BH, 1975, AUTOMATION CYTOGENET; NABHOLZ M, 1969, NATURE, V223, P358, DOI 10.1038/223358a0; NARUM RA, 1988, AM J HUM GENET, V43, pA154; POVEY S, 1980, ANN HUM GENET, V43, P241, DOI 10.1111/j.1469-1809.1980.tb01557.x; RADICE P, 1988, NUCLEIC ACIDS RES, V18, P5062; SOLOMON E, 1976, SOMAT CELL GENET, V2, P125, DOI 10.1007/BF01542626; SOLOMON E, 1979, ANN HUM GENET, V42, P273, DOI 10.1111/j.1469-1809.1979.tb00661.x; SWALLOW DM, 1977, CYTOGENET CELL GENET, V18, P136, DOI 10.1159/000130758; TAKAHASHI M, 1985, CELL, V42, P581, DOI 10.1016/0092-8674(85)90115-1; WHITEHEAD AS, 1982, P NATL ACAD SCI-BIOL, V79, P5021, DOI 10.1073/pnas.79.16.5021; 1989, CYTOGENET CELL GENET, V51, P1	21	45	46	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1991	6	2					339	342						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ134	2000227				2022-12-25	WOS:A1991FZ13400022
J	QUELLE, FW; WOJCHOWSKI, DM				QUELLE, FW; WOJCHOWSKI, DM			PROLIFERATIVE ACTION OF ERYTHROPOIETIN IS ASSOCIATED WITH RAPID PROTEIN TYROSINE PHOSPHORYLATION IN RESPONSIVE B6SUT.EP CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR-FREE CALCIUM; RECOMBINANT HUMAN ERYTHROPOIETIN; FETAL LIVER-CELLS; ERYTHROID PROGENITOR CELLS; HAMSTER OVARY CELLS; ERYTHROLEUKEMIA-CELLS; INTERLEUKIN-2 RECEPTOR; DIFFERENTIATION; GROWTH; KINASE	Erythropoietin is a prime regulator of the growth and terminal differentiation of erythroid blood cells. However, little is understood concerning its molecular mechanism of action. Presently it is shown in the responsive, factor-dependent murine cell line B6SUt.EP that erythropoietin induces the tyrosine phosphorylation of six plasma membrane-associated proteins in a time- and concentration-dependent fashion (i.e. phosphoproteins PY153, PY140, PY100, PY93, PY74, and PY54). Among these, PY153 was prominent. For all proteins, maximal levels of phosphorylation were induced within 3-7 min at low factor concentrations (100-500 pM). These findings establish tyrosine kinase activation as a novel candidate pathway of erythropoietin-induced proliferation. In addition, the tyrosine phosphorylation of six proteins with identical M(r), as well as a M(r) 104,000 protein, was induced in B6SUt.EP cells by interleukin 3. In contrast, no induced tyrosine phosphorylation was detectable in the erythropoietin-responsive, leukemic erythroid cell line, Rauscher Red 1, yet proteins of M(r) 153,000 and 54,000 were shown to be phosphorylated constitutively at relative levels greater than those observed in B6SUt.EP cells. A possible role for these phosphoproteins in hematopoietic cell transformation is considered.	PENN STATE UNIV, DEPT MOLEC & CELL BIOL, UNIVERSITY PK, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park				Quelle, Frederick/0000-0002-1184-6170	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK040242] Funding Source: NIH RePORTER; NIDDK NIH HHS [R29 DK40242] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON SM, 1985, MOL CELL BIOL, V5, P3369, DOI 10.1128/MCB.5.12.3369; BECKMAN BS, 1987, BIOCHEM BIOPH RES CO, V147, P392, DOI 10.1016/S0006-291X(87)80134-1; BONANOUTZEDAKI SA, 1986, EUR J BIOCHEM, V155, P363, DOI 10.1111/j.1432-1033.1986.tb09499.x; CHIUINI F, 1979, ACTA HAEMATOL-BASEL, V61, P251, DOI 10.1159/000207668; CHOI HS, 1987, J BIOL CHEM, V262, P2933; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; DANDREA AD, 1989, CELL, V57, P277, DOI 10.1016/0092-8674(89)90965-3; DAVIS JM, 1987, BIOCHEMISTRY-US, V26, P2633, DOI 10.1021/bi00383a034; de Both N J, 1978, Nature, V272, P626, DOI 10.1038/272626a0; DUNN CDR, 1975, EXP HEMATOL, V3, P65; ESCHBACH JW, 1987, NEW ENGL J MED, V316, P73, DOI 10.1056/NEJM198701083160203; FARRAR WL, 1989, J BIOL CHEM, V264, P12562; FUKUMOTO H, 1989, DEVELOPMENT, V105, P109; GREENBERGER JS, 1983, P NATL ACAD SCI-BIOL, V80, P2931, DOI 10.1073/pnas.80.10.2931; HONMA Y, 1989, CANCER RES, V49, P331; IHLE JN, 1984, ADV VIRAL ONCOL, V4, P95; IMAGAWA S, 1989, BLOOD, V73, P1452; ISFORT R, 1988, J BIOL CHEM, V263, P19203; ISFORT RJ, 1988, P NATL ACAD SCI USA, V85, P7982, DOI 10.1073/pnas.85.21.7982; ITOH N, 1990, SCIENCE, V247, P324, DOI 10.1126/science.2404337; JACOBS K, 1985, NATURE, V313, P806, DOI 10.1038/313806a0; KOYASU S, 1987, EMBO J, V6, P3979, DOI 10.1002/j.1460-2075.1987.tb02740.x; KRANTZ SB, 1963, J BIOL CHEM, V238, P4085; KRYSTAL G, 1983, EXP HEMATOL, V11, P649; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI JP, 1990, NATURE, V343, P762, DOI 10.1038/343762a0; MAYEUX P, 1987, J BIOL CHEM, V262, P13985; MCCAFFERY PJ, 1989, J BIOL CHEM, V264, P10507; MERIDA I, 1990, J BIOL CHEM, V265, P5690; MILLER BA, 1989, BLOOD, V73, P1188; MILLER BA, 1988, J CLIN INVEST, V82, P309, DOI 10.1172/JCI113588; MIYAKE T, 1977, J BIOL CHEM, V252, P5558; MLADENOVIC J, 1988, J LAB CLIN MED, V112, P23; MORLA AO, 1988, MOL CELL BIOL, V8, P2214, DOI 10.1128/MCB.8.5.2214; NIGON V, 1976, INT REV CYTOL, V46, P79, DOI 10.1016/S0074-7696(08)60991-2; NOGUCHI T, 1988, MOL CELL BIOL, V8, P2604, DOI 10.1128/MCB.8.6.2604; QUELLE FW, 1989, BLOOD, V74, P652; RECNY MA, 1987, J BIOL CHEM, V262, P17156; SALTZMAN EM, 1989, J BIOL CHEM, V264, P19979; SASAKI H, 1987, J BIOL CHEM, V262, P12059; SASAKI R, 1987, EUR J BIOCHEM, V168, P43, DOI 10.1111/j.1432-1033.1987.tb13384.x; SAWYER ST, 1984, J BIOL CHEM, V259, P2769; SAWYER ST, 1987, P NATL ACAD SCI USA, V84, P3690, DOI 10.1073/pnas.84.11.3690; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; SORENSEN P, 1989, J BIOL CHEM, V264, P19253; SORENSEN PHB, 1989, BLOOD, V73, P406; SWARUP G, 1982, BIOCHEM BIOPH RES CO, V107, P1104, DOI 10.1016/0006-291X(82)90635-0; SYTKOWSKI AJ, 1980, SCIENCE, V210, P74, DOI 10.1126/science.6932101; TODOKORO K, 1987, P NATL ACAD SCI USA, V84, P4126, DOI 10.1073/pnas.84.12.4126; TOJO A, 1987, BIOCHEM BIOPH RES CO, V148, P443, DOI 10.1016/0006-291X(87)91131-4; TSUDA H, 1989, EXP HEMATOL, V17, P211; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; WANECK GL, 1981, CELL, V26, P79, DOI 10.1016/0092-8674(81)90035-0; WANG JYJ, 1985, MOL CELL BIOL, V5, P3640, DOI 10.1128/MCB.5.12.3640; WEISS TL, 1989, J BIOL CHEM, V264, P1804; WINEARLS CG, 1986, LANCET, V2, P1175, DOI 10.1016/S0140-6736(86)92192-6; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0	59	122	129	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					609	614						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985918				2022-12-25	WOS:A1991EQ33900088
J	SCHNETKAMP, PPM; SZERENCSEI, RT; BASU, DK				SCHNETKAMP, PPM; SZERENCSEI, RT; BASU, DK			UNIDIRECTIONAL NA+, CA2+, AND K+ FLUXES THROUGH THE BOVINE ROD OUTER SEGMENT NA-CA-K EXCHANGER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM EXCHANGE; TRANSPORT; SODIUM	The properties of the Na-Ca exchanger in the plasma membrane of rod outer segments isolated from bovine retinas (ROS) were studied. Unidirectional Ca2+, Na+, and K+ fluxes were measured with radioisotopes and atomic absorption spectroscopy. We measured K+ fluxes associated with the Ca-Ca self-exchange mode of the Na-Ca exchanger to corroborate our previous conclusion that the ROS Na-Ca exchanger differs from Na-Ca exchangers in other tissues by its ability to transport K+ (Scnetkamp, P. P. M., Basu, D. K. & Szerencsei, R. T. (1989) Am. J. Physiol. 257, C153-C157). The Na-Ca-K exchanger was the only functional cation transporter in the plasma membrane of bovine ROS with an upper limit of a flux of 10(5) cations/ROS/s or a current of 0.01 pA contributed by other cation channels, pumps, or carriers; cation fluxes via the Na-Ca-K exchanger amounted to 5 X 10(6) cations/ROS/s or a current of 1 pA. Ca2+ efflux via the forward mode of the Na-Ca-K exchanger did not operate with a fixed single stoichiometry. 1) The Na/Ca coupling ratio was increased from three to four when ionophores were added that could provide electrical compensation for the inward Na-Ca exchange current. 2) The K/Ca coupling ratio could vary by at least 2-fold as a function of the external Na+ and K+ concentration. The results are interpreted in terms of a model that can account for the variable Ca/K coupling ratio: we conclude that the Ca2+ site of the exchanger can translocate independent of translocation of the K+ site, whereas translocation of the K+ site requires occupation of the Ca2+ site, but not its translocation. The results are discussed with respect to the physiological role of Na-Ca-K exchange in rod photoreceptors.			SCHNETKAMP, PPM (corresponding author), UNIV CALGARY,DEPT MED BIOCHEM,3330 HOSP DR NW,CALGARY T2N 4N1,ALBERTA,CANADA.							CERVETTO L, 1989, NATURE, V337, P740, DOI 10.1038/337740a0; LAGNADO L, 1988, P NATL ACAD SCI USA, V85, P4548, DOI 10.1073/pnas.85.12.4548; SCHNETKAMP PPM, 1980, BIOCHIM BIOPHYS ACTA, V598, P66, DOI 10.1016/0005-2736(80)90266-7; SCHNETKAMP PPM, 1989, AM J PHYSIOL, V257, pC153, DOI 10.1152/ajpcell.1989.257.1.C153; SCHNETKAMP PPM, 1986, J PHYSIOL-LONDON, V373, P25, DOI 10.1113/jphysiol.1986.sp016033; SCHNETKAMP PPM, 1979, BIOCHIM BIOPHYS ACTA, V554, P441, DOI 10.1016/0005-2736(79)90383-3; SCHNETKAMP PPM, 1990, IN PRESS PROGR BIOPH; SCHNETKAMP PPM, 1988, BIOPHYS J, V53, P389; SLAUGHTER RS, 1983, J BIOL CHEM, V258, P3183; YASUI K, 1990, EUR J PHYSL, V415, P513	10	48	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					198	206						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985893				2022-12-25	WOS:A1991EQ33900031
J	GERMAN, MS; MOSS, LG; RUTTER, WJ				GERMAN, MS; MOSS, LG; RUTTER, WJ			REGULATION OF INSULIN GENE-EXPRESSION BY GLUCOSE AND CALCIUM IN TRANSFECTED PRIMARY ISLET CULTURES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							TRANSCRIPTION CONTROL REGION; MESSENGER-RNA; PANCREATIC-ISLETS; BETA-CELLS; SEQUENCES; ENHANCER; ELEMENTS; MUSCLE; LINE	To study the regulation of insulin gene expression by physiological regulators, primary cultures of rat islet cells were transfected with portions of the rat insulin I gene 5'-flanking sequence linked to the reporter gene chloramphenicol acetyltransferase (CAT). Incubation of the cells in increasing glucose concentrations led to a parallel increase in both CAT activity and CAT mRNA levels. Pretreatment of the cells with the beta-cell-specific toxin streptozotocin reduced CAT activity 97%. beta-Cell-specific expression of CAT was also demonstrated by co-staining the transfected cells with antisera to both CAT and insulin. Experiments showing a reduction in the response to glucose in the presence of the calcium channel blocker verapamil suggest that calcium plays a role in the glucose response, possibly via regulation of factors interacting with this limited portion of the insulin gene.	UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143; BAYLOR UNIV,DEPT MED,HOUSTON,TX 77030; BAYLOR UNIV,DEPT CELL BIOL,HOUSTON,TX 77030	University of California System; University of California San Francisco; Baylor University; Baylor University	GERMAN, MS (corresponding author), UNIV CALIF SAN FRANCISCO,HORMONE RES INST,SAN FRANCISCO,CA 94143, USA.				NIDDK NIH HHS [DK08359-02, R01 DK021344, DK21344] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021344, R37DK021344, F32DK008359] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BRUNSTEDT J, 1982, BIOCHEM BIOPH RES CO, V106, P1383, DOI 10.1016/0006-291X(82)91267-0; CHELLY J, 1988, NATURE, V333, P858, DOI 10.1038/333858a0; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CROWE DT, 1989, MOL CELL BIOL, V9, P1784, DOI 10.1128/MCB.9.4.1784; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; EIZIRIK DL, 1988, ENDOCRINOLOGY, V122, P1242, DOI 10.1210/endo-122-4-1242; GIDDINGS SJ, 1982, DIABETES, V31, P624, DOI 10.2337/diabetes.31.7.624; HAMMONDS P, 1987, FEBS LETT, V213, P149, DOI 10.1016/0014-5793(87)81481-3; HELLERSTROM C, 1979, DIABETES, V28, P769, DOI 10.2337/diab.28.8.769; KARLSSON O, 1987, P NATL ACAD SCI USA, V84, P8819, DOI 10.1073/pnas.84.24.8819; LONDOS C, 1977, P NATL ACAD SCI USA, V74, P5482, DOI 10.1073/pnas.74.12.5482; MAR JH, 1988, J CELL BIOL, V107, P573, DOI 10.1083/jcb.107.2.573; MOSS LG, 1988, MOL CELL BIOL, V8, P2620, DOI 10.1128/MCB.8.6.2620; MOSS LG, 1987, 69TH END SOC ABSTR M, P29; OHLSSON H, 1988, P NATL ACAD SCI USA, V85, P4228, DOI 10.1073/pnas.85.12.4228; OSTERRIEDER W, 1982, NATURE, V298, P576, DOI 10.1038/298576a0; PHILIPPE J, 1990, J BIOL CHEM, V265, P1465; WELSH M, 1988, P NATL ACAD SCI USA, V85, P116, DOI 10.1073/pnas.85.1.116; WELSH M, 1985, J BIOL CHEM, V260, P3590; WHELAN J, 1989, MOL CELL BIOL, V9, P3253, DOI 10.1128/MCB.9.8.3253	21	156	159	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1990	265	36					22063	22066						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP556	1979979				2022-12-25	WOS:A1990EP55600002
J	SCHROEDER, C; RAYNOSCHEK, C; FUHRMANN, U; DAMM, K; VENNSTROM, B; BEUG, H				SCHROEDER, C; RAYNOSCHEK, C; FUHRMANN, U; DAMM, K; VENNSTROM, B; BEUG, H			THE V-ERB A ONCOGENE CAUSES REPRESSION OF ERYTHROCYTE-SPECIFIC GENES AND AN IMMATURE, ABERRANT DIFFERENTIATION PHENOTYPE IN NORMAL ERYTHROID PROGENITORS	ONCOGENE			English	Article									INST MOLEC PATHOL,DR BOHR GASSE 7,A-1030 VIENNA,AUSTRIA; EUROPEAN MOLEC BIOL LAB,W-6900 HEIDELBERG,GERMANY; KAROLINSKA INST,DEPT MOLEC BIOL,CMB,S-10401 STOCKHOLM 60,SWEDEN	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); European Molecular Biology Laboratory (EMBL); Karolinska Institutet								BEUG H, 1982, CELL, V28, P907, DOI 10.1016/0092-8674(82)90070-8; BEUG H, 1986, J VIROL, V57, P1127, DOI 10.1128/JVI.57.3.1127-1138.1986; BEUG H, 1985, VIROLOGY, V145, P141, DOI 10.1016/0042-6822(85)90209-0; BEUG H, 1981, VIROLOGY, V111, P201, DOI 10.1016/0042-6822(81)90665-6; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; BEUG H, 1977, EXP CELL RES, V107, P417, DOI 10.1016/0014-4827(77)90363-9; BEUG H, 1984, CELL, V36, P963, DOI 10.1016/0092-8674(84)90046-1; BEUG H, 1985, MODERN TRENDS HUMA 6, V29, P290; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DAMM K, 1987, EMBO J, V6, P375, DOI 10.1002/j.1460-2075.1987.tb04765.x; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; FORREST D, 1990, IN PRESS ONCOGENE; FRYKBERG L, 1983, CELL, V32, P227, DOI 10.1016/0092-8674(83)90513-5; FUHRMANN U, 1989, GENE DEV, V3, P2027; FUNG YKT, 1983, CELL, V33, P357, DOI 10.1016/0092-8674(83)90417-8; GANDRILLON O, 1989, CELL, V58, P115, DOI 10.1016/0092-8674(89)90408-X; GANDRILLON O, 1987, CELL, V49, P687, DOI 10.1016/0092-8674(87)90545-9; GRAF T, 1973, VIROLOGY, V54, P398, DOI 10.1016/0042-6822(73)90152-9; GRAF T, 1978, BIOCHIM BIOPHYS ACTA, V516, P269, DOI 10.1016/0304-419X(78)90011-2; GRAF T, 1982, BIOCHIM BIOPHYS ACTA, V651, P245, DOI 10.1016/0304-419X(82)90014-2; HAYMAN MJ, 1982, J CELL BIOCHEM, V18, P351, DOI 10.1002/jcb.1982.240180308; HIHARA H, 1983, J NATL CANCER I, V70, P891; KAHN P, 1984, P NATL ACAD SCI-BIOL, V81, P7122, DOI 10.1073/pnas.81.22.7122; KAHN P, 1986, CELL, V45, P349, DOI 10.1016/0092-8674(86)90320-X; KAHN P, 1986, P HAMBURG, P41; KHAZAIE K, 1988, EMBO J, V7, P3067; KNIGHT J, 1988, GENE DEV, V2, P247, DOI 10.1101/gad.2.2.247; KOWENZ E, 1986, MODERN TRENDS HUMA 7, V31, P199; MAIHLE N J, 1988, Biochimica et Biophysica Acta, V948, P287; MUNOZ A, 1988, EMBO J, V7, P155, DOI 10.1002/j.1460-2075.1988.tb02795.x; RADKE K, 1982, CELL, V31, P643, DOI 10.1016/0092-8674(82)90320-8; SAMARUT J, 1980, J CELL PHYSIOL, V105, P553, DOI 10.1002/jcp.1041050320; SAP J, 1989, NATURE, V340, P242, DOI 10.1038/340242a0; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SCHMIDT JA, 1986, LEUKEMIA RES, V10, P257, DOI 10.1016/0145-2126(86)90023-8; SCHMIDT JA, 1986, CELL, V46, P41, DOI 10.1016/0092-8674(86)90858-5; SEALY L, 1983, VIROLOGY, V130, P155, DOI 10.1016/0042-6822(83)90125-3; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; ZENKE M, 1988, CELL, V52, P107, DOI 10.1016/0092-8674(88)90535-1; ZENKE M, 1990, IN PRESS CELL	42	49	49	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1990	5	10					1445	1453						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK502	1979159				2022-12-25	WOS:A1990EK50200002
J	FEVE, B; EMORINE, LJ; BRIENDSUTREN, MM; LASNIER, F; STROSBERG, AD; PAIRAULT, J				FEVE, B; EMORINE, LJ; BRIENDSUTREN, MM; LASNIER, F; STROSBERG, AD; PAIRAULT, J			DIFFERENTIAL REGULATION OF BETA-1-ADRENERGIC AND BETA-2-ADRENERGIC RECEPTOR PROTEIN AND MESSENGER-RNA LEVELS BY GLUCOCORTICOIDS DURING 3T3-F442A ADIPOSE DIFFERENTIATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									INST COCHIN GENET MOLEC, CNRS, SD1-6231, F-75014 PARIS, FRANCE; UNIV PARIS 07, F-75014 PARIS, FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	FEVE, B (corresponding author), HOP HENRI MONDOR, CNRS, INSERM, U282, 51 AV MARECHAL DELATTRE DE TASSIGNY, F-94010 CRETEIL, FRANCE.			Feve, Bruno/0000-0001-6577-9009				AUSUBEL FM, 1987, CURRENT PROTOCOLS MO, P495; BAHOUTH SW, 1988, MOL PHARMACOL, V34, P318; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BENOVIC JL, 1988, ANNU REV CELL BIOL, V4, P405, DOI 10.1146/annurev.cb.04.110188.002201; BENOVIC JL, 1987, J RECEPTOR RES, V7, P257, DOI 10.3109/10799898709054989; BONDY P K, 1985, P816; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; CHUNG FZ, 1987, FEBS LETT, V211, P200, DOI 10.1016/0014-5793(87)81436-9; COLLINS S, 1988, J BIOL CHEM, V263, P9067; COLLINS S, 1989, P NATL ACAD SCI USA, V86, P4853, DOI 10.1073/pnas.86.13.4853; COLLINS S, 1988, FEBS LETT, V233, P173, DOI 10.1016/0014-5793(88)81378-4; DELAVIERKLUTCHKO C, 1984, FEBS LETT, V169, P151, DOI 10.1016/0014-5793(84)80308-7; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; DOOLEY DJ, 1987, J PHARMACOL METHOD, V18, P131, DOI 10.1016/0160-5402(87)90005-2; EMORINE LJ, 1987, P NATL ACAD SCI USA, V84, P6995, DOI 10.1073/pnas.84.20.6995; EMORINE LJ, 1989, SCIENCE, V245, P1118, DOI 10.1126/science.2570461; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEVE B, 1987, FEBS LETT, V219, P56, DOI 10.1016/0014-5793(87)81190-0; FRASER CM, 1980, BIOCHEM BIOPH RES CO, V94, P390, DOI 10.1016/S0006-291X(80)80233-6; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; GIERSCHIK P, 1986, FEBS LETT, V199, P103, DOI 10.1016/0014-5793(86)81233-9; GILMAN AG, 1984, CELL, V36, P577, DOI 10.1016/0092-8674(84)90336-2; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; GUEST SJ, 1990, J BIOL CHEM, V265, P5370; HADCOCK JR, 1988, P NATL ACAD SCI USA, V85, P8415, DOI 10.1073/pnas.85.22.8415; HADCOCK JR, 1989, J BIOL CHEM, V264, P19928; HAINQUE B, 1987, BIOCHIM BIOPHYS ACTA, V931, P347, DOI 10.1016/0167-4889(87)90226-6; HOFSTEE BHJ, 1952, SCIENCE, V116, P329, DOI 10.1126/science.116.3013.329; KENT RS, 1980, MOL PHARMACOL, V17, P14; KOBILKA BK, 1987, J BIOL CHEM, V262, P7321; LACASA D, 1985, EUR J BIOCHEM, V146, P339, DOI 10.1111/j.1432-1033.1985.tb08658.x; LAI E, 1981, J BIOL CHEM, V256, P2866; LAI E, 1982, J BIOL CHEM, V257, P6691; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUCAS M, 1977, MOL PHARMACOL, V13, P314; MALBON CC, 1988, BIOCHEM BIOPH RES CO, V154, P676, DOI 10.1016/0006-291X(88)90192-1; MCPHERSON GA, 1985, J PHARMACOL METHOD, V14, P213, DOI 10.1016/0160-5402(85)90034-8; MOUSTAID N, 1990, J CELL BIOCHEM, V42, P243, DOI 10.1002/jcb.240420407; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; NAKADA MT, 1987, MOL PHARMACOL, V31, P377; NAKADA MT, 1989, BIOCHEM J, V260, P53, DOI 10.1042/bj2600053; ODONNELL SR, 1980, LIFE SCI, V27, P671, DOI 10.1016/0024-3205(80)90008-9; ODOWD BF, 1989, J BIOL CHEM, V264, P7564; PAIRAULT J, 1987, J CELL PHYSIOL, V132, P279, DOI 10.1002/jcp.1041320212; PAIRAULT J, 1982, EUR J BIOCHEM, V127, P351, DOI 10.1111/j.1432-1033.1982.tb06879.x; PAIRAULT J, 1979, P NATL ACAD SCI USA, V76, P5138, DOI 10.1073/pnas.76.10.5138; PHILIBERT D, 1984, ADRENAL STEROID ANTA, P77; RINGOLD GM, 1988, RECENT PROG HORM RES, V44, P115; RODBELL M, 1980, NATURE, V284, P17, DOI 10.1038/284017a0; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; RUBIN CS, 1977, J BIOL CHEM, V252, P3554; RUSSELL TR, 1976, P NATL ACAD SCI USA, V73, P4516, DOI 10.1073/pnas.73.12.4516; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHULE R, 1988, SCIENCE, V242, P1418, DOI 10.1126/science.3201230; SPIEGELMAN BM, 1983, J BIOL CHEM, V258, P83; STAEHELIN M, 1983, J BIOL CHEM, V258, P3496; STORCH J, 1989, J BIOL CHEM, V264, P10527; WATKINS DC, 1989, BIOCHEM BIOPH RES CO, V165, P929, DOI 10.1016/0006-291X(89)92692-2; WATKINS DC, 1987, J BIOL CHEM, V262, P10651; WATKINS PA, 1982, J BIOL CHEM, V257, P4719; WISE LS, 1979, J BIOL CHEM, V254, P273	62	91	95	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1990	265	27					16343	16349						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ950	1975811				2022-12-25	WOS:A1990DZ95000049
J	AZUMA, K; ARIKI, M; MIYAUCHI, T; USUI, H; TAKEDA, M; SEMBA, K; MATSUZAWA, Y; YAMAMOTO, T; TOYOSHIMA, K				AZUMA, K; ARIKI, M; MIYAUCHI, T; USUI, H; TAKEDA, M; SEMBA, K; MATSUZAWA, Y; YAMAMOTO, T; TOYOSHIMA, K			PURIFICATION AND CHARACTERIZATION OF A RAT-LIVER MEMBRANE TYROSINE-PROTEIN KINASE, THE POSSIBLE PROTOONCOGENE C-YES PRODUCT, P60C-YES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; CELL-MEMBRANES; GENE HCK; PHOSPHORYLATION; RECEPTOR; BINDING; AUTOPHOSPHORYLATION; IDENTIFICATION; EXPRESSION; FRACTIONS	A tyrosine-protein kinase was purified more than 270-fold from the rat liver plasma membrane fraction by successive column chromatographies on Sephacryl S-300, wheat germ agglutinin-agarose, casein-Sepharose, and hydroxylapatite, followed by isoelectrofocusing electrophoresis. The enzyme with pI of 6.2 was a 60-kDa single polypeptide which represented 42% of total protein. The enzyme reacted quantitatively with a monoclonal antibody to the amino-terminal sequence (Cys-3 to Ser-66) specific to the human c-yes protein, but not with antibodies to the specific amino-terminal sequences of the c-src, fyn, and lck proteins. The purified enzyme contained almost no phosphotyrosine residue but was autophosphorylated with Mg.ATP exclusively at tyrosine residues with concomitant increase in the kinase activity. The rates of autophosphorylation of the enzyme and phosphorylation of tyrosine-glutamate (1:4) copolymers, catalyzed by the enzyme were proportional to the square of enzyme concentration, suggesting that p60c-yes undergoes autophosphorylation through intermolecular catalysis, resulting in stimulation of the enzyme activity. Although the enzyme reaction showed an essential requirement for Mg2+ or Mn2+ with optimal concentrations of 20 and 3 mM, respectively, autophosphorylation significantly activated the enzyme only in the presence of Mg2+. Autophosphorylation of the enzyme reduced the K(m) for tyrosine-glutamate copolymers and tubulin, but not for ATP, and increased the V(max) of copolymer and tubulin phosphorylation.	HIROSHIMA UNIV, SCH MED, DEPT BIOCHEM, MINAMI KU, HIROSHIMA 734, JAPAN; UNIV TOKYO, INST MED SCI, TOKYO 108, JAPAN	Hiroshima University; University of Tokyo								BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHRISMAN TD, 1981, J BIOL CHEM, V256, P2981; CLAUSEN T, 1968, ANAL BIOCHEM, V22, P70, DOI 10.1016/0003-2697(68)90260-1; DASGUPTA A, 1978, J BIOL CHEM, V253, P6054; EK B, 1982, NATURE, V295, P419, DOI 10.1038/295419a0; FISCHER S, 1987, BIOCHEM BIOPH RES CO, V143, P819, DOI 10.1016/0006-291X(87)90322-6; HEDO JA, 1981, BIOCHEMISTRY-US, V20, P3385, DOI 10.1021/bi00515a013; HONEGGER AM, 1989, P NATL ACAD SCI USA, V86, P925, DOI 10.1073/pnas.86.3.925; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; JACOBS S, 1983, J BIOL CHEM, V258, P9581; KASUGA M, 1982, NATURE, V298, P667, DOI 10.1038/298667a0; KAWAKAMI T, 1986, MOL CELL BIOL, V6, P4195, DOI 10.1128/MCB.6.12.4195; KONG SK, 1988, J BIOL CHEM, V263, P14523; LEE JC, 1982, METHOD CELL BIOL, V24, P9; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; NISHIMURA J, 1982, P NATL ACAD SCI-BIOL, V79, P4303, DOI 10.1073/pnas.79.14.4303; NISHIZAWA M, 1986, MOL CELL BIOL, V6, P511, DOI 10.1128/MCB.6.2.511; POEHLING HM, 1981, ELECTROPHORESIS, V2, P141, DOI 10.1002/elps.1150020304; QUINTRELL N, 1987, MOL CELL BIOL, V7, P2267, DOI 10.1128/MCB.7.6.2267; Rudolph S A, 1979, Adv Cyclic Nucleotide Res, V10, P107; SCHULTZ AM, 1985, SCIENCE, V227, P427, DOI 10.1126/science.3917576; SEFTON BM, 1987, J CELL BIOL, V104, P1449, DOI 10.1083/jcb.104.6.1449; SEMBA K, 1990, MOL CELL BIOL, V10, P3095, DOI 10.1128/MCB.10.6.3095; SEMBA K, 1986, P NATL ACAD SCI USA, V83, P5459, DOI 10.1073/pnas.83.15.5459; SUDOL M, 1986, MOL CELL BIOL, V6, P2839, DOI 10.1128/MCB.6.8.2839; SUKEGAWA J, 1987, MOL CELL BIOL, V7, P41, DOI 10.1128/MCB.7.1.41; SUKEGAWA J, 1990, ONCOGENE, V5, P611; SVENSSON H, 1961, ACTA CHEM SCAND, V15, P325, DOI 10.3891/acta.chem.scand.15-0325; SWARUP G, 1988, BIOCHEM J, V251, P569, DOI 10.1042/bj2510569; TAMURA S, 1980, EUR J BIOCHEM, V104, P347, DOI 10.1111/j.1432-1033.1980.tb04435.x; TOUSTER O, 1970, J CELL BIOL, V47, P604, DOI 10.1083/jcb.47.3.604; TSUKAMOTO H, 1988, J BIOCHEM, V104, P807, DOI 10.1093/oxfordjournals.jbchem.a122554; USHIRO H, 1980, J BIOL CHEM, V255, P8363; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; VORONOVA AF, 1986, NATURE, V319, P682, DOI 10.1038/319682a0; WEBER K, 1969, J BIOL CHEM, V244, P4406; WONG TW, 1984, J BIOL CHEM, V259, P8505; YAMANASHI Y, 1987, MOL CELL BIOL, V7, P237, DOI 10.1128/MCB.7.1.237; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; YOSHIKAWA K, 1985, J BIOL CHEM, V260, P5091; ZIEGLER SF, 1987, MOL CELL BIOL, V7, P2276, DOI 10.1128/MCB.7.6.2276	42	14	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4831	4839						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002030				2022-12-25	WOS:A1991FC21700027
J	VISSING, H; DALESSIO, M; LEE, B; RAMIREZ, F; BYERS, PH; STEINMANN, B; SUPERTIFURGA, A				VISSING, H; DALESSIO, M; LEE, B; RAMIREZ, F; BYERS, PH; STEINMANN, B; SUPERTIFURGA, A			MULTIEXON DELETION IN THE PROCOLLAGEN-III GENE IS ASSOCIATED WITH MILD EHLERS-DANLOS SYNDROME TYPE-IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE BASE MUTATION; COLLAGEN; REGION; ACID; CDNA; FIBROBLASTS; NUCLEOTIDE; SECRETION; SEQUENCES; MOLECULE	We have characterized a deletion of approximately 9 kilobases which spans from intron 33 to exon 48 of one pro-alpha-1(III) collagen allele in a patient with Ehlers-Danlos syndrome type IV. The mutation results in the production of an in-frame species of mRNA which lacks the sequences corresponding to residues 595-1,008 of the triple-helical domain. Thus, half of the pro-alpha-1(III) chains synthesized by the patient's fibroblasts are nearly 30% shorter than normal. The procollagen III molecules composed of either three normal length or three shortened chains are thermally stable and efficiently secreted. In contrast, the procollagen III molecules that contain one or two shortened chains are unstable and are not secreted. Failure to secrete unstable molecules and a residual functional role of the shortened but stable homotrimers may explain the somewhat milder phenotype of this individual compared with that of another Ehlers-Danlos type IV patient bearing a deletion of similar size in the amino-terminal portion of the alpha-1(III) collagen chain.	CUNY MT SINAI SCH MED,BROOKDALE CTR MOLEC BIOL,NEW YORK,NY 10029; UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA 98195; UNIV WASHINGTON,CTR INHERITED DIS,SEATTLE,WA 98195; UNIV ZURICH,DEPT PEDIAT,DIV METAB,CH-8032 ZURICH,SWITZERLAND	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Zurich			superti-furga, andrea/E-9162-2015	superti-furga, andrea/0000-0002-3543-7531; Byers, Peter H./0000-0001-7786-7030	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR021557, R37AR038648, R01AR038648] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR21557, AR38648] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALAKOKKO L, 1989, BIOCHEM J, V260, P509, DOI 10.1042/bj2600509; BENSONCHANDA V, 1989, GENE, V78, P255, DOI 10.1016/0378-1119(89)90228-X; BORNSTEIN P, 1980, ANNU REV BIOCHEM, V49, P957, DOI 10.1146/annurev.bi.49.070180.004521; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; BYERS PH, 1990, TRENDS GENET, V6, P293, DOI 10.1016/0168-9525(90)90235-X; BYERS PH, 1981, LAB INVEST, V44, P336; BYERS PH, 1983, PRINCIPLES PRACTICE, V2, P836; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHU ML, 1985, J BIOL CHEM, V260, P4357; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; JANECZKO RA, 1989, NUCLEIC ACIDS RES, V17, P6742, DOI 10.1093/nar/17.16.6742; JEFFREYS AJ, 1988, NUCLEIC ACIDS RES, V16, P10953, DOI 10.1093/nar/16.23.10953; LEE B, 1991, J BIOL CHEM, V266, P5256; LEE B, 1989, SCIENCE, V244, P978, DOI 10.1126/science.2543071; LEE B, 1991, IN PRESS AM J HUM GE, V48; LOIDL HR, 1984, NUCLEIC ACIDS RES, V12, P9383, DOI 10.1093/nar/12.24.9383; MILLER EJ, 1976, ARCH BIOCHEM BIOPHYS, V173, P631, DOI 10.1016/0003-9861(76)90300-3; POPE FM, 1975, P NATL ACAD SCI USA, V72, P1314, DOI 10.1073/pnas.72.4.1314; PROCKOP DJ, 1989, CYTOSKELETAL EXTRACE, P81; RAMIREZ F, 1989, COLLAGEN MOL BIOL, V4, P21; Saiki R.K., 1989, PCR TECHNOLOGY, P7; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SEYER JM, 1980, BIOCHEMISTRY-US, V19, P1583, DOI 10.1021/bi00549a008; SUPERTIFURGA A, 1989, HUM GENET, V82, P104, DOI 10.1007/BF00284038; SUPERTIFURGA A, 1988, BIOCHEM BIOPH RES CO, V150, P140, DOI 10.1016/0006-291X(88)90497-4; SUPERTIFURGA A, 1988, J BIOL CHEM, V263, P6226; TILLER GE, 1990, P NATL ACAD SCI USA, V87, P3889, DOI 10.1073/pnas.87.10.3889; TOMAN PD, 1988, NUCLEIC ACIDS RES, V16, P7201, DOI 10.1093/nar/16.14.7201; TROMP G, 1989, J BIOL CHEM, V264, P1349; TROMP G, 1989, J BIOL CHEM, V264, P19313; VISSING H, 1989, J BIOL CHEM, V264, P18265	32	33	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					5244	5248						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002056				2022-12-25	WOS:A1991FC21700081
J	KODUKULA, K; MICANOVIC, R; GERBER, L; TAMBURRINI, M; BRINK, L; UDENFRIEND, S				KODUKULA, K; MICANOVIC, R; GERBER, L; TAMBURRINI, M; BRINK, L; UDENFRIEND, S			BIOSYNTHESIS OF PHOSPHATIDYLINOSITOL GLYCAN-ANCHORED MEMBRANE-PROTEINS - DESIGN OF A SIMPLE PROTEIN SUBSTRATE TO CHARACTERIZE THE ENZYME THAT CLEAVES THE COOH-TERMINAL SIGNAL PEPTIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLACENTAL ALKALINE-PHOSPHATASE; CELL-SURFACE; ENDOPLASMIC-RETICULUM; PHOSPHOLIPASE-C; PURIFICATION; EXPRESSION; SYSTEM	Many nascent proteins that are destined to be anchored to plasma membranes by a phosphatidylinositol glycan (PI-G) are in the range of 50-70 kDa so that changes of 2-3 kDa between precursors and products during processing are not easily detected. Furthermore, PI-G-anchored proteins are generally glycosylated so that changes between the nascent (prepro) proteins and the mature products are not due simply to the loss of signal peptides. These problems have made it difficult to monitor the processing of the prepro form of wild type human placental alkaline phosphatase (PLAP) in a cell-free system. We have designed a smaller and simpler substrate of PI-G "transamidase" derived by deletion of approximately 60% of the internal sequence of preproPLAP 513. This engineered protein, preprominiPLAP 208, retains the NH-2- and COOH-terminal signal peptides of PLAP as well as all the epitopes for site-directed antibodies of the latter, but is devoid of glycosylation sites, the active site, and most of the cysteine residues. With preprominiPLAP, it has been possible to demonstrate, in a cell-free system, step by step conversion to the pro form and then to the mature form, with the concomitant loss of the appropriate signal peptides. These changes were shown to be time- and enzyme concentration-dependent. Studies with Asp-179 site-directed mutants of preprominiPLAP showed the same specificity for amino acids with a monosubstituted beta-carbon at the cleavage/attachment site that were found previously with wild type PLAP.	ROCHE INST MOLEC BIOL,ROCHE RES CTR,DEPT NEUROSCI,340 KINGSLAND ST,NUTLEY,NJ 07110	Roche Holding								BAILEY CA, 1988, ANAL BIOCHEM, V170, P532, DOI 10.1016/0003-2697(88)90669-0; BAILEY CA, 1989, P NATL ACAD SCI USA, V86, P22, DOI 10.1073/pnas.86.1.22; BERGER J, 1988, J BIOL CHEM, V263, P10016; BERGER J, 1987, P NATL ACAD SCI USA, V84, P4885, DOI 10.1073/pnas.84.14.4885; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BUCHANAN JM, 1973, ADV ENZYMOL RAMB, V39, P91; CROSS GAM, 1990, ANNU REV CELL BIOL, V6, P1, DOI 10.1146/annurev.cb.06.110190.000245; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; DAVITZ MA, 1987, SCIENCE, V238, P81, DOI 10.1126/science.2443973; DOERING TL, 1990, J BIOL CHEM, V265, P611; EVANS EA, 1986, P NATL ACAD SCI USA, V83, P581, DOI 10.1073/pnas.83.3.581; FASEL N, 1989, P NATL ACAD SCI USA, V86, P6858, DOI 10.1073/pnas.86.18.6858; FERGUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARNER J, 1979, SCIENCE, V206, P1408, DOI 10.1126/science.228395; LINGAPPA VR, 1977, P NATL ACAD SCI USA, V74, P2432, DOI 10.1073/pnas.74.6.2432; LODISH HF, 1988, J BIOL CHEM, V263, P2107; LOW MG, 1977, BIOCHEM J, V167, P281, DOI 10.1042/bj1670281; LOW MG, 1987, BIOCHEM J, V244, P1; LOW MG, 1988, P NATL ACAD SCI USA, V85, P980, DOI 10.1073/pnas.85.4.980; MICANOVIC R, 1990, P NATL ACAD SCI USA, V87, P157, DOI 10.1073/pnas.87.1.157; MICANOVIC R, 1990, P NATL ACAD SCI USA, V87, P7939, DOI 10.1073/pnas.87.20.7939; PELHAM HRB, 1976, EUR J BIOCHEM, V67, P247, DOI 10.1111/j.1432-1033.1976.tb10656.x; SALTIEL AR, 1990, INSULIN, P289; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TAGUCHI R, 1980, BIOCHIM BIOPHYS ACTA, V619, P48; TATE SS, 1990, FASEB J, V4, P227, DOI 10.1096/fasebj.4.2.2298343; TATE SS, 1985, METHOD ENZYMOL, V113, P400; TIPPER DJ, 1965, P NATL ACAD SCI USA, V54, P1133, DOI 10.1073/pnas.54.4.1133; WALTER P, 1983, METHOD ENZYMOL, V96, P84; WICKNER WT, 1985, SCIENCE, V230, P400, DOI 10.1126/science.4048938; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8	32	58	75	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4464	4470						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999429				2022-12-25	WOS:A1991FA69400069
J	MELKERSONWATSON, LJ; SWEELEY, CC				MELKERSONWATSON, LJ; SWEELEY, CC			PURIFICATION TO APPARENT HOMOGENEITY BY IMMUNOAFFINITY CHROMATOGRAPHY AND PARTIAL CHARACTERIZATION OF THE GM3 GANGLIOSIDE-FORMING ENZYME, CMP-SIALIC ACID-LACTOSYLCERAMIDE ALPHA-2,3-SIALYLTRANSFERASE (SAT-1), FROM RAT-LIVER GOLGI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-SPECIFIC EXPRESSION; UDP-N-ACETYLGALACTOSAMINE; SUB-MAXILLARY GLANDS; SIALYLTRANSFERASE ACTIVITY; RETINOIC ACID; MORPHOLOGICAL-CHANGES; GROWTH-INHIBITION; MELANOMA-CELLS; KB CELLS; GLYCOSYLATION	CMP-sialic acid:lactosylceramide alpha-2,3-sialytransferase (SAT-1) has been purified approximately 40,000-fold to apparent homogeneity from rat liver Golgi. The enzyme was solubilized from Golgi vesicles in 5% lauryldimethylamine oxide and "partially" purified by affinity chromatography twice on CMP-hexanolamine and once on lactosylceramide aldehyde-Sepharose 4B. Final purification was achieved by immunoaffinity chromatography on M12GC7-Gel 10. The M12GC7 monoclonal antibody specifically inhibits and immunoprecipitates SAT-1 activity. Identification of the protein, with an apparent molecular weight by sodium dodecyl sulfate-polyacrylamide gel electrophoresis of about 60,000 daltons, was confirmed by Western blot and immunodetection with M12GC7. SAT-1 specifically catalyzes the transfer of N-acetylneuraminic acid (NeuAc, sialic acid) to lactosylceramide (Gal-beta-1-4Glc-beta-1-O-ceramide), forming G(M3) ganglioside. Studies on substrate specificity indicate that the preferred acceptors have the general structure saccharide beta-1-O-ceramide, a disaccharide being preferred to a monosaccharide. SAT-1 is a glycoprotein. The carbohydrate moieties are detected with specific lectins. Deglycosylation of SAT-1 with N-glycanase results in an increase in a 43,000-dalton band. The two-dimensional electrophoretogram of SAT-1 indicates a pI range of 5.7-6.2 for the 60,000-dalton protein.	MICHIGAN STATE UNIV,DEPT BIOCHEM,RM 401,BIOCHEM BLDG,E LANSING,MI 48824	Michigan State University					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK012434] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK12434] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BASU S, 1990, FASEB J, V4, P2584; BAUBICHONCORTAY H, 1989, GLYCOCONJUGATE J, V6, P115, DOI 10.1007/BF01047894; BURCZAK JD, 1984, BIOCHIM BIOPHYS ACTA, V804, P442, DOI 10.1016/0167-4889(84)90072-7; BURCZAK JD, 1984, J LIPID RES, V25, P1541; BURCZAK JD, 1983, EXP CELL RES, V147, P281, DOI 10.1016/0014-4827(83)90210-0; CAREY DJ, 1980, J BIOL CHEM, V255, P4348; CHATTERJEE S, 1975, J BIOL CHEM, V250, P61; CLAUSEN H, 1990, J BIOL CHEM, V265, P1139; DEUTSCH V, 1983, EXP CELL RES, V149, P237, DOI 10.1016/0014-4827(83)90395-6; DUNBAR BS, 1987, 2 DIMENSIONAL ELECTR, P227; FISHMAN PH, 1974, BIOCHEM BIOPH RES CO, V59, P292, DOI 10.1016/S0006-291X(74)80205-6; Fleischer S, 1974, Methods Enzymol, V31, P6; FUKUDA M, 1981, CANCER RES, V41, P4621; FULLER SA, 1987, CURRENT PROTOCOLS MO, V2, pCH11; GINSBURG E, 1973, P NATL ACAD SCI USA, V70, P2457, DOI 10.1073/pnas.70.8.2457; GU XB, 1990, ANAL BIOCHEM, V185, P151, DOI 10.1016/0003-2697(90)90271-A; GU XB, 1990, BIOCHEM BIOPH RES CO, V166, P387, DOI 10.1016/0006-291X(90)91957-T; HAKOMORI S, 1985, CANCER RES, V45, P2405; HAKOMORI S, 1984, ANNU REV IMMUNOL, V2, P103, DOI 10.1146/annurev.iy.02.040184.000535; HAKOMORI SI, 1990, J BIOL CHEM, V265, P18713; HOLMGREN J, 1980, P NATL ACAD SCI-BIOL, V77, P1947, DOI 10.1073/pnas.77.4.1947; HUBERMAN E, 1979, CANCER RES, V39, P2618; JOZIASSE DH, 1985, J BIOL CHEM, V260, P4941; KANEMITSU K, 1986, GLYCOCONJUGATE J, V3, P143, DOI 10.1007/BF01049372; Kaufman B, 1966, METHODS ENZYMOL, V8, P365; KOEFFLER HP, 1981, CANCER RES, V41, P919; Kundu S K, 1981, Methods Enzymol, V72, P174; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMMERS G, 1988, BIOCHEM J, V256, P623, DOI 10.1042/bj2560623; LAYNE E, 1957, METHOD ENZYMOL, V3, P447, DOI 10.1016/S0076-6879(57)03413-8; LEDER A, 1975, CELL, V5, P319, DOI 10.1016/0092-8674(75)90107-5; LEELAVATHI DE, 1970, BIOCHIM BIOPHYS ACTA, V211, P124, DOI 10.1016/0005-2736(70)90087-8; LOTAN R, 1984, CANCER RES, V44, P5805; MACHER BA, 1978, EXP CELL RES, V117, P95, DOI 10.1016/0014-4827(78)90431-7; MELKERSONWATSON LJ, 1990, BIOCHEM BIOPH RES CO, V172, P165, DOI 10.1016/S0006-291X(05)80188-3; MELKERSONWATSON LJ, 1987, GLYCOCONJUGATE J, V4, P7, DOI 10.1007/BF01048440; MERRIL CR, 1984, METHOD ENZYMOL, V104, P441; MORRE DJ, 1969, BIOCHEM BIOPH RES CO, V37, P813; MORRE DJ, 1971, METHOD ENZYMOL, V22, P130; MOSKAL JR, 1987, CANCER RES, V47, P787; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OHANLON TP, 1989, J BIOL CHEM, V264, P17389; PAULSON JC, 1977, J BIOL CHEM, V252, P2356; PAULSON JC, 1989, TRENDS BIOCHEM SCI, V14, P272, DOI 10.1016/0968-0004(89)90062-5; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; PAULSON JC, 1989, J BIOL CHEM, V264, P10931; PAYATTE R, 1990, CANCER RES, V40, P2465; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; POHLENTZ G, 1988, P NATL ACAD SCI USA, V85, P7044, DOI 10.1073/pnas.85.19.7044; ROTH J, 1978, J HISTOCHEM CYTOCHEM, V26, P1074, DOI 10.1177/26.12.366014; ROTH J, 1985, CELL, V43, P287, DOI 10.1016/0092-8674(85)90034-0; SADLER JE, 1979, J BIOL CHEM, V254, P4434; SADLER JE, 1979, J BIOL CHEM, V254, P5934; SCHUZHENNINGER R, 1989, EUR J BIOCHEM, V185, P327, DOI 10.1111/j.1432-1033.1989.tb15119.x; SCHUZHENNINGER R, 1988, ARCH BIOCHEM BIOPHYS, V262, P49, DOI 10.1016/0003-9861(88)90167-1; SVENNERHOLM L, 1964, J LIPID RES, V5, P145; TANIGUCHI N, 1984, J BIOL CHEM, V259, P5637; TANIGUCHI N, 1982, J BIOL CHEM, V257, P631; TANIGUCHI N, 1985, J BIOL CHEM, V260, P4908; WEINSTEIN J, 1982, J BIOL CHEM, V257, P13835; YU RK, 1976, J BIOL CHEM, V251, P198; YUSUF HKM, 1987, BIOL CHEM H-S, V368, P455, DOI 10.1515/bchm3.1987.368.1.455; 1977, LIPIDS, V12, P455	63	48	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4448	4457						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999428				2022-12-25	WOS:A1991FA69400067
J	ALNEMRI, ES; MAKSYMOWYCH, AB; ROBERTSON, NM; LITWACK, G				ALNEMRI, ES; MAKSYMOWYCH, AB; ROBERTSON, NM; LITWACK, G			CHARACTERIZATION AND PURIFICATION OF A FUNCTIONAL-RAT GLUCOCORTICOID RECEPTOR OVEREXPRESSED IN A BACULOVIRUS SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEIN; DNA-BINDING DOMAIN; NUCLEOTIDE-SEQUENCE; STEROID-RECEPTORS; NUCLEAR-LOCALIZATION; MONOCLONAL-ANTIBODY; EXPRESSION VECTORS; KINASE-ACTIVITY; INSECT CELLS; COMPLEX	The structure-function relationship of the oligomeric unactivated glucocorticoid receptor is not fully understood. An essential step in the process of understanding such a relationship involves the production of large quantities of the receptor. Using a baculovirus expression system we have been able to overproduce a recombinant rat glucocorticoid receptor (rGR). A cDNA coding for the entire rGR was introduced into the genome of the wild type baculovirus, Autographa californica nuclear polyhedrosis virus, by an in vivo recombination event. Based on specific steroid binding, insect cells infected with the recombinant baculovirus expressed 1-3 x 10(6) receptor molecules/cell which is 15-45 times more than that expressed normally in a hepatocyte. The recombinant rGR expressed in insect cells is indistinguishable from the bona fide rGR with respect to immunogenic reactivity, cytoplasmic localization, sedimentation, chromatographic and electrophoretic mobility, and hormone and DNA binding. Furthermore, the recombinant rGR is expressed as a functional protein as demonstrated by its ability to specifically bind a glucocorticoid agonist, to translocate from the cytoplasm to the nucleus upon hormone-binding, and to act as a transcriptional enhancer. Pulse labeling of recombinant baculovirus-infected insect cells with (Pi)-P-32 and isolation of the labeled products by immunoprecipitation demonstrated that the recombinant rGR is a phosphoprotein. Thus, the recombinant rGR expressed in insect cells is biologically active and is suitable for structural and functional analysis. A simple three-step purification procedure of the unactivated recombinant rGR is described.	TEMPLE UNIV,HLTH SCI CTR,SCH MED,FELS INST CANC RES & MOLEC,3420 N BROAD ST,PHILADELPHIA,PA 19140; TEMPLE UNIV,HLTH SCI CTR,SCH MED,DEPT BIOCHEM,PHILADELPHIA,PA 19140	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University					NCI NIH HHS [CA12227] Funding Source: Medline; NIDDK NIH HHS [DK13531] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA012227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK013531] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AURICCHIO F, 1989, J STEROID BIOCHEM, V32, P613, DOI 10.1016/0022-4731(89)90397-X; BAILLY A, 1978, EUR J BIOCHEM, V88, P623, DOI 10.1111/j.1432-1033.1978.tb12489.x; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BLACKMAN RK, 1986, J MOL BIOL, V188, P499, DOI 10.1016/S0022-2836(86)80001-8; Bodine P V, 1990, Receptor, V1, P83; BODINE PV, 1988, J BIOL CHEM, V263, P3501; BODINE PV, 1988, P NATL ACAD SCI USA, V85, P1462, DOI 10.1073/pnas.85.5.1462; BODINE PV, 1990, J BIOL CHEM, V265, P9544; CATELLI MG, 1985, EMBO J, V4, P3131, DOI 10.1002/j.1460-2075.1985.tb04055.x; DAHLMAN K, 1989, J BIOL CHEM, V264, P804; DAHMER MK, 1984, ANNU REV PHYSIOL, V46, P67; DALMAN FC, 1989, J BIOL CHEM, V264, P19815; DALMAN FC, 1988, J BIOL CHEM, V263, P12259; DANIELSEN M, 1986, EMBO J, V5, P2513, DOI 10.1002/j.1460-2075.1986.tb04529.x; DENIS M, 1988, NATURE, V333, P686, DOI 10.1038/333686a0; DENIS M, 1989, J BIOL CHEM, V264, P6005; DOMINGO DL, 1988, J BIOL CHEM, V263, P13386; EISEN LP, 1985, J BIOL CHEM, V260, P1805; ELLIS L, 1988, J VIROL, V62, P1634, DOI 10.1128/JVI.62.5.1634-1639.1988; ERDOS T, 1970, ANAL BIOCHEM, V37, P244, DOI 10.1016/0003-2697(70)90044-8; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FUXE K, 1985, ENDOCRINOLOGY, V117, P1803, DOI 10.1210/endo-117-5-1803; GEHRING U, 1985, FEBS LETT, V179, P138, DOI 10.1016/0014-5793(85)80208-8; GOIDL JA, 1977, BIOCHEMISTRY-US, V16, P2125, DOI 10.1021/bi00629a012; GRANDICS P, 1984, J BIOL CHEM, V259, P3173; GRANDICS P, 1984, BIOCHEM BIOPH RES CO, V120, P59, DOI 10.1016/0006-291X(84)91413-X; GREENFIELD C, 1988, EMBO J, V7, P139, DOI 10.1002/j.1460-2075.1988.tb02793.x; GUSTAFSSON JA, 1987, ENDOCR REV, V8, P185, DOI 10.1210/edrv-8-2-185; HERRERA R, 1988, J BIOL CHEM, V263, P5560; HOECK W, 1990, J BIOL CHEM, V265, P5403; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; KINGSTON RE, 1989, CURRENT PROTOCOLS MO, V2; LEESMILLER SP, 1989, J BIOL CHEM, V264, P2431; LEFEVRE B, 1979, BIOCHIM BIOPHYS ACTA, V585, P266, DOI 10.1016/0304-4165(79)90026-6; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; LITWACK G, 1988, CANCER RES, V48, P2636; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; LUCKOW VA, 1989, VIROLOGY, V170, P31, DOI 10.1016/0042-6822(89)90348-6; LUCKOW VA, 1988, BIO-TECHNOL, V6, P47, DOI 10.1038/nbt0188-47; MAEDA S, 1989, ANNU REV ENTOMOL, V34, P351, DOI 10.1146/annurev.en.34.010189.002031; MENDEL DB, 1988, J BIOL CHEM, V263, P6695; MENDEL DB, 1986, J BIOL CHEM, V261, P3758; MESHINCHI S, 1988, J BIOL CHEM, V263, P16809; MESHINCHI S, 1990, J BIOL CHEM, V265, P4863; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; MILGROM E, 1973, BIOCHEMISTRY-US, V12, P5198, DOI 10.1021/bi00749a029; MILLER LK, 1988, ANNU REV MICROBIOL, V42, P177, DOI 10.1146/annurev.micro.42.1.177; MILLERDIENER A, 1985, P NATL ACAD SCI USA, V82, P4003, DOI 10.1073/pnas.82.12.4003; MOORE SK, 1987, GENE, V56, P29, DOI 10.1016/0378-1119(87)90155-7; ORTI E, 1989, J STEROID BIOCHEM, V34, P85, DOI 10.1016/0022-4731(89)90069-1; PARCHMAN LG, 1977, ARCH BIOCHEM BIOPHYS, V183, P374, DOI 10.1016/0003-9861(77)90371-X; PICARD D, 1988, CELL, V54, P1073, DOI 10.1016/0092-8674(88)90122-5; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; PRATT WB, 1987, J CELL BIOCHEM, V35, P51, DOI 10.1002/jcb.240350105; REBBE NF, 1987, GENE, V53, P235, DOI 10.1016/0378-1119(87)90012-6; REXIN M, 1988, BIOCHEMISTRY-US, V27, P5593, DOI 10.1021/bi00415a030; SAKAUE Y, 1977, BIOCHEM BIOPH RES CO, V77, P533, DOI 10.1016/S0006-291X(77)80012-0; SANCHEZ ER, 1987, J BIOL CHEM, V262, P6986; SCHENA M, 1988, SCIENCE, V241, P965, DOI 10.1126/science.3043665; SCHMIDT TJ, 1985, J BIOL CHEM, V260, P6255; SCHMIDT TJ, 1986, GLUCOCORTICOID HORMO, P35; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; SHERMAN MR, 1984, ANNU REV PHYSIOL, V46, P83; SRINIVASAN G, 1990, MOL ENDOCRINOL, V4, P209, DOI 10.1210/mend-4-2-209; SUMMERS MD, 1987, TEXAS EXPT STATION B, V1555; VEDECKIS WV, 1985, HORMONALLY RESPONSIV, P3; VISSAVAJJHALA P, 1990, J BIOL CHEM, V265, P4746; WIKSTROM AC, 1987, ENDOCRINOLOGY, V120, P1232, DOI 10.1210/endo-120-4-1232; WRANGE O, 1984, J BIOL CHEM, V259, P4534; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209	70	64	66	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3925	3936						12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995640				2022-12-25	WOS:A1991EY68200086
J	KUROO, M; NAGAI, R; NAKAHARA, KI; KATOH, H; TSAI, RC; TSUCHIMOCHI, H; YAZAKI, Y; OHKUBO, A; TAKAKU, F				KUROO, M; NAGAI, R; NAKAHARA, KI; KATOH, H; TSAI, RC; TSUCHIMOCHI, H; YAZAKI, Y; OHKUBO, A; TAKAKU, F			CDNA CLONING OF A MYOSIN HEAVY-CHAIN ISOFORM IN EMBRYONIC SMOOTH-MUSCLE AND ITS EXPRESSION DURING VASCULAR DEVELOPMENT AND IN ARTERIOSCLEROSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; MULTIGENE FAMILY; MESSENGER-RNAS; DNA-SEQUENCE; CELLS; IDENTIFICATION; PATTERN	Adult rabbit smooth muscles contain two types of myosin heavy chain (MHC) isoforms, SM1 and SM2, which are generated through alternative RNA splicing from a single gene (Nagai, R., Kuro-o, M., Babij, P. & Periasamy, M. (1989) J. Biol. Chem. 264, 9734-9737). We previously reported that the expression of SM1 and SM2 during vascular development is differentially regulated at the level of RNA splicing, whereby SM1 is constitutively expressed from early development but SM2 appear after birth (Kuro-o, M., Nagai, R., Tsuchimochi, H., Katoh, H., Yazaki, Y., Ohkubo, A. & Takaku, F. (1989) J. Biol. Chem. 264, 18272-18275). We also demonstrated that embryonic vascular smooth muscles contain a third type of MHC isoform, referred to as SMemb in this report, which comigrates on sodium dodecyl sulfate-polyacrylamide gel electrophoresis with SM2. In the present study we have isolated and characterized a cDNA clone (FSMHC34) for SMemb. FSMHC34 encodes the light meromyosin region including the carboxyl terminus and showed 70% amino acid sequence identity with SM1 or SM2. SMemb is a nonmuscle-type MHC and identical with brain MHC, but clearly distinct from 196-kDa nonmuscle MHC in cultured smooth muscle cells. The expression of SMemb was predominant in embryonic and perinatal aortas, but down-regulated with vascular development. Interestingly SMemb was reexpressed in proliferating smooth muscle cells of arteriosclerotic neointimas. These results suggest that smooth muscle proliferation is coupled to the expression of SMemb and that dedifferentiation of smooth muscles toward the embryonic phenotype is involved in the mechanisms underlying atherosclerosis.	UNIV TOKYO,DEPT INTERNAL MED 3,7-3-1 HONGO,BUNKYO KU,TOKYO 113,JAPAN; UNIV TOKYO,DEPT LAB MED,TOKYO 113,JAPAN; YAMASA SHOYU CO LTD,DIV DIAGNOST,CHIBA,JAPAN	University of Tokyo; University of Tokyo								BABIJ P, 1989, J MOL BIOL, V210, P673, DOI 10.1016/0022-2836(89)90142-3; BERK AJ, 1977, CELL, V12, P721, DOI 10.1016/0092-8674(77)90272-0; CHAMLEYCAMPBELL J, 1979, PHYSIOL REV, V59, P1, DOI 10.1152/physrev.1979.59.1.1; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; IZUMO S, 1986, SCIENCE, V231, P597, DOI 10.1126/science.3945800; JOLESZ F, 1981, ANNU REV PHYSIOL, V43, P531, DOI 10.1146/annurev.ph.43.030181.002531; KATSURAGAWA Y, 1989, EUR J BIOCHEM, V184, P611, DOI 10.1111/j.1432-1033.1989.tb15057.x; KAVINSKY CJ, 1983, J BIOL CHEM, V258, P5196; KAWAMOTO S, 1987, J BIOL CHEM, V262, P7282; KORN ED, 1988, ANNU REV BIOPHYS BIO, V17, P23; KUROO M, 1989, J BIOL CHEM, V264, P18272; MAHDAVI V, 1982, NATURE, V297, P659, DOI 10.1038/297659a0; Maniatis T., 1982, MOL CLONING; MATSUMURA S, 1985, J BIOL CHEM, V260, P1959; MOHAMMAD MA, 1988, FEBS LETT, V228, P109, DOI 10.1016/0014-5793(88)80596-9; MURAKAMI N, 1990, J BIOL CHEM, V265, P1041; NAGAI R, 1989, J BIOL CHEM, V264, P9734; NAGAI R, 1988, P NATL ACAD SCI USA, V85, P1047, DOI 10.1073/pnas.85.4.1047; NGUYEN HT, 1982, P NATL ACAD SCI-BIOL, V79, P5230, DOI 10.1073/pnas.79.17.5230; OHNO S, 1987, NATURE, V325, P161, DOI 10.1038/325161a0; PERIASAMY M, 1984, J BIOL CHEM, V259, P3573; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; ROVNER AS, 1986, AM J PHYSIOL, V250, pC861, DOI 10.1152/ajpcell.1986.250.6.C861; SANGER F, 1977, P NATL ACAD SCI USA, V80, P1194; SHOHET RV, 1989, P NATL ACAD SCI USA, V86, P7726, DOI 10.1073/pnas.86.20.7726; SILBERSTEIN L, 1986, CELL, V46, P1075, DOI 10.1016/0092-8674(86)90707-5; SOEIRO R, 1966, J MOL BIOL, V19, P362; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WEYDERT A, 1987, CELL, V49, P121, DOI 10.1016/0092-8674(87)90762-8; WYDRO RM, 1983, J BIOL CHEM, V258, P670; YANAGISAWA M, 1987, J MOL BIOL, V198, P143, DOI 10.1016/0022-2836(87)90302-0	31	280	288	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3768	3773						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995631				2022-12-25	WOS:A1991EY68200065
J	DIAZ, JF; ANDREU, JM				DIAZ, JF; ANDREU, JM			KINETICS OF DISSOCIATION OF THE TUBULIN-COLCHICINE COMPLEX - COMPLETE REACTION SCHEME AND COMPARISON TO THERMODYNAMIC MEASUREMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE STOPPED FLOW; MICROTUBULE PROTEIN; ANALOG 2-METHOXY-5-(2'; REVERSIBLE INHIBITION; BINDING; BRAIN; PODOPHYLLOTOXIN; TROPOLONE; LIGANDS; TROPONE	The slow dissociation reaction of the tubulin-colchicine complex has been characterized in purified calf brain tubulin and microtubule protein preparations, using [H-3]colchicine and fluorometric measurements. It fits to a single exponential phase, within the accuracy of these measurements. The dissociation is a kinetically unfavorable reaction, with activation energy values of 114 +/- 10 and 94 +/- 10 kJ mol-1 (purified tubulin and microtubule protein, respectively). The kinetic scheme previously proposed for the tubulin-colchicine association (Lambeir, A., and Engelborghs, Y. (1981) J. Biol. Chem. 256, 3279-3282) is: [GRAPHICS] where step 1 is a fast reversible binding and step 2 is a slow conformational change, whose backward rate constant (k-2) was neglected for the association study. This kinetic scheme has now been completed to include the measurements of the rate-limiting dissociation step (k-2), and of the purified calf brain tubulin preparation. The overall binding standard free energy change, calculated from the kinetic measurements, is -42.0 +/- 0.1 kJ mol-1 (fast phase of binding in 10 mM sodium phosphate buffer, 0.1 mM GTP, pH 7.0, at 37-degrees-C). The binding is exothermic and the calculated enthalpy change is -26 +/- 13 kJ mol-1, which coincides with the recently determined calorimetric enthalpy value, -21 +/- 2 kJ mol-1 (Menendez, M., Laynez, J., Medrano, F. J., and Andreu, J. M. (1989) J. Biol. Chem 264, 16367-16371), suggesting that the kinetic scheme and measurements are essentially correct.	CSIC,CTR INVEST BIOL,VELAZQUEZ 144,E-28006 MADRID,SPAIN	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consiglio Nazionale delle Ricerche (CNR)			Díaz, J. Fernando/U-3532-2017	Díaz, J. Fernando/0000-0003-2743-3319; Andreu, Jose M/0000-0001-8064-6933				ANDREU JM, 1982, BIOCHEMISTRY-US, V21, P6465, DOI 10.1021/bi00268a023; ANDREU JM, 1982, BIOCHEMISTRY-US, V21, P534, DOI 10.1021/bi00532a019; ANDREU JM, 1984, BIOCHEMISTRY-US, V23, P1742, DOI 10.1021/bi00303a025; ANDREU JM, 1986, BIOCHEMISTRY-US, V25, P5230, DOI 10.1021/bi00366a037; ANDREU JM, 1991, IN PRESS BIOCHEMISTR; BANE S, 1984, J BIOL CHEM, V259, P7391; BANERJEE A, 1987, FEBS LETT, V219, P103, DOI 10.1016/0014-5793(87)81199-7; BARNES LD, 1983, BIOCHEM BIOPH RES CO, V116, P868; BHATTACH.B, 1974, P NATL ACAD SCI USA, V71, P2627, DOI 10.1073/pnas.71.7.2627; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROSSI A, 1990, FEBS LETT, V262, P5, DOI 10.1016/0014-5793(90)80139-A; BRYAN J, 1972, BIOCHEMISTRY-US, V11, P2611, DOI 10.1021/bi00764a010; DELAVINA S, 1988, BIOCHEMISTRY-US, V27, P5352, DOI 10.1021/bi00414a060; DIEZ JC, 1987, CELL MOTIL CYTOSKEL, V7, P178, DOI 10.1002/cm.970070210; ENGELBORGHS Y, 1987, J BIOL CHEM, V262, P5204; ENGELBORGHS Y, 1986, ANN NY ACAD SCI, V466, P709, DOI 10.1111/j.1749-6632.1986.tb38453.x; GARLAND DL, 1978, BIOCHEMISTRY-US, V17, P4266, DOI 10.1021/bi00613a024; HERMAN G, 1989, P NATL ACAD SCI USA, V86, P4525; IDE G, 1981, J BIOL CHEM, V256, P1684; KARR TL, 1982, METHOD CELL BIOL, V24, P51; LAMBEIR A, 1981, J BIOL CHEM, V256, P3279; LEE JC, 1973, J BIOL CHEM, V248, P7253; MCCLURE WO, 1977, MOL PHARMACOL, V13, P560; MEDRANO FJ, 1989, BIOCHEMISTRY-US, V28, P5589, DOI 10.1021/bi00439a038; MENENDEZ M, 1989, J BIOL CHEM, V264, P16367; MOLLINEDO F, 1989, MOL PHARMACOL, V36, P547; SHERLINE P, 1975, J BIOL CHEM, V250, P5481; TAYLOR EW, 1965, J CELL BIOL, V25, P267; WEISENBERG RC, 1968, BIOCHEMISTRY-US, V7, P4466, DOI 10.1021/bi00852a043; Wilson L., 1973, ADV CELL MOLECULAR B, V3, P21; YEH HJC, 1988, FEBS LETT, V229, P82, DOI 10.1016/0014-5793(88)80802-0	31	52	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2890	2896						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993663				2022-12-25	WOS:A1991EX60000037
J	JANSEN, RW; MOLEMA, G; CHING, TL; OOSTING, R; HARMS, G; MOOLENAAR, F; HARDONK, MJ; MEIJER, DKF				JANSEN, RW; MOLEMA, G; CHING, TL; OOSTING, R; HARMS, G; MOOLENAAR, F; HARDONK, MJ; MEIJER, DKF			HEPATIC ENDOCYTOSIS OF VARIOUS TYPES OF MANNOSE-TERMINATED ALBUMINS - WHAT IS IMPORTANT, SUGAR RECOGNITION, NET CHARGE, OR THE COMBINATION OF THESE FEATURES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER ENDOTHELIAL-CELLS; BETA-D-GLUCOSAMINIDASE; SERUM-ALBUMIN; RAT-LIVER; SINUSOIDAL CELLS; N-ACETYLGLUCOSAMINE; MODIFIED PROTEINS; PLASMA-CLEARANCE; RECEPTOR; GLYCOPROTEINS	We synthesized several para-aminophenyl (pap-) mannose-terminated albumins with varying sugar density (Man7-HSA, Man22-HSA, and Man40-HSA) and compared hepatic uptake with (thio-)mannose-terminated bovine serum albumin (Man-43-AI-BSA) The rate of uptake in isolated perfused rat livers was found to be positively correlated with the sugar density (Man40-HSA = Man22-HSA > Man7-HSA > HSA). Immunohistochemical staining of liver sections showed for both types of neoglycoproteins that uptake occurred in nonparenchymal cells only. Competition experiments with a 500-fold excess of mannan, a known ligand for the mannose/N-acetylglucosamine receptor, that is predominantly localized in endothelial cells, showed complete inhibition of the (thio-)Man43-AI-BSA uptake. In the case of (pap-)mannose-terminated albumins, however, the extent of inhibition by mannan was moderate and decreased markedly with increasing sugar density, being only 20% for (pap-)Man40-HSA. Therefore, we hypothesized that one or more additional removal systems contributed to the clearance of these (pap-)mannose glycoproteins. We found that net negative charge of the (pap-)mannose albumins clearly increased with increasing sugar density, as shown on fast protein liquid chromatography anion-exchange chromatograms. To determine whether the scavenger receptor system that is also mainly present on endothelial cells is involved, we performed competition studies with strongly negatively charged substrates, such as dextran sulfate and formaldehyde-treated human serum albumin (fHSA). An excess of dextran sulfate (500 kDa), indeed blocked the (pap-)mannose-albumin uptake for more than 95%. Dextran sulfate completely inhibited the hepatic uptake of mannan as well, indicating that the polyanion does not discriminate between the scavenger system and the mannose receptor system and should be regarded as an aspecific inhibitor of receptor-mediated endocytotic pathways. Surprisingly, a 500-fold excess of fHSA only moderately (20%) inhibited the clearance of (pap-)Man40-HSA in spite of its high affinity for the scavenger receptor. However, a combination of mannan and fHSA strongly inhibited the uptake of (pap-)Man22-HSA (90%) and to a lesser extent (pap-)Man40-HSA (80%), indicating that a third uptake mechanism may exist that recognizes both mannose groups (or other sugars) and net negative charge. This so far unnoticed receptor system apparently is strongly affected by dextran sulfate and, as shown by immunohistochemistry, is mainly localized on Kupffer cells rather than on the endothelial cells of the liver.	GRONINGEN STATE UNIV,DEPT PATHOL,9713 AW GRONINGEN,NETHERLANDS	University of Groningen	JANSEN, RW (corresponding author), GRONINGEN STATE UNIV,CTR PHARM,DEPT PHARMACOL & THERAPEUT,ANTONIUS DEUSINGLAAN 2,9713 AW GRONINGEN,NETHERLANDS.			Molema, Grietje/0000-0002-4147-6676				ACHORD DT, 1978, CELL, V15, P269, DOI 10.1016/0092-8674(78)90102-2; ASHWELL G, 1974, ADV ENZYMOL RAMB, V41, P99; ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; BLOMHOFF R, 1984, J BIOL CHEM, V259, P8898; BUYS CHCM, 1975, BIOCHIM BIOPHYS ACTA, V392, P95, DOI 10.1016/0304-4165(75)90169-5; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; ESKILD W, 1984, BIOCHIM BIOPHYS ACTA, V803, P63, DOI 10.1016/0167-4889(84)90055-7; ESKILD W, 1988, BIOCHIM BIOPHYS ACTA, V968, P143, DOI 10.1016/0167-4889(88)90001-8; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; HOPPE CA, 1983, J BIOL CHEM, V258, P4193; HORIUCHI S, 1985, J BIOL CHEM, V260, P475; HUBBARD AL, 1979, J CELL BIOL, V83, P47, DOI 10.1083/jcb.83.1.47; KATAOKA M, 1984, J HISTOCHEM CYTOCHEM, V32, P1091, DOI 10.1177/32.10.6434628; KAWAGUCHI K, 1981, J BIOL CHEM, V265, P2230; LEE YC, 1976, BIOCHEMISTRY-US, V15, P3956, DOI 10.1021/bi00663a008; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAEDA H, 1969, J BIOCHEM-TOKYO, V65, P777, DOI 10.1093/oxfordjournals.jbchem.a129077; MEGO JL, 1965, BIOCHIM BIOPHYS ACTA, V100, P136, DOI 10.1016/0304-4165(65)90436-8; Meijer D K, 1981, Methods Enzymol, V77, P81; MONSIGNY M, 1983, BIOL CELL, V47, P95; MORI K, 1983, ARCH BIOCHEM BIOPHYS, V222, P542, DOI 10.1016/0003-9861(83)90552-0; NILSSON M, 1977, BIOCHIM BIOPHYS ACTA, V497, P171, DOI 10.1016/0304-4165(77)90150-7; SCHLESINGER P, 1976, ARCH BIOCHEM BIOPHYS, V177, P606, DOI 10.1016/0003-9861(76)90472-0; SCHLESINGER PH, 1978, BIOCHEM J, V176, P103, DOI 10.1042/bj1760103; SCHLESINGER PH, 1980, BIOCHEM J, V192, P597, DOI 10.1042/bj1920597; STEER CJ, 1979, J BIOL CHEM, V254, P4457; STOCKERT RJ, 1976, BIOCHEM BIOPH RES CO, V68, P988, DOI 10.1016/0006-291X(76)91243-2; SUMMERFIELD JA, 1982, J CLIN INVEST, V69, P1337, DOI 10.1172/JCI110573; TAKATA K, 1988, J BIOL CHEM, V263, P14819; VANDERSLUIJS P, 1986, HEPATOLOGY, V6, P723, DOI 10.1002/hep.1840060431; VERA DR, 1984, J NUCL MED, V25, P779; VLASSARA H, 1985, P NATL ACAD SCI USA, V82, P5588, DOI 10.1073/pnas.82.17.5588; VLASSARA H, 1989, MAILLARD REACTION AG, P205; WISSE E, 1989, CELLS HEPATIC SINUSO, V2, P94; XXIX McBroom C., 1972, METHODS ENZYMOL, V28, P212	35	92	92	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3343	3348						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993707				2022-12-25	WOS:A1991EX60000100
J	MOSKAUG, JO; STENMARK, H; OLSNES, S				MOSKAUG, JO; STENMARK, H; OLSNES, S			INSERTION OF DIPHTHERIA-TOXIN B-FRAGMENT INTO THE PLASMA-MEMBRANE AT LOW PH - CHARACTERIZATION AND TOPOLOGY OF INSERTED REGIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERO CELLS; ENTRY; PURIFICATION; SEQUENCE; CLEAVAGE; MUTANTS; PROTEIN; ACID	When the enzymatically active A-fragment of diphtheria toxin is translocated to the cytosol, the B-fragment inserts into the membrane in such a way that a 25-kDa polypeptide becomes shielded from proteases added to the external medium. We have attempted to determine the boundaries of this polypeptide within the toxin B-fragment as well as the topology of the B-fragment in the membrane. Chemical cleavage of the 25-kDa polypeptide with hydroxylamine and omicron-iodo-sobenzoic acid yielded fragments of sizes indicating that the 25-kDa polypeptide starts at residue approximately 300 and extends to the COOH-terminal end. Experiments where the toxin was labeled with [S-35]cysteine at distinct positions of the B-fragment supported this conclusion. Treatment of cells with inserted B-fragment with L-1-tosyl-amido-2-phenylethyl chloromethyl 1 ketone-treated trypsin and with V8 protease from Staphylococcus aureus yielded protected 27- and 30-kDa fragments in addition to 25-kDa, indicating that the region 240-264 is also at the outside. The topology of the inserted B-fragment is discussed.			MOSKAUG, JO (corresponding author), NORWEGIAN RADIUM HOSP, INST CANC RES, N-0310 OSLO 3, NORWAY.		Stenmark, Harald/B-8868-2008					BARBIERI JT, 1987, INFECT IMMUN, V55, P1647, DOI 10.1128/IAI.55.7.1647-1651.1987; BLACHLYDYSON E, 1990, SCIENCE, V247, P1233, DOI 10.1126/science.1690454; Bornstein P, 1977, Methods Enzymol, V47, P132; CABIAUX V, 1989, J BIOL CHEM, V264, P4928; CARROLL SF, 1988, METHOD ENZYMOL, V165, P68; COLLIER RJ, 1971, J BIOL CHEM, V246, P1496; DRAPER RK, 1980, J CELL BIOL, V87, P849, DOI 10.1083/jcb.87.3.849; DUMONT ME, 1988, J BIOL CHEM, V263, P2087; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; FALMAGNE P, 1985, BIOCHIM BIOPHYS ACTA, V827, P45, DOI 10.1016/0167-4838(85)90099-8; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; GREENFIELD L, 1983, P NATL ACAD SCI-BIOL, V80, P6853, DOI 10.1073/pnas.80.22.6853; LAMBOTTE P, 1980, J CELL BIOL, V87, P837, DOI 10.1083/jcb.87.3.837; MAHONEY WC, 1979, BIOCHEMISTRY-US, V18, P3810, DOI 10.1021/bi00584a026; MCGILL S, 1989, EMBO J, V8, P2843, DOI 10.1002/j.1460-2075.1989.tb08431.x; MORRIS RE, 1985, INFECT IMMUN, V50, P721, DOI 10.1128/IAI.50.3.721-727.1985; MOSKAUG JO, 1988, J BIOL CHEM, V263, P2518; MOSKAUG JO, 1987, J BIOL CHEM, V262, P10339; MYERS DA, 1988, J BIOL CHEM, V263, P17122; OLSNES S, 1980, J BIOL CHEM, V255, P284; PAPPENHEIMER AM, 1977, ANNU REV BIOCHEM, V46, P69, DOI 10.1146/annurev.bi.46.070177.000441; SANDVIG K, 1988, J BIOL CHEM, V263, P12352; SANDVIG K, 1981, J BIOL CHEM, V256, P9068; SANDVIG K, 1980, J CELL BIOL, V87, P828, DOI 10.1083/jcb.87.3.828; STENMARK H, 1989, EMBO J, V8, P2849, DOI 10.1002/j.1460-2075.1989.tb08432.x	25	68	68	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2652	2659						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1990012				2022-12-25	WOS:A1991EV51500096
J	REY, I; SCHWEIGHOFFER, F; BARLAT, I; CAMONIS, J; BOYMARCOTTE, E; GUILBAUD, R; JACQUET, M; TOCQUE, B				REY, I; SCHWEIGHOFFER, F; BARLAT, I; CAMONIS, J; BOYMARCOTTE, E; GUILBAUD, R; JACQUET, M; TOCQUE, B			THE COOH-DOMAIN OF THE PRODUCT OF THE SACCHAROMYCES-CEREVISIAE SCD25 GENE ELICITS ACTIVATION OF P21-RAS PROTEINS IN MAMMALIAN-CELLS	ONCOGENE			English	Note							CDC25 GENE; CYCLASE PATHWAY; TUMOR-PROMOTER; RAS; GAP; SUPPRESSES; MUTATION; CLONING; MUTANTS; GTPASE	The evidence presented here indicates that the domain containing the COOH-terminal part of the Saccharomyces cerevisiae SCD25 gene product (C-domain), which is homologous to the COOH-terminal part of CDC25 protein, can elicit activation of mammalian ras proteins in CHO cells. Transfection of expression vectors carrying the C-domain of SCD25, but not of CDC25, promotes the GTP-bound form of ras proteins as determined by analysis of the guanine nucleotides bound to ras proteins immunoprecipitated by Y13-259 mAb, and enhances transcription of a HIV-LTR-CAT construct. This is the first demonstration of the activation of ras proteins by transfection of a single heterologous gene.	RHONE POULENC SANTE,CRV AIBV,F-94403 VITRY,FRANCE; UNIV PARIS 11,CNRS,URA 1354,INFORMAT GENET & DEV GRP,F-91405 ORSAY,FRANCE	Sanofi-Aventis; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay								ADARI H, 1988, SCIENCE, V240, P518, DOI 10.1126/science.2833817; ARANZANASEISDED.F, 1989, ONCOGENE, V4, P1359; BOYMARCOTTE E, 1989, GENE, V77, P21, DOI 10.1016/0378-1119(89)90355-7; BROEK D, 1987, CELL, V48, P789, DOI 10.1016/0092-8674(87)90076-6; CALES C, 1988, NATURE, V332, P548, DOI 10.1038/332548a0; CAMONIS JH, 1988, MOL CELL BIOL, V8, P2980, DOI 10.1128/MCB.8.7.2980; CAMONIS JH, 1986, EMBO J, V5, P375, DOI 10.1002/j.1460-2075.1986.tb04222.x; CAMONIS JH, 1990, IN PRESS GENE; CRECHET JB, 1990, SCIENCE, V248, P866, DOI 10.1126/science.2188363; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; GIBBS JB, 1987, J BIOL CHEM, V262, P10426; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; IMLER JL, 1988, NATURE, V332, P275, DOI 10.1038/332275a0; JACQUET M, 1989, GUANINE NUCLEOTIDE B, V165, P241; MCCORMICK F, 1989, CELL, V56, P5, DOI 10.1016/0092-8674(89)90976-8; POWERS S, 1989, MOL CELL BIOL, V9, P390, DOI 10.1128/MCB.9.2.390; ROBINSON LC, 1987, SCIENCE, V235, P1218, DOI 10.1126/science.3547648; SASSONECORSI P, 1989, MOL CELL BIOL, V9, P3174, DOI 10.1128/MCB.9.8.3174; SCHWEIGHOFFER F, 1989, ADV 2ND MESSENGER PH, V53, P329; SODROSKI J, 1985, SCIENCE, V229, P74, DOI 10.1126/science.2990041; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; WASYLYK C, 1987, CELL, V48, P525, DOI 10.1016/0092-8674(87)90203-0	23	18	19	0	3	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1991	6	2					347	349						3	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ134	2000228				2022-12-25	WOS:A1991FZ13400024
J	BRENOWITZ, M; MANDAL, N; PICKAR, A; JAMISON, E; ADHYA, S				BRENOWITZ, M; MANDAL, N; PICKAR, A; JAMISON, E; ADHYA, S			DNA-BINDING PROPERTIES OF A LAC REPRESSOR MUTANT INCAPABLE OF FORMING TETRAMERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOOTPRINT TITRATION; OPERATOR; GAL; RECOGNITION; RESOLUTION; COMPLEXES; SITES	The interaction of proteins bound to sites widely separated on the genome is a recurrent motif in both prokaryotic and eukaryotic regulatory systems. Lac repressor mediates the formation of "DNA loops" by the simultaneous interaction of a single protein tetramer with two DNA-binding sites. The DNA-binding properties of a Lac repressor mutant (LacI(adi)) deficient in the association of protein dimers to tetramers was investigated. The results of quantitative footprint and gel mobility-shift titrations suggest that the wild-type Lac repressor (LacI+) binds cooperatively to two operator sites separated by 11 helical turns on a linear DNA restriction fragment by the formation of a "looped complex." LacI(adi) binds to this two-site operator non-cooperatively and without formation of a looped complex. These results demonstrate that the dimer-tetramer association of LacI+ is directly responsible for its cooperative binding and its ability to mediate formation of a looped complex. The I(adi) mutation disrupts the monomer-dimer as well as eliminating the dimer-tetramer association equilibria while the DNA binding affinity of LacI(adi) to a single site is unchanged relative to the wild-type protein. These results suggest that DNA binding and dimer-tetramer association are functionally unlinked. The similarity of the DNA-binding properties of LacI(adi) and Gal repressor, a protein believed to function by mediating the formation of a looped complex, are discussed.	YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT BIOCHEM,BRONX,NY 10461; NCI,MOLEC BIOL LAB,BETHESDA,MD 20892	Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)					NIGMS NIH HHS [GM39929] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM039929, R01GM039929] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; ACKERS GK, 1983, J MOL BIOL, V170, P223, DOI 10.1016/S0022-2836(83)80234-4; ADHYA S, 1989, ANNU REV GENET, V23, P207; AGGARWAL AK, 1988, SCIENCE, V242, P899, DOI 10.1126/science.3187531; BELLOMY GR, 1988, BIOCHEMISTRY-US, V27, P3900, DOI 10.1021/bi00411a002; BOROWIEC JA, 1987, J MOL BIOL, V196, P101, DOI 10.1016/0022-2836(87)90513-4; BOWIE JU, 1989, BIOCHEMISTRY-US, V28, P7139, DOI 10.1021/bi00444a001; BRENOWITZ M, 1990, BIOCHEMISTRY-US, V29, P3374, DOI 10.1021/bi00465a033; BRENOWITZ M, 1986, METHOD ENZYMOL, V130, P132; BRENOWITZ M, 1989, CURRENT PROTOCOLS S, V7; CANN JR, 1989, J BIOL CHEM, V264, P17032; DEUSCHLE U, 1986, P NATL ACAD SCI USA, V83, P4134, DOI 10.1073/pnas.83.12.4134; DEVARGAS LM, 1989, SCIENCE, V244, P1457; ECHOLS H, 1986, SCIENCE, V233, P1050, DOI 10.1126/science.2943018; GILBERT W, 1966, P NATL ACAD SCI USA, V56, P1891, DOI 10.1073/pnas.56.6.1891; HABER R, 1988, P NATL ACAD SCI USA, V85, P9683, DOI 10.1073/pnas.85.24.9683; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; HOCHSCHILD A, 1986, CELL, V44, P681, DOI 10.1016/0092-8674(86)90833-0; Johnson A D, 1980, Methods Enzymol, V65, P839; JORDAN SR, 1988, SCIENCE, V242, P893, DOI 10.1126/science.3187530; KRAMER H, 1987, EMBO J, V6, P1481, DOI 10.1002/j.1460-2075.1987.tb02390.x; LEHMING N, 1988, P NATL ACAD SCI USA, V85, P7947, DOI 10.1073/pnas.85.21.7947; MAJUMDAR A, 1989, J MOL BIOL, V208, P217, DOI 10.1016/0022-2836(89)90383-5; MAJUMDAR A, 1984, P NATL ACAD SCI USA, V85, P9683; MANDAL N, 1990, GENE DEV, V4, P410, DOI 10.1101/gad.4.3.410; OEHLER S, 1990, EMBO J, V9, P973, DOI 10.1002/j.1460-2075.1990.tb08199.x; PACE HC, 1990, P NATL ACAD SCI USA, V87, P1870, DOI 10.1073/pnas.87.5.1870; PICKAR A, 1990, BIOPHYS J, V57, P64; PIRROTTA V, 1970, NATURE, V227, P41, DOI 10.1038/227041a0; ROYER CA, 1990, BIOCHEMISTRY-US, V29, P4959, DOI 10.1021/bi00472a028; SADLER JR, 1983, P NATL ACAD SCI-BIOL, V80, P6785, DOI 10.1073/pnas.80.22.6785; SENEAR DF, 1986, BIOCHEMISTRY-US, V25, P7344, DOI 10.1021/bi00371a016; WARTELL RM, 1988, NUCLEIC ACIDS RES, V16, P11531, DOI 10.1093/nar/16.24.11531; WHITSON PA, 1986, BIOCHEMISTRY-US, V25, P3852, DOI 10.1021/bi00361a017; ZWIEB C, 1989, GENE DEV, V3, P606, DOI 10.1101/gad.3.5.606	35	66	66	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1281	1288						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985947				2022-12-25	WOS:A1991ET17700092
J	MORENO, A; PARES, X				MORENO, A; PARES, X			PURIFICATION AND CHARACTERIZATION OF A NEW ALCOHOL-DEHYDROGENASE FROM HUMAN STOMACH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-LIVER; MOLECULAR-PROPERTIES; ENZYMATIC-PROPERTIES; CATALYTIC PROPERTIES; TISSUE DISTRIBUTION; ISOZYMES; ISOENZYMES	Starch gel electrophoresis of homogenates from human stomach mucosa resolves three alcohol dehydrogenase (ADH) forms: the anodic chi-ADH (class III), the cathodic gamma-ADH (class I), and a new form of slow cathodic mobility that has not been previously characterized. In this work, we describe the purification in three chromatographic steps and the physical and kinetic characterization of this new human alcohol dehydrogenase, which we have named sigma-ADH. The enzyme exhibits the general physicochemical features (M(r), zinc content, subunit M(r), cofactor preference) of all mammalian alcohol dehydrogenases. The kinetic studies show a high K(m) value (41 mM) and a high k(cat) value (280 min-1) for ethanol at pH 7.5. The K(m) decreases as the alcohol increases its chain length. The aldehydes are better substrates than the corresponding alcohols, with m-nitrobenzaldehyde being the best substrate examined. sigma-ADH is strongly inhibited by 4-methylpyrazole, but with a K(i) (10-mu-M) still higher than that for a class I isoenzyme. These properties suggest that sigma-ADH is a class II isoenzyme, different from pi-ADH and similar to that previously described by us in rat stomach. At the high ethanol concentrations in stomach after drinking, sigma-ADH is probably the ADH form with the largest contribution to human gastric ethanol metabolism.	UNIV AUTONOMA BARCELONA, FAC CIENCIES, DEPT BIOQUIM & BIOL MOLEC, E-08193 BARCELONA, SPAIN	Autonomous University of Barcelona			Pares, Xavier/K-8228-2017	Pares, Xavier/0000-0002-5071-9465				ALGAR EM, 1983, EUR J BIOCHEM, V137, P139, DOI 10.1111/j.1432-1033.1983.tb07807.x; BOLEDA MD, 1989, ARCH BIOCHEM BIOPHYS, V274, P74, DOI 10.1016/0003-9861(89)90416-5; BOSRON WF, 1979, BIOCHEMISTRY-US, V18, P1101, DOI 10.1021/bi00573a026; BOSRON WF, 1983, BIOCHEMISTRY-US, V22, P1852, DOI 10.1021/bi00277a017; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burnell JC, 1989, HUMAN METABOLISM ALC, V2, P65; CABALLERIA J, 1989, GASTROENTEROLOGY, V96, P388, DOI 10.1016/0016-5085(89)91562-X; DITLOW CC, 1984, BIOCHEMISTRY-US, V23, P6363, DOI 10.1021/bi00321a012; FREZZA M, 1990, NEW ENGL J MED, V322, P95, DOI 10.1056/NEJM199001113220205; HANDLER JA, 1990, J BIOL CHEM, V265, P1510; HEMPEL JD, 1979, ALCOHOL CLIN EXP RES, V3, P95, DOI 10.1111/j.1530-0277.1979.tb05280.x; HOLMES RS, 1988, INT CONGR SER, V805, P51; HOLMES RS, 1986, ALCOHOL CLIN EXP RES, V10, P623, DOI 10.1111/j.1530-0277.1986.tb05157.x; JULIA P, 1987, EUR J BIOCHEM, V162, P179, DOI 10.1111/j.1432-1033.1987.tb10559.x; KOIVUSALO M, 1989, FEBS LETT, V257, P105, DOI 10.1016/0014-5793(89)81797-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leatherbarrow R.J, 1987, ENZFITTER NONLINEAR; PARES X, 1985, ALCOHOL, V2, P43, DOI 10.1016/0741-8329(85)90013-8; PARES X, 1990, IN PRESS FEBS LETT; ROBERTSON EF, 1987, ANAL BIOCHEM, V167, P290, DOI 10.1016/0003-2697(87)90166-7; SMITH M, 1972, ANN HUM GENET, V35, P243, DOI 10.1111/j.1469-1809.1957.tb01398.x; VALLEE BL, 1983, ISOZYMES-CURR T BIOL, V8, P219; YIN SJ, 1988, BIOCHEM GENET, V26, P343; YOSHIDA A, 1990, IN PRESS ALCOHOLISM	24	165	168	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1128	1133						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985938				2022-12-25	WOS:A1991ET17700071
J	MORTIMORE, GE; KHURANA, KK; MIOTTO, G				MORTIMORE, GE; KHURANA, KK; MIOTTO, G			AMINO-ACID CONTROL OF PROTEOLYSIS IN PERFUSED LIVERS OF SYNCHRONOUSLY FED RATS - MECHANISM AND SPECIFICITY OF ALANINE CO-REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC PROTEIN-DEGRADATION; HEPATOCYTES; DEPRIVATION; INHIBITION; SUPPRESSION; MODULATION; TURNOVER; LEUCINE; INSULIN; INVIVO	The primary control of autophagically mediated proteolysis in perfused rat liver is carried out via two alternate mechanisms in response to specific regulatory amino acids. One (L) elicits direct inhibition at low and high plasma levels, but requires a co-regulatory amino acid to express inhibition at normal concentrations. The second (H) is ineffective at normal levels and below, but active at higher concentrations. Because regulation is subject to unpredictable variability with ad libitum feeding, we have utilized rats synchronously fed 4 h day-1 to stabilize responses. Proteolytic control is seen to evolve in stages: H appears 12 h after the start of feeding; by 18 h L emerges, alternating with H in a statistically predictable way; with omission of the 24-h feeding, H disappears and L remains constant through 42 h. In both 18- and 42-h rats, alanine, glutamate, and aspartate exhibit similar inhibitory activity when added singly to the regulatory group at normal plasma concentrations. However, since alanine, but not glutamate or aspartate, evokes proteolytic acceleration when it is deleted from a full plasma mixture, alanine appears to be the sole co-regulator. Alanine yields co-regulatory effects with normal plasma leucine (0.2 mM) in 18- and 42-h animals and interacts synergistically with 0.8 mM leucine in 42-h but not in 18-h rats where leucine alone inhibits strongly. Because the inactivation of alanine amino-transferase by aminooxyacetate (determined from the conversion of [C-14]alanine to glucose) does not alter the co-regulatory and synergistic effects of alanine, regulation by alanine must be mediated from a site of recognition before transamination.			MORTIMORE, GE (corresponding author), PENN STATE UNIV, MILTON S HERSHEY MED CTR, COLL MED, DEPT CELLULAR & MOLEC PHYSIOL, HERSHEY, PA 17033 USA.		Miotto, Giovanni/S-1903-2016	Miotto, Giovanni/0000-0002-4278-4873	NIDDK NIH HHS [DK-21624] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021624] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALTMAN PL, 1972, BIOL DATA BOOK, V1, P416; CARO LHP, 1989, EUR J BIOCHEM, V181, P717, DOI 10.1111/j.1432-1033.1989.tb14782.x; CONDE RD, 1976, BIOCHEM J, V158, P385, DOI 10.1042/bj1580385; GLAUMANN H, 1981, INT REV CYTOL, V73, P149, DOI 10.1016/S0074-7696(08)61288-7; HOPGOOD MF, 1977, BIOCHEM J, V164, P399, DOI 10.1042/bj1640399; HUTSON NJ, 1982, J BIOL CHEM, V257, P9548; KADOWAKI M, 1989, INTRACELLULAR PROTEO, P488; LEVERVE XM, 1987, FEBS LETT, V219, P455, DOI 10.1016/0014-5793(87)80271-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MIOTTO G, 1989, BIOCHEM BIOPH RES CO, V158, P797, DOI 10.1016/0006-291X(89)92792-7; MIOTTO G, 1990, FASEB Journal, V4, pA848; MORTIMOR.GE, 1970, J BIOL CHEM, V245, P2375; MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543; MORTIMORE GE, 1983, P NATL ACAD SCI-BIOL, V80, P2179, DOI 10.1073/pnas.80.8.2179; MORTIMORE GE, 1972, J BIOL CHEM, V247, P2776; MORTIMORE GE, 1988, J BIOL CHEM, V263, P19545; MORTIMORE GE, 1987, J BIOL CHEM, V262, P16322; MORTIMORE GE, 1988, METHOD ENZYMOL, V166, P461; NEELY AN, 1974, BIOCHIM BIOPHYS ACTA, V338, P458, DOI 10.1016/0304-4165(74)90307-9; PARDRIDGE WM, 1975, AM J PHYSIOL, V228, P1155; PARDRIDGE WM, 1977, AM J PHYSIOL, V232, pE492, DOI 10.1152/ajpendo.1977.232.5.E492; POSO AR, 1984, P NATL ACAD SCI-BIOL, V81, P4270, DOI 10.1073/pnas.81.14.4270; POSO AR, 1982, J BIOL CHEM, V257, P2114; SCHWORER CM, 1981, J BIOL CHEM, V256, P7652; SEGLEN PO, 1984, J CELL BIOL, V99, P435, DOI 10.1083/jcb.99.2.435; SEGLEN PO, 1980, BIOCHIM BIOPHYS ACTA, V630, P103, DOI 10.1016/0304-4165(80)90141-5; SHIMAN R, 1982, J BIOL CHEM, V257, P1213; SOMMERCORN JM, 1981, J BIOL CHEM, V256, P4816; WOODSIDE KH, 1974, J BIOL CHEM, V249, P5458	29	35	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1021	1028						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985931				2022-12-25	WOS:A1991ET17700056
J	TERKUILE, BH; OPPERDOES, FR				TERKUILE, BH; OPPERDOES, FR			GLUCOSE-UPTAKE BY TRYPANOSOMA-BRUCEI - RATE-LIMITING STEPS IN GLYCOLYSIS AND REGULATION OF THE GLYCOLYTIC FLUX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEISHMANIA-TROPICA PROMASTIGOTES; HEXOSE-TRANSPORT; GLYCEROL KINASE; COMPARTMENTATION; PURIFICATION; SPECIFICITY; METABOLISM; DONOVANI; ENZYMES; SYSTEM	Glucose uptake and metabolism in the bloodstream form of the glycosome-containing protozoan parasite Trypanosoma brucei was measured using C-14-labeled glucose in combination with the silicone oil centrifugation technique in short term (5-60 s) incubations. Glucose rather than glucose analogues was used to study the interrelation between the uptake process and the subsequent metabolic steps. Glucose uptake over the plasma membrane occurred by facilitated diffusion, which limited the overall glycolytic rate at external glucose concentrations (glc(out)) below 5 mM. At higher glc(out) another step, either transport over the glycosomal membrane or phosphorylation by hexokinase became rate-limiting. Mathematical modeling assuming that glucose uptake occurs by facilitated diffusion followed by an enzymatic step accurately predicts the experimental data. As predicted by the model, the internal concentration of non-metabolized glucose remains low till glc(out) = 5 mM and increases at higher external concentrations. In contrast to glucose, glycerol entered the cell by simple diffusion. Externally supplied glycerol did not affect glucose metabolism but externally added glucose interfered with glycerol metabolism in a way that suggests that the rate-limiting step is at the level of glycerol kinase. Our observations suggest that the bloodstream form of T. brucei adapts its glucose transport in a way that gives maximum yield at minimum expense.			TERKUILE, BH (corresponding author), INT INST CELLULAR & MOLEC PATHOL,TROP DIS RES UNIT,AVE HIPPOCRATE 74,B-1200 BRUSSELS,BELGIUM.		Opperdoes, Fred/N-9922-2019	Opperdoes, Fred/0000-0003-1984-3764				BERGMEYER HU, 1974, METHOD ENZYMAT AN, P473; CARLSEN A, 1976, ACTA PHYSIOL SCAND, V97, P501, DOI 10.1111/j.1748-1716.1976.tb10290.x; DAMORE T, 1986, BIOCHEM CELL BIOL, V64, P1081, DOI 10.1139/o86-143; EISENTHAL R, 1989, BIOCHIM BIOPHYS ACTA, V985, P81, DOI 10.1016/0005-2736(89)90107-7; ELLENBERGER TE, 1987, J BIOL CHEM, V262, P10053; Fairlamb A. H., 1986, Carbohydrate metabolism in cultured cells., P183; FAIRLAMB AH, 1989, PARASITOLOGY, V99, pS93, DOI 10.1017/S003118200008344X; GAME S, 1986, FEBS LETT, V194, P126, DOI 10.1016/0014-5793(86)80063-1; GRUENBERG J, 1980, J PROTOZOOL, V27, P484, DOI 10.1111/j.1550-7408.1980.tb05404.x; GRUENBERG J, 1978, EUR J BIOCHEM, V89, P461, DOI 10.1111/j.1432-1033.1978.tb12549.x; HAMMOND DJ, 1980, MOL BIOCHEM PARASIT, V2, P77, DOI 10.1016/0166-6851(80)90033-X; JADIN JB, 1963, C INT CTR NATIONAL R, V239; KAPLAN A, 1980, PLANTA, V149, P219, DOI 10.1007/BF00384557; LANHAM SM, 1970, EXP PARASITOL, V28, P521, DOI 10.1016/0014-4894(70)90120-7; MISSET O, 1986, EUR J BIOCHEM, V157, P441, DOI 10.1111/j.1432-1033.1986.tb09687.x; NWAGWU M, 1982, ACTA TROP, V39, P61; ODURO KK, 1980, EXP PARASITOL, V50, P240, DOI 10.1016/0014-4894(80)90025-9; OPPERDOES FR, 1976, FEBS LETT, V62, P169, DOI 10.1016/0014-5793(76)80045-2; OPPERDOES FR, 1984, J CELL BIOL, V98, P1178, DOI 10.1083/jcb.98.4.1178; OPPERDOES FR, 1977, FEBS LETT, V80, P360, DOI 10.1016/0014-5793(77)80476-6; OPPERDOES FR, 1987, ANNU REV MICROBIOL, V41, P127, DOI 10.1146/annurev.mi.41.100187.001015; PETTIGREW DW, 1986, BIOCHEMISTRY-US, V25, P4711, DOI 10.1021/bi00364a039; SCHAEFER FW, 1974, J PROTOZOOL, V21, P592, DOI 10.1111/j.1550-7408.1974.tb03708.x; SCHAEFER FW, 1976, J PROTOZOOL, V23, P446, DOI 10.1111/j.1550-7408.1976.tb03810.x; SOUTHWOR.GC, 1969, J PROTOZOOL, V16, P720, DOI 10.1111/j.1550-7408.1969.tb02332.x; SOUTHWORTH GC, 1970, J PROTOZOOL, V17, P396, DOI 10.1111/j.1550-7408.1970.tb04701.x; Stein W., 2012, TRANSPORT DIFFUSION; VISSER N, 1981, EUR J BIOCHEM, V118, P521, DOI 10.1111/j.1432-1033.1981.tb05550.x; VISSER N, 1980, EUR J BIOCHEM, V103, P623, DOI 10.1111/j.1432-1033.1980.tb05988.x; VONBRANDE R, 1967, J PROTOZOOL, V14, P8; ZILBERSTEIN D, 1984, MOL BIOCHEM PARASIT, V12, P327, DOI 10.1016/0166-6851(84)90089-6; ZILBERSTEIN D, 1985, P NATL ACAD SCI USA, V82, P1716, DOI 10.1073/pnas.82.6.1716	32	63	64	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					857	862						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985967				2022-12-25	WOS:A1991ET17700031
J	WHITE, MJ; HIRSCH, JP; HENRY, SA				WHITE, MJ; HIRSCH, JP; HENRY, SA			THE OPI1 GENE OF SACCHAROMYCES-CEREVISIAE, A NEGATIVE REGULATOR OF PHOSPHOLIPID BIOSYNTHESIS, ENCODES A PROTEIN CONTAINING POLYGLUTAMINE TRACTS AND A LEUCINE ZIPPER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEINS; FOS-JUN INTERACTION; ESCHERICHIA-COLI; AMINO-ACID; PHOSPHATIDYLSERINE SYNTHASE; SECONDARY STRUCTURE; CDP-DIACYLGLYCEROL; GLOBULAR-PROTEINS; LACZ FUSIONS; INO4 LOCI	In Saccharomyces cerevisiae, recessive mutations at the OPI1 locus result in constitutively derepressed expression of inositol 1-phosphate synthase, the product of the INO1 gene. Many of the other enzymes involved in phospholipid biosynthesis are also expressed at high derepressed levels in opi1 mutants. Thus, the OPI1 gene is believed to encode a negative regulator that is required to repress a whole subset of structural genes encoding for phospholipid biosynthetic enzymes. In this study, the OPI1 gene was mapped to chromosome VIII and cloned. When transformed into an opi1 mutant, the cloned DNA was capable of complementing the mutant phenotype and restoring correct regulation to the INO1 structural gene. Construction of two opi1 disruption alleles and subsequent genetic analysis of strains bearing these alleles confirmed that the cloned DNA was homologous to the genomic OPI1 locus. Furthermore, the OPI1 gene was found to be nonessential to the organism since mutants bearing the null allele were viable and exhibited a phenotype similar to that of previously isolated opi1 mutants. Similar to other opi1 mutants, the opi1 disruption mutants accumulated INO1 mRNA constitutively to a level 2-3-fold higher than that observed in wild-type cells. The cloned OPI1 gene was sequenced, and translation of the open reading frame predicted a protein composed of 404 amino acid residues with a molecular weight of 40,036. The predicted Opi1 protein contained a well defined heptad repeat of leucine residues that has been observed in other regulatory proteins. In addition, the predicted protein contained polyglutamine residue stretches which have also been reported in yeast genes having regulatory functions. Sequencing of opi1 mutant alleles, isolated after chemical mutagenesis, revealed that several were the result of a chain termination mutation located within the largest polyglutamine residue stretch.	CARNEGIE MELLON UNIV, DEPT BIOL SCI, PITTSBURGH, PA 15213 USA; COLUMBIA UNIV, DEPT BIOL SCI, NEW YORK, NY 10027 USA	Carnegie Mellon University; Columbia University			Henry, Susan/K-5464-2014		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM019629, R37GM019629] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 19629] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATCHESON CL, 1987, P NATL ACAD SCI USA, V84, P8035, DOI 10.1073/pnas.84.22.8035; BAILIS AM, 1987, MOL CELL BIOL, V7, P167, DOI 10.1128/MCB.7.1.167; BENNETZEN JL, 1982, J BIOL CHEM, V257, P3026; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BRENDEL V, 1989, P NATL ACAD SCI USA, V86, P5698, DOI 10.1073/pnas.86.15.5698; BULLOCK WO, 1987, BIOTECHNIQUES, V5, P376; BURKE RL, 1983, J BIOL CHEM, V258, P2193; CARMAN GM, 1989, ANNU REV BIOCHEM, V58, P635, DOI 10.1146/annurev.biochem.58.1.635; CLEWELL DB, 1969, P NATL ACAD SCI USA, V62, P1159, DOI 10.1073/pnas.62.4.1159; COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; CULBERTSON MR, 1976, J BACTERIOL, V126, P232, DOI 10.1128/JB.126.1.232-242.1976; CULBERTSON MR, 1975, GENETICS, V80, P23; DONAHUE TF, 1981, J BIOL CHEM, V256, P7077; DONAHUE TF, 1981, GENETICS, V98, P491; ELION EA, 1986, MOL CELL BIOL, V6, P2089, DOI 10.1128/MCB.6.6.2089; ELION EA, 1984, CELL, V39, P663, DOI 10.1016/0092-8674(84)90473-2; FASSLER JS, 1989, MOL CELL BIOL, V9, P5602, DOI 10.1128/MCB.9.12.5602; FISCHL AS, 1986, J BIOL CHEM, V261, P3178; FRIED HM, 1981, P NATL ACAD SCI-BIOL, V78, P238, DOI 10.1073/pnas.78.1.238; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GARRETT S, 1989, GENE DEV, V3, P1336, DOI 10.1101/gad.3.9.1336; GASCUEL O, 1988, COMPUT APPL BIOSCI, V4, P357; GENTZ R, 1989, SCIENCE, V243, P1695, DOI 10.1126/science.2494702; GREENBERG ML, 1982, GENETICS, V100, P19; GREENBERG ML, 1982, MOL GEN GENET, V186, P157, DOI 10.1007/BF00331845; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HENRY SA, 1984, ANNU REV GENET, V18, P207; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HINNEBUSCH AG, 1988, MICROBIOL REV, V52, P248, DOI 10.1128/MMBR.52.2.248-273.1988; HIRSCH JP, 1986, MOL CELL BIOL, V6, P3320, DOI 10.1128/MCB.6.10.3320; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; HOLMES DS, 1981, ANAL BIOCHEM, V114, P193, DOI 10.1016/0003-2697(81)90473-5; HOMANN MJ, 1987, J BACTERIOL, V169, P533, DOI 10.1128/jb.169.2.533-539.1987; HOMANN MJ, 1985, J BACTERIOL, V163, P1265, DOI 10.1128/JB.163.3.1265-1266.1985; HUMPHREY T, 1988, TRENDS GENET, V4, P243, DOI 10.1016/0168-9525(88)90028-5; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JARVIS EE, 1989, GENE DEV, V3, P936, DOI 10.1101/gad.3.7.936; JOHNSTON M, 1984, MOL CELL BIOL, V4, P1440, DOI 10.1128/MCB.4.8.1440; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; KLAPHOLZ S, 1982, GENETICS, V100, P387; KLIG LS, 1985, J BACTERIOL, V162, P1135, DOI 10.1128/JB.162.3.1135-1141.1985; KLIG LS, 1988, J BACTERIOL, V170, P1878, DOI 10.1128/jb.170.4.1878-1886.1988; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; KOUZARIDES T, 1989, NATURE, V340, P568, DOI 10.1038/340568a0; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LOEWY BS, 1984, MOL CELL BIOL, V4, P2479, DOI 10.1128/MCB.4.11.2479; MANDEL M, 1970, J MOL BIOL, V53, P159, DOI 10.1016/0022-2836(70)90051-3; Maniatis T., 1982, MOL CLONING; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MULLER MM, 1988, EUR J BIOCHEM, V176, P485, DOI 10.1111/j.1432-1033.1988.tb14306.x; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; ORRWEAVER TL, 1983, METHOD ENZYMOL, V101, P228; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; OSHEA EK, 1989, SCIENCE, V245, P646, DOI 10.1126/science.2503872; PASSMORE S, 1989, GENE DEV, V3, P921, DOI 10.1101/gad.3.7.921; PASSMORE S, 1988, J MOL BIOL, V204, P593, DOI 10.1016/0022-2836(88)90358-0; PFEIFER K, 1989, CELL, V56, P291, DOI 10.1016/0092-8674(89)90903-3; POOLE MA, 1986, J BACTERIOL, V168, P668, DOI 10.1128/jb.168.2.668-672.1986; RANSONE LJ, 1989, GENE DEV, V3, P770, DOI 10.1101/gad.3.6.770; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; RUBY SW, 1983, METHOD ENZYMOL, V101, P253; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASSONECORSI P, 1988, NATURE, V336, P692, DOI 10.1038/336692a0; SCHULTZ J, 1987, MOL CELL BIOL, V7, P3637, DOI 10.1128/MCB.7.10.3637; SENGSTAG C, 1987, NUCLEIC ACIDS RES, V15, P233, DOI 10.1093/nar/15.1.233; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P5125, DOI 10.1093/nar/14.13.5125; Sherman F., 1978, METHODS YEAST GENETI; SMEAL T, 1989, GENE DEV, V3, P2091, DOI 10.1101/gad.3.12b.2091; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STEINER MR, 1972, BIOCHIM BIOPHYS ACTA, V260, P222, DOI 10.1016/0005-2760(72)90035-5; STINCHCOMB DT, 1982, J MOL BIOL, V158, P157, DOI 10.1016/0022-2836(82)90427-2; STRUHL K, 1986, MOL CELL BIOL, V6, P3847, DOI 10.1128/MCB.6.11.3847; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TRUMBLY RJ, 1988, GENE, V73, P97, DOI 10.1016/0378-1119(88)90316-2; TURNER R, 1989, SCIENCE, V243, P1689, DOI 10.1126/science.2494701; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; WAECHTER CJ, 1973, ARCH BIOCHEM BIOPHYS, V158, P401, DOI 10.1016/0003-9861(73)90637-1; WAECHTER CJ, 1971, J BACTERIOL, V105, P837, DOI 10.1128/JB.105.3.837-843.1971; WHITE MJ, 1991, ADV MICROB PHYSIOL, V32, P1, DOI 10.1016/S0065-2911(08)60004-1; YAMASHITA S, 1982, EUR J BIOCHEM, V128, P589; ZARET KS, 1982, CELL, V28, P563, DOI 10.1016/0092-8674(82)90211-2	86	154	157	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					863	872						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985968				2022-12-25	WOS:A1991ET17700032
J	CAPIOD, T; COMBETTES, L; NOEL, J; CLARET, M				CAPIOD, T; COMBETTES, L; NOEL, J; CLARET, M			EVIDENCE FOR BILE ACID-EVOKED OSCILLATIONS OF CA2+-DEPENDENT K+ PERMEABILITY UNRELATED TO A D-MYO-INOSITOL 1,4,5-TRISPHOSPHATE EFFECT IN ISOLATED GUINEA-PIG LIVER-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-C ACTIVITY; CYTOPLASMIC FREE CALCIUM; CYTOSOLIC FREE CA-2+; RAT LACRIMAL GLANDS; HORMONAL-STIMULATION; ISOLATED HEPATOCYTES; 2ND MESSENGER; FURA-2-LOADED HEPATOCYTES; TRISPHOSPHATE RECEPTOR; ION CHANNELS	In single liver cells, the D-myo-inositol 1,4,5-triphosphate (InsP3)-dependent agonists such as noradrenaline and angiotensin II evoke oscillations in intracellular calcium [Ca2+]i resulting mostly from the periodic release and reuptake of calcium from intracellular stores. In the present work, we have reexamined the effects of these agonists and investigated whether the natural bile acid taurolithocholic acid 3-sulfate (TLC-S), which permeabilizes the endoplasmic reticulum, could initiate oscillations of [Ca2+]i. Oscillations of [Ca2+]i were monitored with the Ca2+-dependent K+ permeability in whole-cell voltage-clamped guinea pig liver cells. Our results confirm the presence of two types of oscillations induced by hormones. They could be distinguished by their frequency periods. The fast (type I) had periods ranging from 5 to 12 s and the slow (type II) from 60 to 240 s. They have been respectively attributed to second messenger- and receptor-controlled oscillations, respectively. Our results also show that TLC-S, as noradrenaline and angiotensin II, induced the activation of this Ca2+-dependent K+ current and was able to reproduce both types of oscillations. The bile acid effect was not blocked by intracellular perfusion of heparin known to inhibit both InsP3 binding and InsP3-evoked Ca2+ release in several tissues. In these conditions, TLC-S only evoked type I oscillations, suggesting that these fluctuations could originate from a mechanism that is independent of InsP4 and is an intrinsic property of internal Ca2+ stores.			CAPIOD, T (corresponding author), UNIV PARIS 11,INSERM,U274,BAT 443,F-91405 ORSAY,FRANCE.		CAPIOD, Thierry/K-4234-2017; Combettes, Laurent/L-1842-2013	CAPIOD, Thierry/0000-0002-8448-7041; Combettes, Laurent/0000-0002-1376-4574				BATTY IR, 1985, BIOCHEM J, V232, P211, DOI 10.1042/bj2320211; BERRIDGE MJ, 1990, J BIOL CHEM, V265, P9583; BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; BERRIDGE MJ, 1988, FASEB J, V2, P3074, DOI 10.1096/fasebj.2.15.2847949; BERRIDGE MJ, 1988, P R SOC LOND B, V320, P326; BERTHON B, 1984, FEBS LETT, V167, P19, DOI 10.1016/0014-5793(84)80824-8; BINET A, 1985, BIOCHEM J, V228, P565, DOI 10.1042/bj2280565; BURGESS GM, 1984, NATURE, V309, P63, DOI 10.1038/309063a0; CAPIOD T, 1987, FEBS LETT, V217, P247, DOI 10.1016/0014-5793(87)80672-5; CAPIOD T, 1989, PROC R SOC SER B-BIO, V236, P187, DOI 10.1098/rspb.1989.0020; CAPIOD T, 1989, J PHYSIOL-LONDON, V409, P285, DOI 10.1113/jphysiol.1989.sp017497; CHAMPEIL P, 1989, J BIOL CHEM, V264, P17665; COMBETTES L, 1989, J BIOL CHEM, V264, P157; COMBETTES L, 1988, J BIOL CHEM, V263, P2299; CREBA JA, 1983, BIOCHEM J, V212, P733, DOI 10.1042/bj2120733; CULLEN PJ, 1988, FEBS LETT, V228, P57, DOI 10.1016/0014-5793(88)80584-2; EGASHIRA K, 1980, JPN J PHYSIOL, V30, P81; FIELD AC, 1987, J PHYSIOL-LONDON, V392, P493, DOI 10.1113/jphysiol.1987.sp016793; GRAF P, 1987, BIOCHEM J, V241, P933, DOI 10.1042/bj2410933; GRAY PTA, 1989, PROC R SOC SER B-BIO, V237, P99, DOI 10.1098/rspb.1989.0039; GREEN RD, 1972, EXPERIENTIA, V28, P1073, DOI 10.1007/BF01918681; GUILLEMETTE G, 1989, MOL PHARMACOL, V35, P339; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HAYLETT DG, 1972, J PHYSIOL-LONDON, V225, P721, DOI 10.1113/jphysiol.1972.sp009966; IRVINE RF, 1986, BIOCHEM J, V240, P917, DOI 10.1042/bj2400917; JACOB R, 1990, BIOCHIM BIOPHYS ACTA, V1052, P427, DOI 10.1016/0167-4889(90)90152-4; JOSEPH SK, 1989, BIOCHEM J, V258, P261, DOI 10.1042/bj2580261; JOSEPH SK, 1984, J BIOL CHEM, V259, P3077; KAWANISHI T, 1989, J BIOL CHEM, V264, P12859; KUNO M, 1987, NATURE, V326, P301, DOI 10.1038/326301a0; MALGAROLI A, 1990, J BIOL CHEM, V265, P3005; MARTY A, 1984, J PHYSIOL-LONDON, V357, P293, DOI 10.1113/jphysiol.1984.sp015501; MARTY A, 1989, J PHYSIOL-LONDON, V419, P665, DOI 10.1113/jphysiol.1989.sp017892; MATTHEWS G, 1989, J PHYSIOL-LONDON, V418, P105, DOI 10.1113/jphysiol.1989.sp017830; MAUGER JP, 1985, J BIOL CHEM, V260, P1635; MEYER T, 1990, BIOCHEMISTRY-US, V29, P32, DOI 10.1021/bi00453a004; MEYER T, 1988, P NATL ACAD SCI USA, V85, P5051, DOI 10.1073/pnas.85.14.5051; MONCK JR, 1988, J BIOL CHEM, V263, P4569; NAKANISHI H, 1985, BIOCHEM BIOPH RES CO, V132, P582, DOI 10.1016/0006-291X(85)91173-8; OGDEN DC, 1990, J PHYSIOL-LONDON, V422, P585, DOI 10.1113/jphysiol.1990.sp018002; OSIPCHUK YV, 1990, EMBO J, V9, P697, DOI 10.1002/j.1460-2075.1990.tb08162.x; PENNER R, 1988, NATURE, V334, P499, DOI 10.1038/334499a0; PRENTKI M, 1988, J BIOL CHEM, V263, P11044; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; RENARD D, 1987, BIOCHEM J, V243, P391, DOI 10.1042/bj2430391; ROONEY TA, 1989, J BIOL CHEM, V264, P17131; SUPATTAPONE S, 1988, J BIOL CHEM, V263, P1530; TAYLOR SJ, 1987, BIOCHEM J, V248, P791, DOI 10.1042/bj2480791; THOMAS AP, 1984, J BIOL CHEM, V259, P5574; WAKUI M, 1989, NATURE, V339, P317, DOI 10.1038/339317a0; WILLIAMSON JR, 1989, ANNU REV PHYSIOL, V51, P107, DOI 10.1146/annurev.ph.51.030189.000543; WOODS NM, 1986, NATURE, V319, P600, DOI 10.1038/319600a0; WOODS NM, 1987, CELL CALCIUM, V8, P79, DOI 10.1016/0143-4160(87)90038-8; WORLEY PF, 1987, J BIOL CHEM, V262, P12132	55	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					268	273						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985899				2022-12-25	WOS:A1991EQ33900040
J	MEJILLANO, MR; HIMES, RH				MEJILLANO, MR; HIMES, RH			ASSEMBLY PROPERTIES OF TUBULIN AFTER CARBOXYL GROUP MODIFICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEINS; AMINO-ACID-SEQUENCE; SYNTHETIC PEPTIDES; REGULATORY DOMAIN; TERMINAL DOMAIN; PORCINE BRAIN; BINDING-SITES; BETA-TUBULIN; TAU-PROTEIN; LOCALIZATION	By chemically modifying carboxyl groups we have investigated the role of the highly acidic COOH-terminal domains of alpha- and beta-tubulin in regulating microtubule assembly. Using a carbodiimide-promoted amidation reaction, as many as 25 carboxyl groups were modified by the addition of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide and an amine nucleophile, [C-14] glycine ethyl ester or [H-3]methylamine, to assembled microtubules. Modification occurred primarily in the carboxyl-terminal region as demonstrated by limited proteolysis of modified tubulin by Trypsin, chymotrypsin, subtilisin, and carboxypeptidase Y. Modified tubulin polymerized into microtubles with a critical concentration that was 15% of that for unmodified tubulin. Assembly of modified tubulin and microtubules formed from modified tubulin were less sensitive to Ca2+ and high ionic strength. Ca2+ binding studies under low ionic strength conditions indicated that modified tubulin does not contain the high affinity Ca2+ binding site. While assembly of unmodified tubulin was stimulated by Mg2+ up to 10 mM, assembly of the modified protein was inhibited by concentrations greater than 1 mM. When 24 residues were modified, polymerization was no longer stimulated by microtubule-associated proteins (MAPs) or polylysine and incorporation of high molecular weight MAPs into the polymers was reduced by about 70% compared to unmodified tubulin. These studies demonstrate that chemical modification of carboxyl groups in tubulin, most of which are localized in the COOH-terminal region, leads to an enhanced ability to polymerize and a decrease in interaction with MAPs and other positively charged species.	UNIV KANSAS, DEPT BIOCHEM, LAWRENCE, KS 66045 USA	University of Kansas					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036953] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM36953] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALGAIER J, 1988, BIOCHIM BIOPHYS ACTA, V954, P235, DOI 10.1016/0167-4838(88)90078-7; BALL EH, 1986, ANAL BIOCHEM, V155, P23, DOI 10.1016/0003-2697(86)90218-6; BHATTACHARYYA B, 1985, J BIOL CHEM, V260, P208; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURTON PR, 1981, CELL MUSCLE MOTILITY, V1, P289; DRUBIN D, 1986, METHOD ENZYMOL, V134, P156; KANAZAWA K, 1989, J PROTEIN CHEM, V8, P131, DOI 10.1007/BF01025084; KRAUHS E, 1981, P NATL ACAD SCI-BIOL, V78, P4156, DOI 10.1073/pnas.78.7.4156; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE JC, 1978, ARCH BIOCHEM BIOPHYS, V185, P4, DOI 10.1016/0003-9861(78)90137-6; LITTAUER UZ, 1986, P NATL ACAD SCI USA, V83, P7162, DOI 10.1073/pnas.83.19.7162; MACCIONI RB, 1988, EMBO J, V7, P1957, DOI 10.1002/j.1460-2075.1988.tb03033.x; MACCIONI RB, 1986, EUR J BIOCHEM, V156, P375, DOI 10.1111/j.1432-1033.1986.tb09593.x; MANDELKOW EM, 1985, J MOL BIOL, V185, P311, DOI 10.1016/0022-2836(85)90406-1; MEJILLANO MR, 1990, BIOCHEMISTRY-US, V29, P1208, DOI 10.1021/bi00457a017; NATH JP, 1986, BIOCHEM BIOPH RES CO, V135, P1135, DOI 10.1016/0006-291X(86)91046-6; OLMSTED JB, 1975, BIOCHEMISTRY-US, V14, P2996, DOI 10.1021/bi00684a032; PONSTINGL H, 1981, P NATL ACAD SCI-BIOL, V78, P2757, DOI 10.1073/pnas.78.5.2757; RIVAS CI, 1988, P NATL ACAD SCI USA, V85, P6092, DOI 10.1073/pnas.85.16.6092; ROSENTHAL HE, 1967, ANAL BIOCHEM, V20, P525, DOI 10.1016/0003-2697(67)90297-7; SACKETT DL, 1986, ANN NY ACAD SCI, V466, P460, DOI 10.1111/j.1749-6632.1986.tb38424.x; SACKETT DL, 1985, J BIOL CHEM, V260, P43; SACKETT DL, 1986, J BIOL CHEM, V261, P9070; SERRANO L, 1985, EUR J BIOCHEM, V153, P595, DOI 10.1111/j.1432-1033.1985.tb09342.x; SERRANO L, 1984, P NATL ACAD SCI-BIOL, V81, P5989, DOI 10.1073/pnas.81.19.5989; SERRANO L, 1984, BIOCHEMISTRY-US, V23, P4675, DOI 10.1021/bi00315a024; SERRANO L, 1988, BIOCHEM J, V252, P683, DOI 10.1042/bj2520683; SERRANO L, 1986, J BIOL CHEM, V261, P7076; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; SIOUSSAT TM, 1989, BIOCHEMISTRY-US, V28, P4435, DOI 10.1021/bi00436a047; SOLOMON F, 1977, BIOCHEMISTRY-US, V16, P358, DOI 10.1021/bi00622a003; VERA JC, 1988, P NATL ACAD SCI USA, V85, P6763, DOI 10.1073/pnas.85.18.6763; VERA JC, 1989, BIOCHEMISTRY-US, V28, P333, DOI 10.1021/bi00427a045; WHITE EA, 1987, CELL MOTIL CYTOSKEL, V7, P31, DOI 10.1002/cm.970070105	34	52	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					657	664						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985923				2022-12-25	WOS:A1991EQ33900095
J	GERLACH, TH; ZILE, MH				GERLACH, TH; ZILE, MH			EFFECT OF RETINOIC ACID AND APO-RBP ON SERUM RETINOL CONCENTRATION IN ACUTE-RENAL-FAILURE	FASEB JOURNAL			English	Note						SERUM RETINOL; RENAL FAILURE; VITAMIN-A; RETINOIC ACID; FEEDBACK SIGNAL; APO-RBP	VITAMIN-A HOMEOSTASIS; BINDING PROTEIN; ALL-TRANS; RATS; LIVER; METABOLISM; PLASMA	We recently demonstrated a rapid upregulation of serum retinol-retinol binding protein-transthyretin concentration in rats with short-term acute renal failure. We examine the effect of retinoic acid and apo-retinol binding protein (apo-RBP) on the up-regulation of serum retinol in renal failure. Injection of retinoic acid (10-mu-g) into rats with acute renal failure or sham-operated rats increased circulatory retinoic acid concentration 29-fold within 2 h but did not influence serum retinol concentration in either group. Injection of a large dose of retinoic acid (100-mu-g) decreased serum retinol concentration in rats with acute renal failure (19%) and sham-operated rats (29%). These results suggest that changes in serum retinoic acid concentration within the near-physiological range have no effect on regulation of hepatic retinol release. Injection of a large dose of retinoic acid may depress serum retinol indirectly via a retinol sparing effect in target tissues. In rats with renal failure the serum retinol concentration, elevated 44-52% above that of sham-operated controls, was also increased to 70-164% above controls by the injection of 52-63-mu-g of apo-RBP. This suggests that circulatory apo-RBP can up-regulate serum retinol. Circulatory apo-RBP may be a positive physiological feedback signal from peripheral tissues for hepatic release of retinol.	MICHIGAN STATE UNIV,DEPT FOOD SCI & HUMAN NUTR,E LANSING,MI 48824	Michigan State University								BERNARD A, 1988, CLIN CHIM ACTA, V171, P85, DOI 10.1016/0009-8981(88)90293-8; CULLUM ME, 1986, ANAL BIOCHEM, V153, P23, DOI 10.1016/0003-2697(86)90055-2; CULLUM ME, 1985, TOXICOL APPL PHARM, V81, P177, DOI 10.1016/0041-008X(85)90133-4; CULLUM ME, 1985, J BIOL CHEM, V260, P590; DARLINGTON RB, 1975, STATISTICAL METHODS, P229; GERBER LE, 1980, J NUTR, V110, P343, DOI 10.1093/jn/110.2.343; GERLACH HT, 1990, FASEB J, V4, P2511; GOODMAN DS, 1972, J LIPID RES, V13, P338; Goodman DS, 1984, RETINOIDS, V2, P42; IKEGAMI S, 1989, 14TH P INT C NUTR SE; JENSEN RK, 1988, J NUTR, V118, P416, DOI 10.1093/jn/118.3.416; KEILSON B, 1979, J NUTR, V109, P787, DOI 10.1093/jn/109.5.787; KLEINERB.A, 1971, ARCH BIOCHEM BIOPHYS, V142, P371, DOI 10.1016/0003-9861(71)90295-5; KRISHNAMURTHY S, 1963, J NUTR, V79, P503, DOI 10.1093/jn/79.4.503; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MASAKI K, 1986, TOHOKU J EXP MED, V150, P249, DOI 10.1620/tjem.150.249; NAPOLI JL, 1986, METHOD ENZYMOL, V123, P112, DOI 10.1016/S0076-6879(86)23015-3; NAPOLI JL, 1987, ARCH BIOCHEM BIOPHYS, V255, P95, DOI 10.1016/0003-9861(87)90298-0; RINGLER DH, 1979, LAB RAT, V1, P108; UNDERWOOD BA, 1979, J NUTR, V109, P796, DOI 10.1093/jn/109.5.796; VAHLQUIS.A, 1973, EUR J CLIN INVEST, V3, P352, DOI 10.1111/j.1365-2362.1973.tb00362.x; VAHLQUIST A, 1979, AM J CLIN NUTR, V32, P1433, DOI 10.1093/ajcn/32.7.1433; WOLF G, 1984, PHYSIOL REV, V64, P873, DOI 10.1152/physrev.1984.64.3.873	23	28	28	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998	0892-6638			FASEB J	Faseb J.	JAN	1991	5	1					86	92		10.1096/fasebj.5.1.1991596	http://dx.doi.org/10.1096/fasebj.5.1.1991596			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ET609	1991596				2022-12-25	WOS:A1991ET60900019
J	CANFIELD, VA; OKAMOTO, CT; CHOW, D; DORFMAN, J; GROS, P; FORTE, JG; LEVENSON, R				CANFIELD, VA; OKAMOTO, CT; CHOW, D; DORFMAN, J; GROS, P; FORTE, JG; LEVENSON, R			CLONING OF THE H,K-ATPASE BETA-SUBUNIT - TISSUE-SPECIFIC EXPRESSION, CHROMOSOMAL ASSIGNMENT, AND RELATIONSHIP TO NA,K-ATPASE BETA-SUBUNITS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									YALE UNIV,SCH MED,DEPT CELL BIOL,NEW HAVEN,CT 06510; UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720; MCGILL UNIV,DEPT BIOCHEM,MONTREAL H3G 1Y6,QUEBEC,CANADA	Yale University; University of California System; University of California Berkeley; McGill University				Levenson, Robert/0000-0002-0936-8421	NHLBI NIH HHS [HL-39263] Funding Source: Medline; NIDDK NIH HHS [DK-38972, DK-10141] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038972, R37DK010141, R01DK010141] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BEESLEY RC, 1973, BIOCHIM BIOPHYS ACTA, V307, P372, DOI 10.1016/0005-2736(73)90103-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHOU DY, 1978, ANNU REV BIOCHEM, V47, P251; CHOW D, 1989, FASEB Journal, V3, pA873; DAYHOFF MO, 1983, METHOD ENZYMOL, V91, P524; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; EMANUEL JR, 1987, P NATL ACAD SCI USA, V84, P9030, DOI 10.1073/pnas.84.24.9030; FARLEY RA, 1985, J BIOL CHEM, V260, P3899; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FORTE JG, 1975, GASTROENTEROLOGY, V69, P175; FORTE JG, 1977, GASTROENTEROLOGY, V73, P921; FORTE JG, 1989, HDB PHYSL, V3, P207; Forte JG, 1976, GASTRIC HYDROGEN ION, P302; FRANKEL WN, 1989, J VIROL, V63, P1763, DOI 10.1128/JVI.63.4.1763-1774.1989; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; HAGER KM, 1986, P NATL ACAD SCI USA, V83, P7693, DOI 10.1073/pnas.83.20.7693; HALL K, 1990, BIOCHEMISTRY-US, V29, P701, DOI 10.1021/bi00455a016; HERRERA VLM, 1987, J CELL BIOL, V105, P1855, DOI 10.1083/jcb.105.4.1855; JORGENSEN PL, 1974, BIOCHIM BIOPHYS ACTA, V356, P36, DOI 10.1016/0005-2736(74)90292-2; KENT RB, 1987, P NATL ACAD SCI USA, V84, P5369, DOI 10.1073/pnas.84.15.5369; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEVENSON R, 1991, IN PRESS MOUSE NEWSL, V89; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MAEDA M, 1990, J BIOL CHEM, V265, P9027; MAEDA M, 1988, BIOCHEM BIOPH RES CO, V157, P203, DOI 10.1016/S0006-291X(88)80033-0; MALO D, 1990, GENOMICS, V6, P697, DOI 10.1016/0888-7543(90)90507-Q; MARTINVASALLO P, 1989, J BIOL CHEM, V264, P4613; MCDONOUGH AA, 1990, FASEB J, V4, P1598, DOI 10.1096/fasebj.4.6.2156741; MERCER RW, 1986, MOL CELL BIOL, V6, P3884, DOI 10.1128/MCB.6.11.3884; OKAMOTO CT, 1990, BIOCHIM BIOPHYS ACTA, V1037, P360, DOI 10.1016/0167-4838(90)90038-H; OVCHINNIKOV YA, 1988, FEBS LETT, V233, P87, DOI 10.1016/0014-5793(88)81361-9; SACHS G, 1976, J BIOL CHEM, V251, P7690; SCHNEIDER JW, 1988, METHOD ENZYMOL, V156, P379; SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0; SHULL GE, 1986, J BIOL CHEM, V261, P6788; SHULL GE, 1986, BIOCHEMISTRY-US, V25, P8125, DOI 10.1021/bi00373a001; SHYJAN AW, 1990, J BIOL CHEM, V265, P5166; SILVER J, 1985, J HERED, V76, P436, DOI 10.1093/oxfordjournals.jhered.a110140; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350	40	86	88	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1990	265	32					19878	19884						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ188	1978834				2022-12-25	WOS:A1990EJ18800078
J	QIAN, XD; BECK, WT				QIAN, XD; BECK, WT			PROGESTERONE PHOTOAFFINITY LABELS P-GLYCOPROTEIN IN MULTIDRUG-RESISTANT HUMAN LEUKEMIC LYMPHOBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note									ST JUDE CHILDRENS RES HOSP, DEPT BIOCHEM & CLIN PHARMACOL, 332 N LAUDERDALE, MEMPHIS, TN 38101 USA; UNIV TENNESSEE, CTR HLTH SCI, COLL MED, DEPT PHARMACOL, MEMPHIS, TN 38163 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center					NCI NIH HHS [CA 21756, CA 40570] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA040570] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARCECI RJ, 1988, P NATL ACAD SCI USA, V85, P4350, DOI 10.1073/pnas.85.12.4350; BECK WT, 1979, CANCER RES, V39, P2070; BECK WT, 1987, BIOCHEM PHARMACOL, V36, P2879, DOI 10.1016/0006-2952(87)90198-5; CASEY M L, 1985, P422; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; CORNWELL MM, 1987, FASEB J, V1, P51, DOI 10.1096/fasebj.1.1.2886389; DURE LS, 1980, NATURE, V283, P784, DOI 10.1038/283784a0; GOTTESMAN MM, 1988, J BIOL CHEM, V263, P12163; GROS P, 1986, CELL, V47, P371, DOI 10.1016/0092-8674(86)90594-5; HAMADA H, 1988, CANCER RES, V48, P4926; HORWITZ KB, 1983, ENDOCRINOLOGY, V113, P2195, DOI 10.1210/endo-113-6-2195; JURANKA PF, 1989, FASEB J, V3, P2583, DOI 10.1096/fasebj.3.14.2574119; KARTNER N, 1985, NATURE, V316, P820, DOI 10.1038/316820a0; MARTYR R J, 1973, Biochemistry, V12, P2172, DOI 10.1021/bi00735a025; MOSCOW JA, 1988, J NATL CANCER I, V80, P14, DOI 10.1093/jnci/80.1.14; NAITO M, 1989, BIOCHEM BIOPH RES CO, V158, P1066, DOI 10.1016/0006-291X(89)92830-1; PERACE HL, 1989, P NATL ACAD SCI USA, V86, P5128; QIAN XD, 1990, CANCER RES, V50, P1132; SAFA AR, 1989, BIOCHEM BIOPH RES CO, V162, P1402, DOI 10.1016/0006-291X(89)90830-9; SAFA AR, 1986, J BIOL CHEM, V261, P6137; SAFA AR, 1987, J BIOL CHEM, V262, P7884; SAFA AR, 1988, P NATL ACAD SCI USA, V85, P7178; Spatz R J, 1986, Proc West Pharmacol Soc, V29, P319; SUGAWARA I, 1988, CANCER RES, V48, P1926; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; YANG CPH, 1989, J BIOL CHEM, V264, P782; YUSA K, 1989, CANCER RES, V49, P5002; ZAMORA JM, 1988, MOL PHARMACOL, V33, P454	29	81	84	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1990	265	31					18753	18756						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF739	1977745				2022-12-25	WOS:A1990EF73900011
J	PAL, N; WADEY, RB; BUCKLE, B; YEOMANS, E; PRITCHARD, J; COWELL, JK				PAL, N; WADEY, RB; BUCKLE, B; YEOMANS, E; PRITCHARD, J; COWELL, JK			PREFERENTIAL LOSS OF MATERNAL ALLELES IN SPORADIC WILMS-TUMOR	ONCOGENE			English	Article									INST CHILD HLTH,DEPT HAEMATOL & ONCOL,IMPERIAL CANC RES FUND,MOLEC GENET LAB,LONDON WC1N 1EH,ENGLAND; GREAT ORMOND ST HOSP SICK CHILDREN,DEPT HAEMATOL & ONCOL,LONDON WC1,ENGLAND	Cancer Research UK; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust				Cowell, John/0000-0002-2079-5950				ALLISON J, 1981, BIOCHEM J, V199, P725, DOI 10.1042/bj1990725; ANTONARAKIS SE, 1983, P NATL ACAD SCI-BIOL, V80, P6615, DOI 10.1073/pnas.80.21.6615; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; COUILLIN P, 1989, HUM GENET, V82, P171, DOI 10.1007/BF00284053; COWELL JK, 1989, HUM GENET, V82, P123, DOI 10.1007/BF00284042; DAO DD, 1987, AM J HUM GENET, V41, P202; DRYJA TP, 1989, NATURE, V339, P556, DOI 10.1038/339556a0; ECCLES MR, 1984, HUM GENET, V67, P190, DOI 10.1007/BF00272999; FEARON ER, 1984, NATURE, V309, P176, DOI 10.1038/309176a0; FEINBERG AP, 1983, BIOCHEM BIOPH RES CO, V111, P47, DOI 10.1016/S0006-291X(83)80115-6; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HENDY GN, 1981, P NATL ACAD SCI-BIOL, V78, P7365, DOI 10.1073/pnas.78.12.7365; HENRY I, 1989, P NATL ACAD SCI USA, V86, P3247, DOI 10.1073/pnas.86.9.3247; HOPPENER JWM, 1984, HUM GENET, V66, P309, DOI 10.1007/BF00287635; JEFFREYS AJ, 1979, CELL, V18, P1, DOI 10.1016/0092-8674(79)90348-9; KOUFOS A, 1984, NATURE, V309, P170, DOI 10.1038/309170a0; Maniatis T., 1982, MOL CLONING; MANNENS M, 1988, HUM GENET, V81, P41, DOI 10.1007/BF00283727; NICHOLLS RD, 1989, AM J MED GENET, V33, P66, DOI 10.1002/ajmg.1320330109; ORKIN SH, 1984, NATURE, V309, P172, DOI 10.1038/309172a0; QUAN F, 1985, NUCLEIC ACIDS RES, V13, P8288, DOI 10.1093/nar/13.22.8288; RAIZIS AM, 1985, HUM GENET, V70, P344, DOI 10.1007/BF00295375; REEVE AE, 1984, NATURE, V309, P174, DOI 10.1038/309174a0; REEVE AE, 1989, MOL CELL BIOL, V9, P1799, DOI 10.1128/MCB.9.4.1799; RICCARDI VM, 1978, PEDIATRICS, V61, P604; SCHROEDER WT, 1987, AM J HUM GENET, V40, P413; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPARKES RS, 1983, SCIENCE, V219, P971, DOI 10.1126/science.6823558; TOGUCHIDA J, 1988, CANCER RES, V48, P3939; VANDERMEY AGL, 1989, LANCET, V2, P1291; VANHEYNINGEN V, 1985, P NATL ACAD SCI USA, V82, P8592; WADEY RB, 1989, NUCLEIC ACIDS RES, V17, P3332, DOI 10.1093/nar/17.8.3332; WADEY RB, 1990, IN PRESS ONCOGENE; WATKINS PC, 1987, DNA-J MOLEC CELL BIO, V6, P205, DOI 10.1089/dna.1987.6.205; WILLIAMS JC, 1989, LANCET, V1, P283; WILSON JT, 1978, NUCLEIC ACIDS RES, V5, P563, DOI 10.1093/nar/5.2.563; ZHU XP, 1989, NATURE, V340, P312, DOI 10.1038/340312a0	40	86	86	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	NOV	1990	5	11					1665	1668						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EL401	1980007				2022-12-25	WOS:A1990EL40100008
J	RAJAGOPALAN, S; PARK, JH; PATEL, PD; LEBOVITZ, RM; LIEBERMAN, MW				RAJAGOPALAN, S; PARK, JH; PATEL, PD; LEBOVITZ, RM; LIEBERMAN, MW			CLONING AND ANALYSIS OF THE RAT GAMMA-GLUTAMYL-TRANSFERASE GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									BAYLOR UNIV, DEPT PATHOL, 1 BAYLOR PLAZA, HOUSTON, TX 77030 USA	Baylor College of Medicine; Baylor University					PHS HHS [R37-39392] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALBERT Z, 1964, ACTA HISTOCHEM, V18, P78; ANGEL P, 1987, MOL CELL BIOL, V7, P2256, DOI 10.1128/MCB.7.6.2256; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BLATTNER FR, 1977, SCIENCE, V196, P161, DOI 10.1126/science.847462; CAMERON R, 1978, CANCER RES, V38, P823; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOBERT MN, 1990, J BIOL CHEM, V265, P2352; CHRETIEN S, 1988, P NATL ACAD SCI USA, V85, P6, DOI 10.1073/pnas.85.1.6; COLOMA J, 1986, NUCLEIC ACIDS RES, V14, P1393, DOI 10.1093/nar/14.3.1393; CURTHOYS NP, 1979, ENZYME, V24, P383, DOI 10.1159/000458694; DEMEYTS ER, 1988, P NATL ACAD SCI USA, V85, P8840; DEMPO K, 1981, ONCODEV BIOL MED, V2, P21; FIALA S, 1976, J NATL CANCER I, V57, P591, DOI 10.1093/jnci/57.3.591; FIALA S, 1972, J NATL CANCER I, V48, P1393; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GOLDBARG JA, 1960, ARCH BIOCHEM BIOPHYS, V91, P61, DOI 10.1016/0003-9861(60)90455-0; GRAVES BJ, 1986, CELL, V44, P565, DOI 10.1016/0092-8674(86)90266-7; GRIFFITHS SA, 1989, CANCER LETT, V46, P69, DOI 10.1016/0304-3835(89)90217-6; HANES CS, 1952, BIOCHEM J, V51, P25, DOI 10.1042/bj0510025; HANIGAN MH, 1985, CARCINOGENESIS, V6, P165, DOI 10.1093/carcin/6.2.165; HORIUCHI S, 1978, EUR J BIOCHEM, V87, P429, DOI 10.1111/j.1432-1033.1978.tb12392.x; JAKEN S, 1978, P NATL ACAD SCI USA, V75, P1750, DOI 10.1073/pnas.75.4.1750; JOHNSON PF, 1987, GENE DEV, V1, P133, DOI 10.1101/gad.1.2.133; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAPERCHE Y, 1986, P NATL ACAD SCI USA, V83, P937, DOI 10.1073/pnas.83.4.937; LI Y, 1989, ONCOGENE, V4, P795; LI YC, 1988, P NATL ACAD SCI USA, V85, P344, DOI 10.1073/pnas.85.2.344; LOENEN WAM, 1983, GENE, V26, P171, DOI 10.1016/0378-1119(83)90187-7; LOPEZCASILLAS F, 1989, J BIOL CHEM, V264, P7176; Maniatis T., 1982, MOL CLONING; MATRISIAN LM, 1986, MOL CELL BIOL, V6, P1679, DOI 10.1128/MCB.6.5.1679; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MEISTER A, 1973, SCIENCE, V180, P33, DOI 10.1126/science.180.4081.33; NASH B, 1984, J BIOL CHEM, V259, P678; PARK JH, 1986, MOL GENETICS MAMMALI, P79; PAWLAK A, 1988, J BIOL CHEM, V263, P9913; PERAINO C, 1983, ENV HLTH PERSPECT, V50, P1; REYNOLDS GA, 1984, CELL, V38, P275, DOI 10.1016/0092-8674(84)90549-X; RUTENBURG AM, 1969, J HISTOCHEM CYTOCHEM, V17, P517, DOI 10.1177/17.8.517; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; SEIF I, 1979, NUCLEIC ACIDS RES, V6, P3387, DOI 10.1093/nar/6.10.3387; SINHA S, 1986, CANCER RES, V46, P1440; SOLT DB, 1981, J NATL CANCER I, V67, P193; TANIGUCHI N, 1985, CANCER RES, V45, P5835; Tate S.S., 1980, ENZYMATIC BASIS DETO, VII, P95; TATE SS, 1985, METHOD ENZYMOL, V113, P400; TATEISHI N, 1976, GANN, V67, P215; TSAO MS, 1985, CANCER RES, V45, P5134; WILLIAMS GM, 1980, CARCINOGENESIS, V1, P813, DOI 10.1093/carcin/1.10.813; YOUNG RA, 1981, CELL, V23, P451, DOI 10.1016/0092-8674(81)90140-9; 1989, BLUESCRIPT DNA SEQUE	53	37	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	1990	265	20					11721	11725						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN233	1973164				2022-12-25	WOS:A1990DN23300047
J	IWAHANA, H; ORITA, M; KANAZAWA, H; HAYASHI, K; SEKIYA, T				IWAHANA, H; ORITA, M; KANAZAWA, H; HAYASHI, K; SEKIYA, T			A NEW RFLP IN INTRON-1 OF THE HUMAN C-HA-RAS1 GENE AND ITS CLOSE RELATIONSHIP WITH THE VARIABLE TANDEM REPEATS IN THE REGION 3' TO THE GENE	ONCOGENE			English	Article									NATL CANC CTR,RES INST,DIV ONCOGENE,1-1 TSUKIJI 5 CHOME,CHUO KU,TOKYO 104,JAPAN	National Cancer Center - Japan								ALI IU, 1987, SCIENCE, V238, P185, DOI 10.1126/science.3659909; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; CECCHERININELLI L, 1987, BRIT J CANCER, V56, P1, DOI 10.1038/bjc.1987.143; COHEN JB, 1987, J CELL PHYSL S, V5, P75; FEARON ER, 1985, NATURE, V318, P377, DOI 10.1038/318377a0; GERHARD DS, 1987, NATURE, V325, P73, DOI 10.1038/325073a0; HAYWARD NK, 1988, HUM GENET, V78, P115, DOI 10.1007/BF00278178; HEIGHWAY J, 1986, BRIT J CANCER, V53, P453, DOI 10.1038/bjc.1986.72; KASPERCZYK A, 1989, AM J HUM GENET, V45, P689; KOUFOS A, 1985, NATURE, V316, P330, DOI 10.1038/316330a0; KRONTIRIS TG, 1985, NATURE, V313, P369, DOI 10.1038/313369a0; LEE JH, 1989, CANCER RES, V49, P1220; LIDEREAU R, 1986, JNCI-J NATL CANCER I, V77, P697, DOI 10.1093/jnci/77.3.697; MACKAY J, 1988, LANCET, V2, P1384; MACKAY J, 1988, BRIT J CANCER, V58, P710, DOI 10.1038/bjc.1988.295; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; SANGER F, 1981, SCIENCE, V214, P1305; SCRABLE HJ, 1987, NATURE, V329, P645, DOI 10.1038/329645a0; SEEBURG PH, 1984, NATURE, V312, P71, DOI 10.1038/312071a0; SHIRAISHI M, 1987, JPN J CANCER RES, V78, P1302; SPANDIDOS DA, 1987, FEBS LETT, V218, P41, DOI 10.1016/0014-5793(87)81014-1; SUTHERLAND C, 1986, BRIT J CANCER, V54, P787, DOI 10.1038/bjc.1986.241; THEILLET C, 1986, CANCER RES, V46, P4776; THEIN SL, 1986, NATURE, V321, P84, DOI 10.1038/321084a0; WANG HP, 1988, CYTOGENET CELL GENET, V48, P72, DOI 10.1159/000132593; WYLLIE FS, 1988, BRIT J CANCER, V57, P135, DOI 10.1038/bjc.1988.28; YOSHIMOTO K, 1989, CANCER RES, V49, P2716	28	13	13	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUL	1990	5	7					1049	1053						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP415	1973828				2022-12-25	WOS:A1990DP41500014
J	HILDEBRANDT, JD; KOHNKEN, RE				HILDEBRANDT, JD; KOHNKEN, RE			HORMONE INHIBITION OF ADENYLYL CYCLASE - DIFFERENCES IN THE MECHANISMS FOR INHIBITION BY HORMONES AND G-PROTEIN BETA-GAMMA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											HILDEBRANDT, JD (corresponding author), WORCESTER FDN EXPTL BIOL INC,222 MAPLE AVE,SHREWSBURY,MA 01545, USA.				NIDDK NIH HHS [DK37219] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037219] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKTORIES K, 1983, FEBS LETT, V158, P169, DOI 10.1016/0014-5793(83)80701-7; Birnbaumer L, 1985, Recent Prog Horm Res, V41, P41; BIRNBAUMER L, 1987, TRENDS PHARMACOL SCI, V8, P209, DOI 10.1016/0165-6147(87)90064-2; BOCKAERT J, 1985, EMBO J, V4, P1413, DOI 10.1002/j.1460-2075.1985.tb03795.x; BOKOCH GM, 1987, J BIOL CHEM, V262, P589; BOURNE HR, 1975, SCIENCE, V187, P750, DOI 10.1126/science.163487; CERIONE RA, 1985, BIOCHEMISTRY-US, V24, P4499, DOI 10.1021/bi00338a002; CLARK RB, 1982, MOL PHARMACOL, V22, P609; EVANS T, 1987, J BIOL CHEM, V262, P176; FUNG BKK, 1981, P NATL ACAD SCI-BIOL, V78, P152, DOI 10.1073/pnas.78.1.152; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HAGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; HARRIS BA, 1985, SCIENCE, V229, P1274, DOI 10.1126/science.3839937; HILDEBRANDT JD, 1985, ADV CYCLIC NUCL PROT, V19, P87; HILDEBRANDT JD, 1983, NATURE, V302, P706, DOI 10.1038/302706a0; HILDEBRANDT JD, 1982, J BIOL CHEM, V257, P4723; HILDEBRANDT JD, 1984, J BIOL CHEM, V259, P3178; JAKOBS KH, 1983, NATURE, V303, P177, DOI 10.1038/303177a0; KAHN RA, 1984, J BIOL CHEM, V259, P6235; KANAHO Y, 1984, J BIOL CHEM, V259, P7378; KATADA T, 1984, J BIOL CHEM, V259, P3586; KATADA T, 1984, J BIOL CHEM, V259, P3568; KATADA T, 1986, J BIOL CHEM, V261, P5215; KIM D, 1989, NATURE, V337, P557, DOI 10.1038/337557a0; NEER EJ, 1988, NATURE, V333, P129, DOI 10.1038/333129a0; NORTHUP JK, 1983, J BIOL CHEM, V258, P1369; NORTHUP JK, 1983, J BIOL CHEM, V258, P1361; ROOF DJ, 1985, J BIOL CHEM, V260, P6242; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; SMIGEL MD, 1986, J BIOL CHEM, V261, P1976; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; STRYER L, 1986, ANNU REV CELL BIOL, V2, P391, DOI 10.1146/annurev.cb.02.110186.002135; TORO MJ, 1987, MOL ENDOCRINOL, V1, P669, DOI 10.1210/mend-1-10-669; WATKINS DC, 1987, J BIOL CHEM, V262, P10651	34	37	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	1990	265	17					9825	9830						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH141	1972156				2022-12-25	WOS:A1990DH14100042
J	BARRY, ELR; MOSHER, DF				BARRY, ELR; MOSHER, DF			BINDING AND DEGRADATION OF BLOOD-COAGULATION FACTOR-XIII BY CULTURED FIBROBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV WISCONSIN, DEPT PHYSIOL CHEM, MADISON, WI 53706 USA; UNIV WISCONSIN, DEPT MED, MADISON, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison			Barry, Elizabeth/AAB-7916-2019		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021644] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL21644] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ACHYUTHAN KE, 1988, J BIOL CHEM, V263, P14296; BALE MD, 1986, BIOCHEMISTRY-US, V25, P5667, DOI 10.1021/bi00367a048; BARRY ELR, 1988, J BIOL CHEM, V263, P10464; BARRY ELR, 1989, J BIOL CHEM, V264, P4179; BOCKENSTEDT P, 1986, J CLIN INVEST, V78, P551, DOI 10.1172/JCI112608; CHEN LB, 1978, CELL, V14, P377, DOI 10.1016/0092-8674(78)90123-X; CLARK RAF, 1985, PLASMA FIBRONECTIN S, P197; COHEN I, 1987, THROMB RES, V47, P409, DOI 10.1016/0049-3848(87)90456-7; DAVIE EW, 1986, COLD SPRING HARB SYM, V51, P509, DOI 10.1101/SQB.1986.051.01.062; FOLK JE, 1985, METHOD ENZYMOL, V113, P358; FRANCIS RT, 1986, J BIOL CHEM, V261, P9787; GREENBERG CS, 1985, BLOOD, V66, P1028; GREENBERG CS, 1984, J BIOL CHEM, V259, P4721; GRUNDMANN U, 1986, P NATL ACAD SCI USA, V83, P8024, DOI 10.1073/pnas.83.21.8024; HADA M, 1986, BLOOD, V68, P95; HENRIKSSON P, 1985, J CLIN INVEST, V76, P528, DOI 10.1172/JCI112002; ICHINOSE A, 1986, BIOCHEMISTRY-US, V25, P4633, DOI 10.1021/bi00364a027; IKURA K, 1988, BIOCHEMISTRY-US, V27, P2898, DOI 10.1021/bi00408a035; KESKIOJA J, 1976, CELL, V9, P29, DOI 10.1016/0092-8674(76)90049-0; KRANDIN RL, 1987, BLOOD, V69, P778; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOPACIUK S, 1976, THROMB RES, V8, P453, DOI 10.1016/0049-3848(76)90223-1; LORAND L, 1988, P NATL ACAD SCI USA, V85, P1057, DOI 10.1073/pnas.85.4.1057; LORAND L, 1986, ANN NY ACAD SCI, V485, P144, DOI 10.1111/j.1749-6632.1986.tb34577.x; MARY A, 1988, BIOCHIM BIOPHYS ACTA, V966, P328, DOI 10.1016/0304-4165(88)90082-7; MAXFIELD FR, 1982, J CELL BIOL, V95, P676, DOI 10.1083/jcb.95.2.676; McDonagh J, 1987, HEMOSTASIS THROMBOSI, P289; MCKEOWNLONGO PJ, 1983, J CELL BIOL, V97, P466, DOI 10.1083/jcb.97.2.466; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; MCKEOWNLONGO PJ, 1984, J CELL BIOL, V98, P22, DOI 10.1083/jcb.98.1.22; MOSHER DF, 1983, J BIOL CHEM, V258, P6595; POOLE B, 1981, J CELL BIOL, V90, P665, DOI 10.1083/jcb.90.3.665; SAITO Y, 1986, J BIOL CHEM, V261, P1355; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; TAKAHASHI N, 1986, P NATL ACAD SCI USA, V83, P8019, DOI 10.1073/pnas.83.21.8019; UPCHURCH HF, 1987, IN VITRO CELL DEV B, V23, P795	36	51	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	1990	265	16					9302	9307						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF142	1971626				2022-12-25	WOS:A1990DF14200054
J	WEDEMAYER, GJ; WEMMER, DE; GLAZER, AN				WEDEMAYER, GJ; WEMMER, DE; GLAZER, AN			PHYCOBILINS OF CRYPTOPHYCEAN ALGAE - STRUCTURES OF NOVEL BILINS WITH ACRYLOYL SUBSTITUENTS FROM PHYCOERYTHRIN-566	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISSIMILATORY NITRITE REDUCTASE; CHROOMONAS SP CRYPTOPHYCEAE; ATTACHMENT SITES; BETA-SUBUNIT; B-PHYCOERYTHRIN; ALPHA-SUBUNIT; LINKED PHYCOERYTHROBILINS; CRYPTOMONAD BILIPROTEINS; CYANIDIUM-CALDARIUM; LINKAGE DIVERSITY	Cryptomonad strain CBD phycoerythrin 566 carries four open-chain tetrapyrrole (bilin) prosthetic groups: three singly thioether-linked bilins at alpha-19, beta-82, and beta-158 and a bilin linked through two thioether bonds at beta-50,61 (amino acid sequence numbering from Wilbanks, S. M., Wedemayer, G. J., and Glazer, A. N. (1989) J. Biol. Chem. 264, 17860-17867). The structures of all four peptide-linked prosthetic groups were determined by H-1 NMR spectroscopy. The bilin at beta-82 was identified as phycoerythrobilin (PEB), a common prosthetic group in cyanobacterial and red algal phycobiliproteins. The structures of the remaining bilins were novel. The bilin at alpha-19, designated Cys-bilin 618, differed from PEB in having additional double bonds between C-2 and C-3 of ring A and between C-12' and C-12", i.e. an acryloyl substituent at C-12 of ring C. The doubly linked bilin at beta-50,61 designated DiCys-bilin 584, differed from doubly linked PEB (Schoenleber, R. W., Lundell, D. J., Glazer, A. N., and Rapoport, H. (1984) J. Biol. Chem. 259, 5481-5484) in possessing an acryloyl substituent at C-12 of ring C in place of a propionyl substituent. Similarly, the bilin at beta-158, designated Cys-bilin 584, differed from singly-linked PEB in possessing an acryloyl substituent at C-12 of ring C in place of a propionyl substituent. The three novel cryptomonad bilins join heme d1 and chlorophylls c1, c2, and c3 as the only known porphyrin-derived natural products with acryloyl substituents.	UNIV CALIF BERKELEY LAWRENCE BERKELEY LAB, DIV BIOCHEM & MOLEC BIOL, MCB, STANLEY DONNER ASU, BERKELEY, CA 94720 USA; UNIV CALIF BERKELEY LAWRENCE BERKELEY LAB, DEPT CHEM, BERKELEY, CA 94720 USA; UNIV CALIF BERKELEY LAWRENCE BERKELEY LAB, DIV CHEM BIODYNAM, BERKELEY, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028994] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM28994] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERTH W, 1982, ANAL CHEM, V54, P2029; ALLEN MB, 1959, NATURE, V184, P1047, DOI 10.1038/1841047a0; ANDERSSON LA, 1990, FEBS LETT, V267, P285, DOI 10.1016/0014-5793(90)80946-G; Beale S. I., 1990, BIOSYNTHESIS HEME CH, P287; BEALE SI, 1983, ARCH BIOCHEM BIOPHYS, V227, P279, DOI 10.1016/0003-9861(83)90372-7; BEALE SI, 1984, PLANT PHYSIOL, V16, P7; BISHOP JE, 1986, J BIOL CHEM, V261, P6790; BISHOP JE, 1987, J AM CHEM SOC, V109, P875, DOI 10.1021/ja00237a039; BROOKS C, 1973, ARCH MIKROBIOL, V88, P193, DOI 10.1007/BF00421845; BROWN SB, 1984, BIOCHEM J, V219, P905, DOI 10.1042/bj2190905; BROWN SB, 1989, BIOCHEM J, V261, P259, DOI 10.1042/bj2610259; BROWN SB, 1990, J PHOTOCH PHOTOBIO B, V5, P3, DOI 10.1016/1011-1344(90)85002-E; CHANG CK, 1986, BIOCHEMISTRY-US, V25, P8447, DOI 10.1021/bi00374a019; CHANG CK, 1986, J BIOL CHEM, V261, P8593; CHANG CK, 1985, J BIOL CHEM, V260, P9520; FAWLEY MW, 1989, J PHYCOL, V25, P601, DOI 10.1111/j.1529-8817.1989.tb00267.x; FAWLEY MW, 1989, PLANT PHYSIOL, V91, P727, DOI 10.1104/pp.91.2.727; FOOKES CJR, 1989, J CHEM SOC CHEM COMM, P1827, DOI 10.1039/c39890001827; GANTT E, 1971, J CELL BIOL, V48, P280, DOI 10.1083/jcb.48.2.280; Glazer A. N., 1981, The biochemistry of plants. A comprehensive treatise. Volume 8. Photosynthesis., P51; GLAZER AN, 1985, ANNU REV BIOPHYS BIO, V14, P47, DOI 10.1146/annurev.biophys.14.1.47; GLAZER AN, 1977, FEMS MICROBIOL LETT, V1, P113, DOI 10.1111/j.1574-6968.1977.tb00593.x; GLAZER AN, 1975, ARCH MICROBIOL, V104, P29, DOI 10.1007/BF00447296; GLAZER AN, 1989, J BIOL CHEM, V264, P1; GLAZER AN, 1983, ANNU REV BIOCHEM, V52, P125, DOI 10.1146/annurev.bi.52.070183.001013; GLAZER AN, 1971, ARCH MIKROBIOL, V80, P1, DOI 10.1007/BF00410574; GUARDFRIAR D, 1986, PLANT PHYSIOL, V80, P38, DOI 10.1104/pp.80.1.38; GUARDFRIAR D, 1986, PHOTOCHEM PHOTOBIOL, V43, P81, DOI 10.1111/j.1751-1097.1986.tb05594.x; GUARDFRIAR D, 1989, BIOCHIM BIOPHYS ACTA, V973, P118, DOI 10.1016/S0005-2728(89)80411-6; HAXO FT, 1959, NATURE, V184, P1051, DOI 10.1038/1841051a0; HILL DRA, 1989, PHYCOLOGIA, V28, P455, DOI 10.2216/i0031-8884-28-4-455.1; HILLER RG, 1987, BIOCHIM BIOPHYS ACTA, V923, P98, DOI 10.1016/0304-4165(87)90131-0; JEFFREY SW, 1989, SYST ASSOC SPEC VOL, V38, P13; JEFFREY SW, 1987, BIOCHIM BIOPHYS ACTA, V894, P180, DOI 10.1016/0005-2728(87)90188-5; JUNG J, 1980, BIOCHEMISTRY-US, V19, P24, DOI 10.1021/bi00542a005; KLOTZ AV, 1986, J BIOL CHEM, V261, P6797; KLOTZ AV, 1985, J BIOL CHEM, V260, P4856; LAGARIAS JC, 1988, J BIOL CHEM, V263, P12977; LAGARIAS JC, 1980, J AM CHEM SOC, V102, P4821, DOI 10.1021/ja00534a042; LEMBERG R, 1951, BIOCHEM J, V49, P674, DOI 10.1042/bj0490674; LICHTLE C, 1976, Phycologia, V15, P393, DOI 10.2216/i0031-8884-15-3-393.1; LICHTLE C, 1987, BIOCHIM BIOPHYS ACTA, V894, P76, DOI 10.1016/0005-2728(87)90214-3; LUDWIG M, 1989, J CELL BIOL, V108, P875, DOI 10.1083/jcb.108.3.875; LUNDELL DJ, 1984, J BIOL CHEM, V259, P5472; MACCOLL R, 1983, ARCH MICROBIOL, V135, P194, DOI 10.1007/BF00414479; MACCOLL R, 1990, BIOCHEMISTRY-US, V29, P430, DOI 10.1021/bi00454a018; MACCOLL R, 1983, BIOCHEMISTRY-US, V22, P5568, DOI 10.1021/bi00293a018; MACCOLL R, 1983, J BIOL CHEM, V258, P4327; MACCOLL R, 1973, J BIOL CHEM, V248, P7080; MACCOLL R, 1987, PHYCOBILIPROTEINS, P189; MARTIN CD, 1987, BIOCHIM BIOPHYS ACTA, V923, P88, DOI 10.1016/0304-4165(87)90130-9; MORSCHEL E, 1975, ARCH MICROBIOL, V105, P153, DOI 10.1007/BF00447130; MORSCHEL E, 1977, ARCH MICROBIOL, V113, P83, DOI 10.1007/BF00428585; Moss G P, 1988, Eur J Biochem, V178, P277, DOI 10.1111/j.1432-1033.1988.tb14453.x; NAGY JO, 1985, J BIOL CHEM, V260, P4864; NELSON JR, 1989, J PHYCOL, V25, P761, DOI 10.1111/j.0022-3646.1989.00761.x; OHEOCHA C, 1964, Proc R Ir Acad B, V63, P191; ONG LJ, 1988, LIGHT ENERGY TRANSDU, P102; POOLE RK, 1983, BIOCHIM BIOPHYS ACTA, V726, P205, DOI 10.1016/0304-4173(83)90006-X; RHIEL E, 1989, BOT ACTA, V102, P46, DOI 10.1111/j.1438-8677.1989.tb00066.x; SCHOENLEBER RW, 1984, J BIOL CHEM, V259, P5481; SCHOENLEBER RW, 1984, J BIOL CHEM, V259, P5485; SIDLER W, 1985, BIOL CHEM H-S, V366, P233, DOI 10.1515/bchm3.1985.366.1.233; SIDLER W, 1990, BIOL CHEM H-S, V371, P537, DOI 10.1515/bchm3.1990.371.2.537; SIDLER WA, 1987, PROGR PHOTOSYNTHESIS, V2, P153; SPEARBERNSTEIN L, 1987, PROGR PHOTOSYNTHESIS, V2, P309; SWANSON RV, 1990, ANAL BIOCHEM, V188, P295, DOI 10.1016/0003-2697(90)90609-D; WILBANKS SM, 1989, J BIOL CHEM, V264, P17860	68	31	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4731	4741						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002022				2022-12-25	WOS:A1991FC21700013
J	KOVANEN, PT; KOKKONEN, JO				KOVANEN, PT; KOKKONEN, JO			MODIFICATION OF LOW-DENSITY LIPOPROTEINS BY SECRETORY GRANULES OF RAT SEROSAL MAST-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGES INVITRO; SERUM-LIPOPROTEINS; MEDIATED UPTAKE; CHOLESTEROL; PROTEOGLYCAN; DEGRADATION; ASSOCIATION; AORTA	When low density lipoprotein (LDL) is incubated with granules isolated from rat serosal mast cells, a fraction of LDL is bound to the granule heparin proteoglycan. If incubation is continued at 37-degrees-C, the bound LDL, but not the unbound LDL, is degraded by granule neutral proteases. In the early stage of incubation, all the granule-bound LDL can be released by 0.3 M NaCl (the "salt-sensitive" fraction of LDL). With time, an increasing proportion of the granule-bound LDL requires 0.5 M NaCl for release (the "salt-resistant" fraction of LDL). Chemical analysis showed that, on average, 20% of the apolipoprotein B LDL was lost from the salt-sensitive fraction and 60% from the salt-resistant fraction, without any change in the composition of the lipid portion. Electron microscopic analysis disclosed large fused particles of LDL (diameters up to 100 nm) in the highly proteolyzed salt-resistant fraction, but no fused particles could be found in the less proteolyzed salt-sensitive fraction. We conclude that both binding and extensive degradation of LDL by mast cell granules is required for fusion of LDL particles on the granule surface. As compared with native LDL, the mast cell granule-modified LDL particles exhibit (i) increased particle size, (ii) selective loss of protein (apoB), (iii) a decrease in hydrated density, and (iv) stronger ionic interaction between apoB and heparin proteoglycan. The particles resemble the extracellular lipid droplets found in atherosclerotic lesions of both man and animals. Modification of LDL by mast cells may therefore provide a model of how these lipid structures are formed.			KOVANEN, PT (corresponding author), WIHURI RES INST, KALLIOLINNANTIE 4, SF-00140 HELSINKI, FINLAND.							AVIGAN J, 1959, J BIOL CHEM, V234, P787; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529; BROWN MS, 1975, P NATL ACAD SCI USA, V72, P2925, DOI 10.1073/pnas.72.8.2925; FRANK JS, 1989, J LIPID RES, V30, P967; GALLI SJ, 1984, PROG ALLERGY, V34, P1; GAMBLE W, 1978, J LIPID RES, V19, P1068; GUYTON JR, 1989, ARTERIOSCLEROSIS, V9, pA736; GUYTON JR, 1989, AM J PATHOL, V134, P705; GUYTON JR, 1985, ARTERIOSCLEROSIS, V5, P644, DOI 10.1161/01.ATV.5.6.644; HOFF HF, 1987, EXP MOL PATHOL, V46, P331, DOI 10.1016/0014-4800(87)90054-2; HOFF HF, 1989, ARTERIOSCLEROSIS, V9, P538, DOI 10.1161/01.ATV.9.4.538; IVERIUS PH, 1972, J BIOL CHEM, V247, P2607; JONAS A, 1978, BIOCHIM BIOPHYS ACTA, V528, P47, DOI 10.1016/0005-2760(78)90051-6; KHOO JC, 1988, ARTERIOSCLEROSIS, V8, P348, DOI 10.1161/01.ATV.8.4.348; KOKKONEN JO, 1986, J BIOL CHEM, V261, P6067; KOKKONEN JO, 1989, J BIOL CHEM, V264, P10749; KOKKONEN JO, 1985, J BIOL CHEM, V260, P4756; KOKKONEN JO, 1987, BIOCHEM J, V241, P583, DOI 10.1042/bj2410583; KOKKONEN JO, 1987, P NATL ACAD SCI USA, V84, P2287, DOI 10.1073/pnas.84.8.2287; LAUSTIOLA K, 1986, BIOCHIM BIOPHYS ACTA, V889, P95, DOI 10.1016/0167-4889(86)90013-3; LOWRY OH, 1951, J BIOL CHEM, V193, P265; SCHWARTZ LB, 1984, PROG ALLERGY, V34, P271; SUITS AG, 1989, P NATL ACAD SCI USA, V86, P2713, DOI 10.1073/pnas.86.8.2713; VIJAYAGOPAL P, 1981, J BIOL CHEM, V256, P8234	25	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4430	4436						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999427				2022-12-25	WOS:A1991FA69400064
J	SARKANEN, S; RAZAL, RA; PICCARIELLO, T; YAMAMOTO, E; LEWIS, NG				SARKANEN, S; RAZAL, RA; PICCARIELLO, T; YAMAMOTO, E; LEWIS, NG			LIGNIN PEROXIDASE - TOWARD A CLARIFICATION OF ITS ROLE INVIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASIDIOMYCETE PHANEROCHAETE-CHRYSOSPORIUM; WHITE ROT BASIDIOMYCETE; DEGRADING ENZYME; DIARYLPROPANE OXYGENASE; OXIDATIVE-DEGRADATION; VERATRYL ALCOHOL; FREE-RADICALS; MECHANISM; ETHER; BIODEGRADATION	The extracellular lignin peroxidase from the white-rot basidiomycete Phanerochaete chrysosporium is thought to play an important role in lignin biodegradation. However, the majority of lignin-derived preparations actually experience overall polymerization at the hands of the enzyme in vitro. It has now been found that, in the presence of H2O2 at pH 4.0, the monomeric lignin precursor coniferyl alcohol is polymerized quantitatively by a lignin peroxidase preparation which is uncontaminated with MnII-dependent peroxidases. C-13 NMR spectrometry of the resulting dehydropolymerisates from C-13-labeled monolignols confirms that the frequencies of different interunit linkages are very similar to those engendered through the action of horseradish peroxidase with H2O2. Indeed, lignin peroxidase does not ultimately seem to be a prerequisite for lignin degradation in vivo, yet its activity can still accelerate the conversion of lignin-derived preparations by P. chrysosporium to CO2. Consequently, lignin peroxidase can provisionally be expected to fulfill two important functions. On the one hand, the enzyme may detoxify lower molecular weight phenolic compounds released from lignins during their fungal decomposition. On the other hand, through the introduction of suitable functional groups, lignin peroxidase could indirectly enhance the susceptibility of macromolecular lignin structures toward depolymerization by another enzyme.	VIRGINIA POLYTECH INST & STATE UNIV, DEPT WOOD SCI, BLACKSBURG, VA 24061 USA; VIRGINIA POLYTECH INST & STATE UNIV, DEPT BIOCHEM, BLACKSBURG, VA 24061 USA; UNIV MINNESOTA, DEPT FOREST PROD, ST PAUL, MN 55108 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; University of Minnesota System; University of Minnesota Twin Cities				Lewis, Norman/0000-0001-5742-032X				ANDER P, 1990, J BIOTECHNOL, V13, P189, DOI 10.1016/0168-1656(90)90104-J; ATALLA RH, 1985, SCIENCE, V227, P636, DOI 10.1126/science.227.4687.636; BONNARME P, 1990, APPL ENVIRON MICROB, V56, P210, DOI 10.1128/AEM.56.1.210-217.1990; BRODA P, 1989, ENZYME SYSTEMS FOR LIGNOCELLULOSE DEGRADATION, P121; DUNFORD HB, 1982, ADV INORG BIOCHEM, V4, P41; FENN P, 1984, J WOOD CHEM TECHNOL, V4, P131, DOI 10.1080/02773818408081148; GARVER TM, 1986, HOLZFORSCHUNG, V40, P93; GIERER J, 1979, SVEN PAPPERSTIDN, V82, P71; GIERER J, 1973, ACTA CHEM SCAND, V27, P2909, DOI 10.3891/acta.chem.scand.27-2909; GLENN JK, 1983, BIOCHEM BIOPH RES CO, V114, P1077, DOI 10.1016/0006-291X(83)90672-1; GOLD MH, 1984, ARCH BIOCHEM BIOPHYS, V234, P353, DOI 10.1016/0003-9861(84)90280-7; GOLD MH, 1983, PHOTOCHEM PHOTOBIOL, V38, P647, DOI 10.1111/j.1751-1097.1983.tb03595.x; GOLD MH, 1982, ARCH MICROBIOL, V132, P115, DOI 10.1007/BF00508715; Grisebach H., 1981, The biochemistry of plants. A comprehensive treatise. Volume 7. Secondary plant products., P457; HAEMMERLI SD, 1986, FEMS MICROBIOL LETT, V35, P33, DOI 10.1111/j.1574-6968.1986.tb01494.x; HAEMMERLI SD, 1987, FEBS LETT, V220, P149, DOI 10.1016/0014-5793(87)80893-1; HAMMEL KE, 1986, P NATL ACAD SCI USA, V83, P3708, DOI 10.1073/pnas.83.11.3708; HAMMEL KE, 1985, J BIOL CHEM, V260, P8348; HARVEY PJ, 1989, ENZYME SYSTEMS FOR LIGNOCELLULOSE DEGRADATION, P111; HARVEY PJ, 1986, FEBS LETT, V195, P242, DOI 10.1016/0014-5793(86)80168-5; HARVEY PJ, 1990, J BIOTECHNOL, V13, P169, DOI 10.1016/0168-1656(90)90102-H; HARVEY PJ, 1985, FEBS LETT, V183, P13, DOI 10.1016/0014-5793(85)80943-1; HARVEY PJ, 1987, C INRA, V40, P145; Higuchi T, 1986, WOOD RES, V73, P58; JANSHEKAR H, 1982, ARCH MICROBIOL, V132, P14, DOI 10.1007/BF00690810; KERN HW, 1989, HOLZFORSCHUNG, V43, P375, DOI 10.1515/hfsg.1989.43.6.375; KERSTEN PJ, 1985, J BIOL CHEM, V260, P2609; Kirk T. K., 1980, LIGNIN BIODEGRADATIO, V2; Kirk T.K., 1980, LIGNIN BIODEGRADATIO, V1; KIRK TK, 1986, BIOCHEM J, V236, P279, DOI 10.1042/bj2360279; KONDO R, 1990, J BIOTECHNOL, V13, P181, DOI 10.1016/0168-1656(90)90103-I; KUILA D, 1985, BIOCHEMISTRY-US, V24, P3394, DOI 10.1021/bi00335a002; KUWAHARA M, 1984, FEBS LETT, V169, P247, DOI 10.1016/0014-5793(84)80327-0; LEATHAM GF, 1986, APPL MICROBIOL BIOT, V24, P51, DOI 10.1007/BF00266285; LEISOLA MSA, 1987, J BIOL CHEM, V262, P419; LEISOLA MSA, 1988, CELL CHEM TECHNOL, V22, P267; LEWIS NG, 1987, MACROMOLECULES, V20, P1752, DOI 10.1021/ma00174a006; LEWIS NG, 1990, ANNU REV PLANT PHYS, V41, P455, DOI 10.1146/annurev.pp.41.060190.002323; LYR H, 1962, NATURE, V195, P289, DOI 10.1038/195289a0; MUSHA Y, 1975, WOOD SCI TECHNOL, V9, P45, DOI 10.1007/BF00351914; NEWMAN J, 1986, HOLZFORSCHUNG, V40, P369, DOI 10.1515/hfsg.1986.40.6.369; ODIER E, 1988, BIOCHIMIE, V70, P847, DOI 10.1016/0300-9084(88)90117-4; Putter J., 1974, METHODS ENZYMATIC AN, P685, DOI [DOI 10.1016/B978-0-12-091302-2.50033-5, 10.1016/B978-0-12-091302-2.50033-5]; RENGANATHAN V, 1987, BIOCHEMISTRY-US, V26, P5127, DOI 10.1021/bi00390a035; RENGANATHAN V, 1986, BIOCHEMISTRY-US, V25, P1626, DOI 10.1021/bi00355a027; RENGANATHAN V, 1985, ARCH BIOCHEM BIOPHYS, V241, P304, DOI 10.1016/0003-9861(85)90387-X; ROBERT D, 1989, HOLZFORSCHUNG, V43, P323, DOI 10.1515/hfsg.1989.43.5.323; Ruel K, 1990, BIOTECHNOLOGY PULP P, P83; Saka S., 1985, BIOSYNTHESIS BIODEGR, P51; SARKANEN S, 1991, IN PRESS ACS S SER, V460; SCALBERT A, 1985, PHYTOCHEMISTRY, V24, P1359, DOI 10.1016/S0031-9422(00)81133-4; SCHMIDT HWH, 1989, BIOCHEMISTRY-US, V28, P1776, DOI 10.1021/bi00430a053; SCHOEMAKER HE, 1985, FEBS LETT, V183, P7, DOI 10.1016/0014-5793(85)80942-X; SMITH TL, 1988, NUCLEIC ACIDS RES, V16, P1219, DOI 10.1093/nar/16.3.1219; SREBOTNIK E, 1988, CURR MICROBIOL, V16, P221, DOI 10.1007/BF01568533; TIEN M, 1983, SCIENCE, V221, P661, DOI 10.1126/science.221.4611.661; Tien M, 1987, NATURE, V326, P520, DOI 10.1038/326520a0; TIEN M, 1984, P NATL ACAD SCI-BIOL, V81, P2280, DOI 10.1073/pnas.81.8.2280; UMEZAWA T, 1988, WOOD RES, V75, P21; WALDNER R, 1988, APPL MICROBIOL BIOT, V29, P400, DOI 10.1007/BF00265826; WESTERMARK U, 1974, ACTA CHEM SCAND B, VB 28, P204, DOI 10.3891/acta.chem.scand.28b-0204; WESTERMARK U, 1974, ACTA CHEM SCAND B, VB 28, P209, DOI 10.3891/acta.chem.scand.28b-0209	62	78	79	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3636	3643						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995622				2022-12-25	WOS:A1991EY68200046
J	CHIEN, KY; HUANG, WN; JEAN, JH; WU, WG				CHIEN, KY; HUANG, WN; JEAN, JH; WU, WG			FUSION OF SPHINGOMYELIN VESICLES INDUCED BY PROTEINS FROM TAIWAN COBRA (NAJA-NAJA ATRA) VENOM - INTERACTIONS OF ZWITTERIONIC PHOSPHOLIPIDS WITH CARDIOTOXIN ANALOGS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SEQUENCE; MEMBRANE-FUSION; MOSSAMBICA-MOSSAMBICA; PHOSPHATIDYLSERINE VESICLES; PHASE-TRANSITION; LIPID VESICLES; TOXINS; MECHANISM; KINETICS; DIPALMITOYLPHOSPHATIDYLCHOLINE	Egg sphingomyelin vesicles were used to assay aggregation/fusion activities of proteins from Taiwan (Naja naja atra) venom to avoid the problem of phospholipase A2 contamination during protein purification. It led to the identification of a new cardiotoxin (CTX) analogue protein (CTX V) with major aggregation/fusion, but few hemolysis, activities. On the contrary, cardiotoxin (CTX III) induced significant hemolysis of human red blood cells but exhibited few aggregation/fusion activities. To study the structure/activity relationship of these CTX-induced processes, the amino acid sequence of CTX V was determined and its aggregation/fusion activity was compared with that of CTX III by transmission electron microscopy, quasi-elastic laser light scattering, differential scanning calorimetry, and fluorescence spectroscopy. The results show that the CTX-induced fusion process at temperatures slightly above that of the gel to liquid-crystal-line phase transition of sphingomyelin vesicles can ultimately convert small sonicated vesicles into large fused vesicles with sizes of 1-2-mu-m. The abilities of CTX V to induce the leakage of sphingomyelin vesicles content and to cause the fusion of vesicles are approximately 10-fold higher than those of CTX III. Based on the CTX structures determined in the present and other studies, it is suggested that the amino acid residue X within the well conserved sequence of -Cys-Pro-X-Gly-Lys-Gln-Leu-Cys- plays a role in the interaction of CTX with lipid molecules. The lipid phase transition could further enhance the protein-lipid interaction in the process leading to the fusion of vesicles.	NATL TSING HUA UNIV, INST LIFE SCI, HSINCHU 30043, TAIWAN	National Tsing Hua University								BARENHOLZ Y, 1977, BIOCHEMISTRY-US, V16, P2806, DOI 10.1021/bi00631a035; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BATENBURG AM, 1985, BIOCHEMISTRY-US, V24, P7101, DOI 10.1021/bi00346a013; BLUMENTHAL R, 1987, CURR TOP MEMBR TRANS, V29, P203; BOUGIS P, 1981, BIOCHEMISTRY-US, V20, P4915, DOI 10.1021/bi00520a017; BOUGIS P, 1983, MOL CELL BIOCHEM, V55, P49, DOI 10.1007/BF00229242; BOUGIS PE, 1986, BIOCHEMISTRY-US, V25, P7235, DOI 10.1021/bi00370a070; CHANGEUX JP, 1984, SCIENCE, V225, P1335, DOI 10.1126/science.6382611; CHEN YH, 1981, BIOCHEM INT, V3, P385; CONDREA E, 1965, EXPERIENTIA, V15, P461; Drapeau G R, 1976, Methods Enzymol, V45, P469; DUFOURCQ J, 1982, TOXICON, V20, P165, DOI 10.1016/0041-0101(82)90187-8; DUFTON MJ, 1988, PHARMACOL THERAPEUT, V36, P1, DOI 10.1016/0163-7258(88)90111-8; DUZGUNES N, 1987, BIOCHEMISTRY-US, V26, P8435, DOI 10.1021/bi00399a061; GENZ A, 1986, BIOPHYS J, V50, P1043, DOI 10.1016/S0006-3495(86)83548-2; GROGNET JM, 1988, EUR J BIOCHEM, V172, P383, DOI 10.1111/j.1432-1033.1988.tb13898.x; GULIKKRZYWICKI T, 1981, BIOCHIM BIOPHYS ACTA, V643, P101, DOI 10.1016/0005-2736(81)90222-4; HARVEY AL, 1985, J TOXICOL-TOXIN REV, V4, P41, DOI 10.3109/15569548509014413; HAYASHI K, 1975, BIOCHEM BIOPH RES CO, V64, P360, DOI 10.1016/0006-291X(75)90262-4; HAYASHI K, 1976, FEBS LETT, V66, P210, DOI 10.1016/0014-5793(76)80506-6; HODGES SJ, 1987, EUR J BIOCHEM, V165, P373, DOI 10.1111/j.1432-1033.1987.tb11450.x; HONG K, 1987, CELL FUSION, P269; HSEU TH, 1977, BIOCHEMISTRY-US, V16, P2999, DOI 10.1021/bi00632a030; HUANG CH, 1969, BIOCHEMISTRY-US, V8, P344, DOI 10.1021/bi00829a048; JOUBERT FJ, 1976, EUR J BIOCHEM, V64, P219, DOI 10.1111/j.1432-1033.1976.tb10291.x; KANEDA N, 1977, BIOCHIM BIOPHYS ACTA, V491, P53, DOI 10.1016/0005-2795(77)90040-X; KANTOR HL, 1975, BIOCHEMISTRY-US, V14, P1790, DOI 10.1021/bi00679a035; KLAUSNER RD, 1985, J BIOL CHEM, V260, P3719; KUMAR N, 1981, J BIOL CHEM, V256, P5886; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEE CY, 1968, N-S ARCH PHARMAKOL, V259, P360, DOI 10.1007/BF00536909; LEE CY, 1972, ANNU REV PHARMACOLOG, V12, P265, DOI 10.1146/annurev.pa.12.040172.001405; LEE CY, 1979, HDB EXPT PHARM, V52; LO TB, 1966, J CHIN CHEM SOC-TAIP, V13, P25, DOI 10.1002/jccs.196600004; LOUW AI, 1977, BIOCHIM BIOPHYS ACTA, V498, P143, DOI 10.1016/0304-4165(77)90095-2; LOUW AI, 1974, BIOCHEM BIOPH RES CO, V58, P1022, DOI 10.1016/S0006-291X(74)80246-9; LOUW AI, 1978, BIOCHIM BIOPHYS ACTA, V512, P163, DOI 10.1016/0005-2736(78)90227-4; LOUW AI, 1974, BIOCHIM BIOPHYS ACTA, V336, P470, DOI 10.1016/0005-2795(74)90428-0; LOYTER A, 1988, METHOD BIOCHEM ANAL, V33, P129; LUCY JA, 1986, FEBS LETT, V199, P1, DOI 10.1016/0014-5793(86)81213-3; MAEZAWA S, 1989, BIOCHEMISTRY-US, V28, P1422, DOI 10.1021/bi00429a071; PAGANO RE, 1981, BIOCHEMISTRY-US, V20, P4920, DOI 10.1021/bi00520a018; PETERSSON GL, 1977, ANAL BIOCHEM, V83, P345; REES B, 1990, J MOL BIOL, V214, P281, DOI 10.1016/0022-2836(90)90161-E; REES B, 1987, P NATL ACAD SCI USA, V84, P3132, DOI 10.1073/pnas.84.10.3132; STEINMETZ WE, 1988, EUR J BIOCHEM, V172, P101, DOI 10.1111/j.1432-1033.1988.tb13861.x; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; SUURKUUSK J, 1976, BIOCHEMISTRY-US, V15, P1393, DOI 10.1021/bi00652a007; TAKECHI M, 1987, BIOCHEM INT, V14, P145; TAKECHI M, 1985, BIOCHEM INT, V11, P795; TU AT, 1973, ANNU REV BIOCHEM, V42, P235, DOI 10.1146/annurev.bi.42.070173.001315; VANDENBOSCH H, 1980, BIOCHIM BIOPHYS ACTA, V604, P191; VINCENT JP, 1978, FEBS LETT, V85, P103, DOI 10.1016/0014-5793(78)81258-7; VINCENT JP, 1976, BIOCHEMISTRY-US, V15, P3171; WHITE J, 1983, Q REV BIOPHYS, V16, P151, DOI 10.1017/S0033583500005072; WILSCHUT J, 1980, BIOCHEMISTRY-US, V19, P6011, DOI 10.1021/bi00567a011; WILSCHUT J, 1981, BIOCHEMISTRY-US, V20, P3126, DOI 10.1021/bi00514a022; YANG CC, 1981, TOXICON, V19, P645, DOI 10.1016/0041-0101(81)90102-1	58	74	75	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3252	3259						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993698				2022-12-25	WOS:A1991EX60000088
J	METZELAAR, MJ; WIJNGAARD, PLJ; PETERS, PJ; SIXMA, JJ; NIEUWENHUIS, HK; CLEVERS, HC				METZELAAR, MJ; WIJNGAARD, PLJ; PETERS, PJ; SIXMA, JJ; NIEUWENHUIS, HK; CLEVERS, HC			CD63-ANTIGEN - A NOVEL LYSOSOMAL MEMBRANE GLYCOPROTEIN, CLONED BY A SCREENING-PROCEDURE FOR INTRACELLULAR ANTIGENS IN EUKARYOTIC CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MELANOMA-ASSOCIATED ANTIGEN; MONOCLONAL-ANTIBODY; MOLECULAR-CLONING; FIXED TISSUE; PROTEIN; EXPRESSION; CDNA; IDENTIFICATION; SEQUENCE; GLYCOSYLATION	To clone the CD63 antigen, originally described as a blood platelet activation marker, we adapted the expression cloning procedure of Seed and Aruffo (Seed, B., and Aruffo, A. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 3365-3369) to allow cloning of intracellular antigens. A megakaryocyte expression of cDNA library was transiently transfected into MOP-8 mouse fibroblasts cultured on polyvinylidene difluoride membranes. Individual cells expressing intracellular CD63 were identified by autoradiography. cDNA was extracted from positive spots and reintroduced into Escherichia coli. After two screening rounds, a CD63 cDNA clone was isolated as assessed by immunofluorescence and Western blot analysis. The single long open reading frame of 238 amino acids contained four putative transmembrane regions and three N-glycosylation sites. The CD63 gene was expressed in a wide variety of cells. Surprisingly, CD63 was identical to ME491, an antigen reported as a melanoma-associated antigen (Hotta, H., Ross, A. H., Huebner, K., Isobe, M., Wendeborn, S., Chao, M. V., Ricciardi, R. P., Tsujimoto, Y., Croce, C. M., and Koprowski, H. (1988) Cancer Res. 48, 2955-2962). By immunoelectron microscopy, co-localization with the lysosomal glycoproteins lamp-1 and -2 identified CD63 as a novel lysosomal membrane glycoprotein. CD63 was not related to the lysosomal glycoprotein family but contained the putative lysosomal targeting signal Gly-Tyr in its short cytoplasmic tail.	STATE UNIV UTRECHT,SCH MED,CTR ENDOCRINOL & METAB,CELL BIOL LAB,3508 GA UTRECHT,NETHERLANDS; STATE UNIV UTRECHT HOSP,DEPT CLIN IMMUNOL,3511 GV UTRECHT,NETHERLANDS	Utrecht University; Utrecht University; Utrecht University Medical Center	METZELAAR, MJ (corresponding author), STATE UNIV UTRECHT HOSP,DEPT HAEMATOL,POB 85500,3511 GV UTRECHT,NETHERLANDS.							ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; ATKINSON B, 1984, CANCER RES, V44, P2577; ATKINSON B, 1985, HYBRIDOMA, V4, P243, DOI 10.1089/hyb.1985.4.243; BARRIOCANAL JG, 1986, J BIOL CHEM, V261, P6755; CARLSSON SR, 1988, J BIOL CHEM, V263, P18911; CHEN JW, 1988, J BIOL CHEM, V263, P8754; ERNST CS, 1986, J NATL CANCER I, V77, P387; FEBBRAIO M, 1989, J CELL BIOL, V109, P254; FUKUDA M, 1988, J BIOL CHEM, V263, P18920; GEUZE HJ, 1988, J CELL BIOL, V107, P2491, DOI 10.1083/jcb.107.6.2491; GRUTERS RA, 1989, CANCER RES, V49, P459; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; HOLMSEN H, 1981, Acta Medica Romana, V19, P419; HOTTA H, 1988, CANCER RES, V48, P2955; HOWE CL, 1988, P NATL ACAD SCI USA, V85, P7577, DOI 10.1073/pnas.85.20.7577; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; MARSH M, 1987, J CELL BIOL, V104, P875, DOI 10.1083/jcb.104.4.875; METZELAAR MJ, 1989, LEUKOCYTE TYPING, V4, P1039; MODDERMAN PW, 1989, LEUKOCYTE TYPING, V4, P1042; MULLER WJ, 1984, MOL CELL BIOL, V4, P2406, DOI 10.1128/MCB.4.11.2406; NEEFJES JJ, 1988, EUR J IMMUNOL, V18, P801, DOI 10.1002/eji.1830180522; NIEUWENHUIS HK, 1987, BLOOD, V70, P838; OGURA M, 1985, BLOOD, V66, P1384; PETERS C, 1990, EMBO J, V9, P3497, DOI 10.1002/j.1460-2075.1990.tb07558.x; POHLMANN R, 1988, EMBO J, V7, P2343, DOI 10.1002/j.1460-2075.1988.tb03078.x; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; SIKORA LKJ, 1987, INT J CANCER, V39, P138, DOI 10.1002/ijc.2910390203; SLOT JW, 1988, METHOD MICROBIOL, V20, P211, DOI 10.1016/S0580-9517(08)70053-9; TOKUYASU KT, 1978, J ULTRA MOL STRUCT R, V63, P287, DOI 10.1016/S0022-5320(78)80053-7; VENNEGOOR C, 1985, INT J CANCER, V35, P287, DOI 10.1002/ijc.2910350302; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WILLIAMS MA, 1990, J CELL BIOL, V111, P955, DOI 10.1083/jcb.111.3.955; WYSOCKI LJ, 1978, P NATL ACAD SCI USA, V75, P2844, DOI 10.1073/pnas.75.6.2844	41	363	378	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3239	3245						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993697				2022-12-25	WOS:A1991EX60000086
J	NISHIZAWA, K; YANO, T; SHIBATA, M; ANDO, S; SAGA, S; TAKAHASHI, T; INAGAKI, M				NISHIZAWA, K; YANO, T; SHIBATA, M; ANDO, S; SAGA, S; TAKAHASHI, T; INAGAKI, M			SPECIFIC LOCALIZATION OF PHOSPHOINTERMEDIATE FILAMENT PROTEIN IN THE CONSTRICTED AREA OF DIVIDING CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE FILAMENTS; MITOTIC CELLS; HEAD DOMAIN; VIMENTIN FILAMENTS; MAMMALIAN-CELLS; KINASE-A; PHOSPHORYLATION; MITOSIS; INVITRO; DESMIN	We developed antibodies pG1 and pG2 which recognize glial fibrillary acidic protein (GFAP) in its phosphorylated state. Antibodies pG1 and pG2 were produced against two synthetic peptides, Arg-Arg-Arg-Val-Thr-phosphoSer-Ala-Ala-Arg-Arg-phosphoSer (residues 3-13) and Pro-Gly-Pro-Arg-Leu-phosphoSer-Leu-Ala-Arg-Met-Pro (residues 29-39), respectively. The phosphorylation of these serine residues on the intact GFAP induces disassembly of glial filaments in vitro (Inagaki, M., Gonda, Y., Nishizawa, K., Kitamura, S., Sato, C., Ando, S., Tanabe, K., Kikuchi, K., Tsuiki, S., and Nishi, Y. (1990) J. Biol. Chem. 265, 4722-4729). Immunofluorescence and immunoblotting studies demonstrate that both antibodies react specifically with mitotic astroglial cells, thereby supporting the notion that increased phosphorylation during mitosis may directly influence intracellular organization of the glial filaments. The specific distribution pattern of the phosphoGFAP in the mitotic cells reveals that site-specific phosphorylation events may make way for the locally controlled breakdown of glial filaments in the constricted area, before the final separation of daughter cells.	AICHI CANC CTR,RES INST,EXPTL RADIOL LAB,CHIKUSA KU,NAGOYA,AICHI 464,JAPAN; AICHI CANC CTR,RES INST,ASTROCHEM UNIT,NAGOYA,AICHI 464,JAPAN; AICHI CANC CTR,RES INST,IMMUNOL LAB,NAGOYA,AICHI 464,JAPAN; MED LAB,INA,NAGANO 396,JAPAN; BIOL LAB,INA,NAGANO 396,JAPAN; NAGOYA UNIV,SCH MED,DEPT PATHOL,NAGOYA,AICHI 466,JAPAN	Aichi Cancer Center; Aichi Cancer Center; Aichi Cancer Center; Nagoya University			Inagaki, Masaki/B-9920-2016					ANDO S, 1989, BIOCHEMISTRY-US, V28, P2974, DOI 10.1021/bi00433a035; AUBIN JE, 1980, EXP CELL RES, V129, P149, DOI 10.1016/0014-4827(80)90340-7; Beavo J A, 1974, Methods Enzymol, V38, P299; BLOSE SH, 1982, EXP CELL RES, V142, P57, DOI 10.1016/0014-4827(82)90408-6; BLOSE SH, 1976, J CELL BIOL, V70, P459, DOI 10.1083/jcb.70.2.459; CELIS JE, 1983, J CELL BIOL, V97, P1429, DOI 10.1083/jcb.97.5.1429; CHOU YH, 1989, P NATL ACAD SCI USA, V86, P1885, DOI 10.1073/pnas.86.6.1885; CHOU YH, 1990, CELL, V62, P1063, DOI 10.1016/0092-8674(90)90384-Q; COLBRAN RJ, 1989, BIOCHEM J, V258, P313, DOI 10.1042/bj2580313; DEBUS E, 1983, DIFFERENTIATION, V25, P193, DOI 10.1111/j.1432-0436.1984.tb01355.x; DUNPHY WG, 1988, CELL, V55, P925, DOI 10.1016/0092-8674(88)90234-6; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; EVANS RM, 1988, FEBS LETT, V234, P73, DOI 10.1016/0014-5793(88)81306-1; EVANS RM, 1988, EUR J CELL BIOL, V46, P152; EVANS RM, 1984, J BIOL CHEM, V259, P5372; EVANS RM, 1989, J CELL BIOL, V108, P67, DOI 10.1083/jcb.108.1.67; EVANS RM, 1982, CELL, V29, P43, DOI 10.1016/0092-8674(82)90088-5; FRANKE WW, 1982, CELL, V30, P103, DOI 10.1016/0092-8674(82)90016-2; FRANKE WW, 1983, J CELL BIOL, V97, P1255, DOI 10.1083/jcb.97.4.1255; GEISLER N, 1989, EUR J BIOCHEM, V183, P441, DOI 10.1111/j.1432-1033.1989.tb14947.x; GEISLER N, 1988, EMBO J, V7, P15, DOI 10.1002/j.1460-2075.1988.tb02778.x; GERACE L, 1980, CELL, V19, P277, DOI 10.1016/0092-8674(80)90409-2; GONDA Y, 1990, BIOCHEM BIOPH RES CO, V167, P1316, DOI 10.1016/0006-291X(90)90667-C; GREEN N, 1982, CELL, V28, P477, DOI 10.1016/0092-8674(82)90202-1; HISANAGA S, 1990, CELL REGUL, V1, P237, DOI 10.1091/mbc.1.2.237; HORWITZ B, 1981, EXP CELL RES, V134, P281, DOI 10.1016/0014-4827(81)90427-4; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; INAGAKI M, 1985, J BIOL CHEM, V260, P2922; INAGAKI M, 1990, J BIOL CHEM, V265, P4722; INAGAKI M, 1987, NATURE, V328, P649, DOI 10.1038/328649a0; INAGAKI M, 1988, J BIOL CHEM, V263, P5970; JONES JCR, 1985, J CELL BIOL, V100, P93, DOI 10.1083/jcb.100.1.93; KITAMURA S, 1989, J BIOL CHEM, V264, P5674; LANE EB, 1982, EMBO J, V1, P1365, DOI 10.1002/j.1460-2075.1982.tb01324.x; LOHKA MJ, 1989, J CELL SCI, V92, P131; MEYER HE, 1986, FEBS LETT, V204, P61, DOI 10.1016/0014-5793(86)81388-6; NORBURY CJ, 1989, BIOCHIM BIOPHYS ACTA, V989, P85, DOI 10.1016/0304-419X(89)90036-X; STULL JT, 1977, J BIOL CHEM, V252, P851; TOKUI T, 1990, BIOCHEM BIOPH RES CO, V169, P896, DOI 10.1016/0006-291X(90)91977-Z; TOLLE HG, 1987, EUR J CELL BIOL, V43, P35; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WARD GE, 1990, CELL, V61, P561, DOI 10.1016/0092-8674(90)90469-U; WESTWOOD JT, 1985, J BIOL CHEM, V260, P308; ZACKROFF RV, 1979, P NATL ACAD SCI USA, V76, P6226, DOI 10.1073/pnas.76.12.6226; ZIEVE GW, 1980, J CELL BIOL, V87, P160, DOI 10.1083/jcb.87.1.160; ZIEVE GW, 1980, EXP CELL RES, V126, P397, DOI 10.1016/0014-4827(80)90279-7	46	99	99	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3074	3079						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993680				2022-12-25	WOS:A1991EX60000062
J	SOM, S; FRIEDMAN, S				SOM, S; FRIEDMAN, S			IDENTIFICATION OF A HIGHLY CONSERVED DOMAIN IN THE ECORII METHYLTRANSFERASE WHICH CAN BE PHOTOLABELED WITH S-ADENOSYL-L-[METHYL-H-3]METHIONINE - EVIDENCE FOR UV-INDUCED TRANSMETHYLATION OF CYSTEINE-186	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLEAVAGE; SEQUENCE; ENZYME	DNA methyltransferases can be photolabeled with S-adenosyl-L-methionine (AdoMet). Specific incorporation of radioactivity has been demonstrated after photolabeling with either [methyl-H-3]AdoMet or [S-35]AdoMet (Som, S., and Friedman, S. (1990) J. Biol. Chem. 265, 4278-4283). The labeling is believed to occur at the AdoMet binding site. With the purpose of localizing the site responsible for [methyl-H-3]AdoMet photolabeling, we cleaved the labeled EcoRII methyltransferase by chemical and enzymatic reactions and isolated the radiolabeled peptides by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and high pressure liquid chromatography. The labeled peptides were identified by amino-terminal sequencing. A common region was localized which accounted for 65-70% of the total label. This region includes a highly conserved core sequence present in all DNA (cytosine 5)-methyltransferases. One such fragment was digested further with chymotrypsin, and amino acid analysis of the resulting H-3-labeled peptide was consistent with the sequence Ala-Gly-Phe-Pro-(Cys)-Gln-Pro-Phe-Ser-Leu. However, the cysteine residue was not recovered as carboxymethylcysteine. The Pro-Cys bond was found to be protected from cleavage at cysteine residues after cyanylation. These results suggest that the cysteine residue is modified by the labeling reaction. The chymotryptic fragment was hydrolyzed enzymatically to single amino acids, and the labeled amino acid was identified as S-methylcysteine by thin layer chromatography. These results indicate that the cysteine residue is located at or close to the AdoMet binding site of EcoRII methyltransferase.	SUNY HLTH SCI CTR, DEPT PHARMACOL, BOX 29, 450 CLARKSON AVE, BROOKLYN, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center					PHS HHS [27787] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		DEMPLE B, 1985, P NATL ACAD SCI USA, V82, P2688, DOI 10.1073/pnas.82.9.2688; FONTANA A, 1983, METHOD ENZYMOL, V91, P311; Gracy R W, 1977, Methods Enzymol, V47, P195; Gros E., 1967, METHOD ENZYMOL, V11, P238; KIERDASZUK B, 1988, BIOCHEMISTRY-US, V27, P4952, DOI 10.1021/bi00413a054; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landon, 1977, Methods Enzymol, V47, P145; LAUSTER R, 1989, J MOL BIOL, V206, P305, DOI 10.1016/0022-2836(89)90480-4; MCLAREN AD, 1964, PHOTOCHEMISTRY PROTE, P99; POSFAI J, 1989, NUCLEIC ACIDS RES, V17, P2421, DOI 10.1093/nar/17.7.2421; SEDGWICK B, 1988, J BIOL CHEM, V263, P4430; SMITH KC, 1966, BIOCHEMISTRY-US, V5, P2125, DOI 10.1021/bi00870a046; SOM S, 1987, NUCLEIC ACIDS RES, V15, P313, DOI 10.1093/nar/15.1.313; SOM S, 1990, J BIOL CHEM, V265, P4278; Stark G R, 1977, Methods Enzymol, V47, P129; SWANK RT, 1971, ANAL BIOCHEM, V39, P462, DOI 10.1016/0003-2697(71)90436-2; VARGHESE AJ, 1973, BIOCHEMISTRY-US, V12, P2725, DOI 10.1021/bi00738a027; WU JC, 1987, J BIOL CHEM, V262, P4778	18	49	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2937	2945						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993667				2022-12-25	WOS:A1991EX60000044
J	ZILLIACUS, J; DAHLMANWRIGHT, K; WRIGHT, A; GUSTAFSSON, JA; CARLSTEDTDUKE, J				ZILLIACUS, J; DAHLMANWRIGHT, K; WRIGHT, A; GUSTAFSSON, JA; CARLSTEDTDUKE, J			DNA-BINDING SPECIFICITY OF MUTANT GLUCOCORTICOID RECEPTOR DNA-BINDING DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RESPONSIVE ELEMENT; TARGET GENE SPECIFICITY; FUNCTIONAL DOMAINS; HORMONE RECEPTOR; AMINO-ACIDS; ZINC FINGER; ACTIVATION; TRANSCRIPTION; EXPRESSION; ENHANCER	Mutation of a small number of amino acids in the DNA-binding domain of the estrogen receptor to the corresponding sequence of the glucocorticoid receptor switches the specificity of the receptor in transactivation assays (Mader, S., Kumar, V., de Verneuil, H., and Chambon, P. (1989) Nature 338, 271-274). We have made the corresponding reciprocal mutations in the context of the glucocorticoid receptor DNA-binding domain and studied the binding of wild type and mutant purified proteins to palindromic glucocorticoid and estrogen response elements as well as to elements of intermediate sequence, using gel mobility shift assays. We show here that a protein with two altered amino acids binds glucocorticoid and estrogen response elements with a low but equal affinity, whereas a protein with an additional changed residue has a high affinity for estrogen response elements but still retains a considerable affinity for glucocorticoid response elements. Using binding sites of intermediate sequence we have further characterized the interaction with DNA. The in vitro DNA binding results are confirmed by in vivo transactivation assays in yeast. Finally we suggest a testable model for amino acid/base pair interactions involved in recognition by the glucocorticoid receptor DNA-binding domain of its target sequence.	KAROLINSKA INST,HUDDINGE UNIV HOSP F60,NOVUM,CTR BIOTECHNOL,S-14186 HUDDINGE,SWEDEN	Karolinska Institutet	ZILLIACUS, J (corresponding author), KAROLINSKA INST,HUDDINGE UNIV HOSP F60,NOVUM,DEPT MED NUTR,S-14186 HUDDINGE,SWEDEN.		Wright, Anthony PH/J-8187-2015					BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; CARLSTEDTDUKE J, 1982, P NATL ACAD SCI-BIOL, V79, P4260, DOI 10.1073/pnas.79.14.4260; CARLSTEDTDUKE J, 1987, P NATL ACAD SCI USA, V84, P4437, DOI 10.1073/pnas.84.13.4437; DAHLMAN K, 1989, J BIOL CHEM, V264, P804; DAHLMANWRIGHT K, 1990, J BIOL CHEM, V265, P14030; DANIELSEN M, 1987, MOL ENDOCRINOL, V1, P816, DOI 10.1210/mend-1-11-816; DANIELSEN M, 1989, CELL, V57, P1131, DOI 10.1016/0092-8674(89)90050-0; DENIS M, 1988, J BIOL CHEM, V263, P18520; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FREEDMAN LP, 1988, NATURE, V334, P543, DOI 10.1038/334543a0; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; GODOWSKI PJ, 1988, SCIENCE, V241, P812, DOI 10.1126/science.3043662; GREEN JBA, 1988, MOL GEN GENET, V215, P100, DOI 10.1007/BF00331310; GREEN S, 1987, NATURE, V325, P75, DOI 10.1038/325075a0; GREEN S, 1988, EMBO J, V7, P3037, DOI 10.1002/j.1460-2075.1988.tb03168.x; GUSTAFSSON JA, 1987, ENDOCR REV, V8, P185, DOI 10.1210/edrv-8-2-185; HAM J, 1988, NUCLEIC ACIDS RES, V16, P5263, DOI 10.1093/nar/16.12.5263; HARD T, 1990, SCIENCE, V249, P157, DOI 10.1126/science.2115209; HARD T, 1990, BIOCHEMISTRY-US, V29, P5358; HOLLENBERG SM, 1987, CELL, V49, P39, DOI 10.1016/0092-8674(87)90753-7; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; KLEINHITPASS L, 1986, CELL, V46, P1053, DOI 10.1016/0092-8674(86)90705-1; KLOCK G, 1987, NATURE, V329, P734, DOI 10.1038/329734a0; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; KUMAR V, 1986, EMBO J, V5, P2231, DOI 10.1002/j.1460-2075.1986.tb04489.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MADER S, 1989, NATURE, V338, P271, DOI 10.1038/338271a0; MARTINEZ E, 1987, EMBO J, V6, P3719, DOI 10.1002/j.1460-2075.1987.tb02706.x; MIESFELD R, 1987, SCIENCE, V236, P423, DOI 10.1126/science.3563519; OMALLEY B, 1990, MOL ENDOCRINOL, V4, P363, DOI 10.1210/mend-4-3-363; PICARD D, 1987, EMBO J, V6, P333; PRATT WB, 1988, J BIOL CHEM, V263, P267; RUSCONI S, 1987, EMBO J, V6, P1309, DOI 10.1002/j.1460-2075.1987.tb02369.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHENA M, 1989, GENE DEV, V3, P1590, DOI 10.1101/gad.3.10.1590; SCHENA M, 1988, SCIENCE, V241, P965, DOI 10.1126/science.3043665; SEILERTUYNS A, 1986, NUCLEIC ACIDS RES, V14, P8755, DOI 10.1093/nar/14.22.8755; SHERMAN F, 1986, LABORATORY COURSE MA; STRAHLE U, 1987, P NATL ACAD SCI USA, V84, P7871, DOI 10.1073/pnas.84.22.7871; TSAI SY, 1988, CELL, V55, P361, DOI 10.1016/0092-8674(88)90059-1; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; WEBSTER NJG, 1988, CELL, V54, P199, DOI 10.1016/0092-8674(88)90552-1; WRANGE O, 1978, J BIOL CHEM, V253, P856; WRIGHT APH, 1990, J BIOL CHEM, V265, P14763; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209	46	44	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3101	3106						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993682				2022-12-25	WOS:A1991EX60000065
J	DUCLOS, TW; ZLOCK, LT; MARNELL, L				DUCLOS, TW; ZLOCK, LT; MARNELL, L			DEFINITION OF A C-REACTIVE PROTEIN-BINDING DETERMINANT ON HISTONES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTE CHROMATIN; COMPLEMENT-SYSTEM; LOCALIZATION; H-1; POLYSACCHARIDE; POLYCATIONS; SPECIFICITY; CONSUMPTION; OPERATION; MOLECULE	C-reactive protein (CRP) is an acute phase inflammatory protein in man which binds to phosphocholine, chromatin, histones, and the 70-kDa protein of the U1 small nuclear ribonucleoprotein particle in a calcium-dependent, phosphocholine-inhibitable manner. CRP also binds to other proteins including fibronectin. The determinants involved in CRP binding to these diverse proteins have not been identified. The binding of CRP to histones was examined as these proteins are available in large quantity at high purity and subject to protease digestion with well characterized products. Histone H1 was digested with thrombin and trypsin to produce three distinct fragments, N-terminal, central globular, and C-terminal. CRP was shown only to bind to the C-terminal fragment. Binding to histone H2A was also examined. CRP binding was not diminished by cleavage of the C-terminal fragment but was greatly decreased when the central globular region of H2A was tested. Peptides were prepared to be identical to the N- and C-terminal fragments of H2A. The N-terminal (15 amino acid) fragment of H2A blocked CRP-induced precipitation of phosphocholine-coupled bovine serum albumin and histone H2A, whereas the C-terminal fragment showed no inhibition. Thus we have defined the first reported CRP binding determinant on a protein.	UNIV NEW MEXICO,ALBUQUERQUE,NM 87131	University of New Mexico	DUCLOS, TW (corresponding author), VET ADM MED CTR,2100 RIDGECREST DR SE,ALBUQUERQUE,NM 87108, USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR005583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007173] Funding Source: NIH RePORTER; NCRR NIH HHS [SO7 RR-05583-24] Funding Source: Medline; NIAMS NIH HHS [5T32AR07-173] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALLAN J, 1986, J MOL BIOL, V187, P591, DOI 10.1016/0022-2836(86)90337-2; BOHM L, 1984, BIOSCIENCE REP, V4, P365, DOI 10.1007/BF01122502; CHAPMAN GE, 1976, EUR J BIOCHEM, V61, P69, DOI 10.1111/j.1432-1033.1976.tb09998.x; CHESEBRO B, 1972, BIOCHEMISTRY-US, V11, P766, DOI 10.1021/bi00755a014; DICAMELLI R, 1980, J IMMUNOL, V125, P1933; DUCLOS TW, 1988, J IMMUNOL, V141, P4266; DUCLOS TW, 1990, J IMMUNOL, V145, P3869; DUCLOS TW, 1981, CLIN EXP IMMUNOL, V43, P565; DUCLOS TW, 1989, J IMMUNOL, V143, P2553; EICKBUSH TH, 1976, CELL, V9, P785, DOI 10.1016/0092-8674(76)90141-0; ELIA MC, 1988, J BIOL CHEM, V263, P9958; GITLIN JD, 1977, ARTHRITIS RHEUM, V20, P1491, DOI 10.1002/art.1780200808; HARDIN JA, 1983, P NATL ACAD SCI-BIOL, V80, P7410, DOI 10.1073/pnas.80.24.7410; HARTMAN PG, 1977, EUR J BIOCHEM, V77, P45, DOI 10.1111/j.1432-1033.1977.tb11639.x; HOFFMANN P, 1978, METHODS CELL BIOL CH, V2, P1; JOHNS EW, 1964, BIOCHEM J, V92, P55, DOI 10.1042/bj0920055; KAPLAN MH, 1974, J IMMUNOL, V112, P2135; KUSHNER I, 1961, J EXP MED, V114, P961, DOI 10.1084/jem.114.6.961; MILETICH JP, 1981, METHOD ENZYMOL, V80, P221; MOLD C, 1981, J IMMUNOL, V126, P856; MOLD C, 1981, J EXP MED, V154, P1703, DOI 10.1084/jem.154.5.1703; MORAN F, 1985, BIOPHYS CHEM, V22, P125, DOI 10.1016/0301-4622(85)80033-8; MORTENSEN RF, 1976, J IMMUNOL, V117, P774; NAKAYAMA S, 1982, J IMMUNOL, V128, P2435; OLIVEIRA EB, 1980, J IMMUNOL, V124, P1396; OTTER T, 1987, ANAL BIOCHEM, V162, P370, DOI 10.1016/0003-2697(87)90406-4; POTEMPA LA, 1981, J IMMUNOL, V127, P1509; ROBEY FA, 1984, J BIOL CHEM, V259, P7311; SALONEN EM, 1984, J BIOL CHEM, V259, P1496; SHEPHARD EG, 1986, IMMUNOLOGY, V58, P489; SIEGEL J, 1974, J EXP MED, V140, P631, DOI 10.1084/jem.140.3.631; SWANSON SJ, 1989, J CELL BIOCHEM, V40, P121, DOI 10.1002/jcb.240400112; THOMAS JO, 1975, P NATL ACAD SCI USA, V72, P2626, DOI 10.1073/pnas.72.7.2626; TILLETT WILLIAM S., 1930, JOUR EXP MED, V52, P561, DOI 10.1084/jem.52.4.561; VOLANAKI.JE, 1971, P SOC EXP BIOL MED, V136, P612; WU RS, 1986, CRIT REV BIOCHEM MOL, V20, P201, DOI 10.3109/10409238609083735	36	57	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2167	2171						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989977				2022-12-25	WOS:A1991EV51500026
J	KOIVISTO, UM; MARTINEZVALDEZ, H; BILAN, PJ; BURDETT, E; RAMLAL, T; KLIP, A				KOIVISTO, UM; MARTINEZVALDEZ, H; BILAN, PJ; BURDETT, E; RAMLAL, T; KLIP, A			DIFFERENTIAL REGULATION OF THE GLUT-1 AND GLUT-4 GLUCOSE-TRANSPORT SYSTEMS BY GLUCOSE AND INSULIN IN L6 MUSCLE-CELLS IN CULTURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SKELETAL-MUSCLE; MESSENGER-RNA; SUGAR-TRANSPORT; ADIPOSE-CELLS; HEXOSE UPTAKE; DEPENDENT REGULATION; TISSUE DISTRIBUTION; EMBRYO FIBROBLASTS; RESPONSIVE TISSUES; 3T3-L1 ADIPOCYTES	The regulation by glucose and insulin of the muscle-specific facilitative glucose transport system GLUT-4 was in investigated in L6 muscle cells in culture. Hexose transport activity, mRNA expression, and the subcellular localization of the GLUT-4 protein were analyzed. As observed previously (Walker, P. S., Ramlal, T., Sarabia, V., Koivisto, U.-M., Bilan, P. J., Pessin, J. E., and Klip, A. (1990) J. Biol. Chem, 265, 1516-1523), 24 h of glucose starvation and 24 h of insulin treatment each increase glucose transport activity severalfold. Here we report a differential regulation of the GLUT-4 and GLUT-1 transport systems under these conditions. (a) The level of GLUT-4 mRNA was not affected by glucose starvation and was diminished by prolonged (24 h) administration of insulin; in contrast, the level of GLUT-1 mRNA was elevated under both conditions. (b) Glucose starvation and prolonged insulin administration increased the amount of both GLUT-4 and GLUT-1 proteins in the plasma membrane. (c) In intracellular membranes, glucose starvation elevated, and prolonged insulin administration reduced, the GLUT-4 protein content. In contrast, the GLUT-1 protein content in these membranes decreased with glucose starvation and increased with insulin treatment. Glucose transport was rapidly curbed upon refeeding glucose to glucose-starved cells, with half-maximal reversal after 30 min and maximal reversal after 4 h. This was followed by a marked decrease in the levels of GLUT-1 mRNA without major changes in GLUT-4 mRNA. Neither 2-deoxy-D-glucose nor 3-O-methyl-D-glucose could substitute for D-glucose in these effects. It is proposed that glucose and insulin differentially regulate the two glucose transport systems in L6 muscle cells and that the rapid down-regulation of hexose transport activity by glucose is regulated by posttranslational mechanisms.	HOSP SICK CHILDREN,DEPT CELL BIOL,TORONTO M5G 1X8,ONTARIO,CANADA; HOSP SICK CHILDREN,DEPT IMMUNOL & RHEUMATOL,TORONTO M5G 1X8,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)								ASANO T, 1988, BIOCHEM BIOPH RES CO, V154, P1204, DOI 10.1016/0006-291X(88)90268-9; BELL GI, 1990, DIABETES CARE, V13, P198, DOI 10.2337/diacare.13.3.198; BERGER J, 1989, NATURE, V340, P70, DOI 10.1038/340070a0; BIRNBAUM MJ, 1986, P NATL ACAD SCI USA, V83, P5784, DOI 10.1073/pnas.83.16.5784; BIRNBAUM MJ, 1989, CELL, V57, P306; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURDETT E, 1988, BIOCHEM CELL BIOL, V66, P1126, DOI 10.1139/o88-130; CHARRON MJ, 1989, P NATL ACAD SCI USA, V86, P2535, DOI 10.1073/pnas.86.8.2535; CHARRON MJ, 1990, J BIOL CHEM, V265, P7994; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTOPHER CW, 1976, P NATL ACAD SCI USA, V73, P2429, DOI 10.1073/pnas.73.7.2429; CUSIN I, 1990, BIOCHEM J, V267, P99, DOI 10.1042/bj2670099; DOUEN AG, 1990, FEBS LETT, V261, P256, DOI 10.1016/0014-5793(90)80566-2; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FLIER JS, 1987, J CLIN INVEST, V79, P657, DOI 10.1172/JCI112864; FUKUMOTO H, 1989, J BIOL CHEM, V264, P7776; FUKUMOTO H, 1988, P NATL ACAD SCI USA, V85, P5434, DOI 10.1073/pnas.85.15.5434; GARVEY WT, 1989, SCIENCE, V245, P60, DOI 10.1126/science.2662408; GERMINARIO RJ, 1984, ARCH BIOCHEM BIOPHYS, V234, P559, DOI 10.1016/0003-9861(84)90304-7; HAINQUE B, 1990, J BIOL CHEM, V265, P7982; HASPEL HC, 1986, J BIOL CHEM, V261, P6778; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; KAESTNER KH, 1989, P NATL ACAD SCI USA, V86, P3150, DOI 10.1073/pnas.86.9.3150; KAHN BB, 1989, J CLIN INVEST, V84, P404, DOI 10.1172/JCI114180; KAHN BB, 1988, J CLIN INVEST, V82, P691, DOI 10.1172/JCI113649; KAHN BB, 1989, J CLIN INVEST, V83, P199, DOI 10.1172/JCI113859; KAYANO T, 1988, J BIOL CHEM, V263, P15245; KLETZIEN RF, 1975, J BIOL CHEM, V250, P593; KLIP A, 1987, BIOCHEM J, V242, P131, DOI 10.1042/bj2420131; KLIP A, 1983, ARCH BIOCHEM BIOPHYS, V226, P198, DOI 10.1016/0003-9861(83)90285-0; KLIP A, 1990, DIABETES CARE, V13, P228, DOI 10.2337/diacare.13.3.228; KOSAKI A, 1988, DIABETES, V37, P1583, DOI 10.2337/diabetes.37.11.1583; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maniatis T., 1982, MOL CLONING; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; PARIS S, 1980, BIOCHIM BIOPHYS ACTA, V602, P644, DOI 10.1016/0005-2736(80)90342-9; PEDERSEN O, 1982, METABOLISM, V31, P884, DOI 10.1016/0026-0495(82)90177-9; RAMLAL T, 1988, BIOCHEM BIOPH RES CO, V157, P1329, DOI 10.1016/S0006-291X(88)81020-9; ROSETTI L, 1987, J CLIN INVEST, V79, P1510; SASSON S, 1986, J BIOL CHEM, V261, P6827; SASSON S, 1987, DIABETES, V36, P1041, DOI 10.2337/diabetes.36.9.1041; SIVITZ WI, 1989, NATURE, V340, P72, DOI 10.1038/340072a0; THORENS B, 1988, CELL, V55, P281, DOI 10.1016/0092-8674(88)90051-7; TORDJMAN KM, 1989, P NATL ACAD SCI USA, V86, P7761, DOI 10.1073/pnas.86.20.7761; ULLREY D, 1975, ARCH BIOCHEM BIOPHYS, V167, P410, DOI 10.1016/0003-9861(75)90481-6; VANPUTTEN JPM, 1985, J BIOL CHEM, V260, P7996; WALKER PS, 1989, J BIOL CHEM, V264, P6587; WALKER PS, 1988, J BIOL CHEM, V263, P15594; WALKER PS, 1990, J BIOL CHEM, V265, P1516; WANG PH, 1989, J CLIN INVEST, V84, P62, DOI 10.1172/JCI114170; YAMADA K, 1983, J BIOL CHEM, V258, P9786; YKIJARVINEN H, 1987, DIABETES, V36, P892, DOI 10.2337/diabetes.36.8.892; YOUNG DA, 1986, J BIOL CHEM, V261, P6049; ZORZANO A, 1989, J BIOL CHEM, V264, P12358	54	148	149	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2615	2621						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1990010				2022-12-25	WOS:A1991EV51500091
J	PERSSON, E; VALCARCE, C; STENFLO, J				PERSSON, E; VALCARCE, C; STENFLO, J			THE GAMMA-CARBOXYGLUTAMIC ACID AND EPIDERMAL GROWTH FACTOR-LIKE DOMAINS OF FACTOR-X - EFFECT OF ISOLATED DOMAINS ON PROTHROMBIN ACTIVATION AND ENDOTHELIAL-CELL BINDING OF FACTOR-X	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION FACTOR-XA; BOVINE FACTOR-X; FACTOR-IX; FACTOR-VA; PHOSPHOLIPID SURFACE; HUMAN PLATELETS; COMPLEX; SITE; DERIVATIVES; MECHANISM	Factor Xa is the enzymatically active constituent of the prothrombinase complex, which catalyzes the conversion of prothrombin to thrombin. We have isolated fragments, from tryptic digests of factor X, that consists of the gamma-carboxyglutamic acid (Gla) region linked to one or two epidermal growth factor (EGF)-like domains. Calcium ion binding measurements indicated that these fragments have a native conformation. The factor X-GlaEGF fragments inhibit factor Xa-induced blood clotting in manner suggesting that they compete with factor Xa for phospholipid binding sites. The same conclusion was reached when thrombin generation was studied in a system of purified components (factor Xa, factor Va, prothrombin, phospholipid, and Ca2+). There was no evidence for a strong interaction between the EGF-like domains of factor Xa and factor Va in either system. However, experiments in the purified system without phospholipid indicated a direct, albeit weak, interaction between the Gla region of factor Xa and factor Va and between the COOH-terminal EGF-like domain of factor Xa and factor Va. Using domain-specific Fab fragments, we have confirmed that the conformation of the serine protease region alters dramatically upon activation of factor X. Furthermore, we have demonstrated that the conformation of the Gla region is affected by the activation, whereas the EGF-like domains appear to be unaltered. The association constant for factor X binding to endothelial cells was two orders of magnitude lower than that for binding of factor IX to these cells. Binding of the Gla and GlaEGF fragments suggested Gla-mediated binding to phospholipid rather than binding to a specific receptor.	UNIV LUND,MALMO GEN HOSP,DEPT CLIN CHEM,S-21401 MALMO,SWEDEN	Lund University				Persson, Egon/0000-0003-3005-4926				ASTERMARK J, 1991, J BIOL CHEM, V266, P2438; CHASE T, 1970, METHOD ENZYMOL, V19, P20; CHATTOPADHYAY A, 1989, BLOOD S1, V74; DAHLBACK B, 1978, BIOCHEMISTRY-US, V17, P4938, DOI 10.1021/bi00616a013; DAHLBACK B, 1986, J BIOL CHEM, V261, P9495; FALKE P, 1989, PHARMACOL TOXICOL, V64, P173, DOI 10.1111/j.1600-0773.1989.tb00624.x; FUJIKAWA K, 1973, BIOCHEMISTRY-US, V12, P4938, DOI 10.1021/bi00748a019; FUJIKAWA K, 1972, BIOCHEMISTRY-US, V11, P2285; Harlow E., 1988, ANTIBODIES LABORATOR, P628; HEIMARK RL, 1983, BIOCHEM BIOPH RES CO, V111, P723, DOI 10.1016/0006-291X(83)90365-0; HUSTEN EJ, 1987, J BIOL CHEM, V262, P12953; ISAACS BS, 1986, BIOCHEMISTRY-US, V25, P4958, DOI 10.1021/bi00365a036; JACKSON CM, 1972, BIOCHEMISTRY-US, V11, P4873, DOI 10.1021/bi00776a001; Jesty J, 1976, Methods Enzymol, V45, P95; KEYT B, 1982, J BIOL CHEM, V257, P8687; KRISHNASWAMY S, 1988, J BIOL CHEM, V263, P3823; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; LAURA R, 1980, BIOCHEMISTRY-US, V19, P4859, DOI 10.1021/bi00562a024; LIN SW, 1990, J BIOL CHEM, V265, P144; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MARKWELL MAK, 1982, ANAL BIOCHEM, V125, P427, DOI 10.1016/0003-2697(82)90025-2; MILETICH JP, 1978, J BIOL CHEM, V253, P6908; MILETICH JP, 1977, P NATL ACAD SCI USA, V74, P4033, DOI 10.1073/pnas.74.9.4033; MORITA T, 1986, J BIOL CHEM, V261, P4015; MORITA T, 1984, J BIOL CHEM, V259, P5698; MORITA T, 1980, VITAMIN K METABOLISM, P124; NAWROTH PP, 1986, THROMB RES, V44, P625, DOI 10.1016/0049-3848(86)90164-7; NESHEIM ME, 1979, J BIOL CHEM, V254, P508; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; OWEN W G, 1973, Thrombosis Research, V3, P705, DOI 10.1016/0049-3848(73)90017-0; OWEN WG, 1974, J BIOL CHEM, V249, P594; PERSSON E, 1989, J BIOL CHEM, V264, P16897; PERSSON E, 1991, J BIOL CHEM, V266, P2444; RIMON S, 1987, J BIOL CHEM, V262, P6023; ROSING J, 1986, J BIOL CHEM, V261, P4224; ROSING J, 1980, J BIOL CHEM, V255, P274; SKOGEN WF, 1984, J BIOL CHEM, V259, P2306; STENFLO J, 1976, J BIOL CHEM, V251, P355; STERN DM, 1983, P NATL ACAD SCI-BIOL, V80, P4119, DOI 10.1073/pnas.80.13.4119; STERN DM, 1984, P NATL ACAD SCI-BIOL, V81, P913, DOI 10.1073/pnas.81.3.913; WILDGOOSE P, 1988, BIOCHEM BIOPH RES CO, V152, P1207, DOI 10.1016/S0006-291X(88)80413-3	41	37	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2453	2458						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989997				2022-12-25	WOS:A1991EV51500067
J	TREMBLAY, A; WATERMAN, MR; PARKER, KL; LEHOUX, JG				TREMBLAY, A; WATERMAN, MR; PARKER, KL; LEHOUX, JG			REGULATION OF RAT ADRENAL MESSENGER-RNA AND PROTEIN-LEVELS FOR CYTOCHROME-P-450S AND ADRENODOXIN BY DIETARY-SODIUM DEPLETION OR POTASSIUM INTAKE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENIN-ANGIOTENSIN SYSTEM; SIDE-CHAIN CLEAVAGE; BOVINE ADRENOCORTICAL MITOCHONDRIA; ALDOSTERONE BIOSYNTHESIS; GLOMERULOSA CELLS; STEROID 11-BETA-HYDROXYLASE; RECONSTITUTED SYSTEM; ZONA GLOMERULOSA; CORTEX; CHOLESTEROL	The effect of low sodium and high potassium intake on rat adrenal zona glomerulosa (ZG) and zona fasciculata-reticularis (ZFR) were studied during a 7-day period, by analyzing mRNA and protein levels of various enzymes involved in aldosterone synthesis. In ZG significant increases in cytochrome P-450sec, P-450c21, P-450(11-beta), adrenodoxin mRNA and protein levels were observed after 2 days with either diet, and at day 7 these levels were further increased. The largest mRNA induction was observed at day 7 in sodium-depleted rats for P-450(11-beta), with a 4-fold increase, followed by 2.7- and 2.0-fold increases for P-450sec and P-450c21, respectively. A pattern similar to those of P-450sec and P-450(11-beta) was observed for adrenodoxin with a 2.1-fold increase after 7 days of Na+ restriction. In K+-loaded rats mRNA levels for P-450sec, P-450(11-beta), P-450c21, and adrenodoxin were also increased by 2.2-, 2.1-, 1.5,-, and 1.9-fold respectively. Protein levels of these enzymes were also measured in ZG and showed increases similar to those of their respective mRNAs for both treatments. On the other hand, mRNA levels of P-450sec, P-450(11-beta), P-450c21, and adrenodoxin in ZFR were found significantly lower than in ZG, although they were slightly increased for both treated groups of rats as compared with controls. In addition, ZFR proteins levels of corresponding enzymes did not fluctuate significantly under both ionic regimens. In conclusion, both low sodium and high potassium intakes act primarily on ZG. Their action on plasma aldosterone seems to be mediated by increasing both mRNA and protein and levels of steroidogenic enzymes, especially at the early step (cytochrome P-450sec) and even more at the late steps (cytochrome P-450(11-beta)). In addition, a close relationship appears to exist between the two mitochondrial P-450s and their electron donor adrenodoxin, since their mRNA and protein levels were similarly enhanced for both diets used.	UNIV SHERBROOKE, FAC MED, DEPT BIOCHEM, SHERBROOKE J1H 5N4, QUEBEC, CANADA; UNIV TEXAS, SW MED CTR, DALLAS, TX 75235 USA; DUKE UNIV, MED CTR, HOWARD HUGHES MED INST, DURHAM, NC 27710 USA; DUKE UNIV, MED CTR, DEPT MED, DURHAM, NC 27710 USA	University of Sherbrooke; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Duke University; Howard Hughes Medical Institute; Duke University								AGUILERA G, 1978, P NATL ACAD SCI USA, V75, P4057, DOI 10.1073/pnas.75.8.4057; AGUILERA G, 1979, ENDOCRINOLOGY, V104, P1046, DOI 10.1210/endo-104-4-1046; AHLGREN R, 1990, J BIOL CHEM, V265, P3313; BAUMANN K, 1972, ACTA ENDOCRINOL-COP, V69, P701, DOI 10.1530/acta.0.0690701; BOGERD AM, 1990, MOL ENDOCRINOL, V4, P845, DOI 10.1210/mend-4-6-845; BOGGARAM V, 1989, BIOCHEM BIOPH RES CO, V160, P1227, DOI 10.1016/S0006-291X(89)80134-2; BOYD JE, 1971, ENDOCRINOLOGY, V88, P556, DOI 10.1210/endo-88-3-556; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRALEY LM, 1977, AM J PHYSIOL, V233, pE402, DOI 10.1152/ajpendo.1977.233.5.E402; BROWN RD, 1972, J CLIN INVEST, V51, P1413, DOI 10.1172/JCI106937; DAVIS WW, 1968, J CLIN INVEST, V47, P1425, DOI 10.1172/JCI105834; DEANE HW, 1948, ENDOCRINOLOGY, V43, P133, DOI 10.1210/endo-43-3-133; DOI Y, 1984, HYPERTENSION, V6, pI124, DOI 10.1161/01.HYP.6.2_Pt_2.I124; DOUGLAS J, 1978, ENDOCRINOLOGY, V102, P685, DOI 10.1210/endo-102-3-685; GIROUD CJP, 1956, P SOC EXP BIOL MED, V92, P154; HANDLER JD, 1988, J BIOL CHEM, V263, P13068; HANING R, 1970, Endocrinology, V87, P1147; HARTROFT PM, 1957, ENDOCRINOLOGY, V60, P641; JOHN ME, 1986, BIOCHEMISTRY-US, V25, P2846, DOI 10.1021/bi00358a016; JOHN ME, 1986, P NATL ACAD SCI USA, V83, P4715, DOI 10.1073/pnas.83.13.4715; JOHN ME, 1984, P NATL ACAD SCI-BIOL, V81, P5628, DOI 10.1073/pnas.81.18.5628; KAPLAN NM, 1965, J CLIN INVEST, V44, P2029, DOI 10.1172/JCI105310; KOJIMA I, 1985, BIOCHEM J, V228, P69, DOI 10.1042/bj2280069; KOMINAMI S, 1980, J BIOL CHEM, V255, P3386; KRAMER RE, 1979, J BIOL CHEM, V254, P3953; KRAMER RE, 1982, ARCH BIOCHEM BIOPHYS, V215, P478, DOI 10.1016/0003-9861(82)90106-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBETH JD, 1983, J BIOL CHEM, V258, P5596; LAUBER M, 1987, J STEROID BIOCHEM, V26, P693, DOI 10.1016/0022-4731(87)91041-7; LAUBER M, 1989, ARCH BIOCHEM BIOPHYS, V274, P109, DOI 10.1016/0003-9861(89)90421-9; LEGROS F, 1983, CAN J BIOCHEM CELL B, V61, P538, DOI 10.1139/o83-069; LEHOUX JG, 1974, CAN J BIOCHEM CELL B, V52, P1; LEHOUX JG, 1987, J STEROID BIOCHEM, V27, P1151, DOI 10.1016/0022-4731(87)90202-0; LISCUM L, 1983, J BIOL CHEM, V258, P8450; MARUSIC ET, 1967, J CLIN INVEST, V46, P2101, DOI 10.1172/JCI105697; MCKENNA TJ, 1978, ENDOCRINOLOGY, V103, P1411, DOI 10.1210/endo-103-4-1411; MEULI C, 1983, J STEROID BIOCHEM, V18, P167, DOI 10.1016/0022-4731(83)90083-3; MOUW AR, 1989, J BIOL CHEM, V264, P1305; MULLER J, 1970, EUR J CLIN INVEST, V1, P180, DOI 10.1111/j.1365-2362.1970.tb00615.x; NAKAMARU M, 1985, ENDOCRINOLOGY, V117, P1772, DOI 10.1210/endo-117-5-1772; OGISHIMA T, 1989, J BIOL CHEM, V264, P10935; OHNISHI T, 1986, J BIOCHEM-TOKYO, V100, P1065, DOI 10.1093/oxfordjournals.jbchem.a121786; OKAMURA T, 1985, P NATL ACAD SCI USA, V82, P5705, DOI 10.1073/pnas.82.17.5705; RICE DA, 1990, J BIOL CHEM, V265, P8052; SIMPSON ER, 1988, ANNU REV PHYSIOL, V50, P427, DOI 10.1146/annurev.ph.50.030188.002235; SIMPSON ER, 1979, MOL CELL ENDOCRINOL, V13, P213, DOI 10.1016/0303-7207(79)90082-0; STACHENKO J, 1959, ENDOCRINOLOGY, V64, P730, DOI 10.1210/endo-64-5-730; SUGANO S, 1985, J STEROID BIOCHEM, V23, P1013; SWARTZ SL, 1980, J CLIN ENDOCR METAB, V50, P1071, DOI 10.1210/jcem-50-6-1071; TAKEMORI S, 1984, TRENDS BIOCHEM SCI, V9, P393, DOI 10.1016/0968-0004(84)90223-8; TARJAN E, 1980, ACTA ENDOCRINOL-COP, V94, P381, DOI 10.1530/acta.0.0940381; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TREMBLAY A, 1989, J STEROID BIOCHEM, V34, P385, DOI 10.1016/0022-4731(89)90113-1; TREMBLAY A, 1989, 71ST ANN M END SOC S; VANDER AJ, 1970, AM J PHYSIOL, V219, P455, DOI 10.1152/ajplegacy.1970.219.2.455; WADA A, 1985, J BIOCHEM-TOKYO, V98, P245, DOI 10.1093/oxfordjournals.jbchem.a135264; WATERMAN MR, 1989, TRENDS ENDOCRIN MET, V1, P99, DOI 10.1016/1043-2760(89)90011-8; WHITE BA, 1982, J BIOL CHEM, V257, P8569; WONG M, 1989, J BIOL CHEM, V264, P12867; YANAGIBASHI K, 1986, J BIOL CHEM, V261, P3556	60	39	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2245	2251						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989979				2022-12-25	WOS:A1991EV51500037
J	SJOBRING, U; BJORCK, L; KASTERN, W				SJOBRING, U; BJORCK, L; KASTERN, W			STREPTOCOCCAL PROTEIN-G - GENE STRUCTURE AND PROTEIN-BINDING PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-C; IGG-BINDING; FC-RECEPTORS; IMMUNOGLOBULIN-G; ALBUMIN; SEQUENCE; REGIONS; SITES	Protein G was solubilized from 31 human group C and G streptococcal strains with the muralytic enzyme mutanolysin. As judged by the mobility in sodium dodecyl sulfate-polyacrylamide gel electrophoresis and the binding patterns of the solubilized protein G molecules in Western blot experiments, the strains could be divided into three groups, represented by the group G streptococcal strains C40. The 65-kDa G148 protein G and the 58-kDa C40 protein G showed affinity for both immunoglobulin G (IgG) and human serum albumin (HSA), whereas the 40-kDa G43 protein G bound only IgG. Despite the different molecular patterns, the three protein G species had identical NH2-terminal amino acid sequences. Apart from the 65-kDa peptide, digestion of G148 streptococci with mutanolysin also produced a 52-kDa IgG- and HSA-binding peptide and a 14-kDa HSA-binding peptide. It was demonstrated that these peptides resulted from cleavage of 65-kDa protein G by proteolytic components in the mutanolysin preparation. The protein G genes of the C40 and G43 strains were cloned and sequenced, and their structure was compared to the previously published sequence of the G148 protein G gene. As compared to G148, both the C40 and G43 genes lacked a 210-base pair fragment in the IgG-binding region, accounting for the 10-fold lower affinity of these proteins for IgG. The G43 gene also lacked a 450-base pair fragment in the 5'-end of the gene, explaining why the G43 protein G did not bind HSA. The differences in protein G structure did not correlate with the clinical origin of the strains used in this study. The IgG-binding region of protein G was further mapped. Thus, a peptide corresponding to a single IgG-binding unit was obtained by the cloning and expression of a 303-base pair polymerase chain reaction-generated DNA fragment. The affinity of this 11.5-kDa peptide for human IgG was 8.0 X 10(7) M-1, as determined by Scatchard plots. Finally, a 55-amino acid-long synthetic peptide, corresponding to one of the three repeated domains in the COOH-terminal half of strain G148 protein G, effectively blocked binding of protein G to IgG.	HAGEDORN RES LAB, DK-2820 GENTOFTE, DENMARK	Novo Nordisk; Hagedorn Research Institute	SJOBRING, U (corresponding author), UNIV LUND, DEPT MED MICROBIOL, S-22362 LUND, SWEDEN.							AKERSTROM B, 1987, J BIOL CHEM, V262, P13388; AKERSTROM B, 1986, J BIOL CHEM, V261, P240; AKESSON P, 1990, MOL IMMUNOL, V27, P523, DOI 10.1016/0161-5890(90)90071-7; AUCKENTHALER R, 1983, REV INFECT DIS, V5, P196; BJORCK L, 1987, MOL IMMUNOL, V24, P1113, DOI 10.1016/0161-5890(87)90080-0; BJORCK L, 1989, NATURE, V337, P385, DOI 10.1038/337385a0; BJORCK L, 1984, J IMMUNOL, V133, P969; BJORCK L, 1990, MOL MICROBIOL, V4, P1439, DOI 10.1111/j.1365-2958.1990.tb02054.x; CHRISTENSEN P, 1973, INFECT IMMUN, V7, P881, DOI 10.1128/IAI.7.6.881-885.1973; EFSTRATIOU A, 1989, J MED MICROBIOL, V29, P207, DOI 10.1099/00222615-29-3-207; FAHNESTOCK SR, 1987, TRENDS BIOTECHNOL, V5, P79, DOI 10.1016/S0167-7799(87)80016-1; FAHNESTOCK SR, 1986, J BACTERIOL, V167, P870, DOI 10.1128/jb.167.3.870-880.1986; GOMI H, 1990, J IMMUNOL, V144, P4046; GOWARD CR, 1990, BIOCHEM J, V267, P171, DOI 10.1042/bj2670171; GUSS B, 1986, EMBO J, V5, P1567, DOI 10.1002/j.1460-2075.1986.tb04398.x; HOLLINGSHEAD SK, 1986, J BIOL CHEM, V261, P1677; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MYHRE EB, 1977, INFECT IMMUN, V17, P475, DOI 10.1128/IAI.17.3.475-482.1977; NEVILLE DM, 1971, J BIOL CHEM, V246, P6328; OLSSON A, 1987, EUR J BIOCHEM, V168, P319, DOI 10.1111/j.1432-1033.1987.tb13423.x; REIS KJ, 1986, MOL IMMUNOL, V23, P425, DOI 10.1016/0161-5890(86)90140-9; REIS KJ, 1984, J IMMUNOL, V132, P3091; RENTIERDELRUE F, 1988, NUCLEIC ACIDS RES, V16, P8726, DOI 10.1093/nar/16.17.8726; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LABORATO; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; SJOBRING U, 1989, J IMMUNOL, V143, P2948; SJOBRING U, 1989, MOL MICROBIOL, V3, P319, DOI 10.1111/j.1365-2958.1989.tb00177.x; SJOBRING U, 1988, J IMMUNOL, V140, P1595; Stewart JM, 1984, SOLID PHASE PEPTIDE; STONE GC, 1989, J IMMUNOL, V143, P565; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UHLEN M, 1984, J BIOL CHEM, V259, P1695; VONMERING GO, 1986, MOL IMMUNOL, V23, P811, DOI 10.1016/0161-5890(86)90066-0; WIDEBACK K, 1982, INFECT IMMUN, V38, P1154, DOI 10.1128/IAI.38.3.1154-1163.1982	36	137	143	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					399	405						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985908				2022-12-25	WOS:A1991EQ33900058
J	MAHAFFEY, DT; PEELER, JS; BRODSKY, FM; ANDERSON, RGW				MAHAFFEY, DT; PEELER, JS; BRODSKY, FM; ANDERSON, RGW			CLATHRIN-COATED PITS CONTAIN AN INTEGRAL MEMBRANE-PROTEIN THAT BINDS THE AP-2 SUBUNIT WITH HIGH-AFFINITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV TEXAS,SW MED CTR,DEPT CELL BIOL & NEUROSCI,DALLAS,TX 75235; UNIV CALIF SAN FRANCISCO,DEPT PHARM,SAN FRANCISCO,CA 94143	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco				Brodsky, Frances/0000-0002-1334-9258	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038093] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 20948] Funding Source: Medline; NIGMS NIH HHS [GM 38093] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHLE S, 1988, EMBO J, V7, P919, DOI 10.1002/j.1460-2075.1988.tb02897.x; BECK KA, 1989, J CELL BIOL, V107, pA129; BRANTON D, 1981, CELL, V24, P24, DOI 10.1016/0092-8674(81)90497-9; BRODSKY FM, 1985, J CELL BIOL, V101, P2047, DOI 10.1083/jcb.101.6.2047; BROWN MS, 1983, CELL, V32, P663, DOI 10.1016/0092-8674(83)90052-1; CHIN DJ, 1989, P NATL ACAD SCI USA, V86, P9289, DOI 10.1073/pnas.86.23.9289; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; GOUD B, 1985, J CELL BIOL, V100, P521, DOI 10.1083/jcb.100.2.521; GUAGLIARDI LE, 1990, NATURE, V343, P133, DOI 10.1038/343133a0; HARGREAVES WR, 1980, J BIOL CHEM, V255, P1965; HEUSER JE, 1988, J CELL BIOL, V107, P877, DOI 10.1083/jcb.107.3.877; KEEN JH, 1987, J CELL BIOL, V105, P1989, DOI 10.1083/jcb.105.5.1989; KEEN JH, 1985, ENDOCYTOSIS, P85; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAHAFFEY DT, 1989, J CELL BIOL, V108, P1615, DOI 10.1083/jcb.108.5.1615; MANFREDI JJ, 1987, J BIOL CHEM, V262, P12182; MARSH M, 1980, J MOL BIOL, V142, P439, DOI 10.1016/0022-2836(80)90281-8; MOORE MS, 1987, SCIENCE, V236, P558, DOI 10.1126/science.2883727; PASTERNACK GR, 1985, J BIOL CHEM, V260, P3676; PEARSE BMF, 1987, ANNU REV BIOPHYS BIO, V16, P49, DOI 10.1146/annurev.bb.16.060187.000405; PEARSE BMF, 1984, EMBO J, V3, P1951, DOI 10.1002/j.1460-2075.1984.tb02075.x; PEARSE BMF, 1988, EMBO J, V7, P3331, DOI 10.1002/j.1460-2075.1988.tb03204.x; ROBINSON MS, 1987, J CELL BIOL, V104, P887, DOI 10.1083/jcb.104.4.887; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; UNANUE ER, 1981, CELL, V26, P439, DOI 10.1016/0092-8674(81)90213-0; UNGEWICKELL E, 1981, NATURE, V289, P420, DOI 10.1038/289420a0; VIGERS GPA, 1986, EMBO J, V5, P2079, DOI 10.1002/j.1460-2075.1986.tb04469.x; VIRSHUP DM, 1988, J CELL BIOL, V106, P39, DOI 10.1083/jcb.106.1.39; ZAREMBA S, 1983, J CELL BIOL, V97, P1339, DOI 10.1083/jcb.97.5.1339; [No title captured]	32	84	84	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1990	265	27					16514	16520						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ950	1975814				2022-12-25	WOS:A1990DZ95000073
J	CUNNINGHAM, MD; MICHAELIS, EK				CUNNINGHAM, MD; MICHAELIS, EK			SOLUBILIZATION AND PARTIAL-PURIFICATION OF 3-((+/-)-2-CARBOXYPIPERAZINE-4-YL)-[1,2-H-3]PROPYL-1-PHOSPHONIC ACID RECOGNITION PROTEINS FROM RAT-BRAIN SYNAPTIC-MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV KANSAS,CTR BIOMED RES,2099 CONSTANT AVE,CAMPUS W,LAWRENCE,KS 66045; UNIV KANSAS,DEPT PHARMACOL & TOXICOL,LAWRENCE,KS 66045; UNIV KANSAS,DEPT BIOCHEM,LAWRENCE,KS 66045	University of Kansas; University of Kansas; University of Kansas					NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA004732, R37AA004732] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA 04732] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		AMBAR I, 1988, J NEUROCHEM, V51, P133, DOI 10.1111/j.1471-4159.1988.tb04846.x; ANIS NA, 1983, BRIT J PHARMACOL, V79, P565, DOI 10.1111/j.1476-5381.1983.tb11031.x; BARDSLEY ME, 1985, BIOCHEM BIOPH RES CO, V126, P227, DOI 10.1016/0006-291X(85)90595-9; BERRY SC, 1984, BRIT J PHARMACOL, V83, P179, DOI 10.1111/j.1476-5381.1984.tb10133.x; BIRCH PJ, 1988, EUR J PHARMACOL, V151, P313, DOI 10.1016/0014-2999(88)90814-X; BIRCH PJ, 1988, EUR J PHARMACOL, V156, P177, DOI 10.1016/0014-2999(88)90163-X; CHAPMAN AG, 1987, EUR J PHARMACOL, V139, P91, DOI 10.1016/0014-2999(87)90501-2; CHEN JW, 1988, J BIOL CHEM, V263, P417; COTMAN CW, 1988, ANNU REV NEUROSCI, V11, P61, DOI 10.1146/annurev.neuro.11.1.61; CULLCANDY SG, 1987, NATURE, V325, P525, DOI 10.1038/325525a0; DAVIES J, 1986, BRAIN RES, V382, P169, DOI 10.1016/0006-8993(86)90127-7; EVANS RH, 1977, EXPERIENTIA, V33, P489, DOI 10.1007/BF01922227; FAGG GE, 1987, NEUROSCI LETT, V76, P221, DOI 10.1016/0304-3940(87)90719-1; FAGG GE, 1988, NEUROL NEUR, V46, P59; GEAN PW, 1988, NEUROPHARMACOLOGY, V27, P557, DOI 10.1016/0028-3908(88)90175-X; HARING R, 1986, BIOCHEMISTRY-US, V25, P612, DOI 10.1021/bi00351a015; HARRIS EW, 1986, BRAIN RES, V382, P174, DOI 10.1016/0006-8993(86)90128-9; HARRISON NL, 1985, BRIT J PHARMACOL, V84, P381, DOI 10.1111/j.1476-5381.1985.tb12922.x; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; HONEY CR, 1985, NEUROSCI LETT, V61, P135, DOI 10.1016/0304-3940(85)90414-8; HONORE T, 1987, EUR J PHARMACOL, V136, P137, DOI 10.1016/0014-2999(87)90793-X; IDRISS M, 1985, FEBS LETT, V189, P150, DOI 10.1016/0014-5793(85)80861-9; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KLOOG Y, 1988, BIOCHEMISTRY-US, V27, P843, DOI 10.1021/bi00403a001; LEHMANN J, 1987, J PHARMACOL EXP THER, V240, P737; MARVIZON JCG, 1988, EUR J PHARMACOL, V151, P157, DOI 10.1016/0014-2999(88)90709-1; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; MAYER ML, 1989, NATURE, V338, P425, DOI 10.1038/338425a0; MCKERNAN RM, 1989, J NEUROCHEM, V52, P777, DOI 10.1111/j.1471-4159.1989.tb02522.x; MICHAELIS E, 1987, NEUROCHEM INT, P209; MONAGHAN DT, 1988, P NATL ACAD SCI USA, V85, P9836, DOI 10.1073/pnas.85.24.9836; MONAGHAN DT, 1986, P NATL ACAD SCI USA, V83, P7532, DOI 10.1073/pnas.83.19.7532; MONAHAN JB, 1987, J NEUROCHEM, V48, P1699, DOI 10.1111/j.1471-4159.1987.tb05726.x; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; MUNSON PJ, 1983, METHOD ENZYMOL, V92, P543; MURPHY DE, 1987, J PHARMACOL EXP THER, V240, P778; NEUHOFF V, 1979, H-S Z PHYSIOL CHEM, V360, P1657, DOI 10.1515/bchm2.1979.360.2.1657; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; OLVERMAN HJ, 1986, EUR J PHARMACOL, V131, P161, DOI 10.1016/0014-2999(86)90533-9; PERKINS MN, 1982, NEUROSCI LETT, V32, P65; PULLAN LM, 1987, J NEUROCHEM, V49, P1301, DOI 10.1111/j.1471-4159.1987.tb10024.x; QUIRION R, 1987, TRENDS NEUROSCI, V10, P444, DOI 10.1016/0166-2236(87)90094-4; SEPULVEDA MI, 1989, NEUROSCI LETT, V100, P210, DOI 10.1016/0304-3940(89)90686-1; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SNELL LD, 1988, EUR J PHARMACOL, V156, P105, DOI 10.1016/0014-2999(88)90152-5; VERDOORN TA, 1989, MOL PHARMACOL, V35, P360; WALTHER H, 1986, NEUROSCI LETT, V69, P156, DOI 10.1016/0304-3940(86)90595-1; WATKINS JC, 1987, TRENDS NEUROSCI, V10, P265, DOI 10.1016/0166-2236(87)90171-8; WEILOCH T, 1985, SCIENCE, V230, P681; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104	53	40	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 15	1990	265	14					7768	7778						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DC835	1970819				2022-12-25	WOS:A1990DC83500013
J	DZIARSKI, R				DZIARSKI, R			PEPTIDOGLYCAN AND LIPOPOLYSACCHARIDE BIND TO THE SAME BINDING-SITE ON LYMPHOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADJUVANT-ACTIVE PEPTIDOGLYCANS; LIPID-A; STAPHYLOCOCCAL PEPTIDOGLYCAN; CELL-WALLS; POLYCLONAL ACTIVATION; MURINE SPLENOCYTES; ESCHERICHIA-COLI; INDUCTION; BACTERIAL; SECRETION	Bacterial cell wall peptidoglycan (PGN) and lipopolysaccharide (LPS), which are both macrophage activators and polyclonal B cell mitogens, were shown to bind to the same dominant 70-kDa 6.5 pI protein on the surface of mouse B lymphocytes. This conclusion was supported by the following results: (a) the PGN- and LPS-binding proteins co-migrated following photoaffinity cross-linking and two-dimensional polyacrylamide gel electrophoresis; (b) cross-linking of PGN to this 70-kDa protein was competitively inhibited by LPS (IC50 = 7.3-mu-M), LPS from a deep rough mutant (IC50 = 6.9-mu-M), and lipid A (IC50 = 18-72-mu-M); (c) cross-linking of LPS to this 70-kDa protein was competitively inhibited by polymeric soluble PGN (IC50 = 0.09-mu-M) and sonicated high M(r) PGN (IC50 = 0.6-mu-M); (d) cross-linking of both PGN and LPS to this 70-kDa protein was also competitively inhibited by dextran sulfate (IC50 = 115-124-mu-M); (e) cross-linking of both PGN and LPS to this 70-kDa protein was inhibited by a (GlcNAc)2-specific lectin; and (f) peptide maps of the 70-kDa proteins digested with chymotrypsin, subtilisin, staphylococcal protease V, or papain were identical for PGN- and LPS-binding proteins and unique for each enzyme. Based on competitive inhibition experiments, binding of PGN to the 70-kDa protein was 20-1200 times stronger than the binding of LPS or lipid A on a per mol basis. However, when aggregated micellar structures of LPS or lipid A were considered, the avidities of LPS and PGN binding were similar. These results demonstrate binding of PGN and LPS to the same 70-kDa protein on lymphocytes and suggest that the binding is specific for the (GlcNAc-MurNAc)n backbone of PGN and the (GlcNAc)2 part of lipid A.			DZIARSKI, R (corresponding author), INDIANA UNIV,NW CTR MED EDUC,SCH MED,GARY,IN 46408, USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR036640] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR 36640] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BEUTLER B, 1988, ADV IMMUNOL, V42, P213, DOI 10.1016/S0065-2776(08)60846-9; CHEN TY, 1990, J IMMUNOL, V145, P8; CHIPMAN DM, 1969, SCIENCE, V165, P454, DOI 10.1126/science.165.3892.454; CLEVELAND DW, 1983, METHOD ENZYMOL, V96, P222; CROMARTIE WJ, 1977, J EXP MED, V146, P1585, DOI 10.1084/jem.146.6.1585; DZIARSKI R, 1989, EUR J IMMUNOL, V19, P125, DOI 10.1002/eji.1830190120; DZIARSKI R, 1991, J BIOL CHEM, V266, P4713; DZIARSKI R, 1980, J IMMUNOL, V125, P2478; DZIARSKI R, 1979, INFECT IMMUN, V23, P706, DOI 10.1128/IAI.23.3.706-710.1979; DZIARSKI R, 1982, J IMMUNOL, V128, P1018; DZIARSKI R, 1987, CELL IMMUNOL, V109, P231, DOI 10.1016/0008-8749(87)90307-8; DZIARSKI R, 1988, CELL IMMUNOL, V111, P10, DOI 10.1016/0008-8749(88)90047-0; DZIARSKI R, 1986, BIOL PROPERTIES PEPT, P229; FLEBBE L, 1989, J IMMUNOL, V142, P642; GUENOUNOU M, 1982, ANN INST PASTEUR IMM, VD133, P3; Haeffner-Cavaillon N, 1985, HDB ENDOTOXIN, V3, P1; HAMPTON RY, 1988, J BIOL CHEM, V263, P14802; HARAKUGE S, 1990, J BIOL CHEM, V265, P6606; Heymer B., 1985, IMMUNOLOGY BACTERIAL, P11; Imoto T., 1972, ENZYMES, V7, P665; JOHNSON AG, 1987, REV INFECT DIS, V9, pS512; KANEGASAKI S, 1984, EUR J BIOCHEM, V143, P237, DOI 10.1111/j.1432-1033.1984.tb08364.x; KANOST MR, 1988, ARCH INSECT BIOCHEM, V8, P147, DOI 10.1002/arch.940080302; KIRKLAND TN, 1990, J BIOL CHEM, V265, P9520; KOGA T, 1979, MOL IMMUNOL, V16, P153; KOHASHI O, 1977, Infection and Immunity, V16, P861; KOHASHI O, 1976, J IMMUNOL, V116, P1635; LARSEN NE, 1984, P NATL ACAD SCI-BIOL, V81, P3491, DOI 10.1073/pnas.81.11.3491; LEI MG, 1988, J IMMUNOL, V141, P996; LEI MG, 1988, J IMMUNOL, V141, P1006; LEVINSON AI, 1983, INFECT IMMUN, V39, P290, DOI 10.1128/IAI.39.1.290-296.1983; LOPPNOW H, 1986, EUR J IMMUNOL, V16, P1263, DOI 10.1002/eji.1830161013; Mergenhagen SE, 1980, MICROBIOLOGY+, P1; MORRISON DC, 1975, J BIOL CHEM, V250, P2911; MORRISON DC, 1989, MICROB PATHOGENESIS, V7, P389, DOI 10.1016/0882-4010(89)90019-3; OHNO N, 1989, IMMUNE RESPONSE TO STRUCTURALLY DEFINED PROTEINS : THE LYSOZYME MODEL, P97; OHNO N, 1989, J BIOL CHEM, V264, P4434; PARENT JB, 1990, J BIOL CHEM, V265, P3455; QURESHI N, 1988, J BIOL CHEM, V263, P11971; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.bi.59.070190.001021; RASANEN L, 1981, INFECT IMMUN, V34, P712; Rietschel E T, 1987, Prog Clin Biol Res, V231, P25; RUPLEY JA, 1964, BIOCHIM BIOPHYS ACTA, V83, P245, DOI 10.1016/0926-6526(64)90001-1; SAITOTAKI T, 1980, MICROBIOL IMMUNOL, V24, P209, DOI 10.1111/j.1348-0421.1980.tb00580.x; SAITOTAKI T, 1980, MICROBIOL IMMUNOL, V24, P249, DOI 10.1111/j.1348-0421.1980.tb00585.x; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; STIMPSON SA, 1987, J EXP MED, V165, P1688, DOI 10.1084/jem.165.6.1688; SULTZER BM, 1988, INFECT IMMUN, V56, P3040, DOI 10.1128/IAI.56.12.3040-3045.1988; TAKAHASHI I, 1987, INFECT IMMUN, V65, P57; TAKAYAMA K, 1989, INFECT IMMUN, V57, P1336, DOI 10.1128/IAI.57.4.1336-1338.1989; ULEVITCH RJ, 1984, FED PROC, V43, P2755; VACHERON F, 1986, J NATL CANCER I, V77, P549; VACHERON F, 1983, INFECT IMMUN, V42, P1049, DOI 10.1128/IAI.42.3.1049-1054.1983; WOLLENWEBER HW, 1985, J BIOL CHEM, V260, P5068; ZEIGER AR, 1982, INFECT IMMUN, V37, P1112, DOI 10.1128/IAI.37.3.1112-1118.1982	55	76	76	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4719	4725						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002021				2022-12-25	WOS:A1991FC21700011
J	HASHIMOTO, T; HAYASHI, A; AMANO, Y; KOHNO, J; IWANARI, H; USUDA, S; YAMADA, Y				HASHIMOTO, T; HAYASHI, A; AMANO, Y; KOHNO, J; IWANARI, H; USUDA, S; YAMADA, Y			HYOSCYAMINE 6-BETA-HYDROXYLASE, AN ENZYME INVOLVED IN TROPANE ALKALOID BIOSYNTHESIS, IS LOCALIZED AT THE PERICYCLE OF THE ROOT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED ROOTS; NIGER	Hyoscyamine 6-beta-hydroxylase (H6H; EC 1.14.11.11) catalyzes the first reaction in the biosynthetic pathway from hyoscyamine to scopolamine in several solanaceous plants. Four monoclonal antibodies were raised against H6H purified from cultured roots of Hyoscyamus niger. The IgG1 antibody mAb5 inhibited H6H activities present in cell-free extracts of H. niger roots and specifically recognized 38-40-kDa proteins from six different scopolamine-producing plant species in Western blot analysis after sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis. The other three monoclonal antibodies all recognized SDS-denatured H6H protein from Hyoscyamus species, but did not bind to native H6H. Western blot analysis of protein extracts from various tissues of H. niger using these antibodies showed that H6H is abundant in cultured roots, present in plant roots, but absent in leaf, stem, calyx, cultured cells, and cultured shoots. Immunohistochemical studies using monoclonal antibody and immunogold-silver enhancement detected H6H only in the pericycle cells of the young root in several scopolamine-producing plants. Mature roots that underwent secondary growth and lacked the pericycle did not react with the antibody. This pericycle-specific localization of scopolamine biosynthesis provides an anatomical explanation for the tissue-specific biosynthesis of tropane alkaloids and may be important for translocation of tropane alkaloids from the root to the aerial parts.	INST IMMUNOL,ISHIBASHI,TOCHIGI 32905,JAPAN		HASHIMOTO, T (corresponding author), KYOTO UNIV,FAC AGR,DEPT AGR CHEM,KYOTO 606,JAPAN.							ARVIEUX J, 1988, ANTIBODIES, V1, P113; Esau K., 1977, ANATOMY SEED PLANTS, V2nd Edn., P215; FODOR G, 1959, TETRAHEDRON LETT, V7, P19; HARTMANN T, 1989, PLANTA, V177, P98, DOI 10.1007/BF00392159; HASHIMOTO T, 1989, PLANTA, V178, P123, DOI 10.1007/BF00392535; HASHIMOTO T, 1987, EUR J BIOCHEM, V164, P277, DOI 10.1111/j.1432-1033.1987.tb11055.x; HASHIMOTO T, 1987, PLANT PHYSIOL, V84, P144, DOI 10.1104/pp.84.1.144; HASHIMOTO T, 1986, PLANT PHYSIOL, V81, P619, DOI 10.1104/pp.81.2.619; HASHIMOTO T, 1986, J PLANT PHYSIOL, V124, P61, DOI 10.1016/S0176-1617(86)80178-X; HASHIMOTO T, 1990, PLANT PHYSIOL, V93, P216, DOI 10.1104/pp.93.1.216; HASHIMOTO T, 1991, METHODS PLANT BIOCH, V9, P323; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; O'Brien TP, 1981, STUDY PLANT STRUCTUR, DOI DOI 10.2307/2259948; Oi V.T., 1980, SELECTED METHODS CEL, P351; Waller G.R, 1978, ALKALOID BIOL METABO, P121; YAMADA Y, 1990, P JPN ACAD B-PHYS, V66, P73, DOI 10.2183/pjab.66.73; YAMADA Y, 1989, P JPN ACAD B-PHYS, V65, P156, DOI 10.2183/pjab.65.156	17	136	144	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4648	4653						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999440				2022-12-25	WOS:A1991FA69400095
J	LI, GD; MILANI, D; DUNNE, MJ; PRALONG, WF; THELER, JM; PETERSEN, OH; WOLLHEIM, CB				LI, GD; MILANI, D; DUNNE, MJ; PRALONG, WF; THELER, JM; PETERSEN, OH; WOLLHEIM, CB			EXTRACELLULAR ATP CAUSES CA2+-DEPENDENT AND CA2+-INDEPENDENT INSULIN-SECRETION IN RINM5F CELLS - PHOSPHOLIPASE-C MEDIATES CA2+ MOBILIZATION BUT NOT CA2+ INFLUX AND MEMBRANE DEPOLARIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC-ISLET CELLS; ADRENAL CHROMAFFIN CELLS; DEPENDENT K+ CHANNELS; PROTEIN KINASE-C; CYTOSOLIC CALCIUM; GUANINE-NUCLEOTIDES; INOSITOL 1,4,5-TRISPHOSPHATE; P2-PURINERGIC RECEPTORS; RAT HEPATOCYTES; HL60 CELLS	The mechanism by which extracellular ATP stimulates insulin secretion was investigated in RINm5F cells. ATP depolarized the cells as demonstrated both by using the patch-clamp technique and a fluorescent probe. The depolarization is due to closure of ATP-sensitive K+ channels as shown directly in outside-out membrane patches. ATP also raised cytosolic Ca2+ ([Ca2+]i). At the single cell level the latency of the [Ca2+]i response was inversely related to ATP concentration. The [Ca2+]i rise is due both to inositol trisphosphate mediated Ca2+ mobilization and to Ca2+ influx. The former component, as well as inositol trisphosphate generation, were inhibited by phorbol myristate acetate which uncouples agonist receptors from phospholipase C. This manoeuvre did not block Ca2+ influx or membrane depolarization. Diazoxide, which opens ATP-sensitive K+ channels, attenuated membrane depolarization and part of the Ca2+ influx stimulated by ATP. However, the main Ca2+ influx component was unaffected by L-type channel blockers, suggesting the activation of other Ca2+ conductance pathways. ATP increased the rate of insulin secretion by more than 12-fold but the effect was transient. Prolonged exposure to EGTA dissociated the [Ca2+]i rise from ATP-induced insulin secretion, since the former was abolished and the latter only decreased by about 60%. In contrast, vasopressin-evoked insulin secretion was more sensitive to Ca2+ removal than the accompanying [Ca2+]i rise. Inhibition of phospholipase C stimulation by phorbol myristate acetate abrogated vasopressin but only reduced ATP-induced insulin secretion by 34%. These results suggest that ATP stimulates insulin release by both phospholipase C dependent and distinct mechanisms. The Ca2+-independent component of insulin secretion points to a direct triggering of exocytosis by ATP.	UNIV GENEVA,CTR MED UNIV,DEPT MED,DIV BIOCHIM CLIN,CH-1211 GENEVA 4,SWITZERLAND; UNIV LIVERPOOL,PHYSIOL LAB,MRC,SECRETORY CONTROL RES GRP,LIVERPOOL L69 3BX,ENGLAND	University of Geneva; University of Liverpool			Petersen, Ole H/E-8708-2010	Petersen, Ole/0000-0002-6998-0380				ARKHAMMAR P, 1990, BIOCHEM J, V265, P203, DOI 10.1042/bj2650203; BEAN BP, 1990, J NEUROSCI, V10, P11; BEAN BP, 1990, J NEUROSCI, V10, P1; BENHAM CD, 1987, NATURE, V328, P275, DOI 10.1038/328275a0; BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; BERTRAND G, 1987, BRIT J PHARMACOL, V91, P783, DOI 10.1111/j.1476-5381.1987.tb11276.x; BIDEN TJ, 1988, BIOCHEM J, V251, P435, DOI 10.1042/bj2510435; BIDEN TJ, 1989, INOSITOL LIPIDS CELL, P405; BLACHIER F, 1988, BIOCHIM BIOPHYS ACTA, V970, P222, DOI 10.1016/0167-4889(88)90182-6; BOYER JL, 1989, J BIOL CHEM, V264, P884; BURCH RM, 1986, P NATL ACAD SCI USA, V83, P7201, DOI 10.1073/pnas.83.19.7201; BURNSTOCK G, 1985, GEN PHARMACOL, V16, P433, DOI 10.1016/0306-3623(85)90001-1; BURNSTOCK G, 1972, PHARMACOL REV, V24, P509; CANDELA JLR, 1963, NATURE, V197, P1304; CANDELA JLR, 1963, NATURE, V197, P1210, DOI DOI 10.1038/1971210A0; CHAREST R, 1985, J BIOL CHEM, V260, P5789; CHEEK TR, 1989, J CELL BIOL, V109, P1219, DOI 10.1083/jcb.109.3.1219; COCKCROFT S, 1989, BIOCHEM J, V263, P715, DOI 10.1042/bj2630715; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; DUBYAK GR, 1988, J BIOL CHEM, V263, P18108; DUNNE MJ, 1990, J MEMBRANE BIOL, V114, P53, DOI 10.1007/BF01869384; DUNNE MJ, 1989, EMBO J, V8, P413, DOI 10.1002/j.1460-2075.1989.tb03392.x; DUNNE MJ, 1987, J MEMBRANE BIOL, V99, P215, DOI 10.1007/BF01995702; DUNNE MJ, 1986, J MEMBRANE BIOL, V93, P271, DOI 10.1007/BF01871181; ELMOATASSIM C, 1989, FEBS LETT, V242, P391, DOI 10.1016/0014-5793(89)80508-3; FASOLATO C, 1990, J BIOL CHEM, V265, P20351; FELDMAN JM, 1974, ENDOCRINOLOGY, V94, P388, DOI 10.1210/endo-94-2-388; FINDLAY I, 1985, J MEMBRANE BIOL, V88, P165, DOI 10.1007/BF01868430; FINDLAY I, 1985, J MEMBRANE BIOL, V83, P169, DOI 10.1007/BF01868748; GESCHWIND JF, 1989, BIOCHIM BIOPHYS ACTA, V1012, P107, DOI 10.1016/0167-4889(89)90018-9; GORDON JL, 1986, BIOCHEM J, V233, P309, DOI 10.1042/bj2330309; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HALLAM TJ, 1985, FEBS LETT, V186, P175, DOI 10.1016/0014-5793(85)80703-1; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; IRVINE RF, 1990, FEBS LETT, V263, P5, DOI 10.1016/0014-5793(90)80692-C; IRVING HR, 1987, J BIOL CHEM, V262, P3440; LEITNER JW, 1975, ENDOCRINOLOGY, V95, P662; LI GD, 1988, DIABETOLOGIA, V31, pA514; LOUBATIERES AL, 1972, CR SOC BIOL, V166, P1742; LOUBATIERESMARIANI MM, 1979, EUR J PHARMACOL, V59, P277, DOI 10.1016/0014-2999(79)90291-7; MARTIN SC, 1989, EMBO J, V8, P3595, DOI 10.1002/j.1460-2075.1989.tb08532.x; MCMILLIAN MK, 1988, BIOCHEM J, V255, P291; MILLER RE, 1981, ENDOCR REV, V2, P471, DOI 10.1210/edrv-2-4-471; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; OKAJIMA F, 1989, FEBS LETT, V253, P132, DOI 10.1016/0014-5793(89)80945-7; OKAJIMA F, 1987, J BIOL CHEM, V262, P13483; OSULLIVAN AJ, 1989, EMBO J, V8, P401, DOI 10.1002/j.1460-2075.1989.tb03391.x; PETERRIESCH B, 1988, J CLIN INVEST, V81, P1154, DOI 10.1172/JCI113430; PETERSEN OH, 1987, PHYSIOL REV, V67, P1054, DOI 10.1152/physrev.1987.67.3.1054; PRALONG WF, 1990, EMBO J, V9, P53, DOI 10.1002/j.1460-2075.1990.tb08079.x; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; QUINN SJ, 1988, P NATL ACAD SCI USA, V85, P5754, DOI 10.1073/pnas.85.15.5754; ROONEY TA, 1989, J BIOL CHEM, V264, P17131; ROSSIER JR, 1989, J BIOL CHEM, V264, P16598; Stone TW, 1989, ADV DRUG RES, V18, P292; TRUBE G, 1986, PFLUG ARCH EUR J PHY, V407, P493, DOI 10.1007/BF00657506; ULLRICH S, 1988, J BIOL CHEM, V263, P8615; VALLAR L, 1987, J BIOL CHEM, V262, P5049; VELASCO JM, 1988, FEBS LETT, V231, P366, DOI 10.1016/0014-5793(88)80851-2; WOLLHEIM CB, 1984, FEBS LETT, V177, P17, DOI 10.1016/0014-5793(84)80972-2; WOLLHEIM CB, 1988, EMBO J, V7, P2443, DOI 10.1002/j.1460-2075.1988.tb03090.x; WOLLHEIM CB, 1984, J BIOL CHEM, V259, P2262; WOLLHEIM CB, 1986, J BIOL CHEM, V261, P8314	64	77	78	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3449	3457						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995609				2022-12-25	WOS:A1991EY68200020
J	TAHARA, SM; DIETLIN, TA; DEVER, TE; MERRICK, WC; WORRILOW, LM				TAHARA, SM; DIETLIN, TA; DEVER, TE; MERRICK, WC; WORRILOW, LM			EFFECT OF EUKARYOTIC INITIATION FACTOR-4F ON AUG SELECTION IN A BICISTRONIC MESSENGER-RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							5' NONCODING REGION; ALFALFA MOSAIC-VIRUS; CAP-BINDING-PROTEIN; SECONDARY STRUCTURE; SIMIAN VIRUS-40; 5'-TERMINAL 7-METHYLGUANOSINE; TRANSLATIONAL EFFICIENCY; NONTRANSLATED REGION; INTERNAL INITIATION; INVITRO TRANSLATION	Artificial bicistronic mRNAs based on rabbit beta-globin and bacterial chloramphenicol acetyltransferase protein-coding sequences were tested for translation activity in a mouse astrocytoma cell-free extract. This cell extract exhibited an apparent preference for 5'-distal or internal initiation over 5'-proximal ("first AUG") initiation. 5'-Distal initiation appeared to be 5'-cap independent, suggesting that nonstandard initiation was responsible. This conclusion was based on a lack of inhibition of internal initiation by added cap analog and insensitivity of internal initiation to the presence or absence of a 5'-cap structure. Exogenous reticulocyte initiation factors were tested for effect on 5'-proximal initiation. The only factor with a significant effect was found to be eukaryotic initiation factor 4F, or the cap-binding protein. Addition of this factor promoted 5'-end initiation as evident by a general increase in 5'-proximal open reading frame (ORF) product relative to 5'-distal ORF product. The relative expression of 5'-proximal to 5'-distal ORFs in bicistronic or multicistronic mRNAs may very well be dependent on activity levels of eukaryotic initiation factor 4F and possibly other mRNA-dependent initiation factors.	CASE WESTERN RESERVE UNIV,SCH MED,DEPT BIOCHEM,CLEVELAND,OH 44106	Case Western Reserve University	TAHARA, SM (corresponding author), UNIV SO CALIF,SCH MED,DEPT MICROBIOL,LOS ANGELES,CA 90033, USA.		Dever, Thomas/GSE-0966-2022	Tahara, Stanley/0000-0001-5097-0927; Dever, Thomas/0000-0001-7120-9678	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038512, R01GM026796] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 38512, GM 26796] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAMSON RD, 1987, J BIOL CHEM, V262, P3826; ALKHATIB G, 1988, J VIROL, V62, P4059, DOI 10.1128/JVI.62.11.4059-4069.1988; BROWNING KS, 1988, J BIOL CHEM, V263, P9630; CHANG LJ, 1989, NATURE, V337, P364, DOI 10.1038/337364a0; CHU LY, 1978, BIOCHEMISTRY-US, V17, P2450, DOI 10.1021/bi00605a032; DABROWSKI C, 1988, J VIROL, V62, P3182, DOI 10.1128/JVI.62.9.3182-3192.1988; DANIELSMCQUEEN S, 1983, J BIOL CHEM, V258, P7195; DARZYNKIEWICZ E, 1988, NUCLEIC ACIDS RES, V16, P8953, DOI 10.1093/nar/16.18.8953; DASSO MC, 1990, EUR J BIOCHEM, V187, P361, DOI 10.1111/j.1432-1033.1990.tb15313.x; DIETLIN TA, 1988, FASEB J, V2, pA1359; DONAHUE TF, 1988, CELL, V54, P621, DOI 10.1016/S0092-8674(88)80006-0; DUNCAN R, 1983, J BIOL CHEM, V258, P7228; EDERY I, 1984, BIOCHEMISTRY-US, V23, P2456, DOI 10.1021/bi00306a021; EDERY I, 1985, P NATL ACAD SCI USA, V82, P7590, DOI 10.1073/pnas.82.22.7590; ERNST H, 1985, P NATL ACAD SCI USA, V82, P48, DOI 10.1073/pnas.82.1.48; GEHRKE L, 1983, BIOCHEMISTRY-US, V22, P5157, DOI 10.1021/bi00291a015; GODEFROYCOLBURN T, 1985, EUR J BIOCHEM, V147, P541; GOOD PJ, 1988, J VIROL, V62, P944, DOI 10.1128/JVI.62.3.944-953.1988; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRIFO JA, 1982, J BIOL CHEM, V257, P5246; GRIFO JA, 1983, J BIOL CHEM, V258, P5804; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HIRANO N, 1974, ARCH GES VIRUSFORSCH, V44, P298, DOI 10.1007/BF01240618; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; JANG SK, 1989, J VIROL, V63, P1651, DOI 10.1128/JVI.63.4.1651-1660.1989; KAEMPFER R, 1978, P NATL ACAD SCI USA, V75, P209, DOI 10.1073/pnas.75.1.209; KONARSKA MM, 1984, CELL, V38, P731, DOI 10.1016/0092-8674(84)90268-X; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; KOZAK M, 1986, P NATL ACAD SCI USA, V83, P2850, DOI 10.1073/pnas.83.9.2850; KOZAK M, 1986, CELL, V47, P481, DOI 10.1016/0092-8674(86)90609-4; KOZAK M, 1983, MICROBIOL REV, V47, P1; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWRENCE CB, 1980, NUCLEIC ACIDS RES, V8, P1307, DOI 10.1093/nar/8.6.1307; LAWSON TG, 1986, J BIOL CHEM, V261, P13979; LAWSON TG, 1988, J BIOL CHEM, V263, P7266; MANIATIS T, 1982, MOL CLONING LABORATO, P246; MEEROVITCH K, 1989, GENE DEV, V3, P1026, DOI 10.1101/gad.3.7.1026; MOLDAVE K, 1985, ANNU REV BIOCHEM, V54, P1109, DOI 10.1146/annurev.biochem.54.1.1109; NIELSEN PJ, 1988, EMBO J, V7, P2097, DOI 10.1002/j.1460-2075.1988.tb03049.x; OU JH, 1990, J VIROL, V64, P4578, DOI 10.1128/JVI.64.9.4578-4581.1990; PEABODY DS, 1986, MOL CELL BIOL, V6, P2695, DOI 10.1128/MCB.6.7.2695; PEABODY DS, 1986, MOL CELL BIOL, V6, P2704, DOI 10.1128/MCB.6.7.2704; PELLETIER J, 1988, MOL CELL BIOL, V8, P1103, DOI 10.1128/MCB.8.3.1103; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; PELLETIER J, 1985, CELL, V40, P515, DOI 10.1016/0092-8674(85)90200-4; RAY BK, 1983, P NATL ACAD SCI-BIOL, V80, P663, DOI 10.1073/pnas.80.3.663; RHOADS RE, 1988, TRENDS BIOCHEM SCI, V13, P52, DOI 10.1016/0968-0004(88)90028-X; RIVERA VM, 1988, VIROLOGY, V165, P42, DOI 10.1016/0042-6822(88)90656-3; ROSE JK, 1978, P NATL ACAD SCI USA, V75, P2732, DOI 10.1073/pnas.75.6.2732; SCHUMPERLI D, 1982, CELL, V30, P865, DOI 10.1016/0092-8674(82)90291-4; SONENBERG N, 1987, ADV VIRUS RES, V33, P175, DOI 10.1016/S0065-3527(08)60318-8; TAHARA SM, 1981, J BIOL CHEM, V256, P7691; Warburg O., 1942, BIOCHEM Z, V310, P384; WEBER LA, 1977, P NATL ACAD SCI USA, V74, P3254, DOI 10.1073/pnas.74.8.3254; ZAGURSKY RJ, 1985, GENE ANAL TECH, V2, P89, DOI 10.1016/0735-0651(85)90011-1	58	22	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3594	3601						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995620				2022-12-25	WOS:A1991EY68200040
J	FECHHEIMER, M; MURDOCK, D; CARNEY, M; GLOVER, CVC				FECHHEIMER, M; MURDOCK, D; CARNEY, M; GLOVER, CVC			ISOLATION AND SEQUENCING OF CDNA CLONES ENCODING THE DICTYOSTELIUM-DISCOIDEUM 30,000-DALTON ACTIN-BUNDLING PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-ACTININ; F-ACTIN; CONTAINING-FILAMENTS; BINDING PROTEINS; ANTIBODY PROBES; MUSCLE; ALDOLASE; CLONING; VILLIN; CELLS	The Dictyostelium 30,000-dalton protein is a calcium-regulated actin filament-bundling protein which has been suggested to contribute to the structure and reorganization of filopodia and pseudopodia accompanying cell movements. cDNAs encoding this protein were isolated using antibody and oligonucleotide probes to screen cDNA libraries in phage-lambda. The sequence of the cDNA predicts a protein of 295 amino acids with a molecular weight of 33,355. The sequence reveals two EF-hand calcium-binding regions that provide a structural explanation for calcium regulation of the activity of this protein. The putative calcium-binding region of the 30,000-dalton protein has similarity to sequences of other calcium-regulated actin-binding proteins such as alpha-actinin and fimbrin. One region of the sequence with similarity to both Dictyostelium gelation factor (ABP 120) and fructose bisphosphate aldolase is a potential actin-binding sequence. A highly charged region of the protein is similar to a sequence in human cytovillin that is repeated eight times in chicken gizzard caldesmon. No strong homology to previously identified actin-binding sequences of other actin-binding proteins is apparent. Results from Southern blot experiments indicate that the 30,000-dalton protein is encoded by a single gene in the Dictyostelium genome.	UNIV GEORGIA, DEPT BIOCHEM, ATHENS, GA 30602 USA	University System of Georgia; University of Georgia	FECHHEIMER, M (corresponding author), UNIV GEORGIA, DEPT ZOOL, ATHENS, GA 30602 USA.		Murdock, Deborah/C-3483-2012					ARIMURA C, 1988, EUR J BIOCHEM, V177, P649, DOI 10.1111/j.1432-1033.1988.tb14419.x; BARON MD, 1987, J BIOL CHEM, V262, P17623; BAZARI WL, 1988, P NATL ACAD SCI USA, V85, P4986, DOI 10.1073/pnas.85.14.4986; BLANCHARD A, 1989, J MUSCLE RES CELL M, V10, P280, DOI 10.1007/BF01758424; BRESNICK AR, 1990, J BIOL CHEM, V265, P9236; BRETSCHER A, 1983, J CELL BIOL, V97, P425, DOI 10.1083/jcb.97.2.425; BRYAN J, 1989, J BIOL CHEM, V264, P13873; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; DALE RMK, 1985, PLASMID, V13, P31, DOI 10.1016/0147-619X(85)90053-8; DARRUDA MV, 1990, J CELL BIOL, V111, P1069; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOBERSTEIN S K, 1989, Journal of Cell Biology, V109, p86A; FECHHEIMER M, 1984, J BIOL CHEM, V259, P4514; FECHHEIMER M, 1987, J CELL BIOL, V104, P1539, DOI 10.1083/jcb.104.6.1539; FECHHEIMER M, 1991, METHOD ENZYMOL, V196, P84; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FURUKAWA R, 1990, IN PRESS DEV GENET, V11; GLENNEY JR, 1981, J BIOL CHEM, V256, P8156; GLENNEY JR, 1981, P NATL ACAD SCI-BIOL, V78, P2810, DOI 10.1073/pnas.78.5.2810; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; HAYDEN SM, 1990, J CELL BIOL, V111, P443, DOI 10.1083/jcb.111.2.443; JOHNS JA, 1988, CELL MOTIL CYTOSKEL, V9, P205, DOI 10.1002/cm.970090303; KOENIG M, 1990, J BIOL CHEM, V265, P4560; Korn ED, 1990, CURR OPIN CELL BIOL, V2, P57, DOI 10.1016/S0955-0674(05)80031-6; KRETSINGER RH, 1980, CRC CR REV BIOCH MOL, V8, P119, DOI 10.3109/10409238009105467; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LOOMIS WF, 1971, EXP CELL RES, V64, P484, DOI 10.1016/0014-4827(71)90107-8; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MIYATA H, 1989, J CELL BIOL, V109, P1519, DOI 10.1083/jcb.109.4.1519; MONCRIEF ND, 1990, J MOL EVOL, V30, P522, DOI 10.1007/BF02101108; MORTON DJ, 1977, J CELL BIOL, V74, P1016, DOI 10.1083/jcb.74.3.1016; NOEGEL A, 1987, FEBS LETT, V221, P391, DOI 10.1016/0014-5793(87)80962-6; NOEGEL A, 1985, J MOL BIOL, V185, P447, DOI 10.1016/0022-2836(85)90416-4; NOEGEL A, 1989, J CELL BIOL, V106, P607; PAGLIARO L, 1988, J CELL BIOL, V107, P981, DOI 10.1083/jcb.107.3.981; PAKKANEN R, 1989, J CELL BIOCHEM, V41, P1, DOI 10.1002/jcb.240410102; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; Sambrook J., 1982, MOL CLONING LAB MANU, V1; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAXENA A, 1987, MOL CELL BIOL, V7, P3409, DOI 10.1128/MCB.7.10.3409; SNYDER M, 1987, METHOD ENZYMOL, V154, P107; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPEICHER DW, 1984, NATURE, V311, P177, DOI 10.1038/311177a0; STEWART M, 1980, BIOCHEM J, V186, P99, DOI 10.1042/bj1860099; STOSSEL TP, 1985, ANN REV CELL BIOL, V1, P355; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Taylor D L, 1979, Int Rev Cytol, V56, P57, DOI 10.1016/S0074-7696(08)61821-5; TOLAN DR, 1984, J BIOL CHEM, V259, P1127; TUFTY RM, 1975, SCIENCE, V187, P167, DOI 10.1126/science.1111094; TURUNEN O, 1989, J BIOL CHEM, V264, P16727; Vandekerckhove J, 1990, CURR OPIN CELL BIOL, V2, P41, DOI 10.1016/S0955-0674(05)80029-8; WOOD WI, 1987, METHOD ENZYMOL, V152, P443; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YOUNG RA, 1983, SCIENCE, V222, P778, DOI 10.1126/science.6356359	54	32	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2883	2889						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993662				2022-12-25	WOS:A1991EX60000036
J	KAPLAN, J; JORDAN, I; STURROCK, A				KAPLAN, J; JORDAN, I; STURROCK, A			REGULATION OF THE TRANSFERRIN-INDEPENDENT IRON TRANSPORT-SYSTEM IN CULTURED-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOUND IRON; RAT-LIVER; HEREDITARY HEMOCHROMATOSIS; HUMAN-FIBROBLASTS; RECEPTOR GENE; MESSENGER-RNA; CLEARANCE; CHROMATOGRAPHY; HEPATOCYTES; KINETICS	Mammalian cells accumulate iron via the binding of transferrin to high affinity surface receptors, or through a transferrin-independent pathway which involves the uptake of iron-organic anion chelates by a membrane-based transport system. Previously we determined that the transferrin-independent transport system was present on a wide variety of cultured cells (Sturrock, A., Alexander, J., Lamb, J., Craven, C.M., and Kaplan, J. (1990) J. Biol. Chem. 265, 3139-3145). In this communication we demonstrate that the transferrin-independent iron uptake system is regulated differently than the transferrin-mediated pathway. The activity of the transferrin-independent system was unaffected by changes in cellular growth rate, induction of DNA synthesis and cell division, or depletion of cellular iron. Exposure of cells to ferric or ferrous iron, however, resulted in a time-dependent increase in transport activity, due to a change in V(max) with no change in K(m). Increased transport activity was seen in a variety of cultured cell types, occurred in the presence of cycloheximide, and persisted for hours after removal of iron. The ability of other transition metals to induce changes in transport, or to compete with iron for accumulation by the transferrin-independent uptake system, was critically dependent on the composition of the media in which the cells were incubated. Metals such as Cu2+, or Zn2+, but not Cd2+ or Mn2+, when dissolved in a balanced salt solution buffered with 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, induced changes in the transferrin-independent iron transport system. The same metals which induced changes in transport were ineffective in media containing amino acids, ascorbate, or N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine. The V(max) of the transferrin-independent iron transport system was also elevated by increases in intracellular Ca2+. The effect of iron on transport activity, however, did not result from an iron-induced release of intracellular Ca2+. These results suggest a novel form of regulation in which the presence of extracellular iron induces the appearance of previously cryptic transporters and thus accelerates the clearance of potentially toxic molecules.	UNIV UTAH, MED CTR, COLL MED, DEPT MED, DIV PULM & RESP CARE, SALT LAKE CITY, UT 84112 USA	Utah System of Higher Education; University of Utah	KAPLAN, J (corresponding author), UNIV UTAH, MED CTR, COLL MED, DEPT PATHOL, DIV CELL BIOL & IMMUNOL, SALT LAKE CITY, UT 84112 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030534, R37DK030534, R01DK020630] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 30534, DK 20630] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BASSET P, 1986, CANCER RES, V46, P1644; BRISSOT P, 1985, J CLIN INVEST, V76, P1463, DOI 10.1172/JCI112125; CASEY JL, 1988, ANN NY ACAD SCI, V526, P54, DOI 10.1111/j.1749-6632.1988.tb55492.x; CRAVEN CM, 1987, P NATL ACAD SCI USA, V84, P3457, DOI 10.1073/pnas.84.10.3457; DADONE MM, 1982, AM J CLIN PATHOL, V78, P196, DOI 10.1093/ajcp/78.2.196; GROOTVELD M, 1989, J BIOL CHEM, V264, P4417; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; KOELLER DM, 1989, P NATL ACAD SCI USA, V86, P3574, DOI 10.1073/pnas.86.10.3574; LAMB JE, 1983, J BIOL CHEM, V258, P8751; LANDERS JW, 1958, AM J CLIN PATHOL, V29, P590; LARRICK JW, 1979, J SUPRAMOL STR CELL, V11, P579, DOI 10.1002/jss.400110415; LASKEY J, 1988, EXP CELL RES, V176, P87, DOI 10.1016/0014-4827(88)90123-1; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MOOLENAAR WH, 1984, J BIOL CHEM, V259, P8066; OWEN D, 1987, EMBO J, V6, P1287, DOI 10.1002/j.1460-2075.1987.tb02366.x; PEETERS GA, 1987, AM J PHYSIOL, V253, pH1400, DOI 10.1152/ajpheart.1987.253.6.H1400; RAO K, 1986, MOL CELL BIOL, V6, P236, DOI 10.1128/MCB.6.1.236; SAWATZKI G, 1981, BIOCHIM BIOPHYS ACTA, V667, P132, DOI 10.1016/0005-2795(81)90073-8; SCHMITT RC, 1983, AM J PHYSIOL, V244, pG183, DOI 10.1152/ajpgi.1983.244.2.G183; SMITH JB, 1989, J BIOL CHEM, V264, P7115; STURROCK A, 1990, J BIOL CHEM, V265, P3139; THORSTENSEN K, 1988, J BIOL CHEM, V263, P16837; WARD JH, 1982, J BIOL CHEM, V257, P317; WARD JH, 1984, J BIOL CHEM, V259, P3235; WARD JH, 1984, J LAB CLIN MED, V103, P246; WARD JH, 1982, BIOCHEM J, V208, P19, DOI 10.1042/bj2080019; WHEBY MS, 1963, BLOOD, V22, P416, DOI 10.1182/blood.V22.4.416.416; WRIGHT TL, 1986, J BIOL CHEM, V261, P909; WRIGHT TL, 1988, J BIOL CHEM, V263, P1842	29	202	205	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2997	3004						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993673				2022-12-25	WOS:A1991EX60000052
J	WAHLE, E				WAHLE, E			PURIFICATION AND CHARACTERIZATION OF A MAMMALIAN POLYADENYLATE POLYMERASE INVOLVED IN THE 3' END PROCESSING OF MESSENGER-RNA PRECURSORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(A) POLYMERASE; MULTIPLE FACTORS; CALF THYMUS; RAT-LIVER; CLEAVAGE; INVITRO; SITE; SEPARATION; SEQUENCES; REQUIRES	A polyadenylate polymerase involved in the polyadenylation of pre-mRNA has been purified 6,000-fold to apparent homogeneity from extracts of calf thymus. In the last purification step, anion exchange chromatography separates the enzyme into three major peaks that are indistinguishable by other physical or functional criteria. On denaturing polyacrylamide gels, the two predominant forms of poly(A) polymerase have molecular weights of 57,000 and 60,000. In solution, the enzyme is a monomer. It polymerizes exclusively ATP. The reaction is distributive and proceeds linearly without any lag phase. The requirement for a primer can be satisfied by any of a number of polyribonucleotides. A significantly higher activity in the presence of Mn2+ as opposed to Mg2+ is due to a hundredfold higher affinity for the primer terminus. In the presence of Mg2+ and of a specificity factor partially purified from HeLa cells, the enzyme specifically polyadenylates an RNA that ends at the natural adenovirus L3 polyadenylation site. This reaction depends on the AAUAAA polyadenylation signal.			WAHLE, E (corresponding author), UNIV BASEL,BIOCTR,DEPT CELL BIOL,KLINGELBERGSTR 70,CH-4056 BASEL,SWITZERLAND.			Wahle, Elmar/0000-0003-2504-0677				BARDWELL VJ, 1990, MOL CELL BIOL, V10, P846, DOI 10.1128/MCB.10.2.846; BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHRISTOFORI G, 1988, CELL, V54, P875, DOI 10.1016/S0092-8674(88)91263-9; CHRISTOFORI G, 1989, MOL CELL BIOL, V9, P193, DOI 10.1128/MCB.9.1.193; Edmonds M, 1976, Prog Nucleic Acid Res Mol Biol, V17, P149, DOI 10.1016/S0079-6603(08)60069-0; EDMONDS M, 1982, ENZYMES, V15, P217; EDMONDS M, 1990, METHOD ENZYMOL, V181, P160; ERNS MP, 1989, MOL CELL BIOL, V9, P1435; FERSHT A, 1985, ENZYME STRUCTURE MEC, P106; FRENDEWEY D, 1985, CELL, V42, P355, DOI 10.1016/S0092-8674(85)80131-8; GILMARTIN GM, 1989, GENE DEV, V3, P2180, DOI 10.1101/gad.3.12b.2180; GILMARTIN GM, 1988, GENE DEV, V2, P578, DOI 10.1101/gad.2.5.578; HASELBECK A, 1990, GLYCOCONJUGATE J, V7, P63, DOI 10.1007/BF01050403; HUMPHREY T, 1988, TRENDS GENET, V4, P243, DOI 10.1016/0168-9525(88)90028-5; Jacob ST, 1978, METHOD CANCER RES, V14, P191; KRAMER A, 1985, EMBO J, V4, P3571, DOI 10.1002/j.1460-2075.1985.tb04119.x; KURL RN, 1988, BIOCHEMISTRY-US, V27, P8974, DOI 10.1021/bi00425a015; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANLEY JL, 1988, BIOCHIM BIOPHYS ACTA, V950, P1, DOI 10.1016/0167-4781(88)90067-X; MCDEVITT MA, 1988, GENE DEV, V2, P588, DOI 10.1101/gad.2.5.588; MOORE CL, 1984, CELL, V36, P581, DOI 10.1016/0092-8674(84)90337-4; MOORE CL, 1985, CELL, V41, P845, DOI 10.1016/S0092-8674(85)80065-9; NEVINS JR, 1983, ANNU REV BIOCHEM, V52, P441, DOI 10.1146/annurev.bi.52.070183.002301; NEVINS JR, 1977, J BIOL CHEM, V252, P6939; ROSE KM, 1976, EUR J BIOCHEM, V67, P11, DOI 10.1111/j.1432-1033.1976.tb10626.x; RYNER LC, 1989, MOL CELL BIOL, V9, P4229, DOI 10.1128/MCB.9.10.4229; RYNER LC, 1989, MOL CELL BIOL, V9, P1759, DOI 10.1128/MCB.9.4.1759; Sambrook J, 1989, MOL CLONING LABORATO; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; SOBER HA, 1970, HDB BIOCH, pC4; STAYTON MM, 1983, J BIOL CHEM, V258, P3205; TAKAGAKI Y, 1988, CELL, V52, P731, DOI 10.1016/0092-8674(88)90411-4; TAKAGAKI Y, 1989, GENE DEV, V3, P1711, DOI 10.1101/gad.3.11.1711; TSIAPALIS CM, 1975, J BIOL CHEM, V250, P4486; WICKENS M, 1990, TRENDS BIOCHEM SCI, V15, P277, DOI 10.1016/0968-0004(90)90054-F; WINTERS MA, 1973, J BIOL CHEM, V248, P4756	37	114	116	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3131	3139						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993684				2022-12-25	WOS:A1991EX60000070
J	SUNG, MH; TANIZAWA, K; TANAKA, H; KURAMITSU, S; KAGAMIYAMA, H; HIROTSU, K; OKAMOTO, A; HIGUCHI, T; SODA, K				SUNG, MH; TANIZAWA, K; TANAKA, H; KURAMITSU, S; KAGAMIYAMA, H; HIROTSU, K; OKAMOTO, A; HIGUCHI, T; SODA, K			THERMOSTABLE ASPARTATE-AMINOTRANSFERASE FROM A THERMOPHILIC BACILLUS SPECIES - GENE CLONING, SEQUENCE DETERMINATION, AND PRELIMINARY-X-RAY CHARACTERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARCHAEBACTERIUM SULFOLOBUS-SOLFATARICUS; AMINO-ACID-SEQUENCE; PIG-HEART-MUSCLE; ESCHERICHIA-COLI; PURIFICATION	The gene encoding aspartate aminotransferase of a thermophilic Bacillus species, YM-2, has been cloned and expressed efficiently in Escherichia coli. The primary structure of the enzyme was deduced from nucleotide sequences of the gene and confirmed mostly by amino acid sequences of tryptic peptides. The gene consists of 1,176 base pairs encoding a protein of 392 amino acid residues; the molecular mass of the enzyme subunit is estimated to be 42,661 daltons. The active site lysyl residue that binds the coenzyme pyridoxal phosphate, was identified as Lys-239. Comparison of the amino acid sequence with those of aspartate aminotransferases from other organisms revealed very low overall similarities (13-14%) except for the sequence of the extremely thermostable enzyme from Sulfolobus solfataricus (34%). Several amino acid residues conserved in all the compared sequences include those that have been reported to participate in binding of the coenzyme in three-dimensional structures of the vertebrate and E. coli enzymes. However, the strictly conserved arginyl residue that is essential for binding of the distal carboxyl group of substrates is not found in the corresponding region of the sequences of the thermostable enzymes from the Bacillus species and S. solfataricus. The Bacillus aspartate aminotransferase has been purified from the E. coli clone cell extracts on a large scale and crystallized in the buffered ammonium sulfate solution by the hanging drop method. The crystals are monoclinic with unit cell dimensions a = 121.2 angstrom, b = 110.5 angstrom, c = 81.8 angstrom, and beta = 97.6-degrees, belonging to space group C2, and contain two molecules in the asymmetric unit. The crystals of the enzyme-alpha-methylaspartate complex are isomorphous with those without the substrate analog.	KYOTO UNIV,INST CHEM RES,UJI,KYOTO 611,JAPAN; OSAKA MED COLL,DEPT MED CHEM,TAKATSUKI,OSAKA 569,JAPAN; OSAKA CITY UNIV,FAC SCI,DEPT CHEM,SUMIYOSHI KU,OSAKA 558,JAPAN	Kyoto University; Osaka Medical College; Osaka Metropolitan University								Arnone A, 1985, TRANSAMINASES, P138; BARRA D, 1980, EUR J BIOCHEM, V108, P405, DOI 10.1111/j.1432-1033.1980.tb04736.x; BORISOV VV, 1985, TRANSAMINASES, P155; Christen P, 1985, TRANSAMINASES; CONNELL C, 1987, BIOTECHNIQUES, V5, P342; CUBELLIS MV, 1989, EUR J BIOCHEM, V186, P375, DOI 10.1111/j.1432-1033.1989.tb15219.x; DOONAN S, 1975, BIOCHEM J, V149, P497, DOI 10.1042/bj1490497d; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; INOUE Y, 1989, J BIOL CHEM, V264, P9673; JANSONIUS JN, 1985, TRANSAMINASES, P110; KAGAMIYAMA H, 1980, J BIOL CHEM, V255, P6153; KAMITORI S, 1988, J BIOCHEM-TOKYO, V104, P317, DOI 10.1093/oxfordjournals.jbchem.a122464; KONDO K, 1987, J BIOL CHEM, V262, P8648; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maniatis T., 1982, MOL CLONING; MARINO G, 1988, J BIOL CHEM, V263, P12305; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MCALLISTER WT, 1981, J MOL BIOL, V153, P527, DOI 10.1016/0022-2836(81)90406-X; MEHTA PK, 1989, EUR J BIOCHEM, V186, P249, DOI 10.1111/j.1432-1033.1989.tb15202.x; OVCHINNIKOV YA, 1973, FEBS LETT, V29, P31, DOI 10.1016/0014-5793(73)80008-0; SAITO H, 1963, BIOCHIM BIOPHYS ACTA, V72, P619, DOI 10.1016/0926-6550(63)90386-4; SAKABE N, 1983, J APPL CRYSTALLOGR, V16, P542, DOI 10.1107/S0021889883010973; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SMITH DL, 1989, BIOCHEMISTRY-US, V28, P8161, DOI 10.1021/bi00446a030; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SUNG MH, 1990, J BACTERIOL, V172, P1345, DOI 10.1128/jb.172.3.1345-1351.1990; SUNG MH, 1987, AGR BIOL CHEM TOKYO, V52, P269; TANIZAWA K, 1989, J BIOL CHEM, V264, P2445; [No title captured]	30	62	64	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2567	2572						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1990006				2022-12-25	WOS:A1991EV51500084
J	DUPREZ, V; FERRER, M; CORNET, V; OLIVE, D; DAUTRYVARSAT, A				DUPREZ, V; FERRER, M; CORNET, V; OLIVE, D; DAUTRYVARSAT, A			MODULATION OF INTERLEUKIN-2 INTERNALIZATION AND INTERLEUKIN 2-DEPENDENT CELL-GROWTH BY ANTIRECEPTOR ANTIBODIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY RECEPTORS; ATP-BINDING-SITE; HUMAN T-CELLS; MONOCLONAL-ANTIBODIES; INSULIN-RECEPTOR; MEDIATED ENDOCYTOSIS; SIGNAL TRANSDUCTION; POINT MUTATION; BETA-CHAIN; A431 CELLS	The growth factor interleukin 2 (IL2) binds to and is internalized together with high-affinity surface receptors present on lymphoid cells. This endocytosis thus results in down-regulation of the receptors. However it is not known if the internalization is relevant to the induction of cell growth. In the present study a rat monoclonal antibody to the P55 chain of the IL2 receptor was used to examine the role of receptor internalization in the IL2-dependent autocrine human tumor T cell line IARC 301. When given alone, this antibody did not inhibit IL2 binding, internalization, or IL2-dependent cell proliferation. However, cross-linking by anti-rat immunoglobulins, which did not affect binding of the growth factor, inhibited both IL2 internalization and cell proliferation. Besides offering a novel means for the specific inhibition of the uptake of IL2 bound to IL2 high-affinity receptors, the results are compatible with the association of this receptor-ligand uptake to the growth stimulation by IL2.	INST NATL RECH MED,U119,F-13009 MARSEILLE,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm)	DUPREZ, V (corresponding author), INST PASTEUR,CNRS,URA 361,UNITE GENET SOMAT,25 RUE DR ROUX,F-75724 PARIS 15,FRANCE.							AGGARWAL BB, 1986, J BIOL CHEM, V261, P3652; CANTRELL DA, 1983, J EXP MED, V158, P1895, DOI 10.1084/jem.158.6.1895; CANTRELL DA, 1984, SCIENCE, V224, P1312, DOI 10.1126/science.6427923; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; DEFIZE LHK, 1989, J CELL BIOL, V109, P2495, DOI 10.1083/jcb.109.5.2495; DEPPER JM, 1984, J IMMUNOL, V133, P1691; DUKOVICH M, 1987, NATURE, V327, P518, DOI 10.1038/327518a0; DUPREZ V, 1988, J BIOL CHEM, V263, P12860; DUPREZ V, 1986, J BIOL CHEM, V261, P5450; DUPREZ V, 1985, P NATL ACAD SCI USA, V82, P6932, DOI 10.1073/pnas.82.20.6932; EDELMAN GM, 1976, SCIENCE, V192, P218, DOI 10.1126/science.769162; FALTYNEK CR, 1988, J BIOL CHEM, V263, P7112; FERNANDEZPOL JA, 1985, J BIOL CHEM, V260, P5003; FUJII M, 1986, J IMMUNOL, V137, P1552; FUJII M, 1986, J EXP MED, V163, P550, DOI 10.1084/jem.163.3.550; FUNG MR, 1988, J EXP MED, V168, P1923, DOI 10.1084/jem.168.5.1923; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; GOOTENBERG JE, 1981, J EXP MED, V154, P1403, DOI 10.1084/jem.154.5.1403; HEFFETZ D, 1986, J BIOL CHEM, V261, P889; HEMLER ME, 1984, P NATL ACAD SCI-BIOL, V81, P2172, DOI 10.1073/pnas.81.7.2172; HONEGGER AM, 1987, CELL, V51, P199, DOI 10.1016/0092-8674(87)90147-4; JACOBS S, 1978, SCIENCE, V200, P1283, DOI 10.1126/science.663609; KAHN CR, 1978, P NATL ACAD SCI USA, V75, P4209, DOI 10.1073/pnas.75.9.4209; KAWAMOTO T, 1983, P NATL ACAD SCI-BIOL, V80, P1337, DOI 10.1073/pnas.80.5.1337; KING AC, 1982, J BIOL CHEM, V257, P3053; KUMAR A, 1987, J IMMUNOL, V139, P3680; LEONARD WJ, 1982, NATURE, V300, P267, DOI 10.1038/300267a0; LESLEY JF, 1985, MOL CELL BIOL, V5, P1814, DOI 10.1128/MCB.5.8.1814; MILLS GB, 1988, CELL, V55, P91, DOI 10.1016/0092-8674(88)90012-8; MOOLENAAR WH, 1988, EMBO J, V7, P707, DOI 10.1002/j.1460-2075.1988.tb02866.x; OLIVE D, 1986, EUR J IMMUNOL, V16, P611, DOI 10.1002/eji.1830160605; ROBB RJ, 1984, J EXP MED, V160, P1126, DOI 10.1084/jem.160.4.1126; ROBB RJ, 1987, P NATL ACAD SCI USA, V84, P2002, DOI 10.1073/pnas.84.7.2002; ROBB RJ, 1981, J EXP MED, V154, P1455, DOI 10.1084/jem.154.5.1455; ROBB RJ, 1987, J EXP MED, V165, P1201, DOI 10.1084/jem.165.4.1201; ROBB RJ, 1988, P NATL ACAD SCI USA, V85, P5654, DOI 10.1073/pnas.85.15.5654; SCHECHTER Y, 1978, P NATL ACAD SCI USA, V75, P5788; SCHREIBER AB, 1983, J BIOL CHEM, V258, P846; SHARON M, 1986, SCIENCE, V234, P859, DOI 10.1126/science.3095922; SIEGEL JP, 1987, SCIENCE, V238, P75, DOI 10.1126/science.3116668; SMITH KA, 1985, P NATL ACAD SCI USA, V82, P864, DOI 10.1073/pnas.82.3.864; SMITH KA, 1988, ADV IMMUNOL, V42, P165, DOI 10.1016/S0065-2776(08)60844-5; TAETLE R, 1986, CANCER RES, V46, P1759; TESHIGAWARA K, 1987, J EXP MED, V165, P223, DOI 10.1084/jem.165.1.223; TRISCHITTA V, 1989, J BIOL CHEM, V264, P5041; TSUDO M, 1986, P NATL ACAD SCI USA, V83, P9694, DOI 10.1073/pnas.83.24.9694; TSUDO M, 1987, P NATL ACAD SCI USA, V84, P5394, DOI 10.1073/pnas.84.15.5394; WAKSHULL EM, 1985, P NATL ACAD SCI USA, V82, P8513, DOI 10.1073/pnas.82.24.8513; WANG HM, 1987, J EXP MED, V166, P1055, DOI 10.1084/jem.166.4.1055; WEISSMAN AM, 1986, P NATL ACAD SCI USA, V83, P1463, DOI 10.1073/pnas.83.5.1463	50	27	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1497	1501						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1988432				2022-12-25	WOS:A1991EU49700025
J	MITCHELL, CD; VENTRIS, JA; WARR, TJ; COWELL, JK				MITCHELL, CD; VENTRIS, JA; WARR, TJ; COWELL, JK			MOLECULAR DEFINITION IN A SOMATIC-CELL HYBRID OF A SPECIFIC 2-13 TRANSLOCATION BREAKPOINT IN CHILDHOOD RHABDOMYOSARCOMA	ONCOGENE			English	Article							RETINOBLASTOMA SUSCEPTIBILITY LOCUS; ESTERASE-D GENE; CHROMOSOMAL TRANSLOCATION; ALVEOLAR RHABDOMYOSARCOMA; DNA; FRAGMENTS; SEQUENCES; LINKAGE	A consistent, balanced, reciprocal chromosomal translocation t(2:13) (q35:q14) has been identified in alveolar rhabdomyosarcoma. Somatic cell hybrids have been constructed between rhabdomyosarcoma cell lines carrying the (2:13) translocation and mouse 3T3 cells. One hybrid cell line was shown to have retained the derivative (13:2) chromosome, but segregated the normal chromosome 13 and the derivative (2:13) chromosome. Using available DNA probes from human chromosome 13 we find that the loci for retinoblastoma, esterase D, p7D2, pG24E6.8 and pG14E1.9 lie distally to the 13q14 breakpoint, whereas those for p7F12, pHU10 and pG2E3.1 all lie proximally. Thus we have defined a region of 13q14 of approximately 28 mB which contains the breakpoint associated with this rearrangement.	INST CHILD HLTH,IMPERIAL CANC RES FUND,MOLEC ONCOL LAB,LONDON WC1N 1EH,ENGLAND	Cancer Research UK; University of London; University College London	MITCHELL, CD (corresponding author), INST CHILD HLTH,LEUKAEMIA RES FUND,DEPT HAEMATOL & ONCOL,GUILFORD ST,LONDON WC1N 1EH,ENGLAND.			Cowell, John/0000-0002-2079-5950				BOWCOCK AM, 1987, AM J HUM GENET, V41, P27; BOWCOCK AM, 1988, AM J HUM GENET, V43, P664; CAVENEE W, 1984, AM J HUM GENET, V36, P10; COWELL JK, 1980, J NATL CANCER I, V65, P955; COWELL JK, 1989, CYTOGENET CELL GENET, V52, P1, DOI 10.1159/000132827; COWELL JK, 1986, HUMAN CYTOGENETICS P, P202; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; DOUGLASS EC, 1987, CYTOGENET CELL GENET, V45, P148, DOI 10.1159/000132446; DRYJA TP, 1984, HUM GENET, V65, P320, DOI 10.1007/BF00291555; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRIEND SH, 1987, P NATL ACAD SCI USA, V84, P9059, DOI 10.1073/pnas.84.24.9059; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; HAYASHI Y, 1988, CANCER GENET CYTOGEN, V30, P343, DOI 10.1016/0165-4608(88)90208-7; HIGGINS MJ, 1990, P NATL ACAD SCI USA, V87, P3415, DOI 10.1073/pnas.87.9.3415; HIGGINS MJ, 1989, MOL CELL BIOL, V9, P1; LEPPERT M, 1987, HUMAN GENE MAPPING, V9; MITCHELL CD, 1988, HUM GENET, V81, P57, DOI 10.1007/BF00283730; MITCHELL CD, 1989, ONCOGENE, V4, P253; MORIYAMA M, 1986, CANCER GENET CYTOGEN, V22, P177, DOI 10.1016/0165-4608(86)90204-9; ROWE D, 1987, BRIT J CANCER, V56, P379, DOI 10.1038/bjc.1987.207; Sambrook J, 1989, MOL CLONING LABORATO; SCHEFFER H, 1986, HUM GENET, V74, P249, DOI 10.1007/BF00282543; SCHEFFER H, 1986, NUCLEIC ACIDS RES, V14, P3148, DOI 10.1093/nar/14.7.3148; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SQUIRE J, 1986, P NATL ACAD SCI USA, V83, P6573, DOI 10.1073/pnas.83.17.6573; SQUIRE J, 1985, HUM GENET, V70, P291, DOI 10.1007/BF00295364; TURCCAREL C, 1986, CANCER GENET CYTOGEN, V19, P361, DOI 10.1016/0165-4608(86)90069-5; VALENTINE M, 1989, CYTOGENET CELL GENET, V52, P128, DOI 10.1159/000132861; YOUNG BD, 1988, BRIT J CANCER, V58, P58	29	22	22	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1991	6	1					89	92						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY039	1992447				2022-12-25	WOS:A1991EY03900012
J	WAITZ, W; LOIDL, P				WAITZ, W; LOIDL, P			CELL-CYCLE DEPENDENT ASSOCIATION OF C-MYC PROTEIN WITH THE NUCLEAR MATRIX	ONCOGENE			English	Article							PHYSARUM-POLYCEPHALUM; DNA-REPLICATION; MESSENGER-RNA; V-MYC; TRANSCRIPTIONAL ENHANCER; GENE; EXPRESSION; ONCOGENES; ORGANIZATION; LOCALIZATION	We demonstrate the presence of a c-myc protein with an apparent molecular weight of 67 kd in the lower eukaryote Physarum polycephalum with polyclonal and monoclonal anti-c-myc-antibodies. It is shown that the amount of myc protein present in the nucleus does not fluctuate during the naturally synchronous cell cycle of Physarum. The myc protein remains firmly associated with the nuclear matrix after a variety of matrix preparation procedures. Although the level of c-myc protein is invariant during the cell cycle, the matrix-bound portion of c-myc protein is higher during S-phase as compared to G2-period. In immunoelectron microscopy the immunosignal was considerably stronger in the nuclear matrix compared with unfractionated nuclei, indicating increased accessibility of c-myc protein in nuclear scaffold structures. We show that the nuclear localization of c-myc protein changes during the cell cycle, being transiently but specifically bound to the periphery of the nuclear matrix structure during S-phase.	UNIV INNSBRUCK, FAK MED, INST MIKROBIOL, FRITZ PREGLSTR 3, A-6020 INNSBRUCK, AUSTRIA; INST PATHOL ANAT, A-6020 INNSBRUCK, AUSTRIA	University of Innsbruck								ALITALO K, 1983, NATURE, V306, P274, DOI 10.1038/306274a0; ARIGA H, 1989, EMBO J, V8, P4273, DOI 10.1002/j.1460-2075.1989.tb08613.x; BISHOP JM, 1983, ANNU REV BIOCHEM, V52, P301, DOI 10.1146/annurev.bi.52.070183.001505; CAMPISI J, 1984, CELL, V36, P241, DOI 10.1016/0092-8674(84)90217-4; CLASSON M, 1987, NATURE, V330, P272, DOI 10.1038/330272a0; COOPER S, 1988, J THEOR BIOL, V135, P393, DOI 10.1016/S0022-5193(88)80253-4; Daniel J. W., 1964, METHOD CELL PHYSIOL, P9; EISENMAN RN, 1985, MOL CELL BIOL, V5, P114, DOI 10.1128/MCB.5.1.114; EVAN GI, 1985, CELL, V43, P253, DOI 10.1016/0092-8674(85)90030-3; FISHER JM, 1988, CELL, V54, P813, DOI 10.1016/S0092-8674(88)91131-2; GASSER SM, 1986, EMBO J, V5, P511, DOI 10.1002/j.1460-2075.1986.tb04240.x; GROBNER P, 1985, BIOCHEM J, V232, P21; HANN SR, 1983, CELL, V34, P789, DOI 10.1016/0092-8674(83)90535-4; HANN SR, 1985, NATURE, V314, P366, DOI 10.1038/314366a0; IGUCHIARIGA SMM, 1987, EMBO J, V6, P2365, DOI 10.1002/j.1460-2075.1987.tb02513.x; IGUCHIARIGA SMM, 1988, EMBO J, V7, P3135, DOI 10.1002/j.1460-2075.1988.tb03180.x; JACKSON DA, 1985, EMBO J, V4, P913, DOI 10.1002/j.1460-2075.1985.tb03718.x; KARNJ, 1989, ONCOGENE, V4, P773; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LEBKOWSKI JS, 1982, J MOL BIOL, V156, P325, DOI 10.1016/0022-2836(82)90332-1; LOIDL P, 1987, J BIOL CHEM, V262, P10195; LUSCHER B, 1989, EMBO J, V8, P1111, DOI 10.1002/j.1460-2075.1989.tb03481.x; MIRKOVITCH J, 1984, CELL, V39, P223, DOI 10.1016/0092-8674(84)90208-3; NEWMAN GR, 1989, COLLOIDAL GOLD PRINC, V2, P47; NOTHACKER KD, 1986, EUR J CELL BIOL, V39, P278; OKUDA A, 1989, EXP CELL RES, V185, P258, DOI 10.1016/0014-4827(89)90054-2; PERSSON H, 1984, SCIENCE, V225, P718, DOI 10.1126/science.6463648; RABBITTS PH, 1985, EMBO J, V4, P2009, DOI 10.1002/j.1460-2075.1985.tb03885.x; ROTH J, 1978, J HISTOCHEM CYTOCHEM, V26, P1074, DOI 10.1177/26.12.366014; SHEINESS D, 1979, J VIROL, V31, P514, DOI 10.1128/JVI.31.2.514-521.1979; SLAMON DJ, 1984, SCIENCE, V224, P256, DOI 10.1126/science.6538699; SPECTOR DL, 1987, ONCOGENE, V1, P5; STUDZINSKI GP, 1986, SCIENCE, V234, P467, DOI 10.1126/science.3532322; THOMPSON CB, 1985, NATURE, V314, P363, DOI 10.1038/314363a0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Turnock G, 1979, Prog Nucleic Acid Res Mol Biol, V23, P53; VANSTRAATEN JP, 1987, ONCOGENE RES, V1, P221; VAUGHN JP, 1990, NUCLEIC ACIDS RES, V18, P1965, DOI 10.1093/nar/18.8.1965; WAITZ W, 1988, J CELL SCI, V90, P621	41	68	70	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	1991	6	1					29	35						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY039	1992443				2022-12-25	WOS:A1991EY03900004
J	PRINCE, WS; VILLAREJO, MR				PRINCE, WS; VILLAREJO, MR			OSMOTIC CONTROL OF PROU TRANSCRIPTION IS MEDIATED THROUGH DIRECT ACTION OF POTASSIUM GLUTAMATE ON THE TRANSCRIPTION COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV CALIF DAVIS,DEPT BIOCHEM & BIOPHYS,DAVIS,CA 95616	University of California System; University of California Davis					NIGMS NIH HHS [GM-33778] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033778] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAKKER EP, 1987, J BACTERIOL, V169, P3743, DOI 10.1128/jb.169.8.3743-3749.1987; BARRON A, 1986, J BACTERIOL, V167, P433, DOI 10.1128/jb.167.2.433-438.1986; BOWLUS RD, 1979, J EXP ZOOL, V208, P137, DOI 10.1002/jez.1402080202; BROSIUS J, 1984, GENE, V27, P151, DOI 10.1016/0378-1119(84)90136-7; CASTLE AM, 1986, J BIOL CHEM, V261, P7797; CHAMBERLIN M, 1983, METHOD ENZYMOL, V101, P540; COMEAU DE, 1985, J BACTERIOL, V164, P578, DOI 10.1128/JB.164.2.578-584.1985; DEHASETH P L, 1978, Biochemistry, V17, P1612, DOI 10.1021/bi00602a006; DINNIBIER U, 1988, ARCH MICROBIOL, V150, P348, DOI 10.1007/BF00408306; DOI RH, 1986, MICROBIOL REV, V50, P227, DOI 10.1128/MMBR.50.3.227-243.1986; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; DRUGERLIOTTA J, 1987, J BACTERIOL, V169, P2449, DOI 10.1128/jb.169.6.2449-2459.1987; EPSTEIN W, 1965, J GEN PHYSIOL, V49, P221, DOI 10.1085/jgp.49.2.221; GOWRISHANKAR J, 1989, J BACTERIOL, V171, P1923, DOI 10.1128/jb.171.4.1923-1931.1989; HIGGINS CF, 1988, CELL, V52, P569, DOI 10.1016/0092-8674(88)90470-9; JOVANOVICH SB, 1989, J BIOL CHEM, V264, P7821; LAIMINS LA, 1981, P NATL ACAD SCI-BIOL, V78, P464, DOI 10.1073/pnas.78.1.464; LARSEN PI, 1987, ARCH MICROBIOL, V147, P1, DOI 10.1007/BF00492896; LEIRMO S, 1987, BIOCHEMISTRY-US, V26, P2095, DOI 10.1021/bi00382a006; LERUDULIER D, 1984, SCIENCE, V224, P1064, DOI 10.1126/science.224.4653.1064; Maniatis T., 1982, MOL CLONING; MATOH T, 1987, PLANT PHYSIOL, V84, P173, DOI 10.1104/pp.84.1.173; MAY G, 1986, MOL GEN GENET, V205, P225, DOI 10.1007/BF00430432; MAY G, 1989, MOL MICROBIOL, V3, P1521, DOI 10.1111/j.1365-2958.1989.tb00138.x; MCCAMAN MT, 1982, J BACTERIOL, V152, P848; MCCAMAN MT, 1986, MOL GEN GENET, V204, P148, DOI 10.1007/BF00330202; MEASURES JC, 1975, NATURE, V257, P398, DOI 10.1038/257398a0; NAKANISHI T, 1988, AM J PHYSIOL, V255, P181; OVERDIER DG, 1989, J BACTERIOL, V171, P4694, DOI 10.1128/jb.171.9.4694-4706.1989; PERROUD B, 1985, J BACTERIOL, V161, P393, DOI 10.1128/JB.161.1.393-401.1985; RAMIREZ RM, 1989, P NATL ACAD SCI USA, V86, P1153, DOI 10.1073/pnas.86.4.1153; RICHEY B, 1987, J BIOL CHEM, V262, P7157; SHANER SL, 1982, BIOCHEMISTRY-US, V21, P5539, DOI 10.1021/bi00265a025; Shaw W V, 1975, Methods Enzymol, V43, P737; SLONCZEWSKI JL, 1981, P NATL ACAD SCI-BIOL, V78, P6271, DOI 10.1073/pnas.78.10.6271; STIRLING DA, 1989, MOL MICROBIOL, V3, P1025, DOI 10.1111/j.1365-2958.1989.tb00253.x; SUTHERLAND L, 1986, J BACTERIOL, V168, P805, DOI 10.1128/jb.168.2.805-814.1986; THOMA WJ, 1986, BIOCHEM BIOPH RES CO, V138, P1106, DOI 10.1016/S0006-291X(86)80396-5; XU HS, 1982, MICROBIAL ECOL, V8, P313, DOI 10.1007/BF02010671; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	41	73	74	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1990	265	29					17673	17679						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC766	1976630				2022-12-25	WOS:A1990EC76600050
J	PRYDZ, K; BRANDLI, AW; BOMSEL, M; SIMONS, K				PRYDZ, K; BRANDLI, AW; BOMSEL, M; SIMONS, K			SURFACE DISTRIBUTION OF THE MANNOSE 6-PHOSPHATE RECEPTORS IN EPITHELIAL MADIN-DARBY CANINE KIDNEY-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									EUROPEAN MOLEC BIOL LAB,POSTFACH 102209,W-6900 HEIDELBERG,GERMANY; CNRS,ER64,F-75270 PARIS 06,FRANCE	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS)			Bomsel, Morgane/GSN-1948-2022; Brandli, Andre/N-1620-2013	Brandli, Andre/0000-0002-8932-3644; Simons, Kai/0000-0002-9231-9996; Bomsel, Morgane/0000-0002-9577-7474				BENNETT MK, 1988, EMBO J, V7, P4075, DOI 10.1002/j.1460-2075.1988.tb03301.x; BLEEKEMOLEN JE, 1988, EUR J CELL BIOL, V47, P366; BOMSEL M, 1989, J CELL BIOL, V109, P3243, DOI 10.1083/jcb.109.6.3243; BRANDLI AW, 1989, EMBO J, V8, P3207, DOI 10.1002/j.1460-2075.1989.tb08479.x; BRANDLI AW, 1988, J BIOL CHEM, V263, P16283; BREITFELD PP, 1989, J CELL BIOL, V109, P475, DOI 10.1083/jcb.109.2.475; DAHMS NM, 1989, J BIOL CHEM, V264, P12115; DAHMS NM, 1987, CELL, V50, P181, DOI 10.1016/0092-8674(87)90214-5; DUNCAN JR, 1988, J CELL BIOL, V106, P617, DOI 10.1083/jcb.106.3.617; FULLER S, 1984, CELL, V38, P65, DOI 10.1016/0092-8674(84)90527-0; GLICKMAN JN, 1989, EMBO J, V8, P1041, DOI 10.1002/j.1460-2075.1989.tb03471.x; GODA Y, 1988, CELL, V55, P309, DOI 10.1016/0092-8674(88)90054-2; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; HEMMILA I, 1984, ANAL BIOCHEM, V137, P335, DOI 10.1016/0003-2697(84)90095-2; HOFLACK B, 1985, P NATL ACAD SCI USA, V82, P4428, DOI 10.1073/pnas.82.13.4428; HOFLACK B, 1985, J BIOL CHEM, V260, P2008; JIN M, 1989, J BIOL CHEM, V264, P7675; KORNFELD S, 1987, FASEB J, V1, P462, DOI 10.1096/fasebj.1.6.3315809; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; LOBEL P, 1989, CELL, V57, P787, DOI 10.1016/0092-8674(89)90793-9; LOBEL P, 1988, J BIOL CHEM, V263, P2563; MACDONALD RG, 1988, SCIENCE, V239, P1134, DOI 10.1126/science.2964083; MEISS HK, 1982, MOL CELL BIOL, V2, P1287, DOI 10.1128/MCB.2.10.1287; MORGAN DO, 1987, NATURE, V329, P301, DOI 10.1038/329301a0; MOSTOV KE, 1986, CELL, V47, P359, DOI 10.1016/0092-8674(86)90592-1; OKA Y, 1985, J BIOL CHEM, V260, P9435; PARTON RG, 1989, J CELL BIOL, V109, P3259, DOI 10.1083/jcb.109.6.3259; PEARSE BMF, 1988, EMBO J, V7, P3331, DOI 10.1002/j.1460-2075.1988.tb03204.x; PFEFFER SR, 1988, J MEMBRANE BIOL, V103, P7, DOI 10.1007/BF01871928; PFEFFER SR, 1987, ANNU REV BIOCHEM, V56, P829, DOI 10.1146/annurev.biochem.56.1.829; POHLMANN R, 1987, P NATL ACAD SCI USA, V84, P5575, DOI 10.1073/pnas.84.16.5575; RICHARDSON JCW, 1981, BIOCHIM BIOPHYS ACTA, V673, P26, DOI 10.1016/0304-4165(81)90307-X; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; SAHAGIAN GG, 1984, BIOL CELL, V51, P207, DOI 10.1111/j.1768-322X.1984.tb00300.x; SARGIACOMO M, 1989, J MEMBRANE BIOL, V107, P277, DOI 10.1007/BF01871942; SIMONS K, 1985, ANNU REV CELL BIOL, V1, P243, DOI 10.1146/annurev.cb.01.110185.001331; STEIN M, 1987, EMBO J, V6, P2677, DOI 10.1002/j.1460-2075.1987.tb02559.x; VONBONSDORFF CH, 1985, EMBO J, V4, P2781, DOI 10.1002/j.1460-2075.1985.tb04004.x; VONFIGURA K, 1984, EMBO J, V3, P1281, DOI 10.1002/j.1460-2075.1984.tb01963.x; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167; WANDINGERNESS A, 1990, IN PRESS J BIOL CHEM; WANDINGERNESS A, 1990, IN PRESS INTRACELLUL	42	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 25	1990	265	21					12629	12635						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DP458	1973688				2022-12-25	WOS:A1990DP45800077
J	DATI, C; ANTONIOTTI, S; TAVERNA, D; PERROTEAU, I; DEBORTOLI, M				DATI, C; ANTONIOTTI, S; TAVERNA, D; PERROTEAU, I; DEBORTOLI, M			INHIBITION OF C-ERBB-2 ONCOGENE EXPRESSION BY ESTROGENS IN HUMAN BREAST-CANCER CELLS	ONCOGENE			English	Article									UNIV TURIN,DEPT ANIM BIOL,MOLEC CELL BIOL LAB,VIA ACC ALBERTINA 17,I-10123 TURIN,ITALY	University of Turin			taverna, daniela/J-8358-2016; De Bortoli, Michele/B-5418-2013	taverna, daniela/0000-0002-6365-527X; De Bortoli, Michele/0000-0002-6666-9052; Perroteau, Isabelle/0000-0001-9797-2276				ADNANE J, 1989, ONCOGENE, V4, P1389; ALONSO S, 1986, J MOL EVOL, V23, P11, DOI 10.1007/BF02100994; ARMELIN HA, 1973, P NATL ACAD SCI USA, V70, P2702, DOI 10.1073/pnas.70.9.2702; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BERGER MS, 1988, CANCER RES, V48, P1238; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; COWLEY BD, 1989, J BIOL CHEM, V264, P8389; DEBORTOLI M, 1986, ENDOCRINOLOGY MALIGN, P104; DEBORTOLI ME, 1985, BIOCHEM BIOPH RES CO, V127, P699, DOI 10.1016/S0006-291X(85)80218-7; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GUERIN M, 1988, ONCOGENE RES, V3, P21; GULLICK WJ, 1987, INT J CANCER, V40, P246, DOI 10.1002/ijc.2910400221; HISSOM JR, 1989, ENDOCRINOLOGY, V125, P418, DOI 10.1210/endo-125-1-418; HYNES NE, 1989, J CELL BIOCHEM, V39, P167, DOI 10.1002/jcb.240390208; ISHII S, 1987, P NATL ACAD SCI USA, V84, P4374, DOI 10.1073/pnas.84.13.4374; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; KRUIJER W, 1984, NATURE, V312, P711, DOI 10.1038/312711a0; LACROIX H, 1989, ONCOGENE, V4, P145; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; MURPHY LJ, 1986, CANCER RES, V46, P728; NISHIKURA K, 1983, P NATL ACAD SCI-BIOL, V80, P4822, DOI 10.1073/pnas.80.15.4822; SCHECHTER AL, 1985, SCIENCE, V229, P976, DOI 10.1126/science.2992090; SHIU RPC, 1984, CANCER RES, V44, P1178; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; TAL M, 1987, MOL CELL BIOL, V7, P2597, DOI 10.1128/MCB.7.7.2597; THOMAS DB, 1984, CANCER-AM CANCER SOC, V53, P595, DOI 10.1002/1097-0142(19840201)53:3+<595::AID-CNCR2820531304>3.0.CO;2-Y; THOMPSON NL, 1986, CANCER RES, V46, P3111; TSUDA H, 1989, CANCER RES, V49, P3104; VANDERBURG B, 1989, MOL CELL ENDOCRINOL, V64, P223, DOI 10.1016/0303-7207(89)90149-4; VARLEY JM, 1987, ONCOGENE, V1, P423; VENTER DJ, 1987, LANCET, V2, P69, DOI 10.1016/S0140-6736(87)92736-X; Vonderhaar B, 1984, CONTROL CELL GROWTH, P11; Vonderhaar B. K., 1985, Biological Responses in Cancer, V4, P125; WRIGHT C, 1989, CANCER RES, V49, P2087; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0	41	167	190	0	7	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUL	1990	5	7					1001	1006						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP415	1973827				2022-12-25	WOS:A1990DP41500007
J	EPSTEIN, RJ; DRUKER, BJ; ROBERTS, TM; STILES, CD				EPSTEIN, RJ; DRUKER, BJ; ROBERTS, TM; STILES, CD			MODULATION OF A MR 175,000 C-NEU RECEPTOR ISOFORM IN G8/DHFR CELLS BY SERUM STARVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									HARVARD UNIV,SCH MED,DIV MED,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	EPSTEIN, RJ (corresponding author), HARVARD UNIV,SCH MED,DIV CELL & MOLEC BIOL,44 BINNEY ST,BOSTON,MA 02115, USA.			Druker, Brian/0000-0001-8331-8206				AKIYAMA T, 1988, MOL CELL BIOL, V8, P1019, DOI 10.1128/MCB.8.3.1019; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BERGER MS, 1988, CANCER RES, V48, P1238; BROWN KD, 1984, BIOCHEM BIOPH RES CO, V123, P377, DOI 10.1016/0006-291X(84)90424-8; COUNTAWAY JL, 1989, J BIOL CHEM, V264, P13642; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; DERYNCK R, 1984, CELL, V38, P287, DOI 10.1016/0092-8674(84)90550-6; DICKER SJ, 1989, J BIOL CHEM, V264, P9204; GRAY A, 1983, NATURE, V303, P722, DOI 10.1038/303722a0; GREGORIOU M, 1984, EMBO J, V3, P929, DOI 10.1002/j.1460-2075.1984.tb01910.x; HUNG MC, 1986, P NATL ACAD SCI USA, V83, P261, DOI 10.1073/pnas.83.2.261; KADOWAKI T, 1987, BIOCHEM BIOPH RES CO, V144, P699, DOI 10.1016/S0006-291X(87)80021-9; KING AC, 1982, J BIOL CHEM, V257, P3053; KING CR, 1988, EMBO J, V7, P1647, DOI 10.1002/j.1460-2075.1988.tb02991.x; KOKAI Y, 1988, P NATL ACAD SCI USA, V85, P5389, DOI 10.1073/pnas.85.15.5389; LEE EYHP, 1988, SCIENCE, V241, P218, DOI 10.1126/science.3388033; LEE J, 1989, EMBO J, V8, P167, DOI 10.1002/j.1460-2075.1989.tb03361.x; LEHVASLAIHO H, 1989, EMBO J, V8, P159, DOI 10.1002/j.1460-2075.1989.tb03360.x; LUDLOW JW, 1989, CELL, V56, P57, DOI 10.1016/0092-8674(89)90983-5; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; SCHLESSINGER J, 1978, P NATL ACAD SCI USA, V75, P2659, DOI 10.1073/pnas.75.6.2659; SHOYAB M, 1979, NATURE, V279, P387, DOI 10.1038/279387a0; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; STERN DF, 1988, EMBO J, V7, P995, DOI 10.1002/j.1460-2075.1988.tb02906.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VARLEY JM, 1989, ONCOGENE, V4, P725; WRANN M, 1980, SCIENCE, V210, P1363, DOI 10.1126/science.6254158; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035	29	32	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 25	1990	265	18					10746	10751						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK851	1972380				2022-12-25	WOS:A1990DK85100088
J	RAO, NM; NAGARAJ, R				RAO, NM; NAGARAJ, R			ANOMALOUS STIMULATION OF ESCHERICHIA-COLI ALKALINE-PHOSPHATASE ACTIVITY IN GUANIDINIUM CHLORIDE - MODULATION OF THE RATE-LIMITING STEP AND NEGATIVE COOPERATIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL-CHANGES; SITES REACTIVITY; P-31 NMR; HYDROLYSIS; MECHANISM; KINETICS; PROTEINS; BINDING; STATE; HALF	Guanidinium chloride stimulates the activity of alkaline phosphatase from Escherichia coli, by 3-4-fold. Structural parameters of the enzyme, monitored by fluorescence and circular dichorism, indicate progressive denaturation. This unusual stimulation is shown to be independent of the nature of the substrate and source of the enzyme. Profiles of pH dependence and transphosphorylation reaction indicate that the dephosphorylation step of the catalysis is enhanced in the presence of guanidinium chloride. We demonstrate, by fast-flow kinetics and inhibitor titrations, that guanidinium chloride enhances activity by abolishing negative cooperativity and by accelerating the dissociation of rate-limiting enzyme and substrate (E.P) complex.			RAO, NM (corresponding author), CTR CELLULAR & MOLEC BIOL,UPPAL RD,HYDERABAD 500007,INDIA.							APPELBURY M L, 1969, Journal of Biological Chemistry, V244, P709; APPLEBUR.ML, 1970, J BIOL CHEM, V245, P4968; BALDWIN RL, 1989, TRENDS BIOCHEM SCI, V14, P291, DOI 10.1016/0968-0004(89)90067-4; BALDWIN RL, 1987, PROTEIN STRUCTURE FO, V2, P313; BLOCH W, 1973, J BIOL CHEM, V248, P5794; CHAIDAROGLOU A, 1988, BIOCHEMISTRY-US, V27, P8338, DOI 10.1021/bi00422a008; CHAPPELE.D, 1974, BIOCHEMISTRY-US, V13, P3754, DOI 10.1021/bi00715a022; CHAPPELE.D, 1974, BIOCHEMISTRY-US, V13, P1788, DOI 10.1021/bi00706a002; CHLEBOWSKI JF, 1976, J BIOL CHEM, V251, P1207; CHLEBOWSKI JF, 1972, J BIOL CHEM, V247, P6007; CHLEBOWSKI JF, 1974, J BIOL CHEM, V249, P7192; COLEMAN JE, 1983, ADV ENZYMOL RAMB, V55, P381; COLEMAN JE, 1983, J BIOL CHEM, V258, P386; DAYAN J, 1964, BIOCHIM BIOPHYS ACTA, V81, P620, DOI 10.1016/0926-6569(64)90154-3; DELARCO A, 1982, INT J BIOCHEM, V14, P127, DOI 10.1016/0020-711X(82)90152-5; FERNLEY HN, 1969, BIOCHEM J, V111, P187, DOI 10.1042/bj1110187; FERNLEY HN, 1968, BIOCHEM J, V110, pP11; Fersht A., 1985, ENZYME STRUCTURE MEC; GAREN A, 1960, BIOCHIM BIOPHYS ACTA, V38, P470, DOI 10.1016/0006-3002(60)91282-8; GETTINS P, 1983, J BIOL CHEM, V258, P408; GETTINS P, 1985, J BIOL CHEM, V260, P2875; GETTINS P, 1984, J BIOL CHEM, V259, P4991; Ghelis C., 1982, PROTEIN FOLDING; GOTTESMAN M, 1969, BIOCHEMISTRY-US, V8, P3776, DOI 10.1021/bi00837a043; HARRIS MI, 1968, J BIOL CHEM, V243, P5063; HEPPEL LA, 1962, J BIOL CHEM, V237, P641; HORWITZ JP, 1966, J MED CHEM, V9, P447, DOI 10.1021/jm00321a059; HULL WE, 1976, BIOCHEMISTRY-US, V15, P1547, DOI 10.1021/bi00652a028; JONES SR, 1978, NATURE, V275, P564, DOI 10.1038/275564a0; KENDALL A, 1988, ENZYME DYNAMICS REGU, P411; KIM PS, 1982, ANNU REV BIOCHEM, V51, P459, DOI 10.1146/annurev.bi.51.070182.002331; LAZDUNSKI C, 1969, EUR J BIOCHEM, V7, P294, DOI 10.1111/j.1432-1033.1969.tb19606.x; LAZDUNSKI M, 1972, CURRENT TOPICS CELLU, V6, P267; Levitzki A, 1976, Curr Top Cell Regul, V10, P1; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Malymy M., 1966, METHODS ENZYMOLOGY, V9, P639, DOI [10.1016/0076-6879(66)09129-8, DOI 10.1016/0076-6879(66)09129-8]; McComb Jr RB, 1979, ALKALINE PHOSPHATASE, DOI 10.1007/978-1-4613-2970-1_4; MCCRACKEN S, 1980, J BIOL CHEM, V255, P2396; MIGGIANO GAD, 1987, BIOCHEM J, V248, P551, DOI 10.1042/bj2480551; MORTON RK, 1958, BIOCHEM J, V70, P139, DOI 10.1042/bj0700139; Nozaki Y, 1972, Methods Enzymol, V26, P43; ROIG MG, 1982, INT J BIOCHEM, V14, P655, DOI 10.1016/0020-711X(82)90051-9; SCHWARTZ JH, 1963, P NATL ACAD SCI USA, V49, P871, DOI 10.1073/pnas.49.6.871; SIMPSON RT, 1970, BIOCHEMISTRY-US, V7, P953; Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7; TANFORD C, 1968, ADVANCES PROTEIN CHE, V23, P122; TEIPEL JW, 1971, BIOCHEMISTRY-US, V10, P792, DOI 10.1021/bi00781a011; TEIPEL JW, 1972, BIOCHEMISTRY-US, V11, P4100, DOI 10.1021/bi00772a012; TORRIANIGIRINI A, 1987, PHOSPHATE REGULATION; TSOU CL, 1986, TRENDS BIOCHEM SCI, V11, P427, DOI 10.1016/0968-0004(86)90178-7; VONHIPPEL PH, 1964, SCIENCE, V145, P577, DOI 10.1126/science.145.3632.577; WILSON IB, 1964, J BIOL CHEM, V239, P4182; WYCOFF HW, 1983, ADV ENZYMOL, V55, P453	53	16	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					5018	5024						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002044				2022-12-25	WOS:A1991FC21700053
J	VENEMA, RC; TRAUGH, JA				VENEMA, RC; TRAUGH, JA			PROTEIN-KINASE-C PHOSPHORYLATES GLUTAMYL-TRANSFER RNA-SYNTHETASE IN RABBIT RETICULOCYTES STIMULATED BY TUMOR PROMOTING PHORBOL ESTERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROMOLECULAR COMPLEXES; STRUCTURAL ORGANIZATION; ELONGATION-FACTOR; PURIFICATION; INITIATION; ELECTROPHORESIS; IDENTIFICATION; QUANTITATION; SHEEP; CELLS	A high M(r) synthetase core complex isolated from higher eukaryotes contains aminoacyl-tRNA synthetases specific for arginine, aspartic acid, glutamic acid, glutamine, isoleucine, leucine, lysine, methionine, and proline. Previously, five of the synthetases were shown to be phosphorylated in reticulocytes, and the glutaminyl- and aspartyl-tRNA synthetases were shown to be selectively phosphorylated in response to 8-bromo cAMP (Pendergast, A. M., Venema, R. C., and Traugh, J. A. (1987) J. Biol. Chem. 262, 5939-5942). Exposure of reticulocytes to phorbol 12-myristate 13-acetate stimulates the selective phosphorylation of one synthetase in the complex, glutamyl-tRNA synthetase. Only the glutamyl-tRNA synthetase is modified to a significant extent when the purified complex is phosphorylated in vitro by protein kinase C; up to 0.7 mol of phosphate is incorporated per mol of synthetase. Two-dimensional phosphopeptide mapping shows a single tryptic phosphopeptide, which is identical for the enzyme modified in vitro by protein kinase C or in phorbol 12-myristate 13-acetate-stimulated cells. Phosphorylation in vivo is reproducibly accompanied by a 38 +/- 10% reduction in aminoacylation activity of partially purified glutamyl-tRNA synthetase assayed in vitro. Phosphorylation in vitro has no detectable effect on aminoacylation. This difference may be due to the absence of a required effector molecule which alters activity by interaction with the phosphorylated synthetase. Glutamyl-tRNA synthetase is one of a growing number of translational components, including initiation factors, which are coordinately modified by protein kinase C in response to phorbol 12-myristate 13-acetate.			VENEMA, RC (corresponding author), UNIV CALIF RIVERSIDE,DEPT BIOCHEM,RIVERSIDE,CA 92521, USA.				NIGMS NIH HHS [GM21424] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021424] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEC G, 1989, J BIOL CHEM, V264, P21131; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CIRAKOGLU B, 1985, FEBS LETT, V183, P185; COHEN P, 1983, PHILOS T ROY SOC B, V302, P13, DOI 10.1098/rstb.1983.0034; DEUTSCHER MP, 1984, J CELL BIOL, V99, P373, DOI 10.1083/jcb.99.2.373; DUNCAN R, 1983, J BIOL CHEM, V258, P7228; FLOYD GA, 1980, EUR J BIOCHEM, V106, P269; GONZATTIHACES MI, 1986, J BIOL CHEM, V261, P5266; KELLERMANN O, 1982, J BIOL CHEM, V257, P1041; KELMERS AD, 1971, ANAL BIOCHEM, V44, P486, DOI 10.1016/0003-2697(71)90236-3; KIKKAWA U, 1989, ANNU REV BIOCHEM, V58, P31, DOI 10.1146/annurev.bi.58.070189.000335; KIM UH, 1989, J BIOL CHEM, V264, P20167; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MILBURN SC, 1990, ARCH BIOCHEM BIOPHYS, V276, P6, DOI 10.1016/0003-9861(90)90002-G; MIRANDE M, 1982, J BIOL CHEM, V257, P1049; MORLEY SJ, 1989, J BIOL CHEM, V264, P2401; MORLEY SJ, 1990, J BIOL CHEM, V265, P10611; MOTORIN YA, 1988, FEBS LETT, V238, P262, DOI 10.1016/0014-5793(88)80492-7; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; PENDERGAST AM, 1987, J BIOL CHEM, V262, P5939; PENDERGAST AM, 1985, J BIOL CHEM, V260, P1769; ROACH PJ, 1990, FASEB J, V4, P2961, DOI 10.1096/fasebj.4.12.2168324; RYAZANOV AG, 1987, BIOSYSTEMS, V20, P275, DOI 10.1016/0303-2647(87)90035-9; TRACHSEL H, 1980, P NATL ACAD SCI-BIOL, V77, P770, DOI 10.1073/pnas.77.2.770; Traugh J A, 1979, Methods Enzymol, V60, P534; TRAUGH JA, 1986, PROG NUCLEIC ACID RE, V33, P195; TREVILLYAN JM, 1985, J BIOL CHEM, V260, P3041; TUAZON PT, 1989, J BIOL CHEM, V264, P2773; WALTON GM, 1987, ANAL BIOCHEM, V161, P425, DOI 10.1016/0003-2697(87)90471-4; YANG DCH, 1985, CURR TOP CELL REGUL, V26, P325	30	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					5298	5302						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002062				2022-12-25	WOS:A1991FC21700090
J	IWASAKI, M; JUVONEN, R; LINDBERG, R; NEGISHI, M				IWASAKI, M; JUVONEN, R; LINDBERG, R; NEGISHI, M			ALTERATION OF HIGH AND LOW-SPIN EQUILIBRIUM BY A SINGLE MUTATION OF AMINO ACID-209 IN MOUSE CYTOCHROMES-P450	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							AXIAL LIGAND TRANS; TESTOSTERONE 16-ALPHA-HYDROXYLASE; STEROID 15-ALPHA-HYDROXYLASE; SUBSTRATE-SPECIFICITY; II P-45015-ALPHA; LIVER; IDENTIFICATION; OXYGEN; GENE; CYTOCHROME-P-450	The identities of the amino acid at position 209 are most critical in determining specific coumarin 7- and steroid 15-alpha-hydroxylase activity in P450coh and P450(15-alpha), respectively. This system, therefore, provides us with an excellent model to study the structural basis for P450 specificity as a monooxygenase. We expressed in Saccharomyces cerevisiae a series of the mutated P450s in which residue 209 was substituted with the various amino acids and characterized the spectral property and hydroxylase activity of these mutated P450s. The positioning of a hydrophobic residue including Phe, Leu, and Val at position 209 resulted in shifting the P450 to the high-spin state, while a charged amino acid such as Lys or Asp produced the low-spin form. Moreover, a P450 with Asn or Gly in this position exhibited spectra indicating a mixture of the high- and low-spin forms. This spin alteration, depending upon the hydrophobicity and size of residue at position 209, indicates that this position is likely to reside close to the sixth axial ligand on the distal surface of the heme in these P450s. This proximity of residue 209 to the ligand may explain the critical role of this residue in determining the hydroxylase specificity and activity of these P450s.			IWASAKI, M (corresponding author), NIEHS,REPROD & DEV TOXICOL LAB,PHARMACOGENET SECT,RES TRIANGLE PK,NC 27709, USA.		Negishi, Masahiko/F-7805-2019	Negishi, Masahiko/0000-0002-2076-8928				DAWSON JH, 1982, J BIOL CHEM, V257, P3606; EDWARDS RJ, 1989, BIOCHEMISTRY-US, V28, P3762, DOI 10.1021/bi00435a021; Gunsalus I C, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P1; HARADA N, 1984, J BIOL CHEM, V259, P2285; IMAI M, 1989, P NATL ACAD SCI USA, V86, P7823, DOI 10.1073/pnas.86.20.7823; IMAI Y, 1989, BIOCHEM BIOPH RES CO, V158, P717, DOI 10.1016/0006-291X(89)92780-0; ISHIDA N, 1988, BIOCHEM BIOPH RES CO, V155, P317, DOI 10.1016/S0006-291X(88)81087-8; KAIPAINEN P, 1985, COMP BIOCHEM PHYS C, V81, P293, DOI 10.1016/0742-8413(85)90008-8; LINDBERG RLP, 1989, NATURE, V339, P632, DOI 10.1038/339632a0; NEGISHI M, 1989, BIOCHEMISTRY-US, V28, P4169, DOI 10.1021/bi00436a007; NELSON DR, 1989, BIOCHEMISTRY-US, V28, P656, DOI 10.1021/bi00428a036; OEDA K, 1985, DNA-J MOLEC CELL BIO, V4, P203, DOI 10.1089/dna.1985.4.203; OMURA T, 1964, J BIOL CHEM, V239, P2370; POULOS TL, 1989, NATURE, V339, P580, DOI 10.1038/339580a0; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; RAAG R, 1989, BIOCHEMISTRY-US, V28, P917, DOI 10.1021/bi00428a077; SANGER F, 1980, J MOL BIOL, V259, P1239; SHIMIZU T, 1989, BIOCHIM BIOPHYS ACTA, V995, P116, DOI 10.1016/0167-4838(89)90069-1; SQUIRES EJ, 1988, J BIOL CHEM, V263, P4166; WHITE RE, 1982, J BIOL CHEM, V257, P3073; YOSHIDA Y, 1982, J BIOCHEM-TOKYO, V91, P1651, DOI 10.1093/oxfordjournals.jbchem.a133856	22	58	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3380	3382						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995602				2022-12-25	WOS:A1991EY68200007
J	ROSEN, J; TOMKINSON, B; PETTERSSON, G; ZETTERQVIST, O				ROSEN, J; TOMKINSON, B; PETTERSSON, G; ZETTERQVIST, O			A HUMAN SERINE ENDOPEPTIDASE, PURIFIED WITH RESPECT TO ACTIVITY AGAINST A PEPTIDE WITH PHOSPHOSERINE IN THE P1' POSITION, IS APPARENTLY IDENTICAL WITH PROLYL ENDOPEPTIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; PROLINE CLEAVING ENZYME; LIVER PYRUVATE-KINASE; RAT-LIVER; PHOSPHORYLATION-DEPHOSPHORYLATION; PHOSPHOPROTEIN PHOSPHATASE; SUBSTRATE-SPECIFICITY; HUMAN-ERYTHROCYTES; BRAIN; PROTEOLYSIS	The present work describes the detection, purification, and characterization of a serine endopeptidase with preference for a phosphoserine in the P1' position of the substrate. During probing for the enzyme in crude extracts, as well as during its 64,000-fold purification, P-32-labeled guanidovaleryl-Arg-Ala-Ser(P)-isobutyl amide (I) was used to measure the cleavage of the Ala-Ser(P) bond. With this substrate, k(cat) was 1.7 s-1 and K(m) was 30-mu-M at the pH optimum, 7.5. The enzyme was classified as a serine peptidase from its reaction with a set of inhibitors, among which diisopropyl fluorophosphate was effective at low (20-mu-M) concentration. The endopeptidase showed an M(r) of 74,000 under native as well as denaturing and reducing conditions, indicating that the native enzyme consists of only one major polypeptide chain. The molecular size and inhibition profile suggested identity of this enzyme with prolyl endopeptidase (EC 3.4.21.26). This was supported by its activity against specific substrates, such as succinyl-Gly-Pro-Leu-Pro-7-amido-4-methylcoumarin (K(cat) = 7.2 s-1 and K(m) = 290-mu-M), and by the inhibition of the latter activity by I. Compared with the cleavage of 100-mu-M I, Gly-Val-Leu-Arg-Arg-Ala-Ser-Val-Ala-Gln-Leu, after phosphorylation by cAMP-dependent protein kinase, was cleaved at the Ala-Ser(P) bond at a relative rate of 0.43, while cleavage of the Ala-Ser bond of the unphosphorylated undecapeptide was undetectable, i.e. < 0.03. The pentapeptide Arg-Arg-Pro-Ser-Val was rapidly cleaved at the Pro-Ser bond (relative rate, 2.2). Still, the cleavage of the Pro-Ser(P) bond of the corresponding phosphorylated pentapeptide was even higher (relative rate, 4.0). These data suggest that phosphorylation of a serine residue in the P1' position of at least a few substrates of prolyl endopeptidase will increase the rate of their cleavage.			ROSEN, J (corresponding author), UNIV UPPSALA,CTR BIOMED,DEPT MED & PHYSIOL CHEM,BOX 575,S-75123 UPPSALA,SWEDEN.							ANDREWS PC, 1980, BIOCHEMISTRY-US, V19, P5494, DOI 10.1021/bi00565a005; BALLOU LM, 1986, ENZYMES, V17, P311; BALOW RM, 1983, J BIOL CHEM, V258, P1622; BALOW RM, 1986, J BIOL CHEM, V261, P2409; BARRETT AJ, 1977, PROTEINASES MAMMALIA, P13; Beavo J A, 1974, Methods Enzymol, V38, P299; BENOREPARSONS M, 1989, ARCH BIOCHEM BIOPHYS, V272, P274, DOI 10.1016/0003-9861(89)90220-8; BERGSTROM G, 1978, BIOCHIM BIOPHYS ACTA, V532, P259, DOI 10.1016/0005-2795(78)90580-9; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; CHATTERJEE T, 1984, J BIOL CHEM, V259, P3831; CHEN M, 1989, J BIOL CHEM, V264, P14282; EDLUND B, 1975, BIOCHEM BIOPH RES CO, V67, P1516, DOI 10.1016/0006-291X(75)90198-9; GIBSON DM, 1987, ENZYMES ENZYME CONTR, V18, P179; GREHN L, 1987, J CHEM SOC PERK T 1, P529, DOI 10.1039/p19870000529; HIDER RC, 1985, BIOCHEM J, V229, P485, DOI 10.1042/bj2290485; KEMP BE, 1977, J BIOL CHEM, V252, P4888; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAZON MJ, 1982, J BIOL CHEM, V257, P1128; MERRIFIELD RB, 1969, ADV ENZYMOL RAMB, V32, P221; MOMAND J, 1987, BIOCHEMISTRY-US, V26, P7798, DOI 10.1021/bi00398a040; MORIYAMA A, 1988, BIOCHIM BIOPHYS ACTA, V956, P151, DOI 10.1016/0167-4838(88)90261-0; MORIYAMA A, 1988, J BIOCHEM, V104, P112, DOI 10.1093/oxfordjournals.jbchem.a122404; MORIYAMA A, 1983, J BIOCHEM, V94, P1387, DOI 10.1093/oxfordjournals.jbchem.a134485; MULLER D, 1981, BIOCHEM BIOPH RES CO, V103, P926, DOI 10.1016/0006-291X(81)90899-8; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PERRELLA FW, 1988, ANAL BIOCHEM, V174, P437, DOI 10.1016/0003-2697(88)90042-5; PRATT G, 1989, J BIOL CHEM, V264, P12526; RUPNOW JH, 1979, BIOCHEMISTRY-US, V18, P1206, DOI 10.1021/bi00574a014; SAIFUKU K, 1978, CLIN CHIM ACTA, V84, P85; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; TAYLOR WL, 1980, BIOCHEM BIOPH RES CO, V94, P9, DOI 10.1016/S0006-291X(80)80179-3; TITANJI VPK, 1977, FEBS LETT, V78, P86, DOI 10.1016/0014-5793(77)80279-2; TITANJI VPK, 1980, J BIOL CHEM, V255, P1339; TOMKINSON B, 1987, P NATL ACAD SCI USA, V84, P7508, DOI 10.1073/pnas.84.21.7508; TOMKINSON B, 1991, IN PRESS BIOCHEMISTR; VARRO A, 1988, BIOCHEM J, V256, P951, DOI 10.1042/bj2560951; WANG YH, 1986, J BIOL CHEM, V261, P6909; YOSHIMOTO T, 1981, J BIOCHEM, V90, P325, DOI 10.1093/oxfordjournals.jbchem.a133477; YOSHIMOTO T, 1983, J BIOCHEM, V94, P1179, DOI 10.1093/oxfordjournals.jbchem.a134463; ZETTERQVIST O, 1976, BIOCHEM BIOPH RES CO, V70, P696, DOI 10.1016/0006-291X(76)90648-3	41	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3827	3834						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995635				2022-12-25	WOS:A1991EY68200072
J	POSSANI, LD; MARTIN, BM; FLETCHER, MD; FLETCHER, PL				POSSANI, LD; MARTIN, BM; FLETCHER, MD; FLETCHER, PL			DISCHARGE EFFECT ON PANCREATIC EXOCRINE SECRETION PRODUCED BY TOXINS PURIFIED FROM TITYUS-SERRULATUS SCORPION-VENOM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; 3-DIMENSIONAL STRUCTURE; CENTRUROIDES-NOXIUS; CHANNEL; PURIFICATION; HOFFMANN; CURRENTS; LIGHT; CELLS; MELLO	Three toxic polypeptides were purified from the venom of the Brazilian scorpion Tityus serrulatus by means of gel filtration in Sephadex G-50 and ion-exchange chromatography in carboxymethylcellulose. The peptides are basic molecules with molecular weights in the range of 7000 for which the amino acid compositions and sequences were determined. The effect of the purified peptides on pancreatic exocrine secretion in the guinea pig was studied. Biochemical measurements show that the cells are stimulated by these peptides to discharge their zymogen granules. Light and electron microscopic images confirm the biochemical measurements. At the light microscope level, acinar cells show dramatically fewer zymogen granules than in control pancreas with the appearance of large vacuoles and some loss of morphological integrity. Electron micrographs display apical regions devoid of zymogen granules and condensing vacuoles whereas acinar lumina contain crystalline secretory material. The secretory effect observed in vitro is comparable to that of carbamylcholine and that of the peptidergic secretagogue cholecystokinin-pancreozymin.	E CAROLINA UNIV, SCH MED, DEPT MICROBIOL & IMMUNOL, GREENVILLE, NC 27858 USA; NIMH, ALCOHOL DRUG ABUSE & MENTAL HLTH ADM, CLIN NEUROSCI BRANCH, BETHESDA, MD 20892 USA; UNIV NACL AUTONOMA MEXICO, CTR INVEST INGN GENET & BIOTECNOL, DEPT BIOQUIM, CUERNAVACA 62270, MEXICO	University of North Carolina; East Carolina University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Universidad Nacional Autonoma de Mexico			Possani, Lourival D/J-2397-2013	Fletcher, Paul/0000-0002-3200-4693	NIADDK NIH HHS [AM27114] Funding Source: Medline	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADLER G, 1979, VIRCHOWS ARCH A, V382, P31, DOI 10.1007/BF01102739; AHO HJ, 1982, ACTA PATH MICRO IM A, V90, P367; BARHANIN J, 1982, J BIOL CHEM, V257, P2553; BARTHOLOMEW C, 1970, BMJ-BRIT MED J, V1, P666, DOI 10.1136/bmj.1.5697.666; BECHIS G, 1984, BIOCHEM BIOPH RES CO, V122, P1146, DOI 10.1016/0006-291X(84)91211-7; BERNFELD P, 1955, METHOD ENZYMOL, V1, P149, DOI 10.1016/0076-6879(55)01021-5; CARBONE E, 1983, TOXICON S, V3, P57; EAGLE H, 1959, SCIENCE, V130, P432, DOI 10.1126/science.130.3373.432; EDMAN P, 1967, EUR J BIOCHEM, V1, P80, DOI 10.1111/j.1432-1033.1967.tb00047.x; FLETCHER MD, 1984, DIGEST DIS SCI, V29, pA10; FLETCHER PL, 1978, TOXINS ANIMAL PLANT, P694; FONTECILLACAMPS JC, 1988, P NATL ACAD SCI USA, V85, P7443, DOI 10.1073/pnas.85.20.7443; FONTECILLACAMPS JC, 1980, P NATL ACAD SCI-BIOL, V77, P6496, DOI 10.1073/pnas.77.11.6496; Gomez M. V., 1966, Memorias do Instituto Butantan, V33, P899; HELIN H, 1980, VIRCHOWS ARCH A, V387, P259, DOI 10.1007/BF00454829; JAMIESON JD, 1971, J CELL BIOL, V48, P503, DOI 10.1083/jcb.48.3.503; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; KIRSCH GE, 1989, J GEN PHYSIOL, V93, P67, DOI 10.1085/jgp.93.1.67; KLOPPEL G, 1986, VIRCHOWS ARCH A, V409, P791, DOI 10.1007/BF00710764; LAMPEL M, 1977, VIRCHOWS ARCH A, V373, P97, DOI 10.1007/BF00432156; LUFT JH, 1961, J BIOPHYS BIOCHEM CY, V9, P409, DOI 10.1083/jcb.9.2.409; Machado J.C., 1977, MEM I BUTANTAN, p[40, 1]; MARTIN BM, 1988, TOXICON, V26, P785, DOI 10.1016/0041-0101(88)90319-4; MOORE S, 1963, J BIOL CHEM, V238, P235; PETERSEN OH, 1987, PHYSIOL REV, V67, P1054, DOI 10.1152/physrev.1987.67.3.1054; PETERSEN OH, 1984, NATURE, V307, P693, DOI 10.1038/307693a0; Possani L. D., 1984, HDB NATURAL TOXINS, V2, P513; POSSANI LD, 1982, CARLSBERG RES COMMUN, V47, P285, DOI 10.1007/BF02907789; POSSANI LD, 1985, BIOCHEM J, V229, P739, DOI 10.1042/bj2290739; POSSANI LD, 1977, ARCH BIOCHEM BIOPHYS, V180, P394, DOI 10.1016/0003-9861(77)90053-4; POSSANI LD, 1981, CARLSBERG RES COMMUN, V46, P195, DOI 10.1007/BF02906497; REEVES WJ, 1966, METHOD ENZYMOL, V9, P288; REISFELD RA, 1962, NATURE, V195, P281, DOI 10.1038/195281a0; RICHARDSON KC, 1960, STAIN TECHNOL, V35, P313, DOI 10.3109/10520296009114754; RORSMAN P, 1986, AM J PHYSIOL, V251, pC912, DOI 10.1152/ajpcell.1986.251.6.C912; SCHEELE GA, 1975, J BIOL CHEM, V250, P2660; TOLEDO D, 1976, COMP BIOCHEM PHYS B, V55, P249, DOI 10.1016/0305-0491(76)90240-6; VENABLE JH, 1965, J CELL BIOL, V25, P407, DOI 10.1083/jcb.25.2.407; Waterman J. A., 1938, Transactions of the Royal Society of Tropical Medicine and Hygiene, V31, P607, DOI 10.1016/S0035-9203(38)90154-3; YATANI A, 1988, AM J PHYSIOL, V254, pH443, DOI 10.1152/ajpheart.1988.254.3.H443	40	64	68	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3178	3185						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993690				2022-12-25	WOS:A1991EX60000077
J	ROSIERS, CD; DAVID, F; GARNEAU, M; BRUNENGRABER, H				ROSIERS, CD; DAVID, F; GARNEAU, M; BRUNENGRABER, H			NONHOMOGENEOUS LABELING OF LIVER MITOCHONDRIAL ACETYL-COA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY ACID SYNTHESIS; PERFUSED-RAT-LIVER; METABOLIC COMPARTMENTATION; GLUCONEOGENESIS INVIVO; C-14 TRACER; HEPATOCYTES; PYRUVATE; LACTATE; CYCLE; ACETOACETATE	The specific activity of carbons 1 and 2 of plasma acetoacetate has been used as a measure of the specific activity of liver mitochondrial acetyl-CoA in tracer studies. To test whether or not acetoacetate actually reflects acetyl-CoA, livers were perfused with a mixture of substrates that are converted to mitochondrial acetyl-CoA: 1 mM lactate, 0.2 mM pyruvate, 0.2 mM acetate, and, where indicated, 0.2 mM octanoate or 0.2 mM alpha-ketoisocaproate. In each experiment, one of these substrates was C-13-labeled. Labeling of mitochondrial acetyl-CoA was assessed by three methods: (i) molar percent enrichment of total tissue acetyl-CoA; (ii) molar percent enrichment of carbons 4 and 5 of tissue citrate, the precursor of which is acetyl-CoA; and (iii) molar percent enrichment of carbons 1 and 2 of perfusate ketone bodies. Nonhomogeneous labeling of liver mitochondrial acetyl-CoA occurred under most conditions, i.e. the enrichments of carbons 4 and 5 of citrate were different from enrichments of carbons 1 and 2 of ketone bodies. Thus, based upon our results obtained in perfused livers, we question the validity of measuring the labeling of carbons 1 and 2 of acetoacetate as a noninvasive probe of liver mitochondrial acetyl-CoA.	UNIV MONTREAL,DEPT NUTR,MONTREAL H3C 3J7,QUEBEC,CANADA; UNIV MONTREAL,DEPT BIOCHEM,MONTREAL H3C 3J7,QUEBEC,CANADA	Universite de Montreal; Universite de Montreal			Rosiers, Christine Des/O-6285-2014		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035543] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-35543] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARANYAI JM, 1989, BIOCHEM J, V258, P121, DOI 10.1042/bj2580121; BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441; BRUNENGRABER H, 1973, J BIOL CHEM, V248, P2656; CHEUNG CW, 1989, J BIOL CHEM, V264, P4038; CLEGG J, 1984, BIOESSAYS, V1, P129, DOI 10.1002/bies.950010310; CONSOLI A, 1987, J CLIN INVEST, V80, P1303, DOI 10.1172/JCI113206; DECKER K, 1973, MOL CELL BIOCHEM, V2, P179, DOI 10.1007/BF01795472; ENDEMANN G, 1982, J BIOL CHEM, V257, P3434; FRITZ IB, 1974, REGULATION HEPATIC M, P224; FRITZ IB, 1968, CELLULAR COMPARTMENT, P39; GUTMANN I, 1974, METHOD ENZYMAT AN, V4, P1464; HETENYI G, 1982, FED PROC, V41, P104; JUNGERMANN K, 1986, ENZYME, V35, P161, DOI 10.1159/000469338; KATZ J, 1985, AM J PHYSIOL, V248, pR391, DOI 10.1152/ajpregu.1985.248.4.R391; KELLEHER JK, 1986, AM J PHYSIOL, V250, pE296, DOI 10.1152/ajpendo.1986.250.3.E296; LEISER J, 1988, THESIS DUKE U; LINN TC, 1979, J BIOL CHEM, V254, P1691; LOPESCARDOZO M, 1978, EUR J BIOCHEM, V83, P635, DOI 10.1111/j.1432-1033.1978.tb12133.x; Lowenstein J M, 1968, Biochem Soc Symp, V27, P61; MCGARRY JD, 1971, J BIOL CHEM, V246, P1149; MULLHOFER G, 1977, EUR J BIOCHEM, V75, P331, DOI 10.1111/j.1432-1033.1977.tb11533.x; MULLHOFER G, 1977, EUR J BIOCHEM, V75, P319, DOI 10.1111/j.1432-1033.1977.tb11532.x; MULLHOFER G, 1972, HOPPESEYLERS Z PHYSL, V353, P1462; NORSTEN C, 1990, BIOCHEM J, V265, P569, DOI 10.1042/bj2650569; ROSIERS CD, 1988, ANAL BIOCHEM, V173, P96, DOI 10.1016/0003-2697(88)90165-0; ROSIERS CD, 1990, FASEB J, V4, pA708; ROSIERS CD, 1990, AM J PHYSIOL, V258, pE519; ROSIERS CD, 1988, FASEB J, V2, pA711; Soboll S., 1976, USE ISOLATED LIVER C, P29; SPIVEY HO, 1989, BIOESSAYS, V10, P127, DOI 10.1002/bies.950100409; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; SRIVASTAVA DK, 1986, SCIENCE, V234, P1081, DOI 10.1126/science.3775377; VONGLUTZ G, 1975, EUR J BIOCHEM, V60, P147; WATSON JA, 1970, J BIOL CHEM, V245, P5993; [No title captured]	35	47	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1574	1578						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1988437				2022-12-25	WOS:A1991EU49700035
J	BERKERS, JAM; HENEGOUWEN, PMPVE; BOONSTRA, J				BERKERS, JAM; HENEGOUWEN, PMPVE; BOONSTRA, J			3 CLASSES OF EPIDERMAL GROWTH-FACTOR RECEPTORS ON HELA-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN KINASE-C; LIGAND-BINDING; EGF-RECEPTOR; TRANSFORMED KERATINOCYTES; INDEPENDENT MECHANISMS; SURFACE RECEPTORS; CARCINOMA-CELLS; PHORBOL ESTERS; PC12 CELLS; A431 CELLS	The kinetics of I-125-labeled epidermal growth factor (EGF) binding to receptors on HeLa cells were investigated. Scatchard analysis revealed the presence of 22,000 high affinity receptors (K(d) = 0.12 nM) and 25,000 low affinity receptors per cell (K(d) = 9.2 nM). The kinetic analysis of EGF binding to high affinity receptors was performed with cells pretreated with the monoclonal antibody 2E9, which prevents specifically EGF binding to low affinity receptors. The study of EGF binding to only low affinity receptors was performed with cells pretreated with the phorbol ester phorbol 12-myristate 13-acetate, which induces a conversion of high affinity receptors to low affinity receptors. This kinetic analysis of EGF binding to HeLa cells revealed the presence of three types of receptors. High affinity receptors were found to consist of one receptor type (type I) with a kinetic association constant (k(ass)) of 6.2 x 10(5) M-1.S-1 and a kinetic dissociation constant (k(dis)) of 3.5 x 10(-4)S-1. The low affinity receptors were found to consist of two kinetic distinguishable sites: type II or fast sites with k(ass) = 3.3 x 10(6) M-1.S-1 and k(dis) = 8.1 x 10(-3) S-1 and the type III or slow sites with k(ass) = 3.2 x 10(4) M-1.S-1 and k(dis) = 1.6 x 10(-4) S-1. The regulatory mechanism which may determine the EGF binding characteristics is discussed.			BERKERS, JAM (corresponding author), STATE UNIV UTRECHT,DEPT MOLEC CELL BIOL,PADUALAAN 8,3584 CH UTRECHT,NETHERLANDS.		van Bergen en Henegouwen, Paul/B-8870-2011	van Bergen en Henegouwen, Paul/0000-0001-6050-9042				BELLOT F, 1990, J CELL BIOL, V110, P491, DOI 10.1083/jcb.110.2.491; BERKERS JAM, 1990, BIOCHIM BIOPHYS ACTA, V1052, P453, DOI 10.1016/0167-4889(90)90155-7; BLOCK T, 1983, J NEUROCHEM, V40, P1654, DOI 10.1111/j.1471-4159.1983.tb08139.x; BOEYNAEMS JM, 1980, OUTLINES RECEPTOR TH, P1; BOONSTRA J, 1989, CELL BIOL INT REP, V13, P609, DOI 10.1016/0309-1651(89)90111-2; BOONSTRA J, 1985, EXP CELL RES, V161, P421, DOI 10.1016/0014-4827(85)90098-9; BOONSTRA J, 1985, J CELL PHYSIOL, V123, P347, DOI 10.1002/jcp.1041230309; BOONSTRA J, 1989, NATO ASI SER, V29, P162; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; Clark Alfred Joseph., 1933, MODE ACTION DRUGS CE; COMENS PG, 1982, J BIOL CHEM, V257, P42; DAVIS RJ, 1988, J BIOL CHEM, V263, P9462; DEFIZE LHK, 1989, J CELL BIOL, V109, P2495, DOI 10.1083/jcb.109.5.2495; DOWNWARD J, 1985, J BIOL CHEM, V260, P4538; HENEGOUWEN PMP, 1989, J CELL BIOCHEM, V39, P455; HONEGGER A, 1988, EMBO J, V7, P3045, DOI 10.1002/j.1460-2075.1988.tb03169.x; HONEGGER AM, 1987, CELL, V51, P199, DOI 10.1016/0092-8674(87)90147-4; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; HUNTER T, 1984, NATURE, V311, P414, DOI 10.1038/311414a0; KING AC, 1982, J BIOL CHEM, V257, P3053; KRUPP MN, 1982, J BIOL CHEM, V257, P1489; LANDRETH GE, 1985, J CELL BIOL, V101, P1341, DOI 10.1083/jcb.101.4.1341; LIN CR, 1986, CELL, V44, P839, DOI 10.1016/0092-8674(86)90006-1; LIVNEH E, 1988, MOL CELL BIOL, V8, P2302, DOI 10.1128/MCB.8.6.2302; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; RIEDEL H, 1989, EMBO J, V8, P2943, DOI 10.1002/j.1460-2075.1989.tb08444.x; ROY LM, 1989, J CELL PHYSIOL, V140, P295, DOI 10.1002/jcp.1041400215; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHECHTER AL, 1981, CELL, V24, P867, DOI 10.1016/0092-8674(81)90112-4; SCHLESSINGER J, 1986, J CELL BIOL, V103, P2067, DOI 10.1083/jcb.103.6.2067; SHOYAB M, 1979, NATURE, V279, P387, DOI 10.1038/279387a0; TAIT JF, 1981, J BIOL CHEM, V256, P1086; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; VALE RD, 1983, BIOCHEMISTRY-US, V22, P5022, DOI 10.1021/bi00290a022; WEBER W, 1984, J BIOL CHEM, V259, P4631; WIEGANT FAC, 1986, J CELL BIOL, V103, P87, DOI 10.1083/jcb.103.1.87	36	85	86	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					922	927						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985972				2022-12-25	WOS:A1991ET17700040
J	HILTON, S; BUCKLEY, JT				HILTON, S; BUCKLEY, JT			STUDIES ON THE REACTION-MECHANISM OF A MICROBIAL LIPASE ACYLTRANSFERASE USING CHEMICAL MODIFICATION AND SITE-DIRECTED MUTAGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LECITHIN-CHOLESTEROL ACYLTRANSFERASE; LIPOPROTEIN-LIPASE; GENE FAMILY; SUBSTRATE-SPECIFICITY; MOLECULAR-CLONING; PHOSPHOLIPASE; SEQUENCE; EVOLUTION; ENZYME; CDNA	Aeromonas hydrophila releases a protein which is a member of the lipase superfamily, similar in reaction mechanism to the important mammalian plasma enzyme lecithin-cholesterol acyltransferase. We have used chemical modification and site-directed mutagenesis of the protein to identify amino acids which may be involved in catalysis. The enzyme was unaffected by phenylmethylsulfonyl fluoride, but it was almost completely inhibited by another serine-reactive compound, diethyl p-nitrophenyl phosphate. A serine selectively modified by this reagent was identified by sequencing the amino-terminal region of the protein. It was located at position 16, in the short consensus sequence shared by the enzyme with other lipases. When this serine was changed to asparagine the product was an enzymatically inert protein which nevertheless retained the surface activity of the wild-type enzyme, suggesting its ability to bind to substrate was not changed. Diethylpyrocarbonate treatment drastically reduced the rate of acyl transfer by the native enzyme, but this did not appear to be due to modification of an essential histidine, since inhibition was not reversed by addition of hydroxylamine. We have shown that only two of the histidines in the enzyme can be involved in catalysis (Hilton, S., McCubbin, W. D., Kay, C. M., and Buckley, J. T. (1990) Biochemistry, 29, 9072-9078). Replacing both of these with asparagines had little or no effect on enzyme activity. These results indicate that, in apparent contrast to other lipases, histidine does not participate in the reaction catalyzed by the microbial enzyme. Since catalysis was not inhibited by sulfhydryl reagents, we conclude that a free cysteine is also not required for activity. This may distinguish the microbial enzyme from the mammalian acyltransferase.	UNIV VICTORIA,DEPT BIOCHEM & MICROBIOL,BOX 3055,VICTORIA V8W 3P6,BC,CANADA	University of Victoria								BERNBACK S, 1989, EUR J BIOCHEM, V182, P493; BRADY L, 1990, NATURE, V343, P767, DOI 10.1038/343767a0; BRENNER S, 1988, NATURE, V334, P528, DOI 10.1038/334528a0; BUCKLEY JT, 1983, BIOCHEMISTRY-US, V22, P5490, DOI 10.1021/bi00293a006; BUCKLEY JT, 1982, BIOCHEMISTRY-US, V21, P6699, DOI 10.1021/bi00269a013; BURSTEIN Y, 1974, BIOCHEMISTRY-US, V13, P205, DOI 10.1021/bi00698a030; CHAPUS C, 1976, BIOCHEMISTRY-US, V15, P4980, DOI 10.1021/bi00668a006; DAVIS RC, 1990, J BIOL CHEM, V265, P6291; DECARO JD, 1989, BIOCHIMIE, V71, P1211, DOI 10.1016/0300-9084(89)90026-6; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; GARGOURI Y, 1988, J BIOL CHEM, V263, P2159; GREEN MJ, 1990, BIOCHEMISTRY-US, V29, P2177, DOI 10.1021/bi00460a031; HARWOOD J, 1989, TRENDS BIOCHEM SCI, V14, P126; HILTON S, 1990, BIOCHEMISTRY-US, V29, P9072, DOI 10.1021/bi00490a026; JAUHIAINEN M, 1988, J BIOL CHEM, V263, P6525; JAUHIAINEN M, 1986, J BIOL CHEM, V261, P7032; JENTOFT N, 1983, METHOD ENZYMOL, V91, P570; KAIMAL TNB, 1989, BIOCHIM BIOPHYS ACTA, V999, P331, DOI 10.1016/0167-4838(89)90016-2; KINNUNEN PM, 1988, BIOCHEMISTRY-US, V27, P7344, DOI 10.1021/bi00419a025; KIRCHGESSNER TG, 1989, P NATL ACAD SCI USA, V86, P9647, DOI 10.1073/pnas.86.24.9647; KIRCHGESSNER TG, 1987, J BIOL CHEM, V262, P8463; KOMAROMY MC, 1987, P NATL ACAD SCI USA, V84, P1526, DOI 10.1073/pnas.84.6.1526; Maniatis T., 1982, MOL CLONING; MARAGANORE JM, 1986, TRENDS BIOCHEM SCI, V11, P497, DOI 10.1016/0968-0004(86)90076-9; MEANS GE, 1971, CHEM MODIFICATION PR, P68; Miles E W, 1977, Methods Enzymol, V47, P431; Miller J.H., 1972, EXPT MOL GENETICS; NAKAMAYE KL, 1986, NUCLEIC ACIDS RES, V14, P9679, DOI 10.1093/nar/14.24.9679; NEVILLE DM, 1971, J BIOL CHEM, V246, P6328; PERSOON NLM, 1987, BIOCHIM BIOPHYS ACTA, V917, P186, DOI 10.1016/0005-2760(87)90299-2; PERSSON B, 1989, EUR J BIOCHEM, V179, P39, DOI 10.1111/j.1432-1033.1989.tb14518.x; SAYERS JR, 1988, NUCLEIC ACIDS RES, V16, P791, DOI 10.1093/nar/16.3.791; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8765; THORNTON J, 1988, BIOCHIM BIOPHYS ACTA, V959, P153, DOI 10.1016/0005-2760(88)90026-4; VANOORT MG, 1989, BIOCHEMISTRY-US, V28, P9278, DOI 10.1021/bi00450a007; VANSCHARRENBURG GJ, 1984, BIOCHEMISTRY-US, V26, P6285; WELLS MA, 1973, BIOCHEMISTRY-US, V12, P1086, DOI 10.1021/bi00730a011; WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0; WION KL, 1987, SCIENCE, V235, P1638, DOI 10.1126/science.3823907; WONG KR, 1989, J BACTERIOL, V171, P2523, DOI 10.1128/jb.171.5.2523-2527.1989; YANG CY, 1987, J BIOL CHEM, V262, P3086	41	34	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					997	1000						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985976				2022-12-25	WOS:A1991ET17700052
J	LI, ZP; NICOLL, DA; COLLINS, A; HILGEMANN, DW; FILOTEO, AG; PENNISTON, JT; WEISS, JN; TOMICH, JM; PHILIPSON, KD				LI, ZP; NICOLL, DA; COLLINS, A; HILGEMANN, DW; FILOTEO, AG; PENNISTON, JT; WEISS, JN; TOMICH, JM; PHILIPSON, KD			IDENTIFICATION OF A PEPTIDE INHIBITOR OF THE CARDIAC SARCOLEMMAL NA+-CA2+ EXCHANGER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGE; ROD OUTER SEGMENTS; ERYTHROCYTE-MEMBRANES; CA-2+ PUMP; CALMODULIN; VESICLES; BINDING; TRANSPORT; MUSCLE; K+	The deduced amino acid sequence of the cardiac sarcolemmal Na+-Ca2+ exchanger has a region which could represent a calmodulin binding site. As calmodulin binding regions of proteins often have an autoinhibitory role, a synthetic peptide with this sequence was tested for functional effects on Na+-Ca2+ exchange activity. The peptide inhibits the Na+-dependent Ca2+ uptake (K(I) approximately 1.5-mu-M) and the Na(o)+-dependent Ca2+ efflux of sarcolemmal vesicles in a noncompetitive manner with respect to both Na+ and Ca2+. The peptide is also a potent inhibitor (K(I) approximately 0.1-mu-M) of the Na+-Ca2+ exchange current of excised sarcolemmal patches. The binding site for the peptide on the exchanger is on the cytoplasmic surface of the membrane. The exchanger inhibitory peptide binds calmodulin with a moderately high affinity. From the characteristics of the inhibition of the exchange of sarcolemmal vesicles, we deduce that only inside-out sarcolemmal vesicles participate in the usual Na+-Ca2+ exchange assay. This contrasts with the common assumption that both inside-out and right-side-out vesicles exhibit exchange activity.	UNIV CALIF LOS ANGELES,SCH MED,CARDIOVASC RES LAB,A3-381 CHS,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,DEPT PHYSIOL,LOS ANGELES,CA 90024; UNIV TEXAS,SW MED CTR,DEPT PHYSIOL,DALLAS,TX 75235; MAYO CLIN & MAYO FDN,DEPT BIOCHEM & MOLEC BIOL,ROCHESTER,MN 55905; CHILDRENS HOSP LOS ANGELES,DIV MED GENET,LOS ANGELES,CA 90027	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Mayo Clinic; Children's Hospital Los Angeles				TOMICH, JOHN/0000-0001-7848-8307	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL027821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM043617, R01GM043617, R01GM028835] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 27821] Funding Source: Medline; NIGMS NIH HHS [GM 28835, GM 43617] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON SR, 1986, CALCIUM CELL FUNCTIO, V6, P1; BURNS NR, 1985, BIOCHEMISTRY-US, V24, P3070, DOI 10.1021/bi00333a040; BUSCHMEIER B, 1987, J BIOL CHEM, V262, P9454; CACHIA PJ, 1986, BIOCHEMISTRY-US, V25, P3553, DOI 10.1021/bi00360a013; CERVETTO L, 1989, NATURE, V337, P740, DOI 10.1038/337740a0; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001; ENYEDI A, 1989, J BIOL CHEM, V264, P12313; Fiske CH, 1925, J BIOL CHEM, V66, P375; FRANK JS, 1984, CIRC RES, V54, P414, DOI 10.1161/01.RES.54.4.414; GRAF E, 1981, ARCH BIOCHEM BIOPHYS, V210, P257, DOI 10.1016/0003-9861(81)90187-9; HILGEMANN DW, 1990, NATURE, V344, P242, DOI 10.1038/344242a0; HILGEMANN DW, 1989, PFLUG ARCH EUR J PHY, V415, P247, DOI 10.1007/BF00370601; KACZOROWSKI GJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P287, DOI 10.1016/0304-4157(89)90022-1; KESSLER F, 1990, J BIOL CHEM, V265, P16012; MERRIFIELD RB, 1965, SCIENCE, V150, P178, DOI 10.1126/science.150.3693.178; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; NICOLL DA, 1990, SCIENCE, V250, P562, DOI 10.1126/science.1700476; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Penniston J T, 1980, Ann N Y Acad Sci, V356, P245, DOI 10.1111/j.1749-6632.1980.tb29615.x; PHILIPSON KD, 1985, BIOCHIM BIOPHYS ACTA, V821, P367, DOI 10.1016/0005-2736(85)90107-5; PHILIPSON KD, 1980, AM J PHYSIOL, V238, pH373, DOI 10.1152/ajpheart.1980.238.3.H373; PHILIPSON KD, 1982, J BIOL CHEM, V257, P5111; PHILIPSON KD, 1990, CALCIUM HEART, P85; REEVES JP, 1989, SODIUM CALCIUM EXCHA, P27; SCHNETKAMP PPM, 1989, AM J PHYSIOL, V257, pC153, DOI 10.1152/ajpcell.1989.257.1.C153; SUMIDA M, 1978, J BIOL CHEM, V253, P8772; VEMURI R, 1989, AM J PHYSIOL, V256, pC1273, DOI 10.1152/ajpcell.1989.256.6.C1273; VEMURI R, 1987, BIOCHIM BIOPHYS ACTA, V937, P258; WEISS JN, 1989, J GEN PHYSIOL, V94, P911, DOI 10.1085/jgp.94.5.911	29	243	247	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1014	1020						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985930				2022-12-25	WOS:A1991ET17700055
J	TANAKA, T; KADOWAKI, K; LAZARIDES, E; SOBUE, K				TANAKA, T; KADOWAKI, K; LAZARIDES, E; SOBUE, K			CA2+-DEPENDENT REGULATION OF THE SPECTRIN ACTIN INTERACTION BY CALMODULIN AND PROTEIN 4.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODULATOR-BINDING-PROTEIN; HUMAN-ERYTHROCYTE-MEMBRANE; RED-CELL; F-ACTIN; CYTOSKELETAL PROTEINS; PARTICULATE NATURE; COMPLEX CELLS; RAT-TISSUES; SKELETON; PURIFICATION	The Ca2+-dependent regulation of the erythroid membrane cytoskeleton was investigated. The low-salt extract of erythroid membranes, which is mainly composed of spectrin, protein 4.1, and actin, confers a Ca2+ sensitivity on its interaction with F-actin. This Ca2+ sensitivity is fortified by calmodulin and antagonized by trifluoperazine, a potent calmodulin inhibitor. Additionally, calmodulin is detected in the low-salt extract. These results suggest that calmodulin is the sole Ca2+ -sensitive factor in the low-salt extract. The main target of calmodulin in the erythroid membrane cytoskeleton was further examined. Under native conditions, calmodulin forms a stable and equivalent complex with protein 4.1 as determined by calmodulin affinity chromatography, cross-linking experiments, and fluorescence binding assays with an apparent K(d) of 5.5 x 10(-7) M irrespective of the free Ca2+ concentration. Domain mapping with chymotryptic digestion reveals that the calmodulin-binding site resides within the N-terminal 30-kDa fragment of protein 4.1. In contrast, the interaction of calmodulin with spectrin is unexpectedly weak (K(d) = 1.2 x 10(-4 M). Given the content of calmodulin in erythrocytes (2-5 mu-M), these results imply that the major target for calmodulin in the erythroid membrane cytoskeleton is protein 4.1. Low- and high-shear viscometry and binding assays reveal that an equivalent complex of calmodulin with protein 4.1 regulates the spectrin/actin interaction in a Ca2+ -dependent manner. At a low Ca2+ concentration, protein 4.1 potentiates the actin cross-linking and the actin binding activities of spectrin. At a high Ca2+ concentration, the protein 4.1-potentiated actin cross-linking activity but not the actin binding activity of spectrin is suppressed by Ca2+/calmodulin. The Ca2+-dependent regulation of the spectrin/protein 4.1/calmodulin/actin interaction is discussed.	OSAKA UNIV,CTR BIOMED RES,SCH MED,DEPT NEUROCHEM & NEUROPHARMACOL,4-3-57 NAKANOSHIMA,KITA KU,OSAKA 530,JAPAN; CALTECH,DIV BIOL,PASADENA,CA 91125	Osaka University; California Institute of Technology								AGRE P, 1983, J BIOL CHEM, V258, P6258; ANDERSON JP, 1987, J BIOL CHEM, V262, P6365; BENNETT V, 1985, ANNU REV BIOCHEM, V54, P273, DOI 10.1146/annurev.biochem.54.1.273; BERGLUND A, 1984, FEBS LETT, V172, P109, DOI 10.1016/0014-5793(84)80884-4; BOIVIN P, 1984, BIOCHEM INT, V8, P231; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANTON D, 1981, CELL, V24, P24, DOI 10.1016/0092-8674(81)90497-9; BRENNER SL, 1979, J BIOL CHEM, V254, P8620; BURNS NR, 1985, BIOCHEMISTRY-US, V24, P3070, DOI 10.1021/bi00333a040; CARRAWAY KL, 1989, BIOCHIM BIOPHYS ACTA, V988, P147, DOI 10.1016/0304-4157(89)90017-8; COHEN CM, 1983, SEMIN HEMATOL, V20, P141; COHEN CM, 1980, BIOCHEM BIOPH RES CO, V97, P1429, DOI 10.1016/S0006-291X(80)80025-8; CORREAS I, 1986, J BIOL CHEM, V261, P3310; FOWLER V, 1980, J CELL BIOL, V85, P361, DOI 10.1083/jcb.85.2.361; GARDNER K, 1987, NATURE, V328, P359, DOI 10.1038/328359a0; GARDNER K, 1986, J BIOL CHEM, V261, P1339; GEIGER B, 1985, TRENDS BIOCHEM SCI, V10, P456, DOI 10.1016/0968-0004(85)90031-3; HARAFUJI H, 1980, J BIOCHEM, V87, P1305, DOI 10.1093/oxfordjournals.jbchem.a132868; HUSAIN A, 1984, BIOCHEM BIOPH RES CO, V122, P1194, DOI 10.1016/0006-291X(84)91218-X; JARRETT HW, 1978, J BIOL CHEM, V253, P4676; KAKIUCHI S, 1982, J BIOCHEM-TOKYO, V92, P1041, DOI 10.1093/oxfordjournals.jbchem.a134019; KANDA K, 1986, BIOCHEM BIOPH RES CO, V140, P1051, DOI 10.1016/0006-291X(86)90741-2; KIRKPATRICK FH, 1975, EXPERIENTIA, V31, P653, DOI 10.1007/BF01944610; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACLEANFLETCHER SD, 1980, J CELL BIOL, V85, P414, DOI 10.1083/jcb.85.2.414; MARCHESI VT, 1985, ANNU REV CELL BIOL, V1, P531, DOI 10.1146/annurev.cellbio.1.1.531; MISCHE SM, 1987, J CELL BIOL, V105, P2837, DOI 10.1083/jcb.105.6.2837; NOMURA M, 1987, EUR J BIOCHEM, V163, P467, DOI 10.1111/j.1432-1033.1987.tb10892.x; OHANIAN V, 1984, EUR J BIOCHEM, V144, P375, DOI 10.1111/j.1432-1033.1984.tb08474.x; OLWIN BB, 1984, METHOD ENZYMOL, V102, P148; Penniston J T, 1980, Ann N Y Acad Sci, V356, P245, DOI 10.1111/j.1749-6632.1980.tb29615.x; QUIST EE, 1976, BIOCHEM BIOPH RES CO, V72, P673, DOI 10.1016/S0006-291X(76)80092-7; SECKER PS, 1983, ANAL BIOCHEM, V132, P195; SOBUE K, 1979, FEBS LETT, V105, P105, DOI 10.1016/0014-5793(79)80896-0; SOBUE K, 1981, P NATL ACAD SCI-BIOL, V78, P5652, DOI 10.1073/pnas.78.9.5652; SOBUE K, 1983, P NATL ACAD SCI-BIOL, V80, P6868, DOI 10.1073/pnas.80.22.6868; SOBUE K, 1981, BIOCHEM BIOPH RES CO, V100, P1063, DOI 10.1016/0006-291X(81)91931-8; SOBUE K, 1980, BIOCHEM INT, V1, P561; SOBUE K, 1990, NEUROSCI RES, V13, P80; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; STROMQVIST M, 1988, BIOCHEMISTRY-US, V27, P1104, DOI 10.1021/bi00404a004; UNGEWICKELL E, 1979, NATURE, V280, P811, DOI 10.1038/280811a0	43	94	95	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1134	1140						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985939				2022-12-25	WOS:A1991ET17700072
J	EDWARDS, AM; KANE, CM; YOUNG, RA; KORNBERG, RD				EDWARDS, AM; KANE, CM; YOUNG, RA; KORNBERG, RD			2 DISSOCIABLE SUBUNITS OF YEAST RNA POLYMERASE-II STIMULATE THE INITIATION OF TRANSCRIPTION AT A PROMOTER INVITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINATION SITES	RNA polymerase II lacking the fourth and seventh largest subunits (pol II DELTA-4/7) was purified from Saccharomyces cerevisiae strain rpb-4, in which the gene for the fourth largest subunit is deleted. Pol II DELTA-4/7 was indistinguishable from wild-type pol II (holoenzyme) in promoter-independent initiation/chain elongation activity (400-800 nmol of nucleotide incorporated/10 min/mg of protein at 22-degrees-C), in rate of chain elongation (20-25 nucleotides/s), and in the recognition of pause sites in the DNA template. In contrast to pol II holoenzyme, pol II DELTA-4/7 was inactive in promoter-directed initiation of transcription in vitro. The addition of an equimolar complex of the fourth and seventh largest subunits, purified from pol II holoenzyme by ion-exchange chromatography in the presence of urea, restored promoter-directed initiation activity to pol II DELTA-4/7. The transcriptional activator protein Gal4-VP16 could also elicit promoter-directed initiation by pol II DELTA-4/7 from a promoter with a Gal4 binding site. Complementation was observed between extracts of strain rpb-4, lacking the fourth largest subunit, and strain Y260-1, with a defect in the largest subunit. These extracts were individually inactive, but a mixture would support promoter-directed initiation. The fourth and seventh largest subunits may, therefore, shuttle between polymerase molecules.	STANFORD UNIV,MED CTR,SCH MED,DEPT CELL BIOL,STANFORD,CA 94305; UNIV CALIF BERKELEY,DEPT BIOCHEM & MOLEC BIOL,BERKELEY,CA 94720; MIT,WHITEHEAD INST BIOMED RES,CAMBRIDGE,MA 02139; MIT,DEPT BIOL,CAMBRIDGE,MA 02139	Stanford University; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)			Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Edwards, Aled/0000-0002-4782-6016	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036659, R01GM034365, R01GM036659] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM34963, GM34365, GM36659] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHASMAN D, 1989, MOL CELL BIOL, V11, P4746; CONAWAY JW, 1990, J BIOL CHEM, V265, P7552; DEDRICK RL, 1985, BIOCHEMISTRY-US, V24, P2245, DOI 10.1021/bi00330a019; DEDRICK RL, 1987, J BIOL CHEM, V262, P9098; DEZELEE S, 1976, EUR J BIOCHEM, V65, P543, DOI 10.1111/j.1432-1033.1976.tb10372.x; EDWARDS AM, 1990, P NATL ACAD SCI USA, V87, P2122, DOI 10.1073/pnas.87.6.2122; KADESCH TR, 1982, J BIOL CHEM, V257, P5286; KERPPOLA TK, 1988, MOL CELL BIOL, V8, P4389, DOI 10.1128/MCB.8.10.4389; KERPPOLA TK, 1990, BIOCHEMISTRY-US, V29, P269, DOI 10.1021/bi00453a037; KOLODZIEJ PA, 1990, MOL CELL BIOL, V10, P1915, DOI 10.1128/MCB.10.5.1915; KRAKOW JS, 1976, RNA POLYMERASE, P127; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUE NF, 1989, P NATL ACAD SCI USA, V86, P486, DOI 10.1073/pnas.86.2.486; LUE NF, 1989, SCIENCE, V246, P661, DOI 10.1126/science.2510298; NONET M, 1987, MOL CELL BIOL, V7, P1602, DOI 10.1128/MCB.7.5.1602; REINES D, 1987, J MOL BIOL, V196, P299, DOI 10.1016/0022-2836(87)90691-7; RUET A, 1980, J BIOL CHEM, V255, P6450; RUET A, 1978, EUR J BIOCHEM, V90, P325, DOI 10.1111/j.1432-1033.1978.tb12608.x; SALTZMAN AG, 1989, FASEB J, V3, P1723, DOI 10.1096/fasebj.3.6.2649403; Sentenac A, 1982, MOL BIOL YEAST SACCH, P561; THOMPSON NE, 1990, J BIOL CHEM, V265, P7069; WOYCHIK NA, 1990, TRENDS BIOCHEM SCI, V15, P347, DOI 10.1016/0968-0004(90)90074-L; WOYCHIK NA, 1989, MOL CELL BIOL, V9, P2854, DOI 10.1128/MCB.9.7.2854; WOYCHIK NA, 1990, GENE DEV, V4, P313, DOI 10.1101/gad.4.3.313	24	203	206	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					71	75						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985924				2022-12-25	WOS:A1991EQ33900013
J	REED, PE; KATZENELLENBOGEN, JA				REED, PE; KATZENELLENBOGEN, JA			PROLINE-VALINE PSEUDO PEPTIDE ENOL LACTONES - EFFECTIVE AND SELECTIVE INHIBITORS OF CHYMOTRYPSIN AND HUMAN-LEUKOCYTE ELASTASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORCINE PANCREATIC ELASTASE; MECHANISM-BASED INHIBITORS; RAY-DIFFRACTION ANALYSIS; SERINE PROTEASES; CATHEPSIN-G; ALPHA-CHYMOTRYPSIN; 1.84-A RESOLUTION; A-ALPHA; INACTIVATION; SUBSTRATE	Pro-Val pseudo dipeptides incorporating protio and halo enol lactones were tested for inhibitory activity against the serine proteases human leukocyte elastase (HLE), porcine pancreatic elastase, alpha-chymotrypsin, trypsin, thrombin, and urokinase. The protio enol lactones 1a-c were found to be HLR substrates but were poor alternate substrate inhibitors. The bromo enol lactone trans isomer 2a was found to be a very effective inhibitor of HLE and chymotrypsin, as shown by the binding constants (K(I)), acylation rates (k(a)), inactivation rates, and partition ratios determined for each enzyme. This inhibitor shows better specificity toward its target enzyme HLE than monosubstituted halo enol lactones; we attribute this to a pseudo dipeptide acyl enzyme whose structure is similar to that adopted by good peptide substrates of HLE. Inactivation of chymotrypsin by the bromo enol lactone 2a is permanent, but inactivation of HLE is partially recoverable upon treatment with the nucleophile hydrazine, indicating that lactone 2a produces two species of inactivated HLE. The more stable of these species could be the result of alkylation of His-57 by the electrophilic bromomethyl ketone revealed in the acyl enzyme, and the less stable, hydrazine-reactivatable species could be the result of alkylation of Asp-102 or the hydrolysis of the bromomethyl ketone group in the initially formed acyl enzyme to form a new, more stable acyl enzyme.	UNIV ILLINOIS,DEPT CHEM,URBANA,IL 61801	University of Illinois System; University of Illinois Urbana-Champaign								BAEK DJ, 1990, BIOCHEMISTRY-US, V29, P4305, DOI 10.1021/bi00470a007; BECHET JJ, 1977, BIOCHIMIE, V59, P241, DOI 10.1016/S0300-9084(77)80140-5; BODE W, 1989, BIOCHEMISTRY-US, V28, P1951, DOI 10.1021/bi00431a001; COPP LJ, 1987, BIOCHEMISTRY-US, V26, P169, DOI 10.1021/bi00375a024; DANIELS SB, 1983, J BIOL CHEM, V258, P5046; DANIELS SB, 1986, BIOCHEMISTRY-US, V25, P1436, DOI 10.1021/bi00354a037; DELMAR EG, 1979, ANAL BIOCHEM, V99, P316, DOI 10.1016/S0003-2697(79)80013-5; DOHERTY JB, 1986, NATURE, V322, P192, DOI 10.1038/322192a0; FISHER G, 1988, NAT PROD REP, P465; GROUTAS WC, 1987, MED RES REV, V7, P227, DOI 10.1002/med.2610070205; GUPTON BF, 1984, J BIOL CHEM, V259, P4279; HARPER JW, 1985, BIOCHEMISTRY-US, V24, P1831, DOI 10.1021/bi00329a005; HARPER JW, 1985, BIOCHEMISTRY-US, V24, P7200, DOI 10.1021/bi00346a028; HEMMI K, 1985, BIOCHEMISTRY-US, V24, P1841, DOI 10.1021/bi00329a006; KAM CM, 1988, BIOCHEMISTRY-US, V27, P2574; KETTNER CA, 1984, J BIOL CHEM, V259, P5106; KITZ R, 1962, J BIOL CHEM, V237, P3245; KRANTZ A, 1990, J MED CHEM, V33, P464, DOI 10.1021/jm00164a002; MAIN AR, 1973, ESSAYS TOXICOL, V4, P59; MEHDI S, 1990, BIOCHEM BIOPH RES CO, V166, P595, DOI 10.1016/0006-291X(90)90850-M; MEYER EF, 1985, J AM CHEM SOC, V107, P4091, DOI 10.1021/ja00299a063; MOORMAN AR, 1982, J AM CHEM SOC, V104, P6785, DOI 10.1021/ja00388a053; NAKAJIMA K, 1979, J BIOL CHEM, V254, P4027; NAVIA MA, 1989, P NATL ACAD SCI USA, V86, P7, DOI 10.1073/pnas.86.1.7; NAVIA MA, 1987, NATURE, V327, P79, DOI 10.1038/327079a0; POWERS JC, 1990, BIOCHEMISTRY-US, V29, P3108, DOI 10.1021/bi00464a030; RANDO RR, 1974, SCIENCE, V185, P320, DOI 10.1126/science.185.4148.320; REED PE, 1990, IN PRESS J ORG CHEM; RINGE D, 1986, BIOCHEMISTRY-US, V25, P5633, DOI 10.1021/bi00367a043; ROBERTS NA, 1986, BIOCHEM BIOPH RES CO, V139, P896, DOI 10.1016/S0006-291X(86)80262-5; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHONBAUM G, 1961, J BIOL CHEM, V236, P2930; SILVERMAN RB, 1988, MECHANISM BASED ENZY, V1; SILVERMAN RB, 1988, MECHANISM BASED ENZY, P13; SOFIA MJ, 1986, J MED CHEM, V29, P230, DOI 10.1021/jm00152a011; STEIN RL, 1987, BIOCHEMISTRY-US, V26, P1301, DOI 10.1021/bi00379a015; STEIN RL, 1983, J AM CHEM SOC, V105, P5111, DOI 10.1021/ja00353a042; STEIN RL, 1987, BIOCHEMISTRY-US, V26, P2682, DOI 10.1021/bi00384a005; TAKAHASHI LH, 1988, J MOL BIOL, V201, P423, DOI 10.1016/0022-2836(88)90148-9; TAKAHASHI LH, 1989, J AM CHEM SOC, V111, P3368, DOI 10.1021/ja00191a039; TIAN WX, 1982, BIOCHEMISTRY-US, V21, P1028, DOI 10.1021/bi00534a031; ZIMMERMAN M, 1980, J BIOL CHEM, V255, P9848	42	17	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					13	21						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985887				2022-12-25	WOS:A1991EQ33900004
J	TARELLI, GT; VANONI, MA; NEGRI, A; CURTI, B				TARELLI, GT; VANONI, MA; NEGRI, A; CURTI, B			CHARACTERIZATION OF A FULLY ACTIVE N-TERMINAL-37-KDA POLYPEPTIDE OBTAINED BY LIMITED TRYPTIC CLEAVAGE OF PIG-KIDNEY D-AMINO-ACID OXIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV MILAN,IST FISIOL VET & BIOCHIM,DIPARTIMENTO FISIOL & BIOCHIM GEN,I-20133 MILAN,ITALY; UNIV MILAN,CTR INTERUNIV STUDIO MACROMOLEC,I-20133 MILAN,ITALY	University of Milan; University of Milan			Negri, Armando/H-7914-2017; Vanoni, Maria/AAP-2089-2021	Negri, Armando/0000-0002-8401-7437; Vanoni, Maria/0000-0001-7213-732X				ANTONINI E, 1966, J BIOL CHEM, V241, P2358; BOLOGNESI M, 1978, J BIOL CHEM, V253, P7513; Bright H.B., 1975, ENZYMES, V12B, P421; CURTI B, 1973, BIOCHIM BIOPHYS ACTA, V327, P266, DOI 10.1016/0005-2744(73)90409-9; CURTI B, 1991, CHEM BIOCH FLAVONENZ; DEMORENO MR, 1985, ANAL BIOCHEM, V151, P466, DOI 10.1016/0003-2697(85)90206-4; FONDA ML, 1967, J BIOL CHEM, V242, P3957; FONTANA A, 1989, METHODS PROTEIN SEQU, P315; FUJIWARA M, 1987, ANAL BIOCHEM, V166, P72, DOI 10.1016/0003-2697(87)90547-1; FUKUI K, 1987, FLAVINS FLAVOPROTEIN, P509; GOULD SJ, 1988, J CELL BIOL, V107, P897, DOI 10.1083/jcb.107.3.897; HUNKAPILLER MW, 1985, USER B APPLIED BIOSY, V14; MASSEY V, 1966, J BIOL CHEM, V241, P3417; MASSEY V, 1965, BIOCHEMISTRY-US, V4, P1161, DOI 10.1021/bi00882a027; MASSEY V, 1979, J BIOL CHEM, V254, P9640; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Neurath H., 1980, PROTEIN FOLDING, P501; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PACKMAN LC, 1987, BIOCHEM J, V242, P531, DOI 10.1042/bj2420531; RONCHI S, 1982, J BIOL CHEM, V257, P8824; SCHOPFER LM, 1981, J BIOL CHEM, V256, P7329; VANONI MA, 1987, EUR J BIOCHEM, V167, P261, DOI 10.1111/j.1432-1033.1987.tb13332.x; WILLIAMS CH, 1984, FLAVINS FLAVOPROTEIN, P95	23	18	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1990	265	34					21242	21246						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EL020	1979077				2022-12-25	WOS:A1990EL02000081
J	FENG, B; HILT, DC; MAX, SR				FENG, B; HILT, DC; MAX, SR			TRANSCRIPTIONAL REGULATION OF GLUTAMINE-SYNTHETASE GENE-EXPRESSION BY DEXAMETHASONE IN L6 MUSCLE-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV MARYLAND,SCH MED,DEPT BIOL CHEM,BALTIMORE,MD 21201; UNIV MARYLAND,CTR MED BIOTECHNOL,BALTIMORE,MD 21201; UNIV MARYLAND,DEPT CHEM & BIOCHEM,CATONSVILLE,MD 21228; VET ADM MED CTR,BALTIMORE,MD 21218	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA)	FENG, B (corresponding author), UNIV MARYLAND,SCH MED,DEPT NEUROL,BALTIMORE,MD 21201, USA.				NICHD NIH HHS [HD 16596] Funding Source: Medline; NIDDK NIH HHS [DK 41022] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD016596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041022] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARDAWI MSM, 1985, ESSAYS BIOCHEM, V21, P1; BHANDARI B, 1986, MOL CELL ENDOCRINOL, V47, P49, DOI 10.1016/0303-7207(86)90015-8; CHANG TW, 1978, J BIOL CHEM, V253, P3685; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COTE GJ, 1986, J BIOL CHEM, V261, P5524; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FENG B, 1990, AM J PHYSIOL, V258, pE757, DOI 10.1152/ajpendo.1990.258.5.E757; FENG B, 1990, AM J PHYSIOL, V258, pE702; GOLDBERG AL, 1978, FED PROC, V37, P2301; GOLDSTEIN L, 1986, FED PROC, V45, P2176; HALL JL, 1983, MED CELL BIOL, V3, P354; KOLETSKY AJ, 1986, J IMMUNOL, V137, P1054; KOMINZ DR, 1954, ARCH BIOCHEM BIOPHYS, V50, P148, DOI 10.1016/0003-9861(54)90017-X; KONAGAYA M, 1986, ENDOCRINOLOGY, V119, P375, DOI 10.1210/endo-119-1-375; KONAGAYA M, 1988, J STEROID BIOCHEM, V19, P685; KUMAR S, 1986, J NEUROSCI RES, V16, P251, DOI 10.1002/jnr.490160122; KUO CF, 1989, J MOL BIOL, V208, P45, DOI 10.1016/0022-2836(89)90086-7; LAD R, 1990, IN PRESS DEV BRAIN R; LINDENBAUM MH, 1988, J BIOL CHEM, V263, P5662; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAX SR, 1987, ENDOCRINOLOGY, V120, P1179, DOI 10.1210/endo-120-3-1179; MAX SR, 1988, AM J PHYSIOL, V255, pE397, DOI 10.1152/ajpendo.1988.255.3.E397; MCKNIGHT GS, 1979, J BIOL CHEM, V254, P9050; MEAROW KM, 1989, MOL BRAIN RES, V6, P223, DOI 10.1016/0169-328X(89)90068-5; ODESSEY R, 1974, J BIOL CHEM, V249, P7623; RAVE N, 1979, NUCLEIC ACIDS RES, V6, P3559, DOI 10.1093/nar/6.11.3559; RENNIE MJ, 1986, LANCET, V2, P1008; ROWE WB, 1985, METHOD ENZYMOL, V113, P199; RUDERMAN NB, 1974, J BIOL CHEM, V249, P5500; SARKAR PK, 1983, MOL CELL BIOCHEM, V53-4, P233; SMITH RJ, 1984, J CELL PHYSIOL, V120, P197, DOI 10.1002/jcp.1041200213; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TILDON JT, 1988, GLUTAMINE GLUTAMATE, P167; YAFFE D, 1968, P NATL ACAD SCI USA, V61, P477, DOI 10.1073/pnas.61.2.477	35	38	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	1990	265	30					18702	18706						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EE201	1976636				2022-12-25	WOS:A1990EE20100102
J	STADDON, JM; BARKER, CJ; MURPHY, AC; CHANTER, N; LAX, AJ; MICHELL, RH; ROZENGURT, E				STADDON, JM; BARKER, CJ; MURPHY, AC; CHANTER, N; LAX, AJ; MICHELL, RH; ROZENGURT, E			PASTEURELLA-MULTOCIDA TOXIN, A POTENT MITOGEN, INCREASES INOSITOL 1,4,5-TRISPHOSPHATE AND MOBILIZES CA2+ IN SWISS 3T3 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PHORBOL ESTERS; GROWTH-FACTOR; PARTIAL-PURIFICATION; DERMONECROTIC TOXIN; BACTERIAL TOXINS; DNA-SYNTHESIS; BOMBESIN; VASOPRESSIN; PHOSPHATES	Pasteurella multocida toxin, both native and recombinant, is an extremely potent mitogen for Swiss 3T3 cells and acts to enhance the formation of total inositol phosphates (Rozengurt, E., Higgins, T., Chanter, N., Lax, A. J., and Staddon, J. M. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 123-127). P. multocida toxin also stimulates diacylglycerol production and activates protein kinase C (Staddon, J. M., Chanter, N., Lax, A. J., Higgins, T. E., and Rozengurt, E. (1990) J. Biol. Chem. 265, 11841-11848). Here we analyze, by [H-3]inositol labeling and high performance liquid chromatography, the inositol phosphates in recombinant P. multocida toxin-treated cells. Recombinant P. multocida toxin stimulated increases in [H-3]inositol 1,4,5-trisphosphate ([H-3]Ins(1,4,5)P3) and its metabolic products, including Ins(1,3,4,5)P4, Ins(1,3,4)P3, Ins(1,4)P2, Ins(4/5)P, and Ins(1/3)P. The profile of the increase in the cellular content of these distinct inositol phosphates was very similar to that elicited by bombesin. Furthermore, recombinant P. multocida toxin, like bombesin, mobilizes an intracellular pool of Ca2+. Recombinant P. multocida toxin pretreatment greatly reduces the Ca2+-mobilizing action of bombesin, consistent with Ca2+ mobilization from a common pool by the two agents. The enhancement of inositol phosphates and mobilization of Ca2+ by recombinant P. multocida toxin were blocked by the lysosomotrophic agents methylamine, ammonium chloride, and chloroquine and occurred after a dose-dependent lag period. The stimulation of inositol phosphate production by recombinant P. multocida toxin persisted after removal of extracellular toxin, in contrast to the reversibility of the action of bombesin. Recombinant P. multocida toxin, unlike bombesin and guanosine 5'-O-(gamma-thiotriphosphate), did not cause the release of inositol phosphates in permeabilized cells. These data demonstrate that recombinant P. multocida toxin, acting intracellularly, stimulates the phospholipase C-mediated hydrolysis of phosphatidylinositol 4,5-bisphosphate.	IMPERIAL CANC RES FUND,POB 123,LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND; UNIV BIRMINGHAM,SCH BIOCHEM,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND; AFRC,INST ANIM HLTH,NEWBURY RG16 0NN,BERKS,ENGLAND	Cancer Research UK; University of Birmingham; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute			Michell, Robert H/AAT-4974-2020	Michell, Robert H/0000-0001-9422-9858				BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; BLACKSHEAR PJ, 1986, J BIOL CHEM, V261, P1459; BROWN DM, 1966, BIOCHIM BIOPHYS ACTA, V125, P413, DOI 10.1016/0005-2760(66)90029-4; CHANTER N, 1986, J GEN MICROBIOL, V132, P1089; COFFER A, 1990, FEBS LETT, V263, P80, DOI 10.1016/0014-5793(90)80710-Z; DICKER P, 1980, NATURE, V287, P607, DOI 10.1038/287607a0; DOMINICK MA, 1988, VET PATHOL, V25, P17, DOI 10.1177/030098588802500103; ERUSALIMSKY JD, 1988, J BIOL CHEM, V263, P19188; FOGED NT, 1988, INFECT IMMUN, V56, P1901, DOI 10.1128/IAI.56.8.1901-1906.1988; FOGED NT, 1987, FEMS MICROBIOL LETT, V43, P45, DOI 10.1111/j.1574-6968.1987.tb02095.x; GRADO C, 1961, J BIOL CHEM, V236, P54; GRAF E, 1983, ANAL BIOCHEM, V131, P351, DOI 10.1016/0003-2697(83)90182-3; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HASEGAWASASAKI H, 1988, J BIOL CHEM, V263, P12970; HAWKINS PT, 1986, BIOCHEM J, V238, P507, DOI 10.1042/bj2380507; HESLOP JP, 1986, CELL, V47, P703, DOI 10.1016/0092-8674(86)90513-1; IRVINE RF, 1986, NATURE, V320, P631, DOI 10.1038/320631a0; KAMP EM, 1987, VET MICROBIOL, V13, P235, DOI 10.1016/0378-1135(87)90086-1; KAMPS AMIE, 1990, FEMS MICROBIOL LETT, V67, P187, DOI 10.1111/j.1574-6968.1990.tb13860.x; LAX AJ, 1990, J GEN MICROBIOL, V136, P81, DOI 10.1099/00221287-136-1-81; LAX AJ, 1990, FEBS LETT, V277, P59, DOI 10.1016/0014-5793(90)80809-W; LOPEZRIVAS A, 1984, AM J PHYSIOL, V247, pC156, DOI 10.1152/ajpcell.1984.247.3.C156; LOPEZRIVAS A, 1987, P NATL ACAD SCI USA, V84, P5768, DOI 10.1073/pnas.84.16.5768; MAJERUS PW, 1988, J BIOL CHEM, V263, P3051; MEEK JL, 1986, P NATL ACAD SCI USA, V83, P4162, DOI 10.1073/pnas.83.12.4162; MENDOZA SA, 1986, J CELL BIOL, V102, P2223, DOI 10.1083/jcb.102.6.2223; MICHELL RH, 1990, PHILOS T ROY SOC B, V327, P193, DOI 10.1098/rstb.1990.0054; MIDDLEBROOK JL, 1984, MICROBIOL REV, V48, P199, DOI 10.1128/MMBR.48.3.199-221.1984; MORRIS AJ, 1988, BIOCHEM J, V251, P157, DOI 10.1042/bj2510157; MOSS J, 1988, ADV ENZYMOL RAMB, V61, P303; NAKAI T, 1984, INFECT IMMUN, V46, P429, DOI 10.1128/IAI.46.2.429-434.1984; NANBERG E, 1988, EMBO J, V7, P2741, DOI 10.1002/j.1460-2075.1988.tb03128.x; NEVILLE DM, 1986, ANNU REV BIOCHEM, V55, P195, DOI 10.1146/annurev.biochem.55.1.195; Olsnes S., 1988, IMMUNOTOXINS, P39; PETERSEN SK, 1989, INFECT IMMUN, V57, P3907, DOI 10.1128/IAI.57.12.3907-3913.1989; PETERSEN SK, 1990, MOL MICROBIOL, V4, P821, DOI 10.1111/j.1365-2958.1990.tb00652.x; PFEUFFER T, 1988, CURR TOP CELL REGUL, V29, P129; RIMLER RB, 1986, AM J VET RES, V47, P730; RODRIGUEZPENA A, 1986, EMBO J, V5, P77, DOI 10.1002/j.1460-2075.1986.tb04180.x; ROZENGURT E, 1990, P NATL ACAD SCI USA, V87, P123, DOI 10.1073/pnas.87.1.123; ROZENGURT E, 1983, P NATL ACAD SCI-BIOL, V80, P2936, DOI 10.1073/pnas.80.10.2936; ROZENGURT E, 1986, SCIENCE, V234, P161, DOI 10.1126/science.3018928; ROZENGURT E, 1983, P NATL ACAD SCI USA, V80, P7224; SHEARS SB, 1987, BIOCHEM J, V242, P393, DOI 10.1042/bj2420393; SHEARS SB, 1989, BIOCHEM J, V260, P313, DOI 10.1042/bj2600313; SINNETTSMITH J, 1990, BIOCHEM J, V265, P485, DOI 10.1042/bj2650485; STADDON JM, 1990, J BIOL CHEM, V265, P11841; STEPHENS LR, 1988, BIOCHEM J, V249, P283, DOI 10.1042/bj2490283; TAKUWA N, 1987, J BIOL CHEM, V262, P182; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; TSIEN RY, 1982, J CELL BIOL, V94, P325, DOI 10.1083/jcb.94.2.325; WREGGETT KA, 1987, BIOCHEM J, V245, P933, DOI 10.1042/bj2450933; ZACHARY I, 1985, P NATL ACAD SCI USA, V82, P7616, DOI 10.1073/pnas.82.22.7616	54	67	68	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4840	4847						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002031				2022-12-25	WOS:A1991FC21700028
J	KAPLAN, O; COHEN, JS				KAPLAN, O; COHEN, JS			LYMPHOCYTE-ACTIVATION AND PHOSPHOLIPID PATHWAYS - P-31 MAGNETIC-RESONANCE STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; HUMAN PERIPHERAL LYMPHOCYTES; PROTEIN KINASE-C; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; FRIEND-ERYTHROLEUKEMIA; HELA-CELLS; INTERLEUKIN-2; STIMULATION; MEMBRANE; METABOLISM	P-31 NMR spectra of perfused lymphocytes, embedded in alginate capsules and activated by interleukin-2, were remarkably different from those of control lymphocytes. The main differences were the appearance and gradual increase in phosphodiester signals, glycerophosphocholine and glycerophosphoethanolamine. These metabolic changes also occurred following perfusion with phorbol ester and after incubation with phytohemagglutinin (PHA) and were not dependent on a special growth medium. Nifedipine, a calcium channel blocking drug, inhibited the effects of phytohemagglutinin, but not of interleukin-2. There were no NMR spectral differences between peripheral lymphocytes, stimulated for 3 weeks, and tumor-infiltrating lymphocytes. Thus, sustained accelerated turnover of phosphatidylcholine and phosphatidylethanolamine is an inherent feature of the activation process. P-31 NMR spectra of lymphocytes are characterized by a low signal of phosphocholine. Perfusion studies with high concentrations of choline and the use of dapsone, an inhibitor of cytidylyltransferase, indicated that choline kinase plays a key role in regulating phosphatidylcholine synthesis in human lymphocytes.	NCI, DIV CANC TREATMENT, MED BRANCH, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)								BERRIDGE MJ, 1984, BIOCHEM J, V220, P345, DOI 10.1042/bj2200345; BIRX DL, 1984, J IMMUNOL, V133, P2904; BONNEY RJ, 1979, BIOCHEM PHARMACOL, V28, P2471, DOI 10.1016/0006-2952(79)90010-8; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; BRAND K, 1988, EUR J BIOCHEM, V172, P695, DOI 10.1111/j.1432-1033.1988.tb13944.x; BURT CT, 1984, BIOCHEM MED METAB B, V31, P21, DOI 10.1016/0006-2944(84)90054-1; CABOT MC, 1988, FEBS LETT, V233, P153, DOI 10.1016/0014-5793(88)81374-7; CARPINELLI G, 1984, FEBS LETT, V176, P88, DOI 10.1016/0014-5793(84)80917-5; DALY PF, 1989, CANCER RES, V49, P770; DALY PF, 1987, J BIOL CHEM, V262, P14875; DAWSON R. M. C., 1966, ESSAYS BIOCHEM, V2, P69; EALY PF, 1990, CANCER RES, V50, P552; FOXALL DL, 1984, EXP CELL RES, V154, P521, DOI 10.1016/0014-4827(84)90176-9; GADIAN DG, 1982, NUCL MAGN RESON, P1; GRIER CE, 1985, J CELL PHYSIOL, V124, P131, DOI 10.1002/jcp.1041240121; GUY GR, 1982, CANCER RES, V42, P1980; HIRATA F, 1980, P NATL ACAD SCI-BIOL, V77, P862, DOI 10.1073/pnas.77.2.862; HO AK, 1987, J BIOL CHEM, V262, P11764; HOLMES KT, 1988, MAGN RESON MED BIOL, V1, P75; IMBODEN JB, 1985, J EXP MED, V161, P446, DOI 10.1084/jem.161.3.446; ISAKOV N, 1987, J IMMUNOL, V138, P3100; ITOH K, 1986, CANCER RES, V46, P3011; JACQUELINE E, 1987, THROMB RES, V47, P573; KAPLAN O, 1990, J BIOL CHEM, V265, P13641; KAPLAN O, 1989, FEBS LETT, V258, P55, DOI 10.1016/0014-5793(89)81614-X; KISS Z, 1989, J BIOL CHEM, V264, P1483; KO KWS, 1986, J BIOL CHEM, V261, P7846; KORNFELD H, 1985, J IMMUNOL, V134, P3887; KUNO M, 1987, NATURE, V326, P301, DOI 10.1038/326301a0; MENEGUS F, 1985, FEBS LETT, V187, P151, DOI 10.1016/0014-5793(85)81232-1; MERCHANT TE, 1988, CANCER RES, V48, P5112; MICHELL RH, 1975, BIOCHIM BIOPHYS ACTA, V415, P81, DOI 10.1016/0304-4157(75)90017-9; Narayan K S, 1990, NMR Biomed, V3, P23, DOI 10.1002/nbm.1940030104; NAVON G, 1978, P NATL ACAD SCI USA, V75, P891, DOI 10.1073/pnas.75.2.891; NIWA Y, 1986, ARCH BIOCHEM BIOPHYS, V250, P345, DOI 10.1016/0003-9861(86)90736-8; OGARRA A, 1989, LANCET, V1, P943; PELECH SL, 1984, BIOCHIM BIOPHYS ACTA, V779, P217, DOI 10.1016/0304-4157(84)90010-8; PELECH SL, 1989, TRENDS BIOCHEM SCI, V14, P28, DOI 10.1016/0968-0004(89)90086-8; PETERSEN A, 1986, BIOCHIM BIOPHYS ACTA, V888, P282, DOI 10.1016/0167-4889(86)90227-2; RESCH K, 1976, EUR J IMMUNOL, V6, P168, DOI 10.1002/eji.1830060306; ROOS D, 1970, BIOCHIM BIOPHYS ACTA, V222, P565, DOI 10.1016/0304-4165(70)90182-0; ROSABONO M, 1989, CELL BIOCHEM FUNCT, V7, P219; ROSENBERG SA, 1988, NEW ENGL J MED, V319, P1676, DOI 10.1056/NEJM198812223192527; SHIGEURA HT, 1975, BIOCHEM PHARMACOL, V24, P687, DOI 10.1016/0006-2952(75)90244-0; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; TALMADGE JE, 1987, LIPIDS, V22, P871, DOI 10.1007/BF02535547; TOLLEFSBOL TO, 1985, J CELL PHYSIOL, V122, P98, DOI 10.1002/jcp.1041220115; TOPALIAN SL, 1987, J IMMUNOL METHODS, V102, P127, DOI 10.1016/S0022-1759(87)80018-2; TOYOSHIMA S, 1975, J BIOL CHEM, V250, P1655; VANCE DE, 1979, TRENDS BIOCHEM SCI, V4, P145, DOI 10.1016/0968-0004(79)90001-X; WARDEN CH, 1985, J BIOL CHEM, V260, P6006; WHITLON DS, 1985, BIOCHIM BIOPHYS ACTA, V835, P369, DOI 10.1016/0005-2760(85)90293-0; WRIGHTON SA, 1982, CARCINOGENESIS, V3, P1415, DOI 10.1093/carcin/3.12.1415; WYBRAN J, 1973, Journal of Immunology, V110, P1157	54	23	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3688	3694						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995623				2022-12-25	WOS:A1991EY68200053
J	KLUEPPELBERG, UG; GATES, LK; GORELICK, FS; MILLER, LJ				KLUEPPELBERG, UG; GATES, LK; GORELICK, FS; MILLER, LJ			AGONIST-REGULATED PHOSPHORYLATION OF THE PANCREATIC CHOLECYSTOKININ RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED PROTEIN-PHOSPHORYLATION; EXOCRINE PANCREAS; ENZYME-SECRETION; 29,000-DALTON PROTEIN; PLASMA-MEMBRANES; BINDING PROTEINS; ACINAR-CELLS; SHORT PROBES; PURIFICATION; KINASE	The present study was undertaken to determine if the cholecystokinin (CCK) receptor may be phosphorylated, and to gain insight into its regulation. For this, the ATP pool of rat pancreatic acini was prelabeled with P-32, and the cells were stimulated with various secretagogues. CCK receptors from treated cells were enriched by sequential fractionation to produce plasmalemma, and subsequent solubilization and lectin-affinity chromatography. This protocol detected a phosphorylated M(r) = 85,000-95,000 plasma membrane glycoprotein with features similar to the CCK receptor. Phosphorylation of this protein occurred rapidly (less than 2 min) and in a concentration-dependent manner in response to CCK, and was inhibited by the CCK receptor antagonist L-364,718. Further evidence that this represented the CCK receptor included co-migration of phosphorylated and CCK radioligand affinity-labeled proteins on sodium dodecyl sulfate-polyacrylamide gels, both in native forms and after endoglycosidase F deglycosylation, and the specific adsorption of the phosphoprotein to a CCK analogue affinity resin. Phosphorylation occurred predominantly on serine residues of the receptor protein. Phosphorylation of this protein was also enhanced in response to other secretagogues which, like CCK, stimulate a cascade leading to protein kinase C activation, and in response to direct activation of this enzyme by 12-O-tetradecanoylphorbol 13-acetate. Thus, the pancreatic CCK receptor is phosphorylated in a regulated manner, in response to both homologous and heterologous secretagogues, and to protein kinase C activation.	MAYO CLIN & MAYO FDN,GASTROENTEROL BASIC RES UNIT,GUGGENHEIM 17,ROCHESTER,MN 55905; W HAVEN VET ADM HOSP,W HAVEN,CT 06510	Mayo Clinic				Gorelick, Fred/0000-0001-8293-6803	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034988, R37DK032878, R01DK032878] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK34988, DK32878] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABDELMOUMENE S, 1980, AM J PHYSIOL, V239, pG272, DOI 10.1152/ajpgi.1980.239.4.G272; ANSAH TA, 1986, BIOCHIM BIOPHYS ACTA, V889, P326, DOI 10.1016/0167-4889(86)90195-3; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; BURNHAM DB, 1982, J BIOL CHEM, V257, P523; CHANG RSL, 1986, MOL PHARMACOL, V30, P212; DUONG LT, 1989, J BIOL CHEM, V264, P17990; FREEDMAN SD, 1982, J CELL BIOL, V95, P918, DOI 10.1083/jcb.95.3.918; FREEDMAN SD, 1982, J CELL BIOL, V95, P909, DOI 10.1083/jcb.95.3.909; FREEDMAN SD, 1982, J CELL BIOL, V95, P903, DOI 10.1083/jcb.95.3.903; GAISANO HY, 1989, J CLIN INVEST, V83, P321, DOI 10.1172/JCI113877; GUNTHER GR, 1979, NATURE, V280, P318, DOI 10.1038/280318a0; HENNESSEY JP, 1989, ANAL BIOCHEM, V176, P284, DOI 10.1016/0003-2697(89)90310-2; KLUEPPELBERG UG, 1989, BIOCHEMISTRY-US, V28, P3463, DOI 10.1021/bi00434a047; KLUEPPELBERG UG, 1989, BIOCHEMISTRY-US, V28, P7124, DOI 10.1021/bi00443a051; MERRITT JE, 1986, BIOCHEM J, V236, P337, DOI 10.1042/bj2360337; MILELR LJ, 1981, J BIOL CHEM, V256, P12417; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; MUTT V, 1980, GASTROINTESTINAL HOR, P169; NAIRN AC, 1987, J BIOL CHEM, V262, P7273; PANDOL SJ, 1986, J BIOL CHEM, V261, P4438; PEARSON RK, 1987, J BIOL CHEM, V262, P13850; PEARSON RK, 1987, J BIOL CHEM, V262, P869; POWERS SP, 1988, J BIOL CHEM, V263, P5295; ROBB RA, 1989, IEEE T MED IMAGING, V8, P217, DOI 10.1109/42.34710; ROSENZWEIG SA, 1984, J CELL BIOL, V99, P1110, DOI 10.1083/jcb.99.3.1110; ROSENZWEIG SA, 1983, J CELL BIOL, V96, P1288, DOI 10.1083/jcb.96.5.1288; SAKAMOTO C, 1983, FEBS LETT, V151, P63, DOI 10.1016/0014-5793(83)80343-3; SCHULTZ GS, 1980, EXP CELL RES, V130, P49, DOI 10.1016/0014-4827(80)90041-5; SIBLEY DR, 1987, CELL, V48, P913, DOI 10.1016/0092-8674(87)90700-8; SZECOWKA J, 1989, REGUL PEPTIDES, V24, P215, DOI 10.1016/0167-0115(89)90218-8	31	73	73	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2403	2408						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989991				2022-12-25	WOS:A1991EV51500060
J	TAKAHASHI, M; BUMA, Y; TANIGUCHI, M				TAKAHASHI, M; BUMA, Y; TANIGUCHI, M			IDENTIFICATION OF THE RET PROTOONCOGENE PRODUCTS IN NEUROBLASTOMA AND LEUKEMIA-CELLS	ONCOGENE			English	Article							EXPRESSION; PROTOONCOGENE; RNA	Monoclonal and/or polyclonal antibodies were generated against the products synthesized from two portions of the ret proto-oncogene (c-ret) cDNA expressed in Escherichia coli. These antibodies were reactive in immunoblotting with 150 kd and 170 kd proteins in cell lysates from three human neuroblastoma cell lines expressing the ret proto-oncogene. When the neuroblastoma cells were treated with tunicamycin, a protein with an apparent molecular weight of 120 kd, which is consistent with that of the c-ret protein predicted from the cDNA sequence, appeared on immunoblots. These results indicated that the 150 kd and 170 kd proteins in neuroblastoma cells are produced from a single polypeptide of 120 kd by post-translational glycosylation. Furthermore, the antibodies detected a unique 190 kd protein as well as 150 kd protein in a cell lysate from THP-1 human monocytic leukemia cell line, suggesting that glycosylated forms of the c-ret protein are different between neuroblastoma and leukemia cells.	AICHI CANC CTR,RES INST,EXPTL PATHOL LAB,CHIKUSA KU,NAGOYA,AICHI 464,JAPAN	Aichi Cancer Center	TAKAHASHI, M (corresponding author), NAGOYA UNIV,SCH MED,DEPT PATHOL 2,65 TSURUMAI CHO,NAGOYA,AICHI 466,JAPAN.		TAKAHASHI, Masahide/I-7244-2014; Takahashi, Masahide/AAN-4770-2020	Takahashi, Masahide/0000-0002-2803-2683				IKEDA I, 1990, ONCOGENE, V5, P1291; KIKUCHI T, 1990, HYBRIDOMA, V9, P189, DOI 10.1089/hyb.1990.9.189; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; NAGAO M, 1990, JPN J CANCER RES, V81, P309, DOI 10.1111/j.1349-7006.1990.tb02566.x; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; RETTENMIER CW, 1987, MOL CELL BIOL, V7, P2378, DOI 10.1128/MCB.7.7.2378; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; TAHIRA T, 1988, BIOCHEM BIOPH RES CO, V153, P1290, DOI 10.1016/S0006-291X(88)81368-8; TAHIRA T, 1990, ONCOGENE, V5, P97; TAKAHASHI M, 1987, MOL CELL BIOL, V7, P1378, DOI 10.1128/MCB.7.4.1378; TAKAHASHI M, 1989, ONCOGENE, V4, P805; TAKAHASHI M, 1988, ONCOGENE, V3, P571	12	102	105	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1991	6	2					297	301						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ134	2000222				2022-12-25	WOS:A1991FZ13400016
J	MACDONALD, MJ; MCKENZIE, DI; KAYSEN, JH; WALKER, TM; MORAN, SM; FAHIEN, LA; TOWLE, HC				MACDONALD, MJ; MCKENZIE, DI; KAYSEN, JH; WALKER, TM; MORAN, SM; FAHIEN, LA; TOWLE, HC			GLUCOSE REGULATES LEUCINE-INDUCED INSULIN RELEASE AND THE EXPRESSION OF THE BRANCHED-CHAIN KETOACID DEHYDROGENASE E1-ALPHA SUBUNIT GENE IN PANCREATIC-ISLETS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYRUP-URINE-DISEASE; MESSENGER-RNA; GLUTAMATE-DEHYDROGENASE; ACID DEHYDROGENASE; AMINO-ACID; CELL-LINE; B-CELL; RIN-5F CELLS; HUMAN-BRAIN; BETA-CELLS	Much evidence has accumulated to support the idea that leucine can stimulate insulin release by allosterically activating glutamate dehydrogenase thus enhancing glutamate metabolism. It is less clear how the metabolism of leucine itself contributes to the signal for insulin release. We recently found that culturing pancreatic islets for 1 day at low glucose (1 mM) suppressed glucose-induced insulin release, but preserved leucine-induced insulin release. When islets were cultured at high glucose (20 mM), glucose-induced insulin release was preserved, but leucine-induced insulin release was suppressed (MacDonald, M. J., Fahien, L. A., McKenzie, D.I., and Moran, S.M. (1990) Am. J. Physiol., 259, E548-E554). The suppression of leucine-induced insulin release can be explained by glucose's suppression of the synthesis of the enzyme that catalyzes the first committed step of leucine metabolism, branched chain ketoacid dehydrogenase complex (BCKDH). High glucose suppressed the enzyme activity of the E1 component of the BCKDH complex, as well as the total activity of the BCKDH complex, to usually negligible levels in islets and decreased by an average of 90% the mRNA which encodes E1-alpha, the catalytic subunit of the E1 component of BCKDH, in islets and rat insulinoma cells. Time course studies showed that about 24 h in culture was required to maximally induce or suppress the expression of BCKDH E1-alpha. Culture at high glutamine with or without leucine mimicked to a lesser and more variable degree the effects of high glucose on leucine-induced insulin release and BCKDH E1-alpha mRNA. Leucine-plus-glutamine-induced insulin release was present after culture of islets with glucose and with or without any other secretagogue. Also, glutamate dehydrogenase transcripts and enzyme activity were not significantly altered by varying the concentration of glucose in the culture medium. Thus, leucine's insulinotropism via activation of glutamate dehydrogenase is constitutive. Preproinsulin mRNA levels were markedly increased at high glucose and glyceraldehyde phosphate dehydrogenase transcripts were either unaffected or slightly increased by glucose. Glutamine did not significantly effect the expression of genes other than BCKDH E1-alpha, and leucine had little or no effect on the expression of any of the four genes. The results are consistent with pre-translational regulation by glucose, and possibly also by glutamine, of leucine-induced insulin release and indicate that insulinotropism of the beta cell may be maintained under conditions of fuel shortage by a leucine metabolism-induced insulin secretory mechanism, as opposed to glucose-induced insulin release or to leucine's activation of glutamate dehydrogenase. This may be the first suggestion of a negative glucose responsive element in a gene that controls insulin secretion in the pancreatic beta cell. Glutamine did not significantly effect the expression of genes other than BCKDH E1-alpha, and leucine had little or no effect on the expression of any of the four genes. The results are consistent with pre-translational regulation by glucose, and possibly also by glutamine, of leucine-induced insulin release and indicate that insulinotropism of the beta-cell may be maintained under conditions of fuel shortage by a leucine metabolism-induced insulin secretory mechanism, as opposed to glucose-induced insulin release or the leucine's activation of glutamate dehydrogenase. This may be the first suggestion of a negative glucose responsive element in a gene that controls insulin secretion in the pancreatic beta-cell.	UNIV WISCONSIN, SCH MED, DEPT PHARMACOL, MADISON, WI 53706 USA; UNIV MINNESOTA, SCH MED, DEPT BIOCHEM, MINNEAPOLIS, MN 55455 USA	University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities	MACDONALD, MJ (corresponding author), UNIV WISCONSIN, SCH MED, DEPT PEDIAT, 1300 UNIV AVE, RM 3459, MADISON, WI 53706 USA.		McKenzie, Debbie/G-4459-2015	McKenzie, Debbie/0000-0002-9291-6977	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028348, R55DK028348] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK28348] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BANNER C, 1987, J NEUROCHEM, V49, P246, DOI 10.1111/j.1471-4159.1987.tb03422.x; BURCH PT, 1981, DIABETES, V30, P923, DOI 10.2337/diabetes.30.11.923; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHUANG DT, 1988, METHOD ENZYMOL, V166, P146; FAHIEN LA, 1969, ARCH BIOCHEM BIOPHYS, V130, P449, DOI 10.1016/0003-9861(69)90057-5; FAHIEN LA, 1988, J BIOL CHEM, V263, P13610; GAZDAR AF, 1980, P NATL ACAD SCI-BIOL, V77, P3519, DOI 10.1073/pnas.77.6.3519; GIROIX MH, 1984, BIOCHEM BIOPH RES CO, V119, P543, DOI 10.1016/S0006-291X(84)80282-X; GOODWIN GW, 1988, METHOD ENZYMOL, V166, P189; GYLFE E, 1976, ACTA DIABETOL LAT, V13, P20, DOI 10.1007/BF02591577; HAMMONDS P, 1987, FEBS LETT, V223, P131, DOI 10.1016/0014-5793(87)80523-9; HARPER PAW, 1986, VET REC, V119, P62, DOI 10.1136/vr.119.3.62; HOXWORTH B, 1985, DIABETES, V34, P295, DOI 10.2337/diabetes.34.3.295; HU CWC, 1988, J BIOL CHEM, V263, P9007; HUTTON JC, 1979, BIOCHEM J, V184, P291, DOI 10.1042/bj1840291; HUTTON JC, 1980, J BIOL CHEM, V255, P7340; JACOBY DB, 1989, J BIOL CHEM, V264, P17623; JENSEN MD, 1988, AM J PHYSIOL, V254, pE700, DOI 10.1152/ajpendo.1988.254.6.E700; JUMP DB, 1988, J BIOL CHEM, V263, P7254; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; LEVY J, 1976, METABOLISM, V25, P583, DOI 10.1016/0026-0495(76)90012-3; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACDONALD M, 1976, AM J PHYSIOL, V231, P619, DOI 10.1152/ajplegacy.1976.231.2.619; MACDONALD MJ, 1990, AM J PHYSIOL, V259, pE548, DOI 10.1152/ajpendo.1990.259.4.E548; MACDONALD MJ, 1989, METABOLISM, V38, P450, DOI 10.1016/0026-0495(89)90197-2; MACDONALD MJ, 1990, DIABETES S1, V39, P1016; MALAISSE WJ, 1982, J BIOL CHEM, V257, P8731; MALAISSE WJ, 1985, ADV ENZYME REGUL, V25, P979; MALAISSELAGAE F, 1982, J BIOL CHEM, V257, P3754; Maniatis T., 1982, MOL CLONING; MILNER RDG, 1969, LANCET, V1, P1075; MILNER RDG, 1969, BIOCHIM BIOPHYS ACTA, V192, P154, DOI 10.1016/0304-4165(69)90025-7; NAKATANI Y, 1987, BIOCHEM BIOPH RES CO, V149, P405, DOI 10.1016/0006-291X(87)90381-0; NIELSEN DA, 1985, J BIOL CHEM, V260, P3585; PANTEN U, 1981, MOL PHARMACOL, V20, P76; PANTEN U, 1984, BIOCHEM J, V219, P189, DOI 10.1042/bj2190189; PRAZ GA, 1983, BIOCHEM J, V210, P345, DOI 10.1042/bj2100345; PROSTKO CR, 1989, BIOCHEM J, V258, P295, DOI 10.1042/bj2580295; SCHARP DW, 1973, TRANSPLANTATION, V16, P686, DOI 10.1097/00007890-197312000-00028; SENER A, 1981, P NATL ACAD SCI-BIOL, V78, P5460, DOI 10.1073/pnas.78.9.5460; VAZQUEZ JA, 1986, AM J PHYSIOL, V250, pE615, DOI 10.1152/ajpendo.1986.250.6.E615; WELSH M, 1985, J BIOL CHEM, V260, P3590; WELSH N, 1986, BIOCHIM BIOPHYS ACTA, V887, P58, DOI 10.1016/0167-4889(86)90122-9; WHITE BA, 1982, J BIOL CHEM, V257, P8569; ZHANG B, 1987, J BIOL CHEM, V262, P15220	46	51	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1335	1340						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985951				2022-12-25	WOS:A1991ET17700099
J	SCHIRCH, V; SHOSTAK, K; ZAMORA, M; GAUTAMBASAK, M				SCHIRCH, V; SHOSTAK, K; ZAMORA, M; GAUTAMBASAK, M			THE ORIGIN OF REACTION SPECIFICITY IN SERINE HYDROXYMETHYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL SCANNING CALORIMETRY; TRANSHYDROXYMETHYLASE; MECHANISM; EXCHANGE	Cytosolic serine hydroxymethyltransferase has been shown previously to exhibit both broad substrate and reaction specificity. In addition to cleaving many different 3-hydroxyamino acids to glycine and an aldehyde, the enzyme also catalyzes with several amino acid substrate analogs decarboxylation, transamination, and recemization reactions. To elucidate the relationship of the structure of the substrate to reaction specificity, the interaction of both amino acid and folate substrates and substrate analogs with the enzyme has been studied by three different methods. These methods include investigating the effects of substrates and substrate analogs on the thermal denaturation properties of the enzyme by differential scanning calorimetry, determining the rate of peptide hydrogen exchange with solvent protons, and measuring the optical activity of the active site pyridoxal phosphate. All three methods suggest that the enzyme exists as an equilibrium between "open" and "closed" forms. Amino acid substrates enter and leave the active site in the open form, but catalysis occurs in the closed form. The data suggest that the amino acid analogs that undergo alternate reactions, such as racemization and transamination, bind only to the open form of the enzyme and that the alternate reactions occur in the open form. Therefore, one role for forming the closed form of the enzyme is to block side reactions and confer reaction specificity.			SCHIRCH, V (corresponding author), VIRGINIA COMMONWEALTH UNIV,DEPT BIOCHEM & MOLEC BIOPHYS,RICHMOND,VA 23298, USA.				NCI NIH HHS [CA-09564] Funding Source: Medline; NIGMS NIH HHS [GM 28143] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028143] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arnone A, 1985, TRANSAMINASES, P138; ARTIGUES A, 1990, J BIOL CHEM, V265, P4853; Davis L, 1972, ENZYMES, P33; ENGLANDER SW, 1975, ANN NY ACAD SCI, V244, P10, DOI 10.1111/j.1749-6632.1975.tb41518.x; FARACH MC, 1983, J BIOL CHEM, V258, P4166; JANSONIUS JN, 1985, TRANSAMINASES, P110; KALLEN RG, 1966, J BIOL CHEM, V241, P5851; MARTELL AE, 1989, ACCOUNTS CHEM RES, V22, P115, DOI 10.1021/ar00160a001; METZLER DE, 1957, J AM CHEM SOC, V79, P485, DOI 10.1021/ja01559a068; MILES EW, 1986, BIOCHEMISTRY-US, V25, P4240, DOI 10.1021/bi00363a011; PALEKAR AG, 1973, J BIOL CHEM, V248, P1158; PFISTER K, 1978, P NATL ACAD SCI USA, V75, P145, DOI 10.1073/pnas.75.1.145; RELIMPIO A, 1981, J BIOL CHEM, V256, P4478; SCHIRCH L, 1977, BIOCHEMISTRY-US, V16, P410, DOI 10.1021/bi00622a011; SCHIRCH L, 1980, J BIOL CHEM, V255, P7801; SCHIRCH L, 1982, ADV ENZYMOL RAMB, V53, P83; SCHIRCH L, 1964, J BIOL CHEM, V238, P3801; SCHIRCH LV, 1967, BIOCHEMISTRY-US, V6, P253, DOI 10.1021/bi00853a039; SCHIRCH LV, 1971, J BIOL CHEM, V246, P3961; SHOSTAK K, 1988, BIOCHEMISTRY-US, V27, P8007, DOI 10.1021/bi00421a006; SHRIVER JW, 1990, BIOCHEMISTRY-US, V29, P2556, DOI 10.1021/bi00462a018; SNELL EE, 1985, TRANSAMINASES, P19; STRONG W, 1987, J BIOL CHEM, V262, P12519	23	60	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					759	764						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985962				2022-12-25	WOS:A1991ET17700016
J	WESTERHAUSEN, DR; HOPKINS, WE; BILLADELLO, JJ				WESTERHAUSEN, DR; HOPKINS, WE; BILLADELLO, JJ			MULTIPLE TRANSFORMING GROWTH FACTOR-BETA-INDUCIBLE ELEMENTS REGULATE EXPRESSION OF THE PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 GENE IN HEP G2 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-LUNG FIBROBLASTS; NECROSIS FACTOR-ALPHA; FACTOR-BETA; MESSENGER-RNA; EXTRACELLULAR-MATRIX; COLLAGEN-SYNTHESIS; PHORBOL ESTER; RAT; FACTOR-BETA-1; FIBRONECTIN	Regulation of plasminogen activation by plasminogen activator inhibitor type-1 (PAI-1) is a critical feature of many biological processes. Transforming growth factor-beta (TGF-beta) induces PAI-1 mRNA and protein in several types of cultured cells, including Hep G2 cells. The present study was performed to define mechanisms by which PAI-1 gene expression is regulated by TGF-beta. Nuclear run-on assays performed on Hep G2 cells stimulated with TGF-beta for 6 h showed a 3.8-fold increase in PAI-1 gene transcription. TGF-beta increased the half-life of PAI-1 mRNA in Hep G2 cells 2.5-fold over control values. To characterize transcriptional regulatory mechanisms, we constructed chimeric genes containing PAI-1 5'-flanking DNA fused upstream of the bacterial chloramphenicol acetyltransferase gene in the vector pSVOCAT and transfected Hep G2 cells. Promoter deletion analysis demonstrated that sequences between -791 to -328 and -328 to -186 base pairs upstream of the PAI-1 gene cap site contain TGF-beta responsive elements that conferred TGF-beta inducibility in an orientation and position-independent manner. Further characterization of the larger TGF-beta-inducible enhancer (-791 to -328) located a TGF-beta-inducible element at nucleotides -791 to -546 upstream of the PAI-1 gene cap site. These results demonstrate that PAI-1 gene regulation by TGF-beta in Hep G2 cells is mediated both at a transcriptional level by two specific inducible elements, as well as by post-transcriptional mechanisms.			WESTERHAUSEN, DR (corresponding author), WASHINGTON UNIV,SCH MED,DEPT MED,DIV CARDIOVASC,660 S EUCLID AVE,BOX 8086,ST LOUIS,MO 63110, USA.				NHLBI NIH HHS [HL38868] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038868] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGEL P, 1987, MOL CELL BIOL, V7, P2256, DOI 10.1128/MCB.7.6.2256; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BASCOM CC, 1989, MOL CELL BIOL, V9, P5508, DOI 10.1128/MCB.9.12.5508; BASSOLS A, 1988, J BIOL CHEM, V263, P3039; BOSMA PJ, 1988, J BIOL CHEM, V263, P9129; BOSTROM K, 1988, J BIOL CHEM, V263, P4434; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUZDZINSKI CJ, 1990, J BIOL CHEM, V265, P2078; BUONANNO A, 1986, J BIOL CHEM, V261, P1452; CENTRELLA M, 1987, J BIOL CHEM, V262, P2869; CHAMBARD JC, 1988, J CELL PHYSIOL, V135, P101, DOI 10.1002/jcp.1041350114; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLLETTA G, 1989, CANCER RES, V49, P3457; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; DILLMANN WH, 1983, J BIOL CHEM, V258, P7738; DONOGHUE M, 1988, GENE DEV, V2, P1779, DOI 10.1101/gad.2.12b.1779; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FINE A, 1987, J BIOL CHEM, V262, P3897; FUJII S, 1989, AM J CARDIOL, V63, P1505, DOI 10.1016/0002-9149(89)90016-7; FUNG MR, 1985, P NATL ACAD SCI USA, V82, P3591, DOI 10.1073/pnas.82.11.3591; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; HELSETH E, 1988, APMIS, V96, P845, DOI 10.1111/j.1699-0463.1988.tb00952.x; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; IGNOTZ RA, 1987, J BIOL CHEM, V262, P6443; KERR LD, 1990, CELL, V61, P267, DOI 10.1016/0092-8674(90)90807-Q; KESKIOJA J, 1988, J BIOL CHEM, V263, P3111; KIM SJ, 1990, MOL CELL BIOL, V10, P1492, DOI 10.1128/MCB.10.4.1492; KIM SJ, 1989, J BIOL CHEM, V264, P19373; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; LAIHO M, 1986, J CELL BIOL, V103, P2403, DOI 10.1083/jcb.103.6.2403; LIBOI E, 1988, BIOCHEM BIOPH RES CO, V151, P298, DOI 10.1016/0006-291X(88)90593-1; LUCORE CL, 1988, J BIOL CHEM, V263, P15845; LUND LR, 1987, EMBO J, V6, P1281, DOI 10.1002/j.1460-2075.1987.tb02365.x; MAKELA TP, 1987, MOL CELL BIOL, V7, P3656; MALTER JS, 1989, SCIENCE, V246, P664, DOI 10.1126/science.2814487; Maniatis T., 1982, MOL CLONING; Marzluff W. F., 1984, TRANSCRIPTION TRANSL, P89; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; PERTOVAARA L, 1989, MOL CELL BIOL, V9, P1255, DOI 10.1128/MCB.9.3.1255; PRENDERGAST GC, 1990, MOL CELL BIOL, V10, P1265, DOI 10.1128/MCB.10.3.1265; QUISSELL DO, 1981, AM J PHYSIOL, V241, pC76, DOI 10.1152/ajpcell.1981.241.1.C76; RICCIO A, 1988, NUCLEIC ACIDS RES, V16, P2805, DOI 10.1093/nar/16.7.2805; ROSSI P, 1988, CELL, V52, P405, DOI 10.1016/S0092-8674(88)80033-3; ROTWEIN P, 1986, J BIOL CHEM, V261, P4828; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAWDEY M, 1989, J BIOL CHEM, V264, P10396; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SOLISHERRUZO JA, 1988, J BIOL CHEM, V263, P5841; SPORN MB, 1989, JAMA-J AM MED ASSOC, V262, P938, DOI 10.1001/jama.262.7.938; SPORN MB, 1986, SCIENCE, V233, P532, DOI 10.1126/science.3487831; SPORN MB, 1987, J CELL BIOL, V105, P1039, DOI 10.1083/jcb.105.3.1039; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TRASK RV, 1988, J BIOL CHEM, V263, P17142; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; VANOBBERGHENSCHILLING E, 1988, J BIOL CHEM, V263, P7741; VARGA J, 1987, BIOCHEM J, V247, P597, DOI 10.1042/bj2470597; WUN TC, 1987, FEBS LETT, V210, P11, DOI 10.1016/0014-5793(87)81288-7	61	157	159	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1092	1100						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985937				2022-12-25	WOS:A1991ET17700066
J	BATTISTINI, A; MARZIALI, G; ALBERTINI, R; HABETSWALLNER, D; BULGARINI, D; COCCIA, EM; FIORUCCI, G; ROMEO, G; ORSATTI, R; TESTA, U; AFFABRIS, E; PESCHLE, C; ROSSI, GB				BATTISTINI, A; MARZIALI, G; ALBERTINI, R; HABETSWALLNER, D; BULGARINI, D; COCCIA, EM; FIORUCCI, G; ROMEO, G; ORSATTI, R; TESTA, U; AFFABRIS, E; PESCHLE, C; ROSSI, GB			POSITIVE MODULATION OF HEMOGLOBIN, HEME, AND TRANSFERRIN RECEPTOR SYNTHESIS BY MURINE INTERFERON-ALPHA AND INTERFERON-BETA IN DIFFERENTIATING FRIEND-CELLS - PIVOTAL ROLE OF HEME-SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED ERYTHROLEUKEMIC CELLS; BETA-GLOBIN GENES; MESSENGER-RNA; RIBONUCLEIC-ACID; EXPRESSION; ALPHA; INDUCTION; ACCUMULATION; PROTEIN; CHAIN	Administration of highly purified preparations of murine interferon (IFN)-alpha-1, -alpha-4, -alpha-6, or -beta to Friend leukemia cells induced to differentiate by dimethyl sulfoxide leads to a 100% increase of benzidine-positive (B+) cells. Different efficiencies for the two IFN species have been observed; a 10-fold higher dose of IFN-alpha is needed for stimulation of hemoglobin production and inhibition of cell growth as compared with IFN-beta. Both species of IFN induce a substantial increase in heme, hemoglobin, and transferrin receptor levels. In vitro run-on transcription assays indicate that IFN-beta moderately stimulates transcription of the alpha-globin gene but not the transferrin receptor gene. It is postulated that IFN induces the enhancing effect on differentiation via a marked increase of heme synthesis and number of transferrin receptors, which in turn leads to an enhancement of globin chain synthesis. In this regard, the negative feedback reported in a variety of other cell types for the regulation of transferrin receptor expression by heme does not seem to be operative at maturing Friend erythroleukemia cells, which present evidence for a positive mechanism.	IST SUPER SANITA,UROL LAB,VIALE REGINA ELENA 299,I-00161 ROME,ITALY; IST SUPER SANITA,HEMATOL ONCOL LAB,I-00161 ROME,ITALY; UNIV PARMA,INST PATOL SPECIALE MED,I-43100 PARMA,ITALY; UNIV MESSINA,INST MICROBIOL,I-98100 MESSINA,ITALY	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); University of Parma; University of Messina			Marziali, Giovanna/J-9808-2016; Fiorucci, Gianna/B-3064-2013; BATTISTINI, ANGELA/C-2944-2016; Coccia, Eliana M/B-4752-2013; Romeo, Giovanna/AAB-2613-2019; Testa, Ugo/J-6472-2016; romeo, giovanna/P-8348-2015; Albertini, Roberto/Q-1708-2015	Marziali, Giovanna/0000-0001-7450-1017; Coccia, Eliana M/0000-0002-1606-2949; Testa, Ugo/0000-0001-7900-8942; romeo, giovanna/0000-0002-7638-1001; Albertini, Roberto/0000-0002-9569-0467; AFFABRIS, Elisabetta/0000-0001-5142-8144				AGUET M, 1980, NATURE, V284, P459, DOI 10.1038/284459a0; ALTER BP, 1978, BLOOD, V52, P1047; ANDERSON P, 1982, J BIOL CHEM, V257, P1301; BESANCON F, 1985, J BIOL CHEM, V260, P3074; BRUNS GP, 1965, BIOCHEM BIOPH RES CO, V18, P236, DOI 10.1016/0006-291X(65)90746-1; CHANAY P, 1984, CELL, V38, P257; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLEGG JB, 1966, J MOL BIOL, V19, P91, DOI 10.1016/S0022-2836(66)80052-9; FARRELL PJ, 1979, NATURE, V279, P523, DOI 10.1038/279523a0; FINTER NB, 1984, INTERFERON 1 4; GANGULY S, 1985, J BIOL CHEM, V260, P2167; GILMAN JG, 1976, BIOCHEM J, V155, P231, DOI 10.1042/bj1550231; GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025; GRAYZEL AI, 1966, P NATL ACAD SCI USA, V55, P650, DOI 10.1073/pnas.55.3.650; GROSSBERG SE, 1971, SCIENCE, V171, P77, DOI 10.1126/science.171.3966.77; HOWARD GA, 1970, BIOCHIM BIOPHYS ACTA, V213, P237, DOI 10.1016/0005-2787(70)90028-6; HSIANGYIN H, 1977, SCIENCE, V197, P559; HUNT T, 1972, J MOL BIOL, V66, P471, DOI 10.1016/0022-2836(72)90427-5; JANDL JH, 1959, J CLIN INVEST, V38, P161, DOI 10.1172/JCI103786; KABAT D, 1975, CELL, V5, P331, DOI 10.1016/0092-8674(75)90109-9; KARIN M, 1981, J BIOL CHEM, V256, P3245; KNIGHT E, 1979, P NATL ACAD SCI USA, V76, P1824, DOI 10.1073/pnas.76.4.1824; KUCERA R, 1983, J CELL PHYSIOL, V117, P158, DOI 10.1002/jcp.1041170205; LONDON IM, 1975, FED PROC, V35, P2218; LOUACHE F, 1984, J BIOL CHEM, V259, P1576; MAY WS, 1984, P NATL ACAD SCI-BIOL, V81, P2016, DOI 10.1073/pnas.81.7.2016; MORGAN EH, 1964, BRIT J HAEMATOL, V10, P442, DOI 10.1111/j.1365-2141.1964.tb00721.x; MORITZ T, 1986, BLUT, V53, P361, DOI 10.1007/BF00321098; NUDEL U, 1977, P NATL ACAD SCI USA, V74, P1100, DOI 10.1073/pnas.74.3.1100; ORKIN SH, 1975, J BIOL CHEM, V250, P8753; PADMANABAN G, 1989, TRENDS BIOCHEM SCI, V14, P492, DOI 10.1016/0968-0004(89)90182-5; PELOSI E, 1986, J BIOL CHEM, V261, P3036; PELOSI E, 1986, CANCER RES, V45, P5330; PELOSITESTA E, 1986, CANCER RES, V46, P5330; PROFOUSJUCHELKA HR, 1983, MOL CELL BIOL, V3, P229, DOI 10.1128/MCB.3.2.229; RAEFSKY EL, 1985, J IMMUNOL, V135, P2507; REUBEN RC, 1980, BIOCHIM BIOPHYS ACTA, V605, P325, DOI 10.1016/0304-419X(80)90015-3; REVEL M, 1986, TRENDS BIOCHEM SCI, V11, P166, DOI 10.1016/0968-0004(86)90134-9; ROSS J, 1976, CELL, V8, P513, DOI 10.1016/0092-8674(76)90219-1; Rossi G B, 1985, Interferon, V6, P31; ROSSI GB, 1985, 2 5A SYSTEM MOL CLIN, V202, P285; ROSSI GB, 1987, INTERFERON SYSTEM CU, P285; ROUGEON F, 1977, GENE, V1, P229, DOI 10.1016/0378-1119(77)90047-6; SASSA S, 1988, SEMIN HEMATOL, V25, P312; SASSA S, 1976, J EXP MED, V143, P305, DOI 10.1084/jem.143.2.305; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; STEARNE PA, 1985, J IMMUNOL, V134, P3474; TESTA U, 1987, J RECEPTOR RES, V7, P355, DOI 10.3109/10799898709054993; TESTA U, 1989, J BIOL CHEM, V264, P13181; Testa U, 1985, Curr Top Hematol, V5, P127; THELANDER L, 1983, J BIOL CHEM, V258, P4063; VALKONEN K, 1980, CLIN CHIM ACTA, V107, P223, DOI 10.1016/0009-8981(80)90450-7; VANNICE JL, 1984, P NATL ACAD SCI-BIOL, V81, P4241, DOI 10.1073/pnas.81.14.4241; WARD JH, 1984, J BIOL CHEM, V259, P3235; WARD JH, 1982, BIOCHEM J, V28, P19; WEIL J, 1983, NATURE, V301, P437, DOI 10.1038/301437a0; YEOH GCT, 1979, CELL DIFFER DEV, V8, P331, DOI 10.1016/0045-6039(79)90008-3; ZUCKER WV, 1968, P NATL ACAD SCI USA, V59, P582, DOI 10.1073/pnas.59.2.582; ZWARTHOFF EC, 1985, J GEN VIROL, V66, P685, DOI 10.1099/0022-1317-66-4-685	59	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					528	535						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985914				2022-12-25	WOS:A1991EQ33900078
J	SALTIS, J; HABBERFIELD, AD; EGAN, JJ; LONDOS, C; SIMPSON, IA; CUSHMAN, SW				SALTIS, J; HABBERFIELD, AD; EGAN, JJ; LONDOS, C; SIMPSON, IA; CUSHMAN, SW			ROLE OF PROTEIN-KINASE-C IN THE REGULATION OF GLUCOSE-TRANSPORT IN THE RAT ADIPOSE CELL - TRANSLOCATION OF GLUCOSE TRANSPORTERS WITHOUT STIMULATION OF GLUCOSE-TRANSPORT ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-DEHYDROGENASE ACTIVITY; INSULIN-RESPONSIVE TISSUES; BC3H-1 CULTURED MYOCYTES; PHORBOL ESTER; FAT-CELLS; PLASMA-MEMBRANE; PHOSPHOINOSITIDE METABOLISM; PHOSPHOLIPID-METABOLISM; POTENTIAL MECHANISM; INCREASES MEMBRANE	The possible role of protein kinase C in the regulation of glucose transport in the rat adipose cell has been examined. Both insulin and phorbol 12-myristate 13-acetate (PMA) stimulate 3-O-methylglucose transport in the intact cell ein association with the subcellular redistribution of glucose transporters from the low density microsomes to the plasma membranes, as assessed by cytochalasin B binding. In addition, the actions of insulin of PMA on glucose transport activity and glucose transporter redistribution are additive. Furthermore, PMA accelerates insulin's stimulation of glucose transport activity, reducing the t1/2 from 3.2 +/- 0.4 to 2.1 +/- 0.2 min (means +/- S.E.). However, the effect of PMA on glucose transport activity is almost-equal-to 10% of that for insulin whereas its effect on glucose transporter redistribution is almost-equal-to 50% of the insulin response. Immunoblots of the GLUT1 and GLUT4 glucose transporter isoforms in subcellular membrane fractions also demonstrate that the translocations of GLUT1 in response to PMA and insulin are of similar magnitude whereas the translocation of GLUT4 in response to insulin is markedly greater than that in response to PMA. Thus, glucose transport activity in the intact cell with PMA and insulin correlates more closely with the appearance of GLUT4 in the plasma membrane than cytochalasin B-assayable glucose transporters. Although these data do not clarify the potential role of protein kinase C in the mechanism of insulin action, they do suggest that the mechanism through which insulin and PMA stimulate glucose transport are distinct but interactive.	NIDDKD,MOLEC CELLULAR & NUTR ENDOCRINOL BRANCH,EXPTL DIABET METAB & NUTR SECT,BLDG 10,RM 5N102,BETHESDA,MD 20892; NIDDKD,CELLULAR & DEV BIOL LAB,MEMBRANE REGULAT SECT,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)								AHMAD Z, 1984, J BIOL CHEM, V259, P8743; ALLARD WJ, 1987, BIOCHIM BIOPHYS ACTA, V929, P288, DOI 10.1016/0167-4889(87)90255-2; ANDERSEN PH, 1988, BIOCHEM BIOPH RES CO, V154, P171, DOI 10.1016/0006-291X(88)90666-3; AUGERT G, 1988, J BIOL CHEM, V263, P3600; BERGER J, 1989, NATURE, V340, P70, DOI 10.1038/340070a0; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; BIRNBAUM MJ, 1986, P NATL ACAD SCI USA, V83, P5784, DOI 10.1073/pnas.83.16.5784; CHARRON MJ, 1989, P NATL ACAD SCI USA, V86, P2535, DOI 10.1073/pnas.86.8.2535; CHERQUI G, 1986, ENDOCRINOLOGY, V118, P1759, DOI 10.1210/endo-118-5-1759; COOPER DR, 1987, J BIOL CHEM, V262, P3633; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; DRAZNIN B, 1988, BIOCHEM BIOPH RES CO, V156, P570, DOI 10.1016/S0006-291X(88)80880-5; EGAN JJ, 1988, ANAL BIOCHEM, V175, P552, DOI 10.1016/0003-2697(88)90583-0; EGAN JJ, 1990, P NATL ACAD SCI USA, V87, P1052, DOI 10.1073/pnas.87.3.1052; FARESE RV, 1987, SCIENCE, V236, P586, DOI 10.1126/science.3107122; FARESE RV, 1985, ENDOCRINOLOGY, V116, P2650, DOI 10.1210/endo-116-6-2650; FARESE RV, 1982, J BIOL CHEM, V257, P4042; FARESE RV, 1984, J BIOL CHEM, V259, P7094; FUKUMOTO H, 1989, J BIOL CHEM, V264, P7776; GARCIASAINZ JA, 1980, BIOCHEM J, V186, P781, DOI 10.1042/bj1860781; GIBBS EM, 1986, J BIOL CHEM, V261, P6597; GLYNN BP, 1986, BIOCHEM BIOPH RES CO, V135, P1119, DOI 10.1016/0006-291X(86)91044-2; HOLMAN GD, 1990, J BIOL CHEM, V265, P18172; HONNOR RC, 1985, J BIOL CHEM, V260, P5122; HOUSE C, 1987, J BIOL CHEM, V262, P772; ISHIZUKA T, 1989, FEBS LETT, V257, P337, DOI 10.1016/0014-5793(89)81565-0; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; JOOST HG, 1986, J BIOL CHEM, V261, P33; JOOST HG, 1987, J BIOL CHEM, V262, P11261; JOOST HG, 1988, BIOCHEM J, V249, P155, DOI 10.1042/bj2490155; KAESTNER KH, 1989, P NATL ACAD SCI USA, V86, P3150, DOI 10.1073/pnas.86.9.3150; KAHN BB, 1989, J CLIN INVEST, V84, P404, DOI 10.1172/JCI114180; KARNIELI E, 1981, J BIOL CHEM, V256, P4772; KIRSCH D, 1985, BIOCHEM BIOPH RES CO, V128, P824, DOI 10.1016/0006-291X(85)90121-4; KITAGAWA K, 1985, BIOCHEM BIOPH RES CO, V128, P1303, DOI 10.1016/0006-291X(85)91082-4; KLIP A, 1987, BIOCHEM J, V242, P131, DOI 10.1042/bj2420131; KOEPFERHOBELSBERGER B, 1984, MOL CELL ENDOCRINOL, V36, P123, DOI 10.1016/0303-7207(84)90091-1; KONO T, 1982, J BIOL CHEM, V257, P942; KONO T, 1981, J BIOL CHEM, V256, P6400; KURODA M, 1987, J BIOL CHEM, V262, P245; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE LS, 1979, J CELL PHYSIOL, V99, P451, DOI 10.1002/jcp.1040990319; LIENHARD GE, 1982, BIOCHEM BIOPH RES CO, V105, P1150, DOI 10.1016/0006-291X(82)91090-7; MESSINA JL, 1987, ENDOCRINOLOGY, V121, P1227, DOI 10.1210/endo-121-4-1227; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; MUHLBACHER C, 1988, BIOCHEM J, V249, P865; OKA Y, 1988, J BIOL CHEM, V263, P13432; PENNINGTON SR, 1985, J BIOL CHEM, V260, P1039; ROBERTSON DG, 1989, J BIOL CHEM, V264, P6773; RODBELL M, 1964, J BIOL CHEM, V239, P375; SALTIEL AR, 1986, SCIENCE, V233, P967, DOI 10.1126/science.3016898; SIMPSON IA, 1982, ANAL BIOCHEM, V119, P424, DOI 10.1016/0003-2697(82)90608-X; SIMPSON IA, 1986, ANNU REV BIOCHEM, V55, P1059, DOI 10.1146/annurev.biochem.55.1.1059; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; SIMPSON IA, 1989, DIABETES S2, V38, P42; SIVITZ WI, 1989, NATURE, V340, P72, DOI 10.1038/340072a0; SMAL J, 1989, P NATL ACAD SCI USA, V86, P4705, DOI 10.1073/pnas.86.12.4705; SMITH U, 1984, J BIOL CHEM, V259, P8758; STANDAERT ML, 1987, ENDOCRINOLOGY, V121, P941, DOI 10.1210/endo-121-3-941; STANDAERT ML, 1988, J BIOL CHEM, V263, P8696; STRALFORS P, 1988, NATURE, V335, P554, DOI 10.1038/335554a0; SUZUKI K, 1980, P NATL ACAD SCI-BIOL, V77, P2542, DOI 10.1073/pnas.77.5.2542; TAKAYAMA S, 1988, J BIOL CHEM, V263, P3440; WALAAS SI, 1987, FEBS LETT, V220, P311, DOI 10.1016/0014-5793(87)80837-2; WARDZALA LJ, 1984, J BIOL CHEM, V259, P8378; WHEELER TJ, 1982, BIOCHEM BIOPH RES CO, V105, P89, DOI 10.1016/S0006-291X(82)80014-4; ZORZANO A, 1989, J BIOL CHEM, V264, P12358	68	50	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					261	267						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985898				2022-12-25	WOS:A1991EQ33900039
J	GOMI, T; TAKATA, Y; DATE, T; FUJIOKA, M; AKSAMIT, RR; BACKLUND, PS; CANTONI, GL				GOMI, T; TAKATA, Y; DATE, T; FUJIOKA, M; AKSAMIT, RR; BACKLUND, PS; CANTONI, GL			SITE-DIRECTED MUTAGENESIS OF RAT-LIVER S-ADENOSYLHOMOCYSTEINASE - EFFECT OF CONVERSION OF ASPARTIC ACID-244 TO GLUTAMIC-ACID ON COENZYME BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									TOYAMA MED & PHARMACEUT UNIV,FAC MED,DEPT BIOCHEM,2630 SUGITANI,SUGITANI,TOYAMA 93001,JAPAN; KANAZAWA MED UNIV,DEPT BIOCHEM,KAHOKU,ISHIKAWA 92002,JAPAN; NIMH,GEN & COMPARAT BIOCHEM LAB,BETHESDA,MD 20892	University of Toyama; Kanazawa Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)								ABELES RH, 1982, BIOCHEMISTRY-US, V21, P5557, DOI 10.1021/bi00265a027; ARREDONDOVEGA FX, 1989, ANN HUM GENET, V53, P157, DOI 10.1111/j.1469-1809.1989.tb01780.x; CHIANG PK, 1979, TRANSMETHYLATION, P165; COULTERKARIS DE, 1989, ANN HUM GENET, V53, P169, DOI 10.1111/j.1469-1809.1989.tb01781.x; DELAHABA G, 1986, BIOCHEMISTRY-US, V25, P8337, DOI 10.1021/bi00373a031; DEVOS AM, 1988, SCIENCE, V239, P888, DOI 10.1126/science.2448879; FERSHT AR, 1987, TRENDS BIOCHEM SCI, V12, P301, DOI 10.1016/0968-0004(87)90146-0; FUJIOKA M, 1981, J BIOL CHEM, V256, P1631; GOMI T, 1989, BIOCHIM BIOPHYS ACTA, V994, P172, DOI 10.1016/0167-4838(89)90157-X; GOMI T, 1985, J BIOL CHEM, V260, P2789; GOMI T, 1989, J BIOL CHEM, V264, P16138; HERSHFIELD MS, 1979, J BIOL CHEM, V254, P22; HERSHFIELD MS, 1979, TRANSMETHYLATION, P173; KASIR J, 1988, BIOCHEM BIOPH RES CO, V153, P359, DOI 10.1016/S0006-291X(88)81231-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landon, 1977, Methods Enzymol, V47, P145; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NAKATANI Y, 1972, ANAL BIOCHEM, V49, P225, DOI 10.1016/0003-2697(72)90261-8; NOZARI G, 1986, GENE, V43, P23, DOI 10.1016/0378-1119(86)90004-1; OGAWA H, 1987, P NATL ACAD SCI USA, V84, P719, DOI 10.1073/pnas.84.3.719; PALMER JL, 1979, J BIOL CHEM, V254, P1217; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; WIERENGA RK, 1983, NATURE, V302, P842, DOI 10.1038/302842a0; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	25	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1990	265	27					16102	16107						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ950	1975808				2022-12-25	WOS:A1990DZ95000014
J	HALVERSON, D; MODI, W; DEAN, M; GELMANN, EP; DUNN, KJ; CLANTON, D; OSKARSSON, M; OBRIEN, SJ; BLAIR, DG				HALVERSON, D; MODI, W; DEAN, M; GELMANN, EP; DUNN, KJ; CLANTON, D; OSKARSSON, M; OBRIEN, SJ; BLAIR, DG			AN ONCOGENIC CHROMOSOME-8-9 GENE FUSION ISOLATED FOLLOWING TRANSFECTION OF HUMAN OVARIAN-CARCINOMA CELL-LINE DNA	ONCOGENE			English	Note									NCI, MOLEC ONCOL LAB, POB B, FREDERICK, MD 21701 USA; PROGRAM RESOURCES INC, FREDERICK, MD 21701 USA; NCI, VIRAL CARCINOGENESIS LAB, FREDERICK, MD 21701 USA; GEORGETOWN UNIV, MED CTR, VINCENT T LOMBARDI CANC RES CTR, DIV MED ONCOL, WASHINGTON, DC 20007 USA; BIONET RES LABS INC, FREDERICK, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Georgetown University			Dean, Michael C/G-8172-2012; OBRIEN, STEPHEN/ABD-1346-2020; Dean, Michael/R-7501-2019	Dean, Michael C/0000-0003-2234-0631; OBRIEN, STEPHEN/0000-0001-7857-0757	OFFICE OF THE DIRECTOR, NCI [N01CO074101, N01CO074102] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-74102, N01-CO-74101] Funding Source: Medline	OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AMIN W, 1987, CANCER RES, V47, P6040; BIRCHMEIER C, 1986, MOL CELL BIOL, V6, P3109, DOI 10.1128/MCB.6.9.3109; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; BLAIR DG, 1982, SCIENCE, V218, P1122, DOI 10.1126/science.6293052; BOVI PD, 1987, P NATL ACAD SCI USA, V84, P5660, DOI 10.1073/pnas.84.16.5660; COOPER CS, 1984, NATURE, V311, P29, DOI 10.1038/311029a0; COOPER GM, 1982, SCIENCE, V217, P801, DOI 10.1126/science.6285471; DEAN M, 1987, J PEDIATR-US, V111, P490, DOI 10.1016/S0022-3476(87)80106-3; EVA A, 1985, NATURE, V316, P273, DOI 10.1038/316273a0; FASANO O, 1984, MOL CELL BIOL, V4, P1695, DOI 10.1128/MCB.4.9.1695; GALLI MC, 1981, CANCER-AM CANCER SOC, V47, P1297, DOI 10.1002/1097-0142(19810315)47:6<1297::AID-CNCR2820470611>3.0.CO;2-D; GIBAS Z, 1984, CANCER RES, V44, P1257; GIBAS Z, 1986, CANCER GENET CYTOGEN, V19, P229, DOI 10.1016/0165-4608(86)90051-8; HAGEMEIJER A, 1982, CANCER GENET CYTOGEN, V5, P95, DOI 10.1016/0165-4608(82)90001-2; HAMILTON TC, 1983, CANCER RES, V43, P5379; HAYASHI S, 1978, HISTOCHEM CYTOCHEM, V26, P667; KONALCZYK J, 1983, CANCER GENET CYTOGEN, V9, P383; KOZMA SC, 1988, EMBO J, V7, P147, DOI 10.1002/j.1460-2075.1988.tb02794.x; LATHROP M, 1988, GENOMICS, V3, P361, DOI 10.1016/0888-7543(88)90128-0; LOENEN WAM, 1980, GENE, V10, P249, DOI 10.1016/0378-1119(80)90054-2; Maniatis T., 1982, MOL CLONING; MODI WS, 1987, GENE ANAL TECH, V4, P75; MURRAY MJ, 1981, CELL, V25, P355, DOI 10.1016/0092-8674(81)90054-4; NOGUCHI T, 1987, EMBO J, V6, P1301, DOI 10.1002/j.1460-2075.1987.tb02368.x; OHARA BM, 1986, CANCER RES, V46, P4695; PARK M, 1989, METABOLIC BASIS INHE; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; TAKAHASHI M, 1985, CELL, V42, P581, DOI 10.1016/0092-8674(85)90115-1; WHITE R, 1985, NATURE, V318, P382, DOI 10.1038/318382a0; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3	31	8	8	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	1990	5	7					1085	1089						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP415	1973829				2022-12-25	WOS:A1990DP41500022
J	KOCH, KW; ECKSTEIN, F; STRYER, L				KOCH, KW; ECKSTEIN, F; STRYER, L			STEREOCHEMICAL COURSE OF THE REACTION CATALYZED BY GUANYLATE-CYCLASE FROM BOVINE RETINAL ROD OUTER SEGMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									STANFORD UNIV,MED CTR,SCH MED,SHERMAN FAIRCHILD CTR,DEPT CELL BIOL,STANFORD,CA 94305; MAX PLANCK INST EXPTL MED,CHEM ABT,W-3400 GOTTINGEN,GERMANY	Stanford University; Max Planck Society			Koch, Karl-Wilhelm/C-9551-2015	Koch, Karl-Wilhelm/0000-0003-1501-0044	NEI NIH HHS [EY-02005] Funding Source: Medline; NATIONAL EYE INSTITUTE [R37EY002005, R01EY002005] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		CERVETTO L, 1989, NATURE, V337, P740, DOI 10.1038/337740a0; COHN M, 1982, ACCOUNTS CHEM RES, V15, P326, DOI 10.1021/ar00082a005; CONNOLLY BA, 1982, BIOCHEMISTRY-US, V21, P1983, DOI 10.1021/bi00538a002; ECKSTEIN F, 1981, J BIOL CHEM, V256, P9118; ECKSTEIN F, 1986, TETRAHEDRON LETT, V27, P1657, DOI 10.1016/S0040-4039(00)84340-3; ECKSTEIN F, 1985, ANNU REV BIOCHEM, V54, P367, DOI 10.1146/annurev.bi.54.070185.002055; FLEISCHMAN D, 1979, BIOCHEMISTRY-US, V18, P5060, DOI 10.1021/bi00590a006; FREY AF, 1989, ADV ENZYMOL RELAT AR, V62, P119; GERLT JA, 1980, J BIOL CHEM, V255, P331; GORIDIS C, 1973, FEBS LETT, V30, P163, DOI 10.1016/0014-5793(73)80642-8; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; MCNAUGHTON PA, 1986, NATURE, V322, P261, DOI 10.1038/322261a0; NAKATANI K, 1988, J PHYSIOL-LONDON, V395, P695, DOI 10.1113/jphysiol.1988.sp016942; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; PANNBACKER RG, 1973, SCIENCE, V182, P1138, DOI 10.1126/science.182.4117.1138; PECORARO VL, 1984, BIOCHEMISTRY-US, V23, P5262, DOI 10.1021/bi00317a026; PEPE IM, 1986, FEBS LETT, V203, P73, DOI 10.1016/0014-5793(86)81439-9; PUGH EN, 1986, VISION RES, V26, P1613, DOI 10.1016/0042-6989(86)90051-9; RATTO GM, 1988, J NEUROSCI, V8, P3240; SCHULZ S, 1989, FASEB J, V3, P2026, DOI 10.1096/fasebj.3.9.2568301; SENTER PD, 1983, J BIOL CHEM, V258, P6741; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; ZIMMERMAN AL, 1985, P NATL ACAD SCI USA, V82, P8813, DOI 10.1073/pnas.82.24.8813	26	34	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	1990	265	17					9659	9663						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH141	1972155				2022-12-25	WOS:A1990DH14100017
J	DONG, Y; CAIRNS, W; OKRET, S; GUSTAFSSON, JA				DONG, Y; CAIRNS, W; OKRET, S; GUSTAFSSON, JA			A GLUCOCORTICOID-RESISTANT RAT HEPATOMA-CELL VARIANT CONTAINS FUNCTIONAL GLUCOCORTICOID RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									KAROLINSKA INST,HUDDINGE UNIV HOSP F60,DEPT MED NUTR,NOVUM,S-14186 HUDDINGE,SWEDEN	Karolinska Institutet								BLOOM E, 1980, J STEROID BIOCHEM, V12, P175, DOI 10.1016/0022-4731(80)90267-8; BOURGEOIS S, 1979, CANCER RES, V39, P4749; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DANIELSEN M, 1987, MOL ENDOCRINOL, V1, P816, DOI 10.1210/mend-1-11-816; DANIELSEN M, 1986, EMBO J, V5, P2513, DOI 10.1002/j.1460-2075.1986.tb04529.x; DIAMONDSTONE TI, 1966, ANAL BIOCHEM, V16, P395, DOI 10.1016/0003-2697(66)90220-X; DONG Y, 1988, MOL ENDOCRINOL, V2, P1256, DOI 10.1210/mend-2-12-1256; DONG Y, 1989, J BIOL CHEM, V264, P13679; GAUB MP, 1987, EMBO J, V6, P2313, DOI 10.1002/j.1460-2075.1987.tb02506.x; GEHRING U, 1988, STEROID HORMONE ACTI, P265; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; GROVE JR, 1980, CELL, V21, P47, DOI 10.1016/0092-8674(80)90113-0; HAPGOOD J, 1989, P NATL ACAD SCI USA, V86, P60, DOI 10.1073/pnas.86.1.60; HOLLENBERG SM, 1987, CELL, V49, P39, DOI 10.1016/0092-8674(87)90753-7; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; HUETMINKOWSKI M, 1982, DRUG HORMONE RESISTA, V1, P79; LANGER SJ, 1988, MOL CELL BIOL, V8, P3872, DOI 10.1128/MCB.8.9.3872; MCINTYRE WR, 1985, J BIOL CHEM, V260, P418; MIESFELD R, 1987, SCIENCE, V236, P423, DOI 10.1126/science.3563519; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; MIESFELD R, 1987, STEROID HORMONE ACTI, P193; MORLEY KL, 1987, NUCLEIC ACIDS RES, V15, P6973, DOI 10.1093/nar/15.17.6973; NEMOTO T, 1990, J BIOL CHEM, V265, P2269; NORTHROP JP, 1986, J BIOL CHEM, V261, P1064; NORTHROP JP, 1985, J BIOL CHEM, V260, P6398; OKRET S, 1986, P NATL ACAD SCI USA, V83, P5899, DOI 10.1073/pnas.83.16.5899; RABINDRAN SK, 1987, MOL CELL BIOL, V7, P4211, DOI 10.1128/MCB.7.12.4211; RINGOLD GM, 1977, CELL, V10, P11, DOI 10.1016/0092-8674(77)90134-9; ROSEWICZ S, 1988, J BIOL CHEM, V263, P2581; RUSCONI S, 1987, EMBO J, V6, P1309, DOI 10.1002/j.1460-2075.1987.tb02369.x; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SHIRWANY TA, 1986, BIOCHIM BIOPHYS ACTA, V886, P162, DOI 10.1016/0167-4889(86)90222-3; STRAHLE U, 1987, P NATL ACAD SCI USA, V84, P7871, DOI 10.1073/pnas.84.22.7871; VANDERBILT JN, 1987, MOL ENDOCRINOL, V1, P68, DOI 10.1210/mend-1-1-68; WESTPHAL HM, 1984, EMBO J, V3, P1493, DOI 10.1002/j.1460-2075.1984.tb02001.x; Yamamoto K R, 1976, Recent Prog Horm Res, V32, P3; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; YANG YL, 1989, J STEROID BIOCHEM, V32, P99	39	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1990	265	13					7526	7531						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB307	1970570				2022-12-25	WOS:A1990DB30700066
J	MAKI, H; MO, JY; SEKIGUCHI, M				MAKI, H; MO, JY; SEKIGUCHI, M			A STRONG MUTATOR EFFECT CAUSED BY AN AMINO-ACID CHANGE IN THE ALPHA-SUBUNIT OF DNA POLYMERASE-III OF ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSILON-SUBUNIT; GENE; REPLICATION; HOLOENZYME; MUTATIONS; FIDELITY; MUTANTS; STRAINS; IDENTIFICATION; PURIFICATION	Most potent mutators heretofore detected in Escherichia coli are associated with defects in epsilon-subunit of DNA polymerase III, encoded by the dnaQ gene. To elucidate the role of the alpha-subunit, the catalytic subunit of the polymerase, in maintaining the high fidelity of DNA replication, we isolated a mutator mutant, the mutation (dnaE173) of which resides on the dnaE gene, encoding the alpha-subunit. The dnaE173 mutant was unable to grow in salt-free L broth at temperatures exceeding 44.5-degrees-C and exhibited an increased frequency of spontaneous mutations, 1,000 to 10,000-fold the wild type level, at permissive temperatures. The mutator effect of dnaE173 mutation is dominant over the wild type allele. These phenotypes are caused by a single base substitution, resulting in one amino acid change, Glu612(GAA) --> Lys(AAA), in the alpha-subunit molecule. DNA polymerase III purified from the dnaE173 mutant contained both alpha and epsilon-subunits, in a normal molar ratio. We found no differences between wild type and mutant polymerases in the V(max), thermolabilities, and salt sensitivities. However, the apparent K(m) for the substrate nucleotide of the mutant polymerase was 1/6 of that determined with the wild type polymerase. Although the mutant polymerase retained a normal level of 3' --> 5' exonuclease activity, the proofreading capacity determined by "turnover assay" was significantly lower in the mutant polymerase, as compared with findings in the normal enzyme. It seems likely that the enhanced mutability in the dnaE173 strain results from, at least in part, a defect in the editing function of DNA polymerase III, and further suggests that a portion of the alpha-subunit in which the amino acid change resides may be important for the proper setting of the two subunits at the replication fork so as to facilitate efficient editing during the DNA replication.			MAKI, H (corresponding author), KYUSHU UNIV,FAC MED,DEPT BIOCHEM,FUKUOKA 812,JAPAN.							AKIYAMA M, 1989, P NATL ACAD SCI USA, V86, P3949, DOI 10.1073/pnas.86.11.3949; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROTCORNELANNOYE A, 1985, MOL GEN GENET, V199, P64, DOI 10.1007/BF00327511; CLARKE L, 1976, CELL, V9, P91, DOI 10.1016/0092-8674(76)90055-6; DEGNEN GE, 1974, J BACTERIOL, V117, P477, DOI 10.1128/JB.117.2.477-487.1974; DIFRANCESCO R, 1984, J BIOL CHEM, V259, P5567; DRAKE JW, 1969, NATURE, V221, P1132, DOI 10.1038/2211132a0; DUNCAN BK, 1982, J BACTERIOL, V151, P750, DOI 10.1128/JB.151.2.750-755.1982; ECHOLS H, 1983, P NATL ACAD SCI-BIOL, V80, P2189, DOI 10.1073/pnas.80.8.2189; FERSHT AR, 1982, J MOL BIOL, V156, P37, DOI 10.1016/0022-2836(82)90457-0; FREEMONT PS, 1988, P NATL ACAD SCI USA, V85, P8924, DOI 10.1073/pnas.85.23.8924; HALL RM, 1973, MOL GEN GENET, V121, P271, DOI 10.1007/BF00267054; HORIUCHI T, 1978, MOL GEN GENET, V163, P277, DOI 10.1007/BF00271956; HORIUCHI T, 1989, B I PASTEUR, V87, P309; IKEDA H, 1965, J MOL BIOL, V14, P85, DOI 10.1016/S0022-2836(65)80232-7; JOYCE CM, 1982, J BIOL CHEM, V257, P1958; KONRAD EB, 1978, J BACTERIOL, V133, P1197, DOI 10.1128/JB.133.3.1197-1202.1978; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LU AL, 1983, P NATL ACAD SCI-BIOL, V80, P4639, DOI 10.1073/pnas.80.15.4639; MAKI H, 1987, P NATL ACAD SCI USA, V84, P4389, DOI 10.1073/pnas.84.13.4389; MAKI H, 1989, J BACTERIOL, V171, P3139, DOI 10.1128/jb.171.6.3139-3143.1989; MAKI H, 1985, J BIOL CHEM, V260, P2987; MAKI H, 1988, J BIOL CHEM, V263, P6570; MAKI H, 1983, J BACTERIOL, V153, P1361, DOI 10.1128/JB.153.3.1361-1367.1983; Maniatis T., 1982, MOL CLONING; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; MCHENRY CS, 1979, J BIOL CHEM, V254, P1748; RUSSELL DR, 1982, GENE, V20, P231, DOI 10.1016/0378-1119(82)90042-7; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANJANWALA B, 1989, P NATL ACAD SCI USA, V86, P4421, DOI 10.1073/pnas.86.12.4421; SCHEUERMANN R, 1983, P NATL ACAD SCI-BIOL, V80, P7085, DOI 10.1073/pnas.80.23.7085; SCHEUERMANN RH, 1984, P NATL ACAD SCI-BIOL, V81, P7747, DOI 10.1073/pnas.81.24.7747; SEVASTOPOULOS CG, 1977, P NATL ACAD SCI USA, V74, P3947, DOI 10.1073/pnas.74.9.3947; SLOANE DL, 1988, NUCLEIC ACIDS RES, V16, P6465, DOI 10.1093/nar/16.14.6465; TOMASIEWICZ HG, 1987, J BACTERIOL, V169, P5735, DOI 10.1128/jb.169.12.5735-5744.1987; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WECHSLER JA, 1973, J BACTERIOL, V152, P351; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	38	43	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					5055	5061						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002048				2022-12-25	WOS:A1991FC21700058
J	ROY, SN; PROCYK, R; KUDRYK, BJ; REDMAN, CM				ROY, SN; PROCYK, R; KUDRYK, BJ; REDMAN, CM			ASSEMBLY AND SECRETION OF RECOMBINANT HUMAN FIBRINOGEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; A-ALPHA; B-BETA; CHAINS; BIOSYNTHESIS; HEPATOCYTES; OLIGOSACCHARIDES; DEGRADATION; EXPRESSION	Expression vectors containing full-length cDNAs for each of the human fibrinogen chains were constructed. COS-1 cells were transfected with single vectors, mixtures of two, or with all three vectors and stable cell lines selected. Cells transfected with single vectors, or with mixtures of any two vectors, expressed the appropriate fibrinogen chains but did not secrete them. COS cells transfected with three vectors expressed all of the chains and secreted fibrinogen. COS cells transfected with three vectors contained, intracellularly, a mixture of fibrinogen-related proteins. The four main intracellular products were nascent fibrinogen, an A-alpha.gamma-complex, free A-alpha-chains, and free gamma-chains. This is a similar pattern to that noted in Hep G2 cells. The intracellular forms of fibrinogen were sensitive to endoglycosidase H, indicating that they reside in a pre-Golgi compartment. Secreted fibrinogen was endoglycosidase H-insensitive, suggesting that the secreted glycoprotein moieties were processed in the normal manner. When mixed with plasma fibrinogen, radio-labeled recombinant fibrinogen was incorporated into a thrombin-induced clot. These studies demonstrate that COS cells transfected with all three fibrinogen chain cDNAs are capable of assembling and secreting a functional fibrinogen molecule.	NEW YORK BLOOD CTR,LINDSLEY F KIMBALL RES INST,310 E 67TH ST,NEW YORK,NY 10021	New York Blood Center					NHLBI NIH HHS [HL-37457] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL037457] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALVING BM, 1982, ARCH BIOCHEM BIOPHYS, V217, P1, DOI 10.1016/0003-9861(82)90472-6; AMARA JF, 1989, J CELL BIOL, V109, P3315, DOI 10.1083/jcb.109.6.3315; AMRANI DL, 1983, BIOCHIM BIOPHYS ACTA, V743, P394, DOI 10.1016/0167-4838(83)90398-9; BLOMBACK B, 1985, THROMB RES, V37, P613, DOI 10.1016/0049-3848(85)90094-5; BLOMBACK B, 1979, FIBRINOGEN FIBRIN FO, P223; BOLYARD MG, 1988, GENE, V66, P183, DOI 10.1016/0378-1119(88)90355-1; BOLYARD MG, 1988, FIBRINOGEN, V3, P7; BONIFACINO JS, 1989, J CELL BIOL, V109, P73, DOI 10.1083/jcb.109.1.73; Chung D W, 1980, Ann N Y Acad Sci, V343, P210, DOI 10.1111/j.1749-6632.1980.tb47253.x; CHUNG DW, 1983, BIOCHEMISTRY-US, V22, P3244, DOI 10.1021/bi00282a032; COURTOIS G, 1987, SCIENCE, V238, P688, DOI 10.1126/science.3499668; Crabtree G. R., 1987, MOL BASIS BLOOD DISE, P631; DANISHEFSKY K, 1990, BIOCHIM BIOPHYS ACTA, V1048, P202, DOI 10.1016/0167-4781(90)90057-9; DOOLITTLE RF, 1984, ANNU REV BIOCHEM, V53, P195, DOI 10.1146/annurev.bi.53.070184.001211; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HENSCHEN A, 1983, ANN NY ACAD SCI, V408, P28, DOI 10.1111/j.1749-6632.1983.tb23232.x; HIROSE S, 1988, BIOCHEM J, V251, P373, DOI 10.1042/bj2510373; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; KANT JA, 1983, P NATL ACAD SCI-BIOL, V80, P3953, DOI 10.1073/pnas.80.13.3953; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KUDRYK B, 1982, EUR J BIOCHEM, V125, P673, DOI 10.1111/j.1432-1033.1982.tb06735.x; KUDRYK BJ, 1989, MONOCLONAL ANTIBODIE, P365; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; LORD ST, 1985, DNA-J MOLEC CELL BIO, V4, P33, DOI 10.1089/dna.1985.4.33; NICKERSON JM, 1981, BIOCHEMISTRY-US, V20, P2818, DOI 10.1021/bi00513a017; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; PLANT PW, 1986, J BIOL CHEM, V261, P2331; PROCYK R, 1985, THROMB RES, V40, P833, DOI 10.1016/0049-3848(85)90320-2; REDMAN CM, 1985, BIOCHIM BIOPHYS ACTA, V845, P198; RIXON RM, 1983, BIOCHEMISTRY-US, V21, P3237; ROY SN, 1990, J BIOL CHEM, V265, P6389; Sambrook J, 1989, MOL CLONING LABORATO; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; TRIMBLE RB, 1984, ANAL BIOCHEM, V141, P515, DOI 10.1016/0003-2697(84)90080-0; UZAN G, 1986, BIOCHEM BIOPH RES CO, V140, P543, DOI 10.1016/0006-291X(86)90766-7; YU S, 1980, BIOCHEM BIOPH RES CO, V96, P1032, DOI 10.1016/0006-291X(80)90056-X; YU S, 1984, J BIOL CHEM, V259, P574; YU S, 1987, THROMB RES, V46, P281, DOI 10.1016/0049-3848(87)90290-8; YU S, 1983, J BIOL CHEM, V258, P3407; YU S, 1986, SCHEME INTRACELLULAR, V4, P665	41	57	69	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4758	4763						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002025				2022-12-25	WOS:A1991FC21700017
J	THUREN, T; WILCOX, RW; SISSON, P; WAITE, M				THUREN, T; WILCOX, RW; SISSON, P; WAITE, M			HEPATIC LIPASE HYDROLYSIS OF LIPID MONOLAYERS - REGULATION BY APOLIPOPROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY LIPOPROTEIN; POST-HEPARIN PLASMA; RAT-LIVER PHOSPHOLIPASE-A1; MONO-MOLECULAR FILMS; SUBSTRATE-SPECIFICITY; CATALYZED HYDROLYSIS; TRIGLYCERIDE LIPASE; C-II; A-I; TRIACYLGLYCEROL LIPASE	A monolayer technique was used to study the substrate specificity of hepatic lipase (HL) and the effect of surface pressure and apolipoproteins on hydrolysis of lipid monolayers by this enzyme. HL hydrolyzed readily phosphatidylethanolamine monolayers. Pure trioctanoylglycerol was found to be a poor substrate but when progressively diluted with nonhydrolyzable 1,2-didodecanoylphosphatidylcholine hydrolysis of triacylglycerol by HL reached maximum at a molar ratio of 1:1 triacylglycerol to phosphatidylcholine. The activation of triacylglycerol hydrolysis was not due to altered penetration of HL. The surface pressure optimum of HL for the hydrolysis of phosphatidylethanolamine monolayers was broad between 12.5 and 25 mN/m. When apolipoprotein E was injected beneath the monolayer of phosphatidylethanolamine prior to enzyme addition, a 3-fold activation of HL was observed at surface pressures equal to or below 15 mN/m. Below surface pressures of 20 mN/m apolipoprotein E did not affect the penetration of HL into the lipid-water interface. Apolipoprotein E slightly activated the hydrolysis of triacylglycerol by HL at 10 mN/m. At a high surface pressure of 25 mN/m all apolipoproteins tested (apolipoproteins A-I, A-II, C-I, C-II, C-III, and E) inhibited the penetration into and HL activity on phosphatidylethanolamine. At 18.5 mN/m all apolipoproteins except apolipoprotein E inhibited the hydrolysis of triacylglycerol in the triacylglycerol:phosphatidylcholine mixed film. Based on these results we present a hypothesis that phospholipid present in apolipoprotein E-rich high density lipoprotein-1 and triacylglycerol in intermediate density lipoprotein would be preferred substrates for HL.			THUREN, T (corresponding author), WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT BIOCHEM,300 S HAWTHORNE RD,WINSTON SALEM,NC 27103, USA.				NATIONAL CANCER INSTITUTE [P30CA012197] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK011799] Funding Source: NIH RePORTER; NCI NIH HHS [CA-12197] Funding Source: Medline; NHLBI NIH HHS [HL-31338] Funding Source: Medline; NIDDK NIH HHS [DK-11799] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABDELMAGEED OH, 1989, CHEM PHYS LIPIDS, V50, P163, DOI 10.1016/0009-3084(89)90040-6; AKESSON B, 1976, FEBS LETT, V71, P241, DOI 10.1016/0014-5793(76)80941-6; BAMBERGER M, 1985, BIOCHEMISTRY-US, V24, P3693, DOI 10.1021/bi00335a044; BELCHER JD, 1985, BIOCHEM J, V229, P343, DOI 10.1042/bj2290343; BRECKENRIDGE WC, 1982, ATHEROSCLEROSIS, V45, P161, DOI 10.1016/0021-9150(82)90136-8; BRESLOW JL, 1988, PHYSIOL REV, V68, P85, DOI 10.1152/physrev.1988.68.1.85; BREWER HB, 1986, METHOD ENZYMOL, V128, P223; BROCKMAN HL, 1984, LIPASES, P4; CARLSON LA, 1986, ACTA MED SCAND, V219, P435; COMFURIUS P, 1977, BIOCHIM BIOPHYS ACTA, V488, P36, DOI 10.1016/0005-2760(77)90120-5; DEMEL RA, 1982, BIOCHIM BIOPHYS ACTA, V713, P629, DOI 10.1016/0005-2760(82)90323-X; DOLPHIN PJ, 1985, CAN J BIOCHEM CELL B, V63, P850, DOI 10.1139/o85-107; EIBL H, 1978, P NATL ACAD SCI USA, V75, P4074, DOI 10.1073/pnas.75.9.4074; Eisenberg S, 1986, Methods Enzymol, V129, P347; ENHOLM C, 1975, J BIOL CHEM, V250, P6756; ENHOLM C, 1986, METHOD ENZYMOL, V129, P716; GOLDBERG IJ, 1982, J CLIN INVEST, V70, P1184, DOI 10.1172/JCI110717; GROOT PHE, 1983, BIOCHIM BIOPHYS ACTA, V751, P393, DOI 10.1016/0005-2760(83)90298-9; GROSSER J, 1981, J LIPID RES, V22, P437; HAMILTON JA, 1981, P NATL ACAD SCI-BIOL, V78, P6878, DOI 10.1073/pnas.78.11.6878; IBDAH JA, 1989, BIOCHEMISTRY-US, V28, P1126, DOI 10.1021/bi00429a029; JACKSON RL, 1980, BIOCHEMISTRY-US, V19, P373, DOI 10.1021/bi00543a019; JACKSON RL, 1986, METHOD ENZYMOL, V128, P288; JACKSON RL, 1985, BIOCHEM BIOPH RES CO, V128, P670, DOI 10.1016/0006-291X(85)90098-1; JACKSON RL, 1986, BIOCHEMISTRY-US, V25, P1166, DOI 10.1021/bi00353a033; JACKSON RL, 1976, PHYSIOL REV, V56, P259, DOI 10.1152/physrev.1976.56.2.259; JACKSON RL, 1983, ENZYMES, V16, P141; JAHN CE, 1981, FEBS LETT, V131, P366, DOI 10.1016/0014-5793(81)80405-X; JANSEN H, 1980, BIOCHEM BIOPH RES CO, V92, P53, DOI 10.1016/0006-291X(80)91518-1; JENSEN GL, 1981, ANAL BIOCHEM, V113, P246, DOI 10.1016/0003-2697(81)90073-7; JENSEN GL, 1982, BIOCHIM BIOPHYS ACTA, V710, P464, DOI 10.1016/0005-2760(82)90130-8; Kinnunen P.K.J., 1984, P307; KINNUNEN PKJ, 1976, FEBS LETT, V65, P354, DOI 10.1016/0014-5793(76)80145-7; KINNUNEN PKJ, 1977, MED BIOL, V55, P187; KOMAROMY MC, 1987, P NATL ACAD SCI USA, V84, P1526, DOI 10.1073/pnas.84.6.1526; KUBO M, 1982, J BIOCHEM, V92, P865, DOI 10.1093/oxfordjournals.jbchem.a134000; KUCERA GL, 1988, J BIOL CHEM, V263, P1920; KUCERA GL, 1988, J BIOL CHEM, V263, P12964; KUUSI T, 1979, FEBS LETT, V104, P384, DOI 10.1016/0014-5793(79)80858-3; LABODA HM, 1988, BIOCHEMISTRY-US, V27, P2313, DOI 10.1021/bi00407a011; LABODA HM, 1986, BIOCHIM BIOPHYS ACTA, V876, P233, DOI 10.1016/0005-2760(86)90279-1; LAIRON D, 1980, BIOCHIM BIOPHYS ACTA, V618, P106, DOI 10.1016/0005-2760(80)90058-2; LANDIN B, 1984, J LIPID RES, V25, P559; LANDIS BA, 1987, AM J PHYSIOL, V252, pG805, DOI 10.1152/ajpgi.1987.252.6.G805; Little J A, 1986, Adv Exp Med Biol, V201, P253; Macritchie F, 1978, Adv Protein Chem, V32, P283, DOI 10.1016/S0065-3233(08)60577-X; MILLER KW, 1980, CIRCULATION, V62, pA151; PATEL KM, 1979, LIPIDS, V14, P596, DOI 10.1007/BF02533539; PATSCH JR, 1984, J CLIN INVEST, V74, P2017, DOI 10.1172/JCI111624; PERSOON NLM, 1987, BIOCHIM BIOPHYS ACTA, V917, P186, DOI 10.1016/0005-2760(87)90299-2; PHILLIPS MC, 1986, METHOD ENZYMOL, V128, P387; PIERONI G, 1979, J BIOL CHEM, V254, P90; RALL SC, 1986, METHOD ENZYMOL, V128, P273; REMAN FC, 1978, CHEM PHYS LIPIDS, V21, P223, DOI 10.1016/0009-3084(78)90069-5; RIETSCH J, 1977, J BIOL CHEM, V252, P4313; SCOW RO, 1979, J BIOL CHEM, V254, P6456; SHINOMIYA M, 1982, BIOCHIM BIOPHYS ACTA, V713, P292; SHIRAI K, 1981, BIOCHEM BIOPH RES CO, V100, P591, DOI 10.1016/S0006-291X(81)80217-3; SLOTBOOM AJ, 1978, FEBS LETT, V92, P361, DOI 10.1016/0014-5793(78)80787-X; THUREN T, 1990, BIOCHIM BIOPHYS ACTA, V1046, P178, DOI 10.1016/0005-2760(90)90186-2; TWU JS, 1984, BIOCHIM BIOPHYS ACTA, V792, P330, DOI 10.1016/0005-2760(84)90201-7; VAINIO P, 1983, BIOCHEMISTRY-US, V22, P2270, DOI 10.1021/bi00278a033; VAINIO P, 1983, J BIOL CHEM, V258, P5477; VANTOL A, 1980, BIOCHEM BIOPH RES CO, V94, P101, DOI 10.1016/S0006-291X(80)80193-8; VERGER R, 1976, ANNU REV BIOPHYS BIO, V5, P77, DOI 10.1146/annurev.bb.05.060176.000453; VERGER R, 1973, CHEM PHYS LIPIDS, V10, P127, DOI 10.1016/0009-3084(73)90009-1; VERGER R, 1982, CHEM PHYS LIPIDS, V30, P189, DOI 10.1016/0009-3084(82)90052-4; WAITE M, 1973, J BIOL CHEM, V248, P7985; WAITE M, 1974, J BIOL CHEM, V249, P6401; WAITE M, 1987, HDB LIPID RES, V5, P92; WEISGRABER KH, 1980, J LIPID RES, V21, P316; WSAITE M, 1990, METHODS ENZYMOL	72	72	72	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4853	4861						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002032				2022-12-25	WOS:A1991FC21700030
J	ADKISSON, HD; RISENER, FS; ZARRINKAR, PP; WALLA, MD; CHRISTIE, WW; WUTHIER, RE				ADKISSON, HD; RISENER, FS; ZARRINKAR, PP; WALLA, MD; CHRISTIE, WW; WUTHIER, RE			UNIQUE FATTY-ACID COMPOSITION OF NORMAL CARTILAGE - DISCOVERY OF HIGH-LEVELS OF N-9 EICOSATRIENOIC ACID AND LOW-LEVELS OF N-6 POLYUNSATURATED FATTY-ACIDS	FASEB JOURNAL			English	Note						ESSENTIAL FATTY ACID DEFICIENCY; N-9 EICOSATRIENOIC ACID; GROWTH PLATE CARTILAGE; ARTICULAR CARTILAGE	STEAROYL-COA DESATURASE; EPIPHYSEAL CARTILAGE; ACYL COMPOSITION; MATRIX VESICLES; RAT-LIVER; CHROMATOGRAPHY; BIOSYNTHESIS; CHONDROCYTES; CELLS	We report here the finding that normal, young cartilages, in distinction from all other tissues examined, have unusually high levels of n-9 eicosatrienoic (20:3 cis-DELTA-5,8,11) acid and low levels of n-6 polyunsaturated fatty acids (n-6 PUFA). This pattern is identical to that found in tissues of animals subjected to prolonged depletion of nutritionally essential n-6 polyunsaturated fatty acids (EFA). This apparent deficiency is consistently observed in cartilage of all species so far studied (young chicken, fetal calf, newborn pig, rabbit, and human), even though levels of n-6 PUFA in blood and all other tissues is normal. The n-9 20:3 acid is particularly abundant in phosphatidylethanolamine, phosphatidyl-inositol, and the free fatty acid fractions from the young cartilage. Several factors appear to contribute to the reduction in n-6 PUFA and the appearance of high levels of the n-9 20:3 acid in cartilage: 1) limited access to nutritional sources of EFA due to the impermeability and avascularity of cartilage, 2) rapid metabolism of n-6 PUFA to prostanoids by chondrocytes, and 3) a unique fatty acid metabolism by cartilage. Evidence is presented that each of these factors contributes. Previously, EFA deficiency has been shown to greatly suppress the inflammatory response of leukocytes and rejection of tissues transplanted into allogeneic recipients. Because eicosanoids, which are derived from EFA, have been implicated in the inflammatory responses associated with arthritic disease, reduction of n-6 PUFA and accumulation of the n-9 20:3 acid in cartilage may be important for maintaining normal cartilage structure.	UNIV S CAROLINA,SCH MED,COLUMBIA,SC 29208; UNIV GLASGOW,HANNAH RES INST,AYR KA6 5HL,SCOTLAND	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Glasgow	ADKISSON, HD (corresponding author), UNIV S CAROLINA,DEPT CHEM,COLUMBIA,SC 29208, USA.				NIAMS NIH HHS [AR18983] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR018983] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ADKISSON HD, 1990, ORTHOP T, V14, P423; BOMBARDIERI S, 1981, BRIT J PHARMACOL, V73, P893, DOI 10.1111/j.1476-5381.1981.tb08743.x; BONTA I L, 1981, Progress in Lipid Research, V20, P617; CHRISTIE WW, 1986, LIPIDS, V21, P657, DOI 10.1007/BF02537217; CHRISTIE WW, 1987, J HIGH RES CHROMATOG, V10, P148, DOI 10.1002/jhrc.1240100309; FOLCH J, 1957, J BIOL CHEM, V226, P497; HAVIVI E, 1969, P SOC EXP BIOL MED, V131, P1300, DOI 10.3181/00379727-131-34092; HEINEGARD D, 1987, METHOD ENZYMOL, V145, P336; HOLMAN RT, 1960, J NUTR, V70, P405, DOI 10.1093/jn/70.3.405; HUNZIKER EB, 1984, J CELL BIOL, V98, P277, DOI 10.1083/jcb.98.1.277; ISHIKAWA Y, 1985, J CELL PHYSIOL, V123, P79, DOI 10.1002/jcp.1041230113; KAWASHIMA Y, 1989, BIOCHEM J, V263, P897, DOI 10.1042/bj2630897; KAWASHIMA Y, 1985, BIOCHIM BIOPHYS ACTA, V837, P222; KEMICK MLS, 1989, ADV PROSTAGLANDIN TH, V18, P423; MEAD JF, 1956, J BIOL CHEM, V219, P705; MORRISON WR, 1964, J LIPID RES, V5, P600; NORTHINGTON FK, 1978, CALC TISS RES, V26, P227, DOI 10.1007/BF02013263; OGLESBY TD, 1981, SEMIN ARTHRITIS RHEU, V11, P88, DOI 10.1016/0049-0172(81)90054-8; ROUSER G, 1968, BIOL MEMBRANES PHYSI, P28; SCHREINER GF, 1988, SCIENCE, V240, P1032, DOI 10.1126/science.3285468; STILLO JV, 1980, THESIS U S CAROLINA, P11; WOLINSKY I, 1970, CALC TISS RES, V6, P113, DOI 10.1007/BF02196190; WONG PYK, 1977, PROSTAGLANDINS, V14, P839, DOI 10.1016/0090-6980(77)90301-X; WUTHIER RE, 1975, BIOCHIM BIOPHYS ACTA, V409, P128, DOI 10.1016/0005-2760(75)90087-9; WUTHIER RE, 1978, BIOCHEMISTRY-US, V17, P1431, DOI 10.1021/bi00601a011; WUTHIER RE, 1979, SKELETAL RES EXPT AP, P121; WUTHIER RE, 1973, CLIN ORTHOP RELAT R, V90, P191	27	60	63	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998	0892-6638			FASEB J	Faseb J.	MAR 1	1991	5	3					344	353		10.1096/fasebj.5.3.2001795	http://dx.doi.org/10.1096/fasebj.5.3.2001795			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FC556	2001795				2022-12-25	WOS:A1991FC55600014
J	DECAUX, JF; MARCILLAT, O; PICHARD, AL; HENRY, J; KAHN, A				DECAUX, JF; MARCILLAT, O; PICHARD, AL; HENRY, J; KAHN, A			GLUCOSE-DEPENDENT AND GLUCOSE-INDEPENDENT EFFECT OF INSULIN ON GENE-EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POST-TRANSCRIPTIONAL REGULATION; PYRUVATE-KINASE GENE; RAT HEPATOMA-CELLS; PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; MESSENGER-RNA; CYCLIC-AMP; TYROSINE AMINOTRANSFERASE; HORMONAL-REGULATION; GLUCOKINASE GENE; ALBUMIN GENE	Insulin action on gene expression can be glucose-dependent or -independent. Accumulation of aldolase B mRNA and of an unidentified 5.4-kilobase mRNA as well as accumulation of L-type pyruvate kinase mRNAs (Decaux, J. F., Antoine, B., and Kahn, A. (1989) J. Biol. Chem. 264, 11584-11590) in cultured hepatocytes isolated from fasted rats require the presence of both glucose and insulin, these agents not being effective individually. In contrast, maintaining the amount of albumin and transferrin mRNAs in these hepatocytes requires the presence of insulin alone, glucose having no effect by itself. Transcription of the albumin gene, investigated by run-on assay, is active in the presence of insulin alone, with or without glucose, whereas transcription of the aldolase B gene is stimulated by glucose and insulin together, but not by insulin or glucose alone. In addition, the stability of the albumin and aldolase B mRNAs in cultured hepatocytes is lowered in the absence of glucose and insulin together as compared to the stability in the presence of one or both agents. These results confirm that transduction of the insulin signal occurs via distinct pathways; one of these pathways could involve a secondary insulin-dependent modification of metabolite concentration, whereas other pathways could be more directly related to the activity(ies) of the occupied insulin receptor.			DECAUX, JF (corresponding author), INSERM,U129,UNITE RECH GENET & PATHOL MOLEC,F-75014 PARIS,FRANCE.			DECAUX, Jean-Francois/0000-0003-0014-4197				ALEXANDER MC, 1988, P NATL ACAD SCI USA, V85, P5092, DOI 10.1073/pnas.85.14.5092; BAILEY JM, 1976, ANAL BIOCHEM, V70, P75, DOI 10.1016/S0003-2697(76)80049-8; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHU DTW, 1988, J BIOL CHEM, V263, P13007; CIMBALA MA, 1982, J BIOL CHEM, V257, P7629; CLAYTON DF, 1985, MOL CELL BIOL, V5, P2623, DOI 10.1128/MCB.5.10.2623; CRETTAZ M, 1988, BIOCHEMISTRY-US, V27, P495, DOI 10.1021/bi00401a071; DAVIS BB, 1988, BIOCHEM BIOPH RES CO, V154, P1081, DOI 10.1016/0006-291X(88)90251-3; DEBANT A, 1989, BIOCHEMISTRY-US, V28, P14, DOI 10.1021/bi00427a003; DECAUX JF, 1989, J BIOL CHEM, V264, P11584; DOZIN B, 1986, P NATL ACAD SCI USA, V83, P4705, DOI 10.1073/pnas.83.13.4705; DRAKE RL, 1985, BIOCHEM BIOPH RES CO, V130, P317; ENAT R, 1984, P NATL ACAD SCI-BIOL, V81, P1411, DOI 10.1073/pnas.81.5.1411; FLAIM KE, 1985, AM J PHYSIOL, V249, pE447, DOI 10.1152/ajpendo.1985.249.5.E447; GRANNER D, 1983, NATURE, V305, P549, DOI 10.1038/305549a0; ISOM HC, 1985, P NATL ACAD SCI USA, V82, P3252, DOI 10.1073/pnas.82.10.3252; IYNEDJIAN PB, 1988, J BIOL CHEM, V263, P740; IYNEDJIAN PB, 1989, J BIOL CHEM, V264, P21824; JACOBY DB, 1989, J BIOL CHEM, V264, P17623; JEFFERSON DM, 1984, MOL CELL BIOL, V4, P1929, DOI 10.1128/MCB.4.9.1929; JEFFERSON LS, 1983, J BIOL CHEM, V258, P1369; JEFFERSON LS, 1980, DIABETES, V29, P478; KITAGAWA Y, 1987, EUR J BIOCHEM, V167, P19, DOI 10.1111/j.1432-1033.1987.tb13299.x; LARNER J, 1979, SCIENCE, V206, P1408, DOI 10.1126/science.228395; LEE KL, 1986, ARCH BIOCHEM BIOPHYS, V248, P597, DOI 10.1016/0003-9861(86)90513-8; LLOYD CE, 1987, AM J PHYSIOL, V252, pC205, DOI 10.1152/ajpcell.1987.252.2.C205; MAGNUSON MA, 1989, P NATL ACAD SCI USA, V86, P4838, DOI 10.1073/pnas.86.13.4838; MCKNIGHT GS, 1979, J BIOL CHEM, V254, P9050; MEIENHOFER MC, 1987, EUR J BIOCHEM, V169, P237, DOI 10.1111/j.1432-1033.1987.tb13603.x; MESSINA JL, 1985, J BIOL CHEM, V260, P6418; MILLER DS, 1988, SCIENCE, V240, P506, DOI 10.1126/science.2451860; MOORE PS, 1989, MOL ENDOCRINOL, V3, P1724, DOI 10.1210/mend-3-11-1724; MUNNICH A, 1985, J CLIN INVEST, V75, P1045, DOI 10.1172/JCI111766; MUNNICH A, 1984, J BIOL CHEM, V259, P228; NOGUCHI T, 1985, J BIOL CHEM, V260, P4393; PAULAUSKIS JD, 1989, J BIOL CHEM, V264, P574; PICHARD AL, 1985, BIOCHEM J, V226, P637, DOI 10.1042/bj2260637; ROSEN OM, 1987, SCIENCE, V237, P1452, DOI 10.1126/science.2442814; ROY AK, 1980, J BIOL CHEM, V255, P1614; SALTIEL AR, 1986, SCIENCE, V233, P967, DOI 10.1126/science.3016898; SARGENT TD, 1979, P NATL ACAD SCI USA, V76, P3256, DOI 10.1073/pnas.76.7.3256; SASAKI K, 1984, J BIOL CHEM, V259, P5242; SIMON MP, 1983, J BIOL CHEM, V258, P4576; SIMPSON IA, 1984, SCIENCE, V223, P1301, DOI 10.1126/science.6367041; STRAUS DS, 1987, J BIOL CHEM, V262, P1955; STUMPO DJ, 1988, J BIOL CHEM, V263, P1611; UZAN G, 1984, BIOCHEM BIOPH RES CO, V119, P273, DOI 10.1016/0006-291X(84)91648-6; VAULONT S, 1984, BIOCHEM BIOPH RES CO, V125, P135, DOI 10.1016/S0006-291X(84)80345-9; VAULONT S, 1986, J BIOL CHEM, V261, P7621; WEBER A, 1984, J BIOL CHEM, V259, P1798; WELSH M, 1985, J BIOL CHEM, V260, P3590; WILDEN PA, 1990, P NATL ACAD SCI USA, V87, P3358, DOI 10.1073/pnas.87.9.3358	52	65	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3432	3438						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995607				2022-12-25	WOS:A1991EY68200017
J	HAGA, JA; SHE, JX; KAO, KJ				HAGA, JA; SHE, JX; KAO, KJ			BIOCHEMICAL-CHARACTERIZATION OF 39-KDA CLASS-I HISTOCOMPATIBILITY ANTIGEN IN PLASMA - A SECRETABLE MEMBRANE-PROTEIN DERIVED FROM TRANSMEMBRANE DOMAIN DELETION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE HLA ANTIGENS; DNA-SEQUENCE; HUMAN-SERUM; LIPOPROTEIN FRACTION; T-CELLS; EXPRESSION; TRANSPLANTATION; ANTIBODIES; MOLECULES; RECEPTOR	Three human class I major histocompatibility antigens (HLA) with molecular masses of 44, 39, and 36 kDa were identified in plasma by immunoprecipitation and immunoblotting. Further biochemical characterization showed that these antigens in plasma could be fractionated by Sephacryl S-300 column chromatography into two different pools. The 44-kDa intact HLA heavy chains are detected only in pool I and have an apparent molecular weight of 200,000 as determined by calibrated gel filtration column chromatography. The 39- and 36-kDa HLA heavy chains are present only in pool II and have an apparent molecular weight of 50,000. HLA in pool I can be extracted by Triton X-114 detergent, but 39- and 36-kDa plasma HLA in pool II are water soluble and not extractable by Triton X-114. Amino acid sequences of NH2 termini for 44- and 39-kDa plasma HLA are identical to that of cellular HLA. In contrast, the NH2-terminal amino acid sequence for 36-kDa plasma HLA has not been reported previously for any other proteins. Since the loss of both transmembrane domain and cytoplasmic tail at the carboxyl terminus of HLA will generate a 36-kDa protein, the findings suggest that the 39-kDa HLA might be the product of alternatively spliced mRNA with deletion of the exon coding for transmembrane domain. By using polymerase chain reaction and DNA sequencing, the presence of alternatively spliced mRNA with deletion of the transmembrane domain exon was identified in mononuclear leukocytes of peripheral blood. This alternatively spliced HLA mRNA was not detectable in mononuclear leukocytes of an individual who had no 39-kDa plasma HLA. This finding indicates that the alternatively spliced mRNA in mononuclear leukocytes is responsible for the synthesis of a secretable class I HLA.	UNIV FLORIDA,COLL MED,DEPT PATHOL,GAINESVILLE,FL 32610	State University System of Florida; University of Florida					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035124] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL35124] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLEN JM, 1989, SCIENCE, V243, P378, DOI 10.1126/science.2911749; ALLISON JP, 1977, J IMMUNOL, V118, P1004; ASTER RH, 1973, TRANSPLANTATION, V16, P205, DOI 10.1097/00007890-197309000-00007; BACH FH, 1987, NEW ENGL J MED, V317, P489, DOI 10.1056/NEJM198708203170807; BRODIER C, 1981, J BIOL CHEM, V256, P1604; BRODSKY FM, 1982, J IMMUNOL, V128, P129; CHARLTON RK, 1970, SCIENCE, V170, P636, DOI 10.1126/science.170.3958.636; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COWAN EP, 1987, IMMUNOGENETICS, V25, P241, DOI 10.1007/BF00404694; DAVIES HFS, 1989, TRANSPLANTATION, V47, P524; DOBBE LME, 1988, IMMUNOGENETICS, V27, P203, DOI 10.1007/BF00346587; ELLIS SA, 1990, J IMMUNOL, V144, P731; EMERSON SG, 1982, TRANSPLANTATION, V33, P36, DOI 10.1097/00007890-198201000-00008; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; GUSSOW D, 1987, IMMUNOGENETICS, V25, P313, DOI 10.1007/BF00404424; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P227; KAO KJ, 1990, HUM IMMUNOL, V27, P285, DOI 10.1016/0198-8859(90)90080-9; KAO KJ, 1988, TRANSFUSION, V28, P14, DOI 10.1046/j.1537-2995.1988.28188127942.x; KAO KJ, 1987, BLOOD, V70, P282; KAO KJ, 1986, BLOOD, V68, P627; KOLLER BH, 1988, J IMMUNOL, V141, P897; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; KOTTMANN AH, 1986, IMMUNOGENETICS, V23, P396, DOI 10.1007/BF00372673; KRANGEL MS, 1985, EMBO J, V4, P1205, DOI 10.1002/j.1460-2075.1985.tb03761.x; KRANGEL MS, 1987, HUM IMMUNOL, V20, P155, DOI 10.1016/0198-8859(87)90029-2; KRANGEL MS, 1986, J EXP MED, V163, P1173, DOI 10.1084/jem.163.5.1173; KREITMAN M, 1989, GENE ANAL TECH, V6, P84, DOI 10.1016/0735-0651(89)90021-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MELLOR AL, 1984, CELL, V36, P139, DOI 10.1016/0092-8674(84)90082-5; MONOS DS, 1983, J IMMUNOL, V131, P341; MOOS M, 1988, J BIOL CHEM, V263, P6005; NATALI PG, 1984, CANCER RES, V44, P4679; OROURKE AM, 1990, NATURE, V346, P187, DOI 10.1038/346187a0; PLOEGH HL, 1981, CELL, V24, P287, DOI 10.1016/0092-8674(81)90318-4; POLLARD SG, 1990, TRANSPLANTATION, V47, P659; PORATH J, 1967, NATURE, V215, P1491, DOI 10.1038/2151491a0; RAVETCH JV, 1989, J EXP MED, V170, P481, DOI 10.1084/jem.170.2.481; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNECK J, 1989, CELL, V56, P47, DOI 10.1016/0092-8674(89)90982-3; SPRINGER TA, 1976, P NATL ACAD SCI USA, V73, P2481, DOI 10.1073/pnas.73.7.2481; SPRINGER TA, 1974, P NATL ACAD SCI USA, V71, P1539, DOI 10.1073/pnas.71.4.1539; SRIVASTAVA R, 1985, IMMUNOL REV, V84, P93, DOI 10.1111/j.1600-065X.1985.tb01127.x; STAM NJ, 1986, J IMMUNOL, V137, P2299; STUART SG, 1987, J EXP MED, V166, P1668, DOI 10.1084/jem.166.6.1668; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TRAGARDH L, 1979, SCAND J IMMUNOL, V9, P303, DOI 10.1111/j.1365-3083.1979.tb03168.x; VANROOD JJ, 1970, NATURE, V226, P366, DOI 10.1038/226366a0; VANSOMEREN H, 1974, P NATL ACAD SCI USA, V71, P962; WATKINS DI, 1990, NATURE, V346, P60, DOI 10.1038/346060a0; WESTHOFF U, 1989, TRANSPLANTATION, V48, P891; Zinkernagel R M, 1979, Adv Immunol, V27, P51, DOI 10.1016/S0065-2776(08)60262-X	53	61	63	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3695	3701						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995624				2022-12-25	WOS:A1991EY68200054
J	SAGAMI, H; MATSUOKA, S; OGURA, K				SAGAMI, H; MATSUOKA, S; OGURA, K			FORMATION OF Z,E,E-GERANYLGERANYL DIPHOSPHATE BY RAT-LIVER MICROSOMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERANYLGERANYL PYROPHOSPHATE SYNTHETASE; DOLICHYL PHOSPHATE BIOSYNTHESIS; PIG-LIVER; PURIFICATION; PRENYLTRANSFERASE; ISOMERASE; SYNTHASE	Rat liver microsomes catalyzed the formation of Z,E,E-geranylgeranyl diphosphate from farnesyl diphosphate and isopentenyl diphosphate in the presence of Triton X-100. Studies on product specificity using various primers such as Z,E-farnesyl diphosphate, E,E-farnesyl diphosphate, Z,E,E-geranylgeranyl diphosphate, E,E,E-geranylgeranyl diphosphate, Z,E,E,E-geranylfarnesyl diphosphate, and E,E,E,E-geranylfarnesyl diphosphate suggested that the microsomal dehydrodolichyl diphosphate synthase has such properties that it releases Z,E,E-geranylgeranyl diphosphate, the first intermediate, in the reactions with farnesyl diphosphate as the starting primer. Metabolic labeling of rat liver slices with [2-H-3]mevalonic acid revealed the accumulation of E,E,E-geranylgeranyl (di)phosphates as well as dolichyl (di)phosphate (C85 and C90) and dehydrodolichol (C85 and C90), but no accumulation of Z,E,E-geranylgeranyl (di)phosphate or E,E-farnesyl (di)phosphate was detected. Microsomal enzyme preparations from mouse liver and hamster liver also produced Z,E,E-geranylgeranyl diphosphate from farnesyl diphosphate and isopentenyl diphosphate.			SAGAMI, H (corresponding author), TOHOKU UNIV,CHEM RES INST NONAQUEOUS SOLUT,SENDAI,MIYAGI 980,JAPAN.							ADAIR WL, 1984, J BIOL CHEM, V259, P4441; ADAIR WL, 1982, J BIOL CHEM, V257, P8990; ALLEN CM, 1976, ARCH BIOCHEM BIOPHYS, V175, P236, DOI 10.1016/0003-9861(76)90504-X; BABA T, 1980, ARCH BIOCHEM BIOPHYS, V200, P474, DOI 10.1016/0003-9861(80)90379-3; BABA T, 1987, ARCH BIOCHEM BIOPHYS, V252, P440, DOI 10.1016/0003-9861(87)90050-6; BRINKHAUS FL, 1988, ARCH BIOCHEM BIOPHYS, V266, P607, DOI 10.1016/0003-9861(88)90293-7; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; DAVISSON VJ, 1985, METHOD ENZYMOL, V110, P130; DOGBO O, 1987, BIOCHIM BIOPHYS ACTA, V920, P140, DOI 10.1016/0005-2760(87)90253-0; FARNSWORTH CC, 1989, J BIOL CHEM, V264, P20422; FARNSWORTH CC, 1990, SCIENCE, V247, P320, DOI 10.1126/science.2296721; FUJII H, 1982, BIOCHIM BIOPHYS ACTA, V712, P716; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; GRANGE DK, 1977, BIOCHEM BIOPH RES CO, V79, P734, DOI 10.1016/0006-291X(77)91173-1; GREEN TR, 1975, BIOCHEM BIOPH RES CO, V64, P976, DOI 10.1016/0006-291X(75)90143-6; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; ISHII K, 1986, BIOCHEM J, V233, P773, DOI 10.1042/bj2330773; ISHII K, 1983, BIOCHEM BIOPH RES CO, V116, P500, DOI 10.1016/0006-291X(83)90551-X; KANDUTSCH AA, 1964, J BIOL CHEM, V239, P2507; KELLER RK, 1986, J BIOL CHEM, V261, P2053; NANDI DL, 1964, ARCH BIOCHEM BIOPHYS, V105, P7, DOI 10.1016/0003-9861(64)90230-9; OGURA K, 1972, J BIOCHEM-TOKYO, V72, P1101, DOI 10.1093/oxfordjournals.jbchem.a129997; OSTER MO, 1968, ARCH BIOCHEM BIOPHYS, V127, P112, DOI 10.1016/0003-9861(68)90207-5; RILLING HC, 1990, SCIENCE, V247, P318, DOI 10.1126/science.2296720; SAGAMI H, 1989, BIOCHIM BIOPHYS ACTA, V1002, P218, DOI 10.1016/0005-2760(89)90290-7; SAGAMI H, 1981, BIOCHEM INT, V3, P669; TAKAHASHI I, 1982, J BIOCHEM-TOKYO, V92, P1527, DOI 10.1093/oxfordjournals.jbchem.a134077; WELLNER RB, 1979, FEBS LETT, V104, P379, DOI 10.1016/0014-5793(79)80857-1	28	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3458	3463						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995610				2022-12-25	WOS:A1991EY68200021
J	KUME, A; KOYATA, H; SAKAKIBARA, T; ISHIGURO, Y; KURE, S; HIRAGA, K				KUME, A; KOYATA, H; SAKAKIBARA, T; ISHIGURO, Y; KURE, S; HIRAGA, K			THE GLYCINE CLEAVAGE SYSTEM - MOLECULAR-CLONING OF THE CHICKEN AND HUMAN GLYCINE DECARBOXYLASE CDNAS AND SOME CHARACTERISTICS INVOLVED IN THE DEDUCED PROTEIN STRUCTURES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-SERINE DEHYDRATASE; AMINO-ACID SEQUENCE; ESCHERICHIA-COLI; LIVER-MITOCHONDRIA; RAT-LIVER; MAJOR PATHWAYS; ASPARTIC-ACID; H-PROTEIN; PURIFICATION; ENZYME	A cDNA encoding chicken glycine decarboxylase (pCP15b) was isolated using an antibody specific to this protein. Additional cDNAs were cloned with the aid of the genomic fragments obtained by using the pCP15b cDNA probe. No initiator methionine codon is found in the currently elucidated cDNA sequence, and an ATG codon in an exon is assigned to this role. The precursor glycine decarboxylase deduced from the 3514-base pair nucleotide sequence is comprised of 1,004 amino acids (M(r) = 111,848). The 1,020 amino acid residues are encoded for the precursor form of human glycine decarboxylase (M(r) = 112,869) in the 3,783-base long cDNA sequence of two 1.9-kilobase pair cDNAs with a pentanucleotide overlap. The pyridoxal phosphate binding site lysine and a glycine-rich region, which is suggested to be responsible for the attachment of the phosphate moiety of pyridoxal phosphate, are found in close proximity in both the chicken and human enzymes. This region essential for the enzyme action is suggested to be embedded in a segment rich in beta-turns and random coils and is surrounded by conserved and repetitive amino acid sequences. It is suggested that these structures are involved in the organization of the active site of glycine decarboxylase.	TOYAMA MED & PHARMACEUT UNIV,SCH MED,DEPT BIOCHEM,SUGITANI,TOYAMA 93001,JAPAN	University of Toyama								APPLEBAUM D, 1975, BIOCHEMISTRY-US, V14, P3675, DOI 10.1021/bi00687a025; DILELLA AG, 1987, METHOD ENZYMOL, V152, P199; FUJIWARA K, 1987, BIOCHEM BIOPH RES CO, V149, P621, DOI 10.1016/0006-291X(87)90413-X; FUJIWARA K, 1986, J BIOL CHEM, V261, P8836; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; HAMPL H, 1981, J BIOL CHEM, V256, P2284; HAYASAKA K, 1980, J BIOCHEM-TOKYO, V88, P1193, DOI 10.1093/oxfordjournals.jbchem.a133074; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HIRAGA K, 1980, J BIOL CHEM, V255, P1664; HIRAGA K, 1972, J BIOCHEM-TOKYO, V72, P1285, DOI 10.1093/oxfordjournals.jbchem.a130020; HIRAGA K, 1980, J BIOL CHEM, V255, P1671; HIRAGA K, 1988, BIOCHEM BIOPH RES CO, V151, P758, DOI 10.1016/S0006-291X(88)80345-0; IKENAKA T, 1966, J BIOL CHEM, V241, P5560; KIKUCHI G, 1973, MOL CELL BIOCHEM, V1, P169, DOI 10.1007/BF01659328; KLEIN SM, 1966, J BIOL CHEM, V241, P197; KONISHI K, 1987, BIOCHEMISTRY-US, V26, P8496, DOI 10.1021/bi00399a069; KUME A, 1988, BIOCHEM BIOPH RES CO, V154, P292, DOI 10.1016/0006-291X(88)90683-3; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; MANIATIS T, 1982, MOL CLONING LABORATO, P270; MARCEAU M, 1988, J BIOL CHEM, V263, P16934; MARCEAU M, 1988, J BIOL CHEM, V263, P16926; MARTINI F, 1987, J BIOL CHEM, V262, P5499; Mayes E L, 1984, Methods Mol Biol, V1, P33, DOI 10.1385/0-89603-062-8:33; MIZUSAWA S, 1986, NUCLEIC ACIDS RES, V14, P1319, DOI 10.1093/nar/14.3.1319; Nyhan W.L., 1989, METABOLIC BASIS INHE, P743; OHTSUKA E, 1985, J BIOL CHEM, V260, P2605; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STAUFFER LT, 1986, GENE, V44, P219, DOI 10.1016/0378-1119(86)90185-X; TADA K, 1987, EUR J PEDIATR, V146, P221, DOI 10.1007/BF00716464; TANAKA M, 1986, P NATL ACAD SCI USA, V83, P6030, DOI 10.1073/pnas.83.16.6030; YAMAMOTO M, 1991, J BIOL CHEM, V266, P3317; YOSHIDA T, 1973, J BIOCHEM-TOKYO, V73, P1013, DOI 10.1093/oxfordjournals.jbchem.a130155; YOSHIDA T, 1970, ARCH BIOCHEM BIOPHYS, V139, P380, DOI 10.1016/0003-9861(70)90490-X	33	48	55	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3323	3329						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993704				2022-12-25	WOS:A1991EX60000097
J	NAKAYAMA, M; FUJITA, N; OSAWA, S; ISHIHAMA, A				NAKAYAMA, M; FUJITA, N; OSAWA, S; ISHIHAMA, A			IDENTIFICATION AND CHARACTERIZATION OF RNA-POLYMERASE SIGMA-FACTOR FROM MICROCOCCUS-LUTEUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIXED TRANSCRIPTION SYSTEM; ESCHERICHIA-COLI; PROMOTER SELECTIVITY; DNA; PROTEINS; PURIFICATION; GENETICS; SUBTILIS; STRENGTH; PLASMID	The promoters of Micrococcus luteus, a bacterium whose chromosomal DNA has a high G + C content (74%), diverge from the consensus prokaryotic promoter in having GC-rich DNA sequences at less important positions (Nakayama, M., Fujita, N., Ohama, T., Osawa, S., and Ishihama, A. (1989) Mol. Gen. Genet. 218, 384-389). In order to compare the promoter selectivity of RNA polymerase between M. luteus and Escherichia coli, we purified the enzyme from both organisms. The sets of promoters recognized by the two RNA polymerases were found to overlap partly. Some, but not all, E. coli promoters were found to be correctly transcribed in vitro by M. luteus RNA polymerase as well as the E. coli enzyme. One molecular species of M. luteus sigma-factor, with the apparent molecular mass of 60 kDa, was isolated from purified RNA polymerase. By the addition of either M. luteus or E. coli core enzyme it was reconstituted into active holoenzyme. Likewise, M. luteus core enzyme was reconstituted into a hybrid holoenzyme by the addition of E. coli sigma-subunit. Both hybrid holoenzymes were, however, able to initiate transcription only from promoters which were recognized by both of the native holoenzymes.	NATL INST GENET,DEPT MOLEC GENET,MISHIMA,SHIZUOKA 411,JAPAN; NAGOYA UNIV,FAC SCI,DEPT BIOL,CHIKUSA KU,NAGOYA,AICHI 464,JAPAN	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Nagoya University								BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGESS RR, 1975, BIOCHEMISTRY-US, V14, P4634, DOI 10.1021/bi00692a011; DAVID NA, 1989, P NATL ACAD SCI USA, V86, P830; ERICKSON JW, 1989, GENE DEV, V3, P1462, DOI 10.1101/gad.3.9.1462; FUJITA N, 1987, J BIOL CHEM, V262, P1855; GONZALEZ N, 1977, ARCH BIOCHEM BIOPHYS, V182, P404, DOI 10.1016/0003-9861(77)90521-5; GRIBSKOV M, 1986, NUCLEIC ACIDS RES, V14, P6745, DOI 10.1093/nar/14.16.6745; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; HELMANN JD, 1988, ANNU REV BIOCHEM, V57, P839, DOI 10.1146/annurev.bi.57.070188.004203; HORI H, 1986, BIOSYSTEMS, V19, P162; Ishihama A, 1981, Adv Biophys, V14, P1; ISHIHAMA A, 1988, TRENDS GENET, V4, P282, DOI 10.1016/0168-9525(88)90170-9; KAJITANI M, 1983, NUCLEIC ACIDS RES, V11, P3873, DOI 10.1093/nar/11.12.3873; KAJITANI M, 1983, NUCLEIC ACIDS RES, V11, P671, DOI 10.1093/nar/11.3.671; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LILL UI, 1985, EUR J BIOCHEM, V52, P411; LOSICK R, 1981, CELL, V25, P582, DOI 10.1016/0092-8674(81)90164-1; LOSICK R, 1986, ANNU REV GENET, V20, P625, DOI 10.1146/annurev.ge.20.120186.003205; LOWE PA, 1979, BIOCHEMISTRY-US, V18, P1344, DOI 10.1021/bi00574a034; MARK JB, 1988, CELL, V52, P599; MORITA M, 1979, EUR J BIOCHEM, V97, P435, DOI 10.1111/j.1432-1033.1979.tb13131.x; NAGASE T, 1988, GENE, V67, P49; NAKAYAMA M, 1989, MOL GEN GENET, V218, P384, DOI 10.1007/BF00332399; NOMURA T, 1984, MOL GEN GENET, V193, P8, DOI 10.1007/BF00327407; NOMURA T, 1985, NUCLEIC ACIDS RES, V13, P7647, DOI 10.1093/nar/13.21.7647; OHAMA T, 1987, J BACTERIOL, V169, P4770, DOI 10.1128/jb.169.10.4770-4777.1987; STRAGIER P, 1989, SCIENCE, V243, P507, DOI 10.1126/science.2536191; TANAKA K, 1988, SCIENCE, V242, P1040, DOI 10.1126/science.3194753; TODA T, 1987, SEIKAGAKU, V60, P1248; YURA T, 1979, ANNU REV GENET, V13, P59, DOI 10.1146/annurev.ge.13.120179.000423	31	1	1	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2911	2916						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993665				2022-12-25	WOS:A1991EX60000040
J	NUREKI, O; MURAMATSU, T; SUZUKI, K; KOHDA, D; MATSUZAWA, H; OHTA, T; MIYAZAWA, T; YOKOYAMA, S				NUREKI, O; MURAMATSU, T; SUZUKI, K; KOHDA, D; MATSUZAWA, H; OHTA, T; MIYAZAWA, T; YOKOYAMA, S			METHIONYL-TRANSFER RNA-SYNTHETASE GENE FROM AN EXTREME THERMOPHILE, THERMUS-THERMOPHILUS HB8 - MOLECULAR-CLONING, PRIMARY-STRUCTURE ANALYSIS, EXPRESSION IN ESCHERICHIA-COLI, AND SITE-DIRECTED MUTAGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMYLMETHIONINE TRANSFER-RNA; TRANSCRIPTION FACTOR-IIIA; AMINO-TERMINAL EXTENSION; ASPARTYL-TRANSFER RNA; ZINC-BINDING DOMAINS; NUCLEOTIDE-SEQUENCE; ACID-SEQUENCE; DNA-SEQUENCE; ENZYME; YEAST	The gene for the methionyl-tRNA synthetase (MetRS) from an extreme thermophile, Thermus thermophilus HB8, was cloned and sequenced. By expression of the T. thermophilus MetRS gene in Escherichia coli cells, thermostable MetRS was overproduced and purified to homogeneity by heat treatment and one-step column chromatography. The amino acid sequence of T. thermophilus MetRS showed low identities (approximately 25%) with those of MetRS from E. coli, and cytoplasm and mitochondria of Saccharomyces cerevisiae. However, the amino acid residues in the binding sites for ATP and the anticodon and the 3' terminus of tRNA(Met) are highly conserved among the four MetRS. T. thermophilus MetRS has a zinc finger-like sequence with all the three cysteine residues and a histidine residue. By site-directed mutagenesis of one of the cysteine residues (Cys127) of T. thermophilus MetRS, the SH group was found to be important for methionyl-tRNA synthesis. Just upstream of the structural gene for T. thermophilus MetRS there is a short open reading frame which codes for a methionine-rich peptide and is partly overlapped with an alternative terminator/antiterminator structure, suggesting that transcription of this gene is regulated by attenuation. Further upstream a region contains a nucleotide sequence homologous to that of the 5' half of T. thermophilus initiator tRNA(Met).	UNIV TOKYO,FAC PHARMACEUT SCI,DEPT BIOPHYS & BIOCHEM,7-3-1 HONGO,BUNKYO KU,TOKYO 113,JAPAN; UNIV TOKYO,FAC AGR,DEPT AGR CHEM,BUNKYO KU,TOKYO 113,JAPAN; YOKOHAMA NATL UNIV,FAC ENGN,HODOGAYA KU,YOKOHAMA,KANAGAWA 240,JAPAN	University of Tokyo; University of Tokyo; Yokohama National University			Yokoyama, Shigeyuki/N-6911-2015; Kohda, Daisuke/I-4990-2019	Yokoyama, Shigeyuki/0000-0003-3133-7338; Kohda, Daisuke/0000-0001-8234-3776				ANKILOVA VN, 1988, FEBS LETT, V227, P9, DOI 10.1016/0014-5793(88)81403-0; AOTA S, 1988, NUCLEIC ACIDS RES, V16, P315; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BERG JM, 1988, P NATL ACAD SCI USA, V85, P99, DOI 10.1073/pnas.85.1.99; BRICK P, 1988, J MOL BIOL, V208, P83; BRUNIE S, 1987, J MOL GRAPHICS, V5, P18, DOI 10.1016/0263-7855(87)80039-5; BUTLER JS, 1986, J BACTERIOL, V165, P198, DOI 10.1128/jb.165.1.198-203.1986; CASSIO D, 1971, EUR J BIOCHEM, V20, P283, DOI 10.1111/j.1432-1033.1971.tb01393.x; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; DARDEL F, 1984, J BACTERIOL, V160, P1115, DOI 10.1128/JB.160.3.1115-1122.1984; DONAHUE TF, 1988, CELL, V54, P621, DOI 10.1016/S0092-8674(88)80006-0; EVANS RM, 1988, CELL, V52, P1, DOI 10.1016/0092-8674(88)90522-3; FASIOLO F, 1985, J BIOL CHEM, V260, P5571; FAYAT G, 1983, J MOL BIOL, V171, P239, DOI 10.1016/0022-2836(83)90092-X; GAMPEL A, 1989, P NATL ACAD SCI USA, V86, P6023, DOI 10.1073/pnas.86.16.6023; GARBER MB, 1990, J MOL BIOL, V214, P819, DOI 10.1016/0022-2836(90)90337-L; GHOSH G, 1990, BIOCHEMISTRY-US, V29, P2220, DOI 10.1021/bi00461a003; HARAYOKOYAMA M, 1986, BIOCHEMISTRY-US, V25, P7031, DOI 10.1021/bi00370a041; HARAYOKOYAMA M, 1986, FEBS LETT, V202, P149, DOI 10.1016/0014-5793(86)80667-6; HARAYOKOYAMA M, 1984, J BIOCHEM, V96, P1599, DOI 10.1093/oxfordjournals.jbchem.a134990; HARTLEIN M, 1987, NUCLEIC ACIDS RES, V15, P10199, DOI 10.1093/nar/15.24.10199; HERBERT CJ, 1988, EMBO J, V7, P473, DOI 10.1002/j.1460-2075.1988.tb02835.x; HOUNTONDJI C, 1985, BIOCHEMISTRY-US, V24, P1175, DOI 10.1021/bi00326a018; HOUNTONDJI C, 1990, BIOCHEMISTRY-US, V29, P8190, DOI 10.1021/bi00487a029; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; KAGAWA Y, 1984, J BIOL CHEM, V259, P2956; KOCH GLE, 1974, FEBS LETT, V40, P180, DOI 10.1016/0014-5793(74)80922-1; KOHDA D, 1987, J BIOL CHEM, V262, P558; KOHDA D, 1984, FEBS LETT, V174, P20, DOI 10.1016/0014-5793(84)81069-8; KUNAI K, 1986, EUR J BIOCHEM, V160, P433, DOI 10.1111/j.1432-1033.1986.tb09991.x; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; KUSHIRO A, 1987, EUR J BIOCHEM, V170, P93, DOI 10.1111/j.1432-1033.1987.tb13671.x; LASSAR AB, 1983, SCIENCE, V222, P740, DOI 10.1126/science.6356356; LEON O, 1987, BIOCHEMISTRY-US, V26, P7113, DOI 10.1021/bi00396a037; LEON O, 1987, BIOCHEMISTRY-US, V26, P1933, DOI 10.1021/bi00381a022; LEON O, 1987, BIOCHEMISTRY-US, V26, P5416, DOI 10.1021/bi00391a030; LESTIENNE P, 1984, J BIOL CHEM, V259, P5232; LESTIENNE PP, 1988, NATURE, V335, P503, DOI 10.1038/335503b0; LORBER B, 1983, J BIOL CHEM, V258, P8429; LUDMERER SW, 1987, J BIOL CHEM, V262, P10801; MANIATIS T, 1982, MOL CLONING LABORATO, P326; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; MAYAUX JF, 1982, EUR J BIOCHEM, V128, P41; MAYAUX JF, 1983, P NATL ACAD SCI-BIOL, V80, P6152, DOI 10.1073/pnas.80.20.6152; MECHULAM Y, 1985, J BACTERIOL, V163, P787, DOI 10.1128/JB.163.2.787-791.1985; MELLOT P, 1989, J MOL BIOL, V208, P429, DOI 10.1016/0022-2836(89)90507-X; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; MURAMATSU T, 1988, NATURE, V336, P179, DOI 10.1038/336179a0; NISHIYAMA M, 1986, J BIOL CHEM, V261, P14178; NORMANLY J, 1989, ANNU REV BIOCHEM, V58, P1029, DOI 10.1146/annurev.bi.58.070189.005121; ONO M, 1990, J BIOCHEM-TOKYO, V107, P21, DOI 10.1093/oxfordjournals.jbchem.a123004; OSHIMA T, 1974, INT J SYST BACTERIOL, V24, P102, DOI 10.1099/00207713-24-1-102; PAPE LK, 1985, NUCLEIC ACIDS RES, V13, P6171, DOI 10.1093/nar/13.17.6171; PERONA JJ, 1989, SCIENCE, V246, P1152, DOI 10.1126/science.2686030; PUTNEY SD, 1981, SCIENCE, V213, P1497, DOI 10.1126/science.7025207; PUTNEY SD, 1981, NATURE, V291, P632, DOI 10.1038/291632a0; ROSEVEAR PR, 1988, BIOCHEMISTRY-US, V27, P7931, DOI 10.1021/bi00420a052; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; RUFF M, 1988, J MOL BIOL, V201, P235, DOI 10.1016/0022-2836(88)90450-0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHIMMEL P, 1987, ANNU REV BIOCHEM, V56, P125, DOI 10.1146/annurev.bi.56.070187.001013; SCHIMMEL P, 1989, BIOCHEMISTRY-US, V28, P2747, DOI 10.1021/bi00433a001; SCHULMAN LH, 1987, NUCLEIC ACIDS RES, V15, P10523, DOI 10.1093/nar/15.24.10523; SCHULMAN LH, 1977, J BIOL CHEM, V252, P814; SCHULMAN LH, 1983, P NATL ACAD SCI-BIOL, V80, P6755, DOI 10.1073/pnas.80.22.6755; SCHULMAN LH, 1988, SCIENCE, V242, P765, DOI 10.1126/science.3055296; SCHULMAN LH, 1977, BIOCHEMISTRY-US, V16, P4256, DOI 10.1021/bi00638a020; STARZYK RM, 1989, BIOCHEMISTRY-US, V28, P8479, DOI 10.1021/bi00447a031; STARZYK RM, 1987, SCIENCE, V237, P1614, DOI 10.1126/science.3306924; STERN L, 1977, J BIOL CHEM, V252, P6403; TZAGOLOFF A, 1989, EUR J BIOCHEM, V179, P365, DOI 10.1111/j.1432-1033.1989.tb14562.x; VALENZUELA D, 1986, BIOCHEMISTRY-US, V25, P4555, DOI 10.1021/bi00364a015; WALTER P, 1983, P NATL ACAD SCI-BIOL, V80, P2437, DOI 10.1073/pnas.80.9.2437; WALTER P, 1989, J BIOL CHEM, V264, P17126; WALTER P, 1985, J BIOL CHEM, V80, P15571; WATANABE K, 1976, NUCLEIC ACIDS RES, V3, P1703, DOI 10.1093/nar/3.7.1703; WEBSTER T, 1984, SCIENCE, V226, P1315, DOI 10.1126/science.6390679; WEBSTER TA, 1987, BIOCHEMISTRY-US, V26, P6950, DOI 10.1021/bi00396a014; YAREMCHUK AD, 1990, J MOL BIOL, V213, P631; YARUS M, 1988, CELL, V55, P739, DOI 10.1016/0092-8674(88)90127-4; ZELWER C, 1982, J MOL BIOL, V155, P63, DOI 10.1016/0022-2836(82)90492-2	81	52	54	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3268	3277						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993699				2022-12-25	WOS:A1991EX60000090
J	WALKER, F; BURGESS, AW				WALKER, F; BURGESS, AW			RECONSTITUTION OF THE HIGH-AFFINITY EPIDERMAL GROWTH-FACTOR RECEPTOR ON CELL-FREE MEMBRANES AFTER TRANSMODULATION BY PLATELET-DERIVED GROWTH-FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN KINASE-C; FACTOR TREATMENT DECREASES; 3T3 CELLS; HUMAN-FIBROBLASTS; SWISS-3T3 CELLS; PHORBOL ESTERS; EGF RECEPTOR; PHOSPHORYLATION; MODULATION; ACTIVATION	We have prepared plasma membranes from Balb/c 3T3 fibroblasts to study the transmodulation of the high affinity epidermal growth factor (EGF) receptor. Although phorbol esters do not transmodulate the high affinity EGF receptors on these membranes, the addition of platelet-derived growth factor (PDGF) or EGF to the membranes leads to the loss of high affinity EGF binding and to the phosphorylation of several membrane proteins, including the EGF receptor. The EGF receptor is phosphorylated at tyrosine residues although we have not yet established if this represents direct phosphorylation by the PDGF receptor kinase or is mediated by activation of other cell membrane-associated tyrosine kinases. Upon treatment of the membranes with PDGF, four major phosphoproteins (of apparent molecular masses of 69, 56, 38, and 28 kDa) are released from the membrane and can be retrieved from the supernatant fluid using a reversed-phase cartridge. As assessed by immunoprecipitation with an anti-phosphotyrosine antibody, all four proteins appear to be phosphorylated on tyrosine. The time course of dissociation of these proteins from the membranes closely parallels the loss of high affinity EGF receptors. The high affinity EGF receptor can be reconstituted on PDGF-transmodulated membranes by treating the supernatant fluid with alkaline phosphatase and adding the mixture to the membranes. It appears that dephosphorylation of the released proteins is sufficient to allow reassociation with the membranes and formation of the high affinity EGF receptor complex.	LUDWIG INST CANC RES,MELBOURNE TUMOUR BIOL BRANCH,MELBOURNE,VIC 3050,AUSTRALIA	Ludwig Institute for Cancer Research								BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BONISCHNETZLER M, 1987, P NATL ACAD SCI USA, V84, P7832, DOI 10.1073/pnas.84.22.7832; BOWENPOPE DF, 1983, J CELL BIOL, V96, P679, DOI 10.1083/jcb.96.3.679; COLLINS MKL, 1983, J BIOL CHEM, V258, P1689; COUGHLIN SR, 1989, SCIENCE, V243, P1191; COUNTAWAY JL, 1989, J BIOL CHEM, V264, P13642; COUNTAWAY JL, 1990, J BIOL CHEM, V265, P3407; DAVIS RJ, 1987, J BIOL CHEM, V262, P6832; DAVIS RJ, 1985, CANCER CELL, V3, P101; DECKER SJ, 1989, J BIOL CHEM, V264, P9204; FEARN JC, 1985, CELL, V40, P991, DOI 10.1016/0092-8674(85)90359-9; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; GRAY GM, 1988, J BIOL CHEM, V263, P10714; HOSOI K, 1989, P NATL ACAD SCI USA, V86, P4510, DOI 10.1073/pnas.86.12.4510; HUNTER T, 1984, NATURE, V311, P480, DOI 10.1038/311480a0; KARASAKI Y, 1989, J BIOL CHEM, V264, P6158; LEE LS, 1978, SCIENCE, V202, P313, DOI 10.1126/science.308698; MARGOLIS B, 1990, MOL CELL BIOL, V10, P435, DOI 10.1128/MCB.10.2.435; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; MULDOON LL, 1987, J CELL PHYSIOL, V130, P29, DOI 10.1002/jcp.1041300106; MUNSON, 1981, USERS GUIDE LIGAND P; NORTHWOOD IC, 1989, J BIOL CHEM, V264, P5746; OLASHAW NE, 1986, P NATL ACAD SCI USA, V83, P3834, DOI 10.1073/pnas.83.11.3834; PLEDGER WJ, 1977, P NATL ACAD SCI USA, V74, P4481, DOI 10.1073/pnas.74.10.4481; ROZENGURT E, 1983, P NATL ACAD SCI-BIOL, V80, P7244, DOI 10.1073/pnas.80.23.7244; SHOYAB M, 1981, ARCH BIOCHEM BIOPHYS, V206, P222, DOI 10.1016/0003-9861(81)90084-9; WALKER F, 1985, CELL, V43, P269, DOI 10.1016/0092-8674(85)90032-7; WALKER F, 1988, BIOCHEM J, V256, P109, DOI 10.1042/bj2560109; WASILENKO WJ, 1990, MOL CELL BIOL, V10, P1254, DOI 10.1128/MCB.10.3.1254; WHARTON W, 1982, P NATL ACAD SCI-BIOL, V79, P5567, DOI 10.1073/pnas.79.18.5567; WILEY HS, 1989, J BIOL CHEM, V264, P18912; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034; ZACHARY I, 1985, CANCER SURV, V4, P729	33	41	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2746	2752						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993654				2022-12-25	WOS:A1991EX60000014
J	THOMAS, NSB; BURKE, LC; BYBEE, A; LINCH, DC				THOMAS, NSB; BURKE, LC; BYBEE, A; LINCH, DC			THE PHOSPHORYLATION STATE OF THE RETINOBLASTOMA (RB) PROTEIN IN G0 G1 IS DEPENDENT ON GROWTH STATUS	ONCOGENE			English	Article							SUSCEPTIBILITY GENE-PRODUCT; CELL-CYCLE; OSTEO-SARCOMA; EXPRESSION; DIFFERENTIATION; PROLIFERATION; INTERFERON; SEQUENCE; MITOSIS; KINASE	The product of the retinoblastoma gene (RB) is a nuclear phosphoprotein which is thought to regulate the proliferation of cells. Its phosphorylation state changes with passage through the cell cycle and it has been proposed that RB protein in its hypo-phosphorylated form prevents cells proliferating. We have investigated the phosphorylation state of the RB protein in an actively-dividing human B-lymphoblastoid cell line and after cell cycle arrest caused by alpha-Interferon (alpha-IFN). We show that the phosphorylation state of the RB protein in cells with 2N DNA content depends on whether the cells are actively cycling. Our data is compatible with the proposal that dephosphorylation of the RB protein allows cells to enter a quiescent state. This study sheds light on the molecular mechanisms which may mediate the cytostatic effects of alpha-IFN.			THOMAS, NSB (corresponding author), UNIV COLL & MIDDLESEX SCH MED,DEPT HAEMATOL,98 CHENIES MEWS,LONDON WC1E 6HX,ENGLAND.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BOOKSTEIN R, 1989, MOL CELL BIOL, V9, P1628, DOI 10.1128/MCB.9.4.1628; BUCHKOVICH K, 1989, CELL, V58, P1097, DOI 10.1016/0092-8674(89)90508-4; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; CLEMENS MJ, 1985, BIOCHEM J, V226, P345, DOI 10.1042/bj2260345; COOPER JA, 1989, CELL, V58, P1009, DOI 10.1016/0092-8674(89)90495-9; DARZYNKIEWICZ Z, 1982, J CELL PHYSIOL, V113, P465, DOI 10.1002/jcp.1041130316; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DECAPRIO JA, 1989, CELL, V58, P1085, DOI 10.1016/0092-8674(89)90507-2; DRYJA TP, 1986, P NATL ACAD SCI USA, V83, P7391, DOI 10.1073/pnas.83.19.7391; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; GERDES J, 1984, J IMMUNOL, V133, P1710; HARBOUR JW, 1988, SCIENCE, V241, P353, DOI 10.1126/science.2838909; HOROWITZ JM, 1989, SCIENCE, V243, P937, DOI 10.1126/science.2521957; KLEIN G, 1987, SCIENCE, V238, P1539, DOI 10.1126/science.3317834; LEE EYHP, 1988, SCIENCE, V241, P218, DOI 10.1126/science.3388033; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; LEE WH, 1988, J CELL BIOCHEM, V38, P213, DOI 10.1002/jcb.240380309; LUDLOW JW, 1990, CELL, V60, P387, DOI 10.1016/0092-8674(90)90590-B; MASON DY, 1975, BRIT J HAEMATOL, V31, P361, DOI 10.1111/j.1365-2141.1975.tb00867.x; MCGEE TL, 1989, GENE, V80, P119, DOI 10.1016/0378-1119(89)90256-4; MIHARA K, 1989, SCIENCE, V246, P1300, DOI 10.1126/science.2588006; NURSE P, 1976, MOL GEN GENET, V146, P167, DOI 10.1007/BF00268085; SHENOY S, 1989, CELL, V57, P763, DOI 10.1016/0092-8674(89)90791-5; SILVERMAN RH, 1982, EUR J BIOCHEM, V126, P333; TANG A, 1989, ONCOGENE, V4, P401; TAYA Y, 1989, BIOCHEM BIOPH RES CO, V164, P580, DOI 10.1016/0006-291X(89)91759-2; THOMAS NSB, 1989, J BIOL CHEM, V264, P13697; TOGUCHIDA J, 1989, NATURE, V338, P156, DOI 10.1038/338156a0; VARLEY JM, 1989, ONCOGENE, V4, P725; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; XU HJ, 1989, ONCOGENE, V4, P807; YOKOTA J, 1988, ONCOGENE, V3, P471	35	42	43	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1991	6	2					317	322						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ134	2000225				2022-12-25	WOS:A1991FZ13400019
J	ALSTON, K; ROBINSON, RC; PARK, SS; GELBOIN, HV; FRIEDMAN, FK				ALSTON, K; ROBINSON, RC; PARK, SS; GELBOIN, HV; FRIEDMAN, FK			INTERACTIONS AMONG CYTOCHROMES-P-450 IN THE ENDOPLASMIC-RETICULUM - DETECTION OF CHEMICALLY CROSS-LINKED COMPLEXES WITH MONOCLONAL-ANTIBODIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MICROSOMES; CYTOCHROME-P-450; METABOLISM; LINKING; P-450; PURIFICATION; ENZYMES; FORMS; SEX	The quaternary structure of rat liver cytochrome P-450 within microsomal membranes from 3-methylcholanthrene-treated rats was examined by a novel chemical cross-linking-monoclonal antibody approach. Complex formation among the different forms of P-450 was probed by cross-linking of membrane proteins followed by immunopurification with a monoclonal antibody (mAb) to P-450c, the major 3-methylcholanthrene-inducible form. Subsequent immunoblot analysis of the immunopurified proteins with this mAb indicated that P-450c formed complexes with other microsomal proteins. Immunoblots with mAbs to different P-450s were carried out to identify the P-450s that were cross-linked to P-450c. This approach detected specific cross-linking of P-450c to P-450 2a. Immunoinhibition experiments suggest that P-450 2a further metabolizes the primary phenols produced by P-450c-catalyzed hydroxylation of benzo[alpha]pyrene. Complex formation among membrane-bound enzymes has implications for their catalytic efficiency and an approach combining cross-linking and monoclonal antibody-based characterization of cross-linked proteins will be useful for elucidating such membrane protein macrostructures.	NCI, MOLEC CARCINOGENESIS LAB, BLDG 37, RM 3E24, BETHESDA, MD 20892 USA; BENEDICT COLL, DEPT CHEM, COLUMBIA, SC 29204 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Benedict College			Friedman, Fred K/D-4208-2016	Friedman, Fred/0000-0002-0284-7067	NATIONAL CENTER FOR RESEARCH RESOURCES [R03RR008112] Funding Source: NIH RePORTER; NCRR NIH HHS [CRR08112] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ADESNIK M, 1986, CRIT REV BIOCHEM MOL, V19, P247, DOI 10.3109/10409238609084657; BASKIN LS, 1982, BIOCHEM BIOPH RES CO, V108, P700, DOI 10.1016/0006-291X(82)90886-5; BASKIN LS, 1982, BIOCHIM BIOPHYS ACTA, V684, P263, DOI 10.1016/0005-2736(82)90015-3; BAYLEY H, 1983, PHOTOGENERATED REAGE, P11; CAPDEVILA J, 1978, BIOCHEM BIOPH RES CO, V82, P518, DOI 10.1016/0006-291X(78)90905-1; CAPDEVILA J, 1980, GENETIC ENV FACTORS, P45; CHENG KC, 1986, BIOCHEMISTRY-US, V25, P2397, DOI 10.1021/bi00357a015; CHENG KC, 1984, J BIOL CHEM, V259, P2279; DAS M, 1979, ANNU REV BIOPHYS BIO, V8, P165, DOI 10.1146/annurev.bb.08.060179.001121; de Montellano P. R. Ortiz, 1986, CYTOCHROME P 450 STR; GELBOIN HV, 1980, PHYSIOL REV, V60, P1107, DOI 10.1152/physrev.1980.60.4.1107; GONZALEZ FJ, 1988, PHARMACOL REV, V40, P243; GONZALEZ FJ, 1986, MOL CELL BIOL, V6, P2969, DOI 10.1128/MCB.6.8.2969; GUSTAFSSON JA, 1983, ANNU REV PHYSIOL, V45, P51, DOI 10.1146/annurev.ph.45.030183.000411; INGLEMANSUNDBER.M, 1986, CYTOCHROME P450, P119; KO IY, 1987, CANCER RES, V47, P3101; LU AYH, 1972, BIOCHEM BIOPH RES CO, V46, P1334, DOI 10.1016/S0006-291X(72)80121-9; LU AYH, 1979, PHARMACOL REV, V31, P277; MCINTOSH PR, 1979, FEBS LETT, V105, P217, DOI 10.1016/0014-5793(79)80615-8; MCINTOSH PR, 1980, BIOCHEM J, V187, P227, DOI 10.1042/bj1870227; MYERS MJ, 1990, BIOCHEM BIOPH RES CO, V169, P171, DOI 10.1016/0006-291X(90)91450-7; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.biochem.56.1.945; NEBERT DW, 1968, J BIOL CHEM, V243, P6242; PARK SS, 1986, BIOCHEM PHARMACOL, V35, P2859, DOI 10.1016/0006-2952(86)90477-6; PARK SS, 1982, CANCER RES, V42, P1798; PETERS K, 1977, ANNU REV BIOCHEM, V46, P523, DOI 10.1146/annurev.bi.46.070177.002515; PROUGH RA, 1981, ARCH BIOCHEM BIOPHYS, V212, P136, DOI 10.1016/0003-9861(81)90352-0; RIBIERO O, 1985, CARCINOGENESIS, V10, P1507; SHEETS JJ, 1985, BIOCHEMISTRY-US, V24, P6591, DOI 10.1021/bi00344a043; SRIVASTAVA DK, 1986, CURR TOP CELL REGUL, V28, P1; SRIVASTAVA DK, 1986, SCIENCE, V234, P1081, DOI 10.1126/science.3775377; STANKER LH, 1985, J IMMUNOL METHODS, V76, P157, DOI 10.1016/0022-1759(85)90488-0; THOMAS PE, 1981, J BIOL CHEM, V256, P1044; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WAXMAN DJ, 1988, BIOCHEM PHARMACOL, V37, P71, DOI 10.1016/0006-2952(88)90756-3; WIEBEL FJ, 1975, ARCH BIOCHEM BIOPHYS, V168, P609, DOI 10.1016/0003-9861(75)90293-3; YIP YK, 1972, J BIOL CHEM, V247, P7237	37	61	62	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					735	739						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985961				2022-12-25	WOS:A1991ET17700012
J	INOUE, S; KOGAKI, H; IKEDA, K; SAMEJIMA, Y; OMORISATOH, T				INOUE, S; KOGAKI, H; IKEDA, K; SAMEJIMA, Y; OMORISATOH, T			AMINO-ACID-SEQUENCES OF THE 2 SUBUNITS OF A PHOSPHOLIPASE-A2 INHIBITOR FROM THE BLOOD-PLASMA OF TRIMERESURUS-FLAVOVIRIDIS - SEQUENCE HOMOLOGIES WITH PULMONARY SURFACTANT APOPROTEIN AND ANIMAL LECTINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION DOMAINS; RABBIT NEUTROPHILS; BINDING PROTEINS; II CELLS; CDNA; GLUCOCORTICOIDS; LIPOCORTIN; RECEPTOR; CLONING	Phospholipase A2 inhibitor (PLI), purified from the blood plasma of the Habu snake (Trimeresurus flavoviridis), was separated into two distinct subunits, PLI-A and PLI-B. These subunits were shown to be glycoproteins with molecular weights of around 21,000-22,000. When they were deglycosylated chemically with trifluoromethanesulfonic acid, the molecular weights were found to be 17,000. Their amino acid sequences were determined by alignment of peptides obtained by lysyl endopeptidase digestion and Staphylococcus aureus V8 protease digestion. PLI-A and PLI-B were each composed of 147 amino acid residues with one residue, Asn103, being for N-linked glycosylation, and the molecular weights of their protein portions were calculated to be 16,368 and 16,408, respectively. Each subunit contained four cysteine residues, all of which exist in disulfide linkages (Cys64-Cys141 and Cys119-Cys133). The sequences of PLI-A and PLI-B showed 89.8% homology to each other. When the sequences were compared with those of lipocortins, no significant homologies were detected. But the sequences were significantly homologous to those of COOH-terminal carbohydrate recognition portions of pulmonary surfactant apoprotein and animal lectins.	OSAKA UNIV,FAC SCI,DEPT BIOL,TOYONAKA,OSAKA 560,JAPAN; HOSHI UNIV,FAC PHARM,DEPT HYG CHEM,SHINAGAWA KU,TOKYO 142,JAPAN; NATL INST HLTH,DEPT APPL IMMUNOL,TOKYO 141,JAPAN	Osaka University; Hoshi University; National Institute of Health Sciences - Japan	INOUE, S (corresponding author), OSAKA UNIV PHARMACEUT SCI,DEPT BIOCHEM,MATSUBARA,OSAKA 580,JAPAN.		Inoue, Seiji/E-5128-2010	Inoue, Seiji/0000-0003-0760-1047				AARSMAN AJ, 1987, FEBS LETT, V219, P176, DOI 10.1016/0014-5793(87)81212-7; BLACKWELL GJ, 1980, NATURE, V287, P147, DOI 10.1038/287147a0; CAVINS JF, 1970, ANAL BIOCHEM, V35, P489, DOI 10.1016/0003-2697(70)90211-3; DAVIDSON FF, 1987, J BIOL CHEM, V262, P1698; Di Rosa M, 1984, Prostaglandins, V28, P441, DOI 10.1016/0090-6980(84)90232-6; DOBBS LG, 1987, P NATL ACAD SCI USA, V84, P1010, DOI 10.1073/pnas.84.4.1010; DOEGE K, 1987, J BIOL CHEM, V262, P17757; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; DRICKAMER K, 1986, J BIOL CHEM, V261, P6878; EDGE ASB, 1981, ANAL BIOCHEM, V118, P131, DOI 10.1016/0003-2697(81)90168-8; GEISOW MJ, 1986, TRENDS BIOCHEM SCI, V11, P420, DOI 10.1016/0968-0004(86)90176-3; Goerke J., 1986, HDB PHYSL RESP SYSTE, P247; HALBERG DF, 1987, J BIOL CHEM, V262, P9828; Hayashi R, 1977, Methods Enzymol, V47, P84; HIRATA F, 1980, P NATL ACAD SCI-BIOL, V77, P2533, DOI 10.1073/pnas.77.5.2533; HIRATA F, 1981, J BIOL CHEM, V256, P7730; HOYLE GW, 1988, J BIOL CHEM, V263, P7847; IKUTA K, 1987, P NATL ACAD SCI USA, V84, P819, DOI 10.1073/pnas.84.3.819; KOGAKI H, 1989, J BIOCHEM-TOKYO, V106, P966, DOI 10.1093/oxfordjournals.jbchem.a122983; KRUSIUS T, 1987, J BIOL CHEM, V262, P13120; LUDEN C, 1987, EMBO J, V6, P109; ROSS GF, 1986, J BIOL CHEM, V261, P14283; TAKAHASHI H, 1985, J BIOL CHEM, V260, P2228; TANAKA S, 1986, J BIOCHEM-TOKYO, V99, P281, DOI 10.1093/oxfordjournals.jbchem.a135471; WALLNER BP, 1986, NATURE, V320, P77, DOI 10.1038/320077a0; WHITE RT, 1985, NATURE, V317, P361, DOI 10.1038/317361a0; WILBUR WJ, 1983, P NATL ACAD SCI-BIOL, V80, P726, DOI 10.1073/pnas.80.3.726; WRIGHT JR, 1987, J BIOL CHEM, V262, P2888	28	84	86	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1001	1007						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985928				2022-12-25	WOS:A1991ET17700053
J	RAMAKRISHNAN, V; GERCHMAN, SE				RAMAKRISHNAN, V; GERCHMAN, SE			CLONING, SEQUENCING, AND OVEREXPRESSION OF GENES FOR RIBOSOMAL-PROTEINS FROM BACILLUS-STEAROTHERMOPHILUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCES; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; LARGE SUBUNIT; CRYSTALLIZATION; RNA; POLYMERASE; INITIATION; EXPRESSION; MODEL	Although a low resolution model for the arrangement of the proteins of the small and large ribosomal subunits is known, a detailed mechanistic understanding of the function of the ribosome awaits a high resolution structure of its components. While crystals have been obtained of several ribosomal proteins from Bacillus stearothermophilus, determination of atomic resolution structures of these proteins is impeded by the difficulty of obtaining large amounts of native proteins for crystallographic or NMR studies. We describe here the cloning and overexpression in Escherichia coli of the genes for ribosomal proteins S5, L6, L9, and L18 from B. stearothermophilus. S5 is extremely toxic to E. coli when overexpressed, and we have taken advantage of a new tightly regulated expression system to obtain high yields (more than 100 mg of pure protein/liter of culture) of this protein. The B. stearothermophilus S5 produced in E. coli crystallizes, and the crystals are identical to those obtained from the native protein. The crystals diffract to 2-angstrom resolution.			RAMAKRISHNAN, V (corresponding author), BROOKHAVEN NATL LAB,DEPT BIOL,UPTON,NY 11973, USA.			Ramakrishnan, V/0000-0002-4699-2194				APPELT K, 1983, J BIOL CHEM, V258, P3328; APPELT K, 1981, J BIOL CHEM, V256, P1787; APPELT K, 1983, FEBS LETT, V160, P75, DOI 10.1016/0014-5793(83)80939-9; APPELT K, 1979, FEBS LETT, V103, P66, DOI 10.1016/0014-5793(79)81251-X; BLUNDELL TL, 1976, PROTEIN CRYSTALLOGRA, P191; BROMBACH M, 1986, MOL GEN GENET, V205, P97, DOI 10.1007/BF02428037; CAPEL MS, 1987, SCIENCE, V238, P1403, DOI 10.1126/science.3317832; CHAMBLISS G, 1980, RIBOSOMES STRUCTURE; Dijk J, 1979, Methods Enzymol, V59, P481; GIBBS RA, 1990, ANAL CHEM, V62, P1202, DOI 10.1021/ac00212a004; Hardesty B., 1986, STRUCTURE FUNCTION G; HELD WA, 1974, BIOCHEMISTRY-US, V13, P2115, DOI 10.1021/bi00707a019; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HIGO K, 1973, P NATL ACAD SCI USA, V70, P944, DOI 10.1073/pnas.70.3.944; KIME MJ, 1980, EUR J BIOCHEM, V110, P493, DOI 10.1111/j.1432-1033.1980.tb04891.x; KIMURA J, 1987, FEBS LETT, V210, P85, DOI 10.1016/0014-5793(87)81303-0; KIMURA M, 1984, J BIOL CHEM, V259, P1051; KIMURA M, 1981, FEBS LETT, V136, P58, DOI 10.1016/0014-5793(81)81213-6; KIMURA M, 1980, FEBS LETT, V121, P323, DOI 10.1016/0014-5793(80)80373-5; LEE CC, 1988, SCIENCE, V239, P1288, DOI 10.1126/science.3344434; LEIJONMARCK M, 1980, NATURE, V286, P824, DOI 10.1038/286824a0; LITTLECHILD JA, 1978, BIOCHEMISTRY-US, V17, P3363, DOI 10.1021/bi00609a029; MESSERSCHMIDT A, 1987, J APPL CRYSTALLOGR, V20, P306, DOI 10.1107/S002188988708662X; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; OAKES M, 1986, STRUCTURE FUNCTION G, P47; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LABORATO; SCHULER D, 1988, EMBO J, V7, P1509, DOI 10.1002/j.1460-2075.1988.tb02970.x; STERN S, 1988, J MOL BIOL, V204, P447, DOI 10.1016/0022-2836(88)90588-8; STOFFLER G, 1986, STRUCTURE FUNCTION G, P28; STUDIER FW, 1990, METHOD ENZYMOL, V185, P61; WALLECZEK J, 1988, EMBO J, V7, P3571, DOI 10.1002/j.1460-2075.1988.tb03234.x; WILSON KS, 1986, P NATL ACAD SCI USA, V83, P7251, DOI 10.1073/pnas.83.19.7251; YONATH A, 1986, STRUCTURE FUNCTION G, P112	37	40	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					880	885						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985969				2022-12-25	WOS:A1991ET17700034
J	LORENZ, U; SOCK, E; GRUMMT, F; MOELLING, K				LORENZ, U; SOCK, E; GRUMMT, F; MOELLING, K			ANALYSIS OF DNA-SEQUENCES PRESENT IN COMPLEXES OF V-MYC AND CELLULAR DNA	ONCOGENE			English	Article							AVIAN MYELOCYTOMATOSIS VIRUS; TRANSCRIPTIONAL ENHANCER; TRANSFORMING ABILITY; GENE-PRODUCT; MOUSE CELLS; REPLICATION; LOCALIZATION; ONCOGENE; PROTEIN; BINDING	We have isolated cellular DNA sequences from the myelocytomatosis virus-transformed quail fibroblastic cell-line (MC29-Q8) by indirect immunoprecipitation of v-Myc-DNA complexes and subsequent cloning of the DNA. The v-Myc-DNA complexes were obtained from isolated nuclei pretreated with 150 mM salt and indirect immunoprecipitation of the p110 Gag-Myc protein with the IgG of a Gag-specific monoclonal antibody. A non-specific monoclonal IgG was used as control to account for non-specific interactions. The DNA from the precipitates was isolated, cloned and characterized. 21 positive and 13 control clones with inserts ranging in size from 25 to 330 nucleotides were sequenced and analysed for sequence homologies to known DNA-motives. Some of the sequences over-represented in the specific DNA fragments corresponded to elements which have been previously described to promote DNA amplification. Six of these DNA fragments were tested for their ability to promote DNA amplification by insertion into a plasmid containing the HSV-1 tk gene with a truncated promoter. These constructs were transfected into mouse Ltk- cells which grow under HAT selection only upon amplification of the tk-carrying plasmids. Two of the six DNA fragments showed the capability to amplify their plasmids in cis and create stable cellular clones. Copy numbers of the amplified plasmids in these Ltk+ clones ranged from 470 to 680 whereby the amplified sequences were integrated as large clusters of head-to-tail tandems. The data presented here suggest that the Myc protein may be involved in DNA amplification and therefore may play a role in DNA replication.	MAX PLANCK INST MOLEC GENET,ABT SCHUSTER,IHNESTR 73,W-1000 BERLIN 33,GERMANY; UNIV WURZBURG,INST BIOCHEM,W-8700 WURZBURG,GERMANY	Max Planck Society; University of Wurzburg				Sock, Elisabeth/0000-0001-9925-3136; Lorenz, Ulrike/0000-0002-7933-6855				ARIGA H, 1989, EMBO J, V8, P4273, DOI 10.1002/j.1460-2075.1989.tb08613.x; BADER JP, 1985, J VIROL, V53, P509, DOI 10.1128/JVI.53.2.509-514.1985; BATTEY J, 1983, CELL, V34, P779, DOI 10.1016/0092-8674(83)90534-2; BEIMLING P, 1985, BIOCHEMISTRY-US, V24, P6349, DOI 10.1021/bi00344a005; BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; BROACH JR, 1982, COLD SPRING HARB SYM, V47, P1165, DOI 10.1101/SQB.1983.047.01.132; CHURCHILL MEA, 1989, EMBO J, V8, P4189, DOI 10.1002/j.1460-2075.1989.tb08604.x; CLASSON M, 1987, NATURE, V330, P272, DOI 10.1038/330272a0; COLE MD, 1986, ANNU REV GENET, V20, P361, DOI 10.1146/annurev.ge.20.120186.002045; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; DANG CV, 1989, NATURE, V337, P664, DOI 10.1038/337664a0; DELUCIA AL, 1983, J VIROL, V46, P143, DOI 10.1128/JVI.46.1.143-150.1983; DMITROVSKY E, 1986, NATURE, V322, P748, DOI 10.1038/322748a0; DONNER P, 1983, P NATL ACAD SCI-BIOL, V80, P2861, DOI 10.1073/pnas.80.10.2861; DONNER P, 1982, NATURE, V296, P262, DOI 10.1038/296262a0; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GREISERWILKE I, 1981, J VIROL, V39, P325, DOI 10.1128/JVI.39.1.325-329.1981; HANN SR, 1983, CELL, V34, P789, DOI 10.1016/0092-8674(83)90535-4; HOLST A, 1988, CELL, V52, P355; HOLST A, 1989, CELL, V56, P143; IGUCHIARIGA SMM, 1987, EMBO J, V6, P2365, DOI 10.1002/j.1460-2075.1987.tb02513.x; IGUCHIARIGA SMM, 1988, EMBO J, V7, P3135, DOI 10.1002/j.1460-2075.1988.tb03180.x; IGUCHIARIGA SMM, 1987, NUCLEIC ACIDS RES, V15, P4889, DOI 10.1093/nar/15.12.4889; LACHMAN HM, 1986, P NATL ACAD SCI USA, V83, P6480, DOI 10.1073/pnas.83.17.6480; LAIMINS LA, 1984, J VIROL, V49, P183, DOI 10.1128/JVI.49.1.183-189.1984; LECH K, 1988, CELL, V52, P179, DOI 10.1016/0092-8674(88)90506-5; Maniatis T., 1982, MOL CLONING; RAMSAY G, 1980, NATURE, V288, P170, DOI 10.1038/288170a0; RAMSAY G, 1982, EMBO J, V1, P1111, DOI 10.1002/j.1460-2075.1982.tb01305.x; RAMSAY G, 1984, P NATL ACAD SCI-BIOL, V81, P7742, DOI 10.1073/pnas.81.24.7742; RAMSAY GM, 1982, J VIROL, V41, P745, DOI 10.1128/JVI.41.3.745-753.1982; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIH CK, 1984, P NATL ACAD SCI-BIOL, V81, P4697, DOI 10.1073/pnas.81.15.4697; Stinchcomb D. T, 1981, INITIATION DNA REPLI, P473, DOI 10.1016/b978-0-12-583580-0.50036-4; VARMUS HE, 1987, MOL BASIS BLOOD DISE, P271; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WEGNER M, 1989, NUCLEIC ACIDS RES, V17, P9909, DOI 10.1093/nar/17.23.9909; WEGNER M, 1989, NUCLEIC ACIDS RES, V17, P8783, DOI 10.1093/nar/17.21.8783; ZASTROW G, 1989, NUCLEIC ACIDS RES, V17, P1867, DOI 10.1093/nar/17.5.1867	41	4	4	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1991	6	1					51	57						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY039	1992445				2022-12-25	WOS:A1991EY03900007
J	THORPE, DS; MORKIN, E				THORPE, DS; MORKIN, E			THE CARBOXYL REGION CONTAINS THE CATALYTIC DOMAIN OF THE MEMBRANE FORM OF GUANYLATE-CYCLASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note									UNIV ARIZONA,COLL MED,DEPT PHARMACOL,TUCSON,AZ 85724; UNIV ARIZONA,COLL MED,DEPT INTERNAL MED,TUCSON,AZ 85724	University of Arizona; University of Arizona	THORPE, DS (corresponding author), UNIV ARIZONA,COLL MED,UNIV HEART CTR,TUCSON,AZ 85724, USA.				NHLBI NIH HHS [HL-20984] Funding Source: Medline; NIGMS NIH HHS [GM07533-12] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020984] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHANG M, 1989, NATURE, V341, P68, DOI 10.1038/341068a0; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; CHINKERS M, 1989, SCIENCE, V245, P1392, DOI 10.1126/science.2571188; CHRISMAN TD, 1975, J BIOL CHEM, V250, P374; GARBERS DL, 1975, ARCH BIOCHEM BIOPHYS, V166, P135, DOI 10.1016/0003-9861(75)90372-0; HAMET P, 1984, BIOCHEM BIOPH RES CO, V123, P515, DOI 10.1016/0006-291X(84)90260-2; KATAOKA T, 1985, CELL, V43, P493, DOI 10.1016/0092-8674(85)90179-5; KIMURA H, 1974, J BIOL CHEM, V249, P6910; KOESLING D, 1988, FEBS LETT, V239, P29, DOI 10.1016/0014-5793(88)80539-8; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWE DG, 1989, EMBO J, V8, P1377, DOI 10.1002/j.1460-2075.1989.tb03518.x; MITTAL CK, 1977, J BIOL CHEM, V252, P3136; NAKANE M, 1988, BIOCHEM BIOPH RES CO, V157, P1139, DOI 10.1016/S0006-291X(88)80992-6; RUSSEL M, 1984, J BACTERIOL, V159, P1034, DOI 10.1128/JB.159.3.1034-1039.1984; SCHULZ S, 1989, CELL, V58, P1155, DOI 10.1016/0092-8674(89)90513-8; SENTER PD, 1983, J BIOL CHEM, V258, P6741; SINGH S, 1988, NATURE, V334, P708, DOI 10.1038/334708a0; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; THORPE DS, 1989, J BIOL CHEM, V264, P6545; WALDMAN SA, 1984, J BIOL CHEM, V259, P4332; WALDMAN SA, 1982, J CYCLIC NUCL PROT, V8, P359; WINQUIST RJ, 1984, P NATL ACAD SCI-BIOL, V81, P7661, DOI 10.1073/pnas.81.23.7661	25	59	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1990	265	25					14717	14720						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX400	1975586				2022-12-25	WOS:A1990DX40000006
J	CSERMELY, P; KAHN, CR				CSERMELY, P; KAHN, CR			THE 90-KDA HEAT-SHOCK PROTEIN (HSP-90) POSSESSES AN ATP BINDING-SITE AND AUTOPHOSPHORYLATING ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROUS-SARCOMA VIRUS; OVIDUCT PROGESTERONE-RECEPTOR; LIVER GLUCOCORTICOID RECEPTOR; 2 CELLULAR PHOSPHOPROTEINS; ESCHERICHIA-COLI; KINASE-ACTIVITY; TRANSFORMING PROTEINS; NUCLEOTIDE-BINDING; MAMMALIAN-CELLS; CHICKEN OVIDUCT	The 90-kDa heat shock protein (hsp-90) is an abundant cytosolic protein believed to play a role in maintenance of protein trafficking and closely associated with several steroid hormone receptors. Incubation of highly purified hsp-90 with [gamma-P-32]ATP results in its autophosphorylation on serine residues. There are several lines of evidence which suggest that this activity is due to a kinase intrinsic to hsp-90 rather than some closely associated protein kinases: 1) the phosphorylation persists after the removal of casein kinase II by heparin chromatography and after immunoprecipitation of hsp-90 with anti-hsp-90 antibodies. 2) The approximate k(M) for ATP of the reaction is 0.16 mM, higher than that of many other protein kinases. 3) Phosphorylation is not affected by a number of activators and inhibitors of other known kinases which might associate with hsp-90. 4) The phosphorylation displays a unique cation dependence being most active in the presence of Ca2+ and practically inactive with Mg2+, although the autophosphorylation in the presence of Mg2+ is activated by histones and polyamines. 5) The activity is remarkably heat-stable; incubation of hsp-90 for 20 min at 95-degrees-C results in only a 60% decrease in autophosphorylation. 6) Finally, and most importantly, purified hsp-90 can be labeled with azido-ATP and it is able to bind to ATP-agarose. The binding shows similar cation dependence to the autophosphorylation. These data are in agreement with the presence of a consensus sequence for ATP binding sites in the primary structure of the protein similar to that observed in the 70-kDa heat-shock proteins. Our data suggest the 90-kDa heat shock protein possesses an enzymatic activity analogous in many respects to the similar activity of the 70-kDa heat shock proteins. This may represent an important, previously unrecognized function of hsp-90.	JOSLIN DIABET CTR,DIV RES,1 JOSLIN PL,BOSTON,MA 02215; BRIGHAM & WOMENS HOSP,DEPT MED,BOSTON,MA 02115; HARVARD UNIV,SCH MED,BOSTON,MA 02215	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School			Csermely, Peter/J-2067-2017; Kahn, Ronald/AAY-2435-2021	Csermely, Peter/0000-0001-9234-0659; Kahn, Ronald/0000-0002-7583-9228	FIC NIH HHS [1F05 TW04319-01 B1-5] Funding Source: Medline; NIDDK NIH HHS [DK 33201, DK 36836] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [F05TW004319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, R01DK033201] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADKINS B, 1982, J VIROL, V43, P448, DOI 10.1128/JVI.43.2.448-455.1982; Anderson E. P., 1973, ENZYMES, P49; BARDWELL JCA, 1984, P NATL ACAD SCI-BIOL, V81, P848, DOI 10.1073/pnas.81.3.848; BAULIEU EE, 1987, J CELL BIOCHEM, V35, P161, DOI 10.1002/jcb.240350209; BOND JS, 1987, ANNU REV BIOCHEM, V56, P333, DOI 10.1146/annurev.bi.56.070187.002001; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUGGE J, 1983, MOL CELL BIOL, V3, P9, DOI 10.1128/MCB.3.1.9; BURDON RH, 1986, BIOCHEM J, V240, P313, DOI 10.1042/bj2400313; CARLSSON L, 1983, P NATL ACAD SCI-BIOL, V80, P4664, DOI 10.1073/pnas.80.15.4664; CEGIELSKA A, 1989, BIOCHIMIE, V71, P1071, DOI 10.1016/0300-9084(89)90113-2; CEIGELSKA A, 1989, J BIOL CHEM, V264, P21122; CHIN DT, 1988, J BIOL CHEM, V263, P11718; Colowick SP., 1973, ENZYMES, V9, P1, DOI DOI 10.1016/S1874-6047(08)60113-4; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; DALIE BL, 1990, BIOCHEM BIOPH RES CO, V166, P1284, DOI 10.1016/0006-291X(90)91005-D; DEVER TE, 1987, P NATL ACAD SCI USA, V84, P1814, DOI 10.1073/pnas.84.7.1814; DOUGHERTY JJ, 1987, BIOCHIM BIOPHYS ACTA, V927, P74, DOI 10.1016/0167-4889(87)90067-X; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; FUJITAKI JM, 1984, METHOD ENZYMOL, V107, P23; GARCIA T, 1986, BIOCHEMISTRY-US, V25, P7937, DOI 10.1021/bi00372a023; GARCIA T, 1983, BIOCHEM BIOPH RES CO, V113, P960, DOI 10.1016/0006-291X(83)91092-6; GASC JM, 1990, EXP CELL RES, V186, P362, DOI 10.1016/0014-4827(90)90317-4; HAPGOOD JP, 1986, BIOCHEMISTRY-US, V25, P7529, DOI 10.1021/bi00371a041; HARA T, 1981, FEBS LETT, V128, P33, DOI 10.1016/0014-5793(81)81072-1; HARDESTY B, 1989, BIOCHEM CELL BIOL, V67, P749, DOI 10.1139/o89-112; HATHAWAY GM, 1982, CURR TOP CELL REGUL, V21, P101; HUANG KP, 1986, J BIOL CHEM, V261, P2134; KOST SL, 1989, MOL CELL BIOL, V9, P3829, DOI 10.1128/MCB.9.9.3829; KOYASU S, 1986, P NATL ACAD SCI USA, V83, P8054, DOI 10.1073/pnas.83.21.8054; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEESMILLER SP, 1989, J BIOL CHEM, V264, P2431; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; LIPSICH LA, 1982, MOL CELL BIOL, V2, P875, DOI 10.1128/MCB.2.7.875; LYALL RM, 1989, J BIOL CHEM, V264, P14503; MILLERDIENER A, 1985, P NATL ACAD SCI USA, V82, P4003, DOI 10.1073/pnas.82.12.4003; MOORE SK, 1989, J BIOL CHEM, V264, P5343; NISHIDA E, 1986, J BIOL CHEM, V261, P6033; OMALLEY K, 1985, MOL CELL BIOL, V5, P3476, DOI 10.1128/MCB.5.12.3476; OPPERMANN H, 1981, P NATL ACAD SCI-BIOL, V78, P1067, DOI 10.1073/pnas.78.2.1067; RESCH MD, 1982, J BIOL CHEM, V257, P6978; ROSE DW, 1987, BIOCHEMISTRY-US, V26, P6583, DOI 10.1021/bi00395a003; SANCHEZ ER, 1986, BIOCHEMISTRY-US, V25, P1378, DOI 10.1021/bi00354a028; SANCHEZ ER, 1988, MOL ENDOCRINOL, V2, P756, DOI 10.1210/mend-2-8-756; SCOPES RK, 1973, ENZYMES, V8, P335; SHACTER E, 1984, ANAL BIOCHEM, V138, P416, DOI 10.1016/0003-2697(84)90831-5; SHIH TY, 1980, NATURE, V287, P686, DOI 10.1038/287686a0; SINGH VB, 1984, BIOCHEM BIOPH RES CO, V125, P1067, DOI 10.1016/0006-291X(84)91392-5; SUBJECK JR, 1986, AM J PHYSIOL, V250, pC1, DOI 10.1152/ajpcell.1986.250.1.C1; SULLIVAN WP, 1985, BIOCHEMISTRY-US, V24, P4214, DOI 10.1021/bi00336a060; SZYSZKA R, 1989, BIOCHEMISTRY-US, V28, P1435, DOI 10.1021/bi00430a001; THORNER JW, 1973, ENZYMES, V8, P487; TWINING SS, 1984, ANAL BIOCHEM, V143, P30, DOI 10.1016/0003-2697(84)90553-0; WALKER AI, 1985, EMBO J, V4, P139, DOI 10.1002/j.1460-2075.1985.tb02328.x; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Watts D. C., 1973, ENZYMES, V8, P384; YONEZAWA N, 1988, EUR J BIOCHEM, V177, P1, DOI 10.1111/j.1432-1033.1988.tb14337.x; ZIEMIECKI A, 1986, BIOCHEM BIOPH RES CO, V138, P1298, DOI 10.1016/S0006-291X(86)80424-7; ZYLICZ M, 1983, P NATL ACAD SCI-BIOL, V80, P6431, DOI 10.1073/pnas.80.21.6431	59	141	144	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4943	4950						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002041				2022-12-25	WOS:A1991FC21700043
J	ERIKSON, E; MALLER, JL				ERIKSON, E; MALLER, JL			PURIFICATION AND CHARACTERIZATION OF RIBOSOMAL PROTEIN-S6 KINASE-I FROM XENOPUS EGGS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWISS 3T3 CELLS; ACTIVATED S6 KINASE; PHORBOL ESTER; INSULIN; PHOSPHORYLATION; OOCYTES; SERUM; IDENTIFICATION; PHOSPHATASE-2A; MATURATION	Ribosomal protein S6 kinase I has been purified from unfertilized Xenopus eggs to near homogeneity as a M(r) = 90,000 protein. S6 kinase I is phosphorylated when activated in vivo and can be phosphorylated by mitogen-activated protein kinase in vitro. The purified enzyme is inactivated upon treatment with protein phosphatase 2A. Immunological data and analysis of substrate specificity demonstrate that S6 kinase I is related to, but distinct from, the previously characterized S6 kinase II. Both enzymes are members of the ribosomal protein S6 kinase (rsk) gene family.	UNIV COLORADO,SCH MED,HOWARD HUGHES MED INST,DENVER,CO 80262	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	ERIKSON, E (corresponding author), UNIV COLORADO,SCH MED,DEPT PHARMACOL,DENVER,CO 80262, USA.				NIDDK NIH HHS [DK28353] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028353] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALCORTA DA, 1989, MOL CELL BIOL, V9, P3850, DOI 10.1128/MCB.9.9.3850; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; BALLOU LM, 1988, J BIOL CHEM, V263, P1188; BALLOU LM, 1988, P NATL ACAD SCI USA, V85, P7154, DOI 10.1073/pnas.85.19.7154; BANERJEE P, 1990, P NATL ACAD SCI USA, V87, P8550, DOI 10.1073/pnas.87.21.8550; BLENIS J, 1985, P NATL ACAD SCI USA, V82, P7621, DOI 10.1073/pnas.82.22.7621; BLENIS J, 1987, J BIOL CHEM, V262, P14373; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN RH, 1990, MOL CELL BIOL, V10, P3204, DOI 10.1128/MCB.10.6.3204; CICIRELLI MF, 1988, J BIOL CHEM, V263, P2009; DUNCAN R, 1982, EUR J BIOCHEM, V123, P535; ERIKSON E, 1986, J BIOL CHEM, V261, P350; ERIKSON E, 1987, MOL CELL BIOL, V7, P3147, DOI 10.1128/MCB.7.9.3147; ERIKSON E, 1989, J BIOL CHEM, V264, P13711; ERIKSON E, 1977, VIROLOGY, V80, P177, DOI 10.1016/0042-6822(77)90390-7; ERIKSON E, 1991, IN PRESS METHODS ENZ; FLOCKHART DA, 1982, CRC CR REV BIOCH MOL, V12, P133, DOI 10.3109/10409238209108705; GLASS DB, 1978, ANAL BIOCHEM, V87, P566, DOI 10.1016/0003-2697(78)90707-8; GREGORY JS, 1989, J BIOL CHEM, V264, P18397; JENO P, 1989, J BIOL CHEM, V264, P1293; JENO P, 1988, P NATL ACAD SCI USA, V85, P406, DOI 10.1073/pnas.85.2.406; Johnson R A, 1979, Adv Cyclic Nucleotide Res, V10, P135; JONES SW, 1988, P NATL ACAD SCI USA, V85, P3377, DOI 10.1073/pnas.85.10.3377; KOZMA SC, 1990, P NATL ACAD SCI USA, V87, P7365, DOI 10.1073/pnas.87.19.7365; MALLER JL, 1990, BIOCHEMISTRY-US, V29, P3157, DOI 10.1021/bi00465a001; MARTINPEREZ J, 1986, EMBO J, V5, P725, DOI 10.1002/j.1460-2075.1986.tb04274.x; NOVAKHOFER I, 1984, J BIOL CHEM, V259, P5995; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; PELECH SL, 1986, P NATL ACAD SCI USA, V83, P5968, DOI 10.1073/pnas.83.16.5968; PRICE DJ, 1989, J BIOL CHEM, V264, P13825; PRICE DJ, 1990, P NATL ACAD SCI USA, V87, P7944, DOI 10.1073/pnas.87.20.7944; STEFANOVIC D, 1986, EMBO J, V5, P157, DOI 10.1002/j.1460-2075.1986.tb04190.x; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; SWEET LJ, 1990, MOL CELL BIOL, V10, P2787, DOI 10.1128/MCB.10.6.2787; SWEET LJ, 1990, MOL CELL BIOL, V10, P2413, DOI 10.1128/MCB.10.5.2413; TABARINI D, 1985, P NATL ACAD SCI USA, V82, P4369, DOI 10.1073/pnas.82.13.4369; TABARINI D, 1987, BIOCHEM BIOPH RES CO, V144, P891, DOI 10.1016/S0006-291X(87)80048-7; THOMAS G, 1982, CELL, V30, P235, DOI 10.1016/0092-8674(82)90029-0; TUNG HYL, 1984, EUR J BIOCHEM, V138, P635, DOI 10.1111/j.1432-1033.1984.tb07962.x; VIK TA, 1990, P NATL ACAD SCI USA, V87, P2685, DOI 10.1073/pnas.87.7.2685; WHITEHOUSE S, 1983, METHOD ENZYMOL, V99, P80	42	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					5249	5255						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002057				2022-12-25	WOS:A1991FC21700082
J	FLOYD, CC; GRANT, P; GALLANT, PE; PANT, HC				FLOYD, CC; GRANT, P; GALLANT, PE; PANT, HC			PRINCIPAL NEUROFILAMENT-ASSOCIATED PROTEIN-KINASE IN SQUID AXOPLASM IS RELATED TO CASEIN KINASE-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SEQUENCE; PHOSPHORYLATION SITES; TRIPLET PROTEINS; GIANT-AXON; NF-M; PURIFICATION; POLYPEPTIDES; SUBUNIT; GENE; PROTEOLYSIS	A cytoskeletal extract of pure axoplasm, highly enriched with neurofilaments (ANF), was prepared from the giant axon of the squid. This ANF preparation also contained potent kinase activities which phosphorylated the M(r) > 400,000 (high molecular weight) and M(r) 220,000 squid neurofilament protein subunits. High salt (1 M) extraction of this ANF preparation solubilized most of the neurofilament proteins and kinase activities and gel filtration on an AcA 44 column separated these two components. The neurofilaments eluted in the void volume of the column while the kinase activities eluted in the 17-44-kDa range of the column. Two major kinase activities were measured in this peak of activity. One of these strongly phosphorylated the phosphate acceptor peptide Leu-Arg-Arg-Ala-Ser-Leu-Gly (Kemptide) and was completely inhibited by selective inhibitor of cAMP-dependent kinase Thr-Thr-Tyr-Ala-Asp-Phe-Ile-Ala-Ser-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-NH2 (Wiptide). Since addition of cAMP did not stimulate activity, this suggested that this kinase was a free catalytic subunit of cAMP-dependent kinase associated with the neurofilaments. The second kinase activity most effectively phosphorylated alpha-casein, and this activity was not affected by Wiptide. The alpha-casein phosphorylating activity (ANF kinase) was the principal activity responsible for neurofilament protein phosphorylation, and was not inhibited by various inhibitors against second messenger regulated kinases, suggesting it was related to the casein kinase family. Four lines of evidence indicate ANF kinase was similar to casein kinase I. These were: 1) the apparent molecular weight determined by gel filtration and the chromatographic elution profile on phosphocellulose column corresponded to casein kinase I; 2) heparin, an inhibitor of casein kinase II at 2-5-mu-g/ml, stimulated both ANF kinase and purified casein kinase I at these concentrations, while CKI-7, a relatively selective inhibitor of casein kinase I, inhibited ANF kinase in a comparable dose-response fashion; 3) purified casein kinase I strongly phosphorylated both ANF protein subunits (like ANF kinase) whereas casein kinase II was relatively ineffective; and 4) tryptic peptide maps of the HMW and M(r) 220,000 neurofilament proteins after phosphorylation by ANF kinase or purified casein kinase I showed similar P-32-peptide patterns.	NIH,NEUROBIOL LAB,BETHESDA,MD 20892; MARINE BIOL LAB,WOODS HOLE,MA 02543	National Institutes of Health (NIH) - USA; Marine Biological Laboratory - Woods Hole	FLOYD, CC (corresponding author), NINCDS,NEUROCHEM LAB,BLDG 36,RM 4D20,BETHESDA,MD 20892, USA.							ANGELIDES KJ, 1989, J CELL BIOL, V108, P1495, DOI 10.1083/jcb.108.4.1495; BASS M, 1987, J NEUROCHEM, V49, P1116, DOI 10.1111/j.1471-4159.1987.tb10001.x; BLACKSHEAR PJ, 1988, FASEB J, V2, P2957, DOI 10.1096/fasebj.2.14.2972578; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN A, 1986, BIOCHEM J, V239, P191, DOI 10.1042/bj2390191; Brown A., 1990, SQUID EXPT ANIMALS, P235; BURNETT G, 1954, J BIOL CHEM, V211, P969; CAPUTO CB, 1989, BIOCHIM BIOPHYS ACTA, V1012, P299, DOI 10.1016/0167-4889(89)90112-2; CHIJIWA T, 1989, J BIOL CHEM, V264, P4924; CHUI FC, 1982, J NEUROCHEM, V39, P1252; COHEN RS, 1984, J NEUROSCI, V7, P2056; DAHMUS ME, 1981, J BIOL CHEM, V256, P3319; DOSEMECI A, 1990, CELL MOL NEUROBIOL, V10, P369, DOI 10.1007/BF00711181; EAGLES PAM, 1981, BIOCHEM J, V199, P101, DOI 10.1042/bj1990101; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; GALLANT PE, 1986, J NEUROCHEM, V46, P1573, DOI 10.1111/j.1471-4159.1986.tb01779.x; GEISLER N, 1983, EMBO J, V2, P1295, DOI 10.1002/j.1460-2075.1983.tb01584.x; GEISLER N, 1985, FEBS LETT, V182, P475, DOI 10.1016/0014-5793(85)80357-4; HATHAWAY GM, 1979, J BIOL CHEM, V254, P762; HATHAWAY GM, 1982, CURR TOP CELL REGUL, V21, P101; HOFFMAN PN, 1984, J CELL BIOL, V99, P705, DOI 10.1083/jcb.99.2.705; HOFFMAN PN, 1985, J NEUROSCI, V5, P2920; HOGUEANGELETTI RA, 1982, J NEUROCHEM, V38, P116, DOI 10.1111/j.1471-4159.1982.tb10861.x; JULIEN JP, 1981, J NEUROCHEM, V37, P1579, DOI 10.1111/j.1471-4159.1981.tb06330.x; JULIEN JP, 1982, J BIOL CHEM, V257, P467; JULIEN JP, 1983, J BIOL CHEM, V258, P4019; KAUFMANN E, 1984, FEBS LETT, V170, P81, DOI 10.1016/0014-5793(84)81373-3; KAWAMOTO S, 1987, J BIOL CHEM, V262, P7282; KEMPBE, 1976, FED PROC, V35, P1384; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASEK RJ, 1985, ANN NY ACAD SCI, V455, P462, DOI 10.1111/j.1749-6632.1985.tb50429.x; LEES JF, 1988, EMBO J, V7, P1947, DOI 10.1002/j.1460-2075.1988.tb03032.x; LETERRIER JF, 1981, J CELL BIOL, V90, P755, DOI 10.1083/jcb.90.3.755; LEVY E, 1987, EUR J BIOCHEM, V166, P71, DOI 10.1111/j.1432-1033.1987.tb13485.x; MORRIS JR, 1982, J CELL BIOL, V92, P192, DOI 10.1083/jcb.92.1.192; MYERS MW, 1987, EMBO J, V6, P1617, DOI 10.1002/j.1460-2075.1987.tb02409.x; NAPOLITANO EW, 1987, J NEUROSCI, V7, P2590; PANT HC, 1978, J CELL BIOL, V78, pR23, DOI 10.1083/jcb.78.2.R23; PANT HC, 1986, J BIOL CHEM, V261, P2968; PLEASURE SJ, 1989, J NEUROSCI, V9, P698; RABINOWITZ M, 1969, J BIOL CHEM, V235, P1043; ROSLANSKY PF, 1980, P NATL ACAD SCI-BIOL, V77, P404, DOI 10.1073/pnas.77.1.404; RUNGE MS, 1981, BIOCHEMISTRY-US, V20, P175, DOI 10.1021/bi00504a029; SCHEKERT G, 1982, J BIOL CHEM, V257, P4788; SIHAG RK, 1988, FEBS LETT, V233, P181, DOI 10.1016/0014-5793(88)81380-2; SIHAG RK, 1989, J BIOL CHEM, V264, P457; SIHAG RK, 1990, J BIOL CHEM, V265, P4166; STERNBERGER NH, 1986, P NATL ACAD SCI USA, V82, P4273; SZARO BG, 1989, SOC NEUR ABSTR, V15, P162; TANAKA E, 1984, BIOMED RES-TOKYO, V5, P239, DOI 10.2220/biomedres.5.239; TAO M, 1980, J BIOL CHEM, V255, P2563; TORUDELBAUFFE D, 1983, FEBS LETT, V162, P230, DOI 10.1016/0014-5793(83)80761-3; VALLANO ML, 1985, BIOCHEM BIOPH RES CO, V130, P957, DOI 10.1016/0006-291X(85)91708-5; WIBLE BA, 1989, P NATL ACAD SCI USA, V86, P720, DOI 10.1073/pnas.86.2.720	54	49	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4987	4994						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002043				2022-12-25	WOS:A1991FC21700049
J	HUGHES, AJ; BRYAN, SK; CHEN, H; MOSES, RE; MCHENRY, CS				HUGHES, AJ; BRYAN, SK; CHEN, H; MOSES, RE; MCHENRY, CS			ESCHERICHIA-COLI DNA POLYMERASE-II IS STIMULATED BY DNA POLYMERASE-III HOLOENZYME AUXILIARY SUBUNITS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION COMPLEX; BETA-SUBUNIT; ALTERNATE PATHWAYS; UNWINDING PROTEIN; PRIMED DNA; PURIFICATION; REPLICATION; IDENTIFICATION; MUTAGENESIS; REPAIR	DNA polymerase III of Escherichia coli requires multiple auxiliary factors to enable it to serve as a replicative complex. We demonstrate that auxiliary components of the DNA polymerase III holoenzyme, the gamma-delta-complex and beta-subunit, markedly stimulate DNA polymerase II on long single-stranded templates. DNA polymerase II activity is enhanced by single-stranded DNA binding protein, but the stimulation by gamma-delta and beta can be observed either in the absence or presence of single-stranded DNA binding protein. In contrast with DNA polymerase III, the requirement of DNA polymerase II for gamma-delta cannot be bypassed by large excesses of the beta-subunit at low ionic strength in the absence of the single-stranded DNA binding protein. The product of the DNA polymerase II-gamma-delta-beta reaction on a uniquely primed single-stranded circle is of full template length; the reconstituted enzyme apparently is incapable of strand displacement synthesis. The possible biological implications of these observations are discussed.	BAYLOR UNIV,DEPT CELL BIOL,HOUSTON,TX 77030; BAYLOR UNIV,INST MOLEC GENET,HOUSTON,TX 77030	Baylor University; Baylor College of Medicine; Baylor University	HUGHES, AJ (corresponding author), UNIV COLORADO,HLTH SCI CTR,DEPT BIOCHEM BIOPHYS & GENET,DENVER,CO 80262, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM012571] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 12571] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BONNER CA, 1988, J BIOL CHEM, V263, P18946; BONNER CA, 1990, P NATL ACAD SCI USA, V87, P7663, DOI 10.1073/pnas.87.19.7663; BRIDGES BA, 1976, MOL GEN GENET, V144, P53, DOI 10.1007/BF00277304; BRYAN S, 1988, BIOCHIM BIOPHYS ACTA, V951, P249, DOI 10.1016/0167-4781(88)90093-0; BRYAN S, 1988, DNA REPLICATION MUTA, P305; BRYAN SK, 1990, MUTAT RES, V243, P313, DOI 10.1016/0165-7992(90)90149-E; BURGERS PMJ, 1982, J BIOL CHEM, V257, P1474; CAMPBELL JL, 1972, P NATL ACAD SCI USA, V69, P2090, DOI 10.1073/pnas.69.8.2090; CHEN H, 1989, J BIOL CHEM, V264, P20591; CHEN H, 1990, DNA CELL BIOL, V9, P631, DOI 10.1089/dna.1990.9.631; FAY PJ, 1981, J BIOL CHEM, V256, P976; GRIEP MA, 1989, J BIOL CHEM, V264, P11294; HAGENSEE ME, 1987, P NATL ACAD SCI USA, V84, P4195, DOI 10.1073/pnas.84.12.4195; HIROSHI I, 1990, J BACTERIOL, V172, P6268; HIROTA Y, 1972, P NATL ACAD SCI USA, V69, P3238, DOI 10.1073/pnas.69.11.3238; JOHANSON KO, 1980, J BIOL CHEM, V255, P984; JOHANSON KO, 1982, J BIOL CHEM, V257, P2310; KENYON CJ, 1980, P NATL ACAD SCI-BIOL, V77, P2819, DOI 10.1073/pnas.77.5.2819; KNIPPERS R, 1970, NATURE, V228, P1050, DOI 10.1038/2281050a0; Kornberg A., 1980, DNA REPLICATION; KORNBERG A, 1982, S DNA REPLICATION 19; KORNBERG T, 1971, P NATL ACAD SCI USA, V68, P761, DOI 10.1073/pnas.68.4.761; LADUCA RJ, 1986, J BIOL CHEM, V261, P7550; LIVINGSTON DM, 1975, J BIOL CHEM, V250, P461; MAKI H, 1989, J BACTERIOL, V171, P3139, DOI 10.1128/jb.171.6.3139-3143.1989; MAKI S, 1988, J BIOL CHEM, V263, P6555; MASKER W, 1973, NATURE-NEW BIOL, V244, P242, DOI 10.1038/newbio244242a0; MCHENRY C, 1977, J BIOL CHEM, V252, P648; MCHENRY CS, 1985, MOL CELL BIOCHEM, V66, P71; MCHENRY CS, 1982, J BIOL CHEM, V257, P2657; MCHENRY CS, 1988, ANNU REV BIOCHEM, V57, P519; MCHENRY CS, 1979, J BIOL CHEM, V254, P1748; MCHENRY CS, 1987, DNA REPLICATION RECO, P47; MCMACKEN R, 1987, ESCHERICHIA COLI SAL, V1, P564; MEYER RR, 1980, J BIOL CHEM, V255, P2897; MOK M, 1987, J BIOL CHEM, V262, P16644; MOLINEUX IJ, 1974, J BIOL CHEM, V249, P6090; MOSES R E, 1970, Biochemical and Biophysical Research Communications, V41, P1557, DOI 10.1016/0006-291X(70)90565-6; MOSES R E, 1970, Biochemical and Biophysical Research Communications, V41, P1565, DOI 10.1016/0006-291X(70)90566-8; NIWA O, 1981, P NATL ACAD SCI-BIOL, V78, P7024, DOI 10.1073/pnas.78.11.7024; OBERFELDER R, 1987, J BIOL CHEM, V262, P4190; ODONNELL ME, 1987, J BIOL CHEM, V262, P16558; ODONNELL ME, 1985, J BIOL CHEM, V260, P2884; ROWEN L, 1978, J BIOL CHEM, V253, P758; SIGAL N, 1972, P NATL ACAD SCI USA, V69, P3537, DOI 10.1073/pnas.69.12.3537; STILLMAN B, 1989, ANNU REV CELL BIOL, V5, P197; TAIT RC, 1974, P NATL ACAD SCI USA, V71, P675, DOI 10.1073/pnas.71.3.675; VANWEZENBEEK PMGF, 1980, GENE, V11, P129, DOI 10.1016/0378-1119(80)90093-1; WALKER GC, 1984, MICROBIOL REV, V48, P60, DOI 10.1128/MMBR.48.1.60-93.1984; WICKNER RB, 1972, J BIOL CHEM, V247, P498; WICKNER S, 1974, P NATL ACAD SCI USA, V71, P4120, DOI 10.1073/pnas.71.10.4120; WOLD MS, 1982, P NATL ACAD SCI-BIOL, V79, P4907, DOI 10.1073/pnas.79.16.4907	52	51	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4568	4573						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999435				2022-12-25	WOS:A1991FA69400084
J	BACKMAN, L; PEKRUN, A; GRATZER, WB				BACKMAN, L; PEKRUN, A; GRATZER, WB			FORMATION AND PROPERTIES OF SPECTRIN CONTAINING A TRUNCATED BETA-CHAIN, GENERATED BY AN ENDOGENOUS CALCIUM-DEPENDENT PROTEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-ERYTHROCYTE SPECTRIN; HUMAN RED-CELL; SELF-ASSOCIATION; CALPAIN-I; MEMBRANE SKELETONS; ACTIN; PHOSPHORYLATION; ACTIVATION; PROCALPAIN; PROTEINS	Spectrin chromatographically isolated from human red cell membranes contains a proteolytic activity, inhibited by leupeptin, with a dependence on calcium ions characteristic of a calpain I. The activity accompanies the spectrin on two successive gel filtration columns and is present in both the dimer and the tetramer. It is cryptic in the ghost membrane and in purified membrane skeletons until these are dissociated, apparently because the spectrin is resistant to attack in the tetrameric state. The activity is more strongly expressed in spectrin preparations from young than from old cells. Since the bound enzyme does not detectably change the elution volume of spectrin in gel filtration, it is likely that its molecular weight is low. Its activity reveals itself only in the formation of a modified spectrin, lacking the COOH-terminal, phosphorylated portion of the beta-chain. The phosphorylated fragment (15-20 kDa) can be identified by gel electrophoresis. The proteolytically modified spectrin dimers are unable to associate with like molecules, but are univalent with respect to formation of hybrid tetramers with native spectrin. The association constant for this process is lower than that for self-association of native spectrin by a factor of only 2. The proteolytically modified spectrin behaves similarly in this respect to a truncated spectrin mutant found in a form of hereditary elliptocytosis. The latter also resembles the proteolytic product in that both give rise to the same altered NH2-terminal tryptic fragment from the alpha-chain.	UNIV LONDON KINGS COLL,MRC,MUSCLE & CELL MOTIL UNIT,LONDON WC2B 5RL,ENGLAND	University of London; King's College London	BACKMAN, L (corresponding author), UMEA UNIV,DEPT BIOCHEM,S-90187 UMEA,SWEDEN.							ANDERSON JM, 1979, J BIOL CHEM, V254, P939; BACKMAN L, 1986, J CELL SCI, V80, P281; BENNETT V, 1989, BIOCHIM BIOPHYS ACTA, V988, P107, DOI 10.1016/0304-4157(89)90006-3; BEUTLER E, 1976, J LAB CLIN MED, V88, P328; COHEN CM, 1984, BIOCHEMISTRY-US, V23, P6091, DOI 10.1021/bi00320a029; EBER SW, 1988, J CLIN INVEST, V81, P523, DOI 10.1172/JCI113350; GOPALAKRISHNA R, 1985, ANAL BIOCHEM, V148, P413, DOI 10.1016/0003-2697(85)90247-7; GRASSO M, 1986, BIOCHEM BIOPH RES CO, V138, P87, DOI 10.1016/0006-291X(86)90250-0; GRATZER WB, 1981, METHOD ENZYMOL, V85, P475; HARRIS HW, 1980, J BIOL CHEM, V255, P1512; HATANAKA M, 1984, BIOCHEMISTRY-US, V23, P3272, DOI 10.1021/bi00309a023; INOMATA M, 1989, J BIOL CHEM, V264, P18838; KUBOKI M, 1987, BIOCHIM BIOPHYS ACTA, V929, P164, DOI 10.1016/0167-4889(87)90172-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWLER J, 1982, J CLIN INVEST, V70, P1019, DOI 10.1172/JCI110689; LIU SC, 1980, NATURE, V285, P586, DOI 10.1038/285586a0; MELLONI E, 1989, TRENDS NEUROSCI, V12, P438, DOI 10.1016/0166-2236(89)90093-3; MORRIS M, 1989, BIOCHEMISTRY-US, V28, P8561, DOI 10.1021/bi00447a044; MORRIS SA, 1989, FEBS LETT, V244, P68, DOI 10.1016/0014-5793(89)81164-0; MURAKAMI T, 1981, J BIOCHEM-TOKYO, V90, P1809, DOI 10.1093/oxfordjournals.jbchem.a133659; MURPHY JR, 1973, J LAB CLIN MED, V82, P334; OHANIAN V, 1984, EUR J BIOCHEM, V144, P375, DOI 10.1111/j.1432-1033.1984.tb08474.x; OHANIAN V, 1984, BIOCHEMISTRY-US, V23, P4416, DOI 10.1021/bi00314a027; PINDER JC, 1989, BIOCHEM J, V264, P423, DOI 10.1042/bj2640423; PONTREMOLI S, 1984, P NATL ACAD SCI-BIOL, V81, P6714, DOI 10.1073/pnas.81.21.6714; PONTREMOLI S, 1985, BIOCHIM BIOPHYS ACTA, V831, P335, DOI 10.1016/0167-4838(85)90116-5; POTHIER B, 1987, BLOOD, V69, P1759; SAHR KE, 1990, J BIOL CHEM, V265, P4434; SAMIS JA, 1989, THROMB HAEMOSTASIS, V61, P250; SHAHBAKHTI F, 1986, BIOCHEMISTRY-US, V25, P5969, DOI 10.1021/bi00368a020; SHEETZ MP, 1979, BIOCHIM BIOPHYS ACTA, V557, P122, DOI 10.1016/0005-2736(79)90095-6; SPEICHER DW, 1982, J BIOL CHEM, V257, P9093; UNGEWICKELL E, 1978, EUR J BIOCHEM, V88, P379, DOI 10.1111/j.1432-1033.1978.tb12459.x; WAXMAN L, 1979, ARCH BIOCHEM BIOPHYS, V195, P300, DOI 10.1016/0003-9861(79)90356-4; WINKELMANN JC, 1990, J BIOL CHEM, V265, P11827	35	19	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3835	3840						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995636				2022-12-25	WOS:A1991EY68200073
J	DEVOS, P; CLAESSENS, F; WINDERICKX, J; VANDIJCK, P; CELIS, L; PEETERS, B; ROMBAUTS, W; HEYNS, W; VERHOEVEN, G				DEVOS, P; CLAESSENS, F; WINDERICKX, J; VANDIJCK, P; CELIS, L; PEETERS, B; ROMBAUTS, W; HEYNS, W; VERHOEVEN, G			INTERACTION OF ANDROGEN RESPONSE ELEMENTS WITH THE DNA-BINDING DOMAIN OF THE RAT ANDROGEN RECEPTOR EXPRESSED IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY-TUMOR VIRUS; GLUCOCORTICOID RECEPTOR; PROGESTERONE-RECEPTOR; HORMONE RECEPTOR; PROTEIN-A; GENE; TRANSCRIPTION; POLYPEPTIDES; DERIVATIVES; CLEAVAGE	A fragment of the rat androgen receptor (amino acids 533-637) containing the DNA-binding domain was produced in Escherichia coli as a fusion product with protein A of Staphylococcus aureus. The fusion protein was purified on IgG-Sepharose, a method that does not involve the use of denaturing agents. Approximately 4 mg of fusion protein was obtained from 500 ml of bacterial culture. In gel shift assays, the recombinant DNA-binding domain displays an affinity for a fragment of the long terminal repeat of mouse mammary tumor virus and for an intronic fragment of the gene coding for the C3 component of the androgen-regulated rat prostatic binding protein. In a DNase I footprinting assay, the fusion protein protects a sequence in the C3 fragment that has previously been shown to act as a functional androgen response element. Interestingly, a single base pair mutation in the response element, which abolishes androgen inducibility, also destroys the ability to interact with the recombinant androgen receptor DNA-binding domain.	CATHOLIC UNIV LEUVEN,FAC MED,DEPT BIOCHEM,B-3000 LOUVAIN,BELGIUM; CATHOLIC UNIV LEUVEN,EXPTL MED & ENDOCRINOL LAB,B-3000 LOUVAIN,BELGIUM	KU Leuven; KU Leuven			Claessens, Frank/M-8565-2016	Claessens, Frank/0000-0002-8676-7709				BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BONIFER C, 1989, J STEROID BIOCHEM, V32, P5, DOI 10.1016/0022-4731(89)90006-X; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CHALEPAKIS G, 1990, DNA CELL BIOL, V9, P355, DOI 10.1089/dna.1990.9.355; CHANG C, 1989, ENDOCRINOLOGY, V123, P1097; CHANG CS, 1988, P NATL ACAD SCI USA, V85, P7211, DOI 10.1073/pnas.85.19.7211; CLAESSENS F, 1989, BIOCHEM BIOPH RES CO, V164, P833, DOI 10.1016/0006-291X(89)91534-9; DAHLMAN K, 1989, J BIOL CHEM, V264, P804; DAVIES P, 1988, BIOCHEM SOC T, V16, P695, DOI 10.1042/bst0160695; EDWARDS DP, 1989, MOL ENDOCRINOL, V3, P381, DOI 10.1210/mend-3-2-381; ERIKSSON P, 1990, J BIOL CHEM, V265, P3535; EUL J, 1989, EMBO J, V8, P83, DOI 10.1002/j.1460-2075.1989.tb03351.x; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FEIGELSON P, 1978, ADV ENZYMOL RELAT AR, V47, P274; FREEDMAN LP, 1989, SCIENCE, V245, P298, DOI 10.1126/science.2473529; GOTTESMAN ME, 1980, J MOL BIOL, V140, P57, DOI 10.1016/0022-2836(80)90356-3; GREEN S, 1988, TRENDS GENET, V4, P309, DOI 10.1016/0168-9525(88)90108-4; HAM J, 1988, NUCLEIC ACIDS RES, V16, P5263, DOI 10.1093/nar/16.12.5263; HARD T, 1990, SCIENCE, V249, P157, DOI 10.1126/science.2115209; HARD T, 1990, BIOCHEMISTRY-US, V29, P5358; HEMSCHOOTE K, 1988, J BIOL CHEM, V263, P19159; HOESS A, 1988, BIO-TECHNOL, V6, P1214, DOI 10.1038/nbt1088-1214; HUSMANN DA, 1990, ENDOCRINOLOGY, V126, P2359, DOI 10.1210/endo-126-5-2359; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN KH, 1990, J BIOL CHEM, V265, P5161; LORENI F, 1988, MOL CELL BIOL, V8, P2350, DOI 10.1128/MCB.8.6.2350; Maniatis T., 1982, MOL CLONING; MARSTON FAO, 1986, BIOCHEM J, V240, P1, DOI 10.1042/bj2400001; OMALLEY B, 1990, MOL ENDOCRINOL, V4, P363, DOI 10.1210/mend-4-3-363; PARKER M, 1985, REGULATION ANDROGEN, P175; PARKER MG, 1988, J ENDOCRINOL, V119, P175, DOI 10.1677/joe.0.1190175; PERRY ST, 1985, REGULATION ANDROGEN, P167; POWER RF, 1990, J BIOL CHEM, V265, P1419; ROSENBERG M, 1983, METHOD ENZYMOL, V101, P123; RUSHMERE NK, 1987, MOL CELL ENDOCRINOL, V51, P259, DOI 10.1016/0303-7207(87)90036-0; SCHULE R, 1988, SCIENCE, V242, P1418, DOI 10.1126/science.3201230; SHINE J, 1980, NATURE, V285, P456, DOI 10.1038/285456a0; STANLEY KK, 1984, EMBO J, V3, P1429, DOI 10.1002/j.1460-2075.1984.tb01988.x; TSAI MJ, 1988, COLD SPRING HARB SYM, V53, P381; TSAI SY, 1988, CELL, V55, P361, DOI 10.1016/0092-8674(88)90059-1; UHLEN M, 1984, J BIOL CHEM, V259, P1695; VANDIJCK P, 1989, MOL CELL ENDOCRINOL, V64, P195, DOI 10.1016/0303-7207(89)90146-9; VANLAAR JH, 1989, MOL CELL ENDOCRINOL, V67, P29, DOI 10.1016/0303-7207(89)90227-X; WILLMANN T, 1986, NATURE, V324, P689; WINDERICKX J, 1990, MOL ENDOCRINOL, V4, P657, DOI 10.1210/mend-4-4-657; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209	47	62	62	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3439	3443						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995608				2022-12-25	WOS:A1991EY68200018
J	TIJBURG, PNM; VANHEERDE, WL; LEENHOUTS, HM; HESSING, M; BOUMA, BN; DEGROOT, PG				TIJBURG, PNM; VANHEERDE, WL; LEENHOUTS, HM; HESSING, M; BOUMA, BN; DEGROOT, PG			FORMATION OF MEIZOTHROMBIN AS INTERMEDIATE IN FACTOR-XA-CATALYZED PROTHROMBIN ACTIVATION ON ENDOTHELIAL-CELLS - THE INFLUENCE OF THROMBIN ON THE REACTION-MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION FACTOR-V; BOVINE FACTOR-V; PROTEIN-C; BINDING; IDENTIFICATION; CONVERSION	Incubation of prothrombin on cultured human umbilical vein endothelial cells with factor Xa and calcium ions induced the activation of prothrombin. The mechanism of prothrombin activation was analyzed on sodium dodecyl sulfate gels using immuno- and amido-blotting techniques. It was demonstrated that meizothrombin was formed as an intermediate in prothrombin activation on the endothelial cell surface. In addition, considerable amounts of meizothrombin des-fragment-1 accumulated during prothrombin activation and were not further converted to thrombin. Although preincubation of the endothelial cells with thrombin did not influence the formation of meizothrombin, addition of hirudin to the prothrombin activation mixture inhibited the formation of meizothrombin and meizothrombin des-fragment-1 almost completely. This indicated that the activity of endogenously formed thrombin influenced the formation of meizothrombin via a feedback mechanism. The increased formation of meizothrombin and accumulation of meizothrombin des-fragment-1 in a latter phase of prothrombin activation points to a regulatory mechanism in hemostasis which subdues the formation of the procoagulant alpha-thrombin.			TIJBURG, PNM (corresponding author), UNIV HOSP UTRECHT, DEPT HAEMATOL, POB 85500, 3508 GA UTRECHT, NETHERLANDS.		van Heerde, Waander/L-4357-2015	van Heerde, Waander/0000-0001-7101-8775				AWBREY BJ, 1979, J BIOL CHEM, V254, P4092; CERVENY TJ, 1984, BLOOD, V63, P1467; DOYLE MF, 1990, J BIOL CHEM, V265, P10693; ESMON CT, 1974, J BIOL CHEM, V249, P7798; ESMON CT, 1981, P NATL ACAD SCI-BIOL, V78, P2249, DOI 10.1073/pnas.78.4.2249; ESMON CT, 1979, J BIOL CHEM, V254, P964; ESMON CT, 1974, J BIOL CHEM, V249, P7782; FUJIKAWA K, 1973, BIOCHEMISTRY-US, V12, P4938, DOI 10.1021/bi00748a019; HELDEBRANT CM, 1973, J BIOL CHEM, V248, P3642; HELDEBRANT CM, 1973, J BIOL CHEM, V248, P7149; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; KRISHNASWAMY S, 1986, J BIOL CHEM, V261, P8977; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOLLAR P, 1980, J BIOL CHEM, V255, P279; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MEYERS JCM, 1987, BIOCHEMISTRY-US, V26, P5932; MILETICH JP, 1978, J BIOL CHEM, V253, P6908; NESHEIM ME, 1979, J BIOL CHEM, V254, P1326; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; PATTHY L, 1984, FEBS LETT, V171, P131, DOI 10.1016/0014-5793(84)80473-1; RABIET MJ, 1979, BIOCHIM BIOPHYS ACTA, V584, P66, DOI 10.1016/0304-4165(79)90236-8; RODGERS GM, 1986, J CLIN INVEST, V77, P1909, DOI 10.1172/JCI112519; RODGERS GM, 1983, P NATL ACAD SCI-BIOL, V80, P7001, DOI 10.1073/pnas.80.22.7001; ROSING J, 1986, J BIOL CHEM, V261, P4224; ROSING J, 1980, J BIOL CHEM, V255, P274; STENN KS, 1972, BIOCHEMISTRY-US, V11, P4502, DOI 10.1021/bi00774a012; STONE SR, 1986, BIOCHEMISTRY-US, V25, P4622, DOI 10.1021/bi00364a025; SUTTIE JW, 1977, PHYSIOL REV, V57, P1, DOI 10.1152/physrev.1977.57.1.1; SUZUKI K, 1982, J BIOL CHEM, V257, P6556; TANS G, 1989, THROMB HAEMOSTASIS, V61, P386; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WALKER FJ, 1980, J BIOL CHEM, V255, P5521; WILLEMS C, 1982, EXP CELL RES, V139, P191, DOI 10.1016/0014-4827(82)90332-9	34	25	27	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					4017	4022						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995649				2022-12-25	WOS:A1991EY68200099
J	IANNELLO, RC; MAR, JH; ORDAHL, CP				IANNELLO, RC; MAR, JH; ORDAHL, CP			CHARACTERIZATION OF A PROMOTER ELEMENT REQUIRED FOR TRANSCRIPTION IN MYOCARDIAL-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREATINE-KINASE GENE; CARDIAC ACTIN GENE; TROPONIN-T-GENE; MUSCLE-SPECIFIC ENHANCER; UPSTREAM ELEMENTS; BINDING FACTOR; C-FOS; EXPRESSION; SKELETAL; SEQUENCE	Transcription of the chicken cardiac troponin T (cTNT) gene in myocardial cells requires upstream sequences not required for expression of this gene in embryonic skeletal muscle cells. Deletion analysis shows that the segment between nucleotides -247 and -201 (numbered relative to the transcription initiation site at +1) is capable of conferring cardiac specific expression to a "minimal" cTNT promoter. The cardiac element within this segment contains at least two essential subregions: one residing upstream of position -215, which bears no homologies to known transcription elements, and an A/T-rich segment residing between positions -215 and -201. Conserved M-CAT motifs within the cTNT minimal promoter which are required for activity in skeletal muscle cells are also required for activity in myocardial cells, suggesting an interaction between the upstream cardiac element and proximal promoter elements. Gel-shift experiments demonstrate interaction between the upstream portion of the cardiac element and factor(s) present in the nuclei of cardiac and non-cardiac tissues. Thus, additional cis and trans factors are required for transcription of the cTNT gene in myocardial cells which are not required for expression in skeletal muscle cells.	UNIV CALIF SAN FRANCISCO,DEPT ANAT,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032018] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL35561] Funding Source: Medline; NIGMS NIH HHS [GM32018] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANTIN PB, 1988, BIOTECHNIQUES, V6, P640; BISHOPRIC NH, 1987, J CLIN INVEST, V80, P1194, DOI 10.1172/JCI113179; BOXER LM, 1989, MOL CELL BIOL, V9, P515, DOI 10.1128/MCB.9.2.515; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAUN T, 1989, MOL CELL BIOL, V9, P2513, DOI 10.1128/MCB.9.6.2513; BREITBART RE, 1986, J MOL BIOL, V188, P313, DOI 10.1016/0022-2836(86)90157-9; BRENNAN TJ, 1990, GENE DEV, V4, P582, DOI 10.1101/gad.4.4.582; BUSKIN JN, 1989, MOL CELL BIOL, V9, P2627, DOI 10.1128/MCB.9.6.2627; COHEN A, 1988, NUCLEIC ACIDS RES, V16, P10037, DOI 10.1093/nar/16.21.10037; COOPER TA, 1985, J BIOL CHEM, V260, P1140; COOPER TA, 1984, SCIENCE, V226, P979, DOI 10.1126/science.6095446; CRIBBS LL, 1989, J BIOL CHEM, V264, P10672; DONOGHUE M, 1988, GENE DEV, V2, P1779, DOI 10.1101/gad.2.12b.1779; DYNAN WS, 1989, CELL, V58, P1, DOI 10.1016/0092-8674(89)90393-0; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GARNER M, 1981, NUCLEIC ACIDS RES, V9, P3407; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GORMAN CM, 1985, DNA CLONING, V2, P140; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GUSTAFSON TA, 1987, P NATL ACAD SCI USA, V84, P3122, DOI 10.1073/pnas.84.10.3122; GUSTAFSON TA, 1988, MOL CELL BIOL, V8, P4110, DOI 10.1128/MCB.8.10.4110; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HICKEY R, 1986, MOL CELL BIOL, V6, P3287, DOI 10.1128/MCB.6.9.3287; HORLICK RA, 1989, MOL CELL BIOL, V9, P2396, DOI 10.1128/MCB.9.6.2396; JAYNES JB, 1988, MOL CELL BIOL, V8, P62, DOI 10.1128/MCB.8.1.62; JOHNSON JE, 1989, MOL CELL BIOL, V9, P3393, DOI 10.1128/MCB.9.8.3393; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; LICHTSTEINER S, 1987, CELL, V51, P963, DOI 10.1016/0092-8674(87)90583-6; LONG CS, 1989, J CLIN INVEST, V83, P1078, DOI 10.1172/JCI113951; LONG CS, 1989, DEV BIOL, V127, P228; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; Maniatis T., 1982, MOL CLONING; MAR JH, 1988, P NATL ACAD SCI USA, V85, P6404, DOI 10.1073/pnas.85.17.6404; MAR JH, 1990, MOL CELL BIOL, V10, P4271, DOI 10.1128/MCB.10.8.4271; MAR JH, 1988, J CELL BIOL, V107, P573, DOI 10.1083/jcb.107.2.573; MINTY A, 1986, MOL CELL BIOL, V6, P2137, DOI 10.1128/MCB.6.6.2137; MINTY A, 1986, MOL CELL BIOL, V6, P2125, DOI 10.1128/MCB.6.6.2125; MIWA T, 1987, MOL CELL BIOL, V7, P2803, DOI 10.1128/MCB.7.8.2803; MOHUN TJ, 1989, EMBO J, V8, P1153, DOI 10.1002/j.1460-2075.1989.tb03486.x; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NIKOVITS W, 1986, NUCLEIC ACIDS RES, V14, P3377, DOI 10.1093/nar/14.8.3377; ORDAHL CP, 1980, P NATL ACAD SCI USA, V77, P5419; RISSE G, 1989, EMBO J, V8, P3825, DOI 10.1002/j.1460-2075.1989.tb08560.x; SCHWARTZ RJ, 1989, CELL MOL BIOL MUSCLE, V93, P653; SEIDMAN CE, 1988, P NATL ACAD SCI USA, V85, P4104, DOI 10.1073/pnas.85.11.4104; STERNBERG EA, 1988, MOL CELL BIOL, V8, P2896, DOI 10.1128/MCB.8.7.2896; TRASK RV, 1988, J BIOL CHEM, V263, P17142; WALSH K, 1989, MOL CELL BIOL, V9, P2191, DOI 10.1128/MCB.9.5.2191; WALSH K, 1988, MOL CELL BIOL, V8, P1800, DOI 10.1128/MCB.8.4.1800; WASPE LE, 1990, J CLIN INVEST, V85, P1206, DOI 10.1172/JCI114554; ZAK R, 1972, RES MUSCLE DEV MUSCL, P163; ZARAINHERZBERG A, 1990, J BIOL CHEM, V265, P4670	53	82	85	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3309	3316						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993702				2022-12-25	WOS:A1991EX60000095
J	MALTER, JS; HONG, Y				MALTER, JS; HONG, Y			A REDOX SWITCH AND PHOSPHORYLATION ARE INVOLVED IN THE POSTTRANSLATIONAL UP-REGULATION OF THE ADENOSINE-URIDINE BINDING-FACTOR BY PHORBOL ESTER AND IONOPHORE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; GENE-EXPRESSION; GM-CSF; PROTEIN; STABILITY; DEGRADATION	Messenger RNAs coding for cytokines and lymphokines are extremely unstable due to an AU-rich cis element located in their 3'-untranslated region. Cell activation with phorbol ester 12-O-tetradecanoylphorbol-13-acetate or calcium ionophore has been shown to markedly stabilize these normally labile messages. We have recently described a cytoplasmic protein, denoted the adenosine-uridine binding factor (AUBF) which complexes in vitro to a variety of labile RNAs containing multiple reiterations of the pentamer AUUUA. In order to determine if AUBF plays a role in the stabilization of cytokine and lymphokine mRNAs, we have investigated the mechanisms which control AUBF activity in peripheral blood mononuclear cells as well as Jurkat cells. AUBF is inactive in resting peripheral blood mononuclear cells but can be activated by brief treatment with 12-O-tetradecanoylphorbol-13-acetate or ionophore. Up-regulation is independent of protein synthesis or RNA transcription, suggesting pre-existing AUBF is subject to post-translational modification. AUBF activity can be reversibly blocked by diamide but irreversibly inhibited by n-ethylmaleimide, suggesting that AUBF contains a redox switch as described for other RNA-binding proteins. Finally, AUBF activity is abolished by potato acid phosphatase, demonstrating that AUBF is a phosphoprotein. These data demonstrate that AUBF activity is subject to at least two levels of post-translational regulation and is enhanced by mitogens previously shown to induce the stabilization of AUUUA mRNAs. Based upon these data, we propose that AUBF binding may mediate 12-O-tetradecanoylphorbol-13-acetate and ionophore-mediated labile message stabilization.			MALTER, JS (corresponding author), TULANE UNIV,SCH MED,DEPT PATHOL,NEW ORLEANS,LA 70112, USA.				NCI NIH HHS [CA-01427] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K08CA001427] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BRAWERMAN G, 1989, CELL, V57, P9, DOI 10.1016/0092-8674(89)90166-9; FREEDMAN LP, 1988, NATURE, V334, P543, DOI 10.1038/334543a0; GILLIS P, 1991, J BIOL CHEM, V266, P3172; GREEN LM, 1989, P NATL ACAD SCI USA, V86, P4047, DOI 10.1073/pnas.86.11.4047; HARGROVE JL, 1989, FASEB J, V3, P2360, DOI 10.1096/fasebj.3.12.2676679; HENTZE MW, 1989, SCIENCE, V244, P357, DOI 10.1126/science.2711187; LIN JJ, 1990, SCIENCE, V247, P74, DOI 10.1126/science.2294594; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; MALTER JS, 1989, SCIENCE, V246, P664, DOI 10.1126/science.2814487; MULLNER EW, 1989, CELL, V58, P373, DOI 10.1016/0092-8674(89)90851-9; ROMANIUK PJ, 1985, BIOCHEMISTRY-US, V24, P4239, DOI 10.1021/bi00336a064; ROUAULT TA, 1988, SCIENCE, V241, P1207, DOI 10.1126/science.3413484; ROY C, 1990, NUCLEIC ACIDS RES, V18, P2125, DOI 10.1093/nar/18.8.2125; SCHULER GD, 1988, CELL, V55, P1115, DOI 10.1016/0092-8674(88)90256-5; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; STARZYK RM, 1982, NATURE, V298, P136, DOI 10.1038/298136a0; TANIGUCHI T, 1988, ANNU REV IMMUNOL, V6, P439, DOI 10.1146/annurev.iy.06.040188.002255; WILSON T, 1988, NATURE, V336, P396, DOI 10.1038/336396a0; WODNARFILIPOWICZ A, 1990, P NATL ACAD SCI USA, V87, P777, DOI 10.1073/pnas.87.2.777; ZAJAC-KAYE M, 1990, J BIOL CHEM, V265, P4547	21	195	198	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3167	3171						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993688				2022-12-25	WOS:A1991EX60000075
J	MEHLHORN, RJ				MEHLHORN, RJ			ASCORBATEASCORBIC AND DEHYDROASCORBIC ACID-MEDIATED REDUCTION OF FREE-RADICALS IN THE HUMAN ERYTHROCYTE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPIN PROBES; VITAMIN-E; LIPID-PEROXIDATION; ALPHA-TOCOPHEROL; ASCORBIC-ACID; EPIDERMIS; RESONANCE; MITOCHONDRIA; ANTIOXIDANT; INDIVIDUALS	Nitroxides were used as models of persistent free radicals to study the antioxidant function of ascorbic acid in the human erythrocyte. It was concluded that: 1) ascorbate and other reductant(s) derived from dehydroascorbic acid (DHA) in the presence of thiols are the only significant reducing agents for nitroxides, 2) glutathione and DHA reduce nitroxides by a process that cannot be inhibited by ascorbic acid oxidase, 3) erythrocytes can be depleted of ascorbic acid by exhaustive washing in the presence of membrane-permeable cationic nitroxides such as N,N-dimethylamino-Tempo, 4) ascorbate-depleted cells do not reduce nitroxides; however, nitroxide reduction is restored when the cells are incubated with DHA, 5) reduction of nitroxides in ascorbate-depleted, DHA-treated cells is significantly faster than in buffered solutions of DHA and glutathione, 6) several equivalents of nitroxide are reduced relative to the intracellular ascorbate pool, 7) sustained nitroxide reduction is observed even when most of the intracellular ascorbate is oxidized, 8) spin trapping of oxyradicals in tert-butyl hydroperoxide-treated cells is accelerated with ascorbate depletion and inhibited with ascorbate loading, 9) ascorbate can be quantified within intact cells by analyzing the initial reduction rates of membrane-permeable cationic nitroxides, and 10) DHA-stimulated reduction of cationic nitroxides is slower and less extensive in erythrocytes deficient in glucose-6-phosphate dehydrogenase than in normal erythrocytes.	UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley	MEHLHORN, RJ (corresponding author), UNIV CALIF BERKELEY LAWRENCE BERKELEY LAB, DIV APPL SCI, MAILSTOP 70-193A, BERKELEY, CA 94720 USA.				NIA NIH HHS [AG 04818] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG004818] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BASU S, 1979, BIOCHEM BIOPH RES CO, V90, P1335, DOI 10.1016/0006-291X(79)91182-3; Beauchamp Charles, ANAL BIOCHEM, V44, P276, DOI [10.1016/0003-2697(71)90370-8, DOI 10.1016/0003-2697(71)90370-8]; BELKIN S, 1987, ARCH BIOCHEM BIOPHYS, V256, P232, DOI 10.1016/0003-9861(87)90441-3; Borsook H, 1937, J BIOL CHEM, V117, P237; BRANCA M, 1988, FREE RADICAL BIO MED, V5, P7, DOI 10.1016/0891-5849(88)90057-3; CHRISTINE L, 1956, CLIN CHIM ACTA, V1, P557, DOI 10.1016/0009-8981(56)90043-2; COUET W R, 1985, Magnetic Resonance Imaging, V3, P83, DOI 10.1016/0730-725X(85)90012-8; Couet W R, 1984, Pharm Res, V1, P203, DOI 10.1023/A:1016317212601; DAVIES MJ, 1988, BIOCHIM BIOPHYS ACTA, V964, P28, DOI 10.1016/0304-4165(88)90063-3; DILIBERTO EJ, 1982, J NEUROCHEM, V39, P563, DOI 10.1111/j.1471-4159.1982.tb03982.x; ERIKSSON UG, 1986, J PHARM SCI, V75, P334, DOI 10.1002/jps.2600750404; FINKELSTEIN E, 1984, BIOCHIM BIOPHYS ACTA, V802, P90, DOI 10.1016/0304-4165(84)90038-2; FREI B, 1988, P NATL ACAD SCI USA, V85, P9748, DOI 10.1073/pnas.85.24.9748; FUCHS J, 1989, J INVEST DERMATOL, V93, P633, DOI 10.1111/1523-1747.ep12319780; HILL KE, 1984, BIOCHEM PHARMACOL, V33, P1065, DOI 10.1016/0006-2952(84)90514-8; HUELIN FE, 1949, AUST J SCI RES SER B, V2, P346, DOI 10.1071/BI9490346; HUGHES RE, 1964, NATURE, V203, P1068, DOI 10.1038/2031068a0; INGOLD KU, 1987, ARCH BIOCHEM BIOPHYS, V259, P224, DOI 10.1016/0003-9861(87)90489-9; KEANA JFW, 1984, PHYSIOL CHEM PHYS, V16, P477; Lentner C, 1984, GEIGY SCI TABLES, V3, P132; Mehlhorn R J, 1979, Methods Enzymol, V56, P515; MEHLHORN RJ, 1983, ANN NY ACAD SCI, V414, P180, DOI 10.1111/j.1749-6632.1983.tb31684.x; MEHLHORN RJ, 1984, METHOD ENZYMOL, V105, P215; MEHLHORN RJ, 1982, METHOD ENZYMOL, V88, P751; MORONNE MM, 1990, J MEMBRANE BIOL, V115, P31, DOI 10.1007/BF01869103; NIKI E, 1987, ANN NY ACAD SCI, V498, P186, DOI 10.1111/j.1749-6632.1987.tb23761.x; PACKER JE, 1979, NATURE, V278, P737, DOI 10.1038/278737a0; PACKER L, 1989, BIOCHEM BIOPH RES CO, V159, P229, DOI 10.1016/0006-291X(89)92427-3; PROLLA TA, 1990, FREE RADICAL RES COM, V9, P135, DOI 10.3109/10715769009148581; QUINTANILHA AT, 1977, P NATL ACAD SCI USA, V74, P570, DOI 10.1073/pnas.74.2.570; RAUCKMAN EJ, 1976, J ORG CHEM, V41, P564, DOI 10.1021/jo00865a037; SCARPA M, 1984, BIOCHIM BIOPHYS ACTA, V801, P215, DOI 10.1016/0304-4165(84)90070-9; SCHALLREUTER KU, 1989, FREE RADICAL BIO MED, V6, P519, DOI 10.1016/0891-5849(89)90045-2; SCHALLREUTER KU, 1986, BIOCHEM BIOPH RES CO, V136, P630, DOI 10.1016/0006-291X(86)90487-0; SRIVASTA.SK, 1969, J BIOL CHEM, V244, P9; TAKAGI M, 1988, J NUTR SCI VITAMINOL, V34, P141; THORNALLEY PJ, 1983, BIOCHIM BIOPHYS ACTA, V759, P16, DOI 10.1016/0304-4165(83)90183-6; TURRINI F, 1985, BLOOD, V66, P302; WAGNER ES, 1987, BIOCHIM BIOPHYS ACTA, V902, P133, DOI 10.1016/0005-2736(87)90143-X; WINKLER BS, 1987, BIOCHIM BIOPHYS ACTA, V925, P258, DOI 10.1016/0304-4165(87)90190-5	40	91	91	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2724	2731						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993652				2022-12-25	WOS:A1991EX60000011
J	WENSTRUP, RJ; SHRAGOHOWE, AW; LEVER, LW; PHILLIPS, CL; BYERS, PH; COHN, DH				WENSTRUP, RJ; SHRAGOHOWE, AW; LEVER, LW; PHILLIPS, CL; BYERS, PH; COHN, DH			THE EFFECTS OF DIFFERENT CYSTEINE FOR GLYCINE SUBSTITUTIONS WITHIN ALPHA-2(I) CHAINS - EVIDENCE OF DISTINCT STRUCTURAL DOMAINS WITHIN THE TYPE-I COLLAGEN TRIPLE HELIX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERINATAL OSTEOGENESIS IMPERFECTA; DIFFERENT TRIPEPTIDES; CULTURED FIBROBLASTS; ALPHA-1(I) CHAIN; POINT MUTATION; LETHAL VARIANT; PROCOLLAGEN; STABILITY; GENE; RNA	Affected individuals from two apparently distinct, mild osteogenesis imperfecta families were heterozygous for a G to T transition in the COL1A2 gene that resulted in cysteine for glycine substitutions at position 646 in the alpha-2(I) chain of type I collagen. A child with a moderately severe form of osteogenesis imperfecta was heterozygous for a G to T transition that resulted in a substitution of cysteine for glycine at position 259 in the COL1A2 gene. Type I collagen molecules containing an alpha-2(I) chain with cysteine at position 259 denaturated at a lower temperature than molecules containing an alpha-2(I) chain with cysteine at position 646. In contrast to cysteine for glycine substitutions in the alpha-1(I) chain, the severity of the osteogenesis imperfecta phenotype is not directly proportional to the distance of the mutation from the amino-terminal end of the triple helix. These findings could be explained if the type I collagen triple helix contains discontinuous domains that differ in their contributions to maintaining helix stability.	DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710; UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA 98195; UNIV WASHINGTON,CTR INHERITED DIS,SEATTLE,WA 98195; CEDARS SINAI MED CTR,DIV MED GENET,LOS ANGELES,CA 90048; UNIV CALIF LOS ANGELES,DEPT PEDIAT,LOS ANGELES,CA 90024	Duke University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Cedars Sinai Medical Center; University of California System; University of California Los Angeles	WENSTRUP, RJ (corresponding author), DUKE UNIV,MED CTR,DEPT PEDIAT,DURHAM,NC 27710, USA.			Phillips, Charlotte/0000-0002-7761-3783; Byers, Peter H./0000-0001-7786-7030	NIAMS NIH HHS [AR39837, AR38474, AR21557] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR021557, R29AR039837, R01AR039837, R29AR038474] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BALDWIN CT, 1989, J BIOL CHEM, V264, P3002; BARSH GS, 1981, P NATL ACAD SCI USA, V79, P3838; BATEMAN JF, 1990, ANN NY ACAD SCI, V580, P324, DOI 10.1111/j.1749-6632.1990.tb17941.x; BATEMAN JF, 1988, J BIOL CHEM, V263, P11627; BATEMAN JF, 1984, BIOCHEM J, V217, P103, DOI 10.1042/bj2170103; BATEMAN JF, 1987, J BIOL CHEM, V262, P7021; BERNARD MP, 1983, BIOCHEMISTRY-US, V22, P5213, DOI 10.1021/bi00291a023; BONADIO J, 1985, J BIOL CHEM, V260, P1734; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; BYERS PH, 1989, METABOLIC BASIS INHE, P2805; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COHN DH, 1986, P NATL ACAD SCI USA, V83, P6045, DOI 10.1073/pnas.83.16.6045; CONSTANTINOU CD, 1989, J CLIN INVEST, V83, P574, DOI 10.1172/JCI113920; DEWET W, 1987, J BIOL CHEM, V262, P16032; DOLZ R, 1986, BIOPOLYMERS, V25, P1069, DOI 10.1002/bip.360250607; GUBLER Y, 1983, GENE AMST, V876, P263; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; MARINI JC, 1989, J BIOL CHEM, V264, P11893; PACK M, 1989, J BIOL CHEM, V264, P19694; PATTERSON E, 1989, J BIOL CHEM, V264, P10083; PHILLIPS CL, 1990, J CLIN INVEST, V86, P1723, DOI 10.1172/JCI114897; PRIVALOV PL, 1982, ADV PROTEIN CHEM, V35, P1, DOI 10.1016/S0065-3233(08)60468-4; PROCKOP DJ, 1989, AM J MED GENET, V34, P60, DOI 10.1002/ajmg.1320340112; ROWE DW, 1985, J CLIN INVEST, V76, P604, DOI 10.1172/JCI112012; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; STARMAN BJ, 1989, J CLIN INVEST, V84, P1206, DOI 10.1172/JCI114286; THAKUR S, 1986, BIOPOLYMERS, V25, P1081, DOI 10.1002/bip.360250608; VOGEL BE, 1987, J BIOL CHEM, V262, P14737; WENSTRUP RJ, 1988, J BIOL CHEM, V263, P7734; WENSTRUP RJ, 1986, J CLIN INVEST, V78, P1449, DOI 10.1172/JCI112735; WENSTRUP RJ, 1990, AM J HUM GENET, V46, P975; WILLING MC, 1990, J CLIN INVEST, V85, P282, DOI 10.1172/JCI114424; ZHANG H, 1988, NUCLEIC ACIDS RES, V16, P1220, DOI 10.1093/nar/16.3.1220	36	48	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2590	2594						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1990009				2022-12-25	WOS:A1991EV51500088
J	MORIOKAFUJIMOTO, K; MARUMOTO, R; FUKUDA, T				MORIOKAFUJIMOTO, K; MARUMOTO, R; FUKUDA, T			MODIFIED ENTEROTOXIN SIGNAL SEQUENCES INCREASE SECRETION LEVEL OF THE RECOMBINANT HUMAN EPIDERMAL GROWTH-FACTOR IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; HYDROPHOBIC SEGMENT; HUMAN LYSOZYME; MEMBRANE; PEPTIDES; MUTATIONS; PRECURSOR; CULTURE; EXPORT; REGION	Amino acid substitutions were made in the heatlabile enterotoxin signal sequence of Escherichia coli by recombinant DNA techniques, and their influence on the secretion of recombinant human epidermal growth factor by E. coli was examined. The heat-labile enterotoxin signal sequence is an amino-terminal extension of the octadecapeptide chain and is comprised of three distinct regions: a positively charged amino-terminal region, a central hydrophobic region, and a carboxyl-terminal region with the cleavage site recognized by the signal peptidase. Some alterations in the signal sequence caused a 1.5-3.5-fold increase in the secretion of recombinant human epidermal growth factor. These were the introduction of: (i) polar and small residues into the carboxyl-terminal region (replacement of Pro-4 Leu-3 with Asn-Ala or Ser-Ala), which may give a favorable structure for the recognition and cleavage by the signal peptidase; and (ii) a polar residue into the central hydrophobic region (replacement of Ile-9 with Ser), which may cause an increase of the affinity to the cytoplasmic membrane. In the latter case, a large amount of the unprocessed "precursor" was accumulated. The combination of these modifications, however, did not work additively. An increase in the amino-terminal positive charge (insertion of Lys) had no effect on secretion. These results prove that the level of protein secretion is greatly dependent on the polarity of the carboxyl-terminal region and the hydrophobicity and/or the amphiphilicity of the central region. Moreover, the overall balance of the physicochemical properties of respective regions is important.	TAKEDA CHEM IND LTD, BIOTECHNOL RES LABS, JUSO HONMACHI, YODOGAWA KU, OSAKA 532, JAPAN; TAKEDA CHEM IND LTD, CHEM RES LABS, OSAKA 532, JAPAN	Takeda Chemical Industries; Takeda Chemical Industries								BARNES DW, 1982, J CELL BIOL, V93, P1, DOI 10.1083/jcb.93.1.1; BETLEY MJ, 1986, ANNU REV MICROBIOL, V40, P577, DOI 10.1146/annurev.mi.40.100186.003045; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; BRIGGS MS, 1985, SCIENCE, V228, P1096, DOI 10.1126/science.3158076; CHAN SJ, 1981, P NATL ACAD SCI-BIOL, V78, P5401, DOI 10.1073/pnas.78.9.5401; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; FUJIMOTO K, 1988, J BIOTECHNOL, V8, P77, DOI 10.1016/0168-1656(88)90070-3; GIERASCH LM, 1989, BIOCHEMISTRY-US, V28, P923, DOI 10.1021/bi00429a001; HARDY SJS, 1989, J CELL SCI, P29; IINO T, 1987, J BIOL CHEM, V262, P7412; INOUYE S, 1986, J BIOL CHEM, V261, P970; KENDALL DA, 1988, J BIOL CHEM, V263, P7261; KENDALL DA, 1986, NATURE, V321, P706, DOI 10.1038/321706a0; KOSHLAND D, 1982, CELL, V30, P903, DOI 10.1016/0092-8674(82)90295-1; LEHNHARDT S, 1988, J BIOL CHEM, V263, P10300; MICHAELIS S, 1986, J BACTERIOL, V167, P160, DOI 10.1128/jb.167.1.160-167.1986; NAGAHARI K, 1985, EMBO J, V4, P3589, DOI 10.1002/j.1460-2075.1985.tb04121.x; PERLMAN D, 1983, J MOL BIOL, V167, P391, DOI 10.1016/S0022-2836(83)80341-6; ROSE SP, 1975, J CELL PHYSIOL, V86, P593, DOI 10.1002/jcp.1040860504; ROSENBLATT M, 1980, P NATL ACAD SCI-BIOL, V77, P3983, DOI 10.1073/pnas.77.7.3983; VONHEIJNE G, 1989, PROTEIN ENG, V2, P531, DOI 10.1093/protein/2.7.531; VONHEIJNE G, 1987, FEBS LETT, V213, P238, DOI 10.1016/0014-5793(87)81497-7; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WATSON MEE, 1984, NUCLEIC ACIDS RES, V12, P5145, DOI 10.1093/nar/12.13.5145; WOLFE PB, 1982, J BIOL CHEM, V257, P7898; YAMAMOTO Y, 1989, BIOCHEMISTRY-US, V28, P2728, DOI 10.1021/bi00432a054; YAMAMOTO Y, 1987, BIOCHEM BIOPH RES CO, V149, P431, DOI 10.1016/0006-291X(87)90385-8	27	18	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1728	1732						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1988446				2022-12-25	WOS:A1991EU49700059
J	CHURCH, FC; PRATT, CW; HOFFMAN, M				CHURCH, FC; PRATT, CW; HOFFMAN, M			LEUKOCYTE CHEMOATTRACTANT PEPTIDES FROM THE SERPIN HEPARIN COFACTOR-II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL CHEMOATTRACTANT; BLOOD-COAGULATION; ALPHA-1-PROTEINASE INHIBITOR; TISSUE-INJURY; ELASTASE; ANTITHROMBIN; IDENTIFICATION; INACTIVATION; PROTEINS; INFLAMMATION	Heparin cofactor II (HC) is a plasma serine proteinase inhibitor (serpin) that inhibits the coagulant proteinase alpha-thrombin. We have recently demonstrated that proteolysis of HC by catalytic amounts of polymorphonuclear leukocyte proteinases (elastase or cathepsin G) generates leukocyte chemotaxins (Hoffman, M., Pratt, C. W., Brown, R. L., and Church, F. C. (1989) Blood 73, 1682-1685). One of four peptides produced when HC is degraded by neutrophil elastase has chemotactic activity for both monocytes and neutrophils with maximal migration comparable to formyl-Met-Leu-Phe, the "gold standard" bacterially derived chemotaxin. The amino-terminal sequence of this HC peptide is Asp-Phe-His-Lys-Glu-Asn-Thr-Val-... and the peptide corresponds to Asp-39 to Ile-66 of HC. A variety of synthetic peptides derived from this sequence were evaluated for leukocyte migration activity, and a dodecapeptide from Asp-49 to Tyr-60 (Asp-Trp-Ile-Pro-Glu-Gly-Glu-Glu-Asp-Asp-Asp-Tyr) was identified as the active site for leukocyte chemotactic action. The 12-mer synthetic peptide possesses significant neutrophil chemotactic action at 1 nM (60% of the maximal activity of formyl-Met-Leu-Phe), while a peptide with the reverse sequence has essentially no chemotactic activity. Cross-desensitization experiments also show that pretreatment of neutrophils with a 19-mer peptide (Asn-48 to Ile-66) greatly reduces subsequent chemotaxis to HC-neutrophil elastase proteolysis reaction products. When injected intraperitoneally in mice, the HC-neutrophil elastase digest elicits neutrophil migration. Our results demonstrate that not only does HC function as a thrombin inhibitor, but that limited proteolysis of HC near the amino terminus yields biologically active peptide(s) which might participate in inflammation and in wound healing and tissue repair processes.	UNIV N CAROLINA, DEPT PATHOL, CHAPEL HILL, NC 27599 USA; UNIV N CAROLINA, DEPT MED, CHAPEL HILL, NC 27599 USA; UNIV N CAROLINA, CTR THROMBOSIS & HEMOSTASIS, CHAPEL HILL, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill			Hoffman, Maureane/D-1025-2009	Hoffman, Maureane/0000-0001-7123-0100	NHLBI NIH HHS [HL-32656] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032656] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSSON TR, 1986, SCAND J HAEMATOL, V36, P96; BANDA MJ, 1988, J EXP MED, V167, P1608, DOI 10.1084/jem.167.5.1608; BANDA MJ, 1988, J BIOL CHEM, V263, P4481; BERTINA RM, 1987, THROMB HAEMOSTASIS, V57, P196; BLINDER MA, 1989, J BIOL CHEM, V264, P5128; BLINDER MA, 1988, BIOCHEMISTRY-US, V27, P752, DOI 10.1021/bi00402a039; Carrell R.W, 1986, PROTEINASE INHIBITOR, P403; CARRELL RW, 1985, NATURE, V317, P730, DOI 10.1038/317730a0; CHURCH FC, 1985, ANAL BIOCHEM, V146, P343, DOI 10.1016/0003-2697(85)90549-4; CHURCH FC, 1985, P NATL ACAD SCI USA, V82, P6431, DOI 10.1073/pnas.82.19.6431; CHURCH FC, 1989, BLOOD S, V74, P223; CORBIN LW, 1990, THROMB RES, V57, P77, DOI 10.1016/0049-3848(90)90196-J; DOOLITTLE RF, 1983, SCIENCE, V222, P417, DOI 10.1126/science.6604942; DOOLITTLE RF, 1989, TRENDS BIOCHEM SCI, V14, P244, DOI 10.1016/0968-0004(89)90055-8; ESMON CT, 1989, J BIOL CHEM, V264, P4743; FRAENKELCONRAT H, 1957, METHOD ENZYMOL, V4, P247, DOI 10.1016/0076-6879(57)04059-8; GALLIN JI, 1988, INFLAMMATION BASIC P, P471; GRIFFITH MJ, 1985, J BIOL CHEM, V260, P2218; HENRY RL, 1965, THROMB DIATH HAEMOST, V13, P35; HENSON PM, 1987, J CLIN INVEST, V79, P669, DOI 10.1172/JCI112869; HOFFMAN M, 1989, BLOOD, V73, P1682; HOFFMAN M, 1990, J LEUKOCYTE BIOL, V48, P156, DOI 10.1002/jlb.48.2.156; HORTIN G, 1986, J BIOL CHEM, V261, P5827; HORTIN GL, 1989, J BIOL CHEM, V264, P13979; JANOFF A, 1985, ANNU REV MED, V36, P207; JORDAN RE, 1987, SCIENCE, V237, P777, DOI 10.1126/science.3649921; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; NELSON RD, 1978, INFECT IMMUN, V22, P441, DOI 10.1128/IAI.22.2.441-444.1978; PEMBERTON PA, 1988, NATURE, V336, P257, DOI 10.1038/336257a0; PERLMUTTER DH, 1990, P NATL ACAD SCI USA, V87, P3753, DOI 10.1073/pnas.87.10.3753; PETERSON CB, 1987, J BIOL CHEM, V262, P8061; PLOW EF, 1982, J CLIN INVEST, V69, P564, DOI 10.1172/JCI110482; PRATT CW, 1990, J BIOL CHEM, V265, P6092; PRATT CW, 1989, ANN NY ACAD SCI, V556, P104; ROSENBERG RD, 1987, HEMOSTASIS THROMBOSI, P1373; SAROFF HA, 1983, B MATH BIOL, V45, P117, DOI 10.1007/BF02459391; SIE P, 1987, THROMB RES, V47, P657, DOI 10.1016/0049-3848(87)90104-6; TOLLEFSEN DM, 1985, BLOOD, V66, P769; WACHTFOGEL YT, 1983, J CLIN INVEST, V72, P1672, DOI 10.1172/JCI111126; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; WHINNA HC, 1988, J CELL BIOL, V107, P833; WINTROUB BU, 1981, J CLIN INVEST, V68, P484, DOI 10.1172/JCI110279	43	44	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					704	709						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985958				2022-12-25	WOS:A1991ET17700007
J	SOUVIGNET, C; PELOSIN, JM; DANIEL, S; CHAMBAZ, EM; RANSAC, S; VERGER, R				SOUVIGNET, C; PELOSIN, JM; DANIEL, S; CHAMBAZ, EM; RANSAC, S; VERGER, R			ACTIVATION OF PROTEIN-KINASE-C IN LIPID MONOLAYERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID MONOLAYERS; PHORBOL ESTER; MIXED MICELLES; RAT-BRAIN; CALCIUM; DIACYLGLYCEROL; ASSOCIATION; MEMBRANES; PURIFICATION; SPECIFICITY	The potential of lipid monolayers spread at an air-water interface was investigated as a well defined membrane model able to support protein kinase C (PKC) association and activation. PKC association to a mixed phospholipid from (phosphatidylcholine, phosphatidylserine) could be detected by an increase of the monolayer surface pressure. This association was strikingly dependent upon the presence of submicromolar concentrations of Ca2+. The effect of Ca2+ resulted in an increase of the PKC penetration into the lipid core at a given permissive surface pressure as well as in a marked increase of the critical surface pressure (29-38 dynes/cm) above which the enzyme was excluded from the membrane. Inclusion of diacylglycerol or tetradecanoate phorbol acetate (TPA) did not modify the PKC-monolayer association in a detectable manner. PKC associated to the lipid layer exhibited the expected catalytic property and was fully activated when diacylglycerol or TPA was included in the membrane. PKC activity was highly dependent upon the surface pressure of the lipid monolayer, being optimal between 30 and 25 dynes/cm. Study of the compression isotherm of various diacylglycerol structures revealed that all potent PKC agonists exhibited an expanded liquid phase behavior with collapse pressure below 40 dynes/cm, in contrast to weak activators which showed condensed isotherms with high collapse pressure (almost-equal-to 60 dynes/cm). These observations showed that the lipid monolayer system is well adapted to the study of the molecular mechanisms involved in the regulation of PKC activity at a model membrane interface. They are in line with the suggestion of a major role of Ca2+ in the association (translocation ) of PKC to membrane in living cell and suggest that diacylglycerol (and TPA) might activate membrane-associated PKC through local change in the surrounding lipid phase organization.	CNRS,CTR BIOCHIM & BIOL MOLEC,F-13009 MARSEILLE,FRANCE	Centre National de la Recherche Scientifique (CNRS)	SOUVIGNET, C (corresponding author), CEN,CEA,DBMS,LBIO,BIOCHIM REGULAT CELLULAIRES ENDOCRINES LAB,INSERM,F-38041 GRENOBLE,FRANCE.			, Stephane Ransac/0000-0003-2597-4584				ALKON DL, 1988, SCIENCE, V239, P998, DOI 10.1126/science.2830669; ASHENDEL CL, 1986, CARCINOGENESIS, V7, P517, DOI 10.1093/carcin/7.4.517; BAZZI MD, 1987, BIOCHEMISTRY-US, V26, P5002, DOI 10.1021/bi00390a018; BAZZI MD, 1988, BIOCHEMISTRY-US, V27, P6776, DOI 10.1021/bi00418a020; BAZZI MD, 1987, BIOCHEMISTRY-US, V26, P115, DOI 10.1021/bi00375a017; BAZZI MD, 1987, BIOCHEMISTRY-US, V26, P1974, DOI 10.1021/bi00381a029; BELL RM, 1986, CELL, V45, P631, DOI 10.1016/0092-8674(86)90774-9; BLUME A, 1979, BIOCHIM BIOPHYS ACTA, V557, P32, DOI 10.1016/0005-2736(79)90087-7; BONI LT, 1985, J BIOL CHEM, V260, P819; BOUGIS P, 1981, BIOCHEMISTRY-US, V20, P4915, DOI 10.1021/bi00520a017; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; DEMEL RA, 1975, BIOCHIM BIOPHYS ACTA, V406, P97, DOI 10.1016/0005-2736(75)90045-0; EPAND RM, 1988, BIOSCIENCE REP, V8, P49, DOI 10.1007/BF01128971; EPAND RM, 1987, CHEM-BIOL INTERACT, V63, P239, DOI 10.1016/0009-2797(87)90044-5; GO M, 1987, BIOCHEM BIOPH RES CO, V144, P598; GOPALAKRISHNA R, 1986, J BIOL CHEM, V261, P6438; GRAHAM DE, 1979, J COLLOID INTERF SCI, V70, P403, DOI 10.1016/0021-9797(79)90048-1; HANNUN YA, 1986, J BIOL CHEM, V261, P7184; HANNUN YA, 1985, J BIOL CHEM, V260, P39; HARAFUJI H, 1980, J BIOCHEM, V87, P1305, DOI 10.1093/oxfordjournals.jbchem.a132868; INAGAKI M, 1986, FEBS LETT, V202, P277, DOI 10.1016/0014-5793(86)80701-3; INOUE M, 1977, J BIOL CHEM, V252, P7610; KIKKAWA U, 1982, J BIOL CHEM, V257, P13341; KIMELBERG H, 1971, J BIOL CHEM, V252, P4313; KIMELBERG HK, 1971, BIOCHIM BIOPHYS ACTA, V233, P805, DOI 10.1016/0005-2736(71)90181-7; KISHIMOTO A, 1980, J BIOL CHEM, V255, P2273; Macritchie F, 1978, Adv Protein Chem, V32, P283, DOI 10.1016/S0065-3233(08)60577-X; MAYER LD, 1983, BIOCHEMISTRY-US, V22, P316, DOI 10.1021/bi00271a013; SIEGEL DP, 1989, BIOCHEMISTRY-US, V28, P3703, DOI 10.1021/bi00435a012; TAKAI Y, 1979, J BIOL CHEM, V254, P3692; VERGER R, 1982, CHEM PHYS LIPIDS, V30, P189, DOI 10.1016/0009-3084(82)90052-4; WALTON GM, 1987, ANAL BIOCHEM, V161, P425, DOI 10.1016/0003-2697(87)90471-4; WOLF M, 1985, J BIOL CHEM, V260, P5718	33	54	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					40	44						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985909				2022-12-25	WOS:A1991EQ33900008
J	VARADHACHARY, A; MALONEY, PC				VARADHACHARY, A; MALONEY, PC			RECONSTITUTION OF THE PHOSPHOGLYCERATE TRANSPORT PROTEIN OF SALMONELLA-TYPHIMURIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEXOSE 6-PHOSPHATE ANTIPORT; SUGAR PHOSPHATE-TRANSPORT; DRIVEN ACTIVE-TRANSPORT; ESCHERICHIA-COLI; STREPTOCOCCUS-LACTIS; NUCLEOTIDE-SEQUENCE; MEMBRANE-VESICLES; ANION-EXCHANGE; SYSTEM; MECHANISM	Operation of the phosphoglycerate transport protein (PgtP) of Salmonella typhimurium has been studied in proteoliposomes by using a technique in which membrane protein is solubilized and reconstituted directly from small volumes of cell cultures. When protein from induced cells was reconstituted into phosphate (P(i))-loaded proteoliposomes, it was possible to demonstrate a PgtP-mediated exchange of internal and external phosphate. For this homologous P(i):P(i) antiport, kinetic analysis indicated a Michaelis constant (K(t)) of 1 mM and a maximal velocity of 26 nmol/min mg of protein; arsenate inhibited with a K(i) of 1.3 mM, suggesting that PgtP did not discriminate between these two inorganic substrates. P(i)-loaded proteoliposomes also accumulated 3-phosphoglycerate and phosphoenolpyruvate, establishing for each of them a concentration gradient (in/out) of about 100-fold; phosphoenolpyruvate (K(i) = 70-mu-M) rather than 3-phosphoglycerate (K(t) = 700, K(i) = 900-mu-M) was the preferred substrate for these conditions. We also concluded that such heterologous exchange was a neutral event, since its rate and extent were unaffected by the presence of a protonophore and unresponsive to the imposition of a membrane potential (positive or negative inside). In quantitative work, we found a stoichiometry of 1:1 for the exchange of P(i) and 3-phosphoglycerate, and given an electroneutral exchange, this finding is most easily understood as the overall exchange of divalent P(i) against divalent phosphoglycerate. These experiments establish that PgtP functions as an anion exchange protein and that it shares important mechanistic features with the P(i)-linked antiporters, GlpT and UhpT, responsible for transport of glycerol 3-phosphate and hexose 6-phosphates into Escherichia coli.			VARADHACHARY, A (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT PHYSIOL,BALTIMORE,MD 21205, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024195, R56GM024195] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM24195] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMBUDKAR SV, 1990, J BIOL CHEM, V265, P12287; AMBUDKAR SV, 1986, J BIOL CHEM, V261, P9083; AMBUDKAR SV, 1986, J BIOL CHEM, V261, P79; AMBUDKAR SV, 1984, J BIOL CHEM, V259, P2576; AMBUDKAR SV, 1986, P NATL ACAD SCI USA, V83, P280, DOI 10.1073/pnas.83.2.280; ANANTHRAMA V, 1988, J BIOL CHEM, V264, P7244; BROOKER RJ, 1989, J BIOL CHEM, V264, P8135; CARRASCO N, 1989, BIOCHEMISTRY-US, V28, P2533, DOI 10.1021/bi00432a028; COHEN G N, 1956, Ann Inst Pasteur (Paris), V91, P693; DIETZ GW, 1976, ADV ENZYMOL RAMB, V44, P237; EIGLMEIER K, 1987, MOL MICROBIOL, V1, P251, DOI 10.1111/j.1365-2958.1987.tb01931.x; FLIEGE R, 1978, BIOCHIM BIOPHYS ACTA, V502, P232, DOI 10.1016/0005-2728(78)90045-2; FLUGGE UI, 1983, BIOCHIM BIOPHYS ACTA, V725, P229, DOI 10.1016/0005-2728(83)90195-0; FREEDBERG WB, 1973, J BACTERIOL, V115, P816, DOI 10.1128/JB.115.3.816-823.1973; FREIDRICH MJ, 1987, J BACTERIOL, V169, P3556; FRIEDBERG I, 1972, J BACTERIOL, V112, P1201, DOI 10.1128/JB.112.3.1201-1205.1972; GOLDRICK D, 1988, J BACTERIOL, V170, P3421, DOI 10.1128/jb.170.8.3421-3426.1988; HUGENHOLTZ J, 1981, P NATL ACAD SCI-BIOL, V78, P3446, DOI 10.1073/pnas.78.6.3446; KABACK HR, 1988, ANNU REV PHYSIOL, V50, P243; KAHAN FM, 1974, ANN NY ACAD SCI, V235, P364, DOI 10.1111/j.1749-6632.1974.tb43277.x; LURIA SE, 1957, J BACTERIOL, V74, P461, DOI 10.1002/path.1700740226; MALONEY PC, 1990, MICROBIOL REV, V54, P1; MALONEY PC, 1984, J BACTERIOL, V158, P238, DOI 10.1128/JB.158.1.238-245.1984; MIMMACK ML, 1989, P NATL ACAD SCI USA, V86, P8257, DOI 10.1073/pnas.86.21.8257; MITCHELL P, 1954, J GEN MICROBIOL, V11, P73, DOI 10.1099/00221287-11-1-73; NEWMAN MJ, 1980, J BIOL CHEM, V255, P583; SAIER MH, 1975, J BIOL CHEM, V250, P5089; SONNA LA, 1988, J MEMBRANE BIOL, V101, P267, DOI 10.1007/BF01872841; SONNA LA, 1988, J BIOL CHEM, V263, P6625; VARADHACHARY A, 1990, MOL MICROBIOL, V4, P1407, DOI 10.1111/j.1365-2958.1990.tb00720.x; VENKATESWARAN PS, 1972, J BACTERIOL, V110, P935, DOI 10.1128/JB.110.3.935-944.1972; WINKLER HH, 1970, J BACTERIOL, V101, P470, DOI 10.1128/JB.101.2.470-475.1970	32	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					130	135						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985888				2022-12-25	WOS:A1991EQ33900022
J	MITCHELL, JP; HARDIE, DG; VULLIET, PR				MITCHELL, JP; HARDIE, DG; VULLIET, PR			SITE-SPECIFIC PHOSPHORYLATION OF TYROSINE-HYDROXYLASE AFTER KCL DEPOLARIZATION AND NERVE GROWTH-FACTOR TREATMENT OF PC12 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; ADRENAL CHROMAFFIN CELLS; 56 MM K+; RAT PHEOCHROMOCYTOMA; MULTIPROTEIN KINASE; ENZYME ACTIVATION; RAPID ACTIVATION; PURIFICATION; 3-MONOOXYGENASE; IDENTIFICATION	The phosphorylation and activation of tyrosine hydroxylase was examined in PC12 cells following depolariztion with KC1 or treatment with nerve growth factor. Both treatments activate tyrosine hydroxylase (TH) and increase enzyme phosphorylation. Site-specific analysis of the tryptic phosphopeptides of TH isolated from [P-32]phosphate-labeled PC12 cells demonstrated that the major phosphorylated peptide (termed "H25") did not contain any of the previously reported phosphorylation sites. Phosphoamino acid analysis of this peptide demonstrated that the phosphorylated residue was a serine. Synthetic tryptic peptides containing putative phosphorylation sites were prepared, and subjected to high performance liquid chromatography analysis and isoelectric focusing. The tryptic phosphopeptide containing serine 31 comigrated with the H25 peptide during both of these analytical techniques. The tryptic phosphopeptide produced by the phosphorylation of tyrosine hydroxylase by the recently discovered proline-directed protein kinase and the phosphorylated synthetic phosphopeptide TH2-12 are clearly separated from H25 by this analysis. We conclude that serine 31 is phosphorylated during KC1 depolarization and nerve growth factor treatment of PC12 cells and that this phosphorylation is responsible for the activation of tyrosine hydroxylase. Since this site is not located in a sequence selective for any of the "classical" protein kinases, we suggest that a novel protein kinase may be responsible for the phosphorylation of this site. Since serine 31 has proline residue on the carboxyl-terminal side, the possibility that this kinase may be related to the recently reported proline-directed protein kinase is discussed. Other sites that are also phosphorylated on TH during KC1 depolarization include serine 19, which is known to be phosphorylated by calmodulin-dependent protein kinase II. A schematic model for the regulation of tyrosine hydroxylase activity by phosphorylation of the NH2-terminal regulatory domain is presented.	UNIV CALIF DAVIS,DEPT VET PHARMACOL & TOXICOL,DAVIS,CA 95616; UNIV DUNDEE,DEPT BIOCHEM,DUNDEE DD1 4HN,SCOTLAND	University of California System; University of California Davis; University of Dundee			Hardie, David/Z-1979-2019	Hardie, Grahame/0000-0002-8373-7379				ABATE C, 1988, BIOCHEM BIOPH RES CO, V151, P1446, DOI 10.1016/S0006-291X(88)80524-2; ATKINSON J, 1987, J NEUROCHEM, V49, P1241, DOI 10.1111/j.1471-4159.1987.tb10016.x; BAILEY SW, 1989, BIOCHEMISTRY-US, V28, P494, DOI 10.1021/bi00428a013; BENOREPARSONS M, 1989, ARCH BIOCHEM BIOPHYS, V272, P274, DOI 10.1016/0003-9861(89)90220-8; BONNEFOY E, 1988, EUR J BIOCHEM, V174, P685, DOI 10.1111/j.1432-1033.1988.tb14152.x; CAHILL AL, 1984, P NATL ACAD SCI-BIOL, V81, P7243, DOI 10.1073/pnas.81.22.7243; CAMPBELL DG, 1986, J BIOL CHEM, V261, P489; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; FRENCH TA, 1985, J PHARMACOL EXP THER, V232, P315; GEORGE RJ, 1989, J NEUROCHEM, V52, P274, DOI 10.1111/j.1471-4159.1989.tb10928.x; GREENE LA, 1984, J NEUROCHEM, V42, P1728, DOI 10.1111/j.1471-4159.1984.tb12764.x; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GRIFFITH LC, 1988, J BIOL CHEM, V263, P9542; GRIMA B, 1985, P NATL ACAD SCI USA, V82, P353; HAAVIK J, 1988, BIOCHIM BIOPHYS ACTA, V953, P142, DOI 10.1016/0167-4838(88)90019-2; HALEGOUA S, 1980, CELL, V22, P571, DOI 10.1016/0092-8674(80)90367-0; HAYCOCK JW, 1988, P NATL ACAD SCI USA, V85, P1677, DOI 10.1073/pnas.85.5.1677; HAYCOCK JW, 1990, J BIOL CHEM, V265, P11682; HAYCOCK JW, 1982, J BIOL CHEM, V257, P2641; HOELDTKE R, 1977, J BIOL CHEM, V252, P3160; JOH TH, 1978, P NATL ACAD SCI USA, V75, P4744, DOI 10.1073/pnas.75.10.4744; KWAN SW, 1989, J NEUROSCI RES, V23, P316, DOI 10.1002/jnr.490230311; LEVITT M, 1965, J PHARMACOL EXP THER, V148, P1; MASSERANO JM, 1979, MOL PHARMACOL, V16, P513; MASSERANO JM, 1989, CATECHOLAMINES, V2, P427; MCTIGUE M, 1985, J BIOL CHEM, V260, P9047; POLLOCK RJ, 1981, J NEUROCHEM, V37, P855, DOI 10.1111/j.1471-4159.1981.tb04471.x; REIMANN EM, 1983, METHOD ENZYMOL, V99, P51; ROSKOSKI R, 1987, J NEUROCHEM, V48, P840, DOI 10.1111/j.1471-4159.1987.tb05593.x; TACHIKAWA E, 1987, J NEUROCHEM, V48, P1366, DOI 10.1111/j.1471-4159.1987.tb05673.x; TACHIKAWA E, 1986, MOL PHARMACOL, V30, P476; VULLIET PR, 1984, J BIOL CHEM, V259, P3680; VULLIET PR, 1980, P NATL ACAD SCI-BIOL, V77, P92, DOI 10.1073/pnas.77.1.92; VULLIET PR, 1985, FEBS LETT, V182, P335, DOI 10.1016/0014-5793(85)80328-8; VULLIET PR, 1989, J BIOL CHEM, V264, P16292; VULLIET PR, 1981, FUNCTION REGULATION, P15; WAYMIRE JC, 1988, J BIOL CHEM, V263, P12439; WAYMIRE JC, 1971, ANAL BIOCHEM, V43, P588, DOI 10.1016/0003-2697(71)90291-0; WEINER N, 1978, LIFE SCI, V22, P1197, DOI 10.1016/0024-3205(78)90088-7; YAMAUCHI T, 1981, J BIOL CHEM, V256, P5404; YANAGIHARA N, 1984, MOL PHARMACOL, V26, P141; ZIGMOND RE, 1989, ANNU REV NEUROSCI, V12, P415, DOI 10.1146/annurev.ne.12.030189.002215	42	37	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1990	265	36					22358	22364						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP556	1979980				2022-12-25	WOS:A1990EP55600049
J	TORTORA, G; CHOCHUNG, YS				TORTORA, G; CHOCHUNG, YS			TYPE-II REGULATORY SUBUNIT OF PROTEIN-KINASE RESTORES CAMP-DEPENDENT TRANSCRIPTION IN A CAMP-UNRESPONSIVE CELL-LINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note									NCI,TUMOR IMMUNOL & BIOL LAB,CELLULAR BIOCHEM SECT,BLDG 10,RM 5B38,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Tortora, Giampaolo/AAA-1252-2019	Tortora, Giampaolo/0000-0002-1378-4962				AKERBLOM IE, 1988, SCIENCE, V241, P350, DOI 10.1126/science.2838908; ALLY S, 1988, P NATL ACAD SCI USA, V85, P6319, DOI 10.1073/pnas.85.17.6319; BUCHLER W, 1988, FEBS LETT, V228, P27, DOI 10.1016/0014-5793(88)80577-5; BUSKIRK R, 1985, MOL CELL BIOL, V5, P1984; CLEGG CH, 1987, J BIOL CHEM, V262, P13111; CLEGG CH, 1988, P NATL ACAD SCI USA, V85, P3702; CORBIN JD, 1975, J BIOL CHEM, V250, P218; DEAN M, 1987, ONCOGENE RES, V1, P279; EKANGER R, 1985, J BIOL CHEM, V260, P3393; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GROVE JR, 1987, SCIENCE, V238, P530; HOFFMAN F, 1975, J BIOL CHEM, V250, P7795; HOFMANN F, 1977, J BIOL CHEM, V252, P1441; JAHNSEN T, 1986, J BIOL CHEM, V261, P2352; JHAPPAN C, 1986, J VIROL, V60, P750, DOI 10.1128/JVI.60.2.750-753.1986; LEE DC, 1983, P NATL ACAD SCI-BIOL, V80, P3608, DOI 10.1073/pnas.80.12.3608; LEVY FO, 1988, MOL ENDOCRINOL, V2, P1364, DOI 10.1210/mend-2-12-1364; MCGEADY ML, 1989, ONCOGENE, V4, P1375; MELLON PL, 1989, P NATL ACAD SCI USA, V86, P4887, DOI 10.1073/pnas.86.13.4887; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; OTTEN AD, 1989, J BIOL CHEM, V264, P20255; OYEN O, 1989, FEBS LETT, V246, P57, DOI 10.1016/0014-5793(89)80253-4; RIABOWOL KT, 1988, NATURE, V336, P83, DOI 10.1038/336083a0; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; SANDBERG M, 1987, BIOCHEM BIOPH RES CO, V149, P939, DOI 10.1016/0006-291X(87)90499-2; SCOTT JD, 1987, P NATL ACAD SCI USA, V84, P5192, DOI 10.1073/pnas.84.15.5192; SHOWERS MO, 1986, J BIOL CHEM, V261, P6288; TORTORA G, 1990, Proceedings of the American Association for Cancer Research Annual Meeting, V31, P38; TORTORA G, 1990, P NATL ACAD SCI USA, V87, P705, DOI 10.1073/pnas.87.2.705; TORTORA G, 1989, P NATL ACAD SCI USA, V86, P2849, DOI 10.1073/pnas.86.8.2849; UHLER MD, 1986, J BIOL CHEM, V261, P5360; UHLER MD, 1986, P NATL ACAD SCI USA, V83, P1300, DOI 10.1073/pnas.83.5.1300; WU JC, 1989, J BIOL CHEM, V264, P9989	34	37	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	1990	265	30					18067	18070						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EE201	1976635				2022-12-25	WOS:A1990EE20100007
J	PUOPOLO, K; FORGAC, M				PUOPOLO, K; FORGAC, M			FUNCTIONAL REASSEMBLY OF THE COATED VESICLE PROTON PUMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									TUFTS UNIV,SCH MED,DEPT PHYSIOL,BOSTON,MA 02111	Tufts University			Puopolo, Karen/AAY-7748-2021		NIDDK NIH HHS [P30 DK 34928] Funding Source: Medline; NIGMS NIH HHS [R01 GM034478, GM 34478] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034478, R01GM034478] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADACHI I, 1990, J BIOL CHEM, V265, P967; ADACHI I, 1990, J BIOL CHEM, V265, P960; AMZEL LM, 1983, ANNU REV BIOCHEM, V52, P801, DOI 10.1146/annurev.bi.52.070183.004101; APPS DK, 1989, BIOCHEM J, V263, P81, DOI 10.1042/bj2630081; ARAI H, 1987, J BIOL CHEM, V262, P11006; ARAI H, 1987, BIOCHEMISTRY-US, V26, P6632, DOI 10.1021/bi00395a011; ARAI H, 1989, BIOCHEMISTRY-US, V28, P3075, DOI 10.1021/bi00433a051; ARAI H, 1988, J BIOL CHEM, V263, P8796; BOWMAN BJ, 1988, J BIOL CHEM, V263, P14002; BOWMAN BJ, 1989, J BIOL CHEM, V264, P15606; BOWMAN EJ, 1988, J BIOL CHEM, V263, P13994; FORGAC M, 1984, J BIOL CHEM, V259, P8101; FORGAC M, 1989, PHYSIOL REV, V69, P765, DOI 10.1152/physrev.1989.69.3.765; FUTAI M, 1989, ANNU REV BIOCHEM, V58, P111; GLUCK S, 1987, J BIOL CHEM, V262, P15780; KANE PM, 1989, J BIOL CHEM, V264, P19236; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI SP, 1988, J BIOL CHEM, V263, P16731; MANDEL M, 1988, P NATL ACAD SCI USA, V85, P5521, DOI 10.1073/pnas.85.15.5521; MANOLSON MF, 1988, J BIOL CHEM, V263, P17987; MORIYAMA Y, 1989, J BIOL CHEM, V264, P3577; NELSON H, 1989, J BIOL CHEM, V264, P1775; NELSON N, 1989, TRENDS BIOCHEM SCI, V14, P113, DOI 10.1016/0968-0004(89)90134-5; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; PARRY RV, 1989, J BIOL CHEM, V264, P20025; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; SCHNEIDER E, 1987, MICROBIOL REV, V51, P477, DOI 10.1128/MMBR.51.4.477-497.1987; SENIOR AE, 1983, J MEMBRANE BIOL, V73, P105, DOI 10.1007/BF01870434; XIE XS, 1988, J BIOL CHEM, V263, P9859; YOUNG GPH, 1988, P NATL ACAD SCI USA, V85, P9590, DOI 10.1073/pnas.85.24.9590; ZIMNIAK L, 1988, J BIOL CHEM, V263, P9102	31	68	68	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1990	265	25					14836	14841						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX400	1975587				2022-12-25	WOS:A1990DX40000028
J	HURLBURT, BK; YANOFSKY, C				HURLBURT, BK; YANOFSKY, C			ENHANCED OPERATOR BINDING BY TRP SUPERREPRESSORS OF ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											HURLBURT, BK (corresponding author), STANFORD UNIV,DEPT BIOL SCI,STANFORD,CA 94305, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM011980] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM08136, GM11980] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENNETT GN, 1978, J MOL BIOL, V121, P139, DOI 10.1016/S0022-2836(78)80002-3; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; CAREY J, 1989, J BIOL CHEM, V264, P1941; CAREY J, 1988, P NATL ACAD SCI USA, V85, P975, DOI 10.1073/pnas.85.4.975; ELIASON JL, 1985, CELL, V45, P619; GUNSALUS RP, 1980, P NATL ACAD SCI-BIOL, V77, P7117, DOI 10.1073/pnas.77.12.7117; HAYDOCK PV, 1984, BIOCHEM BIOPH RES CO, V119, P926, DOI 10.1016/0006-291X(84)90862-3; JOACHIMIAK A, 1983, J BIOL CHEM, V258, P2641; KELLEY RL, 1985, P NATL ACAD SCI USA, V82, P483, DOI 10.1073/pnas.82.2.483; KIM JG, 1987, J MOL BIOL, V196, P149, DOI 10.1016/0022-2836(87)90517-1; KLIG LS, 1987, NUCLEIC ACIDS RES, V15, P5339, DOI 10.1093/nar/15.13.5339; KLIG LS, 1988, J BIOL CHEM, V263, P243; LAWSON CL, 1988, PROTEINS, V3, P18, DOI 10.1002/prot.340030103; LIERMO S, 1987, BIOCHEMISTRY-US, V26, P2095; MARMORSTEIN RQ, 1989, J BIOL CHEM, V264, P9149; MARMORSTEIN RQ, 1989, NUCLEIC ACIDS MOL BI, V3, P56; NELSON HCM, 1985, CELL, V42, P549, DOI 10.1016/0092-8674(85)90112-6; OTWINOWSKI Z, 1988, NATURE, V335, P321, DOI 10.1038/335321a0; PALUH JL, 1986, NUCLEIC ACIDS RES, V14, P7851, DOI 10.1093/nar/14.20.7851; RIGGS AD, 1970, J MOL BIOL, V48, P67, DOI 10.1016/0022-2836(70)90219-6; SCHEVITZ RW, 1985, NATURE, V317, P782, DOI 10.1038/317782a0; TAKEDA Y, 1986, J BIOL CHEM, V261, P8608; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6961, DOI 10.1021/bi00527a030; WINTER RB, 1981, BIOCHEMISTRY-US, V20, P6948, DOI 10.1021/bi00527a029; ZHANG RG, 1987, NATURE, V327, P591, DOI 10.1038/327591a0; ZURAWSKI G, 1981, J MOL BIOL, V145, P47, DOI 10.1016/0022-2836(81)90334-X	27	59	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 15	1990	265	14					7853	7858						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DC835	1970820				2022-12-25	WOS:A1990DC83500027
J	CHAMBERS, TC; MCAVOY, EM; JACOBS, JW; EILON, G				CHAMBERS, TC; MCAVOY, EM; JACOBS, JW; EILON, G			PROTEIN KINASE-C PHOSPHORYLATES P-GLYCOPROTEIN IN MULTIDRUG RESISTANT HUMAN KB CARCINOMA-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											CHAMBERS, TC (corresponding author), MERCK SHARP & DOHME LTD,DEPT BIOL CHEM,W POINT,PA 19486, USA.							AQUINO A, 1988, CANCER RES, V48, P3324; BAZZI MD, 1988, BIOCHEM BIOPH RES CO, V152, P336, DOI 10.1016/S0006-291X(88)80719-8; BAZZI MD, 1988, BIOCHEMISTRY-US, V27, P7589, DOI 10.1021/bi00420a003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADLEY G, 1988, BIOCHIM BIOPHYS ACTA, V948, P87, DOI 10.1016/0304-419X(88)90006-6; CARLSEN SA, 1977, BIOCHIM BIOPHYS ACTA, V467, P238, DOI 10.1016/0005-2736(77)90199-7; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; CORNWELL MM, 1986, J BIOL CHEM, V261, P7921; CORNWELL MM, 1987, FASEB J, V1, P51, DOI 10.1096/fasebj.1.1.2886389; CORNWELL MM, 1986, P NATL ACAD SCI USA, V83, P3847, DOI 10.1073/pnas.83.11.3847; CORNWELL MM, 1987, J BIOL CHEM, V262, P2166; FINE RL, 1988, P NATL ACAD SCI USA, V85, P582, DOI 10.1073/pnas.85.2.582; FOJO A, 1985, CANCER RES, V45, P3002; GARMAN D, 1983, BIOCHEM PHARMACOL, V32, P3633, DOI 10.1016/0006-2952(83)90315-5; GOTTESMAN MM, 1988, TRENDS PHARMACOL SCI, V9, P54, DOI 10.1016/0165-6147(88)90117-4; GOTTESMAN MM, 1988, J BIOL CHEM, V263, P12163; GREENBERGER LM, 1988, J NATL CANCER I, V80, P506, DOI 10.1093/jnci/80.7.506; GROS P, 1986, CELL, V47, P371, DOI 10.1016/0092-8674(86)90594-5; HAMADA H, 1986, P NATL ACAD SCI USA, V83, P7785, DOI 10.1073/pnas.83.20.7785; HAMADA H, 1987, CANCER RES, V47, P2860; HAMADA H, 1988, J BIOL CHEM, V263, P1454; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; KARTNER N, 1985, NATURE, V316, P820, DOI 10.1038/316820a0; KIKKAWA U, 1986, ANNU REV CELL BIOL, V2, P149, DOI 10.1146/annurev.cb.02.110186.001053; KIKKAWA U, 1983, METHOD ENZYMOL, V99, P288; KING VF, 1988, J BIOL CHEM, V263, P2238; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MELLADO W, 1987, BIOCHEMISTRY-US, V26, P6900, DOI 10.1021/bi00396a005; OCALLAHAN CM, 1988, J BIOL CHEM, V263, P17342; PASTAN I, 1988, P NATL ACAD SCI USA, V85, P4486, DOI 10.1073/pnas.85.12.4486; RICHERT ND, 1988, BIOCHEMISTRY-US, V27, P7607, DOI 10.1021/bi00420a006; RIORDAN JR, 1985, PHARMACOL THERAPEUT, V28, P51, DOI 10.1016/0163-7258(85)90082-8; ROY SN, 1985, CANCER RES, V45, P3856; SAFA AR, 1987, J BIOL CHEM, V262, P7884; SHEN DW, 1986, J BIOL CHEM, V261, P7762; WHITEHOUSE S, 1983, METHOD ENZYMOL, V99, P80; YANG CPH, 1988, BIOCHEM PHARMACOL, V37, P1417	38	221	229	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1990	265	13					7679	7686						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB307	1970571				2022-12-25	WOS:A1990DB30700089
J	FEUERSTEIN, N; LINDSBERG, ML; TUNG, L; FRANCIS, ML; MOND, JJ				FEUERSTEIN, N; LINDSBERG, ML; TUNG, L; FRANCIS, ML; MOND, JJ			IDENTIFICATION OF A PROMINENT 85-KDA CAMP-DEPENDENT PHOSPHOPROTEIN ASSOCIATED WITH LATE G1 PHASE IN MITOGEN-STIMULATED LYMPHOCYTES-B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; NUCLEAR MATRIX PROTEIN; CYCLIC-AMP; PHORBOL ESTER; CELL ACTIVATION; ANTI-IMMUNOGLOBULIN; GENE-TRANSCRIPTION; SOMATOSTATIN GENE; GROWTH; PROLIFERATION	In order to elucidate late regulatory events which may be involved in the onset of S phase in B lymphocytes, we studied the effect of anti-Ig on phosphorylation of soluble proteins at late G1 phase. Stimulation of murine splenic B lymphocytes with anti-Ig and other mitogens for 18 h was found to be associated with a major increase in phosphorylation of an 85 kDa/pI approximately 5.3 cytosolic protein, conversely, stimulation of the cells with non-mitogenic stimuli did not induce the phosphorylation of pp85. The increase in phosphorylation of pp85 could not be detected after 30 min, was barely detectable after 6 h, but was very prominent after 18 h of stimulation with anti-Ig. Thus, the increase in phosphorylation of pp85 is not an early signal but is rather correlated with the late G1 phase. pp85 could not be detected in the nuclei of either control or stimulated cells. Stimulation of B cells for 30 min with forskolin induced the phosphorylation of pp85, while phorbol ester did not have any effect. The phosphorylation of pp85 was induced by the catalytic subunit of cAMP protein kinase. Comparison of the phosphopeptide map of pp85 phosphorylated by anti-Ig in intact cells to the phosphopeptide map phosphorylated by forskolin or by the catalytic subunit of cAMP protein kinase, showed a striking similarity indicating that cAMP protein kinase may be involved in phosphorylation of pp85 in mitogen-stimulated cells. An increase in intracellular cAMP levels at late G1 phase was found in B cells stimulated by mitogens. These results implicate an important role for cAMP-dependent phosphorylation events, specifically the phosphorylation of pp85/pI 5.3, at late G1 phase during the cell cycle.	UNIFORMED SERV UNIV HLTH SCI, DEPT MED, BETHESDA, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	FEUERSTEIN, N (corresponding author), UNIV PENN, DIABET RES CTR, DEPT BIOCHEM, RM 510, MED EDUC BLDG, PHILADELPHIA, PA 19104 USA.				NATIONAL CANCER INSTITUTE [R29CA048667] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR005415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027465] Funding Source: NIH RePORTER; NCI NIH HHS [R29CA48667-03] Funding Source: Medline; NCRR NIH HHS [S07-RR-05415-29] Funding Source: Medline; NIAID NIH HHS [R0-AI27465] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALBERT KA, 1986, P NATL ACAD SCI USA, V83, P2822, DOI 10.1073/pnas.83.9.2822; Beavo J A, 1974, Methods Enzymol, V38, P299; BIJSTERBOSCH MK, 1985, CELL, V41, P999, DOI 10.1016/S0092-8674(85)80080-5; BRUNSWICK M, 1988, J IMMUNOL, V140, P3364; CAMBIER JC, 1987, ANNU REV IMMUNOL, V5, P175, DOI 10.1146/annurev.immunol.5.1.175; COGGESHALL KM, 1985, J IMMUNOL, V134, P101; COGGESHALL KM, 1986, B LYMPHOCYTE DIFFERE, P2; DEFRANCO AL, 1987, ANNU REV CELL BIOL, V3, P143; DEUTSCH PJ, 1988, P NATL ACAD SCI USA, V85, P7922, DOI 10.1073/pnas.85.21.7922; FEUERSTEIN N, 1985, CANCER RES, V45, P3243; FEUERSTEIN N, 1988, J CELL BIOL, V107, P1629, DOI 10.1083/jcb.107.5.1629; FEUERSTEIN N, 1987, J IMMUNOL, V139, P1818; FEUERSTEIN N, 1983, J BIOL CHEM, V258, P786; FEUERSTEIN N, 1984, CANCER RES, V44, P5227; FEUERSTEIN N, 1987, J BIOL CHEM, V262, P11389; FEUERSTEIN N, 1988, J BIOL CHEM, V263, P10608; FITZ TA, 1989, BIOL REPROD, V40, P250, DOI 10.1095/biolreprod40.2.250; FRIEDMAN DL, 1976, PHYSIOL REV, V56, P652, DOI 10.1152/physrev.1976.56.4.652; GROVE JR, 1987, SCIENCE, V238, P530; HAWRYLOWICZ CM, 1984, IMMUNOLOGY, V51, P327; HONRBECK P, 1986, J BIOL CHEM, V261, P14817; HOVI T, 1973, NATURE-NEW BIOL, V245, P175, DOI 10.1038/newbio245175a0; MIZUGUCHI J, 1986, P NATL ACAD SCI USA, V83, P4474, DOI 10.1073/pnas.83.12.4474; MOND JJ, 1987, P NATL ACAD SCI USA, V84, P8588, DOI 10.1073/pnas.84.23.8588; MONROE JG, 1984, J IMMUNOL, V132, P1472; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MURAGUCHI A, 1984, J IMMUNOL, V133, P1283; NEL AE, 1986, BIOCHEM J, V233, P145, DOI 10.1042/bj2330145; NIGG EA, 1985, EMBO J, V4, P2801, DOI 10.1002/j.1460-2075.1985.tb04006.x; Parker C W, 1979, Ann N Y Acad Sci, V332, P255, DOI 10.1111/j.1749-6632.1979.tb47119.x; PASTAN IH, 1975, ANNU REV BIOCHEM, V44, P491, DOI 10.1146/annurev.bi.44.070175.002423; POZZAN T, 1982, J CELL BIOL, V94, P335, DOI 10.1083/jcb.94.2.335; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; ROZENGURT E, 1983, P NATL ACAD SCI-BIOL, V80, P7244, DOI 10.1073/pnas.80.23.7244; SCHOR S, 1973, J CELL PHYSIOL, V81, P339, DOI 10.1002/jcp.1040810306; SMITH BM, 1988, J BIOL CHEM, V263, P6424; WANG T, 1978, SCIENCE, V201, P155, DOI 10.1126/science.208147; WHITFIELD JF, 1976, IN VITRO CELL DEV B, V12, P1	39	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4746	4751						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002023				2022-12-25	WOS:A1991FC21700015
J	JACOBSON, BL; HE, JJ; VERMERSCH, PS; LEMON, DD; QUIOCHO, FA				JACOBSON, BL; HE, JJ; VERMERSCH, PS; LEMON, DD; QUIOCHO, FA			ENGINEERED INTERDOMAIN DISULFIDE IN THE PERIPLASMIC RECEPTOR FOR SULFATE TRANSPORT REDUCES FLEXIBILITY - SITE-DIRECTED MUTAGENESIS AND LIGAND-BINDING STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALMONELLA-TYPHIMURIUM; PROTEIN-STRUCTURE; CHEMOTAXIS; RESOLUTION; SEQUENCE; LEUCINE; OPERON; BONDS	Using recombinant DNA techniques, an Escherichia coli periplasmic sulfate receptor or sulfate-binding protein involved in active transport has been overexpressed and characterized. This protein is essentially identical in size, sequence, antigenicity, and ligand affinity and specificity to the sulfate receptor from Salmonella typhimurium whose crystal structure has been refined at 2 angstrom resolution. The dehydrated sulfate is bound in the deep cleft between the two lobes of the bilobate protein. Using the structure of the S. typhimurium as a guide, three site-directed mutants (Ser129Cys, Gly46Cys, and Ser129Cys/Gly46Cys) have been made. In the Cys129/Cys46 mutant the disulfide has been successfully introduced across the opening of the ligand-binding site cleft of the E. coli sulfate-binding protein. The dissociation of sulfate from the double mutant protein is very slow under oxidizing conditions and increases more than 200-fold when reducing agent is added. This effect is attributed to a loss of interdomain structural flexibility in the presence of the disulfide, and underscores the importance of protein conformational change in binding protein function.	BAYLOR UNIV, HOWARD HUGHES MED INST, 1 BAYLOR PLAZA, HOUSTON, TX 77030 USA; BAYLOR UNIV, DEPT BIOCHEM & STRUCT BIOL, HOUSTON, TX 77030 USA; RICE UNIV, DEPT BIOCHEM & CELL BIOL, HOUSTON, TX 77251 USA	Baylor College of Medicine; Baylor University; Howard Hughes Medical Institute; Baylor University; Rice University					NIGMS NIH HHS [GM-21371, GM-35649] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035649, R01GM021371] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BROSIUS J, 1984, P NATL ACAD SCI-BIOL, V81, P6929, DOI 10.1073/pnas.81.22.6929; HELLINGA HW, 1985, EUR J BIOCHEM, V149, P363, DOI 10.1111/j.1432-1033.1985.tb08934.x; HORAZDOVSKY BF, 1987, J MOL BIOL, V197, P27, DOI 10.1016/0022-2836(87)90606-1; ISIHARA H, 1980, J BIOL CHEM, V255, P4614; IYER KS, 1973, J BIOL CHEM, V248, P707; JACOBSON BL, 1988, J MOL BIOL, V204, P783, DOI 10.1016/0022-2836(88)90369-5; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LUECKE H, 1990, NATURE, V347, P402, DOI 10.1038/347402a0; MATSUMURA M, 1989, SCIENCE, V243, P792, DOI 10.1126/science.2916125; MILLER DM, 1980, J BIOL CHEM, V255, P2465; MILLER DM, 1983, J BIOL CHEM, V258, P3665; NEU HC, 1965, J BIOL CHEM, V240, P3685; PARDEE AB, 1966, J BIOL CHEM, V241, P5886; PFLUGRATH JW, 1988, J MOL BIOL, V200, P163, DOI 10.1016/0022-2836(88)90341-5; PFLUGRATH JW, 1985, NATURE, V314, P257, DOI 10.1038/314257a0; QUIOCHO FA, 1990, PHILOS T R SOC B, V326, P341, DOI 10.1098/rstb.1990.0016; QUIOCHO FA, 1984, NATURE, V310, P381, DOI 10.1038/310381a0; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; SACK JS, 1989, J MOL BIOL, V206, P171, DOI 10.1016/0022-2836(89)90531-7; SACK JS, 1989, J MOL BIOL, V206, P193, DOI 10.1016/0022-2836(89)90532-9; SAUER RT, 1986, BIOCHEMISTRY-US, V25, P5992, DOI 10.1021/bi00368a024; SCRIPTURE JB, 1987, J MOL BIOL, V197, P37, DOI 10.1016/0022-2836(87)90607-3; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; VERMERSCH PS, 1990, J BIOL CHEM, V265, P16592; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YVAS NK, 1988, SCIENCE, V242, P1290	26	39	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					5220	5225						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002055				2022-12-25	WOS:A1991FC21700078
J	SATO, M; GITLIN, JD				SATO, M; GITLIN, JD			MECHANISMS OF COPPER INCORPORATION DURING THE BIOSYNTHESIS OF HUMAN CERULOPLASMIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILSONS DISEASE; CELL-LINE; PROTEINS; APOCERULOPLASMIN; EXPRESSION; TRANSPORT; RECEPTOR; PLASMA; HEPG2; RATS	To examine the mechanisms of copper incorporation during ceruloplasmin biosynthesis, we developed methods to resolve and identify apo and holoceruloplasmin. The identity of holoceruloplasmin was confirmed by oxidase activity staining, immunoblotting, Cu-67-ligand exchange, and Cu-67-ligand blotting. Following metabolic labeling of human liver and lung cell lines with Cu-67, newly synthesized holoceruloplasmin was detected in the culture media as two species with apparent molecular masses of 84 and 79 kDa. Pulse-chase studies demonstrate that exogenous copper is readily available for incorporation into newly synthesized ceruloplasmin and that the kinetics of apo and holoceruloplasmin synthesis and secretion are identical. Inhibition of N-linked glycosylation did not affect the rate or amount of copper incorporated into newly synthesize ceruloplasmin but did result in the secretion of a single 68-kDa holoceruloplasmin moiety. Despite differences in the kinetics of copper uptake between cell lines a linear rate of copper incorporation into newly synthesized ceruloplasmin was observed with no evidence of copper exchange following biosynthesis. Under the conditions studied, holoceruloplasmin accounted for less than 5% of the total ceruloplasmin synthesized and secreted by each cell line. The data indicate that copper is incorporated into newly synthesized ceruloplasmin early in the course of biosynthesis by a process independent of N-linked carbohydrate addition. This process of copper incorporation results in an apparent conformational change in the ceruloplasmin molecule which does not affect the secretory rate of the protein.	WASHINGTON UNIV,SCH MED,EDWARD MALLINCKRODT DEPT PEDIAT,ST LOUIS,MO 63110	Washington University (WUSTL)					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041536] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL41536] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AISEN P, 1965, J BIOL CHEM, V240, P1974; ANDERSON BF, 1990, NATURE, V344, P784, DOI 10.1038/344784a0; BOUMA ME, 1989, IN VITRO CELL DEV B, V25, P267; CLEVELAND DW, 1983, METHOD ENZYMOL, V96, P222; DECAMERON CT, 1987, BIOCHEM J, V248, P669; Ettinger MJ, 1984, COPPER PROTEIN COPPE, V3, P175; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; FREEDMAN JH, 1989, J BIOL CHEM, V264, P5598; FRIEDEN E, 1986, CLIN PHYSIOL BIOCH, V4, P11; GITLIN D, 1960, NATURE, V185, P693, DOI 10.1038/185693a0; GITLIN JD, 1988, J BIOL CHEM, V263, P6281; GOLDSTEIN IM, 1979, J BIOL CHEM, V254, P4040; GORDON DT, 1987, AM J PHYSIOL, V252, pE327, DOI 10.1152/ajpendo.1987.252.3.E327; HHANSEN JES, 1988, ELECTROPHORESIS, V9, P273; HO MK, 1983, J BIOL CHEM, V258, P2766; HOLTZMAN NA, 1970, J BIOL CHEM, V245, P2350; HOLTZMAN NA, 1970, J BIOL CHEM, V245, P2354; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUDA I, 1974, PEDIATR RES, V8, P821, DOI 10.1203/00006450-197410000-00001; MCKEE DJ, 1971, BIOCHEMISTRY-US, V10, P3880, DOI 10.1021/bi00797a013; MESSERSCYHMIDT A, 1990, EUR J BIOCHEM, V187, P241; MORELL AG, 1958, SCIENCE, V127, P588, DOI 10.1126/science.127.3298.588-a; NOYER M, 1980, ANAL BIOCHEM, V102, P450, DOI 10.1016/0003-2697(80)90181-5; ORTEL TL, 1984, P NATL ACAD SCI-BIOL, V81, P4761, DOI 10.1073/pnas.81.15.4761; PARENT JB, 1985, BIOCHIM BIOPHYS ACTA, V846, P44, DOI 10.1016/0167-4889(85)90108-9; ROBERTS BE, 1973, P NATL ACAD SCI USA, V70, P2330, DOI 10.1073/pnas.70.8.2330; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; SATO M, 1990, J BIOL CHEM, V265, P2533; SCHWARTZ AL, 1981, J BIOL CHEM, V256, P8878; STERNLIEB I, 1979, GASTROENTEROLOGY, V77, P138; STERNLIEB L, 1961, J CLIN INVEST, V40, P1834; STOCKERT RJ, 1986, HEPATOLOGY, V6, P60, DOI 10.1002/hep.1840060112; STRUNK RC, 1985, J BIOL CHEM, V260, P5280; TAKAHASHI N, 1984, P NATL ACAD SCI-BIOL, V81, P390, DOI 10.1073/pnas.81.2.390; VIERLING JM, 1970, GASTROENTEROLOGY, V74, P652; WALKER FJ, 1990, J BIOL CHEM, V265, P1834	36	180	182	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					5128	5134						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002050				2022-12-25	WOS:A1991FC21700067
J	NOJIRI, H; STROUD, M; HAKOMORI, S				NOJIRI, H; STROUD, M; HAKOMORI, S			A SPECIFIC TYPE OF GANGLIOSIDE AS A MODULATOR OF INSULIN-DEPENDENT CELL-GROWTH AND INSULIN-RECEPTOR TYROSINE KINASE-ACTIVITY - POSSIBLE ASSOCIATION OF GANGLIOSIDE-INDUCED INHIBITION OF INSULIN-RECEPTOR FUNCTION AND MONOCYTIC DIFFERENTIATION INDUCTION IN HL-60 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMYELOCYTIC LEUKEMIA-CELLS; MONOCLONAL-ANTIBODIES; MEDIATED MODULATION; LINE HL-60; SERUM-FREE; PHOSPHORYLATION; CULTURE; SYSTEM; GM3; SPHINGOSINE	Insulin-dependent cell growth has been correlated with insulin receptor function, particularly receptor-associated kinase activity, in in vitro studies. The insulin-dependent phosphorylation of the 95-kDa receptor subunit was clearly inhibited, in a concentration-dependent manner, by the presence of unbranched neolacto series gangliosides having a NeuAc2 --> 3Gal terminus, particularly 2 --> 3-sialosylparagloboside (2 --> 3SPG; IV3NeuAc-nLc4), but not by other gangliosides with a NeuAc2 --> 6Gal terminus or by branched neolacto series gangliosides (e.g. G10). Such inhibition of phosphorylation was minimal with ganglio series gangliosides and negligible with sphingosine, neutral glycolipids, or sulfatide. 2 --> 3SPG did not affect insulin binding to the insulin receptor. Insulin-dependent cell growth and its inhibition by 2 --> 3SPG were observed in three human cell lines so far tested: lymphoid cell line IM9, promyelocytic leukemia cell line HL-60, and erythroleukemia cell line K562. Since IM9 cells contain a much higher quantity of insulin receptor than do HL-60 or K562 cells, insulin-dependent receptor phosphorylation and its inhibition by 2 --> 3SPG in intact cells were clearly observed with IM9 cells. Receptor phosphorylation in intact cells was inhibited when cells were preincubated in the presence of 2 --> 3SPG. Insulin-dependent growth of HL-60 and K562 cells was also inhibited by prolonged culture (96-144 h) with exogenous 2 --> 3SPG. Subsequent to the inhibition of insulin-dependent HL-60 cell growth, a remarkable phenotypic transformation was observed, i.e. changes in morphology, enzymes, and cell-surface markers to those characteristic of monocytes. The level of 2 --> 3SPG in HL-60 cells increased when cells were cultured with 1-alpha,25-dihydroxyvitamin D3 to the same degree seen in cells cultured with 5-mu-M 2 --> 3SPG. Both these treatments led to inhibition of insulin-dependent cell growth, followed by induction of monocytic differentiation. Thus, the cellular level of 2 --> 3SPG may modulate insulin-dependent cell growth and define the lineage specificity of differentiation through modulation of receptor-associated kinase activity.	UNIV WASHINGTON,DEPT PATHOBIOL,SEATTLE,WA 98195	University of Washington; University of Washington Seattle	NOJIRI, H (corresponding author), BIOMEMBRANE INST,SEATTLE,WA 98119, USA.				NATIONAL CANCER INSTITUTE [R35CA042505] Funding Source: NIH RePORTER; NCI NIH HHS [CA 42505] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDREWS RG, 1983, BLOOD, V62, P124; BARNES D, 1980, ANAL BIOCHEM, V102, P255, DOI 10.1016/0003-2697(80)90151-7; BERNSTEIN ID, 1982, J IMMUNOL, V128, P876; BREITMAN TR, 1980, EXP CELL RES, V126, P494, DOI 10.1016/0014-4827(80)90296-7; BREMER EG, 1984, J BIOL CHEM, V259, P6818; BREMER EG, 1986, J BIOL CHEM, V261, P2434; BREMER EG, 1982, BIOCHEM BIOPH RES CO, V106, P711, DOI 10.1016/0006-291X(82)91769-7; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; CUATRECASAS P, 1972, P NATL ACAD SCI USA, V69, P318, DOI 10.1073/pnas.69.2.318; CZECH MP, 1985, ANNU REV PHYSIOL, V47, P357, DOI 10.1146/annurev.ph.47.030185.002041; ESPINAL J, 1988, TRENDS BIOCHEM SCI, V13, P367, DOI 10.1016/0968-0004(88)90170-3; FAHEY JL, 1971, ANN NY ACAD SCI, V190, P221, DOI 10.1111/j.1749-6632.1971.tb13537.x; GAVIN JR, 1974, P NATL ACAD SCI USA, V71, P84, DOI 10.1073/pnas.71.1.84; HAKOMORI S, 1986, HDB EXPT IMMUNOLOGY, V1; HAKOMORI SI, 1981, ANNU REV BIOCHEM, V50, P733, DOI 10.1146/annurev.bi.50.070181.003505; HANAI N, 1988, J BIOL CHEM, V263, P10915; HANAI N, 1988, J BIOL CHEM, V263, P6296; HANNUN YA, 1987, SCIENCE, V235, P670, DOI 10.1126/science.3101176; HARING HU, 1982, BIOCHEM BIOPH RES CO, V108, P1538, DOI 10.1016/S0006-291X(82)80082-X; HIGGINS TJ, 1984, J LIPID RES, V25, P1007; HWANG DL, 1985, J RECEPTOR RES, V5, P367, DOI 10.3109/10799898509041888; KASUGA M, 1982, SCIENCE, V215, P185, DOI 10.1126/science.7031900; KASUGA M, 1981, P NATL ACAD SCI-BIOL, V78, P6917, DOI 10.1073/pnas.78.11.6917; KASUGA M, 1982, J BIOL CHEM, V257, P392; KASUGA M, 1985, METHOD ENZYMOL, V109, P609; KREUTTER D, 1987, J BIOL CHEM, V262, P1633; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI CY, 1973, J HISTOCHEM CYTOCHEM, V21, P1; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; MCLEOD DL, 1974, BLOOD, V44, P517, DOI 10.1182/blood.V44.4.517.517; MOMOMURA K, 1988, BIOCHEM BIOPH RES CO, V155, P1181, DOI 10.1016/S0006-291X(88)81264-6; NOJIRI H, 1986, P NATL ACAD SCI USA, V83, P782, DOI 10.1073/pnas.83.3.782; NOJIRI H, 1988, J BIOL CHEM, V263, P7443; NOJIRI H, 1984, BLOOD, V64, P534; NOJIRI H, 1989, J CELL BIOL, V107, pA208; NORES GA, 1988, CARBOHYD RES, V179, P393, DOI 10.1016/0008-6215(88)84135-1; ROVERA G, 1979, P NATL ACAD SCI USA, V76, P2779, DOI 10.1073/pnas.76.6.2779; ROZENGURT E, 1986, SCIENCE, V234, P161, DOI 10.1126/science.3018928; SCHLESSINGER J, 1988, TRENDS BIOCHEM SCI, V13, P443, DOI 10.1016/0968-0004(88)90219-8; SINCLAIR J, 1988, BLOOD, V72, P66; SUZUKI K, 1964, LIFE SCI, V3, P1227, DOI 10.1016/0024-3205(64)90040-2; TANAKA H, 1983, BIOCHEM BIOPH RES CO, V117, P86, DOI 10.1016/0006-291X(83)91544-9; URDAL DL, 1983, BLOOD, V62, P1022; WRIGHT SD, 1983, P NATL ACAD SCI-BIOL, V80, P5699, DOI 10.1073/pnas.80.18.5699	44	155	156	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4531	4537						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999434				2022-12-25	WOS:A1991FA69400079
J	MATSUOKA, S; SAGAMI, H; KURISAKI, A; OGURA, K				MATSUOKA, S; SAGAMI, H; KURISAKI, A; OGURA, K			VARIABLE PRODUCT SPECIFICITY OF MICROSOMAL DEHYDRODOLICHYL DIPHOSPHATE SYNTHASE FROM RAT-LIVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOLICHYL PHOSPHATE BIOSYNTHESIS; LIQUID-CHROMATOGRAPHIC METHOD; TISSUES; PYROPHOSPHATE; METABOLISM; SYNTHETASE; SITE	Several detergents activated microsomal dehydrodolichyl diphosphate synthase of rat liver, but the chain length of products shifted downward from C90 and C95 with increasing concentration of the detergents. Maximum activation was observed at the concentration of 2% Triton X-100, 30 mM octyl glucoside, 30 mM 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, and 10 mM deoxycholate with the product chain length being C80-C85, C65-C75, C70-C75, and C55-C65, respectively. The activity of Triton X-100 solubilized enzyme was decreased by asolectin, phosphatidylethanolamine, and phosphatidylcholine. The chain lengths of products formed in the presence of these phospholipids were C85 and C90. In the presence of both phosphatidylcholine and Mg2+ the solubilized enzyme was able to produce C90 and C95 dehydrodolichyl diphosphates like native microsomal enzyme. Microsomal enzyme preparations from rat liver, brain, and testis catalyzed the formation of dehydrodolichyl diphosphates with the same chain lengths as those of the natural dolichols occurring in individual tissues. The chain length distribution of dehydrodolichyl products by (rat liver) microsomes also depended on the concentration of substrates. Not only did increasing the concentration of isopentenyl diphosphate lead to longer chain product, but decreasing that of farnesyl diphosphate increased product chain length.	TOHOKU UNIV,CHEM RES INST NONAQUEOUS SOLUT,SENDAI,MIYAGI 980,JAPAN	Tohoku University								ADAIR WL, 1987, ARCH BIOCHEM BIOPHYS, V259, P589; ADAIR WL, 1984, J BIOL CHEM, V259, P4441; ADAIR WL, 1982, J BIOL CHEM, V257, P8990; BABA T, 1980, ARCH BIOCHEM BIOPHYS, V200, P474, DOI 10.1016/0003-9861(80)90379-3; BABA T, 1987, ARCH BIOCHEM BIOPHYS, V252, P440, DOI 10.1016/0003-9861(87)90050-6; BRUENGER E, 1988, ANAL BIOCHEM, V173, P321, DOI 10.1016/0003-2697(88)90196-0; CHAUDHARY N, 1982, LIPIDS, V17, P558, DOI 10.1007/BF02535384; CHEN Z, 1988, ARCH BIOCHEM BIOPHYS, V266, P98, DOI 10.1016/0003-9861(88)90240-8; CHOJNACKI T, 1988, BIOCHEM J, V251, P1; CRICK DC, 1989, BIOCHIM BIOPHYS ACTA, V1004, P180, DOI 10.1016/0005-2760(89)90266-X; EGGENS I, 1983, BIOCHIM BIOPHYS ACTA, V751, P355, DOI 10.1016/0005-2760(83)90294-1; EKSTROM TJ, 1987, J BIOL CHEM, V262, P4090; EKSTROM TJ, 1984, J BIOL CHEM, V259, P460; FUJII H, 1982, BIOCHIM BIOPHYS ACTA, V712, P716; GRANGE DK, 1977, BIOCHEM BIOPH RES CO, V79, P734, DOI 10.1016/0006-291X(77)91173-1; SAGAMI H, 1989, BIOCHIM BIOPHYS ACTA, V1002, P218, DOI 10.1016/0005-2760(89)90290-7; SAKAKIHARA Y, 1985, J NEUROCHEM, V44, P1535, DOI 10.1111/j.1471-4159.1985.tb08792.x; STOLL J, 1988, J BIOL CHEM, V263, P10774; STRUCK DK, 1980, BIOCH GLYCOPROTEINS, P35; WELLNER RB, 1979, FEBS LETT, V104, P379, DOI 10.1016/0014-5793(79)80857-1; WONG TK, 1982, J BIOL CHEM, V257, P6619; YAMADA K, 1986, ANAL BIOCHEM, V156, P380, DOI 10.1016/0003-2697(86)90268-X; YAMADA K, 1985, ANAL BIOCHEM, V150, P26, DOI 10.1016/0003-2697(85)90437-3	23	79	86	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3464	3468						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995611				2022-12-25	WOS:A1991EY68200022
J	SATO, T; OELLER, PW; THEOLOGIS, A				SATO, T; OELLER, PW; THEOLOGIS, A			THE 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE OF CUCURBITA - PURIFICATION, PROPERTIES, EXPRESSION IN ESCHERICHIA-COLI, AND PRIMARY STRUCTURE DETERMINATION BY DNA-SEQUENCE ANALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ETHYLENE BIOSYNTHESIS; MONOCLONAL-ANTIBODIES; MESSENGER-RNA; MAXIMA DUCH; KEY ENZYME; ACID; IDENTIFICATION; INACTIVATION; METHIONINE; CLEAVAGE	The key regulatory enzyme in the biosynthetic pathway of the plant hormone ethylene is 1-aminocyclopropane-1-carboxylic acid (ACC) synthase (EC 4.4.1.14). We have partially purified ACC synthase 6,000-fold from Cucurbita fruit tissue treated with indoleacetic acid + benzyladenine + aminooxyacetic acid + LiCl. The enzyme has a specific activity of 35,000 nmol/h/mg protein, a pH optimum of 9.5, an isoelectric point of 5.0, a K(m) of 17-mu-M with respect to S-adenosylmethionine, and is a dimer of two identical subunits of approximately 46,000 Da each. The subunit exists in vivo as a 55,000-Da species similar in size to the primary in vitro translation product. DNA sequence analysis of the cDNA clone pACC1 revealed that the coding region of the ACC synthase mRNA spans 493 amino acids corresponding to a 55,779-Da polypeptide; and expression of the coding sequence (pACC1) in Escherichia coli as a COOH terminus hybrid of beta-galactosidase or as a nonhybrid polypeptide catalyzed the conversion of S-adenosylmethionine to ACC (Sato, T., and Theologis, A. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 6621-6625). Immunoblotting experiments herein show that the molecular mass of the beta-galactosidase hybrid polypeptide is 170,000 Da, and the size of the largest nonhybrid polypeptide is 53,000 Da. The data suggest that the enzyme is post-translationally processed during protein purification.	USDA ARS,CTR PLANT GENE EXPRESS,ALBANY,CA 94710; UNIV CALIF BERKELEY,DEPT PLANT BIOL,BERKELEY,CA 94720	United States Department of Agriculture (USDA); University of California System; University of California Berkeley					NIGMS NIH HHS [GM-35447] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035447] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abeles F.B, 1973, ETHYLENE PLANT BIOL; ACASTER MA, 1983, PLANT PHYSIOL, V72, P139, DOI 10.1104/pp.72.1.139; ADAMS DO, 1979, P NATL ACAD SCI USA, V76, P170, DOI 10.1073/pnas.76.1.170; BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; BLEECKER AB, 1988, PLANTA, V173, P385, DOI 10.1007/BF00401025; BLEECKER AB, 1986, P NATL ACAD SCI USA, V83, P7755, DOI 10.1073/pnas.83.20.7755; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROSIUS J, 1988, VECTORS SURVEY MOL C, P205; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; Davis R., 1980, ADV BACTERIAL GENETI; DAYHOFF MO, 1978, ATLAS PROTEIN SEQ S3, V5, P363; DEBOER HA, 1983, P NATL ACAD SCI-BIOL, V80, P21; GEEK BF, 1983, CHEM ENG NEWS, V61, P43; GIUDICE LC, 1979, P NATL ACAD SCI USA, V76, P4798, DOI 10.1073/pnas.76.10.4798; HAYASHI H, 1990, ANNU REV BIOCHEM, V59, P87, DOI 10.1146/annurev.biochem.59.1.87; HEIDECKER G, 1986, ANNU REV PLANT PHYS, V37, P439, DOI 10.1146/annurev.arplant.37.1.439; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; HEYLIN M, 1988, CHEM ENG NEWS, V66, P25, DOI 10.1021/cen-v066n033.p025; JOHNSON LM, 1985, CELL, V43, P369, DOI 10.1016/0092-8674(85)90042-X; KAUFMAN DL, 1986, SCIENCE, V232, P1138, DOI 10.1126/science.3518061; KENDE H, 1989, PLANT PHYSIOL, V91, P1, DOI 10.1104/pp.91.1.1; KIMURA J, 1980, SELECTED METHODS CEL, P278; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LISADA CC, 1979, ANAL BIOCHEM, V100, P140; MEHTA AM, 1988, P NATL ACAD SCI USA, V85, P8810, DOI 10.1073/pnas.85.23.8810; MESSING J, 1983, METHOD ENZYMOL, V101, P20; NAKAJIMA N, 1988, PLANT CELL PHYSIOL, V29, P989; NAKAJIMA N, 1986, PLANT CELL PHYSIOL, V27, P969; NIEDER M, 1986, PLANT PHYSIOL, V81, P156, DOI 10.1104/pp.81.1.156; PRIVALLE LS, 1987, ARCH BIOCHEM BIOPHYS, V253, P333, DOI 10.1016/0003-9861(87)90186-X; RIOV J, 1982, PLANT PHYSIOL, V70, P136, DOI 10.1104/pp.70.1.136; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATO T, 1989, P NATL ACAD SCI USA, V86, P6621, DOI 10.1073/pnas.86.17.6621; SATOH S, 1988, PLANT PHYSIOL, V88, P109, DOI 10.1104/pp.88.1.109; STORMO GD, 1986, MAXIMIZING GENE EXPR, P195; TSAI DS, 1988, ARCH BIOCHEM BIOPHYS, V264, P632, DOI 10.1016/0003-9861(88)90329-3; VAN DER STRAETEN D, 1989, EUR J BIOCHEM, V182, P639; VIERSTRA RD, 1982, P NATL ACAD SCI-BIOL, V79, P5272, DOI 10.1073/pnas.79.17.5272; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; YANG SF, 1984, ANNU REV PLANT PHYS, V35, P155, DOI 10.1146/annurev.pp.35.060184.001103; YANG SF, 1989, PLANT NITROGEN METAB, P263; YU YB, 1979, ARCH BIOCHEM BIOPHYS, V198, P280, DOI 10.1016/0003-9861(79)90420-X; YUNG KH, 1982, BIOCHEM BIOPH RES CO, V104, P771, DOI 10.1016/0006-291X(82)90704-5; ZABIN I, 1980, OPERON, P89	47	55	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3752	3759						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995630				2022-12-25	WOS:A1991EY68200063
J	ULLRICH, O; MANN, K; HAASE, W; KOCHBRANDT, C				ULLRICH, O; MANN, K; HAASE, W; KOCHBRANDT, C			BIOSYNTHESIS AND SECRETION OF AN OSTEOPONTIN-RELATED 20-KDA POLYPEPTIDE IN THE MADIN-DARBY CANINE KIDNEY-CELL LINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLARIZED EPITHELIAL-CELL; DEVELOPMENTAL EXPRESSION; INSITU HYBRIDIZATION; MOLECULAR-CLONING; 2AR OSTEOPONTIN; RAT BONE; PROTEINS; PHOSPHOPROTEIN; GLYCOPROTEIN; MDCK	We describe a 20-kDa phosphorylated polypeptide, which is secreted constitutively at the apical surface of the kidney-derived Madin-Darby canine kidney cell line. Using polyclonal antibodies raised against this protein, we show that it is generated from a 60-kDa O-glycosylated, sulfated, and phosphorylated precursor protein by an intracellular proteolytic maturation step, which is pH-sensitive. Amino acid sequence analysis of the 20-kDa secreted polypeptide demonstrated that it displays 70% identity with the carboxyl-terminal amino acids of human osteopontin. The amino-terminal amino acid of the 20-kDa polypeptide corresponds to amino acid 213 of human osteopontin. Thrombin has been shown to cleave rat osteopontin in vivo and in vitro at amino acid 153, yielding two fragments of 28 and 26 kDa. A similar cleavage product can be detected by thrombin treatment of the 60-kDa precursor, suggesting that the precursor is identical or closely related to osteopontin. In the rat nephron, the protein has been localized along the luminal surfaces of the proximal and distal tubule and the collecting duct cells. These results show that in the kidney-derived cell line Madin-Darby canine kidney osteopontin or a closely related protein is proteolytically processed to a 20-kDa polypeptide, raising the possibility that diverse functions of osteopontin in various tissues might be attributed to specific processing to distinct polypeptides.	UNIV FRANKFURT, INST BIOCHEM, MOLEK GENET ABT, ROBERT MAYER STR 7-9, W-6000 FRANKFURT, GERMANY; MAX PLANCK INST BIOPHYS, W-6000 FRANKFURT, GERMANY; MAX PLANCK INST BIOCHEM, W-8033 MARTINSRIED, GERMANY	Goethe University Frankfurt; Max Planck Society; Max Planck Society			Mann, Karlheinz/C-4254-2008					BARTLES JR, 1987, J CELL BIOL, V105, P1241, DOI 10.1083/jcb.105.3.1241; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412; CAPLAN MJ, 1987, NATURE, V329, P632, DOI 10.1038/329632a0; CRAIG AM, 1988, BIOCHEM BIOPH RES CO, V157, P166, DOI 10.1016/S0006-291X(88)80028-7; CRAIG AM, 1989, J BIOL CHEM, V264, P9682; FRANZEN A, 1985, BIOCHEM J, V232, P715, DOI 10.1042/bj2320715; GRAHAM RC, 1966, J HISTOCHEM CYTOCHEM, V14, P291, DOI 10.1177/14.4.291; HERRING GM, 1976, BIOCHEM J, V159, P749, DOI 10.1042/bj1590749; KIEFER MC, 1989, NUCLEIC ACIDS RES, V17, P3306, DOI 10.1093/nar/17.8.3306; KIRSZBAUM L, 1989, EMBO J, V8, P711, DOI 10.1002/j.1460-2075.1989.tb03430.x; KONDORKOCH C, 1985, CELL, V43, P297, DOI 10.1016/0092-8674(85)90035-2; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; MAINS RE, 1983, TRENDS NEUROSCI, V6, P229, DOI 10.1016/0166-2236(83)90100-5; MARK MP, 1988, CELL TISSUE RES, V251, P23, DOI 10.1007/BF00215443; MAXFIELD FR, 1982, J CELL BIOL, V95, P676, DOI 10.1083/jcb.95.2.676; NEMIR M, 1989, J BIOL CHEM, V264, P18202; NOMURA S, 1988, J CELL BIOL, V106, P441, DOI 10.1083/jcb.106.2.441; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; OLMSTED JB, 1981, J BIOL CHEM, V256, P1955; PARCZYK K, 1989, EUR J CELL BIOL, V48, P353; PICCIONI R, 1982, METHODS CHLOROPLAST, P985; PRINCE CW, 1987, COLLAGEN REL RES, V7, P305; PRINCE CW, 1987, J BIOL CHEM, V262, P2900; REINHOLT FP, 1989, CONNECT TISSUE RES, V22, P286; SENGER DR, 1989, BIOCHIM BIOPHYS ACTA, V996, P43, DOI 10.1016/0167-4838(89)90092-7; SENGER DR, 1988, CANCER RES, V48, P5770; SMITH JH, 1987, J CELL BIOCHEM, V34, P13, DOI 10.1002/jcb.240340103; SWANSON GJ, 1989, HEARING RES, V41, P169, DOI 10.1016/0378-5955(89)90008-7; TAUB M, 1979, P NATL ACAD SCI USA, V76, P3338, DOI 10.1073/pnas.76.7.3338; URBAN J, 1987, J CELL BIOL, V105, P2735, DOI 10.1083/jcb.105.6.2735; WALTER P, 1979, P NATL ACAD SCI USA, V76, P1795, DOI 10.1073/pnas.76.4.1795; YOON K, 1987, BIOCHEM BIOPH RES CO, V148, P1129, DOI 10.1016/S0006-291X(87)80250-4; ZHANG R, 1990, J BIOL CHEM, V265, P15375	34	52	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3518	3525						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995615				2022-12-25	WOS:A1991EY68200030
J	LUNDKATZ, S; INNERARITY, TL; ARNOLD, KS; CURTISS, LK; PHILLIPS, MC				LUNDKATZ, S; INNERARITY, TL; ARNOLD, KS; CURTISS, LK; PHILLIPS, MC			C-13 NMR EVIDENCE THAT SUBSTITUTION OF GLUTAMINE FOR ARGININE-3500 IN FAMILIAL DEFECTIVE APOLIPOPROTEIN-B-100 DISRUPTS THE CONFORMATION OF THE RECEPTOR-BINDING DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							LOW-DENSITY LIPOPROTEIN; LYSINE RESIDUES; B-100; SEQUENCE	Familial defective apoB-100 is a genetic mutation that is characterized by abnormal low density lipoprotein (LDL) and moderate hypercholesterolemia. Heterozygotes for this disorder possess two populations of LDL. One has normal receptor binding, and the other, which can be isolated by monoclonal antibody 19 immunoaffinity chromatography, has almost no binding activity. The mutation that disrupts binding is a Gln for Arg substitution of apoB-100 residue 3500. NMR spectra of LDL containing ((CH3)-C-13)2Lys residues show that chemically modified Lys exist in two microenvironments. In normal human LDL, there are about 50 Lys with pK 8.9 and 170 Lys with pK 10.5; an upper limit of 10 pK 8.9 Lys may be particularly involved in binding to the LDL receptor. Examination of the mixture of normal LDL and mutant LDL from five patients shows that the latter have fewer pK 8.9 Lys. In purified defective LDL at least seven Lys are redistributed from the active to normal pool. The CD spectra of mutant and normal LDL are identical. Therefore, substitution of Gln for Arg at position 3500 induces a change in local conformation which disrupts the receptor-binding domain of apoB-100.	MED COLL PENN, DEPT PHYSIOL & BIOCHEM, PHILADELPHIA, PA 19129 USA; UNIV CALIF SAN FRANCISCO, DEPT PATHOL, CARDIOVASC RES INST, CARDIOVASC DIS LABS, SAN FRANCISCO, CA 94140 USA; UNIV CALIF SAN FRANCISCO, DEPT MED, SAN FRANCISCO, CA 94140 USA; SCRIPPS CLIN & RES FDN, DEPT IMMUNOL, LA JOLLA, CA 92037 USA	Drexel University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Scripps Research Institute				Phillips, Michael/0000-0002-7147-8007	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL041633] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL41633, HL22632] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AVIRAM M, 1988, J BIOL CHEM, V263, P16842; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; CLADARAS C, 1986, EMBO J, V5, P3495, DOI 10.1002/j.1460-2075.1986.tb04675.x; GOORMAGHTIGH E, 1989, BIOCHIM BIOPHYS ACTA, V1006, P147, DOI 10.1016/0005-2760(89)90338-X; HAMILTON JA, 1986, METHOD ENZYMOL, V128, P472; INNERARITY TL, 1990, J LIPID RES, V31, P1337; INNERARITY TL, 1987, P NATL ACAD SCI USA, V84, P6919, DOI 10.1073/pnas.84.19.6919; INNERARITY TL, 1987, ACTA MED SCAND, P51; INNERARITY TL, 1988, ARTERIOSCLEROSIS, V8, pA551; JENTOFT N, 1983, METHOD ENZYMOL, V91, P570; KNOTT TJ, 1986, NATURE, V323, P734, DOI 10.1038/323734a0; LUNDKATZ S, 1986, BIOCHEMISTRY-US, V25, P1562, DOI 10.1021/bi00355a016; LUNDKATZ S, 1988, J BIOL CHEM, V263, P13831; MILNE R, 1989, J BIOL CHEM, V264, P19754; PHILLIPS ML, 1989, J LIPID RES, V30, P415; REIJNGOUD DJ, 1984, BIOCHEMISTRY-US, V23, P726, DOI 10.1021/bi00299a022; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; SORIA LF, 1989, P NATL ACAD SCI USA, V86, P587, DOI 10.1073/pnas.86.2.587; WEISGRABER KH, 1988, P NATL ACAD SCI USA, V85, P9758, DOI 10.1073/pnas.85.24.9758; WEISGRABER KH, 1978, J BIOL CHEM, V253, P9053; YANG CY, 1986, NATURE, V323, P738, DOI 10.1038/323738a0; YOUNG SG, 1989, J LIPID RES, V30, P443	23	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2701	2704						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993649				2022-12-25	WOS:A1991EX60000006
J	OSAWA, Y; HIGHET, RJ; BAX, A; POHL, LR				OSAWA, Y; HIGHET, RJ; BAX, A; POHL, LR			CHARACTERIZATION BY NMR OF THE HEME-MYOGLOBIN ADDUCT FORMED DURING THE REDUCTIVE METABOLISM OF BRCCL3 - COVALENT BONDING OF THE PROXIMAL HISTIDINE TO THE RING-I VINYL GROUP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER CYTOCHROME-P-450; HEPATIC CYTOCHROME-P-450; PROSTHETIC HEME; PROTEIN ADDUCTS; SUICIDE INACTIVATION; MECHANISM; CHLORAMPHENICOL; HEMOPROTEINS; DEGRADATION; DESTRUCTION	The reductive debromination of BrCCl3 by ferrous deoxymyoglobin leads to the covalent bonding of the prosthetic heme to the protein. We have previously shown, by the use of peptide mapping and mass spectrometry, that histidine residue 93 is covalently bound to the heme moiety. In the present study the structure of the heme adduct was more completely determined by H-1 and C-13 NMR techniques. We have found that the ring I vinyl group of the prosthetic heme was altered by the addition of a histidine imidazole nitrogen to the alpha-carbon and a CCl2 moiety to the beta-carbon. The electronic absorption spectra of the oxidized and reduced states of the altered heme-protein indicated that the heme-iron exists in a bis-histidine-ligated form. Analysis of the crystal structure of native myoglobin suggested that for the altered heme-protein, histidine residues 97 and 64 are ligated to the heme-iron and that residue 97 has replaced the native proximal histidine residue 93. These movements, in effect a "histidine shuffle" at the active site, may be responsible for the enhanced reducing activity of the altered protein.	NHLBI,CHEM LAB,BETHESDA,MD 20892; NIDDKD,CHEM PHYS LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	OSAWA, Y (corresponding author), NHLBI,CHEM PHARMACOL LAB,BLDG 10,RM 8N110,BETHESDA,MD 20892, USA.							ATOR MA, 1987, J BIOL CHEM, V262, P1542; AUGUSTO O, 1982, J BIOL CHEM, V257, P1288; AUGUSTO O, 1982, J BIOL CHEM, V257, P6231; BAX A, 1986, J AM CHEM SOC, V108, P2093, DOI 10.1021/ja00268a061; BONDOC LL, 1989, J BIOL CHEM, V264, P6134; BORNHEIM LM, 1987, MOL PHARMACOL, V32, P299; BRUNORI M, 1971, BIOCHEMISTRY-US, V10, P1604, DOI 10.1021/bi00785a016; CAJACOB CA, 1988, J BIOL CHEM, V263, P18640; CATALANO CE, 1989, J BIOL CHEM, V264, P10534; CORREIA MA, 1987, ARCH BIOCHEM BIOPHYS, V258, P436, DOI 10.1016/0003-9861(87)90365-1; DAVIES HW, 1986, ARCH BIOCHEM BIOPHYS, V244, P387, DOI 10.1016/0003-9861(86)90128-1; DAVIES HW, 1986, CHEM-BIOL INTERACT, V58, P345, DOI 10.1016/S0009-2797(86)80108-9; DAVIES HW, 1985, BIOCHEM PHARMACOL, V34, P3203, DOI 10.1016/0006-2952(85)90172-8; DAVIES HW, 1986, BIOL REACT INTERMED, V3, P253; DECKER C, 1986, BIOCHEM BIOPH RES CO, V136, P1162, DOI 10.1016/0006-291X(86)90456-0; DEMONTELLANO PRO, 1981, J BIOL CHEM, V256, P6708; DEMONTELLANO PRO, 1983, ANNU REV PHARMACOL, V23, P481; FREEMAN R, 1981, J MAGN RESON, V42, P341, DOI 10.1016/0022-2364(81)90227-4; GUENGERICH FP, 1978, BIOCHEMISTRY-US, V17, P3633, DOI 10.1021/bi00610a033; GUENGERICH FP, 1986, BIOCHEM BIOPH RES CO, V138, P193, DOI 10.1016/0006-291X(86)90265-2; HALPERT J, 1980, MOL PHARMACOL, V17, P427; HALPERT J, 1982, MOL PHARMACOL, V21, P166; HALPERT JR, 1985, J BIOL CHEM, V260, P8397; HOLLENBERG PF, 1988, FASEB J, V2, P563; KALINOWSKI HO, 1988, CARBON 13 NMR SPECTR, P294; LIVINGSTON DJ, 1983, SCIENCE, V220, P71, DOI 10.1126/science.6828881; LUNETTA JM, 1989, MOL PHARMACOL, V35, P10; MARION D, 1988, J MAGN RESON, V80, P528, DOI 10.1016/0022-2364(88)90250-8; MIKI K, 1986, J BIOCHEM-TOKYO, V100, P277, DOI 10.1093/oxfordjournals.jbchem.a121713; OMURA T, 1970, J BIOCHEM-TOKYO, V67, P249, DOI 10.1093/oxfordjournals.jbchem.a129248; OSAWA Y, 1990, J BIOL CHEM, V265, P10340; OSAWA Y, 1989, CHEM RES TOXICOL, V2, P131, DOI 10.1021/tx00009a001; OSAWA Y, 1989, J AM CHEM SOC, V111, P4462, DOI 10.1021/ja00194a048; OSAWA Y, 1990, FASEB J, V4, pA2282; SATOH H, 1987, PROGR DRUG METABOLIS, P187; SCHAEFER WH, 1985, BIOCHEMISTRY-US, V24, P3254, DOI 10.1021/bi00334a027; SPRINGER BA, 1989, J BIOL CHEM, V264, P3057; VARADARAJAN R, 1989, SCIENCE, V243, P69, DOI 10.1126/science.2563171; WALLACE WJ, 1982, J BIOL CHEM, V257, P4966	39	31	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3208	3214						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993694				2022-12-25	WOS:A1991EX60000081
J	TSUCHIYA, M; PRICE, SR; TSAI, SC; MOSS, J; VAUGHAN, M				TSUCHIYA, M; PRICE, SR; TSAI, SC; MOSS, J; VAUGHAN, M			MOLECULAR-IDENTIFICATION OF ADP-RIBOSYLATION FACTOR MESSENGER-RNAS AND THEIR EXPRESSION IN MAMMALIAN-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING-PROTEINS; RIBOSYLTRANSFERASE ACTIVITY; CHOLERA-TOXIN; ADENYLATE-CYCLASE; GTP; ALIGNMENTS; COFACTOR; SEQUENCE; BOVINE; ACID	ADP-ribosylation factors (ARFs) are approximately 20-kDa guanine nucleotide-binding proteins that serve as GTP-dependent allosteric activators of cholera toxin ADP-ribosyltransferase activity. Four species of mammalian ARF, termed ARF 1-4, have been identified by cloning. Hybridization of a bovine ARF 2 cDNA under low stringency with mammalian poly(A)+ RNA resulted in multiple bands that were subsequently assigned to the known ARF genes using ARF-specific oligonucleotide probes. The relative signal intensities of some bands (e.g. the 3.8- and 1.3-kilobase (kb) mRNAs) that hybridized with the cDNA were not, however, consistent with the intensities observed with the individual ARF-specific oligonucleotide probes. These inconsistencies suggested that other ARF-like mRNAs were comigrating with known ARF mRNAs. To explore this possibility, a cyclic AMP-differentiated HL-60 Lambda ZAP library was screened using the bovine ARF 2 cDNA. Clones corresponding to known ARF genes (1, 3, and 4) were identified by hybridization of positive clones with oligonucleotide probes specific for each ARF species; ARF 2 cDNA-positive, oligonucleotide-negative clones were sequenced. Two new ARF-like genes, ARF 5 and 6, encoding proteins of 180 and 175 amino acids, respectively, were identified. Both proteins contain consensus sequences believed to be involved in guanine nucleotide binding and GTP hydrolysis. ARF 5 was most similar in deduced amino acid sequence to ARF 4, which also has 180 amino acids. ARF 6, whose deduced amino acid sequence is identical with that of a putative chicken pseudogene (CPS1) except for a serine/threonine substitution, was different from other ARF species in size and deduced amino acid sequence. With mammalian poly(A)+ RNA from a variety of tissues and cultured cells, ARF 5 preferentially hybridized with a 1.3-kb mRNA, whereas ARF 6 hybridized with 1.8- and 4.2- kb mRNAs. The fact that the sizes of these mRNAs are similar to those of other ARFs (ARF 1, 1.9 kb; ARF 2, 2.6 kb; ARF 3, approximately 3.8 and 1.3 kb; ARF 4, 1.8 kb) explain the previously observed inconsistencies between the cDNA and ARF-specific oligonucleotide hybridization patterns. All six ARF cDNAs are more similar to each other than to other approximately 20-kDa guanine nucleotide-binding proteins.			TSUCHIYA, M (corresponding author), NHLBI,CELLULAR METAB,BETHESDA,MD 20892, USA.							ALSIP GR, 1986, NUCLEIC ACIDS RES, V14, P2123, DOI 10.1093/nar/14.5.2123; BIRNBAUMER L, 1987, KIDNEY INT, V32, pS14; BOBAK DA, 1989, P NATL ACAD SCI USA, V86, P6101, DOI 10.1073/pnas.86.16.6101; BOBAK DA, 1990, BIOCHEMISTRY-US, V29, P855, DOI 10.1021/bi00456a600; BOBAK DA, 1990, ADP RIBOSYLATING TOX, P439; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FINKELSTEIN RA, 1973, CRC CRIT R MICROBIOL, V2, P553; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151; KAHN RA, 1984, J BIOL CHEM, V259, P6228; KAHN RA, 1986, J BIOL CHEM, V261, P7906; KELLY MT, 1986, PEDIATR INFECT DIS J, V5, pS101; MONACO L, 1990, P NATL ACAD SCI USA, V87, P2206, DOI 10.1073/pnas.87.6.2206; MOSS J, 1977, J BIOL CHEM, V252, P2455; MOSS J, 1978, P NATL ACAD SCI USA, V75, P3621, DOI 10.1073/pnas.75.8.3621; MOSS J, 1988, ADV ENZYMOL RAMB, V61, P303; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; NODA M, 1990, BIOCHIM BIOPHYS ACTA, V1034, P195, DOI 10.1016/0304-4165(90)90076-9; PENG Z, 1989, Biofactors, V2, P45; PRICE SR, 1988, P NATL ACAD SCI USA, V85, P5488, DOI 10.1073/pnas.85.15.5488; PRICE SR, 1990, ADP RIBOSYLATING TOX, P397; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEWELL JL, 1988, P NATL ACAD SCI USA, V85, P4620, DOI 10.1073/pnas.85.13.4620; STEARNS T, 1990, P NATL ACAD SCI USA, V87, P1238, DOI 10.1073/pnas.87.3.1238; TSAI SC, 1987, P NATL ACAD SCI USA, V84, P5139, DOI 10.1073/pnas.84.15.5139; TSAI SC, 1988, J BIOL CHEM, V263, P1768; TSUCHIYA M, 1989, BIOCHEMISTRY-US, V28, P9668, DOI 10.1021/bi00451a019; ZAHRAOUI A, 1989, J BIOL CHEM, V264, P12394	29	185	196	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2772	2777						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993656				2022-12-25	WOS:A1991EX60000019
J	CHEN, WY; WIGHT, DC; CHEN, NY; COLEMAN, TA; WAGNER, TE; KOPCHICK, JJ				CHEN, WY; WIGHT, DC; CHEN, NY; COLEMAN, TA; WAGNER, TE; KOPCHICK, JJ			MUTATIONS IN THE 3RD ALPHA-HELIX OF BOVINE GROWTH-HORMONE DRAMATICALLY AFFECT ITS INTRACELLULAR-DISTRIBUTION INVITRO AND GROWTH ENHANCEMENT IN TRANSGENIC MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN TRANSLOCATION; SCANNING MUTAGENESIS; ADIPOSE TISSUE; IN-VITRO; GENE; FRAGMENTS; EXPRESSION; RECEPTOR; MEMBRANES; PROLACTIN	To investigate the relationship between the secondary structure of the third alpha-helix (amino acids 109-126) of bovine growth hormone (bGH) and the biological activity of the molecule, proline or glycine residues have been used as substitutes for native amino acids at positions 114, 118, 121, and 126, respectively. Mutations at the positions 114, 118, and 121 resulted in a dramatic decrease in bGH secretion by transiently transfected mouse L cells whereas the substitution of glycine for glutamate at position 126 (bGH-E126G) did not affect secretion. Immunofluorescence staining revealed that those nonsecretory bGH mutations possessed a different intracellular location as compared with wild-type bGH or the mutated secretory forms of bGH. Similar results were seen in the distribution of these mutated bGH molecules in transfected rat GH-3 cells. Transgenic mice that express wild-type bGH or bGH-E126G grew to approximately 1.6 times the mass of nontransgenic littermates. Transgenic mice that express two nonsecretory forms of mutated bGHs were found to lack the enhanced mouse growth phenotype in spite of elevated levels of serum bGH. These results suggest that the secondary structure in the third alpha-helix of bGH may be important for efficient intracellular targeting in vitro and in growth promotion in transgenic mice.	OHIO UNIV,DEPT ZOOL,MOLEC & CELLULAR BIOL PROGRAM,ATHENS,OH 45701; OHIO UNIV,EDISON ANIM BIOTECHNOL CTR,ATHENS,OH 45701	University System of Ohio; Ohio University; University System of Ohio; Ohio University								ABDELMEGUID SS, 1987, P NATL ACAD SCI USA, V84, P6434, DOI 10.1073/pnas.84.18.6434; ANDREWS P, 1966, NATURE, V209, P155, DOI 10.1038/209155a0; ASTON R, 1983, EMBO J, V2, P493, DOI 10.1002/j.1460-2075.1983.tb01452.x; BREMS DN, 1987, J BIOL CHEM, V262, P2590; CHEEK DB, 1974, HDB PHYSIOLOGY END 2, V4, P159; CHEN CH, 1977, BIOCHEMISTRY-US, V16, P2110, DOI 10.1021/bi00629a010; CHEN WY, 1990, P NATL ACAD SCI USA, V87, P5061, DOI 10.1073/pnas.87.13.5061; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; CUNNINGHAM BC, 1989, SCIENCE, V243, P1330, DOI 10.1126/science.2466339; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Davis S.L., 1988, J ANIM SCI, V66, P84; DELLACHA JM, 1966, EXPERIENTIA, V22, P16, DOI 10.1007/BF01897741; EILERS M, 1988, CELL, V52, P481, DOI 10.1016/0092-8674(88)90458-8; ELLIS GJ, 1966, FED PROC, V25, P348; FERNADEZ E, 1990, IN PRESS ANAL BIOCH; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GOODMAN HM, 1986, HUMAN GROWTH HORMONE, P499; GRAF L, 1976, EUR J BIOCHEM, V64, P333, DOI 10.1111/j.1432-1033.1976.tb10306.x; HARA K, 1978, BIOCHEMISTRY-US, V17, P550, DOI 10.1021/bi00596a028; ISAKSSON OGP, 1987, ENDOCR REV, V8, P426, DOI 10.1210/edrv-8-4-426; ISAKSSON OGP, 1985, ANNU REV PHYSIOL, V47, P483, DOI 10.1146/annurev.ph.47.030185.002411; KLEMPNAUER KH, 1984, CELL, V37, P537, DOI 10.1016/0092-8674(84)90384-2; KOPCHICK JJ, 1985, DNA-J MOLEC CELL BIO, V4, P23, DOI 10.1089/dna.1985.4.23; KOPCHICK JJ, 1989, REV BRAS GENET, V12, P37; KOPCHICK JJ, 1979, J VIROL, V30, P610, DOI 10.1128/JVI.30.2.610-623.1979; KOSTYO JL, 1986, HUMAN GROWTH HORMONE, P449; KOSTYO JL, 1974, HDB PHYSIOLOGY     2, V4, P187; LEWIS UJ, 1984, ANNU REV PHYSIOL, V46, P33; LI CH, 1975, P NATL ACAD SCI USA, V72, P3878, DOI 10.1073/pnas.72.10.3878; LINGAPPA VR, 1977, P NATL ACAD SCI USA, V74, P2432, DOI 10.1073/pnas.74.6.2432; LOPATA MA, 1984, NUCLEIC ACIDS RES, V12, P5707, DOI 10.1093/nar/12.14.5707; Maniatis T., 1984, MOL CLONING; MARTIN JB, 1973, NEW ENGL J MED, V288, P1384, DOI 10.1056/NEJM197306282882606; MCGRANE MM, 1988, J BIOL CHEM, V263, P11443; PALADINI AC, 1979, TRENDS BIOCHEM SCI, V4, P256, DOI 10.1016/0968-0004(79)90217-2; PALADINI AC, 1983, CRC CR REV BIOCH MOL, V15, P25, DOI 10.3109/10409238309102800; PALMITER RD, 1982, NATURE, V300, P611, DOI 10.1038/300611a0; PANDIAN MR, 1971, ENDOCRINOLOGY, V88, P928, DOI 10.1210/endo-88-4-928; RUSSELL J, 1981, J BIOL CHEM, V256, P296; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIGEL MB, 1981, ENDOCRINOLOGY, V108, P1600, DOI 10.1210/endo-108-4-1600; SWISLOCKI NI, 1970, ENDOCRINOLOGY, V87, P900, DOI 10.1210/endo-87-5-900; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VERNER K, 1988, SCIENCE, V241, P1307, DOI 10.1126/science.2842866; VICEPSMADORE D, 1983, J BIOL CHEM, V258, P2689; VLASUK GP, 1983, EXPT MANIPULATION GE, P291; WOYCHIK RP, 1982, NUCLEIC ACIDS RES, V10, P7197, DOI 10.1093/nar/10.22.7197	47	70	79	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2252	2258						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989980				2022-12-25	WOS:A1991EV51500038
J	LANGEVELD, JPM; NOELKEN, ME; HARD, K; TODD, P; VLIEGENTHART, JFG; ROUSE, J; HUDSON, BG				LANGEVELD, JPM; NOELKEN, ME; HARD, K; TODD, P; VLIEGENTHART, JFG; ROUSE, J; HUDSON, BG			BOVINE GLOMERULAR-BASEMENT-MEMBRANE - LOCATION AND STRUCTURE OF THE ASPARAGINE-LINKED OLIGOSACCHARIDE UNITS AND THEIR POTENTIAL ROLE IN THE ASSEMBLY OF THE 7-S COLLAGEN-IV TETRAMER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CHORIONIC-GONADOTROPIN; AMINO-ACID-SEQUENCE; REGION 7S DOMAIN; NONCOLLAGENOUS DOMAIN; LIQUID-CHROMATOGRAPHY; LATERAL ASSOCIATIONS; GOODPASTURE ANTIGEN; CARBOHYDRATE CHAINS; MOLECULAR-STRUCTURE; MAGNETIC-RESONANCE	Collagen IV contains an amino-terminal tetramerization domain (7 S) that is involved in aggregation and cross-linking as part of the process of self-assembly of the collagen IV matrix of basement membranes. We determined the structure and location of the Asn-linked oligosaccharides of the 7 S tetramer. Two glycopeptides, GP-1 and GP-2, were isolated from tryptic digests of the 7 S tetramer and were characterized. GP-1 and GP-2 are derived from the alpha-1(IV) chain and the alpha-2(IV) chain, respectively. Each glycopeptide contained one sequence, -Asn-Xaa-Thr-, which was shown to be N-glycosylated at Asn, corresponding to position 126 of the alpha-1 chains and 138 of the alpha-2 chain. H-1 NMR spectroscopic analysis of the oligosaccharide moiety from each glycopeptide indicated essentially identical structures. Each oligosaccharide is a biantennary N-acetyllactosamine type of N-linked oligosaccharide with a broad heterogeneity in the presence of the sugar residues at their nonreducing termini as indicated. [GRAPHICS] The location of the Asn-linked oligosaccharide units and Hyl-linked disaccharide units and their orientation with respect to the surface of the triple helix were calculated using two models. We conclude that both units are important determinants in the assembly of the 7 S tetramer.	UNIV KANSAS, MED CTR, DEPT BIOCHEM, KANSAS CITY, KS 66103 USA; VET ADM MED CTR, KANSAS CITY, MO 64128 USA; STATE UNIV UTRECHT, DEPT BIOORGAN CHEM, UTRECHT, NETHERLANDS	University of Kansas; University of Kansas Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Utrecht University				Hudson, Billy/0000-0002-5420-4100	NIADDK NIH HHS [AM 18381] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM018381] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARUMUGHAM RG, 1986, BIOCHIM BIOPHYS ACTA, V883, P112, DOI 10.1016/0304-4165(86)90142-X; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BLANKEN WM, 1985, ANAL BIOCHEM, V145, P322, DOI 10.1016/0003-2697(85)90369-0; BLUMBERG B, 1987, J BIOL CHEM, V262, P5947; BUTKOWSKI RJ, 1987, J BIOL CHEM, V262, P7874; BUTKOWSKI RJ, 1985, J BIOL CHEM, V260, P3739; CARR SA, 1986, ANAL BIOCHEM, V157, P396, DOI 10.1016/0003-2697(86)90643-3; CHAPLIN MF, 1982, ANAL BIOCHEM, V123, P336, DOI 10.1016/0003-2697(82)90455-9; DAMM JBL, 1988, GLYCOCONJUGATE J, V5, P221, DOI 10.1007/BF01049083; DAMM JBL, 1987, GLYCOCONJUGATE J, V4, P129, DOI 10.1007/BF01049451; DEAN DC, 1981, J BIOL CHEM, V256, P7543; DENNIS JW, 1984, J CELL BIOL, V99, P1416, DOI 10.1083/jcb.99.4.1416; DIXIT SN, 1983, COLLAGEN REL RES, V3, P263; DUBE S, 1988, J BIOL CHEM, V263, P17516; ENGEL J, 1987, METHOD ENZYMOL, V145, P3; FARQUHAR MG, 1982, NEW TRENDS BASEMENT, P9; FRASER RDB, 1979, J MOL BIOL, V129, P463, DOI 10.1016/0022-2836(79)90507-2; FUJIWARA S, 1988, BIOCHEM J, V252, P453, DOI 10.1042/bj2520453; GEYER R, 1984, BIOCHEMISTRY-US, V23, P5628, DOI 10.1021/bi00318a038; GLANVILLE RW, 1985, EUR J BIOCHEM, V152, P213, DOI 10.1111/j.1432-1033.1985.tb09186.x; Goldstein I., 1986, LECTINS, DOI DOI 10.1016/B978-0-12-449945-4.50007-5; HARRINGTON WF, 1961, ADV PROTEIN CHEM, V16, P1; HEWICK RM, 1981, J BIOL CHEM, V256, P7990; HOFMANN H, 1978, J MOL BIOL, V125, P137, DOI 10.1016/0022-2836(78)90342-X; HOMANS SW, 1987, P NATL ACAD SCI USA, V84, P1202, DOI 10.1073/pnas.84.5.1202; HOSTIKKA SL, 1988, J BIOL CHEM, V263, P19488; HUBER R, 1976, NATURE, V264, P415, DOI 10.1038/264415a0; HUDSON BG, 1972, J BIOL CHEM, V247, P4239; HUDSON BG, 1989, LAB INVEST, V61, P256; INAGAKI F, 1987, FEBS LETT, V212, P91, DOI 10.1016/0014-5793(87)81563-6; KNIBBS RN, 1989, BIOCHEMISTRY-US, V28, P6379, DOI 10.1021/bi00441a034; KUHN K, 1981, FEBS LETT, V125, P123, DOI 10.1016/0014-5793(81)81012-5; LANGEVELD JPM, 1988, J BIOL CHEM, V263, P10481; LEUSHNER JRA, 1987, BIOCHEM CELL BIOL, V65, P501, DOI 10.1139/o87-064; LEVINE MJ, 1979, J BIOL CHEM, V254, P8121; MARTIN GR, 1988, ADV PROTEIN CHEM, V39, P1; MATZUK MM, 1989, J BIOL CHEM, V264, P2409; MUTHUKUMARAN G, 1989, J BIOL CHEM, V264, P6310; PLUMMER TH, 1984, J BIOL CHEM, V259, P700; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785, DOI 10.1146/annurev.bi.57.070188.004033; RICE RV, 1964, ARCH BIOCHEM BIOPHYS, V105, P409, DOI 10.1016/0003-9861(64)90025-6; RISLEY JM, 1985, J BIOL CHEM, V260, P5488; RISTELI J, 1980, EUR J BIOCHEM, V108, P239, DOI 10.1111/j.1432-1033.1980.tb04717.x; SAIRAM MR, 1989, FASEB J, V3, P1915, DOI 10.1096/fasebj.3.8.2542111; SAKURAI Y, 1986, J BIOL CHEM, V261, P6654; SATO T, 1976, J BIOL CHEM, V251, P4062; SAUS J, 1989, J BIOL CHEM, V264, P6318; SCHUPPAN D, 1984, BIOCHEM J, V220, P227, DOI 10.1042/bj2200227; SCHWARTZ WE, 1980, ANAL BIOCHEM, V106, P43, DOI 10.1016/0003-2697(80)90116-5; SCHWARZ U, 1986, EUR J BIOCHEM, V157, P49, DOI 10.1111/j.1432-1033.1986.tb09636.x; SHOTTON DM, 1979, J MOL BIOL, V131, P303, DOI 10.1016/0022-2836(79)90078-0; SIEBOLD B, 1987, EUR J BIOCHEM, V168, P569, DOI 10.1111/j.1432-1033.1987.tb13455.x; SIEBOLD B, 1988, EUR J BIOCHEM, V120, P203; SOININEN R, 1987, FEBS LETT, V225, P188; SPIRO RG, 1967, J BIOL CHEM, V242, P1923; STRUCK DK, 1980, BIOCH GLYCOPROTEINS, P35; TIMPL R, 1981, EUR J BIOCHEM, V120, P203, DOI 10.1111/j.1432-1033.1981.tb05690.x; Traub W, 1971, Adv Protein Chem, V25, P243, DOI 10.1016/S0065-3233(08)60281-8; TRAUB W, 1969, NATURE, V221, P914, DOI 10.1038/221914a0; TSILIBARY EC, 1986, J CELL BIOL, V103, P2467, DOI 10.1083/jcb.103.6.2467; VLIEGENTHART JFG, 1983, ADV CARBOHYD CHEM BI, V41, P209, DOI 10.1016/S0065-2318(08)60059-1; WIESLANDER J, 1985, J BIOL CHEM, V260, P8564; WOLF AV, 1975, HDB CHEM PHYSICS, pD205; YURCHENCO PD, 1986, J HISTOCHEM CYTOCHEM, V34, P93, DOI 10.1177/34.1.3510247; YURCHENCO PD, 1988, AM J PATHOL, V132, P278; YURCHENCO PD, 1987, J CELL BIOL, V105, P2559, DOI 10.1083/jcb.105.6.2559	67	34	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2622	2631						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1990011				2022-12-25	WOS:A1991EV51500092
J	ZAGORSKI, W; CASTAING, B; HERBERT, CJ; LABOUESSE, M; MARTIN, R; SLONIMSKI, PP				ZAGORSKI, W; CASTAING, B; HERBERT, CJ; LABOUESSE, M; MARTIN, R; SLONIMSKI, PP			PURIFICATION AND CHARACTERIZATION OF THE SACCHAROMYCES-CEREVISIAE MITOCHONDRIAL LEUCYL TRANSFER-RNA SYNTHETASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST MITOCHONDRIA; ESCHERICHIA-COLI; MATURASE; INTRON; GENES; PROTEINS; ENDONUCLEASE; SEQUENCES; DOUGLASII; NUCLEUS	We have purified the product of the NAM2 gene, the mitochondrial leucyl-tRNA synthetase, from yeast mitochondria. The purified protein cross-reacts with antibodies raised against the product of a LacZ/NAM2 gene fusion and antibodies raised against the purified Escherichia coli leucyl-tRNA synthetase. The mass as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis is about 100 kDa, consistent with the size predicted by the gene sequence (102 kDa). The N-terminal sequence of the protein has been determined and shows that the first nine amino acids predicted by the gene sequence have been removed, probably during transport into the mitochondria.	POLISH ACAD SCI,INST BIOCHEM & BIOPHYS,WARSAW 42,POLAND; CNRS,INST BIOL MOLEC & CELLULAIRE,F-67084 STRASBOURG,FRANCE	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	ZAGORSKI, W (corresponding author), UNIV PIERRE & MARIE CURIE,CTR GENET MOLEC,CNRS LAB,F-91198 GIF SUR YVETTE,FRANCE.			Castaing, Bertrand/0000-0001-5077-8978				AKINS RA, 1987, CELL, V50, P331, DOI 10.1016/0092-8674(87)90488-0; BANROQUES J, 1986, CELL, V46, P837, DOI 10.1016/0092-8674(86)90065-6; BAUW G, 1989, P NATL ACAD SCI USA, V86, P7701, DOI 10.1073/pnas.86.20.7701; BERLANI RE, 1980, NUCLEIC ACIDS RES, V8, P5017, DOI 10.1093/nar/8.21.5017; DELAHODDE A, 1989, CELL, V56, P431, DOI 10.1016/0092-8674(89)90246-8; DELASALLE H, 1982, CELL, V28, P721, DOI 10.1016/0092-8674(82)90051-4; DHAWALE S, 1981, P NATL ACAD SCI-BIOL, V78, P1778, DOI 10.1073/pnas.78.3.1778; DUJARDIN G, 1982, NATURE, V298, P628, DOI 10.1038/298628a0; DUJARDIN G, 1980, MOL GEN GENET, V179, P469, DOI 10.1007/BF00271736; DUJARDIN G, 1983, MITOCHONDRIA 1983, P233; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V988, P1, DOI 10.1016/0304-4157(89)90002-6; HERBERT CJ, 1988, EMBO J, V7, P473, DOI 10.1002/j.1460-2075.1988.tb02835.x; HERBERT CJ, 1988, MOL GEN GENET, V213, P297, DOI 10.1007/BF00339595; HOLMES WM, 1977, P NATL ACAD SCI USA, V74, P1393, DOI 10.1073/pnas.74.4.1393; KOZLOWSKI M, 1988, ANAL BIOCHEM, V172, P332; LABOUESSE M, 1987, EMBO J, V6, P713, DOI 10.1002/j.1460-2075.1987.tb04812.x; LABOUESSE M, 1983, EMBO J, V2, P269, DOI 10.1002/j.1460-2075.1983.tb01416.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LECAER JP, 1988, ANAL BIOCHEM, V169, P246, DOI 10.1016/0003-2697(88)90281-3; LI M, 1979, CELL, V18, P47, DOI 10.1016/0092-8674(79)90352-0; ROE B, 1973, BIOCHIM BIOPHYS ACTA, V319, P25, DOI 10.1016/0005-2787(73)90037-3; SCHNELLER JM, 1976, NUCLEIC ACIDS RES, V3, P1151, DOI 10.1093/nar/3.5.1151; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4340; TZAGOLOFF A, 1988, J BIOL CHEM, V263, P850; WENZLAU JM, 1989, CELL, V56, P421, DOI 10.1016/0092-8674(89)90245-6	25	12	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2537	2541						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1990003				2022-12-25	WOS:A1991EV51500080
J	BANERJEE, A; LUDUENA, RF				BANERJEE, A; LUDUENA, RF			DISTINCT COLCHICINE BINDING-KINETICS OF BOVINE BRAIN TUBULIN LACKING THE TYPE-III ISOTYPE OF BETA-TUBULIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE	In mammalian brain, beta-tubulin occurs as a mixture of four isotypes designated as types I, II, III, and IV. It has been speculated in recent years that the different tubulin isotypes may confer functional diversity to microtubules. In an effort to investigate whether different tubulin isotypes differ in their functional properties we have studied the colchicine binding kinetics of bovine brain tubulin upon removal of the beta-III isotype. We found that the removal of the beta-III isotype alters the binding kinetics from biphasic to monophasic with the disappearance of the slow phase. The kinetics become biphasic with the reappearance of the slow phase when the beta-III-depleted tubulin was mixed with the beta-III fraction eluted from the affinity column with 0.5 M NaCl. The analysis of the kinetic data reveals that the tubulin dimers containing beta-III bind colchicine at an on-rate constant of 35 M-1 s-1 while those lacking beta-III bind at 182 M-1 s-1. Our results strongly suggest that the beta-subunit plays a very important role in the interaction of tubulin with colchicine.			BANERJEE, A (corresponding author), UNIV TEXAS,HLTH SCI CTR,DEPT BIOCHEM,SAN ANTONIO,TX 78284, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023476] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 23476] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BANERJEE A, 1987, FEBS LETT, V219, P103, DOI 10.1016/0014-5793(87)81199-7; BANERJEE A, 1990, J BIOL CHEM, V265, P1794; BANERJEE A, 1988, J BIOL CHEM, V263, P3029; BEHNKE O, 1967, J CELL SCI, V2, P169; BHATTACH.B, 1974, P NATL ACAD SCI USA, V71, P2627, DOI 10.1073/pnas.71.7.2627; CLEVELAND DW, 1985, ANNU REV BIOCHEM, V54, P331, DOI 10.1146/annurev.bi.54.070185.001555; DUSTIN P, 1984, MICROTUBULES, P3; Fulton C., 1976, CELL MOTILITY, P987; GARLAND DL, 1978, BIOCHEMISTRY-US, V17, P4266, DOI 10.1021/bi00613a024; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lakowicz J.R., 1983, PRINCIPLES FLUORESCE, P1; LAMBEIR A, 1981, J BIOL CHEM, V256, P3279; LUDENA RF, 1982, BIOCHEMISTRY-US, V21, P4787; LUDENA RF, 1988, FEBS LETT, V230, P142; MONTEIRO MJ, 1988, J MOL BIOL, V199, P439, DOI 10.1016/0022-2836(88)90616-X; SULLIVAN KF, 1986, P NATL ACAD SCI USA, V83, P4327, DOI 10.1073/pnas.83.12.4327; SULLIVAN KF, 1988, ANNU REV CELL BIOL, V4, P687, DOI 10.1146/annurev.cb.04.110188.003351; VILLASANTE A, 1986, MOL CELL BIOL, V6, P2409, DOI 10.1128/MCB.6.7.2409	18	45	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1689	1691						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1988443				2022-12-25	WOS:A1991EU49700052
J	KERKHOFF, E; BISTER, K				KERKHOFF, E; BISTER, K			MYC PROTEIN-STRUCTURE - LOCALIZATION OF DNA-BINDING AND PROTEIN DIMERIZATION DOMAINS	ONCOGENE			English	Article							AVIAN MYELOCYTOMATOSIS VIRUS; NUCLEOTIDE-SEQUENCE; CARBOXY TERMINUS; GENE; MC29; TRANSFORMATION; MUTANTS; REGION; FIBROBLASTS; DELETION	Wildtype and mutant v-Myc proteins were overexpressed in Escherichia coli using the T7 RNA polymerase system, and the in vitro DNA-binding activities of partially or highly purified proteins were analysed by native DNA-cellulose chromatography. For the construction of the expression plasmids, cloned proviral DNA from wildtype MC29 or from its spontaneous deletion mutant Q10C was used, the latter lacking internal v-myc sequences. Both the wildtype (p59) and the mutant (p42) recombinant protein contain at their amino termini 12 amino acids encoded by the vector, followed by 11 gag amino acids and 9 amino acids encoded by v-myc sequences derived from noncoding c-myc sequences. In addition, p59 contains 416 amino acids encoded by v-myc sequences derived from the complete chicken c-myc coding region, whereas p42 lacks 120 amino acids from the central region of the Myc protein including the highly acidic domain. Two additional proteins were engineered which contain the first 309 (p53) or the last 107 (p16) amino acids, respectively, of the Myc protein sequence in addition to vector-encoded amino acids. The p16 protein represents the carboxyl terminus of the Myc protein sequence containing both a muscle determination gene (MyoD1) homology region, including a basic motif and an amphipathic helix-loop-helix motif, and a leucine heptad repeat. All proteins, except p53 which lacks the carboxyl-terminal Myc protein sequences, bound to native DNA-cellulose and were eluted with 200-500 mM NaCl. Based on the DNA-binding activities of recombinant or spontaneous mutant v-Myc proteins extracted from bacterial or from transformed avian cells, we conclude that the DNA-binding domain of avian Myc proteins is confined within the last 86 carboxyl-terminal amino acids. The same region is also shown to be necessary and sufficient for Myc protein dimerization. This 86-amino acid region essentially encompasses a putative basic DNA contact surface and a tandem array of two presumed protein dimerization motifs, helix-loop-helix and leucine repeat.	UNIV COLOGNE,FAK MED,INST BIOCHEM,W-5000 COLOGNE 41,GERMANY	University of Cologne			Bister, Klaus/AFA-9400-2022	Bister, Klaus/0000-0001-6545-5653				ABEL T, 1989, NATURE, V341, P24, DOI 10.1038/341024a0; ALBIGES-RIZO C, 1990, J MOL BIOL, V212, P247, DOI 10.1016/0022-2836(90)90121-2; BADER JP, 1985, J VIROL, V53, P509, DOI 10.1128/JVI.53.2.509-514.1985; BECKMANN H, 1990, GENE DEV, V4, P167, DOI 10.1101/gad.4.2.167; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BIEGALKE BJ, 1987, J VIROL, V61, P2138, DOI 10.1128/JVI.61.7.2138-2142.1987; BISTER K, 1986, ADV CANCER RES, V47, P99, DOI 10.1016/S0065-230X(08)60199-2; BISTER K, 1977, VIROLOGY, V82, P431, DOI 10.1016/0042-6822(77)90017-4; BISTER K, 1982, J VIROL, V41, P754, DOI 10.1128/JVI.41.3.754-766.1982; BISTER K, 1987, ONCOGENE, V1, P97; BOS TJ, 1989, ONCOGENE, V4, P123; CROUCH DH, 1990, ONCOGENE, V5, P683; DANG CV, 1989, NATURE, V337, P664, DOI 10.1038/337664a0; DANG CV, 1989, MOL CELL BIOL, V9, P2477, DOI 10.1128/MCB.9.6.2477; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; DWARKI VJ, 1990, EMBO J, V9, P225, DOI 10.1002/j.1460-2075.1990.tb08099.x; ELLIS HM, 1990, CELL, V61, P27, DOI 10.1016/0092-8674(90)90212-W; ENRIETTO PJ, 1983, VIROLOGY, V124, P164, DOI 10.1016/0042-6822(83)90300-8; ENRIETTO PJ, 1989, VIROLOGY, V168, P256, DOI 10.1016/0042-6822(89)90265-1; HEANEY ML, 1986, J VIROL, V60, P167, DOI 10.1128/JVI.60.1.167-176.1986; HERMANN R, 1981, BIOCHEMISTRY-US, V20, P5195, DOI 10.1021/bi00521a015; JANSEN HW, 1983, J VIROL, V48, P61, DOI 10.1128/JVI.48.1.61-73.1983; LASSAR AB, 1989, CELL, V58, P823, DOI 10.1016/0092-8674(89)90935-5; LUSCHER B, 1989, EMBO J, V8, P1111, DOI 10.1002/j.1460-2075.1989.tb03481.x; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; PATSCHINSKY T, 1986, J VIROL, V59, P341, DOI 10.1128/JVI.59.2.341-353.1986; PATSCHINSKY T, 1984, VIROLOGY, V136, P348, DOI 10.1016/0042-6822(84)90171-5; PRENDERGAST GC, 1989, NATURE, V341, P392, DOI 10.1038/341392a0; RAMSAY G, 1980, NATURE, V288, P170, DOI 10.1038/288170a0; REDDY EP, 1983, P NATL ACAD SCI-BIOL, V80, P2500, DOI 10.1073/pnas.80.9.2500; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Vogt P K, 1990, Semin Cancer Biol, V1, P27; VOGT PK, 1989, TRENDS BIOCHEM SCI, V14, P172, DOI 10.1016/0968-0004(89)90268-5; WALTHER N, 1986, VIROLOGY, V154, P219, DOI 10.1016/0042-6822(86)90444-7; WATT RA, 1985, MOL CELL BIOL, V5, P448, DOI 10.1128/MCB.5.3.448	39	30	32	0	4	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1991	6	1					93	102						10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY039	1992448				2022-12-25	WOS:A1991EY03900013
J	MCGUIRE, JJ; HAILE, WH; BEY, P; COWARD, JK				MCGUIRE, JJ; HAILE, WH; BEY, P; COWARD, JK			DL-3,3-DIFLUOROGLUTAMATE - AN ENHANCER OF FOLYLPOLYGLUTAMATE ELONGATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV MICHIGAN,DEPT CHEM,ANN ARBOR,MI 48108; MERRELL DOW PHARMACEUT INC,CINCINNATI,OH 45215; UNIV MICHIGAN,DEPT MED CHEM,ANN ARBOR,MI 48108	University of Michigan System; University of Michigan; Dow Chemical Company; University of Michigan System; University of Michigan	MCGUIRE, JJ (corresponding author), NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,GRACE CANC DRUG CTR,666 ELM ST,BUFFALO,NY 14263, USA.				NATIONAL CANCER INSTITUTE [R01CA028097, P30CA024538, P01CA013038] Funding Source: NIH RePORTER; NCI NIH HHS [CA13038, CA28097, CA24538] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BALINSKA M, 1981, CANCER RES, V41, P2751; BEY P, 1983, J MED CHEM, V26, P1551, DOI 10.1021/jm00365a002; CHABNER BA, 1985, J CLIN INVEST, V76, P907, DOI 10.1172/JCI112088; CICHOWICZ DJ, 1987, BIOCHEMISTRY-US, V26, P513, DOI 10.1021/bi00376a025; CLARKE L, 1987, ARCH BIOCHEM BIOPHYS, V256, P585, DOI 10.1016/0003-9861(87)90616-3; GALIVAN J, 1985, BIOCHEM PHARMACOL, V34, P2995, DOI 10.1016/0006-2952(85)90028-0; JENCKS WP, 1976, CRC HDB BIOCH MOL BI, P305; KOLB M, 1988, SYNTHESIS-STUTTGART, P469; LICATO NJ, 1990, J MED CHEM, V33, P1022, DOI 10.1021/jm00165a021; MATHERLY LH, 1987, PHARMACOL THERAPEUT, V35, P27, DOI 10.1016/0163-7258(87)90104-5; MCBURNEY MW, 1974, CELL, V2, P173, DOI 10.1016/0092-8674(74)90091-9; MCGUIRE JJ, 1983, ADV EXP MED BIOL, V163, P199; MCGUIRE JJ, 1980, J BIOL CHEM, V255, P5776; MCGUIRE JJ, 1985, J BIOL CHEM, V260, P6747; MCGUIRE JJ, 1989, CANCER RES, V49, P4517; MCGUIRE JJ, 1988, BIOCHEM PHARMACOL, V37, P3931, DOI 10.1016/0006-2952(88)90076-7; MCGUIRE JJ, 1984, FOLATES PTERINS, V1, P135; NIMEC Z, 1983, ARCH BIOCHEM BIOPHYS, V226, P671, DOI 10.1016/0003-9861(83)90337-5; RUSTUM YM, 1989, EXPANDING ROLE FOLAT; SEGEL IH, 1975, ENZYME KINETICS, P18; SHANE B, 1983, ADV EXP MED BIOL, V163, P149	21	16	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1990	265	24					14073	14079						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV278	1974895				2022-12-25	WOS:A1990DV27800005
J	SISTONEN, L; KOSKINEN, PJ; LEHVASLAIHO, H; LEHTOLA, L; BRAVO, R; ALITALO, K				SISTONEN, L; KOSKINEN, PJ; LEHVASLAIHO, H; LEHTOLA, L; BRAVO, R; ALITALO, K			DOWN-REGULATION OF THE EARLY GENOMIC GROWTH-FACTOR RESPONSE IN NEU ONCOGENE-TRANSFORMED CELLS	ONCOGENE			English	Article									UNIV HELSINKI, DEPT VIROL, CANC BIOL LAB, HAARTMANINK 3, SF-00290 HELSINKI 29, FINLAND; UNIV HELSINKI, DEPT PATHOL, CANC BIOL LAB, SF-00290 HELSINKI, FINLAND; SQUIBB INST MED RES, DEPT MOLEC BIOL, PRINCETON, NJ 08543 USA	University of Helsinki; University of Helsinki			Alitalo, Kari K/J-5013-2014; Koskinen, Päivi J/G-8939-2014	Alitalo, Kari K/0000-0002-7331-0902; Sistonen, Lea/0000-0003-1341-2867				ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; BARGMANN CI, 1988, P NATL ACAD SCI USA, V85, P5394, DOI 10.1073/pnas.85.15.5394; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BLOCHLINGER K, 1984, MOL CELL BIOL, V4, P2929, DOI 10.1128/MCB.4.12.2929; BOUCHARD L, 1989, CELL, V57, P931, DOI 10.1016/0092-8674(89)90331-0; BRAVO R, 1986, EMBO J, V5, P695, DOI 10.1002/j.1460-2075.1986.tb04269.x; BRAVO R, 1990, IN PRESS GROWTH FACT; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; HUNG MC, 1989, P NATL ACAD SCI USA, V86, P2545, DOI 10.1073/pnas.86.8.2545; JAGGI R, 1986, EMBO J, V5, P2609, DOI 10.1002/j.1460-2075.1986.tb04541.x; KOSKINEN P, 1990, ONCOGENE, V5, P615; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; Lehtola L, 1989, GROWTH FACTORS, V1, DOI 10.3109/08977198909000256; LEHVASLAIHO H, 1989, EMBO J, V8, P159, DOI 10.1002/j.1460-2075.1989.tb03360.x; LEHVASLAIHO H, 1990, J CELL BIOCHEM, V42, P123, DOI 10.1002/jcb.240420303; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; LIN AH, 1988, MOL CELL BIOL, V8, P5052, DOI 10.1128/MCB.8.11.5052; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; NESTOR JJ, 1985, BIOCHEM BIOPH RES CO, V129, P226, DOI 10.1016/0006-291X(85)91426-3; PANDIELLA A, 1989, ONCOGENE, V4, P1299; PERTOVAARA L, 1989, MOL CELL BIOL, V9, P1255, DOI 10.1128/MCB.9.3.1255; RUSSELL WC, 1975, NATURE, V253, P461, DOI 10.1038/253461a0; RYSECK RP, 1989, EMBO J, V8, P3327, DOI 10.1002/j.1460-2075.1989.tb08494.x; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; SCHWAB M, 1983, NATURE, V303, P497, DOI 10.1038/303497a0; SISTONEN L, 1989, J CELL BIOL, V109, P1911, DOI 10.1083/jcb.109.5.1911; SISTONEN L, 1989, EMBO J, V8, P815, DOI 10.1002/j.1460-2075.1989.tb03442.x; SISTONEN L, 1987, EXP CELL RES, V168, P518, DOI 10.1016/0014-4827(87)90024-3; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; STERN DF, 1986, MOL CELL BIOL, V6, P1729, DOI 10.1128/MCB.6.5.1729; STERN DF, 1988, MOL CELL BIOL, V8, P3969, DOI 10.1128/MCB.8.9.3969; STERNBERG MJE, 1989, NATURE, V339, P587, DOI 10.1038/339587a0; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; YARDEN Y, 1989, P NATL ACAD SCI USA, V86, P3179, DOI 10.1073/pnas.86.9.3179; ZULLO JN, 1988, MOL CELL BIOL, V8, P5080, DOI 10.1128/MCB.8.12.5080	44	10	10	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUN	1990	5	6					815	821						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP553	1972791				2022-12-25	WOS:A1990DP55300006
J	DZIARSKI, R				DZIARSKI, R			DEMONSTRATION OF PEPTIDOGLYCAN-BINDING SITES ON LYMPHOCYTES AND MACROPHAGES BY PHOTOAFFINITY CROSS-LINKING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCAL PEPTIDOGLYCAN; MURINE SPLENOCYTES; MURAMYL PEPTIDES; PROTEINS; STIMULATION; ACTIVATION; SECRETION	One dominant binding site (70 kDa 6.5 pI protein) for bacterial cell wall peptidoglycan (PGN), a macrophage activator and polyclonal B cell mitogen, was demonstrated on mouse B and T lymphocytes and macrophages by photoaffinity cross-linking and two-dimensional polyacrylamide gel electrophoresis. This binding site was not present on erythrocytes. The binding was specific for polymeric PGN and was competitively inhibited by unlabeled PGN with IC50 = 48-mu-g/ml (0.38-mu-M). The binding was partially inhibited by O-acetylated PGN monomers (IC50 = 469-mu-g/ml, 521-mu-M), dextran sulfate (IC50 = 1024-mu-g/ml, 124-mu-M), and (GlcNAc)3 (IC50 = 6.6 mg/ml, 10 mM), and was not inhibited by non-O-acetylated PGN monomers and dimers, muramyl dipeptide, PGN pentapeptide, GlcNAc, teichoic acid, protein A, and gelatin. The cell surface location of the 70-kDa PGN-binding protein was indicated by the ability of PGN to bind to this protein in intact metabolically inactive cells (at 4-degrees-C and in the presence of 0.1% NaN3) and by the ability to extract the 70-kDa PGN-binding protein from viable B lymphocytes by noncytotoxic concentration of n-octyl-beta-D-glucopyranoside.			DZIARSKI, R (corresponding author), INDIANA UNIV,NW CTR MED EDUC,SCH MED,GARY,IN 46408, USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR036640] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR 36640] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		DEPEDRO MA, 1980, FEMS MICROBIOL LETT, V9, P215, DOI 10.1016/0378-1097(80)90127-5; DZIARSKI R, 1989, EUR J IMMUNOL, V19, P125, DOI 10.1002/eji.1830190120; DZIARSKI R, 1980, J IMMUNOL, V125, P2478; DZIARSKI R, 1979, INFECT IMMUN, V23, P706, DOI 10.1128/IAI.23.3.706-710.1979; DZIARSKI R, 1991, J BIOL CHEM, V266, P4719; DZIARSKI R, 1987, CELL IMMUNOL, V109, P231, DOI 10.1016/0008-8749(87)90307-8; DZIARSKI R, 1988, CELL IMMUNOL, V111, P10, DOI 10.1016/0008-8749(88)90047-0; DZIARSKI R, 1984, IMMUNOLOGY, V53, P563; DZIARSKI R, 1986, BIOL PROPERTIES PEPT, P229; DZIARSKI R, 1976, ZENTRALBL BAKTERIOL, V5, P393; Heymer B., 1985, IMMUNOLOGY BACTERIAL, P11; KANOST MR, 1988, ARCH INSECT BIOCHEM, V8, P147, DOI 10.1002/arch.940080302; LEI MG, 1988, J IMMUNOL, V141, P996; LEI MG, 1988, J IMMUNOL, V141, P1006; LEVINSON AI, 1983, INFECT IMMUN, V39, P290, DOI 10.1128/IAI.39.1.290-296.1983; LIMBIRD LE, 1986, CELL SURFACE RECEPTO, P51; MARRIOTT SJ, 1987, J VIROL, V61, P375, DOI 10.1128/JVI.61.2.375-382.1987; MARTIN SA, 1987, J BIOL CHEM, V262, P7514; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PARISH CR, 1985, CELL IMMUNOL, V91, P201, DOI 10.1016/0008-8749(85)90044-9; PARISH CR, 1988, J IMMUNOL, V141, P3498; PERKINS HR, 1969, BIOCHEM J, V111, P195, DOI 10.1042/bj1110195; RUOHO AE, 1984, MEMBRANES DETERGENTS, P119; RUPLEY JA, 1964, BIOCHIM BIOPHYS ACTA, V83, P245, DOI 10.1016/0926-6526(64)90001-1; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; SILVERMAN DHS, 1986, J IMMUNOL, V136, P2195; SILVERMAN DHS, 1985, BIOCHEM BIOPH RES CO, V131, P1160, DOI 10.1016/0006-291X(85)90212-8; SWITZER RC, 1979, ANAL BIOCHEM, V98, P231, DOI 10.1016/0003-2697(79)90732-2; TENU JP, 1989, INT J IMMUNOPHARMACO, V11, P653, DOI 10.1016/0192-0561(89)90151-3; WEISS A, 1989, FUNDAMENTAL IMMUNOLO, P359; WOLLENWEBER HW, 1985, J BIOL CHEM, V260, P5068; ZEIGER AR, 1982, INFECT IMMUN, V37, P1112, DOI 10.1128/IAI.37.3.1112-1118.1982; [No title captured]	33	62	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4713	4718						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002020				2022-12-25	WOS:A1991FC21700010
J	GARDLIK, S; RAJAGOPALAN, KV				GARDLIK, S; RAJAGOPALAN, KV			OXIDATION OF MOLYBDOPTERIN IN SULFITE OXIDASE BY FERRICYANIDE - EFFECT ON ELECTRON-TRANSFER ACTIVITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLYBDENUM COFACTOR; DEMOLYBDOSULFITE OXIDASE; INVITRO RECONSTITUTION; XANTHINE-OXIDASE; RAT-LIVER; PURIFICATION; MECHANISM; PTERIN	The attenuation of the sulfite:cytochrome c activity of sulfite oxidase upon treatment with ferricyanide was demonstrated to be the result of oxidation of the pterin ring of the molybdenum cofactor in the enzyme. Oxidation of molybdopterin (MPT) was detected in several ways. Ferricyanide treatment not only abolished the ability of sulfite oxidase to serve as a source of MPT to reconstitute the aponitrate reductase in extracts of the Neurospora crassa mutant nit-1 but also eliminated the ability of sulfite oxidase to reduce dichlorobenzenoneindophenol after anaerobic denaturation. Additionally, the absorption spectrum of anaerobically denatured ferricyanide-treated molybdenum fragment of rat liver sulfite oxidase was typical of fully oxidized pterins. Ferricyanide treatment had no effect on the protein of sulfite oxidase of on the sulfhydryl-containing side chain of MPT. Quantitation of the ferricyanide reaction showed that 2 mol of ferricyanide were reduced per mol of MPT oxidized, yielding a fully oxidized pterin. These results corroborate the previously reported conclusion that the native state of reduction of MPT in sulfite oxidase is at the dihydro level (Gardlik, S., and Rajagopalan, K. V. (1990) J. Biol. Chem. 265, 13047-13054). As a result of oxidation of the pterin ring, the affinity of MPT for molybdenum is decreased, leading to eventual loss of molybdenum. Because the loss of molybdenum is slow, a population of sulfite oxidase molecules can exist in which molybdenum is complexed to oxidized MPT. These molecules retain sulfite:O2 activity, a function apparently dependent solely on the molybdenum-thiolate complex, yet have greatly decreased sulfite:cytochrome c activity, a function requiring heme as well as the molybdenum center of holoenzyme. These observations suggest that the pterin ring of MPT participates in enzyme function, possibly in electron transfer, directly in catalysis, or by controlling the oxidation/reduction potential of molybdenum.			GARDLIK, S (corresponding author), DUKE UNIV,MED CTR,DEPT BIOCHEM,DURHAM,NC 27710, USA.				NIGMS NIH HHS [GM00091] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; AMY NK, 1979, J BACTERIOL, V140, P114, DOI 10.1128/JB.140.1.114-124.1979; ARCHER MC, 1972, CAN J BIOCHEM CELL B, V50, P1174, DOI 10.1139/o72-160; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COHEN HJ, 1971, J BIOL CHEM, V246, P359; DIX TA, 1988, ACCOUNTS CHEM RES, V21, P101, DOI 10.1021/ar00147a002; GARDLIK S, 1990, J BIOL CHEM, V265, P13047; HASEGAWA H, 1978, J BIOCHEM-TOKYO, V84, P499, DOI 10.1093/oxfordjournals.jbchem.a132153; JOHNSON JL, 1974, J BIOL CHEM, V249, P5056; JOHNSON JL, 1982, P NATL ACAD SCI-BIOL, V79, P6856, DOI 10.1073/pnas.79.22.6856; JOHNSON JL, 1977, J BIOL CHEM, V252, P4994; JOHNSON JL, 1977, J BIOL CHEM, V252, P2017; JOHNSON JL, 1984, J BIOL CHEM, V259, P5414; JOHNSON JL, 1976, J CLIN INVEST, V58, P543, DOI 10.1172/JCI108499; JONES HP, 1977, J BIOL CHEM, V252, P4988; KAUFMAN S, 1975, CHEM BIOL PTERIDINES, P291; KESSLER DL, 1974, BIOCHIM BIOPHYS ACTA, V370, P399, DOI 10.1016/0005-2744(74)90101-6; KESSLER DL, 1972, J BIOL CHEM, V247, P6566; KESSLER DL, 1973, THESIS DUKE U; KRAMER SP, 1987, J BIOL CHEM, V262, P16357; RAJAGOPALAN KV, 1982, FED PROC, V41, P2608	21	40	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4889	4895						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002036				2022-12-25	WOS:A1991FC21700035
J	HUGHES, SD; QUAADE, C; MILBURN, JL; CASSIDY, L; NEWGARD, CB				HUGHES, SD; QUAADE, C; MILBURN, JL; CASSIDY, L; NEWGARD, CB			EXPRESSION OF NORMAL AND NOVEL GLUCOKINASE MESSENGER-RNAS IN ANTERIOR-PITUITARY AND ISLET CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GLUCOSE TRANSPORTER; FUNCTIONAL EXPRESSION; SECRETING CELL; ALPHA-ACTIN; RAT-LIVER; GENE; CDNA; INSULIN; SEQUENCE; CLONING	The glucose-phosphorylating enzyme glucokinase likely plays an important role in regulating glucose-stimulated insulin secretion from the islets of Langerhans and has previously been thought to be expressed only in that tissue and in liver. In this study, we demonstrate high levels of glucokinase mRNA in the anterior pituitary cell line AtT20ins, which has been engineered to secrete correctly processed insulin, as well as in primary anterior pituitary tissue. Unlike islet or liver cells, expression of glucokinase mRNA in anterior pituitary cells was not accompanied by expression of the high K(m) glucose transporter (GLUT-2) mRNA. The glucokinase transcript in anterior pituitary cells was similar in size to islet glucokinase mRNA, which has a unique, elongated 5'-end relative to the liver glucokinase message. Amplification and sequence analysis of the glucokinase mRNA expressed in islets, RIN1046-38 cells, and anterior pituitary cells confirmed that the glucokinase transcripts in these cell types contain the same 5'-sequence. In addition, a novel alternative transcript was identified that contains a 52-nucleotide deletion and that predicts a 58-amino acid peptide as a result of a frame shift. Both the deleted and undeleted transcripts were found in islets, RIN cells, and AtT20ins cells, whereas only the deleted product was identified in primary anterior pituitary tissue. An antibody prepared against a peptide found at the N terminus of the islet isoform of glucokinase easily detected a protein with a size predicted by the undeleted transcript in extracts prepared from islets, RIN1046-38 cells, and AtT20ins cells. Since both the glucokinase protein and mRNA are naturally expressed in AtT20ins and RIN1046-38 cells, we compared the effect of varying concentrations of glucose on insulin secretion from the two lines. Insulin secretion from RIN1046-38 cells was stimulated by glucose in a dose-dependent manner over the range 0-2.5 mM, where it reached a maximum. AtT20ins cells, in contrast, exhibited no response to glucose at any concentration tested, despite the fact that insulin secretion from both cell lines was stimulated by incubation with dibutyryl cAMP. We conclude that glucokinase expression in AtT20ins cells may be necessary, but is not sufficient to confer glucose-stimulated insulin secretion.	UNIV TEXAS,SW MED CTR,CTR DIABET RES,GIFFORD LABS,5323 HARRY HINES BLVD,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT BIOCHEM,DALLAS,TX 75235	Diabetes & Endocrine Center; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK042582] Funding Source: NIH RePORTER; NIDDK NIH HHS [1-PO1-DK42582] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDREONE TL, 1989, J BIOL CHEM, V264, P363; ASHCROFT SJH, 1986, DIABETOLOGIA, V29, P727, DOI 10.1007/BF00870283; ASHCROFT SJH, 1981, ISLETS LANGERHANS BI, P117; ASHLEY PL, 1985, BIOCHEMISTRY-US, V24, P4512, DOI 10.1021/bi00338a005; BIRNBAUM MJ, 1987, SCIENCE, V235, P1495, DOI 10.1126/science.3029870; BIRNBAUM MJ, 1986, P NATL ACAD SCI USA, V83, P5784, DOI 10.1073/pnas.83.16.5784; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAN SJ, 1979, P NATL ACAD SCI USA, V76, P5036, DOI 10.1073/pnas.76.10.5036; CHEN L, 1990, P NATL ACAD SCI USA, V87, P4088, DOI 10.1073/pnas.87.11.4088; CLARK SA, 1990, ENDOCRINOLOGY, V126, P1895, DOI 10.1210/endo-126-4-1895; CLARK SA, 1990, IN PRESS ENDOCRINOLO; FLIER JS, 1987, SCIENCE, V235, P1492, DOI 10.1126/science.3103217; GAZDAR AF, 1980, P NATL ACAD SCI-BIOL, V77, P3519, DOI 10.1073/pnas.77.6.3519; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; HAYZER DJ, 1990, BIOCHEM J, V270, P261, DOI 10.1042/bj2700261; IYNEDJIAN PB, 1986, P NATL ACAD SCI USA, V83, P1998, DOI 10.1073/pnas.83.7.1998; IYNEDJIAN PB, 1989, P NATL ACAD SCI USA, V86, P7838, DOI 10.1073/pnas.86.20.7838; IYNEDJIAN PB, 1987, J BIOL CHEM, V262, P6032; IYNEDJIAN PB, 1989, J BIOL CHEM, V264, P21824; JOHNSON JH, 1990, NEW ENGL J MED, V322, P653, DOI 10.1056/NEJM199003083221003; JOHNSON JH, 1990, J BIOL CHEM, V265, P6548; JOHNSON JH, 1990, SCIENCE, V250, P546, DOI 10.1126/science.2237405; KUWAJIMA M, 1986, J BIOL CHEM, V261, P8849; LACHMANN PJ, 1986, CIBA F SYMP, V119, P25; LAUB O, 1983, J BIOL CHEM, V258, P6043; LEAVITT J, 1985, NATURE, V316, P840, DOI 10.1038/316840a0; MAGNUSON MA, 1989, J BIOL CHEM, V264, P15936; MAGNUSON MA, 1989, P NATL ACAD SCI USA, V86, P4838, DOI 10.1073/pnas.86.13.4838; MEGLASSON M D, 1986, Diabetes Metabolism Reviews, V2, P163; MEGLASSON MD, 1984, AM J PHYSIOL, V246, pE1, DOI 10.1152/ajpendo.1984.246.1.E1; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MOORE HPH, 1983, CELL, V35, P531, DOI 10.1016/0092-8674(83)90187-3; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; NELSON C, 1988, SCIENCE, V239, P1400, DOI 10.1126/science.2831625; NEWGARD CB, 1986, P NATL ACAD SCI USA, V83, P8132, DOI 10.1073/pnas.83.21.8132; NEWGARD CB, 1990, BIOCHEM SOC T, V18, P851, DOI 10.1042/bst0180851; ORCI L, 1990, P NATL ACAD SCI USA, V87, P9953, DOI 10.1073/pnas.87.24.9953; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; PERMUTT MA, 1989, P NATL ACAD SCI USA, V86, P8688, DOI 10.1073/pnas.86.22.8688; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; QUAADE C, 1991, IN PRESS FEBS LETT; REYMOND MJ, 1984, ACTA ENDOCRINOL-COP, V106, P459, DOI 10.1530/acta.0.1060459; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHIMIZU T, 1988, DIABETES, V37, P1524, DOI 10.2337/diabetes.37.11.1524; SHIMIZU T, 1988, DIABETES, V37, P563, DOI 10.2337/diabetes.37.5.563; SHOWS TB, 1987, DIABETES, V36, P546, DOI 10.2337/diabetes.36.4.546; THORENS B, 1988, CELL, V55, P281, DOI 10.1016/0092-8674(88)90051-7	48	78	91	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4521	4530						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999433				2022-12-25	WOS:A1991FA69400078
J	NAKAYAMA, TA; KHORANA, HG				NAKAYAMA, TA; KHORANA, HG			MAPPING OF THE AMINO-ACIDS IN MEMBRANE-EMBEDDED HELICES THAT INTERACT WITH THE RETINAL CHROMOPHORE IN BOVINE RHODOPSIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE; BACTERIORHODOPSIN; EXPRESSION; ACTIVATION; TRANSDUCIN; SEQUENCE	By using a photoactivatable analog of 11-cis-retinal in rhodopsin, we have previously identified the amino acids Phe-115, Ala-117, Glu-122, Trp-126, Ser-127, and Trp-265 as major sites of cross-linking to the chromophore. To further investigate the amino acids that interact with retinal, we have now used site-directed mutagenesis to replace a variety of amino acids in the membrane-embedded helices in bovine rhodopsin, including those that were indicated by cross-linking studies. The mutant rhodopsin genes were expressed in monkey kidney cells (COS-1) and purified. The mutant proteins were studied for their spectroscopic properties and their ability to activate transducin. Substitution of the two amino acids, Trp-265 and Glu-122 by Tyr, Phe, and Ala and by Gln, Asp and Ala, respectively, resulted in blue-shifted (20-30 nm) chromophore, and substitution of Trp-265 by Ala resulted in marked reduction in the extent of chromophore regeneration. Light-dependent bleaching behavior was significantly altered in Ala-117 --> Phe, Trp-265 --> Phe, Ala, and Ala-292 --> Asp mutants. Transducin activation was reduced in these mutants, in particular Trp-265 mutants, as well as in Glu-122 --> Gln, Trp-126 --> Leu (Ala), Pro-267 --> Ala (Asn, Ser), and Tyr-268 --> Phe mutants. These findings indicate that Trp-265 is located close to retinal and Glu-122, Trp-126, and probably Tyr-268 are also likely to be near retinal.	MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA; MIT, DEPT CHEM, CAMBRIDGE, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)					NIAID NIH HHS [AI11479] Funding Source: Medline; NIGMS NIH HHS [GM28289] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI011479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028289, R37GM028289] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHARBRE M, 1979, VISION RES, V19, P1005; FERRETTI L, 1986, P NATL ACAD SCI USA, V83, P599, DOI 10.1073/pnas.83.3.599; FRANKE RR, 1988, J BIOL CHEM, V263, P2119; GANTER UM, 1988, J PHOTOCH PHOTOBIO B, V2, P417, DOI 10.1016/1011-1344(88)85070-X; HARGRAVE PA, 1983, BIOPHYS STRUCT MECH, V9, P235, DOI 10.1007/BF00535659; JANSSEN JJM, 1990, FEBS LETT, V260, P113, DOI 10.1016/0014-5793(90)80080-3; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; KHORANA HG, 1988, P NATL ACAD SCI USA, V85, P7917, DOI 10.1073/pnas.85.21.7917; LO KM, 1984, P NATL ACAD SCI-BIOL, V81, P2285, DOI 10.1073/pnas.81.8.2285; MATSUMOTO H, 1975, NATURE, V258, P523, DOI 10.1038/258523a0; NAKAYAMA TA, 1990, J BIOL CHEM, V265, P15762; NAKAYAMA TA, 1989, THESIS MIT; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P937, DOI 10.1021/bi00456a013; NATHANS J, 1983, CELL, V34, P807, DOI 10.1016/0092-8674(83)90537-8; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; OVCHINNIKOV YA, 1982, BIOORG KHIM+, V8, P1011; RAFERTY CN, 1981, PHOTOCHEM PHOTOBIOL, V33, P229, DOI 10.1111/j.1751-1097.1981.tb05329.x; RAFFERTY CN, 1979, PHOTOCHEM PHOTOBIOL, V29, P109, DOI 10.1111/j.1751-1097.1979.tb09268.x; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; TOWNER P, 1981, EUR J BIOCHEM, V117, P353, DOI 10.1111/j.1432-1033.1981.tb06345.x; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; WESSLINGRESNICK M, 1987, J BIOL CHEM, V262, P3697; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154	24	207	208	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4269	4275						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999419				2022-12-25	WOS:A1991FA69400041
J	SCHILDBACH, JF; PANKA, DJ; PARKS, DR; JAGER, GC; NOVOTNY, J; HERZENBERG, LA; MUDGETTHUNTER, M; BRUCCOLERI, RE; HABER, E; MARGOLIES, MN				SCHILDBACH, JF; PANKA, DJ; PARKS, DR; JAGER, GC; NOVOTNY, J; HERZENBERG, LA; MUDGETTHUNTER, M; BRUCCOLERI, RE; HABER, E; MARGOLIES, MN			ALTERED HAPTEN RECOGNITION BY 2 ANTIDIGOXIN HYBRIDOMA VARIANTS DUE TO VARIABLE REGION POINT MUTATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN; 3-DIMENSIONAL STRUCTURE; BINDING-SPECIFICITY; HIGH-AFFINITY; SOMATIC HYPERMUTATION; ARSONATE IDIOTYPE; GENIN ACTIVITY; ANTIBODIES; COMPLEX; RECOMBINATION	Two spontaneous variants of the murine anti-digoxin antibody-producing hybridoma cell line 26-10 were isolated by two-color fluorescence-activated cell sorting on the basis of altered hapten binding. The variable region sequences of the antibodies produced by the mutant lines revealed that each contains a single amino acid change in the heavy chain second complementarity determining region. A Tyr to His change at position 50 leads to a 40-fold reduction in affinity for digoxin. A Ser to Phe mutation at position 52 results in a 300-fold reduction in affinity for digoxin. A competition assay involving 33 digoxin analogues was used to examine the specificity of hapten binding of 26-10 and the two mutant antibodies. The position 50 mutant has a distinct specificity change; it exhibits a preference for digoxin congeners containing a hydroxyl group at the steroid 12 position, whereas the 26-10 parent does not. The affinities of all three antibodies for hapten are progressively lowered by substitutions of increasing size at the digoxin steroid D ring 16 position. Although 26-10 binds digoxin and its genin form equally, 12 and 16 steroid position substitutions which lower affinity also confer a preference for a sugar at the steroid 3 position. These results suggest that position 50 contributes to specificity of the antibody and that alterations of the hapten can lead to differences in recognition, possibly through a shift in hapten orientation within the binding site.	MASSACHUSETTS GEN HOSP, DEPT MED, BOSTON, MA 02114 USA; MASSACHUSETTS GEN HOSP, DEPT SURG, BOSTON, MA 02114 USA; HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA; STANFORD UNIV, DEPT GENET, STANFORD, CA 94305 USA; BRISTOL MYERS CO, SQUIBB PHARMACEUT RES INST, PRINCETON, NJ 08543 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Stanford University; Bristol-Myers Squibb				Schildbach, Joel/0000-0002-3038-9745	NHLBI NIH HHS [P01-HL19259] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL019259] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AMIT AG, 1986, SCIENCE, V233, P747, DOI 10.1126/science.2426778; BEREK C, 1988, IMMUNOL REV, V105, P5, DOI 10.1111/j.1600-065X.1988.tb00763.x; BRAUER AW, 1975, BIOCHEMISTRY-US, V14, P3029, DOI 10.1021/bi00684a036; BRAUER AW, 1984, ANAL BIOCHEM, V137, P134, DOI 10.1016/0003-2697(84)90359-2; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRUCCOLERI RE, 1987, BIOPOLYMERS, V26, P137, DOI 10.1002/bip.360260114; BRUGGEMANN M, 1986, EMBO J, V5, P1561, DOI 10.1002/j.1460-2075.1986.tb04397.x; BRUGGEMANN M, 1982, EMBO J, V1, P629, DOI 10.1002/j.1460-2075.1982.tb01219.x; BRUNS RF, 1983, ANAL BIOCHEM, V132, P74, DOI 10.1016/0003-2697(83)90427-X; BUSH IE, 1952, BIOCHEM J, V52, P643, DOI 10.1042/bj0520643; COOK WD, 1982, P NATL ACAD SCI-BIOL, V79, P1240, DOI 10.1073/pnas.79.4.1240; DIAMOND B, 1984, P NATL ACAD SCI-BIOL, V81, P5841, DOI 10.1073/pnas.81.18.5841; DILDROP R, 1982, EMBO J, V1, P635, DOI 10.1002/j.1460-2075.1982.tb01220.x; EISEN HN, 1964, BIOCHEMISTRY-US, V3, P996, DOI 10.1021/bi00895a027; FIELDS JZ, 1978, J BIOL CHEM, V253, P3251; FRENCH DL, 1989, SCIENCE, V244, P1152, DOI 10.1126/science.2658060; FULLERTON DS, 1979, SCIENCE, V205, P917, DOI 10.1126/science.224455; FULLERTON DS, 1979, J MED CHEM, V22, P529, DOI 10.1021/jm00191a014; GO K, 1981, CRYST STRUCT COMMUN, V10, P1329; GO K, 1980, ACTA CRYSTALLOGR B, V36, P1811, DOI 10.1107/S0567740880007297; GO K, 1980, ACTA CRYSTALLOGR B, V36, P3034, DOI 10.1107/S0567740880010746; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; Hardy RR, 1986, HDB EXPT IMMUNOLOGY, V1; HERRON JN, 1989, PROTEINS, V5, P271, DOI 10.1002/prot.340050404; HERZENBERG LA, 1985, BIOTECHNOLOGY DIAGNO, P3; HUDSON NW, 1990, J IMMUNOL, V145, P2718; HUDSON NW, 1987, J IMMUNOL, V139, P2715; Kabat E. A., 1987, SEQUENCES PROTEINS I, DOI 10.1016/0003-2697(84)90805-4; KARLE IL, 1969, ACTA CRYSTALL B-STRU, VB 25, P434, DOI 10.1107/S0567740869002391; KOCKS C, 1988, P NATL ACAD SCI USA, V85, P8206, DOI 10.1073/pnas.85.21.8206; KRAWINKEL U, 1983, P NATL ACAD SCI-BIOL, V80, P4997, DOI 10.1073/pnas.80.16.4997; MOSTAD A, 1982, ACTA CHEM SCAND B, V36, P635, DOI 10.3891/acta.chem.scand.36b-0635; MUDGETTHUNTER M, 1985, MOL IMMUNOL, V22, P477, DOI 10.1016/0161-5890(85)90132-4; MUDGETTHUNTER M, 1982, J IMMUNOL, V129, P1165; MUNSON PJ, 1979, ENDOCRINOLOGY, V105, P1377; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; MUNSON PJ, 1983, METHOD ENZYMOL, V92, P543; NEAR RI, 1990, MOL IMMUNOL, V27, P901, DOI 10.1016/0161-5890(90)90157-U; OHNO S, 1985, P NATL ACAD SCI USA, V82, P2945, DOI 10.1073/pnas.82.9.2945; PADLAN EA, 1989, P NATL ACAD SCI USA, V86, P5938, DOI 10.1073/pnas.86.15.5938; PANKA DJ, 1987, J IMMUNOL, V139, P2385; PANKA DJ, 1988, P NATL ACAD SCI USA, V85, P3080, DOI 10.1073/pnas.85.9.3080; RAYMOND W. D., 1939, ANALYST, V64, P113; ROHRER DC, 1983, ACTA CRYSTALLOGR B, V39, P272, DOI 10.1107/S0108768183002396; ROSE DR, 1990, P NATL ACAD SCI USA, V87, P338, DOI 10.1073/pnas.87.1.338; RUDIKOFF S, 1982, P NATL ACAD SCI-BIOL, V79, P1979, DOI 10.1073/pnas.79.6.1979; RUDKOFF S, 1983, CONTEMP TOP MOLEC IM, V9, P169; SATOW Y, 1986, J MOL BIOL, V190, P593, DOI 10.1016/0022-2836(86)90245-7; SCHARF SJ, 1986, SCIENCE, V233, P1076, DOI 10.1126/science.3461561; SHARON J, 1989, J IMMUNOL, V142, P596; SHERIFF S, 1987, P NATL ACAD SCI USA, V84, P8075, DOI 10.1073/pnas.84.22.8075; SMITH JA, 1987, BIOCHEMISTRY-US, V26, P604, DOI 10.1021/bi00376a036; SMITH JA, 1984, BIOCHEMISTRY-US, V23, P4726, DOI 10.1021/bi00315a031; SMITH TW, 1970, BIOCHEMISTRY-US, V9, P331, DOI 10.1021/bi00804a020; SMITH TW, 1972, J CLIN INVEST, V51, P1583, DOI 10.1172/JCI106956; STEINER LA, 1967, J EXP MED, V126, P1161, DOI 10.1084/jem.126.6.1161; STEINER LA, 1967, J EXP MED, V126, P1185, DOI 10.1084/jem.126.6.1185	57	38	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4640	4647						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999439				2022-12-25	WOS:A1991FA69400094
J	YAMADA, H; OMATAYAMADA, T; LENGYEL, P				YAMADA, H; OMATAYAMADA, T; LENGYEL, P			CHARACTERIZATION OF RECESSIVE (MEDIATOR-) REVERTANTS FROM NIH-3T3 CELLS TRANSFORMED WITH A C-H-RAS ONCOGENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE SARCOMA-VIRUS; GTPASE-ACTIVATING PROTEIN; ESCHERICHIA-COLI; GLUCOSE TRANSPORTER; KINASE; GENE; PHOSPHORYLATION; IDENTIFICATION; RESISTANCE; INDUCTION	We have reported earlier the isolation of two recessive, serum- and anchorage-dependent revertants from an NIH 3T3 line which had been transformed with multiple copies of a c-H-ras oncogene. In both revertants the oncogene was fully expressed and fusion of either revertant with normal (untransformed) cells or of the two revertants with one another resulted in transformed progeny. These, and other data indicate that the transforming activity of the c-H-ras oncogene is impaired in the two revertants, in consequence of defects in distinct genes needed to mediate this activity. Here, we describe some of the biochemical features of the revertants. In both of these (as in the transformed line) the bulk of the ras-p21 protein was found in the membrane fraction. This suggests proper posttranslational processing. Furthermore, no difference was detected either in the ras-p21 protein GTPase stimulating activity of GAP or in the extent of GAP-tyrosine phosphorylation among growing cultures of the two revertants, the transformed line and the parental NIH 3T3 line. The level of glucose transporter mRNA was severalfold higher in the transformed line than in the NIH 3T3 line. In the two revertants, however, the level was as low as that in the NIH 3T3 line. This indicates that the reversion impaired the effect of the c-H-ras oncogene on transcription. The raf oncogene (proposed to increase transcription factor activity) could retransform both revertants. Moreover, as revealed in experiments with growing cultures, neither transformation by the c-H-ras oncogene nor reversion from the transformed state altered the electrophoretic mobility of the raf protein or the level of its actin kinase activity. These results suggest that transformation by the c-H-ras oncogene is not mediated by the activation of raf protein kinase. The tyrosine phosphorylation of the p34cdc2 protein kinase (a cell cycle regulatory enzyme) was severalfold higher in the transformed line than in the NIH 3T3 line. The level of p34cdc2 protein kinase phosphorylation was as high in the R260 revertant as in the transformed line and as low in the R116 revertant as in the NIH 3T3 line. We are attempting to identify the defective mediator genes impairing the transforming activity of the c-H-ras oncogene in the two revertants.	YALE UNIV, DEPT MOLEC BIOPHYS & BIOCHEM, 260 WHITNEY AVE, NEW HAVEN, CT 06511 USA	Yale University					NATIONAL CANCER INSTITUTE [P01CA016038] Funding Source: NIH RePORTER; NCI NIH HHS [CA 16038] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BARRETT CB, 1990, MOL CELL BIOL, V10, P310, DOI 10.1128/MCB.10.1.310; BIRNBAUM MJ, 1987, SCIENCE, V235, P1495, DOI 10.1126/science.3029870; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; DAVIS LG, 1986, BASIC METHODS MOL BI, P286; DRAETTA G, 1988, NATURE, V336, P738, DOI 10.1038/336738a0; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; FLIER JS, 1987, SCIENCE, V235, P1492, DOI 10.1126/science.3103217; GRITZ L, 1983, GENE, V25, P179, DOI 10.1016/0378-1119(83)90223-8; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HATANAKA M, 1974, BIOCHIM BIOPHYS ACTA, V355, P77, DOI 10.1016/0304-419X(74)90008-0; HATTORI S, 1985, MOL CELL BIOL, V5, P1449, DOI 10.1128/MCB.5.6.1449; HOSHINO M, 1988, MOL CELL BIOL, V8, P4169, DOI 10.1128/MCB.8.10.4169; JONES PA, 1986, CANCER RES, V46, P461; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KEDAR PS, 1990, MOL CELL BIOL, V10, P3852, DOI 10.1128/MCB.10.7.3852; KOLCH W, 1988, BIOCHIM BIOPHYS ACTA, V949, P233, DOI 10.1016/0167-4781(88)90087-5; MOELLING K, 1984, NATURE, V312, P558, DOI 10.1038/312558a0; MOLLOY CJ, 1989, NATURE, V342, P711, DOI 10.1038/342711a0; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; OWEN RD, 1990, P NATL ACAD SCI USA, V87, P3866, DOI 10.1073/pnas.87.10.3866; OWEN RD, 1990, MOL CELL BIOL, V10, P1; PONDAVEN P, 1990, GENE DEV, V4, P9, DOI 10.1101/gad.4.1.9; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; RAPP UR, 1988, HDB ONCOGENES, P213; Sambrook J, 1989, MOL CLONING LABORATO; SAMID D, 1987, MOL CELL BIOL, V7, P2196, DOI 10.1128/MCB.7.6.2196; SATAKE M, 1988, ONCOGENE, V3, P69; SATOH T, 1987, MOL CELL BIOL, V7, P4553, DOI 10.1128/MCB.7.12.4553; SCHAFER WR, 1989, SCIENCE, V245, P379, DOI 10.1126/science.2569235; SCHULTZ AM, 1985, VIROLOGY, V146, P78, DOI 10.1016/0042-6822(85)90054-6; SCOLNICK EM, 1979, P NATL ACAD SCI USA, V76, P5355, DOI 10.1073/pnas.76.10.5355; SHIH TY, 1979, VIROLOGY, V96, P64, DOI 10.1016/0042-6822(79)90173-9; SHIH TY, 1982, J VIROL, V42, P253, DOI 10.1128/JVI.42.1.253-261.1982; SISTONEN L, 1989, EMBO J, V8, P815, DOI 10.1002/j.1460-2075.1989.tb03442.x; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; STERN D, 1986, MOL CELL BIOL, V6, P1279; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; WASYLYK C, 1987, CELL, V48, P525, DOI 10.1016/0092-8674(87)90203-0; Weinberg R. A., 1989, ONCOGENES MOL ORIGIN; WEST M, 1990, FEBS LETT, V259, P245, DOI 10.1016/0014-5793(90)80019-F; WILLUMSEN BM, 1984, EMBO J, V3, P2581, DOI 10.1002/j.1460-2075.1984.tb02177.x; WOLFMAN A, 1990, SCIENCE, V248, P67, DOI 10.1126/science.2181667; YAMADA H, 1990, MOL CELL BIOL, V10, P1822, DOI 10.1128/MCB.10.4.1822	47	4	4	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					4002	4009						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995648				2022-12-25	WOS:A1991EY68200097
J	LINDQVIST, Y; BRANDEN, CI; MATHEWS, FS; LEDERER, F				LINDQVIST, Y; BRANDEN, CI; MATHEWS, FS; LEDERER, F			SPINACH GLYCOLATE OXIDASE AND YEAST FLAVOCYTOCHROME-B2 ARE STRUCTURALLY HOMOLOGOUS AND EVOLUTIONARILY RELATED ENZYMES WITH DISTINCTLY DIFFERENT FUNCTION AND FLAVIN MONONUCLEOTIDE BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLAVOPROTEIN TRIMETHYLAMINE DEHYDROGENASE; CATALYZED REACTIONS; LACTATE OXIDASE; CYTOCHROME B2; MECHANISMS; HYDROXYLATION; RESOLUTION; CHEMISTRY; PROTEIN; ADDUCTS	A comparison of the three-dimensional structures of the flavin mononucleotide (FMN)-dependent enzymes glycolate oxidase, flavocytochrome b2, and trimethylamine dehydrogenase is presented. Their flavin-binding domains all have the same structural motif, the 8-fold-beta/alpha-barrel domain, which is also present in a large number of other enzymes. FMN is bound in a similar fashion in all three enzymes. The binding site is at the carboxyl-terminal end of the eight beta-strands of the barrel where the active site is invariably found in this type of domain structure. The similarity of the structures of glycolate oxidase and flavocytochrome b2 extends to the loop regions and even outside the beta/alpha-barrels with a root mean square deviation of 0.93 angstrom for 311 superimposed C-alpha-atoms and with a sequence identity of 37%. A detailed analysis of their active sites shows, however, that the orientation of FMN is significantly different in the two structures due to different conformations of residues in the end of strand one. Thus, in flavocytochrome b2 a hydrogen bond is formed between the FMN N-5 position and the main chain amide of Ala-198, while in glycolate oxidase, the ring system is tilted away from the strand, creating a pocket on the re-side of the FMN ring where a water molecule is bound. Model building shows that this site could accommodate the hydroperoxide moiety of a FMN-4a-hydroperoxide intermediate. Thus, in the course of evolution, a few mutations in, and close to, the active sites have fine tuned these enzymes to exert their specific functions as an oxidase or transferase, respectively.	WASHINGTON UNIV,SCH MED,DEPT CELL BIOL & PHYSIOL,ST LOUIS,MO 63110; HOP NECKER ENFANTS MALAD,CNRS,UA 122,INSERM,U25,F-75743 PARIS 15,FRANCE	Washington University (WUSTL); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	LINDQVIST, Y (corresponding author), SWEDISH UNIV AGR SCI,CTR BIOMED,DEPT MOLEC BIOL,BOX 590,S-75224 UPPSALA,SWEDEN.		Lindqvist, Ylva/F-9009-2010	Lindqvist, Ylva/0000-0003-3162-8661	PHS HHS [20530] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		APPELBY CA, 1954, NATURE, V173, P749; Baker A.L., 1966, METHODS ENZYMOL, V9, P338; BOLOGNESI M, 1978, ACTA CRYSTALLOGR B, V34, P821, DOI 10.1107/S0567740878004124; Bright H.B., 1975, ENZYMES, V12B, P421; BRUICE TC, 1980, ACCOUNTS CHEM RES, V13, P256, DOI 10.1021/ar50152a002; CAPEILLEREBLAND.C, 1975, EUR J BIOCHEM, V54, P5469; CEDERLUND E, 1988, EUR J BIOCHEM, V173, P523, DOI 10.1111/j.1432-1033.1988.tb14029.x; DUOBIS J, 1990, BIOCHEMISTRY-US, V29, P6393; EBERLEIN G, 1983, J AM CHEM SOC, V105, P6685, DOI 10.1021/ja00360a024; ENTSCH B, 1976, J BIOL CHEM, V251, P2550; FENDRICH G, 1982, BIOCHIM BIOPHYS ACTA, V702, P242, DOI 10.1016/0167-4838(82)90509-X; FRIGERIO NA, 1985, J BIOL CHEM, V231, P135; GENET R, 1990, BIOCHEM J, V266, P301, DOI 10.1042/bj2660301; GERVAIS M, 1980, EUR J BIOCHEM, V111, P357, DOI 10.1111/j.1432-1033.1980.tb04949.x; GHISLA S, 1980, J BIOL CHEM, V255, P5688; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; Ghisla S., 1982, FLAVINS FLAVOPROTEIN, P133; GUIARD B, 1974, P NATL ACAD SCI USA, V71, P2539, DOI 10.1073/pnas.71.6.2539; GUIARD B, 1985, EMBO J, V4, P3265, DOI 10.1002/j.1460-2075.1985.tb04076.x; HEMMERICH P, 1973, ANN NY ACAD SCI, V212, P13, DOI 10.1111/j.1749-6632.1973.tb47583.x; JACQ C, 1974, EUR J BIOCHEM, V41, P311, DOI 10.1111/j.1432-1033.1974.tb03271.x; JONES TA, 1990, CRYSTALLOGRAPHIC MOD, P189; LABEYRIE F, 1966, BIOCHIM BIOPHYS ACTA, V128, P492, DOI 10.1016/0926-6593(66)90010-5; LEBIODA L, 1982, J MOL BIOL, V162, P445, DOI 10.1016/0022-2836(82)90537-X; LEDERER F, 1985, EUR J BIOCHEM, V139, P59; LEDERER F, 1987, FLAVINS FLAVOPROTEIN, P133; LEDERER F, 1990, CHEM BIOCH FLAVOENZY, V2; LIM LW, 1988, J BIOL CHEM, V263, P3075; LIM LW, 1986, J BIOL CHEM, V261, P5140; LINDQVIST Y, 1985, P NATL ACAD SCI USA, V82, P6855, DOI 10.1073/pnas.82.20.6855; LINDQVIST Y, 1989, J MOL BIOL, V209, P151, DOI 10.1016/0022-2836(89)90178-2; LINDQVIST Y, 1989, J BIOL CHEM, V264, P3624; LOCKRIDGE O, 1972, J BIOL CHEM, V247, P8097; MANSTEIN DJ, 1986, BIOCHEMISTRY-US, V25, P6807, DOI 10.1021/bi00370a012; MIZIORKO HM, 1983, ANNU REV BIOCHEM, V52, P507, DOI 10.1146/annurev.bi.52.070183.002451; OHLSSON I, 1974, J MOL BIOL, V89, P339, DOI 10.1016/0022-2836(74)90523-3; PORTER DJT, 1973, J BIOL CHEM, V248, P4400; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; ROSSMANN MG, 1975, J BIOL CHEM, V250, P7525; SCHREUDER HA, 1990, BIOCHEMISTRY-US, V29, P3101, DOI 10.1021/bi00464a029; TEGONI M, 1988, J BIOL CHEM, V263, P19278; URBAN P, 1985, J BIOL CHEM, V260, P1115; VOLOKITA M, 1987, J BIOL CHEM, V262, P15825; WALSH C, 1980, ACCOUNTS CHEM RES, V13, P148, DOI 10.1021/ar50149a004; XIA ZX, 1990, J MOL BIOL, V212, P837, DOI 10.1016/0022-2836(90)90240-M	45	110	112	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3198	3207						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993693				2022-12-25	WOS:A1991EX60000080
J	YAMAMOTO, M; KOYATA, H; MATSUI, C; HIRAGA, K				YAMAMOTO, M; KOYATA, H; MATSUI, C; HIRAGA, K			THE GLYCINE CLEAVAGE SYSTEM - OCCURRENCE OF 2 TYPES OF CHICKEN H-PROTEIN MESSENGER-RNAS PRESUMABLY FORMED BY THE ALTERNATIVE USE OF THE POLYADENYLATION CONSENSUS SEQUENCES IN A SINGLE EXON	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOMETHYL CARRIER PROTEIN; PRIMARY BILIARY-CIRRHOSIS; AMINO-ACID SEQUENCE; NUCLEOTIDE-SEQUENCE; LIPOIC ACID; DEHYDROGENASE COMPLEX; DIHYDROLIPOAMIDE ACETYLTRANSFERASE; PROSTHETIC GROUP; LIVER; CDNA	Several cDNAs encoding H-protein, a constituent of the glycine cleavage system, were cloned from chicken liver cDNA libraries with an antibody raised against rat H-protein or with a nick-translated cDNA of an immunoreactive clone. The structure of the H-protein cDNA consisting of 910 base pairs was determined using clones with an apparent overlap in the nucleotide sequence. The cDNA encodes the precursor form of H-protein that is comprised of 39 amino acid residues for a mitochondrial presequence and 125 amino acid residues for the mature protein, following a 5' untranslated region of 13 base pairs. There are two genuine consensus sequences for the cleavage/polyadenylation of the precursor H-protein mRNA in the 3' untranslated region of the cDNA sequence. We showed by comparison with the delta-aminolevulinate synthase gene that only one copy of the H-protein cDNA occurs in the haploid genome of the chicken. Nevertheless, two types of H-protein mRNAs, which differ by the length of their 3' untranslated region, are produced in liver. The chicken H-protein gene extends over 8 kilobase pairs on the genome and includes 5 exons that encode the entire cDNA sequence. Two AATAAA motifs are coded in the last exons of this gene, suggesting that the differently size H-protein mRNAs are produced by the alternative use of these motifs.	TOYAMA MED & PHARMACEUT UNIV,SCH MED,DEPT BIOCHEM,SUGITANI,TOYAMA 93001,JAPAN	University of Toyama			Yamamoto, Masayuki/A-4873-2010	Yamamoto, Masayuki/0000-0002-9073-9436				BRADFORD AP, 1987, FEBS LETT, V222, P211, DOI 10.1016/0014-5793(87)80221-1; CHOI OR, 1986, NATURE, V323, P731, DOI 10.1038/323731a0; FUJIWARA K, 1979, ARCH BIOCHEM BIOPHYS, V197, P454, DOI 10.1016/0003-9861(79)90267-4; FUJIWARA K, 1986, J BIOL CHEM, V261, P8836; FYRBERG EA, 1980, CELL, V19, P365, DOI 10.1016/0092-8674(80)90511-5; GERSHWIN ME, 1987, J IMMUNOL, V138, P3525; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HIRAGA K, 1980, J BIOL CHEM, V255, P1664; HIRAGA K, 1981, J CLIN INVEST, V68, P525, DOI 10.1172/JCI110284; HIRAGA K, 1980, J BIOL CHEM, V255, P1671; HIRAGA K, 1988, BIOCHEM BIOPH RES CO, V151, P758, DOI 10.1016/S0006-291X(88)80345-0; HUMMEL KB, 1988, J BIOL CHEM, V263, P6165; KIKUCHI G, 1973, MOL CELL BIOCHEM, V1, P169, DOI 10.1007/BF01659328; KOCHI H, 1976, ARCH BIOCHEM BIOPHYS, V173, P71, DOI 10.1016/0003-9861(76)90236-8; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Krainer AR, 1988, TRANSCRIPTION SPLICI, P131; LAU KS, 1988, BIOCHEMISTRY-US, V27, P1972, DOI 10.1021/bi00406a025; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; MAGUIRE DJ, 1986, NUCLEIC ACIDS RES, V14, P1379, DOI 10.1093/nar/14.3.1379; MCDEVITT MA, 1986, EMBO J, V5, P2907, DOI 10.1002/j.1460-2075.1986.tb04586.x; MCLAUCHLAN J, 1985, NUCLEIC ACIDS RES, V13, P1347, DOI 10.1093/nar/13.4.1347; MIZUSAWA S, 1986, NUCLEIC ACIDS RES, V14, P1319, DOI 10.1093/nar/14.3.1319; MOTOKAWA Y, 1969, ARCH BIOCHEM BIOPHYS, V135, P402, DOI 10.1016/0003-9861(69)90556-6; ROBINSON JR, 1973, J BIOL CHEM, V248, P5319; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SETZER DR, 1982, J BIOL CHEM, V257, P5143; SPENCER ME, 1984, EUR J BIOCHEM, V141, P361, DOI 10.1111/j.1432-1033.1984.tb08200.x; STEPHENS PE, 1983, EUR J BIOCHEM, V133, P481, DOI 10.1111/j.1432-1033.1983.tb07490.x; VANDEWATER J, 1988, J EXP MED, V167, P1791, DOI 10.1084/jem.167.6.1791; YAMAMOTO M, 1988, J BIOL CHEM, V263, P15973; YOSHIDA T, 1973, J BIOCHEM-TOKYO, V73, P1013, DOI 10.1093/oxfordjournals.jbchem.a130155	31	30	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3317	3322						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993703				2022-12-25	WOS:A1991EX60000096
J	HALEY, JD; WATERFIELD, MD				HALEY, JD; WATERFIELD, MD			CONTRIBUTORY EFFECTS OF DENOVO TRANSCRIPTION AND PREMATURE TRANSCRIPT TERMINATION IN THE REGULATION OF HUMAN EPIDERMAL GROWTH-FACTOR RECEPTOR PROTOONCOGENE RNA-SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C PHOSPHORYLATION; HUMAN CARCINOMA-CELLS; EGF-RECEPTOR; MESSENGER-RNA; GENE-EXPRESSION; PROMOTER REGION; PHORBOL ESTER; OWN RECEPTOR; MYC GENE; DNA	Overexpression of the epidermal growth factor (EGF) receptor (c-erbB) proto-oncogene is a frequent occurrence in human carcinoma and appears to accompany autocrine or paracrine transforming growth factor-alpha expression, which in model systems can result in activation of EGF receptor tyrosine kinase activity and phenotypic transformation. Here we have investigated the transcriptional regulation of the EGF receptor gene, by run-on transcription in isolated nuclei derived from epithelioid tumor lines. The level of transcription was measured at various points on the 100-kilobase pair EGF receptor gene locus, on either sense or antisense DNA strands. We find the level of sense strand transcription along exon 1 is 8-fold higher than transcription in exons 2-26. Primary EGF receptor transcripts appear to pause or terminate prematurely between exons 1 and 2. Termination was mapped to a sequenced region approximately 2 kilobase pairs 3' of exon 1, proximal to a previously reported DNase I hypersensitive site and an enhancer-like activity. Transcription in the CpG-rich region surrounding exon 1 is bidirectional, with antisense transcripts initiating in intron 1 and extending through the coding first exon. Activation of protein kinase C results in a 5-fold induction of EGF receptor transcription, accompanied by a slow release in the block RNA elongation between exon 2 and exon 26, showing that EGF receptor RNA synthesis may be altered by changes in de novo transcription and by a block to RNA elongation.	LUDWIG INST CANC RES,LONDON W1 8BT,ENGLAND	Ludwig Institute for Cancer Research	HALEY, JD (corresponding author), ONCOGENE SCI INC,350 COMMUNITY DR,MANHASSET,NY 11030, USA.							ADAMSON ED, 1981, MOL CELL BIOCHEM, V34, P129, DOI 10.1007/BF02359619; BENDER TP, 1987, SCIENCE, V237, P1473, DOI 10.1126/science.3498214; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; BJORGE JD, 1989, J BIOL CHEM, V264, P4021; BJORGE JD, 1987, J BIOL CHEM, V262, P6615; BOONSTRA J, 1985, EXP CELL RES, V161, P421, DOI 10.1016/0014-4827(85)90098-9; CARLIN CR, 1985, EXP CELL RES, V159, P17, DOI 10.1016/S0014-4827(85)80033-1; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; CLARK AJL, 1985, P NATL ACAD SCI USA, V82, P8374, DOI 10.1073/pnas.82.24.8374; DAVIS RJ, 1988, J BIOL CHEM, V263, P9462; DENHARDT DT, 1966, BIOCHEM BIOPH RES CO, V23, P641, DOI 10.1016/0006-291X(66)90447-5; DIFIORE PP, 1987, CELL, V51, P1063, DOI 10.1016/0092-8674(87)90592-7; DOWNWARD J, 1985, J BIOL CHEM, V260, P4538; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; EARP HS, 1986, J BIOL CHEM, V261, P4777; EICK D, 1986, NUCLEIC ACIDS RES, V14, P8331, DOI 10.1093/nar/14.21.8331; FERNANDEZPOL JA, 1989, J BIOL CHEM, V264, P4151; FREIDENBERG GR, 1986, J BIOL CHEM, V261, P752; GROUDINE M, 1982, CELL, V30, P131, DOI 10.1016/0092-8674(82)90019-8; HALEY J, 1987, ONCOGENE RES, V1, P375; HALEY JD, 1989, ONCOGENE, V4, P273; HALEY JD, 1987, ONCOGENES GENES GROW, P41; HUDSON LG, 1989, MOL ENDOCRINOL, V3, P400, DOI 10.1210/mend-3-2-400; HUNTER T, 1984, NATURE, V311, P480, DOI 10.1038/311480a0; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; ISHII S, 1985, P NATL ACAD SCI USA, V82, P4920, DOI 10.1073/pnas.82.15.4920; JOHNSON AC, 1988, MOL CELL BIOL, V8, P4174, DOI 10.1128/MCB.8.10.4174; JOHNSON AC, 1988, J BIOL CHEM, V263, P5693; KAGEYAMA R, 1988, P NATL ACAD SCI USA, V85, P5016, DOI 10.1073/pnas.85.14.5016; KAGEYAMA R, 1988, J BIOL CHEM, V263, P6329; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; KESSLER M, 1989, J BIOL CHEM, V264, P9785; KUDLOW JE, 1986, J BIOL CHEM, V261, P4134; LIN CR, 1984, SCIENCE, V224, P843, DOI 10.1126/science.6326261; LINTON JP, 1989, MOL CELL BIOL, V9, P3058, DOI 10.1128/MCB.9.7.3058; LOWNDES NF, 1989, MOL CELL BIOL, V9, P3758, DOI 10.1128/MCB.9.9.3758; MAEKAWA T, 1989, J BIOL CHEM, V264, P5488; Maniatis T., 1982, MOL CLONING; MERLINO GT, 1984, SCIENCE, V224, P417, DOI 10.1126/science.6200934; MERLINO GT, 1985, MOL CELL BIOL, V5, P1722, DOI 10.1128/MCB.5.7.1722; MESSING J, 1981, NUCLEIC ACIDS RES, V9, P309, DOI 10.1093/nar/9.2.309; MILLER H, 1989, MOL CELL BIOL, V9, P5340, DOI 10.1128/MCB.9.12.5340; NEPVEU A, 1987, ONCOGENE, V1, P243; NEPVEU A, 1986, EMBO J, V5, P2859, DOI 10.1002/j.1460-2075.1986.tb04580.x; OZANNE B, 1986, J PATHOL, V149, P9, DOI 10.1002/path.1711490104; PRYWES R, 1986, CELL, V47, P777, DOI 10.1016/0092-8674(86)90520-9; RESNEKOV O, 1989, J BIOL CHEM, V264, P9953; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SHEN SH, 1981, CELL, V26, P191, DOI 10.1016/0092-8674(81)90302-0; SHIMIZU N, 1982, CYTOGENET CELL GENET, V32, P316; SPENCER CA, 1990, ONCOGENE, V5, P777; STERN DF, 1987, SCIENCE, V235, P321, DOI 10.1126/science.3492043; TAYLOR JM, 1976, BIOCHIM BIOPHYS ACTA, V442, P324, DOI 10.1016/0005-2787(76)90307-5; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; VELU TJ, 1987, SCIENCE, V238, P1408, DOI 10.1126/science.3500513; VELU TJ, 1989, MOL CELL BIOL, V9, P1772, DOI 10.1128/MCB.9.4.1772; WEINTRAUB H, 1981, CELL, V24, P333, DOI 10.1016/0092-8674(81)90323-8; WELLS A, 1988, P NATL ACAD SCI USA, V85, P7597, DOI 10.1073/pnas.85.20.7597	61	60	63	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1746	1753						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1988448				2022-12-25	WOS:A1991EU49700062
J	HUANG, R; KUCERA, GL; RITTENHOUSE, SE				HUANG, R; KUCERA, GL; RITTENHOUSE, SE			ELEVATED CYTOSOLIC CA2+ ACTIVATES PHOSPHOLIPASE-D IN HUMAN PLATELETS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SIGNAL TRANSDUCTION; PHOSPHATIDIC-ACID; DIACYLGLYCEROL FORMATION; INOSITOL TRISPHOSPHATE; STIMULATED PLATELETS; HUMAN-NEUTROPHILS; PHOSPHATIDYLCHOLINE; THROMBIN; PHOSPHATIDYLETHANOL	We have examined the activation of phospholipase D in human platelets treated with alpha-thrombin. When incubated with 1-O-[9,10-H-3(2)]hexadecyl-2-lysophosphatidylcholine (PtdCho) and 1-alkyl-[P-32]lysoPtdCho for 2 h, platelets formed H-3/P-32-labeled PtdCho in a ratio of 11:1. After incubation of such labeled platelets with alpha-thrombin for 5 min, increased accumulation of H-3/P-32-labeled phosphatidic acid (PtdOH) was detected in the same ratio, indicating the action of phospholipase D. The Ca2+ ionophore A23187 and alpha-thrombin each stimulated the formation of labeled PtdOH as above in a time- and concentration-dependent manner, with only minor changes in labeled diglyceride. A23187 was able to cause increases in labeled PtdOH comparable to those observed with alpha-thrombin. beta-Phorbol 12,13-dibutyrate, an activator of protein kinase C, only slightly stimulated the accumulation of labeled PtdOH. The protein kinase C inhibitor, staurosporine, totally blocked these changes but only slightly inhibited the increases in labeled PtdOH promoted by alpha-thrombin. These results suggest that an increase in intracellular Ca2+, rather than protein kinase C activity, is a major factor regulating phospholipase D in platelets exposed to alpha-thrombin. We have also examined the relative contributions of phospholipase D and diglyceride kinase (following phospholipase C action) to PtdOH accumulation in [P-32]P(i)-labeled platelets by comparing the P-32-specific radioactivities of PtdOH, PtdCho, and metabolic gamma-ATP in control and alpha-thrombin-exposed platelets. Based on these determinations, we conclude that 13 and 87% of incremental PtdOH in human platelets exposed to alpha-thrombin arises via phospholipase D acting on PtdCho and phospholipase C/diglyceride kinase, respectively.	UNIV VERMONT, COLL MED, DEPT BIOCHEM, BURLINGTON, VT 05405 USA	University of Vermont					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038622, T32HL007594] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-38622, HL-07594] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGWU DE, 1989, BIOCHEM BIOPH RES CO, V159, P79, DOI 10.1016/0006-291X(89)92407-8; AGWU DE, 1989, J BIOL CHEM, V264, P1405; AUGERT G, 1989, J BIOL CHEM, V264, P21689; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; BILLAH MM, 1989, J BIOL CHEM, V264, P17069; BOCCKINO SB, 1987, FEBS LETT, V225, P201, DOI 10.1016/0014-5793(87)81157-2; BOCCKINO SB, 1987, J BIOL CHEM, V262, P15309; BROEKMAN MJ, 1981, J BIOL CHEM, V256, P8271; CABOT MC, 1988, BIOCHIM BIOPHYS ACTA, V959, P46, DOI 10.1016/0005-2760(88)90148-8; CABOT MC, 1989, FEBS LETT, V245, P85, DOI 10.1016/0014-5793(89)80197-8; DETURCO EBR, 1977, J CHROMATOGR, V137, P194; EXTON JH, 1990, J BIOL CHEM, V265, P1; EXTON JH, 1990, ADV 2ND MESSENGER PH, V24, P152; HOLMSEN H, 1983, ANAL BIOCHEM, V131, P266, DOI 10.1016/0003-2697(83)90165-3; KING WG, 1989, J BIOL CHEM, V264, P6070; LAPETINA EG, 1979, BIOCHIM BIOPHYS ACTA, V573, P394, DOI 10.1016/0005-2760(79)90072-9; LISCOVITCH M, 1989, J BIOL CHEM, V264, P11762; MARTIN TW, 1989, J BIOL CHEM, V264, P8847; MICHELL RH, 1975, BIOCHIM BIOPHYS ACTA, V415, P81, DOI 10.1016/0304-4157(75)90017-9; PAI JK, 1988, J BIOL CHEM, V263, P12472; RITTENHOUSE SE, 1983, P NATL ACAD SCI-BIOL, V80, P5417, DOI 10.1073/pnas.80.17.5417; RITTENHOUSESIMMONS S, 1979, J CLIN INVEST, V63, P580, DOI 10.1172/JCI109339; RUBIN R, 1988, BIOCHEM BIOPH RES CO, V156, P1090, DOI 10.1016/S0006-291X(88)80744-7; STEEN VM, 1985, THROMB HAEMOSTASIS, V54, P680; SURLES JR, 1985, J MED CHEM, V28, P73, DOI 10.1021/jm00379a015; TARVER AP, 1987, J BIOL CHEM, V262, P17268; TETTENBORN CS, 1988, BIOCHEM BIOPH RES CO, V155, P249, DOI 10.1016/S0006-291X(88)81076-3; VERHOEVEN AJM, 1988, ANAL BIOCHEM, V174, P672, DOI 10.1016/0003-2697(88)90072-3; WUTHIER RE, 1966, J LIPID RES, V7, P544	29	101	101	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1652	1655						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1988442				2022-12-25	WOS:A1991EU49700047
J	DOWNING, W; DENNIS, PP				DOWNING, W; DENNIS, PP			RNA-POLYMERASE ACTIVITY MAY REGULATE TRANSCRIPTION INITIATION AND ATTENUATION IN THE RPLKAJLRPOBC OPERON IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-PROTEIN GENE; SUBUNIT SYNTHESIS; AUTOGENOUS REGULATION; STRINGENT CONTROL; MESSENGER-RNA; GROWTH-RATES; BETA-SUBUNIT; SIGMA-FACTOR; RPOBC; EXPRESSION	The relationship between global RNA transcription capacity and transcript initiation, attenuation, and stability in the rplKAJLrpoBC operon of Escherichia coli has been examined. The rplKAJLrpoBC operon encodes in order the four large ribosome subunit proteins, L11, L1, L10, and L12, and the two large beta and beta' subunits of RNA polymerase. Operon transcripts are initiated at two promoters, P(L11) and P(L10). The L12-beta intergenic space contains a transcription attenuator which, during balanced growth, terminates about 80% of the transcripts exiting the L12 gene; the remaining transcripts read through into the beta and beta' encoding genes. The capacity for global transcription initiation was modulated using a strain carrying a temperature-sensitive, initiation-defective mutation in rpoC. Following a shift to 39-degrees-C, the global transcription initiation capacity was reduced to about one-half the level at 30-degrees-C. This partial restriction resulted in a decrease in the stability of distal beta mRNA, whereas the stability of proximal L11-L1 and L10-L12 mRNA was not changed. Measurements of the synthesis rates of L11-L1, L10-L12, and beta mRNAs relative to total RNA synthesis indicated that this operon was selectively transcribed when the initiation capacity of RNA polymerase was limited. The synthesis rates of L11-L1 and L10-L12 mRNA increased about 2-fold, whereas the synthesis rate of beta mRNA increased nearly 5-fold. The relative transcription of other ribosome component genes and the alpha subunit gene exhibited only a modest increase during the partial restriction. Protection from S1 nuclease was used to demonstrate that the preferential transcription within the operon of beta mRNA was the consequence of active regulation of termination-antitermination at the attenuator structure in the L12-beta intergenic space. These results demonstrate that global transcription capacity may be an important parameter in determining both initiation and attenuation of transcription of the rplKAJLrpoBC ribosomal protein-RNA polymerase operon.			DOWNING, W (corresponding author), UNIV BRITISH COLUMBIA,DEPT BIOCHEM,VANCOUVER V6T 1W5,BC,CANADA.							AN G, 1980, J BACTERIOL, V144, P904, DOI 10.1128/JB.144.3.904-916.1980; BARACCHINI E, 1988, J BIOL CHEM, V263, P2597; BARRY G, 1980, P NATL ACAD SCI-BIOL, V77, P3331, DOI 10.1073/pnas.77.6.3331; BARRY G, 1979, P NATL ACAD SCI USA, V76, P4922, DOI 10.1073/pnas.76.10.4922; BEDWELL DM, 1986, MOL GEN GENET, V204, P17, DOI 10.1007/BF00330181; BERK AJ, 1978, P NATL ACAD SCI USA, V75, P1274, DOI 10.1073/pnas.75.3.1274; BRADWELL J, 1989, EMBO J, V8, P3401; BREMER H, 1973, J MOL BIOL, V75, P161, DOI 10.1016/0022-2836(73)90536-6; BRUCKNER R, 1981, MOL GEN GENET, V183, P277, DOI 10.1007/BF00270629; Cashel M, 1987, ESCHERICHIA COLI SAL, P1410; DENNIS PP, 1979, J BIOL CHEM, V254, P7540; DENNIS PP, 1984, J BIOL CHEM, V259, P3202; DENNIS PP, 1977, J MOL BIOL, V115, P603, DOI 10.1016/0022-2836(77)90105-X; DENNIS PP, 1977, P NATL ACAD SCI USA, V74, P5416, DOI 10.1073/pnas.74.12.5416; DENNIS PP, 1974, P NATL ACAD SCI USA, V71, P3819, DOI 10.1073/pnas.71.10.3819; DENNIS PP, 1985, J BACTERIOL, V161, P803, DOI 10.1128/JB.161.2.803-806.1985; DOWNING WL, 1987, J MOL BIOL, V194, P609, DOI 10.1016/0022-2836(87)90238-5; ENGBAEK F, 1976, MOL GEN GENET, V143, P291, DOI 10.1007/BF00269405; Favaloro J, 1980, Methods Enzymol, V65, P718; FUKUDA R, 1978, J BIOL CHEM, V253, P4501; GROSS G, 1976, MOL GEN GENET, V147, P337, DOI 10.1007/BF00582886; GROSSMAN AD, 1984, CELL, V38, P383, DOI 10.1016/0092-8674(84)90493-8; HAYWARD RS, 1978, MOL GEN GENET, V160, P77, DOI 10.1007/BF00275121; HIRSCHMAN J, 1985, P NATL ACAD SCI USA, V82, P7525, DOI 10.1073/pnas.82.22.7525; HOOPES BC, 1987, ESCHERICHIA COLI SAL, P1231; HUNT TP, 1985, P NATL ACAD SCI USA, V82, P8453, DOI 10.1073/pnas.82.24.8453; IWAKURA Y, 1974, MOL GEN GENET, V133, P1, DOI 10.1007/BF00268673; JASKUNAS SR, 1975, P NATL ACAD SCI USA, V72, P5036, DOI 10.1073/pnas.72.12.5036; JENSEN KF, 1990, MICROBIOL REV, V54, P89, DOI 10.1128/MMBR.54.2.89-100.1990; JINKSROBERTSON S, 1987, ESCHERICHIA COLI SAL, P1358; KIRSCHBAUM JB, 1975, P NATL ACAD SCI USA, V72, P2375, DOI 10.1073/pnas.72.6.2375; LANDICK R, 1987, ESCHERICHIA COLI SAL, P1276; LINN T, 1978, NATURE, V276, P33, DOI 10.1038/276033a0; LITTLE R, 1979, J BACTERIOL, V137, P115, DOI 10.1128/JB.137.1.115-123.1979; MAHER DL, 1977, MOL GEN GENET, V155, P203, DOI 10.1007/BF00393161; Maniatis T., 1982, MOL CLONING; Maxam A M, 1980, Methods Enzymol, V65, P499; MEEK DW, 1986, MOL GEN GENET, V202, P500, DOI 10.1007/BF00333284; Miller J.H., 1972, EXPT MOL GENETICS; NEWMAN AJ, 1979, MOL GEN GENET, V169, P195, DOI 10.1007/BF00271671; PASSADOR L, 1989, J BACTERIOL, V171, P6234, DOI 10.1128/jb.171.11.6234-6242.1989; POST LE, 1979, P NATL ACAD SCI USA, V76, P1697, DOI 10.1073/pnas.76.4.1697; RALLING G, 1987, J BACTERIOL, V169, P2277, DOI 10.1128/jb.169.5.2277-2280.1987; SHEPHERD NS, 1980, J BACTERIOL, V141, P1098, DOI 10.1128/JB.141.3.1098-1108.1980; TAYLOR WE, 1979, GENE, V6, P331, DOI 10.1016/0378-1119(79)90073-8; THOMAS MS, 1987, J MOL BIOL, V196, P333, DOI 10.1016/0022-2836(87)90694-2; VONGABAIN A, 1983, P NATL ACAD SCI-BIOL, V80, P653; YAMAMOTO M, 1978, P NATL ACAD SCI USA, V75, P3891, DOI 10.1073/pnas.75.8.3891; YANG HL, 1981, MOL GEN GENET, V183, P514; ZILLIG W, 1976, RNA POLYMERASE, P101	50	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1304	1311						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985949				2022-12-25	WOS:A1991ET17700095
J	HAMILTON, JA; BHAMIDIPATI, SP; KODALI, DR; SMALL, DM				HAMILTON, JA; BHAMIDIPATI, SP; KODALI, DR; SMALL, DM			THE INTERFACIAL CONFORMATION AND TRANSBILAYER MOVEMENT OF DIACYLGLYCEROLS IN PHOSPHOLIPID-BILAYERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR MAGNETIC-RESONANCE; PROTEIN KINASE-C; EGG PHOSPHATIDYLCHOLINE VESICLES; LATTICE RELAXATION MEASUREMENTS; CHOLESTERYL OLEATE; OVERHAUSER ENHANCEMENT; SIGNAL TRANSDUCTION; INVERSION-RECOVERY; MOLECULAR PACKING; NMR	The interaction of diacylglycerols, primarily 1,2-dilauroyl-sn-glycerol (1,2-DLG), with egg phosphatidylcholine (PC) bilayers was studied by NMR spectroscopy and other physical techniques. In the low proportions used (less-than-or-equal-to 20 mol % with respect to total lipid), 1,2-DLG formed bilayers with PC with no hexagonal phase separation, as assessed by light, polarizing and electron microscopy, and P-31 and C-13 NMR spectroscopy. The C-13-carbonyl chemical shift of 90% [C-13]carbonyl 1,2-DLG was monitored in small unilamellar vesicles as a function of relative DLG content (1.5-20%) and temperature (10-55-degrees-C). The chemically inequivalent sn-1 and sn-2 carbonyls gave a single, narrow resonance in vesicles, in contrast to neat 1,2-DLG and 1,2-DLG in organic solvents, whose spectra showed two well-separated carbonyl resonances. The chemical shift of 1,2-DLG in PC shows that the carbonyl groups are proximal to the aqueous interface, necessitating orientation of the DLG molecule along the normal to the bilayer. Both carbonyl groups are H-bonded to H2O, but the secondary ester (sn-2) carbonyl is relatively more hydrated than the primary ester (sn-1) carbonyl. the C-13-carbonyl chemical shift data further suggest that the interfacial conformation resembles that of crystalline and liquid crystalline lamellar 1,2-dilauroyl-sn-glycero-3-phosphatidylethanolamine and certain PCs, in which the glycerol backbone is perpendicular to the bilayer plane. This conformation is different from that of crystalline 1,2-dilauroyl-sn-glycerol, in which the glycerol backbone is parallel to the bilayer plane. Between 1.5 and 8% DLG in vesicles, the chemical shift of the 1,2-DLG carbonyl at a given temperature was constant. However, above 8% DLG the chemical shift at each temperature increased with increasing DLG concentration, suggesting increased hydration at higher DLG content. At low temperatures C-13 NMR spectra of vesicles with the highest proportions of 1,2-DLG studied (15 and 20%) showed two DLG carbonyl resonances, which most likely represent 1,2-DLG on outer and inner leaflets of the vesicle bilayer. The two peaks collapsed into a single resonance by 38-degrees-C, at which temperature the two environments equilibrate with a rate constant of approximately 60 s-1 (t1/2 approximately 10 ms). Thus, transbilayer movement of DLG is extremely fast compared with phospholipids. In vesicles the 1,3-isomer of DLG exhibited a narrow carbonyl peak slightly downfield from that of 1,2-DLG. Acyl chain migration from 1,2-DLG to 1,3-DLG was monitored directly in the vesicle by time-dependent NMR measurements.			HAMILTON, JA (corresponding author), BOSTON UNIV,SCH MED,HOUSMAN MED RES CTR,DEPT BIOPHYS,BOSTON,MA 02118, USA.			Small, Donald/0000-0002-3072-243X; Hamilton, James/0000-0002-4747-7071	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL026335] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-07291, HL-26335] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLAN D, 1978, NATURE, V276, P289, DOI 10.1038/276289a0; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; BIRDSALL NJ, 1972, J CHEM SOC PERK T 2, P1441, DOI 10.1039/p29720001441; BLUME A, 1988, BIOCHEMISTRY-US, V27, P8239, DOI 10.1021/bi00421a038; BRAACHMAKSVYTIS VLB, 1988, BIOPHYS J, V53, P839, DOI 10.1016/S0006-3495(88)83163-1; BULDT G, 1978, NATURE, V271, P182, DOI 10.1038/271182a0; CABRAL DJ, 1987, BIOCHEMISTRY-US, V26, P1801, DOI 10.1021/bi00381a002; CANET D, 1975, J MAGN RESON, V18, P199, DOI 10.1016/0022-2364(75)90238-3; CAREY MC, 1983, ANNU REV PHYSIOL, V45, P651, DOI 10.1146/annurev.ph.45.030183.003251; CISTOLA DP, 1986, BIOCHEMISTRY-US, V25, P2804, DOI 10.1021/bi00358a011; DAS S, 1986, BIOCHEMISTRY-US, V25, P2882, DOI 10.1021/bi00358a022; DEBOECK H, 1989, BIOCHEMISTRY-US, V28, P7439, DOI 10.1021/bi00444a043; DODDRELL D, 1972, J CHEM PHYS, V56, P3683, DOI 10.1063/1.1677747; EPAND RM, 1985, BIOCHEMISTRY-US, V24, P7092, DOI 10.1021/bi00346a011; FOLCH J, 1957, J BIOL CHEM, V226, P497; GANONG BR, 1986, P NATL ACAD SCI USA, V83, P1184, DOI 10.1073/pnas.83.5.1184; GANONG BR, 1984, BIOCHEMISTRY-US, V23, P4971; Gorenstein DG, 1984, PHOSPHORUS 31 NMR PR; HAMILTON JA, 1989, BIOCHEMISTRY-US, V28, P2514, DOI 10.1021/bi00432a025; HAMILTON JA, 1983, J BIOL CHEM, V258, P2821; HAMILTON JA, 1982, J BIOL CHEM, V257, P7318; HAMILTON JA, 1981, P NATL ACAD SCI-BIOL, V78, P6878, DOI 10.1073/pnas.78.11.6878; HAUSER H, 1981, BIOCHIM BIOPHYS ACTA, V650, P21, DOI 10.1016/0304-4157(81)90007-1; HITCHCOCK PB, 1974, P NATL ACAD SCI USA, V71, P3036, DOI 10.1073/pnas.71.8.3036; HUTTON WC, 1977, CHEM PHYS LIPIDS, V19, P255, DOI 10.1016/0009-3084(77)90047-0; HYBL A, 1971, ACTA CRYSTALL B-STRU, VB 27, P977, DOI 10.1107/S0567740871003340; KODALI D, 1990, IN PRESS BIOCHEMISTR; KODALI DR, 1990, CHEM PHYS LIPIDS, V52, P163, DOI 10.1016/0009-3084(90)90111-4; LEE MH, 1989, J BIOL CHEM, V264, P14797; LOOMIS CR, 1981, J LIPID RES, V20, P525; MAVIS RD, 1972, J BIOL CHEM, V247, P2835; Miller K. W., 1987, NEW COMPREHENSIVE BI, V14, P1; MIMS MP, 1988, BIOCHEMISTRY-US, V27, P5290, DOI 10.1021/bi00414a051; NIEVA JL, 1989, BIOCHEMISTRY-US, V28, P7364, DOI 10.1021/bi00444a032; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; NORTON RS, 1977, J AM CHEM SOC, V99, P79, DOI 10.1021/ja00443a016; OPELLA SJ, 1976, J CHEM PHYS, V64, P2533, DOI 10.1063/1.432503; PASCHER I, 1981, J MOL BIOL, V153, P791, DOI 10.1016/0022-2836(81)90419-8; QUINN D, 1982, PROG LIPID RES, V22, P37; ROBERTS JKM, 1985, MODERN PHYSICAL METH, P1; ROSEVEAR FB, 1954, J AM OIL CHEM SOC, V31, P628, DOI 10.1007/BF02545595; SASS M, 1977, J MAGN RESON, V25, P263, DOI 10.1016/0022-2364(77)90021-X; SCHMIDT CF, 1977, BIOCHEMISTRY-US, V16, P3948, DOI 10.1021/bi00637a002; SERDAREVICH B, 1967, J AM OIL CHEM SOC, V44, P381, DOI 10.1007/BF02666775; SIEGEL DP, 1989, BIOCHEMISTRY-US, V28, P5010, DOI 10.1021/bi00438a016; SMABY JM, 1987, J BIOL CHEM, V262, P8206; SMABY JM, 1985, BIOPHYS J, V48, P701, DOI 10.1016/S0006-3495(85)83828-5; SMALL DM, 1966, BIOCHIM BIOPHYS ACTA, V125, P563, DOI 10.1016/0005-2760(66)90044-0; SMALL DM, 1986, HDB LIPID RES, V4, P475; THOMAS AE, 1965, J AM OIL CHEM SOC, V42, P789, DOI 10.1007/BF02631865; YEAGLE PL, 1976, BIOCHEM BIOPH RES CO, V69, P775, DOI 10.1016/0006-291X(76)90942-6	51	95	95	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1177	1186						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985941				2022-12-25	WOS:A1991ET17700078
J	LAZAR, JB; WINANT, RC; JOHNSON, PH				LAZAR, JB; WINANT, RC; JOHNSON, PH			HIRUDIN - AMINO-TERMINAL RESIDUES PLAY A MAJOR ROLE IN THE INTERACTION WITH THROMBIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							HUMAN ALPHA-THROMBIN; NUCLEAR MAGNETIC-RESONANCE; BINDING-SITE; DISTANCE GEOMETRY; IDENTIFICATION; SPECIFICITY; PEPTIDES; COMPLEX	Amino acid substitutions within the amino-terminal 5 residues of the thrombin-specific inhibitor hirudin dramatically alter its ability to inhibit the thrombin-catalyzed hydrolysis of both a chromogenic substrate and fibrinogen. Replacing the highly conserved Tyr-3 residue with Trp or Phe increases hirudin's affinity for thrombin 3-6-fold (decreases the inhibition constant, K(i)) whereas Thr results in a 450-fold increase in K(i). A more extensive modification involving deletion of the amino-terminal Val, and Tyr-3-->Val, Thr-4-->Gln, and Asp-5-->Ile replacement, results in a large reduction in thrombin inhibitory activity corresponding to greater than a 10(7)-fold increase in K(i) and a 10(3)-fold increase in IC50, using D-Phe-L-pipecolyl-Arg-p-nitroanilide (S-2238) and fibrinogen, respectively, as substrates. Kinetic analysis of these mutant proteins and synthetic peptide fragments and available structural information on thrombin and hirudin derived from protein crystallography and two-dimensional NMR studies indicate that the amino-terminal region of hirudin binds at the apolar binding/active site region of thrombin, with Tyr-3 occupying the S3 specificity site. The large effect of these modifications on hirudin activity suggests that alteration of the amino-terminal segment can destabilize the interaction of other regions of hirudin with thrombin.	SRI INT,DEPT MOLEC BIOL,20501,333 RAVENSWOOD AVE,MENLO PK,CA 94025	SRI International								BERLINER LJ, 1977, BIOCHEMISTRY-US, V16, P4622, DOI 10.1021/bi00640a015; BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x; BRAUN PJ, 1988, BIOCHEMISTRY-US, V27, P6517, DOI 10.1021/bi00417a048; CHANG JY, 1990, FEBS LETT, V260, P209, DOI 10.1016/0014-5793(90)80105-R; CHANG JY, 1989, J BIOL CHEM, V264, P7141; CHANG JY, 1990, FEBS LETT, V261, P287, DOI 10.1016/0014-5793(90)80573-2; CLORE GM, 1987, EMBO J, V6, P529, DOI 10.1002/j.1460-2075.1987.tb04785.x; DENNIS S, 1990, EUR J BIOCHEM, V188, P61, DOI 10.1111/j.1432-1033.1990.tb15371.x; DODT J, 1988, FEBS LETT, V229, P87, DOI 10.1016/0014-5793(88)80803-2; Erickson B. W., 1976, PROTEINS, VII, P255; FENTON JW, 1988, BIOCHEMISTRY-US, V27, P7106, DOI 10.1021/bi00418a066; FOLKERS PJM, 1989, BIOCHEMISTRY-US, V28, P2601, DOI 10.1021/bi00432a038; FURIE B, 1982, J BIOL CHEM, V257, P3875; JOHNSON PH, 1989, SEMIN THROMB HEMOST, V15, P302, DOI 10.1055/s-2007-1002723; JOHNSON PH, 1990, IN PRES SHAEMOSTASIS; KRSTENANSKY JL, 1987, FEBS LETT, V211, P10, DOI 10.1016/0014-5793(87)81264-4; KRSTENANSKY JL, 1987, J MED CHEM, V30, P1688, DOI 10.1021/jm00392a030; MAO SJT, 1988, BIOCHEMISTRY-US, V27, P8170, DOI 10.1021/bi00421a027; Morrison J.F., 1985, COMMENTS MOL CELL BI, V2, P347; NI F, 1989, BIOCHEMISTRY-US, V28, P3082, DOI 10.1021/bi00433a052; OWEN TJ, 1988, J MED CHEM, V31, P1009, DOI 10.1021/jm00400a020; POZSGAY M, 1981, EUR J BIOCHEM, V115, P491; SCHARF M, 1989, FEBS LETT, V255, P105, DOI 10.1016/0014-5793(89)81070-1; SEGEL IH, 1975, ENZYME KINETICS, P109; STONE SR, 1989, BIOCHEMISTRY-US, V28, P6857, DOI 10.1021/bi00443a012; STONE SR, 1986, BIOCHEMISTRY-US, V25, P4622, DOI 10.1021/bi00364a025; TAKAGI T, 1974, BIOCHEMISTRY-US, V13, P750, DOI 10.1021/bi00701a018; WALEH NS, 1985, P NATL ACAD SCI USA, V82, P8389, DOI 10.1073/pnas.82.24.8389; WALLACE A, 1989, BIOCHEMISTRY-US, V28, P10079, DOI 10.1021/bi00452a030	29	42	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					685	688						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985956				2022-12-25	WOS:A1991ET17700003
J	MUKAI, K; NISHIMURA, M; KIKUCHI, S				MUKAI, K; NISHIMURA, M; KIKUCHI, S			STOPPED-FLOW INVESTIGATION OF THE REACTION OF VITAMIN-C WITH TOCOPHEROXYL RADICAL IN AQUEOUS TRITON X-100 MICELLAR SOLUTIONS - THE STRUCTURE-ACTIVITY RELATIONSHIP OF THE REGENERATION REACTION OF TOCOPHEROL BY VITAMIN-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-SPIN-RESONANCE; ANTIOXIDANT ACTIVITY; MODEL RADICALS; ASCORBIC-ACID	A kinetic study of the reaction between vitamin c (L-ascorbic acid, AsH2) and a tocopheroxyl radical (7-tert-butyl-5-isopropyltocopheroxyl) in Triton X-100 micellar solution has been performed using stopped-flow spectrophometry. The second-order rate constants (k2) obtained showed notable pH dependence with a broad maximum around pH 8. For instance, the k2 values obtained were 26 M-1 S-1 at pH 3, 322 M-1 S-1 at pH 7, and 273 M-1 S-1 at pH 10. A good correlation between the rate constants and the mole fraction of ascorbate monoanion (AsH-) was observed, showing that ascorbate (AsH-) can regenerate the tocopherol from tocopheroxyl in biological systems. Furthermore, the results indicate that reduced ascorbic acid (AsH2) does not have the ability to regenerate the tocopherol in aqueous solution. On the other hand, it was found that Ash2 can reduce the tocopheroxyl to tocopherol in benzene/ethanol (2:1) mixtures, although the rate of reaction is only approximately 15% of that observed in micellar solution at pH 7.			MUKAI, K (corresponding author), EHIME UNIV,FAC SCI,DEPT CHEM,MATSUYAMA,EHIME 790,JAPAN.							BURTON GW, 1985, J AM CHEM SOC, V107, P7053, DOI 10.1021/ja00310a049; CRAESCU CT, 1982, REV ROUM BIOCHIM, V19, P15; KOCHERGINSKII NM, 1981, BIOPHYSICS, V26, P449; LIU YC, 1988, REV CHEM INTERMED, V10, P269, DOI 10.1007/BF03155996; LIU YC, 1985, ACTA CHIM SINICA, P342; MUKAI K, 1984, B CHEM SOC JPN, V57, P3507, DOI 10.1246/bcsj.57.3507; MUKAI K, 1989, J ORG CHEM, V54, P552, DOI 10.1021/jo00264a010; MUKAI K, 1986, B CHEM SOC JPN, V59, P2899, DOI 10.1246/bcsj.59.2899; MUKAI K, 1982, CHEM PHYS LIPIDS, V30, P337, DOI 10.1016/0009-3084(82)90027-5; MUKAI K, 1989, BIOCHIM BIOPHYS ACTA, V993, P168, DOI 10.1016/0304-4165(89)90159-1; MUKAI K, 1987, BIOCHEM BIOPH RES CO, V146, P134, DOI 10.1016/0006-291X(87)90701-7; MULLER E, 1959, CHEM BER-RECL, V92, P474, DOI 10.1002/cber.19590920232; NIKI E, 1982, CHEM LETT, P789, DOI 10.1246/cl.1982.789; PACKER JE, 1979, NATURE, V278, P737, DOI 10.1038/278737a0; SCARPA M, 1984, BIOCHIM BIOPHYS ACTA, V801, P215, DOI 10.1016/0304-4165(84)90070-9; TAPPEL AL, 1968, GERIATRICS, V23, P96; WINDHOLZ M, 1983, MERCK INDEX, P844	17	102	105	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					274	278						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985900				2022-12-25	WOS:A1991EQ33900041
J	KODURU, PRK; OFFIT, K				KODURU, PRK; OFFIT, K			MOLECULAR-STRUCTURE OF DOUBLE RECIPROCAL TRANSLOCATIONS - SIGNIFICANCE IN B-CELL LYMPHOMAGENESIS	ONCOGENE			English	Note							C-MYC ONCOGENE; BCL-2 GENE; FOLLICULAR LYMPHOMA; BURKITT-LYMPHOMA; CHROMOSOME-TRANSLOCATION; LOCUS; ACTIVATION; LEUKEMIA; REGION; REARRANGEMENTS	The molecular structure of reciprocal translocations associated with low grade and high grade non-Hodgkin's lymphomas occurring together was analysed in two tumors. Sequential biopsies documented histological transformation of a large cell lymphoma to an immunoblastic lymphoma bearing t(14;18)(q32;q21) and t(8;22)(q24;q11). A second tumor, a small non-cleaved cell lymphoma, demonstrated a t(8;14)(q24;q11) as well as t(18;22)(q21;q11). DNA analysis from these tumors showed rearrangements at the Ig heavy chain, kappa and lambda light chains, BCL2 and c-MYC loci. Utilizing multiple enzyme digests and different probes spanning the BCL2, c-MYC and Ig genes, mapping of DNA break-points was performed. In both these tumors primary translocation events dysregulating the BCL2 or c-MYC were identified to have occurred in a pre-B-cell. Based on these results and those published previously, a sequence of B-cell development during which somatic recombination errors lead to the genesis of specific translocations is proposed. From these studies it is inferred that secondary dysregulation of a c-MYC in a lymphoma tumor carrying dysregulated BCL2 gene leads to rapid progression to high grade disease.	MEM SLOAN KETTERING CANC CTR, CANC GENET & CYTOGENET LAB, NEW YORK, NY 10021 USA; CORNELL UNIV, N SHORE UNIV HOSP, COLL MED, SPECIAL CYTOGENET LAB, MANHASSET, NY 11030 USA; MEM SLOAN KETTERING CANC CTR, DEPT MED, LYMPHOMA SERV, NEW YORK, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Northwell Health; North Shore University Hospital; Memorial Sloan Kettering Cancer Center					NCI NIH HHS [CA 34775] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA034775] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADACHI M, 1989, P NATL ACAD SCI USA, V86, P2771, DOI 10.1073/pnas.86.8.2771; ALT FW, 1986, IMMUNOL REV, V89, P5, DOI 10.1111/j.1600-065X.1986.tb01470.x; BAKSHI A, 1985, CELL, V41, P889; BLANCHARD JM, 1985, NATURE, V317, P443, DOI 10.1038/317443a0; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; CROCE CM, 1983, P NATL ACAD SCI-BIOL, V80, P6922, DOI 10.1073/pnas.80.22.6922; DEJONG D, 1988, NEW ENGL J MED, V318, P1373, DOI 10.1056/NEJM198805263182106; GAUWERKY CE, 1988, P NATL ACAD SCI USA, V85, P8548, DOI 10.1073/pnas.85.22.8548; GRANINGER WB, 1987, J CLIN INVEST, V80, P1512, DOI 10.1172/JCI113235; HANN SR, 1985, NATURE, V314, P366, DOI 10.1038/314366a0; HIETER PA, 1981, NATURE, V294, P536, DOI 10.1038/294536a0; HIETER PA, 1981, NATURE, V290, P368, DOI 10.1038/290368a0; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; LEDER P, 1983, SCIENCE, V222, P765, DOI 10.1126/science.6356357; LEE JT, 1989, J CLIN INVEST, V84, P1454, DOI 10.1172/JCI114320; MAGRATH I, 1983, SCIENCE, V222, P1094, DOI 10.1126/science.6316501; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; MUFTI GJ, 1983, BLOOD, V62, P1142; NERI A, 1988, P NATL ACAD SCI USA, V85, P2748, DOI 10.1073/pnas.85.8.2748; PEGORARO L, 1984, P NATL ACAD SCI-BIOL, V81, P7166, DOI 10.1073/pnas.81.22.7166; PELICCI PG, 1986, P NATL ACAD SCI USA, V83, P2984, DOI 10.1073/pnas.83.9.2984; RAVETCH JV, 1981, CELL, V27, P583, DOI 10.1016/0092-8674(81)90400-1; REED JC, 1987, SCIENCE, V236, P1295, DOI 10.1126/science.3495884; RICHARDSON ME, 1987, BLOOD, V70, P444; SEIDMAN JG, 1978, NATURE, V276, P790, DOI 10.1038/276790a0; SHOWE LC, 1987, P NATL ACAD SCI USA, V84, P2824, DOI 10.1073/pnas.84.9.2824; TSUJIMOTO Y, 1987, P NATL ACAD SCI USA, V84, P1329, DOI 10.1073/pnas.84.5.1329; TSUJIMOTO Y, 1989, P NATL ACAD SCI USA, V86, P1958, DOI 10.1073/pnas.86.6.1958; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; WIMAN KG, 1984, P NATL ACAD SCI-BIOL, V81, P6798, DOI 10.1073/pnas.81.21.6798; YUNIS JJ, 1987, NEW ENGL J MED, V316, P79, DOI 10.1056/NEJM198701083160204	32	11	11	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	1991	6	1					145	148						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY039	1992441				2022-12-25	WOS:A1991EY03900020
J	BLOY, C; HERMAND, P; BLANCHARD, D; CHERIFZAHAR, B; GOOSSENS, D; CARTRON, JP				BLOY, C; HERMAND, P; BLANCHARD, D; CHERIFZAHAR, B; GOOSSENS, D; CARTRON, JP			SURFACE ORIENTATION AND ANTIGEN PROPERTIES OF RH AND LW POLYPEPTIDES OF THE HUMAN ERYTHROCYTE-MEMBRANE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									INST NATL TRANSFUS SANGUINE,INSERM,U76,6 RUE ALEXANDRE CABANEL,F-75015 PARIS,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm)				Cherif-Zahar, Baya/0000-0002-4965-7252; HERMAND, Patricia/0000-0003-0628-9733				AVENT ND, 1988, BIOCHEM J, V256, P1043, DOI 10.1042/bj2561043; BENNETT V, 1983, METHOD ENZYMOL, V96, P313; BLANCHARD D, 1988, BLOOD, V72, P1424; BLOY C, 1990, BLOOD, V75, P2245; BLOY C, 1988, BLOOD, V72, P661; BLOY C, 1988, MOL IMMUNOL, V25, P925, DOI 10.1016/0161-5890(88)90131-9; BLOY C, 1989, MOL IMMUNOL, V26, P1013, DOI 10.1016/0161-5890(89)90065-5; CARTRON JP, 1987, MONOCLONAL ANTIBODIE, P69; CORBI AL, 1988, J BIOL CHEM, V263, P12403; DEVETTEN MP, 1988, J BIOL CHEM, V263, P18193; DRANSFIELD I, 1989, EMBO J, V8, P3759, DOI 10.1002/j.1460-2075.1989.tb08552.x; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; GAHMBERG CG, 1983, EMBO J, V2, P223, DOI 10.1002/j.1460-2075.1983.tb01409.x; GAHMBERG CG, 1984, J IMMUNOL, V133, P334; GOGSTAD GO, 1982, BIOCHIM BIOPHYS ACTA, V689, P21, DOI 10.1016/0005-2736(82)90184-5; GOOSSENS D, 1987, J IMMUNOL METHODS, V101, P193, DOI 10.1016/0022-1759(87)90150-5; GREEN FA, 1967, IMMUNOCHEMISTRY, V4, P247, DOI 10.1016/0019-2791(67)90186-3; GREEN FA, 1972, J BIOL CHEM, V247, P881; Hayashi R, 1977, Methods Enzymol, V47, P84; KONIGSHAUS GJ, 1984, TRANSFUSION, V24, P536, DOI 10.1046/j.1537-2995.1984.24685066821.x; KRAHMER M, 1987, FEBS LETT, V226, P105, DOI 10.1016/0014-5793(87)80560-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSON RS, 1989, J CELL BIOL, V108, P703, DOI 10.1083/jcb.108.2.703; LATRON F, 1987, BIOCHEM J, V247, P757, DOI 10.1042/bj2470757; LIEBERMAN DM, 1987, BIOCHIM BIOPHYS ACTA, V903, P34; LOMAS CG, 1985, MED LAB SCI, V42, P88; MALLINSON G, 1986, BIOCHEM J, V234, P649, DOI 10.1042/bj2340649; MOLLISON PL, 1987, BLOOD TRANSFUSION CL, P453; PIDARD D, 1986, BLOOD, V67, P604; PINTERIC L, 1975, BLOOD, V45, P709; POLLACK W, 1965, ANN NY ACAD SCI, V51, P892; PYTELA R, 1988, EMBO J, V7, P1371, DOI 10.1002/j.1460-2075.1988.tb02953.x; Race RR., 1975, BLOOD GROUPS MAN; RIDGWELL K, 1984, FEBS LETT, V174, P7, DOI 10.1016/0014-5793(84)81066-2; RYAN CA, 1974, J BIOL CHEM, V249, P5495; SABOORI AM, 1988, P NATL ACAD SCI USA, V85, P4042, DOI 10.1073/pnas.85.11.4042; SCHMID RW, 1957, ANAL CHEM, V29, P264, DOI 10.1021/ac60122a026; SONNEBORN HH, 1984, BIOTEST B, V2, P145; Steck T L, 1974, Methods Enzymol, V31, P172; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; WAINWRIGHT SD, 1989, BIOCHEM J, V258, P211, DOI 10.1042/bj2580211; WICKNER WT, 1985, SCIENCE, V230, P400, DOI 10.1126/science.4048938	43	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1990	265	35					21482	21487						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM456	1979326				2022-12-25	WOS:A1990EM45600019
J	YANG, CPH; COHEN, D; GREENBERGER, LM; HSU, SIH; HORWITZ, SB				YANG, CPH; COHEN, D; GREENBERGER, LM; HSU, SIH; HORWITZ, SB			DIFFERENTIAL TRANSPORT-PROPERTIES OF 2 MDR GENE-PRODUCTS ARE DISTINGUISHED BY PROGESTERONE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT MOLEC PHARMACOL, F-248, 1300 MORRIS PK AVE, BRONX, NY 10461 USA; YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT CELL BIOL, BRONX, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine					NATIONAL CANCER INSTITUTE [R35CA039821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER; NCI NIH HHS [CA39821] Funding Source: Medline; NIGMS NIH HHS [T32GM 7288] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKIYAMA SI, 1988, MOL PHARMACOL, V33, P144; ARCECI RJ, 1988, P NATL ACAD SCI USA, V85, P4350, DOI 10.1073/pnas.85.12.4350; BECK WT, 1988, BIOCHEM BIOPH RES CO, V153, P959, DOI 10.1016/S0006-291X(88)81321-4; BECK WT, 1986, CANCER RES, V46, P778; BRUGGEMANN EP, 1989, J BIOL CHEM, V264, P15483; CANOGAUCI DF, 1987, BIOCHEM PHARMACOL, V36, P2115, DOI 10.1016/0006-2952(87)90139-0; CHIN JE, 1989, MOL CELL BIOL, V9, P3808, DOI 10.1128/MCB.9.9.3808; CHOI K, 1988, CELL, V53, P519, DOI 10.1016/0092-8674(88)90568-5; COHEN D, 1990, LIFE SCI, V46, P489, DOI 10.1016/0024-3205(90)90004-B; CORNWELL MM, 1986, J BIOL CHEM, V261, P7921; CROOP JM, 1989, MOL CELL BIOL, V9, P1346, DOI 10.1128/MCB.9.3.1346; ENDICOTT JA, 1989, ANNU REV BIOCHEM, V58, P137, DOI 10.1146/annurev.bi.58.070189.001033; FOJO AT, 1987, P NATL ACAD SCI USA, V84, P265, DOI 10.1073/pnas.84.1.265; FORD JM, 1989, MOL PHARMACOL, V35, P105; GREENBERGER LM, 1989, FEBS LETT, V257, P419, DOI 10.1016/0014-5793(89)81586-8; GREENBERGER LM, 1987, J BIOL CHEM, V262, P13685; GREENBERGER LM, 1988, P NATL ACAD SCI USA, V85, P3762, DOI 10.1073/pnas.85.11.3762; GREENBERGER LM, 1990, J BIOL CHEM, V265, P4394; Hait W N, 1989, Cancer Commun, V1, P35; HITCHINS RN, 1988, EUR J CANCER CLIN ON, V24, P449, DOI 10.1016/S0277-5379(98)90015-3; HORIO M, 1989, J BIOL CHEM, V264, P14880; HSU SIH, 1989, J BIOL CHEM, V264, P12053; HSU SIH, 1990, IN PRESS MOL CELL BI; KAMIWATARI M, 1989, CANCER RES, V49, P3190; KESSEL D, 1985, CANCER RES, V45, P1687; KLOHS WD, 1988, MOL PHARMACOL, V34, P180; LEVER JE, 1977, J BIOL CHEM, V252, P1990; LOTHSTEIN L, 1989, J BIOL CHEM, V264, P16054; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NAITO M, 1989, CANCER RES, V49, P1452; NG WF, 1989, MOL CELL BIOL, V9, P1224, DOI 10.1128/MCB.9.3.1224; NOGAE I, 1987, BRIT J CANCER, V56, P267, DOI 10.1038/bjc.1987.188; RAMU A, 1984, CANCER RES, V44, P144; RAMU A, 1984, CANCER RES, V44, P4392; ROGAN AM, 1984, SCIENCE, V224, P994, DOI 10.1126/science.6372095; ROY SN, 1985, CANCER RES, V45, P3856; SAFA AR, 1987, J BIOL CHEM, V262, P7884; SHIRAISHI N, 1986, CANCER LETT, V30, P251, DOI 10.1016/0304-3835(86)90049-2; SIITERI PK, 1977, ANN NY ACAD SCI, V286, P384, DOI 10.1111/j.1749-6632.1977.tb29431.x; SLATER LM, 1986, J CLIN INVEST, V77, P1405, DOI 10.1172/JCI112450; SUGAWARA I, 1988, CANCER RES, V48, P1926; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; TSURUO T, 1983, CANCER RES, V43, P2267; TSURUO T, 1981, CANCER RES, V41, P1967; VANDERBLIEK AM, 1989, ADV CANCER RES, V52, P165; WILLINGHAM MC, 1986, CANCER RES, V46, P5941; YANG CPH, 1988, BIOCHEM PHARMACOL, V37, P1417; YANG CPH, 1989, J BIOL CHEM, V264, P782; YOSHIMURA A, 1989, J BIOL CHEM, V264, P16282; Yoshinaga K., 1976, Implantation of the ovum., P3; ZEHEB R, 1987, BIOCHEM BIOPH RES CO, V143, P732, DOI 10.1016/0006-291X(87)91415-X	51	100	106	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	1990	265	18					10282	10288						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK851	1972378				2022-12-25	WOS:A1990DK85100022
J	LEE, FJS; LIN, LW; SMITH, JA				LEE, FJS; LIN, LW; SMITH, JA			A GLUCOSE-REPRESSIBLE GENE ENCODES ACETYL-COA HYDROLASE FROM SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									MASSACHUSETTS GEN HOSP,DEPT PATHOL,BOSTON,MA 02114; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	LEE, FJS (corresponding author), MASSACHUSETTS GEN HOSP,DEPT MOLEC BIOL,BOSTON,MA 02114, USA.			LEE, FANG-JEN/0000-0002-2167-2426				ALLFREY VG, 1984, METHOD ENZYMOL, V107, P224; AUGEN J, 1986, TRENDS BIOCHEM SCI, V11, P494, DOI 10.1016/0968-0004(86)90075-7; BERNSON VSM, 1976, EUR J BIOCHEM, V67, P403, DOI 10.1111/j.1432-1033.1976.tb10705.x; DRIESSEN HPC, 1985, CRIT REV BIOCHEM MOL, V18, P281, DOI 10.3109/10409238509086784; EBISUNO S, 1988, AM J PHYSIOL, V255, pR724, DOI 10.1152/ajpregu.1988.255.5.R724; FRENKEL EP, 1977, J BIOL CHEM, V252, P504; GERGELY J, 1952, J BIOL CHEM, V198, P323; GRIGAT KP, 1979, BIOCHEM J, V177, P71, DOI 10.1042/bj1770071; GUO LH, 1983, NUCLEIC ACIDS RES, V11, P5521, DOI 10.1093/nar/11.16.5521; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HEWICK RM, 1981, J BIOL CHEM, V256, P7990; JENCKS WP, 1972, J BIOL CHEM, V247, P3756; KLEIN U, 1978, P NATL ACAD SCI USA, V75, P5185, DOI 10.1073/pnas.75.10.5185; KNOWLES SE, 1974, BIOCHEM J, V142, P401, DOI 10.1042/bj1420401; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LATHE R, 1985, J MOL BIOL, V183, P1, DOI 10.1016/0022-2836(85)90276-1; LEE FJS, 1989, EUR J BIOCHEM, V184, P21, DOI 10.1111/j.1432-1033.1989.tb14985.x; LEE FJS, 1988, J BIOL CHEM, V263, P14948; LEE FJS, 1989, J BIOL CHEM, V264, P12339; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LOWE PN, 1988, BIOCHEM J, V250, P789, DOI 10.1042/bj2500789; MAHAN DE, 1975, BIOCHEM J, V145, P25, DOI 10.1042/bj1450025; MATTEUCCI MD, 1981, J AM CHEM SOC, V103, P3185, DOI 10.1021/ja00401a041; NAMBOODIRI MAA, 1980, J BIOL CHEM, V255, P6032; NEFF NF, 1983, CELL, V33, P211, DOI 10.1016/0092-8674(83)90350-1; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PERSSON B, 1985, EUR J BIOCHEM, V152, P523, DOI 10.1111/j.1432-1033.1985.tb09227.x; PRASS RL, 1980, J BIOL CHEM, V255, P5215; ROBINSON JB, 1976, BIOCHEM BIOPH RES CO, V71, P959, DOI 10.1016/0006-291X(76)90748-8; ROSKOSKI R, 1974, J BIOL CHEM, V249, P2156; RUDMAN D, 1979, J BIOL CHEM, V254, P102; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; SEVERIN S. E., 1967, BIOKHIMIYA, V32, P125; SHERMAN F, 1986, METHODS YEAST GENETI, P79; SINHA ND, 1984, NUCLEIC ACIDS RES, V12, P4539, DOI 10.1093/nar/12.11.4539; SOLING HD, 1985, EUR J BIOCHEM, V147, P111, DOI 10.1111/j.1432-1033.1985.tb08726.x; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SUGGS SV, 1981, DEV BIOL USING PURIF, P683; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TSUNASAWA S, 1984, METHOD ENZYMOL, V106, P165; WEBER WW, 1985, PHARMACOL REV, V37, P25; WONG WW, 1985, P NATL ACAD SCI USA, V82, P7711, DOI 10.1073/pnas.82.22.7711; ZOLLER M, 1985, DNA NY, V3, P479	43	46	48	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1990	265	13					7413	7418						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB307	1970569				2022-12-25	WOS:A1990DB30700050
J	REEMS, JA; GRIEP, MA; MCHENRY, CS				REEMS, JA; GRIEP, MA; MCHENRY, CS			PROOFREADING ACTIVITY OF DNA POLYMERASE-III RESPONDS LIKE ELONGATION ACTIVITY TO AUXILIARY SUBUNITS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; INITIATION COMPLEX; PRIMED DNA; REPLICATION PROTEINS; SPONTANEOUS MUTATION; PROCESSIVE SYNTHESIS; BETA-SUBUNIT; SIZE CLASSES; HOLOENZYME; EXONUCLEASE	A comparison of the 3' --> 5' proofreading properties between Escherichia coli DNA polymerase III holoenzyme and DNA polymerase III' was conducted. This study indicated that the influence of the holoenzyme auxiliary subunits on the proofreading exonuclease parallels their effect on the elongation reaction. At physiological ionic strengths the auxiliary subunits markedly stimulated the exonuclease rate in an ATP-dependent reaction, while the exonuclease rate of DNA polymerase III' was not affected by ATP. E. coli single-stranded DNA binding protein stimulated the 3' --> 5' exonuclease activity of holoenzyme and inhibited DNA polymerase III'. Similarly, the auxiliary subunits and ATP converted the proofreading activity to a highly processive exonuclease. Our observation, that the exonuclease activity of the DNA polymerase III holoenzyme responded to ATP, salt, and E. coli single-stranded DNA-binding protein like the elongation activity, is consistent with the polymerase and exonuclease subunits acting within the same complex in a coordinated reaction.			REEMS, JA (corresponding author), UNIV COLORADO,HLTH SCI CTR,DEPT BIOCHEM BIOPHYS & GENET,DENVER,CO 80262, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035695] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM-35695] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alberts BM, 1975, ICN UCLA S MOL CELL, V3, P241; BAMBARA RA, 1978, J BIOL CHEM, V253, P413; BEDINGER P, 1983, J BIOL CHEM, V258, P9649; BERKOWITZ SA, 1971, BIOCHEMISTRY-US, V13, P4825; BURGERS PMJ, 1982, J BIOL CHEM, V257, P1468; COX EC, 1983, P NATL ACAD SCI-BIOL, V80, P2295, DOI 10.1073/pnas.80.8.2295; COX EC, 1976, ANNU REV GENET, V10, P135, DOI 10.1146/annurev.ge.10.120176.001031; CRUTE JJ, 1983, J BIOL CHEM, V258, P1344; DIFRANCESCO R, 1984, J BIOL CHEM, V259, P5667; ECHOLS H, 1983, P NATL ACAD SCI-BIOL, V80, P2189, DOI 10.1073/pnas.80.8.2189; FAY PJ, 1981, J BIOL CHEM, V256, P976; FAY PJ, 1982, J BIOL CHEM, V257, P5692; FERSHT AR, 1982, J MOL BIOL, V156, P37, DOI 10.1016/0022-2836(82)90457-0; FERSHT AR, 1983, J MOL BIOL, V165, P669, DOI 10.1016/S0022-2836(83)80273-3; FOWLER RG, 1986, J BACTERIOL, V167, P130, DOI 10.1128/jb.167.1.130-137.1986; GEFTER ML, 1971, P NATL ACAD SCI USA, V68, P3150, DOI 10.1073/pnas.68.12.3150; GRIEP MA, 1990, BIOCHEMISTRY-US, V29, P9006, DOI 10.1021/bi00490a018; GRIEP MA, 1989, J BIOL CHEM, V264, P11294; HAGERMAN PJ, 1985, BIOCHEMISTRY-US, V24, P7033, DOI 10.1021/bi00346a001; HORIUCHI T, 1978, MOL GEN GENET, V163, P277, DOI 10.1007/BF00271956; HUANG CC, 1981, J BIOL CHEM, V256, P4087; Ingraham J., 1987, ESCHERICHA COLI SALM, V2, P1543; JENCKS WP, 1969, CATALYSIS CHEM ENZYM, P555; JOHANSON KO, 1982, J BIOL CHEM, V257, P2310; JOHANSON KO, 1984, J BIOL CHEM, V259, P4589; KUNKEL TA, 1979, P NATL ACAD SCI USA, V76, P6331, DOI 10.1073/pnas.76.12.6331; LADUCA RJ, 1983, BIOCHEMISTRY-US, V22, P5177, DOI 10.1021/bi00291a018; LIVINGSTON DM, 1975, J BIOL CHEM, V250, P470; MAKI H, 1987, P NATL ACAD SCI USA, V84, P4389, DOI 10.1073/pnas.84.13.4389; MAKI S, 1988, J BIOL CHEM, V263, P6555; MCHENRY C, 1977, J BIOL CHEM, V252, P6478; MCHENRY CS, 1982, J BIOL CHEM, V257, P2657; MCHENRY CS, 1988, ANNU REV BIOCHEM, V57, P519; MCHENRY CS, 1979, J BIOL CHEM, V254, P1748; MCHENRY CS, 1986, MECHANISMS DNA REPLI, P47; MOK M, 1987, J BIOL CHEM, V262, P16644; OBERFELDER R, 1987, J BIOL CHEM, V262, P4190; ODONNELL M, 1990, J BIOL CHEM, V265, P1179; ODONNELL ME, 1987, J BIOL CHEM, V262, P16558; RICHEY B, 1987, J BIOL CHEM, V262, P7157; SCHEUERMANN RH, 1984, P NATL ACAD SCI-BIOL, V81, P7747, DOI 10.1073/pnas.81.24.7747; STUDWELL PS, 1990, J BIOL CHEM, V265, P1171; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; WELCH MM, 1982, J BACTERIOL, V152, P351; WICKNER S, 1976, P NATL ACAD SCI USA, V73, P3511, DOI 10.1073/pnas.73.10.3511; WICKNER W, 1973, P NATL ACAD SCI USA, V70, P3679, DOI 10.1073/pnas.70.12.3679	46	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4878	4882						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002034				2022-12-25	WOS:A1991FC21700033
J	FUKUMOTO, Y; TANASE, S; NAGASHIMA, F; UEDA, S; IKEGAMI, K; MORINO, Y				FUKUMOTO, Y; TANASE, S; NAGASHIMA, F; UEDA, S; IKEGAMI, K; MORINO, Y			STRUCTURAL AND FUNCTIONAL-ROLE OF THE AMINO-TERMINAL REGION OF PORCINE CYTOSOLIC ASPARTATE-AMINOTRANSFERASE - CATALYTIC AND STRUCTURAL-PROPERTIES OF ENZYME DERIVATIVES TRUNCATED ON THE AMINO-TERMINAL SIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PIG HEART; TRANSAMINASE; PROTEINS; CONSTRUCTION; METHIONINE; EXPRESSION; CLEAVAGE; GENE; ACID	In porcine cytosolic aspartate aminotransferase, a dimeric enzyme, the amino-terminal region anchoring onto the neighboring subunit is linked to the adjoining floppy peptide segment (residues 12-47), an integral part of the small domain whose facile movement upon substrate binding is a striking "induced fit" feature of this enzyme. To assess the contribution by the amino-terminal region to small domain movement and protein stability, a series of enzyme derivatives truncated on the amino-terminal side (residues 1-9) was prepared by using oligonucleotide-directed in vitro mutagenesis. Deletion of residues 1-3 showed no effect on catalytic activity and heat stability. Del 1-5 mutant enzyme with an extra methionine at position 5 showed only 43% of the k(cat) value (in the overall transamination) of the wild-type enzyme. Further deletion up to residue 9 resulted in a slight decrease in k(cat) values. Del 1-9 mutant enzyme still retained a k(cat) value of 33% that of wild-type enzyme. K(m) values for aspartate and 2-oxoglutarate increased sharply upon deletion of residues 1-9. Accordingly, Del 1-9 mutant enzyme showed a striking decrease in the k(cat)/K(m) value, to only 2% of that for the wild-type enzyme. Deletion of amino-terminal residues 1-9 resulted also in a large decrease in thermostability and in an enhanced susceptibility to limited proteolysis by protease 401, which is known to cleave at Leu20 of the wild-type enzyme. These findings indicate that an increase in the conformational freedom of the floppy segment (residues 12-47) would occur upon the loss of most of the anchorage region thereby presenting an entropic barrier to conformational changes that facilitate substrate binding with high affinity.	KUMAMOTO UNIV,SCH MED,DEPT BIOCHEM,2-2-1 HONJO,KUMAMOTO 860,JAPAN; KUMAMOTO UNIV,SCH MED,DEPT UROL,KUMAMOTO 860,JAPAN	Kumamoto University; Kumamoto University								Arnone A, 1985, TRANSAMINASES, P138; BENBASSAT A, 1987, J BACTERIOL, V169, P751, DOI 10.1128/jb.169.2.751-757.1987; FASELLA P, 1966, BIOCHEMISTRY-US, V5, P197, DOI 10.1021/bi00865a026; FLINTA C, 1986, EUR J BIOCHEM, V154, P193, DOI 10.1111/j.1432-1033.1986.tb09378.x; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; IRIARTE A, 1984, J BIOL CHEM, V259, P723; JENKINS WT, 1959, J BIOL CHEM, V234, P51; JENKINS WT, 1966, J BIOL CHEM, V241, P5667; KHYSEANDERSON J, 1984, J BIOCHEM BIOPH METH, V10, P203; KRAMER W, 1984, NUCLEIC ACIDS RES, V12, P9441, DOI 10.1093/nar/12.24.9441; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LO KM, 1984, P NATL ACAD SCI-BIOL, V81, P2285, DOI 10.1073/pnas.81.8.2285; Maniatis T., 1982, MOL CLONING; METZLER CM, 1988, J MOL BIOL, V203, P197, DOI 10.1016/0022-2836(88)90102-7; MICHUDA CM, 1970, J BIOL CHEM, V245, P262; MIKI T, 1987, PROTEIN ENG, V1, P327, DOI 10.1093/protein/1.4.327; MORINO Y, 1977, J BIOCHEM, V82, P847, DOI 10.1093/oxfordjournals.jbchem.a131760; MURAO S, 1984, AGR BIOL CHEM TOKYO, V48, P2163, DOI 10.1080/00021369.1984.10866470; NAGASHIMA F, 1989, BIOCHEMISTRY-US, V28, P1153, DOI 10.1021/bi00429a033; NAGASHIMA F, 1986, J BIOCHEM, V99, P1017, DOI 10.1093/oxfordjournals.jbchem.a135565; SAKODA M, 1976, J BIOCHEM-TOKYO, V80, P547, DOI 10.1093/oxfordjournals.jbchem.a131310; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TERANISHI H, 1978, J BIOL CHEM, V253, P8842	24	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4187	4193						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999412				2022-12-25	WOS:A1991FA69400029
J	MOREAU, P; MORRE, DJ				MOREAU, P; MORRE, DJ			CELL-FREE TRANSFER OF MEMBRANE-LIPIDS - EVIDENCE FOR LIPID PROCESSING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS-G-PROTEIN; RAT-LIVER; ENDOPLASMIC-RETICULUM; GOLGI-APPARATUS; FREE SYSTEM; TRANSPORT; RECONSTITUTION; COMPLEX; PHOSPHOLIPIDS; FRACTIONS	A latent phospholipase A is concentrated in cis elements of rat liver Golgi apparatus, the presumed sites of fusion of the fusion of the 50-70-nm transition vesicles formed from endoplasmic reticulum. As a result, conversion of transferred phospholipids to their corresponding lysoforms may provide an index of post transfer lipid processing in a corresponding reconstituted membrane transfer system. To label the phosphatidylcholine of transitional endoplasmic reticulum in vitro, [C-14]CDP-choline and endogenous cytidyltransferases were used. In the reconstituted transfer system, the radiolabeled phosphatidylcholine was transferred via transition vesicles to Golgi apparatus immobilized on nitrocellulose strips in a time- and temperature-dependent process. Transfer was promoted by ATP and the ATP-dependent transfer was specific for cis Golgi apparatus elements as acceptor. Trans Golgi apparatus elements were ineffective as acceptors. Median Golgi apparatus elements were intermediate. A portion of the transferred phosphatidylcholine was converted subsequently to lysophosphatidylcholine also in a time- and ATP-dependent manner. The phospholipase A activity of the Golgi apparatus was more than 90% latent (active site located on the lumens of the Golgi apparatus membranes). Therefore, the lipid-containing vesicles derived from endoplasmic reticulum must have combined with cis Golgi apparatus membranes as the basis for Golgi apparatus-dependent phospholipase A processing of endoplasmic reticulum-derived phosphatidylcholine. Since the lipids were processed by phospholipase A in approximately the same proportion as occurs in situ, the findings offer evidence both for the specificity of the ATP-dependent component of cell-free lipid transfer from endoplasmic reticulum to Golgi apparatus and its fidelity to lipid transfer observed in vivo.	CNRS,INST BIOCHIM CELLULAIRE & NEUROCHIM,F-33077 BORDEAUX,FRANCE	Centre National de la Recherche Scientifique (CNRS)	MOREAU, P (corresponding author), PURDUE UNIV,DEPT MED CHEM,W LAFAYETTE,IN 47907, USA.				NIGMS NIH HHS [GM 44675] Funding Source: Medline; PHS HHS [H11508] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044675] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; BALCH WE, 1983, METHOD ENZYMOL, V98, P37; BALCH WE, 1986, J BIOL CHEM, V261, P4681; BALCH WE, 1987, J CELL BIOL, V104, P749, DOI 10.1083/jcb.104.3.749; BECKERS CJM, 1987, CELL, V50, P523, DOI 10.1016/0092-8674(87)90025-0; BELL RM, 1980, ANNU REV BIOCHEM, V49, P459, DOI 10.1146/annurev.bi.49.070180.002331; BISHOP WR, 1988, ANNU REV CELL BIOL, V4, P579, DOI 10.1146/annurev.cb.04.110188.003051; DUNPHY WG, 1985, CELL, V42, P13, DOI 10.1016/S0092-8674(85)80097-0; GRUENBERG J, 1989, ANNU REV CELL BIOL, V5, P453; JELSEMA CL, 1978, J BIOL CHEM, V253, P7960; KEENAN TW, 1970, BIOCHEMISTRY-US, V9, P19, DOI 10.1021/bi00803a003; MOREAU P, 1991, J BIOL CHEM, V266, P4322; MORRE D J, 1984, Biotechniques, V2, P224; MORRE DJ, 1972, PREP BIOCHEM, V2, P61, DOI 10.1080/00327487208061453; MORRIS RJ, 1983, J HISTOCHEM CYTOCHEM, V31, P263, DOI 10.1177/31.2.6131917; NOWACK DD, 1987, P NATL ACAD SCI USA, V84, P6098, DOI 10.1073/pnas.84.17.6098; PAULIK M, 1988, J BIOL CHEM, V263, P17738; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; TABAS I, 1979, J BIOL CHEM, V254, P1655; VAN MEER G, 1989, ANNU REV CELL BIOL, V5, P247, DOI 10.1146/annurev.cellbio.5.1.247; VANGOLDE LM, 1971, BIOCHIM BIOPHYS ACTA, V249, P318, DOI 10.1016/0005-2736(71)90109-X; ZAMBRANO F, 1975, BIOCHIM BIOPHYS ACTA, V380, P357, DOI 10.1016/0005-2760(75)90104-6	22	28	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4329	4333						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999422				2022-12-25	WOS:A1991FA69400050
J	TAMKUN, MM; KNOTH, KM; WALBRIDGE, JA; KROEMER, H; RODEN, DM; GLOVER, DM				TAMKUN, MM; KNOTH, KM; WALBRIDGE, JA; KROEMER, H; RODEN, DM; GLOVER, DM			MOLECULAR-CLONING AND CHARACTERIZATION OF 2 VOLTAGE-GATED K+ CHANNEL CDNAS FROM HUMAN VENTRICLE	FASEB JOURNAL			English	Note						DELAYED RECTIFIER; TRANSIENT OUTWARD CURRENT; HUMAN K+ CHANNEL CDNA; K+ CHANNEL GENES; CARDIAC EXPRESSION	POTASSIUM CHANNEL; MEMBRANE-PROTEIN; RAT-BRAIN; EXPRESSION; GENE; DNA; DROSOPHILA; SYSTEMS; KINASE	K+ channels represent the most complex class of voltage-gated ion channels from both functional and structural standpoints. In the heart these channels are responsible for the rapid repolarizing phases of the action potential and are the targets of several antiarrhythmic drugs. Full-length cDNA clones were isolated from human ventricular libraries that encode two voltage-gated K+ channels. These two cDNAs, designated HK1 and HK2, encode proteins of 653 and 605 amino acids, respectively. HK1 is the human equivalent (98% identity) of an inactivating K+ channel previously described in rat heart (RHK1) whereas the HK2 channel is 86% identical to a cloned rat brain K+ channel (Kv1). The only amino acid sequence identity (72%) between HK1 and HK2 is within the central region containing the membrane spanning domains. Northern blot analysis of human mRNA indicated that HK1 is slightly more abundant in ventricle than atrium whereas HK2 is much more abundant in atrium relative to ventricle. Both channel transcripts are present in ventricle at levels equivalent to voltage-gated Na+ channels. Analysis of the gene encoding HK1 suggests the coding sequence is intronless and is represented once in the human genome.	VANDERBILT UNIV,SCH MED,DEPT PHARMACOL,NASHVILLE,TN 37205	Vanderbilt University	TAMKUN, MM (corresponding author), VANDERBILT UNIV,SCH MED,DEPT MOLEC PHYSIOL & BIOPHYS,NASHVILLE,TN 37205, USA.		Roden, Dan/ABD-5412-2021		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 32694] Funding Source: Medline; NIGMS NIH HHS [GM 07347, GM 41325] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ausubel F. M., 1988, CURRENT PROTOCOLS MO; BACANER MB, 1986, P NATL ACAD SCI USA, V83, P2223, DOI 10.1073/pnas.83.7.2223; BAUMANN A, 1988, EMBO J, V7, P2457, DOI 10.1002/j.1460-2075.1988.tb03092.x; CHANDY KG, 1990, SCIENCE, V247, P973, DOI 10.1126/science.2305265; CHRISTIE MJ, 1989, SCIENCE, V244, P221, DOI 10.1126/science.2539643; CHRISTIE MJ, 1990, NEURON, V2, P405; COOK NS, 1988, TRENDS PHARMACOL SCI, V9, P21, DOI 10.1016/0165-6147(88)90238-6; DOUGLASS J, 1990, J IMMUNOL, V144, P4841; EVANS WE, 1990, IN PRESS MOL PHARM; FOLANDER K, 1990, P NATL ACAD SCI USA, V87, P2975, DOI 10.1073/pnas.87.8.2975; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GANONG WF, 1979, REV MED PHYSL, P415; GRUPE A, 1990, EMBO J, V9, P1749, DOI 10.1002/j.1460-2075.1990.tb08299.x; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; HARTZELL HC, 1988, PROG BIOPHYS MOL BIO, V52, P165, DOI 10.1016/0079-6107(88)90014-4; HAWORTH RA, 1989, CIRC RES, V65, P1157, DOI 10.1161/01.RES.65.4.1157; Hille B, 1984, IONIC CHANNELS EXCIT; HUBBARD SC, 1981, ANNU REV BIOCHEM, V50, P555, DOI 10.1146/annurev.bi.50.070181.003011; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; IVERSON LE, 1990, J NEUROSCI, V10, P2903; KAMB A, 1989, P NATL ACAD SCI USA, V86, P4372, DOI 10.1073/pnas.86.12.4372; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; MCCORMACK T, 1990, P NATL ACAD SCI USA, V87, P5227, DOI 10.1073/pnas.87.13.5227; MCKINNON D, 1989, J BIOL CHEM, V264, P8230; MURAI T, 1989, BIOCHEM BIOPH RES CO, V161, P176, DOI 10.1016/0006-291X(89)91577-5; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; REHM H, 1989, BIOCHEMISTRY-US, V28, P6455, DOI 10.1021/bi00441a044; ROBERTSON DW, 1990, J MED CHEM, V33, P1529, DOI 10.1021/jm00168a001; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; SUZUKI H, 1988, FEBS LETT, V228, P195, DOI 10.1016/0014-5793(88)80615-X; SWANSON R, 1990, NEURON, V4, P929, DOI 10.1016/0896-6273(90)90146-7; TEMPEL BL, 1988, NATURE, V332, P837, DOI 10.1038/332837a0; TSENGCRANK JCL, 1990, FEBS LETT, V268, P63, DOI 10.1016/0014-5793(90)80973-M; YOKOYAMA S, 1989, FEBS LETT, V259, P37, DOI 10.1016/0014-5793(89)81488-7; ZETTERQVIST O, 1982, FEBS LETT, V139, P287, DOI 10.1016/0014-5793(82)80872-7	36	247	257	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998	0892-6638			FASEB J	Faseb J.	MAR 1	1991	5	3					331	337		10.1096/fasebj.5.3.2001794	http://dx.doi.org/10.1096/fasebj.5.3.2001794			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FC556	2001794				2022-12-25	WOS:A1991FC55600012
J	PANDAK, WM; LI, YC; CHIANG, JYL; STUDER, EJ; GURLEY, EC; HEUMAN, DM; VLAHCEVIC, ZR; HYLEMON, PB				PANDAK, WM; LI, YC; CHIANG, JYL; STUDER, EJ; GURLEY, EC; HEUMAN, DM; VLAHCEVIC, ZR; HYLEMON, PB			REGULATION OF CHOLESTEROL 7-ALPHA-HYDROXYLASE MESSENGER-RNA AND TRANSCRIPTIONAL ACTIVITY BY TAUROCHOLATE AND CHOLESTEROL IN THE CHRONIC BILIARY DIVERTED RAT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILE-ACID SYNTHESIS; LIVER MICROSOMES; COA REDUCTASE; 7-ALPHA-HYDROXYLASE; ENZYMES; BIOSYNTHESIS; HEPATOCYTES; METABOLISM; SUBSTRATE	Cholesterol 7-alpha-hydroxylase catalyzes the rate-limiting step in the bile acid biosynthetic pathway. Regulation of this pathway is thought to occur solely as a result of a negative feedback control mechanism that is dependent upon the flux and composition of bile salts undergoing enterohepatic circulation. We have used the chronic biliary diverted (CBD) rat model to study the mechanism of regulation of cholesterol 7-alpha-hydroxylase by taurocholate. As compared to nonoperated controls, CBD rats exhibited a 4.2-fold increase in cholesterol 7-alpha-hydroxylase-specific activity, a 4.5-fold increase in enzyme mass, a 10-fold increase in steady-state mRNA levels, and a 3.4-fold increase in transcriptional (nuclear "run-on") activity. Intraduodenal infusion of taurocholate at a rate of 36-mu-mol/100 g/h for 48 h in CBD rats caused a significant (p < 0.05) decrease (64%) in cholesterol 7-alpha-hydroxylase-specific activity, mass (72%), steady-state mRNA levels (74%), and transcriptional activity (57%) as compared to CBD controls. Cholesterol feeding increased cholesterol 7-alpha-hydroxylase-specific activity (288%), poly(A) RNA levels (291%), and transcriptional activity (220%) as compared to control animals. These results provide convincing evidence that bile salts, either directly or indirectly, down-regulate in vivo transcription of the cholesterol 7-alpha-hydroxylase gene, which is probably the major mechanism regulating the levels of this enzyme. The results of this study also suggest that the promoter for cholesterol 7-alpha-hydroxylase may have both bile salt- and sterol-responsive elements.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT MICROBIOL,RICHMOND,VA 23298; NORTHEASTERN OHIO UNIV,COLL MED,DEPT BIOCHEM & MOLEC PATHOL,ROOTSTOWN,OH 44272	Virginia Commonwealth University; Northeast Ohio Medical University (NEOMED)	PANDAK, WM (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT MED,RICHMOND,VA 23298, USA.			Chiang, John/0000-0001-9360-7650	NIDDK NIH HHS [R01 DK044442] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044442] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERGSTROM S, 1958, ACTA PHYSIOL SCAND, V43, P1, DOI 10.1111/j.1748-1716.1958.tb01572.x; BJORKHEM I, 1988, J LIPID RES, V29, P136; BJORKHEM I, 1985, STEROLS BILE ACIDS, P231; BOSTROM H, 1982, J BIOL CHEM, V257, P1755; BOTHAM KM, 1981, BIOCHIM BIOPHYS ACTA, V666, P236; CHAING JYL, 1990, J BIOL CHEM, V265, P3889; CHIANG JYL, 1983, BIOCHIM BIOPHYS ACTA, V750, P291, DOI 10.1016/0005-2760(83)90031-0; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLARKE CF, 1985, J BIOL CHEM, V260, P4363; DANIELSSON H, 1975, ANNU REV BIOCHEM, V44, P233, DOI 10.1146/annurev.bi.44.070175.001313; DANIELSSON H, 1967, EUR J BIOCHEM, V2, P44, DOI 10.1111/j.1432-1033.1967.tb00103.x; DANZINGER RG, 1971, J CLIN INVEST, V50, P2809; DAVIS RA, 1983, J BIOL CHEM, V258, P4079; EINARSSON K, 1989, J LIPID RES, V30, P1477; EINARSSON K, 1974, METABOL CLIN EXP, V22, P1477; ERIKSSON S, 1957, P SOC EXP BIOL MED, V94, P578; HEUMAN DM, 1988, HEPATOLOGY, V8, P358, DOI 10.1002/hep.1840080228; HEUMAN DM, 1989, J LIPID RES, V30, P1161; HEUMAN DM, 1988, HEPATOLOGY, V8, P892, DOI 10.1002/hep.1840080431; HYLEMON PB, 1989, ANAL BIOCHEM, V182, P212, DOI 10.1016/0003-2697(89)90581-2; JELINEK DF, 1990, J BIOL CHEM, V265, P8190; KUBASKA WM, 1985, J BIOL CHEM, V260, P3459; LI YC, 1990, J BIOL CHEM, V265, P12012; LINIAL M, 1985, SCIENCE, V230, P1126, DOI 10.1126/science.2999973; MYANT NB, 1977, J LIPID RES, V18, P133; NOSHIRO M, 1989, FEBS LETT, V257, P97, DOI 10.1016/0014-5793(89)81795-8; OGISHIMA T, 1987, J BIOL CHEM, V262, P7646; PANDAK WM, 1990, J LIPID RES, V31, P79; SCALLEN TJ, 1983, P NATL ACAD SCI-BIOL, V80, P2477, DOI 10.1073/pnas.80.9.2477; SHEFER S, 1969, J LIPID RES, V10, P646; SHEFER S, 1973, J LIPID RES, V14, P573; SHEFFER S, 1970, J LIPID RES, V11, P404; STRAKA NS, 1990, J BIOL CHEM, V265, P7145; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; THOMPSON JC, 1953, P SOC EXP BIOL MED, V83, P246	35	189	191	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3416	3421						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995604				2022-12-25	WOS:A1991EY68200014
J	THOMAS, DC; ROBERTS, JD; KUNKEL, TA				THOMAS, DC; ROBERTS, JD; KUNKEL, TA			HETERODUPLEX REPAIR IN EXTRACTS OF HUMAN HELA-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA MISMATCH-REPAIR; BASE-PAIR MISMATCHES; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; MUTATIONAL SPECIFICITY; DIFFERENT EFFICIENCIES; POLYMERASES-ALPHA; PROTEIN BINDS; GENE; REPLICATION	A general repair process for DNA heteroduplexes has been detected in HeLa cell extracts. Using a variety of M13mp2 DNA substrates containing single-base mismatches and extra nucleotides, extensive repair is observed after incubation with HeLa cell cytoplasmic extracts and subsequent transfection of bacterial cells with the treated DNA. Most, but not all, mispairs as well as two frameshift heteroduplexes are repaired efficiently. Parallel measurements of repair in HeLa extracts and in Escherichia coli suggest that repair specificities are similar for the two systems. The presence of a nick in the molecule is required for efficient repair in HeLa cell extracts, and the strand containing the nick is the predominantly repaired strand. Mismatch-dependent DNA synthesis is observed when radiolabeled restriction fragments, produced by reaction of the extract with heteroduplex and homoduplex molecules, are compared. Specific labeling of fragments, representing a region of approximately 1,000 base pairs and containing the nick and the mismatch, is detected for the heteroduplex substrate but not the homoduplex. The repair reaction is complete after 20 min and requires added Mg2+, ATP, and an ATP-regenerating system, but not dNTPs, which are present at sufficient levels in the extract. An inhibitor of DNA polymerase-beta, dideoxythymidine 5'-triphosphate, does not inhibit mismatch-specific DNA synthesis. Aphidicolin, an inhibitor of DNA polymerases-alpha, delta, and epsilon, inhibits both semiconservative replication and repair synthesis in the extract. Butylphenyl-dGTP also inhibits both replicative and repair synthesis but at a concentration known to inhibit DNA polymerase-alpha preferentially rather than delta or epsilon. This suggests that DNA polymerase-alpha may function in mismatch repair.	NIEHS,MOLEC GENET LAB,RES TRIANGLE PK,NC 27709	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)			Kunkel, Thomas A./D-5088-2019	Kunkel, Thomas A./0000-0002-9900-1788				ABASTADO JP, 1984, P NATL ACAD SCI-BIOL, V81, P5792, DOI 10.1073/pnas.81.18.5792; AU KG, 1988, P NATL ACAD SCI USA, V85, P9163, DOI 10.1073/pnas.85.23.9163; AU KG, 1989, P NATL ACAD SCI USA, V86, P8877, DOI 10.1073/pnas.86.22.8877; BISHOP DK, 1989, P NATL ACAD SCI USA, V86, P3713, DOI 10.1073/pnas.86.10.3713; BROOKS P, 1989, P NATL ACAD SCI USA, V86, P4425, DOI 10.1073/pnas.86.12.4425; BROWN TC, 1987, CELL, V50, P945, DOI 10.1016/0092-8674(87)90521-6; BROWN TC, 1988, CELL, V54, P705, DOI 10.1016/S0092-8674(88)80015-1; BURGERS PMJ, 1990, EUR J BIOCHEM, V191, P617, DOI 10.1111/j.1432-1033.1990.tb19165.x; CLAVERYS JP, 1986, MICROBIOL REV, V50, P133, DOI 10.1128/MMBR.50.2.133-165.1986; CRUTE JJ, 1986, BIOCHEMISTRY-US, V25, P26, DOI 10.1021/bi00349a005; DEPAMPHILIS ML, 1980, ANNU REV BIOCHEM, V49, P627, DOI 10.1146/annurev.bi.49.070180.003211; DRAKE JW, 1969, NATURE, V221, P1132, DOI 10.1038/2211132a0; DRESLER SL, 1986, NUCLEIC ACIDS RES, V14, P7093, DOI 10.1093/nar/14.17.7093; FOLGER KR, 1985, MOL CELL BIOL, V5, P70, DOI 10.1128/MCB.5.1.70; FUJII H, 1989, J BIOL CHEM, V264, P10057; GLAZER PM, 1987, MOL CELL BIOL, V7, P218, DOI 10.1128/MCB.7.1.218; HARE JT, 1985, P NATL ACAD SCI USA, V82, P7350, DOI 10.1073/pnas.82.21.7350; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; JACKSON DA, 1990, NUCLEIC ACIDS RES, V18, P753; JIRICNY J, 1988, P NATL ACAD SCI USA, V85, P8860, DOI 10.1073/pnas.85.23.8860; JONES M, 1987, CELL, V50, P621, DOI 10.1016/0092-8674(87)90035-3; KRAMER B, 1984, CELL, V38, P879, DOI 10.1016/0092-8674(84)90283-6; KRAMER B, 1989, MOL CELL BIOL, V9, P4432, DOI 10.1128/MCB.9.10.4432; KRAMER W, 1989, J BACTERIOL, V171, P5339, DOI 10.1128/jb.171.10.5339-5346.1989; KUNKEL TA, 1985, J BIOL CHEM, V260, P5787; KUNKEL TA, 1985, J BIOL CHEM, V260, P2866; KUNKEL TA, 1988, J BIOL CHEM, V263, P4450; KUNKEL TA, 1984, P NATL ACAD SCI-BIOL, V81, P1494, DOI 10.1073/pnas.81.5.1494; KUNKEL TA, 1986, J BIOL CHEM, V261, P160; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; Lee M Y, 1981, Prog Nucleic Acid Res Mol Biol, V26, P83; LEE MYWT, 1985, NUCLEIC ACIDS RES, V13, P8623, DOI 10.1093/nar/13.23.8623; LI JJ, 1985, MOL CELL BIOL, V5, P1238, DOI 10.1128/MCB.5.6.1238; LIEB M, 1985, MOL GEN GENET, V199, P465; LINTON JP, 1989, MOL CELL BIOL, V9, P3058, DOI 10.1128/MCB.9.7.3058; LU AL, 1984, COLD SPRING HARB SYM, V49, P589, DOI 10.1101/SQB.1984.049.01.066; LU AL, 1988, CELL, V54, P805, DOI 10.1016/S0092-8674(88)91109-9; MESELSON M, 1988, RECOMBINATION GENETI, P91; MILLER LK, 1976, P NATL ACAD SCI USA, V73, P3073, DOI 10.1073/pnas.73.9.3073; MODRICH P, 1987, ANNU REV BIOCHEM, V56, P435, DOI 10.1146/annurev.biochem.56.1.435; MUSTERNASSAL C, 1986, P NATL ACAD SCI USA, V83, P7618, DOI 10.1073/pnas.83.20.7618; RADICELLA JP, 1988, P NATL ACAD SCI USA, V85, P9674, DOI 10.1073/pnas.85.24.9674; RADMAN M, 1986, ANNU REV GENET, V20, P523, DOI 10.1146/annurev.ge.20.120186.002515; RADMAN M, 1988, GENETIC RECOMBINATIO, P162; ROBERTS JD, 1988, P NATL ACAD SCI USA, V85, P7064, DOI 10.1073/pnas.85.19.7064; SCHAAPER RM, 1989, GENETICS, V121, P205; STEPHENSON C, 1989, J BIOL CHEM, V264, P21177; SU SS, 1986, P NATL ACAD SCI USA, V83, P5057, DOI 10.1073/pnas.83.14.5057; SU SS, 1988, J BIOL CHEM, V263, P6829; SYVAOJA J, 1990, P NATL ACAD SCI USA, V87, P6664, DOI 10.1073/pnas.87.17.6664; THOMAS DC, 1986, J BIOL CHEM, V261, P4496; WAQAR MA, 1978, NUCLEIC ACIDS RES, V6, P1933; WIEBAUER K, 1990, P NATL ACAD SCI USA, V87, P5842, DOI 10.1073/pnas.87.15.5842; WIEBAUER K, 1989, NATURE, V339, P234, DOI 10.1038/339234a0; WILLIAMSON MS, 1985, GENETICS, V110, P609; WOLD MS, 1989, J BIOL CHEM, V264, P2801; ZELL R, 1987, EMBO J, V6, P1809, DOI 10.1002/j.1460-2075.1987.tb02435.x	57	303	310	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3744	3751						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995629				2022-12-25	WOS:A1991EY68200062
J	VONCK, J; ARFMAN, N; DEVRIES, GE; VANBEEUMEN, J; VANBRUGGEN, EFJ; DIJKHUIZEN, L				VONCK, J; ARFMAN, N; DEVRIES, GE; VANBEEUMEN, J; VANBRUGGEN, EFJ; DIJKHUIZEN, L			ELECTRON-MICROSCOPIC ANALYSIS AND BIOCHEMICAL-CHARACTERIZATION OF A NOVEL METHANOL DEHYDROGENASE FROM THE THERMOTOLERANT BACILLUS-SP C1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED ALCOHOL-DEHYDROGENASE; AMINO-ACID-SEQUENCE; SACCHAROMYCES-CEREVISIAE; ZYMOMONAS-MOBILIS; ESCHERICHIA-COLI; BIOLOGICAL MACROMOLECULES; POLYOL DEHYDROGENASES; GENE; PURIFICATION; STRAINS	Methanol dehydrogenase from the thermotolerant Bacillus sp. C1 was studied by electron microscopy and image processing. Two main projections can be distinguished: one exhibits 5-fold symmetry and has a diameter of 15 nm, the other is rectangular with sides of 15 and 9 nm. Subsequent image processing showed that the 5-fold view possesses mirror symmetry. The rectangular views can be divided into two separate classes, one of which has 2-fold rotational symmetry. It is concluded that methanol dehydrogenase is a decameric molecule, and a tentative model is presented. The estimated molecular weight is 430,000, based on a subunit molecular weight of 43,000. The enzyme contains one zinc and one to two magnesium ions per subunit. N-terminal amino acid sequence analysis revealed substantial similarity with alcohol dehydrogenases from Saccharomyces cerevisiae, Zymomonas mobilis, Clostridium acetobutylicum, and Escherichia coli, which contain iron or zinc but no magnesium. In view of the aberrant structural and kinetic properties, it is proposed to distinguish the enzyme from common alcohol dehydrogenases (EC 1.1.1.1) by using the name NAD-dependent methanol dehydrogenase.	STATE UNIV GHENT,MICROBIOL & MICROBIAL GENET LAB,B-9000 GHENT,BELGIUM; STATE UNIV GRONINGEN,DEPT MICROBIOL,9751 NN HAREN,NETHERLANDS	Ghent University; University of Groningen	VONCK, J (corresponding author), STATE UNIV GRONINGEN,BIOCHEM LAB,9747 AG GRONINGEN,NETHERLANDS.		Dijkhuizen, Lubbert/E-9454-2014; Dijkhuizen, Lubbert/K-3539-2019	Dijkhuizen, Lubbert/0000-0003-2312-7162; Vonck, Janet/0000-0001-5659-8863				ARFMAN N, 1991, J BIOL CHEM, V266, P3955; ARFMAN N, 1989, ARCH MICROBIOL, V152, P280, DOI 10.1007/BF00409664; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branden C.-I., 1975, ENZYMES, V11, P103; CHALMERS RM, 1990, J GEN MICROBIOL, V136, P637, DOI 10.1099/00221287-136-4-637; CONWAY T, 1989, J BACTERIOL, V171, P3754, DOI 10.1128/jb.171.7.3754-3759.1989; CONWAY T, 1987, J BACTERIOL, V169, P2591, DOI 10.1128/jb.169.6.2591-2597.1987; DIJKHUIZEN L, 1988, FEMS MICROBIOL LETT, V52, P209; DREWKE C, 1988, BIOCHIM BIOPHYS ACTA, V950, P54, DOI 10.1016/0167-4781(88)90072-3; DUESTER G, 1986, NUCLEIC ACIDS RES, V14, P1931, DOI 10.1093/nar/14.5.1931; EKLUND H, 1976, J MOL BIOL, V102, P61, DOI 10.1016/0022-2836(76)90073-5; FRIEDEN C, 1962, BIOCHIM BIOPHYS ACTA, V62, P421, DOI 10.1016/0006-3002(62)90274-3; HARRIS I, 1964, NATURE, V203, P30, DOI 10.1038/203030a0; HOU CT, 1983, ARCH BIOCHEM BIOPHYS, V223, P297, DOI 10.1016/0003-9861(83)90595-7; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P486; INOUE H, 1965, BIOCHEM BIOPH RES CO, V21, P432, DOI 10.1016/0006-291X(65)90400-6; JAENICKE R, 1987, PROG BIOPHYS MOL BIO, V49, P117, DOI 10.1016/0079-6107(87)90011-3; JENDROSSEK D, 1988, J BACTERIOL, V170, P5248, DOI 10.1128/jb.170.11.5248-5256.1988; JORNVALL H, 1981, P NATL ACAD SCI-BIOL, V78, P4226, DOI 10.1073/pnas.78.7.4226; JORNVALL H, 1987, EUR J BIOCHEM, V167, P195, DOI 10.1111/j.1432-1033.1987.tb13323.x; KESHAV KF, 1990, J BACTERIOL, V172, P2491, DOI 10.1128/jb.172.5.2491-2497.1990; PERETZ M, 1989, BIOCHEMISTRY-US, V28, P6549, DOI 10.1021/bi00442a004; SCOPES RK, 1983, FEBS LETT, V156, P303, DOI 10.1016/0014-5793(83)80517-1; SHEEHAN MC, 1988, BIOCHEM J, V252, P661, DOI 10.1042/bj2520661; THATCHER DR, 1980, BIOCHEM J, V187, P875, DOI 10.1042/bj1870875; VANHEEL M, 1984, ULTRAMICROSCOPY, V13, P165, DOI 10.1016/0304-3991(84)90066-4; VANHEEL M, 1985, EMBO J, V4, P2389, DOI 10.1002/j.1460-2075.1985.tb03944.x; VANHEEL M, 1981, ULTRAMICROSCOPY, V7, P113, DOI 10.1016/0304-3991(81)90001-2; VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/0304-3991(81)90059-0; VANHOLDE KE, 1958, J PHYS CHEM-US, V62, P734, DOI 10.1021/j150564a025; WILLIAMSON VM, 1987, MOL GEN GENET, V209, P374, DOI 10.1007/BF00329668; YOUNGLESON JS, 1989, GENE, V78, P355, DOI 10.1016/0378-1119(89)90238-2	32	40	43	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3949	3954						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995642				2022-12-25	WOS:A1991EY68200089
J	ARGILES, JM; LOPEZSORIANO, FJ				ARGILES, JM; LOPEZSORIANO, FJ			THE ENERGY-STATE OF TUMOR-BEARING RATS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOLIC ALTERATIONS; LIVER; PHOSPHORYLATION; SARCOMA; ENZYMES; CANCER; MICE; HOST; GLUCONEOGENESIS; HEPATOCYTES	Rats bearing the Walker-256 carcinosarcoma have a profoundly altered liver metabolite content with significant increases in the concentrations of glucose 6-phosphate, fructose 1,6-bisphosphate, citrate, lactate, and alanine, while the concentrations of glucose, pyruvate, dihydroxyacetone phosphate, and glutamine are decreased. As a result of these changes both the cytosolic NAD+/NADH ratio and the cytosolic phosphorylation potential are significantly lowered while no changes are detected in either the cytosolic NADP+/NADPH ratio or the mitochondrial NAD+/NADH ratio. These hepatic changes are accompanied by marked increases in the circulating concentrations of lactate, non-esterified fatty acids, and triacylglycerols. The activities of both liver hexokinase and phosphofructokinase are also significantly elevated in the tumor-bearing rats. The changes observed both in the redox state and phosphorylation potential are in agreement with the energy imbalance associated with tumor burden.			ARGILES, JM (corresponding author), UNIV BARCELONA, FAC BIOL, DEPT BIOQUIM & FISIOL, DIAGONAL 645, E-08071 BARCELONA, SPAIN.		Lopez-Soriano, Francisco J./W-4947-2018	Lopez-Soriano, Francisco J./0000-0003-1493-3023				ARGILES JM, 1988, MOL CELL BIOCHEM, V81, P3; BASERGA R, 1961, ARCH PATHOL, V72, P142; BEITNER R, 1985, REGULATION CARBOHYDR, V1, P1; Bergmeyer H. U., 1974, METHOD ENZYMAT AN, P1577; Bergmeyer H.U., 1974, METHOD ENZYMAT AN, VVol. 3., P1196; Bergmeyer H.U., 1974, METHODS ENZYMATIC AN, P1836; Bergmeyer HU, 1974, METHOD ENZYMAT AN, P430; BERGMEYER HU, 1974, METHOD ENZYMAT AN, P574; COSTA G, 1977, CANCER RES, V37, P2327; CZOK R, 1974, METHOD ENZYMAT AN, P1424; Czok R., 1974, METHOD ENZYMAT AN, V3, P1446; Dagley S, 1974, METHOD ENZYMAT AN, P1562; DECKER K, 1974, METHOD ENZYMAT AN, P1988; EGGSTEIN M, 1966, KLIN WOCHENSCHR, V44, P262, DOI 10.1007/BF01747716; EKMAN L, 1982, J SURG RES, V33, P23, DOI 10.1016/0022-4804(82)90005-1; EVANS RD, 1988, BIOCHEM J, V252, P65, DOI 10.1042/bj2520065; FREDERICK GL, 1954, P AM ASSOC CANC RES, V1, P14; GOLD J, 1968, ONCOLOGY-BASEL, V22, P185, DOI 10.1159/000224450; GRANZOW C, 1972, EUR J CANCER, V8, P225, DOI 10.1016/0014-2964(72)90048-5; GREENGARD O, 1971, BIOCHIM BIOPHYS ACTA, V237, P476, DOI 10.1016/0304-4165(71)90266-2; Gutmann I., 1974, METHODS ENZYMATIC AN, P1464; HERZFELD A, 1977, CANCER RES, V37, P231; HERZFELD A, 1972, CANCER RES, V32, P1826; JAMDAR SC, 1970, J BIOL CHEM, V245, P2779; JASANI B, 1978, BRIT J CANCER, V38, P287, DOI 10.1038/bjc.1978.200; KNOX WE, 1976, ENZYME PATTERNS FETA; Krebs H. A., 1969, ENERGY LEVEL METABOL, P329; Lang G., 1974, METHODS ENZYMATIC AN, P1238; LANOUE KF, 1977, HORMONES CANCER, P131; LAVIETES BB, 1978, BIOCHEM BIOPH RES CO, V84, P202; LEVIN L, 1981, S AFR MED J, V59, P553; Lund P., 1974, METHODS ENZYMATIC AN, V4, P1719; MCALLISTER RA, 1982, J SURG RES, V33, P500, DOI 10.1016/0022-4804(82)90068-3; Mellanby J, 1974, METHOD ENZYMAT AN, P1840; MICHAL G, 1974, METHOD ENZYMAT AN, P1314; Parsons LD, 1941, J PATHOL BACTERIOL, V52, P305, DOI 10.1002/path.1700520304; Pedersen P L, 1978, Prog Exp Tumor Res, V22, P190; REINHART GD, 1980, BIOCHEMISTRY-US, V19, P1477, DOI 10.1021/bi00548a034; RIVERA S, 1988, BIOCHEM J, V249, P443, DOI 10.1042/bj2490443; ROSE IA, 1967, J BIOL CHEM, V242, P1635; SABINE JR, 1967, CANCER RES, V27, P793; Shapot V S, 1979, Adv Cancer Res, V30, P89, DOI 10.1016/S0065-230X(08)60895-7; SHIMIZU S, 1979, ANAL BIOCHEM, V98, P341, DOI 10.1016/0003-2697(79)90151-9; SHONK CE, 1964, CANCER RES, V24, P709; SIEBERT G, 1974, METHOD ENZYMAT AN, P1570; SINGH J, 1982, FEBS LETT, V150, P325, DOI 10.1016/0014-5793(82)80761-8; SINGH J, 1980, CANCER RES, V40, P1699; SISTARE FD, 1985, J BIOL CHEM, V260, P2748; VEECH RL, 1979, J BIOL CHEM, V254, P6538; VEECH RL, 1972, BIOCHEM J, V127, P387, DOI 10.1042/bj1270387; WARBURG O, 1930, METABOLISM TUMORS; WATERHOUSE C, 1979, CANCER RES, V39, P1968; WEBER MJ, 1984, FED PROC, V43, P2246; WILLIAMSON DH, 1974, METHOD ENZYMAT AN, P1679; WOLLENBERGER A, 1960, PFLUG ARCH GES PHYS, V270, P399, DOI 10.1007/BF00362995; WOOD R, 1975, LIPIDS, V10, P736, DOI 10.1007/BF02532314	56	38	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2978	2982						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993670				2022-12-25	WOS:A1991EX60000049
J	HUBER, PW; BLOBE, GC; HARTMANN, KM				HUBER, PW; BLOBE, GC; HARTMANN, KM			CONFORMATIONAL STUDIES OF THE NUCLEIC-ACID BINDING-SITES FOR XENOPUS TRANSCRIPTION FACTOR-IIIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							5S RNA GENE; REPRESSOR OPERATOR COMPLEX; INTRAGENIC CONTROL REGION; INTERNAL CONTROL REGION; LAEVIS OOCYTES; FACTOR-A; CIRCULAR-DICHROISM; B-FORM; RIBOSOMAL-PROTEINS; FUNCTIONAL DOMAINS	The CD spectrum of a restriction fragment that contains a single copy of a Xenopus borealis somatic 5 S rRNA gene, like those of two smaller fragments from the binding site for transcription factor IIIA (TFIIIA), is that of B-form DNA. Under dehydrating conditions (76% ethanol) the 5 S rDNA undergoes a transition into an A conformation. The spectra of the three fragments, however, do exhibit some perturbation in that the longwave positive peaks are shifted to shorter wavelengths and have enhanced rotational strength compared with reference B-form spectra. The helical repeats measured for the smaller fragments indicate that the helix winding angle can account for these features in the CD spectra. We suggest that G:C-rich boxes that punctuate not only the TFIIIA binding site but the whole 5 S gene are responsible for the conformational perturbation manifest in the CD spectra and may play a role in the recognition of the DNA by the factor. The spectrum of the gene is unchanged in the presence of TFIIIA, indicating that the structural heterogeneity of the DNA persists upon complex formation. The CD spectra of native TFIIIA.5 S rRNA particles isolated from oocytes and of particles reconstituted in vitro are identical and only moderately different from the spectrum of free 5 S rRNA, suggesting that the protein effects only limited changes in the secondary and/or tertiary structure of the RNA. The helical structure of the two binding sites is discussed with respect to a common mode of interaction of TFIIIA with DNA and RNA.			HUBER, PW (corresponding author), UNIV NOTRE DAME,DEPT CHEM & BIOCHEM,NOTRE DAME,IN 46556, USA.		Blobe, Gerard/AAJ-5945-2020	Blobe, Gerard/0000-0002-4274-8901	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038200] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABOULELA F, 1988, NUCLEIC ACIDS RES, V16, P3559; ANDERSEN J, 1986, J BIOL CHEM, V261, P2912; ANDERSEN J, 1984, BIOCHEMISTRY-US, V23, P5759, DOI 10.1021/bi00319a014; ANDERSON JE, 1987, NATURE, V326, P846, DOI 10.1038/326846a0; BAUDIN F, 1989, NUCLEIC ACIDS RES, V17, P2043, DOI 10.1093/nar/17.5.2043; BEAR DG, 1977, NUCLEIC ACIDS RES, V4, P2511, DOI 10.1093/nar/4.7.2511; BOGENHAGEN DF, 1985, J BIOL CHEM, V260, P6466; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN RS, 1985, FEBS LETT, V186, P271, DOI 10.1016/0014-5793(85)80723-7; CALLACI TP, 1990, BIOCHEMISTRY-US, V29, P4653, DOI 10.1021/bi00471a021; CHAN A, 1979, BIOCHEMISTRY-US, V18, P84, DOI 10.1021/bi00568a013; CHRISTIANSEN J, 1987, EMBO J, V6, P453, DOI 10.1002/j.1460-2075.1987.tb04775.x; DIAKUN GP, 1986, NATURE, V324, P698, DOI 10.1038/324698a0; EVANS RM, 1988, CELL, V52, P1, DOI 10.1016/0092-8674(88)90522-3; FAIRALL L, 1986, J MOL BIOL, V192, P577, DOI 10.1016/0022-2836(86)90278-0; FAIRALL L, 1989, EMBO J, V8, P1809, DOI 10.1002/j.1460-2075.1989.tb03575.x; GOTTESFELD JM, 1987, MOL CELL BIOL, V7, P1612, DOI 10.1128/MCB.7.5.1612; GOTTESFELD JM, 1987, NATURE, V329, P460, DOI 10.1038/329460a0; HANAS JS, 1985, J BIOL CHEM, V260, P3316; HANAS JS, 1983, P NATL ACAD SCI-BIOL, V80, P2142, DOI 10.1073/pnas.80.8.2142; HANAS JS, 1989, BIOCHEMISTRY-US, V28, P4083, DOI 10.1021/bi00435a068; HONDA BM, 1980, CELL, V22, P119, DOI 10.1016/0092-8674(80)90160-9; HUBER PW, 1984, P NATL ACAD SCI-BIOL, V81, P322, DOI 10.1073/pnas.81.2.322; HUBER PW, 1986, P NATL ACAD SCI USA, V83, P1593, DOI 10.1073/pnas.83.6.1593; IVANOV VI, 1973, BIOPOLYMERS, V12, P89, DOI 10.1002/bip.1973.360120109; JOHNSON BB, 1981, BIOCHEMISTRY-US, V20, P73, DOI 10.1021/bi00504a013; JONES BN, 1983, J CHROMATOGR, V266, P471, DOI 10.1016/S0021-9673(01)90918-5; LASSAR AB, 1983, SCIENCE, V222, P740, DOI 10.1126/science.6356356; MARTIN TE, 1969, J MOL BIOL, V43, P151, DOI 10.1016/0022-2836(69)90085-0; Maxam A M, 1980, Methods Enzymol, V65, P499; MCCALL M, 1986, NATURE, V322, P661, DOI 10.1038/322661a0; MCCONKEY GA, 1987, MOL CELL BIOL, V7, P486, DOI 10.1128/MCB.7.1.486; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; OTWINOWSKI Z, 1988, NATURE, V335, P321, DOI 10.1038/335321a0; PECK LJ, 1981, NATURE, V292, P375, DOI 10.1038/292375a0; PELHAM HRB, 1980, P NATL ACAD SCI-BIOL, V77, P4170, DOI 10.1073/pnas.77.7.4170; PICARD B, 1979, P NATL ACAD SCI USA, V76, P241, DOI 10.1073/pnas.76.1.241; PIELER T, 1983, FEBS LETT, V157, P283, DOI 10.1016/0014-5793(83)80562-6; PIELER T, 1985, EMBO J, V4, P1847, DOI 10.1002/j.1460-2075.1985.tb03859.x; PIELER T, 1985, EMBO J, V4, P3751, DOI 10.1002/j.1460-2075.1985.tb04144.x; PIELER T, 1987, CELL, V48, P91, DOI 10.1016/0092-8674(87)90359-X; RHODES D, 1986, CELL, V46, P123, DOI 10.1016/0092-8674(86)90866-4; ROMANIUK PJ, 1985, NUCLEIC ACIDS RES, V13, P5369, DOI 10.1093/nar/13.14.5369; ROMANIUK PJ, 1989, BIOCHEMISTRY-US, V28, P1388, DOI 10.1021/bi00429a067; SAENGER W, 1983, PRINCIPLES NUCLEIC A, P228; SAKONJU S, 1982, CELL, V31, P395, DOI 10.1016/0092-8674(82)90133-7; SANDS MS, 1987, MOL CELL BIOL, V7, P3985, DOI 10.1128/MCB.7.11.3985; SHANG ZG, 1988, ANAL BIOCHEM, V168, P156, DOI 10.1016/0003-2697(88)90023-1; SMITH DR, 1984, CELL, V37, P645, DOI 10.1016/0092-8674(84)90396-9; ULBRICH N, 1978, J BIOL CHEM, V253, P9049; VRANA KE, 1988, MOL CELL BIOL, V8, P1684, DOI 10.1128/MCB.8.4.1684; WANG JC, 1979, P NATL ACAD SCI USA, V76, P200, DOI 10.1073/pnas.76.1.200; WINDSOR WT, 1988, J BIOL CHEM, V263, P10272	53	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3278	3286						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993700				2022-12-25	WOS:A1991EX60000091
J	HASELBECK, RJ; MCALISTERHENN, L				HASELBECK, RJ; MCALISTERHENN, L			ISOLATION, NUCLEOTIDE-SEQUENCE, AND DISRUPTION OF THE SACCHAROMYCES-CEREVISIAE GENE ENCODING MITOCHONDRIAL NADP(H)-SPECIFIC ISOCITRATE DEHYDROGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MALATE-DEHYDROGENASE; ACTIVE-SITE; PIG-HEART; YEAST; PHOSPHORYLATION; ANALOG; 2',5'-BISPHOSPHATE; SUBSTRATE; PROTEINS	Mitochondrial NADP(H)-specific isocitrate dehydrogenase (IDP1) was purified from yeast cells grown with acetate as a carbon source. IDP1 was shown to be a dimer with a subunit molecular weight of approximately 45,000. Immunochemical levels of IDP1 were found to vary in inverse proportion with those of mitochondrial NAD(H)-specific isocitrate dehydrogenase in cells grown with glucose or with acetate as a carbon source. A 20-residue amino-terminal sequence was obtained for IDP1, and degenerate oligonucleotides were used to synthesize a 50-base pair polymerase chain reaction product corresponding to the coding region for a portion of the amino terminus. The 50-base pair DNA fragment was used as a hybridization probe to identify plasmids containing the IDP1 gene in a yeast genomic DNA library. The complete nucleotide sequence of the IDP1 coding region was determined and translated into a 412-residue amino acid sequence for the mature protein which is preceded by a putative 16-residue mitochondrial targeting presequence. A haploid yeast strain containing a chromosomal disruption of the IDP1 locus was constructed and found to be capable of growth with glucose but not with other carbon sources, suggesting that IDP1 provides a critical function and may be the primary source of NADPH in yeast mitochondria.	UNIV CALIF IRVINE,COLL MED,DEPT BIOL CHEM,IRVINE,CA 92717	University of California System; University of California Irvine					NIGMS NIH HHS [GM-39404] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039404] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY JM, 1987, J BIOL CHEM, V262, P12620; BAILEY JM, 1985, BIOCHEMISTRY-US, V24, P5367, DOI 10.1021/bi00341a015; BARNES LD, 1972, BIOCHEMISTRY-US, V11, P4322, DOI 10.1021/bi00773a019; BOTSTEIN D, 1979, GENE, V8, P12; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURKE WF, 1974, BIOCHIM BIOPHYS ACTA, V351, P333, DOI 10.1016/0005-2795(74)90196-2; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CLIFTON D, 1978, GENETICS, V88, P1; Colman R F, 1975, Adv Enzyme Regul, V13, P413, DOI 10.1016/0065-2571(75)90028-X; COLMAN RF, 1989, BIOCHEM SOC T, V17, P307, DOI 10.1042/bst0170307; COMPTON T, 1990, PCR PROTOCOLS GUIDE, P39; DAUM G, 1982, J BIOL CHEM, V257, P3028; DOBSON MJ, 1982, NUCLEIC ACIDS RES, V10, P2625, DOI 10.1093/nar/10.8.2625; EHRLICH RS, 1987, J BIOL CHEM, V262, P12614; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GANGLOFF SP, 1990, MOL CELL BIOL, V10, P3551, DOI 10.1128/MCB.10.7.3551; GARNAK M, 1979, SCIENCE, V203, P1111, DOI 10.1126/science.34215; HATHAWAY JA, 1963, J BIOL CHEM, V238, P2875; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jones E. W., 1982, MOL BIOL YEAST SACCH, P181; KELLY JH, 1981, J BIOL CHEM, V256, P330; KEYS DA, 1990, J BACTERIOL, V172, P4280, DOI 10.1128/jb.172.8.4280-4287.1990; KORNBERG A, 1951, J BIOL CHEM, V189, P123; KOSHLAND DE, 1985, CURR TOP CELL REGUL, V27, P13; LAPORTE DC, 1985, J BIOL CHEM, V260, P563; LAPORTE DC, 1982, NATURE, V300, P458, DOI 10.1038/300458a0; LOWE CR, 1984, METHOD ENZYMOL, V104, P97; MACHADO A, 1975, MOL CELL BIOCHEM, V6, P93, DOI 10.1007/BF01732003; MCALISTER L, 1982, J BIOL CHEM, V257, P7181; MCALISTERHENN L, 1987, J BACTERIOL, V169, P5157, DOI 10.1128/jb.169.11.5157-5166.1987; NAYSMYTH KA, 1980, CELL, V19, P753; PLAUT GWE, 1983, BIOCH METABOLIC PROC, P285; PLAUT GWE, 1970, CURR TOP CELL REGUL, V2, P1; POLAKIS ES, 1965, BIOCHEM J, V97, P284, DOI 10.1042/bj0970284; RALEIGH EA, 1988, NUCLEIC ACIDS RES, V16, P1563, DOI 10.1093/nar/16.4.1563; REEVES HC, 1972, BIOCHIM BIOPHYS ACTA, V258, P27, DOI 10.1016/0005-2744(72)90964-3; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; RydstroM J., 1976, ENZYME, V13, P51; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P281; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; THOMPSON LM, 1988, BIOCHEMISTRY-US, V27, P8393, DOI 10.1021/bi00422a015; THORSNESS PE, 1987, J BIOL CHEM, V262, P10422; UHR ML, 1974, J BIOL CHEM, V249, P2920; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; WALES DS, 1980, J GEN MICROBIOL, V116, P93; WU M, 1987, J BIOL CHEM, V262, P12275	47	75	103	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2339	2345						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989987				2022-12-25	WOS:A1991EV51500051
J	MAWAL, MR; DESHMUKH, DR				MAWAL, MR; DESHMUKH, DR			ALPHA-AMINOADIPATE AMINOTRANSFERASE AND KYNURENINE AMINOTRANSFERASE ACTIVITIES FROM RAT-KIDNEY - EVIDENCE FOR SEPARATE IDENTITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURIFICATION	alpha-Aminoadipate aminotransferase and kynurenine aminotransferase activities from rat kidney are reportedly associated with the same protein. We observed that when the supernatant fraction was maintained at pH 4.5 for 75 min, 100% of kynurenine aminotransferase activity was lost, whereas only 40% of aminoadipate aminotransferase activity was lost. We purified alpha-aminoadipate aminotransferase and kynurenine aminotransferase from rat kidney supernatant fraction to electrophoretic homogeneity by ammonium sulfate fractionation, DEAE-Sephacel, and hydroxylapatite chromatography. Kynurenine aminotransferase activity was precipitated by pH treatment. The remaining aminoadipate aminotransferase activity was concentrated and injected into rabbits to raise antibodies that were used to prepare an affinity column. A mixture of animoadipate aminotransferase and kynurenine aminotransferase activities obtained after hydroxylapatite chromatography was subjected to affinity chromatography. Aminoadipate aminotransferase and kynurenine aminotransferase activities resolved as separate peaks, providing evidence that the two activities are associated with two different proteins.	WAYNE STATE UNIV,CHILDRENS HOSP MICHIGAN,DEPT PEDIAT,DETROIT,MI 48201	Children's Hospital of Michigan; Wayne State University								Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x; DESHMUKH DR, 1989, BIOCHEM J, V261, P761, DOI 10.1042/bj2610761; FISCHER MH, 1980, AM J MED GENET, V5, P35, DOI 10.1002/ajmg.1320050106; HUDSON L, 1980, PRACTICAL IMMUNOLOGY, P238; KHATER M, 1986, J EXP MED, V164, P1505, DOI 10.1084/jem.164.5.1505; KNOX WE, 1953, BIOCHEM J, V53, P379, DOI 10.1042/bj0530379; KORNBERG A, 1955, METHOD ENZYMOL, V1, P441, DOI 10.1016/0076-6879(55)01072-0; MASON M, 1985, TRANSAMINASES, P439; NAKATANI Y, 1970, BIOCHIM BIOPHYS ACTA, V198, P219, DOI 10.1016/0005-2744(70)90054-9; SCHMIDT E, 1974, METHOD ENZYMAT AN, P650; TAKEUCHI F, 1983, BIOCHIM BIOPHYS ACTA, V743, P323, DOI 10.1016/0167-4838(83)90389-8; TOBES MC, 1977, J BIOL CHEM, V252, P4591; TOBES MC, 1975, BIOCHEM BIOPH RES CO, V62, P390, DOI 10.1016/S0006-291X(75)80151-3	15	19	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2573	2575						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1990007				2022-12-25	WOS:A1991EV51500085
J	LUCKEY, M; LING, R; DOSE, A; MALLOY, B				LUCKEY, M; LING, R; DOSE, A; MALLOY, B			ROLE OF A DISULFIDE BOND IN THE THERMAL-STABILITY OF THE LAMB PROTEIN TRIMER IN ESCHERICHIA-COLI OUTER-MEMBRANE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALTOSE-BINDING PROTEIN; SODIUM DODECYL-SULFATE; RECEPTOR PROTEIN; GEL-ELECTROPHORESIS; PHAGE; MUTAGENESIS; MALTOPORIN; SALMONELLA; SELECTION; SEQUENCE	In order to understand the unusual heat resistance of LamB protein (the outer membrane component of the maltose transport system in Escherichia coli and its receptor for bacteriophage lambda), we investigated the role of its 2 cysteinyl residues. Our studies show that Cys22 and Cys38 form an intrasubunit disulfide bond which contributes to the heat stability of the LamB protein trimer. Physical evidence for the disulfide was obtained by using site-directed mutagenesis to convert Asn36 to Met, which allowed cyanogen bromide cleavage between the 2 cysteines. Upon reduction one of the N36M fragments migrated as two pieces, resolved by two-dimensional polyacrylamide gel electrophoresis. Other mutagenized LamB proteins, in which 1 or both Cys residues were converted to Ser, exhibited a sharp loss of thermal stability. In contrast to wild-type LamB protein trimer, which does not dissociate to monomers even after 60 min at 100-degrees-C, only 10-15% of the mutant LamB proteins remain trimeric after boiling 10 min. The disulfide bond in LamB protein is not required for its transport function, since both mutagenized LamB protein and N-ethylmaleimide-labeled LamB protein exhibit normal uptake of sugars in proteoliposomes. Finally, the disulfide bond must not be between subunits of the LamB trimer since reversible dissociation of trimer is achieved by low pH or denaturants in the absence of reducing agent.			LUCKEY, M (corresponding author), SAN FRANCISCO STATE UNIV,DEPT CHEM & BIOCHEM,SAN FRANCISCO,CA 94132, USA.				NIAID NIH HHS [AI00800, AI20727] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R23AI020727, K04AI000800] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALTENBACH C, 1990, SCIENCE, V248, P1088, DOI 10.1126/science.2160734; BAVOIL P, 1981, J BIOL CHEM, V256, P1385; CHARBIT A, 1988, J MOL BIOL, V201, P487, DOI 10.1016/0022-2836(88)90630-4; CLEMENT JM, 1981, CELL, V27, P507, DOI 10.1016/0092-8674(81)90392-5; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; DEVRIES GE, 1984, P NATL ACAD SCI-BIOL, V81, P6080, DOI 10.1073/pnas.81.19.6080; EISELE JL, 1990, J BIOL CHEM, V265, P10217; FERENCI T, 1989, FEMS MICROBIOL LETT, V61, P335, DOI 10.1016/0378-1097(89)90221-8; GARAVITO RM, 1983, J MOL BIOL, V164, P313, DOI 10.1016/0022-2836(83)90079-7; HARDY SJS, 1988, P NATL ACAD SCI USA, V85, P7109, DOI 10.1073/pnas.85.19.7109; ISHII JN, 1981, FEBS LETT, V134, P217, DOI 10.1016/0014-5793(81)80605-9; KRATZIN HD, 1989, ANAL BIOCHEM, V183, P1, DOI 10.1016/0003-2697(89)90161-9; KUHL PW, 1980, BIOCHIM BIOPHYS ACTA, V622, P63, DOI 10.1016/0005-2795(80)90158-0; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUCKEY M, 1983, J BACTERIOL, V153, P1056, DOI 10.1128/JB.153.2.1056-1059.1983; LUCKEY M, 1980, P NATL ACAD SCI-BIOL, V77, P167, DOI 10.1073/pnas.77.1.167; LUGTENBERG B, 1975, FEBS LETT, V58, P254, DOI 10.1016/0014-5793(75)80272-9; MATSUMURA M, 1989, NATURE, V342, P291, DOI 10.1038/342291a0; NAKAE T, 1979, BIOCHEM BIOPH RES CO, V88, P774, DOI 10.1016/0006-291X(79)91475-X; NAKAE T, 1976, J BIOL CHEM, V251, P2176; NIKAIDO H, 1984, P NATL ACAD SCI-BIOL, V81, P1048, DOI 10.1073/pnas.81.4.1048; PAGE MGP, 1986, BIOCHEM J, V235, P651, DOI 10.1042/bj2350651; PALVA ET, 1979, FEBS LETT, V99, P77, DOI 10.1016/0014-5793(79)80253-7; RASMUSSEN BA, 1987, GENE DEV, V1, P185, DOI 10.1101/gad.1.2.185; ROOSSIEN FF, 1984, BIOCHEMISTRY-US, V23, P211, DOI 10.1021/bi00297a006; SANDERMANN H, 1972, J BIOL CHEM, V247, P5123; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHENKMAN S, 1984, J BIOL CHEM, V259, P7570; STAUFFER KA, 1990, J MOL BIOL, V211, P297, DOI 10.1016/0022-2836(90)90351-L; VOGEL H, 1986, J MOL BIOL, V190, P191, DOI 10.1016/0022-2836(86)90292-5; VOLKIN DB, 1987, J BIOL CHEM, V262, P2945; WETZEL R, 1988, P NATL ACAD SCI USA, V85, P401, DOI 10.1073/pnas.85.2.401; ZOLLER MJ, 1983, METHOD ENZYMOL, V100, P468	35	29	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1866	1871						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1988451				2022-12-25	WOS:A1991EU49700076
J	BRANDON, SD; MASARACCHIA, RA				BRANDON, SD; MASARACCHIA, RA			MULTISITE PHOSPHORYLATION OF A SYNTHETIC PEPTIDE DERIVED FROM THE CARBOXYL TERMINUS OF THE RIBOSOMAL PROTEIN-S6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWISS 3T3 CELLS; S6 KINASE-ACTIVITY; EPIDERMAL GROWTH-FACTOR; PHORBOL ESTER; RAT-LIVER; ACTIVATION; INSULIN; PURIFICATION; PROTEASE; SITES	The synthetic peptide AKRRRLSSLRASTSKSESSQK (S6-21) which corresponds to the carboxyl-terminal 21 amino acids of human ribosomal protein s6 was synthesized and tested as a substrate for S6/H4 kinase purified from human placenta. The specific activity of the enzyme with the synthetic peptide and 40 S ribosomes was 45 and 23 nmol/min/mg, respectively. The S6/H4 kinase activity with S6-21 was greater than the enzyme activity with any other substrate tested, including histones, protamine, and casein and several other synthetic peptides. The phosphorylation of the peptide was not inhibited by inhibitors of several other proteins kinases. S6/H4 kinase catalyzed the phosphorylation of three major sites in the synthetic peptide and the 40 S ribosomes. A fourth site in S6-21 was phosphorylated more slowly. The principal phosphorylation sites were serines in the acidic carboxyl-terminal domain of the peptide. A serine (Ser-7 or -8) in the amino-terminal domain was phosphorylated at approximately 25% the rate of the carboxyl-terminal domain serines. The data suggest that multiple S6 kinases may be required to phosphorylate S6 at all five sites which are modified in vivo.	UNIV N TEXAS,DEPT BIOCHEM,BOX 13048,DENTON,TX 76203	University of North Texas System; University of North Texas Denton								BLENIS J, 1985, P NATL ACAD SCI USA, V82, P7621, DOI 10.1073/pnas.82.22.7621; BLENIS J, 1987, J BIOL CHEM, V262, P14373; BURKHARD SJ, 1983, J BIOL CHEM, V258, P4003; CHAN YL, 1988, J BIOL CHEM, V263, P2891; COBB MH, 1986, J BIOL CHEM, V261, P2994; COBB MH, 1983, J BIOL CHEM, V258, P2472; DELAHOUSSAYE BA, 1983, J BIOL CHEM, V258, P4272; DELGRANDE RW, 1982, EUR J BIOCHEM, V123, P421; DONAHUE MJ, 1984, J BIOL CHEM, V259, P435; DUVERNAY VH, 1978, BIOCHEMISTRY-US, V17, P2045, DOI 10.1021/bi00604a003; ECKOLS TK, 1983, EUR J BIOCHEM, V134, P249, DOI 10.1111/j.1432-1033.1983.tb07558.x; ERIKSON E, 1986, J BIOL CHEM, V261, P350; ERIKSON E, 1989, J BIOL CHEM, V264, P13711; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; GABRIELLI B, 1984, FEBS LETT, V175, P219, DOI 10.1016/0014-5793(84)80740-1; GIUGNI TD, 1988, J BIOL CHEM, V263, P18988; GLASS DB, 1978, ANAL BIOCHEM, V87, P566, DOI 10.1016/0003-2697(78)90707-8; HASSELL TC, 1988, BIOCHIM BIOPHYS ACTA, V957, P1, DOI 10.1016/0167-4838(88)90151-3; HEINZE H, 1988, J BIOL CHEM, V263, P4139; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; JENO P, 1989, J BIOL CHEM, V264, P1293; LARSSON R, 1988, J BIOL CHEM, V263, P17452; LEPEUCH CJ, 1983, P NATL ACAD SCI-BIOL, V80, P6858; LUBBEN TH, 1983, J BIOL CHEM, V258, P3992; MASARACCHIA RA, 1988, INSULIN ACTION DIABE, P169; MATSUDA Y, 1987, J BIOL CHEM, V262, P2832; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; NEMENOFF RA, 1986, ARCH BIOCHEM BIOPHYS, V245, P196, DOI 10.1016/0003-9861(86)90205-5; NOVAKHOFER I, 1984, J BIOL CHEM, V259, P5995; PALEN E, 1987, J BIOL CHEM, V262, P3518; PELECH SL, 1987, J BIOL CHEM, V262, P11598; PELECH SL, 1986, P NATL ACAD SCI USA, V83, P5968, DOI 10.1073/pnas.83.16.5968; PRICE DJ, 1989, J BIOL CHEM, V264, P13825; REIMANN EM, 1971, J BIOL CHEM, V246, P1986; SOMMERCORN J, 1987, P NATL ACAD SCI USA, V84, P8834, DOI 10.1073/pnas.84.24.8834; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; TABARINI D, 1985, P NATL ACAD SCI USA, V82, P4369, DOI 10.1073/pnas.82.13.4369; TABARINI D, 1987, BIOCHEM BIOPH RES CO, V144, P891, DOI 10.1016/S0006-291X(87)80048-7; TAHARA SM, 1982, EUR J BIOCHEM, V126, P395; THOMAS G, 1982, CELL, V30, P235, DOI 10.1016/0092-8674(82)90029-0; WETTENHALL REH, 1982, FEBS LETT, V148, P207, DOI 10.1016/0014-5793(82)80809-0; WETTENHALL REH, 1983, FEBS LETT, V162, P171, DOI 10.1016/0014-5793(83)81072-2; WETTENHALL REH, 1984, J BIOL CHEM, V259, P2084; WETTENHALL REH, 1982, FEBS LETT, V140, P263, DOI 10.1016/0014-5793(82)80910-1	44	18	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					380	385						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985906				2022-12-25	WOS:A1991EQ33900055
J	MURAKAMI, Y; KATAHIRA, M; MAKINO, R; HAYASHI, K; HIROHASHI, S; SEKIYA, T				MURAKAMI, Y; KATAHIRA, M; MAKINO, R; HAYASHI, K; HIROHASHI, S; SEKIYA, T			INACTIVATION OF THE RETINOBLASTOMA GENE IN A HUMAN LUNG-CARCINOMA CELL-LINE DETECTED BY SINGLE-STRAND CONFORMATION POLYMORPHISM ANALYSIS OF THE POLYMERASE CHAIN-REACTION PRODUCT OF CDNA	ONCOGENE			English	Article							SUSCEPTIBILITY GENE; HUMAN DNA; C-MYC; EXPRESSION; AMPLIFICATION; MUTATIONS; SEQUENCE; CANCER; IDENTIFICATION; ORGANIZATION	Combined use of a simple, sensitive method of DNA analysis of nucleotide substitutions, namely, single-strand conformation polymorphism analysis of polymerase chain reation products (PCR-SSCP), and the reverse transcriptase reaction (RT) is an effective method for mRNA analysis. We used this RT-PCR-SSCP method to detect abnormal retinoblastoma (RB) gene transcripts in human tumor cell lines. Results showed the presence of two types of RB gene transcripts in a giant cell lung carcinoma cell line Lu65: a minor mRNA species with a base substitution that created a stop codon in the nucleotide sequence corresponding to exon 2 of the gene, and a major species of mRNA without the nucleotide sequence corresponding to that of exon 2. PCR-SSCP analysis of the genomic DNA also revealed that Lu65 cells contained the mutated RB allele, but not the normal allele. These results suggested that in Lu65 cells, both RB alleles were inactivated. The transcript without the exon 2 sequence, probably due to alternative splicing, was also found in all the other human cells examined, as a very minor species.	NATL CANC CTR,RES INST,DIV ONCOGENE,1-1 TSUKIJI 5 CHOME,CHUO KU,TOKYO 104,JAPAN; NATL CANC CTR,RES INST,DIV PATHOL,TOKYO 104,JAPAN	National Cancer Center - Japan; National Cancer Center - Japan								CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DUNN JM, 1988, SCIENCE, V241, P1797, DOI 10.1126/science.3175621; DUNN JM, 1989, MOL CELL BIOL, V9, P4596, DOI 10.1128/MCB.9.11.4596; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FRIEND SH, 1987, P NATL ACAD SCI USA, V84, P9059, DOI 10.1073/pnas.84.24.9059; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HARBOUR JW, 1988, SCIENCE, V241, P353, DOI 10.1126/science.2838909; HAYASHI K, 1989, NUCLEIC ACIDS RES, V17, P3605, DOI 10.1093/nar/17.9.3605; HONG FD, 1989, P NATL ACAD SCI USA, V86, P5502, DOI 10.1073/pnas.86.14.5502; HOROWITZ JM, 1989, SCIENCE, V243, P937, DOI 10.1126/science.2521957; KAWASAKI ES, 1988, P NATL ACAD SCI USA, V85, P5698, DOI 10.1073/pnas.85.15.5698; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LEE EYHP, 1988, P NATL ACAD SCI USA, V85, P6017, DOI 10.1073/pnas.85.16.6017; LEE EYHP, 1988, SCIENCE, V241, P218, DOI 10.1126/science.3388033; LEE WH, 1987, SCIENCE, V235, P1394, DOI 10.1126/science.3823889; NUDEL U, 1983, NUCLEIC ACIDS RES, V11, P1759, DOI 10.1093/nar/11.6.1759; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SHEW JY, 1990, P NATL ACAD SCI USA, V87, P6, DOI 10.1073/pnas.87.1.6; TANG A, 1989, ONCOGENE, V4, P401; TAYA Y, 1984, EMBO J, V3, P2943, DOI 10.1002/j.1460-2075.1984.tb02236.x; XU HJ, 1989, ONCOGENE, V4, P807; YAMADA H, 1986, BIOCHEM BIOPH RES CO, V140, P167, DOI 10.1016/0006-291X(86)91072-7; YAMADA T, 1985, JPN J CANCER RES, V76, P967; YOKOTA J, 1988, ONCOGENE, V3, P471; YOSHIMOTO K, 1986, JPN J CANCER RES, V77, P540	30	45	49	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1991	6	1					37	42						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY039	1992444				2022-12-25	WOS:A1991EY03900005
J	ZHENG, LM; OJCIUS, DM; LIU, CC; KRAMER, MD; SIMON, MM; PARR, EL; YOUNG, JDE				ZHENG, LM; OJCIUS, DM; LIU, CC; KRAMER, MD; SIMON, MM; PARR, EL; YOUNG, JDE			IMMUNOGOLD LABELING OF PERFORIN AND SERINE ESTERASES IN GRANULATED METRIAL GLAND-CELLS	FASEB JOURNAL			English	Note						PERFORIN; SERINE ESTERASE; NATURAL KILLER CELL; GRANULATED METRIAL GLAND CELL; PLACENTA	NATURAL-KILLER CELLS; PORE-FORMING PROTEIN; TOXIC LYMPHOCYTES-T; TROPHOBLAST CELLS; CYTO-TOXICITY; MOUSE; LOCALIZATION; MECHANISM; DIFFERENTIATION; IMMUNOGLOBULIN	Cytotoxic T lymphocytes (CTL) and natural killer (NK) cells are cytolytic lymphocytes known to produce a pore-forming protein, named perforin or cytolysin, that lyses target cells by creating large pores on the target plasma membrane. Besides perforin, the granules of CTL and NK cells contain a family of serine esterases. Perforin has also been localized in granulated metrial gland (GMG) cells of the murine embryo implantation site by light microscopic immunostaining. Ultrastructural immunogold labeling with antibodies against perforin and a serine esterase (MTSP 1 or granzyme A) shows that GMG cells contain both perforin and serine esterases in the fine granular matrix of their granules. Perforin has been located in all of the granules, whereas gold particles corresponding to serine esterases have been found in most of the granules. Results from the double immunogold technique indicate that perforin and serine esterases colocalize to most of the same granules in GMG cells. This study supports the view that GMG cells are related to cytolytic lymphocytes.	LAB MOLEC BIOL & IMMUNOL,W-6900 HEIDELBERG,GERMANY; MAX PLANCK INST IMMUNBIOL,W-7800 FREIBURG,GERMANY; SO ILLINOIS UNIV,SCH MED,CARBONDALE,IL 62901	Max Planck Society; Southern Illinois University System; Southern Illinois University	ZHENG, LM (corresponding author), ROCKEFELLER UNIV,CELLULAR PHYSIOL & IMMUNOL LAB,NEW YORK,NY 10021, USA.							BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; BULMER D, 1968, J ANAT, V103, P479; GROSCURTH P, 1987, J IMMUNOL, V138, P2749; HALLER O, 1977, J EXP MED, V145, P1411, DOI 10.1084/jem.145.5.1411; HENKART PA, 1985, ANNU REV IMMUNOL, V3, P31, DOI 10.1146/annurev.iy.03.040185.000335; HERBERMAN RB, 1986, ANNU REV IMMUNOL, V4, P651, DOI 10.1146/annurev.iy.04.040186.003251; JANEWAY CA, 1989, NATURE, V341, P108, DOI 10.1038/341108a0; JENNE D, 1988, P NATL ACAD SCI USA, V85, P4814, DOI 10.1073/pnas.85.13.4814; KRAMER MD, 1989, EUR J IMMUNOL, V19, P151, DOI 10.1002/eji.1830190124; MITCHELL BS, 1981, J REPROD IMMUNOL, V3, P237, DOI 10.1016/0165-0378(81)90045-0; MITCHELL BS, 1984, IMMUNOLOGY, V53, P63; MITCHELL BS, 1987, J REPROD FERTIL, V81, P59; MUKHTAR DDY, 1989, J REPROD IMMUNOL, V15, P269, DOI 10.1016/0165-0378(89)90017-X; OJCIUS DM, 1990, CANCER CELL-MON REV, V2, P138; ORTALDO JR, 1984, ANNU REV IMMUNOL, V2, P359, DOI 10.1146/annurev.iy.02.040184.002043; PARR EL, 1987, BIOL REPROD, V37, P1327, DOI 10.1095/biolreprod37.5.1327; PEEL S, 1983, CELL TISSUE RES, V233, P647; PEEL S, 1984, J ANAT, V139, P593; PEEL S, 1977, J ANAT, V123, P687; PERSECHINI PM, 1989, J IMMUNOL METHODS, V124, P7, DOI 10.1016/0022-1759(89)90179-8; PETERS PJ, 1990, IMMUNOL TODAY, V11, P28; PODACK ER, 1985, IMMUNOL TODAY, V6, P21, DOI 10.1016/0167-5699(85)90164-1; SANTOLI D, 1979, IMMUNOL REV, V44, P125, DOI 10.1111/j.1600-065X.1979.tb00269.x; STEWART I, 1984, J ANAT, V139, P627; STEWART I, 1977, CELL TISSUE RES, V184, P517; STEWART I, 1988, PLACENTA, V9, P417, DOI 10.1016/0143-4004(88)90054-9; TAKAYAMA H, 1987, J EXP MED, V166, P725, DOI 10.1084/jem.166.3.725; TSCHOPP J, 1988, BIOCHEMISTRY-US, V27, P2641, DOI 10.1021/bi00408a001; YOUNG JDE, 1986, CELL, V44, P849, DOI 10.1016/0092-8674(86)90007-3; YOUNG JDE, 1989, PHYSIOL REV, V69, P250, DOI 10.1152/physrev.1989.69.1.250; YOUNG JDE, 1986, SCIENCE, V233, P180	31	48	49	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998	0892-6638			FASEB J	Faseb J.	JAN	1991	5	1					79	85		10.1096/fasebj.5.1.1991594	http://dx.doi.org/10.1096/fasebj.5.1.1991594			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ET609	1991594				2022-12-25	WOS:A1991ET60900018
J	GACHERU, SN; TRACKMAN, PC; SHAH, MA; OGARA, CY; SPACCIAPOLI, P; GREENAWAY, FT; KAGAN, HM				GACHERU, SN; TRACKMAN, PC; SHAH, MA; OGARA, CY; SPACCIAPOLI, P; GREENAWAY, FT; KAGAN, HM			STRUCTURAL AND CATALYTIC PROPERTIES OF COPPER IN LYSYL OXIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									BOSTON UNIV,SCH MED,DEPT BIOCHEM,BOSTON,MA 02118; CLARK UNIV,DEPT CHEM,WORCESTER,MA 01610	Boston University; Clark University			Trackman, Philip C/AAX-9280-2021; Greenaway, Frederick T/A-7174-2009	Trackman, Philip C/0000-0001-5064-614X; 	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR018880, R37AR018880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM042104] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR18880] Funding Source: Medline; NIGMS NIH HHS [R15 GM42104] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AULD DS, 1988, METHOD ENZYMOL, V158, P13, DOI 10.1016/0076-6879(88)58043-6; BARKER R, 1979, BIOCHEM J, V177, P289, DOI 10.1042/bj1770289; BUCKINGHAM K, 1981, P SOC EXP BIOL MED, V166, P310; CHOU WS, 1969, J BIOL CHEM, V244, P5785; GACHERU SN, 1988, J BIOL CHEM, V263, P16704; GIARTOSIO A, 1988, BIOCHEM BIOPH RES CO, V154, P66, DOI 10.1016/0006-291X(88)90650-X; GRANT J, 1978, BIOCHEM BIOPH RES CO, V83, P1216, DOI 10.1016/0006-291X(78)91524-3; GREENAWAY FT, 1977, BIOCHIM BIOPHYS ACTA, V490, P62, DOI 10.1016/0005-2795(77)90106-4; HARRIS ED, 1974, BIOCHIM BIOPHYS ACTA, V341, P332, DOI 10.1016/0005-2744(74)90226-5; HOLMQUIST B, 1988, METHOD ENZYMOL, V158, P6, DOI 10.1016/0076-6879(88)58042-4; Jordan R E, 1977, Adv Exp Med Biol, V79, P531; KAGAN HM, 1974, BIOCHIM BIOPHYS ACTA, V365, P223, DOI 10.1016/0005-2795(74)90267-0; KAGAN HM, 1983, ARCH BIOCHEM BIOPHYS, V221, P158, DOI 10.1016/0003-9861(83)90132-7; KAGAN HM, 1982, METHOD ENZYMOL, V82, P637; KAGAN HM, 1979, BIOCHEM J, V177, P203, DOI 10.1042/bj1770203; KAGAN HM, 1986, BIOL EXTRACELLULAR M, V1, P321; KLUETZ MD, 1980, BIOPHYS J, V29, P283, DOI 10.1016/S0006-3495(80)85132-0; KNOWLES PF, 1987, BIOCHEM J, V241, P603, DOI 10.1042/bj2410603; KNOWLES PF, 1984, COPPER PROTEINS COPP, P103; KUIVANIEMI H, 1984, J BIOL CHEM, V259, P6996; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MALMSTROM BG, 1968, BIOCHIM BIOPHYS ACTA, V156, P67, DOI 10.1016/0304-4165(68)90105-0; MCCRACKEN J, 1987, J AM CHEM SOC, V109, P4064, DOI 10.1021/ja00247a037; MILLER EJ, 1965, J BIOL CHEM, V240, P3623; PEISACH J, 1974, ARCH BIOCHEM BIOPHYS, V165, P691, DOI 10.1016/0003-9861(74)90298-7; RODRIGUEZ EJ, 1989, J AM CHEM SOC, V11, P7947; Shieh J J, 1976, Adv Exp Med Biol, V74, P447; Siegel R C, 1979, Int Rev Connect Tissue Res, V8, P73; SIEGEL RC, 1970, BIOCHEMISTRY-US, V9, P4486, DOI 10.1021/bi00825a004; STASSEN FLH, 1976, BIOCHIM BIOPHYS ACTA, V438, P49, DOI 10.1016/0005-2744(76)90222-9; SULLIVAN KA, 1982, J BIOL CHEM, V257, P13520; SUZUKI S, 1983, BIOCHEMISTRY-US, V22, P1630, DOI 10.1021/bi00276a016; TRACKMAN PC, 1981, ANAL BIOCHEM, V113, P336, DOI 10.1016/0003-2697(81)90086-5; VANDERMEER RA, 1986, FEBS LETT, V206, P111, DOI 10.1016/0014-5793(86)81350-3; VANDERMEER RA, 1986, BIOCHEM J, V239, P789, DOI 10.1042/bj2390789; WILLIAMS MA, 1985, ANAL BIOCHEM, V149, P430, DOI 10.1016/0003-2697(85)90594-9; WILLIAMSON PR, 1986, J BIOL CHEM, V261, P6302; WILLIAMSON PR, 1986, J BIOL CHEM, V261, P9477	38	93	97	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1990	265	31					19022	19027						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF739	1977746				2022-12-25	WOS:A1990EF73900054
J	MATSUNAGA, E; ZEUGIN, T; ZANGER, UM; AOYAMA, T; MEYER, UA; GONZALEZ, FJ				MATSUNAGA, E; ZEUGIN, T; ZANGER, UM; AOYAMA, T; MEYER, UA; GONZALEZ, FJ			SEQUENCE REQUIREMENTS FOR CYTOCHROME-P-450IID1 CATALYTIC ACTIVITY - A SINGLE AMINO-ACID CHANGE (ILE380 PHE) SPECIFICALLY DECREASES VMAX OF THE ENZYME FOR BUFURALOL BUT NOT DEBRISOQUINE HYDROXYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV BASEL,BIOCTR,DEPT PHARMACOL,CH-4056 BASEL,SWITZERLAND	University of Basel	MATSUNAGA, E (corresponding author), NCI,MOLEC CARCINOGENESIS LAB,BETHESDA,MD 20892, USA.		Zanger, Ulrich M./A-9364-2012	Zanger, Ulrich M./0000-0002-5276-2002				ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; AOYAMA T, 1989, J BIOL CHEM, V264, P10388; CHAKRABARTI S, 1985, MOL CELL BIOL, V5, P3403, DOI 10.1128/MCB.5.12.3403; FURUYA H, 1989, BIOCHEM BIOPH RES CO, V160, P669, DOI 10.1016/0006-291X(89)92485-6; GONZALEZ FJ, 1987, DNA-J MOLEC CELL BIO, V6, P149, DOI 10.1089/dna.1987.6.149; GONZALEZ FJ, 1989, PHARMACOL REV, V40, P243; GOTOH O, 1983, J BIOCHEM, V93, P807, DOI 10.1093/jb/93.3.807; GUENGERICH FP, 1983, BIOCHEMISTRY-US, V22, P2811, DOI 10.1021/bi00281a007; GUENGERICH FP, 1987, MAMMALIAN CYTOCHROME, V1; GUENGERICH FP, 1987, MAMMALIAN CYTOCHROME, V2; IMAI Y, 1988, FEBS LETT, V234, P313, DOI 10.1016/0014-5793(88)80106-6; Jefcoate C R, 1978, Methods Enzymol, V52, P258; KRONBACH T, 1987, ANAL BIOCHEM, V162, P24, DOI 10.1016/0003-2697(87)90006-6; KUPFER A, 1982, BIOCHEM PHARMACOL, V31, P3193, DOI 10.1016/0006-2952(82)90549-4; LINDBERG RLP, 1989, NATURE, V339, P632, DOI 10.1038/339632a0; MACKETT M, 1984, J VIROL, V49, P857, DOI 10.1128/JVI.49.3.857-864.1984; MATSUNAGA E, 1989, BIOCHEMISTRY-US, V28, P7349, DOI 10.1021/bi00444a030; NEBERT DW, 1989, DNA-J MOLEC CELL BIO, V8, P1, DOI 10.1089/dna.1.1989.8.1; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P943; OMURA T, 1964, J BIOL CHEM, V239, P2379; POULOS TL, 1989, NATURE, V339, P580, DOI 10.1038/339580a0; POULOS TL, 1985, J BIOL CHEM, V260, P6122; POULOS TL, 1986, BIOCHEMISTRY-US, V25, P5314, DOI 10.1021/bi00366a049; SHIMIZU T, 1988, BIOCHEMISTRY-US, V27, P4138, DOI 10.1021/bi00411a035; ZANGER UM, 1988, BIOCHEMISTRY-US, V27, P5447, DOI 10.1021/bi00415a010; ZANGER UM, 1988, P NATL ACAD SCI USA, V85, P8256, DOI 10.1073/pnas.85.21.8256	26	77	77	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1990	265	28					17197	17201						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA857	1976628				2022-12-25	WOS:A1990EA85700076
J	TOTA, MR; STRADER, CD				TOTA, MR; STRADER, CD			CHARACTERIZATION OF THE BINDING DOMAIN OF THE BETA-ADRENERGIC-RECEPTOR WITH THE FLUORESCENT ANTAGONIST CARAZOLOL - EVIDENCE FOR A BURIED LIGAND-BINDING SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											TOTA, MR (corresponding author), MERCK SHARP & DOHME LTD,DEPT MOLEC PHARMACOL & BIOCHEM,RAHWAY,NJ 07065, USA.							AOKI C, 1989, BRAIN RES, V493, P331, DOI 10.1016/0006-8993(89)91168-2; BELIKOVA TP, 1958, OPT SPEKTROSK, V1, P168; BIRKS JB, 1968, J PHYS PT B ATOM M P, V1, P958, DOI 10.1088/0022-3700/1/5/324; BIRKS JB, 1970, PHOTOPHYSICS AROMATI, P433; CALHOUN D B, 1986, Proteins Structure Function and Genetics, V1, P109, DOI 10.1002/prot.340010202; CALHOUN DB, 1983, BIOCHEMISTRY-US, V22, P1533, DOI 10.1021/bi00276a003; CARON MG, 1979, J BIOL CHEM, V254, P2923; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; DIXON RAF, 1987, EMBO J, V6, P3269, DOI 10.1002/j.1460-2075.1987.tb02645.x; DIXON RAF, 1987, NATURE, V326, P73, DOI 10.1038/326073a0; DOHLMAN HG, 1988, BIOCHEMISTRY-US, V27, P1813, DOI 10.1021/bi00406a002; DUGGLEBY RG, 1984, COMPUT BIOL MED, V14, P447, DOI 10.1016/0010-4825(84)90045-3; EATON DF, 1988, J PHOTOCH PHOTOBIO B, V2, P523, DOI 10.1016/1011-1344(88)85081-4; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; EFTINK MR, 1975, P NATL ACAD SCI USA, V72, P3290, DOI 10.1073/pnas.72.9.3290; FINDLAY JBC, 1986, BIOCHEM J, V238, P625, DOI 10.1042/bj2380625; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; GEORGE ST, 1989, BIOCHEM BIOPH RES CO, V163, P1265, DOI 10.1016/0006-291X(89)91114-5; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; HARGRAVE PA, 1984, VISION RES, V24, P1487, DOI 10.1016/0042-6989(84)90311-0; IJZERMAN AP, 1988, J COMPUT AID MOL DES, V2, P43, DOI 10.1007/BF01532052; INNIS RB, 1979, LIFE SCI, V24, P2255, DOI 10.1016/0024-3205(79)90102-4; KERLAVAGE A R, 1986, Proteins Structure Function and Genetics, V1, P287, DOI 10.1002/prot.340010403; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAKOWICZ JR, 1983, PRINCIPLES FLUORESCE, P258; RENK GE, 1988, BIOPHYS J, V53, P361, DOI 10.1016/S0006-3495(88)83113-8; RENK GE, 1987, AM CHEM SOC, V109, P6193; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P309; STRADER CD, 1988, J BIOL CHEM, V263, P10267; STRADER CD, 1989, FASEB J, V3, P1825, DOI 10.1096/fasebj.3.7.2541037; STRADER CD, 1989, J BIOL CHEM, V264, P13572; STRADER CD, 1987, P NATL ACAD SCI USA, V84, P4384, DOI 10.1073/pnas.84.13.4384; STRADER CD, 1988, J CELL BIOL, V107, P64; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; SUMPTER WC, 1954, CHEM HETEROCYCLIC CO, V8, P284; THOMAS DD, 1978, P NATL ACAD SCI USA, V75, P5746, DOI 10.1073/pnas.75.12.5746; THOMAS DD, 1982, J MOL BIOL, V154, P145, DOI 10.1016/0022-2836(82)90422-3; TOTA MR, 1987, BIOCHEMISTRY-US, V26, P8175, DOI 10.1021/bi00399a023; VOLTZ R, 1966, J CHIM PHYS, V63, P1253, DOI 10.1051/jcp/1966631253; WANG HY, 1989, J BIOL CHEM, V264, P14424; WONG SKF, 1988, J BIOL CHEM, V263, P7925	42	105	105	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1990	265	28					16891	16897						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA857	1976626				2022-12-25	WOS:A1990EA85700034
J	AHUJA, HG; TESTA, MP; CLINE, MJ				AHUJA, HG; TESTA, MP; CLINE, MJ			VARIATION IN THE PROTEIN CODING REGION OF THE HUMAN P53 GENE	ONCOGENE			English	Note											AHUJA, HG (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,JONSSON COMPREHENS CANC CTR,DIV HEMATOL ONCOL,LOS ANGELES,CA 90024, USA.				PHS HHS [50275] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AHUJA H, 1989, P NATL ACAD SCI USA, V86, P6783, DOI 10.1073/pnas.86.17.6783; CRAWFORD L, 1983, INT REV EXP PATHOL, V25, P1; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; ELIYAHU D, 1988, ONCOGENE, V3, P313; HARLOW E, 1985, MOL CELL BIOL, V5, P1601, DOI 10.1128/MCB.5.7.1601; LAMB P, 1986, MOL CELL BIOL, V6, P1379, DOI 10.1128/MCB.6.5.1379; MASUDA H, 1987, P NATL ACAD SCI USA, V84, P7716, DOI 10.1073/pnas.84.21.7716; MOWAT M, 1985, NATURE, V314, P633, DOI 10.1038/314633a0; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; WOLF D, 1984, MOL CELL BIOL, V4, P1402, DOI 10.1128/MCB.4.7.1402	13	33	34	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	SEP	1990	5	9					1409	1410						2	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EC241	1977117				2022-12-25	WOS:A1990EC24100020
J	PANDEY, KN; SINGH, S				PANDEY, KN; SINGH, S			MOLECULAR-CLONING AND EXPRESSION OF MURINE GUANYLATE-CYCLASE ATRIAL-NATRIURETIC-FACTOR RECEPTOR CDNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									VANDERBILT UNIV, MED CTR, SCH MED, DEPT BIOCHEM, NASHVILLE, TN 37232 USA; VANDERBILT UNIV, MED CTR, SCH MED, DEPT PHARMACOL, NASHVILLE, TN 37232 USA	Vanderbilt University; Vanderbilt University					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD025527, R01HD010254] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 25527, HD 10254] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANANDSRIVASTAVA MB, 1984, BIOCHEM BIOPH RES CO, V121, P855, DOI 10.1016/0006-291X(84)90756-3; ASCOLI M, 1981, ENDOCRINOLOGY, V108, P88, DOI 10.1210/endo-108-1-88; ATARASHI K, 1984, SCIENCE, V224, P992, DOI 10.1126/science.6326267; ATLAS SA, 1984, NATURE, V309, P717, DOI 10.1038/309717a0; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BEX F, 1985, EUR J PHARMACOL, V115, P125, DOI 10.1016/0014-2999(85)90595-3; BUDZIK GP, 1987, BIOCHEM BIOPH RES CO, V144, P422, DOI 10.1016/S0006-291X(87)80527-2; BURNETT JC, 1984, AM J PHYSIOL, V247, pF863, DOI 10.1152/ajprenal.1984.247.5.F863; CHANG M, 1989, NATURE, V341, P68, DOI 10.1038/341068a0; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; CURRIE MG, 1983, SCIENCE, V221, P71, DOI 10.1126/science.6857267; DEBOLD AJ, 1981, LIFE SCI, V28, P89, DOI 10.1016/0024-3205(81)90370-2; DELEAN A, 1984, ENDOCRINOLOGY, V115, P1636; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; FLYNN TG, 1983, BIOCHEM BIOPH RES CO, V117, P859, DOI 10.1016/0006-291X(83)91675-3; FULLER F, 1988, J BIOL CHEM, V263, P9395; GARBERS DL, 1989, J BIOL CHEM, V264, P9103; GARCIA R, 1984, BIOCHEM BIOPH RES CO, V119, P685, DOI 10.1016/S0006-291X(84)80304-6; GOODFRIEND TL, 1984, LIFE SCI, V35, P1675, DOI 10.1016/0024-3205(84)90179-6; GRAMMER RT, 1983, BIOCHEM BIOPH RES CO, V116, P696, DOI 10.1016/0006-291X(83)90581-8; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HAMET P, 1984, BIOCHEM BIOPH RES CO, V123, P515, DOI 10.1016/0006-291X(84)90260-2; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANSBROUGH JR, 1981, J BIOL CHEM, V256, P1447; HIROSE S, 1985, BIOCHEM BIOPH RES CO, V130, P574, DOI 10.1016/0006-291X(85)90455-3; HORVATH J, 1986, P NATL ACAD SCI USA, V83, P3444, DOI 10.1073/pnas.83.10.3444; INAGAMI T, 1989, J BIOL CHEM, V264, P3043; JACOBS BB, 1968, J NATL CANCER I, V41, P1141; JAISWAL N, 1986, FEBS LETT, V199, P121, DOI 10.1016/0014-5793(86)81236-4; KOESLING D, 1988, FEBS LETT, V239, P29, DOI 10.1016/0014-5793(88)80539-8; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; KUNO T, 1986, J BIOL CHEM, V261, P5817; LEITMAN DC, 1988, J BIOL CHEM, V263, P3720; LEITMAN DC, 1986, J BIOL CHEM, V261, P1650; LOWE DG, 1989, EMBO J, V8, P1377, DOI 10.1002/j.1460-2075.1989.tb03518.x; MAACK T, 1984, AM J MED, V77, P1069, DOI 10.1016/0002-9343(84)90190-6; MAACK T, 1987, SCIENCE, V238, P675, DOI 10.1126/science.2823385; MELOCHE S, 1988, BIOCHEMISTRY-US, V27, P8151, DOI 10.1021/bi00421a025; MISONO KS, 1985, BIOCHEM BIOPH RES CO, V130, P994, DOI 10.1016/0006-291X(85)91713-9; MUKHOPADHYAY AK, 1986, FEBS LETT, V202, P111, DOI 10.1016/0014-5793(86)80659-7; MUKHOPADHYAY AK, 1986, BIOCHEM J, V239, P463, DOI 10.1042/bj2390463; NAKANE M, 1988, BIOCHEM BIOPH RES CO, V157, P1139, DOI 10.1016/S0006-291X(88)80992-6; PANDEY KN, 1988, J BIOL CHEM, V263, P13406; PANDEY KN, 1986, BIOCHEM BIOPH RES CO, V138, P399, DOI 10.1016/0006-291X(86)90295-0; PANDEY KN, 1985, BIOCHEM BIOPH RES CO, V133, P800, DOI 10.1016/0006-291X(85)90975-1; PANDEY KN, 1987, ENDOCRINOLOGY, V121, P1195, DOI 10.1210/endo-121-3-1195; PANDEY KN, 1986, BIOCHEMISTRY-US, V25, P8467, DOI 10.1021/bi00374a022; PAUL AK, 1987, SCIENCE, V235, P1224, DOI 10.1126/science.2881352; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; SABATINI DD, 1982, J CELL BIOL, V92, P1, DOI 10.1083/jcb.92.1.1; SAMSON WK, 1985, NEUROENDOCRINOLOGY, V40, P277, DOI 10.1159/000124085; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCARBOROUGH RM, 1986, J BIOL CHEM, V261, P2960; SCHENK DB, 1987, P NATL ACAD SCI USA, V84, P1521, DOI 10.1073/pnas.84.6.1521; SCHENK DB, 1985, J BIOL CHEM, V260, P4887; SCHULZ S, 1989, CELL, V58, P1155, DOI 10.1016/0092-8674(89)90513-8; SEIDAH NG, 1984, P NATL ACAD SCI-BIOL, V81, P2640, DOI 10.1073/pnas.81.9.2640; SEN I, 1986, BIOCHEM BIOPH RES CO, V135, P480, DOI 10.1016/0006-291X(86)90019-7; SHIMONAKA M, 1987, J BIOL CHEM, V262, P5510; SINGH S, 1988, NATURE, V334, P708, DOI 10.1038/334708a0; TAKAYANAGI R, 1987, J BIOL CHEM, V262, P12104; THORPE DS, 1989, J BIOL CHEM, V264, P6545; VANDLEN RL, 1985, J BIOL CHEM, V260, P889; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WALDMAN SA, 1984, J BIOL CHEM, V259, P4332; YIP CC, 1985, J BIOL CHEM, V260, P8229	69	141	146	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	1990	265	21					12342	12348						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DP458	1973687				2022-12-25	WOS:A1990DP45800039
J	LITOSCH, I				LITOSCH, I			G-PROTEIN REGULATION OF PHOSPHOLIPASE-C ACTIVITY IN A MEMBRANE-SOLUBILIZED SYSTEM OCCURS THROUGH A MG2+ AND TIME-DEPENDENT MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING-PROTEIN; ADENYLATE-CYCLASE ACTIVITY; LIVER PLASMA-MEMBRANES; GUANINE-NUCLEOTIDE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; HUMAN-PLATELETS; BOVINE BRAIN; POLYPHOSPHOINOSITIDE PHOSPHODIESTERASE; INOSITOL 1,4,5-TRISPHOSPHATE; PERTUSSIS TOXIN	GTP-binding proteins have been implicated to function as key transducing elements in the mechanism underlying receptor activation of a membrane-associated phospholipase C activity. In the present study, the regulation of phospholipase C activity by GTP-binding proteins has been characterized in a detergent-solubilized system derived from bovine brain membranes. Guanosine-5'-(3-O-thio)triphosphate (GTP-gamma-S) and guanyl-5'-yl imidodiphosphate (Gpp(NH)p) stimulated a dose-dependent increase in phospholipase C activity with half-maximal activation at 0.6-mu-M and 10-mu-M, respectively. The maximal degree of stimulation due to Gpp(NH)p or GTP-gamma-S was comparable. 100-mu-M GTP had only a slight stimulatory effect on phospholipase C activity. Adenine nucleotides, 100-mu-M adenylyl-imidodiphosphate and ATP, did not stimulate phospholipase C activity, indicating that specific guanine nucleotide-dependent regulation of phospholipase C activity was preserved in the solubilized state. Gpp(NH)p or GTP-gamma-S stimulation of phospholipase C activity was time-dependent and required Mg2+. Mg2+ regulated the time course for activation of phospholipase C by guanine nucleotides and the ability of guanine nucleotides to promote an increase in the Ca2+ sensitivity of phospholipase C. 200-mu-M GDP-beta-S or 5 mM EDTA rapidly reversed the activation due to GTP-gamma-S or Gpp(NH)p. These findings demonstrate that G protein regulation of phospholipase C activity in a bovine brain membrane-solubilized system occurs through a Mg2+ and time-dependent mechanism. Activation is readily reversible upon addition of excess GDP-beta-S or removal of Mg2+.			LITOSCH, I (corresponding author), UNIV MIAMI,SCH MED,DEPT MOLEC & CELLULAR PHARMACOL,MIAMI,FL 33101, USA.							BALDASSARE JJ, 1989, BIOCHEMISTRY-US, V28, P6010, DOI 10.1021/bi00440a043; BALDASSARE JJ, 1988, BIOCHEM BIOPH RES CO, V154, P351, DOI 10.1016/0006-291X(88)90692-4; BANNO Y, 1988, J BIOL CHEM, V263, P11459; BENNETT CF, 1987, J BIOL CHEM, V262, P13789; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; BIZZARRI C, 1990, P NATL ACAD SCI USA, V87, P4889, DOI 10.1073/pnas.87.12.4889; BOYER JL, 1989, J BIOL CHEM, V264, P13917; BOYER JL, 1989, J BIOL CHEM, V264, P884; BRASS LF, 1986, J BIOL CHEM, V261, P6838; COCKCROFT S, 1987, TRENDS BIOCHEM SCI, V12, P75, DOI 10.1016/0968-0004(87)90035-1; COCKCROFT S, 1985, NATURE, V314, P534, DOI 10.1038/314534a0; FUKUI T, 1988, J BIOL CHEM, V263, P17730; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HOFMANN SL, 1982, J BIOL CHEM, V257, P6461; HOKIN LE, 1985, ANNU REV BIOCHEM, V54, P205, DOI 10.1146/annurev.biochem.54.1.205; HOMMA Y, 1988, J BIOL CHEM, V263, P6592; IRVINE RF, 1985, BIOCHEM J, V229, P505, DOI 10.1042/bj2290505; IYENGAR R, 1981, J BIOL CHEM, V256, P1042; KAMATA T, 1988, P NATL ACAD SCI USA, V85, P5799, DOI 10.1073/pnas.85.16.5799; KIKUCHI A, 1986, J BIOL CHEM, V261, P1558; Koenig H, 1974, Methods Enzymol, V31, P457; LITOSCH I, 1989, BIOCHEM J, V261, P325, DOI 10.1042/bj2610325; LITOSCH I, 1989, BIOCHEM J, V261, P245, DOI 10.1042/bj2610245; LITOSCH I, 1985, J BIOL CHEM, V260, P5464; LITOSCH I, 1990, G PROTEINS MEDIATORS, P155; MARTIN TFJ, 1989, J BIOL CHEM, V264, P20917; MICHELL RH, 1975, BIOCHIM BIOPHYS ACTA, V415, P81, DOI 10.1016/0304-4157(75)90017-9; MORRIS JA, 1990, J BIOL CHEM, V265, P13508; NORTHUP JK, 1980, P NATL ACAD SCI-BIOL, V77, P6516, DOI 10.1073/pnas.77.11.6516; PERRIN DD, 1967, TALANTA, V14, P833, DOI 10.1016/0039-9140(67)80105-X; PFEUFFER T, 1977, J BIOL CHEM, V252, P7224; RAPIEJKO PJ, 1986, BIOCHEM J, V240, P35, DOI 10.1042/bj2400035; REBECCHI MJ, 1987, J BIOL CHEM, V262, P12526; ROBERTSON S, 1984, METHOD PHARMACOL, V5, P63, DOI DOI 10.1007/978-1-4684-4778-1_6; ROSS EM, 1978, J BIOL CHEM, V253, P6401; RYU SH, 1987, J BIOL CHEM, V262, P12511; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SCHIMMEL RJ, 1986, BIOCHEM BIOPH RES CO, V135, P823, DOI 10.1016/0006-291X(86)91002-8; SMITH CD, 1985, J BIOL CHEM, V260, P5875; SMITH CD, 1986, SCIENCE, V232, P97, DOI 10.1126/science.3006254; SMITH RM, 1974, CRITICAL STABILITY C, V1, P1; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; STERNWEIS PC, 1981, J BIOL CHEM, V256, P1517; TAYLOR SJ, 1987, BIOCHEM J, V248, P791, DOI 10.1042/bj2480791; TAYLOR SJ, 1990, J BIOL CHEM, V265, P17150; UHING RJ, 1986, J BIOL CHEM, V261, P2140; YATANI A, 1988, NATURE, V336, P680, DOI 10.1038/336680a0; YOUNT RG, 1971, BIOCHEMISTRY-US, V10, P2484, DOI 10.1021/bi00789a009	48	28	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4764	4771						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002026				2022-12-25	WOS:A1991FC21700018
J	MILLER, DM; DELGADO, R; CHIRGWIN, JM; HARDIES, SC; HOROWITZ, PM				MILLER, DM; DELGADO, R; CHIRGWIN, JM; HARDIES, SC; HOROWITZ, PM			EXPRESSION OF CLONED BOVINE ADRENAL RHODANESE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER RHODANESE; PROTEIN; ENZYME; CELLS; DNA; SEQUENCES; EVOLUTION; FORMS	A cDNA for the enzyme rhodanese (thiosulfate:cyanide sulfurtransferase, EC 2.8.1.1) has been cloned from a bovine adrenal library. An initiator methionine codon precedes the amino-terminal amino acid found in the isolated protein. Rhodanese is synthesized in the cytoplasm and transferred to the mitochondrial matrix. Thus, any amino-terminal sequence required for organelle import is retained in the mature protein. Furthermore, the DNA sequence shows that there are three additional amino acids, Gly-Lys-Ala, at the carboxyl terminus that are not found by protein sequencing. Additionally, comparison of the published amino acid sequence with that encoded by the open reading frame revealed three differences in the amino acid sequence. Comparison of the bovine and chicken liver sequences shows an overall level of 70% sequence homology, but there is complete identity of all residues that have been implicated in the function of the enzyme. When two mammalian cells, cos-7 and 293 cells, were transiently transfected with a plasmid containing the rhodanese coding region, rhodanese activity in lysates increased approximately 20-fold. Fluorograms of denaturing polyacrylamide gels detected a large increase in a polypeptide that co-migrated with the native protein and reacted with anti-rhodanese antibodies. Nondenaturing gels showed two active species that co-migrated with the two major electrophoretic forms purified by current procedures. Escherichia coli, transformed with a plasmid containing the rhodanese coding region, showed a 15-fold increase in rhodanese activity over baseline values. When the E. coli recombinant protein was analyzed on a nondenaturing gel, only one species was observed that co-electrophoresed with the more electropositive variant seen in purified bovine liver rhodanese. This single variant could be converted by carboxypeptidase B digestion to a form of the enzyme that co-migrated with the more electronegative species isolated from bovine liver. Thus, two major, enzymatically active electrophoretic variants, commonly observed in mammalian cells, can be accounted for by carboxyl-terminal processing without recourse to other post-translational modifications.	UNIV TEXAS, HLTH SCI CTR, DEPT PATHOL, SAN ANTONIO, TX 78284 USA; UNIV TEXAS, HLTH SCI CTR, DEPT MED, SAN ANTONIO, TX 78284 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	MILLER, DM (corresponding author), UNIV TEXAS, HLTH SCI CTR, DEPT BIOCHEM, SAN ANTONIO, TX 78284 USA.				NHGRI NIH HHS [HG00190] Funding Source: Medline; NIGMS NIH HHS [GM25177] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025177] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMANN E, 1985, GENE, V40, P184; BLUMENTHAL KM, 1971, J BIOL CHEM, V246, P2430; BOGGARAM V, 1985, BIOCHEM BIOPH RES CO, V130, P407, DOI 10.1016/0006-291X(85)90431-0; CANNELLA C, 1981, EUR J BIOCHEM, V119, P491, DOI 10.1111/j.1432-1033.1981.tb05634.x; CERLETTI P, 1986, TRENDS BIOCHEM SCI, V11, P369, DOI 10.1016/0968-0004(86)90206-9; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; FAUST PL, 1987, J CELL BIOL, V105, P1937, DOI 10.1083/jcb.105.5.1937; FITCH WM, 1976, J MOL EVOL, V8, P13, DOI 10.1007/BF01738880; GRANTHAM R, 1981, NUCLEIC ACIDS RES, V9, pR43; GUILBAULT GG, 1971, ANAL BIOCHEM, V43, P42, DOI 10.1016/0003-2697(71)90105-9; HANAHAN D, 1983, METHOD ENZYMOL, V100, P333; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V988, P1, DOI 10.1016/0304-4157(89)90002-6; HEINRIKSON R, FRONTIERS BIOCH BIOP, P163; Hol W G, 1985, Adv Biophys, V19, P133, DOI 10.1016/0065-227X(85)90053-X; HOL WGJ, 1983, FUND APPL TOXICOL, V3, P370, DOI 10.1016/S0272-0590(83)80007-4; HOROWITZ P, 1983, J BIOL CHEM, V258, P1614; HOROWITZ P, 1981, FED PROC, V40, P1859; KOHANSKI RA, 1990, J PROTEIN CHEM, V9, P369, DOI 10.1007/BF01024612; LANE RD, 1986, J IMMUNOL METHODS, V92, P261, DOI 10.1016/0022-1759(86)90174-2; LEMIRE BD, 1989, J BIOL CHEM, V264, P20206; Maizel JV, 1971, METHOD VIROL, V5, P179; Maniatis T., 1982, MOL CLONING; OGATA K, 1989, J BIOL CHEM, V264, P2718; OKAYAMA H, 1983, MOL CELL BIOL, V3, P280, DOI 10.1128/MCB.3.2.280; PELHAM HRB, 1988, EMBO J, V7, P913, DOI 10.1002/j.1460-2075.1988.tb02896.x; PLOEGMAN JH, 1978, NATURE, V273, P124, DOI 10.1038/273124a0; ROBINSON A, 1987, BIOCHEM J, V246, P249, DOI 10.1042/bj2460249; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHERMAN F, 1985, BIOESSAYS, V3, P27, DOI 10.1002/bies.950030108; SORBO BH, 1953, ACTA CHEM SCAND, V7, P1137, DOI 10.3891/acta.chem.scand.07-1137; TOOHEY JI, 1989, BIOCHEM J, V264, P625, DOI 10.1042/bj2640625; ULLRICH A, 1984, EMBO J, V3, P361, DOI 10.1002/j.1460-2075.1984.tb01812.x; WEBER K, 1969, J BIOL CHEM, V244, P4406; WESTLEY J, 1983, FUND APPL TOXICOL, V3, P377, DOI 10.1016/S0272-0590(83)80008-6; WESTLEY J, 1973, ADV ENZYMOL RAMB, V39, P327; WILSON AC, 1977, ANNU REV BIOCHEM, V46, P573, DOI 10.1146/annurev.bi.46.070177.003041; GIBCO LABORATORIES C	39	82	85	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4686	4691						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002017				2022-12-25	WOS:A1991FC21700006
J	CHANG, EC; CRAWFORD, BF; HONG, Z; BILINSKI, T; KOSMAN, DJ				CHANG, EC; CRAWFORD, BF; HONG, Z; BILINSKI, T; KOSMAN, DJ			GENETIC AND BIOCHEMICAL-CHARACTERIZATION OF CU,ZN SUPEROXIDE-DISMUTASE MUTANTS IN SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION INITIATION SITES; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; YEAST; CATALASE; OXYGEN; ACID; PROTEINS; DNA	The allele scd1 is a recessive chromosomal mutation in Saccharomyces cerevisiae that eliminates Cu,Zn superoxide dismutase (SOD-1) activity. SOD-1- strains are unable to grow in 100% O2 in rich medium and are methionine and lysine auxotrophic when grown in air (Bilinski, T., Krawiec, Z., Liczmanski, A., and Litwinska, J. (1985) Biochem. Biophys. Res. Commun. 130, 533-539). In this report, scd1 was genetically mapped to the right arm of chromosome X, 11 centimorgans proximal to cdc11. The gene for SOD-1 (SOD1) was physically mapped by Southern blot to restriction fragments containing CDC11. scd1 failed to complement a complete deletion of SOD1. Thus, scd1 maps to the SOD1 locus and is designated sod1-1. The molecular basis for the lack of SOD-1 activity in sodl-1 carrying strains has also been established. The size and amount of SOD-1 mRNA in the mutant were essentially the same as in wild type cells. Western blot analysis showed that the SOD-1 dimer and 16-kilodalton subunit that co-migrated electrophoretically with wild type yeast SOD-1 were abundant in mutant cell extracts. However, two additional SOD-1 immunoreactive polypeptides were detected in these extracts in both denaturing and nondenaturing gels. None of the SOD-1 immunoreactive species in the mutant extracts exhibited superoxide dismutase activity. Transformants of the mutant strain carrying episomal, wild type SOD1 expressed wild type, active SOD-1 protein, indicating that the mutant allele had no discernible effect on the correct synthesis and activation of apoSOD-1. Size exclusion chromatography of soluble cell extracts derived from wild type and SOD1 deletion strains identified a copper binding peak that corresponded to SOD-1. This copper-binding fraction was absent in cell extracts from the sod1-1-containing strain although Western blot analysis of the corresponding chromatographic fractions showed that SOD-1 polypeptide was present in these fractions. Sequence data derived from the cloned genes showed that sod1-1 differed from SOD1 only in the adjacent 5'-noncoding region. The biochemical data indicate that this genetic alteration results in the synthesis of a collection of SOD-1 polypeptides that fail to bind copper and may also fail to completely self-associate. Both phenotypes could be due to the inability of these polypeptides to adopt the native SOD-1 conformation.	SUNY BUFFALO, SCH MED & BIOMED SCI, DEPT BIOCHEM, BUFFALO, NY 14214 USA; ACAD AGR LUBLIN, ZAMOSC COLL AGR, PL-22400 ZAMOSC, POLAND	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Life Sciences in Lublin								AEBI H, 1984, METHOD ENZYMOL, V105, P121; Beauchamp Charles, ANAL BIOCHEM, V44, P276, DOI [10.1016/0003-2697(71)90370-8, DOI 10.1016/0003-2697(71)90370-8]; BERMINGHAMMCDONOGH O, 1988, P NATL ACAD SCI USA, V85, P4789, DOI 10.1073/pnas.85.13.4789; BEYER WF, 1987, ANAL BIOCHEM, V161, P559, DOI 10.1016/0003-2697(87)90489-1; BIELSKI BHJ, 1983, J BIOL CHEM, V258, P4759; BILINSKI T, 1985, BIOCHEM BIOPH RES CO, V130, P533, DOI 10.1016/0006-291X(85)90449-8; BILINSKI T, 1988, OXY RADICALS MOL BIO, V82, P109; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; BOTSTEIN D, 1979, GENE, V8, P17, DOI 10.1016/0378-1119(79)90004-0; BOVERIS A, 1978, P65; CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x; CHANG EC, 1990, J BACTERIOL, V172, P1840, DOI 10.1128/jb.172.4.1840-1845.1990; CHANG EC, 1989, J BIOL CHEM, V264, P12172; FARR SB, 1986, P NATL ACAD SCI USA, V83, P8268, DOI 10.1073/pnas.83.21.8268; FRIDOVICH I, 1989, J BIOL CHEM, V264, P7761; GRALLA EB, 1988, OXY RADICALS MOL BIO, V82, P173; HAHN S, 1985, P NATL ACAD SCI USA, V82, P8562, DOI 10.1073/pnas.82.24.8562; HALLIWELL B, 1984, FREE RADICAL BIO MED, P67; HARTIG A, 1986, EUR J BIOCHEM, V160, P487, DOI 10.1111/j.1432-1033.1986.tb10065.x; HOLM C, 1986, GENE, V42, P169, DOI 10.1016/0378-1119(86)90293-3; INGRAHAM LL, 1985, BIOCH DIOXYGEN, P255; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jones E. W., 1982, MOL BIOL YEAST SACCH, P181; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWRENCE CW, 1975, GENETICS, V81, P615; MARRES CAM, 1985, EUR J BIOCHEM, V147, P153, DOI 10.1111/j.1432-1033.1985.tb08731.x; Mortimer R K, 1975, Methods Cell Biol, V11, P221, DOI 10.1016/S0091-679X(08)60325-8; MORTIMER RK, 1985, MICROBIOL REV, V49, P181, DOI 10.1128/MMBR.49.3.181-213.1985; NAGAWA F, 1985, P NATL ACAD SCI USA, V82, P8557, DOI 10.1073/pnas.82.24.8557; NG R, 1980, P NATL ACAD SCI-BIOL, V77, P3912, DOI 10.1073/pnas.77.7.3912; OTEY CA, 1986, ANAL BIOCHEM, V157, P71, DOI 10.1016/0003-2697(86)90197-1; OYANAGUI Y, 1984, ANAL BIOCHEM, V142, P290; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P2502; Sambrook J, 1989, MOL CLONING LABORATO; SCOTT MD, 1987, J BIOL CHEM, V262, P3640; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SRIPATI CE, 1978, METHOD CELL BIOL, V21, P61; VALDIVIA E, 1983, CAN J MICROBIOL, V29, P1200, DOI 10.1139/m83-183; VANLOON APGM, 1986, P NATL ACAD SCI USA, V83, P3820; WESTERBEEKMARRES CAM, 1988, EUR J BIOCHEM, V174, P611, DOI 10.1111/j.1432-1033.1988.tb14142.x; 1984, DIFCO MANUAL, P1135	41	68	70	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4417	4424						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999425				2022-12-25	WOS:A1991FA69400062
J	GETTINS, P; WARDLAW, SA				GETTINS, P; WARDLAW, SA			NMR RELAXATION PROPERTIES OF SE-77-LABELED PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR MAGNETIC-RESONANCE; DEPENDENT GLUTATHIONE-PEROXIDASE; CHEMICAL-SHIFT; RAT PLASMA; SELENIUM; SELENOCYSTEINE; PURIFICATION	A Se-77-containing moiety has been attached to cysteine residues in bovine hemoglobin, reduced ribonuclease A, and glutathione by reaction with [Se-77]6,6'-diselenobis(3-nitrobenzoic acid). The resultant species contain Se-S linkages that have Se-77 NMR absorptions in the range range of 568-580 ppm. Spectra have been recorded at 4.7 and 9.7 tesla (T). For labeled hemoglobin a line width of 250 Hz is seen at 4.7 T and 1000 Hz at 9.4 T. This quadrupling of line width with doubling of observational field strength is consistent with exclusive relaxation by the chemical shift anisotropy (CSA) mechanism. These line widths are greater than expected for a molecule the size of hemoglobin and indicate some aggregation at the high concentrations used. Upon dissociation and partial unfolding of the hemoglobin subunits, the line widths of the selenium resonance decrease to 35 and 120 Hz at 4.7 and 9.4 T, respectively. The spin-lattice relaxation time (T1) for the dissociated hemoglobin at 9.4 T was found to be 220 ms. Together with a value of 377 ms for the spin-spin relaxation time (T2), determined from the line width, an estimate of the CSA was made. This gave a value of 890 ppm, which is in accord with other values for Se(II) linked only by single bonds. When this value for the CSA is used, together with the CSA contribution to the line width, in estimating a correlation time for seleno(3-nitrobenzoic acid) (SeNB)-labeled glutathione, a value of 4 x 10(-11) s is obtained. For SeNB-labeled denatured ribonuclease, four distinct resonances are resolvable at 4.7 T and five resonances at 9.4 T. From T1 values for these resonances and the value of 890 ppm for the CSA, an appropriate correlation time of 0.1 ns was determined, which should result in Se-77 resonances of 0.2-1.0 Hz at 4.7 and 9.4 T, respectively. Much greater apparent line widths are observed, which are attributed to microheterogeneity resulting from formation of inter- and intramolecular disulfide linkages. It is concluded that when there are no complications from protein aggregation or chemical exchange, the CSA values anticipated to exist in glutathione peroxidase or other selenoproteins should result in resonances with line widths in the range from 27 to 170 Hz, depending on field strength. These resonances should therefore be observable in the intact protein, if Se-77-enriched material is available.	VANDERBILT UNIV,MED CTR,SCH MED,CTR MOLEC TOXICOL,NASHVILLE,TN 37232	Vanderbilt University	GETTINS, P (corresponding author), VANDERBILT UNIV,MED CTR,SCH MED,DEPT BIOCHEM,NASHVILLE,TN 37232, USA.				NIGMS NIH HHS [GM39509] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039509] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMICONI G, 1971, EUR J BIOCHEM, V22, P321, DOI 10.1111/j.1432-1033.1971.tb01547.x; AVISSAR N, 1989, J BIOL CHEM, V264, P15850; AWASTHI YC, 1975, J BIOL CHEM, V250, P5144; BURK RF, 1982, ARCH BIOCHEM BIOPHYS, V213, P73, DOI 10.1016/0003-9861(82)90441-6; BURK RF, 1983, ANNU REV NUTR, V3, P53, DOI 10.1146/annurev.nu.03.070183.000413; CAMPBELL TW, 1945, J AM CHEM SOC, V67, P1965, DOI 10.1021/ja01227a029; DOWD D, 1988, MAGN RESON CHEM, V26, P1, DOI 10.1002/mrc.1260260102; FIELD EO, 1955, BIOCHEM J, V60, P655; FLOHE L, 1971, KLIN WOCHENSCHR, V49, P669, DOI 10.1007/BF01487101; GEIDROC DP, 1989, BIOCHEMISTRY-US, V28, P2410; GETTINS P, 1988, J BIOL CHEM, V263, P10208; KIRSHNER AG, 1964, BIOCHEMISTRY-US, V3, P291, DOI 10.1021/bi00891a002; KOMA A, 1972, SOLID STATE COMMUN, V10, P823, DOI 10.1016/0038-1098(72)90201-3; LEVY GC, 1975, J AM CHEM SOC, V97, P5031, DOI 10.1021/ja00850a057; LUTHRA NP, 1981, ANAL BIOCHEM, V117, P94, DOI 10.1016/0003-2697(81)90697-7; LUTHRA NP, 1982, J BIOL CHEM, V257, P1142; MADDIPATI KR, 1987, J BIOL CHEM, V262, P17398; McFarlane H.C.E., 1983, NMR NEWLY ACCESSIBLE, P275; MOTSENBOCKER MA, 1982, BIOCHIM BIOPHYS ACTA, V719, P147, DOI 10.1016/0304-4165(82)90318-X; MULLEN GP, 1986, BIOCHEMISTRY-US, V25, P5625, DOI 10.1021/bi00367a042; ODOM JD, 1979, J AM CHEM SOC, V101, P5815, DOI 10.1021/ja00513a058; PERKOFF GT, 1962, J BIOL CHEM, V237, P2820; RHEINBOLDT H, 1955, CHEM BER-RECL, V88, P666, DOI 10.1002/cber.19550880512; TOSSELL JA, 1988, J MAGN RESON, V80, P39, DOI 10.1016/0022-2364(88)90055-8; TOYODA H, 1989, BIOCHIM BIOPHYS ACTA, V1008, P301, DOI 10.1016/0167-4781(89)90020-1; WITTWER AJ, 1984, BIOCHEMISTRY-US, V23, P4650, DOI 10.1021/bi00315a021; WONG TC, 1984, J MAGN RESON, V57, P463, DOI 10.1016/0022-2364(84)90261-0; YANG JG, 1989, J NUTR, V119, P1010, DOI 10.1093/jn/119.7.1010; YANG JG, 1987, J BIOL CHEM, V262	29	22	22	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3422	3426						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995605				2022-12-25	WOS:A1991EY68200015
J	MALLICK, S; HARRIS, BG; COOK, PF				MALLICK, S; HARRIS, BG; COOK, PF			KINETIC MECHANISM OF NAD-MALIC ENZYME FROM ASCARIS-SUUM IN THE DIRECTION OF REDUCTIVE CARBOXYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE; PH	Initial velocity studies in the absence and presence of product and dead-end inhibitors suggest a steady-state random mechanism of malic enzyme in the direction of reductive carboxylation of pyruvate. For this quadreactant enzymatic reaction (Mn2+ is a pseudoreactant), initial velocity patterns were obtained under conditions in which two substrates were maintained at saturating concentrations while one reactant was varied at several fixed concentrations of the other. Data from the resulting reciprocal plots, analyzed in terms of a bireactant mechanism, are consistent with a sequential mechanism with an obligatory order of addition of metal prior to pyruvate. NAD is competitive against NADH whether pyruvate and CO2 are maintained at low or high concentrations, whereas it is noncompetitive against pyruvate and CO2. Thio-NADH, alpha-ketobutyrate, and nitrite were used as deadend analogs of NADH, pyruvate, and CO2, respectively. Thio-NADH is competitive against NADH, whereas it is noncompetitive against pyruvate and CO2, in accordance with a random mechanism. Alpha-ketobutyrate and nitrite gave noncompetitive inhibition against all substrates. The noncompetitive patterns observed for alpha-ketobutyrate versus pyruvate and nitrite versus CO2 suggest binding of the inhibitor to both the E.Mn.NADH and E.Mn.NAD complexes. Primary deuterium isotope effects are equal on all kinetic parameters, in agreement with the random mechanism, and suggest equal off-rates for NAD from E.Mn.NAD as well as pyruvate and NADH from E.Mn.NADH. pyruvate. Data are consistent with an overall symmetry in the malic enzyme reaction in the two reaction directions with a requirement for metal bound prior to pyruvate and malate.	TEXAS COLL OSTEOPATH MED,DEPT MICROBIOL & IMMUNOL,3500 CAMP BOWIE BLVD,FT WORTH,TX 76107; TEXAS COLL OSTEOPATH MED,DEPT BIOCHEM & MOLEC BIOL,FT WORTH,TX 76107	University of North Texas System; University of North Texas Health Science Center					NIAID NIH HHS [AI 24155] Funding Source: Medline; NIGMS NIH HHS [GM 36799] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036799] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN BL, 1981, MOL BIOCHEM PARASIT, V2, P367, DOI 10.1016/0166-6851(81)90088-8; CHEN CY, 1988, BIOCHEMISTRY-US, V27, P212, DOI 10.1021/bi00401a032; Cleland W W, 1979, Methods Enzymol, V63, P103; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104, DOI 10.1016/0926-6569(63)90211-6; KIICK DM, 1986, BIOCHEMISTRY-US, V25, P227, DOI 10.1021/bi00349a032; KIICK DM, 1984, BIOCHEMISTRY-US, V23, P5454, DOI 10.1021/bi00318a012; LANDSPERGER WJ, 1976, J BIOL CHEM, V251, P3599; LANDSPERGER WJ, 1978, J BIOL CHEM, V253, P1868; Martell A.E., 1979, CRITICAL STABILITY C; NUIRY II, 1985, BIOCHIM BIOPHYS ACTA, V829, P295, DOI 10.1016/0167-4838(85)90201-8; ORR GA, 1984, ANAL BIOCHEM, V142, P232, DOI 10.1016/0003-2697(84)90544-X; PARK SH, 1989, BIOCHEMISTRY-US, V28, P6334, DOI 10.1021/bi00441a027; PARK SH, 1984, BIOCHEMISTRY-US, V23, P5446, DOI 10.1021/bi00318a011; SCHIMERLIK MI, 1977, BIOCHEMISTRY-US, V16, P565, DOI 10.1021/bi00623a001; VIOLA RE, 1979, ANAL BIOCHEM, V96, P334, DOI 10.1016/0003-2697(79)90590-6; VIOLA RE, 1982, METHOD ENZYMOL, V87, P353	16	36	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2732	2738						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993653				2022-12-25	WOS:A1991EX60000012
J	AGARWAL, R; RAJASEKHARAN, KN; BURKE, M				AGARWAL, R; RAJASEKHARAN, KN; BURKE, M			IDENTIFICATION OF THE SITE OF PHOTOCROSS-LINKING FORMED IN THE ABSENCE OF MAGNESIUM NUCLEOTIDE FROM SH2 (CYS-697) IN MYOSIN SUBFRAGMENT-1 LABELED WITH 4'-MALEIMIDYLBENZOPHENONE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENERGY-TRANSFER MEASUREMENTS; ESSENTIAL SULFHYDRYL-GROUPS; GLYCINE-RICH LOOP; ADENOSINE-TRIPHOSPHATASE; CROSS-LINKING; SPATIAL PROXIMITY; ACTIVE-SITE; HEAVY-CHAIN; BINDING; THIOL	The site of photocross-linking between Cys-697 (SH2), prelabeled with 4'-[C-14]maleimidylbenzophenone, and the 50-kDa segment of myosin S1 on irradiation in the absence of nucleotide has been determined by isolation of the 20-50-kDa adduct and subsequent tryptic proteolysis. Isolation and partial sequencing of the radioactively labeled peptide indicate that the site of cross-linking is Arg-239. This result indicates that, in the absence of nucleotide, Arg-239 resides at about 1.0 nm form SH2 and, on the basis of the recent work of Sutoh and Hiratsuka (Sutoh, K. and Hiratsuka T. (1988) Biochemistry 27, 2964-2969) places Arg-239 at no more than 1.45 nm from either Lys-184 or Lys-189 of the nucleotide-binding "glycine-rich" loop prior to the binding of nucleotide.			AGARWAL, R (corresponding author), CASE WESTERN RESERVE UNIV,CASE INST TECHNOL,DEPT BIOL,CLEVELAND,OH 44106, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015319] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 15319] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AUDEMARD E, 1988, J MUSCLE RES CELL M, V9, P197, DOI 10.1007/BF01773891; BAILIN G, 1972, J BIOL CHEM, V247, P7815; BOTTS J, 1989, P NATL ACAD SCI USA, V86, P2204, DOI 10.1073/pnas.86.7.2204; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURKE M, 1990, FEBS LETT, V262, P185, DOI 10.1016/0014-5793(90)80185-L; BURKE M, 1977, BIOCHEMISTRY-US, V16, P5559, DOI 10.1021/bi00644a026; CHAEN S, 1989, P NATL ACAD SCI USA, V86, P1510, DOI 10.1073/pnas.86.5.1510; CHAUSSEPIED P, 1988, BIOCHEMISTRY-US, V27, P1778, DOI 10.1021/bi00405a059; CHAUSSEPIED P, 1986, P NATL ACAD SCI USA, V83, P2037, DOI 10.1073/pnas.83.7.2037; CREMO CR, 1989, J BIOL CHEM, V264, P6608; DALBEY RE, 1983, BIOCHEMISTRY-US, V22, P4696, DOI 10.1021/bi00289a014; DOSREMEDIOS CG, 1987, J MUSCLE RES CELL M, V8, P97, DOI 10.1007/BF01753986; DUKE J, 1976, P NATL ACAD SCI USA, V73, P302, DOI 10.1073/pnas.73.2.302; GARLAND F, 1988, J BIOL CHEM, V263, P11621; HIRATSUKA T, 1987, BIOCHEMISTRY-US, V26, P3168, DOI 10.1021/bi00385a034; HUSTON EE, 1988, BIOCHEMISTRY-US, V27, P8945, DOI 10.1021/bi00425a011; KEANE AM, 1990, NATURE, V344, P265, DOI 10.1038/344265a0; KISHINO A, 1988, NATURE, V334, P74, DOI 10.1038/334074a0; MORNET D, 1989, J MUSCLE RES CELL M, V10, P10, DOI 10.1007/BF01739853; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; PERKINS WJ, 1984, J BIOL CHEM, V259, P8786; RAJASEKHARAN KN, 1989, J BIOL CHEM, V264, P10810; REISLER E, 1974, BIOCHEMISTRY-US, V13, P2014, DOI 10.1021/bi00707a003; REISLER E, 1974, BIOCHEMISTRY-US, V13, P3837, DOI 10.1021/bi00716a001; SCHAUB MC, 1975, H-S Z PHYSIOL CHEM, V356, P325, DOI 10.1515/bchm2.1975.356.1.325; SUTOH K, 1988, BIOCHEMISTRY-US, V27, P2964, DOI 10.1021/bi00408a045; SUZUKI R, 1987, J BIOL CHEM, V262, P11410; SUZUKI R, 1990, J BIOL CHEM, V265, P4939; TAO T, 1981, BIOCHEMISTRY-US, V20, P5051, DOI 10.1021/bi00520a035; TITANI K, 1982, ANAL BIOCHEM, V123, P408, DOI 10.1016/0003-2697(82)90465-1; TONG SW, 1990, J BIOL CHEM, V265, P4893; TOYOSHIMA YY, 1987, NATURE, V328, P536, DOI 10.1038/328536a0; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WELLS JA, 1979, P NATL ACAD SCI USA, V76, P4966, DOI 10.1073/pnas.76.10.4966; WELLS JA, 1980, J BIOL CHEM, V255, P1598; YAMAGUCHI M, 1966, J BIOCHEM, V59, P24, DOI 10.1093/oxfordjournals.jbchem.a128254	36	8	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2272	2275						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989981				2022-12-25	WOS:A1991EV51500041
J	LLOUBES, R; GRANGERSCHNARR, M; LAZDUNSKI, C; SCHNARR, M				LLOUBES, R; GRANGERSCHNARR, M; LAZDUNSKI, C; SCHNARR, M			INTERACTION OF A REGULATORY PROTEIN WITH A DNA TARGET CONTAINING 2 OVERLAPPING BINDING-SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-TERMINAL DOMAIN; ESCHERICHIA-COLI K-12; LEXA REPRESSOR; NUCLEOTIDE-SEQUENCE; OPERATOR DNA; REGION; GENE; MUTAGENESIS; SPECIFICITY; MECHANISM	The LexA repressor from Escherichia coli regulates the transcription of about 20 different genes upon binding to single or multiple operators. In this work we study the interaction of LexA with the control region of the caa gene (coding for the bacterial toxin colicin A) that contains two operators (01 and 02) which overlap by at least 2 base pairs relevant for sequence specific DNA recognition. This arrangement raises the question of how the LexA molecules which bind to the central overlapping part of the two operators avoid steric clashes and further, of whether the interaction of LexA with the two operators is cooperative or not. To address these questions we have constructed two mutant operators (01+02- and 01-02+) for which the two most strongly conserved base pairs in each of the external operator half-sites have been mutated. Using methylation interference with the complex formation of LexA with the wild-type and these two mutant operators we could show: 1) that the two mutant operators behave symmetrically in that the methylation of one crucial guanine base in both operator half-sites interferes strongly with complex formation, 2) but that in the wild-type operator (containing four functional operator-half-sites) only the two external half-operators give rise to interference if this crucial guanine base is methylated, whereas methylation of the two equivalent guanine bases within the two central (over-lapping) operator half-sites does not lead to interference with the formation of a complex where both operators are occupied simultaneously. These data suggest that the centrally bound LexA molecules adopt a somewhat different binding mode than those bound to the external half-operators in order to avoid steric clashes and/or to optimize protein-protein contacts which are likely to be at the origin of the binding cooperatively that we could demonstrate by quantitative DNase I footprinting and gel retardation experiments. While the methylation interference experiments revealed a non-equivalence for the binding of externally and centrally bound LexA molecules, both methylation protection and hydroxyl radical foot-printing were unable to reveal this difference, suggesting that the difference between the two binding modes should be fairly subtle.	UNIV STRASBOURG 1,INSERM,INST BIOL MOLEC & CELLULAIRE,CNRS,UPR 6201,15 RUE RENE DESCARTES,F-67084 STRASBOURG,FRANCE; CTR BIOCHIM & BIOL MOLEC,F-13402 MARSEILLE,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg				LLOUBES, Roland/0000-0002-9520-1053				BATY D, 1987, P NATL ACAD SCI USA, V84, P1152, DOI 10.1073/pnas.84.5.1152; BERTRANDBURGGRAF E, 1987, J MOL BIOL, V193, P293, DOI 10.1016/0022-2836(87)90220-8; BRENT R, 1981, P NATL ACAD SCI-BIOL, V78, P4204, DOI 10.1073/pnas.78.7.4204; DAVIDSON BE, 1989, MOL MICROBIOL, V3, P1639, DOI 10.1111/j.1365-2958.1989.tb00149.x; EBINA Y, 1983, J BIOL CHEM, V258, P3258; GRANGERSCHNARR M, 1988, FEBS LETT, V231, P437, DOI 10.1016/0014-5793(88)80866-4; GRANGERSCHNARR M, 1986, FEBS LETT, V198, P61, DOI 10.1016/0014-5793(86)81185-1; GRANGERSCHNARR M, 1988, ANAL BIOCHEM, V174, P235, DOI 10.1016/0003-2697(88)90540-4; HENDRICKSON W, 1985, P NATL ACAD SCI USA, V82, P3129, DOI 10.1073/pnas.82.10.3129; HURSTEL S, 1990, BIOCHEMISTRY-US, V29, P1961, DOI 10.1021/bi00459a043; HURSTEL S, 1986, EMBO J, V5, P793, DOI 10.1002/j.1460-2075.1986.tb04283.x; HURSTEL S, 1988, EMBO J, V7, P269, DOI 10.1002/j.1460-2075.1988.tb02809.x; KRAMER B, 1984, CELL, V38, P879, DOI 10.1016/0092-8674(84)90283-6; KUMAMOTO AA, 1987, GENE DEV, V1, P556, DOI 10.1101/gad.1.6.556; LAMERICHS RMJN, 1989, P NATL ACAD SCI USA, V86, P6863, DOI 10.1073/pnas.86.18.6863; LITTLE JW, 1985, P NATL ACAD SCI USA, V82, P2301, DOI 10.1073/pnas.82.8.2301; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; LLOUBES R, 1988, J MOL BIOL, V204, P1049, DOI 10.1016/0022-2836(88)90062-9; LLOUBES R, 1986, NUCLEIC ACIDS RES, V14, P2621, DOI 10.1093/nar/14.6.2621; Maxam A M, 1980, Methods Enzymol, V65, P499; MORLON J, 1988, MOL GEN GENET, V211, P231, DOI 10.1007/BF00330599; MOSSING MC, 1985, J MOL BIOL, V186, P295, DOI 10.1016/0022-2836(85)90106-8; OTWINOWSKI Z, 1988, NATURE, V335, P321, DOI 10.1038/335321a0; PHILLIPS SEV, 1989, NATURE, V341, P711, DOI 10.1038/341711a0; SARAI A, 1989, P NATL ACAD SCI USA, V86, P6513, DOI 10.1073/pnas.86.17.6513; SCHNARR M, 1984, FEBS LETT, V171, P207, DOI 10.1016/0014-5793(84)80489-5; SCHNARR M, 1988, FEBS LETT, V234, P56, DOI 10.1016/0014-5793(88)81302-4; SCHNARR M, 1985, BIOCHEMISTRY-US, V24, P2812, DOI 10.1021/bi00332a032; SLILATY SN, 1987, P NATL ACAD SCI USA, V84, P3987, DOI 10.1073/pnas.84.12.3987; THLIVERIS A, 1989, THESIS U ARIZONA; WALKER GC, 1984, MICROBIOL REV, V48, P60, DOI 10.1128/MMBR.48.1.60-93.1984; WERTMAN KF, 1984, P NATL ACAD SCI-BIOL, V81, P3801, DOI 10.1073/pnas.81.12.3801; WERTMAN KF, 1985, J BACTERIOL, V163, P376, DOI 10.1128/JB.163.1.376-384.1985	33	27	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2303	2312						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989984				2022-12-25	WOS:A1991EV51500046
J	ZHANG, J; CORDEN, JL				ZHANG, J; CORDEN, JL			PHOSPHORYLATION CAUSES A CONFORMATIONAL CHANGE IN THE CARBOXYL-TERMINAL DOMAIN OF THE MOUSE RNA POLYMERASE-II LARGEST SUBUNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; REPEAT DOMAIN; TRANSCRIPTION; 5,6-DICHLORO-1-BETA-D-RIBOFURANOSYLBENZIMIDAZOLE; INITIATION; INVIVO	The carboxyl-terminal domain (CTD) of the largest subunit of eukaryotic RNA polymerase II can be phosphorylated by a p34cdc2/CDC28-containing CTD kinase. Phosphorylated serine (or threonine) is located at positions 2 and 5 in the repetitive heptapeptide consensus sequence Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7. We show here that phosphorylation of the mouse CTD retards its electrophoretic mobility in sodium dodecyl sulfate-polyacrylamide gels in a way similar to that observed for the II0 form of the largest subunit of RNA polymerase II phosphorylated in vivo. At the maximum level of phosphorylation by CTD kinase in vitro, there are 15-20 phosphates evenly distributed among the 52 heptapeptide repeats that comprise the mouse CTD. Gel filtration chromatography and sucrose gradient ultracentrifugation analyses indicate that phosphorylation induces a dramatic conformational change in the CTD with the phosphorylated form adopting a far more extended structure than the unphosphorylated CTD.	JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT MOLEC BIOL & GENET,BALTIMORE,MD 21205	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University								AHEARN JM, 1987, J BIOL CHEM, V262, P10695; ALLISON LA, 1988, MOL CELL BIOL, V8, P321, DOI 10.1128/MCB.8.1.321; ALLISON LA, 1985, CELL, V42, P599, DOI 10.1016/0092-8674(85)90117-5; BARTOLOMEI MS, 1988, MOL CELL BIOL, V8, P330, DOI 10.1128/MCB.8.1.330; CADENA DL, 1987, J BIOL CHEM, V262, P12468; Cantor C. R., 1980, BIOPHYSICAL CHEM 3, P1019; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; CISEK LJ, 1989, NATURE, V339, P679, DOI 10.1038/339679a0; CISEK LJ, 1990, IN PRESS METHODS ENZ; CORDEN JL, 1990, TRENDS BIOCHEM SCI, V15, P383, DOI 10.1016/0968-0004(90)90236-5; CORDEN JL, 1985, P NATL ACAD SCI USA, V82, P7924; DAHMUS ME, 1981, J BIOL CHEM, V256, P3319; GUILFOYLE TJ, 1989, PLANT CELL, V1, P827, DOI 10.1105/tpc.1.8.827; KIM WY, 1986, J BIOL CHEM, V261, P14219; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAYBOURN PJ, 1989, J BIOL CHEM, V264, P6693; LAYBOURN PJ, 1990, J BIOL CHEM, V265, P13165; LEE JM, 1989, P NATL ACAD SCI USA, V86, P3624, DOI 10.1073/pnas.86.10.3624; LI WB, 1989, NUCLEIC ACIDS RES, V17, P9621, DOI 10.1093/nar/17.23.9621; MATSUSHIMA N, 1990, PROTEINS, V7, P125, DOI 10.1002/prot.340070204; MORENO S, 1990, CELL, V61, P549, DOI 10.1016/0092-8674(90)90463-O; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; NONET M, 1987, CELL, V50, P909, DOI 10.1016/0092-8674(87)90517-4; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; PAYNE JM, 1989, J BIOL CHEM, V264, P19621; SIGLER PB, 1988, NATURE, V333, P210, DOI 10.1038/333210a0; STEVENS A, 1989, BIOCHEM BIOPH RES CO, V159, P508, DOI 10.1016/0006-291X(89)90022-3; SUZUKI M, 1990, NATURE, V344, P562, DOI 10.1038/344562a0; WOYCHIK H, 1990, TRENDS BIOCHEM SCI, V15, P347; ZANDOMENI R, 1986, J BIOL CHEM, V261, P3414; ZEHRING WA, 1988, P NATL ACAD SCI USA, V85, P3698, DOI 10.1073/pnas.85.11.3698	31	74	75	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2297	2302						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989983				2022-12-25	WOS:A1991EV51500045
J	SHEN, SH; CHRETIEN, P; BASTIEN, L; SLILATY, SN				SHEN, SH; CHRETIEN, P; BASTIEN, L; SLILATY, SN			PRIMARY SEQUENCE OF THE GLUCANASE GENE FROM OERSKOVIA-XANTHINEOLYTICA - EXPRESSION AND PURIFICATION OF THE ENZYME FROM ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIABLE YEAST-CELLS; ARTHROBACTER-LUTEUS; LYSIS; MUTAGENESIS; ZYMOLYASE; CLEAVAGE; CLONING	A 2.7-kilobase fragment of DNA from Oerskovia xanthineolytica containing the gene for a beta-1,3-glucanase has been isolated and its complete nucleotide sequence determined. The sequence was found to contain two large open reading frames. Purification of the mature native enzyme and subsequent amino-terminal sequencing defined the glucanase gene in one reading frame which potentially encodes a protein of 548 amino acids. We have expressed this glucanase gene in Escherichia coli under control of the lacUV5 promoter and found the product to be secreted into the periplasm as a mature enzyme of about the same molecular weight as that of the native protein. The recombinant enzyme was purified to near homogeneity by a single step of high performance liquid chromatography. The ability of the recombinant enzyme to digest beta-glucan substrates and to lyse viable yeast cells was found to be indistinguishable from that of the native protein. Deletion of the cysteine-rich carboxyl-terminal 117 amino acids of the enzyme, which also contain two duplicated segments, abolished the lytic activity but did not significantly affect the glucanase function of the protein. The possible involvement of this domain in interaction with the yeast cell wall is discussed.			SHEN, SH (corresponding author), NATL RES COUNCIL CANADA,BIOTECHNOL RES INST,MOLEC GENET SECT,6100 ROYALMT AVE,MONTREAL H4P 2R2,QUEBEC,CANADA.							[Anonymous], 1982, METABOLISM GENE EXPR; BEGUIN P, 1985, J BACTERIOL, V162, P102; DOI K, 1986, J BACTERIOL, V168, P1272, DOI 10.1128/jb.168.3.1272-1276.1986; DOI K, 1971, J BIOCHEM-TOKYO, V70, P711, DOI 10.1093/oxfordjournals.jbchem.a129686; DOI K, 1973, J BIOCHEM-TOKYO, V73, P667, DOI 10.1093/oxfordjournals.jbchem.a130127; DOI K, 1976, AGR BIOL CHEM TOKYO, V40, P1660; EY PL, 1986, METHOD ENZYMOL, V121, P497; FULLER F, 1982, GENE, V19, P43, DOI 10.1016/0378-1119(82)90187-1; HOLAN Z, 1980, FOLIA MICROBIOL, V25, P501, DOI 10.1007/BF02897218; HOLMES WM, 1983, CELL, V32, P1029; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P399; KANEKO T, 1973, AGR BIOL CHEM TOKYO, V37, P2295, DOI 10.1080/00021369.1973.10861005; KITAMURA K, 1982, AGR BIOL CHEM TOKYO, V46, P963, DOI 10.1080/00021369.1982.10865178; KITAMURA K, 1974, J GEN APPL MICROBIOL, V20, P323, DOI 10.2323/jgam.20.323; KITAMURA K, 1971, ARCH BIOCHEM BIOPHYS, V145, P402, DOI 10.1016/0003-9861(71)90053-1; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; Maniatis T., 1982, MOL CLONING; MANNERS DJ, 1973, BIOCHEM J, V135, P19, DOI 10.1042/bj1350019; MEADE HM, 1982, J BACTERIOL, V149, P114, DOI 10.1128/JB.149.1.114-122.1982; NOSSAL NG, 1966, J BIOL CHEM, V241, P3055; ROBERTS LM, 1985, J BIOL CHEM, V260, P5682; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCOTT JH, 1980, J BACTERIOL, V142, P414, DOI 10.1128/JB.142.2.414-423.1980; SHEN SH, 1990, GENE AMST, V84, P303; TANAKA H, 1965, J BACTERIOL, V89, P1570, DOI 10.1128/JB.89.6.1570-1580.1965; UHLEN M, 1984, J BIOL CHEM, V259, P1695; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683	30	92	99	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1058	1063						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985933				2022-12-25	WOS:A1991ET17700061
J	STEINMANN, B; BRUCKNER, P; SUPERTIFURGA, A				STEINMANN, B; BRUCKNER, P; SUPERTIFURGA, A			CYCLOSPORINE-A SLOWS COLLAGEN TRIPLE-HELIX FORMATION INVIVO - INDIRECT EVIDENCE FOR A PHYSIOLOGICAL-ROLE OF PEPTIDYL-PROLYL CIS-TRANS-ISOMERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN CYCLOPHILIN; I PROCOLLAGEN INCELLULO; OSTEOGENESIS IMPERFECTA; INTRACELLULAR DEGRADATION; GENE; ISOMERIZATION; TEMPERATURE; BONDS; CONFORMATION; FIBROBLASTS	Peptidyl-prolyl cis-trans-isomerase accelerates otherwise slow, rate-limiting isomerization steps during folding of proteins in vitro, but is not yet securely identified with any specific physiologic role. Peptidyl-prolyl cis-trans-isomerase and the cyclosporin A (CsA)-binding protein cyclophilin are identical, and peptidyl-prolyl cis-trans-isomerase activity is inhibited by the immunosuppressive drug CsA in vitro. To establish a possible physiologic role of peptidyl-prolyl cis-trans-isomerase, we have studied the folding of procollagen I in suspended chick embryo tendon fibroblasts. Folding of procollagen I is slowed by CsA: the time needed for 50% of the molecules to reach a completely helical confirmation is 8.5 min in the absence and 13.5 min in the presence of 5-mu-M CsA; and the calculated products, k x K, of the rate constant (k) and the equilibrium constant (K) of peptidyl-prolyl cis-trans isomerization are 2.10 and 1.30 s-1, respectively. In contrast, folding of purified collagen III in vitro is unaffected by CsA. In cultured human fibroblasts, CsA caused posttranslational overmodification (hydroxylation of lysine 32.1 versus 22.1%) and increased intracellular degradation (18.7 versus 12.5%), and hence decreased production (10.2 versus 13.2% of total protein synthesis) of collagens I and III, indicating that procollagen folding is slowed by CsA also in human fibroblasts. We conclude that peptidyl-prolyl cis-trans-isomerase (and hence cyclophilin) accelerates protein folding in living cells. Furthermore, the CsA-induced changes in collagen metabolism are reminiscent of those observed in several variants of osteogenesis imperfecta caused by structural abnormalities in the procollagen chains which impair helix formation.	UNIV ZURICH,DEPT PEDIAT,DIV METAB,CH-8032 ZURICH,SWITZERLAND; SWISS FED INST TECHNOL,DEPT BIOCHEM,CH-8092 ZURICH,SWITZERLAND	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich			Bruckner, Peter/F-4817-2019; superti-furga, andrea/E-9162-2015	Bruckner, Peter/0000-0002-5566-5611; superti-furga, andrea/0000-0002-3543-7531				ATKINSON K, 1982, LANCET, V2, P1165; BACHINGER HP, 1987, J BIOL CHEM, V262, P17144; BERG RA, 1980, P NATL ACAD SCI-BIOL, V77, P4746, DOI 10.1073/pnas.77.8.4746; BIENKOWSKI RS, 1990, BIOCHEM BIOPH RES CO, V168, P479, DOI 10.1016/0006-291X(90)92346-2; BONADIO J, 1985, NATURE, V316, P363, DOI 10.1038/316363a0; BRUCKNER P, 1981, EUR J BIOCHEM, V118, P607, DOI 10.1111/j.1432-1033.1981.tb05562.x; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; BRUCKNER P, 1984, EUR J BIOCHEM, V140, P391, DOI 10.1111/j.1432-1033.1984.tb08114.x; BYERS PH, 1989, METABOLIC BASIS INHE, P2805; DAVIS JM, 1989, J BIOL CHEM, V264, P8956; DRUGGE RJ, 1988, TRANSPL P, V20, P301; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; FISCHER G, 1989, NOVA ACTA LEOPOLDINA, V61, P35; FREEDMAN RB, 1989, NATURE, V337, P407, DOI 10.1038/337407a0; GREEN H, 1964, NATURE, V204, P347, DOI 10.1038/204347a0; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; KELLER H, 1985, COLLAGEN REL RES, V5, P245; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; KIVIRIKKO KI, 1984, EXTRACELLULAR MATRIX, P83; LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0; Miller EJ, 1984, EXTRACELLULAR MATRIX, P41; MOVSOWITZ C, 1988, ENDOCRINOLOGY, V123, P2571, DOI 10.1210/endo-123-5-2571; NIEDERBERGER W, 1983, TRANSPLANT P, V15, P2419; RAO VH, 1989, J BIOL CHEM, V264, P1793; SCHNEUWLY S, 1989, P NATL ACAD SCI USA, V86, P5390, DOI 10.1073/pnas.86.14.5390; SHEVACH EM, 1985, ANNU REV IMMUNOL, V3, P397; SHIEH BH, 1989, NATURE, V338, P67, DOI 10.1038/338067a0; STEINMANN B, 1981, FEBS LETT, V133, P142, DOI 10.1016/0014-5793(81)80491-7; STEINMANN B, 1984, J BIOL CHEM, V259, P1129; STEINMANN B, 1990, Matrix, V10, P248; STEINMANN B, 1990, EXPERIENTIA, V46, P40; SUPERTIFURGA A, 1988, BIOCHEM BIOPH RES CO, V150, P140, DOI 10.1016/0006-291X(88)90497-4; TAKAHASHI N, 1989, NATURE, V337, P473, DOI 10.1038/337473a0; TROPSCHUG M, 1989, NATURE, V342, P953, DOI 10.1038/342953a0; TROPSCHUG M, 1988, J BIOL CHEM, V263, P14433	37	287	292	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1299	1303						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985948				2022-12-25	WOS:A1991ET17700094
J	WAYS, K; RIDDLE, R; WAYS, M; COOK, P				WAYS, K; RIDDLE, R; WAYS, M; COOK, P			EFFECT OF PHORBOL ESTERS ON CYTOSOLIC PROTEIN-KINASE-C CONTENT AND ACTIVITY IN THE HUMAN MONOBLASTOID U937 CELL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED DIFFERENTIATION; MAMMALIAN-TISSUES; ACTIVATION; LINE; PHOSPHORYLATION; PROENZYME	12-O-Tetradecanoylphorbol-13-acetate (TPA) stimulates the human monoblastoid U937 cell to differentiate into a mature monocyte/macrophage-like cell. Since TPA may produce cellular responses by activating protein kinase C, the effects of TPA on kinase activity in the U937 cell were investigated. Brief exposures (less-than-or-equal-to 60 min) to TPA dramatically diminished protein kinase C-dependent phosphorylation of histone and endogenous substrates. However, using a peptide substrate corresponding to residues 720-737 of protein kinase C-epsilon, Ca2+-, phospholipid-, and diacylglycerol-dependent kinase activity was reduced only modestly after exposure to TPA. This phospholipid-dependent kinase activity coeluted on DEAE chromatography with protein kinase C. Examination of cytosolic protein kinase C content by Western blot analysis demonstrated a moderate decline in kinase content after TPA treatment. The decline was due primarily to loss of an 80-kDa species with preservation of a 76-kDa protein. The immunoreactive 76-kDa protein observed after TPA treatment comigrated on DEAE chromatography with the kinase activity phosphorylating the protein kinase C-epsilon peptide and had an elution profile similar to protein kinase C derived from untreated cells. Using antisera recognizing the catalytic and regulatory domains of the kinase, no evidence for proteolytic degradation of protein kinase C was observed. Although incubation of extracts from vehicle and TPA-treated cells inhibited the activity of partially purified protein kinase C, the degree of inhibition was similar in the two extracts. These findings suggest that TPA markedly diminishes protein kinase C-dependent phosphorylation of histone and endogenous substrates in part by altering kinase substrate specificity. These observations provide evidence for a novel post-translational process that can modulate protein kinase C-dependent phosphorylation.	E CAROLINA UNIV, SCH MED, DEPT MED, DIV INFECT DIS, GREENVILLE, NC 27858 USA	University of North Carolina; East Carolina University	WAYS, K (corresponding author), E CAROLINA UNIV, SCH MED, DEPT MED, DIV ENDOCRINOL, GREENVILLE, NC 27858 USA.				NATIONAL CANCER INSTITUTE [R29CA043823] Funding Source: NIH RePORTER; NCI NIH HHS [R29 CA 43823] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BALLESTER R, 1985, J BIOL CHEM, V260, P5194; BLACKSHEAR PJ, 1985, J BIOL CHEM, V260, P3304; BOINER C, 1989, J BIOL CHEM, V264, P13902; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; CHIDA K, 1986, J BIOL CHEM, V261, P3013; COLLINS MKL, 1982, J CELL PHYSIOL, V112, P42, DOI 10.1002/jcp.1041120108; INOUE M, 1977, J BIOL CHEM, V252, P7610; ISAKOV N, 1990, J BIOL CHEM, V265, P2091; KISHIMOTO A, 1983, J BIOL CHEM, V258, P1156; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lerner RA, 1981, P NATL ACAD SCI USA, V78, P3404; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NISHIZUKA Y, 1989, JAMA-J AM MED ASSOC, V262, P1826, DOI 10.1001/jama.262.13.1826; PARKER PJ, 1986, SCIENCE, V233, P853, DOI 10.1126/science.3755547; PHILLIPS MA, 1983, J BIOL CHEM, V258, P2875; RODRIGUEZPENA A, 1984, BIOCHEM BIOPH RES CO, V120, P1053, DOI 10.1016/S0006-291X(84)80213-2; SCHAAP D, 1989, FEBS LETT, V243, P351, DOI 10.1016/0014-5793(89)80160-7; SOLANKI V, 1981, P NATL ACAD SCI-BIOL, V78, P1722, DOI 10.1073/pnas.78.3.1722; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; TAKAI Y, 1977, J BIOL CHEM, V252, P7603; WAYS DK, 1986, CANCER RES, V46, P6049; WAYS DK, 1988, CANCER RES, V48, P5779; WAYS DK, 1987, CANCER RES, V47, P3344	23	37	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1258	1264						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985944				2022-12-25	WOS:A1991ET17700088
J	BERGHARD, A; GRADIN, K; TOFTGARD, R				BERGHARD, A; GRADIN, K; TOFTGARD, R			SERUM AND EXTRACELLULAR CALCIUM MODULATE INDUCTION OF CYTOCHROME-P-450IA1 IN HUMAN KERATINOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											BERGHARD, A (corresponding author), KAROLINSKA INST,NOVUM,CTR BIOTECHNOL,S-14152 HUDDINGE,SWEDEN.							BICKERS DR, 1984, J INVEST DERMATOL, V83, P51, DOI 10.1111/1523-1747.ep12261680; BOYCE ST, 1983, IN VITRO MODELS CANC; BRENNAN JK, 1975, IN VITRO CELL DEV B, V11, P354, DOI 10.1007/BF02616371; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DIGIOVANNI J, 1989, CANCER RES, V49, P5567; FISHER JM, 1990, J BIOL CHEM, V265, P9676; FLOYD EE, 1989, MOL CELL BIOL, V9, P4846, DOI 10.1128/MCB.9.11.4846; FUJISAWASEHARA A, 1987, NUCLEIC ACIDS RES, V15, P4179, DOI 10.1093/nar/15.10.4179; GUO JF, 1990, J INVEST DERMATOL, V94, P86, DOI 10.1111/1523-1747.ep12873939; HARRIS M, 1989, CANCER RES, V49, P4531; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; HINES RN, 1988, CARCINOGENESIS, V9, P1599, DOI 10.1093/carcin/9.9.1599; ISRAEL DI, 1985, J BIOL CHEM, V260, P5648; JAISWAL AK, 1985, SCIENCE, V228, P80, DOI 10.1126/science.3838385; LECHNER JF, 1982, IN VITRO CELL DEV B, V18, P633; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.biochem.56.1.945; PIECHACZYK M, 1984, NUCLEIC ACIDS RES, V12, P6951, DOI 10.1093/nar/12.18.6951; PILLAI S, 1990, J CELL PHYSIOL, V143, P294, DOI 10.1002/jcp.1041430213; PITTELKOW MR, 1986, J INVEST DERMATOL, V86, P410, DOI 10.1111/1523-1747.ep12285684; POHL RJ, 1984, DRUG METAB DISPOS, V12, P25; REINERS JJ, 1990, P NATL ACAD SCI USA, V87, P1825, DOI 10.1073/pnas.87.5.1825; SAFE SH, 1986, ANNU REV PHARMACOL, V26, P371, DOI 10.1146/annurev.pa.26.040186.002103; Sambrook J, 1989, MOL CLONING LABORATO; SUSKIND RR, 1985, SCAND J WORK ENV HEA, V11, P165, DOI 10.5271/sjweh.2240; WATSON AJ, 1988, CARCINOGENESIS, V9, P1581, DOI 10.1093/carcin/9.9.1581; WHITLOCK JP, 1989, DRUG METAB REV, V20, P839, DOI 10.3109/03602538909103583; WHITLOCK JP, 1990, ANNU REV PHARMACOL, V30, P251; WILLE JJ, 1984, J CELL PHYSIOL, V121, P31, DOI 10.1002/jcp.1041210106; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207	29	51	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1990	265	34					21086	21090						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EL020	1979076				2022-12-25	WOS:A1990EL02000059
J	KAMBADUR, R; LEWIS, M; CHANG, SL; FLAVIN, M				KAMBADUR, R; LEWIS, M; CHANG, SL; FLAVIN, M			CHARACTERIZATION OF PUTATIVE CYTOSKELETAL PROTEINS FROM A TRYPANOSOMATID AND THEIR COMPARATIVE BINDING TO MICROTUBULES AND SOLUBLE TUBULIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									NHLBI, CELL BIOL LAB, BETHESDA, MD 20892 USA; NIH, DIV RES SERV, BIOMED ENGN & INSTRUMENTAT BRANCH, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA								ANDREU JM, 1986, ANN NY ACAD SCI, V466, P626, DOI 10.1111/j.1749-6632.1986.tb38438.x; BRAMBLETT GT, 1989, CELL MOTIL CYTOSKEL, V13, P145, DOI 10.1002/cm.970130303; BRAMBLETT GT, 1987, P NATL ACAD SCI USA, V84, P3259, DOI 10.1073/pnas.84.10.3259; Gracy R W, 1975, Methods Enzymol, V41, P392; GRAIN J, 1986, INT REV CYTOL, V104, P153, DOI 10.1016/S0074-7696(08)61926-9; HUITOREL P, 1985, EUR J BIOCHEM, V150, P265, DOI 10.1111/j.1432-1033.1985.tb09016.x; KLOTZ IM, 1985, Q REV BIOPHYS, V18, P227, DOI 10.1017/S0033583500000354; KNOTT GD, 1979, COMPUT PROG BIOMED, V10, P271, DOI 10.1016/0010-468X(79)90075-8; MARKWELL MAK, 1982, ANAL BIOCHEM, V125, P427, DOI 10.1016/0003-2697(82)90025-2; OPPERDOES FR, 1984, J CELL BIOL, V98, P1178, DOI 10.1083/jcb.98.4.1178; OPPERDOES FR, 1988, TRENDS BIOCHEM SCI, V13, P255, DOI 10.1016/0968-0004(88)90158-2; SHERWIN T, 1989, CELL, V57, P211, DOI 10.1016/0092-8674(89)90959-8; WOODS A, 1989, J CELL SCI, V93, P491	13	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1990	265	34					20959	20965						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EL020	1979074				2022-12-25	WOS:A1990EL02000039
J	MOSS, J; STANLEY, SJ; LEVINE, RL				MOSS, J; STANLEY, SJ; LEVINE, RL			INACTIVATION OF BACTERIAL GLUTAMINE-SYNTHETASE BY ADP-RIBOSYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									NHLBI, BIOCHEM LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	MOSS, J (corresponding author), NHLBI, CELLULAR METAB LAB, BLDG 10, RM 5N307, BETHESDA, MD 20892 USA.		Levine, Rodney L/D-9885-2011					Aktories K, 1990, ADP RIBOSYLATING TOX, P79; ALMASSY RJ, 1986, NATURE, V323, P304, DOI 10.1038/323304a0; BURZIO LO, 1979, J BIOL CHEM, V254, P3029; CLIMENT I, 1989, ANAL BIOCHEM, V182, P226, DOI 10.1016/0003-2697(89)90584-8; COLANDUONI JA, 1985, BIOCHEM BIOPH RES CO, V126, P412, DOI 10.1016/0006-291X(85)90621-7; COLOMBO G, 1986, J BIOL CHEM, V261, P587; DIDSBURY J, 1989, J BIOL CHEM, V264, P16378; GODEAU F, 1984, ANAL BIOCHEM, V137, P287, DOI 10.1016/0003-2697(84)90087-3; HAYAISHI O, 1977, ANNU REV BIOCHEM, V46, P95, DOI 10.1146/annurev.bi.46.070177.000523; JONES BN, 1983, J CHROMATOGR, V266, P471, DOI 10.1016/S0021-9673(01)90918-5; KAWAICHI M, 1980, J BIOL CHEM, V255, P816; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE H, 1984, P NATL ACAD SCI-BIOL, V81, P2703, DOI 10.1073/pnas.81.9.2703; LEVINE RL, 1983, J BIOL CHEM, V258, P1828; LEVINE RL, 1982, BIOCHEMISTRY-US, V21, P2600, DOI 10.1021/bi00540a004; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MILLER RE, 1974, ARCH BIOCHEM BIOPHYS, V163, P155, DOI 10.1016/0003-9861(74)90465-2; MIWA M, 1979, P NATL ACAD SCI USA, V76, P595, DOI 10.1073/pnas.76.2.595; MOSS J, 1981, P NATL ACAD SCI-BIOL, V78, P4809, DOI 10.1073/pnas.78.8.4809; MOSS J, 1988, BIOCHEMISTRY-US, V27, P5819, DOI 10.1021/bi00415a063; MOSS J, 1977, J BIOL CHEM, V252, P2455; MOSS J, 1978, P NATL ACAD SCI USA, V75, P3621, DOI 10.1073/pnas.75.8.3621; MOSS J, 1980, J BIOL CHEM, V255, P5838; MOSS J, 1978, J CLIN INVEST, V62, P281, DOI 10.1172/JCI109127; MOSS J, 1988, ADV ENZYMOL RAMB, V61, P303; MOSS J, 1984, J BIOL CHEM, V259, P5100; MOSS J, 1985, P NATL ACAD SCI USA, V82, P5603, DOI 10.1073/pnas.82.17.5603; OGATA N, 1980, J BIOL CHEM, V255, P7610; OGATA N, 1980, J BIOL CHEM, V255, P7616; OKAZAKI H, 1980, BIOCHIMIE, V62, P147, DOI 10.1016/S0300-9084(80)80190-8; PAPPENHEIMER AM, 1977, ANNU REV BIOCHEM, V46, P69, DOI 10.1146/annurev.bi.46.070177.000441; PEKALA PH, 1983, CURR TOP CELL REGUL, V22, P1; POWERS SG, 1975, P NATL ACAD SCI USA, V72, P2616, DOI 10.1073/pnas.72.7.2616; RHEE SG, 1989, ADV ENZYMOLOGY RELAT, P37; RIQUELME PT, 1979, J BIOL CHEM, V254, P3018; SEKINE A, 1989, J BIOL CHEM, V264, P8602; Shapiro B., 1970, METHOD ENZYMOL, V17A, P910, DOI 10.1016/0076-6879(71)17305-3; SOMAN G, 1984, BIOCHEM BIOPH RES CO, V120, P973, DOI 10.1016/S0006-291X(84)80202-8; STADTMAN ER, 1979, ANAL BIOCHEM, V95, P275, DOI 10.1016/0003-2697(79)90217-3; TANIGAWA Y, 1984, J BIOL CHEM, V259, P2022; TANUMA S, 1989, BIOCHIM BIOPHYS ACTA, V1010, P246, DOI 10.1016/0167-4889(89)90168-7; TANUMA S, 1987, J BIOCHEM-TOKYO, V101, P821, DOI 10.1093/jb/101.3.821; TANUMA S, 1988, J BIOL CHEM, V263, P5485; TIEMEIER DC, 1972, J BIOL CHEM, V247, P2272; TSUCHIYA M, 1986, ANAL BIOCHEM, V157, P381, DOI 10.1016/0003-2697(86)90641-X; UI M, 1990, ADP RIBOSYLATING TOX, P45; VANDEKERCKHOVE J, 1988, J BIOL CHEM, V263, P696; VANDOP C, 1984, J BIOL CHEM, V259, P696; VANNESS BG, 1980, J BIOL CHEM, V255, P710; VAUGHAN M, 1981, CURR TOP CELL REGUL, V20, P205; WATKINS PA, 1984, J BIOL CHEM, V259, P1378; WEST RE, 1985, J BIOL CHEM, V260, P4428; WICK MJ, 1990, ADP RIBOSYLATING TOX, P31; WOOLFOLK CA, 1966, ARCH BIOCHEM BIOPHYS, V116, P177, DOI 10.1016/0003-9861(66)90026-9; YAMASHITA MM, 1989, J BIOL CHEM, V264, P17681; YOST DA, 1983, J BIOL CHEM, V258, P4926	56	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1990	265	34					21056	21060						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EL020	1979075				2022-12-25	WOS:A1990EL02000055
J	LUND, KA; OPRESKO, LK; STARBUCK, C; WALSH, BJ; WILEY, HS				LUND, KA; OPRESKO, LK; STARBUCK, C; WALSH, BJ; WILEY, HS			QUANTITATIVE-ANALYSIS OF THE ENDOCYTIC SYSTEM INVOLVED IN HORMONE-INDUCED RECEPTOR INTERNALIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV UTAH, SCH MED, DIV CELL BIOL & IMMUNOL, SALT LAKE CITY, UT 84132 USA; UNIV UTAH, SCH MED, DIV HEMATOL & ONCOL, SALT LAKE CITY, UT 84132 USA; UNIV UTAH, VET ADM MED CTR, SCH MED, SALT LAKE CITY, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA); Utah System of Higher Education; University of Utah				Wiley, Steven/0000-0003-0232-6867	NIDDK NIH HHS [DK33602] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033602] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON RGW, 1981, J CELL BIOL, V88, P441, DOI 10.1083/jcb.88.2.441; ANDERSON RGW, 1977, NATURE, V270, P695, DOI 10.1038/270695a0; ANDERSON RGW, 1977, CELL, V10, P351, DOI 10.1016/0092-8674(77)90022-8; ANDERSON RGW, 1982, J CELL BIOL, V93, P523, DOI 10.1083/jcb.93.3.523; BENVENISTE M, 1988, J CELL BIOL, V106, P1903, DOI 10.1083/jcb.106.6.1903; BERTICS PJ, 1988, J BIOL CHEM, V263, P3610; BROWN MS, 1983, CELL, V32, P663, DOI 10.1016/0092-8674(83)90052-1; CARPENTIER JL, 1981, J CELL BIOL, V91, P17, DOI 10.1083/jcb.91.1.17; CHEN WS, 1987, NATURE, V328, P820, DOI 10.1038/328820a0; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; DAVIS CG, 1987, J BIOL CHEM, V262, P4075; DEFIZE LHK, 1989, J CELL BIOL, V109, P2495, DOI 10.1083/jcb.109.5.2495; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; FELDMAN HA, 1972, ANAL BIOCHEM, V48, P317, DOI 10.1016/0003-2697(72)90084-X; GLENNEY JR, 1988, CELL, V52, P675, DOI 10.1016/0092-8674(88)90405-9; GLICKMAN JN, 1989, EMBO J, V8, P1041, DOI 10.1002/j.1460-2075.1989.tb03471.x; GOLDSTEIN B, 1981, CELL BIOPHYS, V3, P251, DOI 10.1007/BF02782627; GOLDSTEIN B, 1981, P NATL ACAD SCI-BIOL, V78, P5695, DOI 10.1073/pnas.78.9.5695; GOLDSTEIN JL, 1979, NATURE, V279, P679, DOI 10.1038/279679a0; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; GOUD B, 1985, J CELL BIOL, V100, P521, DOI 10.1083/jcb.100.2.521; HAIGLER HT, 1979, J CELL BIOL, V81, P382, DOI 10.1083/jcb.81.2.382; HONEGGER AM, 1987, CELL, V51, P199, DOI 10.1016/0092-8674(87)90147-4; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; HOPKINS CR, 1985, J CELL SCI, P173; IACOPETTA BJ, 1988, CELL, V54, P485, DOI 10.1016/0092-8674(88)90069-4; KIRCHHAUSEN T, 1989, P NATL ACAD SCI USA, V86, P2612, DOI 10.1073/pnas.86.8.2612; KLAUSNER RD, 1984, P NATL ACAD SCI-BIOL, V81, P3005, DOI 10.1073/pnas.81.10.3005; LAUFFENBURGER D, 1983, INT REV CYTOL, V84, P269, DOI 10.1016/S0074-7696(08)61020-7; LAZAROVITS J, 1988, CELL, V53, P743, DOI 10.1016/0092-8674(88)90092-X; LEHRMAN MA, 1985, CELL, V41, P735, DOI 10.1016/S0092-8674(85)80054-4; LIN CR, 1986, CELL, V44, P839, DOI 10.1016/0092-8674(86)90006-1; LIVNEH E, 1987, EMBO J, V6, P2669, DOI 10.1002/j.1460-2075.1987.tb02558.x; MAHAFFEY DT, 1989, J CELL BIOL, V108, P1615, DOI 10.1083/jcb.108.5.1615; MCCLAIN DA, 1987, J BIOL CHEM, V262, P14663; MCKANNA JA, 1979, P NATL ACAD SCI USA, V76, P5689, DOI 10.1073/pnas.76.11.5689; MCKINLEY DN, 1988, J CELL PHYSIOL, V136, P389, DOI 10.1002/jcp.1041360302; MERLINO GT, 1984, SCIENCE, V224, P417, DOI 10.1126/science.6200934; MOSTOV KE, 1986, CELL, V47, P359, DOI 10.1016/0092-8674(86)90592-1; OPRESKO LK, 1987, J BIOL CHEM, V262, P4116; OPRESKO LK, 1987, J BIOL CHEM, V262, P4109; PEARSE BMF, 1985, EMBO J, V4, P2457, DOI 10.1002/j.1460-2075.1985.tb03956.x; PEARSE BMF, 1987, ANNU REV BIOPHYS BIO, V16, P49, DOI 10.1146/annurev.bb.16.060187.000405; PRYWES R, 1986, EMBO J, V5, P2179, DOI 10.1002/j.1460-2075.1986.tb04482.x; ROTH TF, 1964, J CELL BIOL, V20, P313, DOI 10.1083/jcb.20.2.313; ROTHENBERGER S, 1987, CELL, V49, P423, DOI 10.1016/0092-8674(87)90295-9; SAVAGE CR, 1972, J BIOL CHEM, V247, P7609; SCHLESSINGER J, 1978, P NATL ACAD SCI USA, V75, P2659, DOI 10.1073/pnas.75.6.2659; STARBUCK C, 1990, CHEM ENG SCI, V45, P2367, DOI 10.1016/0009-2509(90)80117-W; STEIN BS, 1986, J BIOL CHEM, V261, P319; STEINMAN RM, 1976, J CELL BIOL, V68, P665, DOI 10.1083/jcb.68.3.665; WARD JH, 1982, J BIOL CHEM, V257, P317; WATTS C, 1985, J CELL BIOL, V100, P633, DOI 10.1083/jcb.100.2.633; WILEY HS, 1978, BIOL REPROD, V18, P762, DOI 10.1095/biolreprod18.5.762; WILEY HS, 1988, J CELL BIOL, V107, P801, DOI 10.1083/jcb.107.2.801; WILEY HS, 1982, J BIOL CHEM, V257, P4222; WILEY HS, 1981, CELL, V25, P433, DOI 10.1016/0092-8674(81)90061-1; WILEY HS, 1985, CURR TOP MEMBR TRANS, V24, P369; WILEY HS, 1979, ANAL BIOCHEM, V97, P145, DOI 10.1016/0003-2697(79)90338-5; WILLINGHAM MC, 1983, EXP CELL RES, V146, P163, DOI 10.1016/0014-4827(83)90334-8; [No title captured]	61	169	170	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	1990	265	26					15713	15723						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY964	1975591				2022-12-25	WOS:A1990DY96400059
J	FONG, YL; SODERLING, TR				FONG, YL; SODERLING, TR			STUDIES ON THE REGULATORY DOMAIN OF CA-2+ CALMODULIN-DEPENDENT PROTEIN KINASE-II - FUNCTIONAL ANALYSES OF ARGININE-283 USING SYNTHETIC INHIBITORY PEPTIDES AND SITE-DIRECTED MUTAGENESIS OF THE ALPHA-SUBUNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									VANDERBILT UNIV,MED CTR,SCH MED,DEPT MOLEC PHYSIOL & BIOPHYS,NASHVILLE,TN 37232	Vanderbilt University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041292] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 41292] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENNETT MK, 1983, J BIOL CHEM, V258, P2735; BENNETT MK, 1987, P NATL ACAD SCI USA, V84, P1794, DOI 10.1073/pnas.84.7.1794; BULLEIT RF, 1988, NEURON, V1, P63, DOI 10.1016/0896-6273(88)90210-3; COLBRAN RJ, 1989, BIOCHEM J, V258, P313, DOI 10.1042/bj2580313; COLBRAN RJ, 1988, J BIOL CHEM, V263, P18145; COLBRAN RJ, 1989, J BIOL CHEM, V264, P4800; COLBRAN RJ, 1990, IN PRESS CURR TOP CE, V31; FONG YL, 1989, J BIOL CHEM, V264, P16759; GOLDENRING JR, 1983, J BIOL CHEM, V258, P2632; GOPALAKRISHNA R, 1982, BIOCHEM BIOPH RES CO, V104, P830, DOI 10.1016/0006-291X(82)90712-4; HANLEY RM, 1989, NUCLEIC ACIDS RES, V17, P3992, DOI 10.1093/nar/17.10.3992; HANLEY RM, 1987, SCIENCE, V237, P293, DOI 10.1126/science.3037704; HANSON PI, 1989, NEURON, V3, P59, DOI 10.1016/0896-6273(89)90115-3; HASHIMOTO Y, 1987, ARCH BIOCHEM BIOPHYS, V252, P418, DOI 10.1016/0003-9861(87)90048-8; HASHIMOTO Y, 1987, J BIOL CHEM, V262, P8051; HODGES RS, 1975, ANAL BIOCHEM, V65, P241, DOI 10.1016/0003-2697(75)90509-6; KELLY PT, 1988, P NATL ACAD SCI USA, V85, P4991, DOI 10.1073/pnas.85.14.4991; Kennedy MB, 1987, CALCIUM CELL FUNCTIO, P61; KWIATKOWSKI AP, 1990, BIOCHEMISTRY-US, V29, P153, DOI 10.1021/bi00453a019; LEVINE H, 1987, EUR J BIOCHEM, V168, P481, DOI 10.1111/j.1432-1033.1987.tb13442.x; LICKTEIG R, 1988, J BIOL CHEM, V263, P19232; LIN CR, 1987, P NATL ACAD SCI USA, V84, P5962, DOI 10.1073/pnas.84.16.5962; LOU LL, 1989, J NEUROSCI, V9, P2020; MILLER SG, 1988, NEURON, V1, P593, DOI 10.1016/0896-6273(88)90109-2; NAIRN AC, 1985, ANNU REV BIOCHEM, V54, P931, DOI 10.1146/annurev.bi.54.070185.004435; OHTA Y, 1988, J BIOL CHEM, V263, P11540; PATTON B L, 1988, Society for Neuroscience Abstracts, V14, P107; PAYNE ME, 1988, J BIOL CHEM, V263, P7190; PEARSONRB, 1985, J BIOL CHEM, V260, P14471; ROSKOSKI R, 1985, METHOD ENZYMOL, V99, P3; SCHULMAN H, 1989, TRENDS BIOCHEM SCI, V14, P62, DOI 10.1016/0968-0004(89)90045-5; SCHWORER CM, 1988, J BIOL CHEM, V263, P13486; SODERLING TR, 1990, J BIOL CHEM, V265, P1823; SODERLING TR, 1986, C INSERM, V139, P141; THIEL G, 1988, P NATL ACAD SCI USA, V85, P6337, DOI 10.1073/pnas.85.17.6337; YAMAUCHI T, 1983, EUR J BIOCHEM, V132, P15, DOI 10.1111/j.1432-1033.1983.tb07319.x; YAMAUCHI T, 1985, BIOCHEM BIOPH RES CO, V129, P213, DOI 10.1016/0006-291X(85)91424-X; YAMAUCHI T, 1989, J BIOL CHEM, V264, P19108	38	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 5	1990	265	19					11091	11097						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL655	1972705				2022-12-25	WOS:A1990DL65500049
J	WALZ, FG; KITAREEWAN, S				WALZ, FG; KITAREEWAN, S			SPERMINE STABILIZATION OF FOLDED RIBONUCLEASE-T1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											WALZ, FG (corresponding author), KENT STATE UNIV,DEPT CHEM,KENT,OH 44242, USA.							ARNI R, 1988, J BIOL CHEM, V263, P15358; AXELSEN PH, 1989, BIOPHYS J, V56, P43, DOI 10.1016/S0006-3495(89)82651-7; CHEN LXQ, 1987, BIOPHYS J, V51, P865, DOI 10.1016/S0006-3495(87)83414-8; CREIGHTON TE, 1988, BIOESSAYS, V8, P57, DOI 10.1002/bies.950080204; EFTINK MR, 1987, BIOPHYS J, V52, P467, DOI 10.1016/S0006-3495(87)83235-6; FLOGEL R, 1988, FEBS LETT, V240, P29, DOI 10.1016/0014-5793(88)80334-X; HAVSTEEN BH, 1989, J THEOR BIOL, V140, P101, DOI 10.1016/S0022-5193(89)80032-3; HOFFMANN E, 1988, EUR J BIOCHEM, V177, P539, DOI 10.1111/j.1432-1033.1988.tb14406.x; IGARASHI K, 1975, BIOCHEM BIOPH RES CO, V67, P1070, DOI 10.1016/0006-291X(75)90783-4; IIDA S, 1969, BIOCHEMISTRY-US, V8, P3897, DOI 10.1021/bi00838a003; KOEPKE J, 1989, J MOL BIOL, V206, P475, DOI 10.1016/0022-2836(89)90495-6; KOSTREWA D, 1989, BIOCHEMISTRY-US, V28, P7592, DOI 10.1021/bi00445a014; LIN LN, 1988, BIOCHIM BIOPHYS ACTA, V956, P256, DOI 10.1016/0167-4838(88)90142-2; MACKERELL AD, 1988, BIOCHEMISTRY-US, V27, P4547, DOI 10.1021/bi00412a049; MITANI M, 1986, J BIOL CHEM, V261, P8824; MORGAN JE, 1989, BIOCHEMISTRY-US, V28, P5095, DOI 10.1021/bi00438a029; NAKAI C, 1977, BIOCHEMISTRY-US, V16, P5636, DOI 10.1021/bi00644a039; NISHIKAWA S, 1987, BIOCHEMISTRY-US, V26, P8620, DOI 10.1021/bi00400a019; NISHIKAWA S, 1988, BIOCHEM BIOPH RES CO, V150, P68, DOI 10.1016/0006-291X(88)90487-1; OOBATAKE M, 1979, J BIOCHEM-TOKYO, V86, P65; OOBATAKE M, 1979, J BIOCHEM, V86, P55; OSTERMAN HL, 1978, BIOCHEMISTRY-US, V17, P4124, DOI 10.1021/bi00613a003; PACE C N, 1975, Critical Reviews in Biochemistry, V3, P1, DOI 10.3109/10409237509102551; PACE CN, 1986, J MOL BIOL, V188, P477, DOI 10.1016/0022-2836(86)90169-5; PACE CN, 1988, BIOCHEMISTRY-US, V27, P3242, DOI 10.1021/bi00409a018; PACE CN, 1980, J BIOL CHEM, V255, P3862; PACE CN, 1989, BIOCHEMISTRY-US, V28, P2520, DOI 10.1021/bi00432a026; PACE CN, 1988, J BIOL CHEM, V263, P11820; PANTOLIANO MW, 1987, BIOCHEMISTRY-US, V26, P2077, DOI 10.1021/bi00382a002; PERRY LJ, 1984, SCIENCE, V226, P555, DOI 10.1126/science.6387910; PROVENCHER SW, 1983, PROGR SCI COMPUTING, V2, P304; RENARD M, 1973, BIOCHEMISTRY-US, V12, P4713, DOI 10.1021/bi00747a026; SCHELLMAN JA, 1976, BIOPOLYMERS, V15, P999, DOI 10.1002/bip.1976.360150513; SCHELLMAN JA, 1975, BIOPOLYMERS, V14, P999, DOI 10.1002/bip.1975.360140509; SCHWARZ FP, 1988, BIOCHEMISTRY-US, V27, P8429, DOI 10.1021/bi00422a020; SHIRLEY BA, 1989, J BIOL CHEM, V264, P11621; Sillen L, 1964, STABILITY CONSTANTS; SUGIO S, 1988, J BIOCHEM-TOKYO, V103, P354, DOI 10.1093/oxfordjournals.jbchem.a122274; TAKAHASHI K, 1988, J BIOCHEM-TOKYO, V104, P375, DOI 10.1093/oxfordjournals.jbchem.a122476; TAKAHASHI K, 1972, J BIOCHEM, V72, P1469, DOI 10.1093/oxfordjournals.jbchem.a130039; Takahashi K., 1982, ENZYMES, V15, p435 468; TAM SC, 1984, J CHEM SOC FARAD T 1, V80, P2255, DOI 10.1039/f19848002255; THOMSON JA, 1989, J BIOL CHEM, V264, P11614; Tiktopulo E I, 1974, Biophys Chem, V1, P349, DOI 10.1016/0301-4622(74)85004-0; VILLAFRANCA JE, 1987, BIOCHEMISTRY-US, V26, P2182, DOI 10.1021/bi00382a017; VOGEL RH, 1986, EMBL DA08 EUR MOL BI; WALZ FG, 1973, BIOCHEMISTRY-US, V12, P4846, DOI 10.1021/bi00748a006; WALZ FG, 1977, BIOCHEMISTRY-US, V16, P4568, DOI 10.1021/bi00640a005; WATKINS JB, 1978, SCIENCE, V199, P1084, DOI 10.1126/science.564548; WETZEL R, 1988, P NATL ACAD SCI USA, V85, P401, DOI 10.1073/pnas.85.2.401; WILSON HR, 1987, J CHEM SOC FARAD T 1, V83, P1885, DOI 10.1039/f19878301885	51	12	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1990	265	13					7127	7137						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB307	1970567				2022-12-25	WOS:A1990DB30700009
J	EELKEMA, JA; ODONNELL, MA; BROOKER, RJ				EELKEMA, JA; ODONNELL, MA; BROOKER, RJ			AN ANALYSIS OF LACTOSE PERMEASE SUGAR SPECIFICITY MUTATIONS WHICH ALSO AFFECT THE COUPLING BETWEEN PROTON AND LACTOSE TRANSPORT .2. 2ND SITE REVERTANTS OF THE THIODIGALACTOSIDE-DEPENDENT PROTON LEAK BY THE VAL177/ASN319 PERMEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; LAC PERMEASE; ENHANCED RECOGNITION; ACTIVE-TRANSPORT; DIRECTED MUTANTS; CARRIER PROTEIN; MALTOSE; MOVEMENTS; SYSTEM	The double mutant of the lactose permease containing Val177/Asn319 exhibits proton leakiness by two pathways (see Brooker, R. J. (1991) J. Biol Chem. 266, 4131-4138). One type of H+ leakiness involves the uncoupled influx of H+ (leak A pathway) while a second type involves the coupled influx of H+ and galactosides in conjunction with uncoupled galactoside efflux (leak B pathway). In the current study, 14 independent lactose permease mutants were isolated from the Val177/Asn319 parent which were resistant to thiodigalactoside growth inhibition but retained the ability to transport maltose. All of these mutants contained a third mutation (besides Val177/Asn319) at one of two sites. Eight of the mutants had Ile303 changed to Phe, while six of the mutants had Tyr236 changed to Asn or His. Each type of triple mutant was characterized with regard to sugar transport, H+ leakiness, and sugar specificity. Like the parental strain, all three types of triple mutant showed moderate rates of downhill lactose transport and were defective in the uphill accumulation of sugars. However, with regard to proton leakiness, the triple mutants fell into two distinct categories. The mutant containing Phe303 was generally less H+ leaky than the parent either via the leak A or leak B pathway. In contrast, the triple mutants containing position 236 substitutions (Asn or His) were actually more H+ leaky via the leak A pathway and exhibited similar H+ leakiness via the leak B pathway at high thiodigalactoside concentrations. The ability of the position 236 mutants to grow better than the parent in the presence of low concentrations of thiodigalactoside appears to be due to a decrease in affinity for this particular sugar rather than a generalized defect in H+ leakiness. Finally, the triple mutants showed a sugar specificity profile which was different from either the Val177/Asn319 parent, the single Val177 mutant, or the wild-type strain. These results are discussed with regard to the effects of mutations on both the sugar and H+ transport pathways.	UNIV MINNESOTA,DEPT GENET & CELL BIOL,ST PAUL,MN 55108; UNIV MINNESOTA,INST ADV STUDIES BIOL PROC TECHNOL,ST PAUL,MN 55108	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities					NIAID NIH HHS [AI24204] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024204] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BROOKER RJ, 1985, P NATL ACAD SCI USA, V82, P3959, DOI 10.1073/pnas.82.12.3959; BROOKER RJ, 1989, J BIOL CHEM, V264, P8135; BROOKER RJ, 1985, J BIOL CHEM, V260, P6181; BROOKER RJ, 1991, J BIOL CHEM, V266, P4131; CARRASCO N, 1989, BIOCHEMISTRY-US, V28, P2533, DOI 10.1021/bi00432a028; COHEN GN, 1956, ANN IN PASTEUR PARIS, V91, P683; COLLINS JC, 1989, J BIOL CHEM, V264, P14698; CRANE RK, 1977, REV PHYSIOL BIOCH P, V78, P99, DOI 10.1007/BFb0027722; CRANE RK, 1962, FED PROC, V21, P891; CRANE RK, 1960, PHYSIOL REV, V40, P784; EDDY AA, 1971, BIOCHEM J, V122, P701, DOI 10.1042/bj1220701; FOSTER DL, 1983, J BIOL CHEM, V258, P31; FRANCO PJ, 1989, J BIOL CHEM, V264, P15988; Gabrovec S, 1974, ARHEOLO KI VESTNIK, V25, P287; KOMOR E, 1973, FEBS LETT, V38, P16, DOI 10.1016/0014-5793(73)80501-0; MENICK DR, 1987, BIOCHEMISTRY-US, V26, P6638, DOI 10.1021/bi00395a012; Miller J. H., 1972, EXPT MOL GENETICS, P433; Mitchell P., 1963, BIOCHEM SOC SYMP, V22, P142; PUTTNER IB, 1989, BIOCHEMISTRY-US, V28, P2525, DOI 10.1021/bi00432a027; RICKENBERG HV, 1956, ANN I PASTEUR PARIS, V91, P829; SLAYMAN CL, 1974, P NATL ACAD SCI USA, V71, P1935, DOI 10.1073/pnas.71.5.1935; TEATHER RM, 1980, EUR J BIOCHEM, V108, P223, DOI 10.1111/j.1432-1033.1980.tb04715.x; WEST IC, 1970, BIOCHEM BIOPH RES CO, V41, P655, DOI 10.1016/0006-291X(70)90063-X; WILSON TH, 1983, CELL MEMBR METH REV, V1, P1; WILSON TH, 1980, ANN NY ACAD SCI, V341, P465	26	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4139	4144						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999408				2022-12-25	WOS:A1991FA69400021
J	SAKAKIBARA, H; WATANABE, M; HASE, T; SUGIYAMA, T				SAKAKIBARA, H; WATANABE, M; HASE, T; SUGIYAMA, T			MOLECULAR-CLONING AND CHARACTERIZATION OF COMPLEMENTARY-DNA ENCODING FOR FERREDOXIN-DEPENDENT GLUTAMATE SYNTHASE IN MAIZE LEAF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGHER-PLANTS; ROOT-NODULES; NITROGEN ASSIMILATION; ESCHERICHIA-COLI; LEAVES; PURIFICATION; NITRATE; ENZYMES; BARLEY; LIGHT	The sequence of ferredoxin-dependent glutamate synthase (EC 1.4.7.1) mRNA from maize has been determined. Complementary DNAs were isolated from a cDNA library of light-induced leaf poly(A)+ RNA constructed in an expression vector. An open reading frame beginning at an ATG codon at nucleotide 328 of the longest cDNA (5617-bases long) encoded 1616 amino acid residues. The amino terminus of the purified mature enzyme coincided with the cysteine residue at position 98 of the predicted sequence. This enzyme is homologous with the large subunit of Escherichia coli NADPH-dependent glutamate synthase having about 42% identical residues between the two proteins. The enzyme also contains a short region similar to a potential FMN-binding region of yeast flavocytochrome b2. The cDNA hybridizes to an RNA band about 5.5 kilobases whose steady-state level is markedly increased upon illumination of etiolated maize seedlings. Analysis of genomic DNA indicates the presence of a single-copy gene for ferredoxin glutamate synthase in maize.	NAGOYA UNIV,SCH AGR,DEPT AGR CHEM,NAGOYA 46401,JAPAN	Nagoya University			Hase, Toshiharu/H-9271-2013; Sakakibara, Hitoshi/A-6040-2010	Sakakibara, Hitoshi/0000-0001-5449-6492				ADMAN ET, 1973, J BIOL CHEM, V248, P3987; ANDERSON MP, 1989, PLANT PHYSIOL, V90, P351, DOI 10.1104/pp.90.1.351; BOTELLA JR, 1988, PLANT PHYSIOL, V87, P255, DOI 10.1104/pp.87.1.255; CAMPBELL WH, 1990, PLANT PHYSIOL, V92, P1, DOI 10.1104/pp.92.1.1; CHEN FL, 1988, PLANT PHYSIOL, V88, P1411, DOI 10.1104/pp.88.4.1411; COMMERE B, 1986, PLANT PHYSIOL, V80, P859, DOI 10.1104/pp.80.4.859; FUKUYAMA K, 1988, J MOL BIOL, V199, P183, DOI 10.1016/0022-2836(88)90388-9; FUKUYAMA K, 1980, NATURE, V286, P522, DOI 10.1038/286522a0; GOWRI G, 1989, PLANT PHYSIOL, V90, P792, DOI 10.1104/pp.90.3.792; HECHT U, 1988, PLANTA, V175, P130, DOI 10.1007/BF00402890; HEMMILA IA, 1978, BIOCHEM J, V173, P45, DOI 10.1042/bj1730045; HIRASAWA M, 1984, J BIOCHEM, V95, P983, DOI 10.1093/oxfordjournals.jbchem.a134725; KEEGSTRA K, 1989, ANNU REV PLANT PHYS, V40, P471, DOI 10.1146/annurev.pp.40.060189.002351; KELLY JL, 1986, J BIOL CHEM, V261, P348; KENDALL AC, 1986, PLANTA, V168, P316, DOI 10.1007/BF00392355; KIMATA Y, 1989, PLANT PHYSIOL, V89, P1193, DOI 10.1104/pp.89.4.1193; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAHNERS K, 1988, PLANT PHYSIOL, V88, P741, DOI 10.1104/pp.88.3.741; LEA PJ, 1974, NATURE, V251, P614, DOI 10.1038/251614a0; LEDERER F, 1985, EUR J BIOCHEM, V152, P419, DOI 10.1111/j.1432-1033.1985.tb09213.x; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; MANIATIS T., 1982, MOL CLONING LABORATO, P382; MARQUEZ AJ, 1988, PLANT PHYSIOL BIOCH, V26, P645; MATOH T, 1980, PLANT CELL PHYSIOL, V21, P1461, DOI 10.1093/pcp/21.8.1461; MATOH T, 1982, PLANTA, V154, P289, DOI 10.1007/BF00393905; MCGOOKIN R, 1984, METHOD MOL BIOL, V2, P113; Miflin B. J., 1980, The biochemistry of plants. A comprehensive treatise. Volume 5. Amino acids and derivatives., P169; MILLER RE, 1972, J BIOL CHEM, V247, P7407; OAKS A, 1985, ANNU REV PLANT PHYS, V36, P345; OLIVER G, 1987, GENE, V60, P1, DOI 10.1016/0378-1119(87)90207-1; RICHARDS E, 1987, CURRENT PROTOCOLS MO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SLATER RJ, 1984, METHOD MOL BIOL, V2, P117; SOMERVILLE CR, 1980, NATURE, V286, P257, DOI 10.1038/286257a0; SUZUKI A, 1982, PLANT PHYSIOL, V69, P848, DOI 10.1104/pp.69.4.848; SUZUKI A, 1987, PLANT PHYSIOL, V84, P578, DOI 10.1104/pp.84.3.578; SUZUKI A, 1984, FEBS LETT, V173, P204, DOI 10.1016/0014-5793(84)81047-9; SUZUKI A, 1985, PLANT PHYSIOL, V78, P374, DOI 10.1104/pp.78.2.374; SUZUKI A, 1984, PHYSIOL VEG, V22, P471; SUZUKI A, 1982, PLANT PHYSIOL, V70, P827, DOI 10.1104/pp.70.3.827; TAMURA G, 1980, PLANT SCI LETT, V19, P209, DOI 10.1016/0304-4211(80)90074-7; TROTTA PP, 1974, P NATL ACAD SCI USA, V71, P4607, DOI 10.1073/pnas.71.11.4607; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WALLSGROVE RM, 1982, PLANTA, V154, P473, DOI 10.1007/BF01267816; WALLSGROVE RM, 1977, J EXP BOT, V28, P588, DOI 10.1093/jxb/28.3.588; WATANABE M, 1985, SOIL SCI PLANT NUTR, V31, P573, DOI 10.1080/00380768.1985.10557465; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	47	131	133	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2028	2035						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989968				2022-12-25	WOS:A1991EV51500006
J	TURCOTTE, B; MEYER, ME; BELLARD, M; DRETZEN, G; GRONEMEYER, H; CHAMBON, P				TURCOTTE, B; MEYER, ME; BELLARD, M; DRETZEN, G; GRONEMEYER, H; CHAMBON, P			CONTROL OF TRANSCRIPTION OF THE CHICKEN PROGESTERONE-RECEPTOR GENE - INVITRO AND INVIVO STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER RIBONUCLEIC-ACID; HUMAN ESTROGEN-RECEPTOR; 5' FLANKING REGION; OVALBUMIN GENE; RESPONSIVE ELEMENT; CHROMATIN STRUCTURE; VITELLOGENIN GENE; ENHANCER FUNCTION; STEROID-HORMONES; BINDING DOMAINS	To study the promoter of the chicken progesterone receptor (cPR) gene and the relevance of several progestin-responsive elements therein, chimeric genes were constructed which contained the 5'-flanking region of the cPR gene linked to promoterless globin or chloramphenicol acetyltransferase sequences. Cell-specific initiation of transcription was observed in transiently transfected chicken embryo fibroblasts when using 876 base pairs of the cPR gene upstream region. Transcription from these reporter genes could be induced by progestins in the presence of cPR form A but not of form B. In keeping with these data, three in vitro progesterone receptor (PR)-binding sites were identified in the cPR promoter region by DNase I protection assays. However, in vivo, nuclear run-on transcription demonstrated that neither primary stimulation with progestins, nor treatment of secondarily estrogen-stimulated chicks with progestins, glucocorticoids, or androgens resulted in any significant change of cPR gene transcription in the oviduct, thus suggesting a cell- and/or development-specific role for these progestin-responsive elements. Although estrogen is known to increase PR levels in the chick oviduct, this effect does not involve stimulation of PR gene transcription, as demonstrated here by nuclear run-on experiments, the analysis of DNase I hypersensitive sites, and transient cotransfection studies. Since acute withdrawal from estrogen-stimulation markedly decreased the level of cPR mRNAs in chick oviduct when analyzed by Northern blotting, we conclude that estrogen-dependent stimulation of PR levels in the oviduct is a post-transcriptional process.	FAC MED STRASBOURG, INST CHIM BIOL,CNRS,GENET MOLEC EUCARYOTES LAB, INSERM,U184, 11 RUE HUMANN, F-67085 STRASBOURG, FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg			Gronemeyer, Hinrich/H-7002-2016; Gronemeyer, Hinrich/AAH-5575-2019; Gronemeyer, Hinrich/G-6240-2011	Gronemeyer, Hinrich/0000-0001-9454-2449; Gronemeyer, Hinrich/0000-0001-9454-2449; Gronemeyer, Hinrich/0000-0001-9454-2449				AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; Baulieu E.E., 1985, ANTIPROGESTIN STEROI, P1; BEATO M, 1989, J STEROID BIOCHEM, V32, P737, DOI 10.1016/0022-4731(89)90521-9; BECKER P, 1984, EMBO J, V3, P2015, DOI 10.1002/j.1460-2075.1984.tb02084.x; BELLARD M, 1986, EMBO J, V5, P567, DOI 10.1002/j.1460-2075.1986.tb04248.x; BOCQUEL MT, 1989, NUCLEIC ACIDS RES, V17, P2581, DOI 10.1093/nar/17.7.2581; BREATHNACH R, 1983, NUCLEIC ACIDS RES, V11, P7119, DOI 10.1093/nar/11.20.7119; BURCH JBE, 1983, CELL, V33, P65, DOI 10.1016/0092-8674(83)90335-5; BURCH JBE, 1988, MOL CELL BIOL, V8, P1123, DOI 10.1128/MCB.8.3.1123; COMPERE SJ, 1981, J BIOL CHEM, V256, P6341; CONNEELY OM, 1987, MOL ENDOCRINOL, V1, P517, DOI 10.1210/mend-1-8-517; DEVILLIERS J, 1981, NUCLEIC ACIDS RES, V9, P6251, DOI 10.1093/nar/9.23.6251; DIERICH A, 1987, EMBO J, V6, P2305, DOI 10.1002/j.1460-2075.1987.tb02505.x; DYNAN WS, 1986, TRENDS GENET, V2, P196, DOI 10.1016/0168-9525(86)90226-X; EUL J, 1989, EMBO J, V8, P83, DOI 10.1002/j.1460-2075.1989.tb03351.x; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GINZBURG I, 1980, NUCLEIC ACIDS RES, V8, P3553, DOI 10.1093/nar/8.16.3553; GREEN S, 1988, TRENDS GENET, V4, P309, DOI 10.1016/0168-9525(88)90108-4; GRONEMEYER H, 1987, EMBO J, V6, P3985, DOI 10.1002/j.1460-2075.1987.tb02741.x; HAGER LJ, 1980, J BIOL CHEM, V255, P7796; HAM J, 1988, NUCLEIC ACIDS RES, V16, P5263, DOI 10.1093/nar/16.12.5263; HEILIG R, 1982, NUCLEIC ACIDS RES, V10, P4363, DOI 10.1093/nar/10.14.4363; JELTSCH JM, 1990, J BIOL CHEM, V265, P3967; KASTNER P, 1990, J BIOL CHEM, V265, P12163; KAYE JS, 1986, EMBO J, V5, P277, DOI 10.1002/j.1460-2075.1986.tb04210.x; KLEINHITPASS L, 1986, CELL, V46, P1053, DOI 10.1016/0092-8674(86)90705-1; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; LEMEUR M, 1981, CELL, V23, P561, DOI 10.1016/0092-8674(81)90152-5; LOOSFELT H, 1984, J BIOL CHEM, V259, P4196; Maniatis T., 1982, MOL CLONING; MARTINEZ E, 1987, EMBO J, V6, P3719, DOI 10.1002/j.1460-2075.1987.tb02706.x; Maxam A M, 1980, Methods Enzymol, V65, P499; MCKNIGHT GS, 1979, J BIOL CHEM, V254, P9050; MESTER J, 1977, EUR J BIOCHEM, V72, P405, DOI 10.1111/j.1432-1033.1977.tb11265.x; MEYER ME, 1989, CELL, V57, P433, DOI 10.1016/0092-8674(89)90918-5; MEYER ME, 1990, EMBO J, V9, P3923, DOI 10.1002/j.1460-2075.1990.tb07613.x; MILGROM E, 1973, J BIOL CHEM, V248, P6366; MOEN RC, 1980, DEV BIOL, V78, P450, DOI 10.1016/0012-1606(80)90346-2; NARDULLI AM, 1988, ENDOCRINOLOGY, V122, P935, DOI 10.1210/endo-122-3-935; NUNEZ AM, 1989, EMBO J, V8, P823, DOI 10.1002/j.1460-2075.1989.tb03443.x; OHARE K, 1979, NUCLEIC ACIDS RES, V7, P321, DOI 10.1093/nar/7.2.321; PALMITER RD, 1974, P NATL ACAD SCI USA, V71, P2357, DOI 10.1073/pnas.71.6.2357; PALMITER RD, 1977, COLD SPRING HARB SYM, V42, P639, DOI 10.1101/SQB.1978.042.01.066; READ LD, 1988, MOL ENDOCRINOL, V2, P263, DOI 10.1210/mend-2-3-263; SCHIMKE RT, 1973, KAROLINSKA S RES MET, V6, P357; SCHMID W, 1989, EMBO J, V8, P2257, DOI 10.1002/j.1460-2075.1989.tb08350.x; SHEPHERD JH, 1980, J CELL BIOL, V87, P142, DOI 10.1083/jcb.87.1.142; SHERMAN MR, 1970, J BIOL CHEM, V245, P6085; SORIANO P, 1982, EMBO J, V1, P579, DOI 10.1002/j.1460-2075.1982.tb01211.x; TOFT DO, 1972, ENDOCRINOLOGY, V90, P1041, DOI 10.1210/endo-90-4-1041; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; TORA L, 1988, NATURE, V333, P185, DOI 10.1038/333185a0; TORA L, 1989, EMBO J, V8, P1981, DOI 10.1002/j.1460-2075.1989.tb03604.x; TURCOTTE B, 1986, NUCLEIC ACIDS RES, V14, P9827, DOI 10.1093/nar/14.24.9827; WEBSTER NJG, 1988, CELL, V54, P199, DOI 10.1016/0092-8674(88)90552-1; WEI LL, 1988, MOL ENDOCRINOL, V2, P62, DOI 10.1210/mend-2-1-62; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YLIKOMI T, 1984, J STEROID BIOCHEM, V20, P445, DOI 10.1016/0022-4731(84)90251-6; ZARET KS, 1984, CELL, V38, P29, DOI 10.1016/0092-8674(84)90523-3; ZENKE M, 1986, EMBO J, V5, P387, DOI 10.1002/j.1460-2075.1986.tb04224.x	62	35	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2582	2589						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1990008				2022-12-25	WOS:A1991EV51500087
J	STOVER, P; SCHIRCH, V				STOVER, P; SCHIRCH, V			5-FORMYLTETRAHYDROFOLATE POLYGLUTAMATES ARE SLOW TIGHT-BINDING INHIBITORS OF SERINE HYDROXYMETHYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT LIVER; 10-FORMYLTETRAHYDROFOLATE SYNTHETASE; ENZYME; TRANSHYDROXYMETHYLASE; TETRAHYDROFOLATE; PURIFICATION; TETRAHYDROPTEROYLPOLYGLUTAMATES; COOPERATIVITY; CONVERSION; REDUCTASE	The interaction of the mono- and triglutamate forms of 5-methyltetrahydrofolate and 5-formyltetrahydrofolate with serine hydroxymethyltransferase were determined by several methods. These methods included: determining dissociation constants by observing the absorbance at 502 nm of a ternary complex of the enzyme, glycine, and the folate compounds; determining inhibition constants from steady-state reactions; and determining the rate of formation and breakdown of the enzyme inhibitor complex by rapid reaction kinetics. Studies of the dissociation and inhibitor constants showed that both 5-methyltetrahydrofolate and 5-formyltetrahydrofolate have essentially the same affinity for the enzyme-glycine binary complex. However, rapid reaction and steady-state kinetic studies showed that the triglutamate form of 5-formyltetrahydrofolate both binds and is released much more slowly from the enzyme-glycine binary complex, compared with the triglutamate form of 5-methyltetrahydrofolate. The results also showed that only one rotamer of 5-formyltetrahydrofolate binds at the active site of serine hydroxymethyltransferase. The results are discussed in terms of the possible role of 5-formyltetrahydrofolate polyglutamates in regulation of one-carbon metabolism.	VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT BIOCHEM & MOLEC BIOPHYS, RICHMOND, VA 23298 USA	Virginia Commonwealth University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028143] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 28143] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BIRDSALL B, 1981, BIOCHEMISTRY-US, V20, P7186, DOI 10.1021/bi00528a021; BLAKELY RL, 1984, CHEM BIOCH FOLATES, V1, P80; CHEN MS, 1973, J BIOL CHEM, V248, P7979; FEENEY J, 1980, J CHEM SOC PERK T 2, P176, DOI 10.1039/p29800000176; FRIEDEN C, 1980, BIOCHEMISTRY-US, V19, P5303, DOI 10.1021/bi00564a024; GAVILANES F, 1982, J BIOL CHEM, V257, P1431; HOPKINS S, 1984, J BIOL CHEM, V259, P5618; HORNE DW, 1989, ARCH BIOCHEM BIOPHYS, V270, P729, DOI 10.1016/0003-9861(89)90556-0; JENCKS DA, 1987, J BIOL CHEM, V262, P2485; KVALNESKRICK K, 1987, BIOCHEMISTRY-US, V26, P7391, DOI 10.1021/bi00397a029; LEE HK, 1985, J PHARM SCI, V74, P273, DOI 10.1002/jps.2600740310; MATTHEWS RG, 1982, BIOCHEMISTRY-US, V21, P1230, DOI 10.1021/bi00535a019; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; POE M, 1980, BIOCHEMISTRY-US, V19, P4576, DOI 10.1021/bi00561a006; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHIRCH L, 1977, BIOCHEMISTRY-US, V16, P410, DOI 10.1021/bi00622a011; SCHIRCH L, 1981, J BIOL CHEM, V256, P6245; SCHIRCH L, 1980, J BIOL CHEM, V255, P7801; SCHIRCH L, 1982, ADV ENZYMOL RAMB, V53, P83; SCHIRCH L, 1978, ARCH BIOCHEM BIOPHYS, V189, P283, DOI 10.1016/0003-9861(78)90214-X; SCHIRCH L, 1975, J BIOL CHEM, V250, P1939; SCHIRCH LV, 1967, BIOCHEMISTRY-US, V6, P253, DOI 10.1021/bi00853a039; SCHIRCH V, 1985, J BACTERIOL, V163, P1; SEGAL IH, 1975, ENZYME KINETICS, P109; SHOSTAK K, 1988, BIOCHEMISTRY-US, V27, P8007, DOI 10.1021/bi00421a006; STOVER P, 1990, J BIOL CHEM, V265, P14227; STRONG W, 1987, J BIOL CHEM, V262, P12519; STRONG WB, 1989, BIOCHEMISTRY-US, V28, P9430, DOI 10.1021/bi00450a028; VILLAR E, 1985, J BIOL CHEM, V260, P2245; WITTWER AJ, 1981, J BIOL CHEM, V256, P4102	30	106	108	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1543	1550						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1988436				2022-12-25	WOS:A1991EU49700031
J	PRATT, RD; FERREIRA, GC; PEDERSEN, PL				PRATT, RD; FERREIRA, GC; PEDERSEN, PL			MITOCHONDRIAL PHOSPHATE-TRANSPORT - IMPORT OF THE H+/PI SYMPORTER AND ROLE OF THE PRESEQUENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-ATP CARRIER; PROTEIN IMPORT; UNCOUPLING PROTEIN; INNER MEMBRANE; CLEAVAGE; SEQUENCE; BINDING; MATRIX	The rat liver mitochondrial phosphate transporter contains a 44-amino acid presequence. The role of this presequence is not clear since the ADP/ATP carrier and the brown fat uncoupling protein, related members of a family of inner membrane anion transporters, lack a presequence and contain targeting information within the mature protein. Here, we present evidence that the rat liver mitochondrial phosphate transporter can be synthesized in vitro, imported into mitochondria, and processed to a protein of M(r) 33,000. Import requires the membrane potential and external nucleotide triphosphate. The presequence inserts into the outer mitochondrial membrane, and import proceeds via a process similar to other proteins destined for the inner membrane or matrix. A mutant phosphate transporter lacking 35 amino acids at the NH2 terminus of the presequence has little capacity for mitochondrial import. The rat liver phosphate transporter is also imported and processed by rat kidney mitochondria and by mitochondria from the yeast Saccharomyces cerevisiae. A site-directed mutation of the N-ethyl-maleimide reactive cysteine 41 does not affect import or processing. The results presented show that optimal import of the mitochondrial phosphate transporter, unlike the ADP/ATP carrier and the brown fat uncoupling protein, is dependent on a presequence. As these carriers are believed to have evolved from a single gene, it seems likely that the H+/P(i) carrier, known to be present in prokaryotes, appeared first and that subsequent evolutionary events leading to the other anion carriers eliminated the presequence.	JOHNS HOPKINS UNIV,SCH MED,DEPT BIOL CHEM,MOLEC & CELLULAR BIOENERGET LAB,725 N WOLFE ST,BALTIMORE,MD 21205	Johns Hopkins University			Ferreira, Gloria C/A-4709-2012	Ferreira, Gloria C/0000-0001-9279-2217	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [K12AM001298] Funding Source: NIH RePORTER; NIADDK NIH HHS [K12-AM01298] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADRIAN GS, 1986, MOL CELL BIOL, V6, P626, DOI 10.1128/MCB.6.2.626; AQUILA H, 1987, FEBS LETT, V212, P1, DOI 10.1016/0014-5793(87)81546-6; CHEN WJ, 1987, CELL, V49, P651, DOI 10.1016/0092-8674(87)90541-1; DAUM G, 1982, J BIOL CHEM, V257, P3028; DOUGLAS MG, 1986, MICROBIOL REV, V50, P166, DOI 10.1128/MMBR.50.2.166-178.1986; FERREIRA GC, 1989, J BIOL CHEM, V264, P15628; GLASER SM, 1990, MOL CELL BIOL, V10, P1873, DOI 10.1128/MCB.10.5.1873; HARTL FU, 1990, SCIENCE, V247, P930, DOI 10.1126/science.2406905; HARTL FU, 1989, BIOCHIM BIOPHYS ACTA, V988, P1, DOI 10.1016/0304-4157(89)90002-6; JACOBS EE, 1956, J BIOL CHEM, V223, P147; KAPLAN RS, 1986, J BIOL CHEM, V261, P2767; KOLBE HVJ, 1985, J BIOL CHEM, V260, P5899; KRAMER R, 1989, BIOCHIM BIOPHYS ACTA, V974, P1, DOI 10.1016/S0005-2728(89)80160-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIU XQ, 1988, J CELL BIOL, V107, P503, DOI 10.1083/jcb.107.2.503; Pedersen P L, 1978, Methods Cell Biol, V20, P411, DOI 10.1016/S0091-679X(08)62030-0; PFANNER N, 1987, EMBO J, V6, P3449, DOI 10.1002/j.1460-2075.1987.tb02668.x; PFANNER N, 1987, J BIOL CHEM, V262, P7528; PFANNER N, 1988, EUR J BIOCHEM, V175, P205, DOI 10.1111/j.1432-1033.1988.tb14185.x; RUNSWICK MJ, 1987, EMBO J, V6, P1367, DOI 10.1002/j.1460-2075.1987.tb02377.x; Sambrook J, 1989, MOL CLONING LABORATO; SCHMIDT B, 1984, EUR J BIOCHEM, V144, P581, DOI 10.1111/j.1432-1033.1984.tb08505.x; SMAGULA CS, 1988, J CELL BIOCHEM, V36, P323, DOI 10.1002/jcb.240360402; SOLLNER T, 1989, CELL, V59, P1061, DOI 10.1016/0092-8674(89)90762-9; STUART RA, 1990, CELL, V60, P31, DOI 10.1016/0092-8674(90)90713-O	25	28	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1276	1280						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985946				2022-12-25	WOS:A1991ET17700091
J	GASSMANN, M; THOMMES, P; WEISER, T; HUBSCHER, U				GASSMANN, M; THOMMES, P; WEISER, T; HUBSCHER, U			EFFICIENT PRODUCTION OF CHICKEN EGG-YOLK ANTIBODIES AGAINST A CONSERVED MAMMALIAN PROTEIN	FASEB JOURNAL			English	Article									UNIV ZURICH, DEPT PHARMACOL & BIOCHEM, CH-8057 ZURICH, SWITZERLAND	University of Zurich								ALTSCHUH D, 1984, J IMMUNOL METHODS, V69, P1, DOI 10.1016/0022-1759(84)90270-9; ANKERSTROM B, 1985, J IMMUNOL, V135, P2589; BADE H, 1984, J IMMUNOL METHODS, V72, P421, DOI 10.1016/0022-1759(84)90010-3; BAUWENS RM, 1987, CLIN CHIM ACTA, V170, P37, DOI 10.1016/0009-8981(87)90381-0; BURGER D, 1985, THROMB RES, V40, P283, DOI 10.1016/0049-3848(85)90340-8; BURGERS PMJ, 1988, NUCLEIC ACIDS RES, V16, P6297, DOI 10.1093/nar/16.14.6297; BURGERS PMJ, 1989, PROG NUCLEIC ACID RE, V37, P235; CARROLL SB, 1983, J BIOL CHEM, V258, P24; FERTEL R, 1981, BIOCHEM BIOPH RES CO, V102, P1028, DOI 10.1016/0006-291X(81)91641-7; FRENCH VI, 1970, IMMUNOLOGY, V18, P645; GOTTSTEIN B, 1985, Z PARASITENKD, V71, P273, DOI 10.1007/BF00926279; HASSL A, 1988, J IMMUNOL METHODS, V110, P225, DOI 10.1016/0022-1759(88)90107-X; KUHLMANN R, 1988, J VET MED B, V35, P610; LESLIE GA, 1969, J EXP MED, V130, P1337, DOI 10.1084/jem.130.6.1337; LOSCH U, 1986, J VET MED B, V33, P609; PATTERSON R, 1962, J GEN PHYSIOL, V45, P501, DOI 10.1085/jgp.45.3.501; POLSON A, 1980, IMMUNOL COMMUN, V9, P495, DOI 10.3109/08820138009066011; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; PRELICH G, 1987, NATURE, V326, P471, DOI 10.1038/326471a0; RICKE SC, 1988, APPL ENVIRON MICROB, V54, P596, DOI 10.1128/AEM.54.2.596-599.1988; ROSE ME, 1974, EUR J IMMUNOL, V4, P521, DOI 10.1002/eji.1830040715; SONG CS, 1985, J IMMUNOL, V135, P3354; SPADARI S, 1989, MUTAT RES, V219, P147, DOI 10.1016/0921-8734(89)90009-X; TAM LQ, 1975, P SOC EXP BIOL MED, V150, P340; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VIEIRA JGH, 1984, J IMMUNOASSAY, V5, P121, DOI 10.1080/01971528408063002; YOLKEN RH, 1988, PEDIATRICS, V81, P291	27	309	328	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	1990	4	8					2528	2532		10.1096/fasebj.4.8.1970792	http://dx.doi.org/10.1096/fasebj.4.8.1970792			5	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE393	1970792				2022-12-25	WOS:A1990DE39300014
J	LANG, F; FRIEDRICH, F; KAHN, E; WOLL, E; HAMMERER, M; WALDEGGER, S; MALY, K; GRUNICKE, H				LANG, F; FRIEDRICH, F; KAHN, E; WOLL, E; HAMMERER, M; WALDEGGER, S; MALY, K; GRUNICKE, H			BRADYKININ-INDUCED OSCILLATIONS OF CELL-MEMBRANE POTENTIAL IN CELLS EXPRESSING THE HA-RAS ONCOGENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; V-MOS; PHOSPHATIDYLINOSITOL TURNOVER; EPITHELIOID CELLS; GROWTH-FACTORS; MICROINJECTION; SIGNAL; DESENSITIZATION; TRANSFORMATION; NIH-3T3-CELLS	Products of ras genes are putative elements of growth factor signal transduction. However, the mechanism of action of these proteins in normal and malignant growth is as yet obscure. To test for functional consequences of ras oncogene expression, electrophysiological experiments were performed on NIH-3T3 fibroblasts transfected with a transforming Ha-ras MMTV-LTR construct expressing the oncogene on treatment with dexamethasone (+ras). Transfected cells in the absence of dexamethasone (-ras) and nontransfected cells in the presence of dexamethasone (oras) served as controls. In -ras and oras, bradykinin induces a single, transient hyperpolarization. In +ras, bradykinin elicits oscillations of cell membrane potential throughout the presence of the hormone by activation of calcium-sensitive K+ channels. The oscillations of cell membrane potential are abolished in the absence of extracellular calcium. As evident from fura 2 fluorescence, bradykinin leads to a transient increase of intracellular calcium both in the presence and absence of extracellular calcium. Oscillations of intracellular calcium could be observed in +ras cells, if bradykinin was applied at reduced extracellular sodium concentration possibly to impair calcium extrusion via the sodium/calcium exchange. Bradykinin induces oscillations of cell membrane potential similarly in -ras cells loaded with GTP[S], a nonhydrolyzable analogue of GTP. Thus, the altered response of ras oncogene expressing cells to bradykinin relates to the GTP binding property of the ras protein. It is concluded that in cells expressing ras oncogene but not in other fibroblasts bradykinin mimics the effect of growth factors on the cell membrane.	UNIV INNSBRUCK,INST BIOCHEM,A-6010 INNSBRUCK,AUSTRIA	University of Innsbruck	LANG, F (corresponding author), UNIV INNSBRUCK,INST PHYSIOL,FRITZ PREGL STR 3,A-6010 INNSBRUCK,AUSTRIA.							ALMERS W, 1985, FEBS LETT, V192, P13, DOI 10.1016/0014-5793(85)80033-8; ALONSO T, 1988, P NATL ACAD SCI USA, V85, P4271, DOI 10.1073/pnas.85.12.4271; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; DOPPLER W, 1987, GENE, V54, P147, DOI 10.1016/0378-1119(87)90357-X; DOWNWARD J, 1988, COLD SPRING HARB SYM, V53, P883, DOI 10.1101/SQB.1988.053.01.101; DOWNWARD J, 1988, P NATL ACAD SCI USA, V85, P5774, DOI 10.1073/pnas.85.16.5774; FERAMISCO JR, 1984, CELL, V38, P109, DOI 10.1016/0092-8674(84)90531-2; FLEISCHMAN LF, 1986, SCIENCE, V231, P407, DOI 10.1126/science.3001936; FOSKETT JK, 1989, P NATL ACAD SCI USA, V86, P167, DOI 10.1073/pnas.86.1.167; FRIEDRICH F, 1988, J MEMBRANE BIOL, V106, P149, DOI 10.1007/BF01871397; GOUSTIN AS, 1986, CANCER RES, V46, P1015; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAGAG N, 1987, MOL CELL BIOL, V7, P1984, DOI 10.1128/MCB.7.5.1984; HALL A, 1988, COLD SPRING HARB SYM, V53, P855, DOI 10.1101/SQB.1988.053.01.098; JAGGI R, 1986, EMBO J, V5, P2609, DOI 10.1002/j.1460-2075.1986.tb04541.x; JURNAK F, 1990, CELL, V60, P525, DOI 10.1016/0092-8674(90)90652-U; MALY K, 1988, MOL CELL BIOL, V8, P4212, DOI 10.1128/MCB.8.10.4212; MALY K, 1989, J BIOL CHEM, V264, P11839; MALY K, 1989, ADV ENZYME REGUL, V27, P121; MCCORMICK F, 1989, CELL, V56, P5, DOI 10.1016/0092-8674(89)90976-8; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; PANDIELLA A, 1989, J BIOL CHEM, V264, P12914; PARRIES G, 1987, P NATL ACAD SCI USA, V84, P2648, DOI 10.1073/pnas.84.9.2648; PAULMICHL M, 1987, PFLUG ARCH EUR J PHY, V408, P408, DOI 10.1007/BF00581137; REISER G, 1985, PFLUG ARCH EUR J PHY, V405, P260, DOI 10.1007/BF00582570; SAKMANN B, 1983, SINGLE CHANNEL RECOR; SANTOS E, 1989, FASEB J, V3, P2151, DOI 10.1096/fasebj.3.10.2666231; SCOTT RH, 1986, NEUROSCI LETT, V69, P59, DOI 10.1016/0304-3940(86)90414-3; STACEY DW, 1984, NATURE, V310, P508, DOI 10.1038/310508a0; STACEY DW, 1988, COLD SPRING HARB SYM, V53, P871, DOI 10.1101/SQB.1988.053.01.100; SWANN K, 1989, EMBO J, V8, P3711, DOI 10.1002/j.1460-2075.1989.tb08546.x; WAKELAM MJO, 1989, BIOCHEM J, V259, P737, DOI 10.1042/bj2590737	33	99	100	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4938	4942						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002040				2022-12-25	WOS:A1991FC21700042
J	LUND, E; BOBERG, KM; BYSTROM, S; OLUND, J; CARLSTROM, K; BJORKHEM, I				LUND, E; BOBERG, KM; BYSTROM, S; OLUND, J; CARLSTROM, K; BJORKHEM, I			FORMATION OF NOVEL C21-BILE ACIDS FROM CHOLESTEROL IN THE RAT - STRUCTURE IDENTIFICATION OF THE MAJOR DIHYDROXYLATED AND TRIHYDROXYLATED SPECIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILE-ACIDS	We recently showed that previously unknown di- and trihydroxylated C21-bile acids are major degradation products of sitosterol and campesterol in bile-fistulated female Wistar rats. Using a mixture of 4-C-14- and 22-H-3-labeled cholesterol it was shown that such C21-bile acids are formed also from cholesterol in amounts up to about 25% of the total formation of bile acids. The C21-bile acids were formed from labeled cholesterol also in perfused rat liver, demonstrating that the liver is the site of synthesis. The major trihydroxylated C21-bile acids in bile were identified, by means of mass spectrometry, NMR, stereospecific dehydrogenases, and reagents, as 5-beta-pregnan-3-alpha, 11-beta, 15-beta-triol-21-oic acid and 5-beta-pregnan-3-alpha, 11-beta, 15-alpha-triol-21-oic acid. The corresponding 11-oxo-isomers were also present. A minor trihydroxylated C21-bile acid was identified as 5-beta-pregnan-3-alpha, 11-beta, 16-triol-21-oic acid. The major dihydroxylated C21-bile acid was identified by the same means as 5-alpha-pregnan-3-alpha, 12-alpha-diol-21-oic acid. Male rats converted 4-C-14-cholesterol into C21-bile acids less efficiently than did female rats. None of the C21-bile acids from male rats contained a 15-hydroxyl group. It is speculated that the novel C21-bile acids are formed both from cholesterol and from plant sterols by an initial hydroxylation at C21 followed by peroxisomal or mitochondrial beta-oxidation. The presence of a hydroxyl group at C-15 may facilitate this reaction. The above formation of C21-bile acids shows that mammalian liver is able to degrade the side chain of cholesterol beyond the C24 stage, even in the absence of a blocking group at C24. C21-bile acids, or one of their precursors, are hydroxylated in the liver by a hitherto unknown 11-beta-hydroxylase. The possible physiological importance of the C21-bile acids is discussed.	KAROLINSKA INST, HUDDINGE HOSP, DEPT CLIN CHEM, S-14104 HUDDINGE, SWEDEN; KAROLINSKA INST, HUDDINGE HOSP, GYNECOL & RES CTR, S-14104 HUDDINGE, SWEDEN; ROYAL INST TECHNOL, DEPT ORGAN CHEM, S-10044 STOCKHOLM 70, SWEDEN	Karolinska Institutet; Karolinska Institutet; Royal Institute of Technology	LUND, E (corresponding author), UNIV OSLO, RIKSHOSP, INST CLIN BIOCHEM, OSLO, NORWAY.			Bjorkhem, Ingemar/0000-0001-6087-9190; Bjorkhem, Ingemar/0000-0002-0575-9425				ALME B, 1977, J LIPID RES, V18, P339; BJORKHEM I, 1975, ANAL BIOCHEM, V68, P404, DOI 10.1016/0003-2697(75)90636-3; BJORKHEM I, 1985, NEW COMPREHENSIVE BI, V12, P231; BOBERG KM, 1990, J BIOL CHEM, V265, P7967; BRIDGEMA.JE, 1970, J CHEM SOC C, P250, DOI 10.1039/j39700000250; BUDZIKIEWICZ H, 1962, J AM CHEM SOC, V84, P1430, DOI 10.1021/ja00867a019; CARLSTROM K, 1981, J LIPID RES, V22, P1225; FIESER LF, 1953, J AM CHEM SOC, V75, P4386, DOI 10.1021/ja01114a002; GUSTAFSSON JA, 1974, J BIOL CHEM, V249, P1940; JODOI Y, 1987, TETRAHEDRON, V43, P487; NUSSIM M, 1964, J ORG CHEM, V29, P1120, DOI 10.1021/jo01028a032; PYREK JS, 1982, LIPIDS, V17, P241; SEGLEN PO, 1972, BIOCHIM BIOPHYS ACTA, V264, P398, DOI 10.1016/0304-4165(72)90002-5; WALLER GR, 1972, BIOCH APPLICATIONS M; ZURCHER RF, 1963, HELV CHIM ACTA, V46, P2054, DOI 10.1002/hlca.19630460625	15	15	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4929	4937						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002039				2022-12-25	WOS:A1991FC21700041
J	MORLEY, SJ; DEVER, TE; ETCHISON, D; TRAUGH, JA				MORLEY, SJ; DEVER, TE; ETCHISON, D; TRAUGH, JA			PHOSPHORYLATION OF EIF-4F BY PROTEIN-KINASE-C OR MULTIPOTENTIAL S6 KINASE STIMULATES PROTEIN-SYNTHESIS AT INITIATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							INFECTED HELA-CELLS; CAP-BINDING-PROTEIN; MESSENGER-RNA TRANSLATION; FACTOR-III; POLIOVIRUS INFECTION; RIBOSOMAL PROTEIN-S6; COMPLEX; 7-METHYLGUANOSINE; PURIFICATION; RECOGNITION	Eukaryotic initiation factor (eIF) 4F, a multiprotein cap binding complex, has been shown to be phosphorylated in vivo in response to phorbol 12-myristate 13-acetate and insulin (Morley, S. J., and Traugh, J. A. (1990) J. Biol. Chem. 264, 2401-2404; Morley, S. J., and Traugh, J. A. (1990) J. Biol. Chem. 265, 10611-10616). The effect of phosphorylation on the activity of purified eIF-4F, utilizing both protein kinase C and a multifunctional S6 kinase, previously identified as protease activated kinase II, has been examined; these protein kinases modify eIF-4F p25 and p220 and eIF-4F p220, respectively. Studies with an eIF-4F-dependent protein synthesis system showed that phosphorylation of eIF-4F with either protein kinase resulted in a 3-5-fold stimulation of translation relative to the nonphosphorylated control. Chemical cross-linking of eIF-4F to cap-labeled mRNA, showed that phosphorylation increased the interaction of both the p25 and p220 subunits of eIF-4F with the 5' end of mRNA. This effect was manifested by a stimulation of initiation complex formation as measured by an increase in the association of labeled mRNA with 40 S ribosomal subunits in the translation system. Thus, phosphorylation of eIF-4F enhances binding to mRNA, resulting in a stimulation of protein synthesis at initiation.	UNIV CALIF RIVERSIDE,DEPT BIOCHEM,RIVERSIDE,CA 92521; CASE WESTERN RESERVE UNIV,SCH MED,DEPT BIOCHEM,CLEVELAND,OH 44106; UNIV KANSAS,MED CTR,DEPT MICROBIOL,KANSAS CITY,KS 66103	University of California System; University of California Riverside; Case Western Reserve University; University of Kansas; University of Kansas Medical Center				Dever, Thomas/0000-0001-7120-9678	NIGMS NIH HHS [GM 26738, GM 21424, GM 26796] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026738, R01GM026796, R01GM021424] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAMSON RD, 1988, J BIOL CHEM, V263, P6016; ABRAMSON RD, 1987, J BIOL CHEM, V262, P3826; BONNEAU AM, 1987, J BIOL CHEM, V262, P11134; BUCKLEY B, 1987, J BIOL CHEM, V262, P13599; BURKHARD SJ, 1983, J BIOL CHEM, V258, P4003; DUNCAN R, 1987, J BIOL CHEM, V262, P380; DUNCAN R, 1983, J BIOL CHEM, V258, P7236; EDERY I, 1983, J BIOL CHEM, V258, P1398; ETCHISON D, 1984, J VIROL, V51, P832, DOI 10.1128/JVI.51.3.832-837.1984; ETCHISON D, 1982, J BIOL CHEM, V257, P4806; GRIFO JA, 1983, J BIOL CHEM, V258, P5804; GRIFO JA, 1984, J BIOL CHEM, V259, P8648; HIREMATH LS, 1989, J BIOL CHEM, V264, P1132; Jagus R, 1981, Prog Nucleic Acid Res Mol Biol, V25, P127, DOI 10.1016/S0079-6603(08)60484-5; JARAMILLO M, 1990, BIOCHIM BIOPHYS ACTA, V1050, P134, DOI 10.1016/0167-4781(90)90154-T; JOSHIBARVE S, 1990, J BIOL CHEM, V265, P2979; KRYSTOSEK A, 1975, J BIOL CHEM, V250, P6077; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; LEE KAW, 1985, J VIROL, V54, P515, DOI 10.1128/JVI.54.2.515-524.1985; LODISH HF, 1977, J BIOL CHEM, V252, P1181; Merrick W C, 1979, Methods Enzymol, V60, P101, DOI 10.1016/S0076-6879(79)60010-1; MOLDAVE K, 1985, ANNU REV BIOCHEM, V54, P1109, DOI 10.1146/annurev.biochem.54.1.1109; MORLEY SJ, 1989, J BIOL CHEM, V264, P2401; MORLEY SJ, 1990, J BIOL CHEM, V265, P10611; MORLEY SJ, 1990, BIOCHIMIE, V72, P259, DOI 10.1016/0300-9084(90)90081-Q; MUTHUKRISHNAN S, 1976, BIOCHEMISTRY-US, V15, P5761, DOI 10.1021/bi00671a012; PAIN VM, 1986, BIOCHEM J, V235, P625, DOI 10.1042/bj2350625; PALEN E, 1987, J BIOL CHEM, V262, P3518; PERISIC O, 1983, J BIOL CHEM, V258, P9589; RAY BK, 1985, J BIOL CHEM, V260, P7651; RHOADS RE, 1988, TRENDS BIOCHEM SCI, V13, P52, DOI 10.1016/0968-0004(88)90028-X; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; SONENBERG N, 1977, P NATL ACAD SCI USA, V74, P4288, DOI 10.1073/pnas.74.10.4288; SONENBERG N, 1978, P NATL ACAD SCI USA, V75, P4843, DOI 10.1073/pnas.75.10.4843; SONENBERG N, 1988, PROG NUCLEIC ACID RE, V35, P173, DOI 10.1016/S0079-6603(08)60614-5; SZCZESNASKORUPA E, 1981, EUR J BIOCHEM, V121, P163, DOI 10.1111/j.1432-1033.1981.tb06445.x; TAHARA SM, 1981, J BIOL CHEM, V256, P7691; TUAZON PT, 1989, J BIOL CHEM, V264, P2773; TUAZON PT, 1990, J BIOL CHEM, V265, P10617; WALTON GM, 1987, ANAL BIOCHEM, V161, P425, DOI 10.1016/0003-2697(87)90471-4; WODNARFILIPOWIC.A, 1987, EUR J BIOCHEM, V92, P69	41	91	91	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4669	4672						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002015				2022-12-25	WOS:A1991FC21700003
J	BRYANT, C; DELUCA, M				BRYANT, C; DELUCA, M			PURIFICATION AND CHARACTERIZATION OF AN OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE FROM ENTEROBACTER-CLOACAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AROMATIC NITRO-COMPOUNDS; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; XANTHINE-OXIDASE; REDUCTION; 1-NITROPYRENE; NITROIMIDAZOLES; METABOLISM; REDUCTASES; PROTEINS	The reductive products of several nitroaromatic compounds have been found to be toxic, mutagenic, and carcinogenic. The nitroreductases present in intestinal microflora have been implicated in the biotransformation of these compounds to their deleterious metabolites. A "classical" nitroreductase has been purified from Enterobacter cloacae 587-fold using a protocol which yields approximately 1 mg of purified nitroreductase from 10 liters of cell culture. An analysis of the physical properties of the nitroreductase indicates that the enzyme is active as a monomer with a calculated molecular mass of 27 kDa. FMN has been identified as a required flavin cofactor and is present at a stoichiometry of 0.88 mol of FMN bound/mol of active enzyme. The enzyme was found capable of reducing nitrofurazone under aerobic conditions indicating that the mechanism involves an obligatory two-electron transfer. Thus, this enzyme can be classified as an oxygen-insensitive nitroreductase. The purified nitroreductase can utilize either NADH or NADPH as a source of reducing equivalents and can reduce a variety of nitroaromatic compounds including nitrofurans and nitrobenzenes as well as quinones. Studies in which the rates of nitroreduction for a series of para substituted nitrobenzene derivatives were determined suggest that a linear free energy relationship exists between the rate and the redox midpoint potential of the substrate.	UNIV CALIF SAN DIEGO,DEPT CHEM,LA JOLLA,CA 92093	University of California System; University of California San Diego								ADAMS GE, 1979, INT J RADIAT BIOL, V35, P151, DOI 10.1080/09553007914550161; ANDERSON RF, 1979, BRIT J CANCER, V39, P705, DOI 10.1038/bjc.1979.124; ASNIS RE, 1957, ARCH BIOCHEM BIOPHYS, V66, P208, DOI 10.1016/0003-9861(57)90551-9; BECKETT AH, 1959, J MED PHARMACEUT CH, V1, P135, DOI 10.1021/jm50003a002; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BLAKESLEY RW, 1977, ANAL BIOCHEM, V82, P580, DOI 10.1016/0003-2697(77)90197-X; BLUMER JL, 1980, CANCER RES, V40, P4599; BRYANT C, 1991, J BIOL CHEM, V266, P4126; BRYANT DW, 1981, CAN J MICROBIOL, V27, P81, DOI 10.1139/m81-013; CLARKE ED, 1980, BIOCHEM PHARMACOL, V29, P2684, DOI 10.1016/0006-2952(80)90087-8; CLARKE ED, 1982, BIOCHEM PHARMACOL, V31, P3237, DOI 10.1016/0006-2952(82)90556-1; COHEN SM, 1978, NITROFURANS CHEM MET, P171; DOI T, 1983, CHEM PHARM BULL, V31, P1105; DURAND RE, 1981, ADV RADIAT BIOL, V9, P75; GAVIN JJ, 1966, ARCH BIOCHEM BIOPHYS, V113, P399, DOI 10.1016/0003-9861(66)90205-0; GILLETTE JR, 1968, MOL PHARMACOL, V4, P541; GRUNBERG E, 1973, ANNU REV MICROBIOL, V27, P317, DOI 10.1146/annurev.mi.27.100173.001533; Hansch C, 1979, SUBSTITUENT CONSTANT; HARTTER DR, 1985, TOXICITY NITROAROMAT, P1; HEFLICH RH, 1985, MUTAT RES, V149, P25, DOI 10.1016/0027-5107(85)90005-3; HORIE S, 1982, J BIOCHEM, V92, P661, DOI 10.1093/oxfordjournals.jbchem.a133977; IYAANAGI T, 1987, CHEM SCRIPTA A, V27, P31; IYANAGI T, 1969, BIOCHIM BIOPHYS ACTA, V172, P370, DOI 10.1016/0005-2728(69)90133-9; IYANAGI T, 1970, BIOCHIM BIOPHYS ACTA, V216, P282, DOI 10.1016/0005-2728(70)90220-3; KATO R, 1970, BIOCHEM PHARMACOL, V19, P45, DOI 10.1016/0006-2952(70)90328-X; KINOUCHI T, 1986, JPN J CANCER RES, V77, P356; KINOUCHI T, 1983, APPL ENVIRON MICROB, V46, P596, DOI 10.1128/AEM.46.3.596-604.1983; KUTCHER WW, 1984, BIOCHEM PHARMACOL, V33, P799, DOI 10.1016/0006-2952(84)90465-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEWIS AJ, 1977, MODERN DRUG ENCY THE, P608; MASSEY V, 1966, J BIOL CHEM, V241, P3417; MCCALLA DR, 1975, CAN J MICROBIOL, V21, P1484, DOI 10.1139/m75-220; MCCOY EC, 1984, BIOCH BASIS CHEM CAR, P57; MERMELSTEIN R, 1985, TOXICITY NITROAROMAT; MIRSALIS JC, 1982, NATURE, V295, P322, DOI 10.1038/295322a0; MULLER M, 1983, SURGERY, V93, P165; NARAI N, 1984, J PHARMACOBIO-DYNAM, V7, P407; OLIVE PL, 1979, BRIT J CANCER, V40, P89, DOI 10.1038/bjc.1979.144; ORNA MV, 1989, J BIOL CHEM, V264, P12379; PETERSON FJ, 1979, J BIOL CHEM, V254, P4009; PITTS JN, 1978, SCIENCE, V202, P515, DOI 10.1126/science.705341; PROCHASKA HJ, 1986, J BIOL CHEM, V261, P1372; REPASKE R, 1965, J BIOL CHEM, V240, P4774; RICKERT DE, 1984, CRC CR REV TOXICOL, V13, P217, DOI 10.3109/10408448409003373; ROSENKRANZ HS, 1980, SCIENCE, V209, P1039, DOI 10.1126/science.6996095; SUGIMURA T, 1966, CANCER RES, V26, P1717; TATSUMI K, 1986, CANCER RES, V46, P1089; TATSUMI K, 1978, CHEM PHARM BULL, V26, P1713; TATSUMI K, 1982, J PHARMACOBIO-DYNAM, V5, P423; TOKIWA H, 1981, MUTAT RES, V91, P321, DOI 10.1016/0165-7992(81)90008-7; VANCE WA, 1984, ENVIRON MUTAGEN, V6, P797, DOI 10.1002/em.2860060607; WARDMAN P, 1987, British Journal of Cancer, V55, P172; WATANABE M, 1990, NUCLEIC ACIDS RES, V18, P1059, DOI 10.1093/nar/18.4.1059; WATANABE M, 1987, BIOCHEM BIOPH RES CO, V147, P974, DOI 10.1016/S0006-291X(87)80165-1; WEST SB, 1982, CHEM-BIOL INTERACT, V41, P281, DOI 10.1016/0009-2797(82)90106-5; WHELLER LA, 1975, J PHARMACOL EXP THER, V194, P135	56	189	193	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4119	4125						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999405				2022-12-25	WOS:A1991FA69400018
J	ADACHI, H; OHTA, T; MATSUZAWA, H				ADACHI, H; OHTA, T; MATSUZAWA, H			SITE-DIRECTED MUTANTS, AT POSITION 166, OF RTEM-1 BETA-LACTAMASE THAT FORM A STABLE ACYL-ENZYME INTERMEDIATE WITH PENICILLIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ACTIVE-SITE; 6-BETA-BROMOPENICILLANIC ACID; CRYSTAL-STRUCTURE; BACILLUS-CEREUS; CLONING VECTORS; MUTAGENESIS; PROTEINS; INACTIVATION; SERINE	Class A beta-lactamases are known to hydrolyze substrates through a Ser70-linked acyl-enzyme intermediate, although the detailed mechanism remains unknown. On the basis of the tertiary structure of the active site, the role of Glu166 of class A enzymes was investigated by replacing the residue in RTEM-1 beta-lactamase with Ala, Asp, Gln, or Asn. All the mutants, in contrast to the wild-type, accumulated a covalent complex with benzylpenicillin which corresponds to an acyl-enzyme intermediate. For the Asp mutant, the complex decayed slowly and the hydrolytic activity was slightly retained both in vivo and in vitro. In contrast, the other mutants lost the hydrolytic activity completely and their complexes were stable. These results indicate that the side-chain carboxylate of Glu166 acts as a special catalyst for deacylation. Residues for deacylation have not been identified in other acyl enzymes, such as serine proteases and class C beta-lactamases. Furthermore, the acyl-enzyme intermediates obtained are so stable that they are considered to be ideal materials for crystallographic studies for elucidating the catalytic mechanism in more detail. In addition, the mutants can more easily form inclusion bodies than the wild-type, when they are produced in a large amount, suggesting that the residue also plays an important role in proper folding of the enzyme.			ADACHI, H (corresponding author), UNIV TOKYO, DEPT AGR CHEM, BUNKYO KU, TOKYO 113, JAPAN.							AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; BOISSINOT M, 1990, J BIOL CHEM, V265, P1225; CARTWRIGHT SJ, 1989, BIOCHEM J, V263, P905, DOI 10.1042/bj2630905; CHANG YH, 1990, P NATL ACAD SCI USA, V87, P2823, DOI 10.1073/pnas.87.7.2823; CHRISTENSEN H, 1990, BIOCHEM J, V266, P853; COHEN SA, 1980, BIOCHEMISTRY-US, V19, P3996, DOI 10.1021/bi00558a017; DALBADIEMCFARLAND G, 1986, BIOCHEMISTRY-US, V25, P332, DOI 10.1021/bi00350a008; DALBADIEMCFARLAND G, 1982, P NATL ACAD SCI-BIOL, V79, P6409, DOI 10.1073/pnas.79.21.6409; DIDEBERG O, 1987, BIOCHEM J, V245, P911, DOI 10.1042/bj2450911; DUBE DK, 1989, BIOCHEMISTRY-US, V28, P5703, DOI 10.1021/bi00440a001; ELLERBY LM, 1990, BIOCHEMISTRY-US, V29, P5797, DOI 10.1021/bi00476a022; FISHER J, 1980, BIOCHEMISTRY-US, V19, P2895, DOI 10.1021/bi00554a012; FISHER J, 1981, BIOCHEMISTRY-US, V20, P2726, DOI 10.1021/bi00513a004; GEORGIOU G, 1986, APPL ENVIRON MICROB, V52, P1157, DOI 10.1128/AEM.52.5.1157-1161.1986; GHRAYEB J, 1984, EMBO J, V3, P2437, DOI 10.1002/j.1460-2075.1984.tb02151.x; HEALEY WJ, 1989, PROTEINS, V6, P275, DOI 10.1002/prot.340060310; HERZBERG O, 1987, SCIENCE, V236, P694, DOI 10.1126/science.3107125; JAURIN B, 1981, P NATL ACAD SCI-BIOL, V78, P4897, DOI 10.1073/pnas.78.8.4897; JORIS B, 1984, BIOCHEM J, V223, P271, DOI 10.1042/bj2230271; JORIS B, 1988, BIOCHEM J, V250, P313, DOI 10.1042/bj2500313; KNOTTHUNZIKER V, 1982, BIOCHEM J, V207, P315, DOI 10.1042/bj2070315; KNOTTHUNZIKER V, 1980, BIOCHEM J, V187, P797, DOI 10.1042/bj1870797; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMINET AA, 1989, EMBO J, V8, P1469, DOI 10.1002/j.1460-2075.1989.tb03530.x; MADGWICK PJ, 1987, BIOCHEM J, V248, P657, DOI 10.1042/bj2480657; Maniatis T., 1982, MOL CLONING; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MOEWS PC, 1990, PROTEINS, V7, P156, DOI 10.1002/prot.340070205; MURPHY BP, 1988, BIOCHEM J, V256, P669, DOI 10.1042/bj2560669; OEFNER C, 1990, NATURE, V343, P284, DOI 10.1038/343284a0; OLIPHANT AR, 1989, P NATL ACAD SCI USA, V86, P9094, DOI 10.1073/pnas.86.23.9094; PRATT RF, 1988, BIOCHEM J, V254, P919, DOI 10.1042/bj2540919; RICHARDS JH, 1986, NATURE, V323, P187, DOI 10.1038/323187a0; SCHULTZ SC, 1986, P NATL ACAD SCI USA, V83, P1588, DOI 10.1073/pnas.83.6.1588; SIGAL IS, 1984, J BIOL CHEM, V259, P5327; SPRATT BG, 1975, NATURE, V254, P516, DOI 10.1038/254516a0; SUTCLIFFE JG, 1978, P NATL ACAD SCI USA, V75, P3737, DOI 10.1073/pnas.75.8.3737; TAKAGI H, 1988, BIO-TECHNOL, V6, P948, DOI 10.1038/nbt0888-948; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; VIRDEN R, 1990, BIOCHEMISTRY-US, V29, P145, DOI 10.1021/bi00453a018; YAMAGUCHI A, 1987, FEBS LETT, V218, P126, DOI 10.1016/0014-5793(87)81031-1; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	44	144	152	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3186	3191						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993691				2022-12-25	WOS:A1991EX60000078
J	CHAMMAS, R; VEIGA, SS; LINE, S; POTOCNJAK, P; BRENTANI, RR				CHAMMAS, R; VEIGA, SS; LINE, S; POTOCNJAK, P; BRENTANI, RR			ASN-LINKED OLIGOSACCHARIDE-DEPENDENT INTERACTION BETWEEN LAMININ AND GP120/140 - AN ALPHA-6/BETA-1 INTEGRIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SEQUENCE; CELL ATTACHMENT; MELANOMA-CELLS; BINDING-SITE; RECEPTOR; FIBRONECTIN; ADHESION; GLYCOPROTEIN; RECOGNITION; METASTASIS	Receptor-mediated recognition and adhesion to laminin, a specific glycoprotein from basement membranes, exert an important role in many biological phenomena. Studying cell surface proteins of B16-F10, a metastatic murine melanoma cell line, we identified a 120-140 kDa glycoprotein (gp120/140) that binds laminin. This glycoprotein was recognized by a polyclonal antibody raised against the human fibronectin receptor beta-1-integrin chain, as well as immunoprecipitated by an anti-alpha-6 chain (monoclonal antibody GoH3), characterizing it as an alpha-6/beta-1-integrin. Its binding to laminin was specific and displayed moderate affinity, as its apparent dissociation constant was 18 nM. To characterize the influence of carbohydrate moieties on the laminin-gp120/140 interaction, metaperiodate oxidation, metabolic inhibition of glycosylation, and enzymatic deglycosylation studies were performed. Our results indicate that gp120/140 Asn-linked oligosaccharides play a part in this interaction. Reciprocally, both metaperiodate and N-glycanase treatment of native laminin reduced its binding to gp120/140, characterizing the latter as a lectin-like molecule. These results point to glycosylation processes as a possible mechanism for variable binding specificity profiles among integrins.	LUDWIG INST CANC RES,RUA ANTONIO PRUDENTE 109-4,BR-01509 SAO PAULO,BRAZIL	Ludwig Institute for Cancer Research			Line, Sergio/H-5272-2012; Veiga, Silvio Sanches/C-2194-2013; Chammas, Roger/A-8004-2011	Line, Sergio/0000-0002-6574-9464; Veiga, Silvio Sanches/0000-0002-9691-1225; Chammas, Roger/0000-0003-0342-8726				BOBIT JM, 1987, ADV CARBONYDR CHEM B, V11, P1; Brentani Ricardo, 1989, Critical Reviews in Oncogenesis, V1, P247; CLEMENT B, 1990, J CELL BIOL, V110, P185, DOI 10.1083/jcb.110.1.185; DEAN JW, 1990, J BIOL CHEM, V265, P12553; DENNIS JW, 1989, ONCOGENE, V4, P853; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; DILLNER L, 1988, EXP CELL RES, V177, P186, DOI 10.1016/0014-4827(88)90036-5; EGGENS I, 1989, J BIOL CHEM, V264, P9476; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; ELICES MJ, 1989, P NATL ACAD SCI USA, V86, P9906, DOI 10.1073/pnas.86.24.9906; FUJIWARA S, 1988, BIOCHEM J, V252, P453, DOI 10.1042/bj2520453; GEHLSEN KR, 1989, J BIOL CHEM, V264, P19034; GEHLSEN KR, 1988, SCIENCE, V241, P1228, DOI 10.1126/science.2970671; GRAF J, 1987, CELL, V48, P989, DOI 10.1016/0092-8674(87)90707-0; HALL DE, 1990, J CELL BIOL, V110, P2175, DOI 10.1083/jcb.110.6.2175; HEMLER ME, 1989, J BIOL CHEM, V264, P6529; HUMPHRIES MJ, 1986, CANCER RES, V46, P5215; HUMPHRIES MJ, 1986, P NATL ACAD SCI USA, V83, P1752, DOI 10.1073/pnas.83.6.1752; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; IRIMURA T, 1981, CANCER RES, V41, P3411; Johnson D. A., 1984, Gene Analysis Techniques, V1, P3, DOI 10.1016/0735-0651(84)90049-9; KOJIMA N, 1989, J BIOL CHEM, V264, P20159; KRAMER RH, 1986, CANCER RES, V46, P1980; KRAMER RH, 1989, J BIOL CHEM, V264, P15642; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGUINO LR, 1989, J CELL BIOL, V109, P2455, DOI 10.1083/jcb.109.5.2455; LOPES JD, 1985, SCIENCE, V229, P275, DOI 10.1126/science.3160113; MARTIN GR, 1987, ANNU REV CELL BIOL, V3, P57, DOI 10.1146/annurev.cellbio.3.1.57; NEWTON SA, 1989, JNCI-J NATL CANCER I, V81, P1024, DOI 10.1093/jnci/81.13.1024; OZ OK, 1989, INT J CANCER, V44, P343, DOI 10.1002/ijc.2910440226; PASQUALINI R, 1989, J BIOL CHEM, V264, P14566; PAULSSON M, 1987, EUR J BIOCHEM, V166, P11, DOI 10.1111/j.1432-1033.1987.tb13476.x; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; RAMOS DM, 1990, CANCER RES, V50, P728; RUNYAN RB, 1988, J CELL BIOL, V107, P1863, DOI 10.1083/jcb.107.5.1863; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SHARON N, 1989, SCIENCE, V246, P227, DOI 10.1126/science.2552581; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; SMALHEISER NR, 1987, P NATL ACAD SCI USA, V84, P6457, DOI 10.1073/pnas.84.18.6457; SONNENBERG A, 1988, NATURE, V336, P487, DOI 10.1038/336487a0; STOCKER G, 1989, ANAL BIOCHEM, V179, P245, DOI 10.1016/0003-2697(89)90123-1; SUZUKI S, 1985, EMBO J, V4, P2519, DOI 10.1002/j.1460-2075.1985.tb03965.x; TIMPL R, 1979, J BIOL CHEM, V254, P9933; TOMASELLI KJ, 1988, J CELL BIOL, V107, P1241, DOI 10.1083/jcb.107.3.1241; TRUDEL GC, 1989, BIOCHEM BIOPH RES CO, V163, P1338, DOI 10.1016/0006-291X(89)91125-X; TURPEENNIEMIHUJANEN T, 1986, J BIOL CHEM, V261, P1883; VANLENTEN L, 1971, J BIOL CHEM, V246, P1889; WEVER UM, 1986, P NATL ACAD SCI USA, V83, P7137; WOO HJ, 1990, J BIOL CHEM, V265, P7097	49	70	70	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3349	3355						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993708				2022-12-25	WOS:A1991EX60000101
J	GILLIS, P; MALTER, JS				GILLIS, P; MALTER, JS			THE ADENOSINE-URIDINE BINDING-FACTOR RECOGNIZES THE AU-RICH ELEMENTS OF CYTOKINE, LYMPHOKINE, AND ONCOGENE MESSENGER-RNAS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNTRANSLATED REGION; GM-CSF; PROTEIN; SEQUENCE; DEGRADATION; STABILITY; TURNOVER; GENE; FOS	Selective mRNA degradation is an important control point in the transient expression of a variety of mRNAs coding for growth regulators. A variety of labile mRNAs coding for lymphokines, cytokines, and oncogenes contain within their 3'-untranslated region an AU-rich region shown to destabilize these messages. We recently identified a cytosolic protein, adenosine-uridine binding (AUBF), which complexes with four tandem AUUUA reiterations of a synthetic RNA transcript. We now show that AUBF forms RNase T1-resistant band-shifted complexes with a variety of in vitro transcribed mRNAs including granulocyte-macrophage colony-stimulating factor, interferon-gamma, interleukin-3, c-fos, and v-myc. Formation of complexes was specifically inhibited by AUUUA containing RNA, but not by irrelevant RNA. After brief ultraviolet light-induced cross-linking, AUBF.RNA complexes with the exception of c-fos comigrated on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Mutations within the AUUUA motifs demonstrate that both nucleotide sequence and secondary structure are important in AUBF.AUUUA RNA complex formation. Based upon these data, we suggest AUBF may interact with a variety of labile mRNAs with multiple AUUUA reiterations or single reiterations within an AU-rich 3'-untranslated region.	TULANE UNIV,SCH MED,DEPT PATHOL,NEW ORLEANS,LA 70112	Tulane University					NCI NIH HHS [CA-01427] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K08CA001427] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BREWER G, 1988, MOL CELL BIOL, V8, P1697, DOI 10.1128/MCB.8.4.1697; GIERL A, 1988, EMBO J, V7, P4045, DOI 10.1002/j.1460-2075.1988.tb03298.x; JONES TR, 1987, MOL CELL BIOL, V7, P4513, DOI 10.1128/MCB.7.12.4513; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; LEWIS CD, 1988, GENE DEV, V2, P863, DOI 10.1101/gad.2.7.863; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; MALTER JS, 1989, SCIENCE, V246, P664, DOI 10.1126/science.2814487; MALTER JS, 1991, J BIOL CHEM, V266, P3167; MEIJLINK F, 1985, P NATL ACAD SCI USA, V82, P4987, DOI 10.1073/pnas.82.15.4987; MITCHELL RL, 1985, CELL, V40, P209, DOI 10.1016/0092-8674(85)90324-1; MULLNER EW, 1989, CELL, V58, P373, DOI 10.1016/0092-8674(89)90851-9; RAGHOW R, 1987, TRENDS BIOCHEM SCI, V12, P358, DOI 10.1016/0968-0004(87)90165-4; SCHULER GD, 1988, CELL, V55, P1115, DOI 10.1016/0092-8674(88)90256-5; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; TURNER DH, 1987, COLD SPRING HARB SYM, V52, P123, DOI 10.1101/SQB.1987.052.01.017; WODNARFILIPOWICZ A, 1990, P NATL ACAD SCI USA, V87, P777, DOI 10.1073/pnas.87.2.777; ZHANG XY, 1986, NUCLEIC ACIDS RES, V14, P8387, DOI 10.1093/nar/14.21.8387	17	234	239	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3172	3177						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993689				2022-12-25	WOS:A1991EX60000076
J	SCHNELL, DJ; BLOBEL, G; PAIN, D				SCHNELL, DJ; BLOBEL, G; PAIN, D			SIGNAL PEPTIDE ANALOGS DERIVED FROM 2 CHLOROPLAST PRECURSORS INTERACT WITH THE SIGNAL RECOGNITION SYSTEM OF THE CHLOROPLAST ENVELOPE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSIT PEPTIDE; PROTEIN IMPORT; SMALL SUBUNIT; TRANSPORT; BINDING; CARBOXYLASE; SEQUENCES; MEMBRANE; REQUIRES; RECEPTOR	We have used synthetic peptides representing segments of the signal sequences of preferredoxin (pFd) and the precursor of the small subunit of ribulose-1,5-bisphosphate carboxylase (pS) to study interactions with the signal sequence recognition system at the chloroplast surface. Peptides representing the COOH-terminal 30 amino acids of the pFd and pS signal peptides were able to completely and reversibly inhibit the import of their homologous precursors into isolated chloroplasts at a 2.5-mu-M concentration. Import was blocked at the level of precursor binding to the chloroplast. This inhibition of precursor binding and import was not due to disruption of chloroplast integrity as incubation of isolated chloroplasts with the peptides did not cause measurable perturbation of the envelope membranes. The peptides also were able to block the import of the heterologous precursor protein, suggesting that pS and pFd share a common signal sequence recognition system. Visualization of the bound peptides at the chloroplast surface by indirect immunofluorescence microscopy using antipeptide antibodies gave a marked punctate staining pattern. This pattern is consistent with the localization of chloroplast import receptor(s) at contact zones between the inner and outer envelope membranes.			SCHNELL, DJ (corresponding author), ROCKEFELLER UNIV,HOWARD HUGHES MED INST,CELL BIOL LAB,NEW YORK,NY 10021, USA.							ANDERSON DJ, 1983, METHOD ENZYMOL, V96, P111; BUVINGER WE, 1989, J BIOL CHEM, V264, P1195; CLINE K, 1985, J BIOL CHEM, V260, P3691; CORUZZI G, 1983, J BIOL CHEM, V258, P1399; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; FRIEDMAN AL, 1989, PLANT PHYSIOL, V89, P993, DOI 10.1104/pp.89.3.993; GREEN N, 1982, CELL, V28, P477, DOI 10.1016/0092-8674(82)90202-1; KEEGSTRA K, 1989, ANNU REV PLANT PHYS, V40, P471, DOI 10.1146/annurev.pp.40.060189.002351; LUBBEN TH, 1989, PLANT MOL BIOL, V12, P13, DOI 10.1007/BF00017443; MURAKAMI H, 1988, J CELL BIOL, V107, P2051, DOI 10.1083/jcb.107.6.2051; PAIN D, 1987, P NATL ACAD SCI USA, V84, P3288, DOI 10.1073/pnas.84.10.3288; PAIN D, 1988, NATURE, V331, P232, DOI 10.1038/331232a0; POSNETT DN, 1988, J BIOL CHEM, V263, P1719; REISS B, 1987, MOL GEN GENET, V209, P116, DOI 10.1007/BF00329845; REISS B, 1989, P NATL ACAD SCI USA, V86, P886, DOI 10.1073/pnas.86.3.886; ROBINSON C, 1984, EUR J BIOCHEM, V142, P337, DOI 10.1111/j.1432-1033.1984.tb08291.x; SCHNELL DJ, 1990, J CELL BIOL, V111, P1825, DOI 10.1083/jcb.111.5.1825; SMEEKENS S, 1986, CELL, V46, P365, DOI 10.1016/0092-8674(86)90657-4; SMEEKENS S, 1989, MOL GEN GENET, V216, P178, DOI 10.1007/BF00332249; SMEEKENS S, 1985, NUCLEIC ACIDS RES, V13, P3179, DOI 10.1093/nar/13.9.3179; WAEGEMANN K, 1990, FEBS LETT, V261, P89, DOI 10.1016/0014-5793(90)80643-W; WASMANN CC, 1988, J BIOL CHEM, V263, P617	22	48	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3335	3342						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993706				2022-12-25	WOS:A1991EX60000099
J	TSERNG, KY; JIN, SJ				TSERNG, KY; JIN, SJ			METABOLIC CONVERSION OF DICARBOXYLIC-ACIDS TO SUCCINATE IN RAT-LIVER HOMOGENATES - A STABLE ISOTOPE TRACER STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLOFIBRATE-TREATED RATS; OMEGA-OXIDATION; FATTY-ACIDS; BETA-OXIDATION; CHAIN; INVITRO; INVIVO; COMPARTMENTATION; TURNOVER; COA	The metabolic conversion of dicarboxylic acids into succinate and other gluconeogenic intermediates in rat liver homogenates was investigated using [1,2,3,4-C-13(4)]dodecanedioic acid as tracer. Isotope enrichments in 3-hydroxybutyrate, succinate, fumarate, and malate, as well as dicarboxylates (dodecanedioic, sebacic, suberic, and adipic acids) were measured with selected ion monitoring capillary column gas chromatograph-mass spectrometry. Significant enrichment in the M + 4 (four labeled carbons) ion of succinate (0.4-2.9%) was detected, unequivocally demonstrating the direct conversion of dicarboxylate into succinate. In addition, significant enrichment of the M + 2 ion of succinate was also observed. This labeled species was generated from labeled acetyl-CoA through the tricarboxylic acid cycle. The partition of acetyl-CoA into the tricarboxylic acid cycle relative to ketone body formation was higher in the beta-oxidation of dicarboxylate than monocarboxylate. Therefore, in addition to the production of succinate, the beta-oxidation of dodecanedioate resulted in the channeling of the acetyl-CoA produced to the tricarboxylic acid cycle instead of to acetoacetate production. The enrichments in lower chain dicarboxylates are consistent with a partial bidirectional beta-oxidation of dodecanedioic acid. In addition to the expected M + 0 and M + 4 labels, significant M + 2 species were detected in suberic and adipic acids. These M + 2-labeled species were produced from the released free dicarboxylate intermediates which were then reactivated and metabolized. In these experiments, the overall succinate production was derived 4% from the direct conversion of dodecanedioic acid and 11% from the indirect route via acetyl-CoA through tricarboxylic acid.	VET ADM MED CTR, RES SERV, CLEVELAND, OH 44106 USA; CASE WESTERN RESERVE UNIV, SCH MED, DEPT PHARMACOL, CLEVELAND, OH 44106 USA; CASE WESTERN RESERVE UNIV, SCH MED, DEPT MED, CLEVELAND, OH 44106 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Case Western Reserve University					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035979] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-35979] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERGSETH S, 1988, BIOCHIM BIOPHYS ACTA, V961, P103, DOI 10.1016/0005-2760(88)90135-X; BILLINGTON D, 1978, BIOCHEM PHARMACOL, V27, P2879, DOI 10.1016/0006-2952(78)90204-6; BJORKHEM I, 1970, EUR J BIOCHEM, V14, P473, DOI 10.1111/j.1432-1033.1970.tb00313.x; CERDAN S, 1988, J BIOL CHEM, V263, P11664; DRAYE JP, 1988, EUR J BIOCHEM, V178, P183, DOI 10.1111/j.1432-1033.1988.tb14442.x; HAMBERG M, 1971, J BIOL CHEM, V246, P7411; ICHIHARA K, 1969, BIOCHIM BIOPHYS ACTA, V2176, P704; KOLVRAA S, 1986, BIOCHIM BIOPHYS ACTA, V876, P515, DOI 10.1016/0005-2760(86)90039-1; LEIGHTON F, 1989, J BIOL CHEM, V264, P10347; MORTENSEN PB, 1990, PROG CLIN BIOL RES, V321, P249; MORTENSEN PB, 1984, DAN MED BULL, V31, P121; MORTENSEN PB, 1981, BIOCHIM BIOPHYS ACTA, V666, P394, DOI 10.1016/0005-2760(81)90298-8; MORTENSEN PB, 1980, BIOCHIM BIOPHYS ACTA, V620, P177, DOI 10.1016/0005-2760(80)90199-X; MORTENSEN PB, 1981, BIOCHIM BIOPHYS ACTA, V664, P335, DOI 10.1016/0005-2760(81)90056-4; RUSOFF II, 1960, TOXICOL APPL PHARM, V32, P316; SHIPLEY RA, 1972, TRACER METHODS IN VI, P148; SUZUKI H, 1989, BIOCHIM BIOPHYS ACTA, V990, P25, DOI 10.1016/S0304-4165(89)80007-8; TSERNG KY, 1989, METABOLISM, V38, P655, DOI 10.1016/0026-0495(89)90103-0; TSERNG KY, 1983, AM J PHYSIOL, V245, pE476, DOI 10.1152/ajpendo.1983.245.5.E476; TSERNG KY, 1983, AM J PHYSIOL, V245, pE308, DOI 10.1152/ajpendo.1983.245.3.E308; ULLMAN EF, 1961, J AM CHEM SOC, V83, P2379, DOI 10.1021/ja01471a033; VAMECQ J, 1989, AM J PHYSIOL, V256, pG680, DOI 10.1152/ajpgi.1989.256.4.G680; VAMECQ J, 1989, J BIOCHEM-TOKYO, V106, P216, DOI 10.1093/oxfordjournals.jbchem.a122835; Verkade PE, 1934, BIOCHEM J, V28, P31, DOI 10.1042/bj0280031; VIANEYLIAUD C, 1987, J INHERIT METAB DIS, V10, P159, DOI 10.1007/BF01812855; VONGLUTZ G, 1975, EUR J BIOCHEM, V60, P147; WADE F, 1977, BIOCHIM BIOPHYS ACTA, V487, P261; WADE F, 1971, J BIOCH, V70, P1065	28	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2924	2929						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993666				2022-12-25	WOS:A1991EX60000042
J	NG, SF; HANAUSKEABEL, HM; ENGLARD, S				NG, SF; HANAUSKEABEL, HM; ENGLARD, S			COSUBSTRATE BINDING-SITE OF PSEUDOMONAS SP AK1 GAMMA-BUTYROBETAINE HYDROXYLASE - INTERACTIONS WITH STRUCTURAL ANALOGS OF ALPHA-KETOGLUTARATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLYL 4-HYDROXYLASE; 2-OXOGLUTARATE; CARNITINE; METABOLISM; ASCORBATE; ENZYME	Forty-one aromatic and aliphatic analogs of alpha-ketoglutarate were studied kinetically for their interaction with the alpha-ketoglutarate binding site of gamma-butyrobetaine hydroxylase obtained from Pseudomonas sp. AKI. Together, the compounds represent structural permutations probing the contribution of: 1) the C5 carboxyl group of alpha-ketoglutarate (domain I); 2) the C1-C2 keto acid moiety of alpha-ketoglutarate (domain II); 3) the distance between domains I and II; and 4) the spatial relationship of the two domains required for optimal interaction with the cosubstrate binding site. All compounds were competitive inhibitors for alpha-ketoglutarate (K(m) 0.018 mM). Functionally, two subsites of the cosubstrate binding site were evident: subsite I for polar interaction with the C5 carboxyl group, and subsite II, comprising of two distinct cis-oriented coordination sites of the catalytic ferrous ion which interact with the C1-C2 keto acid moiety. The most efficient inhibitors were pyridine 2,4-dicarboxylate (K(i) 0.0002 mM) and 3,4-dihydroxybenzoate (K(i) 0.0006 mM). Both compounds contain a carboxyl group and a chelating moiety corresponding to domains I and II of alpha-ketoglutarate, respectively. The fixed orientation of these groups in both analogs was used to assess intersubsite distance and spatial relationship required for optimal interaction with the cosubstrate binding site. Binding at subsite I and chelation at subsite II were indispensible for effective competitive inhibition. The distance between these two domains also helped determine whether attachment at the cosubstrate binding site would be catalytically productive. This was emphasized by the failure of either oxaloacetate or alpha-ketoadipinate to promote hydroxylation. Optimal interdomain distance, however, was not sufficient for cosubstrate utilization, as pyridine 2,4-dicarboxylate, with an interdomain distance identical to alpha-ketoglutarate in its staggered conformation, did not sustain hydroxylation. In the overall, these studies suggest that alpha-ketoglutarate utilization occurs in a ligand reaction at the active site ferrous ion of gamma-butyrobetaine hydroxylase. This is of particular interest since the delineated stereochemical mode of oxidative decarboxylation could generate the reactive oxo-iron species that was shown experimentally to promote gamma-butyrobetaine hydroxylation by an abstraction-recombination mechanism (Blanchard, J. S., and Englard, S. (1983) Biochemistry 22, 5922-5928; Englard, S., Blanchard, J.S., and Midelfort, C.F. (1985) Biochemistry 24, 1110-1116).	YESHIVA UNIV ALBERT EINSTEIN COLL MED, DEPT BIOCHEM, BRONX, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine					NIADDK NIH HHS [5R0I AM-21194] Funding Source: Medline	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ACHESON RM, 1959, J CHEM SOC, P4140; AVDEEF A, 1978, J AM CHEM SOC, V100, P5362, DOI 10.1021/ja00485a018; BLANCHARD JS, 1983, BIOCHEMISTRY-US, V22, P5922, DOI 10.1021/bi00294a036; BREMER J, 1983, PHYSIOL REV, V63, P1420, DOI 10.1152/physrev.1983.63.4.1420; BYLICKI A, 1959, B ACAD POL SCI SC, V7, P117; CHENG KL, 1954, ANAL CHEM, V26, P536, DOI 10.1021/ac60087a031; Cleland W W, 1979, Methods Enzymol, V63, P103; EBERT PS, 1962, BIOCHEM BIOPH RES CO, V8, P305, DOI 10.1016/0006-291X(62)90283-8; ENGLARD S, 1986, ANNU REV NUTR, V6, P365, DOI 10.1146/annurev.nu.06.070186.002053; ENGLARD S, 1985, BIOCHEMISTRY-US, V24, P1110, DOI 10.1021/bi00326a007; GUNZLER V, 1987, BIOCHEM J, V242, P163; HANAUSKEABEL HM, 1987, FEBS LETT, V214, P236, DOI 10.1016/0014-5793(87)80062-5; HANAUSKEABEL HM, 1982, J THEOR BIOL, V94, P421, DOI 10.1016/0022-5193(82)90320-4; HANAUSKEABEL HM, 1988, COLLAGEN REL RES, V8, P530; HANAUSKEABEL HM, 1983, THESIS PHILLIPS U MA; HOLME E, 1984, BIOSCIENCE REP, V4, P433, DOI 10.1007/BF01122509; HOLME E, 1982, BIOCHEM BIOPH RES CO, V107, P518, DOI 10.1016/0006-291X(82)91522-4; KIVIRIKKO KI, 1989, FASEB J, V3, P1609, DOI 10.1096/fasebj.3.5.2537773; LEVINE RJ, 1974, DUNCANS DISEASES MET, P1197; LINDSTEDT G, 1977, BIOCHEMISTRY-US, V16, P2181, DOI 10.1021/bi00629a022; MAJAMAA K, 1985, BIOCHEM J, V229, P127, DOI 10.1042/bj2290127; MAJAMAA K, 1986, J BIOL CHEM, V261, P7819; MAJAMAA K, 1984, EUR J BIOCHEM, V138, P239, DOI 10.1111/j.1432-1033.1984.tb07907.x; Martell A.E., 1973, METAL IONS BIOLOGICA, V2, P207; MARTELL AE, 1973, CRITICAL STABILITY C, V1, P367; MARTELL AE, 1977, CRITICAL STABILITY C, V3, P200; MIGAL PK, 1973, ZH NEORG KHIM, V18, P536; MORIMOTO I, 1963, B CHEM SOC JPN, V36, P605, DOI 10.1246/bcsj.36.605; MYLLYLA R, 1984, J BIOL CHEM, V259, P5403; NG SF, 1988, THESIS A EINSTEIN CO; REBOUCHE CJ, 1986, ANNU REV NUTR, V6, P41, DOI 10.1146/annurev.nu.06.070186.000353; SMITH RM, 1989, CRITICAL STABILITY C, V6, P378; Vamecq J, 1989, Essays Biochem, V24, P115	33	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1526	1533						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1988434				2022-12-25	WOS:A1991EU49700029
J	SHUTTLEWORTH, TJ; THOMPSON, JL				SHUTTLEWORTH, TJ; THOMPSON, JL			EFFECT OF TEMPERATURE ON RECEPTOR-ACTIVATED CHANGES IN [CA2+]I AND THEIR DETERMINATION USING FLUORESCENT-PROBES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE; ENDOPLASMIC-RETICULUM; CALCIUM RELEASE; MUSCLE-CELLS; CA-2+; MOBILIZATION	Several recent studies of intracellular Ca2+ concentration ([Ca2+]i using fluorescent indicators have involved experiments performed at nonphysiological temperatures, frequently room temperature. In the studies reported here, a reduction in temperature was shown to influence the measurement of [Ca2+]i in two major ways. The first is an effect on the value for the K(d) (apparent dissociation constant) used in the calculation of [Ca2+]i. The K(d) values for indo- 1 and fura-2 were found to change with temperature in a manner analogous to the related compounds [ethylene-bis(oxyethylenenitrilo)]tetraacetic acid and bis-(o-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid. Experiments showed that the use of previously published K(d) values (measured at 37-degrees-C) in experiments at room temperature results in errors of at least 25% in the calculated [Ca2+]i. The second arises from the differential temperature sensitivities of the physiological processes that make up any particular value of [Ca2+]i While resting [Ca2+]i was relatively unaffected by reduced temperature (27-degrees-C, 13-degress-C), changes in [Ca2+]i following stimulation were profoundly influenced and in a way that was not simply predictable. Analysis of the responses indicated that the observed effects resulted largely from a temperature-dependent reduction in the rate of Ca2+ removal from the cytosol together with an additional component, namely a marked reduction in Ca2+ entry, at the lower temperature (13-degrees-C). The net result was observed as changes in the initial rise in [Ca2+]i on stimulation, together with more profound, and complex, effects on the sustained elevation in [Ca2+]i following stimulation. This latter component was markedly increased at 27-degrees-C, but was decreased in cells at 13-degrees-C.			SHUTTLEWORTH, TJ (corresponding author), UNIV ROCHESTER,SCH MED & DENT,DEPT PHYSIOL,ROCHESTER,NY 14642, USA.				NIGMS NIH HHS [GM-40457] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BROOKS RC, 1989, J BIOL CHEM, V264, P20147; CHUEH SH, 1986, J BIOL CHEM, V261, P13883; DIVIRGILIO F, 1990, CELL CALCIUM, V11, P57, DOI 10.1016/0143-4160(90)90059-4; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; GUNTER TE, 1988, AM J PHYSIOL, V255, pC304, DOI 10.1152/ajpcell.1988.255.3.C304; HARRISON SM, 1987, BIOCHIM BIOPHYS ACTA, V925, P133, DOI 10.1016/0304-4165(87)90102-4; HENNE V, 1986, FEBS LETT, V202, P267, DOI 10.1016/0014-5793(86)80699-8; JOSEPH SK, 1986, J BIOL CHEM, V261, P4658; MALGAROLI A, 1987, J CELL BIOL, V105, P2145, DOI 10.1083/jcb.105.5.2145; MOLLARD P, 1988, J BIOL CHEM, V263, P19570; MOORE EDW, 1990, CELL CALCIUM, V11, P157, DOI 10.1016/0143-4160(90)90068-6; OSIPCHUK YV, 1990, EMBO J, V9, P697, DOI 10.1002/j.1460-2075.1990.tb08162.x; POENIE M, 1990, CELL CALCIUM, V11, P85, DOI 10.1016/0143-4160(90)90062-Y; REINLIB L, 1989, AM J PHYSIOL, V257, pG950, DOI 10.1152/ajpgi.1989.257.6.G950; ROE MW, 1990, CELL CALCIUM, V11, P63, DOI 10.1016/0143-4160(90)90060-8; SHUTTLEWORTH TJ, 1990, BIOCHEM J, V266, P719, DOI 10.1042/bj2660719; SHUTTLEWORTH TJ, 1989, AM J PHYSIOL 1, V257, pC1020; SMITH JB, 1985, J BIOL CHEM, V260, P4413; TSIEN RY, 1982, J CELL BIOL, V94, P325, DOI 10.1083/jcb.94.2.325; ZAVOICO GB, 1988, J BIOL CHEM, V263, P9635	21	129	130	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1410	1414						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1988427				2022-12-25	WOS:A1991EU49700012
J	ANTRAS, J; LASNIER, F; PAIRAULT, J				ANTRAS, J; LASNIER, F; PAIRAULT, J			ADIPSIN GENE-EXPRESSION IN 3T3-F442A ADIPOCYTES IS POSTTRANSCRIPTIONALLY DOWN-REGULATED BY RETINOIC ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE PROTEASE HOMOLOG; ADIPOSE CONVERSION; LIPOPROTEIN-LIPASE; GLYCEROPHOSPHATE DEHYDROGENASE; MESSENGER-RNA; 3T3 CELLS; VITAMIN-A; DIFFERENTIATION; TRANSCRIPTION; INSULIN	Retinoic acid (RA) has been shown to inhibit the differentiation of 3T3 adipogenic cell lines. In this report, the steady-state levels of several adipose-specific mRN As were studied in mature adipocytes treated with RA. Northern blot analysis showed that, following a 24-h exposure of 3T3-F442A adipocytic cultures to RA (10-mu-M), there was a 4-5-fold decrease of adipsin mRNA level. In contrast, actin, adipocyte P2, lipoprotein lipase, and glycerophosphate dehydrogenase mRNA levels were unchanged during the same interval. The rate of adipsin and actin gene transcription, assessed by nuclear run-on assays, remained unchanged in adipocytes exposed to RA. The half-life (t1/2) of adipsin mRNA, determined by pulse-chase with [H-3] uridine, was greatly shortened in RA-treated adipocytes (t1/2 approximately 7.3 h) as compared with untreated cells (t1/2 approximately 37.6 h). Conversely, actin mRNA stability was not altered by the drug. These results suggest that RA can specifically down-regulate adipsin expression in adi-pocytes at a posttranscriptional level without inducing the reversal of adipocyte differentiation.	HOP HENRI MONDOR, INSERM, U282, 51 AV ML DELATTRE DETASSIGNY, F-94010 CRETEIL, FRANCE	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)								BENYA PD, 1986, DEV BIOL, V118, P296, DOI 10.1016/0012-1606(86)90096-5; BERNLOHR DA, 1984, P NATL ACAD SCI-BIOL, V81, P5468, DOI 10.1073/pnas.81.17.5468; BERNLOHR DA, 1985, J BIOL CHEM, V260, P5563; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; CLARKE CL, 1990, J BIOL CHEM, V265, P12694; CLEVELAND D W, 1989, New Biologist, V1, P121; COOK KS, 1987, SCIENCE, V237, P402, DOI 10.1126/science.3299705; COOK KS, 1985, P NATL ACAD SCI USA, V82, P6480, DOI 10.1073/pnas.82.19.6480; COOK KS, 1985, J CELL BIOL, V100, P514, DOI 10.1083/jcb.100.2.514; DANI C, 1989, MOL CELL ENDOCRINOL, V63, P199, DOI 10.1016/0303-7207(89)90096-8; DAVIES PJA, 1985, J BIOL CHEM, V260, P5166; DETHE H, 1989, EMBO J, V8, P429, DOI 10.1002/j.1460-2075.1989.tb03394.x; DJIAN P, 1985, J CELL PHYSIOL, V124, P554, DOI 10.1002/jcp.1041240327; DUGAIL I, 1989, BIOCHEM J, V257, P917, DOI 10.1042/bj2570917; DUGAIL I, 1990, J BIOL CHEM, V265, P1831; ECKEL RH, 1977, BIOCHEM BIOPH RES CO, V78, P288, DOI 10.1016/0006-291X(77)91252-9; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FEVE B, 1989, MOL CELL ENDOCRINOL, V67, P17, DOI 10.1016/0303-7207(89)90226-8; FLIER JS, 1987, SCIENCE, V237, P405, DOI 10.1126/science.3299706; FUCHS E, 1981, CELL, V25, P617, DOI 10.1016/0092-8674(81)90169-0; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; GREEN K, 1979, ACTA OBSTET GYN SCAN, P15; GREEN S, 1988, TRENDS GENET, V4, P309, DOI 10.1016/0168-9525(88)90108-4; HAUSSLER M, 1983, P NATL ACAD SCI-BIOL, V80, P5525, DOI 10.1073/pnas.80.18.5525; HU L, 1990, MOL CELL BIOL, V10, P391, DOI 10.1128/MCB.10.1.391; HUNT CR, 1986, P NATL ACAD SCI USA, V83, P3786, DOI 10.1073/pnas.83.11.3786; JETTEN AM, 1979, EXP CELL RES, V124, P381, DOI 10.1016/0014-4827(79)90213-1; KURIHARCUCH W, 1978, CELL, V14, P53, DOI 10.1016/0092-8674(78)90300-8; KURIHARCUCH W, 1982, DIFFERENTIATION, V23, P164, DOI 10.1111/j.1432-0436.1982.tb01279.x; Maniatis T, 1982, MOL CLONING LABORATO; MOUSTAID N, 1990, J CELL BIOCHEM, V42, P243, DOI 10.1002/jcb.240420407; MURRAY T, 1980, J SUPRAMOL STR CELL, V14, P255, DOI 10.1002/jss.400140214; NEGREL R, 1978, P NATL ACAD SCI USA, V75, P6054, DOI 10.1073/pnas.75.12.6054; OLIVECRONA T, 1987, J BIOL CHEM, V262, P10748; PACIFICI M, 1980, EXP CELL RES, V129, P469, DOI 10.1016/0014-4827(80)90517-0; PAIRAULT J, 1987, J CELL PHYSIOL, V132, P279, DOI 10.1002/jcp.1041320212; PAIRAULT J, 1979, P NATL ACAD SCI USA, V76, P5138, DOI 10.1073/pnas.76.10.5138; PAIRAULT J, 1988, EXP CELL RES, V177, P27, DOI 10.1016/0014-4827(88)90022-5; ROBERTS AB, 1984, RETINOIDS, V2, P209; ROSEN BS, 1989, SCIENCE, V244, P1483, DOI 10.1126/science.2734615; SIDHU RS, 1979, J BIOL CHEM, V254, P1111; SPIEGELMAN BM, 1983, J BIOL CHEM, V258, P83; SPIEGELMAN BM, 1989, J BIOL CHEM, V264, P1811; SPIEGELMAN BM, 1980, J BIOL CHEM, V255, P8811; SPOONER PM, 1979, J BIOL CHEM, V254, P1305; STRICKLAND S, 1978, CELL, V15, P393, DOI 10.1016/0092-8674(78)90008-9; THALLER C, 1987, NATURE, V327, P625, DOI 10.1038/327625a0; VAULONT S, 1984, BIOCHEM BIOPH RES CO, V125, P135, DOI 10.1016/S0006-291X(84)80345-9; WILKISON WO, 1990, J BIOL CHEM, V265, P477; WION KL, 1987, SCIENCE, V235, P1638, DOI 10.1126/science.3823907; WISE LS, 1979, J BIOL CHEM, V254, P273; WISE LS, 1978, CELL, V13, P233, DOI 10.1016/0092-8674(78)90192-7; ZEZULAK KM, 1985, MOL CELL BIOL, V5, P419, DOI 10.1128/MCB.5.2.419	54	85	87	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1157	1161						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985940				2022-12-25	WOS:A1991ET17700075
J	DANIEL, V; MAKSYMOWYCH, AB; ALNEMRI, ES; LITWACK, G				DANIEL, V; MAKSYMOWYCH, AB; ALNEMRI, ES; LITWACK, G			CELL-FREE SYNTHESIS OF RAT GLUCOCORTICOID RECEPTOR IN RABBIT RETICULOCYTE LYSATE - INVITRO SYNTHESIS OF RECEPTOR IN MR 90,000 HEAT-SHOCK PROTEIN-DEPLETED LYSATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROID-RECEPTORS; BINDING PHOSPHOPROTEIN; PURIFICATION; ACTIVATION; COMPLEX; TRANSLATION; ASSOCIATION; COMPONENT; MODULATOR; ACID	The glucocorticoid receptor is present in the cytosol of cell extracts as a large nonactivated (i.e. non-DNA-binding) approximately 9 S (M(r) 300,000) complex. Experimental evidence indicates that the purified nonactivated glucocorticoid receptor contains a single steroid-binding protein and two approximately 90-kDa nonsteroid-binding subunits identified as heat shock protein (hsp) 90. Translation of the glucocorticoid receptor mRNA in vitro in reticulocyte lysates produces a large nonactivated glucocorticoid receptor complex similar to that found in cytosols. The cell-free synthesized glucocorticoid receptor is able to bind steroid and can be activated further to the DNA-binding form. To test the hypothesis of an active role played by hsp90 in the stabilization of a competent steroid-binding conformation of the glucocorticoid receptor, we have synthesized the receptor in a reticulocyte lysate that has been depleted of hsp90 by immunoadsorption with AC88 anti-hsp90. Although the translation capacity of the reticulocyte system was reduced considerably upon hsp90 removal, the glucocorticoid receptor was synthesized, and a significant number of molecules were found to bind [H-3]triamcinolone acetonide. Chromatography on DEAE-cellulose showed that most of the receptor molecules synthesized in hsp90-depleted lysate had lost the capacity to form an oligomeric receptor complex. Addition of purified rat liver hsp90 to the hsp90-depleted lysate before translation did not increase steroid binding nor did it restore formation of the heteromeric receptor complex. Analysis of [S-35] methionine-labeled glucocorticoid receptor molecules synthesized in the hsp90-depleted lysate showed the production of polypeptides differing from the expected chromatographic pattern on DEAE-cellulose. Upon addition of purified hsp90 to the hsp90-depleted lysate, before translation, the S-35-labeled synthesized receptor fractionated on DEAE-cellulose as an intermediate peak between activated and nonactivated receptor forms. The data suggest that hsp90 alone may not be sufficient for the formation of the nonactivated steroid receptor complex.	TEMPLE UNIV,HLTH SCI CTR,SCH MED,FELS INST CANC RES & MOLEC BIOL,PHILADELPHIA,PA 19140; TEMPLE UNIV,HLTH SCI CTR,SCH MED,DEPT BIOCHEM,PHILADELPHIA,PA 19140	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University					NATIONAL CANCER INSTITUTE [P30CA012227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007162, R01DK013531] Funding Source: NIH RePORTER; NCI NIH HHS [CA12227] Funding Source: Medline; NIDDK NIH HHS [DK13531, T32 DK07162] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BODINE PV, 1988, J BIOL CHEM, V263, P3501; BODINE PV, 1988, P NATL ACAD SCI USA, V85, P1462, DOI 10.1073/pnas.85.5.1462; BODINE PV, 1990, J BIOL CHEM, V265, P9544; BRESNICK EH, 1988, BIOCHEMISTRY-US, V27, P2866, DOI 10.1021/bi00408a030; BRESNICK EH, 1989, J BIOL CHEM, V264, P4992; CATELLI MG, 1985, EMBO J, V4, P3131, DOI 10.1002/j.1460-2075.1985.tb04055.x; DALMAN FC, 1989, J BIOL CHEM, V264, P19815; DENIS M, 1989, J BIOL CHEM, V264, P6005; DENIS M, 1988, ANAL BIOCHEM, V173, P405, DOI 10.1016/0003-2697(88)90207-2; DENIS M, 1987, J BIOL CHEM, V262, P11803; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; GEHRING U, 1985, FEBS LETT, V179, P138, DOI 10.1016/0014-5793(85)80208-8; HOUSLEY PR, 1985, J BIOL CHEM, V260, P3810; MATTS RL, 1989, J BIOL CHEM, V264, P15542; MENDEL DB, 1988, J BIOL CHEM, V263, P6695; MENDEL DB, 1986, J BIOL CHEM, V261, P3758; MIESFELD R, 1986, CELL, V46, P3389; OKRET S, 1985, BIOCHEMISTRY-US, V24, P6581, DOI 10.1021/bi00344a041; REXIN M, 1988, BIOCHEMISTRY-US, V27, P5593, DOI 10.1021/bi00415a030; RIEHL RM, 1985, BIOCHEMISTRY-US, V24, P6586, DOI 10.1021/bi00344a042; SANCHEZ ER, 1985, J BIOL CHEM, V260, P2398; SCHMIDT TJ, 1985, J BIOL CHEM, V260, P6255; SHERMAN MR, 1984, ANNU REV PHYSIOL, V46, P83; VEDECKIS WV, 1985, HORMONALLY RESPONSIV, P3; WEBB ML, 1985, BIOCHEMISTRY-US, V24, P1946, DOI 10.1021/bi00329a022; WEBB ML, 1986, BIOCHEM BIOPH RES CO, V140, P204, DOI 10.1016/0006-291X(86)91077-6; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209	27	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1320	1325						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985950				2022-12-25	WOS:A1991ET17700097
J	BURCHAM, PC; HARMAN, AW				BURCHAM, PC; HARMAN, AW			ACETAMINOPHEN TOXICITY RESULTS IN SITE-SPECIFIC MITOCHONDRIAL DAMAGE IN ISOLATED MOUSE HEPATOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED HEPATIC NECROSIS; P-BENZOQUINONE IMINE; COVALENT BINDING; INDUCED HEPATOTOXICITY; METABOLITE; RESPIRATION; GLUTATHIONE; INHIBITION; LIVER; RAT	Exposure of isolated mouse hepatocytes to a toxic concentration of acetaminophen (5 mM) resulted in damage to the mitochondrial respiratory apparatus. The nature of this damage was investigated by measuring respiration stimulated by site-specific substrates in digitonin-permeabilized hepatocytes after acetaminophen exposure. Respiration stimulated by succinate at energy-coupling site 2 was most sensitive to inhibition and was decreased by 47% after 1 h. Respiration supported by NADH-linked substrates (site 1) was also decreased but to a lesser extent, while there was no decrease in the rate of ascorbate + N,N,N',N'-tetramethyl-p-phenylenediamine (TMPD)-supported respiration (site 3). The loss of mitochondrial respiratory function was accompanied by a decrease in ATP levels and ATP/ADP ratios in the cytosolic compartment and was preceded by a loss of reduced glutathione in both the cytosol and mitochondria. All these effects occurred well before the loss of cell membrane integrity. The putative toxic metabolite of acetaminophen, N-acetyl-p-benzoquinonimine (NAPQI), produced a similar pattern of respiratory dysfunction in isolated hepatic mitochondria. Respiration stimulated by succinate- and NADH-linked substrates was very sensitive to 50-mu-M NAPQI, while ascorbate + TMPD-supported respiration was unaffected. The interaction between NAPQI and the respiratory chain was further investigated using submitochondrial particles. Succinate dehydrogenase (associated with respiratory complex II) was found to be very sensitive to NAPQI, while NADH dehydrogenase (respiratory complex I) was inhibited to a lesser extent. Our results indicate that a loss of the ability to utilize succinate- and NADH-linked substrates due to attack of the respiratory chain by NAPQI causes a disruption of energy homeostasis in acetaminophen hepatotoxicity.	UNIV WESTERN AUSTRALIA,QUEEN ELIZABETH II MED CTR,DEPT PHARMACOL,NEDLANDS,WA 6009,AUSTRALIA	University of Western Australia								ALBANO E, 1985, MOL PHARMACOL, V28, P306; BARBERO MC, 1984, ARCH BIOCHEM BIOPHYS, V228, P560, DOI 10.1016/0003-9861(84)90023-7; BIRGE RB, 1988, BIOCHEM PHARMACOL, V37, P3383, DOI 10.1016/0006-2952(88)90686-7; BONNER WD, 1955, METHOD ENZYMOL, V1, P722, DOI 10.1016/0076-6879(55)01126-9; Brautigan D L, 1978, Methods Enzymol, V53, P128; BROCKS DG, 1980, BIOCHEM J, V188, P207, DOI 10.1042/bj1880207; BURCHAM PC, 1990, TOXICOL LETT, V50, P37, DOI 10.1016/0378-4274(90)90250-P; Cain K., 1987, BIOCH TOXICOLOGY PRA, P217; COOKSON SL, 1978, J IMMUNOL METHODS, V23, P169, DOI 10.1016/0022-1759(78)90120-5; DAHLIN DC, 1982, J MED CHEM, V25, P885, DOI 10.1021/jm00350a001; DARLEYUSMAR VM, 1987, MITOCHONDRIA PRACTIC, P113; DEVALIA JL, 1983, BIOCHEM PHARMACOL, V32, P2602, DOI 10.1016/0006-2952(83)90027-8; ERECINSKA M, 1981, INHIBITORS MITOCHOND, P1; ESTERLINE RL, 1989, BIOCHEM PHARMACOL, V38, P2387, DOI 10.1016/0006-2952(89)90481-4; FISCHER LJ, 1981, J PHARMACOL EXP THER, V219, P281; GALANTE Y, 1978, METHOD ENZYMOL, V52, P15; GRIMM H, 1973, BIOSTATISTICS PHARMA, V2, P675; HARMAN AW, 1985, RES COMMUN CHEM PATH, V49, P215; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; HEMS R, 1968, BIOCHEM J, V107, P807, DOI 10.1042/bj1070807; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Jaworek D, 1974, METHODS ENZYMATIC AN, P2127, DOI 10.1016/B978-0-12-091304-6.50066-5; JOLLOW DJ, 1973, J PHARMACOL EXP THER, V187, P195; KATYARE SS, 1989, BRIT J PHARMACOL, V96, P51, DOI 10.1111/j.1476-5381.1989.tb11783.x; KLEINBAUM DG, 1988, APPLIED REGRESSION A, P365; LAMPRECHT W, 1974, METHOD ENZYMAT AN, V4, P2101; MARTENSSON J, 1989, P NATL ACAD SCI USA, V86, P5296, DOI 10.1073/pnas.86.14.5296; MEREDITH J, 1982, J BIOL CHEM, V257, P3747; MEYERS LL, 1988, TOXICOL APPL PHARM, V93, P378, DOI 10.1016/0041-008X(88)90040-3; MINER DJ, 1979, BIOCHEM PHARMACOL, V28, P3285, DOI 10.1016/0006-2952(79)90123-0; MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P211; Moldeus P, 1978, Methods Enzymol, V52, P60; MOORE M, 1985, J BIOL CHEM, V260, P3035; MORRE D, 1972, METHOD ENZYMOL, V22, P130; NAHAPETIAN A, 1975, J AGR FOOD CHEM, V23, P1179, DOI 10.1021/jf60202a014; NAKAE D, 1988, ARCH BIOCHEM BIOPHYS, V267, P651, DOI 10.1016/0003-9861(88)90073-2; Nedergaard J, 1979, Methods Enzymol, V55, P3; OHNISHI T, 1987, CURR TOP BIOENERG, V15, P37; ORRENIUS S, 1983, CELLULAR PATHOBIOLOG, P123; RAMSAY RR, 1989, ARCH BIOCHEM BIOPHYS, V273, P449, DOI 10.1016/0003-9861(89)90504-3; RIESKE JS, 1981, INHIBITORS MITOCHOND, P109; SCHMIDT E, 1974, METHOD ENZYMAT AN, V2, P650; Seifter S, 1988, LIVER BIOL PATHOBIOL, P279; SOBOLL S, 1978, EUR J BIOCHEM, V87, P377, DOI 10.1111/j.1432-1033.1978.tb12387.x; STREETER AJ, 1984, CHEM-BIOL INTERACT, V48, P349, DOI 10.1016/0009-2797(84)90145-5; STREY B, 1981, INHIBITORS MITOCHOND, P101; TIRMENSTEIN MA, 1989, J BIOL CHEM, V264, P9814; TIRMENSTEIN MA, 1990, J BIOL CHEM, V265, P3059; TZAGOLOFF A, 1982, MITOCHONDRIA, P41; WALKER RM, 1980, LAB INVEST, V42, P181; [No title captured]	51	175	179	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					5049	5054						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002047				2022-12-25	WOS:A1991FC21700057
J	WEISS, J; WRIGHT, G; BEKKERS, ACAPA; VANDENBERGH, CJ; VERHEIJ, HM				WEISS, J; WRIGHT, G; BEKKERS, ACAPA; VANDENBERGH, CJ; VERHEIJ, HM			CONVERSION OF PIG PANCREAS PHOSPHOLIPASE-A2 BY PROTEIN ENGINEERING INTO ENZYME ACTIVE AGAINST ESCHERICHIA-COLI TREATED WITH THE BACTERICIDAL PERMEABILITY-INCREASING PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; SUBSTRATE-BINDING; BOVINE; VENOM; CLASSIFICATION; DETERMINANTS; DEGRADATION; RESOLUTION; REGION	Phospholipases A2 (PLA-2) are conserved enzymes that can vary widely in their activity toward certain biological targets. Activity of PLA-2 toward Escherichia coli treated with the bactericidal/permeability-increasing protein (BPI) of granulocytes has been detected only in "Group II" PLA-2 (lacking Cys11-Cys77) and correlates with overall basicity and the presence of a cluster of basic amino acids within a variable surface region near the NH2 terminus (including residues 6, 7, 10, 11, and 15). We now show that of five pancreatic PLA-2 ("Group I" enzymes) tested from different species of mammals, the human enzyme that is most basic both globally (pI 8.7) and locally (Arg-6, Lys-7, and Lys-10) is active toward BPI-treated E. coli (approximately 1-2% activity of the most active Group II PLA-2) whereas the other four PLA-2 are essentially inactive (< 0.1%). The cDNA of the pig pancreatic PLA-2 (pI 6.4; Arg-6, Ser-7, Lys-10) has been modified by site-specific mutagenesis and the wild-type and mutant PLA-2 have been expressed in and purified from either E. coli or Saccharomyces cerevisiae to determine more precisely the structural determinants of PLA-2 activity toward BPI-treated E. coli. The single substitution of lysine (or arginine) for Ser-7 transformed the pig pancreatic PLA-2 into an active enzyme toward BPI-treated E. coli possessing 25-50% the activity of the human PLA-2. Additional modifications to increase global basicity (increase in net charge up to +4) caused a further (up to 2-fold) increase in activity. All mutant PLA-2 still containing Ser-7 possessed little or no activity toward BPI-treated E. coli. Changes in activity toward BPI-treated E. coli were accompanied by parallel changes in enzyme binding to this target. In contrast, substitution of lysine (or arginine) for Ser-7 caused little or no alteration of enzyme activity toward either autoclaved E. coli or egg yolk lipoproteins indicating no major effects on the catalytic properties of the PLA-2. This study demonstrates directly the role of NH2-terminal basic residues in the action of PLA-2 on BPI-treated E. coli and suggests that these properties mainly facilitate PLA-2 binding to this biological target.	NYU,SCH MED,DEPT MED,NEW YORK,NY 10016; STATE UNIV UTRECHT,CTR BIOMEMBRANES & LIPID ENZYMOL,DEPT BIOCHEM,UTRECHT,NETHERLANDS	New York University; Utrecht University	WEISS, J (corresponding author), NYU,SCH MED,DEPT MICROBIOL,NEW YORK,NY 10016, USA.			Weiss, Jerrold/0000-0003-1476-4485; Wright, Grace/0000-0002-6043-7277	NIAID NIH HHS [AI 18571] Funding Source: Medline; NIDDK NIH HHS [R37 DK 05472] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK005472] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BRUNIE S, 1985, J BIOL CHEM, V260, P9742; CARTER P, 1985, NUCLEIC ACIDS RES, V13, P4431, DOI 10.1093/nar/13.12.4431; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; CHO WW, 1988, J BIOL CHEM, V263, P11237; DAVIDSON FF, 1991, IN PRESS J MOL EVOL; DEGEUS P, 1983, MOL GEN GENET, V190, P150, DOI 10.1007/BF00330338; DEGEUS P, 1987, NUCLEIC ACIDS RES, V15, P3743, DOI 10.1093/nar/15.9.3743; DIJKSTRA BW, 1981, J MOL BIOL, V147, P97, DOI 10.1016/0022-2836(81)90081-4; DIJKSTRA BW, 1983, J MOL BIOL, V168, P163, DOI 10.1016/S0022-2836(83)80328-3; DUFTON MJ, 1983, EUR J BIOCHEM, V137, P545, DOI 10.1111/j.1432-1033.1983.tb07860.x; DUFTON MJ, 1983, EUR J BIOCHEM, V137, P537, DOI 10.1111/j.1432-1033.1983.tb07859.x; DUTILH CE, 1975, EUR J BIOCHEM, V53, P91, DOI 10.1111/j.1432-1033.1975.tb04045.x; ELSBACH P, 1985, J BIOL CHEM, V260, P1618; ELSBACH P, 1988, BIOCHIM BIOPHYS ACTA, V947, P29, DOI 10.1016/0304-4157(88)90018-4; EVENBERG A, 1977, J BIOL CHEM, V252, P1189; FLEER EAM, 1978, EUR J BIOCHEM, V82, P261, DOI 10.1111/j.1432-1033.1978.tb12019.x; FORST S, 1982, J BIOL CHEM, V257, P4055; FORST S, 1986, BIOCHEMISTRY-US, V25, P8381, DOI 10.1021/bi00374a008; FORST S, 1987, BIOCHIM BIOPHYS ACTA, V920, P221, DOI 10.1016/0005-2760(87)90098-1; FORST S, 1986, BIOCHEMISTRY-US, V25, P4039; HEINRIKSON RL, 1977, J BIOL CHEM, V252, P4913; KINI RM, 1987, J BIOL CHEM, V262, P14402; KINI RM, 1989, TOXICON, V27, P613, DOI 10.1016/0041-0101(89)90013-5; KRAMER W, 1984, NUCLEIC ACIDS RES, V12, P9441, DOI 10.1093/nar/12.24.9441; KUIPERS OP, 1989, SCIENCE, V244, P82, DOI 10.1126/science.2704992; KUIPERS OP, 1989, PROTEIN ENG, V2, P467, DOI 10.1093/protein/2.6.467; LAMBEAU G, 1990, J BIOL CHEM, V265, P9526; MARAGANORE JM, 1984, J BIOL CHEM, V259, P3839; MOLLIER P, 1989, EUR J BIOCHEM, V185, P263, DOI 10.1111/j.1432-1033.1989.tb15111.x; Nieuwenhuizen W, 1974, Methods Enzymol, V32, P147; OOI CE, 1987, J BIOL CHEM, V262, P14891; PATRIARC.P, 1972, BIOCHIM BIOPHYS ACTA, V280, P45, DOI 10.1016/0005-2760(72)90211-1; PUIJK WC, 1979, BIOCHIM BIOPHYS ACTA, V580, P411, DOI 10.1016/0005-2795(79)90153-3; RANDOLPH A, 1982, J BIOL CHEM, V257, P2155; RENETSEDER R, 1985, J BIOL CHEM, V260, P1627; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; VANDENBERGH CJ, 1987, EUR J BIOCHEM, V170, P241; VANDENBERGH CJ, 1989, THESIS U UTRECHT UTR; VANSCHARRENBURG GJM, 1983, EUR J BIOCHEM, V133, P83; VERHEIJ HM, 1980, EUR J BIOCHEM, V112, P25, DOI 10.1111/j.1432-1033.1980.tb04982.x; VERHEIJ HM, 1983, BIOCHIM BIOPHYS ACTA, V747, P93, DOI 10.1016/0167-4838(83)90126-7; VERHEIJ HM, 1981, REV PHYSL BIOCH PHAR, V91, P92; Waite M, 1987, HDB LIPID RES, V5, P155; WEISS J, 1979, J BIOL CHEM, V254, P1010; WETZEL R, 1988, PROTEIN ENG, V2, P1, DOI 10.1093/protein/2.1.1; WRIGHT GC, 1990, J CLIN INVEST, V85, P1925, DOI 10.1172/JCI114655; WRIGHT GW, 1990, J BIOL CHEM, V265, P6675	47	46	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4162	4167						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999411				2022-12-25	WOS:A1991FA69400025
J	JANICKBUCKNER, D; BARUA, AB; OLSON, JA				JANICKBUCKNER, D; BARUA, AB; OLSON, JA			INDUCTION OF HL-60 CELL-DIFFERENTIATION BY WATER-SOLUBLE AND NITROGEN-CONTAINING CONJUGATES OF RETINOIC ACID AND RETINOL	FASEB JOURNAL			English	Note						RETINOIDS; HL-60 CELLS; CELL DIFFERENTIATION	ONCOGENE EXPRESSION; CHEMICAL SYNTHESIS; BETA-GLUCURONIDE; LINE HL-60; RECEPTOR; IDENTIFICATION; GROWTH; GAMMA	Retinoids induce the promyelocytic cell line, HL-60, to differentiate along the granulocytic pathway in vitro. A number of water-soluble and nitrogen-containing retinoids were synthesized in our laboratory [retinoyl-glucose (RAGL), retinyl-glucose (ROGL), retinoyl-adenosine (RADS), retinoyl-adenine (RAD), retinoyl-beta-glucuronide (beta-RAG), and retinoyl-alpha-glucuronide (alpha-RAG)]. These retinoids (10(-5) to 10(-8) M), as well as retinoic acid (RA) and retinol (ROL), were tested for their ability to induce the differentiation of HL-60 cells in vitro and to affect cell growth and viability during a 24- to 72-h incubation period. Differentiation was assessed by measuring the percentage of cells expressing the Mac-1 antigen on their cell surfaces. RA and the conjugates of RA were all quite active in inducing HL-60 cell differentiation, whereas ROL and ROGL had much less activity at equimolar concentrations. Beta-RAG, alpha-RAG, RADS, and RAD were less toxic, whereas the glucose conjugates of retinol and retinoic acid (ROGL and RAGL) were both considerably more toxic than either RA or ROL at equimolar concentrations. All retinoids affected cell growth in a dose-dependent fashion. At 24 h, free RA or ROL was not detected in the cells after incubation with any of the retinoid conjugates.	IOWA STATE UNIV SCI & TECHNOL,DEPT BIOCHEM & BIOPHYS,AMES,IA 50011	Iowa State University					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039733] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-39733] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARUA A B, 1989, FASEB Journal, V3, pA468; BARUA AB, 1985, J LIPID RES, V26, P258; BARUA AB, 1985, FED PROC, V44, P772; BARUA AB, 1988, BIOCHEM J, V252, P415, DOI 10.1042/bj2520415; BARUA AB, 1987, BIOCHEM J, V244, P231, DOI 10.1042/bj2440231; BARUA AB, 1985, J LIPID RES, V26, P1277; BARUA AB, 1990, 9TH INT S CAR KYOT, P62; BARUA AB, 1989, Patent No. 4855463; BRAND N, 1988, NATURE, V332, P850, DOI 10.1038/332850a0; BREITMAN TR, 1980, EXP CELL RES, V126, P494, DOI 10.1016/0014-4827(80)90296-7; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; COLLINS SJ, 1987, BLOOD, V70, P1233; DAVIES PJA, 1985, J BIOL CHEM, V260, P5166; DETHE H, 1989, EUR MOL BIOL ORG J, V8, P426; DUFER J, 1989, LEUKEMIA RES, V13, P621, DOI 10.1016/0145-2126(89)90131-8; FONTANA JA, 1986, CANCER RES, V46, P2469; GALLUP JM, 1987, P SOC EXP BIOL MED, V186, P269; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; GUNNING D B, 1989, FASEB Journal, V3, pA467; GUNNING D B, 1990, FASEB Journal, V4, pA660; IMAIZUMI M, 1988, CANCER RES, V48, P6733; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; KRUST A, 1989, P NATL ACAD SCI USA, V86, P5310, DOI 10.1073/pnas.86.14.5310; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; MILLER BA, 1985, J IMMUNOL, V134, P3286; NATH KAMALENDU, 1967, J NUTR, V93, P461; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; SIETSEMA WK, 1982, J NUTR, V112, P1481, DOI 10.1093/jn/112.8.1481; TAKAHASHI N, 1989, J BIOL CHEM, V264, P5159; TAKAHASHI N, 1990, FASEB J, V4, pA2057; WRIGHT SD, 1983, P NATL ACAD SCI-BIOL, V80, P5699, DOI 10.1073/pnas.80.18.5699; WU X, 1988, LEUKEMIA RES, V13, P869; ZELENT A, 1989, NATURE, V339, P714, DOI 10.1038/339714a0; ZILE MH, 1987, P NATL ACAD SCI USA, V84, P2208, DOI 10.1073/pnas.84.8.2208	34	41	42	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998	0892-6638			FASEB J	Faseb J.	MAR 1	1991	5	3					320	325		10.1096/fasebj.5.3.2001792	http://dx.doi.org/10.1096/fasebj.5.3.2001792			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FC556	2001792				2022-12-25	WOS:A1991FC55600010
J	BUBB, MR; LEWIS, MS; KORN, ED				BUBB, MR; LEWIS, MS; KORN, ED			THE INTERACTION OF MONOMERIC ACTIN WITH 2 BINDING-SITES ON ACANTHAMOEBA ACTOBINDIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-ACTIN; POLYMERIZATION; INHIBITION; PROFILIN	Actobindin was previously shown to be an 88-residue polypeptide (M(r) 9761) with an internal tandem repeat of 33-34 amino acids. Sedimentation equilibrium experiments have confirmed this M(r) for native actobindin. Pyreneglyoxal-labeled actobindin had a similar M(r) by sedimentation equilibrium analysis and bound to actin in a manner qualitatively similar to unmodified actobindin as determined by gel electrophoretic analysis of covalently cross-linked products. The stoichiometry of the actin-actobindin interaction was determined from the change in apparent M(r) of pyreneglyoxal-labeled actobindin in the presence of actin, as determined by scanning the ultracentrifuge cell at a wavelength that detected only the labeled protein. These data were consistent with the formation of a complex containing two actin and one actobindin molecules. The overall K(D) describing the binding of the first actin to either of the two sites on actobindin was 3.3-mu-M. The binding constant for the second actin suggested either negative cooperativity or inequality of the two actin-binding sites. Similar binding constants were obtained by analysis of the fluorescence enhancement that occurred when actobindin bound to actin labeled with either pyrene iodoacetamide or 4-(N-iodoacetoxyethyl-N-methyl)-7-nitrobenz-2-oxa-1,3-diazole. Cross-linking experiments with 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide and N-hydroxysulfosuccinimide qualitatively agreed with predictions made from a two-binding site model. Additionally, both the fluorescence and cross-linking experiments suggested that the interaction of the two actin molecules may contribute to the stability of the heterotrimeric complex.	NIH, NATL CTR RES RESOURCES, BIOMED ENGN & INSTRUMENTAT PROGRAM, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA	BUBB, MR (corresponding author), NHLBI, CELL BIOL LAB, BETHESDA, MD 20892 USA.		Korn, Edward D/F-9929-2012	Korn, Edward/0000-0003-3867-6295				BUBB MR, 1991, METHOD ENZYMOL, V196, P119; CHATELIER RC, 1987, BIOPHYS CHEM, V28, P121, DOI 10.1016/0301-4622(87)80081-9; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; KNOTT GD, 1979, COMPUT PROG BIOMED, V10, P271, DOI 10.1016/0010-468X(79)90075-8; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; LAMBOOY PK, 1988, J BIOL CHEM, V263, P12836; LAMBOOY PK, 1986, J BIOL CHEM, V261, P7150; LEE S, 1988, ANAL BIOCHEM, V168, P148, DOI 10.1016/0003-2697(88)90022-X; MIKI M, 1984, BIOCHIM BIOPHYS ACTA, V786, P188, DOI 10.1016/0167-4838(84)90088-8; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; TOBACMAN LS, 1982, J BIOL CHEM, V257, P4166; VANDEKERCKHOVE J, 1990, J BIOL CHEM, V265, P12801; WEBER K, 1969, J BIOL CHEM, V244, P4406	14	40	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3820	3826						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995634				2022-12-25	WOS:A1991EY68200071
J	COOPER, LF; ELIA, DM; TABAK, LA				COOPER, LF; ELIA, DM; TABAK, LA			SECRETAGOGUE-COUPLED CHANGES IN THE EXPRESSION OF GLUTAMINE GLUTAMIC ACID-RICH PROTEINS (GRPS) - ISOPROTERENOL INDUCES CHANGES IN GRP TRANSCRIPT EXPRESSION AND CHANGES IN ISOFORMS SECRETED	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT SUBMANDIBULAR GLANDS; MESSENGER-RNAS; SALIVARY-GLANDS; AGAROSE GELS; GLYCOPROTEIN; INDUCTION; SEQUENCE; PLASMIDS; DNA	Glutamine/glutamic-acid rich proteins (GRPs) are a family of rat submandibular gland acinar proteins which are secreted in response to beta-adrenergic agonists such as isoproterenol. Two forms of GRP transcripts have been identified by isolating plasmids containing cDNAs which code for two distinct GRPs, termed GRP-Ca and GRP-Cb. GRP-Ca and GRP-Cb have identical sequences up to nucleotide 670. This is followed by a unique 90- (GRP-Ca) or 95- (GRP-Cb) base pair element. Both forms have common 3' nucleotide sequences, although the GRP-Cb stop codon is 27 base pairs further 3' from the start site of transcription. Systemic exposure to isoproterenol results in a decrease in the relative steady-state level of GRP-Ca transcripts within 24 h, whereas GRP-Cb message increases after several days of isoproterenol treatment. The demonstration that secretagogues such as isoproterenol can modulate changes in salivary protein expression suggests that the machinery responsible for exocytosis is functionally coupled to the cellular apparatus involved in acinar protein production.	UNIV ROCHESTER, SCH MED & DENT, DEPT DENT RES, ROCHESTER, NY 14642 USA; UNIV ROCHESTER, SCH MED & DENT, DEPT BIOCHEM, ROCHESTER, NY 14642 USA	University of Rochester; University of Rochester				Cooper, Lyndon/0000-0002-6577-781X	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE008108, K16DE000159, R37DE008108] Funding Source: NIH RePORTER; NIDCR NIH HHS [K-16 DE 00159, DE-08108] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ABE K, 1980, J DENT RES, V59, P1627, DOI 10.1177/00220345800590101201; ABE K, 1978, ARCH ORAL BIOL, V23, P367, DOI 10.1016/0003-9969(78)90094-8; ANN DK, 1987, J BIOL CHEM, V262, P899; ENRIETTO PJ, 1983, CELL, V35, P369, DOI 10.1016/0092-8674(83)90170-8; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HADCOCK JR, 1988, P NATL ACAD SCI USA, V85, P5021, DOI 10.1073/pnas.85.14.5021; HAN JH, 1987, BIOCHEMISTRY-US, V26, P1617, DOI 10.1021/bi00380a020; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HARLEY CB, 1987, GENE ANAL TECH, V4, P17, DOI 10.1016/0735-0651(87)90013-6; HEINRICH G, 1987, J BIOL CHEM, V262, P5262; HOLMES DS, 1981, ANAL BIOCHEM, V114, P193, DOI 10.1016/0003-2697(81)90473-5; KOUSVELARI E, 1988, EXP CELL RES, V179, P194, DOI 10.1016/0014-4827(88)90358-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LATHE R, 1985, J MOL BIOL, V183, P1, DOI 10.1016/0022-2836(85)90276-1; LEVINE M, 1989, CELL, V59, P405, DOI 10.1016/0092-8674(89)90024-X; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACDONALD RJ, 1988, BIOCHEM J, V253, P313, DOI 10.1042/bj2530313; MANDEL ID, 1987, J DENT RES, V66, P623, DOI 10.1177/00220345870660S203; Maniatis T., 1982, MOL CLONING; MATSUURA S, 1990, J DENT RES, V69, P239; MEHANSHO H, 1985, J BIOL CHEM, V260, P4418; MIRELS L, 1987, J BIOL CHEM, V262, P7289; MOREIRA JE, 1989, J HISTOCHEM CYTOCHEM, V37, P515, DOI 10.1177/37.4.2926128; NEVINS JR, 1983, ANNU REV BIOCHEM, V52, P441, DOI 10.1146/annurev.bi.52.070183.002301; RAVE N, 1979, NUCLEIC ACIDS RES, V6, P3559, DOI 10.1093/nar/6.11.3559; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; SCHNEYER LH, 1972, PHYSIOL REV, V52, P720, DOI 10.1152/physrev.1972.52.3.720; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SLIHAVY TJ, 1984, EXPT GENE FUSIONS, P191; SREEBNY LM, 1971, J BIOL CHEM, V246, P3879; TABAK LA, 1985, ARCH BIOCHEM BIOPHYS, V242, P383, DOI 10.1016/0003-9861(85)90222-X; WATSON GE, 1989, J DENT RES, V68, P1739, DOI 10.1177/00220345890680120401; WEBER K, 1969, J BIOL CHEM, V244, P4406; WILLIAMS JA, 1984, ANNU REV PHYSIOL, V46, P361; ZIEMER MA, 1982, J BIOL CHEM, V257, P1176	36	17	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3532	3539						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995617				2022-12-25	WOS:A1991EY68200032
J	KIMIZUKA, F; OHDATE, Y; KAWASE, Y; SHIMOJO, T; TAGUCHI, Y; HASHINO, K; GOTO, S; HASHI, H; KATO, I; SEKIGUCHI, K; TITANI, K				KIMIZUKA, F; OHDATE, Y; KAWASE, Y; SHIMOJO, T; TAGUCHI, Y; HASHINO, K; GOTO, S; HASHI, H; KATO, I; SEKIGUCHI, K; TITANI, K			ROLE OF TYPE-III HOMOLOGY REPEATS IN CELL ADHESIVE FUNCTION WITHIN THE CELL-BINDING DOMAIN OF FIBRONECTIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARG-GLY-ASP; HUMAN-PLASMA FIBRONECTIN; ESCHERICHIA-COLI; FRAGMENTS; IDENTIFICATION; SITE; ATTACHMENT; FIBROBLASTS; MUTAGENESIS; RECEPTORS	Recombinant fibronectin (FN) fragments and their mutant proteins were produced to elucidate the role of type III homology repeats in cell adhesive activity within the cell-binding domain of FN. Cell adhesive activity of the 11.5-kDa fragment, the cell attachment site of the cell-binding domain, was < 0.1% that of native FN despite the presence of the Arg-Gly-Asp-Ser sequence. The activity increased as type III homology repeats were added to the N terminus of the 11.5-kDa fragment, and a 52-kDa fragment with four additional type III repeats had almost the same activity of native FN. Deletion of Arg-Gly-Asp from the fully active fragments completely abolished the cell adhesive activity. Deletion of one or two repeats from the 52-kDa fragment affected the extent of the cell adhesive activity, the degree of the effect being inversely correlated with the distance of the deletion from the type III repeat containing Arg-Gly-Asp-Ser. Rearrangement of type III repeats caused much loss of activity. These results suggest that the number and kinds of type III repeats and their correct alignment rather than the putative synergistic site decide the extent of the specific cell adhesive activity.	FUJITA HLTH UNIV, SCH MED, INST COMPREHENS MED SCI, TOYOAKE, AICHI 47011, JAPAN	Fujita Health University	KIMIZUKA, F (corresponding author), TAKARA SHUZO CO LTD, BIOTECHNOL RES LABS, SETA 3-4-1, OTSU, SHIGA 52021, JAPAN.							AKIYAMA SK, 1985, J BIOL CHEM, V260, P3256; AKIYAMA SK, 1985, J BIOL CHEM, V260, P402; AKIYAMA SK, 1987, ADV ENZYMOL RAMB, V59, P1; BUCK CA, 1987, ANNU REV CELL BIOL, V3, P179, DOI 10.1146/annurev.cb.03.110187.001143; DUFOUR S, 1988, EMBO J, V7, P2661, DOI 10.1002/j.1460-2075.1988.tb03119.x; GHRAYEB J, 1984, EMBO J, V3, P2437, DOI 10.1002/j.1460-2075.1984.tb02151.x; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HUMPHRIES MJ, 1986, J CELL BIOL, V103, P2637, DOI 10.1083/jcb.103.6.2637; HUMPHRIES MJ, 1987, J BIOL CHEM, V262, P6886; HYNES RO, 1986, SCI AM, V254, P42, DOI 10.1038/scientificamerican0686-42; IZZARD CS, 1986, EXP CELL RES, V165, P320, DOI 10.1016/0014-4827(86)90586-0; KATAYAMA M, 1989, EXP CELL RES, V185, P229, DOI 10.1016/0014-4827(89)90051-7; KORNBLIHTT AR, 1985, EMBO J, V4, P1755, DOI 10.1002/j.1460-2075.1985.tb03847.x; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LATERRA J, 1983, J CELL BIOL, V96, P112, DOI 10.1083/jcb.96.1.112; MAEDA T, 1989, J BIOL CHEM, V264, P15165; MAKI M, 1987, FEBS LETT, V223, P174, DOI 10.1016/0014-5793(87)80531-8; Mosher DF, 1988, FIBRONECTIN; NEU HC, 1965, J BIOL CHEM, V240, P3685; OBARA M, 1987, FEBS LETT, V213, P261, DOI 10.1016/0014-5793(87)81502-8; OBARA M, 1988, CELL, V53, P649, DOI 10.1016/0092-8674(88)90580-6; PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985; RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X; RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SAUNDERS S, 1988, J CELL BIOL, V106, P423, DOI 10.1083/jcb.106.2.423; SEKIGUCHI K, 1986, BIOCHEMISTRY-US, V25, P4936, DOI 10.1021/bi00365a032; STREETER HB, 1987, J CELL BIOL, V105, P507, DOI 10.1083/jcb.105.1.507; THIERY JP, 1985, ANNU REV CELL BIOL, V1, P91, DOI 10.1146/annurev.cellbio.1.1.91; WOODS A, 1986, EMBO J, V5, P665, DOI 10.1002/j.1460-2075.1986.tb04265.x; YAMADA KM, 1984, J CELL BIOL, V99, P29, DOI 10.1083/jcb.99.1.29; YAMADA KM, 1983, ANNU REV BIOCHEM, V52, P761, DOI 10.1146/annurev.bi.52.070183.003553	34	58	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3045	3051						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993677				2022-12-25	WOS:A1991EX60000058
J	KUROKI, Y; AKINO, T				KUROKI, Y; AKINO, T			PULMONARY SURFACTANT PROTEIN-A (SP-A) SPECIFICALLY BINDS DIPALMITOYLPHOSPHATIDYLCHOLINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II CELLS; PHOSPHOLIPID-BINDING; TUBULAR MYELIN; HIGH-AFFINITY; CALCIUM-IONS; LUNG; SECRETION; COMPONENTS; CONVERSION	Phospholipids are the major components of pulmonary surfactant. Dipalmitoylphosphatidylcholine is believed to be especially essential for the surfactant function of reducing the surface tension at the air-liquid interface. Surfactant protein A (SP-A) with a reduced denatured molecular mass of 26-38 kDa, characterized by a collagen-like structure and N-linked glycosylation, interacts strongly with a mixture of surfactant-like phospholipids. In the present study the direct binding of SP-A to phospholipids on a thin layer chromatogram was visualized using I-125-SP-A as a probe, so that the phospholipid specificities of SP-A binding and the structural requirements of SP-A and phospholipids for the binding could be examined. Although I-125-SP-A bound phosphatidylcholine and sphingomyeline, it was especially strong in binding dipalmitoylphosphatidylcholine, but failed to bind phosphatidylglycerol, phosphatidylinositol, phosphatidylethanolamine, and phosphatidylserine. Labeled SP-A also exhibited strong binding to distearoylphosphatidylcholine, but weak binding to dimyristoyl-, 1-palmitoyl-2-linoleoyl-, and dilinoleoylphosphatidylcholine. Unlabeled SP-A readily competed with labeled SP-A for phospholipid binding. SP-A strongly bound dipalmitoylglycerol produced by phospholipase C treatment of dipalmitoylphosphatidylcholine, but not palmitic acid. This protein also failed to bind lysophosphatidylcholine produced by phospholipase A2 treatment of dipalmitoylphosphatidylcholine. I-125-SP-A shows almost no binding to dipalmitoylphosphatidylglycerol and dipalmitoylphosphatidylethanolamine. The addition of 10 mM EGTA into the binding buffer reduced much of the I-125-SP-A binding to phospholipids. Excess deglycosylated SP-A competed with labeled SP-A for binding to dipalmitoylphosphatidylcholine, but the excess collagenase-resistant fragment of SP-A failed. From these data we conclude that 1) SP-A specifically and strongly binds dipalmitoylphosphatidylcholine, 2) SP-A binds the nonpolar group of phospholipids, 3) the second positioned palmitate is involved in dipalmitoylphosphatidylcholine binding, and 4) the specificities of polar groups of dipalmitoylglycerophospholipids also appear to be important for SP-A binding, 5) the phospholipid binding activity of SP-A is dependent upon calcium ions and the integrity of the collagenous domain of SP-A, but not on the oligosaccharide moiety of SP-A. SP-A may play an important role in the regulation of recycling and intra- and extracellular movement of dipalmitoylphosphatidylcholine.			KUROKI, Y (corresponding author), SAPPORO MED COLL,DEPT BIOCHEM,S 1,W 17,CHUO KU,SAPPORO,HOKKAIDO 060,JAPAN.							BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BENSON BJ, 1984, BIOCHIM BIOPHYS ACTA, V793, P18, DOI 10.1016/0005-2760(84)90048-1; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529; CLEMENTS JA, 1965, HDB PHYSL, P31; DETHLOFF LA, 1986, BIOCHEM J, V233, P111, DOI 10.1042/bj2330111; DOBBS LG, 1987, P NATL ACAD SCI USA, V84, P1010, DOI 10.1073/pnas.84.4.1010; FAUVEL J, 1987, FEBS LETT, V221, P397, DOI 10.1016/0014-5793(87)80963-8; FORNSTEDT N, 1975, FEBS LETT, V57, P187, DOI 10.1016/0014-5793(75)80713-7; GLENNEY JR, 1987, J CELL BIOL, V104, P503, DOI 10.1083/jcb.104.3.503; HAWGOOD S, 1987, P NATL ACAD SCI USA, V84, P66, DOI 10.1073/pnas.84.1.66; HAWGOOD S, 1985, BIOCHEMISTRY-US, V24, P184, DOI 10.1021/bi00322a026; KING RJ, 1981, BIOCHIM BIOPHYS ACTA, V647, P159, DOI 10.1016/0005-2736(81)90242-X; KING RJ, 1979, BIOCHIM BIOPHYS ACTA, V557, P86, DOI 10.1016/0005-2736(79)90092-0; KING RJ, 1983, J BIOL CHEM, V258, P672; KING RJ, 1972, AM J PHYSIOL, V223, P707, DOI 10.1152/ajplegacy.1972.223.3.707; KLEE CB, 1988, BIOCHEMISTRY-US, V27, P6645, DOI 10.1021/bi00418a001; KUROKI Y, 1988, J BIOL CHEM, V263, P3388; KUROKI Y, 1988, P NATL ACAD SCI USA, V85, P5566, DOI 10.1073/pnas.85.15.5566; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAGNANI JL, 1980, ANAL BIOCHEM, V109, P399, DOI 10.1016/0003-2697(80)90667-3; RICE WR, 1987, J APPL PHYSIOL, V63, P692, DOI 10.1152/jappl.1987.63.2.692; ROSS GF, 1986, J BIOL CHEM, V261, P14283; SANDERS RL, 1980, ANAT REC, V198, P485, DOI 10.1002/ar.1091980310; TSAO FHC, 1990, BIOCHIM BIOPHYS ACTA, V1045, P29, DOI 10.1016/0005-2760(90)90200-H; WILLIAMS MC, 1977, J CELL BIOL, V72, P260, DOI 10.1083/jcb.72.2.260; WRIGHT JR, 1987, J BIOL CHEM, V262, P2888; WRIGHT JR, 1989, P NATL ACAD SCI USA, V86, P5410, DOI 10.1073/pnas.86.14.5410	29	161	162	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3068	3073						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993679				2022-12-25	WOS:A1991EX60000061
J	MAY, G; SUTTON, C; GOULD, H				MAY, G; SUTTON, C; GOULD, H			PURIFICATION AND CHARACTERIZATION OF KU-2, AN OCTAMER-BINDING PROTEIN RELATED TO THE AUTOANTIGEN-KU	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN GENE; IMMUNOGLOBULIN GENES; PROMOTER INVITRO; NUCLEAR FACTOR; AUTO-ANTIGEN; DNA; TRANSCRIPTION; ENHANCER; SEQUENCE; IDENTIFICATION	The octamer motif (ATTTGCAT) is an important regulatory element in eukaryotic gene expression. A previously unidentified protein that recognizes this motif has been isolated from the human B cell line, Daudi. The protein, which we term Ku-2, bears a close resemblance to the DNA-binding autoantigen Ku. Like Ku, it is a heterodimer with subunits of 83 and 72 kDa; antisera raised against either subunit of Ku cross-react with Ku-2. Two peptides have been sequenced and show a strong similarity to regions in the corresponding subunits of Ku. The sequences are not identical, however, suggesting that Ku-2 may be a B cell homologue of Ku. Both Ku and Ku-2 bind to the termini of DNA duplexes, but Ku-2 also binds to an internal octamer motif. It is not known whether Ku shares the latter property or whether the octamer binding is a consequence of sequence differences between the two proteins. Ku-2 does not react with antisera against the POU domain of the octamer-binding protein Oct-2, indicating that the DNA binding domains of the two proteins are dissimilar despite the ability of both to bind to the octamer motif. We discuss the evidence for the existence of a family of octamer-binding proteins related to Ku.	CELLTECH LTD, SLOUGH, BERKS, ENGLAND	Celltech Group Ltd	MAY, G (corresponding author), UNIV LONDON KINGS COLL, DEPT BIOPHYS CELL & MOLEC BIOL, 26-29 DRURY LANE, LONDON WC2B 5RL, ENGLAND.							BAUMRUKER T, 1988, GENE DEV, V2, P1400, DOI 10.1101/gad.2.11.1400; BUTEL JS, 1986, BIOCHIM BIOPHYS ACTA, V865, P171, DOI 10.1016/0304-419X(86)90027-2; CHAN JYC, 1989, J BIOL CHEM, V264, P3651; DEVRIES E, 1989, J MOL BIOL, V208, P65, DOI 10.1016/0022-2836(89)90088-0; FERGUSON KA, 1964, METABOLISM, V13, P985, DOI 10.1016/S0026-0495(64)80018-4; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; FRANCOEUR AM, 1986, J IMMUNOL, V136, P1648; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; GERSTER T, 1987, EMBO J, V6, P1323, DOI 10.1002/j.1460-2075.1987.tb02371.x; Ham J, 1989, CURR OPIN CELL BIOL, V1, P503, DOI 10.1016/0955-0674(89)90012-4; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; HUNT T, 1989, CELL, V59, P949, DOI 10.1016/0092-8674(89)90747-2; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; KAUFMAN PD, 1989, CELL, V59, P359, DOI 10.1016/0092-8674(89)90297-3; KEMLER I, 1990, FASEB J, V4, P1444, DOI 10.1096/fasebj.4.5.2407588; KLOBECK HG, 1984, NUCLEIC ACIDS RES, V12, P6995, DOI 10.1093/nar/12.18.6995; KNUTH MW, 1990, J BIOL CHEM, V265, P17911; LANDOLFI NF, 1986, NATURE, V323, P548, DOI 10.1038/323548a0; LEBOWITZ JH, 1988, GENE DEV, V2, P1227, DOI 10.1101/gad.2.10.1227; MIMORI T, 1990, P NATL ACAD SCI USA, V87, P1777, DOI 10.1073/pnas.87.5.1777; MIMORI T, 1986, J BIOL CHEM, V261, P2274; MIMORI T, 1981, J CLIN INVEST, V68, P611, DOI 10.1172/JCI110295; MIMORI T, 1986, J BIOL CHEM, V261, P375; MISKIMINS WK, 1986, J CELL BIOL, V103, P1781, DOI 10.1083/jcb.103.5.1781; ONEILL EA, 1988, SCIENCE, V241, P1210, DOI 10.1126/science.3413485; PRABHAKAR BS, 1990, J CLIN INVEST, V86, P1301, DOI 10.1172/JCI114838; RABBITTS TH, 1983, NATURE, V306, P806, DOI 10.1038/306806a0; REEVES WH, 1989, J BIOL CHEM, V264, P5047; REEVES WH, 1985, J EXP MED, V161, P18, DOI 10.1084/jem.161.1.18; REEVES WH, 1987, J RHEUMATOL, V14, P97; ROBERTS MR, 1989, CELL REGUL, V1, P151, DOI 10.1091/mbc.1.1.151; ROSENFELD PJ, 1986, J BIOL CHEM, V261, P1398; SCHEIDEREIT C, 1987, CELL, V51, P783, DOI 10.1016/0092-8674(87)90101-2; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; SCHREIBER E, 1988, EMBO J, V7, P4221, DOI 10.1002/j.1460-2075.1988.tb03319.x; SINGH H, 1986, NATURE, V319, P154, DOI 10.1038/319154a0; STAUDT LM, 1986, NATURE, V323, P640, DOI 10.1038/323640a0; STUIVER MH, 1990, J EXP MED, V172, P1049, DOI 10.1084/jem.172.4.1049; TANAKA M, 1988, GENE DEV, V2, P1764, DOI 10.1101/gad.2.12b.1764; WILDEMAN AG, 1984, EMBO J, V3, P3129, DOI 10.1002/j.1460-2075.1984.tb02269.x; WU C, 1987, SCIENCE, V238, P1247, DOI 10.1126/science.3685975; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0; YANEVA M, 1986, BIOCHEMISTRY-US, V25, P5057, DOI 10.1021/bi00366a013; YANEVA M, 1989, J BIOL CHEM, V264, P13407	45	64	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3052	3059						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993678				2022-12-25	WOS:A1991EX60000059
J	WU, CH; WALTON, CM; WU, GY				WU, CH; WALTON, CM; WU, GY			PROPEPTIDE-MEDIATED REGULATION OF PROCOLLAGEN SYNTHESIS IN IMR-90 HUMAN LUNG FIBROBLAST CELL-CULTURES - EVIDENCE FOR TRANSCRIPTIONAL CONTROL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL PROPEPTIDES; COLLAGEN-SYNTHESIS; I PROCOLLAGEN; LIVER; PROTEINS; TENDON; AMINO	We have demonstrated previously that the carboxyl- and amino-terminal propeptides of type I procollagen can inhibit procollagen synthesis by specifically decreasing procollagen mRNA levels. The objective of the present experiments was to determine the mechanism by which propeptides cause these pretranslational effects. IMR-90 fibroblasts were exposed to medium containing carboxyl-terminal propeptide of type I procollagen, and nuclear run-off assays were performed by hybridization to a specific alpha-1 chain type I procollagen cDNA probe. Specific type I procollagen transcription rates were found to be decreased by 50% in the presence of 75 nM carboxyl-terminal propeptide compared with control (untreated) cells. Total cellular transcription rates as well as beta-actin mRNA rates were not affected significantly by any concentration of carboxyl-terminal propeptide. Propeptide radiolabeled with I-125 was found to be taken up by cultured cells. Furthermore, exogenous carboxyl-terminal propeptide levels increased in the cytosolic compartment and eventually reached a steady-state level of 18 +/- 2 pmol/g cell protein by 30 min. Of particular interest was the finding that levels of radiolabeled carboxyl-terminal propeptide were also detected in the nuclear fraction and increased with time, reaching a plateau after 60 min of incubation. Incubation of nuclei from IMR-90 cells in medium containing varying concentrations of carboxyl-terminal propeptide resulted in nuclear transcription rates that were decreased by 40% compared with untreated controls. Beta-actin nuclear message levels remained unchanged under identical conditions. We conclude that carboxyl-terminal propeptide of type I procollagen can be internalized and become associated with the nuclear compartment. This suggests a feedback regulatory role on procollagen synthesis by a direct effect on procollagen gene transcription.	UNIV CONNECTICUT,SCH MED,DEPT MED,DIV GASTROENTEROL LIVER DIS,FARMINGTON,CT 06030	University of Connecticut					NATIONAL CANCER INSTITUTE [K04CA001110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037982] Funding Source: NIH RePORTER; NCI NIH HHS [CA-01110] Funding Source: Medline; NIDDK NIH HHS [DK-37982] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAUM BJ, 1980, J BIOL CHEM, V255, P2843; DION AS, 1987, J MOL BIOL, V193, P127, DOI 10.1016/0022-2836(87)90632-2; HORLEIN D, 1981, P NATL ACAD SCI-BIOL, V78, P6163, DOI 10.1073/pnas.78.10.6163; KAPUSCINSKI J, 1977, ANAL BIOCHEM, V83, P252, DOI 10.1016/0003-2697(77)90533-4; KENT G, 1976, P NATL ACAD SCI USA, V73, P3719, DOI 10.1073/pnas.73.10.3719; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEUNG MKK, 1979, J BIOL CHEM, V254, P224; MARTIN GR, 1975, ADV ENZYMOL RAMB, V42, P167; MCKNIGHT GS, 1979, J BIOL CHEM, V254, P9050; NICHOLS WW, 1977, SCIENCE, V196, P60, DOI 10.1126/science.841339; OLSEN BR, 1976, ARCH BIOCHEM BIOPHYS, V175, P341, DOI 10.1016/0003-9861(76)90516-6; OTTO JM, 1987, J CELL BIOL, V105, P1067, DOI 10.1083/jcb.105.3.1067; PAGLIA L, 1979, BIOCHEMISTRY-US, V18, P5030, DOI 10.1021/bi00589a034; PAGLIA LM, 1981, BIOCHEMISTRY-US, V20, P3323; PELTONEN L, 1980, P NATL ACAD SCI-BIOL, V77, P6179, DOI 10.1073/pnas.77.10.6179; PETERKOFSKY B, 1971, BIOCHEMISTRY-US, V10, P988, DOI 10.1021/bi00782a009; RAGHOW R, 1984, J BIOL CHEM, V259, P2718; ROJKIND M, 1979, GASTROENTEROLOGY, V76, P710; ROJKIND M, 1976, P NATL ACAD SCI USA, V73, P539, DOI 10.1073/pnas.73.2.539; ROWE DW, 1978, BIOCHEMISTRY-US, V10, P988; SCHLUMBERGER W, 1988, EUR J CELL BIOL, V46, P244; STALLCUP MR, 1983, J BIOL CHEM, V258, P2802; WU CH, 1986, J BIOL CHEM, V261, P482; WU CH, 1986, HEPATOLOGY, V6, P1173	24	52	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2983	2987						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993671				2022-12-25	WOS:A1991EX60000050
J	DEMILIA, JC; MATHEYPREVOT, B; JAROS, K; WOLF, B; STEELE, G; SUMMERHAYES, IC				DEMILIA, JC; MATHEYPREVOT, B; JAROS, K; WOLF, B; STEELE, G; SUMMERHAYES, IC			PRENEOPLASTIC LESIONS INDUCED BY MYC AND SRC ONCOGENES IN A HETEROTOPIC RAT COLON	ONCOGENE			English	Article							PROTEIN-KINASE ACTIVITY; TRANSGENIC MICE; CELL-LINES; COLORECTAL CANCERS; GENE-MUTATIONS; HA-RAS; TRANSFORMATION; CARCINOMA; DEREGULATION; VIRUS	With the use of viral vectors harboring myc and src oncogenes, we have assessed the potential contribution of these different elements to colonic neoplasia using a transplantation technique resulting in the formation of a heterotopic colon in Wistar Furth rats. While myc alone induced atypia and some dysplasia, src induced focal dysplastic lesions throughout the colon mucosa with evidence of metaplasia. In contrast, lesions induced by myc and src acting cooperatively, were highly dysplastic with evidence of tumor formation after protracted periods. These results indicated the formation of histologically distinct preneoplastic lesions elicited by the action of a single oncogene in colon implants with the production of adenocarcinomas when such oncogenic elements act cooperatively. This model provides an opportunity for studies of the action of different oncogenes, acting singly or in combination, in the multi-step progression to colon tumor formation.	NEW ENGLAND DEACONESS HOSP, CANC BIOL LAB, 50 BINNEY ST, BOSTON, MA 02215 USA; HARVARD UNIV, SCH MED, DANA FARBER CANC INST, DEPT PEDIAT ONCOL, BOSTON, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School					NATIONAL CANCER INSTITUTE [P01CA044704] Funding Source: NIH RePORTER; NCI NIH HHS [CA44704] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BOLEN JB, 1987, P NATL ACAD SCI USA, V84, P2251, DOI 10.1073/pnas.84.8.2251; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; DOTTO GP, 1988, P NATL ACAD SCI USA, V85, P6389, DOI 10.1073/pnas.85.17.6389; EDWARDS PAW, 1988, ONCOGENE, V2, P407; ERISMAN MD, 1988, ONCOGENE, V2, P367; ERISMAN MD, 1985, MOL CELL BIOL, V5, P1969, DOI 10.1128/MCB.5.8.1969; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; JOYCE AD, 1988, J UROLOGY, V140, P1067, DOI 10.1016/S0022-5347(17)41928-8; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LEDER A, 1986, CELL, V45, P485, DOI 10.1016/0092-8674(86)90280-1; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; NEWBOLD RF, 1983, NATURE, V304, P648, DOI 10.1038/304648a0; RASSOULZADEGAN M, 1982, NATURE, V300, P713, DOI 10.1038/300713a0; ROOP DR, 1986, NATURE, V323, P822, DOI 10.1038/323822a0; ROSEN N, 1986, J BIOL CHEM, V261, P3754; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; STRICKLAND JE, 1988, CANCER RES, V48, P165; THOMPSON TC, 1989, CELL, V56, P917, DOI 10.1016/0092-8674(89)90625-9; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; WAGNER HE, 1990, ONCOGENE, V5, P557	23	18	18	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	1991	6	2					303	309						7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ134	2000223				2022-12-25	WOS:A1991FZ13400017
J	DEVILEE, P; VANVLIET, M; KUIPERSDIJKSHOORN, N; PEARSON, PL; CORNELISSE, CJ				DEVILEE, P; VANVLIET, M; KUIPERSDIJKSHOORN, N; PEARSON, PL; CORNELISSE, CJ			SOMATIC GENETIC CHANGES ON CHROMOSOME-18 IN BREAST CARCINOMAS - IS THE DCC GENE INVOLVED	ONCOGENE			English	Article							COLORECTAL CARCINOMAS; RETINOBLASTOMA GENE; RECESSIVE MUTATION; CELL CARCINOMA; SHORT ARM; HETEROZYGOSITY; CANCER; TUMORS; EXPRESSION; DELETION	Recently, a gene has been isolated from the long arm of chromosome 18 which was shown to be frequently deleted in colorectal carcinomas and hence designated the DCC gene (Fearon et al., 1990). To explore the possible involvement of this gene in breast cancer, we have used 5 polymorphic DNA markers (one for 18p, and four for 18q) to examine the status of chromosome 18 in 49 primary breast carcinomas by comparing the genotypes of lymphocyte and tumour DNA samples. Imbalance of alleles, resulting in allelic loss or duplication, was observed in 17 cases (38% of informative cases). In 13 of these, this imbalance included the locus D18S8 located within the DCC gene region. In the remaining 4 cases this locus was not involved, with the affected chromosome region mapping proximally of D18S8 in 3 cases, and distally in 1 case. These results indicate that chromosome 18 is rearranged in breast cancer more frequently than is expected on the basis of cytogenetic data alone, and warrant a closer inspection of the DCC gene in this tumour.	LEIDEN UNIV,DEPT HUMAN GENET,2333 AL LEIDEN,NETHERLANDS; LEIDEN UNIV,DEPT PATHOL,2333 AL LEIDEN,NETHERLANDS	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC			DEVILEE, PETER/ABR-2140-2022					BEERMAN H, 1990, INT J CANCER, V45, P34, DOI 10.1002/ijc.2910450108; BERGERHEIM U, 1989, CANCER RES, V49, P1390; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; CHEN LC, 1989, P NATL ACAD SCI USA, V86, P7204, DOI 10.1073/pnas.86.18.7204; DEVILEE P, 1990, CYTOGENET CELL GENET, V53, P52, DOI 10.1159/000132893; DEVILEE P, 1989, GENOMICS, V5, P554, DOI 10.1016/0888-7543(89)90023-2; DEVILEE P, 1991, IN PRESS CANCER RES; DEVILEE P, 1990, IN PRESS CANCER SURV; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FEARON ER, 1987, SCIENCE, V238, P193, DOI 10.1126/science.2889267; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; GENDLER SJ, 1990, INT J CANCER, V45, P431, DOI 10.1002/ijc.2910450309; GENUARDI M, 1989, AM J HUM GENET, V45, P73; HOLLIDAY R, 1989, TRENDS GENET, V5, P42, DOI 10.1016/0168-9525(89)90020-6; HOROWITZ JM, 1990, P NATL ACAD SCI USA, V87, P2775, DOI 10.1073/pnas.87.7.2775; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; KIDD KK, 1989, CYTOGEN CELL GENET, V51; Klein G, 1981, NATURE, V294, P313, DOI 10.1038/294313a0; KNUDSON AG, 1985, CANCER RES, V45, P1437; LUNDBERG C, 1987, P NATL ACAD SCI USA, V84, P2372, DOI 10.1073/pnas.84.8.2372; MACKAY J, 1988, LANCET, V2, P1384; MITELMAN F, 1988, CATALOG CHROMOSOME A; MONPEZAT JP, 1988, INT J CANCER, V41, P404, DOI 10.1002/ijc.2910410315; MOTOMURA K, 1988, Genomics, V2, P180, DOI 10.1016/0888-7543(88)90101-2; SAGER R, 1989, SCIENCE, V246, P1406, DOI 10.1126/science.2574499; TANG A, 1988, SCIENCE, V242, P263, DOI 10.1126/science.3175651; TOGUCHIDA J, 1988, CANCER RES, V48, P3939; TRENT JM, 1987, ONCOGENES HORMONES B, P142; VARLEY JM, 1989, ONCOGENE, V4, P725; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; YOKOTA J, 1987, P NATL ACAD SCI USA, V84, P9252, DOI 10.1073/pnas.84.24.9252	32	98	100	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1991	6	2					311	315						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ134	2000224				2022-12-25	WOS:A1991FZ13400018
J	IDE, H; PETRULLO, LA; HATAHET, Z; WALLACE, SS				IDE, H; PETRULLO, LA; HATAHET, Z; WALLACE, SS			PROCESSING OF DNA-BASE DAMAGE BY DNA-POLYMERASES - DIHYDROTHYMINE AND BETA-UREIDOISOBUTYRIC ACID AS MODELS FOR INSTRUCTIVE AND NONINSTRUCTIVE LESIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMINE GLYCOL LESIONS; RADIATION-INDUCED REDUCTION; ESCHERICHIA-COLI; DEOXYRIBONUCLEIC-ACID; EXONUCLEASE ACTIVITY; WEIGLE REACTIVATION; IONIZING-RADIATION; OXIDATIVE DAMAGE; AQUEOUS-SOLUTION; OXYGEN RADICALS	The processing of unrepaired DNA lesions is a key to understanding and predicting the biological end points of particular DNA damages. In this study, we prepared single-stranded f1 phage (f1-K12) DNA containing dihydrothymine or beta-ureidoisobutyric acid as models for instructive or noninstructive base lesions and assessed the potential biological consequences of these lesions in vitro and in vivo. To determine the effect of the two lesions on in vitro DNA synthesis, the extent of DNA synthesis was measured by H-3-labeled nucleotide incorporation, and the newly synthesized DNA was analyzed by DNA sequencing gels. The results showed that dihydrothymine in the template was at most a weak block to in vitro DNA synthesis catalyzed by Escherichia coli DNA polymerase I Klenow fragment (Pol I) and T4 DNA polymerase. In contrast, beta-ureiodiosobutyric acid constituted a very strong (probably absolute) replicative block in vitro. With Pol I, termination bands were observed either opposite or one base prior to (3' to) the putative beta-ureidoisobutyric acid depending on its position in the template. However, when DNA synthesis was catalyzed by Pol I lacking a 3' --> 5' exonuclease activity, termination bands were only observed opposite beta-ureidoisobutyric acid, with purine nucleotides being incorporated preferentially opposite the lesion. With T4 DNA polymerase that contains a very active 3' --> 5' exonuclease activity, DNA synthesis was arrested almost exclusively one base prior to (3' to) the putative beta-ureidoisobutyric acid site in the template. We also measured survival of transfecting DNA containing dihydrothymine or beta-ureidoisobutyric acid in an attempt to correlate the in vitro data with in vivo processing. In keeping with the results obtained in vitro, dihydrothymine present in transfecting f1-K12 DNA did not constitute an inactivating lesion. On the other hand, it took 0.9 beta-ureidoisobutyric acid residues per molecule to inactivate transfecting f1-K12 DNA, indicating that the lesion was an absolute replicative block in vivo. When host cells were ultraviolet-irradiated to induce the SOS response, a slight increase (about 2-fold) in survival of transfecting f1-K12 DNA containing beta-ureidoisobutyric acid was observed. The potential effects of the structures of base lesions on lesion-polymerase interactions are discussed.	UNIV VERMONT,DEPT MICROBIOL & MOLEC GENET,BURLINGTON,VT 05405	University of Vermont				Wallace, Susan S./0000-0002-3906-0321	NCI NIH HHS [CA33657] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA033657, R01CA033657] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ACHEY PM, 1983, RADIAT RES, V93, P609, DOI 10.2307/3576040; AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251; AMES BN, 1987, ANN INTERN MED, V107, P526; [Anonymous], 1985, DNA REPAIR; BASU AK, 1989, P NATL ACAD SCI USA, V86, P7677, DOI 10.1073/pnas.86.20.7677; BONNER CA, 1988, J BIOL CHEM, V263, P18946; BRIDGES BA, 1985, P NATL ACAD SCI USA, V82, P4193, DOI 10.1073/pnas.82.12.4193; CLARK JM, 1986, NUCLEIC ACIDS RES, V14, P737, DOI 10.1093/nar/14.2.737; CLARK JM, 1987, BIOCHEMISTRY-US, V26, P5404, DOI 10.1021/bi00391a028; CLARK JM, 1987, BIOCHEMISTRY-US, V26, P5398, DOI 10.1021/bi00391a027; COHN WE, 1956, J AM CHEM SOC, V78, P2863, DOI 10.1021/ja01593a063; CUNNINGHAM RP, 1985, P NATL ACAD SCI USA, V82, P474, DOI 10.1073/pnas.82.2.474; DEMPLE B, 1980, NATURE, V287, P203, DOI 10.1038/287203a0; FERSHT AR, 1983, J MOL BIOL, V165, P669, DOI 10.1016/S0022-2836(83)80273-3; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; FRIEDBERG EC, 1988, MICROBIOL REV, V52, P70, DOI 10.1128/MMBR.52.1.70-102.1988; FROEHLICH B, 1981, MOL GEN GENET, V184, P416, DOI 10.1007/BF00352515; FURLONG EA, 1986, BIOCHEMISTRY-US, V25, P4344, DOI 10.1021/bi00363a025; HARIHARAN PV, 1977, RADIAT RES, V69, P375, DOI 10.2307/3574445; HAYES RC, 1988, J MOL BIOL, V201, P239, DOI 10.1016/0022-2836(88)90135-0; HAYES RC, 1983, GENE, V21, P1, DOI 10.1016/0378-1119(83)90141-5; HAYES RC, 1986, NUCLEIC ACIDS RES, V14, P1045, DOI 10.1093/nar/14.2.1045; HUANG WM, 1972, J BIOL CHEM, V247, P3139; HUBBARD K, 1989, BIOCHEMISTRY-US, V28, P4382, DOI 10.1021/bi00436a039; HUTCHINSON F, 1985, PROG NUCLEIC ACID RE, V32, P115, DOI 10.1016/S0079-6603(08)60347-5; IDE H, 1987, ANTICARCINOGENESIS AND RADIATION PROTECTION, P145; IDE H, 1987, BIOCHEMISTRY-US, V26, P964, DOI 10.1021/bi00377a042; IDE H, 1988, NUCLEIC ACIDS RES, V16, P11339, DOI 10.1093/nar/16.23.11339; IDE H, 1985, NUCLEIC ACIDS RES, V13, P8035, DOI 10.1093/nar/13.22.8035; Karle I. L., 1976, PHOTOCHEM PHOTOBIOL, V1, P483; KONDO Y, 1968, J AM CHEM SOC, V90, P764, DOI 10.1021/ja01005a038; KOW YW, 1985, P NATL ACAD SCI USA, V82, P8354, DOI 10.1073/pnas.82.24.8354; KOW YW, 1989, BIOCHEMISTRY-US, V28, P3280, DOI 10.1021/bi00434a024; LARSON KL, 1987, BIOCHEMISTRY-US, V26, P2471, DOI 10.1021/bi00383a011; LASPIA MF, 1989, J MOL BIOL, V207, P53, DOI 10.1016/0022-2836(89)90440-3; LECLERC JE, 1984, MOL GEN GENET, V197, P414, DOI 10.1007/BF00329937; LU C, 1986, P NATL ACAD SCI USA, V83, P619, DOI 10.1073/pnas.83.3.619; Maniatis T., 1982, MOL CLONING; MASAMUNE Y, 1976, MOL GEN GENET, V149, P335, DOI 10.1007/BF00268536; MELAMEDE RJ, 1987, ANTICARCINOGENESIS AND RADIATION PROTECTION, P139; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Miller J.H., 1972, EXPT MOL GENETICS; MILLER JH, 1984, CELL, V37, P675, DOI 10.1016/0092-8674(84)90400-8; MOORE P, 1979, NATURE, V278, P664, DOI 10.1038/278664a0; MOORE PD, 1982, P NATL ACAD SCI-BIOL, V79, P7166, DOI 10.1073/pnas.79.23.7166; MOORE PD, 1981, P NATL ACAD SCI-BIOL, V78, P110, DOI 10.1073/pnas.78.1.110; NISHIMOTO S, 1983, J AM CHEM SOC, V105, P6740, DOI 10.1021/ja00360a047; Nygaard OF, 1987, ANTICARCINOGENESIS R; RANDALL SK, 1987, J BIOL CHEM, V262, P6864; ROBERTS JJ, 1978, ADV RADIAT BIOL, V7, P211; ROUET P, 1985, CANCER RES, V45, P6113; SAGHER D, 1985, NUCLEIC ACIDS RES, V13, P4285, DOI 10.1093/nar/13.12.4285; SAGHER D, 1983, BIOCHEMISTRY-US, V22, P4518, DOI 10.1021/bi00288a026; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAAPER RM, 1981, P NATL ACAD SCI-BIOL, V78, P1773, DOI 10.1073/pnas.78.3.1773; SCHULHOF JC, 1988, NUCLEIC ACIDS RES, V16, P319, DOI 10.1093/nar/16.1.319; SIMIC MG, 1986, MECHANISMS DNA DAMAG; SINGER B, 1982, ANNU REV BIOCHEM, V52, P655; TAKESHITA M, 1987, J BIOL CHEM, V262, P10171; TEOULE R, 1978, J AM CHEM SOC, V100, P6749, DOI 10.1021/ja00489a034; TEOULE R, 1987, INT J RADIAT BIOL, V51, P573, DOI 10.1080/09553008414552111; TEOULE R, 1978, EFFECTS IONIZING RAD, P171; WADA T, 1982, INT J RADIAT BIOL, V42, P215, DOI 10.1080/09553008214551111; WALLACE S S, 1987, British Journal of Cancer, V55, P118; WALLACE SS, 1988, ENVIRON MOL MUTAGEN, V12, P431, DOI 10.1002/em.2860120411; WALLACE SS, 1988, MECHANISMS CONSEQUEN, P151; Wang SY., 1976, PHOTOCHEM PHOTOBIOL	67	71	73	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1469	1477						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1988431				2022-12-25	WOS:A1991EU49700021
J	STRULOVICI, B; DANIELISSAKANI, S; BAXTER, G; KNOPF, J; SULTZMAN, L; CHERWINSKI, H; NESTOR, J; WEBB, DR; RANSOM, J				STRULOVICI, B; DANIELISSAKANI, S; BAXTER, G; KNOPF, J; SULTZMAN, L; CHERWINSKI, H; NESTOR, J; WEBB, DR; RANSOM, J			DISTINCT MECHANISMS OF REGULATION OF PROTEIN KINASE-C-EPSILON BY HORMONES AND PHORBOL DIESTERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN LYMPHOCYTES-T; CELL ANTIGEN RECEPTOR; PHOSPHOLIPASE-C; ADENYLATE-CYCLASE; GENE-EXPRESSION; BRAIN CYTOSOL; BOVINE BRAIN; ACTIVATION; PHOSPHORYLATION; DIACYLGLYCEROL	In this study, we examined the effects of T cell activators on the regulation of protein kinase C (PKC) isozymes present in thymocytes. Using affinity-purified anti-PKC antisera, we determined that the major PKC isoforms in murine thymocytes are PKC-beta and PKC-epsilon. The CD4+/CD8+ thymocyte subset expressed high levels of both PKC-beta and PKC-epsilon, whereas the CD4-/CD8- subset expressed much less of both. PKC-beta was down-regulated following treatment of thymocytes with phorbol 12-myristate acetate (PMA) (2 X 10(-8) M) or ionomycin (0.4-mu-M). In contrast, PMA did not induce the down-regulation of PKC-epsilon down-regulation, similar to its effect on PKC-beta. Similar observations were made on a promonocytic cell line, U937, which expresses PKC-alpha, PKC-beta (Strulovici, B., Daniel-Issakani, S., Oto, E., Nestor, J., Jr., Chan, H., and Tsou, A.-P. (1989) Biochemistry 28, 3569-3576), and PKC-epsilon. To facilitate the study of PKC-beta and PKC-epsilon, we established a Chinese hamster ovary cell line which expresses murine PKC-epsilon in addition to endogenous PKC-alpha and PKC-beta. Both PKC isoforms (beta and epsilon) were mostly in particulate form. PMA treatment left the majority of immunoreactive PKC-epsilon intact. By contrast, thrombin treated caused the disappearance of particulate and cytosolic PKC-epsilon (60% by 10 min nd 80% by 1 h). PMA and thrombin promoted the down-regulation of PKC-beta with similar kinetics (100% down-regulation by 3 h). These results indicate that: 1) thymocytes express PKC-epsilon; and 2) this isozyme exhibits a novel form of regulation and distinct from the other PKC isozymes.	SYNTEX INC,INST BIOORGAN CHEM,PALO ALTO,CA 94304; GENET INST,CAMBRIDGE,MA 02140	Syntex Corporation	STRULOVICI, B (corresponding author), SYNTEX INC,INST CANC & DEV BIOL,DEPT BIOCHEM,S3-1,3401 HILLVIEW AVE,PALO ALTO,CA 94304, USA.			Nestor, John/0000-0002-6834-2547				ACRES RB, 1986, J BIOL CHEM, V261, P6210; ANDERSON WB, 1985, ADV CYCLIC NUCL PROT, V19, P287; ASHKENAZI A, 1989, CELL, V56, P487, DOI 10.1016/0092-8674(89)90251-1; BERIDGE MJ, 1989, JAMA-J AM MED ASSOC, V262, P1834; BERRY N, 1989, J IMMUNOL, V143, P1407; BESTERMAN JM, 1986, P NATL ACAD SCI USA, V83, P6785, DOI 10.1073/pnas.83.18.6785; BEYERS AD, 1988, J IMMUNOL, V141, P3463; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CANTRELL D, 1987, NATURE, V325, P540, DOI 10.1038/325540a0; CANTRELL DA, 1985, P NATL ACAD SCI USA, V82, P8158, DOI 10.1073/pnas.82.23.8158; CANTRELL DA, 1988, EUR J IMMUNOL, V18, P1391, DOI 10.1002/eji.1830180914; DANIELISSAKANI S, 1989, J BIOL CHEM, V264, P20240; DEEPER JM, 1984, J IMMUNOL, V133, P3054; FARRAR WL, 1986, J IMMUNOL, V136, P1266; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HEIDENREICH KA, 1990, J BIOL CHEM, V265, P15076; HURLEY TR, 1989, SCIENCE, V245, P407, DOI 10.1126/science.2787934; IRVING HR, 1987, J BIOL CHEM, V262, P3440; JAKEN S, 1987, P NATL ACAD SCI USA, V84, P4418, DOI 10.1073/pnas.84.13.4418; KAUFMAN RJ, 1987, EMBO J, V6, P2172; KISHIMOTO A, 1989, J BIOL CHEM, V264, P4088; KNOPF JL, 1986, CELL, V46, P491, DOI 10.1016/0092-8674(86)90874-3; KORETZKY GA, 1989, J IMMUNOL, V143, P1692; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lerner RA, 1981, P NATL ACAD SCI USA, V78, P3404; MELLONI E, 1986, J BIOL CHEM, V261, P4101; MURAKAMI K, 1986, J BIOL CHEM, V261, P5424; NAOR Z, 1988, MOL ENDOCRINOL, V2, P1043, DOI 10.1210/mend-2-11-1043; NIEDEL J E, 1986, P47; NISHIZUKA Y, 1989, JAMA-J AM MED ASSOC, V262, P1826, DOI 10.1001/jama.262.13.1826; ONO Y, 1988, J BIOL CHEM, V263, P6927; PARKER PJ, 1989, MOL CELL ENDOCRINOL, V65, P1, DOI 10.1016/0303-7207(89)90159-7; PFEFFER LM, 1990, P NATL ACAD SCI USA, V87, P6537, DOI 10.1073/pnas.87.17.6537; PONTREMOLI S, 1987, P NATL ACAD SCI USA, V84, P398, DOI 10.1073/pnas.84.2.398; ROSOFF PM, 1988, CELL, V54, P73, DOI 10.1016/0092-8674(88)90181-X; ROZENGURT E, 1983, P NATL ACAD SCI-BIOL, V80, P7244, DOI 10.1073/pnas.80.23.7244; RYU SH, 1987, P NATL ACAD SCI USA, V84, P6649, DOI 10.1073/pnas.84.19.6649; RYU SH, 1987, J BIOL CHEM, V262, P12511; SAMELSON LE, 1987, J IMMUNOL, V139, P2708; SAMELSON LE, 1985, P NATL ACAD SCI USA, V82, P1969, DOI 10.1073/pnas.82.7.1969; SCHAAP D, 1989, FEBS LETT, V243, P351, DOI 10.1016/0014-5793(89)80160-7; SHEARMAN MS, 1988, FEBS LETT, V234, P387, DOI 10.1016/0014-5793(88)80122-4; SHELTON ER, 1990, J NEUROCHEM, V55, P60, DOI 10.1111/j.1471-4159.1990.tb08821.x; STAHL ML, 1988, NATURE, V332, P1269; STRULOVICI B, 1987, BIOCHEMISTRY-US, V26, P6005, DOI 10.1021/bi00393a009; STRULOVICI B, 1989, BIOCHEMISTRY-US, V28, P3569, DOI 10.1021/bi00434a063; UI M, 1984, TRENDS PHARMACOL SCI, V5, P277, DOI 10.1016/0165-6147(84)90444-9; WILSON DB, 1985, J BIOL CHEM, V260, P1046	48	128	128	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					168	173						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985890				2022-12-25	WOS:A1991EQ33900027
J	ZHAO, HF; LABRIE, C; SIMARD, J; DELAUNOIT, Y; TRUDEL, C; MARTEL, C; RHEAUME, E; DUPONT, E; LUUTHE, V; PELLETIER, G; LABRIE, F				ZHAO, HF; LABRIE, C; SIMARD, J; DELAUNOIT, Y; TRUDEL, C; MARTEL, C; RHEAUME, E; DUPONT, E; LUUTHE, V; PELLETIER, G; LABRIE, F			CHARACTERIZATION OF RAT 3-BETA-HYDROXYSTEROID DEHYDROGENASE DELTA-5-DELTA-4 ISOMERASE CDNAS AND DIFFERENTIAL TISSUE-SPECIFIC EXPRESSION OF THE CORRESPONDING MESSENGER-RNAS IN STEROIDOGENIC AND PERIPHERAL-TISSUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE-ANALYSIS; 3-BETA-HYDROXY-5-ENE-STEROID DEHYDROGENASE; 17-BETA-HYDROXYSTEROID OXIDOREDUCTASE; 3-BETA-HYDROXYSTEROID DEHYDROGENASE; VENTRAL PROSTATE; GENE-EXPRESSION; HUMAN-FETUS; DEHYDROEPIANDROSTERONE; PURIFICATION; METABOLISM	The conversion of 3-beta-hydroxy-5-ene steroids by the enzyme complex 3-beta-hydroxysteroid dehydrogenase/DELTA-5-DELTA-4 isomerase (3-beta-HSD) is an essential step in the biosynthesis of all classes of hormonal steroids. We report the characterization of two types of cDNA clones encoding rat 3-beta-HSD isolated from a rat ovary lambda-gt11 cDNA library with a human 3-beta-HSD cDNA probe. Both type I and type II cDNAs encode proteins of 372 amino acids having 94% homology. Transient expression of the type I and type II 3-beta-HSD cDNAs in HeLa human cervical carcinoma cells reveals that both proteins possess 3-beta-hydroxysteroid dehydrogenase as well as DELTA-5-DELTA-4 isomerase activities for both DELTA-5-for both DELTA-5-pregnene and DELTA-5-androstene precursors, although the type I 3-beta-HSD protein is more active than the type II. RNA blot analysis using type I 3-beta-HSD cDNA identifies major mRNA transcripts of 1.7 kilobase in rat ovary, testis, and adrenal poly(A)+ RNA. RNase protection assay using type I- and type II-specific cRNA probes revealed the existence of the two corresponding mRNas in male and female rat adrenals and gonads as well as in female adipose tissue while only type I mRNA is present in male and female kidney. Moreover, in situ hybridization performed using type-specific labeled 24-mer oligonucleotides confirms that type I is the major mRNA species in the ovary and further indicates that both mRNA species have a similar cellular distribution in the ovarian tissue with the highest level of expression found in corpora lutea. Immunoblot analysis using polyclonal antibodies raised against purified human placental 3-beta-HSD identified a single 42-kDa band in rat ovary, testis, and adrenal, which agrees with the calculated molecular masses of 41,911 and 42,150 daltons for the type I and II proteins, respectively. Determination of 3-beta-HSD enzymatic activity using [C-14]pregnenolone and [C-14]dehydroepiandrosterone as substrates shows that 3-beta-HSD activity is present not only in the gonads and adrenals of animals of both sexes, but also in many peripheral tissues including adipose tissue, mammary gland, kidney, liver, prostate, seminal vesicle, uterus, skin, brain, heart, thymus, pancreas, lung, and spleen. The present data indicate the existence of two mRNAs encoding rat 3-beta-HSD and their differential tissular distribution in both steroidogenic and peripheral tissues. The presence of 3-beta-HSD activity in non-classical steroidogenic tissues suggests that this enzyme is likely to play a major role in controlling intracellular levels of androgens and estrogens in peripheral target tissues.	CHU LAVAL, RES CTR,MOLEC ENDOCRINOL LAB,MRC, MOLEC ENDOCRINOL GRP,2705 LAURIER BLVD, QUEBEC CITY G1V 4G2, QUEBEC, CANADA; UNIV LAVAL, QUEBEC CITY G1K 7P4, QUEBEC, CANADA	Laval University; Laval University			Rheaume, Eric/ABA-4918-2021	Simard, Jacques/0000-0001-6906-3390; Rheaume, Eric/0000-0002-0554-0984				ABULHAJJ YJ, 1975, STEROIDS, V26, P488, DOI 10.1016/0039-128X(75)90068-9; ACEVEDO HF, 1963, J CLIN ENDOCR METAB, V23, P885, DOI 10.1210/jcem-23-9-885; BONNEY RC, 1985, J STEROID BIOCHEM, V23, P347, DOI 10.1016/0022-4731(85)90415-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAMERON EHD, 1966, J ENDOCRINOL, V35, pR19; CASEY ML, 1983, J STEROID BIOCHEM, V18, P449, DOI 10.1016/0022-4731(83)90064-X; CASEY ML, 1982, ENDOCR REV, V3, P396, DOI 10.1210/edrv-3-4-396; CHEATUM SG, 1966, BIOCHIM BIOPHYS ACTA, V122, P1, DOI 10.1016/0926-6593(66)90086-5; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DUPONT E, 1990, ENDOCRINOLOGY, V127, P1394, DOI 10.1210/endo-127-3-1394; EASTMAN AR, 1977, J ENDOCRINOL, V72, P225, DOI 10.1677/joe.0.0720225; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; EVANS CT, 1987, J BIOL CHEM, V262, P6914; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FERRE F, 1975, STEROIDS, V26, P551, DOI 10.1016/0039-128X(75)90050-1; FORD HC, 1974, J BIOL CHEM, V249, P1363; GILMAN M, 1989, CURRENT PROTOCOLS MO; HARADA N, 1988, BIOCHEM BIOPH RES CO, V156, P725, DOI 10.1016/S0006-291X(88)80903-3; HARPER ME, 1974, J ENDOCRINOL, V60, P117, DOI 10.1677/joe.0.0600117; ISHIIOHBA H, 1986, J STEROID BIOCHEM, V25, P555; ISHIIOHBA H, 1986, J STEROID BIOCHEM, V24, P753; KINGSTON RE, 1987, CURRENT PROTOCOLS MO; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LABRIE C, 1988, ENDOCRINOLOGY, V123, P1412, DOI 10.1210/endo-123-3-1412; LABRIE C, 1989, ENDOCRINOLOGY, V124, P2745, DOI 10.1210/endo-124-6-2745; LABRIE F, 1985, GENITOURINARY CANCER, P193; LACHANCE Y, 1990, IN PRESS J BIOL CHEM; LACOSTE D, 1990, ANN NY ACAD SCI, V595, P389, DOI 10.1111/j.1749-6632.1990.tb34313.x; LORENCE MC, 1990, ENDOCRINOLOGY, V126, P2493, DOI 10.1210/endo-126-5-2493; Luu The V, 1989, Mol Endocrinol, V3, P1301; LUU-THE V, 1990, Molecular Endocrinology, V4, P268; Luu-The V, 1988, CLIN INVEST MED, V11, pC200; MCALLISTER JM, 1988, ENDOCRINOLOGY, V122, P2012, DOI 10.1210/endo-122-5-2012; MELLON SH, 1989, J CLIN INVEST, V84, P1497, DOI 10.1172/JCI114325; MILEWICH L, 1977, J STEROID BIOCHEM, V8, P277, DOI 10.1016/0022-4731(77)90020-6; MILEWICH L, 1985, METABOLISM, V34, P938, DOI 10.1016/0026-0495(85)90142-8; MILEWICH L, 1989, J ENDOCRINOL, V123, P509, DOI 10.1677/joe.0.1230509; PERUCHO M, 1989, STRATEGIES MOL BIOL, P37; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; RAO JKM, 1986, BIOCHIM BIOPHYS ACTA, V869, P197, DOI 10.1016/0167-4838(86)90295-5; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANO Y, 1981, J CLIN ENDOCR METAB, V52, P994, DOI 10.1210/jcem-52-5-994; SELDEN RF, 1986, MOL CELL BIOL, V6, P3173, DOI 10.1128/MCB.6.9.3173; STJOHN TP, 1987, CURRENT PROTOCOLS MO; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; THE VL, 1989, MOL ENDOCRINOL, V3, P1310, DOI 10.1210/mend-3-8-1310; THOMAS JL, 1988, J STEROID BIOCHEM, V31, P785, DOI 10.1016/0022-4731(88)90287-7; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194; ZHAO HF, 1989, FEBS LETT, V259, P153, DOI 10.1016/0014-5793(89)81516-9	54	192	197	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					583	593						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985917				2022-12-25	WOS:A1991EQ33900085
J	HEERDT, BG; MOLINAS, S; DEITCH, D; AUGENLICHT, LH				HEERDT, BG; MOLINAS, S; DEITCH, D; AUGENLICHT, LH			AGGRESSIVE SUBTYPES OF HUMAN COLORECTAL TUMORS FREQUENTLY EXHIBIT AMPLIFICATION OF THE C-MYC GENE	ONCOGENE			English	Article							HUMAN-COLON CARCINOMA; HUMAN-LUNG CANCER; N-MYC; CELL-CARCINOMA; RAS ONCOGENES; EXPRESSION; MUTATIONS; DNA; NEUROBLASTOMAS; REARRANGEMENT	Expression of the c-myc gene is often elevated in human colorectal tumors, but reported amplification of the locus is rare. Here we demonstrate that modest amplification of c-myc is frequently found in aggressive subtypes of colorectal cancer. Careful quantitation of c-myc copy number has shown amplification in 53.8% (7/13) mucinous tumors, 42.3% (3/7) poorly differentiated tumors and a single poorly differentiated APUD tumor. This contrasts with amplification in 6.9% (2/29) moderately to well differentiated tumors, a value which is in agreement with that in previously published reports. Such changes in gene copy number may represent an important aspect of the genomic alterations which accumulate during the development of colorectal tumors.	MONTEFIORE MED CTR,DEPT PATHOL,BRONX,NY 10467; ALBERT EINSTEIN MED CTR,BRONX,NY 10467	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University	HEERDT, BG (corresponding author), MONTEFIORE MED CTR,DEPT ONCOL,111 E 210TH ST,BRONX,NY 10467, USA.				NCI NIH HHS [P30-CA1330, CA41372, CA40558] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA040558, K04CA001330, R01CA041372] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALEXANDER RJ, 1986, GASTROENTEROLOGY, V91, P1503, DOI 10.1016/0016-5085(86)90208-8; ALMAGRO UA, 1983, CANCER, V52, P1453, DOI 10.1002/1097-0142(19831015)52:8<1453::AID-CNCR2820520819>3.0.CO;2-9; Augenlicht L. H., 1989, CELL MOL BIOL COLON, P165; AUGENLICHT LH, 1987, CANCER RES, V47, P6017; AUGENLICHT LH, 1982, CANCER RES, V42, P1088; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Battey, 1986, BASIC METHODS MOL BI; BISHOP JM, 1987, ONCOGENES GROWTH FAC, P1; BOS JL, 1989, CANCER RES, V49, P4682; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; BURMER GC, 1989, CANCER RES, V49, P2141; BURMER GC, 1989, P NATL ACAD SCI USA, V86, P2403, DOI 10.1073/pnas.86.7.2403; CHOWDHURY JR, 1975, DIS COLON RECTUM, V18, P332, DOI 10.1007/BF02587396; COLLINS FS, 1984, PROG NUCLEIC ACID RE, V31, P315, DOI 10.1016/S0079-6603(08)60382-7; DALLAFAVERA R, 1983, SCIENCE, V219, P963, DOI 10.1126/science.6401867; ERISMAN MD, 1988, CANCER RES, V48, P1350; ERISMAN MD, 1985, MOL CELL BIOL, V5, P1969, DOI 10.1128/MCB.5.8.1969; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FEARON ER, 1987, SCIENCE, V238, P193, DOI 10.1126/science.2889267; FIDLER IJ, 1981, EUR J CANCER, V17, P487, DOI 10.1016/0014-2964(81)90049-9; FINELY GG, 1989, ONCOGENE, V4, P963; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; HAYWARD WS, 1981, NATURE, V290, P475, DOI 10.1038/290475a0; HEERDT BG, 1990, EXP CELL RES, V186, P54, DOI 10.1016/0014-4827(90)90209-S; HEERDT BG, 1990, CANCER RES, V50, P1596; HEPPNER GH, 1984, CANCER RES, V44, P2259; KOSS LG, 1989, HUM PATHOL, V20, P528, DOI 10.1016/0046-8177(89)90244-X; LAW DJ, 1988, SCIENCE, V241, P961, DOI 10.1126/science.2841761; LEVIN B, 1986, CANCER GENET CYTOGEN, V19, P159, DOI 10.1016/0165-4608(86)90383-3; LITTLE CD, 1983, NATURE, V306, P194, DOI 10.1038/306194a0; LUI IOL, 1985, PATHOLOGY, V17, P31, DOI 10.3109/00313028509063720; Maniatis T., 1982, MOL CLONING; MELTZER SJ, 1987, GASTROENTEROLOGY, V92, P1174, DOI 10.1016/S0016-5085(87)91074-2; NAU MM, 1984, CURR TOP MICROBIOL, V113, P172; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; PATHAK S, 1989, CELL MOL BIOL COLON, P139; POSTE G, 1980, NATURE, V283, P139, DOI 10.1038/283139a0; RABBITTS PH, 1985, EMBO J, V4, P3727, DOI 10.1002/j.1460-2075.1985.tb04141.x; SADAHIRO S, 1989, CANCER, V64, P1113, DOI 10.1002/1097-0142(19890901)64:5<1113::AID-CNCR2820640524>3.0.CO;2-5; SASAKI M, 1989, CANCER RES, V49, P4402; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SHTIVELMAN E, 1989, MOL CELL BIOL, V9, P1148, DOI 10.1128/MCB.9.3.1148; SIKORA K, 1987, CANCER-AM CANCER SOC, V59, P1289, DOI 10.1002/1097-0142(19870401)59:7<1289::AID-CNCR2820590710>3.0.CO;2-O; SLEISENGER MH, 1989, GASTROINTESTINAL DIS, P1535; SYMONDS DA, 1976, CANCER, V37, P1891, DOI 10.1002/1097-0142(197604)37:4<1891::AID-CNCR2820370439>3.0.CO;2-Z; UMPLEBY HC, 1985, BRIT J SURG, V72, P715, DOI 10.1002/bjs.1800720915; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; WOLLEY RC, 1982, J NATL CANCER I, V69, P15; WONG AJ, 1986, SCIENCE, V233, P461, DOI 10.1126/science.3014659; YANDER G, 1985, CANCER RES, V45, P4433; YOKOTA J, 1986, SCIENCE, V231, P261, DOI 10.1126/science.3941898	52	69	70	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1991	6	1					125	129						5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY039	1992440				2022-12-25	WOS:A1991EY03900017
J	KINSELLA, MG; WIGHT, TN				KINSELLA, MG; WIGHT, TN			FORMATION OF HIGH-MOLECULAR-WEIGHT DERMATAN SULFATE PROTEOGLYCAN IN BOVINE AORTIC ENDOTHELIAL-CELL CULTURES - EVIDENCE FOR TRANSGLUTAMINASE-CATALYZED CROSS-LINKING TO FIBRONECTIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											KINSELLA, MG (corresponding author), UNIV WASHINGTON,SCH MED,DEPT PATHOL,SM-30,SEATTLE,WA 98195, USA.				NHLBI NIH HHS [HL 18645] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018645] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BALE MD, 1986, BIOCHEMISTRY-US, V25, P5677; BARRY ELR, 1988, J BIOL CHEM, V263, P10464; Birckbichler P J, 1978, Ann N Y Acad Sci, V312, P354, DOI 10.1111/j.1749-6632.1978.tb16813.x; BIRCKBICHLER PJ, 1981, P NATL ACAD SCI-BIOL, V78, P5005, DOI 10.1073/pnas.78.8.5005; BOCKENSTEDT P, 1986, J CLIN INVEST, V78, P551, DOI 10.1172/JCI112608; BOWNESS JM, 1987, J BIOL CHEM, V262, P1022; CHANG SK, 1986, J BIOL CHEM, V261, P8112; COCUZZI ET, 1986, J BIOL CHEM, V261, P8122; DUNHAM JS, 1978, BIOCHIM BIOPHYS ACTA, V506, P242, DOI 10.1016/0005-2736(78)90395-4; FESUS L, 1986, EUR J BIOCHEM, V154, P371, DOI 10.1111/j.1432-1033.1986.tb09407.x; FOLK JE, 1980, ANNU REV BIOCHEM, V49, P517, DOI 10.1146/annurev.bi.49.070180.002505; Franzblau C, 1971, COMPREHENSIVE BIOC C, V26C, P659; GREENBERG CS, 1987, BLOOD, V70, P702; HADA M, 1986, BLOOD, V68, P95; HISS D, 1987, EUR J BIOCHEM, V162, P89, DOI 10.1111/j.1432-1033.1987.tb10546.x; JUPRELLESORET M, 1988, BIOCHEM J, V250, P421, DOI 10.1042/bj2500421; KESKIOJA J, 1976, CELL, V9, P29, DOI 10.1016/0092-8674(76)90049-0; KINSELLA MG, 1986, J CELL BIOL, V102, P679, DOI 10.1083/jcb.102.3.679; KINSELLA MG, 1988, BIOCHEMISTRY-US, V27, P2136, DOI 10.1021/bi00406a048; KINSELLA MG, 1988, J BIOL CHEM, V263, P19222; KORNER G, 1989, BIOCHEM J, V262, P633, DOI 10.1042/bj2620633; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LORAND L, 1984, MOL CELL BIOCHEM, V58, P9, DOI 10.1007/BF00240602; LOWEKRENTZ LJ, 1984, BIOCHEMISTRY-US, V23, P2621, DOI 10.1021/bi00307a013; LYNCH GW, 1987, J BIOL CHEM, V262, P1772; MARTINEZ J, 1989, J BIOL CHEM, V264, P20502; MCDONAGH RP, 1981, FEBS LETT, V127, P174, DOI 10.1016/0014-5793(81)80198-6; MORITA H, 1990, BIOCHEM J, V265, P61, DOI 10.1042/bj2650061; MOSHER DF, 1979, J CLIN INVEST, V64, P781, DOI 10.1172/JCI109524; MOSHER DF, 1976, J BIOL CHEM, V251, P1639; MOSHER DF, 1983, ANN NY ACAD SCI, V408, P583, DOI 10.1111/j.1749-6632.1983.tb23275.x; NARA K, 1989, J BIOL CHEM, V264, P19308; PARTHASARATHY N, 1984, J BIOL CHEM, V259, P2749; PIAZZA GA, 1989, BIOCHEM J, V262, P327, DOI 10.1042/bj2620327; RICHTER H, 1981, H-S Z PHYSIOL CHEM, V362, P399, DOI 10.1515/bchm2.1981.362.1.399; SLIFE CW, 1986, J BIOL CHEM, V261, P3451; TANZER ML, 1973, SCIENCE, V180, P561, DOI 10.1126/science.180.4086.561; TYRRELL DJ, 1986, J BIOL CHEM, V261, P4833; UPCHURCH HF, 1987, IN VITRO CELL DEV B, V23, P795; WASTESON A, 1973, BIOCHEM J, V136, P1069, DOI 10.1042/bj1361069; YAMAGATA M, 1986, J BIOL CHEM, V261, P3526	41	33	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1990	265	29					17891	17898						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC766	1976631				2022-12-25	WOS:A1990EC76600081
J	CHIBA, I; TAKAHASHI, T; NAU, MM; DAMICO, D; CURIEL, DT; MITSUDOMI, T; BUCHHAGEN, DL; CARBONE, D; PIANTADOSI, S; KOGA, H; REISSMAN, PT; SLAMON, DJ; HOLMES, EC; MINNA, JD				CHIBA, I; TAKAHASHI, T; NAU, MM; DAMICO, D; CURIEL, DT; MITSUDOMI, T; BUCHHAGEN, DL; CARBONE, D; PIANTADOSI, S; KOGA, H; REISSMAN, PT; SLAMON, DJ; HOLMES, EC; MINNA, JD			MUTATIONS IN THE P53 GENE ARE FREQUENT IN PRIMARY, RESECTED NON-SMALL-CELL LUNG-CANCER	ONCOGENE			English	Article									NATL NAVAL MED CTR, NCI, NAVY MED ONCOL BRANCH, BLDG 8, ROOM 5101, BETHESDA, MD 20814 USA; UNIFORMED SERV UNIV HLTH SCI, BETHESDA, MD 20814 USA; JOHNS HOPKINS UNIV HOSP, CTR ONCOL, BALTIMORE, MD 21205 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT SURG, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT MED, LOS ANGELES, CA 90024 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Walter Reed National Military Medical Center; Uniformed Services University of the Health Sciences - USA; Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA			Takahashi, Takashi/I-7262-2014	Takahashi, Takashi/0000-0003-0615-7001; Mitsudomi, Tetsuya/0000-0001-9860-8505				BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BARTEK J, 1990, ONCOGENE, V5, P893; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; Cox DR., 1989, ANAL BINARY DATA; DELEO AB, 1979, P NATL ACAD SCI USA, V76, P2420, DOI 10.1073/pnas.76.5.2420; DOHERTY PJ, 1989, ANAL BIOCHEM, V177, P7, DOI 10.1016/0003-2697(89)90003-1; ELIYAHU D, 1985, NATURE, V316, P158, DOI 10.1038/316158a0; ELIYAHU D, 1989, P NATL ACAD SCI USA, V86, P8763, DOI 10.1073/pnas.86.22.8763; FEARON ER, 1987, SCIENCE, V238, P193, DOI 10.1126/science.2889267; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; HARLOW E, 1985, MOL CELL BIOL, V5, P1601, DOI 10.1128/MCB.5.7.1601; HARRIS N, 1986, MOL CELL BIOL, V6, P4650, DOI 10.1128/MCB.6.12.4650; HINDS P, 1989, J VIROL, V63, P739, DOI 10.1128/JVI.63.2.739-746.1989; HU QJ, 1990, EMBO J, V9, P1147, DOI 10.1002/j.1460-2075.1990.tb08221.x; HUANG S, 1990, EMBO J, V9, P1815, DOI 10.1002/j.1460-2075.1990.tb08306.x; IGGO R, 1990, LANCET, V335, P675, DOI 10.1016/0140-6736(90)90801-B; ISOBE M, 1986, NATURE, V320, P84, DOI 10.1038/320084a0; JENKINS JR, 1984, NATURE, V312, P651, DOI 10.1038/312651a0; JENKINS JR, 1988, J VIROL, V62, P3903, DOI 10.1128/JVI.62.10.3903-3906.1988; KAELIN WG, 1990, MOL CELL BIOL, V10, P3761, DOI 10.1128/MCB.10.7.3761; LAMB P, 1986, MOL CELL BIOL, V6, P1379, DOI 10.1128/MCB.6.5.1379; LANE DP, 1990, GENE DEV, V4, P1, DOI 10.1101/gad.4.1.1; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LAVIGUEUR A, 1989, MOL CELL BIOL, V9, P3982, DOI 10.1128/MCB.9.9.3982; LAW DJ, 1988, SCIENCE, V241, P961, DOI 10.1126/science.2841761; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; LOECHLER EL, 1984, P NATL ACAD SCI-BIOL, V81, P6271, DOI 10.1073/pnas.81.20.6271; MATLASHEWSKI GJ, 1987, MOL CELL BIOL, V7, P961, DOI 10.1128/MCB.7.2.961; MAZUR M, 1988, SOMAT CELL MOLEC GEN, V14, P393, DOI 10.1007/BF01534647; MCBRIDE OW, 1986, P NATL ACAD SCI USA, V83, P130, DOI 10.1073/pnas.83.1.130; MERCER WE, 1990, ONCOGENE, V5, P973; MERCER WE, 1990, P NATL ACAD SCI USA, V87, P6166, DOI 10.1073/pnas.87.16.6166; Minna JD, 1989, CANCER PRINCIPLES PR, P591; MONTANDON AJ, 1989, NUCLEIC ACIDS RES, V17, P3347, DOI 10.1093/nar/17.9.3347; MOUNTAIN CF, 1986, CHEST, V89, pS225, DOI 10.1378/chest.89.4.225S; MOWAT M, 1985, NATURE, V314, P633, DOI 10.1038/314633a0; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P5707, DOI 10.1093/nar/16.12.5707; NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SELLERS TA, 1990, J NATL CANCER I, V82, P1272, DOI 10.1093/jnci/82.15.1272; SLAMON DJ, 1984, SCIENCE, V224, P256, DOI 10.1126/science.6538699; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SOUSSI T, 1990, J VIROL, V64, P967; SOUSSI T, 1987, ONCOGENE, V1, P71; SOUSSI T, 1989, J VIROL, V63, P3894, DOI 10.1128/JVI.63.9.3894-3901.1989; SOUSSI T, 1990, ONCOGENE, V5, P945; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; TAKAHASHI T, 1990, J CLIN INVEST, V86, P363, DOI 10.1172/JCI114710; WESTON A, 1989, P NATL ACAD SCI USA, V86, P5099, DOI 10.1073/pnas.86.13.5099; WINTER E, 1985, P NATL ACAD SCI USA, V82, P7575, DOI 10.1073/pnas.82.22.7575; YOKOTA J, 1987, P NATL ACAD SCI USA, V84, P9252, DOI 10.1073/pnas.84.24.9252; ZAKUTHOURI R, 1985, EMBO J, V4, P1251, DOI 10.1002/j.1460-2075.1985.tb03768.x	56	636	652	0	19	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	OCT	1990	5	10					1603	1610						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK502	1979160				2022-12-25	WOS:A1990EK50200024
J	KONG, IS; LOPEZCASILLAS, F; KIM, KH				KONG, IS; LOPEZCASILLAS, F; KIM, KH			ACETYL-COA CARBOXYLASE MESSENGER-RNA SPECIES WITH OR WITHOUT INHIBITORY CODING SEQUENCE FOR SER-1200 PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									PURDUE UNIV,DEPT BIOCHEM,W LAFAYETTE,IN 47907	Purdue University System; Purdue University; Purdue University West Lafayette Campus					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK012865] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK12865] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON DJ, 1983, METHOD ENZYMOL, V96, P110; BIANCHI A, 1990, J BIOL CHEM, V265, P1502; CALZONE FJ, 1987, METHOD ENZYMOL, V152, P611; CARLSON CA, 1974, ARCH BIOCHEM BIOPHYS, V164, P490, DOI 10.1016/0003-9861(74)90059-9; CARLSON CA, 1973, J BIOL CHEM, V248, P378; CORKEY BE, 1989, J BIOL CHEM, V264, P21608; DASSO MC, 1989, NUCLEIC ACIDS RES, V17, P3129, DOI 10.1093/nar/17.8.3129; GOODSON J, 1984, BIOCHEM BIOPH RES CO, V122, P694, DOI 10.1016/S0006-291X(84)80089-3; HARDIE DG, 1980, MOL ASPECTS CELLULAR, V1, P33; HAYSTEAD TAJ, 1988, EUR J BIOCHEM, V175, P339, DOI 10.1111/j.1432-1033.1988.tb14202.x; HAYSTEAD TAJ, 1988, EUR J BIOCHEM, V175, P347, DOI 10.1111/j.1432-1033.1988.tb14203.x; KIM KH, 1983, CURR TOP CELL REGUL, V22, P143; KIM KH, 1989, FASEB J, V3, P2250, DOI 10.1096/fasebj.3.11.2570725; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Lane M D, 1974, Curr Top Cell Regul, V8, P139; LOPEZCASILLAS F, 1987, ARCH BIOCHEM BIOPHYS, V257, P63, DOI 10.1016/0003-9861(87)90543-1; LOPEZCASILLAS F, 1988, P NATL ACAD SCI USA, V85, P5784, DOI 10.1073/pnas.85.16.5784; LOPEZCASILLAS F, 1989, J BIOL CHEM, V264, P7176; LOPEZCASILLAS F, 1989, GENE, V83, P311, DOI 10.1016/0378-1119(89)90117-0; LUO XC, 1989, P NATL ACAD SCI USA, V86, P4042, DOI 10.1073/pnas.86.11.4042; MANIATIS T, 1982, MOL CLONING LABORATO, P458; MCGARRY JD, 1978, J BIOL CHEM, V253, P4128; MUNDAY MR, 1988, EUR J BIOCHEM, V175, P331, DOI 10.1111/j.1432-1033.1988.tb14201.x; Numa S, 1984, FATTY ACID METABOLIS, P1; PAPE ME, 1988, ARCH BIOCHEM BIOPHYS, V267, P104, DOI 10.1016/0003-9861(88)90013-6; PAPE ME, 1989, MOL CELL BIOL, V9, P974, DOI 10.1128/MCB.9.3.974; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; THAMPY KG, 1985, J BIOL CHEM, V260, P6318; THAMPY KG, 1988, J BIOL CHEM, V263, P6447; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; WATKINS PA, 1977, P NATL ACAD SCI USA, V74, P1499	33	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1990	265	23					13695	13701						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DU275	1974251				2022-12-25	WOS:A1990DU27500048
J	SLUNGAARD, A; MAHONEY, JR				SLUNGAARD, A; MAHONEY, JR			THIOCYANATE IS THE MAJOR SUBSTRATE FOR EOSINOPHIL PEROXIDASE IN PHYSIOLOGICAL FLUIDS - IMPLICATIONS FOR CYTOTOXICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; SCHISTOSOMA-MANSONI; HYPEREOSINOPHILIC SYNDROME; CATALYZED INCORPORATION; BACTERICIDAL ACTIVITY; HYPOCHLOROUS ACID; MOLECULAR-CLONING; BLOOD EOSINOPHILS; MYELOPEROXIDASE; NEUTROPHILS	The potent cytotoxic capacity of eosinophils for parasites and host tissue has in part been attributed to the catalytic action of eosinophil peroxidase (EPO), which preferentially oxidizes Br- to the powerful bleaching oxidant HOBr in buffers that mimic serum halide composition (100 mM Cl-, 20-100-mu-M Br-, < 1-mu-M I-). However, serum also contains 20-120-mu-M SCN-, a pseudohalide whose peroxidative product, HOSCN, is a weak, primarily sulfhydryl-reactive oxidant. Because of its relative abundance and high oxidation potential, we hypothesized that SCN-, not Br- or I-, is the major substrate for EPO in physiologic fluids. We find that in Earle's buffer (100 mM Cl-) supplemented with 100-mu-M Br- and varying concentrations of SCN-, HOBr production by activated eosinophils and purified EPO, assayed by conversion of fluorescein to dibromofluorescein, was 50% inhibited (ID50) by only 1-mu-M SCN-. SCN- also blocked (ID50 10-mu-M) EPO oxidation of I- to HOI, assayed as iodofluorescein, despite the presence of 100-mu-M (i.e. grossly supraphysiologic) I-. Thionitrobenzoic acid oxidation kinetics indicate that SCN- is the initial species oxidized by EPO in equimolar mixtures of SCN- and Br- and in human serum. EPO also catalyzed the covalent incorporation of [C-14]SCN- into proteins in buffers regardless of Br- concentration and in human serum. Comparing the cytotoxicity of HOSCN and HOBr for host cells, we find that even subphysiologic concentrations of SCN- (3.3-10-mu-M) nearly completely abrogate the potent Br--dependent toxicity of EPO for Cr-51-labeled aortic endothelial cells and isolated working rat hearts, recently developed models of eosinophilic endocarditis. Thus, HOSCN, hitherto best known as a bacteriostatic agent in saliva and milk, is likely also the major oxidant produced by EPO in physiologic fluids, and the presence of SCN- averts damage to EPO-coated host tissues that might otherwise accrue as a result of HOBr generation. In view of these findings, the potential role of HOSCN in eosinophil killing of parasitic pathogens deserves close examination.	UNIV MINNESOTA, SCH MED, DEPT SURG, MINNEAPOLIS, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	SLUNGAARD, A (corresponding author), UNIV MINNESOTA, SCH MED, DEPT INTERNAL MED, MINNEAPOLIS, MN 55455 USA.				PHS HHS [R0-1 A125625] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AGOSTI JM, 1987, J ALLERGY CLIN IMMUN, V79, P496, DOI 10.1016/0091-6749(87)90368-X; ALBRICH JM, 1981, P NATL ACAD SCI-BIOL, V78, P210, DOI 10.1073/pnas.78.1.210; AUNE TM, 1977, EUR J BIOCHEM, V80, P209, DOI 10.1111/j.1432-1033.1977.tb11873.x; AUNE TM, 1977, BIOCHEMISTRY-US, V16, P4611, DOI 10.1021/bi00640a013; AYARS GH, 1989, AM REV RESPIR DIS, V140, P125; Barker MH, 1936, J AMER MED ASSOC, V106, P762; BASS DA, 1980, J CLIN INVEST, V66, P1265, DOI 10.1172/JCI109978; BHARGAVA KK, 1983, MOL BIOCHEM PARASIT, V9, P29, DOI 10.1016/0166-6851(83)90054-3; BOLSCHER BGJM, 1984, BIOCHIM BIOPHYS ACTA, V784, P177, DOI 10.1016/0167-4838(84)90125-0; BUJAK JS, 1974, BLOOD, V43, P727, DOI 10.1182/blood.V43.5.727.727; CARLSON MGC, 1985, J IMMUNOL, V134, P1875; CARLSSON J, 1984, INFECT IMMUN, V44, P581, DOI 10.1128/IAI.44.3.581-586.1984; Dakin HD, 1916, BMJ-BRIT MED J, V1916, P160, DOI 10.1136/bmj.1.2874.160; DECHATELET LR, 1977, BLOOD, V50, P525; DOLINSKY M, 1951, J ASSOC OFF AGR CHEM, V34, P114; FAUCI AS, 1982, ANN INTERN MED, V97, P78, DOI 10.7326/0003-4819-97-1-78; GLEICH GJ, 1986, ADV IMMUNOL, V39, P177, DOI DOI 10.1016/S0065-2776(08)60351-X; GRAICHEN C, 1959, J ASSOC OFF AGR CHEM, V42, P149; GRISHAM MB, 1990, AM J PHYSIOL, V258, pC115, DOI 10.1152/ajpcell.1990.258.1.C115; HIMMELHOCH SR, 1969, BIOCHEMISTRY-US, V8, P914, DOI 10.1021/bi00831a022; HOLZBECHER J, 1980, CLIN BIOCHEM, V13, P277, DOI 10.1016/S0009-9120(80)80009-9; HUGHES MN, 1975, CHEM BIOCH THIOCYANI, P8; HURST JK, 1984, J BIOL CHEM, V259, P4812; JONG EC, 1984, AM J TROP MED HYG, V33, P104, DOI 10.4269/ajtmh.1984.33.104; JONG EC, 1981, J IMMUNOL, V126, P468; JONG EC, 1980, J IMMUNOL, V124, P1949; JONG EC, 1980, J IMMUNOL, V124, P1378; KAZURA JW, 1981, J CLIN INVEST, V67, P93, DOI 10.1172/JCI110037; Klebanoff S.J., 1982, ADV HOST DEFENSE MEC, P111; KLEBANOFF SJ, 1989, J IMMUNOL, V143, P239; LISSITZKY S, 1959, B SOC CHIM FR, P389; MAYENO AN, 1989, J BIOL CHEM, V264, P5660; MKOJI GM, 1989, BIOCHEM PHARMACOL, V38, P4307, DOI 10.1016/0006-2952(89)90530-3; NATHAN CF, 1982, J EXP MED, V155, P1291, DOI 10.1084/jem.155.5.1291; NEELY JR, 1967, AM J PHYSIOL, V212, P804; OAKLEY CM, 1977, BRIT HEART J, V39, P233; OKA S, 1981, ANAL CHEM, V53, P588, DOI 10.1021/ac00227a007; PARRILLO JE, 1979, AM J MED, V67, P572, DOI 10.1016/0002-9343(79)90227-4; PINCUS SH, 1983, J INVEST DERMATOL, V80, P278, DOI 10.1111/1523-1747.ep12534646; PINCUS SH, 1981, BLOOD, V58, P1175; ROBERTS RL, 1985, BLOOD, V65, P433; ROSEN H, 1982, J BIOL CHEM, V257, P13731; RYAN US, 1986, J TISSUE CULTURE MET, V10, P3; SAKAMAKI K, 1989, J BIOL CHEM, V264, P16828; SLUNGAARD A, 1991, J EXP MED, V173, P117, DOI 10.1084/jem.173.1.117; SLUNGAARD A, 1990, J EXP MED, V171, P2025, DOI 10.1084/jem.171.6.2025; TAUBER AI, 1979, INFLAMMATION, V3, P261, DOI 10.1007/BF00914183; TEN RM, 1989, J EXP MED, V169, P1757, DOI 10.1084/jem.169.5.1757; TENOVUO J, 1984, ARCH ORAL BIOL, V29, P445, DOI 10.1016/0003-9969(84)90025-6; THOMAS EL, 1982, BIOCHEMISTRY-US, V21, P6299, DOI 10.1021/bi00267a040; THOMAS EL, 1986, J BIOL CHEM, V261, P9694; Thomas EL, 1985, LACTOPEROXIDASE SYST, P31; THOMAS EL, 1986, METHOD ENZYMOL, V132, P578; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; WEISS SJ, 1986, SCIENCE, V234, P200, DOI 10.1126/science.3018933; WEISS SJ, 1983, SCIENCE, V222, P625, DOI 10.1126/science.6635660; WOOD JL, 1975, CHEM BIOCH THIOCYANI, P9; WOOD JL, 1975, CHEM BIOCH THIOCYANI, P156	58	112	112	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4903	4910						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002037				2022-12-25	WOS:A1991FC21700037
J	MOREAU, P; RODRIGUEZ, M; CASSAGNE, C; MORRE, DM; MORRE, DJ				MOREAU, P; RODRIGUEZ, M; CASSAGNE, C; MORRE, DM; MORRE, DJ			TRAFFICKING OF LIPIDS FROM THE ENDOPLASMIC-RETICULUM TO THE GOLGI-APPARATUS IN A CELL-FREE SYSTEM FROM RAT-LIVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSITION VESICLE FORMATION; VIRUS-G-PROTEIN; PLASMA-MEMBRANE; INTRACELLULAR-TRANSPORT; CHOLESTEROL; PHOSPHOLIPIDS; RECONSTITUTION; PHOSPHATIDYLCHOLINE; COMPLEX; SECRETION	Trafficking and sorting of lipids during transport from the endoplasmic reticulum to the Golgi apparatus was studied using a cell-free system from rat liver. Transitional elements of the endoplasmic reticulum were prepared from liver slices prelabeled with [C-14]-or [H-3]acetate as the donor fraction. Non-radioactive Golgi apparatus were immobilized on nitrocellulose as the acceptor. When reconstituted, the radiolabeled donor retained a capacity to transfer labeled lipids to the non-radioactive Golgi apparatus acceptor. Transfer exhibited two kinetically different components. One was stimulated by ATP, facilitated by cytosol and inhibited by guanosine 5'-O-(thiotriphosphate) and N-ethylmaleimide. In parallel with protein transport, the ATP-dependent lipid transfer occurred with a temperature transition at about 20-degrees-C. The other was not stimulated by ATP, did not require cytosol, was acceptor unspecific, was unaffected by inhibitors and, while temperature dependent, did not exhibit a sharp temperature transition. The ATP-independent transfer was non-vesicular. In contrast, the ATP-dependent transfer was vesicular. Transition vesicles isolated by preparative free-flow electrophoresis, when used as the donor fraction, transferred lipids to Golgi apparatus acceptor with a 5-6-fold greater efficiency than that exhibited by the unfractionated transitional endoplasmic reticulum. Formation of transition vesicles was ATP-dependent. Transferred lipids were chiefly phosphatidylcholine and cholesterol. Membrane triglycerides, major constituents of the transitional endoplasmic reticulum membranes, were both depleted in the transition vesicle-enriched fractions and not transferred to Golgi apparatus suggestive of lipid sorting prior to or during transition vesicle formation. The characteristics of the ATP plus cytosol-dependent transfer were similar to those for protein transfer mediated by transition vesicles. Thus, the 50-70-nm vesicles derived from transitional endoplasmic reticulum appear to function in the trafficking of both newly synthesized proteins and lipids from the endoplasmic reticulum to the Golgi apparatus.	PURDUE UNIV, DEPT FOODS & NUTR, W LAFAYETTE, IN 47907 USA; CNRS, INST BIOCHIM CELLULAIRE & NEUROCHIM, F-33077 BORDEAUX, FRANCE	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Centre National de la Recherche Scientifique (CNRS)	MOREAU, P (corresponding author), PURDUE UNIV, DEPT MED CHEM, W LAFAYETTE, IN 47907 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD011508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044675] Funding Source: NIH RePORTER; NICHD NIH HHS [HD11508] Funding Source: Medline; NIGMS NIH HHS [GM44675] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BACKER JM, 1987, NATURE, V327, P341, DOI 10.1038/327341a0; BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; BALCH WE, 1986, J BIOL CHEM, V261, P4681; BALCH WE, 1987, J CELL BIOL, V104, P749, DOI 10.1083/jcb.104.3.749; BECKERS CJM, 1987, CELL, V50, P523, DOI 10.1016/0092-8674(87)90025-0; BELL RM, 1981, J LIPID RES, V22, P391; BISHOP WR, 1985, CELL, V42, P51, DOI 10.1016/S0092-8674(85)80100-8; CHLAPOWSKI FJ, 1971, J CELL BIOL, V50, P634, DOI 10.1083/jcb.50.3.634; DAWSON RMC, 1973, SUB-CELL BIOCHEM, V2, P69; DEGRELLA RF, 1982, J BIOL CHEM, V257, P4256; DEMEL RA, 1977, BIOCHIM BIOPHYS ACTA, V465, P1, DOI 10.1016/0005-2736(77)90350-9; DESILVA NS, 1981, J BIOL CHEM, V256, P5845; DUNPHY WG, 1985, CELL, V42, P13, DOI 10.1016/S0092-8674(85)80097-0; FARQUHAR MG, 1981, METHOD CELL BIOL, V23, P399, DOI 10.1016/S0091-679X(08)61511-3; FARQUHAR MG, 1985, ANNU REV CELL BIOL, V1, P447, DOI 10.1146/annurev.cb.01.110185.002311; FRIES E, 1980, P NATL ACAD SCI-BIOL, V77, P3870, DOI 10.1073/pnas.77.7.3870; HASELBECK A, 1986, P NATL ACAD SCI USA, V83, P2017, DOI 10.1073/pnas.83.7.2017; HEAPE AM, 1985, J CHROMATOGR, V322, P391, DOI 10.1016/S0021-9673(01)97702-7; HIGGINS JA, 1987, J LIPID RES, V28, P268; JACOBSOHN MK, 1989, LIPIDS, V24, P375, DOI 10.1007/BF02535144; JELSEMA CL, 1978, J BIOL CHEM, V253, P7960; JUGUELIN H, 1986, DEV BRAIN RES, V25, P249, DOI 10.1016/0165-3806(86)90214-2; KAPLAN MR, 1985, J CELL BIOL, V101, P441, DOI 10.1083/jcb.101.2.441; KAPLAN MR, 1985, J CELL BIOL, V101, P446, DOI 10.1083/jcb.101.2.446; LANGE Y, 1984, J BIOL CHEM, V259, P4624; LONGMUIR KJ, 1987, CURR TOP MEMBR TRANS, V29, P129; MILLS JT, 1984, P NATL ACAD SCI-BIOL, V81, P1385, DOI 10.1073/pnas.81.5.1385; MOREAU P, 1991, J BIOL CHEM, V266, P4329; Morre D J, 1977, Int Rev Cytol Suppl, P61; MORRE DJ, 1979, BIOCHIM BIOPHYS ACTA, V559, P71; MORRE DJ, 1989, BIOTECHNIQUES, V7, P946; MORRE DJ, 1986, PROTOPLASMA, V132, P110, DOI 10.1007/BF01275798; MORRE DJ, 1972, PREP BIOCHEM, V2, P61, DOI 10.1080/00327487208061453; MORRE DJ, 1987, CELL SURF REV, V4, P1; MORRE DJ, 1971, RESULTS PROBLEMS CEL, V2, P82; NOWACK DD, 1987, P NATL ACAD SCI USA, V84, P6098, DOI 10.1073/pnas.84.17.6098; PAGANO RE, 1988, TRENDS BIOCHEM SCI, V13, P202, DOI 10.1016/0968-0004(88)90082-5; PAULIK M, 1988, J BIOL CHEM, V263, P17738; ROTHMAN JE, 1987, CELL, V50, P521, DOI 10.1016/0092-8674(87)90024-9; SIMONS K, 1987, EMBO J, V6, P2241, DOI 10.1002/j.1460-2075.1987.tb02496.x; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; SLEIGHT RG, 1987, ANNU REV PHYSIOL, V49, P193; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; URBANI L, 1990, J BIOL CHEM, V265, P1919; VAN MEER G, 1989, ANNU REV CELL BIOL, V5, P247, DOI 10.1146/annurev.cellbio.5.1.247; VANCE JE, 1988, J BIOL CHEM, V263, P5898; VANDENBOSCH H, 1972, REV PHYSL BIOCH PHAR, V66, P13; VANDIJCK PWM, 1976, BIOCHIM BIOPHYS ACTA, V455, P576, DOI 10.1016/0005-2736(76)90326-6; WILGRAM GF, 1963, J BIOL CHEM, V238, P2615; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5; ZEIGEL RF, 1962, J CELL BIOL, V15, P45, DOI 10.1083/jcb.15.1.45	51	44	52	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4322	4328						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999421				2022-12-25	WOS:A1991FA69400049
J	ADACHI, Y; ISHIDATAKAHASHI, A; TAKAHASHI, C; TAKANO, E; MURACHI, T; HATANAKA, M				ADACHI, Y; ISHIDATAKAHASHI, A; TAKAHASHI, C; TAKANO, E; MURACHI, T; HATANAKA, M			PHOSPHORYLATION AND SUBCELLULAR-DISTRIBUTION OF CALPASTATIN IN HUMAN HEMATOPOIETIC SYSTEM CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED NEUTRAL PROTEASE; CALCIUM-DEPENDENT PROTEASE; CA-2+-DEPENDENT CYSTEINE PROTEINASE; CALPAIN-I; KINASE-C; TRANSFORMING GENE; SEQUENCE-ANALYSIS; INHIBITOR; TYROSINE; BINDING	Calpastatin is an endogenous inhibitor protein acting specifically on calpain (EC 3.4.22.17; Ca2+-dependent cysteine proteinase). The phosphorylation of calpastatin was investigated in human hematopoietic system cell lines. Microheterogeneity of calpastatin was observed, in which 118- and 116-kDa forms were named calpastatin a and b, respectively. The phosphorylation of both calpastatins was identified in all cell lines examined and occurred mainly at serine residues with trace amounts of phosphothreonine in vivo. The incubation of cells with 12-O-tetradecanoylphorbol-13-acetate increased the incorporation of P-32-orthophosphate into calpastatin a. Two-dimensional maps of P-32-labeled phosphopeptide from both calpastatins were identical except for additional minor spots for calpastatin a. [S-35]methionine-labeled calpastatins a and b were localized mainly in the cytosol, and only 6% of cellular calpastatins were detected in the membrane fraction. By contrast, more than 30% of the P-32-labeled calpastatins a and b were distributed in the membrane fraction. Thus, the phosphorylation of calpastatin may be involved in regulating the calpain-calpastatin protein kinase system by its subcellular distribution.	KYOTO UNIV, INST VIRUS RES, KYOTO 606, JAPAN; KYOTO UNIV, FAC MED, DEPT CLIN SCI & LAB MED, KYOTO 606, JAPAN	Kyoto University; Kyoto University								ADACHI Y, 1988, BIOL CHEM H-S, V369, P223; ADACHI Y, 1990, ADV SEC MESS PHOSPH, V24, P478; ADACHI Y, 1986, BIOCHEM BIOPH RES CO, V136, P1090, DOI 10.1016/0006-291X(86)90445-6; AKIYAMA T, 1986, J BIOL CHEM, V261, P4797; BEER DG, 1984, ARCH BIOCHEM BIOPHYS, V228, P207, DOI 10.1016/0003-9861(84)90062-6; CABAUD PG, 1958, AM J CLIN PATHOL, V30, P234, DOI 10.1093/ajcp/30.3.234; CASSEL D, 1982, J BIOL CHEM, V257, P9845; COURTNEIDGE SA, 1980, P NATL ACAD SCI-BIOL, V77, P3783, DOI 10.1073/pnas.77.7.3783; DRUMMOND GI, 1968, J BIOL CHEM, V243, P5532; EMORI Y, 1987, P NATL ACAD SCI USA, V84, P3590, DOI 10.1073/pnas.84.11.3590; EMORI Y, 1986, J BIOL CHEM, V261, P9472; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; GAZDAR AF, 1980, BLOOD, V55, P409; GIRARD PR, 1986, J BIOL CHEM, V261, P370; HOSHIJIMA M, 1986, CANCER RES, V46, P3000; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; IMAJOH S, 1987, J BIOCHEM-TOKYO, V101, P447, DOI 10.1093/oxfordjournals.jbchem.a121930; IMAJOH S, 1986, J BIOCHEM-TOKYO, V100, P633, DOI 10.1093/oxfordjournals.jbchem.a121755; INOUE M, 1977, J BIOL CHEM, V252, P7610; KISHIMOTO A, 1989, J BIOL CHEM, V264, P4088; KITAHARA A, 1985, FEBS LETT, V184, P120, DOI 10.1016/0014-5793(85)80666-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; MAKI M, 1989, J BIOL CHEM, V264, P18866; MAKI M, 1988, J BIOL CHEM, V263, P10254; MELLGREN RL, 1980, FEBS LETT, V109, P129, DOI 10.1016/0014-5793(80)81326-3; MELLGREN RL, 1983, ARCH BIOCHEM BIOPHYS, V191, P638; MELLONI E, 1985, P NATL ACAD SCI USA, V82, P6435, DOI 10.1073/pnas.82.19.6435; MIYOSHI I, 1981, NATURE, V294, P770, DOI 10.1038/294770a0; MURACHI T, 1989, BIOCHEM SOC SYMP, V55, P29; Murachi T, 1980, Adv Enzyme Regul, V19, P407; MURACHI T, 1983, TRENDS BIOCHEM SCI, V8, P167, DOI 10.1016/0968-0004(83)90165-2; Murachi T, 1987, NEUROPEPTIDES THEIR, P202; MURACHI T, 1989, CALCIUM PROTEIN SIGN, P445; Murachi T. M., 1983, CALCIUM CELL FUNCTIO, V4, P377; NISHIURA I, 1978, J BIOCHEM-TOKYO, V84, P1657, DOI 10.1093/oxfordjournals.jbchem.a132296; NISHIZUKA Y, 1983, TRENDS BIOCHEM SCI, V8, P13, DOI 10.1016/0968-0004(83)90061-0; OHNO S, 1984, NATURE, V312, P566, DOI 10.1038/312566a0; OKITANI A, 1976, FED PROC, V35, P1746; SAKIHAMA T, 1985, P NATL ACAD SCI USA, V82, P6075, DOI 10.1073/pnas.82.18.6075; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; SCHNEIDER WC, 1945, J BIOL CHEM, V161, P293; SUZUKI K, 1987, TRENDS BIOCHEM SCI, V12, P103, DOI 10.1016/0968-0004(87)90048-X; TAKANO E, 1988, BIOCHEMISTRY-US, V27, P1964, DOI 10.1021/bi00406a024; WAXMAN L, 1978, J BIOL CHEM, V253, P5888; WEAVER RA, 1969, BIOCHIM BIOPHYS ACTA, V173, P377, DOI 10.1016/0005-2736(69)90003-0; YOSHIMURA N, 1983, J BIOL CHEM, V258, P8883; YOSHIMURA N, 1984, J BIOL CHEM, V259, P9847	49	61	63	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3968	3972						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995645				2022-12-25	WOS:A1991EY68200092
J	FOSTER, CS; GILLIES, DRB; GLICK, MC				FOSTER, CS; GILLIES, DRB; GLICK, MC			PURIFICATION AND CHARACTERIZATION OF GDP-L-FUC-N-ACETYL-BETA-D-GLUCOSAMINIDE ALPHA-1-]3FUCOSYLTRANSFERASE FROM HUMAN NEUROBLASTOMA-CELLS - UNUSUAL SUBSTRATE SPECIFICITIES OF THE TUMOR ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NEURO-BLASTOMA; BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; HUMAN COLONIC ADENOCARCINOMA; HUMAN-LUNG CANCER; MONOCLONAL-ANTIBODY; FUCOSYL-TRANSFERASE; CARBOHYDRATE DETERMINANTS; LINKED OLIGOSACCHARIDES; AFFINITY-CHROMATOGRAPHY; GLYCOPROTEIN-SYNTHESIS	Fucosyl residues in the alpha-1 --> 3 linkage to N-acetylglucosamine (Fuc-alpha-1 --> 3GlcNAc) on oligosaccharides of glycoproteins and glycolipids have been detected in certain human tumors and are developmentally expressed (reviewed in Foster, C.S., and Glick, M.C. (1988) Adv. Neuroblastoma Res. 2, 421-432). In order to understand control mechanisms for the biosynthesis of these fucosylated glycoconjugates, GDP-L-Fuc-N-acetyl-beta-D-glucosaminide alpha-1 --> 3fucosyltransferase was purified from human neuroblastoma cells, CHP 134, utilizing either the immobilized oligosaccharide or disaccharide substrates. The enzyme, extracted from CHP 134 cells, was purified by DEAE- and SP-Sephadex chromatography and then by either immobilized substrate. alpha-1 --> 3Fucosyltransferase was obtained in approximately 10% yield and was purified 45,000-fold from the cell extract. The kinetic properties of the enzyme showed an apparent K(GDP-Fuc) 43-mu-M, K(Gal-beta-1 --> 4GlcNAc 0.4 mM, K(Gal-beta-1 --> 4Glc) 8.1 mM, and K(Fuc-alpha-1 --> 2Gal-beta-1 --> 4Glc 1.0 mM. Polyacrylamide gel electrophoresis of the affinity-purified enzyme showed two proteins which migrated, M(r) = 45,000-40,000. The enzyme differed in substrate specificity, pH optimum, response to N-ethylmaleimide and ion requirements from the enzymes purified from human milk or serum. The inability of alpha-1 --> 3fucosyltransferase to transfer to substrates containing NeuAc-alpha-2 --> 3 or alpha-2 --> 6Gal is in contrast to the reports for the enzyme in other human tumors. This substrate specificity correlates with the oligosaccharide residues thus far defined on glycoproteins of CHP 134 cells since NeuAc and Fuc-alpha-1 --> 3GlcNAc have yet to be detected on the same oligosaccharide antenna. However, the enzyme transfers to Fuc-alpha-1 --> 2Gal-beta-1 --> 4GlcNAc/Glc with higher activity than the unfucosylated disaccharides, although neither alpha-1 --> 2-fucosyltransferase nor Fuc-alpha-1 --> 2 residues have been detected in CHP 134 cells. The different substrate specificities of alpha-1 --> 3-fucosyltransferase isolated from human tumors and normal sources leads to the suggestion that a family of alpha-1 --> 3fucosyltransferases may exist and that they may be differentially expressed in human tumors.	CHILDRENS HOSP PHILADELPHIA,JOSEPH STOKES JR RES INST,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT PEDIAT,PHILADELPHIA,PA 19104	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania					NCI NIH HHS [R01 CA 37853] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA037853] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALHADEFF JA, 1989, CRIT REV ONCOL HEMAT, V9, P37, DOI 10.1016/S1040-8428(89)80014-9; BENDIAK B, 1987, J BIOL CHEM, V262, P5775; Beyer T A, 1981, Adv Enzymol Relat Areas Mol Biol, V52, P23; BEYER TA, 1980, J BIOL CHEM, V255, P5364; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHESTER MA, 1976, EUR J BIOCHEM, V69, P584; EPPENBERGERCASTORI S, 1989, GLYCOCONJUGATE J, V6, P101, DOI 10.1007/BF01047893; FINNE J, 1980, CANCER RES, V40, P2580; FLEMING S, 1986, HISTOCHEM J, V18, P61, DOI 10.1007/BF01675358; FOSTER CS, 1987, BIOCHEM SOC T, V15, P398, DOI 10.1042/bst0150398; FUKUDA M, 1985, Biochimica et Biophysica Acta, V780, P119; FUKUDA MN, 1986, J BIOL CHEM, V261, P2376; GILLIES DRB, 1990, GLYCONJUGATE J, V7, P100; GLICK MC, 1962, J BIOL CHEM, V237, P981; GLICK MC, 1980, METASTATIC TUMOR GRO, P11; HAKOMORI S, 1984, J BIOL CHEM, V259, P4672; HANSSON GC, 1985, J BIOL CHEM, V260, P9388; HOLMES EH, 1989, ARCH BIOCHEM BIOPHYS, V274, P633, DOI 10.1016/0003-9861(89)90479-7; HOLMES EH, 1987, J BIOL CHEM, V262, P15649; HOLMES EH, 1985, J BIOL CHEM, V260, P7619; HOWARD DR, 1987, J BIOL CHEM, V262, P16830; JEFFREY AM, 1975, BIOCHEM BIOPH RES CO, V62, P608, DOI 10.1016/0006-291X(75)90442-8; JOHNSON PH, 1987, BIOCHEM SOC T, V15, P396, DOI 10.1042/bst0150396; JOHNSON PH, 1982, BIOCHEM SOC T, V10, P445; JOHNSON PH, 1985, GLYCOCONJUGATES, V1, P222; JOZIASSE DH, 1987, J BIOL CHEM, V262, P2025; KIM YS, 1986, CANCER RES, V46, P5985; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE EU, 1989, J BIOL CHEM, V264, P13848; LEIBOLD DM, 1988, J CELL PHYSIOL, V137, P411, DOI 10.1002/jcp.1041370304; LEVERY SB, 1986, CARBOHYD RES, V151, P311, DOI 10.1016/S0008-6215(00)90351-3; LLOYD KO, 1983, IMMUNOGENETICS, V17, P537, DOI 10.1007/BF00696877; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MIZOGUCHI A, 1984, J BIOL CHEM, V259, P1949; MONTREUIL J, 1983, BIOCHEM SOC T, V11, P134, DOI 10.1042/bst0110134; NISHIKAWA Y, 1988, J BIOL CHEM, V263, P8270; PAULSON JC, 1978, J BIOL CHEM, V253, P5617; PAULSON JC, 1989, J BIOL CHEM, V264, P10931; PRIEELS JP, 1981, J BIOL CHEM, V256, P456; RAJAN VP, 1989, J BIOL CHEM, V264, P11158; RETTIG WJ, 1985, CANCER RES, V45, P815; SADLER JE, 1982, METHOD ENZYMOL, V83, P458; SAKAMOTO J, 1986, CANCER RES, V46, P1553; SANTER UV, 1983, CANCER RES, V43, P4159; SANTER UV, 1983, CARBOHYD RES, V120, P197, DOI 10.1016/0008-6215(83)88017-3; SANTER UV, 1980, BIOCHEM BIOPH RES CO, V96, P219, DOI 10.1016/0006-291X(80)91203-6; SANTER UV, 1989, EUR J BIOCHEM, V181, P249, DOI 10.1111/j.1432-1033.1989.tb14719.x; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SHAO MC, 1989, BIOCHEMISTRY-US, V28, P4077, DOI 10.1021/bi00435a067; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; SPITALNIK SL, 1986, CANCER RES, V46, P4751; SPOHR U, 1985, CAN J CHEM, V63, P2659, DOI 10.1139/v85-441; SUDA K, 1987, CANCER RES, V47, P2782; VOYNOW JA, 1988, ANAL BIOCHEM, V168, P367, DOI 10.1016/0003-2697(88)90331-4; WEINSTEIN J, 1987, J BIOL CHEM, V262, P17735; WOODBURY RA, 1986, CANCER RES, V46, P3692	57	42	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3526	3531						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995616				2022-12-25	WOS:A1991EY68200031
J	ROSEJOHN, S; HIPP, E; LENZ, D; LEGRES, LG; KORR, H; HIRANO, T; KISHIMOTO, T; HEINRICH, PC				ROSEJOHN, S; HIPP, E; LENZ, D; LEGRES, LG; KORR, H; HIRANO, T; KISHIMOTO, T; HEINRICH, PC			STRUCTURAL AND FUNCTIONAL-STUDIES ON THE HUMAN INTERLEUKIN-6 RECEPTOR - BINDING, CROSS-LINKING, INTERNALIZATION, AND DEGRADATION OF INTERLEUKIN-6 BY FIBROBLASTS TRANSFECTED WITH HUMAN INTERLEUKIN-6-RECEPTOR CDNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE-PHASE PROTEINS; HEPATOCYTE-STIMULATING FACTOR; ADULT HUMAN HEPATOCYTES; PRIMARY CULTURES; CELL-LINES; FACTOR-II; RAT; DNA; DIFFERENTIATION; EXPRESSION	A cDNA coding for the human interleukin-6 receptor (IL-6-R) has been expressed stably in murine NIH/3T3 fibroblasts. Transfected cells exhibited a single class of binding sites for I-125-labeled recombinant human interleukin-6 (I-125-rhIL-6) (K(d) = 440 pM, 20,000 receptors per cell). Affinity cross-linking of I-125-rhIL-6 to the IL-6-R-expressing NIH/3T3 cells led to the detection of three I-125-rhIL-6-containing protein complexes with molecular masses of 100, 120, and 200 kDa suggesting a complex organization of the IL-6-R in the plasma membrane. IL-6 added to the transfected NIH/3T3 cells exerted growth inhibition. This anti-growth effect was observed by the measurement of cell numbers and ornithine decarboxylase mRNA expression. IL-6-R overexpressing fibroblasts internalized I-125-rhIL-6. Intracellular limited proteolysis of IL-6 could be demonstrated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. A possible implication of skin fibroblasts in the catabolism of IL-6 is discussed.	RHEIN WESTFAL TH AACHENKLINIKUM,INST BIOCHEM,PAUWELSSTR 30,W-5100 AACHEN,GERMANY; RHEIN WESTFAL TH AACHEN,INST ANAT ZELLBIOL,INST MED TECH,W-5100 AACHEN,GERMANY; OSAKA UNIV,INST MOLEC & CELLULAR BIOL,SUITA,OSAKA 565,JAPAN	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; Osaka University			LEGRES, Luc/A-7650-2012; Rose-John, Stefan/A-7998-2010; Kishimoto, Tadamitsu/C-8470-2009; Hirano, Toshio/C-8194-2009	Rose-John, Stefan/0000-0002-7519-3279; 				ANDUS T, 1988, EUR J BIOCHEM, V173, P287, DOI 10.1111/j.1432-1033.1988.tb13997.x; ANDUS T, 1987, FEBS LETT, V221, P18, DOI 10.1016/0014-5793(87)80344-7; [Anonymous], 1989, Ann N Y Acad Sci, V557, P1; CASTELL J, 1990, EUR J BIOCHEM, V189, P113, DOI 10.1111/j.1432-1033.1990.tb15466.x; CASTELL JV, 1988, EUR J BIOCHEM, V177, P357, DOI 10.1111/j.1432-1033.1988.tb14384.x; CASTELL JV, 1988, FEBS LETT, V232, P347, DOI 10.1016/0014-5793(88)80766-X; CASTELL JV, 1989, FEBS LETT, V242, P237, DOI 10.1016/0014-5793(89)80476-4; CHEN L, 1988, P NATL ACAD SCI USA, V85, P8037, DOI 10.1073/pnas.85.21.8037; COULIE PG, 1989, EUR J IMMUNOL, V19, P2107, DOI 10.1002/eji.1830191121; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GAULDIE J, 1987, P NATL ACAD SCI USA, V84, P7251, DOI 10.1073/pnas.84.20.7251; GEIGER T, 1988, EUR J IMMUNOL, V18, P717, DOI 10.1002/eji.1830180510; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GREENFELL S, 1989, BIOCHEM J, V264, P813; HATAKEYAMA M, 1989, CELL, V59, P837, DOI 10.1016/0092-8674(89)90607-7; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; HEMPSTEAD BL, 1989, SCIENCE, V243, P373, DOI 10.1126/science.2536190; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; HIRANO T, 1985, P NATL ACAD SCI USA, V82, P5490, DOI 10.1073/pnas.82.16.5490; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; KISHIMOTO T, 1988, ANNU REV IMMUNOL, V6, P485, DOI 10.1146/annurev.iy.06.040188.002413; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMERS JMJ, 1975, BIOCHIM BIOPHYS ACTA, V394, P31, DOI 10.1016/0005-2736(75)90202-3; MARINKOVIC S, 1989, J IMMUNOL, V142, P808; MARKWELL MAK, 1982, ANAL BIOCHEM, V125, P427, DOI 10.1016/0003-2697(82)90025-2; MIYAURA C, 1988, FEBS LETT, V234, P17, DOI 10.1016/0014-5793(88)81293-6; MOSHAGE HJ, 1988, BIOCHEM BIOPH RES CO, V155, P112, DOI 10.1016/S0006-291X(88)81056-8; QWARNSTROM EE, 1988, J BIOL CHEM, V263, P8261; ROSEJOHN S, 1988, GENE, V74, P465, DOI 10.1016/0378-1119(88)90179-5; ROSEJOHN S, 1990, EUR J BIOCHEM, V190, P79, DOI 10.1111/j.1432-1033.1990.tb15548.x; Sambrook J, 1989, MOL CLONING LABORATO; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHERRER K, 1962, BIOCHEM BIOPH RES CO, V7, P486, DOI 10.1016/0006-291X(62)90341-8; SCHIEL X, 1990, EUR J IMMUNOL, V20, P883, DOI 10.1002/eji.1830200425; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546	37	54	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3841	3846						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995637				2022-12-25	WOS:A1991EY68200074
J	SELLAR, GC; DEBEER, MC; LELIAS, JM; SNYDER, PW; GLICKMAN, LT; FELSBURG, PJ; WHITEHEAD, AS				SELLAR, GC; DEBEER, MC; LELIAS, JM; SNYDER, PW; GLICKMAN, LT; FELSBURG, PJ; WHITEHEAD, AS			DOG SERUM AMYLOID-A PROTEIN - IDENTIFICATION OF MULTIPLE ISOFORMS DEFINED BY CDNA AND PROTEIN ANALYSES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY LIPOPROTEIN; MESSENGER-RNA; GENE-EXPRESSION; SAA; SEQUENCE; MOUSE; INDUCTION; DNA; HYBRIDIZATION; POLYARTERITIS	Five distinct serum amyloid A (SAA) cDNA clones have been isolated from a library constructed using hepatic mRNA isolated from an individual beagle dog with canine pain syndrome. This implies the existence of at least three SAA genes in the dog genome. One clone predicts a truncated "amyloid A-like" SAA molecule and offers a possible alternative mechanism for the pathogenesis of secondary amyloidosis. Relative to the human and mouse SAA proteins, an additional peptide of eight amino acids is specified by each of the dog cDNA clones. The existence of this peptide in all acute phase dog SAA proteins was confirmed by polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate of acute phase high density lipoprotein and provides supporting evidence for gene conversion as a mechanism for maintaining the homogeneity of the SAA gene family within a species. Analysis of hepatic RNA following induction of an acute phase response shows a dramatic increase in SAA mRNA concentration; the SAA transcripts show a transient increase in size early in inflammation due to an increase in polyadenylation.	CHILDRENS HOSP MED CTR,CTR BLOOD RES,DIV IMMUNOL,300 LONGWOOD AVE,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115; UNIV KENTUCKY,MED CTR,DIV RHEUMATOL,LEXINGTON,KY 40536; HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,DEPT HEMATOL & ONCOL,BOSTON,MA 02215; PURDUE UNIV,SCH VET MED,DEPT PATHOBIOL,W LAFAYETTE,IN 47907	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; University of Kentucky; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Purdue University System; Purdue University; Purdue University West Lafayette Campus								ALBASSAM MA, 1989, J AM VET MED ASSOC, V194, P1595; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BALTIMORE D, 1981, CELL, V24, P592, DOI 10.1016/0092-8674(81)90082-9; BALTZ ML, 1986, CLIN EXP IMMUNOL, V66, P701; BENSON MD, 1989, J LAB CLIN MED, V113, P67; BRISSETTE L, 1989, J BIOL CHEM, V264, P19327; BROOKS PN, 1984, LAB ANIM, V18, P285, DOI 10.1258/002367784780958088; CARRAZANA EJ, 1988, MOL CELL BIOL, V8, P2267, DOI 10.1128/MCB.8.6.2267; COCHRANE AW, 1988, J MOL BIOL, V203, P555, DOI 10.1016/0022-2836(88)90192-1; DWULET FE, 1987, J LAB CLIN MED, V110, P322; DWULET FE, 1988, BIOCHEMISTRY-US, V27, P1677, DOI 10.1021/bi00405a044; ERIKSEN N, 1980, P NATL ACAD SCI-BIOL, V77, P6860, DOI 10.1073/pnas.77.11.6860; FOLCH J, 1957, J BIOL CHEM, V226, P497; GRUNSTEIN M, 1975, P NATL ACAD SCI USA, V72, P3961, DOI 10.1073/pnas.72.10.3961; HARCOURT RA, 1978, VET REC, V102, P519, DOI 10.1136/vr.102.24.519; HOFFMAN JS, 1982, J BIOL CHEM, V257, P510; HOFFMAN JS, 1984, J EXP MED, V159, P641, DOI 10.1084/jem.159.2.641; HUSEBEKK A, 1985, SCAND J IMMUNOL, V21, P283, DOI 10.1111/j.1365-3083.1985.tb01431.x; JOHNSON KH, 1989, COMP BIOCHEM PHYS B, V94, P765, DOI 10.1016/0305-0491(89)90162-4; KLUVEBECKERMAN B, 1986, BIOCHEM GENET, V24, P795, DOI 10.1007/BF00554519; KLUVEBECKERMAN B, 1989, COMP BIOCHEM PHYS B, V94, P175, DOI 10.1016/0305-0491(89)90030-8; KLUVEBECKERMAN B, 1988, J CLIN INVEST, V82, P1670, DOI 10.1172/JCI113779; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWELL CA, 1986, J BIOL CHEM, V261, P8442; LOWELL CA, 1986, J BIOL CHEM, V261, P8453; MCADAM KPWJ, 1976, J EXP MED, V144, P1121, DOI 10.1084/jem.144.4.1121; MEEK RL, 1989, P NATL ACAD SCI USA, V86, P1890, DOI 10.1073/pnas.86.6.1890; MERCER JFB, 1985, NUCLEIC ACIDS RES, V13, P7929, DOI 10.1093/nar/13.22.7929; PAEK I, 1987, MOL CELL BIOL, V7, P1496, DOI 10.1128/MCB.7.4.1496; PARMELEE DC, 1982, BIOCHEMISTRY-US, V21, P3298, DOI 10.1021/bi00257a008; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIPE JD, 1985, BIOCHEMISTRY-US, V24, P2931, DOI 10.1021/bi00333a018; SLETTEN K, 1989, SCAND J IMMUNOL, V30, P117, DOI 10.1111/j.1365-3083.1989.tb01195.x; STEARMAN RS, 1986, NUCLEIC ACIDS RES, V14, P797, DOI 10.1093/nar/14.2.797; STEINKASSERER A, 1990, BIOCHEM J, V268, P187, DOI 10.1042/bj2680187; STRACHAN AF, 1988, BIOCHEM J, V250, P203, DOI 10.1042/bj2500203; STRACHAN AF, 1989, J BIOL CHEM, V264, P18368; STRACHAN AF, 1989, BIOCHEM J, V263, P365, DOI 10.1042/bj2630365; TAYLOR BA, 1984, MOL GEN GENET, V195, P491, DOI 10.1007/BF00341452; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WHITEHEAD AS, 1990, BIOCHEM J, V266, P283, DOI 10.1042/bj2660283; WOO P, 1987, J BIOL CHEM, V262, P15790; YAMAMOTO K, 1985, P NATL ACAD SCI USA, V82, P2915, DOI 10.1073/pnas.82.9.2915; YAMAMOTO K, 1986, SCIENCE, V232, P227, DOI 10.1126/science.3456645; ZAHEDI K, 1989, J IMMUNOL, V143, P2880	46	33	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3505	3510						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995613				2022-12-25	WOS:A1991EY68200028
J	NAGAMATSU, S; CHAN, SJ; FALKMER, S; STEINER, DF				NAGAMATSU, S; CHAN, SJ; FALKMER, S; STEINER, DF			EVOLUTION OF THE INSULIN GENE SUPERFAMILY - SEQUENCE OF A PREPROINSULIN-LIKE GROWTH-FACTOR CDNA FROM THE ATLANTIC HAGFISH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I; RIBONUCLEIC-ACID; MESSENGER-RNA; CLONING; TISSUES; HORMONE	Complementary DNAs encoding a preproinsulin-like growth factor (prepro-IGF) have been cloned from a primitive vertebrate species, the Atlantic hagfish, by using a DNA amplification strategy based on the polymerase chain reaction. A composite sequence containing a 414-nucleotide open reading frame encoding 138 amino acids and 164 nucleotides in the 3'-untranslated region was obtained. The deduced partial sequence of hagfish prepro-IGF reveals that it is organized like the mammalian prepro-IGFs with an unusually large (> 39-amino acid) signal peptide (initiator methionine residue is missing), 29-amino acid B, 15-amino acid C, 21-amino acid A, 10-amino acid D, and 26-amino acid E domains. All the invariant residues necessary to form the correct tertiary fold of an insulin-like molecule have been conserved in hagfish IGF. Sequence comparisons revealed that the A and B domains of hagfish IGF are equally similar to those of human IGF-I (35 out of 50 amino acids) or IGF-II (37 out of 53 amino acids). In contrast, the similarity between hagfish and mammalian pro-IGFs in the C, D, and E domains is relatively low. Northern blot analysis of RNA isolated from hagfish brain, heart, liver, skeletal muscle, and islet organ, however, indicated that hagfish IGF, like mammalian IGF-I, is expressed predominantly in the liver as a 4.2-kilobase transcript. DNA blot analysis revealed that hagfish IGF is a single copy gene. The predicted sequence of hagfish prepro-IGF thus demonstrates that the divergence of the IGF and insulin genes occurred prior to the separation of the Agnatha and that the organization and tertiary structure of IGF have been well maintained throughout 550 million years of vertebrate evolution.	UNIV CHICAGO,DEPT MED,CHICAGO,IL 60637; UNIV CHICAGO,HOWARD HUGHES MED INST,CHICAGO,IL 60637; KAROLINSKA INST & HOSP,DEPT PATHOL,S-10401 STOCKHOLM,SWEDEN	University of Chicago; Howard Hughes Medical Institute; University of Chicago; Karolinska Institutet; Karolinska University Hospital	NAGAMATSU, S (corresponding author), UNIV CHICAGO,DEPT BIOCHEM & MOLEC BIOL,CHICAGO,IL 60637, USA.				NIDDK NIH HHS [DK 20595, DK 13914] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK013914, P60DK020595, R37DK013914] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADAMS H, 1963, BIOL MYXINE, P450; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BELL GI, 1986, NUCLEIC ACIDS RES, V14, P7873, DOI 10.1093/nar/14.20.7873; BELL GI, 1980, NATURE, V284, P26, DOI 10.1038/284026a0; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; CAO QP, 1989, MOL ENDOCRINOL, V3, P2005, DOI 10.1210/mend-3-12-2005; CASCIERI MA, 1988, FASEB J, V2, P8577; CHAN SJ, 1990, P NATL ACAD SCI USA, V87, P9319, DOI 10.1073/pnas.87.23.9319; CHAN SJ, 1981, J BIOL CHEM, V256, P7595; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CORDELL B, 1979, CELL, V18, P533, DOI 10.1016/0092-8674(79)90070-9; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; DEMEYTS P, 1990, MOL ENDOCRINOL, V4, P409, DOI 10.1210/mend-4-3-409; DERCOLE AJ, 1980, DEV BIOL, V75, P315, DOI 10.1016/0012-1606(80)90166-9; FROESCH ER, 1985, ANNU REV PHYSIOL, V47, P443; FROESCH ER, 1985, DIABETOLOGIA, V28, P485, DOI 10.1007/BF00281982; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; HEIJNE GV, 1986, NUCLEIC ACIDS RES, V14, P4683; HEISER JB, 1979, VERTEBRATE LIFE, P113; ISAACS N, 1978, NATURE, V271, P278, DOI 10.1038/271278a0; IWAMI M, 1989, DEV GROWTH DIFFER, V31, P31; JANSEN M, 1983, NATURE, V306, P609, DOI 10.1038/306609a0; KAJIMOTO Y, 1990, MOL ENDOCRINOL, V4, P217, DOI 10.1210/mend-4-2-217; KAJIMOTO Y, 1989, MOL ENDOCRINOL, V3, P1907, DOI 10.1210/mend-3-12-1907; KIMURA M, 1974, P NATL ACAD SCI USA, V71, P2848, DOI 10.1073/pnas.71.7.2848; KIMURA M, 1983, NEUTRAL THEORY MOL E, P149; LAGUEUX M, 1990, EUR J BIOCHEM, V187, P249, DOI 10.1111/j.1432-1033.1990.tb15302.x; MANIATIS T, 1982, MOL CLONING LABORATO, P109; NAGAGAWA SH, 1987, J BIOL CHEM, V262, P12054; NAGAGAWA SH, 1986, J BIOL CHEM, V261, P7332; NISHI M, 1989, P NATL ACAD SCI USA, V86, P5738, DOI 10.1073/pnas.86.15.5738; PERLER F, 1980, CELL, V20, P555, DOI 10.1016/0092-8674(80)90641-8; PLISETSKAYA EM, 1985, REGUL PEPTIDES, V22, P105; RINDERKNECHT E, 1978, FEBS LETT, V89, P283, DOI 10.1016/0014-5793(78)80237-3; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; ROBERTS CT, 1987, MOL ENDOCRINOL, V1, P243, DOI 10.1210/mend-1-3-243; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHULDINER AR, 1989, J BIOL CHEM, V264, P9428; SHULDINER AR, 1990, BIOCHEM BIOPH RES CO, V166, P223, DOI 10.1016/0006-291X(90)91934-K; SMIT AB, 1988, NATURE, V331, P535, DOI 10.1038/331535a0; SOROKIN AV, 1982, GENE, V20, P367, DOI 10.1016/0378-1119(82)90205-0; TAVAKKOL A, 1988, MOL ENDOCRINOL, V2, P674, DOI 10.1210/mend-2-8-674; UNDERWOOD LE, 1986, CLIN ENDOCRINOL META, V15, P59, DOI 10.1016/S0300-595X(86)80042-1	43	88	90	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2397	2402						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989990				2022-12-25	WOS:A1991EV51500059
J	MIRMIRA, RG; NAKAGAWA, SH; TAGER, HS				MIRMIRA, RG; NAKAGAWA, SH; TAGER, HS			IMPORTANCE OF THE CHARACTER AND CONFIGURATION OF RESIDUES-B24, RESIDUES-B25, AND RESIDUES-B26 IN INSULIN-RECEPTOR INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOLOGICAL-ACTIVITY; CIRCULAR-DICHROISM; B-CHAIN; SHORTENED INSULIN; INVITRO POTENCY; BINDING REGION; TYROSINE A14; SIDE-CHAIN; MAIN CHAIN; SEMISYNTHESIS	By use of isolated canine hepatocytes and insulin analogs prepared by trypsin-catalyzed semisynthesis, we have investigated the importance of the aromatic triplet Phe(B24)-Phe(B25)-Tyr(B26) of the COOH-terminal B-chain domain of insulin in directing the affinity of insulin-receptor interactions. Analysis of the receptor binding potencies of analogs bearing transpositions or replacements (by Tyr, D-Tyr or their corresponding 3,5-diiodo derivatives) in this region demonstrates a wide divergence in the acceptance both of configurational change (with [D-Tyr(B24),Phe(B26)]insulin and [D-Tyr(B25),Phe(B26)]insulin exhibiting 160 and 0.1% of the receptor binding potency of insulin, respectively) and of detailed side chain structure (with [Tyr(B24),Phe(B26)] insulin and [Tyr(B25),Phe(B26)insulin exhibiting 2 and 80% of the receptor binding potency of insulin, respectively). Additional experiments addressed the solvent accessibilities of the 4 tyrosine residues of insulin and the insulin analogs at selected peptide concentrations by use of analytical radioiodination. Whereas two analogs ([Tyr(B25),Phe(B26)]insulin and [D-Tyr(B24),Phe(B26)]insulin) were found to undergo self aggregation, no strict correlation was found between the ability of an analog to aggregate and its potency for interaction with the insulin receptor. Related findings are discussed in terms of the interplay between side chain and main chain structure in the COOH-terminal domain of the insulin B-chain and the structural attributes of insulin that determine the affinity of insulin-receptor interactions.	UNIV CHICAGO,DEPT BIOCHEM & MOLEC BIOL,920 E 58TH ST,CHICAGO,IL 60637	University of Chicago			Mirmira, Raghavendra G/AAD-7592-2020	Mirmira, Raghavendra G/0000-0002-5013-6075	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018347, P60DK020595, R37DK018347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-18347, DK-20595] Funding Source: Medline; NIGMS NIH HHS [GM-07281] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASSOIAN RK, 1981, J BIOL CHEM, V256, P4042; ASSOIAN RK, 1982, P NATL ACAD SCI-BIOL, V79, P5147, DOI 10.1073/pnas.79.17.5147; BAJAJ M, 1986, BIOCHEM J, V238, P345, DOI 10.1042/bj2380345; BAJAJ M, 1983, EUR J BIOCHEM, V135, P535, DOI 10.1111/j.1432-1033.1983.tb07685.x; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Blundell T., 1972, ADV PROTEIN CHEM, V26, P279; BONNEVIENIELSEN V, 1982, P NATL ACAD SCI-BIOL, V79, P2167, DOI 10.1073/pnas.79.7.2167; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; CASARETTO M, 1987, BIOL CHEM H-S, V368, P709, DOI 10.1515/bchm3.1987.368.1.709; DEMEYTS P, 1990, MOL ENDOCRINOL, V4, P409, DOI 10.1210/mend-4-3-409; DEMEYTS P, 1978, NATURE, V273, P504; DEREWENDA U, 1990, HDB EXPT PHARM, V92, P23; DODSON EJ, 1979, CAN J BIOCHEM CELL B, V57, P469, DOI 10.1139/o79-060; DODSON EJ, 1983, BIOPOLYMERS, V22, P281, DOI 10.1002/bip.360220137; FISCHER WH, 1985, BIOL CHEM H-S, V366, P521, DOI 10.1515/bchm3.1985.366.1.521; FLOURET G, 1977, BIOCHEMISTRY-US, V16, P2119, DOI 10.1021/bi00629a011; FREYCHET P, 1971, BIOCHEM BIOPH RES CO, V43, P400, DOI 10.1016/0006-291X(71)90767-4; GOLDMAN J, 1974, BIOCHEMISTRY-US, V13, P4566, DOI 10.1021/bi00719a015; GRAU U, 1985, DIABETES, V34, P1174, DOI 10.2337/diabetes.34.11.1174; HAMLIN JL, 1974, J BIOL CHEM, V249, P21; INOUYE K, 1981, BIOPOLYMERS, V20, P1845, DOI 10.1002/bip.1981.360200909; INOUYE K, 1979, J AM CHEM SOC, V101, P751, DOI 10.1021/ja00497a051; JEFFREY PD, 1976, BIOCHEMISTRY-US, V15, P4660, DOI 10.1021/bi00666a018; JOHNSON WC, 1988, ANNU REV BIOPHYS BIO, V17, P145, DOI 10.1146/annurev.bb.17.060188.001045; JORGENSEN KH, 1980, DIABETOLOGIA, V19, P546; KOBAYASHI M, 1982, BIOCHEM J, V206, P597, DOI 10.1042/bj2060597; KOBAYASHI M, 1982, BIOCHEM BIOPH RES CO, V107, P329, DOI 10.1016/0006-291X(82)91708-9; LINDE S, 1981, DIABETES, V30, P1, DOI 10.2337/diabetes.30.1.1; MASSAGLIA A, 1969, BIOCHEM J, V115, P11, DOI 10.1042/bj1150011; MIRMIRA RG, 1989, J BIOL CHEM, V264, P6349; NAKAGAWA SH, 1987, J BIOL CHEM, V262, P12054; NAKAGAWA SH, 1986, J BIOL CHEM, V261, P7332; POCKER Y, 1980, BIOCHEMISTRY-US, V19, P5043, DOI 10.1021/bi00563a017; POCKER Y, 1981, BIOCHEMISTRY-US, V20, P4354, DOI 10.1021/bi00518a019; PULLEN RA, 1976, NATURE, V259, P369, DOI 10.1038/259369a0; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; ROY M, 1990, J BIOL CHEM, V265, P5448; SONNE O, 1983, H-S Z PHYSIOL CHEM, V364, P101, DOI 10.1515/bchm2.1983.364.1.101; STRAZZA S, 1985, ARCH BIOCHEM BIOPHYS, V238, P30, DOI 10.1016/0003-9861(85)90137-7; STRICKLAND EH, 1976, BIOCHEMISTRY-US, V15, P3875, DOI 10.1021/bi00662a035; TAGER H, 1980, P NATL ACAD SCI-BIOL, V77, P3181, DOI 10.1073/pnas.77.6.3181; TAGER HS, 1990, HDB EXPT PHARM, V92, P41; WEISS MA, 1989, BIOCHEMISTRY-US, V28, P9855, DOI 10.1021/bi00451a046; WOLLMER A, 1981, H-S Z PHYSIOL CHEM, V362, P581, DOI 10.1515/bchm2.1981.362.1.581	44	110	122	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1428	1436						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1988428				2022-12-25	WOS:A1991EU49700015
J	NAKAGAWA, K; MORISHIMA, N; SHIBATA, T				NAKAGAWA, K; MORISHIMA, N; SHIBATA, T			A MATURASE-LIKE SUBUNIT OF THE SEQUENCE-SPECIFIC ENDONUCLEASE ENDO.SCEI FROM YEAST MITOCHONDRIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SPECIFIC ENDONUCLEASE; MEIOTIC GENE CONVERSION; MESSENGER-RNA MATURASE; ENDO-SCE-I; SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE-SEQUENCE; MEMBRANE SYSTEM; FLANKING EXONS; READING FRAME; GEL-ELECTROPHORESIS	Some yeast strains possess a sequence-specific endonuclease, Endo.SceI, which is a heterodimeric enzyme localized in mitochondria. The larger subunit (75 kDa) of Endo.SceI, encoded by a nuclear gene (ENS1), is transported from the cytosol into the mitochondria. In this study, we determined the partial amino acid sequence of the smaller subunit (50 kDa) of Endo.SceI. The determined sequence matched well the partial sequence deduced from a mitochondrial open reading frame (RF3). The RF3 locus is known to exhibit polymorphism since this reading frame in some yeast strains is supposed to encode a maturase-like protein, whereas in other strains, the frame is interrupted by GC clusters, which thus break the frame. Southern blot analysis of various yeast strains showed that the continuity of RF3 is correlated with the presence of Endo.SceI activity. These data indicate that the continuous RF3 sequence is a functional gene (ENS2) coding for the smaller subunit of Endo.SceI. The results of cytoduction, by which the continuous RF3 sequence was transferred into a yeast strain lacking mitochondrial DNA, confirmed this conclusion. This study suggests the involvement of Endo.SceI in genetic recombination of mitochondrial DNA.	INST PHYS & CHEM RES,MICROBIOL LAB,WAKO,SAITAMA 35101,JAPAN	RIKEN			Morishima, Nobuhiro/D-3946-2017					AEBERSOLD RH, 1987, P NATL ACAD SCI USA, V84, P6970, DOI 10.1073/pnas.84.20.6970; ANZIANO PQ, 1982, CELL, V30, P925, DOI 10.1016/0092-8674(82)90297-5; BONITZ SG, 1980, J BIOL CHEM, V255, P1927; CARIGNANI G, 1983, CELL, V35, P733, DOI 10.1016/0092-8674(83)90106-X; COLLEAUX L, 1986, CELL, V44, P521, DOI 10.1016/0092-8674(86)90262-X; CORUZZI G, 1981, J BIOL CHEM, V256, P2780; DELAHODDE A, 1989, CELL, V56, P431, DOI 10.1016/0092-8674(89)90246-8; DELASALLE H, 1982, CELL, V28, P721, DOI 10.1016/0092-8674(82)90051-4; DUJON B, 1980, CELL, V20, P185, DOI 10.1016/0092-8674(80)90246-9; GROOT GSP, 1978, BIOCHIM BIOPHYS ACTA, V517, P457, DOI 10.1016/0005-2787(78)90212-5; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HENSGENS LAM, 1983, CELL, V32, P379, DOI 10.1016/0092-8674(83)90457-9; HOLMES DS, 1981, ANAL BIOCHEM, V114, P193, DOI 10.1016/0003-2697(81)90473-5; HUDSPETH MES, 1980, BIOCHIM BIOPHYS ACTA, V610, P221, DOI 10.1016/0005-2787(80)90003-9; JACQUIER A, 1985, CELL, V41, P383, DOI 10.1016/S0092-8674(85)80011-8; KOSTRIKEN R, 1983, CELL, V35, P167, DOI 10.1016/0092-8674(83)90219-2; LABOUESSE M, 1983, EMBO J, V2, P269, DOI 10.1002/j.1460-2075.1983.tb01416.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANCASHIRE WE, 1979, MOL GEN GENET, V170, P333, DOI 10.1007/BF00267067; LAZOWSKA J, 1980, CELL, V22, P333, DOI 10.1016/0092-8674(80)90344-X; MACREADIE IG, 1985, CELL, V41, P395, DOI 10.1016/S0092-8674(85)80012-X; Maniatis T., 1982, MOL CLONING; MESSING J, 1981, NUCLEIC ACIDS RES, V9, P309, DOI 10.1093/nar/9.2.309; MICHEL F, 1984, CURR GENET, V8, P307, DOI 10.1007/BF00419729; MICHEL F, 1982, BIOCHIMIE, V64, P867, DOI 10.1016/S0300-9084(82)80349-0; MORISHIMA N, 1990, J BIOL CHEM, V265, P15189; NAKAGAWA K, 1988, EUR J BIOCHEM, V171, P23, DOI 10.1111/j.1432-1033.1988.tb13753.x; NICOLAS A, 1989, NATURE, V338, P35, DOI 10.1038/338035a0; NOBREGA FG, 1980, J BIOL CHEM, V255, P9828; RUSSELL DW, 1986, MOL CELL BIOL, V6, P4281, DOI 10.1128/MCB.6.12.4281; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SERAPHIN B, 1985, NUCLEIC ACIDS RES, V13, P3005, DOI 10.1093/nar/13.8.3005; SERAPHIN B, 1987, J BIOL CHEM, V262, P10146; Sherman F., 1986, METHODS YEAST GENETI; SHIBATA T, 1984, J BIOL CHEM, V259, P499; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Spencer J.F.T., 1989, YEAST GENETICS MANUA; SUN H, 1989, NATURE, V338, P87, DOI 10.1038/338087a0; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; WARING RB, 1982, P NATL ACAD SCI-BIOL, V79, P6332, DOI 10.1073/pnas.79.20.6332; WATABE H, 1983, J BIOL CHEM, V258, P4663; WATABE HO, 1984, J BIOCHEM-TOKYO, V95, P1677, DOI 10.1093/oxfordjournals.jbchem.a134781; WATABE HO, 1981, J BIOCHEM-TOKYO, V90, P1623, DOI 10.1093/oxfordjournals.jbchem.a133637; WEISSBRUMMER B, 1982, CELL, V29, P527, DOI 10.1016/0092-8674(82)90169-6; WENZLAU JM, 1989, CELL, V56, P421, DOI 10.1016/0092-8674(89)90245-6; WILBUR WJ, 1983, P NATL ACAD SCI-BIOL, V80, P726, DOI 10.1073/pnas.80.3.726; XIONG Y, 1988, CELL, V55, P235, DOI 10.1016/0092-8674(88)90046-3	48	57	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1977	1984						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1988456				2022-12-25	WOS:A1991EU49700091
J	KUMAR, GB; BLACK, PN				KUMAR, GB; BLACK, PN			LINKER MUTAGENESIS OF A BACTERIAL FATTY-ACID TRANSPORT PROTEIN - IDENTIFICATION OF DOMAINS WITH FUNCTIONAL IMPORTANCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PROTEIN; FADL GENE-PRODUCT; ESCHERICHIA-COLI; INSERTION MUTAGENESIS; LONG; CLONING; PURIFICATION; MUTANTS; SYSTEM; LAMB	The product of the fadL gene (FadL) of Escherichia coli is a multifunctional integral outer-membrane protein required for the specific binding and transport of exogenous long-chain fatty acids [C12-C18]. FadL also serves as a receptor for the bacteriophage T2. In order to define regions of functional importance within FadL, the fadL gene has been mutagenized by the insertion of single-stranded hexameric linkers into the unique SadI restriction site that lies towards the 3' end of the gene and into four HpaII restriction sites distributed throughout the coding region. The five insertion mutants were classified into three groups based on their specific growth rates (alpha) in minimal media containing the long-chain fatty acid oleate (C18:1) as a sole carbon and energy source: Ole(slow), alpha = 0.035-0.045; Ole +/-, alpha = 0.020-0.035; and Ole-, alpha less-than-or-equal-to 0.005 (wild-type, alpha = 0.07-0.10). The hexameric insertion at the SalI site (fadL allele termed S1; insertion after amino acid 410) conferred an Ole(slow) phenotype and resulted in a reduction of long-chain fatty acid transport (36% the wild-type level). This insertion mutant, however, bound oleic acid at wild-type levels and was fully functional as a receptor for the bacteriophage T2. The modified FadL-S1 protein did not have the heat-modifiable property characteristic of wild-type FadL. Insertions in the four HpaII sites (fadL alleles termed H1, H2, H3, and H5; after amino acids 41, 81, 238, and 389, respectively) resulted in all three classes of mutants. The fadL insertion mutant H5 was defective for long-chain fatty acid transport but bound oleic acid at significant levels. Together with the S1 allele, these data suggest that the carboxyl terminus of FadL is crucial for long-chain fatty acid transport. The insertion mutants H1 and H2 were defective for both oleic acid binding and transport suggesting that the amino terminus of FadL is important for long-chain fatty acid binding and transport. The fadL linker mutant H3 was defective in oleic acid binding yet had significant levels of oleic acid transport. These studies delineated for the first time different regions of the fadL gene that encode domains of FadL implicated in the binding and transport of long-chain fatty acids.	UNIV TENNESSEE,CTR HLTH SCI,COLL MED,DEPT BIOCHEM,MEMPHIS,TN 38163	University of Tennessee System; University of Tennessee Health Science Center				Black, Paul/0000-0002-6272-6881				BARANY F, 1985, P NATL ACAD SCI USA, V82, P4202, DOI 10.1073/pnas.82.12.4202; BARANY F, 1985, GENE, V37, P111, DOI 10.1016/0378-1119(85)90263-X; BLACK PN, 1987, J BIOL CHEM, V262, P1412; BLACK PN, 1990, BIOCHIM BIOPHYS ACTA, V1046, P97, DOI 10.1016/0005-2760(90)90099-J; BLACK PN, 1988, J BACTERIOL, V170, P2850, DOI 10.1128/jb.170.6.2850-2854.1988; BLACK PN, 1985, J BIOL CHEM, V260, P1780; BOUGESBOCQUET B, 1984, J CELL BIOCHEM, V24, P217, DOI 10.1002/jcb.240240304; BOULAIN JC, 1986, MOL GEN GENET, V205, P339, DOI 10.1007/BF00430448; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CARMEL G, 1990, J BACTERIOL, V172, P1861, DOI 10.1128/jb.172.4.1861-1869.1990; Cronan JE, 1987, ESCHERICHIA COLI SAL, P31; DAGERT M, 1979, GENE, V6, P23, DOI 10.1016/0378-1119(79)90082-9; DEGEUS P, 1983, MOL GEN GENET, V190, P150, DOI 10.1007/BF00330338; FRERMAN FE, 1973, ARCH BIOCHEM BIOPHYS, V159, P434, DOI 10.1016/0003-9861(73)90471-2; GOLDSTEIN J, 1990, J BACTERIOL, V172, P1225, DOI 10.1128/jb.172.3.1225-1231.1990; GUDMUNDSDOTTIR A, 1988, J BIOL CHEM, V263, P14224; HANCOCK REW, 1987, BACTERIAL OUTER MEMB, P187; HUMPHREYS GO, 1975, BIOCHIM BIOPHYS ACTA, V383, P457, DOI 10.1016/0005-2787(75)90318-4; ISHHOROWICZ D, 1981, NUCLEIC ACIDS RES, V9, P2989, DOI 10.1093/nar/9.13.2989; KAMEDA K, 1981, J BIOL CHEM, V256, P5702; KLEIN K, 1971, EUR J BIOCHEM, V19, P442, DOI 10.1111/j.1432-1033.1971.tb01334.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LLOYD AD, 1990, J BACTERIOL, V172, P1688, DOI 10.1128/jb.172.4.1688-1693.1990; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALOY SR, 1981, J BIOL CHEM, V256, P3735; Miller J. H., 1972, EXPT MOL GENETICS, P433; NAKAMURA K, 1976, J BIOCHEM, V80, P1411, DOI 10.1093/oxfordjournals.jbchem.a131414; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; NUNN WD, 1986, MICROBIOL REV, V50, P179, DOI 10.1128/MMBR.50.2.179-192.1986; NUNN WD, 1978, P NATL ACAD SCI USA, V75, P3377, DOI 10.1073/pnas.75.7.3377; NUNN WD, 1979, J BIOL CHEM, V254, P9130; NUNN WD, 1986, J BIOL CHEM, V261, P167; ROCK CO, 1985, J BIOL CHEM, V260, P2720; SAIER MH, 1985, MECHANISMS REGULATIO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463	35	39	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1348	1353						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985953				2022-12-25	WOS:A1991ET17700101
J	MEHEGAN, JP; TOBACMAN, LS				MEHEGAN, JP; TOBACMAN, LS			COOPERATIVE INTERACTIONS BETWEEN TROPONIN MOLECULES BOUND TO THE CARDIAC THIN FILAMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT SKELETAL-MUSCLE; X-RAY-DIFFRACTION; MYOSIN SUBFRAGMENT-1; F-ACTIN; ADENOSINE-TRIPHOSPHATASE; EQUILIBRIUM BINDING; PARTIAL EXTRACTION; TROPOMYOSIN-ACTIN; COMPLEX; ACTOMYOSIN	Striated muscle thin filaments contain many troponin molecules, which contact each other indirectly via tropomyosin and actin. Such allosteric interactions between troponin molecules may be responsible for cooperative Ca2+ binding to the regulatory sites of the cardiac thin filament (Tobacman, L. S., and Sawyer, D. S. (1990) J. Biol. Chem. 265, 931-939). To test whether thin filament-bound troponin molecules interact, we studied the competitive binding of troponin and troponin T-troponin I (an inhibitory complex lacking the Ca2+ binding subunit troponin C) to actin-tropomyosin. The relative affinities of these two forms of troponin for the thin filament depended upon their relative concentrations. Under conditions where total binding was saturated, each form binds with greater apparent affinity to sites that have similar neighbors. A theoretical model for competitive binding of two ligands to interacting sites on a linear lattice was developed and fit to the data. Surprisingly, energetically unfavorable interactions occurred between adjacent troponin and troponin T-troponin I molecules not only in the presence of Ca2+, but also in the presence of [ethylenebis(oxyethylenenitrilo)]tetraacetic acid and/or myosin subfragment 1. Removal of Ca2+ strengthened the affinity of troponin for the thin filament less than 50%. These results suggest that, even in the absence of myosin, long range allosteric interactions occur between troponin molecules. The detailed involvement of tropomyosin and actin in these interactions remains to be established.	UNIV IOWA,DEPT BIOCHEM,IOWA CITY,IA 52242	University of Iowa	MEHEGAN, JP (corresponding author), UNIV IOWA,DEPT MED,IOWA CITY,IA 52242, USA.				NHLBI NIH HHS [HL 38834] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038834, R29HL038834] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BRANDT PW, 1987, J MOL BIOL, V195, P885, DOI 10.1016/0022-2836(87)90492-X; CHALOVICH JM, 1982, J BIOL CHEM, V257, P2432; CHOU YJ, 1990, J BIOL CHEM, V265, P538; EBASHI S, 1966, J BIOCHEM-TOKYO, V59, P425, DOI 10.1093/oxfordjournals.jbchem.a128320; Greaser M. L., 1972, COLD SPRING HARB SYM, V37, P235; GREENE L, 1982, J BIOL CHEM, V257, P3993; Haselgrove J. C., 1972, COLD SPRING HARB SYM, V37, P341; HEELEY DH, 1988, BIOCHEMISTRY-US, V27, P8227, DOI 10.1021/bi00421a036; HEELEY DH, 1987, J BIOL CHEM, V262, P9971; HILL TL, 1980, P NATL ACAD SCI-BIOL, V77, P3186, DOI 10.1073/pnas.77.6.3186; HILL TL, 1983, P NATL ACAD SCI-BIOL, V80, P60, DOI 10.1073/pnas.80.1.60; HILL TL, 1985, COOPERATIVITY THEORY, P182; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; HOLROYDE MJ, 1980, J BIOL CHEM, V255, P1688; Huxley H. E., 1972, COLD SPRING HARB SYM, V37, P361; INGRAHAM RH, 1984, J BIOL CHEM, V259, P9544; ISHII Y, 1987, BIOCHEMISTRY-US, V26, P4922, DOI 10.1021/bi00390a005; JACKSON P, 1975, BIOCHEM J, V151, P85, DOI 10.1042/bj1510085; KRESS M, 1986, J MOL BIOL, V188, P325, DOI 10.1016/0022-2836(86)90158-0; LIN TI, 1983, BIOCHEM BIOPH RES CO, V114, P447, DOI 10.1016/0006-291X(83)90800-8; MAK AS, 1981, BIOCHEM BIOPH RES CO, V101, P208, DOI 10.1016/S0006-291X(81)80032-0; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; MOSS RL, 1985, J GEN PHYSIOL, V86, P585, DOI 10.1085/jgp.86.4.585; MOSS RL, 1986, J GEN PHYSIOL, V87, P761, DOI 10.1085/jgp.87.5.761; OHTSUKI I, 1979, J BIOCHEM, V86, P491, DOI 10.1093/oxfordjournals.jbchem.a132549; PAN BS, 1989, J BIOL CHEM, V264, P8495; PARRY DAD, 1973, J MOL BIOL, V75, P33, DOI 10.1016/0022-2836(73)90527-5; PEARLSTONE JR, 1983, J BIOL CHEM, V258, P2534; SHIGEKAWA M, 1973, J BIOCHEM, V73, P1135, DOI 10.1093/oxfordjournals.jbchem.a130185; TAO T, 1990, SCIENCE, V247, P1339, DOI 10.1126/science.2138356; TOBACMAN LS, 1988, J BIOL CHEM, V263, P2668; TOBACMAN LS, 1986, BIOCHEMISTRY-US, V25, P798, DOI 10.1021/bi00352a010; TOBACMAN LS, 1987, BIOCHEMISTRY-US, V26, P492, DOI 10.1021/bi00376a022; TOBACMAN LS, 1990, J BIOL CHEM, V265, P931; VANEYK JE, 1988, J BIOL CHEM, V263, P1726; WEGNER A, 1979, J MOL BIOL, V131, P839, DOI 10.1016/0022-2836(79)90204-3; WEGNER A, 1981, BIOCHEMISTRY-US, V20, P5633, DOI 10.1021/bi00522a043; WHITE SP, 1987, NATURE, V325, P826, DOI 10.1038/325826a0; WILLIAMS DL, 1988, BIOCHEMISTRY-US, V27, P6987, DOI 10.1021/bi00418a048; YANG YZ, 1979, J BIOL CHEM, V254, P7137	41	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					966	972						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985974				2022-12-25	WOS:A1991ET17700047
J	YUN, SJ; HIRAOKA, Y; NISHIZAWA, M; TAKIO, K; TITANI, K; NOGI, Y; FUKASAWA, T				YUN, SJ; HIRAOKA, Y; NISHIZAWA, M; TAKIO, K; TITANI, K; NOGI, Y; FUKASAWA, T			PURIFICATION AND CHARACTERIZATION OF THE YEAST NEGATIVE REGULATORY PROTEIN GAL80	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; UPSTREAM ACTIVATING SEQUENCES; SACCHAROMYCES-CEREVISIAE; PROMOTER REGION; GENE; EXPRESSION; BINDING; CLUSTER; PRODUCT; PEPTIDE	Transcription of the GAL genes encoding the enzymes responsible for galactose metabolism in the yeast Saccharomyces cerevisiae is regulated through an interplay of two regulatory proteins, GAL4 and GAL80. GAL4 binds to upstream activating sequences of GAL (UAS(G)) and activates their transcription in yeast growing in the presence of galactose. GAL80 binds to GAL4 and inhibits the activation function of GAL4 in yeast growing without galactose. We have purified GAL80 in its native form as a protein that reacts with an antiserum raised against a synthetic peptide of 18 amino acid residues in the GAL80 sequence. Purification was performed through ammonium sulfate precipitation, streptomycin precipitation, DEAE-cellulose column chromatography, and gel filtration. From 50 g of wet cells, a final sample of 2.3 mg with a purity of more than 80% was obtained. The molecular size of the purified protein in both the native and denatured states was estimated to be approximately 50 kDa, indicating that GAL80 exists as a monomer in yeast cells. The amino-terminal residue of GAL80 was found to be acetylmethionine. The purified protein was shown to bind GAL4. We have also purified mutant GAL80 proteins encoded by two different alleles of gal80 known to be incapable of inhibiting the function of GAL4. These proteins were, in fact, unable to bind GAL4.	KEIO UNIV,SCH MED,DEPT MICROBIOL,35 SHINANOMACHI,SHINJUKU KU,TOKYO 160,JAPAN; KEIO UNIV,SCH MED,MOLEC GENET LAB,SHINJUKU KU,TOKYO 160,JAPAN; FRONTIER RES PROGRAM,WAKO,SAITAMA 35001,JAPAN	Keio University; Keio University								BOTSTEIN D, 1979, GENE, V8, P17, DOI 10.1016/0378-1119(79)90004-0; BRAM RJ, 1985, P NATL ACAD SCI USA, V82, P43, DOI 10.1073/pnas.82.1.43; BROACH JR, 1979, J MOL BIOL, V131, P41, DOI 10.1016/0022-2836(79)90300-0; CHANG JY, 1983, METHOD ENZYMOL, V91, P41, DOI 10.1016/S0076-6879(83)91009-1; CHASMAN DI, 1990, MOL CELL BIOL, V10, P2916, DOI 10.1128/MCB.10.6.2916; DOUGLAS HC, 1966, GENETICS, V54, P911; DREYER WJ, 1967, METHOD ENZYMOL, V11, P32; FUKASAWA T, 1982, METHOD ENZYMOL, V89, P584; GINIGER E, 1985, CELL, V40, P767, DOI 10.1016/0092-8674(85)90336-8; GORGA FR, 1982, BIOCHEMISTRY-US, V21, P1905, DOI 10.1021/bi00537a031; HANDA H, 1987, GENE, V58, P127; HASHIMOTO Y, 1983, PROTEIN NUCLIC ACID, V28, P1220; HEWICK RM, 1981, J BIOL CHEM, V256, P7990; JOHNSTON M, 1984, MOL CELL BIOL, V4, P1440, DOI 10.1128/MCB.4.8.1440; JOHNSTON M, 1987, MICROBIOL REV, V51, P458, DOI 10.1128/MMBR.51.4.458-476.1987; JOHNSTON SA, 1987, CELL, V50, P143, DOI 10.1016/0092-8674(87)90671-4; LUE NF, 1987, MOL CELL BIOL, V7, P3446, DOI 10.1128/MCB.7.10.3446; MA J, 1987, CELL, V50, P137, DOI 10.1016/0092-8674(87)90670-2; MAHONEY WC, 1980, J BIOL CHEM, V255, P1199; MATSUMOTO K, 1978, J BACTERIOL, V134, P446, DOI 10.1128/JB.134.2.446-457.1978; NOGI Y, 1989, MOL CELL BIOL, V9, P3009, DOI 10.1128/MCB.9.7.3009; NOGI Y, 1986, J BACTERIOL, V165, P101, DOI 10.1128/jb.165.1.101-106.1986; NOGI Y, 1984, NUCLEIC ACIDS RES, V12, P9287, DOI 10.1093/nar/12.24.9287; PARTHUN MR, 1990, J BIOL CHEM, V265, P209; PERLMAN D, 1979, CELL, V16, P89, DOI 10.1016/0092-8674(79)90190-9; SALMERON JM, 1990, GENETICS, V125, P21; STJOHN TP, 1981, J MOL BIOL, V152, P285, DOI 10.1016/0022-2836(81)90244-8; TAJIMA M, 1986, MOL CELL BIOL, V6, P246, DOI 10.1128/MCB.6.1.246; TORCHIA TE, 1986, GENETICS, V113, P229; Tsunasawa S, 1976, Methods Enzymol, V45, P552; TSUYUMU S, 1973, P NATL ACAD SCI USA, V70, P919, DOI 10.1073/pnas.70.3.919; UEMURA H, 1986, GENE, V45, P67; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; WALKER LE, 1985, P NATL ACAD SCI USA, V82, P539, DOI 10.1073/pnas.82.2.539; WEST RW, 1984, MOL CELL BIOL, V4, P2467, DOI 10.1128/MCB.4.11.2467	35	22	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					693	697						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985957				2022-12-25	WOS:A1991ET17700005
J	ONISHI, H; MAITA, T; MATSUDA, G; FUJIWARA, K				ONISHI, H; MAITA, T; MATSUDA, G; FUJIWARA, K			LYS-65 AND GLU-168 ARE THE RESIDUES FOR CARBODIIMIDE-CATALYZED CROSS-LINKING BETWEEN THE 2 HEADS OF RIGOR SMOOTH-MUSCLE HEAVY-MEROMYOSIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									NAGASAKI UNIV,SCH MED,DEPT BIOCHEM,NAGASAKI 852,JAPAN	Nagasaki University	ONISHI, H (corresponding author), NATL CARDIOVASC CTR,RES INST,DEPT STRUCT ANAL,SUITA,OSAKA 565,JAPAN.							AMOS LA, 1982, NATURE, V299, P467, DOI 10.1038/299467a0; ATKINSON MAL, 1986, J BIOL CHEM, V261, P1844; BONET A, 1987, J BIOL CHEM, V262, P16524; CREMO CR, 1989, J BIOL CHEM, V264, P6608; FRY DC, 1986, P NATL ACAD SCI USA, V83, P907, DOI 10.1073/pnas.83.4.907; FRY DC, 1985, BIOCHEMISTRY-US, V24, P4680, DOI 10.1021/bi00338a030; IKEBE M, 1978, J BIOCHEM, V83, P1643, DOI 10.1093/oxfordjournals.jbchem.a132077; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAITA T, 1987, J BIOCHEM, V102, P133, DOI 10.1093/oxfordjournals.jbchem.a122025; MARIANNEPEPIN T, 1983, FEBS LETT, V159, P211, DOI 10.1016/0014-5793(83)80448-7; MOORE PB, 1970, J MOL BIOL, V50, P279, DOI 10.1016/0022-2836(70)90192-0; OKAMOTO Y, 1980, J BIOCHEM, V88, P361, DOI 10.1093/oxfordjournals.jbchem.a132981; ONISHI H, 1990, BIOCHEMISTRY-US, V29, P3013, DOI 10.1021/bi00464a018; ONISHI H, 1989, BIOCHEMISTRY-US, V28, P1905, DOI 10.1021/bi00430a071; Onishi H, 1985, Adv Biophys, V19, P21, DOI 10.1016/0065-227X(85)90050-4; ONISHI H, 1989, BIOCHEMISTRY-US, V28, P1898, DOI 10.1021/bi00430a070; PAI EF, 1977, J MOL BIOL, V114, P37, DOI 10.1016/0022-2836(77)90281-9; SELLERS JR, 1984, J BIOL CHEM, V259, P4203; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; SUTOH K, 1986, P NATL ACAD SCI USA, V83, P212, DOI 10.1073/pnas.83.2.212; TOKUNAGA M, 1987, NATURE, V329, P635, DOI 10.1038/329635a0; TONG SW, 1983, J BIOL CHEM, V258, P3100; TOYOSHIMA C, 1985, J BIOCHEM-TOKYO, V97, P219, DOI 10.1093/oxfordjournals.jbchem.a135048; VIBERT P, 1982, J MOL BIOL, V157, P299, DOI 10.1016/0022-2836(82)90236-4; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WARRICK HM, 1987, ANNU REV CELL BIOL, V3, P379, DOI 10.1146/annurev.cb.03.110187.002115	26	13	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1990	265	31					19362	19368						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF739	1977747				2022-12-25	WOS:A1990EF73900103
J	DANIELSEN, EM				DANIELSEN, EM			PERTURBATION OF INTESTINAL MICROVILLAR ENZYME-BIOSYNTHESIS BY AMINO-ACID-ANALOGS - EVIDENCE THAT DIMERIZATION IS REQUIRED FOR THE TRANSPORT OF AMINOPEPTIDASE N OUT OF THE ENDOPLASMIC-RETICULUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											DANIELSEN, EM (corresponding author), UNIV COPENHAGEN, PANUM INST, DEPT BIOCHEM C, DK-2200 COPENHAGEN, DENMARK.							Alpers D. H., 1987, PHYSL GASTROINTESTIN, P1469; BARTLES JR, 1987, J CELL BIOL, V105, P1241, DOI 10.1083/jcb.105.3.1241; BLOK J, 1984, CELL BIOL INT REP, V8, P993, DOI 10.1016/0309-1651(84)90086-9; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; CRINE P, 1982, J BIOL CHEM, V257, P832; DANIELSEN EM, 1983, J BIOCHEM BIOPH METH, V8, P41, DOI 10.1016/0165-022X(83)90019-2; DANIELSEN EM, 1984, EUR J BIOCHEM, V145, P653, DOI 10.1111/j.1432-1033.1984.tb08606.x; DANIELSEN EM, 1990, BIOCHEMISTRY-US, V29, P305, DOI 10.1021/bi00453a042; DANIELSEN EM, 1984, FEBS LETT, V166, P28, DOI 10.1016/0014-5793(84)80038-1; DANIELSEN EM, 1989, J BIOL CHEM, V264, P13726; DANIELSEN EM, 1983, BIOCHEM J, V212, P161, DOI 10.1042/bj2120161; DANIELSEN EM, 1984, BIOCHEM BIOPH RES CO, V122, P82; DANIELSEN EM, 1986, BIOCHEM J, V240, P777, DOI 10.1042/bj2400777; DANIELSEN EM, 1982, BIOCHEM J, V204, P639, DOI 10.1042/bj2040639; DANIELSEN EM, 1982, BIOCHEM J, V202, P647, DOI 10.1042/bj2020647; DANIELSEN EM, 1987, MAMMALIAN ECTOENZYME, P47; HARBOE N, 1973, MANUAL QUANTITATIVE, P161; HARTMAN FC, 1967, BIOCHEMISTRY-US, V6, P2439, DOI 10.1021/bi00860a021; HAURI HP, 1985, P NATL ACAD SCI USA, V82, P4423, DOI 10.1073/pnas.82.13.4423; HORTIN G, 1983, METHOD ENZYMOL, V96, P777; HORTIN G, 1980, J BIOL CHEM, V255, P7051; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATTER K, 1989, J BIOL CHEM, V264, P13131; NAIM HY, 1988, J CLIN INVEST, V82, P667, DOI 10.1172/JCI113646; NAIM HY, 1987, BIOCHEM J, V241, P427, DOI 10.1042/bj2410427; NOE BD, 1981, J BIOL CHEM, V256, P4940; OLSEN J, 1988, FEBS LETT, V238, P307, DOI 10.1016/0014-5793(88)80502-7; PELHAM HRB, 1989, EMBO J, V8, P3171, DOI 10.1002/j.1460-2075.1989.tb08475.x; RICHES DWH, 1974, BIOCHEM J, V142, P575; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; SCHMITZ J, 1973, BIOCHIM BIOPHYS ACTA, V323, P98, DOI 10.1016/0005-2736(73)90434-3; SEMENZA G, 1986, ANNU REV CELL BIOL, V2, P255, DOI 10.1146/annurev.cellbio.2.1.255; SIMONS K, 1985, ANNU REV CELL BIOL, V1, P243, DOI 10.1146/annurev.cb.01.110185.001331; SJOSTROM H, 1985, J PEDIATR GASTR NUTR, V4, P980, DOI 10.1097/00005176-198512000-00021; SJOSTROM H, 1978, EUR J BIOCHEM, V88, P503, DOI 10.1111/j.1432-1033.1978.tb12476.x; SJOSTROM H, 1980, J BIOL CHEM, V255, P1332; SVENDSEN PJ, 1973, MANUAL QUANTITATIVE, P69; TAE HJ, 1983, METHOD ENZYMOL, V91, P580; WANG CS, 1975, ANAL BIOCHEM, V63, P414, DOI 10.1016/0003-2697(75)90363-2; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8; WINDMUELLER HG, 1981, J BIOL CHEM, V256, P3012; [No title captured]	45	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	1990	265	24					14566	14571						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV278	1974897				2022-12-25	WOS:A1990DV27800076
J	PRESS, MF; CORDONCARDO, C; SLAMON, DJ				PRESS, MF; CORDONCARDO, C; SLAMON, DJ			EXPRESSION OF THE HER-2/NEU PROTOONCOGENE IN NORMAL HUMAN ADULT AND FETAL TISSUES	ONCOGENE			English	Article									MEM SLOAN KETTERING CANC CTR,DEPT PATHOL,NEW YORK,NY 10021; UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,DIV HEMATOL & ONCOL,LOS ANGELES,CA 90024	Memorial Sloan Kettering Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	PRESS, MF (corresponding author), UNIV SO CALIF,DEPT PATHOL,2011 ZONAL AVE,LOS ANGELES,CA 90033, USA.				NATIONAL CANCER INSTITUTE [R01CA047538, U01CA047538, R01CA048780] Funding Source: NIH RePORTER; NCI NIH HHS [CA471779, CA48780, CA47538] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARTOW S, 1989, LAB INVEST, V62, pA8; COHEN JA, 1989, ONCOGENE, V4, P81; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; DEPOTTER CR, 1989, HISTOPATHOLOGY, V15, P351; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; DREBIN JA, 1985, CELL, V41, P695, DOI 10.1016/S0092-8674(85)80050-7; EKBLOM P, 1989, FASEB J, V3, P2141, DOI 10.1096/fasebj.3.10.2666230; GUSTERSON BA, 1988, MOL CELL PROBE, V2, P383; HUDZIAK RM, 1987, P NATL ACAD SCI USA, V84, P7159, DOI 10.1073/pnas.84.20.7159; KING CR, 1985, SCIENCE, V229, P974, DOI 10.1126/science.2992089; KOKAI Y, 1987, P NATL ACAD SCI USA, V84, P8498, DOI 10.1073/pnas.84.23.8498; KRAUS MH, 1987, EMBO J, V6, P605, DOI 10.1002/j.1460-2075.1987.tb04797.x; MORI S, 1989, LAB INVEST, V61, P93; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; PAIK S, 1990, J CLIN ONCOL, V8, P103, DOI 10.1200/JCO.1990.8.1.103; PRESS MF, 1986, AM J PATHOL, V123, P280; PRESS MF, 1988, AM J PATHOL, V131, P112; PRESS MF, 1984, LAB INVEST, V51, P495; PRESS MF, 1984, LAB INVEST, V50, P480; PRESS MF, 1988, ENDOCRINOLOGY, V122, P1165, DOI 10.1210/endo-122-3-1165; QUIRKE P, 1989, BRIT J CANCER, V60, P64, DOI 10.1038/bjc.1989.221; RO J, 1989, CANCER RES, V49, P6941; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; SEMBA K, 1985, P NATL ACAD SCI USA, V82, P6497, DOI 10.1073/pnas.82.19.6497; SHIH C, 1981, NATURE, V290, P261, DOI 10.1038/290261a0; SLAMON DJ, 1989, CANCER CEL, V7, P371; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1988, SCIENCE, V240, P1796, DOI 10.1126/science.240.4860.1796; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; VANDEVIJVER MJ, 1988, NEW ENGL J MED, V319, P1239, DOI 10.1056/NEJM198811103191902; WRIGHT C, 1989, CANCER RES, V49, P2087	33	548	604	1	15	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JUL	1990	5	7					953	962						10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DP415	1973830				2022-12-25	WOS:A1990DP41500002
J	SCHNYDER, T; WINKLER, H; GROSS, H; EPPENBERGER, HM; WALLIMANN, T				SCHNYDER, T; WINKLER, H; GROSS, H; EPPENBERGER, HM; WALLIMANN, T			CRYSTALLIZATION OF MITOCHONDRIAL CREATINE-KINASE - GROWING OF LARGE PROTEIN CRYSTALS AND ELECTRON-MICROSCOPIC INVESTIGATION OF MICROCRYSTALS CONSISTING OF OCTAMERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; FORMS; PURIFICATION; LOCALIZATION; BRAIN	Mitochondrial creatine kinase isolated from chicken cardiac muscle was crystallized by vapor diffusion techniques. Depending on the growth conditions, fine needles and platelets as well as large single crystals appeared after a few days. Large crystals were shown to diffract to at least 3.2 angstrom resolution (Schnyder, T., Winkler, H., Gross, H., Sargent, D., Eppenberger, H. M., and Wallimann, T. (1990) Biophys J. 57, 420 and thus are suited for a detailed X-ray analysis in the future. The relatively high density of single crystals measured by a linear organic solvent density gradient indicates a tight packing of mitochondrial creatine kinase molecules within the crystals. Microcrystals, however, were subjected to electron optical examination either after prefixation with glutaraldehyde followed by conventional negative staining or by freeze-fracturing crystals in mother liquor and heavy metal replication with platinum/carbon. In both cases the crystals exhibited a square lattice with parameters of a = b = 139 angstrom and a = b = 132 angstrom in negatively stained and replicated crystals, respectively. No other lattice parameters were found, suggesting that these microcrystals represent a quasi-cubic three-dimensional lattice, which is in accordance with the finding that the building blocks of the crystals are the cube-like octamers described (Schnyder, T., Engel, A., Lustig, A., and Wallimann, T. (1988) J. Biol. Chem. 263, 16954-16962). Digital image processing applied to electron micrographs of crystals clearly revealed the arrangement of mitochondrial creatine kinase octamers in the crystal lattice as well as the subdivision of the octamer into its subdomains at a resolution of 23 angstrom.	SWISS FED INST TECHNOL, INST CELL BIOL, CH-8093 ZURICH, SWITZERLAND	Swiss Federal Institutes of Technology Domain; ETH Zurich			Wallimann, Theo/C-6047-2008	Wallimann, Theo/0000-0003-4957-5836				ADAMS V, 1989, BIOCHIM BIOPHYS ACTA, V981, P213, DOI 10.1016/0005-2736(89)90031-X; BLUM HE, 1983, J BIOCHEM, V94, P1247, DOI 10.1093/oxfordjournals.jbchem.a134470; BODE W, 1985, BIOL CHEM H-S, V366, P287, DOI 10.1515/bchm3.1985.366.1.287; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGESS AN, 1978, J MOL BIOL, V123, P691, DOI 10.1016/0022-2836(78)90213-9; EPPENBERGER HM, 1983, ISOZYMES-CURR T BIOL, V7, P19; GILLILAND GL, 1983, J MOL BIOL, V170, P791, DOI 10.1016/S0022-2836(83)80132-6; GROSS H, 1985, ULTRAMICROSCOPY, V16, P287, DOI 10.1016/0304-3991(85)90098-1; HAAS RC, 1990, J BIOL CHEM, V265, P6921; HAAS RC, 1989, J BIOL CHEM, V264, P2890; HAMBURG RJ, 1990, J BIOL CHEM, V265, P6403; HERSHENSON S, 1986, J BIOL CHEM, V261, P3732; HOSSLE JP, 1988, BIOCHEM BIOPH RES CO, V151, P408, DOI 10.1016/0006-291X(88)90608-0; JACOBS H, 1964, BIOCHEM BIOPH RES CO, V16, P516, DOI 10.1016/0006-291X(64)90185-8; KEUTEL HJ, 1968, BIOCHEMISTRY-US, V7, P4283, DOI 10.1021/bi00852a020; KOTTKE M, 1991, IN PRESS BIOCH BIOPH; LIPSKAYA TY, 1989, BIOCHEM INT, V18, P1161; MARCILLAT O, 1987, BIOCHIM BIOPHYS ACTA, V890, P233, DOI 10.1016/0005-2728(87)90024-7; MCPHERSON A, 1973, J MOL BIOL, V81, P83, DOI 10.1016/0022-2836(73)90249-0; SCHLEGEL J, 1988, J BIOL CHEM, V263, P16963; SCHLEGEL J, 1988, J BIOL CHEM, V263, P16942; SCHLEGEL J, 1990, J BIOL CHEM, V265, P9221; SCHNYDER T, 1990, BIOPHYS J, V57, pA420; SCHNYDER T, 1988, J BIOL CHEM, V263, P16954; SCHNYDER T, 1989, CYTOSKELETAL EXTRACE, V3, P39; SCHNYDER T, 1991, IN PRESS J CELL BIOL; SCHOLTE HR, 1973, BIOCHIM BIOPHYS ACTA, V291, P764, DOI 10.1016/0005-2736(73)90479-3; TAKASAWA T, 1981, J BIOCHEM, V89, P1619, DOI 10.1093/oxfordjournals.jbchem.a133357; WALLIMANN T, 1984, J BIOL CHEM, V259, P5238; Wallimann T, 1985, Cell Muscle Motil, V6, P239; Wallimann T, 1989, Prog Clin Biol Res, V315, P159; WALLIMANN T, 1990, ISOENZYMES STRUCTURE, V344, P877; WYSS M, 1990, J BIOL CHEM, V265, P15900	33	36	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					5318	5322						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002064				2022-12-25	WOS:A1991FC21700093
J	TRAYNOR, D; KAY, RR				TRAYNOR, D; KAY, RR			THE DIF-1 SIGNALING SYSTEM IN DICTYOSTELIUM - METABOLISM OF THE SIGNAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION-INDUCING FACTOR; STALK CELL-DIFFERENTIATION; DISCOIDEUM; MORPHOGEN; MONOLAYERS; INDUCTION; SLUG	DIF-1 is a novel, chlorinated alkyl phenone from Dictyostelium which, at very low concentrations, induces amoebae to differentiate into stalk cells and may act as a morphogen in the formation of the prestalk-prespore pattern during development. We report here the existence of a developmentally regulated metabolic pathway which inactivates DIF-1. Radioisotopically labeled DIF-1 was synthesized, incubated with developing cells, the metabolites recovered, and then analyzed by high pressure liquid chromatography and TLC. At least 12 metabolites are produced and the early steps of a complex metabolic pathway have been deduced by following the flow of counts from one metabolite to another and by determining the fate of purified metabolites when they are incubated with cells. The first metabolite, DM1, is largely cell-associated whereas the more distal ones are found mainly in the medium. Metabolism inactivates DIF-1, since DM1 retains only 7% of the specific activity of DIF-1 in the stalk cell differentiation bioassay and later metabolites possess even less activity. Metabolism is developmentally regulated, increasing toward the end of aggregation to reach maximal levels at the tipped mound stage, as endogenous DIF-1 levels are themselves rising. Cells at this stage of development possess the capacity to metabolize their endogenous DIF-1 with a half-life of a few minutes. We suggest that DIF-1 metabolism is important to prevent the DIF-1 receptor system from becoming saturated by excess ligand, thus allowing cells to respond to changes in DIF-1 production. Metabolism may also produce other effector molecules from DIF-1 or produce DIF-1 gradients in the aggregate by the localized destruction of DIF-1.	MRC,MOLEC BIOL LAB,CAMBRIDGE CB2 2QH,ENGLAND	MRC Laboratory Molecular Biology				Kay, Robert R/0000-0001-9836-7967				BERKS M, 1989, SCI PROG, V73, P17; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BROOKMAN JJ, 1982, DEV BIOL, V91, P191, DOI 10.1016/0012-1606(82)90022-7; BROOKMAN JJ, 1987, DEVELOPMENT, V100, P119; EARLY AE, 1988, DEVELOPMENT, V103, P519; HAUSSLER MR, 1968, J BIOL CHEM, V243, P4055; HENDERSON EJ, 1975, J BIOL CHEM, V250, P4730; INSALL R, 1990, EMBO J, V9, P3323, DOI 10.1002/j.1460-2075.1990.tb07532.x; JERMYN KA, 1987, DEVELOPMENT, V100, P745; KAY RR, 1987, METHOD CELL BIOL, V28, P433; KAY RR, 1988, DEV GENET, V9, P579, DOI 10.1002/dvg.1020090434; KAY RR, 1983, EUR J BIOCHEM, V136, P51, DOI 10.1111/j.1432-1033.1983.tb07703.x; KAY RR, 1983, NATURE, V303, P242, DOI 10.1038/303242a0; KAY RR, 1989, DEVELOPMENT CAMB S, V7, P81; KONIJN TM, 1967, P NATL ACAD SCI USA, V58, P1152, DOI 10.1073/pnas.58.3.1152; KOPACHIK W, 1983, CELL, V33, P397, DOI 10.1016/0092-8674(83)90421-X; MASENTO MS, 1988, BIOCHEM J, V256, P23, DOI 10.1042/bj2560023; MEINHARDT H, 1983, DIFFERENTIATION, V24, P191, DOI 10.1111/j.1432-0436.1983.tb01319.x; MORRIS HR, 1988, BIOCHEM J, V249, P903, DOI 10.1042/bj2490903; MORRIS HR, 1987, NATURE, V328, P811, DOI 10.1038/328811a0; SOBOLEWSKI A, 1983, DIFFERENTIATION, V25, P93; THALLER C, 1990, NATURE, V345, P815, DOI 10.1038/345815a0; TOWN C, 1979, P NATL ACAD SCI USA, V76, P308, DOI 10.1073/pnas.76.1.308; TOWN C, 1978, DEV BIOL, V63, P412, DOI 10.1016/0012-1606(78)90145-8; TOWN CD, 1976, NATURE, V262, P717, DOI 10.1038/262717a0; TRAYNOR D, 1989, THESIS U CAMBRIDGE; WANG M, 1989, DEVELOPMENT, V105, P569; WANG M, 1986, DIFFERENTIATION, V33, P24, DOI 10.1111/j.1432-0436.1986.tb00406.x; WATTS DJ, 1970, BIOCHEM J, V119, P171, DOI 10.1042/bj1190171; WILLIAMS JG, 1987, CELL, V49, P185, DOI 10.1016/0092-8674(87)90559-9; WURSTER B, 1990, DEV BIOL, V140, P189, DOI 10.1016/0012-1606(90)90066-R	31	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					5291	5297						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002061				2022-12-25	WOS:A1991FC21700089
J	BEUTLER, E; KUHL, W; GELBART, T; FORMAN, L				BEUTLER, E; KUHL, W; GELBART, T; FORMAN, L			DNA-SEQUENCE ABNORMALITIES OF HUMAN GLUCOSE-6-PHOSPHATE-DEHYDROGENASE VARIANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-ERYTHROCYTE GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; HEMOLYTIC-ANEMIA; POINT MUTATIONS; CDNA; CPG; IDENTIFICATION; DINUCLEOTIDE; METHYLATION; DEFICIENCY; CLONING	Over 400 supposedly biochemically and genetically distinct variants of glucose-6-phosphate dehydrogenase (G6PD) have been described in the past. In order to investigate these variants at the DNA sequence level we have now determined the relevant sequences of introns of G6PD and describe a method which allows us to rapidly determine the sequence of the entire coding region of G6PD. This technique was applied to six variants that cause G6PD deficiency to be functionally so severe as to result in nonspherocytic hemolytic anemia. Although the patients were all unrelated, G6PD Marion, Gastonia, and Minnesota each had identical mutations, a G --> T at nucleotide (nt) 637 in exon 6 leading to a Val --> Leu substitution at amino acid 213. The mutations of Nashville and Anaheim were identical to each other, viz. G -- > A at nt 1178 in exon 10 producing a Arg --> His substitution at amino acid 393. G6PD Loma Linda had a C --> A substitution at nt 1089 in exon 10, producing a Asn --> Lys change at amino acid 363. The results confirm our earlier results suggesting that the NADP-binding site is in a small region of exon 10 and suggest the possibility that this area is also concerned with the binding of glucose-6-P.			BEUTLER, E (corresponding author), SCRIPPS CLIN & RES FDN,RES INST,LA JOLLA,CA 92037, USA.				NCRR NIH HHS [RR00833] Funding Source: Medline; NHLBI NIH HHS [HL25552] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL025552, R01HL025552] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Betke K., 1967, WHO TECHNICAL REPORT, V366; BEUTLER E, 1989, P NATL ACAD SCI USA, V86, P192, DOI 10.1073/pnas.86.1.192; BEUTLER E, 1986, AM J HEMATOL, V23, P25, DOI 10.1002/ajh.2830230105; BEUTLER E, 1988, MEDICINE, V67, P311, DOI 10.1097/00005792-198809000-00003; BEUTLER E, 1990, BIOMED BIOCHIM ACTA, V49, pS236; BEUTLER E, 1989, BLOOD, V74, P2550; BEUTLER E, 1990, SEMIN HEMATOL, V27, P137; BEUTLER E, 1990, IN PRESS HUM GENET; BHADBHADE MM, 1987, FEBS LETT, V211, P243, DOI 10.1016/0014-5793(87)81445-X; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; BUETLER E, 1990, AM J HUM GENET, V47, P1008; CAMARDELLA L, 1988, EUR J BIOCHEM, V171, P485, DOI 10.1111/j.1432-1033.1988.tb13815.x; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; DEVITA G, 1989, AM J HUM GENET, V44, P233; GAETANI GF, 1990, HUM GENET, V84, P337; HIRONO A, 1988, P NATL ACAD SCI USA, V85, P3951, DOI 10.1073/pnas.85.11.3951; HIRONO A, 1989, P NATL ACAD SCI USA, V86, P10015, DOI 10.1073/pnas.86.24.10015; HIRONO A, 1988, BLOOD S1, V72, pA44; Maniatis T., 1982, MOL CLONING; MARTINI G, 1986, EMBO J, V5, P1849, DOI 10.1002/j.1460-2075.1986.tb04436.x; PAGE A, 1987, COMPUT APPL BIOSCI, V3, P49; PERRY DJ, 1989, MOL BIOL MED, V6, P239; PERSICO MG, 1986, NUCLEIC ACIDS RES, V14, P2511, DOI 10.1093/nar/14.6.2511; PERSICO MG, 1986, GLUCOSE 6 PHOSPHATE, P503; TAKIZAWA T, 1987, Genomics, V1, P228, DOI 10.1016/0888-7543(87)90048-6; TAKIZAWA T, 1986, P NATL ACAD SCI USA, V83, P4157, DOI 10.1073/pnas.83.12.4157; VIGLIETTO G, 1990, ANN HUM GENET, V54, P1, DOI 10.1111/j.1469-1809.1990.tb00355.x; VIVESCORRONS JL, 1990, AM J HUM GENET, V47, P575; VULLIAMY TJ, 1988, P NATL ACAD SCI USA, V85, P5171, DOI 10.1073/pnas.85.14.5171; VULLIAMY TJ, 1989, NUCLEIC ACIDS RES, V17, P5868, DOI 10.1093/nar/17.14.5868; YOSHIDA A, 1973, SCIENCE, V179, P532, DOI 10.1126/science.179.4073.532; YOSHIDA A, 1971, B WORLD HEALTH ORGAN, V45, P243	33	91	94	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4145	4150						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999409				2022-12-25	WOS:A1991FA69400022
J	FYFE, JC; RAMANUJAM, KS; RAMASWAMY, K; PATTERSON, DF; SEETHARAM, B				FYFE, JC; RAMANUJAM, KS; RAMASWAMY, K; PATTERSON, DF; SEETHARAM, B			DEFECTIVE BRUSH-BORDER EXPRESSION OF INTRINSIC FACTOR-COBALAMIN RECEPTOR IN CANINE INHERITED INTESTINAL COBALAMIN MALABSORPTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROUGH ENDOPLASMIC-RETICULUM; FACTOR-MEDIATED ABSORPTION; POLYACRYLAMIDE GELS; SUCRASE-ISOMALTASE; FACTOR VITAMIN-B12; ILEAL MUCOSA; MEMBRANE; TRANSPORT; RAT; PURIFICATION	Ligand binding activity of intrinsic factor-cobalamin receptor (IFCR) was determined in homogenates and isolated brush-border membranes (BBM) of ileum and kidney from dogs exhibiting simple autosomal recessive inheritance of selective cobalamin malabsorption (Fyfe, J. C., Giger, U., Hall, C. A., Jezyk, P. F., Klumpp, S. A., Levine, J. S., and Patterson, D. F. (1991) Pediatr. Res. 29, 24-31). IFCR activity of affected dog ileal homogenates was 3-4-fold higher than normal whereas IFCR activity in affected dog kidney homogenates was one-tenth of normal. The recovery of IFCR activity in the BBM of ileum and renal cortex of affected dogs was 30- and 20-fold less than normal, respectively. The dissociation constant (K(d)) for intrinsic factor-cobalamin was similar in BBM of both tissues and was the same in affected and normal dogs. In the affected dog ileal BBM, activities of alkaline phosphatase and sucrase-isomaltase and vesicular transport of glucose and Na+-taurocholate were normal. Immunoblots showed no IFCR cross-reactive material in the ileal or renal BBM of affected dogs. IFCR purified by affinity chromatography from kidney of both normal and affected dogs had an M(r) = 230,000. However, amino acid analysis revealed that the affected dog IFCR had more lysine than the normal, and protease cleavage of the purified IFCRs revealed different peptide maps. Asparagine-linked oligosaccharides of both proteins were sensitive to peptide N-glycosidase F cleavage, but only the affected dog IFCR was endoglycosidase H sensitive. These results suggest that cobalamin malabsorption in this canine family is caused by inefficient BBM expression of IFCR due to a mutation of IFCR and its retention in an early biosynthetic compartment.	VET ADM MED CTR, MILWAUKEE, WI 53226 USA; MED COLL WISCONSIN, DIV GASTROENTEROL, MILWAUKEE, WI 53226 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Medical College of Wisconsin	FYFE, JC (corresponding author), UNIV PENN, SCH VET, MED GENET SECT, PHILADELPHIA, PA 19104 USA.			Fyfe, John C/0000-0002-5774-3150	NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR002512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026638] Funding Source: NIH RePORTER; NCRR NIH HHS [RR 02512] Funding Source: Medline; NIDDK NIH HHS [NIDDK 26638] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BATT RM, 1989, AM J PHYSIOL, V257, pG344, DOI 10.1152/ajpgi.1989.257.3.G344; BENBASSA.I, 1969, ISRAEL J MED SCI, V5, P62; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; DAHLQVIST A, 1964, ANAL BIOCHEM, V7, P18, DOI 10.1016/0003-2697(64)90115-0; FYFE JC, 1989, J AM ANIM HOSP ASSOC, V25, P533; FYFE JC, 1991, PEDIATR RES, V29, P24, DOI 10.1203/00006450-199101000-00006; GAREN A, 1960, BIOCHIM BIOPHYS ACTA, V38, P470, DOI 10.1016/0006-3002(60)91282-8; GRASBECK R, 1960, ACTA MED SCAND, V167, P289; HAGEDORN CH, 1977, GASTROENTEROLOGY, V73, P1019; HAKAMI N, 1971, NEW ENGL J MED, V285, P1163, DOI 10.1056/NEJM197111182852103; HARIG JM, 1989, AM J PHYSIOL, V256, pG618, DOI 10.1152/ajpgi.1989.256.3.G618; HAURI HP, 1979, P NATL ACAD SCI USA, V76, P5183, DOI 10.1073/pnas.76.10.5183; HAURI HP, 1985, P NATL ACAD SCI USA, V82, P4423, DOI 10.1073/pnas.82.13.4423; HOOPER DC, 1973, J CLIN INVEST, V52, P3074, DOI 10.1172/JCI107506; HOPFER U, 1973, J BIOL CHEM, V248, P25; IMERSLUND O, 1960, Acta Paediatr Suppl, V49(Suppl 119), P1; KAPADIA CR, 1983, J CLIN INVEST, V71, P440, DOI 10.1172/JCI110788; KATZ M, 1974, J CLIN INVEST, V53, P1274, DOI 10.1172/JCI107674; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVINE JS, 1984, J CELL BIOL, V98, P1111, DOI 10.1083/jcb.98.3.1111; LEVINE JS, 1985, GASTROENTEROLOGY, V88, P1132, DOI 10.1016/S0016-5085(85)80071-8; LILLIBRIDGE CB, 1967, GASTROENTEROLOGY, V52, P792; LODISH HF, 1988, J BIOL CHEM, V263, P2107; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACKENZI.IL, 1972, NEW ENGL J MED, V286, P1021, DOI 10.1056/NEJM197205112861902; MCKUSICK VA, 1990, MENDELIAN INHERITANC, P1411; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; RAMANUJAM KS, 1991, IN PRESS AM J PHYSL; ROTHENBERG SP, 1978, BRIT J HAEMATOL, V40, P401, DOI 10.1111/j.1365-2141.1978.tb05812.x; SCHMITZ J, 1973, BIOCHIM BIOPHYS ACTA, V323, P98, DOI 10.1016/0005-2736(73)90434-3; Schneider W J, 1983, Mol Biol Med, V1, P353; SEETHARAM B, 1981, J BIOL CHEM, V256, P3785; SEETHARAM B, 1983, BIOCHEM BIOPH RES CO, V115, P238, DOI 10.1016/0006-291X(83)90995-6; SEETHARAM B, 1985, AM J PHYSIOL, V248, pG326, DOI 10.1152/ajpgi.1985.248.3.G326; SEETHARAM B, 1985, NUTR REV, V43, P97, DOI 10.1111/j.1753-4887.1985.tb06875.x; SEETHARAM B, 1988, J BIOL CHEM, V263, P4443; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; SJOSTROM H, 1978, EUR J BIOCHEM, V88, P503, DOI 10.1111/j.1432-1033.1978.tb12476.x; YANG Y, 1985, J CLIN INVEST, V76, P2057, DOI 10.1172/JCI112208; ZOKAEEM G, 1987, AM J HUM GENET, V40, P537	41	87	88	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4489	4494						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999430				2022-12-25	WOS:A1991FA69400073
J	DEEB, RS; PEYTON, DH				DEEB, RS; PEYTON, DH			H-1 AND 119SN MAGNETIC-RESONANCE STUDY OF THE SNIV PROTOPORPHYRIN-IX COMPLEX OF EQUINE MYOGLOBIN - STRUCTURE OF THE PORPHYRIN-BINDING POCKET	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPERM WHALE MYOGLOBIN; HEME ORIENTATIONAL DISORDER; CARBON-MONOXIDE; H-1-NMR SPECTRA; LABILE PROTON; SPECTROSCOPY; NMR; HEMOGLOBIN; RESOLUTION; HYPERBILIRUBINEMIA	Tin protoporphyrin IX (SnPP) is being used in the treatment of hyperbilirubinemia. We have studied the SnPP complex with equine myoglobin (EqMb) by H-1 and Sn-119 nuclear magnetic resonance spectroscopy (NMR) as a general model for SnPP interaction with hemoproteins. The complex formed from SnPP and EqMb, SnPP.EqMb, was found to have essentially the same porphyrin-binding pocket as EqMbCO, including the same porphyrin orientation in the major form of EqMbCO. Sn-119 NMR spectroscopy has been used to demonstrate that the proximal His93F8-metal coordination is likely to be intact in SnPP.EqMb. Minor shifts in the side chain positions of some of the residues are indicated, possibly reflecting the presence of water in the sixth coordination site. SnPP.EqMb appears to be stable; it persists at room temperature for weeks and exhibits very slow exchange rates (H-2 for H-1) for a large number of amide protons in the pH range 7-9.	PORTLAND STATE UNIV, DEPT CHEM, PORTLAND, OR 97207 USA	Portland State University				Peyton, David/0000-0001-5828-055X				BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BAX A, 1983, J MAGN RESON, V53, P517, DOI 10.1016/0022-2364(83)90225-1; BERTINI I, 1986, NMR PARAMAGNETIC MOL, P166; BRAUNSCHWEILER L, 1983, MOL PHYS, V48, P535, DOI 10.1080/00268978300100381; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; BRESLOW E, 1986, J BIOL CHEM, V261, P3135; CUTNELL JD, 1981, J AM CHEM SOC, V103, P3567, DOI 10.1021/ja00402a053; DALVIT C, 1986, J INORG BIOCHEM, V28, P303, DOI 10.1016/0162-0134(86)80094-0; DALVIT C, 1985, BIOCHEMISTRY-US, V24, P3398, DOI 10.1021/bi00335a003; DALVIT C, 1987, J MOL BIOL, V194, P313, DOI 10.1016/0022-2836(87)90378-0; DRUMMOND GS, 1981, P NATL ACAD SCI-BIOL, V78, P6466, DOI 10.1073/pnas.78.10.6466; DRUMMOND GS, 1984, J CLIN INVEST, V74, P142, DOI 10.1172/JCI111394; EVANS SV, 1988, J BIOL CHEM, V263, P4263; GEBE JA, 1989, BIOCHEM BIOPH RES CO, V161, P290, DOI 10.1016/0006-291X(89)91594-5; GRIKO YV, 1988, J MOL BIOL, V202, P127, DOI 10.1016/0022-2836(88)90525-6; HAN KH, 1989, BIOCHEMISTRY-US, V28, P2169, DOI 10.1021/bi00431a031; HARRISON SC, 1965, J BIOL CHEM, V240, P299; INUBUSHI T, 1983, BIOCHEMISTRY-US, V22, P2904, DOI 10.1021/bi00281a019; JOHNSON CE, 1958, J CHEM PHYS, V29, P1012, DOI 10.1063/1.1744645; KENNEDY MA, 1989, J AM CHEM SOC, V111, P3195, DOI 10.1021/ja00191a014; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; La Mar G.N, 1979, BIOL APPLICATIONS MA, P305; LAMAR GN, 1983, J MOL BIOL, V168, P887, DOI 10.1016/S0022-2836(83)80080-1; LAMAR GN, 1989, J AM CHEM SOC, V111, P485, DOI 10.1021/ja00184a014; LECOMTE JTJ, 1985, BIOCHEMISTRY-US, V24, P7388, DOI 10.1021/bi00346a054; LEE HC, 1985, J AM CHEM SOC, V107, P4087, DOI 10.1021/ja00299a060; MABBUTT BC, 1985, BIOCHIM BIOPHYS ACTA, V832, P175, DOI 10.1016/0167-4838(85)90329-2; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; MCGRATH TM, 1978, BIOCHIM BIOPHYS ACTA, V534, P99, DOI 10.1016/0005-2795(78)90480-4; MOORE CD, 1990, BIOCHEMISTRY-US, V29, P1984, DOI 10.1021/bi00460a004; MULLEREBERHARD U, 1988, METHOD ENZYMOL, V163, P536; NATAN MJ, 1989, J AM CHEM SOC, V111, P6468, DOI 10.1021/ja00198a093; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; SHAKA AJ, 1983, J MAGN RESON, V53, P313, DOI 10.1016/0022-2364(83)90035-5; TAKANO T, 1977, J MOL BIOL, V110, P537, DOI 10.1016/S0022-2836(77)80111-3; TAKANO T, 1977, J MOL BIOL, V110, P569, DOI 10.1016/S0022-2836(77)80112-5; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X; TRAYLOR TG, 1980, J AM CHEM SOC, V102, P2844, DOI 10.1021/ja00528a058; WHITTEN DG, 1971, J AM CHEM SOC, V93, P2291, DOI 10.1021/ja00738a031; WUTHRICH K, 1986, NMR PROTEINS NUCLEIC, P28; YU LP, 1990, BIOCHEMISTRY-US, V29, P2578, DOI 10.1021/bi00462a021; [No title captured]	42	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3728	3733						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995626				2022-12-25	WOS:A1991EY68200059
J	LU, WP; RAGSDALE, SW				LU, WP; RAGSDALE, SW			REDUCTIVE ACTIVATION OF THE COENZYME-A ACETYL-COA ISOTOPIC EXCHANGE-REACTION CATALYZED BY CARBON-MONOXIDE DEHYDROGENASE FROM CLOSTRIDIUM-THERMOACETICUM AND ITS INHIBITION BY NITROUS-OXIDE AND CARBON-MONOXIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR PROTEIN; ELECTRON-PARAMAGNETIC-RES; ACETOGENIC BACTERIA; PHENYLALANINE-HYDROXYLASE; KINETIC CHARACTERIZATION; AUTOTROPHIC PATHWAY; MULTICOPPER ENZYME; ACETATE SYNTHESIS; PURIFICATION; BINDING	The final steps in the synthesis of acetyl-CoA by CO dehydrogenase (CODH) have been studied by following the exchange reaction between CoA and the CoA moiety of acetyl-CoA. This reaction had been studied earlier (Pezacka, E., and Wood, H. G. (1986) J. Biol. Chem. 261, 1609-1615 and Ramer, W. E., Raybuck, S. A., Orme-Johnson, W. H., and Walsh, C. T. (1989) Biochemistry 28, 4675-4680). The CoA/acetyl-CoA exchange activity was determined at various controlled redox potentials and was found to be activated by a one-electron reduction with half-maximum activity occurring at -486 mV. There is approximately 2000-fold stimulation of the exchange by performing the reaction at -575 mV relative to the rate at -80 mV. Binding of CoA to CODH is not sensitive to the redox potential; therefore, the reductive activation affects some step other than association/dissociation of CoA. We propose that a metal center on CODH with a midpoint reduction potential of less-than-or-equal-to -486 mV is activated by a one-electron reduction to cleave the carbonyl-sulfur bond and/or bind the acetyl group of acetyl-CoA. Based on a comparison of the redox dependence of this reaction with that for methylation of CODH (Lu, W-P., Harder, S. R., and Ragsdale, S. W. (1990) J. Biol. Chem. 265, 3124-3133) and CO2 reduction and formation of the Ni-Fe-C EPR signal (Lindahl, P. A., Munck, E., and Ragsdale, S. W. (1990) J. Biol. Chem. 265, 3873-3879), we propose that the assembly of the acetyl group of acetyl-CoA, i.e. binding the methyl group of the methylated corrinoid/iron-sulfur protein, binding CO, and methyl migration to form the acetyl-CODH intermediate, occur at the novel Ni-Fe3-4 containing site in CODH. CO has two effects on the CoA/acetyl-CoA exchange: it activates the reaction due to its reductive capacity and it acts as a noncompetitive inhibitor. We also discovered that the CoA/acetyl-CoA exchange was inhibited by nitrous oxide via an oxidative mechanism. In the presence of a low-potential electron donor, CODH becomes a nitrous oxide reductase which catalytically converts N2O to N2. This study combined with earlier results (Lu, W-P., Harder, S. R., and Ragsdale, S. W. (1990) J. Biol. Chem. 265, 3124-3133) establishes that the two-subunit form of CODH is completely active in all reactions known to be catalyzed by CODH.			LU, WP (corresponding author), UNIV WISCONSIN,DEPT CHEM,MILWAUKEE,WI 53201, USA.							BANERJEE RV, 1990, FASEB J, V4, P1450, DOI 10.1096/fasebj.4.5.2407589; BANKS RGS, 1968, J CHEM SOC A, P2886, DOI 10.1039/j19680002886; Bard A. J., 1980, ELECTROCHEMICAL METH; Bell J.E., 1988, PROTEINS ENZYMES; BEVINGTON PR, 1969, DATA REDUCTION ERROR, P237; BLACK S, 1983, J BIOL CHEM, V258, P2112; BLACKBURN R, 1976, J CHEM SOC FARAD T, V73, P250; BONAM D, 1984, J BACTERIOL, V159, P693, DOI 10.1128/JB.159.2.693-699.1984; CONOVER RC, 1990, J AM CHEM SOC, V112, P4562, DOI 10.1021/ja00167a074; COYLE CL, 1985, EUR J BIOCHEM, V153, P459, DOI 10.1111/j.1432-1033.1985.tb09324.x; CRAWFORD NA, 1989, ARCH BIOCHEM BIOPHYS, V271, P223, DOI 10.1016/0003-9861(89)90273-7; DIEKERT G, 1984, ARCH MICROBIOL, V138, P224, DOI 10.1007/BF00402125; DIXON HBF, 1979, BIOCHEM J, V177, P249, DOI 10.1042/bj1770249; ELLIOTT JI, 1978, ARCH BIOCHEM BIOPHYS, V97, P37; FAN CL, 1990, IN PRESS BIOCHEMISTR; FELDMAN HA, 1972, ANAL BIOCHEM, V48, P317, DOI 10.1016/0003-2697(72)90084-X; FERNANDEZ VM, 1984, BIOCHIM BIOPHYS ACTA, V780, P1; FISCHER R, 1990, ARCH MICROBIOL, V153, P156, DOI 10.1007/BF00247814; HARDER SR, 1989, ANAL BIOCHEM, V181, P283, DOI 10.1016/0003-2697(89)90244-3; HARDER SR, 1989, BIOCHEMISTRY-US, V28, P9080, DOI 10.1021/bi00449a019; HU SI, 1982, J BACTERIOL, V149, P440, DOI 10.1128/JB.149.2.440-448.1982; JANICK PA, 1983, BIOCHEMISTRY-US, V22, P396, DOI 10.1021/bi00271a025; LEBERTZ H, 1987, J AM CHEM SOC, V109, P3173, DOI 10.1021/ja00244a066; LENN ND, 1990, BIOCHEMISTRY-US, V29, P3709, DOI 10.1021/bi00467a017; LINDAHL PA, 1990, J BIOL CHEM, V265, P3880; LINDAHL PA, 1990, J BIOL CHEM, V265, P3873; Ljungdahl L G, 1978, Methods Enzymol, V53, P360; LJUNGDAHL LG, 1986, ANNU REV MICROBIOL, V40, P415, DOI 10.1146/annurev.mi.40.100186.002215; LU WP, 1990, J BIOL CHEM, V265, P3124; MAROTA JJA, 1984, BIOCHEMISTRY-US, V23, P1303, DOI 10.1021/bi00301a044; MICHALSKI WP, 1986, BIOCHIM BIOPHYS ACTA, V872, P50, DOI 10.1016/0167-4838(86)90146-9; PEMBER SO, 1986, BIOCHEMISTRY-US, V25, P6619; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; PEZACKA E, 1986, J BIOL CHEM, V261, P1609; PEZACKA E, 1984, ARCH MICROBIOL, V137, P63, DOI 10.1007/BF00425809; RAGSDALE SW, 1987, J BIOL CHEM, V262, P14289; RAGSDALE SW, 1982, BIOCHEM BIOPH RES CO, V108, P658, DOI 10.1016/0006-291X(82)90880-4; RAGSDALE SW, 1985, J BIOL CHEM, V260, P3970; RAGSDALE SW, 1983, BIOCHEM BIOPH RES CO, V115, P658, DOI 10.1016/S0006-291X(83)80195-8; RAGSDALE SW, 1985, P NATL ACAD SCI USA, V82, P6811, DOI 10.1073/pnas.82.20.6811; RAGSDALE SW, 1983, J BIOL CHEM, V258, P2364; RAGSDALE WS, 1988, BIOINORGANIC CHEM NI, P311; RAMER SE, 1989, BIOCHEMISTRY-US, V28, P4675, DOI 10.1021/bi00437a025; RAYBUCK SA, 1988, BIOCHEMISTRY-US, V27, P7698, DOI 10.1021/bi00420a019; RIESTER J, 1989, EUR J BIOCHEM, V178, P751, DOI 10.1111/j.1432-1033.1989.tb14506.x; ROUVIERE PE, 1988, J BACTERIOL, V170, P3946, DOI 10.1128/jb.170.9.3946-3952.1988; Segel I.H., 1975, ENZYME KINETICS; SHANMUGASUNDARAM T, 1988, Biofactors, V1, P147; SHANMUGASUNDARAM T, 1988, BIOCHEMISTRY-US, V27, P6499, DOI 10.1021/bi00417a045; SLIGAR S, 1976, BIOCHEMISTRY-US, V15, P6399; SNYDER SW, 1987, J BIOL CHEM, V262, P6515; STAVROPOULOS P, 1990, J AM CHEM SOC, V112, P5385, DOI 10.1021/ja00169a076; WALLICK DE, 1984, BIOCHEMISTRY-US, V23, P1295, DOI 10.1021/bi00301a043; WALSH TA, 1979, BIOCHEM J, V177, P29, DOI 10.1042/bj1770029; WATT GD, 1986, BIOCHEMISTRY-US, V25, P8156, DOI 10.1021/bi00373a005; WEAST RC, 1985, HDB CHEM PHYSICS, pD58; Weber K., 1975, PROTEINS, VI, P179; WOOD HG, 1986, BIOCHEM INT, V12, P421; WOOD HG, 1986, TRENDS BIOCHEM SCI, V11, P14, DOI 10.1016/0968-0004(86)90223-9	59	63	64	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3554	3564						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995618				2022-12-25	WOS:A1991EY68200035
J	DOEGE, KJ; SASAKI, M; KIMURA, T; YAMADA, Y				DOEGE, KJ; SASAKI, M; KIMURA, T; YAMADA, Y			COMPLETE CODING SEQUENCE AND DEDUCED PRIMARY STRUCTURE OF THE HUMAN CARTILAGE LARGE AGGREGATING PROTEOGLYCAN, AGGRECAN - HUMAN-SPECIFIC REPEATS, AND ADDITIONAL ALTERNATIVELY SPLICED FORMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHOCYTE HOMING RECEPTOR; AMINO-ACID-SEQUENCES; LINK PROTEIN; CORE PROTEIN; CDNA CLONES; MOLECULAR-CLONING; DOMAINS; GENE; RAT; ADHESION	We have obtained the complete coding sequence of the large aggregating chondroitin sulfate proteoglycan of human cartilage (aggrecan) from a combination of cDNA and genomic exon sequencing. We screened a human costal chondrocyte cDNA library, using rat aggrecan cDNA probes, and obtained three nonoverlapping clones totaling 6.2 kilobases in length. These clones were sequenced, and the sequence of the gaps between clones was obtained from genomic exon fragments and polymerase chain reaction-amplified cDNA. The composite sequence is 7137 nucleotides long, encoding 2316 amino acids. The human and rat aggrecan amino acid sequences are about 75% identical, with domains ranging from 100% to about 60% of conserved amino acids. The human sequence contains two regions of highly conserved repeats not found in rat aggrecan: 11 repeats of a hexameric sequence in the keratan sulfate attachment domain, E-E-P-(S,F)-P-S; and a 19-amino acid sequence reiterated 19 times, in the CS-1 portion of the serine-glycine-containing region. There are at least three forms of aggrecan transcripts, generated by alternative exon usage, and the form reported here is the shortest and also the most prevalent, lacking both the epidermal growth factor-like domain, and the complement regulatory protein-like sequence.	OREGON HLTH SCI UNIV, DEPT BIOCHEM & MOLEC BIOL, PORTLAND, OR 97201 USA; NATL BEPPU HOSP, BEPPU, OITA 87401, JAPAN; OSAKA UNIV, SCH MED, DEPT ORTHOPED SURG, OSAKA 553, JAPAN; NIDR, DEV BIOL & ANOMALIES LAB, BETHESDA, MD 20892 USA	Oregon Health & Science University; Osaka University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	DOEGE, KJ (corresponding author), OREGON HLTH SCI UNIV, SHRINERS HOSP CRIPPLED CHILDREN, 3101 SW SAM JACKSON PK RD, PORTLAND, OR 97201 USA.							ANDRES JL, 1989, J CELL BIOL, V109, P3137, DOI 10.1083/jcb.109.6.3137; ANTONSSON P, 1989, J BIOL CHEM, V264, P16170; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; BALDWIN CT, 1989, J BIOL CHEM, V264, P15747; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BOWEN BR, 1990, J CELL BIOL, V110, P147, DOI 10.1083/jcb.110.1.147; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHOPRA RK, 1985, BIOCHEM J, V232, P277, DOI 10.1042/bj2320277; DEAK F, 1986, P NATL ACAD SCI USA, V83, P3766, DOI 10.1073/pnas.83.11.3766; DEININGER PL, 1983, ANAL BIOCHEM, V129, P216, DOI 10.1016/0003-2697(83)90072-6; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOEGE K, 1986, P NATL ACAD SCI USA, V83, P3761, DOI 10.1073/pnas.83.11.3761; DOEGE K, 1987, J BIOL CHEM, V262, P17757; DOEGE K, 1990, BIOCHEM SOC T, V18, P200, DOI 10.1042/bst0180200; DOEGE K, 1986, J BIOL CHEM, V261, P8108; DOEGE K, 1988, COLLAGEN REL RES, V8, P486; DOEGE K, 1990, COLLAGEN GENES STRUC, P137; DUDHIA J, 1989, J MOL BIOL, V206, P749, DOI 10.1016/0022-2836(89)90581-0; DUDHIA J, 1989, ORTH RES SOC T, V14, P8; FISHER LW, 1989, J BIOL CHEM, V264, P4571; FOSANG AJ, 1989, BIOCHEM J, V261, P801, DOI 10.1042/bj2610801; GENG JG, 1990, NATURE, V343, P757, DOI 10.1038/343757a0; GOLDSTEIN LA, 1989, CELL, V56, P1063, DOI 10.1016/0092-8674(89)90639-9; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HALBERG DF, 1988, J BIOL CHEM, V263, P9486; Hascall V.C., 1981, CELL BIOL EXTRACELLU, P39; HEINEGARD D, 1985, BIOCHEM J, V225, P95, DOI 10.1042/bj2250095; HOURCADE D, 1989, ADV IMMUNOL, V45, P381, DOI 10.1016/S0065-2776(08)60697-5; ISEMURA M, 1975, BIOCHIM BIOPHYS ACTA, V411, P11, DOI 10.1016/0304-4165(75)90280-9; JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3; KIMURA T, 1989, EUR J BIOCHEM, V179, P71, DOI 10.1111/j.1432-1033.1989.tb14522.x; KOHNO K, 1985, J BIOL CHEM, V260, P4441; KRUEGER RC, 1990, J BIOL CHEM, V265, P12088; LASKY LA, 1989, CELL, V56, P1045, DOI 10.1016/0092-8674(89)90637-5; Maniatis T., 1982, MOL CLONING; MORGELIN M, 1988, BIOCHEM J, V253, P175; NEAME PJ, 1987, J BIOL CHEM, V262, P17768; OLDBERG A, 1987, BIOCHEM J, V243, P255, DOI 10.1042/bj2430255; PERIN JP, 1986, FEBS LETT, V206, P73, DOI 10.1016/0014-5793(86)81343-6; PERIN JP, 1983, INT J BIOL MACROMOL, V5, P57, DOI 10.1016/0141-8130(83)90080-6; PUISSANT C, 1990, BIOTECHNIQUES, V8, P148; RUOSLAHTI E, 1988, ANNU REV CELL BIOL, V4, P229, DOI 10.1146/annurev.cb.04.110188.001305; SAI S, 1986, P NATL ACAD SCI USA, V83, P5081, DOI 10.1073/pnas.83.14.5081; Saiki R.K., 1989, PCR TECHNOLOGY, P7; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAUNDERS S, 1989, J CELL BIOL, V108, P1547, DOI 10.1083/jcb.108.4.1547; SIEGELMAN MH, 1989, SCIENCE, V243, P1165, DOI 10.1126/science.2646713; SIEGELMAN MH, 1990, CELL, V61, P611, DOI 10.1016/0092-8674(90)90473-R; SMITH BD, 1975, ARCH BIOCHEM BIOPHYS, V166, P181, DOI 10.1016/0003-9861(75)90378-1; STADEN R, 1982, NUCLEIC ACIDS RES, V10, P2951, DOI 10.1093/nar/10.9.2951; STAMENKOVIC I, 1989, CELL, V56, P1057, DOI 10.1016/0092-8674(89)90638-7; STOOLMAN LM, 1989, CELL, V56, P907, DOI 10.1016/0092-8674(89)90620-X; TANAKA T, 1988, J BIOL CHEM, V263, P15831; WATSON J, 1990, IN PRESS J EXP MED; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x	55	400	419	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					894	902						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985970				2022-12-25	WOS:A1991ET17700036
J	IWATA, M; CARLSON, SS				IWATA, M; CARLSON, SS			A LARGE CHONDROITIN SULFATE BASEMENT MEMBRANE-ASSOCIATED PROTEOGLYCAN EXISTS AS A DISULFIDE-STABILIZED COMPLEX OF SEVERAL PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLINERGIC SYNAPTIC VESICLES; EXTRACELLULAR-MATRIX; HEPARAN-SULFATE; KERATAN SULFATE; ELECTRIC ORGAN; PROTEOHEPARAN SULFATE; MONOCLONAL-ANTIBODIES; SKELETAL-MUSCLE; CORE PROTEIN; GLYCOSAMINOGLYCANS	Proteoglycan (PG)-1000 (formerly TAP-1) is a large (M(r) = 10(6)) highly glycosylated chondroitin sulfate proteoglycan found associated with Schwann cell and electrocyte basement membranes in elasmobranch electric fish. Previously, purified PG-1000 was visualized in the electron microscope as a "bottlebrush" structure about 345 nm long with about 20 side projections of 113 nm. This molecule was characterized with material purified from electric organ under denaturing and reducing conditions. Here we report that PG-1000, when purified under denaturing conditions without exposure to a reducing agent, exists as a complex of several proteins. In addition to PG-1000, this complex consists of a somewhat smaller, heavily glycosylated protein (beta-component) and three smaller proteins with M(r) values of 39,000, 21,00, and 18,000. The complex remains intact when exposed to denaturing and nonreducing conditions but falls apart in denaturing and reducing conditions. Presumably the complex is stabilized by disulfide bonds. The beta-component of the PG-1000 complex is probably a proteoglycan. However, unlike PG-1000, the beta-component does not contain chondroitin sulfate chains and lacks the epitope, T1, that is found on PG-1000. both molecules share a protease-insensitive antigenic site, SV4, which is probably a modified keratan sulfate epitope. Evidence for the identity of this antigen is that it is found as a minor subfraction in commercial preparations of shark cartilage chondroitin and corneal keratan sulfates but not in other glycosaminoglycan preparations. These SV4 antigens are resistant to chondroitin ABC lyase digestion. However, the SV4 antigen in commercial keratan sulfate is cleaved by keratinase to a smaller antigenic fragment.			IWATA, M (corresponding author), UNIV WASHINGTON,DEPT PHYSIOL & BIOPHYS,SEATTLE,WA 98195, USA.				NINDS NIH HHS [NS 22367-05] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022367] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BHAVANANDAN VP, 1968, J BIOL CHEM, V243, P1052; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CARLSON SS, 1980, J CELL BIOL, V87, P98, DOI 10.1083/jcb.87.1.98; CARLSON SS, 1986, J CELL BIOL, V103, P509, DOI 10.1083/jcb.103.2.509; CARLSON SS, 1982, ANAL BIOCHEM, V122, P364, DOI 10.1016/0003-2697(82)90296-2; CARLSON SS, 1983, J BIOL CHEM, V258, P1082; CARLSON SS, 1987, J CELL BIOL, V105, P3075, DOI 10.1083/jcb.105.6.3075; CARLSON SS, 1989, NEUROBIOLOGY GLYCOCO, P309; CARLSTEDT I, 1983, J BIOL CHEM, V258, P1629; COMPER WD, 1978, PHYSIOL REV, V58, P255, DOI 10.1152/physrev.1978.58.1.255; CORREIA JJ, 1987, ARCH BIOCHEM BIOPHYS, V255, P244, DOI 10.1016/0003-9861(87)90391-2; COSTER L, 1983, BIOCHEM J, V215, P417; Farquhar M. G., 1981, CELL BIOL EXTRACELLU, V1981, P335; FREEDMAN RB, 1989, CELL, V57, P1069, DOI 10.1016/0092-8674(89)90043-3; FREEDMAN RB, 1984, TRENDS BIOCHEM SCI, V9, P438, DOI 10.1016/0968-0004(84)90152-X; GODFREY EW, 1988, J CELL BIOL, V106, P1263, DOI 10.1083/jcb.106.4.1263; GODFREY EW, 1984, J CELL BIOL, V99, P615, DOI 10.1083/jcb.99.2.615; Hascall V.C., 1981, CELL BIOL EXTRACELLU, P39; HASSELL JR, 1986, ANNU REV BIOCHEM, V55, P539, DOI 10.1146/annurev.bi.55.070186.002543; HISS D, 1987, EUR J BIOCHEM, V162, P89, DOI 10.1111/j.1432-1033.1987.tb10546.x; HOCKFIELD S, 1987, SCIENCE, V237, P67, DOI 10.1126/science.3603010; HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0; IWATA M, 1989, Society for Neuroscience Abstracts, V15, P681; KANWAR YS, 1979, P NATL ACAD SCI USA, V76, P4493, DOI 10.1073/pnas.76.9.4493; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LORIES V, 1987, J BIOL CHEM, V262, P854; LOWEKRENTZ LJ, 1984, BIOCHEMISTRY-US, V23, P2621, DOI 10.1021/bi00307a013; MAYNE R, 1985, COLLAGEN REL RES, V5, P449; MCDONALD JA, 1988, ANNU REV CELL BIOL, V4, P183, DOI 10.1146/annurev.cb.04.110188.001151; MEHMET H, 1986, EUR J BIOCHEM, V157, P385, DOI 10.1111/j.1432-1033.1986.tb09680.x; NAKAZAWA K, 1975, J BIOL CHEM, V250, P912; NAKAZAWA K, 1986, SEIKAGAKU JIKKEN KOZ, V4, P319; PAULSSON M, 1987, COLLAGEN REL RES, V7, P443; REIST NE, 1987, J CELL BIOL, V105, P2457, DOI 10.1083/jcb.105.6.2457; SANES JR, 1983, ANNU REV PHYSIOL, V45, P581, DOI 10.1146/annurev.ph.45.030183.003053; SANES JR, 1985, TRENDS NEUROSCI, V8, P523, DOI 10.1016/0166-2236(85)90188-2; SANES JR, 1978, J CELL BIOL, V78, P176, DOI 10.1083/jcb.78.1.176; SCUDDER P, 1986, EUR J BIOCHEM, V157, P365, DOI 10.1111/j.1432-1033.1986.tb09678.x; SETO M, 1982, J IMMUNOL, V128, P201; WASTESON A, 1971, J CHROMATOGR, V59, P87, DOI 10.1016/S0021-9673(01)80009-1; YANAGISHITA M, 1987, METHOD ENZYMOL, V138, P279	41	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					323	333						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985903				2022-12-25	WOS:A1991EQ33900048
J	AGUZZI, A; KLEIHUES, P; HECKL, K; WIESTLER, OD				AGUZZI, A; KLEIHUES, P; HECKL, K; WIESTLER, OD			CELL TYPE-SPECIFIC TUMOR-INDUCTION IN NEURAL TRANSPLANTS BY RETROVIRUS-MEDIATED ONCOGENE TRANSFER	ONCOGENE			English	Article							MIDDLE-T-ONCOGENE; EMBRYONAL CARCINOMA-CELLS; CENTRAL NERVOUS-SYSTEM; ROUS SARCOMA VIRUS; TRANSGENIC MICE; EXPRESSION; PP60C-SRC; PROTEIN; VECTOR; DIFFERENTIATION	Using a neural transplantation model which mimics structural and functional properties of the normal rat brain to a high extent, we have taken a novel approach to study the transforming potential of activated oncogenes in the developing brain. Single cell suspensions prepared from fetal rat brains were infected with replication-defective retroviral vectors encoding oncogenes and stereotaxically injected into the caudoputamen of adult F344 rats. Rats carrying transplants expressing the polyoma middle T antigen developed endothelial hemangiomas in the graft which in 70% of the recipient animals led to fatal cerebral hemorrhage within 13-50 days after transplantation. Expression of the v-src gene caused astrocytic and mesenchymal tumors with a 70% incidence after latency periods of 2-6 months, but no endothelial lesions. It was found by in situ hybridization that these oncogenes are expressed in all cell types present in the graft. This indicates that cell-type specific transformation is due to differential susceptibility of the respective target cell to the oncogenes, rather than selective integration or expression of the retroviral construct. The highly efficient gene transfer by retroviral vectors into fetal brain transplants provides a challenging experimental strategy to study differentiation and oncogenesis in the CNS.	UNIV ZURICH, DEPT PATHOL, NEUROPATHOL LAB, SCHMELZBERGSTR 12, CH-8091 ZURICH, SWITZERLAND	University of Zurich			Aguzzi, Adriano/A-3351-2008	Aguzzi, Adriano/0000-0002-0344-6708				AGUZZI A, 1990, New Biologist, V2, P533; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BAUTCH VL, 1987, CELL, V51, P529, DOI 10.1016/0092-8674(87)90122-X; BIGNER DD, 1977, EXPT TUMORS CENTRAL; BOULTER CA, 1987, NUCLEIC ACIDS RES, V15, P7194, DOI 10.1093/nar/15.17.7194; BOULTER CA, 1988, ONCOGENE, V2, P207; BRINSTER RL, 1984, CELL, V37, P367, DOI 10.1016/0092-8674(84)90367-2; BRUGGE JS, 1985, NATURE, V316, P554, DOI 10.1038/316554a0; BURGER PC, 1988, CANCER RES, V48, P2871; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; CEPKO CL, 1989, ANNU REV NEUROSCI, V12, P47, DOI 10.1146/annurev.ne.12.030189.000403; CEPKO CL, 1984, CELL, V37, P1053, DOI 10.1016/0092-8674(84)90440-9; CLOYD MW, 1975, J NATL CANCER I, V54, P1479, DOI 10.1093/jnci/54.6.1479; CONE RD, 1984, P NATL ACAD SCI-BIOL, V81, P6349, DOI 10.1073/pnas.81.20.6349; EDWARDS PAW, 1988, ONCOGENE, V2, P407; GAGE FH, 1984, DEV NEUROSCI-BASEL, V6, P137, DOI 10.1159/000112341; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; HAGUENAU F, 1971, JNCI-J NATL CANCER I, V46, P539; IVANKOVIC S, 1968, Z KREBSFORSCH KLIN O, V71, P320, DOI 10.1007/BF00524414; JAHNER D, 1982, NATURE, V298, P623, DOI 10.1038/298623a0; KATSUKI M, 1988, SCIENCE, V241, P593, DOI 10.1126/science.2456614; KELLER G, 1985, NATURE, V318, P149, DOI 10.1038/318149a0; Kleihues P, 1976, Int Rev Exp Pathol, V15, P153; KLEIHUES P, 1984, PROG EXP TUMOR RES, V27, P1; LEBEAU JM, 1987, MOL CELL BIOL, V7, P4115, DOI 10.1128/MCB.7.11.4115; LYNCH SA, 1986, SCIENCE, V234, P873, DOI 10.1126/science.3095923; MESSING A, 1985, NATURE, V316, P461, DOI 10.1038/316461a0; MONTESANO R, 1990, IN PRESS CELL; PERANTONI AO, 1987, P NATL ACAD SCI USA, V84, P6317, DOI 10.1073/pnas.84.17.6317; READHEAD C, 1987, CELL, V48, P703, DOI 10.1016/0092-8674(87)90248-0; SMALL JA, 1986, P NATL ACAD SCI USA, V83, P8288, DOI 10.1073/pnas.83.21.8288; STOUT JT, 1985, NATURE, V317, P250, DOI 10.1038/317250a0; STUHLMANN H, 1984, P NATL ACAD SCI-BIOL, V81, P7151, DOI 10.1073/pnas.81.22.7151; THOMPSON TC, 1989, CELL, V56, P917, DOI 10.1016/0092-8674(89)90625-9; VICK NA, 1971, J NEUROPATH EXP NEUR, V30, P354, DOI 10.1097/00005072-197107000-00004; WIESTLER OD, 1988, J IMMUNOL METHODS, V110, P153, DOI 10.1016/0022-1759(88)90098-1; WIESTLER OD, 1988, MOL CELL BIOL, V8, P502, DOI 10.1128/MCB.8.1.502; WIESTLER OD, 1988, EXP CELL BIOL, V56, P190; WILLIAMS RL, 1988, CELL, V52, P121; WILLIAMS RL, 1989, CELL, V57, P1053, DOI 10.1016/0092-8674(89)90343-7	41	47	49	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	1991	6	1					113	118						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY039	1992439				2022-12-25	WOS:A1991EY03900015
J	RECNY, MA; NEIDHARDT, EA; SAYRE, PH; CIARDELLI, TL; REINHERZ, EL				RECNY, MA; NEIDHARDT, EA; SAYRE, PH; CIARDELLI, TL; REINHERZ, EL			STRUCTURAL AND FUNCTIONAL-CHARACTERIZATION OF THE CD2 IMMUNOADHESION DOMAIN - EVIDENCE FOR INCLUSION OF CD2 IN AN ALPHA-BETA-PROTEIN FOLDING CLASS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DEPT MED,IMMUNOBIOL LAB,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DEPT BIOL CHEM,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DEPT MOLEC PHARMACOL,BOSTON,MA 02115; DARTMOUTH COLL,DEPT PHARMACOL & TOXICOL,CAMBRIDGE,MA 02139	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Dartmouth College	RECNY, MA (corresponding author), PROCEPT INC,DEPT PROT BIOCHEM,840 MEM DR,CAMBRIDGE,MA 02139, USA.				NIAID NIH HHS [AI2126] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AHMED SA, 1985, J BIOL CHEM, V260, P3716; ALCOVER A, 1988, EMBO J, V7, P1973, DOI 10.1002/j.1460-2075.1988.tb03035.x; ALCOVER A, 1986, P NATL ACAD SCI USA, V83, P2614, DOI 10.1073/pnas.83.8.2614; ALCOVER A, 1987, IMMUNOLOGY REV, V95, P1; AMZEL LM, 1979, ANNU REV BIOCHEM, V48, P961, DOI 10.1146/annurev.bi.48.070179.004525; ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P3365; BIERER BE, 1988, P NATL ACAD SCI USA, V85, P1194, DOI 10.1073/pnas.85.4.1194; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; BURNETT RM, 1974, J BIOL CHEM, V249, P4383; CARLISLE CH, 1974, J MOL BIOL, V85, P1, DOI 10.1016/0022-2836(74)90125-9; CLAYTON LK, 1987, EUR J IMMUNOL, V17, P1367, DOI 10.1002/eji.1830170922; DAVIES DR, 1983, ANNU REV IMMUNOL, V1, P87, DOI 10.1146/annurev.iy.01.040183.000511; DIAMOND DJ, 1988, P NATL ACAD SCI USA, V85, P1615, DOI 10.1073/pnas.85.5.1615; HENNESSEY JP, 1981, BIOCHEMISTRY-US, V20, P1085, DOI 10.1021/bi00508a007; HOWARD FD, 1981, J IMMUNOL, V126, P2117; HUNIG T, 1986, EUR J IMMUNOL, V16, P1615, DOI 10.1002/eji.1830161223; HUNIG T, 1987, NATURE, V326, P298, DOI 10.1038/326298a0; HURLE MR, 1987, PROTEINS, V2, P210, DOI 10.1002/prot.340020306; HUSSEY RE, 1988, NATURE, V331, P78, DOI 10.1038/331078a0; KAMOUN M, 1981, J EXP MED, V153, P207, DOI 10.1084/jem.153.1.207; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANG G, 1988, EMBO J, V7, P1675, DOI 10.1002/j.1460-2075.1988.tb02995.x; LEVITT M, 1976, NATURE, V261, P552, DOI 10.1038/261552a0; MANAVALAN P, 1983, NATURE, V305, P831, DOI 10.1038/305831a0; MEUER SC, 1984, CELL, V36, P897, DOI 10.1016/0092-8674(84)90039-4; MOINGEON P, 1989, NATURE, V339, P312, DOI 10.1038/339312a0; MOINGEON P, 1989, IMMUNOL REV, V111, P111, DOI 10.1111/j.1600-065X.1989.tb00544.x; MOULT J, 1976, J MOL BIOL, V100, P179, DOI 10.1016/S0022-2836(76)80147-7; PANTALEO G, 1987, EUR J IMMUNOL, V17, P55, DOI 10.1002/eji.1830170110; PETERSON A, 1987, NATURE, V329, P842, DOI 10.1038/329842a0; SAYRE PH, 1987, P NATL ACAD SCI USA, V84, P2941, DOI 10.1073/pnas.84.9.2941; SAYRE PH, 1989, J EXP MED, V169, P995, DOI 10.1084/jem.169.3.995; SELVARAJ P, 1987, NATURE, V326, P400, DOI 10.1038/326400a0; SEWELL WA, 1986, P NATL ACAD SCI USA, V83, P8718, DOI 10.1073/pnas.83.22.8718; SEWELL WA, 1987, EUR J IMMUNOL, V17, P1015, DOI 10.1002/eji.1830170718; SHAW S, 1986, NATURE, V323, P262, DOI 10.1038/323262a0; SICILIANO RS, 1985, NATURE, V317, P428; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; WILLIAMS AF, 1987, J EXP MED, V165, P368, DOI 10.1084/jem.165.2.368; WYCKOFF HW, 1970, J BIOL CHEM, V245, P305; YANG SY, 1986, J IMMUNOL, V137, P1097	42	50	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	1990	265	15					8542	8549						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD976	1971273				2022-12-25	WOS:A1990DD97600035
J	MEUCCI, E; MORDENTE, A; MARTORANA, GE				MEUCCI, E; MORDENTE, A; MARTORANA, GE			METAL-CATALYZED OXIDATION OF HUMAN SERUM-ALBUMIN - CONFORMATIONAL AND FUNCTIONAL-CHANGES - IMPLICATIONS IN PROTEIN AGING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIXED-FUNCTION OXIDATION; PARA-NITROPHENYL ACETATE; OXYGEN RADICALS; HISTIDINE-RESIDUES; MODEL COMPOUNDS; BINDING; FLUORESCENCE; DEGRADATION; BOVINE; ENZYMES	Mild oxidative stress, as elicited by ascorbate, oxygen, and trace metals, affects the binding properties of human serum albumin via purely conformational changes. In fact, no gross alteration can be observed in the electrophoretic and chromatographic patterns of albumin, whereas localized modifications are indicated by the changes in absorption and fluorescence spectra and in polarization degree. The oxidized protein presents a small increase of bityrosine production and a time-dependent increase in the content of carbonyl groups, whereas proteolytic susceptibility is unchanged. A higher affinity for cis-parinaric acid and a slight loss of solubility in high salt indicate a greater surface hydrophobicity. Pinpoint denaturation of the albumin molecule is also suggested by a decreased "esterase" activity in the presence of p-nitrophenyl acetate. Conformational stability evaluated through thermal shock and addition of moderate amounts of guanidine indicate that the oxidized protein is more heat-resistant, less flexible, and more rigid than the native one. Although limited, structural damages afforded by the oxidative stress cause alterations of albumin binding properties as documented by experiments with probes and physiological ligands. The loss of biological activity of human serum albumin induced by ascorbate system appears of medical relevance, because it can affect drug metabolism and particularly drug tolerance in the elderly.			MEUCCI, E (corresponding author), UNIV CATTOLICA SACRO CUORE, FAC MED & CHIRURG, IST CHIM BIOL, LARGO F VITO 1, I-00168 ROME, ITALY.		Mordente, Alvaro/AAB-7290-2019	MORDENTE, Alvaro/0000-0003-3260-9796; MEUCCI, Elisabetta/0000-0002-8821-8041				AMICI A, 1989, J BIOL CHEM, V264, P3341; BEYNON RJ, 1986, AM J PHYSIOL, V251, pC141, DOI 10.1152/ajpcell.1986.251.2.C141; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUSBY TF, 1981, J BIOL CHEM, V256, P2140; CANTOR CR, 1980, BIOPHYSICAL CHEM 2, P404; CHEN RF, 1967, J BIOL CHEM, V242, P173; CONRAD RH, 1970, BIOCHEMISTRY-US, V9, P1540, DOI 10.1021/bi00809a010; DANIEL E, 1966, BIOCHEMISTRY-US, V5, P1893, DOI 10.1021/bi00870a016; DAVIES KJA, 1987, J BIOL CHEM, V262, P9895; DAVIES KJA, 1987, J BIOL CHEM, V262, P9908; DAVIES KJA, 1987, J BIOL CHEM, V262, P9902; EDWARDS FB, 1969, BIOCHIM BIOPHYS ACTA, V194, P234; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; FEDERICI MM, 1985, BIOCHEMISTRY-US, V24, P647, DOI 10.1021/bi00324a017; FUCCI L, 1983, P NATL ACAD SCI-BIOL, V80, P1521, DOI 10.1073/pnas.80.6.1521; GHELIS C, 1982, PROTEIN FOLDING, P223; ICHIKAWA T, 1981, BIOCHIM BIOPHYS ACTA, V671, P33, DOI 10.1016/0005-2795(81)90090-8; KATO A, 1980, BIOCHIM BIOPHYS ACTA, V624, P13, DOI 10.1016/0005-2795(80)90220-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEATHERBARROW RJ, 1980, BIOCHEM J, V189, P27, DOI 10.1042/bj1890027; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; LEHRER SS, 1971, BIOPHYS SOC ANN M, V11; LENZ AG, 1989, ANAL BIOCHEM, V177, P419, DOI 10.1016/0003-2697(89)90077-8; LEVINE RL, 1984, METHOD ENZYMOL, V107, P370; LEVINE RL, 1982, BIOCHEMISTRY-US, V21, P2600, DOI 10.1021/bi00540a004; LEVINE RL, 1977, CLIN CHEM, V23, P2292; MARGINEDAROMEU A, 1976, BIOCHIM BIOPHYS ACTA, V439, P175, DOI 10.1016/0005-2795(76)90174-4; MARTORANA GE, 1987, 2ND NAT M PROT 87 FL, P88; MARX G, 1986, BIOCHEM J, V236, P397, DOI 10.1042/bj2360397; MARX G, 1984, REV BIOCHEM TOXICOL, V6, P65; MEANS GE, 1975, BIOCHEMISTRY-US, V14, P4989, DOI 10.1021/bi00693a031; MEUCCI E, 1987, ITAL J BIOCHEM, V36, P75; MEUCCI E, 1988, 14TH INT C BIOCH PRA, V5, P72; MEUCCI E, 1989, 19TH FEBS M ROM; MORDENTE A, 1988, ARCH BIOCHEM BIOPHYS, V264, P502, DOI 10.1016/0003-9861(88)90315-3; MORDENTE A, 1988, 3RD NAT M PROT 88 NA; OLIVER CN, 1987, J AM GERIATR SOC, V35, P947, DOI 10.1111/j.1532-5415.1987.tb02297.x; PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0; QAW FS, 1986, MOL CELL BIOCHEM, V71, P121, DOI 10.1007/BF00214770; RIVETT AJ, 1990, ARCH BIOCHEM BIOPHYS, V278, P26, DOI 10.1016/0003-9861(90)90226-O; RIVETT AJ, 1985, ARCH BIOCHEM BIOPHYS, V243, P624, DOI 10.1016/0003-9861(85)90540-5; Romeu A M, 1975, Biochim Biophys Acta, V409, P376, DOI 10.1016/0005-2760(75)90033-8; SHARMA HK, 1980, J BIOL CHEM, V255, P5043; SKLAR LA, 1977, BIOCHEMISTRY-US, V16, P5100, DOI 10.1021/bi00642a024; STEINHARDT J, 1971, BIOCHEMISTRY-US, V10, P4005, DOI 10.1021/bi00798a001; SUGIYAMA Y, 1985, BIOCHEM PHARMACOL, V34, P821, DOI 10.1016/0006-2952(85)90762-2; Taylor Ronald P, 1977, ALBUMIN STRUCTURE FU, P183; TERADA H, 1980, BIOCHIM BIOPHYS ACTA, V622, P161, DOI 10.1016/0005-2795(80)90027-6; TERADA H, 1976, BIOCHIM BIOPHYS ACTA, V453, P26, DOI 10.1016/0005-2795(76)90247-6; THOMPSON ST, 1976, P NATL ACAD SCI USA, V73, P361, DOI 10.1073/pnas.73.2.361; TILDON JT, 1972, J BIOL CHEM, V247, P1265; TOLLEFSBOL TO, 1986, J AM GERIATR SOC, V34, P282, DOI 10.1111/j.1532-5415.1986.tb04225.x; TUKAMOTO T, 1974, CHEM PHARM BULL, V22, P385; UCHIDA K, 1988, AGR BIOL CHEM TOKYO, V52, P1529; WALLACE SM, 1987, CLIN PHARMACOKINET, V12, P41, DOI 10.2165/00003088-198712010-00004	55	119	126	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4692	4699						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002018				2022-12-25	WOS:A1991FC21700007
J	DUPUY, C; VIRION, A; OHAYON, R; KANIEWSKI, J; DEME, D; POMMIER, J				DUPUY, C; VIRION, A; OHAYON, R; KANIEWSKI, J; DEME, D; POMMIER, J			MECHANISM OF HYDROGEN-PEROXIDE FORMATION CATALYZED BY NADPH OXIDASE IN THYROID PLASMA-MEMBRANE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT H2O2 GENERATION; NICOTINAMIDE ADENINE-DINUCLEOTIDE; HORSERADISH-PEROXIDASE; MEDIATED OXIDATION; SUPEROXIDE ANION; FRACTION; CALCIUM; SYSTEM	The thyroid plasma membrane contains a Ca2+ -regulated NADPH-dependent H2O2 generating system which provides H2O2 for the thyroid peroxidase-catalyzed biosynthesis of thyroid hormones. The plasma membrane fraction contains a Ca2+ -independent cytochrome c reductase activity which is not inhibited by superoxide dismutase. But it is not known whether H2O2 is produced directly from molecular oxygen (O2) or formed via dismutation of superoxide anion (O2-). Indirect evidence from electron scavenger studies indicates that the H2O2 generating system does not liberate O2-, but studies using the modified peroxidase, diacetyldeuteroheme horseradish peroxidase, to detect O2- indicate that H2O2 is provided via the dismutation of O2-. The present results provide indirect evidence that the cytochrome c reductase activity is not a component of the NADPH-dependent H2O2 generator, since it was removed by washing the plasma membranes with 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid without affecting H2O2 generation. Spectral studies with diacetyldeuteroheme-substituted horseradish peroxidase showed that the thyroid NADPH-dependent H2O2 generator does not catalyze superoxide anion formation. The O2- adduct compound (compound III) was formed but was completely inhibited by catalase, indicating that the initial product was H2O2. The rate of NADPH oxidation also increased in the presence of diacetylheme peroxidase. This increase was blocked by catalase and was greatly enhanced by superoxide dismutase. The O2- adduct compound (compound III) was produced in the presence of NADPH when glucose-glucose oxidase (which does not produce O2-) was used as the H2O2 generator. NADPH oxidation occurred simultaneously and was enhanced by superoxide dismutase. We conclude that O2- formation occurs in the presence of an H2O2 generator, diacetylheme peroxidase and NADPH, but that it is not the primary product of the H2O2 generator. We suggest that O2- formation results from oxidation of NADPH, catalyzed by the diacetylheme peroxidase compound I, producing NADP-degrees, which in turn reacts with O2 to give O2-.	INSERM,U96,UNITE RECH GLANDE THYROIDE & REGULAT HORMONALE,78 RUE GEN LECLERC,F-94275 LE KREMLIN BICETR,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm)								AHN C S, 1970, Endocrinology, V86, P396; BJORKMAN U, 1981, J ULTRA MOL STRUCT R, V74, P105, DOI 10.1016/S0022-5320(81)80113-X; Chance B, 1951, ENZYMES, V2, P428; DEME D, 1985, FEBS LETT, V186, P107, DOI 10.1016/0014-5793(85)81349-1; DUPUY C, 1989, EUR J BIOCHEM, V185, P597, DOI 10.1111/j.1432-1033.1989.tb15155.x; DUPUY C, 1988, FEBS LETT, V233, P74, DOI 10.1016/0014-5793(88)81358-9; LAND EJ, 1971, BIOCHIM BIOPHYS ACTA, V234, P34, DOI 10.1016/0005-2728(71)90126-5; LIPPES HA, 1986, ENDOCRINOLOGY, V118, P1306, DOI 10.1210/endo-118-4-1306; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAKINO R, 1986, J BIOL CHEM, V261, P1444; MAKINO R, 1972, J BIOCHEM-TOKYO, V72, P655, DOI 10.1093/oxfordjournals.jbchem.a129943; MICHOT JL, 1985, EUR J BIOCHEM, V148, P441, DOI 10.1111/j.1432-1033.1985.tb08859.x; NAKAMURA Y, 1989, J BIOL CHEM, V264, P4759; NAKAMURA Y, 1987, J BIOCHEM-TOKYO, V102, P1121, DOI 10.1093/oxfordjournals.jbchem.a122150; TAKAYAMA K, 1977, BIOCHEMISTRY-US, V16, P1921, DOI 10.1021/bi00628a025; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X; VIRION A, 1984, MOL CELL ENDOCRINOL, V36, P95, DOI 10.1016/0303-7207(84)90088-1; VIRION A, 1985, ARCH BIOCHEM BIOPHYS, V242, P41, DOI 10.1016/0003-9861(85)90477-1; YOKOTA K, 1977, BIOCHEMISTRY-US, V16, P1913, DOI 10.1021/bi00628a024	19	100	102	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3739	3743						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995628				2022-12-25	WOS:A1991EY68200061
J	BURDETT, V				BURDETT, V			PURIFICATION AND CHARACTERIZATION OF TET(M), A PROTEIN THAT RENDERS RIBOSOMES RESISTANT TO TETRACYCLINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-SEQUENCE ANALYSIS; ESCHERICHIA-COLI; STREPTOCOCCAL TETM; RNA-POLYMERASE; CLONED GENES; PLASMID DNA; DETERMINANT; EXPRESSION; LEVEL; TRANSPOSON	The tet(M) tetracycline resistance gene has been found in a wide variety of clinically important bacteria. It has been shown previously (Burdett, V. (1986) J. Bacteriol. 165, 564-569) that the tet(M) gene product mediates resistance at the level of protein synthesis as judged by in vitro assay. Using this assay, large amounts of protein were purified from an Escherichia coli overproducer expressing the gene under control of a T7 promoter. The purified activity consists of a single polypeptide of molecular weight 68,000 by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and was confirmed to be the tet(M) gene product by amino-terminal sequence analysis. Purified Tet(M) has an associated ribosome-dependent GTPase with the specific activity being similar to that of the corresponding activity associated with elongation factor G. Since Tet(M) also displays substantial homology to elongation factor G throughout its length, Tet(M) may function as an analog of this elongation factor.			BURDETT, V (corresponding author), DUKE UNIV,MED CTR,DEPT MICROBIOL,DURHAM,NC 27710, USA.				NIAID NIH HHS [AI15619] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015619] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON DG, 1983, APPL ENVIRON MICROB, V46, P549, DOI 10.1128/AEM.46.3.549-552.1983; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BISMUTH R, 1990, ANTIMICROB AGENTS CH, V34, P1611, DOI 10.1128/AAC.34.8.1611; BOTT KF, 1968, BACTERIOL REV, V32, P370, DOI 10.1128/MMBR.32.4_Pt_1.370-378.1968; BUCK MA, 1990, BIOCHEMISTRY-US, V29, P5374, DOI 10.1021/bi00474a024; BURDETT V, 1982, J BACTERIOL, V149, P995, DOI 10.1128/JB.149.3.995-1004.1982; BURDETT V, 1990, NUCLEIC ACIDS RES, V18, P6137, DOI 10.1093/nar/18.20.6137; BURDETT V, 1986, J BACTERIOL, V165, P564, DOI 10.1128/jb.165.2.564-569.1986; BURDETT V, 1987, PLASMID, V17, P79; BURDETT V, 1982, MICROBIOLOGY 1982, P155; CLEWELL DB, 1986, ANNU REV MICROBIOL, V40, P635, DOI 10.1146/annurev.mi.40.100186.003223; COURVALIN P, 1986, MOL GEN GENET, V205, P291, DOI 10.1007/BF00430441; DEVER TE, 1987, P NATL ACAD SCI USA, V84, P1814, DOI 10.1073/pnas.84.7.1814; DUBNAU E, 1976, MOL GEN GENET, V147, P1, DOI 10.1007/BF00337929; FELICETT.L, 1969, BIOCHEMISTRY-US, V8, P3428, DOI 10.1021/bi00836a044; FILER D, 1981, EUR J BIOCHEM, V120, P69, DOI 10.1111/j.1432-1033.1981.tb05671.x; GAWRONBURKE C, 1982, NATURE, V300, P281, DOI 10.1038/300281a0; GOLDMAN RA, 1983, BIOCHEMISTRY-US, V22, P359, DOI 10.1021/bi00271a020; HACHLER H, 1987, ANTIMICROB AGENTS CH, V31, P1033, DOI 10.1128/AAC.31.7.1033; HAMEL E, 1972, J BIOL CHEM, V247, P805; JONES MD, 1980, EUR J BIOCHEM, V108, P507, DOI 10.1111/j.1432-1033.1980.tb04748.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBLANC DJ, 1988, J BACTERIOL, V170, P3618, DOI 10.1128/jb.170.8.3618-3626.1988; LUCASLEN.J, 1966, P NATL ACAD SCI USA, V55, P1562, DOI 10.1073/pnas.55.6.1562; MANAVATHU EK, 1988, GENE, V62, P17, DOI 10.1016/0378-1119(88)90576-8; MANAVATHU EK, 1990, ANTIMICROB AGENTS CH, V34, P71, DOI 10.1128/AAC.34.1.71; Maniatis T., 1982, MOL CLONING; MARTIN P, 1986, NUCLEIC ACIDS RES, V14, P7047, DOI 10.1093/nar/14.17.7047; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Moller W., 1974, RIBOSOMES, P711; MORSE SA, 1986, ANTIMICROB AGENTS CH, V30, P664, DOI 10.1128/AAC.30.5.664; OHNUKI T, 1985, J BACTERIOL, V161, P1010, DOI 10.1128/JB.161.3.1010-1016.1985; ROBERTS MC, 1985, ANTIMICROB AGENTS CH, V28, P141, DOI 10.1128/AAC.28.1.141; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; SANCHEZPESCADOR R, 1988, NUCLEIC ACIDS RES, V16, P1216, DOI 10.1093/nar/16.3.1216; SANCHEZPESCADOR R, 1988, NUCLEIC ACIDS RES, V16, P1218, DOI 10.1093/nar/16.3.1218; SANGER F, 1982, J MOL BIOL, V162, P729, DOI 10.1016/0022-2836(82)90546-0; SOUGAKOFF W, 1987, FEMS MICROBIOL LETT, V44, P153, DOI 10.1016/0378-1097(87)90218-7; STAEHELIN T, 1971, METHODS ENZYMOLOGY C, V20, P449; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; ZENGEL JM, 1984, NUCLEIC ACIDS RES, V12, P2181, DOI 10.1093/nar/12.4.2181	41	103	114	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2872	2877						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993661				2022-12-25	WOS:A1991EX60000034
J	CORTINA, G; BARBIERI, JT				CORTINA, G; BARBIERI, JT			LOCALIZATION OF A REGION OF THE S1-SUBUNIT OF PERTUSSIS TOXIN REQUIRED FOR EFFICIENT ADP-RIBOSYLTRANSFERASE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISLET-ACTIVATING PROTEIN; BORDETELLA-PERTUSSIS; S-1 SUBUNIT; ADENINE-NUCLEOTIDES; NAD GLYCOHYDROLASE; ESCHERICHIA-COLI; DIPHTHERIA-TOXIN; GENE; IDENTIFICATION; EXPRESSION	Purified recombinant S1 subunit of pertussis toxin (rS1) possessed similar NAD glycohydrolase and ADP-ribosyltransferase activities as S1 subunit purified from pertussis toxin. Purified rS1 and C180 peptide, a deletion peptide which contains amino acids 1-180 of rS1, had K(m) values for NAD of 24 and 13-mu-M and k(cat) values of 22 and 24 h-1, respectively, in the NAD glycohydrolase reaction. In contrast, under linear velocity conditions, the C180 peptide possessed less than 1% of the ADP-ribosyltransferase activity of rS1 using transducin as target. Radiolabeled tryptic peptides of transducin that had been ADP-ribosylated by either rS1 or C180 peptide were identical which suggested that both rS1 and C180 peptide ADP-ribosylated the same amino acid within transducin. To extend the functional primary amino acid map of the S1 subunit, two carboxyl-terminal deletions were constructed. One deletion, C195, removed the 40 carboxyl-terminal amino acids and the other, C219, removed the 16 carboxyl-terminal amino acids of the S1 subunit. Both C195 and C219 migrated in reduced sodium dodecyl sulfate-polyacrylamide gel electrophoresis with apparent molecular masses of 22,000 and 27,500 Da, respectively. Relative to the C180 peptide C195 possessed 10-20-fold increase and C219 possessed 100-150-fold increase in ADP-ribosyltransferase activities. In addition, C219 appeared to have the same ADP-ribosyltransferase activity as rS1. These studies indicate that (i) rS1, purified from Escherichia coli, possesses biochemical properties similar to S1 subunit purified from pertussis toxin, (ii) amino acids 1-180 of the S1 subunit contain residues required for NAD binding, N-glycosidic cleavage, and transfer of ADP-ribose to transducin, and (iii) residues between 181 and 219 of the S1 subunit are required for efficient ADP-ribosyltransferase activity.	MED COLL WISCONSIN,DEPT MICROBIOL,MILWAUKEE,WI 53226	Medical College of Wisconsin					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI025079] Funding Source: NIH RePORTER; NIAID NIH HHS [AI25079] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ASKELOF P, 1990, P NATL ACAD SCI USA, V87, P1347, DOI 10.1073/pnas.87.4.1347; BAEHR W, 1982, J BIOL CHEM, V257, P6452; BARBIERI JT, 1990, INFECT IMMUN, V58, P999, DOI 10.1128/IAI.58.4.999-1003.1990; BARBIERI JT, 1988, INFECT IMMUN, V56, P1934, DOI 10.1128/IAI.56.8.1934-1941.1988; BARBIERI JT, 1989, J BACTERIOL, V171, P4362, DOI 10.1128/JB.171.8.4362-4369.1989; BARBIERI JT, 1989, INFECT IMMUN, V57, P3549, DOI 10.1128/IAI.57.11.3549-3554.1989; BARTLEY TD, 1989, P NATL ACAD SCI USA, V86, P8353, DOI 10.1073/pnas.86.21.8353; BURNETTE WN, 1988, BIO-TECHNOL, V6, P699, DOI 10.1038/nbt0688-699; BURNS DL, 1987, J BIOL CHEM, V262, P17677; BURNS DL, 1986, J BIOL CHEM, V261, P4324; CARROLL SF, 1987, J BIOL CHEM, V262, P8707; CIEPLAK W, 1988, P NATL ACAD SCI USA, V85, P4667, DOI 10.1073/pnas.85.13.4667; COCKLE SA, 1989, FEBS LETT, V249, P329, DOI 10.1016/0014-5793(89)80652-0; CORTINA G, 1989, J BIOL CHEM, V264, P17322; HEWLETT EL, 1983, INFECT IMMUN, V40, P198; HURLEY JB, 1984, SCIENCE, V226, P860, DOI 10.1126/science.6436980; KANDEL J, 1974, J BIOL CHEM, V249, P2088; KASLOW HR, 1990, INFECT IMMUN, V58, P746, DOI 10.1128/IAI.58.3.746-752.1990; KATADA T, 1982, J BIOL CHEM, V257, P3739; KATADA T, 1982, P NATL ACAD SCI-BIOL, V79, P3129, DOI 10.1073/pnas.79.10.3129; LIM LK, 1985, J BIOL CHEM, V260, P2585; LOCHT C, 1990, J BIOL CHEM, V265, P4552; LOCHT C, 1986, SCIENCE, V232, P1258, DOI 10.1126/science.3704651; Maniatis T., 1982, MOL CLONING; MOSS J, 1980, J BIOL CHEM, V255, P5838; MOSS J, 1983, J BIOL CHEM, V258, P1879; MOSS J, 1986, BIOCHEMISTRY-US, V25, P2720, DOI 10.1021/bi00357a066; NICOSIA A, 1986, P NATL ACAD SCI USA, V83, P4631, DOI 10.1073/pnas.83.13.4631; PIZZA M, 1989, SCIENCE, V246, P497, DOI 10.1126/science.2683073; STRAUCH KL, 1988, P NATL ACAD SCI USA, V85, P1576, DOI 10.1073/pnas.85.5.1576; TAMURA M, 1982, BIOCHEMISTRY-US, V21, P5516, DOI 10.1021/bi00265a021; VANDOP C, 1984, J BIOL CHEM, V259, P23; WEISS AA, 1986, ANNU REV MICROBIOL, V40, P661, DOI 10.1146/annurev.micro.40.1.661	33	14	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3022	3030						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993675				2022-12-25	WOS:A1991EX60000055
J	GROS, P; KALK, KH; HOL, WGJ				GROS, P; KALK, KH; HOL, WGJ			CALCIUM-BINDING TO THERMITASE - CRYSTALLOGRAPHIC STUDIES OF THERMITASE AT 0,5, AND 100 M-MU CALCIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGLIN-C; 3-DIMENSIONAL STRUCTURE; MOLECULAR-DYNAMICS; THERMOACTINOMYCES-VULGARIS; SUBTILISIN CARLSBERG; THERMAL-STABILITY; SERINE PROTEASE; PROTEINASE-K; ION BINDING; RESOLUTION	The three-dimensional crystal structure of thermitase complexed with eglin-c in the presence of 100 mM calcium has been determined and refined at 2.0-angstrom resolution to a R-factor of 16.8%. This crystal structure is compared with previously determined structures of thermitase at 0 and 5 mM calcium concentration. In the presence of 100 mM calcium all three calcium binding sites in thermitase are fully occupied. At 100 mM CaCl2 the "weak" calcium binding is occupied by a calcium ion, which is chelated by three protein ligands and four water molecules in a pentagonal bipyramid geometry. Thermitase has, apparently, a monovalent and divalent cation binding position at 2.5-angstrom distance from each other at this site. At low calcium concentrations the monovalent-ion position is occupied by a sodium or potassium ion. The "medium strength" binding site shows in the presence of 100 mM CaCl2 a square antiprism arrangement with eight ligands, of which seven are donated by the protein. At low calcium concentrations we observe a distorted pentagonal bipyramid coordination at this site. The largest difference between these two conformations is observed for ligand Asp-60, which has two conformations with 0.8-angstrom difference in C-alpha positions. The "strong" calcium binding site has a pentagonal bipyramid coordination and is fully occupied in all three structures. Structural changes on binding calcium to the weak and "medium strength" calcium binding sites of thermitase are limited to the direct surroundings of these sites. Thermitase resembles in this respect subtilisin BPN' and does not exhibit long-range shifts as have been reported for proteinase K.	STATE UNIV GRONINGEN,DEPT MED,BIOSON RES INST,9747 AG GRONINGEN,NETHERLANDS	University of Groningen			Gros, Piet/AAD-6452-2019; Gros, Piet/I-5569-2016	Gros, Piet/0000-0002-7782-2585; Gros, Piet/0000-0002-7782-2585				AGARWAL RC, 1978, ACTA CRYSTALLOGR A, V34, P791, DOI 10.1107/S0567739478001618; BAJORATH J, 1989, NATURE, V337, P481, DOI 10.1038/337481a0; BETZEL C, 1988, EUR J BIOCHEM, V178, P155, DOI 10.1111/j.1432-1033.1988.tb14440.x; BODE W, 1987, EUR J BIOCHEM, V166, P673, DOI 10.1111/j.1432-1033.1987.tb13566.x; BOEL E, 1990, BIOCHEMISTRY-US, V29, P6244, DOI 10.1021/bi00478a019; BOTT R, 1988, J BIOL CHEM, V263, P7895; BRIEDIGKEIT L, 1989, FEBS LETT, V253, P83, DOI 10.1016/0014-5793(89)80935-4; BUCHANAN JD, 1986, BIOPHYS CHEM, V23, P183, DOI 10.1016/0301-4622(86)85003-7; DIJKSTRA BW, 1981, J MOL BIOL, V147, P97, DOI 10.1016/0022-2836(81)90081-4; DRENTH J, 1972, EUR J BIOCHEM, V26, P177, DOI 10.1111/j.1432-1033.1972.tb01754.x; FROMMEL C, 1989, PROTEINS, V5, P22, DOI 10.1002/prot.340050105; FROMMEL C, 1981, BIOCHIM BIOPHYS ACTA, V670, P25, DOI 10.1016/0005-2795(81)90044-1; FUJINAGA M, 1989, J APPL CRYSTALLOGR, V22, P1, DOI 10.1107/S0021889888009550; GROS P, 1989, J MOL BIOL, V210, P347, DOI 10.1016/0022-2836(89)90336-7; GROS P, 1989, ACTA CRYSTALLOGR B, V45, P488, DOI 10.1107/S0108768189006038; HERZBERG O, 1986, J BIOL CHEM, V261, P2638; HOLMES MA, 1982, J MOL BIOL, V160, P623, DOI 10.1016/0022-2836(82)90319-9; JONES TA, 1978, J APPL CRYSTALLOGR A, V34, P931; LESK AM, 1985, METHOD ENZYMOL, V115, P381; MATTHEWS BW, 1974, J BIOL CHEM, V249, P8030; MCPHALEN CA, 1988, BIOCHEMISTRY-US, V27, P6582, DOI 10.1021/bi00417a058; MELOUN B, 1985, FEBS LETT, V183, P195, DOI 10.1016/0014-5793(85)80775-4; PANTOLIANO MW, 1988, BIOCHEMISTRY-US, V27, P8311, DOI 10.1021/bi00422a004; PFULGRATH JW, 1986, MADNES USERS GUIDE; RAMAKRISHNAN C, 1965, BIOPHYS J, V5, P909, DOI 10.1016/S0006-3495(65)86759-5; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; TEPLYAKOV AV, 1990, J MOL BIOL, V214, P261, DOI 10.1016/0022-2836(90)90160-N; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; van Gunsteren W. F., 1987, GRONINGEN MOL SIMULA; VOORDOUW G, 1976, BIOCHEMISTRY-US, V15, P3716, DOI 10.1021/bi00662a012; WRIGHT CS, 1969, NATURE, V221, P235, DOI 10.1038/221235a0	32	57	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2953	2961						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993669				2022-12-25	WOS:A1991EX60000046
J	HUNYADY, L; MERELLI, F; BAUKAL, AJ; BALLA, T; CATT, KJ				HUNYADY, L; MERELLI, F; BAUKAL, AJ; BALLA, T; CATT, KJ			AGONIST-INDUCED ENDOCYTOSIS AND SIGNAL GENERATION IN ADRENAL GLOMERULOSA CELLS - A POTENTIAL MECHANISM FOR RECEPTOR-OPERATED CALCIUM ENTRY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; SMOOTH-MUSCLE CELLS; ANGIOTENSIN-II; INTRACELLULAR POTASSIUM; MEDIATED ENDOCYTOSIS; DOWN-REGULATION; INTERNALIZATION; METABOLISM; SECRETION; DEPLETION	The relationships between receptor-mediated endocytosis and the generation of intracellular signals were analyzed in angiotensin II (AII)-stimulated adrenal glomerulosa cells. In cells equilibrated with I-125-AII analogs at 4-degrees-C, specifically bound agonist but not antagonist AII derivatives were rapidly internalized at 37-degrees-C. AII-induced internalization was not influenced by the presence or absence of extracellular Ca2+ but was inhibited by treatment with phenylarsine oxide (PAO) or by arresting coated pit formation with hypotonic shock and potassium depletion. Inhibition of internalization by PAO was prevented by the bifunctional sulfhydryl reagent dithiothreitol but only partially reversed by mercaptoethanol, and readdition of K+ restored internalization in K+-depleted cells. Treatment with PAO did not impair the initial AII-induced elevations of inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) and cytoplasmic calcium ([Ca2+]i) but reduced the sustained phase of the Ins(1,4,5)P3 response by 85% and abolished the second phase of the cytoplasmic Ca2+ response; these responses were restored by concomitant treatment with dithiothreitol. Inhibition of AII-receptor internalization by K+ depletion also caused selective loss of the sustained phase of the AII-induced Ca2+ response. Thus, blockade of AII-receptor internalization has similar effects as extracellular Ca2+ deficiency, which abolishes the sustained but not the early AII-induced increases in Ins(1,4,5)P3 production and and [Ca2+]i. The close correlations between AII-induced internalization and the generation of Ins(1,4,5)P3 and [Ca2+]i responses suggest that endocytosis of the agonist-receptor complex is necessary to maintain the production of these intracellular signals. It is also possible that receptor-operated vesicular uptake of extracellular Ca2+ makes a significant contribution to the sustained [Ca2+]i responses of certain agonist-stimulated target cells.	NICHHD,ENDOCRINOL & REPROD RES BRANCH,BLDG 10,RM B1L-400,9000 ROCKVILLE PIKE,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)				Balla, Tamas/0000-0002-9077-3335				BALCH WE, 1989, J BIOL CHEM, V264, P16965; BALLA T, 1989, ARCH BIOCHEM BIOPHYS, V270, P398, DOI 10.1016/0003-9861(89)90043-X; BALLA T, 1987, J BIOL CHEM, V262, P9952; BALLA T, 1988, J BIOL CHEM, V263, P4083; BAUKAL AJ, 1988, J BIOL CHEM, V263, P6087; BEGUINOT L, 1984, P NATL ACAD SCI-BIOL, V81, P2384, DOI 10.1073/pnas.81.8.2384; BIANCHI C, 1986, ENDOCRINOLOGY, V118, P2605, DOI 10.1210/endo-118-6-2605; CANTAU B, 1988, J BIOL CHEM, V263, P10443; CAPPONI AM, 1984, J BIOL CHEM, V259, P8863; CARSON MC, 1987, MOL ENDOCRINOL, V1, P147, DOI 10.1210/mend-1-2-147; CATT KJ, 1979, NATURE, V280, P109, DOI 10.1038/280109a0; CHUEH SH, 1987, J BIOL CHEM, V262, P13857; CROZAT A, 1986, ENDOCRINOLOGY, V118, P2312, DOI 10.1210/endo-118-6-2312; DELAFONTAINE P, 1987, J BIOL CHEM, V262, P14549; GHOSH TK, 1989, NATURE, V340, P236, DOI 10.1038/340236a0; GRIENDLING KK, 1987, J BIOL CHEM, V262, P14555; GUILLEMETTE G, 1987, BIOCHEM BIOPH RES CO, V142, P15, DOI 10.1016/0006-291X(87)90445-1; HARAGUCHI K, 1990, P NATL ACAD SCI USA, V87, P1208, DOI 10.1073/pnas.87.3.1208; HERTEL C, 1985, J BIOL CHEM, V260, P2547; HUNYADY L, 1990, ENDOCRINOLOGY, V126, P1001, DOI 10.1210/endo-126-2-1001; HUNYADY L, 1990, 72ND END SOC ANN M A, P261; KNUTSON VP, 1983, J BIOL CHEM, V258, P2139; KOJIMA I, 1987, J BIOL CHEM, V262, P4557; KOJIMA I, 1985, J BIOL CHEM, V260, P9177; LARKIN JM, 1983, CELL, V33, P273, DOI 10.1016/0092-8674(83)90356-2; MACKIE CM, 1977, CLIN SCI MOL MED, V53, P289, DOI 10.1042/cs0530289; RINK TJ, 1990, ANNU REV PHYSIOL, V52, P431, DOI 10.1146/annurev.ph.52.030190.002243; SPAT A, 1989, J ENDOCRINOL, V122, P361, DOI 10.1677/joe.0.1220361; SPAT A, 1988, J STEROID BIOCHEM, V29, P443, DOI 10.1016/0022-4731(88)90256-7; ULLIAN ME, 1989, J CLIN INVEST, V84, P8540	30	81	81	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2783	2788						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993657				2022-12-25	WOS:A1991EX60000021
J	YAO, ZM; BLACKHART, BD; LINTON, MF; TAYLOR, SM; YOUNG, SG; MCCARTHY, BJ				YAO, ZM; BLACKHART, BD; LINTON, MF; TAYLOR, SM; YOUNG, SG; MCCARTHY, BJ			EXPRESSION OF CARBOXYL-TERMINALLY TRUNCATED FORMS OF HUMAN APOLIPOPROTEIN-B IN RAT HEPATOMA-CELLS - EVIDENCE THAT THE LENGTH OF APOLIPOPROTEIN-B HAS A MAJOR EFFECT ON THE BUOYANT DENSITY OF THE SECRETED LIPOPROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SEQUENCE; FAMILIAL HYPOBETALIPOPROTEINEMIA; IMMUNOCHEMICAL HETEROGENEITY; B-100; IDENTIFICATION; ANTIBODIES; DELETION; CDNA; GENE; RNA	We examined the relationship between the size of human apolipoprotein (apo) B and the formation and secretion of apoB-containing lipoprotein particles. Stable transformants of the rat hepatoma cell line McA-RH7777 harboring a variety of human apoB cDNA constructs were established, and these produced carboxyl-terminally truncated apoB proteins (apoB18, -B23, -B28, -B31, -B48, and -B53). Immunoblotting of apoB proteins secreted into the culture medium and fractionated by equilibrium density ultracentrifugation revealed that each of the truncated apoB species was secreted from the cells. The peak densities of the apoB-containing particles decreased as the length of the apoB proteins increased. Apolipoproteins B18 and B23 appeared at the bottom of the salt gradient (d = 1.23 g/ml), whereas particles containing apoB28, -B31, -B37, -B48, and -B53 exhibited progressive decreases in density. The density distribution of secreted apolipoproteins was not affected by the expression or secretion of these recombinant apoB species. As determined by nondenaturing gel electrophoresis, apoB28, -B31, -B37, -B48, and -B53 formed their own discrete particles, and there was a direct correlation between the size of the particles and the length of the apoB species. The efficiency and rate of secretion of these truncated forms of apoB were studied by measuring the decrease of immunoprecipitated S-35-labeled apoB proteins in the cells and their accumulation in the medium. Proteins corresponding to apoB28 or larger were rapidly and efficiently secreted, whereas apoB18 and apoB23 were secreted much more slowly. These data imply that the size of these truncated apoB forms governs the lipid content of the apoB-containing lipoproteins formed as well as the kinetics of secretion.	UNIV CALIF SAN FRANCISCO,CARDIOVASC RES INST,GLADSTONE FDN LABS CARDIOVASC DIS,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; The J David Gladstone Institutes				Young, Stephen/0000-0001-7270-3176	NHLBI NIH HHS [HL41633] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL041633] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; BLACKHART BD, 1990, J BIOL CHEM, V265, P8358; BLANCHE PJ, 1981, BIOCHIM BIOPHYS ACTA, V665, P408, DOI 10.1016/0005-2760(81)90253-8; BORCHARDT RA, 1987, J BIOL CHEM, V262, P16394; BOSTROM K, 1988, J BIOL CHEM, V263, P4434; BOSTROM K, 1989, J BIOL CHEM, V264, P15701; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN SH, 1986, J BIOL CHEM, V261, P2918; CLADARAS C, 1986, EMBO J, V5, P3495, DOI 10.1002/j.1460-2075.1986.tb04675.x; COLLINS DR, 1988, NUCLEIC ACIDS RES, V16, P8361, DOI 10.1093/nar/16.17.8361; CURTISS LK, 1982, J BIOL CHEM, V257, P5213; CURTISS LK, 1985, J BIOL CHEM, V260, P2982; DAVIES MS, 1989, J BIOL CHEM, V264, P13395; ELOVSON J, 1981, P NATL ACAD SCI-BIOL, V78, P157, DOI 10.1073/pnas.78.1.157; GRAHAM LD, 1989, CIRCULATION S2, V80, P466; HERBERT PN, 1983, METABOLIC BASIS INHE, P589; HUANG LS, 1989, J BIOL CHEM, V264, P11394; INNERARITY TL, 1987, J CLIN INVEST, V80, P1794, DOI 10.1172/JCI113273; KNOTT TJ, 1986, NATURE, V323, P734, DOI 10.1038/323734a0; KRUL ES, 1989, ARTERIOSCLEROSIS, V9, P856, DOI 10.1161/01.ATV.9.6.856; LAW SW, 1986, P NATL ACAD SCI USA, V83, P8142, DOI 10.1073/pnas.83.21.8142; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAHLEY RW, 1984, J LIPID RES, V25, P1277; MARCEL YL, 1987, ARTERIOSCLEROSIS, V7, P166, DOI 10.1161/01.ATV.7.2.166; SATO R, 1990, J BIOL CHEM, V265, P11880; SCHUMAKER VN, 1986, METHOD ENZYMOL, V128, P155; SORIA LF, 1989, P NATL ACAD SCI USA, V86, P587, DOI 10.1073/pnas.86.2.587; TANABE S, 1989, IN VITRO CELL DEV B, V25, P1129; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANCE DE, 1984, BIOCHIM BIOPHYS ACTA, V792, P39, DOI 10.1016/0005-2760(84)90280-7; YANG CY, 1989, ARTERIOSCLEROSIS, V9, P96, DOI 10.1161/01.ATV.9.1.96; YAO ZM, 1988, J BIOL CHEM, V263, P2998; YOUNG SG, 1987, J BIOL CHEM, V262, P16604; YOUNG SG, 1987, J CLIN INVEST, V79, P1831, DOI 10.1172/JCI113025; YOUNG SG, 1990, CIRCULATION, V82, P1574, DOI 10.1161/01.CIR.82.5.1574; YOUNG SG, 1990, J CLIN INVEST, V85, P933, DOI 10.1172/JCI114522; YOUNG SG, 1988, SCIENCE, V241, P591, DOI 10.1126/science.3399894; YOUNG SG, 1989, NEW ENGL J MED, V320, P1604, DOI 10.1056/NEJM198906153202407	38	160	160	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3300	3308						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993701				2022-12-25	WOS:A1991EX60000094
J	DAHAN, D; SPANIER, R; RAHAMIMOFF, H				DAHAN, D; SPANIER, R; RAHAMIMOFF, H			THE MODULATION OF RAT-BRAIN NA+-CA2+ EXCHANGE BY K+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROD OUTER SEGMENTS; CARDIAC SARCOLEMMAL VESICLES; PLASMA-MEMBRANE VESICLES; SODIUM-CALCIUM EXCHANGER; SQUID AXONS; NA+/CA-2+ EXCHANGER; GIANT-AXONS; EFFLUX; RECONSTITUTION; IDENTIFICATION	The involvement of potassium ions in the Na+-Ca2+ exchange process was studied in rat brain synaptic plasma membrane (SPM) vesicles. Addition of equimolar [K+] to the intravesicular and the extravesicular medium led to a stimulation of the Na+ gradient-dependent Ca2+ influx; this stimulation was noticeable already at 0.5 mM and reached its maximum at 2 mM K+. The magnitude of the K+ stimulation was between 1.3-2.5-fold in different SPM preparations. K+ ions also stimulated the Na+-dependent Ca2+ efflux. K+ stimulation of Na+-Ca2+ exchange is of considerable specificity, since it is not mimicked by either Li+ or H+. The following lines of evidence suggest that K+ modulation of Na+-Ca2+ exchange involves the catalytic moiety of the transporter itself and not an unrelated K+ channel which modulates the membrane potential. 1) K+ stimulation of the transport process was conserved following reconstitution of the transporter into phospholipid-rich liposomes, an experimental condition which presumably separates the native membrane proteins among different vesicular structures. 2) K+ stimulation of Na+ gradient-dependent Ca2+ influx persists also when the build up of negative inside membrane potential is prevented by addition of carbonyl cyanide p-trifluoromethoxy phenylhydrazone which renders the membrane highly permeable to protons both in the native and the reconstituted preparation. 3) K+ stimulation of Na+ gradient-dependent Ca2+ influx is obtained also when tetraethylammonium chloride, 2,3-diaminopyridine and Cs+ are added to the Ca2+ uptake medium. Reconstituted SPM vesicles take up Rb-86+ in response to activation of Na+ gradient-dependent Ca2+ influx. The ratio of Ca2+ taken up to by SPM vesicles in a Na+ gradient-dependent manner to the corresponding amounts of Rb+ taken up varies between 8-5 in different SPM preparations. If the stoichiometry of the process is 1 Rb+/1 Ca2+, then Rb+ cotransport is mediated by 10-20% of the transporters present in the preparation.	HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DEPT BIOCHEM,IL-91010 JERUSALEM,ISRAEL	Hebrew University of Jerusalem								ALLEN TJA, 1986, J PHYSIOL-LONDON, V378, P53, DOI 10.1113/jphysiol.1986.sp016207; ALLEN TJA, 1986, J PHYSIOL-LONDON, V378, P77, DOI 10.1113/jphysiol.1986.sp016208; ALLEN TJA, 1989, SODIUM CALCIUM EXCHA; Baker P F, 1972, Prog Biophys Mol Biol, V24, P177, DOI 10.1016/0079-6107(72)90007-7; BAKER PF, 1976, J PHYSIOL-LONDON, V259, P103, DOI 10.1113/jphysiol.1976.sp011457; BARZILAI A, 1984, P NATL ACAD SCI-BIOL, V81, P6521, DOI 10.1073/pnas.81.20.6521; BARZILAI A, 1987, J BIOL CHEM, V262, P10315; BARZILAI A, 1987, BIOCHEMISTRY-US, V26, P6113, DOI 10.1021/bi00393a025; BLAUSTEIN MP, 1977, BIOPHYS J, V20, P79, DOI 10.1016/S0006-3495(77)85538-0; CERVETTO L, 1989, NATURE, V337, P740, DOI 10.1038/337740a0; COOK NJ, 1988, J BIOL CHEM, V263, P11382; DIPOLO R, 1984, BIOCHIM BIOPHYS ACTA, V776, P313, DOI 10.1016/0005-2736(84)90220-7; ERDREICH A, 1983, EUR J PHARMACOL, V90, P193, DOI 10.1016/0014-2999(83)90237-6; FURMAN J, 1990, BRAIN RES, V532, P41; GASKO OD, 1976, ANAL BIOCHEM, V72, P57, DOI 10.1016/0003-2697(76)90506-6; HERMONILEVINE M, 1990, BIOCHEMISTRY-US, V29, P4940, DOI 10.1021/bi00472a026; HORACKOVA M, 1979, J GEN PHYSIOL, V73, P402; LEDERER WJ, 1983, J PHYSIOL-LONDON, V341, P325, DOI 10.1113/jphysiol.1983.sp014808; LONGONI S, 1987, BIOCHEM BIOPH RES CO, V145, P1059, DOI 10.1016/0006-291X(87)91544-0; LONGONI S, 1988, AM J PHYSIOL, V255, pC870, DOI 10.1152/ajpcell.1988.255.6.C870; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mullins LJ, 1981, ION TRANSPORT HEART; PHILIPSON KD, 1982, CIRC RES, V50, P287, DOI 10.1161/01.RES.50.2.287; PHILIPSON KD, 1981, J BIOL CHEM, V256, P3698; PHILIPSON KD, 1988, BIOCHIM BIOPHYS ACTA, V945, P298, DOI 10.1016/0005-2736(88)90492-0; RAHAMIMOFF H, 1984, BIOCHIM BIOPHYS ACTA, V773, P279, DOI 10.1016/0005-2736(84)90092-0; RAHAMIMOFF H, 1979, FEBS LETT, V104, P111, DOI 10.1016/0014-5793(79)81094-7; RAHAMIMOFF H, 1984, CALCIUM NEURONAL FUN, P47; REEVES JP, 1984, J BIOL CHEM, V259, P7733; SCHNETKAMP PPM, 1989, AM J PHYSIOL, V257, pC153, DOI 10.1152/ajpcell.1989.257.1.C153; SEIGEL E, 1988, J BIOL CHEM, V263, P14614; SHELTAWY A, 1969, CHROMATOGR ELECTROPH, V1, P450; SLAUGHTER RS, 1983, J BIOL CHEM, V258, P3183; SOLDATI L, 1985, J BIOL CHEM, V260, P3321	34	43	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2067	2075						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989970				2022-12-25	WOS:A1991EV51500012
J	MARIDOR, G; PARK, W; KREK, W; NIGG, EA				MARIDOR, G; PARK, W; KREK, W; NIGG, EA			CASEIN KINASE-II - CDNA SEQUENCES, DEVELOPMENTAL EXPRESSION, AND TISSUE DISTRIBUTION OF MESSENGER-RNAS FOR ALPHA-SUBUNIT, ALPHA'-SUBUNIT, AND BETA-SUBUNIT OF THE CHICKEN ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT SKELETAL-MUSCLE; SYNTHETIC PEPTIDES; GLYCOGEN-SYNTHASE; CATALYTIC SUBUNIT; MOLECULAR-CLONING; PROTEIN-KINASES; GROWTH-FACTOR; CELL-GROWTH; CALF THYMUS; TS TYPE-2	We report the complete primary structures, as deduced from cloned cDNAS, of two catalytic (alpha and alpha') and one beta-subunit of chicken casein kinase II. The alpha and alpha'-subunits are closely related to each other but differ in their carboxyl termini; moreover, minor differences are distributed throughout the entire lengths of the two proteins, indicating that they are derived from separate genes. Comparison of the chicken protein sequences with those of their mammalian homologs reveals a high degree of evolutionary conservation of all three subunits. Northern analyses were carried out to study the expression of casein kinase II subunits during chicken embryonic development as well as in adult tissues. A single transcript migrating at 1 kilobase was detected when using a beta-specific probe, but multiple transcripts ranging in size from 1.45 to 2.8 kilobase were revealed by alpha- and alpha'-specific probes. Expression of mRNA for all three subunits was high in early embryos but decreased substantially during embryonic development. A comparative analysis of casein kinase II expression in different adult tissues revealed two major findings. First, relative levels of expression of the two catalytic subunits displayed a pronounced tissue specificity, consistent with the possibility that alpha and alpha'-subunits may carry out specialized functions. Second, no correlation was observed between levels of transcripts for the catalytic subunits and those of mRNA for the beta-subunit.	SWISS INST EXPTL CANC RES,CH-1066 EPALINGES,SWITZERLAND; KYUNG POOK NATL UNIV,COLL NAT SCI,DEPT MICROBIOL,TAEGU 702701,SOUTH KOREA	Swiss Institute Experimental Cancer Research; Kyungpook National University				nigg, erich/0000-0003-4835-5719				ACKERMAN P, 1989, J BIOL CHEM, V264, P11958; CARROLL D, 1989, J BIOL CHEM, V264, P7345; CARROLL D, 1988, COLD SPRING HARB SYM, V53, P91, DOI 10.1101/SQB.1988.053.01.014; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CHENWU JLP, 1988, MOL CELL BIOL, V8, P4981, DOI 10.1128/MCB.8.11.4981; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COCHET C, 1983, BIOCHIM BIOPHYS ACTA, V743, P1, DOI 10.1016/0167-4838(83)90411-9; COCHET C, 1983, J BIOL CHEM, V258, P1403; DAHMUS GK, 1984, J BIOL CHEM, V259, P9001; DAHMUS ME, 1981, J BIOL CHEM, V256, P3319; DEPAOLIROACH AA, 1981, J BIOL CHEM, V256, P8955; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; FEIGE JJ, 1983, BIOCHEMISTRY-US, V22, P1452, DOI 10.1021/bi00275a020; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FIRZLAFF J M, 1989, New Biologist, V1, P44; GEAHLEN RL, 1984, BIOCHIM BIOPHYS ACTA, V804, P169, DOI 10.1016/0167-4889(84)90146-0; GRAESSER FA, 1988, VIROLOGY, V165, P13; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HATHAWAY GM, 1979, J BIOL CHEM, V254, P762; HATHAWAY GM, 1982, CURR TOP CELL REGUL, V21, P101; HATHAWAY GM, 1981, J BIOL CHEM, V256, P1442; HELLERHARRISON RA, 1989, BIOCHEMISTRY-US, V28, P9053, DOI 10.1021/bi00449a014; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HU ED, 1990, J BIOL CHEM, V265, P5072; HUANG KP, 1982, J BIOL CHEM, V257, P3236; JAKOBI R, 1989, EUR J BIOCHEM, V183, P227, DOI 10.1111/j.1432-1033.1989.tb14917.x; KLARLUND JK, 1988, J BIOL CHEM, V263, P15872; KREBS EG, 1988, COLD SPRING HARB SYM, V53, P77, DOI 10.1101/SQB.1988.053.01.012; KREK W, 1989, EMBO J, V8, P3071, DOI 10.1002/j.1460-2075.1989.tb08458.x; KUENZEL EA, 1987, J BIOL CHEM, V262, P9136; LANGLOIS AJ, 1974, CANCER RES, V34, P1457; LEHNER CF, 1986, J BIOL CHEM, V261, P3293; LITCHFIELD DW, 1990, J BIOL CHEM, V265, P7638; LOZEMAN FJ, 1990, BIOCHEMISTRY-US, V29, P8436, DOI 10.1021/bi00488a034; LUESCHER B, 1990, NATURE, V344, P517; LUESCHER B, 1989, EMBO J, V8, P1111; MARCHIORI F, 1988, BIOCHIM BIOPHYS ACTA, V971, P332; MEGGIO F, 1984, EUR J BIOCHEM, V145, P593, DOI 10.1111/j.1432-1033.1984.tb08598.x; MEGGIO F, 1984, J BIOL CHEM, V259, P4576; MEISNER H, 1989, BIOCHEMISTRY-US, V28, P4072, DOI 10.1021/bi00435a066; MOSCOVICI C, 1982, EXPRESSION DIFFERENT, P435; NAKAGAWA J, 1989, J CELL SCI, V94, P449; PADMANABHA R, 1987, J BIOL CHEM, V262, P1829; PADMANABHA R, 1990, MOL CELL BIOL, V10, P4089, DOI 10.1128/MCB.10.8.4089; PEREZ M, 1987, EUR J BIOCHEM, V170, P493, DOI 10.1111/j.1432-1033.1987.tb13726.x; PEREZ M, 1988, FEBS LETT, V238, P273, DOI 10.1016/0014-5793(88)80495-2; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; PINNA LA, 1990, PEPT PROT PHOSPH, P145; PROWALD K, 1984, FEBS LETT, V176, P479, DOI 10.1016/0014-5793(84)81222-3; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SAXENA A, 1987, MOL CELL BIOL, V7, P3409, DOI 10.1128/MCB.7.10.3409; SCHNEIDER HR, 1986, EUR J BIOCHEM, V161, P733, DOI 10.1111/j.1432-1033.1986.tb10501.x; SCHNEIDER HR, 1989, BIOTEC EUROPE, V6, P82; SOMMERCORN J, 1987, J BIOL CHEM, V262, P3839; SOMMERCORN J, 1987, P NATL ACAD SCI USA, V84, P4851; TAKIO K, 1987, P NATL ACAD SCI USA, V84, P4851, DOI 10.1073/pnas.84.14.4851	57	96	100	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2362	2368						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989988				2022-12-25	WOS:A1991EV51500054
J	ARSELIN, G; GANDAR, JC; GUERIN, B; VELOURS, J				ARSELIN, G; GANDAR, JC; GUERIN, B; VELOURS, J			ISOLATION AND COMPLETE AMINO-ACID-SEQUENCE OF THE MITOCHONDRIAL ATP SYNTHASE EPSILON-SUBUNIT OF THE YEAST SACCHAROMYCES-CEREVISIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSINE-TRIPHOSPHATASE COMPLEX; PERFORMANCE LIQUID-CHROMATOGRAPHY; TERMINAL SEQUENCE; PURIFICATION; F1-ATPASE; STOICHIOMETRY; PROTEINS	All five subunits of yeast mitochondrial F1-ATPase have been isolated by reverse-phase high performance liquid chromatography. This procedure allows micro-preparative purification of all the subunits with 60% recoveries. The complete amino acid sequence of the epsilon-subunit has been established. This has been achieved by the sequence analysis of subnanomole amounts of the intact molecule and that of peptides derived by enzymatic digestion with endoproteinase Arg-C and by chemical cleavage with hydroxylamine. Yeast ATP synthase epsilon-subunit is composed of 61 residues with a calculated molecular mass of 6612 Da. This polypeptide is rather basic since it contains 7 basic residues and 3 acidic residues. This study shows a slight similarity with the bovine epsilon-subunit ATP synthase since there are 16 identical residues.	UNIV BORDEAUX 2,INST BIOCHIM CELLULAIRE & NEUROCHIM,CNRS,1 RUE CAMILLE ST SAENS,F-33077 BORDEAUX,FRANCE	Centre National de la Recherche Scientifique (CNRS); Universite de Bordeaux								ANSORGE W, 1983, ELECTROPHORESIS 82, P235; BEECHEY RB, 1975, BIOCHEM J, V148, P533, DOI 10.1042/bj1480533; Bornstein P, 1977, Methods Enzymol, V47, P132; CRABB JW, 1985, BIOCHEM INT, V11, P255; DAUM G, 1982, J BIOL CHEM, V257, P3028; ESPARZA M, 1981, FEBS LETT, V134, P63, DOI 10.1016/0014-5793(81)80551-0; FALSON P, 1986, J BIOL CHEM, V261, P7151; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GORNALL AG, 1949, J BIOL CHEM, V177, P751; Guerin B, 1979, Methods Enzymol, V55, P149; HARE PE, 1988, METHODS PROTEIN SEQU, P2; HEINRIKSON RL, 1984, ANAL BIOCHEM, V136, P65, DOI 10.1016/0003-2697(84)90307-5; Hirs CHW, 1967, METHOD ENZYMOL, P59, DOI [10.1016/S0076-6879(67)11008-2, DOI 10.1016/S0076-6879(67)11008-2]; LANG B, 1977, ANAL BIOCHEM, V77, P110, DOI 10.1016/0003-2697(77)90295-0; LARDY HA, 1953, J BIOL CHEM, V210, P357; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MERRIL CR, 1983, METHOD ENZYMOL, V96, P230; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; PENIN F, 1979, BIOCHIM BIOPHYS ACTA, V548, P63, DOI 10.1016/0005-2728(79)90187-7; PEVEC B, 1984, 3RD EUR BIOEN C HA A, V3, P351; RYRIE IJ, 1979, BIOCHIM BIOPHYS ACTA, V545, P1, DOI 10.1016/0005-2728(79)90108-7; RYRIE IJ, 1977, ARCH BIOCHEM BIOPHYS, V184, P464, DOI 10.1016/0003-9861(77)90456-8; SENIOR AE, 1988, PHYSIOL REV, V68, P177, DOI 10.1152/physrev.1988.68.1.177; SIMPSON RJ, 1988, EUR J BIOCHEM, V176, P187, DOI 10.1111/j.1432-1033.1988.tb14267.x; TAKEDA M, 1985, J BIOL CHEM, V260, P5458; TAKEDA M, 1986, J BIOL CHEM, V261, P5126; TAKESHIGE K, 1976, H-S Z PHYSIOL CHEM, V357, P1605, DOI 10.1515/bchm2.1976.357.2.1605; TODD RD, 1980, J BIOL CHEM, V255, P5461; TZAGOLOFF A, 1971, J BIOL CHEM, V246, P7328; VELOURS J, 1987, EUR J BIOCHEM, V164, P579, DOI 10.1111/j.1432-1033.1987.tb11166.x; WALKER JE, 1985, J MOL BIOL, V184, P677, DOI 10.1016/0022-2836(85)90313-4	31	25	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					723	727						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985960				2022-12-25	WOS:A1991ET17700010
J	WERNER, S; VIEHWEGER, P; HOFSCHNEIDER, PH; ROTH, WK				WERNER, S; VIEHWEGER, P; HOFSCHNEIDER, PH; ROTH, WK			LOW MITOGENIC RESPONSE TO EGF AND TGF-ALPHA - A CHARACTERISTIC FEATURE OF CULTURED KAPOSIS-SARCOMA DERIVED CELLS	ONCOGENE			English	Article							EPIDERMAL GROWTH-FACTOR; LONG-TERM CULTURE; HUMAN-FIBROBLASTS; PREREPLICATIVE PHASE; BINDING; INVITRO; ACID	We have investigated the mitogenicity of Epidermal Growth Factor (EGF) and Transforming Growth Factor alpha (TGF-alpha) for cultured Kaposi's sarcoma derived cells (KS cells). In contrast to control fibroblasts from the same patients, KS cells revealed only a weak mitogenic response to these growth factors. Neither EGF nor TGF-alpha were able to substitute for Platelet-derived growth factor (PDGF) when KS cells were grown in PDGF-depleted Platelet-Poor-Plasma serum (PPPS)-supplemented medium. The low mitogenicity of EGF and TGF-alpha for KS cells is not based upon a reduced expression of EGF receptor mRNA and protein in KS cells. However, the binding of EGF to KS cells is about 50% lower than that to fibroblasts. This reduced binding is not due to an occupation of the receptors by TGF-alpha since the expression level of this mitogen in different KS cell lines does not correlate with their capacity to bind EGF. In contrast, the low EGF binding seems to be an intrinsic feature of the EGF receptors of KS cells. In spite of the low mitogenicity of EGF for the tumor cells, the expression of c-myc, PDGF-A and Fibroblast growth factor 5 (FGF-5) mRNA is equally induced by purified EGF in KS cells and fibroblasts. This shows that at least the signal transduction pathways which lead to the expression of these genes are functional in KS cells.	MAX PLANCK INST BIOCHEM,DEPT VIRUS RES,KLOPFERSPITZ 18A,W-8033 MARTINSRIED,GERMANY	Max Planck Society				Werner, Sabine/0000-0001-7397-8710				AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BETSHOLTZ C, 1986, NATURE, V320, P695, DOI 10.1038/320695a0; BOVI PD, 1986, CANCER RES, V46, P6333; BOWENPOPE DF, 1982, J BIOL CHEM, V257, P5161; CARPENTER G, 1975, J BIOL CHEM, V250, P4297; CARPENTER G, 1990, GROWTH REGULATORY PE, P69; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DERYNCK R, 1985, CANCER CELL, V3, P79; GOTTLIEB GJ, 1982, HUM PATHOL, V13, P882, DOI 10.1016/S0046-8177(82)80047-6; HELDIN CH, 1988, EMBO J, V7, P1387, DOI 10.1002/j.1460-2075.1988.tb02955.x; Kaposi M., 1872, ARCH DERMATOL SYPHIL, V4, P265, DOI 10.1007/BF01830024; KATOH M, 1990, BIOCHEM BIOPH RES CO, V167, P1065, DOI 10.1016/0006-291X(90)90631-V; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; NAKAMURA S, 1988, SCIENCE, V242, P426, DOI 10.1126/science.3262925; PAULSSON Y, 1987, NATURE, V328, P715, DOI 10.1038/328715a0; ROTH WK, 1988, INT J CANCER, V42, P767, DOI 10.1002/ijc.2910420523; ROTHWK, 1989, ONCOGENE, V4, P483; SALAHUDDIN SZ, 1988, SCIENCE, V242, P430, DOI 10.1126/science.2459779; SCHER CD, 1979, BIOCHIM BIOPHYS ACTA, V560, P217, DOI 10.1016/0304-419X(79)90020-9; SCHIRREN CG, 1990, BRIT J DERMATOL, V123, P373; SNOVER DC, 1985, CLIN BIOCH ANAL, V20, P181; WERNER S, 1990, EXP CELL RES, V187, P98, DOI 10.1016/0014-4827(90)90122-Q; WERNER S, 1989, INT J CANCER, V6, P1137; WESTERMARK B, 1985, J CELL PHYSIOL, V124, P43, DOI 10.1002/jcp.1041240108; ZHAN XI, 1988, MOL CELL BIOL, V8, P3487, DOI 10.1128/MCB.8.8.3487	25	6	6	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1991	6	1					59	64						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY039	1992446				2022-12-25	WOS:A1991EY03900008
J	TAMAI, I; SAFA, AR				TAMAI, I; SAFA, AR			COMPETITIVE INTERACTION OF CYCLOSPORINS WITH THE VINCA ALKALOID-BINDING SITE OF P-GLYCOPROTEIN IN MULTIDRUG-RESISTANT CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV CHICAGO,PRITZKER SCH MED,DEPT MED,HEMATOL ONCOL SECT,BOX 420,5841 S MARYLAND AVE,CHICAGO,IL 60637	University of Chicago			TAMAI, Ikumi/D-8412-2015		NATIONAL CANCER INSTITUTE [R29CA047652] Funding Source: NIH RePORTER; NCI NIH HHS [CA-47652] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ATKINSON K, 1984, J CLIN PATHOL, V37, P1167, DOI 10.1136/jcp.37.10.1167; BECK WT, 1988, BIOCHEM BIOPH RES CO, V153, P959, DOI 10.1016/S0006-291X(88)81321-4; BIEDLER JL, 1975, J NATL CANCER I, V55, P671, DOI 10.1093/jnci/55.3.671; BIEDLER JL, 1970, CANCER RES, V30, P1174; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADLEY G, 1988, BIOCHIM BIOPHYS ACTA, V948, P87, DOI 10.1016/0304-419X(88)90006-6; BUSCHE R, 1989, EUR J BIOCHEM, V183, P189, DOI 10.1111/j.1432-1033.1989.tb14912.x; CHAMBERS SK, 1989, CANCER RES, V49, P6275; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; CORNWELL MM, 1986, P NATL ACAD SCI USA, V83, P3847, DOI 10.1073/pnas.83.11.3847; DURETTE PL, 1988, TRANSPLANT P, V20, P51; ENDICOTT JA, 1989, ANNU REV BIOCHEM, V58, P137, DOI 10.1146/annurev.bi.58.070189.001033; FOXWELL BMJ, 1989, MOL PHARMACOL, V36, P543; GAVERIAUX C, 1989, BRIT J CANCER, V60, P867, DOI 10.1038/bjc.1989.381; GERLACH JH, 1986, NATURE, V324, P485, DOI 10.1038/324485a0; GROS P, 1986, CELL, V47, P371, DOI 10.1016/0092-8674(86)90594-5; GROS P, 1986, NATURE, V323, P728, DOI 10.1038/323728a0; HARDING MW, 1986, J BIOL CHEM, V261, P8547; HORIO M, 1988, P NATL ACAD SCI USA, V85, P3580, DOI 10.1073/pnas.85.10.3580; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; NAITO M, 1988, J BIOL CHEM, V263, P11887; PEARCE HL, 1989, P NATL ACAD SCI USA, V86, P5128, DOI 10.1073/pnas.86.13.5128; PETERSON RHF, 1983, CANCER RES, V43, P222; SAFA AR, 1990, BIOCHEM BIOPH RES CO, V166, P259; SAFA AR, 1989, BIOCHEM BIOPH RES CO, V162, P1402, DOI 10.1016/0006-291X(89)90830-9; SAFA AR, 1986, J BIOL CHEM, V261, P6137; SAFA AR, 1988, P NATL ACAD SCI USA, V85, P7187, DOI 10.1073/pnas.85.19.7187; SAFA AR, 1987, J BIOL CHEM, V262, P7884; SAFA AR, 1989, AM ASS CANCER RES, V30, P498; SAFA AR, 1989, ANTI-CANCER DRUG, V191, P277; SAYDJARI R, 1986, J NATL CANCER I, V77, P1087; SKOVSGAARD T, 1978, CANCER RES, V38, P4722; SLATER LM, 1986, J CLIN INVEST, V77, P1405, DOI 10.1172/JCI112450; TWENTYMAN PR, 1988, BRIT J CANCER, V57, P254, DOI 10.1038/bjc.1988.55; WARTBURG A, 1986, PROG ALLERGY, V38, P28; YANG CPH, 1989, J BIOL CHEM, V264, P782	36	172	175	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1990	265	27					16509	16513						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ950	1975813				2022-12-25	WOS:A1990DZ95000072
J	MIHALIK, SJ; MCGUINNESS, M; WATKINS, PA				MIHALIK, SJ; MCGUINNESS, M; WATKINS, PA			PURIFICATION AND CHARACTERIZATION OF PEROXISOMAL L-PIPECOLIC ACID OXIDASE FROM MONKEY LIVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE METABOLISM; RAT-BRAIN; ZELLWEGER SYNDROME; PROTEINS; IDENTIFICATION; DEHYDROGENASE; OXIDATION; PATHWAY; BINDING; ORGANS	L-Pipecolic acid oxidase has been purified to near homogeneity from Rhesus monkey liver. The protein, a yellow monomer, has a molecular weight of 46,000 by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and a pI of 8.9. It contains a covalently bound flavin with absorption maxima at 457 and 383 nm and a shoulder at 480 nm. The purified enzyme is most reactive toward L-pipecolic acid, with lesser reactivities toward L-proline and sarcosine. The enzyme has no significant reactivity toward the D-enantiomer of pipecolic acid or toward any other amino acid tested. Benzoic acid is a competitive inhibitor of the enzyme with a K(i) of 750-mu-M. The K(m) of the purified enzyme is 3.7 mM for L-pipecolic acid. With less purified preparations, the reaction product is alpha-aminoadipic acid. The purified enzyme, however, produces an intermediate which reacts with ortho-aminobenzaldehyde to form an alpha-aminoadipic acid semialdehyde adduct. Thus, the formation of alpha-aminoadipic acid requires at least two enzymes.	JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University	MIHALIK, SJ (corresponding author), KENNEDY INST HANDICAPPED CHILDREN,707 N BROADWAY,BALTIMORE,MD 21205, USA.			Watkins, Paul A./0000-0002-3246-1405	NCRR NIH HHS [RR05808] Funding Source: Medline; NICHD NIH HHS [HD24061, HD10981] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD010981] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADAMS E, 1980, ANNU REV BIOCHEM, V49, P1005, DOI 10.1146/annurev.bi.49.070180.005041; ASPEN AJ, 1962, BIOCHEMISTRY-US, V1, P600, DOI 10.1021/bi00910a009; BAGINSKY ML, 1966, J BACTERIOL, V92, P424, DOI 10.1128/JB.92.2.424-432.1966; BAGINSKY ML, 1967, J BACTERIOL, V94, P1034, DOI 10.1128/JB.94.4.1034-1039.1967; BARBER MJ, 1987, BIOCHEM J, V242, P89, DOI 10.1042/bj2420089; BASSO LV, 1962, J BIOL CHEM, V237, P2239; BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; BLAKE RL, 1976, BIOCHEM GENET, V14, P739, DOI 10.1007/BF00485338; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALVERT AF, 1966, J BIOL CHEM, V241, P409; CHANG YF, 1978, J NEUROCHEM, V30, P347, DOI 10.1111/j.1471-4159.1978.tb06536.x; CHANG YF, 1990, BIOCHIM BIOPHYS ACTA, V1038, P300, DOI 10.1016/0167-4838(90)90241-7; CHANG YF, 1978, J NEUROCHEM, V30, P355, DOI 10.1111/j.1471-4159.1978.tb06537.x; CHANG YF, 1976, BIOCHEM BIOPH RES CO, V69, P174, DOI 10.1016/S0006-291X(76)80288-4; CHANG YF, 1982, NEUROCHEM RES, V7, P577, DOI 10.1007/BF00965124; CHANG YF, 1981, LIFE SCI, V28, P407, DOI 10.1016/0024-3205(81)90086-2; DULEY J, 1975, ANAL BIOCHEM, V69, P164, DOI 10.1016/0003-2697(75)90577-1; EDMONDSON DE, 1991, IN PRESS CHEM BIOCH, V1; GLAZER AN, 1976, LABORATORY TECHNIQUE, V4, P13; GROVE J, 1968, BIOCHIM BIOPHYS ACTA, V165, P113, DOI 10.1016/0304-4165(68)90195-5; GROVE JA, 1969, BIOCHIM BIOPHYS ACTA, V184, P329, DOI 10.1016/0304-4165(69)90035-X; GROVE JA, 1972, ARCH BIOCHEM BIOPHYS, V151, P464, DOI 10.1016/0003-9861(72)90522-X; HARDY MR, 1988, ANAL BIOCHEM, V170, P54, DOI 10.1016/0003-2697(88)90089-9; HIGASHINO K, 1971, ARCH BIOCHEM BIOPHYS, V142, P606, DOI 10.1016/0003-9861(71)90525-X; HUTZLER J, 1968, BIOCHIM BIOPHYS ACTA, V158, P62, DOI 10.1016/0304-4165(68)90072-X; KINZEL JJ, 1982, J BACTERIOL, V151, P1073, DOI 10.1128/JB.151.3.1073-1077.1982; KRAMAR R, 1970, ENZYMOLOGIA, V39, P101; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAM S, 1986, BIOCHIM BIOPHYS ACTA, V882, P254, DOI 10.1016/0304-4165(86)90162-5; Lazarow P. B., 1989, METABOLIC BASIS INHE, P1479; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; MASSEY V, 1966, J BIOL CHEM, V241, P3417; MASSEY V, 1965, BIOCHEMISTRY-US, V4, P1161, DOI 10.1021/bi00882a027; MIHALIK SJ, 1989, PEDIATR RES, V25, P548, DOI 10.1203/00006450-198905000-00024; MIHALIK SJ, 1989, J BIOL CHEM, V264, P2509; NEGRI A, 1987, J BIOL CHEM, V262, P10026; NISHIO H, 1981, NEUROCHEM RES, V6, P1241, DOI 10.1007/BF00964346; NOMURA Y, 1978, Journal of Pharmacobio-Dynamics, V1, P251; NOMURA Y, 1981, NEUROCHEM RES, V6, P391, DOI 10.1007/BF00963854; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; RAO DR, 1962, J BIOL CHEM, V237, P2232; RAO VV, 1990, BIOCHIM BIOPHYS ACTA, V1038, P295, DOI 10.1016/0167-4838(90)90240-G; SCARPULLA RC, 1978, J BIOL CHEM, V253, P5997; SINGER TP, 1984, METHOD ENZYMOL, V106, P369; SWENSON RP, 1982, J BIOL CHEM, V257, P8817; TAHAKAMA K, 1982, BRAIN RES, V239, P294; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WANDERS RJA, 1989, BIOCHEM BIOPH RES CO, V164, P550, DOI 10.1016/0006-291X(89)91754-3; WANDERS RJA, 1988, BIOCHEM BIOPH RES CO, V154, P33, DOI 10.1016/0006-291X(88)90645-6; WITTWER AJ, 1981, J BIOL CHEM, V256, P4102; 1986, POLYACRYLAMIDE GEL E, P54	51	39	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4822	4830						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002029				2022-12-25	WOS:A1991FC21700026
J	KANYO, ZF; CHRISTIANSON, DW				KANYO, ZF; CHRISTIANSON, DW			BIOLOGICAL RECOGNITION OF PHOSPHATE AND SULFATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALMONELLA-TYPHIMURIUM; ANTITHROMBIN-III; BINDING PROTEIN; ANTI-THROMBIN; HIGH-AFFINITY; TRANSFER-RNA; HEPARIN; PENTASACCHARIDE; IDENTIFICATION; INHIBITORS	The biological recognition of trigonal pyramids has been studied in a statistical analysis of the Cambridge Structural Data Base. The preferential stereochemistry of pyramidal anion-Lewis acid interactions is easily described for the phosphonyl dianion (R-PO3(2-), as found in the phosphate group) and the sulfonyl monoanion (R-SO3-, as found in the sulfate group) by trans/gauche conformational terminology. Interactions between these pyramidal anions and metals generally prefer gauche geometry (as defined by the R-X = O-M(n+) torsion angle, X = P or S). Interactions between phosphonyls and hydrogen bond donors likewise display a preference for gauche orientation. Interactions between sulfonyls and hydrogen bond donors exhibit a preference for gauche stereochemistry and also cluster in eclipsed regions. These hydrogen bond motifs provide a greater understanding of the function of pyramidal anions in biological structure and function. For example, interactions of the sulfate monoanion are important for the binding of heparin, a sulfated glycosaminoglycan, to antithrombin III.	UNIV PENN, DEPT CHEM, PHILADELPHIA, PA 19104 USA	University of Pennsylvania					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007229] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM7229-15] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALEXANDER RS, 1990, J AM CHEM SOC, V112, P933, DOI 10.1021/ja00159a004; ALLEN FH, 1983, ACCOUNTS CHEM RES, V16, P146, DOI 10.1021/ar00089a001; ALLEN FH, 1979, ACTA CRYSTALLOGR B, V35, P2331, DOI 10.1107/S0567740879009249; BEETZ T, 1986, TETRAHEDRON LETT, V27, P5889, DOI 10.1016/S0040-4039(00)85356-3; BENDER SL, 1989, BIOCHEMISTRY-US, V28, P7560, DOI 10.1021/bi00445a010; BJORK I, 1982, J BIOL CHEM, V257, P9487; CARRELL RW, 1987, COLD SPRING HARB SYM, V52, P527, DOI 10.1101/SQB.1987.052.01.060; CHOAY J, 1983, BIOCHEM BIOPH RES CO, V116, P492, DOI 10.1016/0006-291X(83)90550-8; FRESCO JR, 1966, COLD SPRING HARB SYM, V31, P527, DOI 10.1101/SQB.1966.031.01.068; GOUAUX JE, 1987, BIOCHEM BIOPH RES CO, V142, P893; HOLBROOK SR, 1977, NUCLEIC ACIDS RES, V4, P2811, DOI 10.1093/nar/4.8.2811; HOYLAERTS M, 1984, J BIOL CHEM, V259, P5670; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; JACK A, 1977, J MOL BIOL, V111, P315, DOI 10.1016/S0022-2836(77)80054-5; JORDAN R, 1979, J BIOL CHEM, V254, P2902; KUTZELNIGG W, 1977, PURE APPL CHEM, V49, P981, DOI 10.1351/pac197749070981; LINDAHL U, 1983, J BIOL CHEM, V258, P9826; LUECKE H, 1990, NATURE, V347, P402, DOI 10.1038/347402a0; OLSON ST, 1981, J BIOL CHEM, V256, P1073; PERIANA RA, 1980, J AM CHEM SOC, V102, P3923, DOI 10.1021/ja00531a040; PETERSON CB, 1987, J BIOL CHEM, V262, P8061; PFLUGRATH JW, 1988, J MOL BIOL, V200, P163, DOI 10.1016/0022-2836(88)90341-5; PFLUGRATH JW, 1985, NATURE, V314, P257, DOI 10.1038/314257a0; ROSENFIELD RE, 1984, J MOL GRAPHICS, V2, P43, DOI 10.1016/0263-7855(84)80032-6; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; SAMAMA JP, 1989, J MOL BIOL, V210, P877, DOI 10.1016/0022-2836(89)90116-2; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; WALLMEIER H, 1979, J AM CHEM SOC, V101, P2804, DOI 10.1021/ja00505a002; WIDLANSKI T, 1989, BIOCHEMISTRY-US, V28, P7572, DOI 10.1021/bi00445a011	29	85	85	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4264	4268						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999418				2022-12-25	WOS:A1991FA69400040
J	GILLESPIE, LS; HILLESLAND, KK; KNAUER, DJ				GILLESPIE, LS; HILLESLAND, KK; KNAUER, DJ			EXPRESSION OF BIOLOGICALLY-ACTIVE HUMAN ANTITHROMBIN-III BY RECOMBINANT BACULOVIRUS IN SPODOPTERA-FRUGIPERDA CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARIN-BINDING-SITE; SELECTIVE CHEMICAL MODIFICATION; MOLECULAR-WEIGHT; COFACTOR; IDENTIFICATION; PURIFICATION; SPECTROSCOPY; INHIBITION	Antithrombin III (ATIII) is a plasma-borne serine protease inhibitor that plays a pivotal role in the regulation of hemostasis. The cDNA for ATIII has been available, but genetic studies on the functional domains of ATIII have not progressed because of the absence of an expression system that will yield sufficient quantities of biologically active protein for biochemical analyses. In the present studies the cDNA of the human antithrombin III gene was inserted into the vector pVL 1393, which is suitable for cotransfection of Spodoptera frugiperda (Sf9) insect cells with Baculovirus wild-type DNA. Recombinant virus particles were selected by the presence of occlusion-negative plaques. Upon infection with purified recombinant virus, Sf9 cells secreted 10-35-mu-g of ATIII/1 x 10(6) cells. Southern analysis of DNA from infected cells demonstrated incorporation of the full-length cDNA into the Baculovirus recombinant, and RNase protection experiments verified the presence of full-length transcript. This recombinant ATIII protein was immunologically reactive with antisera raised against native human ATIII, formed stable complexes with thrombin, and was heparin-accelerated at the same concentration as native human ATIII. In addition, the recombinant ATIII retained specificity for the same molecular species of heparin that activates authentic human ATIII. This is the first successful production of active, recombinant ATIII in quantities that will allow purification on the milligram scale and permit a biochemical analysis of genetically engineered variants.	UNIV CALIF IRVINE,DEPT DEV & CELL BIOL,STEINHAUS HALL,IRVINE,CA 92717	University of California System; University of California Irvine					PHS HHS [R01-FM34001] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		CHANG JY, 1989, J BIOL CHEM, V264, P3111; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAMUS PS, 1973, NATURE, V246, P355, DOI 10.1038/246355a0; EINARSSON R, 1977, BIOCHIM BIOPHYS ACTA, V490, P104, DOI 10.1016/0005-2795(77)90110-6; Favaloro J, 1980, Methods Enzymol, V65, P718; GETTINS P, 1987, BIOCHEMISTRY-US, V26, P4403, DOI 10.1021/bi00388a032; HOWARD EW, 1986, J BIOL CHEM, V261, P684; JORDAN RE, 1980, J BIOL CHEM, V255, P81; KURACHI K, 1976, BIOCHEMISTRY-US, V15, P373, DOI 10.1021/bi00647a021; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIU CS, 1987, J BIOL CHEM, V262, P17356; Maniatis T., 1982, MOL CLONING; MIYAMOTO C, 1985, MOL CELL BIOL, V5, P2860, DOI 10.1128/MCB.5.10.2860; NESHEIM M, 1986, J BIOL CHEM, V261, P3214; PETERSEN TE, 1977, PHYSL INHIBITORS COA, P43; PETERSON CB, 1987, J BIOL CHEM, V262, P8061; ROSENBERG RD, 1977, SEMIN HEMATOL, V14, P427; ROSENBERG RD, 1973, J BIOL CHEM, V248, P6490; ROSENFELD L, 1987, BIOCHEMISTRY-US, V25, P639; SMITH JW, 1990, BIOCHEMISTRY-US, V29, P8950, DOI 10.1021/bi00490a010; SMITH JW, 1987, J BIOL CHEM, V262, P11964; STEAD N, 1976, J BIOL CHEM, V251, P6481; STEPHENS AW, 1987, P NATL ACAD SCI USA, V84, P3886, DOI 10.1073/pnas.84.11.3886; STONE AL, 1982, P NATL ACAD SCI-BIOL, V79, P7190, DOI 10.1073/pnas.79.23.7190; SUMMERS MD, 1988, MANUAL METHODS BACUL	25	30	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3995	4001						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995647				2022-12-25	WOS:A1991EY68200096
J	OKAYAMA, M; OGURI, K; YOSHIDA, K; OHKITA, T				OKAYAMA, M; OGURI, K; YOSHIDA, K; OHKITA, T			PURIFICATION AND CHARACTERIZATION OF NOVEL HEPARAN-SULFATE PROTEOGLYCANS PRODUCED BY MURINE ERYTHROLEUKEMIA-CELLS IN THE GROWING PHASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETORY GRANULE PROTEOGLYCANS; HUMAN-PLATELET PROTEOGLYCAN; NATURAL-KILLER FUNCTION; RABBIT BONE-MARROW; MAST-CELLS; BIOCHEMICAL-CHARACTERIZATION; SYNTHESIZED INVITRO; GLYCOSAMINOGLYCANS; DIFFERENTIATION; BIOSYNTHESIS	Murine erythroleukemia cells (Friend erythroleukemia cells of a C-10-6 line) synthesized sulfated glycosaminoglycans consisting mainly of heparan sulfate (more than 95%) with a small amount of chondroitin 4-sulfate. The heparan sulfate occurred as proteoglycans, of which the cell-associated component was separated into urea-insoluble (UI) and urea-soluble (US) fractions. The UI proteoglycan consisted of a single homogeneous molecular species with an estimated M(r) of 360,000 (C(UI)PG), whereas the US component was composed of two subfractions: a homogeneous species with an M(r) of 280,000 (C(US)PGI) and a mixture of compounds with M(r) values of less than 80,000 (C(US)PGII), which were isolated in yields of about 110, 340, and 80-mu-g of hexuronate (HexUA), respectively, from 1.37 g of an acetone powder prepared from 5.7 X 10(9) cells in the logarithmic phase of growth. The proteoglycan released into the medium (12 liters) was a single homogeneous species with an M(r) of 320,000 (MPG) which was purified in a yield of 500-mu-g of hexuronate. The major, cell-associated proteoglycan, C(US)PGI, had very high contents of serine and glycine, accounting for approximately 80% of the total amino acids. This proteoglycan as well as the other two large proteoglycans, C(UI)PG and MPG, were highly resistant to degradation by various proteinases. These three proteoglycans, C(UI)PG, C(US)PGI, and MPG, had heparan sulfates with estimated M(r) values of 32,000, 27,000, and 30,000. On the other hand, the M(r) of the smaller proteoglycan, C(UI)PGII, was not significantly different before and after beta-elimination, indicating that it contains only a small peptide, if any. The heparan sulfate of this proteoglycan consisted of smaller and heterogeneous molecular species with M(r) values of 26,000, 20,000, and 4,000. Digestion of these heparan sulfates with heparitinase I plus II resulted in almost complete depolymerization and gave six unsaturated disaccharides, DELTA-HexUA-GlcNAc, DELTA-HexUA-Glc-NAc(6-SO4), DELTA-HexUA-GlcNSO3, DELTA-HexUA-GlcNSO3 (6-SO4), DELTA-HexUA(2-SO4)-GlcNSO3, and DELTA-HexUA(2-SO4)-GlcNSO4)-GlcNSO3(6-SO4). The relative amounts of these disaccharides generated from the individual heparan sulfates showed that an average ratio of sulfate residues to repeating disaccharide units of the C(US)PGII-derived heparan sulfate (0.97) was significantly higher than those of the other three large proteoglycan-derived glycosaminoglycans (0.54-0.70).	SEIKAGAKU KOGYO CO,TOKYO RES INST,TOKYO 189,JAPAN		OKAYAMA, M (corresponding author), NATL NAGOYA HOSP,CLIN RES INST,4-1-1 SANNOMARU,NAKA KU,NAGOYA 460,JAPAN.							AVILA JL, 1978, BIOCHEM J, V171, P489, DOI 10.1042/bj1710489; AVRAHAM S, 1988, J BIOL CHEM, V263, P7292; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; BLAND CE, 1982, J BIOL CHEM, V257, P8661; BLAND CE, 1984, J IMMUNOL, V132, P1937; BOAS NF, 1953, J BIOL CHEM, V204, P553; BOURDON MA, 1985, P NATL ACAD SCI USA, V82, P1321, DOI 10.1073/pnas.82.5.1321; DVORAK AM, 1983, J EXP MED, V157, P843, DOI 10.1084/jem.157.3.843; Elson LA, 1933, BIOCHEM J, V27, P1824, DOI 10.1042/bj0271824; FEDARKO NS, 1986, J CELL BIOL, V102, P587, DOI 10.1083/jcb.102.2.587; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; FUKUDA M, 1984, BIOL GLYCOPROTEINS, P183; GAHMBERG CG, 1979, J BIOL CHEM, V254, P7442; GALLAGHER JT, 1986, BIOCHEM J, V236, P313, DOI 10.1042/bj2360313; HUANG SS, 1982, J BIOL CHEM, V257, P1546; IKAWA Y, 1976, BIBL HAEMATOL, V43, P37; ISHIHARA M, 1987, J BIOL CHEM, V262, P4708; ISHIHARA M, 1986, J BIOL CHEM, V261, P3575; JACOBSSON KG, 1987, BIOCHEM J, V246, P409, DOI 10.1042/bj2460409; KATO T, 1982, BIOPOLYMERS, V21, P1623, DOI 10.1002/bip.360210812; KAWAHARA K, 1984, CARBOHYD POLYM, V4, P335, DOI 10.1016/0144-8617(84)90049-3; KIMATA K, 1974, J BIOL CHEM, V249, P1646; KOBAYASHI S, 1983, J BIOL CHEM, V258, P2051; KOLSET SO, 1983, BIOCHEM J, V210, P661, DOI 10.1042/bj2100661; LEVINE SP, 1990, BLOOD, V75, P902; LEVITT D, 1983, J CELL BIOL, V97, P351, DOI 10.1083/jcb.97.2.351; LINDAHL U, 1973, J BIOL CHEM, V248, P7234; LINDAHL U, 1987, BIOL PROTEOGLYCANS, P59; LOHMANDER LS, 1990, J BIOL CHEM, V265, P5802; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUIKART SD, 1986, EXP HEMATOL, V14, P672; MACDERMOTT RP, 1985, J EXP MED, V162, P1771, DOI 10.1084/jem.162.6.1771; MARKS PA, 1978, ANNU REV BIOCHEM, V47, P419, DOI 10.1146/annurev.bi.47.070178.002223; MCCUSKEY RS, 1972, BLOOD-J HEMATOL, V39, P697, DOI 10.1182/blood.V39.5.697.697; MCQUILLAN DJ, 1989, J BIOL CHEM, V264, P13245; METCALFE DD, 1982, BIOCHIM BIOPHYS ACTA, V715, P196, DOI 10.1016/0304-4165(82)90359-2; METCALFE DD, 1980, J BIOL CHEM, V255, P1753; METCALFE DD, 1980, BIOCHEM J, V185, P367, DOI 10.1042/bj1850367; MINGUELL JJ, 1989, BLOOD, V73, P1821; MORRIS AJ, 1989, BIOCHEM J, V260, P479, DOI 10.1042/bj2600479; MURATE T, 1989, LEUKEMIA RES, V13, P227, DOI 10.1016/0145-2126(89)90016-7; NAKANISHI H, 1986, SEIKAGAKU, V58, P782; NICODEMUS CF, 1990, J BIOL CHEM, V265, P5889; OGURI K, 1987, BLOOD, V70, P501; Oguri K, 1987, Keio J Med, V36, P67; OGURI K, 1985, SEIKAGAKU, V57, P1178; OGURI K, 1985, GLYCOCONJUGATES, V1, P323; OKAYAMA E, 1988, BLOOD, V72, P745; OKAYAMA M, 1986, BIOCHEM J, V233, P73, DOI 10.1042/bj2330073; OKAYAMA M, 1981, GLYCOCONJUGATES, P371; PARMLEY RT, 1983, BLOOD, V61, P257; PARMLEY RT, 1985, BLOOD, V66, P20; PERIN JP, 1988, BIOCHEM J, V255, P1007, DOI 10.1042/bj2551007; RAZIN E, 1982, J BIOL CHEM, V257, P7229; REUBEN RC, 1976, P NATL ACAD SCI USA, V73, P862, DOI 10.1073/pnas.73.3.862; RIDER CC, 1987, MOL IMMUNOL, V24, P963, DOI 10.1016/0161-5890(87)90007-1; ROBINSON HC, 1978, J BIOL CHEM, V253, P6687; ROTHENBERG ME, 1988, J BIOL CHEM, V263, P13901; SAITO H, 1968, J BIOL CHEM, V243, P1536; SELDIN DC, 1985, J BIOL CHEM, V260, P1131; SPACKMAN DH, 1958, ANAL CHEM, V30, P1190, DOI 10.1021/ac60139a006; STEVENS RL, 1986, CIBA F SYMP, V124, P272; STEVENS RL, 1985, J BIOL CHEM, V260, P4194; TERADA M, 1978, P NATL ACAD SCI USA, V75, P2795, DOI 10.1073/pnas.75.6.2795; UHLINHANSEN L, 1987, CELL DIFFER DEV, V21, P189, DOI 10.1016/0045-6039(87)90455-6; WIGHT TN, 1986, BLOOD, V67, P1333; YAOITA E, 1990, J BIOL CHEM, V265, P522; YOSHIDA K, 1989, ANAL BIOCHEM, V177, P327, DOI 10.1016/0003-2697(89)90061-4; YURT RW, 1977, J BIOL CHEM, V252, P518	69	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3808	3819						12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995633				2022-12-25	WOS:A1991EY68200070
J	KURE, S; KOYATA, H; KUME, A; ISHIGURO, Y; HIRAGA, K				KURE, S; KOYATA, H; KUME, A; ISHIGURO, Y; HIRAGA, K			THE GLYCINE CLEAVAGE SYSTEM - THE COUPLED EXPRESSION OF THE GLYCINE DECARBOXYLASE GENE AND THE H-PROTEIN GENE IN THE CHICKEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; LIVER-MITOCHONDRIA; MAJOR PATHWAYS; BETA-SUBUNIT; TRANSCRIPTION; RAT; PURIFICATION; YEAST; DEHYDROGENASE; SACCHAROMYCES	Regulation of the transcription of the glycine decarboxylase gene and the H-protein gene was examined in chicken. Northern analysis suggested and run-off transcription confirmed that the glycine decarboxylase gene transcription is exclusively tissue-specific and takes place at different efficiencies in liver, kidney, and brain which are the chicken tissues exhibiting the glycine cleavage activity. No evidence for the glycine decarboxylase gene transcription was obtained in heart, spleen, and skeletal muscle. Basal and tissue-specific transcription of the H-protein gene can be distinguished. The tissue-specific transcription coordinates with transcription of the glycine decarboxylase gene in active tissues, while low abundance H-protein and its mRNA, products of the basal transcription, exist in inactive tissues with small amounts of T-protein. Apparently, T-protein is synthesized by a process similar to that for H-protein. Glycine decarboxylase mRNA levels show a linear relationship with H-protein mRNA levels and with specific activities of the glycine cleavage reaction in active tissues. Tissue-specific distribution of the glycine cleavage activity is primarily determined by the expression of the glycine decarboxylase gene. The coordinate and tissue-specific transcription of the genes for the constituent proteins plays a key role in determining the magnitude of the glycine cleavage activity in chicken tissues and, thereby, the tissue-specificity of glycine metabolism.	TOYAMA MED & PHARMACEUT UNIV,SCH MED,DEPT BIOCHEM,SUGITANI,TOYAMA 93001,JAPAN	University of Toyama								ATCHISON ML, 1988, ANNU REV CELL BIOL, V4, P127, DOI 10.1146/annurev.cellbio.4.1.127; CHIRALA SS, 1987, J BIOL CHEM, V262, P4231; FYRBERG EA, 1980, CELL, V19, P365, DOI 10.1016/0092-8674(80)90511-5; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; HIRAGA K, 1980, J BIOL CHEM, V255, P1664; HIRAGA K, 1972, J BIOCHEM-TOKYO, V72, P1285, DOI 10.1093/oxfordjournals.jbchem.a130020; HIRAGA K, 1980, J BIOL CHEM, V255, P1671; HIRAGA K, 1988, BIOCHEM BIOPH RES CO, V151, P758, DOI 10.1016/S0006-291X(88)80345-0; KIKUCHI G, 1973, MOL CELL BIOCHEM, V1, P169, DOI 10.1007/BF01659328; KLEIN SM, 1966, J BIOL CHEM, V241, P197; KUME A, 1991, J BIOL CHEM, V266, P3323; KUME A, 1988, BIOCHEM BIOPH RES CO, V154, P292, DOI 10.1016/0006-291X(88)90683-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAUGHON A, 1982, P NATL ACAD SCI-BIOL, V79, P6827, DOI 10.1073/pnas.79.22.6827; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; MOHAMED AH, 1988, J BIOL CHEM, V263, P12315; ODESSEY R, 1982, BIOCHEM J, V204, P353, DOI 10.1042/bj2040353; OKAMURAIKEDA K, 1982, J BIOL CHEM, V257, P135; ORLOWSKI J, 1988, J BIOL CHEM, V263, P10436; RANDLE PJ, 1987, ENZYMES, V18, P97; SCHIBLER U, 1987, ANNU REV GENET, V21, P237, DOI 10.1146/annurev.ge.21.120187.001321; SCHIBLER U, 1983, CELL, V13, P504; STJOHN TP, 1981, J MOL BIOL, V152, P317, DOI 10.1016/0022-2836(81)90245-X; STJOHN TP, 1981, J MOL BIOL, V152, P285, DOI 10.1016/0022-2836(81)90244-8; YAMAMOTO M, 1991, J BIOL CHEM, V266, P3317; YANOFSKY C, 1982, ANNU REV GENET, V16, P113; YEAMAN SJ, 1978, BIOCHEMISTRY-US, V17, P2364, DOI 10.1021/bi00605a017; YOSHIDA T, 1973, J BIOCHEM-TOKYO, V73, P1013, DOI 10.1093/oxfordjournals.jbchem.a130155; YOSHIDA T, 1970, ARCH BIOCHEM BIOPHYS, V139, P380, DOI 10.1016/0003-9861(70)90490-X	29	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3330	3334						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993705				2022-12-25	WOS:A1991EX60000098
J	RUF, W; REHEMTULLA, A; EDGINGTON, TS				RUF, W; REHEMTULLA, A; EDGINGTON, TS			PHOSPHOLIPID-INDEPENDENT AND PHOSPHOLIPID-DEPENDENT INTERACTIONS REQUIRED FOR TISSUE FACTOR RECEPTOR AND COFACTOR FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION FACTOR-X; FACTOR-VII; CELLULAR RECEPTOR; BLOOD-COAGULATION; FACTOR-IX; EXTRINSIC PATHWAY; HUMAN-PROTHROMBIN; PROTEASE CASCADE; ACTIVATION; BINDING	Membrane anchoring of tissue factor (TF), the cell receptor for coagulation factor VIIa (VIIa), exemplifies an effective mechanism to localize proteolysis at the cell surface. A recombinant TF mutant (TF1-219), deleted of membrane spanning and intracellular domains, was used to evaluate the role of phospholipid interactions for assembly of substrate with the catalytic TF.VIIa complex. TF1-219 was secreted by cells rather than expressed as a cell membrane protein. Unlike free VIIa, TF1-219 as well as the TF1-219.VIIa complex demonstrated no stable association with phospholipid. In the absence of lipid, kinetic evaluation of substrate factor X cleavage by free VIIa, TF.VIIa, and TF1-219.VIIa suggests that the catalytic function of VIIa rather than substrate recognition is enhanced by complex formation. Furthermore, compared with free factor X, factor X on phospholipid was preferentially cleaved as a substrate by TF1-219.VIIa. TF-dependent initiation of the coagulation protease cascades thus involves an enhancement of the activation of factor X on the cell surface by a crucial role of the TF transmembrane domain to membrane anchor the reaction, by the TF extracellular domain to provide protein-protein interactions with VIIa to enhance the activity of the catalytic domain of VIIa, and the preferential presentation of factor X as a substrate when associated with phospholipid surfaces.			RUF, W (corresponding author), Scripps Res Inst, RES INST, DEPT IMMUNOL, LA JOLLA, CA 92037 USA.				NCI NIH HHS [P01-CA-41085] Funding Source: Medline; NHLBI NIH HHS [P01-HL-16411] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA041085] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL016411] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BACH R, 1986, BIOCHEMISTRY-US, V25, P4007, DOI 10.1021/bi00362a005; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BLOOM JW, 1989, THROMB RES, V54, P261, DOI 10.1016/0049-3848(89)90084-4; BOM VJJ, 1990, BIOCHEM J, V265, P327, DOI 10.1042/bj2650327; BROOKS SPJ, 1986, INT J BIOMED COMPUT, V19, P89, DOI 10.1016/0020-7101(86)90003-6; BROZE GJ, 1982, J CLIN INVEST, V70, P526, DOI 10.1172/JCI110644; BROZE GJ, 1985, J BIOL CHEM, V260, P917; BURRI BJ, 1987, BIOCHIM BIOPHYS ACTA, V923, P176, DOI 10.1016/0304-4165(87)90002-X; CARSON SD, 1981, THROMB HAEMOSTASIS, V44, P12; CHATTOPADHYAY A, 1989, J BIOL CHEM, V264, P11035; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P698, DOI 10.1021/bi00623a022; DRAKE TA, 1989, J CELL BIOL, V109, P389, DOI 10.1083/jcb.109.1.389; FAIR DS, 1983, BLOOD, V62, P784; FAIR DS, 1987, J BIOL CHEM, V262, P11692; FAIR DS, 1979, J CLIN INVEST, V64, P884, DOI 10.1172/JCI109554; FORMAN SD, 1986, P NATL ACAD SCI USA, V83, P4675, DOI 10.1073/pnas.83.13.4675; GALVIN JB, 1987, J BIOL CHEM, V262, P2199; GUHA A, 1986, P NATL ACAD SCI USA, V83, P299, DOI 10.1073/pnas.83.2.299; KINGSTON RE, 1987, CURRENT PROTOCOLS MO; KISIEL W, 1976, BIOCHEMISTRY-US, V15, P4901, DOI 10.1021/bi00667a023; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; KUROSAWA S, 1987, J BIOL CHEM, V262, P2206; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVINSON A, 1984, Journal of Molecular and Applied Genetics, V2, P507; MACKMAN N, 1989, BIOCHEMISTRY-US, V28, P1755, DOI 10.1021/bi00430a050; MALHOTRA OP, 1982, BIOCHIM BIOPHYS ACTA, V702, P185, DOI 10.1016/0167-4838(82)90501-5; MALHOTRA OP, 1985, J BIOL CHEM, V260, P279; MANLY DT, 1988, THROMB RES, V49, P343, DOI 10.1016/0049-3848(88)90314-3; MERTENS K, 1984, BIOCHEM J, V223, P599, DOI 10.1042/bj2230599; MORRISSEY JH, 1987, CELL, V50, P129, DOI 10.1016/0092-8674(87)90669-6; MORRISSEY JH, 1988, THROMB RES, V50, P481, DOI 10.1016/0049-3848(88)90197-1; MORRISSEY JH, 1988, THROMB RES, V52, P247, DOI 10.1016/0049-3848(88)90084-9; NELSESTUEN GL, 1978, BIOCHEMISTRY-US, V17, P2134, DOI 10.1021/bi00604a017; NEMERSON Y, 1986, BIOCHEMISTRY-US, V25, P4020, DOI 10.1021/bi00362a006; PLOPLIS VA, 1987, J BIOL CHEM, V262, P9503; SAKAI T, 1990, J BIOL CHEM, V265, P1890; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; SHERRILL GB, 1988, THROMB RES, V52, P53; SILVERBERG SA, 1977, J BIOL CHEM, V252, P8481; SKOGEN WF, 1983, BIOCHEM BIOPH RES CO, V111, P14, DOI 10.1016/S0006-291X(83)80110-7; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANDIEIJEN G, 1981, BIOCHEMISTRY-US, V20, P7096, DOI 10.1021/bi00528a007; WILLIAMS EB, 1989, J BIOL CHEM, V264, P7536; ZUR M, 1982, J BIOL CHEM, V257, P5623; ZUR M, 1980, J BIOL CHEM, V255, P5703	45	220	250	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2158	2166						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989976				2022-12-25	WOS:A1991EV51500025
J	WIESMULLER, L; WITTBRODT, J; NOEGEL, AA; SCHLEICHER, M				WIESMULLER, L; WITTBRODT, J; NOEGEL, AA; SCHLEICHER, M			PURIFICATION AND CDNA-DERIVED SEQUENCE OF ADENYLOSUCCINATE SYNTHETASE FROM DICTYOSTELIUM-DISCOIDEUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING PROTEINS; PURINE METABOLISM; MESSENGER-RNA; GENE; SPECIFICITY; INHIBITORS; SECRETION; PRODUCT; CLONING; LYASE	Adenylosuccinate synthetase (IMP:L-aspartate ligase (GDP), EC 6.3.4.4) plays an important role in purine biosynthesis catalyzing the GTP-dependent conversion of IMP to AMP. The enzyme was purified from the cytosol of Dictyostelium discoideum using GTP-agarose chromatography as the critical step. It has an apparent molecular mass of 44 kDa. Monoclonal antibodies identified several forms of the enzyme with pI values between 8.1 and 9.0. Michaelis-Menten constants (K(m)) were low for the nucleotide substrates IMP (K(m) = 30-mu-M) and GTP (K(m) = 35-mu-M) as compared with the value for aspartic acid (K(m) = 440-mu-M). These values are in good agreement with constants reported from other organisms. Immunological studies indicated that the protein is predominantly localized in the cytosol and only partially associated with particulate fractions. The enzyme is present throughout the developmental cycle of D. discoideum. Using monoclonal antibodies, the gene cloned from a lambda-gt11 expression library. The complete sequence represents the first reported primary structure of an eucaryotic adenylosuccinate synthetase. Southern blots hybridized with a cDNA probe demonstrate that adenylosuccinate synthetase is encoded by a single gene and contains at least one intron. The deduced amino acid sequence shows 43% identity to adenylosuccinate synthetase from Escherichia coli. Homologous regions include short sequence motifs, such as the glycine-rich loop which is typical for GTP-binding proteins.	MAX PLANCK INST BIOCHEM,W-8033 MARTINSRIED,GERMANY; GENZENTRUM,W-8033 MARTINSRIED,GERMANY	Max Planck Society			Wittbrodt, Joachim/D-4735-2014	Wittbrodt, Joachim/0000-0001-8550-7377				ANDRE E, 1988, J BIOL CHEM, V263, P722; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOMBLIES L, 1990, J CELL BIOL, V110, P669, DOI 10.1083/jcb.110.3.669; CLARK SW, 1977, COMP BIOCHEM PHYS B, V58, P63, DOI 10.1016/0305-0491(77)90128-6; CLARK SW, 1976, BIOCHIM BIOPHYS ACTA, V437, P87, DOI 10.1016/0304-4165(76)90349-4; CONNOLLY T, 1989, CELL, V57, P599, DOI 10.1016/0092-8674(89)90129-3; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DEVOS AM, 1988, SCIENCE, V239, P88; DONG Q, 1990, J BIOL CHEM, V265, P6235; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HARTMANN H, 1989, J BIOL CHEM, V264, P12639; Henderson J.F., 1973, NUCLEOTIDE METABOLIS, P3; HOFFEE PA, 1978, METHOD ENZYMOL, V51, P3; ISHII K, 1970, J BIOCHEM-TOKYO, V68, P171, DOI 10.1093/oxfordjournals.jbchem.a129343; JACKSON RC, 1975, BIOCHEM BIOPH RES CO, V66, P526, DOI 10.1016/0006-291X(75)90542-2; KIMMEL AR, 1980, NUCLEIC ACIDS RES, V8, P5599, DOI 10.1093/nar/8.23.5599; KNECHT DA, 1984, ANAL BIOCHEM, V136, P180, DOI 10.1016/0003-2697(84)90321-X; LACOMBE ML, 1986, J BIOL CHEM, V261, P6811; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARKHAM GD, 1977, ARCH BIOCHEM BIOPHYS, V184, P24, DOI 10.1016/0003-9861(77)90322-8; MATSUDA Y, 1977, BIOCHEM BIOPH RES CO, V78, P766, DOI 10.1016/0006-291X(77)90245-5; MCCORMICK F, 1985, SCIENCE, V230, P78, DOI 10.1126/science.3898366; Messing J, 1979, RECOMBINANT DNA TECH, V2, P43; MITCHISON T, 1984, MOL BIOL CYTOSKELETO, P27; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; NEWELL PC, 1969, J BACTERIOL, V100, P763, DOI 10.1128/JB.100.2.763-768.1969; NOEGEL A, 1985, J MOL BIOL, V185, P447, DOI 10.1016/0022-2836(85)90416-4; NOEGEL A, 1985, EMBO J, V4, P3805, DOI 10.1002/j.1460-2075.1985.tb04151.x; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OGAWA H, 1977, J BIOCHEM, V81, P859, DOI 10.1093/oxfordjournals.jbchem.a131550; ROSSOMANDO EF, 1978, ANTIMICROB AGENTS CH, V14, P476, DOI 10.1128/AAC.14.3.476; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHEEL J, 1989, J BIOL CHEM, V264, P2832; SCHLEICHER M, 1986, FEBS LETT, V200, P156, DOI 10.1016/0014-5793(86)80529-4; SCHLEICHER M, 1984, EMBO J, V3, P2095, DOI 10.1002/j.1460-2075.1984.tb02096.x; SCHULZ GE, 1987, COLD SPRING HARB SYM, V52, P429, DOI 10.1101/SQB.1987.052.01.050; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; SPECTOR T, 1979, J BIOL CHEM, V254, P8422; SPECTOR T, 1982, BIOCHEM PHARMACOL, V31, P225, DOI 10.1016/0006-2952(82)90215-5; SPECTOR T, 1976, BIOCHIM BIOPHYS ACTA, V445, P509, DOI 10.1016/0005-2744(76)90104-2; STAYTON MM, 1983, CURR TOP CELL REGUL, V22, P103; SUGGS SV, 1981, DEV BIOL USING PURIF, P638; THOMPSON RC, 1988, TRENDS BIOCHEM SCI, V13, P91, DOI 10.1016/0968-0004(88)90047-3; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANDERWE.MB, 1974, J BIOL CHEM, V249, P7282; WIESMULLER L, 1990, J BIOL CHEM, V265, P6339; WOLFE SA, 1988, J BIOL CHEM, V263, P19147; WYNGAARDEN JB, 1963, J BIOL CHEM, V238, P1054; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	54	26	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2480	2485						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989999				2022-12-25	WOS:A1991EV51500071
J	JARVIS, TC; NEWPORT, JW; VONHIPPEL, PH				JARVIS, TC; NEWPORT, JW; VONHIPPEL, PH			STIMULATION OF THE PROCESSIVITY OF THE DNA-POLYMERASE OF BACTERIOPHAGE-T4 BY THE POLYMERASE ACCESSORY PROTEINS - THE ROLE OF ATP HYDROLYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T4 GENE-45 PROTEIN; REPLICATION PROTEINS; BINDING-PROTEIN; 45 PROTEINS; DUPLEX DNA; COMPLEX; TEMPLATES; MECHANISM; SEQUENCES; SYSTEM	In this paper we examine the role of the DNA polymerase accessory proteins in modulating the processivity of DNA synthesis by the bacteriophage T4-coded five protein "holoenzyme" replication complex in vitro. Primed single-stranded DNA was used as a template for the DNA synthesis reactions, and buffer conditions were chosen to mimic in vivo salt concentrations. We find that the accessory proteins significantly increase the DNA-bound lifetime of the holoenzyme complex but that the maximum lifetime of the complex is still less than 10 s at 22-degrees-C. The accessory proteins greatly enhance the processivity of the holoenzyme relative to that of the polymerase alone. ATP hydrolysis catalyzed by the accessory proteins complex is required to achieve this enhancement. We have investigated the temporal relationship between ATP hydrolysis by the accessory proteins and primer elongation by the holoenzyme and find that ATPase activity is required for initial assembly of the holoenzyme complex but not for elongation per se. Thus we conclude that the increased processivity displayed by the holoenzyme in moving through regions of template secondary structure reflects the high intrinsic processivity of the holoenzyme complex itself rather than a requirement for a concomitant ATPase-driven helicase activity during elongation. We have also measured the ATPase activity of the accessory proteins as a function of polymerase concentration and find that the rate of ATP hydrolysis catalyzed by this complex decreases significantly when the accessory proteins are assembled (with polymerase and gene 32 protein) into the five-protein holoenzyme and coupled to primer elongation. Based on these results we discuss mechanisms by which the ATPase activity of the polymerase accessory proteins might stimulate the overall processivity of the holoenzyme.	UNIV OREGON,DEPT CHEM,EUGENE,OR 97403	University of Oregon	JARVIS, TC (corresponding author), UNIV OREGON,INST MOLEC BIOL,EUGENE,OR 97403, USA.			von Hippel, Peter H./0000-0003-2512-8097	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007759, R01GM029158, R37GM015792, R01GM015792] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-15792, GM-29158, GM-07759] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABBOTTS J, 1988, J BIOL CHEM, V263, P15094; ALBERTS B, 1977, NUCLEIC ACID PROTEIN, P31; ALBERTS BM, 1970, NATURE, V227, P1313, DOI 10.1038/2271313a0; ALBERTS BM, 1980, ICN UCLA S MOL CELL, V19, P449; BEDINGER P, 1983, J BIOL CHEM, V258, P9649; BEDINGER P, 1989, J BIOL CHEM, V264, P16880; CHA TA, 1989, J BIOL CHEM, V264, P12220; CHA TA, 1988, CANCER CELL, V6, P1; CHARETTE MF, 1986, NUCLEIC ACIDS RES, V14, P3343, DOI 10.1093/nar/14.8.3343; DOLEJSI MK, 1988, THESIS U OREGON; FAIRFIELD FR, 1983, J BIOMOL STRUCT DYN, V1, P715, DOI 10.1080/07391102.1983.10507477; FORMOSA T, 1983, P NATL ACAD SCI-BIOL, V80, P2442, DOI 10.1073/pnas.80.9.2442; FRIEDEN C, 1979, ANNU REV BIOCHEM, V48, P471, DOI 10.1146/annurev.bi.48.070179.002351; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HILLEBRAND GG, 1985, J BIOL CHEM, V260, P3116; HOCKENSMITH JW, 1987, UCLA S MOL CELL BIOL, V47, P111; HUANG CC, 1981, J BIOL CHEM, V256, P4087; HUBER HE, 1987, J BIOL CHEM, V262, P16224; JARVIS TC, 1990, UCLA SYM BI, V127, P261; JARVIS TC, 1990, J BIOL CHEM, V265, P15160; JARVIS TC, 1989, J BIOL CHEM, V264, P12717; JARVIS TC, 1989, J BIOL CHEM, V264, P12709; JARVIS TC, 1989, THESIS U OREGON; JENSEN DE, 1976, J BIOL CHEM, V251, P7215; KAOHUANG Y, 1977, P NATL ACAD SCI USA, V74, P4228, DOI 10.1073/pnas.74.10.4228; KENNY MK, 1989, P NATL ACAD SCI USA, V86, P9757, DOI 10.1073/pnas.86.24.9757; KUBASEK WL, 1988, THESIS U OREGON; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; LADUCA RJ, 1983, BIOCHEMISTRY-US, V22, P5177, DOI 10.1021/bi00291a018; LINDBERG G, 1989, J BIOL CHEM, V264, P12700; MACE DC, 1984, J MOL BIOL, V177, P313, DOI 10.1016/0022-2836(84)90459-5; MACE DC, 1984, J MOL BIOL, V177, P295, DOI 10.1016/0022-2836(84)90458-3; MACE DC, 1984, J MOL BIOL, V177, P279, DOI 10.1016/0022-2836(84)90457-1; MCHENRY CS, 1988, BIOCHIM BIOPHYS ACTA, V951, P240, DOI 10.1016/0167-4781(88)90092-9; MIZRAHI V, 1985, BIOCHEMISTRY-US, V24, P4010, DOI 10.1021/bi00336a031; MUNN M, 1986, THESIS U CALIFORNIA; NEWPORT JW, 1980, THESIS U OREGON; NEWPORT JW, 1980, MECHANISTIC STUDIES, V19, P485; Nossal N.G., 1983, BACTERIOPHAGE T4, P71; NOSSAL NG, 1979, J BIOL CHEM, V254, P6032; NOSSAL NG, 1983, ANNU REV BIOCHEM, V53, P581; ODONNELL M, 1990, J BIOL CHEM, V265, P1179; PIPERNO JR, 1978, J BIOL CHEM, V253, P5180; PIPERNO JR, 1978, J BIOL CHEM, V253, P5174; RICHARDSON RW, 1990, UCLA SYM BI, V127, P247; ROTH AC, 1982, J BIOL CHEM, V257, P1267; RUSH J, 1989, J BIOL CHEM, V264, P10943; SELICK HE, 1987, DNA REPLICATION RECO, V47, P183; SINHA NK, 1980, J BIOL CHEM, V255, P4290; SPICER EK, 1984, J BIOL CHEM, V259, P5425; SPICER EK, 1988, J BIOL CHEM, V263, P7478; SPICER EK, 1982, J BIOL CHEM, V257, P8972; SPICER EK, 1983, BACTERIOPHAGE T4, P291; TSURIMOTO T, 1990, P NATL ACAD SCI USA, V87, P1023, DOI 10.1073/pnas.87.3.1023; VENKATESAN M, 1982, J BIOL CHEM, V257, P2435; VENKATESAN M, 1982, J BIOL CHEM, V257, P2426; VONHIPPEL PH, 1975, PROTEIN LIGAND INTER, P452; WEAVER DT, 1982, J BIOL CHEM, V257, P2075; YAGER TD, 1987, ESCHERICHIA COLI SAL, P1241; YAGER TD, 1991, IN PRESS BIOCHEMISTR	60	57	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1830	1840						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1988449				2022-12-25	WOS:A1991EU49700072
J	DESVERGNE, B; PETTY, KJ; NIKODEM, VM				DESVERGNE, B; PETTY, KJ; NIKODEM, VM			FUNCTIONAL-CHARACTERIZATION AND RECEPTOR-BINDING STUDIES OF THE MALIC ENZYME THYROID-HORMONE RESPONSE ELEMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE PROMOTER ACTIVITY; EXPRESSION; PROTEIN; TRANSCRIPTION; INDUCTION; SEQUENCE; SITE	We previously showed that the 5'-flanking region of the malic enzyme (ME) gene contains a cis-regulatory element (-281 to -261) that binds thyroid hormone receptors and confers triiodothyronine (T3) inducibility of transcription to the ME promoter (Petty, K. J., Desvergne, B., Mitsuhashi, T., and Nikodem, V. M. (1990) J. Biol. Chem. 265, 7395-7400). In this report, we have used deletion and mutation analyses of the ME thyroid hormone response element (TRE) to evaluate the roles of several subregions of TRE in T3 binding and transactivation. ME TRE was shown to act as an enhancer conferring T3 responsiveness to a heterologous promoter thymidine kinase. Although T3 treatment induced the promoter activity, the absence of hormone resulted in repression as measured by the level of chloramphenicol acetyltransferase expression in the NIH 3T3 transient expression system in the presence of overexpressed receptor. The degree of repression was similar to the degree of T3 induction observed for the same TRE mutants. Mutation and deletion analyses indicated that the functional TRE is comprised of discrete regions that are not contiguous, with a dominant role of a cluster of G residues and an AGGACA sequence. Both functions, induction and repression of transcription, correlated with receptor binding to the ME TRE as determined by competition binding assays using wild type and mutated TRE as competitors.			DESVERGNE, B (corresponding author), NIDDKD,CLIN ENDOCRINOL BRANCH,BETHESDA,MD 20892, USA.		Desvergne, Beatrice/C-8892-2016	Desvergne, Beatrice/0000-0001-5483-288X				BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENT GA, 1989, J BIOL CHEM, V264, P178; BRENT GA, 1989, MOL ENDOCRINOL, V3, P1996, DOI 10.1210/mend-3-12-1996; BURNSIDE J, 1989, J BIOL CHEM, V264, P6886; CARR FE, 1989, MOL ENDOCRINOL, V3, P709, DOI 10.1210/mend-3-4-709; CHATTERJEE VKK, 1989, P NATL ACAD SCI USA, V86, P9114, DOI 10.1073/pnas.86.23.9114; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; DOZIN B, 1985, BIOCHEMISTRY-US, V24, P5581, DOI 10.1021/bi00341a044; DOZIN B, 1986, J BIOL CHEM, V261, P290; FLUG F, 1987, J BIOL CHEM, V262, P6373; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; GLASS CK, 1987, NATURE, V329, P738, DOI 10.1038/329738a0; GRAUPNER G, 1989, NATURE, V340, P653, DOI 10.1038/340653a0; IZUMO S, 1988, NATURE, V334, P539, DOI 10.1038/334539a0; KOENIG RJ, 1987, P NATL ACAD SCI USA, V84, P5670, DOI 10.1073/pnas.84.16.5670; LARSEN PR, 1986, J BIOL CHEM, V261, P4373; LAVIN TN, 1988, J BIOL CHEM, V263, P9418; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MORIOKA H, 1988, MOL CELL BIOL, V8, P3542, DOI 10.1128/MCB.8.8.3542; NORMAN MF, 1989, J BIOL CHEM, V264, P12063; NORTON PA, 1985, MOL CELL BIOL, V5, P281, DOI 10.1128/MCB.5.2.281; PETTY KJ, 1990, J BIOL CHEM, V265, P7395; PETTY KJ, 1989, J BIOL CHEM, V264, P11483; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAP J, 1990, EMBO J, V9, P887, DOI 10.1002/j.1460-2075.1990.tb08186.x; SAP J, 1989, NATURE, V340, P242, DOI 10.1038/340242a0; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; WONDISFORD FE, 1989, J BIOL CHEM, V264, P14601; WONG NCW, 1989, J BIOL CHEM, V264, P4466; YE ZS, 1988, J BIOL CHEM, V263, P7821; ZILZ ND, 1990, J BIOL CHEM, V265, P8136	34	124	125	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1008	1013						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985929				2022-12-25	WOS:A1991ET17700054
J	SAKAIDA, I; THOMAS, AP; FARBER, JL				SAKAIDA, I; THOMAS, AP; FARBER, JL			INCREASES IN CYTOSOLIC CALCIUM-ION CONCENTRATION CAN BE DISSOCIATED FROM THE KILLING OF CULTURED-HEPATOCYTES BY TERT-BUTYL HYDROPEROXIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROSOMAL CA-2+ SEQUESTRATION; PERFUSED RAT-LIVER; FURA-2-LOADED HEPATOCYTES; THIOL DEPLETION; 2ND MESSENGER; STIMULATION; INJURY; OSCILLATIONS; COMPARTMENTATION; MOBILIZATION	Digital imaging fluorescence microscopy was used to study the effect of tert-butyl hydroperoxide (TBHP) on the cytosolic free calcium concentration ([Ca2+]i) of single rat hepatocytes in primary culture. Within minutes of the addition of TBHP, individual hepatocytes displayed one or more peaks of increased [Ca2+]i that promptly returned to the prestimulation level. This was followed by a slower increase of [Ca2+]i that reached a plateau of 696 +/- 260 nM (basal 194 +/- nM) after 20 min. Another rise in [Ca2+]i, abrupt and much larger, preceded the death of the cells after about 45 min. Pretreatment of the hepatocytes with deferoxamine, a ferric iron chelator, or the addition of the antioxidants N,N'-diphenyl-p-phenylenediamine or catechol prevented the loss of viability. Neither the number of hepatocytes displaying the initial [Ca2+]i transients nor the magnitude of these oscillations was affected by deferoxamine, N,N'-diphenyl-p-phenyl-enediamine, or catechol. However, both the plateau phase and the abrupt rise in [Ca2+]i were prevented. Treatment of the hepatocytes with TBHP in a low calcium buffer (< 2-mu-M Ca2+) reduced or abolished the initial [Ca2+]i transients and eliminated both the plateau phase and abrupt rise in [Ca2+]i. The onset of cell death was delayed by 10 min in the low calcium medium. Addition of 3.5 mM EGTA to the cultures lowered the basal calcium concentration, prevented both the initial [Ca2+]i spikes and the delayed changes, and further prolonged the onset of cell death. These data indicate that the killing of the cultured hepatocytes by TBHP can be dissociated from changes in intracellular calcium homeostasis. An influx of extracellular Ca2+ ions may aggravate somewhat the mechanisms of cell injury by an oxidative stress and accelerate the time of onset of cell death.	THOMAS JEFFERSON UNIV,DEPT PATHOL & CELL BIOL,PHILADELPHIA,PA 19104	Jefferson University			Thomas, Andrew/C-6755-2013	Thomas, Andrew/0000-0002-9026-7467	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK038422, R01DK038422, R01DK038305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA007186] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA 07186] Funding Source: Medline; NIDDK NIH HHS [DK 38422, DK 38305] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BELLOMO G, 1985, HEPATOLOGY, V5, P876, DOI 10.1002/hep.1840050529; BELLOMO G, 1984, FEBS LETT, V168, P38, DOI 10.1016/0014-5793(84)80202-1; BELLOMO G, 1982, P NATL ACAD SCI-BIOL, V79, P6842, DOI 10.1073/pnas.79.22.6842; BELLOMO G, 1984, EUR J BIOCHEM, V144, P19, DOI 10.1111/j.1432-1033.1984.tb08425.x; BLACKMORE PF, 1984, J BIOL CHEM, V259, P2322; BURGESS GM, 1984, NATURE, V309, P63, DOI 10.1038/309063a0; DEWITT LM, 1983, J PHYSIOL-LONDON, V346, P395; DIMONTE D, 1984, ARCH BIOCHEM BIOPHYS, V267, P640; EXTON JH, 1988, FASEB J, V2, P2670, DOI 10.1096/fasebj.2.11.2456243; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; JONES DP, 1983, J BIOL CHEM, V258, P6390; JOSEPH SK, 1985, J BIOL CHEM, V260, P2508; JOSEPH SK, 1984, J BIOL CHEM, V259, P3077; KASS GEN, 1989, J BIOL CHEM, V264, P15192; KAWANISHI T, 1989, J BIOL CHEM, V264, P12859; KYLE ME, 1989, BIOCHEM PHARMACOL, V38, P3797, DOI 10.1016/0006-2952(89)90588-1; MASAKI N, 1989, ARCH BIOCHEM BIOPHYS, V269, P390, DOI 10.1016/0003-9861(89)90122-7; MOORE GA, 1987, FEBS LETT, V224, P331, DOI 10.1016/0014-5793(87)80479-9; MOORE M, 1985, J BIOL CHEM, V260, P3035; NICOTERA P, 1986, J BIOL CHEM, V261, P4628; ORRENIUS S, 1986, KLIN WOCHENSCHR, V64, P138; ROONEY TA, 1989, J BIOL CHEM, V264, P17131; RUSH GF, 1986, TOXICOL APPL PHARM, V85, P324, DOI 10.1016/0041-008X(86)90339-X; RUSH GF, 1986, TOXICOL APPL PHARM, V84, P607, DOI 10.1016/0041-008X(86)90267-X; RUSH GF, 1985, TOXICOL APPL PHARM, V78, P473, DOI 10.1016/0041-008X(85)90255-8; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; SIES H, 1975, EUR J BIOCHEM, V57, P503, DOI 10.1111/j.1432-1033.1975.tb02325.x; SIES H, 1972, FEBS LETT, V27, P171, DOI 10.1016/0014-5793(72)80434-4; SMITH MT, 1985, TOXICOL APPL PHARM, V81, P213, DOI 10.1016/0041-008X(85)90157-7; SPAT A, 1986, NATURE, V319, P514, DOI 10.1038/319514a0; STARKE PE, 1986, J BIOL CHEM, V261, P3006; WILLIAMSON JR, 1985, AM J PHYSIOL, V248, pC203, DOI 10.1152/ajpcell.1985.248.3.C203; WOODS NM, 1987, CELL CALCIUM, V8, P79, DOI 10.1016/0143-4160(87)90038-8; WOODS NM, 1986, NATURE, V329, P719	34	95	95	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					717	722						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985959				2022-12-25	WOS:A1991ET17700009
J	SPANGLER, R; BAILEY, SC; SYTKOWSKI, AJ				SPANGLER, R; BAILEY, SC; SYTKOWSKI, AJ			ERYTHROPOIETIN INCREASES C-MYC MESSENGER-RNA BY A PROTEIN-KINASE C-DEPENDENT PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							MOUSE ERYTHROLEUKEMIA-CELLS; GENE-EXPRESSION; POTENT INHIBITOR; DOWN-REGULATION; PHORBOL ESTERS; GROWTH-HORMONE; DIFFERENTIATION; PHOSPHORYLATION; STAUROSPORINE; SPHINGOSINE	The peptide hormone erythropoietin is a major regulator of red blood cell production. While red blood cell development has been studied intensively, little is known about the intracellular signaling events that follow the binding of erythropoietin to its receptor on the target cell. We report here that erythropoietin-induced activation of the immediate early gene c-myc requires protein kinase C and that the binding of erythropoietin causes rapid phosphorylation of the major protein kinase C substrate, p80. Our results also argue for modulation of activity of a second signal transduction element in addition to protein kinase C.	NEW ENGLAND DEACONESS HOSP, DIV HEMATOL & ONCOL, CELL & MOLEC BIOL LAB, BOSTON, MA 02215 USA; HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02215 USA	Harvard University; Harvard Medical School					NIDDK NIH HHS [R01 DK 38841] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038841] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALBERT KA, 1986, P NATL ACAD SCI USA, V83, P2822, DOI 10.1073/pnas.83.9.2822; BLACKSHEAR PJ, 1989, CLIN RES, V37, P554; BLACKSHEAR PJ, 1986, J BIOL CHEM, V261, P1459; CASTLE S, 1985, BIOCHEM BIOPH RES CO, V132, P688, DOI 10.1016/0006-291X(85)91187-8; CHENG GH, 1989, MOL CELL BIOL, V9, P2332, DOI 10.1128/MCB.9.6.2332; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; de Both N J, 1978, Nature, V272, P626, DOI 10.1038/272626a0; DMITROVSKY E, 1986, NATURE, V322, P748, DOI 10.1038/322748a0; DOGLIO A, 1989, P NATL ACAD SCI USA, V86, P1148, DOI 10.1073/pnas.86.4.1148; FAN XD, 1988, P NATL ACAD SCI USA, V85, P5122, DOI 10.1073/pnas.85.14.5122; FAUCHER M, 1988, J BIOL CHEM, V263, P5319; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GHOSH TK, 1990, SCIENCE, V248, P1653, DOI 10.1126/science.2163543; GODSON C, 1990, J BIOL CHEM, V265, P8369; HANNUN YA, 1986, J BIOL CHEM, V261, P2604; HATCH CL, 1987, ANAL BIOCHEM, V162, P283, DOI 10.1016/0003-2697(87)90038-8; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HUANG FL, 1989, J BIOL CHEM, V264, P4238; JENIS DM, 1989, INT J CELL CLONING, V7, P190, DOI 10.1002/stem.5530070306; KIKKAWA U, 1989, ANNU REV BIOCHEM, V58, P31, DOI 10.1146/annurev.bi.58.070189.000335; LACHMAN HM, 1984, NATURE, V310, P592, DOI 10.1038/310592a0; LOOMIS CR, 1988, J BIOL CHEM, V263, P1682; MARY D, 1989, J BIOL CHEM, V264, P14498; MELLONI E, 1990, P NATL ACAD SCI USA, V87, P4417, DOI 10.1073/pnas.87.12.4417; NARINDRASORASAK S, 1987, J BIOL CHEM, V262, P10497; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; OLASHAW NE, 1988, ADV SEC MESS PHOSPH, V22, P139; PROCHOWNIK EV, 1986, NATURE, V322, P848, DOI 10.1038/322848a0; RAMSAY RG, 1986, P NATL ACAD SCI USA, V83, P6849, DOI 10.1073/pnas.83.18.6849; ROSS EM, 1980, ANNU REV BIOCHEM, V49, P553, DOI 10.1146/annurev.bi.49.070180.002533; ROZENGURT E, 1983, P NATL ACAD SCI-BIOL, V80, P7244, DOI 10.1073/pnas.80.23.7244; SEHGAL PB, 1987, P NATL ACAD SCI USA, V84, P3663, DOI 10.1073/pnas.84.11.3663; SHENONG GLC, 1982, CELL, V31, P443, DOI 10.1016/0092-8674(82)90137-4; SIMEK SL, 1989, P NATL ACAD SCI USA, V86, P7410, DOI 10.1073/pnas.86.19.7410; SMAL J, 1989, P NATL ACAD SCI USA, V86, P4705, DOI 10.1073/pnas.86.12.4705; SPANGLER R, 1989, P NATL ACAD SCI USA, V86, P7017, DOI 10.1073/pnas.86.18.7017; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; TODOKORO K, 1988, P NATL ACAD SCI USA, V85, P8900, DOI 10.1073/pnas.85.23.8900; VEGESNA RVK, 1988, MOL PHARMACOL, V33, P537; WINKLER JD, 1988, BIOCHEM BIOPH RES CO, V157, P521, DOI 10.1016/S0006-291X(88)80280-8; YUMOTO Y, 1990, J CELL PHYSIOL, V143, P243, DOI 10.1002/jcp.1041430207; ZHANG H, 1990, J BIOL CHEM, V265, P76	42	64	70	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					681	684						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985955				2022-12-25	WOS:A1991ET17700002
J	WU, LNY; GENGE, BR; WUTHIER, RE				WU, LNY; GENGE, BR; WUTHIER, RE			ASSOCIATION BETWEEN PROTEOGLYCANS AND MATRIX VESICLES IN THE EXTRACELLULAR-MATRIX OF GROWTH PLATE CARTILAGE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE NASAL CARTILAGE; LINK PROTEIN; EPIPHYSEAL CARTILAGE; HYALURONIC-ACID; MEDIATED MINERALIZATION; FREEZE SUBSTITUTION; COLLAGEN; CALCIUM; CHONDROCYTES; AGGREGATION	Matrix vesicles (MV) are microstructures localized to the extracellular matrix of developing hard tissues that induce mineral formation. MV proteins are not well characterized, and little is known of how they interact with the surrounding matrix. However, recent electron microscopic studies indicate that MV interact with matrix proteins in growth plate cartilage. In the studies now reported, procedures developed for dissecting various components from isolated MV led to the discovery that two major vesicle proteins (38 and 46 kDa) are readily released from MV by low ionic strength solutions. These low ionic strength-soluble proteins (LISSP) were shown to be major fragments of the link protein (LP) and hyaluronic acid-binding region (HABR) of matrix proteoglycans: they react immunologically with highly specific monoclonal antibodies to LP and HABR, and the NH2-terminal sequence of the 38-kDa LISSP is essentially identical to residues 40-78 of chicken cartilage LP and that the 46-kDa LISSP represents HABR. Release of both LISSP is enhanced by hyaluronidase treatment, indicating anchorage by a hyaluronate-mediated mechanism. Both LP and HABR are firmly attached to MV in either isotonic or hypertonic solutions. In contrast, our other studies show that dissociation of type II collagen from MV occurs only with hypertonic salts which do not release the LISSP. Thus, strong interactions occur under physiological conditions between MV and both the proteoglycans and collagens, but these take place by different mechanisms.	UNIV S CAROLINA,DEPT CHEM,BIOMINERALIZAT RES LAB,COLUMBIA,SC 29208	University of South Carolina; University of South Carolina System; University of South Carolina Columbia					NIAMS NIH HHS [AR18983] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR018983] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALI SY, 1970, P NATL ACAD SCI USA, V67, P1513, DOI 10.1073/pnas.67.3.1513; ANDERSON HC, 1969, J CELL BIOL, V41, P59, DOI 10.1083/jcb.41.1.59; ARSENAULT AL, 1988, J ULTRA MOL STRUCT R, V98, P32, DOI 10.1016/S0889-1605(88)80932-7; BAKER JR, 1979, J BIOL CHEM, V254, P2387; BAKER JR, 1987, METHOD ENZYMOL, V144, P401; CATERSON B, 1985, J BIOL CHEM, V260, P1348; CHANDRASEKHAR S, 1983, J BIOL CHEM, V258, P6226; DEAK F, 1986, P NATL ACAD SCI USA, V83, P3766, DOI 10.1073/pnas.83.11.3766; Eyre D, 1987, STRUCTURE FUNCTION C, P261; GENGE BR, 1989, J BIOL CHEM, V264, P10917; GENGE BR, 1988, J BIOL CHEM, V263, P18513; HALE JE, 1987, J BIOL CHEM, V262, P1916; HARDINGHAM TE, 1974, BIOCHEM J, V139, P565, DOI 10.1042/bj1390565; HARDINGHAM TE, 1972, BIOCHIM BIOPHYS ACTA, V279, P401, DOI 10.1016/0304-4165(72)90160-2; HASCALL VC, 1982, METHOD ENZYMOL, V82, P769; HASCALL VC, 1988, ISI ATLAS-BIOCHEM, V1, P189; HASCALL VC, 1974, J BIOL CHEM, V249, P4232; HEINEGARD D, 1987, METHOD ENZYMOL, V144, P305; HEINEGARD D, 1989, FASEB J, V3, P2042, DOI 10.1096/fasebj.3.9.2663581; HEINEGARD D, 1987, METHOD ENZYMOL, V145, P336; HEINEGARD D, 1974, J BIOL CHEM, V249, P4250; HOSOKAWA R, 1988, J BIOL CHEM, V263, P10045; HUNTER GK, 1987, CONNECT TISSUE RES, V16, P111, DOI 10.3109/03008208709001999; HUNZIKER EB, 1984, J CELL BIOL, V98, P267, DOI 10.1083/jcb.98.1.267; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDIS WJ, 1990, ANAT REC, V226, P153, DOI 10.1002/ar.1092260205; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; NEAME PJ, 1987, J BIOL CHEM, V262, P17768; POOLE AR, 1989, ANAT REC, V224, P167; REGISTER TC, 1984, J BIOL CHEM, V259, P922; SAJDERA S, 1969, J BIOL CHEM, V244, P77; SCHMID TM, 1984, J ULTRA MOL STRUCT R, V86, P186, DOI 10.1016/S0022-5320(84)80057-X; SCHMID TM, 1985, J CELL BIOL, V100, P598, DOI 10.1083/jcb.100.2.598; SOMMARIN Y, 1983, BIOCHEM J, V214, P777, DOI 10.1042/bj2140777; TAKAGI M, 1989, J HISTOCHEM CYTOCHEM, V37, P1025, DOI 10.1177/37.7.2659660; TANG LH, 1979, J BIOL CHEM, V254, P523; TENGBLAD A, 1981, BIOCHEM J, V199, P297, DOI 10.1042/bj1990297; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Van der Rest M, 1987, STRUCTURE FUNCTION C, P195; VAUGHAN L, 1988, J CELL BIOL, V106, P991, DOI 10.1083/jcb.106.3.991; WATKINS EL, 1980, BIOCHIM BIOPHYS ACTA, V631, P289, DOI 10.1016/0304-4165(80)90303-7; WU LNY, 1989, J BIOL CHEM, V264, P21346; WU LNY, 1991, J BIOL CHEM, V266, P1195; Wuthier R.E., 1985, CHEM BIOL MINERALIZE, P113; WUTHIER RE, 1977, CALC TISS RES, V23, P125, DOI 10.1007/BF02012777; WUTHIER RE, 1988, ISI ATLAS-BIOCHEM, V1, P231; WUTHIER RE, 1985, J BIOL CHEM, V260, P5972	48	44	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1187	1194						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985942				2022-12-25	WOS:A1991ET17700079
J	PATEJUNAS, G; YOUNG, AP				PATEJUNAS, G; YOUNG, AP			CONSTITUTIVE AND GLUCOCORTICOID-MEDIATED ACTIVATION OF GLUTAMINE-SYNTHETASE GENE-EXPRESSION IN THE DEVELOPING CHICKEN RETINA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									OHIO STATE UNIV,CTR BIOTECHNOL,207 RIGHTMIRE HALL,1060 CARMACK RD,COLUMBUS,OH 43210; OHIO STATE UNIV,COLL PHARM,DIV PHARMACOL,COLUMBUS,OH 43210; UNIV ILLINOIS,DEPT CHEM,CHICAGO,IL 60680	Ohio State University; Ohio State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital					NEI NIH HHS [EY05063] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY005063] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		CHEUNG A, 1987, J ENDOCRINOL, V113, P159, DOI 10.1677/joe.0.1130159; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COX KH, 1984, DEV BIOL, V101, P485, DOI 10.1016/0012-1606(84)90162-3; FALDUTO MT, 1989, FASEB J, V3, P2623, DOI 10.1096/fasebj.3.14.2574120; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; KLEIN ES, 1987, J BIOL CHEM, V262, P520; LAMERS WH, 1982, P NATL ACAD SCI-BIOL, V79, P5137, DOI 10.1073/pnas.79.17.5137; LINSER P, 1979, P NATL ACAD SCI USA, V76, P6476, DOI 10.1073/pnas.76.12.6476; MAGNUSON SR, 1988, DEV BIOL, V130, P536, DOI 10.1016/0012-1606(88)90348-X; Maniatis T., 1982, MOL CLONING; MARIE C, 1981, J ENDOCRINOL, V90, P193, DOI 10.1677/joe.0.0900193; MAX SR, 1987, ENDOCRINOLOGY, V120, P1179, DOI 10.1210/endo-120-3-1179; MOGUILEWSKY M, 1984, J STEROID BIOCHEM, V20, P271, DOI 10.1016/0022-4731(84)90216-4; MOSCONA AA, 1963, DEV BIOL, V7, P192, DOI 10.1016/0012-1606(63)90117-9; MOSCONA AA, 1970, BIOCHEM BIOPH RES CO, V39, P943, DOI 10.1016/0006-291X(70)90415-8; MOSCONA AA, 1980, GLUTAMINE METABOLISM, P299; MOSCONA AA, 1972, FED EUR BIOCHEM SOC, V24, P1; MOSCONA M, 1979, DIFFERENTIATION, V13, P165, DOI 10.1111/j.1432-0436.1979.tb01579.x; OKRET S, 1986, P NATL ACAD SCI USA, V83, P5899, DOI 10.1073/pnas.83.16.5899; PATEJUNAS G, 1987, J CELL BIOCHEM, V35, P205, DOI 10.1002/jcb.240350304; PATEJUNAS G, 1987, MOL CELL BIOL, V7, P1070, DOI 10.1128/MCB.7.3.1070; PATEJUNAS G, 1989, THESIS U ILLINOIS CH; PIDDINGTON R, 1970, J EMBRYOL EXP MORPH, V23, P729; PIDDINGTON R, 1967, BIOCHIM BIOPHYS ACTA, V141, P429, DOI 10.1016/0304-4165(67)90120-1; PU HF, 1990, GENE, V89, P259, DOI 10.1016/0378-1119(90)90014-I; PU HF, 1989, GENE, V81, P169, DOI 10.1016/0378-1119(89)90348-X; REIFLEHRER L, 1974, J CELL BIOL, V63, P312, DOI 10.1083/jcb.63.1.312; REIFLEHRER L, 1968, BIOCHEM BIOPH RES CO, V33, P984, DOI 10.1016/0006-291X(68)90410-5; ROSEWICZ S, 1988, J BIOL CHEM, V263, P2581; SCHWARTZ RJ, 1973, J BIOL CHEM, V248, P6426; SIEGEL HS, 1976, DEV BIOL, V50, P510, DOI 10.1016/0012-1606(76)90169-X; SOH BM, 1978, DEV BIOL, V64, P316, DOI 10.1016/0012-1606(78)90081-7; VANNICE JL, 1984, P NATL ACAD SCI-BIOL, V81, P4241, DOI 10.1073/pnas.81.14.4241; VARDIMON L, 1988, P NATL ACAD SCI USA, V85, P5981, DOI 10.1073/pnas.85.16.5981; VARDIMON L, 1986, P NATL ACAD SCI USA, V83, P9060, DOI 10.1073/pnas.83.23.9060; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209	36	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1990	265	25					15280	15285						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX400	1975588				2022-12-25	WOS:A1990DX40000091
J	LEE, RT; ICHIKAWA, Y; FAY, M; DRICKAMER, K; SHAO, MC; LEE, YC				LEE, RT; ICHIKAWA, Y; FAY, M; DRICKAMER, K; SHAO, MC; LEE, YC			LIGAND-BINDING CHARACTERISTICS OF RAT SERUM-TYPE MANNOSE-BINDING PROTEIN (MBP-A) - HOMOLOGY OF BINDING-SITE ARCHITECTURE WITH MAMMALIAN AND CHICKEN HEPATIC LECTINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLGALACTOSAMINE-SPECIFIC LECTIN; CARBOHYDRATE-RECOGNITION DOMAINS; REDUCTIVE AMINATION; LIVER; GLYCOPROTEINS; 1-THIOGLYCOSIDES; NEOGLYCOPROTEINS; OLIGOSACCHARIDES; GLYCOPEPTIDES; HEPATOCYTES	Sugar-binding characteristics of rat serum mannose-binding protein (MBP) were studied using the carbohydrate-recognition domain of this protein expressed from a cloned cDNA. To assess the binding affinity of various test compounds, they were added as inhibitors in a binding assay in which I-125-MBP was incubated with yeast cells and the extent of binding was estimated from the radioactivity associated with the pelleted cells. The results of such inhibition assays suggest that MBP has a small binding site which is probably of the trough-type. The 3- and 4-OH of the target sugar are indispensable, while the 6-OH is not required. These characteristics are shared by the rat hepatic lectin and chicken hepatic lectin, both of which are C-type lectins containing carbohydrate-recognition domains highly homologous to that of MBP. Apparently, the related primary structures of these lectins give rise to similar gross architecture of their binding sites, despite the fact that each exhibits different sugar binding specificities.	JOHNS HOPKINS UNIV,MCCOLLUM PRATT INST,BALTIMORE,MD 21218; COLUMBIA UNIV,DEPT BIOCHEM & MOLEC BIOPHYS,NEW YORK,NY 10032; SHANGHAI MED UNIV,SHANGHAI,PEOPLES R CHINA	Johns Hopkins University; Columbia University; Fudan University	LEE, RT (corresponding author), JOHNS HOPKINS UNIV,DEPT BIOL,BALTIMORE,MD 21218, USA.				NIDDK NIH HHS [DK09970] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK009970, R01DK009970] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASHWELL G, 1974, ADV ENZYMOL RAMB, V41, P99; BECKER JW, 1976, NATURE, V259, P406, DOI 10.1038/259406a0; CHEN LM, 1988, FASEB J, V2, P2819, DOI 10.1096/fasebj.2.12.3410198; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; DRICKAMER K, 1986, J BIOL CHEM, V261, P6878; DRICKAMER K, 1988, BIOCHEM SOC T, V17, P13; FUHLENDORFF J, 1987, BIOCHEMISTRY-US, V26, P6757, DOI 10.1021/bi00395a027; GIGA Y, 1987, J BIOL CHEM, V262, P6197; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; HALBERG DF, 1987, J BIOL CHEM, V262, P9828; HICKMAN S, 1972, J BIOL CHEM, V247, P2156; ICHIKAWA Y, 1990, J CARBOHYD CHEM, V9, P707, DOI 10.1080/07328309008543865; ICHIKAWA Y, 1990, GLYCOCONJUGATE J, V7, P335, DOI 10.1007/BF01073377; KAWASAKI N, 1989, J BIOCHEM-TOKYO, V106, P483, DOI 10.1093/oxfordjournals.jbchem.a122878; KAWASAKI T, 1987, VERTEBRATE LECTINS, P92; KUHLENSCHMIDT TB, 1984, BIOCHEMISTRY-US, V23, P3569, DOI 10.1021/bi00311a001; KUHLMAN M, 1989, J EXP MED, V169, P1733, DOI 10.1084/jem.169.5.1733; LEE RT, 1989, BIOCHEMISTRY-US, V28, P1856, DOI 10.1021/bi00430a064; LEE RT, 1990, J BIOL CHEM, V265, P7864; LEE RT, 1979, CARBOHYD RES, V77, P149, DOI 10.1016/S0008-6215(00)83801-X; LEE RT, 1980, BIOCHEMISTRY-US, V19, P156, DOI 10.1021/bi00542a024; LEE RT, 1974, CARBOHYD RES, V37, P193, DOI 10.1016/S0008-6215(00)87074-3; LEE RT, 1982, BIOCHEMISTRY-US, V21, P6292, DOI 10.1021/bi00267a039; LEE RT, 1989, BIOCHEMISTRY-US, V28, P8351, DOI 10.1021/bi00447a013; LEE YC, 1976, BIOCHEMISTRY-US, V15, P3956, DOI 10.1021/bi00663a008; LEE YC, 1965, BIOCHEMISTRY-US, V4, P257, DOI 10.1021/bi00878a013; LEE YC, 1982, GLYCOCONJUGATES, V4, P57; LEMIEUX RU, 1989, CHEM SOC REV, V18, P347, DOI 10.1039/cs9891800347; LOEB JA, 1987, J BIOL CHEM, V262, P3022; MIZUNO Y, 1981, J BIOL CHEM, V256, P4247; OHTA M, 1990, J BIOL CHEM, V265, P1980; OKA S, 1988, ARCH BIOCHEM BIOPHYS, V260, P257, DOI 10.1016/0003-9861(88)90448-1; Porath J, 1976, Methods Enzymol, V44, P19; SCHNEIDEMANN J, 1975, CARBOHYD RES, V39, P156, DOI 10.1016/S0008-6215(00)82650-6; STOWELL CP, 1980, BIOCHEMISTRY-US, V19, P4904, DOI 10.1021/bi00562a031; SUZUKI T, 1990, J BIOL CHEM, V265, P1274; TAYLOR ME, 1987, BIOCHIM BIOPHYS ACTA, V915, P60, DOI 10.1016/0167-4838(87)90125-7; TOWNSEND R, 1981, BIOCHEM J, V194, P209, DOI 10.1042/bj1940209; WEIGEL PH, 1979, CARBOHYD RES, V70, P83, DOI 10.1016/S0008-6215(00)83272-3; WONG TC, 1987, CARBOHYD RES, V170, P27, DOI 10.1016/0008-6215(87)85003-6	40	134	135	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4810	4815						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002028				2022-12-25	WOS:A1991FC21700024
J	OKAMURAIKEDA, K; FUJIWARA, K; YAMAMOTO, M; HIRAGA, K; MOTOKAWA, Y				OKAMURAIKEDA, K; FUJIWARA, K; YAMAMOTO, M; HIRAGA, K; MOTOKAWA, Y			ISOLATION AND SEQUENCE DETERMINATION OF CDNA-ENCODING T-PROTEIN OF THE GLYCINE CLEAVAGE SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SEQUENCE; CHICKEN LIVER; H-PROTEIN; P-PROTEIN; PURIFICATION; MECHANISM; SYNTHASE; COMPONENT; SERINE; CODON	T-protein is a component of the glycine cleavage system and catalyzes the tetrahydrofolate-dependent reaction. A partial cDNA for chicken T-protein was isolated by screening a chicken liver cDNA library with oligonucleotide probes based on amino acid sequences. The clone (CT5C) contains a 675-base pair insert encoding the C-terminal half of the T-protein. Screening of a bovine liver lambda-gt10 cDNA library with the insert of CT5C as a probe detected a clone, BT5A, with an insert of about 2 kilobase pairs. The 1191-base pair coding region encodes a precursor protein of 397 amino acids (M(r) 42,852) comprised of a 22-residue mitochondrial targeting sequence and a 375-residue mature protein (M(r) 40,534). The 33 amino acids immediately following the targeting sequence correspond exactly to those determined by sequence analysis of the amino terminus of the purified bovine T-protein. The mature protein contains several hydrophilic segments with a cluster of arginine and lysine. The T-protein cDNA probe hybridized to an mRNA species of about 2 kilobases in bovine brain, lung, heart, and liver. A probe for H-protein hybridized with two species of mRNA in these tissues and weak signals were also found in spleen. Although the enzymatic activities of T-protein and H-protein were found in these tissues where transcripts were found, activity of P-protein was detected only in liver and brain. Southern blot analysis of genomic DNA suggested that T-protein is a single copy gene.	TOYAMA MED & PHARMACEUT UNIV,SCH MED,DEPT BIOCHEM,SUGITANI,TOYAMA 93001,JAPAN	University of Toyama	OKAMURAIKEDA, K (corresponding author), UNIV TOKUSHIMA,INST ENZYME RES,TOKUSHIMA 770,JAPAN.		Yamamoto, Masayuki/A-4873-2010	Yamamoto, Masayuki/0000-0002-9073-9436				BELANGER C, 1989, J BIOL CHEM, V264, P4837; BLAKLEY RL, 1984, FOLATES PTERINS, V1, P207; DUBY A, 1987, CURRENT PROTOCOLS MO; ELWOOD PC, 1989, J BIOL CHEM, V264, P14893; FUJIWARA K, 1979, ARCH BIOCHEM BIOPHYS, V197, P454, DOI 10.1016/0003-9861(79)90267-4; FUJIWARA K, 1987, BIOCHEM BIOPH RES CO, V149, P621, DOI 10.1016/0006-291X(87)90413-X; FUJIWARA K, 1986, J BIOL CHEM, V261, P8836; FUJIWARA K, 1990, J BIOL CHEM, V265, P17463; FUJIWARA K, 1984, J BIOL CHEM, V259, P664; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GIRVITZ SC, 1980, ANAL BIOCHEM, V106, P492, DOI 10.1016/0003-2697(80)90553-9; GORNALL AG, 1949, J BIOL CHEM, V177, P751; HANAHAN D, 1985, DNA CLONING PRACTICA, V1, P121; HARDY LW, 1987, SCIENCE, V235, P448, DOI 10.1126/science.3099389; HAYASAKA K, 1983, PEDIATR RES, V17, P967, DOI 10.1203/00006450-198312000-00008; HIRAGA K, 1980, J BIOL CHEM, V255, P1664; JENNINGS I, 1990, J BIOL CHEM, V265, P1885; KINGSTON RE, 1987, CURRENT PROTOCOLS MO; KOCHI H, 1974, J BIOCHEM, V75, P1113, DOI 10.1093/oxfordjournals.jbchem.a130483; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Maniatis T., 1982, MOL CLONING; MARTINI F, 1989, J BIOL CHEM, V264, P8509; OHTSUKA E, 1985, J BIOL CHEM, V260, P2605; OKAMURAIKEDA K, 1987, J BIOL CHEM, V262, P6746; OKAMURAIKEDA K, 1982, J BIOL CHEM, V257, P135; ROISE D, 1988, J BIOL CHEM, V263, P4509; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SELDEN RF, 1987, CURRENT PROTOCOLS MO; SHANNON KW, 1988, J BIOL CHEM, V263, P7717; Strauss WM, 1987, CURRENT PROTOCOLS MO, P631; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; YAMAMOTO M, 1988, J BIOL CHEM, V263, P15973; YOSHIDA T, 1973, J BIOCHEM-TOKYO, V73, P1013, DOI 10.1093/oxfordjournals.jbchem.a130155	34	24	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4917	4921						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002038				2022-12-25	WOS:A1991FC21700039
J	SIEGMUND, HU; KAUFMAN, S				SIEGMUND, HU; KAUFMAN, S			HYDROXYLATION OF 4-METHYLPHENYLALANINE BY RAT-LIVER PHENYLALANINE-HYDROXYLASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATION; CHROMATOGRAPHY; PURIFICATION; LYSOLECITHIN; SUBSTRATE; INVIVO	Rat liver phenylalanine hydroxylase that has been activated with lysolecithin catalyzes the hydroxylation of 4-methylphenylalanine in the presence of a pterin cofactor. Two products, 4-hydroxymethylphenylalanine and 3-methyltyrosine, can be detected. The total amount of amino acids hydroxylated is equal to the amount of tetrahydropterin oxidized. Isotopic labeling studies with (O2)-O-18 and (H2O)-O-18 show that the hydroxyl groups of both products are derived from molecular oxygen and not from water. Results obtained with H-2-labeled substrates support the conclusion that these products are formed via different mechanistic pathways. Our previous investigations on substrate analogs, as well as the present results, indicate that a highly reactive oxygen-containing intermediate, such as an enzyme-bound iron-oxo compound, must be the hydroxylating species. Our present results could stimulate further discussion of the possibility that the reaction mechanism for the "NIH-shift" of the methyl group may not involve the spontaneous opening of an epoxide intermediate.	NIMH, NEUROCHEM LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)								ABITA JP, 1984, J BIOL CHEM, V259, P4560; COLBERT JE, 1990, J AM CHEM SOC, V112, P3993, DOI 10.1021/ja00166a041; CRAINE JE, 1972, J BIOL CHEM, V247, P6082; DALY J, 1968, ARCH BIOCHEM BIOPHYS, V125, P136, DOI 10.1016/0003-9861(68)90647-4; DAVIS MD, 1989, J BIOL CHEM, V264, P8585; FISHER DB, 1973, J BIOL CHEM, V248, P4345; FISHER DB, 1973, J BIOL CHEM, V248, P4300; GUROFF G, 1966, BIOCHEM BIOPH RES CO, V25, P622, DOI 10.1016/0006-291X(66)90500-6; GUROFF G, 1967, SCIENCE, V157, P1524, DOI 10.1126/science.157.3796.1524; HARADA N, 1984, J BIOL CHEM, V259, P3005; KANG SK, 1985, SYNTHESIS-STUTTGART, P1161; KATOPODIS AG, 1984, J AM CHEM SOC, V106, P7928, DOI 10.1021/ja00337a049; KAUBISCH N, 1972, BIOCHEMISTRY-US, V11, P3080, DOI 10.1021/bi00766a022; KAUFMAN S, 1982, J BIOL CHEM, V257, P4667; KAUFMAN S, 1987, METHOD ENZYMOL, V142, P3; KAUFMAN S, 1959, J BIOL CHEM, V234, P2683; KAUFMAN S, 1962, BIOCHEM BIOPH RES CO, V9, P497, DOI 10.1016/0006-291X(62)90115-8; KAUFMAN S, 1987, ENZYMES B, V18, P217; LEHMANN WD, 1986, ARCH BIOCHEM BIOPHYS, V250, P180, DOI 10.1016/0003-9861(86)90715-0; LEWIS TR, 1951, J AM CHEM SOC, V73, P2109, DOI 10.1021/ja01149a059; METZGER H, 1959, METHOD ORGAN CHEM, V1, P332; MILLER RJ, 1988, BIOCHEMISTRY-US, V27, P3658, DOI 10.1021/bi00410a021; ODONNELL MJ, 1984, SYNTHESIS-STUTTGART, P313; PELLIZZA.ED, 1971, ANAL BIOCHEM, V44, P312, DOI 10.1016/0003-2697(71)90377-0; PHILLIPS RS, 1984, J BIOL CHEM, V259, P2474; SHIMAN R, 1979, J BIOL CHEM, V254, P1300; SHIMAN R, 1982, J BIOL CHEM, V257, P839; UDENFRIEND S, 1952, J BIOL CHEM, V196, P227; WALSH C, 1979, ENZYMATIC REACTION M, P120	29	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2903	2910						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993664				2022-12-25	WOS:A1991EX60000039
J	DONOVAN, MA; LAUE, TM				DONOVAN, MA; LAUE, TM			A NOVEL TRYPSIN-INHIBITOR FROM THE HEMOLYMPH OF THE HORSESHOE-CRAB LIMULUS-POLYPHEMUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SEQUENCE; S-AMINOETHYLATED PROTEIN; ULTRA-CENTRIFUGE; BLOOD; VENOM	Trypsin inhibitory activity from the hemolymph of Limulus polyphemus was found to co-purify with coagulogen (the clottable protein in blood coagulation) after acidification, ammonium sulfate precipitation, and gel filtration. Limulus trypsin inhibitor (LTI) was separated from coagulogen by ion-exchange chromatography on carboxymethyl-Sephadex. LTI is an inhibitor of trypsin (K(i) = 3.3 nM) on both high and low molecular weight substrates. It also inhibits chymotrypsin but has little or no effect on thrombin, thermolysin, pepsin, or papain, nor does LTI inhibit the proteolytic cascade produced in endotoxin-stimulated Limulus amoebocyte lysate coagulation. Electrophoresis under nonreducing conditions on denaturing polyacrylamide gel yields a doublet migrating with an estimated M(r) of 20,000. Under reducing conditions, a single broad band migrates with an estimated M(r) of 15,000. The native structure is a monomer of moderate asymmetry with a molecular weight of 16,300 and a s20,w(0) = 1.5(5), as determined by analytical ultracentrifugation. The amino acid composition of LTI yields a calculated molecular weight of 15,680 and a calculated partial specific volume of 0.71(7) ml/g. LTI does not contain methionine, tryptophan, or detectable levels of reducing carbohydrate. The NH2-terminal sequence (V-S-P-P-F-I-K-Q-T-K-F-S-T-X-F-L-G-X-S-S) consists primarily of hydrophobic amino acid residues. Comparison of the amino acid composition and amino-terminal sequence of LTI with those of other known protease inhibitors reveals no significant similarity to other trypsin inhibitors. The novel physical characteristics suggest that LTI represents a new type of protease inhibitor.	UNIV NEW HAMPSHIRE,DEPT BIOCHEM,DURHAM,NH 03824	University System Of New Hampshire; University of New Hampshire			Laue, Tom/AAI-5136-2020	Laue, Tom/0000-0003-3571-9368				ANDREWS PC, 1987, ANAL BIOCHEM, V161, P524, DOI 10.1016/0003-2697(87)90484-2; ARMSTRONG PB, 1984, THROMB HAEMOSTASIS, V52, P117; ARMSTRONG PB, 1985, BIOCHIM BIOPHYS ACTA, V827, P453, DOI 10.1016/0167-4838(85)90232-8; ARMSTRONG PB, 1985, J EXP ZOOL, V236, P1, DOI 10.1002/jez.1402360102; Arnon R., 1970, PAPAIN METHODS ENZYM, V19, P226, DOI DOI 10.1016/0076-6879(70)19017-3; BARTELT DC, 1977, ARCH BIOCHEM BIOPHYS, V179, P189, DOI 10.1016/0003-9861(77)90103-5; BARTELT DC, 1971, J BIOL CHEM, V246, P2218; CECHOVA D, 1971, COLLECT CZECH CHEM C, V36, P3342; CORNISHBOWDEN A, 1983, METHOD ENZYMOL, V91, P60; CRAIG PA, 1989, J BIOL CHEM, V264, P5452; DONOVAN MA, 1990, THESIS U NEW HAMPSHI; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; GANDER JE, 1984, METHOD ENZYMOL, V104, P447; GREEN NM, 1953, BIOCHEM J, V54, P347, DOI 10.1042/bj0540347; HIRS CHW, 1956, J BIOL CHEM, V219, P611; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; JORGENSEN JH, 1973, APPL MICROBIOL, V26, P521, DOI 10.1128/AEM.26.4.521-524.1973; KOIDE T, 1973, EUR J BIOCHEM, V32, P417, DOI 10.1111/j.1432-1033.1973.tb02624.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laue T. M, 1981, THESIS U CONNECTICUT; LAUE TM, 1979, BIOPHYS J, V25, pA164; LORAND L, 1976, METHOD ENZYMOL, V45, P637; MCMEEKIN TL, 1952, SCIENCE, V116, P142, DOI 10.1126/science.116.3006.142; NAKAMURA S, 1976, J BIOCHEM, V80, P1011, DOI 10.1093/oxfordjournals.jbchem.a131357; PESSEN H, 1985, METHOD ENZYMOL, V117, P219; QUIGLEY JP, 1985, J BIOL CHEM, V260, P2715; RAMESH N, 1988, J BIOL CHEM, V263, P11523; RITONJA A, 1983, BIOCHIM BIOPHYS ACTA, V748, P429, DOI 10.1016/0167-4838(83)90189-9; SHISHIKURA F, 1983, J BIOCHEM, V94, P1279, DOI 10.1093/oxfordjournals.jbchem.a134473; SIMPSON RJ, 1976, J BIOL CHEM, V251, P1936; SOLUM N O, 1973, Thrombosis Research, V2, P55, DOI 10.1016/0049-3848(73)90080-7; TAKAGI T, 1979, BIOMEDICAL APPLICATI, P169; TAKAHASHI H, 1974, J BIOCHEM, V76, P721; Teller D C, 1973, Methods Enzymol, V27, P346; Teller D C, 1979, Methods Enzymol, V61, P103; VANHOLDE KE, 1985, PHYSICAL BIOCH, P117; WILLIAMS RC, 1972, ANAL BIOCHEM, V48, P164, DOI 10.1016/0003-2697(72)90180-7; YAMAMOTO M, 1983, J BIOCHEM, V94, P849, DOI 10.1093/oxfordjournals.jbchem.a134427; YPHANTIS DA, 1956, J PHYS CHEM-US, V60, P623; YPHANTIS DA, 1964, BIOCHEMISTRY-US, V3, P297, DOI 10.1021/bi00891a003; [No title captured]; PROTEIN IDENTIFICATI	42	22	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2121	2125						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989974				2022-12-25	WOS:A1991EV51500020
J	RANGNEKAR, VV; WAHEED, S; DAVIES, TJ; TOBACK, FG; RANGNEKAR, VM				RANGNEKAR, VV; WAHEED, S; DAVIES, TJ; TOBACK, FG; RANGNEKAR, VM			ANTIMITOGENIC AND MITOGENIC ACTIONS OF INTERLEUKIN-1 IN DIVERSE CELL-TYPES ARE ASSOCIATED WITH INDUCTION OF GRO GENE-EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR NECROSIS FACTOR; C-FOS; RECOMBINANT INTERLEUKIN-1; SUBTRACTIVE HYBRIDIZATION; NUCLEOTIDE-SEQUENCE; HUMAN-FIBROBLASTS; EPITHELIAL-CELLS; CYTO-TOXICITY; MESSENGER-RNA; IL-1	Interleukin-1 (IL-1) is an antiproliferative factor for growing human melanoma A375-C6 cells. To define the molecular basis for the action of IL-1, we set out to identify early genes induced by the cytokine in the absence of the de novo protein synthesis. cDNA libraries were constructed from A375-C6 cells that were exposed or unexposed to IL-1 plus cycloheximide. Subtractive hybridization was used to prepare a library that was enriched for IL-1-induced clones. Two of these clones were shown by Northern analysis to represent IL-1-inducible genes. Nucleotide sequencing identified these genes as gro/melanoma growth stimulatory activity, which encodes a cell secretory product, and c-jun, which encodes a transcription factor. IL-1 caused persistent steady state elevation of gro mRNA but only transient induction of c-jun. Northern analysis using gene probes for the transcription factors c-fos and Egr-1 revealed that IL-1 induced c-fos but not Egr-1 expression in these cells. This indicates that differential early gene expression characterizes the growth-inhibitory action of IL-1. In contrast, serum, which is mitogenic for these cells, induces c-jun, c-fos, and Egr-1, but not gro expression. These data imply that in A375-C6 cells, both growth-inhibitory and stimulatory signals can channel their action through c-fos and c-jun genes. As gro induction was specifically associated with the antimitogenic action of IL-1, we studied the effect of the cytokine on gro gene expression in other types of cells. IL-1 was mitogenic for human glioblastoma and monkey kidney epithelial cells and induced gro whereas other mitogens did not. Thus, IL-1 can induce gro gene expression in diverse cell types, whether it acts to stimulate or inhibit proliferation. Like other cytokines gro may play diverse cell-specific roles in growth control.	UNIV CHICAGO,DEPT MED,NEPHROL SECT,CHICAGO,IL 60637	University of Chicago					NIDDK NIH HHS [DK 37227, DK 18413, DK 39689] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037227, R01DK039689, R01DK018413] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANISOWICZ A, 1988, P NATL ACAD SCI USA, V85, P9645, DOI 10.1073/pnas.85.24.9645; ANISOWICZ A, 1987, P NATL ACAD SCI USA, V84, P7188, DOI 10.1073/pnas.84.20.7188; AURON PE, 1984, P NATL ACAD SCI-BIOL, V81, P7907, DOI 10.1073/pnas.81.24.7907; BIRD TA, 1986, NATURE, V324, P263, DOI 10.1038/324263a0; BOHMANN D, 1987, SCIENCE, V238, P1336; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CURRAN T, 1985, CANCER SURV, V4, P655; DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3; DOWER SK, 1986, NATURE, V324, P266, DOI 10.1038/324266a0; DUGUID JR, 1988, P NATL ACAD SCI USA, V85, P5738, DOI 10.1073/pnas.85.15.5738; ENDO Y, 1986, IMMUNOBIOLOGY, V172, P316, DOI 10.1016/S0171-2985(86)80113-9; ENDO Y, 1988, J IMMUNOL, V141, P2342; FREEDMAN AS, 1988, J IMMUNOL, V141, P3398; GAFFNEY EV, 1986, CANCER RES, V46, P3834; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HANKS SK, 1988, P NATL ACAD SCI USA, V85, P79, DOI 10.1073/pnas.85.1.79; ICHINOSE Y, 1988, CANCER IMMUNOL IMMUN, V27, P7; KARTHA S, 1987, AM J PHYSIOL, V252, pF1175, DOI 10.1152/ajprenal.1987.252.6.F1175; KARTHA S, 1985, AM J PHYSIOL, V249, pF697; KILIAN PL, 1986, J IMMUNOL, V136, P4509; LACHMAN LB, 1986, J IMMUNOL, V136, P3098; LACHMAN LB, 1987, J IMMUNOL, V138, P2913; LE JM, 1987, LAB INVEST, V56, P234; LEOF EB, 1986, P NATL ACAD SCI USA, V83, P2453, DOI 10.1073/pnas.83.8.2453; LIN JX, 1987, J BIOL CHEM, V262, P11908; LOVETT D, 1986, J IMMUNOL, V136, P340; MANIATIS T, 1982, MOL CLONING LAB MANU; MARCH CJ, 1985, NATURE, V315, P641, DOI 10.1038/315641a0; MATSUSHIMA K, 1985, PHYSL METABOLIC IMMU, V1, P253; MIZEL SB, 1982, IMMUNOL REV, V63, P51, DOI 10.1111/j.1600-065X.1982.tb00411.x; MORINAGA Y, 1989, J IMMUNOL, V143, P3538; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; NAKAMURA S, 1986, JPN J CANCER RES, V77, P767; ONOZAKI K, 1985, J IMMUNOL, V135, P314; ONOZAKI K, 1985, J IMMUNOL, V135, P3962; OPPENHEIM JJ, 1986, IMMUNOL TODAY, V7, P45, DOI 10.1016/0167-5699(86)90124-6; RICHMOND A, 1988, EMBO J, V7, P2025, DOI 10.1002/j.1460-2075.1988.tb03042.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASSONECORSI P, 1988, CELL, V54, P553, DOI 10.1016/0092-8674(88)90077-3; SCHMIDT JA, 1982, J IMMUNOL, V128, P2177; SIMS JE, 1988, SCIENCE, V241, P585, DOI 10.1126/science.2969618; SIVE HL, 1988, NUCLEIC ACIDS RES, V16, P10937, DOI 10.1093/nar/16.22.10937; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; VERMA IM, 1986, TRENDS GENET, V2, P93, DOI 10.1016/0168-9525(86)90191-5; WEN DZ, 1989, EMBO J, V8, P1761, DOI 10.1002/j.1460-2075.1989.tb03569.x	46	43	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2415	2422						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989993				2022-12-25	WOS:A1991EV51500062
J	BERTRAN, J; ROCA, A; POLA, E; TESTAR, X; ZORZANO, A; PALACIN, M				BERTRAN, J; ROCA, A; POLA, E; TESTAR, X; ZORZANO, A; PALACIN, M			MODIFICATION OF SYSTEM-A AMINO-ACID CARRIER BY DIETHYL PYROCARBONATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE VESICLES; ISOLATED RAT HEPATOCYTES; ESSENTIAL HISTIDINE RESIDUE; TRANSPORT-SYSTEM; ALANINE TRANSPORT; ANIMAL-CELLS; LACTATE-DEHYDROGENASE; HEPATOMA-CELLS; LIVER; INSULIN	Sodium-dependent alanine transport in plasma membrane vesicles from rat liver was inactivated in a time- and concentration-dependent fashion by prior treatment of membranes with the acylating reagent diethyl pyrocarbonate (DEPC). Both components of Na+/alanine cotransport (systems A and ASC) were inhibited. Exposure of vesicles to p-bromophenacyl bromide and methyl p-nitrobenzenesulfonate, which share with DEPC reactivity against histidine residues, also led to inhibition of alanine transport through systems A and ASC. The presence of Na+ (100 mM NaCl) and L-alanine (10 mM) during exposure of vesicles to DEPC protected against inactivation of system A (but not system ASC) transport activity. This protective effect was specific and required the presence of L-alanine since the presence of L-phenylalanine alone (10 mM) or L-phenylalanine plus Na+ (100 mM NaCl) did not cause any detectable protection. This overall pattern of protection is opposite to that previously found against specific sulfhydryl reagents (i.e. Nethylmaleimide), where protection of system ASC was nearly maximal. The pH profile for DEPC-dependent inhibition of system A transport activity suggests modification of amino acid residue(s) with a pK(r) of approximately 7, most likely histidine(s), in close parallel with the pH dependence of system A transport activity. Our results suggest the presence of critical histidine residues on the system A carrier that may be responsible for the pH dependence of system A transport activity.	UNIV BARCELONA,FAC BIOL,DEPT BIOQUIM & FISIOL,AVDA DIAGONAL 645,E-08028 BARCELONA,SPAIN	University of Barcelona			Palacín, Manuel/G-9786-2015; Zorzano, Antonio/R-5479-2018	Palacin, Manuel/0000-0002-8670-293X; Bertran, Joan/0000-0002-4276-336X				Aronson N N Jr, 1974, Methods Enzymol, V31, P90; BARBER EF, 1983, J BIOL CHEM, V258, P1851; BLOXHAM DP, 1981, BIOCHEM J, V193, P93, DOI 10.1042/bj1930093; BRACY DS, 1986, J BIOL CHEM, V261, P1514; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARIAPPA R, 1990, J BIOL CHEM, V265, P1470; CHENG KC, 1989, J BIOL CHEM, V264, P19666; CHILES TC, 1988, AM J PHYSIOL, V255, pC340, DOI 10.1152/ajpcell.1988.255.3.C340; CROMARTIE TH, 1981, BIOCHEMISTRY-US, V20, P5416, DOI 10.1021/bi00522a010; DICKENSON CJ, 1975, EUR J BIOCHEM, V52, P595, DOI 10.1111/j.1432-1033.1975.tb04031.x; FEHLMANN M, 1979, J BIOL CHEM, V254, P431; GUIDOTTI GG, 1978, BIOCHIM BIOPHYS ACTA, V515, P329, DOI 10.1016/0304-4157(78)90009-6; GUMA A, 1988, BIOCHEM J, V253, P625, DOI 10.1042/bj2530625; HAYES MR, 1983, BIOCHEM J, V214, P489, DOI 10.1042/bj2140489; HOLBROOK JJ, 1973, BIOCHEM J, V131, P729, DOI 10.1042/bj1310729; IZUHARA K, 1989, BIOCHEMISTRY-US, V28, P4725, DOI 10.1021/bi00437a032; KILBERG MS, 1982, J MEMBRANE BIOL, V69, P1, DOI 10.1007/BF01871236; KILBERG MS, 1980, J BIOL CHEM, V255, P4011; KILBERG MS, 1981, J BIOL CHEM, V256, P3304; KILBERG MS, 1985, J CELL PHYSIOL, V122, P290, DOI 10.1002/jcp.1041220219; LECAM A, 1977, J BIOL CHEM, V252, P148; LUNDBLAD RL, 1984, CHEM REAGENTS PROTEI, V1, pCH9; LUNDBLAD RL, 1984, CHEM REAGENTS PROTEI, V2, pCH3; MCCORMICK JI, 1988, P NATL ACAD SCI USA, V85, P7877, DOI 10.1073/pnas.85.21.7877; Miles E W, 1977, Methods Enzymol, V47, P431; PILCH PF, 1982, BIOCHEMISTRY-US, V21, P5638, DOI 10.1021/bi00265a039; POLA E, 1990, BIOCHEM J, V271, P297, DOI 10.1042/bj2710297; SAIER MH, 1988, J MEMBRANE BIOL, V104, P1, DOI 10.1007/BF01871898; SHOTWELL MA, 1983, TRENDS BIOCHEM SCI, V8, P314, DOI 10.1016/0968-0004(83)90099-3; SIPS HJ, 1981, J MEMBRANE BIOL, V62, P231, DOI 10.1007/BF01998168; SIPS HJ, 1980, EUR J BIOCHEM, V105, P217, DOI 10.1111/j.1432-1033.1980.tb04492.x; VANAMELSVOORT JMM, 1978, BIOCHEM J, V174, P1083, DOI 10.1042/bj1741083; WUARIN F, 1989, BIOCHIM BIOPHYS ACTA, V981, P185, DOI 10.1016/0005-2736(89)90027-8	33	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					798	802						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985965				2022-12-25	WOS:A1991ET17700022
J	SUZUKI, Y; YOSHIDA, K; HONDA, E; SINOHARA, H				SUZUKI, Y; YOSHIDA, K; HONDA, E; SINOHARA, H			MOLECULAR-CLONING AND SEQUENCE-ANALYSIS OF CDNAS CODING FOR GUINEA-PIG ALPHA-1-ANTIPROTEINASE-S AND ALPHA-1-ANTIPROTEINASE-F AND CONTRAPSIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-1-PROTEINASE INHIBITOR; REACTIVE CENTER REGIONS; ALPHA-MACROGLOBULIN; PROTEASE INHIBITOR; MESSENGER-RNA; RAT PLASMA; TRANSCRIPTIONAL REGULATION; PROTEINASE-INHIBITORS; TRYPSIN-INHIBITORS; MOUSE PLASMA	The cDNAs encoding two isoforms, S (slow) and F (fast), of alpha1-antiproteinase (also referred to as alpha-1-antitrypsin or alpha-1-proteinase inhibitor) as well as contrapsin were obtained by screening lambda-gt 11 cDNA library prepared from inflamed guinea pig liver. The sequence analyses of these cDNAs and NH2-terminal peptides of the purified proteins revealed that both isoforms of alpha-1-antiproteinase consist of 405 amino acid residues including a signal peptide of 24 residues and that contrapsin consists of 410 amino acid residues with the same length of the signal peptide. Guinea pig contrapsin had 89, 88, 62, 42, and 41% homology to its own alpha-1-antiproteinases F and S, rat alpha-1-antiproteinase, mouse and rat contrapsins, respectively. This suggests that guinea pig contrapsin is not orthologous to mouse and rat contrapsins and that it developed from a much later duplication of alpha-1-antiproteinase gene after the guinea pig had diverged from the murine lineage. The available data suggest that the reactive site region of alpha-1-antiproteinase can be categorized into orthodox and unorthodox types: the former has P3-P'3 consensus sequence of Xaa-Pro-Met-Ser-Xaa-Pro, where Xaa is Leu, Ile, Val, or Met, while the latter, which occurs in species having multiple alpha-1-antiproteinase isoforms, has the sequence whose P1 Met has changed to other amino acids. Thus, the reactive site region of the orthodox type, which occurs in all seven mammals examined to date, is highly conserved. This is in marked contrast to the fact that the same region is hypervariable among the paralogous proteins belonging to the serpin super-family.	KINKI UNIV, INST LIFE SCI, SAYAMA, OSAKA 589, JAPAN	Kindai University (Kinki University)	SUZUKI, Y (corresponding author), KINKI UNIV, SCH MED, DEPT BIOCHEM, SAYAMA, OSAKA 589, JAPAN.							ABRAMS WR, 1978, BIOCHEMISTRY-US, V17, P3556, DOI 10.1021/bi00610a021; AIELLO LP, 1988, J BIOL CHEM, V263, P4013; AULAK KS, 1988, BIOCHEM J, V253, P615, DOI 10.1042/bj2530615; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BERNINGER RW, 1976, BIOCHEM J, V159, P95, DOI 10.1042/bj1590095; BROWN WM, 1989, NUCLEIC ACIDS RES, V17, P6398, DOI 10.1093/nar/17.15.6398; Carrell R.W, 1986, PROTEINASE INHIBITOR, P403; Carrell R. W., 1987, THROMB DIATH HAEMO, P1; CHAO S, 1990, BIOCHEMISTRY-US, V29, P323, DOI 10.1021/bi00454a004; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; DALE RMK, 1985, PLASMID, V13, P31, DOI 10.1016/0147-619X(85)90053-8; DAYHOFF MO, 1972, ATLAS PROTEIN SEQUEN, V5, P17; DAYHOFF MO, 1972, ATLAS PROTEIN SEQUEN, V5, P89; ENGHILD JJ, 1989, J BIOL CHEM, V264, P11428; ESNARD F, 1985, FEBS LETT, V182, P125, DOI 10.1016/0014-5793(85)81168-6; GOODMAN M, 1987, COLD SPRING HARB SYM, V52, P875, DOI 10.1101/SQB.1987.052.01.096; HEIDTMANN H, 1986, PROTEINASE INHIBITOR, P441; HILL RE, 1987, NATURE, V326, P96, DOI 10.1038/326096a0; HILL RE, 1984, NATURE, V311, P175, DOI 10.1038/311175a0; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; IKEHARA Y, 1981, EUR J BIOCHEM, V115, P253, DOI 10.1111/j.1432-1033.1981.tb05231.x; KOJ A, 1978, BIOCHEM J, V169, P589, DOI 10.1042/bj1690589; KRAUTER KS, 1986, DNA-J MOLEC CELL BIO, V5, P29, DOI 10.1089/dna.1986.5.29; KUEHN L, 1984, BIOCHEM J, V218, P953, DOI 10.1042/bj2180953; LASKOWSKI M, 1987, COLD SPRING HARB SYM, V52, P545, DOI 10.1101/SQB.1987.052.01.062; LONBERGHOLM K, 1987, J BIOL CHEM, V262, P438; MATHESON NR, 1986, J BIOL CHEM, V261, P404; MODHA J, 1988, PARASITOLOGY, V96, P99, DOI 10.1017/S0031182000081683; NATHOO S, 1982, ARCH BIOCHEM BIOPHYS, V219, P306, DOI 10.1016/0003-9861(82)90161-8; NORTHEMANN W, 1989, BIOCHEMISTRY-US, V28, P84, DOI 10.1021/bi00427a013; OKUBO K, 1989, SEIKAGAKU, V61, P982; SAITO A, 1985, J BIOL CHEM, V260, P775; SAITO A, 1985, J BIOCHEM-TOKYO, V98, P501, DOI 10.1093/oxfordjournals.jbchem.a135305; SAITO A, 1988, SEIKAGAKU, V60, P938; SAITO A, 1985, 13TH INT C BIOCH, P704; SAMBROOK J, 1989, MOL CLONING LABORATO, V1; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STEPHENS AW, 1987, J BIOL CHEM, V262, P1044; SUZUKI Y, 1986, J BIOCHEM-TOKYO, V99, P1655, DOI 10.1093/oxfordjournals.jbchem.a135640; SUZUKI Y, 1990, J BIOCHEM, V107, P173, DOI 10.1093/oxfordjournals.jbchem.a123021; SUZUKI Y, 1986, BIOL CHEM H-S, V367, P579, DOI 10.1515/bchm3.1986.367.2.579; TAGA H, 1979, GAN TO KAGAKURYOHO S, V6, P321; TAKAHARA H, 1983, TOHOKU J EXP MED, V139, P265, DOI 10.1620/tjem.139.265; TAKAHARA H, 1980, J BIOCHEM, V88, P417, DOI 10.1093/oxfordjournals.jbchem.a132988; TAKAHARA H, 1982, J BIOL CHEM, V257, P2438; TAKAHARA H, 1983, J BIOCHEM, V93, P1411, DOI 10.1093/oxfordjournals.jbchem.a134276; TECCE MF, 1986, BIOCHEMISTRY-US, V25, P5831, DOI 10.1021/bi00367a073; TRAVIS J, 1985, J BIOL CHEM, V260, P4384; TRAVIS J, 1981, METHOD ENZYMOL, V80, P765; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; WRISTON JC, 1981, J MOL EVOL, V17, P1, DOI 10.1007/BF01792418; YOON JB, 1987, J BIOL CHEM, V262, P4284; YOUNG CL, 1978, ATLAS PROTEIN SEQ S3, V5, P73	54	42	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					928	932						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985973				2022-12-25	WOS:A1991ET17700041
J	DICKINSON, CJ; YAMADA, T				DICKINSON, CJ; YAMADA, T			GASTRIN-AMIDATING ENZYME IN THE PORCINE PITUITARY AND ANTRUM - CHARACTERIZATION OF MOLECULAR-FORMS AND SUBSTRATE-SPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE AMIDATION; DELTA-PH; MONOOXYGENASE; RAT; TISSUE; IDENTIFICATION; PROGASTRIN; CORTICOTROPHS; VESICLES; ATRIUM	As is the case with many other peptide hormones of the brain and intestine, the formation of biologically active gastrin from a glycine-extended processing intermediate occurs via the action of a peptidylglycyl alpha-amidating monooxygenase (PAM). The observation that gastrin exists primarily as unamidated precursors in the pituitary but as amidated gastrin in the antrum prompted this study to examine whether the amidating enzymes in the two organs were different in their characteristics. Amidating activity was quantified by measuring the conversion of glycine-extended tridecagastrin (G13-Gly) to amidated tridecagastrin and glycine-extended hexapancreatic polypeptide (PP6-Gly) to amidated hexapancreatic polypeptide by radioimmunoassay. Two molecular forms of amidating activity was identified in both the procine antrum and pituitary. The first, PAM-A, had an apparent M(r) of 51,000 and a net negative charge at pH 7.0, whereas PAM-B was smaller (M(r) almost-equal-to 30,000) and had a net positive charge at pH 7.0. Both molecular forms were similar in their cofactor requirements (copper, ascorbic acid, and catalase) and ph optima in the antrum and pituitary. The K(m) was significantly lower and the V(max) higher for PP6-Gly than for G13-Gly in the pituitary and antrum. These data suggest that although there is no difference between antral and pituitary PAM, the selective affinity of PAM for certain substrates may provide a mechanism for the differential amidation of different hormones within a given tissue or cell.	UNIV MICHIGAN,MED CTR,DEPT INTERNAL MED,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan	DICKINSON, CJ (corresponding author), UNIV MICHIGAN,MED CTR,DEPT PEDIAT,ANN ARBOR,MI 48109, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933, R01DK034306, F32DK007860] Funding Source: NIH RePORTER; NIDDK NIH HHS [F32-DK07860, P30-DK34933, R01-DK34306] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BRADBURY AF, 1983, BIOCHEM BIOPH RES CO, V112, P372, DOI 10.1016/0006-291X(83)91473-0; BRADBURY AF, 1988, BIOCHEM BIOPH RES CO, V154, P1293, DOI 10.1016/0006-291X(88)90280-X; BRADBURY AF, 1982, NATURE, V298, P686, DOI 10.1038/298686a0; DICKINSON CJ, 1990, REGUL PEPTIDES, V28, P223, DOI 10.1016/0167-0115(90)90020-W; EIPPER BA, 1983, P NATL ACAD SCI-BIOL, V80, P5144, DOI 10.1073/pnas.80.16.5144; EIPPER BA, 1987, MOL ENDOCRINOL, V1, P777, DOI 10.1210/mend-1-11-777; EIPPER BA, 1988, J BIOL CHEM, V263, P8371; GLEMBOTSKI CC, 1984, J BIOL CHEM, V259, P6385; GREGORY H, 1964, NATURE, V204, P931, DOI 10.1038/204931a0; HILSTED L, 1988, GASTROENTEROLOGY, V94, P96, DOI 10.1016/0016-5085(88)90615-4; KIZER JS, 1986, ENDOCRINOLOGY, V118, P2262, DOI 10.1210/endo-118-6-2262; LOH YP, 1984, J BIOL CHEM, V259, P8238; MATSUMOTO M, 1987, AM J PHYSIOL, V252, pG315, DOI 10.1152/ajpgi.1987.252.3.G315; MAY V, 1988, J BIOL CHEM, V263, P7550; MAY V, 1985, J BIOL CHEM, V260, P6224; MURTHY ASN, 1987, MOL ENDOCRINOL, V1, P290, DOI 10.1210/mend-1-4-290; OUAFIK L, 1989, J BIOL CHEM, V264, P5839; REHFELD JF, 1981, J BIOL CHEM, V256, P426; REHFELD JF, 1981, AM J PHYSIOL, V240, pG255, DOI 10.1152/ajpgi.1981.240.4.G255; REHFELD JF, 1986, J BIOL CHEM, V261, P5841; RUSSELL JT, 1981, J BIOL CHEM, V256, P5950; STOFFERS DA, 1989, P NATL ACAD SCI USA, V86, P735, DOI 10.1073/pnas.86.2.735; SUGANO K, 1985, J BIOL CHEM, V260, P1724; SUGANO K, 1985, BIOCHEM BIOPH RES CO, V126, P72, DOI 10.1016/0006-291X(85)90572-8; TAYLOR IL, 1983, PEPTIDES, V4, P245, DOI 10.1016/0196-9781(83)90122-5; WAND GS, 1985, NEUROENDOCRINOLOGY, V41, P482, DOI 10.1159/000124223; WAND GS, 1985, METABOLISM, V34, P1044, DOI 10.1016/0026-0495(85)90077-0; YOO OJ, 1982, P NATL ACAD SCI-BIOL, V79, P1049, DOI 10.1073/pnas.79.4.1049	28	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					334	338						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985904				2022-12-25	WOS:A1991EQ33900049
J	ZABEL, U; SCHRECK, R; BAEUERLE, PA				ZABEL, U; SCHRECK, R; BAEUERLE, PA			DNA-BINDING OF PURIFIED TRANSCRIPTION FACTOR NF-KAPPA - AFFINITY, SPECIFICITY, ZN2+ DEPENDENCE, AND DIFFERENTIAL HALF-SITE RECOGNITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B; RNA-POLYMERASE; ZINC FINGERS; PROTEIN; PURIFICATION; GENE; ACTIVATION; ENHANCER; PROMOTER; ELEMENT	A rapid purification procedure for the NF-k(B) transcription factor from the cytosol of human placenta is demonstrated which exploits the insensitivity of the NF-k(B).DNA complex toward the intercalating agent chloroquine. Purified NF-k(B) required 100 mM KCl or NaCl and a p H of 7.5 to optimally bind to DNA. Equilibrium of binding was reached within less than 5 min in the absence of competitor DNA and after 1 h in the presence of 0.1 mg/ml poly(dI-dC). DNA binding of NF-k(B) was specifically blocked by the chelating agent 1,10-orthophenantroline and could only be reconstituted by addition of Zn2+. Under optimal binding conditions, the dissociation constant for the complex of the purified NF-k(B) with its most frequent cognate DNA motif 5'-GGGACTTTCC-3' was in the range of 10(-12) to 10(-13) M. Various other cis-acting k(B) motifs were recognized by NF-k(B) with lower affinities. A comparative analysis of known NF-k(B)-binding sites and competition experiments with synthetic polynucleotides and oligonucleotides encompassing only one half-site or single-stranded k(B) motifs suggested that the two DNA-binding monomers in the NF-k(B) protein complex can interact differentially with the half-sites of the decameric cognate motif.	UNIV MUNICH,CTR GENE,MOLEC BIOL LAB,W-8033 MARTINSRIED,GERMANY	University of Munich								BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BAEUERLE PA, 1989, GENE DEV, V3, P1689, DOI 10.1101/gad.3.11.1689; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BAEUERLE PA, 1991, HORMONAL CONTROL REG, P409; BALDWIN AS, 1990, MOL CELL BIOL, V10, P1406, DOI 10.1128/MCB.10.4.1406; BALDWIN AS, 1988, P NATL ACAD SCI USA, V85, P723, DOI 10.1073/pnas.85.3.723; BOHNLEIN E, 1988, CELL, V53, P827, DOI 10.1016/0092-8674(88)90099-2; CLARK L, 1988, GENE DEV, V2, P991, DOI 10.1101/gad.2.8.991; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; EVANS RM, 1988, CELL, V52, P1, DOI 10.1016/0092-8674(88)90522-3; FALCHUK KH, 1976, BIOCHEMISTRY-US, V15, P4468, DOI 10.1021/bi00665a021; FAN CM, 1990, GENE DEV, V4, P29, DOI 10.1101/gad.4.1.29; FRANKEL AD, 1988, SCIENCE, V240, P70, DOI 10.1126/science.2832944; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; HEUKESHOVEN J, 1988, ELECTROPHORESIS, V9, P28, DOI 10.1002/elps.1150090106; HOYOS B, 1989, SCIENCE, V244, P457, DOI 10.1126/science.2497518; KAWAKAMI K, 1988, P NATL ACAD SCI USA, V85, P4700, DOI 10.1073/pnas.85.13.4700; KLUG A, 1987, TRENDS BIOCHEM SCI, V12, P464, DOI 10.1016/0968-0004(87)90231-3; Lammeli UK, 1970, NATURE, V227, P680; LENARDO MJ, 1989, CELL, V57, P287, DOI 10.1016/0092-8674(89)90966-5; LENARDO MJ, 1988, P NATL ACAD SCI USA, V85, P8825, DOI 10.1073/pnas.85.23.8825; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; LILIENBAUM A, 1990, J VIROL, V64, P256, DOI 10.1128/JVI.64.1.256-263.1990; MEISTERERNST M, 1988, NUCLEIC ACIDS RES, V16, P4419, DOI 10.1093/nar/16.10.4419; MIYATAKE S, 1988, MOL CELL BIOL, V8, P5581, DOI 10.1128/MCB.8.12.5581; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; RON D, 1990, MOL CELL BIOL, V10, P1023, DOI 10.1128/MCB.10.3.1023; SCHRECK R, 1990, MOL CELL BIOL, V10, P1281, DOI 10.1128/MCB.10.3.1281; SCHROTER H, 1987, NUCLEIC ACIDS RES, V15, P10145, DOI 10.1093/nar/15.24.10145; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SHIRAKAWA F, 1989, MOL CELL BIOL, V9, P2424, DOI 10.1128/MCB.9.6.2424; URBAN MB, 1990, IN PRESS GENES DEV; VISVANATHAN KV, 1989, EMBO J, V8, P1129, DOI 10.1002/j.1460-2075.1989.tb03483.x; WU FK, 1988, EMBO J, V7, P2117, DOI 10.1002/j.1460-2075.1988.tb03051.x; YANO O, 1987, EMBO J, V6, P3317, DOI 10.1002/j.1460-2075.1987.tb02652.x; ZABEL U, 1990, CELL, V61, P255, DOI 10.1016/0092-8674(90)90806-P	37	361	364	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					252	260						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985897				2022-12-25	WOS:A1991EQ33900038
J	VLAHOS, CJ; DEKKER, EE				VLAHOS, CJ; DEKKER, EE			ACTIVE-SITE RESIDUES OF 2-KETO-4-HYDROXYGLUTARATE ALDOLASE FROM ESCHERICHIA-COLI - BROMOPYRUVATE INACTIVATION AND LABELING OF GLUTAMATE-45	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV MICHIGAN,DEPT BIOL CHEM,M5315 MED SCI 1,1301 CATHERINE RD,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan					NIDDK NIH HHS [DK-03718] Funding Source: Medline; NIGMS NIH HHS [5-T-32-GM07767-06] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK003718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007767] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRIOLA DP, 1987, BIOCHEMISTRY-US, V26, P5679, DOI 10.1021/bi00392a015; Carraway K L, 1972, Methods Enzymol, V25, P616, DOI 10.1016/S0076-6879(72)25060-1; DAVIS DJ, 1983, BIOCHEM BIOPH RES CO, V112, P508, DOI 10.1016/0006-291X(83)91494-8; Dekker E E, 1975, Methods Enzymol, V42, P285; Dekker E E, 1975, Methods Enzymol, V42, P280; DEKKER EE, 1962, J BIOL CHEM, V237, P2218; DEKKER EE, 1977, BIOORGANIC CHEM ENZY, V1, P59; GRADY SR, 1979, BIOCHIM BIOPHYS ACTA, V568, P234, DOI 10.1016/0005-2744(79)90290-0; GUPTA SC, 1984, J BIOL CHEM, V259, P12; HARTMAN FC, 1974, BIOCHEM BIOPH RES CO, V57, P85, DOI 10.1016/S0006-291X(74)80360-8; HUDSON PJ, 1975, BIOCHEM BIOPH RES CO, V65, P213, DOI 10.1016/S0006-291X(75)80081-7; KITSON RP, 1980, THESIS U MICHIGAN; KOBES RD, 1971, BIOCHIM BIOPHYS ACTA, V250, P238, DOI 10.1016/0005-2744(71)90139-2; KOBES RD, 1971, BIOCHEMISTRY-US, V10, P388, DOI 10.1021/bi00779a005; LEHNINGER AL, 1975, BIOCHEMISTRY-US, P231; LOWE PN, 1984, BIOCHEMISTRY-US, V23, P91, DOI 10.1021/bi00296a015; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAITRA U, 1963, J BIOL CHEM, V238, P3660; MELOCHE HP, 1978, BIOCHEM BIOPH RES CO, V84, P589, DOI 10.1016/0006-291X(78)90746-5; MELOCHE HP, 1970, BIOCHEMISTRY-US, V9, P5050, DOI 10.1021/bi00828a002; MELOCHE HP, 1973, SCIENCE, V181, P350, DOI 10.1126/science.181.4097.350; MELOCHE HP, 1967, BIOCHEMISTRY-US, V6, P2273, DOI 10.1021/bi00860a002; NISHIHARA H, 1972, J BIOL CHEM, V247, P5079; RUTTER WJ, 1964, FED PROC, V23, P1248; TARR GE, 1986, MICROCHARACTERIZATIO, P155; THOME F, 1985, BIOCHIMIE, V67, P249, DOI 10.1016/S0300-9084(85)80053-5; VLAHOS CJ, 1985, J BIOL CHEM, V260, P5480; VLAHOS CJ, 1988, J BIOL CHEM, V263, P11683; VLAHOS CJ, 1986, J BIOL CHEM, V261, P1049; WANG JK, 1981, J BIOL CHEM, V256, P1793	30	14	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1990	265	33					20384	20389						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ525	1978721				2022-12-25	WOS:A1990EJ52500053
J	STEVENS, VL; RAETZ, CRH				STEVENS, VL; RAETZ, CRH			CLASS-F THY-1-NEGATIVE MURINE LYMPHOMA-CELLS ARE DEFICIENT IN ETHER LIPID BIOSYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									MERCK SHARP & DOHME LTD,DEPT BIOCHEM,R80K,BOX 2000,RAHWAY,NJ 07065	Merck & Company								BANGS JD, 1985, P NATL ACAD SCI USA, V82, P3207, DOI 10.1073/pnas.82.10.3207; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CHAPMAN A, 1980, J BIOL CHEM, V255, P4441; DOERING TL, 1989, J BIOL CHEM, V264, P11168; DOERING TL, 1990, J BIOL CHEM, V265, P611; ESKO JD, 1980, J BIOL CHEM, V255, P4474; FATEMI SH, 1988, J BIOL CHEM, V263, P1288; FERGUSON MAJ, 1988, SCIENCE, V239, P753, DOI 10.1126/science.3340856; GUPTA D, 1988, SCIENCE, V242, P1446, DOI 10.1126/science.2904699; HOMANS SW, 1988, NATURE, V333, P269, DOI 10.1038/333269a0; Horrocks L. A., 1982, PHOSPHOLIPIDS, P51; LOW MG, 1988, SCIENCE, V239, P268, DOI 10.1126/science.3276003; LUHRS CA, 1989, J BIOL CHEM, V264, P21446; MASTERSON WJ, 1989, CELL, V56, P793, DOI 10.1016/0092-8674(89)90684-3; MATO JM, 1987, J BIOL CHEM, V262, P2131; MOSER HW, 1987, DEV NEUROSCI-BASEL, V9, P1, DOI 10.1159/000111604; NISHIJIMA M, 1979, J BIOL CHEM, V254, P7837; ORLANDI PA, 1987, J BIOL CHEM, V262, P10384; PETERS TJ, 1972, J EXP MED, V136, P1117, DOI 10.1084/jem.136.5.1117; ROBERTS WL, 1988, J BIOL CHEM, V263, P18766; ROBERTS WL, 1988, BIOCHEM BIOPH RES CO, V150, P271, DOI 10.1016/0006-291X(88)90516-5; ROBERTS WL, 1988, J BIOL CHEM, V263, P18776; SCHLOSSMAN DM, 1977, ARCH BIOCHEM BIOPHYS, V182, P732, DOI 10.1016/0003-9861(77)90555-0; SCHLOSSMAN DM, 1976, J BIOL CHEM, V251, P5738; SCHUTGENS RBH, 1986, EUR J PEDIATR, V144, P430, DOI 10.1007/BF00441734; SINGH I, 1983, J LIPID RES, V24, P662; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; TARTAKOFF A, 1988, J CELL BIOL, V107, P3202; TROWBRIDGE IS, 1978, CELL, V14, P21, DOI 10.1016/0092-8674(78)90297-0; TURCO SJ, 1989, J BIOL CHEM, V264, P6711; WALTER EI, 1990, J IMMUNOL, V144, P1030; ZOELLER RA, 1986, P NATL ACAD SCI USA, V83, P5170, DOI 10.1073/pnas.83.14.5170; ZOELLER RA, 1989, J BIOL CHEM, V264, P21872; ZOELLER RA, 1988, J BIOL CHEM, V263, P11590	34	27	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1990	265	26					15653	15658						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY964	1975590				2022-12-25	WOS:A1990DY96400051
J	THOMMES, P; HUBSCHER, U				THOMMES, P; HUBSCHER, U			DNA HELICASE FROM CALF THYMUS - PURIFICATION TO APPARENT HOMOGENEITY AND BIOCHEMICAL-CHARACTERIZATION OF THE ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV ZURICH,DEPT PHARMACOL & BIOCHEM,WINTERTHURERSTR 190,CH-8057 ZURICH,SWITZERLAND	University of Zurich								ABDELMONEM M, 1983, P NATL ACAD SCI-BIOL, V80, P4659, DOI 10.1073/pnas.80.15.4659; AMUNDSEN SK, 1986, P NATL ACAD SCI USA, V83, P5558, DOI 10.1073/pnas.83.15.5558; AREZZO F, 1987, ANAL BIOCHEM, V167, P387, DOI 10.1016/0003-2697(87)90181-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURGERS PMJ, 1990, IN PRESS EUR J BIOCH; CARON PR, 1985, P NATL ACAD SCI USA, V82, P4925, DOI 10.1073/pnas.82.15.4925; CHA TA, 1989, J BIOL CHEM, V264, P12220; CRUTE JJ, 1988, NUCLEIC ACIDS RES, V16, P6585, DOI 10.1093/nar/16.14.6585; CRUTE JJ, 1989, P NATL ACAD SCI USA, V86, P2186, DOI 10.1073/pnas.86.7.2186; DENHARDT DT, 1967, P NATL ACAD SCI USA, V57, P813, DOI 10.1073/pnas.57.3.813; DOWNEY KM, 1990, IN PRESS MOL MECHANI; FOCHER F, 1989, NUCLEIC ACIDS RES, V17, P1805, DOI 10.1093/nar/17.5.1805; FOCHER F, 1988, NUCLEIC ACIDS RES, V16, P6279, DOI 10.1093/nar/16.14.6279; GEIDER K, 1981, ANNU REV BIOCHEM, V50, P233, DOI 10.1146/annurev.bi.50.070181.001313; HUBSCHER U, 1985, NUCLEIC ACIDS RES, V13, P5471, DOI 10.1093/nar/13.15.5471; HUBSCHER U, 1979, P NATL ACAD SCI USA, V76, P6284, DOI 10.1073/pnas.76.12.6284; JOGENEEL CV, 1984, J BIOL CHEM, V259, P12925; KORNBERG A, 1978, J BIOL CHEM, V253, P3298; KORNBERG A, 1988, J BIOL CHEM, V263, P1; Kornberg A., 1982, DNA REPLICATION S; Kornberg A., 1980, DNA REPLICATION; KUMURA K, 1984, J BIOL CHEM, V259, P1560; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKEN RS, 1988, J BIOL CHEM, V263, P5512; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; LECHNER RL, 1983, J BIOL CHEM, V258, P1185; LEEDS JM, 1987, MOL CELL BIOL, V7, P532, DOI 10.1128/MCB.7.1.532; LIU CC, 1981, J BIOL CHEM, V256, P2813; LU AL, 1984, COLD SPRING HARB SYM, V49, P589, DOI 10.1101/SQB.1984.049.01.066; Maniatis T., 1982, MOL CLONING; MATSON SW, 1985, J BIOL CHEM, V260, P2281; MATSON SW, 1986, J BIOL CHEM, V261, P169; OTTIGER H, 1987, NUCLEIC ACIDS RES, V15, P4789, DOI 10.1093/nar/15.12.4789; POLL EHA, 1988, BIOCHEMISTRY-US, V27, P8701, DOI 10.1021/bi00424a002; SAPP M, 1986, NUCLEIC ACIDS RES, V14, P6803, DOI 10.1093/nar/14.17.6803; SEKI M, 1988, BIOCHEMISTRY-US, V27, P1766, DOI 10.1021/bi00405a057; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; SMALE ST, 1986, MOL CELL BIOL, V6, P4077, DOI 10.1128/MCB.6.11.4077; SPADARI S, 1989, MUTAT RES, V219, P147, DOI 10.1016/0921-8734(89)90009-X; STAHL H, 1986, EMBO J, V5, P1939, DOI 10.1002/j.1460-2075.1986.tb04447.x; STAHL H, 1987, BIOCHIM BIOPHYS ACTA, V910, P1, DOI 10.1016/0167-4781(87)90088-1; SUGINO A, 1986, J BIOL CHEM, V261, P1744; SUNG P, 1987, P NATL ACAD SCI USA, V84, P8951, DOI 10.1073/pnas.84.24.8951; TAN CK, 1986, J BIOL CHEM, V261, P2310; TANAKA S, 1982, J BIOL CHEM, V257, P8386; THOMMES P, 1986, BIOCHEMISTRY-US, V25, P1308; WIEKOWSKI M, 1988, J BIOL CHEM, V263, P436; WIPPITS NS, 1980, ANNU REV GENET, V14, P41; WOOD ER, 1987, J BIOL CHEM, V262, P15269; YARRANTON GT, 1979, J BIOL CHEM, V254, P1997	50	40	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1990	265	24					14347	14354						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV278	1974896				2022-12-25	WOS:A1990DV27800043
J	GEORGE, MD; VOLLBERG, TM; FLOYD, EE; STEIN, JP; JETTEN, AM				GEORGE, MD; VOLLBERG, TM; FLOYD, EE; STEIN, JP; JETTEN, AM			REGULATION OF TRANSGLUTAMINASE TYPE-II BY TRANSFORMING GROWTH FACTOR-BETA-1 IN NORMAL AND TRANSFORMED HUMAN EPIDERMAL-KERATINOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									NIEHS, PULM PATHOBIOL LAB, CELL BIOL SECT, RES TRIANGLE PK, NC 27709 USA; UNIV TEXAS, SCH MED, DEPT INTERNAL MED, HOUSTON, TX 77225 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Texas System			Jetten, Anton/C-3736-2019	Jetten, Anton/0000-0003-0954-4445				BERSTEN AM, 1983, BIOCHIM BIOPHYS ACTA, V762, P429, DOI 10.1016/0167-4889(83)90008-3; BIRCKBICHLER PJ, 1985, HYBRIDOMA, V4, P179, DOI 10.1089/hyb.1985.4.179; Boyce S.T., 1983, J INVEST DERMATOL S, V81, P33; BRUNNER AM, 1988, MOL CELL BIOL, V8, P2229, DOI 10.1128/MCB.8.5.2229; BYRD JC, 1987, J BIOL CHEM, V262, P11699; CHIEFETZ S, 1988, J BIOL CHEM, V263, P10783; CHIOCCA EA, 1988, J BIOL CHEM, V263, P11584; CHIOCCA EA, 1989, J CELL BIOCHEM, V39, P293, DOI 10.1002/jcb.240390309; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DAVIES PJA, 1985, J BIOL CHEM, V260, P5166; DEAN DC, 1989, AM J RESP CELL MOL, V1, P5, DOI 10.1165/ajrcmb/1.1.5; DERYNCK R, 1986, J BIOL CHEM, V261, P4377; DERYNCK R, 1985, NATURE, V316, P701, DOI 10.1038/316701a0; DUGAICZYK A, 1983, BIOCHEMISTRY-US, V22, P1605, DOI 10.1021/bi00276a013; ECKERT RL, 1989, ENVIRON HEALTH PERSP, V80, P109, DOI 10.2307/3430736; FESUS L, 1987, FEBS LETT, V224, P104, DOI 10.1016/0014-5793(87)80430-1; FLORINI JR, 1986, J BIOL CHEM, V261, P6509; FLOYD EE, 1989, MOL CELL BIOL, V9, P4846, DOI 10.1128/MCB.9.11.4846; FOLK JE, 1980, ANNU REV BIOCHEM, V49, P517, DOI 10.1146/annurev.bi.49.070180.002505; GENTRY LE, 1988, MOL CELL BIOL, V8, P4162, DOI 10.1128/MCB.8.10.4162; GLICK AB, 1989, CELL REGUL, V1, P87, DOI 10.1091/mbc.1.1.87; HEBERT CD, 1989, CANCER RES, V49, P3196; ICHINOSE A, 1988, P NATL ACAD SCI USA, V85, P5829, DOI 10.1073/pnas.85.16.5829; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; IKURA K, 1988, BIOCHEMISTRY-US, V27, P2898, DOI 10.1021/bi00408a035; JETTEN AM, 1989, J INVEST DERMATOL, V92, P203, DOI 10.1111/1523-1747.ep12276731; JETTEN AM, 1989, J INVEST DERMATOL, V93, P108, DOI 10.1111/1523-1747.ep12277374; JETTEN AM, 1986, EXP CELL RES, V167, P539, DOI 10.1016/0014-4827(86)90193-X; JETTEN AM, 1986, J BIOL CHEM, V261, P5097; KESKIOJA J, 1988, J BIOL CHEM, V263, P3111; KIM SJ, 1989, J BIOL CHEM, V264, P402; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE KN, 1989, BIOCHEM BIOPH RES CO, V162, P1370, DOI 10.1016/0006-291X(89)90825-5; LEE KN, 1987, BIOCHIM BIOPHYS ACTA, V928, P22, DOI 10.1016/0167-4889(87)90081-4; LEOF EB, 1986, P NATL ACAD SCI USA, V83, P2453, DOI 10.1073/pnas.83.8.2453; LICHTI U, 1985, J BIOL CHEM, V260, P1422; MACCIONI RB, 1986, MOL CELL BIOCHEM, V69, P161; Maniatis T., 1982, MOL CLONING; MASUI T, 1986, P NATL ACAD SCI USA, V83, P2438, DOI 10.1073/pnas.83.8.2438; MIYAZONO K, 1988, J BIOL CHEM, V263, P6407; MOORE WT, 1984, J BIOL CHEM, V259, P2794; MOSES HL, 1985, CANCER CELL, V3, P65; OLSON EN, 1986, J CELL BIOL, V103, P1799, DOI 10.1083/jcb.103.5.1799; PENTTINEN RP, 1988, P NATL ACAD SCI USA, V85, P1105, DOI 10.1073/pnas.85.4.1105; PIACENTINI M, 1988, J BIOL CHEM, V263, P3790; PITTELKOW MR, 1986, J INVEST DERMATOL, V86, P500; REARICK JI, 1986, J BIOL CHEM, V261, P13898; REISS M, 1987, CANCER RES, V47, P6705; RHEINWALD JG, 1980, CELL, V22, P629, DOI 10.1016/0092-8674(80)90373-6; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; ROBERTS AB, 1985, P NATL ACAD SCI USA, V82, P119, DOI 10.1073/pnas.82.1.119; ROBERTS AB, 1990, IN PRESS PEPTIDE GRO; ROSSI P, 1988, CELL, V52, P405, DOI 10.1016/S0092-8674(88)80033-3; RUBIN AL, 1986, CANCER RES, V46, P2356; SELKOE DJ, 1982, P NATL ACAD SCI-BIOL, V79, P6070, DOI 10.1073/pnas.79.19.6070; SEYEDIN SM, 1985, P NATL ACAD SCI USA, V82, P2267, DOI 10.1073/pnas.82.8.2267; SHIPLEY GD, 1986, CANCER RES, V46, P2068; SHIPLEY GD, 1985, P NATL ACAD SCI USA, V82, P4147, DOI 10.1073/pnas.82.12.4147; SPORN MB, 1987, J CELL BIOL, V105, P1039, DOI 10.1083/jcb.105.3.1039; STERN DF, 1986, MOL CELL BIOL, V6, P870, DOI 10.1128/MCB.6.3.870; THACHER SM, 1985, CELL, V40, P685, DOI 10.1016/0092-8674(85)90217-X; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WAKEFIELD LM, 1987, J CELL BIOL, V105, P965, DOI 10.1083/jcb.105.2.965; ZATLOUKAL K, 1989, LAB INVEST, V61, P603	64	90	91	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 5	1990	265	19					11098	11104						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL655	1972706				2022-12-25	WOS:A1990DL65500050
J	VANBEEUMEN, J; VANBUN, S; CANTERS, GW; LOMMEN, A; CHOTHIA, C				VANBEEUMEN, J; VANBUN, S; CANTERS, GW; LOMMEN, A; CHOTHIA, C			THE STRUCTURAL HOMOLOGY OF AMICYANIN FROM THIOBACILLUS-VERSUTUS TO PLANT PLASTOCYANINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLUE COPPER PROTEIN; METHYLAMINE DEHYDROGENASE; PARACOCCUS-DENITRIFICANS; RESOLUTION; REACTIVITY	The complete amino acid sequence of the blue copper protein amicyanin of Thiobacillus versutus, induced when the bacterium is grown on methylamine, has been determined as follows: QDKITVTSEKPVAAADVPADAVVVGIEKMKYLTPEVTIKAGETVYWVNGEVMPHNVAFKKGIVGEDAFRGEMMTKDQAYAITFNEAGSYDYFCTPHPFMRGKVIVE. The four copper ligand residues in this 106-residue-containing polypeptide chain are His54, Cys93, His96, and Met99. The Thiobacillus amicyanin is 52% similar to the amicyanin of Pseudomonas AM1, the only other copper protein known with the same spacing between the second histidine ligand and the methionine ligand. T. versutus amicyanin contains no cysteine bridge and is more closely related to the plant copper protein plastocyanin than to the bacterial copper protein azurin. Alignment of the two known amicyanin sequences with the consensus sequence of the plastocyanins and comparison with the known three-dimensional structure of poplar leaves plastocyanin reveals that the bacterial proteins have the same overall structure with two beta-sheets packed face to face. The major structural differences between the amicyanins and the plastocyanins appear to be located in two of the five loops that connect the six identified beta-strands of the amicyanins. The first of these two loops, connecting strands F and G, contains a ligand histidine and must have a different conformation from the same loop in the plastocyanins because it is shorter by two amino acids. Further differences occur in the loop connecting the strands D and E. This loop contains only 17 residues in amicyanin whereas the corresponding loop of plastocyanin contains 25 residues. Despite these differences the amicyanins appear much closer related to the plastocyanins than to the azurins. The present findings demonstrate that the occurrence of blue copper proteins with clearly plastocyanin-like features is not restricted to photosynthetic redox chains.	STATE UNIV GHENT,MICROBIOL & MICROBIAL GENET LAB,B-9000 GHENT,BELGIUM; LEIDEN STATE UNIV,GORLAEUS LABS,DEPT CHEM,2300 RA LEIDEN,NETHERLANDS; MRC,MOLEC BIOL LAB,CAMBRIDGE CB2 2QM,ENGLAND	Ghent University; Leiden University; Leiden University - Excl LUMC								AMBLER RP, 1985, BIOCHEM J, V232, P451, DOI 10.1042/bj2320451; CHOTHIA C, 1982, J MOL BIOL, V160, P309, DOI 10.1016/0022-2836(82)90178-4; COLMAN PM, 1978, NATURE, V272, P319, DOI 10.1038/272319a0; CRESTFIELD AM, 1963, J BIOL CHEM, V238, P2413; GUSS JM, 1983, J MOL BIOL, V169, P521; HARRISON AP, 1983, INT J SYST BACTERIOL, V33, P211, DOI 10.1099/00207713-33-2-211; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P486; HUSAIN M, 1985, J BIOL CHEM, V260, P4626; HUSAIN M, 1986, BIOCHEMISTRY-US, V25, P2431, DOI 10.1021/bi00357a020; INGLIS AS, 1983, METHOD ENZYMOL, V91, P324; JENKINS O, 1984, MICROBIAL GROWTH C1, P255; KATOH S, 1962, J BIOCHEM-TOKYO, V51, P32, DOI 10.1093/oxfordjournals.jbchem.a127497; LOMMEN A, 1990, J BIOL CHEM, V265, P2768; LOMMEN A, 1988, EUR J BIOCHEM, V176, P213, DOI 10.1111/j.1432-1033.1988.tb14271.x; MCGINNIS J, 1988, INORG CHEM, V27, P2306, DOI 10.1021/ic00286a018; PETRATOS K, 1988, J MOL BIOL, V199, P545, DOI 10.1016/0022-2836(88)90626-2; RYDEN L, 1984, COPPER PROTEINS COPP, P157; SHOJI A, 1985, SEIKAGAKU, V57, P1036; SYKES AG, 1985, CHEM SOC REV, V14, P283, DOI 10.1039/cs9851400283; TAYLOR BF, 1969, J BACTERIOL, V100, P487, DOI 10.1128/JB.100.1.487-497.1969; TOBARI J, 1981, BIOCHEM BIOPH RES CO, V101, P502, DOI 10.1016/0006-291X(81)91288-2; VANBEEUMEN J, 1986, ADV METHODS PROTEIN, P256; VANHOUWELINGEN T, 1985, EUR J BIOCHEM, V153, P75; VELLIEUX FMD, 1989, EMBO J, V8, P2171, DOI 10.1002/j.1460-2075.1989.tb08339.x; YANO H, 1989, Protein Sequences and Data Analysis, V2, P385	25	23	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4869	4877						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002033				2022-12-25	WOS:A1991FC21700032
J	PALIDA, FA; ETTINGER, MJ				PALIDA, FA; ETTINGER, MJ			IDENTIFICATION OF PROTEINS INVOLVED IN INTRACELLULAR COPPER-METABOLISM - LOW-LEVELS OF A ALMOST-EQUAL-TO-48-KDA COPPER-BINDING PROTEIN IN THE BRINDLED MOUSE MODEL OF MENKES DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED SKIN FIBROBLASTS; KINKY HAIR DISEASE; MOTTLED MOUSE; CU-64 METABOLISM; MOBR MICE; METALLOTHIONEIN; TRANSPORT; MUTANTS; DEFICIENCY; DEFECT	Little is known about copper metabolism at the cellular level. The brindled mouse is an animal model of Menkes disease which is an inborn error of copper metabolism. Control and brindled mice were used to identify copper-binding proteins with possible roles in normal copper metabolism that are affected by the defect in the brindled mice. When Cu-64-labeled hepatic or renal cytosols from control mice were applied to Mono Q or Superose columns, a almost-equal-to 48-kDa protein coeluted with the protein fractions which contained the radiolabeled copper. Large decreases in copper binding were detected in these fractions from the brindled mice. The same column fractions which showed decreased copper binding showed large decreases in the levels of the almost-equal-to 48-kDa protein. Decreased copper binding and almost-equal-to 48-kDa protein were not simply secondary to the abnormal hepatic and renal copper levels that are found in the brindled mice since although their liver copper levels are low, their kidney copper levels are high. Elevated levels of an almost-equal-to 80-kDa heat shock protein were also detected in the hepatic and renal cytosols from the brindled mice. Consistent with expression of the primary defect in both the liver and kidney, the levels of the almost-equal-to 48- and almost-equal-to 80-kDa proteins were affected similarly in both organs. Irrespective of how the low levels of the almost-equal-to 48-kDa protein may be related to the basic defect in the brindled mice, the data are consistent with an important role for the almost-equal-to 48-kDa protein in intracellular copper metabolism.	SUNY BUFFALO,DEPT BIOCHEM,BUFFALO,NY 14214	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019708] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK 19708] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERATIS NG, 1978, PEDIATR RES, V12, P699, DOI 10.1203/00006450-197806000-00004; CAMAKARIS J, 1979, BIOCHEM J, V180, P597, DOI 10.1042/bj1800597; CAMAKARIS J, 1980, BIOCHEM GENET, V18, P117, DOI 10.1007/BF00504364; CHAN WY, 1978, CLIN CHIM ACTA, V88, P495, DOI 10.1016/0009-8981(78)90284-X; COX DR, 1983, HUM GENET, V64, P61, DOI 10.1007/BF00289481; DANKS DM, 1977, INORG PERSPECT BIOL, V1, P73; DANKS DM, 1973, SCIENCE, V179, P1140, DOI 10.1126/science.179.4078.1140; DARWISH HM, 1983, J BIOL CHEM, V258, P3621; DARWISH HM, 1984, AM J PHYSIOL, V246, pG72, DOI 10.1152/ajpgi.1984.246.1.G72; ETTINGER MJ, 1986, FASEB J, V45, P2800; ETTINGER MJ, 1987, LIFE CHEM REPORTS, V5, P169; FREEDMAN JH, 1989, J BIOL CHEM, V264, P5598; GOKA TJ, 1976, P NATL ACAD SCI USA, V73, P604, DOI 10.1073/pnas.73.2.604; HERD SM, 1987, BIOCHEM J, V247, P341, DOI 10.1042/bj2470341; HUNT DM, 1976, LIFE SCI, V19, P1913, DOI 10.1016/0024-3205(76)90124-7; HUNT DM, 1974, NATURE, V249, P852, DOI 10.1038/249852a0; LABADIE GU, 1981, PEDIATR RES, V15, P257, DOI 10.1203/00006450-198103000-00012; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEONE A, 1985, CELL, V40, P301, DOI 10.1016/0092-8674(85)90144-8; MANN JR, 1979, BIOCHEM J, V180, P605, DOI 10.1042/bj1800605; MANN JR, 1980, BIOCHEM J, V186, P629, DOI 10.1042/bj1860629; MARCEAU N, 1970, AM J PHYSIOL, V218, P377, DOI 10.1152/ajplegacy.1970.218.2.377; MARCEAU N, 1973, BIOCHIM BIOPHYS ACTA, V328, P351, DOI 10.1016/0005-2795(73)90268-7; MARCEAU N, 1973, BIOCHIM BIOPHYS ACTA, V328, P338, DOI 10.1016/0005-2795(73)90267-5; OFARRELL TZ, 1977, CELL, V112, P1133; OWEN CA, 1981, WILSONMS DISEASE; PACKMAN S, 1987, J CLIN INVEST, V79, P1338, DOI 10.1172/JCI112959; PALIDA FA, 1990, BIOCHEM J, V268, P359, DOI 10.1042/bj2680359; PALIDA FA, 1989, THESIS STATE U NEW Y; PHILLIPS M, 1986, BIOCHEM J, V238, P177, DOI 10.1042/bj2380177; PORT AE, 1979, BIOCHEM J, V183, P721, DOI 10.1042/bj1830721; PRINS HW, 1979, J INORG BIOCHEM, V10, P19, DOI 10.1016/S0162-0134(00)81002-8; RAUCH H, 1983, J HERED, V74, P141, DOI 10.1093/oxfordjournals.jhered.a109751; RIORDAN JR, 1982, J BIOL CHEM, V257, P4639; ROYCE PM, 1980, BIOCHEM J, V192, P579, DOI 10.1042/bj1920579; Sass-Kortsak A, 1965, Adv Clin Chem, V8, P1; SAYED AK, 1981, P SOC EXP BIOL MED, V166, P153; SCHMIDT CJ, 1984, SCIENCE, V224, P1104, DOI 10.1126/science.6719135; SONE T, 1987, J BIOL CHEM, V262, P5878; TERAO T, 1973, AM J PHYSIOL, V224, P682, DOI 10.1152/ajplegacy.1973.224.3.682; TERAO T, 1976, TOHOKU J EXP MED, V120, P209, DOI 10.1620/tjem.120.209; WALDROP GL, 1990, BIOCHEM J, V267, P417, DOI 10.1042/bj2670417; WALDROP GL, 1990, AM J PHYSIOL, V259, pG219, DOI 10.1152/ajpgi.1990.259.2.G219; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2	44	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4586	4592						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999436				2022-12-25	WOS:A1991FA69400087
J	YOKOYAMA, S; KEZDY, FJ				YOKOYAMA, S; KEZDY, FJ			MONOLAYERS OF LONG-CHAIN LECITHINS AT THE AIR-WATER-INTERFACE AND THEIR HYDROLYSIS BY PHOSPHOLIPASE-A2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID MONOLAYERS; PANCREATIC PHOSPHOLIPASE-A2; KINETIC ANALYSIS; CROTALUS-ATROX; PHOSPHATIDYLCHOLINE; PRESSURE	The behavior of phosphatidylcholine monolayers at the air/water interface was studied by measuring their surface isotherm, surface potential, surface viscosity, and rate of hydrolysis by the dimeric phospholipase A2 from the venom of Crotalus atrox. The monolayers showed typical liquid-expanded behavior. In this phase, the surface potential was linearly dependent on surface concentration and extrapolated at zero concentration to a value characteristic of a liquid hydrocarbon/water interface. The rate of the reaction was measured by monitoring changes in area at constant surface pressure for 1,2-dioctanoyl- and 1,2-didecanoyl-3-sn-phosphatidylcholines, and by monitoring changes in surface potential for 1,2-dimyristoyl-, 1,2-dipalmitoyl-, 1-palmitoyl-2-oleoyl-, and 1-oleoyl-2-palmitoyl-sn-glycero-3-phosphocholines. The enzymatic hydrolysis is first order with respect to the enzyme-calcium complex which forms with a K(d) = 1.5 mM. A mechanism is proposed to account for the dependency of the reaction rates on the surface concentration of the substrate. We postulate that the rate-limiting step is the decomposition of a quaternary complex formed from two phospholipid molecules, one calcium ion and one dimeric enzyme. The rate is independent of the surface pressure per se; addition of inert lipids to a monolayer at constant area, and hence constant surface concentration of the substrate, increases the surface pressure without changing the surface density of the substrate yielding maximal enzymatic rate. The enzyme is specific for loosely packed substrate molecules in the liquid-expanded state: transition into the liquid-condensed state or compression of the liquid-expanded layer beyond 80 angstrom 2/phospholipid strongly inhibits the enzymatic reaction. Our results show that surface recognition is a direct consequence of a bifunctional active site since it is only at a phospholipid surface that the distance between two substrate molecules is optimal for forming a catalytically competent enzyme-Ca2+-(substrate)2 complex.	UPJOHN CO,BIOPOLYMERS GRP,KALAMAZOO,MI 49001; UNIV CHICAGO,DEPT BIOCHEM,CHICAGO,IL 60637	Pfizer; University of Chicago	YOKOYAMA, S (corresponding author), UNIV ALBERTA,LIPID & LIPOPROT RES GRP,EDMONTON T6G 2S2,ALBERTA,CANADA.				NHLBI NIH HHS [HL SCOR 15062] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL015062] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTENBACH C, 1984, BIOCHEMISTRY-US, V23, P3913, DOI 10.1021/bi00312a019; BERGERON JA, 1967, J COLLOID INTERF SCI, V23, P292, DOI 10.1016/0021-9797(67)90115-4; BUKOWSKI T, 1986, BIOCHEMISTRY-US, V25, P8024, DOI 10.1021/bi00372a035; CHO WW, 1988, J BIOL CHEM, V263, P11237; COHEN H, 1976, J COLLOID INTERF SCI, V56, P240, DOI 10.1016/0021-9797(76)90249-6; COLACICCO G, 1971, NATURE, V233, P202, DOI 10.1038/233202a0; Dennis EA, 1983, ENZYMES, P307; HACHIMORI Y, 1971, BIOCHEMISTRY-US, V10, P4084, DOI 10.1021/bi00798a012; HOUSER H, 1968, BIOCHEM J, V109, P909; KUPFERBERG JP, 1981, J BIOL CHEM, V256, P6274; LAGOCKI JW, 1970, J AM CHEM SOC, V92, P2923, DOI 10.1021/ja00712a058; Langmuir I, 1933, J CHEM PHYS, V1, P756, DOI 10.1063/1.1749243; Nutting GC, 1940, J AM CHEM SOC, V62, P3155, DOI 10.1021/ja01868a073; PHILLIPS MC, 1968, BIOCHIM BIOPHYS ACTA, V163, P301, DOI 10.1016/0005-2736(68)90115-6; PIERONI G, 1983, EUR J BIOCHEM, V132, P639, DOI 10.1111/j.1432-1033.1983.tb07411.x; SAITO K, 1962, BIOCHEMISTRY-US, V1, P521, DOI 10.1021/bi00909a025; SEHGAL KC, 1979, BIOCHIM BIOPHYS ACTA, V552, P11, DOI 10.1016/0005-2736(79)90242-6; SHEN BW, 1975, J AM CHEM SOC, V97, P1205, DOI 10.1021/ja00838a040; TOMASSELLI AG, 1989, J BIOL CHEM, V264, P10041; VERGER R, 1976, ANNU REV BIOPHYS BIO, V5, P77, DOI 10.1146/annurev.bb.05.060176.000453; VERHEIJ HM, 1981, REV PHYSIOL BIOCH P, V91, P91; ZOGRAFI G, 1971, CHEM PHYS LIPIDS, V7, P185, DOI 10.1016/0009-3084(71)90001-6	22	16	16	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4303	4308						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999420				2022-12-25	WOS:A1991FA69400046
J	FARMER, EE; MOLOSHOK, TD; SAXTON, MJ; RYAN, CA				FARMER, EE; MOLOSHOK, TD; SAXTON, MJ; RYAN, CA			OLIGOSACCHARIDE SIGNALING IN PLANTS - SPECIFICITY OF OLIGOURONIDE-ENHANCED PLASMA-MEMBRANE PROTEIN-PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITOR-INDUCING FACTOR; SOYBEAN GLYCINE-MAX; TOMATO LEAVES; KINASE; FRAGMENTS; ELICITORS; CULTURES; ACID	The in vitro phosphorylation by [gamma-P-32]ATP of a 34-kDa plasma membrane-associated protein (pp34) from tomato and potato is strongly enhanced in the presence of alpha-1,4-D-polygalacturonic acid (PGA) fragments (Farmer, E. E., Pearce, G., and Ryan, C. A. (1989) Proc. Natl. Acad. Sci. U.S.A. 86, 1539-1542) that activate the expression of defensive and developmental genes in plant tissues. [gamma-S-35]ATP, but not [gamma-S-35]GTP, has now been found to strongly label pp34 in the presence of the PGA fragments. PGA-enhanced phosphorylation of pp34 is at one or more threonine residue(s) and therefore is the product of a serine/threonine kinase. Alpha-1,4-L-Polyguluronic acid (PGU) enhances thiophosphorylation of pp34, but is less effective than PGA. Beta-1,4-D-Polymannuronic acid (PMA) is inactive. In vivo synthesis of proteinase inhibitors in tomato leaves in response to PGA, PGU, and PMA parallels enhancing activities in in vitro phosphorylation assays. The minimum oligogalacturonide lengths that enhance in vitro thiophosphorylation of pp34 are about 14-15 residues, which are near the minimum sizes of uronides required to elicit a variety of localized defensive and developmental responses in plants. The lengths of biologically active galacturonic acid oligomers are of the same length that form strong intermolecular complexes in solution with Ca2+. Uronide-Ca2+ complexes are proposed to be the active molecular species that initiate the signal transduction pathways regulating uronide-responsive genes.	UNIV CALIF DAVIS,PLANT GROWTH LAB,DAVIS,CA 95616	University of California System; University of California Davis	FARMER, EE (corresponding author), WASHINGTON STATE UNIV,INST BIOL CHEM,PULLMAN,WA 99164, USA.		Farmer, Edward E/H-1635-2011					BISHOP PD, 1984, J BIOL CHEM, V259, P3172; BISHOP PD, 1981, P NATL ACAD SCI-BIOL, V78, P3536, DOI 10.1073/pnas.78.6.3536; BRUCE RJ, 1989, PLANT PHYSIOL, V91, P889, DOI 10.1104/pp.91.3.889; CERVONE F, 1989, NATO ASI SERIES H, V36, P85; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; COUGHLAN S, 1987, J BIOL CHEM, V262, P8402; DARVILL AG, 1984, ANNU REV PLANT PHYS, V35, P243, DOI 10.1146/annurev.pp.35.060184.001331; DIETRICH A, 1990, J BIOL CHEM, V265, P6360; DUBIOS M, 1956, ANAL CHEM, V28, P350, DOI DOI 10.1021/AC60111A017; EBERHARD S, 1989, PLANT CELL, V1, P747, DOI 10.1105/tpc.1.8.747; FARMER EE, 1990, CURR T PL B, V9, P249; FARMER EE, 1989, P NATL ACAD SCI USA, V86, P1539, DOI 10.1073/pnas.86.5.1539; FARMER EE, 1989, NATO ASI H, V36, P49; GRAB D, 1989, PLANTA, V179, P340, DOI 10.1007/BF00391079; GRASDALEN H, 1981, CARBOHYD RES, V89, P179, DOI 10.1016/S0008-6215(00)85243-X; GUILFOYLE TJ, 1989, PLANT CELL, V1, P827, DOI 10.1105/tpc.1.8.827; HAUG A, 1967, ACTA CHEM SCAND, V21, P691, DOI 10.3891/acta.chem.scand.21-0691; HIDDINGA HJ, 1988, SCIENCE, V241, P451, DOI 10.1126/science.3393910; Hodges T K, 1974, Methods Enzymol, V32, P392; JIN DF, 1984, PLANT PHYSIOL, V74, P989, DOI 10.1104/pp.74.4.989; KAMPS MP, 1989, ANAL BIOCHEM, V176, P22, DOI 10.1016/0003-2697(89)90266-2; KOHN R, 1975, PURE APPL CHEM, V42, P371, DOI 10.1351/pac197542030371; RANJEVA R, 1987, ANNU REV PLANT PHYS, V38, P73, DOI 10.1146/annurev.pp.38.060187.000445; RYAN CA, 1967, ANAL BIOCHEM, V19, P434, DOI 10.1016/0003-2697(67)90233-3; RYAN CA, 1987, ANNU REV CELL BIOL, V3, P295, DOI 10.1146/annurev.cellbio.3.1.295; SCHALLER GE, 1988, PLANTA, V173, P509, DOI 10.1007/BF00958964; SCHMIDT WE, 1987, P NATL ACAD SCI USA, V84, P4117, DOI 10.1073/pnas.84.12.4117; SHORT TW, 1990, PLANT PHYSIOL, V92, P179, DOI 10.1104/pp.92.1.179; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; Toubart P, 1985, NATURE, V314, P615; TRAUTMAN R, 1971, IMMUNOCHEMISTRY, V8, P901, DOI 10.1016/0019-2791(71)90429-0; WEST CA, 1984, STRUCTURE FUNCTION B, P359; WONG YS, 1989, PLANT PHYSIOL, V91, P709, DOI 10.1104/pp.91.2.709; YOSHIDA S, 1983, PLANT PHYSIOL, V72, P105, DOI 10.1104/pp.72.1.105	34	133	137	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3140	3145						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993685				2022-12-25	WOS:A1991EX60000071
J	MARINO, MW; FELD, LJ; JAFFE, EA; PFEFFER, LM; HAN, HM; DONNER, DB				MARINO, MW; FELD, LJ; JAFFE, EA; PFEFFER, LM; HAN, HM; DONNER, DB			PHOSPHORYLATION OF THE PROTOONCOGENE PRODUCT EUKARYOTIC INITIATION FACTOR-4E IS A COMMON CELLULAR-RESPONSE TO TUMOR-NECROSIS-FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							CAP-BINDING PROTEIN; HUMAN-ENDOTHELIAL CELLS; AMINO-ACID SEQUENCE; MESSENGER-RNA; CYTO-TOXICITY; FACTOR-ALPHA; IDENTIFICATION; MECHANISMS; RECEPTOR; EIF-4F	The initiation of mRNA translation is regulated by the reversible phosphorylation of several initiation factors. We report here that tumor necrosis factor-alpha (TNF) rapidly stimulates phosphorylation of one such factor, an mRNA cap binding protein, in several cell types which are important in vitro models of TNF action. This protein has been purified, sequenced, and identified as the proto-oncogene product eukaryotic initiation factor 4E. These data show that phosphorylation of a key component of the cellular translational machinery is a common early event in the various actions of TNF in diverse cell types.	MEM SLOAN KETTERING CANC CTR,NEW YORK,NY 10021; CORNELL UNIV,GRAD SCH MED SCI,SLOAN KETTERING DIV,ITHACA,NY 14853; CORNELL UNIV,MED CTR,COLL MED,DEPT MED,DIV HEMATOL ONCOL,NEW YORK,NY 10021; CORNELL UNIV,MED CTR,COLL MED,SPECIALIZED CTR RES THROMBOSIS,NEW YORK,NY 10021; ROCKEFELLER UNIV,VIROL & CELL PHYSIOL LAB,NEW YORK,NY 10021	Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University; Rockefeller University				Pfeffer, Lawrence/0000-0003-2809-1234	NCI NIH HHS [CA44747] Funding Source: Medline; NIADDK NIH HHS [AM30788] Funding Source: Medline; NIGMS NIH HHS [GM36716] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM030788] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA044747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036716] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AEBERSOLD RH, 1987, P NATL ACAD SCI USA, V84, P6970, DOI 10.1073/pnas.84.20.6970; ARRIGO AP, 1990, MOL CELL BIOL, V10, P1276, DOI 10.1128/MCB.10.3.1276; BERKOW RL, 1988, J LEUKOCYTE BIOL, V44, P345, DOI 10.1002/jlb.44.5.345; BIRD TA, 1989, J IMMUNOL, V142, P126; BONNEAU AM, 1987, J BIOL CHEM, V262, P11134; BRENNER C, 1988, MOL CELL BIOL, V8, P3556, DOI 10.1128/MCB.8.8.3556; BROWNING KS, 1987, J BIOL CHEM, V262, P11228; DONATO NJ, 1989, J CELL BIOCHEM, V41, P139, DOI 10.1002/jcb.240410305; DONATO NJ, 1989, J BIOL CHEM, V264, P20474; DUNCAN R, 1987, J BIOL CHEM, V262, P380; HAN J, 1990, J EXP MED, V171, P465, DOI 10.1084/jem.171.2.465; HEPBURN A, 1988, FEBS LETT, V227, P175, DOI 10.1016/0014-5793(88)80892-5; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; JAFFE EA, 1987, J BIOL CHEM, V262, P8557; JOSHIBARVE S, 1990, J BIOL CHEM, V265, P2979; KASPAR RL, 1990, J BIOL CHEM, V265, P3619; KAUR P, 1988, FEBS LETT, V241, P6, DOI 10.1016/0014-5793(88)81019-6; KOHNO M, 1990, BIOCHEM J, V267, P91, DOI 10.1042/bj2670091; KULL FC, 1988, NAT IMMUN CELL GROW, V7, P254; KUNKEL SL, 1989, CRIT REV IMMUNOL, V9, P93; LAWSON TG, 1988, J BIOL CHEM, V263, P7266; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; MARINO MW, 1989, P NATL ACAD SCI USA, V86, P8417, DOI 10.1073/pnas.86.21.8417; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; RAY BK, 1983, P NATL ACAD SCI-BIOL, V80, P663, DOI 10.1073/pnas.80.3.663; RHOADS RE, 1988, TRENDS BIOCHEM SCI, V13, P52, DOI 10.1016/0968-0004(88)90028-X; ROBAYE B, 1989, BIOCHEM BIOPH RES CO, V163, P301, DOI 10.1016/0006-291X(89)92135-9; ROSEN OM, 1981, COLD SPRING HARBOR C, V8, P715; ROSENBLUM MG, 1989, CRIT REV IMMUNOL, V9, P21; RYCHLIK W, 1987, P NATL ACAD SCI USA, V84, P945, DOI 10.1073/pnas.84.4.945; SCHUTZE S, 1989, J BIOL CHEM, V264, P3562; SONENBERG N, 1988, PROG NUCLEIC ACID RE, V35, P173, DOI 10.1016/S0079-6603(08)60614-5; STONE KL, 1989, TECHNIQUES PROTEIN C, P377; WALTZ K, 1987, TRANSLATIONAL CONTRO, P157	34	42	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2685	2688						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993647				2022-12-25	WOS:A1991EX60000002
J	SUNG, WL; ZAHAB, DM; BARBIER, JR; WATSON, D; YAGUCHI, M; NEUGEBAUER, W; WILLICK, GE				SUNG, WL; ZAHAB, DM; BARBIER, JR; WATSON, D; YAGUCHI, M; NEUGEBAUER, W; WILLICK, GE			SPECIFIC DEGENERATE CODONS ENHANCED SELECTIVE EXPRESSION OF HUMAN PARATHYROID-HORMONE IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PREPROPARATHYROID HORMONE; SECONDARY STRUCTURE; SEQUENCE; PROTEINS	Specific degenerate codons in the amino-terminal region of a synthetic human parathyroid hormone (PTH) gene exerted dramatic effects on both products and yield of expression of this 84-amino acid polypeptide in Escherichia coli. With adenine-rich degenerate codons constituting the PTH-(1-5) region, intact PTH has been expressed as the only PTH product at 6.5 mg/liter. In contrast, with guanine-rich degenerate codons, the predominant product was analogue PTH-(8-84). Use of cytosine- or thymine-rich degenerate codons generated only a small amount of immunoreactive product (0.2 mg/l). With the amino terminal region reconstituted with adenine-rich degenerate codons, the mid and carboxyl regions of the synthetic gene were also reconstructed to imitate the E. coli-favored codon degeneracy. Expression yielded the intact PTH at 20 mg/liter. Gel electrophoresis and Western blots, with antibodies specific to the amino or carboxyl terminus of PTH, indicated only a single PTH-related polypeptide, with the same mobility as a synthetic intact PTH sample. Amino acid sequencing, composition analysis, mass spectrometry, and the adenylate cyclase bioassays confirmed the purified product as the processed intact PTH.			SUNG, WL (corresponding author), NATL RES COUNCIL CANADA,DEPT BIOL SCI,OTTAWA K1A 0R6,ONTARIO,CANADA.							BORN W, 1987, J BONE MINER RES, V2, P353; BORN W, 1987, MOL ENDOCRINOL, V1, P5, DOI 10.1210/mend-1-1-5; BREYEL E, 1987, 3RD C EUR BIOT, V111, P363; CHEN GFT, 1990, NUCLEIC ACIDS RES, V18, P1465, DOI 10.1093/nar/18.6.1465; CHEN HR, 1982, DNA-J MOLEC CELL BIO, V1, P365, DOI 10.1089/dna.1982.1.365; HALL MN, 1982, NATURE, V295, P616, DOI 10.1038/295616a0; HENDY GN, 1981, P NATL ACAD SCI-BIOL, V78, P7365, DOI 10.1073/pnas.78.12.7365; Hirs C. H. W, 1967, METHODS ENZYMOL, V11, P197; HOGSET A, 1990, J BIOL CHEM, V265, P7338; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MORELLE G, 1988, BIOCHIM BIOPHYS ACTA, V950, P459, DOI 10.1016/0167-4781(88)90146-7; POSNETT DN, 1988, J BIOL CHEM, V263, P1719; RABBANI SA, 1988, J BIOL CHEM, V263, P1307; REEVE J, 1980, BMJ-BRIT MED J, V280, P1340, DOI 10.1136/bmj.280.6228.1340; SHERMAN F, 1985, BIOESSAYS, V3, P27, DOI 10.1002/bies.950030108; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; SIMPSON RJ, 1976, J BIOL CHEM, V251, P1936; STEWART JM, 1984, SOLID PHASE PEPTIDE, P1; SUNG WL, 1986, GENE, V47, P261, DOI 10.1016/0378-1119(86)90069-7; SUNG WL, 1986, BIOCHEM CELL BIOL, V64, P133, DOI 10.1139/o86-021; TINOCO I, 1973, NATURE-NEW BIOL, V246, P40, DOI 10.1038/newbio246040a0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VARENNE S, 1986, J THEOR BIOL, V120, P99, DOI 10.1016/S0022-5193(86)80020-0; WINGENDER E, 1989, J BIOL CHEM, V264, P4367	24	14	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2831	2835						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993659				2022-12-25	WOS:A1991EX60000028
J	UENO, M; OGAWA, H; MATSUMOTO, I; SENO, N				UENO, M; OGAWA, H; MATSUMOTO, I; SENO, N			A NOVEL MANNOSE-SPECIFIC AND SUGAR SPECIFICALLY AGGREGATABLE LECTIN FROM THE BARK OF THE JAPANESE PAGODA TREE (SOPHORA-JAPONICA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; VICIA-FABA; DOLICHOS-BIFLORUS; CHEMICAL CHARACTERIZATION; CLERODENDRON-TRICHOTOMUM; AFFINITY-CHROMATOGRAPHY; LINKED OLIGOSACCHARIDES; CONCANAVALIN-A; PLANT-LECTINS; PISUM-SATIVUM	A new D-mannose/D-glucose-specific lectin (B-SJA-II) was isolated from the bark of the Japanese pagoda tree, Sophora japonica. B-SJA-II was separated from a well known D-galactose/N-acetyl-D-galactosamine-specific lectin (B-SJA-I) by affinity chromatography on lactamyl-Sepharose, then purified by affinity chromatography on maltamyl-Sepharose. On sodium dodecyl sulfate-polyacrylamide gel electrophoresis, B-SJA-II gave four bands: subunit a-1 (M(r) = 19,400), a-2 (M(r) = 18,200), b-1 (M(r) = 15,000), and b-2 (M(r) = 13,200). Carbohydrate analysis and binding study with horseradish peroxidase-labeled lectins on the bands electroblotted onto polyvinylidene difluoride membrane showed that the three subunits other than b-2 have N-linked oligosaccharides typical of plant glycoproteins. The binding assay with horseradish peroxidase-glycoproteins revealed that all the subunits can bind sugar specifically with fetuin and asialofetuin. Furthermore, B-SJA-II aggregated to form precipitates in the absence of a specific sugar and became soluble upon addition of the specific sugar. The results indicate that each subunit has a sugar-binding site for the mannosyl core of N-linked oligosaccharide chains and recognizes each other sugar specifically to form aggregates. According to the N-terminal amino acid sequences obtained, the subunits are classified into two groups. The first group (a-1 and a-2) has an N-terminal sequence 50% identical with that of other S. japonica lectins (Hankins, C. N., Kindinger, J. I., and Shannon, L. M. (1988) Plant Physiol. 86, 67-70) and the amino acid sequence initiating at position 123 of concanavalin A (Cunningham, B. (1975) J. Biol. Chem 250, 1503-1512), while the N-terminal sequence of the second group (b-1 and b-2) is homologous to that of concanavalin A, but completely different from that of the first group.	OCHANOMIZU UNIV,FAC SCI,DEPT CHEM,BUNKYO KU,TOKYO 112,JAPAN	Ochanomizu University								ALLEN AK, 1979, BIOCHEM J, V183, P133, DOI 10.1042/bj1830133; ALLEN AK, 1973, BIOCHEM J, V135, P307, DOI 10.1042/bj1350307; ASHFORD D, 1987, EUR J BIOCHEM, V166, P311, DOI 10.1111/j.1432-1033.1987.tb13516.x; BOWLES DJ, 1986, J CELL BIOL, V102, P1284, DOI 10.1083/jcb.102.4.1284; BROEKAERT WF, 1984, BIOCHEM J, V221, P163, DOI 10.1042/bj2210163; CHIEN SM, 1974, IMMUNOCHEMISTRY, V11, P501, DOI 10.1016/0019-2791(74)90122-0; CUNNINGHAM BA, 1975, J BIOL CHEM, V250, P1503; DAZZO FB, 1978, BIOCHIM BIOPHYS ACTA, V539, P276, DOI 10.1016/0304-4165(78)90032-6; ETZLER ME, 1980, BIOCHEM BIOPH RES CO, V96, P92, DOI 10.1016/0006-291X(80)91185-7; ETZLER ME, 1985, ANNU REV PLANT PHYS, V36, P209, DOI 10.1146/annurev.pp.36.060185.001233; Etzler ME, 1986, LECTINS PROPERTIES F, P371; FORIERS A, 1981, J BIOL CHEM, V256, P5550; FOURNET B, 1987, EUR J BIOCHEM, V166, P321, DOI 10.1111/j.1432-1033.1987.tb13517.x; GADE W, 1981, J BIOL CHEM, V256, P2905; GATEHOUSE JA, 1980, PHYSIOL PLANTARUM, V49, P437, DOI 10.1111/j.1399-3054.1980.tb03331.x; Goldstein I., 1986, LECTINS, DOI DOI 10.1016/B978-0-12-449945-4.50007-5; HANKINS CN, 1987, PLANT PHYSIOL, V83, P825, DOI 10.1104/pp.83.4.825; HANKINS CN, 1988, PLANT PHYSIOL, V86, P67, DOI 10.1104/pp.86.1.67; HAPNER KD, 1979, BIOCHIM BIOPHYS ACTA, V580, P186, DOI 10.1016/0005-2795(79)90209-5; HEMPERLY JJ, 1982, J BIOL CHEM, V257, P7903; HEMPERLY JJ, 1979, J BIOL CHEM, V254, P6803; HERMAN EM, 1988, PLANT PHYSIOL, V86, P1027, DOI 10.1104/pp.86.4.1027; HIGGINS TJV, 1983, J BIOL CHEM, V258, P9544; HIRANO H, 1989, J PROTEIN CHEM, V8, P115, DOI 10.1007/BF01025083; HOPP TP, 1982, J BIOL CHEM, V257, P4473; HOREJSI V, 1978, BIOCHIM BIOPHYS ACTA, V532, P98, DOI 10.1016/0005-2795(78)90452-X; KIJIMOTOOCHIAI S, 1985, ANAL BIOCHEM, V147, P222, DOI 10.1016/0003-2697(85)90031-4; KIJNE JW, 1980, PLANT SCI LETT, V18, P65, DOI 10.1016/0304-4211(80)90022-X; KILPATRICK DC, 1980, BIOCHEM J, V185, P269, DOI 10.1042/bj1850269; KITAGAKI H, 1985, J BIOCHEM-TOKYO, V97, P791, DOI 10.1093/oxfordjournals.jbchem.a135119; KITAGAKIOGAWA H, 1986, EUR J BIOCHEM, V161, P779, DOI 10.1111/j.1432-1033.1986.tb10507.x; KRUPE M, 1952, NATURWISSENSCHAFTEN, V39, P284; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMB JE, 1983, PLANT PHYSIOL, V71, P879, DOI 10.1104/pp.71.4.879; MATSUMOTO I, 1981, ANAL BIOCHEM, V116, P103, DOI 10.1016/0003-2697(81)90329-8; MATSUMOTO I, 1983, J BIOCHEM-TOKYO, V93, P763, DOI 10.1093/jb/93.3.763; MCPHERSON A, 1987, J BIOL CHEM, V262, P1791; MIKAMI H, 1983, BUNSEKI KAGAKU, V32, pE207; NAKAGAWA S, 1989, ANAL BIOCHEM, V181, P75, DOI 10.1016/0003-2697(89)90395-3; NAKANE PK, 1975, METHOD ENZYMOL, V37, P137; OGAWA H, 1990, ANAL BIOCHEM, V190, P165, DOI 10.1016/0003-2697(90)90175-9; OLSNES S, 1982, J BIOL CHEM, V257, P13263; PEUMANS WJ, 1984, FEBS LETT, V177, P99, DOI 10.1016/0014-5793(84)80989-8; PEUMANS WJ, 1984, PLANTA, V160, P222, DOI 10.1007/BF00402858; PEUMANS WJ, 1985, PLANTA, V164, P75, DOI 10.1007/BF00391028; PEUMANS WJ, 1986, MOL BIOL SEED STORAG, P53; PORETZ RD, 1974, BIOCHEMISTRY-US, V13, P250, DOI 10.1021/bi00699a004; PRIGENT MJ, 1984, CARBOHYD RES, V131, P83, DOI 10.1016/0008-6215(84)85406-3; QUINN JM, 1987, ARCH BIOCHEM BIOPHYS, V258, P535, DOI 10.1016/0003-9861(87)90375-4; SABNIS DD, 1978, PLANTA, V142, P97, DOI 10.1007/BF00385126; SHANNON LM, 1986, MOL BIOL SEED STORAG, P73; SPACKMAN DH, 1958, ANAL CHEM, V30, P1190, DOI 10.1021/ac60139a006; TAATJES DJ, 1988, HISTOCHEM J, V20, P478, DOI 10.1007/BF01002646; TAKAHASHI N, 1982, FEBS LETT, V146, P139, DOI 10.1016/0014-5793(82)80721-7; TALBOT CF, 1978, BIOCHEMISTRY-US, V17, P1474, DOI 10.1021/bi00601a018; TAZAKI K, 1989, PLANT CELL PHYSIOL, V30, P899, DOI 10.1093/oxfordjournals.pcp.a077822; TERAO T, 1973, J BIOCHEM, V74, P199, DOI 10.1093/oxfordjournals.jbchem.a130226; TREVELYAN WE, 1952, BIOCHEM J, V50, P298, DOI 10.1042/bj0500298; TROWBRIDGE IS, 1974, J BIOL CHEM, V249, P6004; VODKIN LO, 1986, PLANT PHYSIOL, V81, P558, DOI 10.1104/pp.81.2.558; WAXDAL MJ, 1974, BIOCHEMISTRY-US, V13, P3671, DOI 10.1021/bi00715a008; WU AM, 1981, ARCH BIOCHEM BIOPHYS, V209, P191, DOI 10.1016/0003-9861(81)90272-1	62	43	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3146	3153						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993686				2022-12-25	WOS:A1991EX60000072
J	HUISMAN, GW; WONINK, E; MEIMA, R; KAZEMIER, B; TERPSTRA, P; WITHOLT, B				HUISMAN, GW; WONINK, E; MEIMA, R; KAZEMIER, B; TERPSTRA, P; WITHOLT, B			METABOLISM OF POLY(3-HYDROXYALKANOATES) (PHAS) BY PSEUDOMONAS-OLEOVORANS - IDENTIFICATION AND SEQUENCES OF GENES AND FUNCTION OF THE ENCODED PROTEINS IN THE SYNTHESIS AND DEGRADATION OF PHA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY-BETA-HYDROXYBUTYRATE; ALCALIGENES-EUTROPHUS H16; BROAD HOST RANGE; ACETOACETYL-COA REDUCTASE; ESCHERICHIA-COLI; NUCLEOTIDE-SEQUENCE; ALKALINE EXTRACTION; ZOOGLOEA-RAMIGERA; COSMID CLONING; DNA	Pseudomonas oleovorans accumulates poly(3-hydroxyalkanoates) (PHAs) after growth on medium chain length hydrocarbons. Large amounts of this polyester are synthesized when cells are grown under nitrogen-limiting conditions. When nitrogen is resupplied in the medium, the accumulated PHA is degraded. In this paper, we describe mutants which are defective in the synthesis or in the degradation of PHA. These mutants were used to select DNA fragments which encode PHA polymerases and a PHA depolymerase. A 25-kilobase (kb) DNA fragment was isolated from P. oleovorans that complements a Pseudomonas putida mutant unable to accumulate PHA. Subcloning resulted in the assignment of a 6.4-kb EcoRI fragment as the pha locus, containing genetic information of PHA synthesis. Mutants in the PHA degradation pathway were also complemented by this fragment, indicating that genes encoding PHA biosynthetic and degradative enzymes are clustered. Analysis of the DNA sequence of the 6.4-kb fragment revealed the presence of two open reading frames encoding PHA polymerases based on homology to the poly(3-hydroxybutyrate) polymerase from Alcaligenes eutrophus. A third open reading frame complemented the PHA degradation mutation and is likely to encode a PHA depolymerase. The presence of two PHA polymerases is due to a 2098-base pair DNA duplication. The PHA polymerases are 53% identical and show 35-40% identity to the poly(3-hydroxybutyrate) polymerase. No clear difference in specificity was found for the PHA polymerases. However, with the pha locus cloned on a multicopy vector, a polymer was accumulated that contains a significantly higher amount of substrate-derived monomers. An increase in the rate of polyester synthesis versus oxidation of the monomers in the beta-oxidation explains these findings.	STATE UNIV GRONINGEN,GRONINGEN BIOTECHNOL CTR,DEPT BIOCHEM,NIJENBORGH 16,9747 AG GRONINGEN,NETHERLANDS	University of Groningen			Witholt, Bernard/A-7340-2012	Huisman, Gjalt/0000-0003-1955-1120				ALDRICH TL, 1988, J BACTERIOL, V170, P1297, DOI 10.1128/jb.170.3.1297-1304.1988; BAGDASARIAN M, 1981, GENE, V16, P237, DOI 10.1016/0378-1119(81)90080-9; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BRANDL H, 1988, APPL ENVIRON MICROB, V54, P1977, DOI 10.1128/AEM.54.8.1977-1982.1988; BYROM D, 1987, TRENDS BIOTECHNOL, V5, P246, DOI 10.1016/0167-7799(87)90100-4; CAPON RJ, 1983, PHYTOCHEMISTRY, V22, P1181, DOI 10.1016/0031-9422(83)80217-9; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; CRAWFORD IP, 1989, BIOCHIMIE, V71, P521, DOI 10.1016/0300-9084(89)90183-1; DAVISON J, 1987, GENE, V51, P275, DOI 10.1016/0378-1119(87)90316-7; Dawes E A, 1973, Adv Microb Physiol, V10, P135, DOI 10.1016/S0065-2911(08)60088-0; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; DITTA G, 1980, P NATL ACAD SCI-BIOL, V77, P7347, DOI 10.1073/pnas.77.12.7347; DIXON R, 1986, MOL GEN GENET, V203, P129, DOI 10.1007/BF00330393; EGGINK G, 1984, PROG IND MICROBIOL, V20, P373; FICKETT JW, 1982, NUCLEIC ACIDS RES, V10, P5303, DOI 10.1093/nar/10.17.5303; FINDLAY RH, 1983, APPL ENVIRON MICROB, V45, P71, DOI 10.1128/AEM.45.1.71-78.1983; FRIEDMAN AM, 1982, GENE, V18, P289, DOI 10.1016/0378-1119(82)90167-6; GRIEBEL RJ, 1971, J BACTERIOL, V108, P782, DOI 10.1128/JB.108.2.782-789.1971; HAYWOOD GW, 1989, BIOTECHNOL LETT, V11, P471, DOI 10.1007/BF01026644; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151; HUISMAN GW, 1989, APPL ENVIRON MICROB, V55, P1949, DOI 10.1128/AEM.55.8.1949-1954.1989; ISHHOROWICZ D, 1981, NUCLEIC ACIDS RES, V9, P2989, DOI 10.1093/nar/9.13.2989; KING PP, 1982, J CHEM TECHNOL BIOT, V32, P2; LAGEVEEN RG, 1988, APPL ENVIRON MICROB, V54, P2924, DOI 10.1128/AEM.54.12.2924-2932.1988; Maniatis T., 1982, MOL CLONING; MORETT E, 1988, P NATL ACAD SCI USA, V85, P9401, DOI 10.1073/pnas.85.24.9401; OW DW, 1985, J BACTERIOL, V161, P868, DOI 10.1128/JB.161.3.868-874.1985; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PEOPLES OP, 1989, MOL MICROBIOL, V3, P349, DOI 10.1111/j.1365-2958.1989.tb00180.x; PEOPLES OP, 1989, J BIOL CHEM, V264, P15293; PEOPLES OP, 1989, J BIOL CHEM, V264, P15298; PEOPLES OP, 1987, J BIOL CHEM, V262, P97; PERSSON B, 1989, EUR J BIOCHEM, V179, P39, DOI 10.1111/j.1432-1033.1989.tb14518.x; POOL R, 1989, SCIENCE, V245, P1187, DOI 10.1126/science.245.4923.1187; PREUSTING H, 1990, MACROMOLECULES, V23, P4220, DOI 10.1021/ma00221a007; SAITO T, 1989, J BACTERIOL, V171, P184, DOI 10.1128/jb.171.1.184-189.1989; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHUBERT P, 1988, J BACTERIOL, V170, P5837, DOI 10.1128/jb.170.12.5837-5847.1988; SCHWARTZ RD, 1973, APPL MICROBIOL, V26, P217, DOI 10.1128/AEM.26.2.217-218.1973; SHINE J, 1975, NATURE, V254, P34, DOI 10.1038/254034a0; SLATER SC, 1988, J BACTERIOL, V170, P4431, DOI 10.1128/jb.170.10.4431-4436.1988; TOMITA K, 1983, BIOCH METABOLIC PROC; WALLEN LL, 1974, ENVIRON SCI TECHNOL, V8, P576, DOI 10.1021/es60091a007; WITHOLT B, 1972, J BACTERIOL, V109, P350, DOI 10.1128/JB.109.1.350-364.1972	45	241	257	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2191	2198						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989978				2022-12-25	WOS:A1991EV51500029
J	UCHIUMI, T; TRAUT, RR; ELKON, K; KOMINAMI, R				UCHIUMI, T; TRAUT, RR; ELKON, K; KOMINAMI, R			A HUMAN AUTOANTIBODY SPECIFIC FOR A UNIQUE CONSERVED REGION OF 28-S RIBOSOMAL-RNA INHIBITS THE INTERACTION OF ELONGATION FACTOR-1-ALPHA AND FACTOR-II WITH RIBOSOMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC LUPUS-ERYTHEMATOSUS; ESCHERICHIA-COLI RIBOSOMES; RAT-LIVER RIBOSOMES; PROTEIN-SYNTHESIS; RIBONUCLEIC-ACID; BINDING-SITE; EUKARYOTIC RIBOSOMES; NUCLEOTIDE-SEQUENCE; CROSS-LINKING; 23S RNA	An autoantibody reactive with a conserved sequence of 28 S rRNA (anti-28 S) was identified in serum from a patient with systemic lupus erythematosus. Anti-28 S protected a unique 59-nucleotide fragment synthesized in vitro against RNase T1 digestion. RNA sequence analysis revealed that it corresponded to residues 1944-2002 in human 28 S rRNA and 1767-1825 in mouse 28 S rRNA. These sequences are identical and highly conserved throughout all known eukaryotic 28 S rRNAs. In addition, this fragment is homologous to residues 1052-1110 of Escherichia coli 23 S rRNA that lies within the GTP hydrolysis center of the 50 S ribosomal subunit. Anti-28 S and its Fab fragments strongly inhibited poly(U)-directed polyphenylalanine synthesis, but had no effect on ribosomal peptidyltransferase activity. This effect resulted from inhibition of the binding of elongation factors EF-1-alpha and EF-2 to ribosomes and of the associated GTP hydrolysis. The inhibitory effect was almost completely suppressed by preincubation of anti-28 S with 28 S rRNA or in vitro synthesized RNA fragments containing the immunoreactive region. These results show that the immunoreactive conserved region of 28 S rRNA participates in the interaction of ribosomes with the two elongation factors in protein synthesis.	UNIV CALIF DAVIS, SCH MED, DEPT BIOL CHEM, DAVIS, CA 95616 USA; CORNELL UNIV, HOSP SPECIAL SURG, COLL MED, NEW YORK, NY 10021 USA	University of California System; University of California Davis; Cornell University	UCHIUMI, T (corresponding author), NIIGATA UNIV, SCH MED, DEPT BIOCHEM, NIIGATA 951, JAPAN.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR038915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035375] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR-38915] Funding Source: Medline; NIGMS NIH HHS [GM35375] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEAUCLERK AAD, 1984, J BIOL CHEM, V259, P6559; BENSON S, 1975, EUR J BIOCHEM, V59, P573, DOI 10.1111/j.1432-1033.1975.tb02484.x; BUNN CC, 1986, J EXP MED, V163, P1281, DOI 10.1084/jem.163.5.1281; Cundliffe E., 1986, STRUCTURE FUNCTION G, P586; Cundliffe E., 1980, RIBOSOMES STRUCTURE, P555; DAHLBERG AE, 1989, CELL, V57, P525, DOI 10.1016/0092-8674(89)90122-0; DEUTSCHER AL, 1988, P NATIONAL ACADEMY S, V85, P3299; DONISKELLER H, 1980, NUCLEIC ACIDS RES, V8, P3133, DOI 10.1093/nar/8.14.3133; EILAT D, 1980, EUR J IMMUNOL, V10, P841, DOI 10.1002/eji.1830101108; ELKON K, 1986, P NATL ACAD SCI USA, V83, P7419, DOI 10.1073/pnas.83.19.7419; ENDO Y, 1982, J BIOL CHEM, V257, P9054; ENDO Y, 1987, J BIOL CHEM, V262, P5908; England T E, 1980, Methods Enzymol, V65, P65; Engvall E, 1980, Methods Enzymol, V70, P419; FERNANDEZPUENTES C, 1977, FEBS LETT, V78, P143, DOI 10.1016/0014-5793(77)80292-5; FRAPPIER L, 1987, J MOL BIOL, V193, P751, DOI 10.1016/0022-2836(87)90356-1; GONZALEZ IL, 1985, P NATL ACAD SCI USA, V82, P7666, DOI 10.1073/pnas.82.22.7666; GORSKI JL, 1987, J MOL EVOL, V24, P236, DOI 10.1007/BF02111237; HAMEL E, 1972, J BIOL CHEM, V247, P805; HARDIN JA, 1982, J CLIN INVEST, V70, P141, DOI 10.1172/JCI110587; HASSOUNA N, 1984, NUCLEIC ACIDS RES, V12, P3563, DOI 10.1093/nar/12.8.3563; HAUSNER TP, 1987, BIOCHIMIE, V69, P911, DOI 10.1016/0300-9084(87)90225-2; HORAK I, 1977, EUR J BIOCHEM, V79, P375, DOI 10.1111/j.1432-1033.1977.tb11818.x; Iwasaki K, 1979, Methods Enzymol, V60, P657; KAZIRO Y, 1978, BIOCHIM BIOPHYS ACTA, V505, P95, DOI 10.1016/0304-4173(78)90009-5; KENNY JW, 1979, J MOL BIOL, V135, P151, DOI 10.1016/0022-2836(79)90345-0; KOMINAMI R, 1987, J MOL BIOL, V193, P217, DOI 10.1016/0022-2836(87)90639-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMON EW, 1970, IMMUNOLOGY, V19, P439; LILLEHAUG JR, 1975, BIOCHEMISTRY-US, V14, P1225, DOI 10.1021/bi00677a021; LOENING UE, 1967, BIOCHEM J, V102, P251, DOI 10.1042/bj1020251; MAASSEN JA, 1978, J BIOL CHEM, V253, P2777; MACKEEN LA, 1979, FEBS LETT, V101, P387, DOI 10.1016/0014-5793(79)81050-9; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; Moller W., 1974, RIBOSOMES, P711; Monro RE., 1971, METHOD ENZYMOL, V20, P472; MONTANARO L, 1975, BIOCHEM J, V146, P127, DOI 10.1042/bj1460127; NAG B, 1986, J BIOL CHEM, V261, P13892; NISHIMURA S, 1967, BIOCHIM BIOPHYS ACTA, V142, P133, DOI 10.1016/0005-2787(67)90522-9; NOLLER HF, 1984, ANNU REV BIOCHEM, V53, P119, DOI 10.1146/annurev.bi.53.070184.001003; PETTERSSON I, 1976, FEBS LETT, V64, P135, DOI 10.1016/0014-5793(76)80267-0; PETTERSSON I, 1979, FEBS LETT, V98, P139, DOI 10.1016/0014-5793(79)80170-2; PORTER RR, 1959, BIOCHEM J, V73, P119, DOI 10.1042/bj0730119; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHMIDT FJ, 1981, J BIOL CHEM, V256, P2301; SKOLD SE, 1983, NUCLEIC ACIDS RES, V11, P4923, DOI 10.1093/nar/11.14.4923; STARK M, 1979, J MOL BIOL, V134, P767, DOI 10.1016/0022-2836(79)90485-6; STARK MJR, 1980, MOL GEN GENET, V180, P11, DOI 10.1007/BF00267346; TAN EM, 1982, ADV IMMUNOL, V33, P167, DOI 10.1016/S0065-2776(08)60836-6; THOMPSON HA, 1974, BIOCHEMISTRY-US, V13, P1348, DOI 10.1021/bi00704a007; THOMPSON J, 1988, J MOL BIOL, V203, P457, DOI 10.1016/0022-2836(88)90012-5; THOMPSON J, 1982, J BIOL CHEM, V257, P7915; UCHIUMI T, 1986, J BIOL CHEM, V261, P9668; UCHIUMI T, 1990, J BIOL CHEM, V265, P89; UCHIUMI T, 1986, EUR J BIOCHEM, V156, P37, DOI 10.1111/j.1432-1033.1986.tb09545.x; UCHIUMI T, 1987, P NATL ACAD SCI USA, V84, P5580, DOI 10.1073/pnas.84.16.5580; UCHIUMI T, 1983, EUR J BIOCHEM, V132, P495, DOI 10.1111/j.1432-1033.1983.tb07388.x; WEISSBACH H, 1980, RIBOSOMES STRUCTURE, P377; WILUSZ J, 1986, J BIOL CHEM, V261, P5467	59	49	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2054	2062						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989969				2022-12-25	WOS:A1991EV51500010
J	VANETTEN, RL; DAVIDSON, R; STEVIS, PE; MACARTHUR, H; MOORE, DL				VANETTEN, RL; DAVIDSON, R; STEVIS, PE; MACARTHUR, H; MOORE, DL			COVALENT STRUCTURE, DISULFIDE BONDING, AND IDENTIFICATION OF REACTIVE SURFACE AND ACTIVE-SITE RESIDUES OF HUMAN PROSTATIC ACID-PHOSPHATASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEQUENCE-ANALYSIS; PLASMID DNA; CHROMATOGRAPHY; EXPRESSION; CLONING; PROTEIN; GENE; HETEROGENEITY; PURIFICATION; CLEAVAGE	The pairing of the half-cysteine residues of human prostatic acid phosphatase was established by proteolytic digestion and analysis of the resulting peptide mixtures by fast atom bombardment mass spectrometry (FAB-MS). An independently derived, full length cDNA clone was used as the basis for the interpretation of the FAB-MS data. The sequence of the native protein is that predicted from the present cDNA sequence, except for the carboxyl-terminal end and some possible post-translational deamidations. Isolated human prostatic acid phosphatase was found to have multiple carboxyl-terminal ends, terminating in Thr, Glu, and Asp, corresponding to residues 349-351 of the 354-residue protein that is predicted from the cDNA sequence after removal of a leader peptide. The protein contains no free sulfhydryl groups. The identical monomer chains of the dimeric native enzyme are found to contain three disulfide bonds, specifically Cys-129 to Cys-340, Cys-183 to Cys-281, and Cys-315 to Cys-319. In view of the conserved positions of cysteines in the homologous human and rat liver lysosomal acid phosphatases, an identical disulfide bonding pattern may be predicted for those proteins. The location of a potential antigenic site was established by selective labeling of proximate tyrosine residues predicted to be on the surface. A conserved RHGXRXP sequence is present in the prostatic, lysosomal, Escherichia coli, and yeast acid phosphatases and is predicted to be of mechanistic significance. In addition, residue Arg-54 is shown to be an active site residue by reaction of the enzyme with phenylglyoxal. Interestingly, this residue is present in a sequence RXRY (R,H) that is also present in lysosomal phosphatase and in recently described protein tyrosine phosphatases.			VANETTEN, RL (corresponding author), PURDUE UNIV,DEPT CHEM,W LAFAYETTE,IN 47907, USA.							BATGEMAN RC, 1989, J BIOL CHEM, V264, P6151; BAZAN JF, 1989, P NATL ACAD SCI USA, V86, P9642, DOI 10.1073/pnas.86.24.9642; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Bodansky O, 1972, Adv Clin Chem, V15, P43, DOI 10.1016/S0065-2423(08)60159-6; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; CHERNOFF J, 1990, P NATL ACAD SCI USA, V87, P2735, DOI 10.1073/pnas.87.7.2735; CRIMMINS DL, 1989, ANAL BIOCHEM, V176, P255, DOI 10.1016/0003-2697(89)90305-9; DOMANSKI J, 1964, BIOCHIM BIOPHYS ACTA, V92, P405, DOI 10.1016/0926-6569(64)90203-2; DUNCAN PH, 1984, CLIN CHEM, V30, P1327; EVANS CT, 1988, BIOCHEMISTRY-US, V27, P4680, DOI 10.1021/bi00413a015; FOLZ RJ, 1988, J BIOL CHEM, V263, P2070; FONTANA A, 1986, PRACTICAL PROTEIN CH, P68; GEIER C, 1989, EUR J BIOCHEM, V183, P611, DOI 10.1111/j.1432-1033.1989.tb21090.x; GOTTSCHALK S, 1989, EMBO J, V8, P3215, DOI 10.1002/j.1460-2075.1989.tb08480.x; GUAN KL, 1990, P NATL ACAD SCI USA, V87, P1501, DOI 10.1073/pnas.87.4.1501; HEBBARD MD, 1983, CLIN CHEM, V29, P1886; HIMENO M, 1989, BIOCHEM BIOPH RES CO, V162, P1044, DOI 10.1016/0006-291X(89)90779-1; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; HOUMARD J, 1972, P NATL ACAD SCI USA, V69, P3506, DOI 10.1073/pnas.69.12.3506; Huggins C, 1941, CANCER RES, V1, P293; LATHE R, 1985, J MOL BIOL, V183, P1, DOI 10.1016/0022-2836(85)90276-1; LUCHTERW.E, 1974, BIOCHIM BIOPHYS ACTA, V365, P349, DOI 10.1016/0005-2795(74)90008-7; MANFIOLETTI G, 1988, NUCLEIC ACIDS RES, V16, P2873, DOI 10.1093/nar/16.7.2873; MANIATIS T, 1982, MOL CLONING LABORATO, P326; MCWHERTER CA, 1984, ANAL BIOCHEM, V141, P523, DOI 10.1016/0003-2697(84)90081-2; MOORE DL, 1984, THESIS PURDUE U W LA; MORRIS MF, 1989, CLIN CHIM ACTA, V182, P9, DOI 10.1016/0009-8981(89)90145-9; NICOLS R, 1988, ANAL BIOCHEM, V170, P110; OSTROWSKI W, 1980, MALE ACCESSORY SEX G, P197; POHLMANN R, 1988, EMBO J, V7, P2343, DOI 10.1002/j.1460-2075.1988.tb03078.x; RISLEY J M, 1990, Journal of Protein Chemistry, V9, P366; SHARIEF FS, 1989, BIOCHEM BIOPH RES CO, V160, P79, DOI 10.1016/0006-291X(89)91623-9; SMITH D, 1990, IN PRESS CRC REV; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TAGA EM, 1983, PROSTATE, V4, P141, DOI 10.1002/pros.2990040205; THANNHAUSER TW, 1984, ANAL BIOCHEM, V138, P181, DOI 10.1016/0003-2697(84)90786-3; ULLRICH A, 1984, EMBO J, V3, P361, DOI 10.1002/j.1460-2075.1984.tb01812.x; VANETTEN RL, 1978, CLIN CHEM, V24, P1525; VANETTEN RL, 1982, ANN NY ACAD SCI, V390, P27; VIHKO P, 1978, CLIN CHEM, V24, P466; VIHKO P, 1988, FEBS LETT, V236, P275, DOI 10.1016/0014-5793(88)80037-1; VINCENT JB, 1990, FEBS LETT, V263, P265, DOI 10.1016/0014-5793(90)81389-6; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WINDLE BE, 1988, BIOTECHNIQUES, V6, P403	45	137	143	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2313	2319						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989985				2022-12-25	WOS:A1991EV51500047
J	WILLIAMS, JS; ROSEVEAR, PR				WILLIAMS, JS; ROSEVEAR, PR			NUCLEAR OVERHAUSER EFFECT STUDIES ON THE CONFORMATIONS OF MG(ALPHA,BETA-METHYLENE)ATP BOUND TO ESCHERICHIA-COLI METHIONYL-TRANSFER RNA-SYNTHETASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPIN DIFFUSION; MECHANISM; BINDING; ADENOSINE; NMR; RECOGNITION; KINASE; ATP	Internuclear distances obtained from nuclear Overhauser effects were used in combination with a distance geometry algorithm to determine the conformation of Mg(alpha,-beta-methylene)ATP bound to the Escherichia coli truncated methionyl-tRNA synthetase (DELTA-MTS) both in the absence and presence of cognate and noncognate amino acids. Mg(alpha,-beta-methylene)ATP, a nonhydrolyzable analog of ATP, was used to prevent hydrolysis of the nucleotide in the presence of either cognate or noncognate amino acids. Kinetic analysis showed that Mg(alpha,-beta-methylene)ATP was a linear competitive inhibitor with respect to ATP in the ATP-pyrophosphate exchange reaction with a K(i) = 1.2 mM. The pattern of internuclear Overhauser effects on Mg(alpha,-beta-methylene)ATP bound to DELTA-MTS was qualitatively consistent only with an anti glycosidic torsional angle, suggesting that the adenosine portion of the nucleotide is uniquely oriented in the binary enzyme-nucleotide complex. Nearly identical patterns of nuclear Overhauser effects were also observed in ternary complexes containing either cognate L-methionine or noncognate L-homocysteine amino acids. Distance geometry calculations permitted the range and conformational space of the allowed adenine-ribose glycosidic torsional angles in each of the complexes to be better defined and compared. Average adenine-ribose glycosidic torsional angles for enzyme-bound Mg(alpha,-beta-methylene)ATP of -106 +/- 9-degrees, -99 +/- 11-degrees, and -97 +/- 11-degrees were determined for the DELTA-MTS . Mg(alpha,-beta-methylene)ATP, DELTA-MTS . Mg(alpha,-beta-methylene)ATP . L-methionine, and DELTA-MTS . Mg(alpha,-beta-methylene)ATP . L-homocysteine complexes, respectively. Comparison of the three enzyme-bound conformations showed that a single nucleotide structure having an adenine-ribose glycosidic torsional angle of -98-degrees with a 3'-endo to O4'-exo ribose sugar pucker was, within error, consistent with the experimental internuclear distances obtained in all three complexes. The nearly identical anti glycosidic torsional angles observed in all three complexes demonstrates that the conformation of the adenosine moiety of the enzyme-bound nucleotide is not sensitive to the presence or to the nature of the amino acid bound at the aminoacyladenylate site. Therefore, conformational changes known to occur in the methionyl-tRNA synthetase upon ligand binding appear not to alter the bound conformation of the nucleotide. Information on the conformation and arrangement of substrates bound at the aminoacyladenylate site of DELTA-MTS is necessary for understanding the molecular mechanisms involved in amino acid activation and discrimination.	UNIV TEXAS, SCH MED, DEPT BIOCHEM & MOLEC BIOL, HOUSTON, TX 77225 USA	University of Texas System					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041232] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 41232] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTONA C, 1972, J AM CHEM SOC, V94, P8205, DOI 10.1021/ja00778a043; BARKER DG, 1982, EUR J BIOCHEM, V127, P449; BLANQUET S, 1973, EUR J BIOCHEM, V36, P213, DOI 10.1111/j.1432-1033.1973.tb02903.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRICK P, 1989, J MOL BIOL, V208, P83, DOI 10.1016/0022-2836(89)90090-9; BRUNIE S, 1987, J MOL GRAPHICS, V5, P18, DOI 10.1016/0263-7855(87)80039-5; BURBAUM JJ, 1990, PROTEINS, V7, P99, DOI 10.1002/prot.340070202; CASSIO D, 1971, EUR J BIOCHEM, V20, P283, DOI 10.1111/j.1432-1033.1971.tb01393.x; CLORE GM, 1983, J MAGN RESON, V53, P423, DOI 10.1016/0022-2364(83)90215-9; CLORE GM, 1985, J MAGN RESON, V61, P158, DOI 10.1016/0022-2364(85)90279-3; CRIPPEN GM, 1988, DISTANCE GEOMETRY CO; FAYAT G, 1974, EUR J BIOCHEM, V44, P335, DOI 10.1111/j.1432-1033.1974.tb03490.x; FAYAT G, 1977, BIOCHEMISTRY-US, V16, P2570, DOI 10.1021/bi00630a039; FERSHT AR, 1984, ANGEW CHEM INT EDIT, V23, P467, DOI 10.1002/anie.198404673; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P1250, DOI 10.1021/bi00574a021; FREIST W, 1989, BIOCHEMISTRY-US, V28, P6787, DOI 10.1021/bi00443a001; HEINRIKSON RL, 1976, BIOCHEM J, V105, P17; KALK A, 1976, J MAGN RESON, V24, P343, DOI 10.1016/0022-2364(76)90115-3; KEEPERS JW, 1984, J MAGN RESON, V57, P404, DOI 10.1016/0022-2364(84)90257-9; KUNTZ ID, 1979, BIOPOLYMERS, V18, P939, DOI 10.1002/bip.1979.360180414; LEATHERBARROW RJ, 1985, P NATL ACAD SCI USA, V82, P7840, DOI 10.1073/pnas.82.23.7840; LEVY HR, 1983, BIOCHEMISTRY-US, V22, P2792, DOI 10.1021/bi00281a004; MELLOT P, 1989, J MOL BIOL, V208, P429, DOI 10.1016/0022-2836(89)90507-X; MONTEILHET C, 1984, J MOL BIOL, V173, P477, DOI 10.1016/0022-2836(84)90392-9; NEIDLE S, 1976, ACTA CRYSTALLOGR B, V32, P1850, DOI 10.1107/S0567740876006511; ROSEVEAR PR, 1989, METHOD ENZYMOL, V177, P333; ROSEVEAR PR, 1983, BIOCHEMISTRY-US, V22, P3439, DOI 10.1021/bi00283a021; ROSEVEAR PR, 1987, BIOCHEMISTRY-US, V26, P5338, DOI 10.1021/bi00391a018; ROSEVEAR PR, 1984, J BIOL CHEM, V259, P1436; ROSEVEAR PR, 1988, BIOCHEMISTRY-US, V27, P7931, DOI 10.1021/bi00420a052; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; Saenger W., 1984, PRINCIPLES NUCLEIC A, P9; SCHIMMEL PR, 1979, ANNU REV BIOCHEM, V48, P601, DOI 10.1146/annurev.bi.48.070179.003125; TROPP J, 1981, BIOCHEMISTRY-US, V20, P2133, DOI 10.1021/bi00511a010; WAGNER G, 1979, J MAGN RESON, V33, P675, DOI 10.1016/0022-2364(79)90180-X; WELLS TNC, 1986, BIOCHEMISTRY-US, V25, P1881, DOI 10.1021/bi00356a007	36	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2089	2098						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989972				2022-12-25	WOS:A1991EV51500015
J	DRAGANI, TA; MANENTI, G; COLOMBO, BM; FALVELLA, FS; GARIBOLDI, M; PIEROTTI, MA; DELLAPORTA, G				DRAGANI, TA; MANENTI, G; COLOMBO, BM; FALVELLA, FS; GARIBOLDI, M; PIEROTTI, MA; DELLAPORTA, G			INCIDENCE OF MUTATIONS AT CODON-61 OF THE HA-RAS GENE IN LIVER-TUMORS OF MICE GENETICALLY SUSCEPTIBLE AND RESISTANT TO HEPATOCARCINOGENESIS	ONCOGENE			English	Article							TRANSGENIC MICE; B6C3F1 MOUSE; DIETHYLNITROSAMINE HEPATOCARCINOGENESIS; HEPATOCELLULAR-CARCINOMA; N-NITROSODIETHYLAMINE; ACTIVATED ONCOGENES; INFANT MOUSE; KI-RAS; EXPRESSION; LESIONS	By selective oligonucleotide hybridization of polymerase chain reaction (PCR) amplified tumor DNAs we have analysed the incidence of mutations at codon 61 of the Ha-ras gene in 42 liver tumors spontaneously developed in Balb/c, C3Hf and B6C3 male mice, and in 79 liver tumors induced by the chemical carcinogens diethylnitrosamine (NDEA) and urethan in B6C3 and B6C male and female mice. The incidence of Ha-ras gene mutations in both spontaneously developed and urethan-induced liver tumors was 50%-63% in mice genetically susceptible to hepatocarcinogenesis (C3Hf, B6C3) and 7%-9% in mice genetically resistant (Balb/c, B6C). Urethan-induced tumors showed about the same incidence of ras mutations in male and in female B6C3 mice. NDEA-induced tumors showed a low incidence of Ha-ras mutations in both the hybrid mice (3/18 and 1/13 in B6C3 and B6C male mice, respectively). The most frequently found mutations were a C --> A transversion at the 1st base of codon 61 in spontaneous tumors, and an A --> T transversion at the 2nd base in urethan-induced tumors. Our results indicate that liver tumors induced by NDEA or urethan or spontaneously arisen have a different pattern of Ha-ras mutations at codon 61 and that these mutations constitute a rare molecular alteration in the pathogenesis of liver tumors in genetically resistant mice.			DRAGANI, TA (corresponding author), IST NAZL TUMORI,DIV EXPTL ONCOL A,VIA G VENEZIAN 1,I-20133 MILAN,ITALY.		Manenti, Giacomo/J-3339-2017; Gariboldi, Manuela/K-4744-2016; Dragani, Tommaso A./K-4493-2016	Manenti, Giacomo/0000-0002-4887-4482; Pierotti, Marco Alessandro/0000-0002-7431-8332; Gariboldi, Manuela/0000-0001-8406-165X; Dragani, Tommaso A./0000-0001-5915-4598				ALBINO AP, 1984, NATURE, V308, P69, DOI 10.1038/308069a0; BACHMANN B, 1990, NUCLEIC ACIDS RES, V18, P1309, DOI 10.1093/nar/18.5.1309; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BECKER FF, 1982, CANCER RES, V42, P3918; BECKER FF, 1985, CANCER RES, V45, P768; BONHAM K, 1989, MOL CARCINOGEN, V2, P34, DOI 10.1002/mc.2940020106; BUCHMANN A, 1989, MOL CARCINOGEN, V2, P121, DOI 10.1002/mc.2940020303; DELLAPORTA G, 1978, TOXICOL APPL PHARM, V43, P293, DOI 10.1016/0041-008X(78)90009-1; DELLAPORTA G, 1990, TERATOGEN CARCIN MUT, V10, P137; DELLAPORTA G, 1984, J CANCER RES CLIN, V108, P308; DELLAPORTA G, 1982, CARCINOGENESIS, V3, P647; DIWAN BA, 1986, CARCINOGENESIS, V7, P215, DOI 10.1093/carcin/7.2.215; DRAGANI TA, 1990, CARCINOGENESIS, V11, P953, DOI 10.1093/carcin/11.6.953; DRAGANI TA, 1987, J CANCER RES CLIN, V113, P223, DOI 10.1007/BF00396377; DRAGANI TA, 1986, CANCER RES, V46, P1915; DRAGANI TA, 1984, TUMORI J, V70, P485, DOI 10.1177/030089168407000603; DRINKWATER NR, 1986, CARCINOGENESIS, V7, P1701, DOI 10.1093/carcin/7.10.1701; FARBER E, 1984, CANCER RES, V44, P5463; FRITH CH, 1984, MOUSE LIVER NEOPLASI, P85; FRITH CH, 1980, J ENVIRON PATHOL TOX, V3, P329; GOLDFARB S, 1983, ENVIRON HEALTH PERSP, V50, P149, DOI 10.2307/3429545; GOLDFARB S, 1985, CANCER RES, V45, P909; HANAHAN D, 1988, ANNU REV GENET, V22, P479, DOI 10.1146/annurev.ge.22.120188.002403; HANIGAN MH, 1988, CARCINOGENESIS, V9, P885, DOI 10.1093/carcin/9.6.885; HELD WA, 1989, EMBO J, V8, P183, DOI 10.1002/j.1460-2075.1989.tb03363.x; ISHIKAWA F, 1985, JPN J CANCER RES, V76, P425; LAND H, 1983, SCIENCE, V222, P771, DOI 10.1126/science.6356358; LEON J, 1988, MOL CELL BIOL, V8, P786, DOI 10.1128/MCB.8.2.786; MARONPOT RR, 1987, ARCH TOXICOL S, V10, P10; MULDER MP, 1989, ONCOGENE, V4, P1345; NERI A, 1988, P NATL ACAD SCI USA, V85, P9268, DOI 10.1073/pnas.85.23.9268; REYNOLDS SH, 1987, SCIENCE, V237, P1309, DOI 10.1126/science.3629242; SANDGREN EP, 1989, ONCOGENE, V4, P715; STOWERS SJ, 1988, CARCINOGENESIS, V9, P271, DOI 10.1093/carcin/9.2.271; TADA M, 1990, CANCER RES, V50, P1121; TAKADA S, 1989, ONCOGENE, V4, P189; TSUDA H, 1989, JPN J CANCER RES, V80, P196, DOI 10.1111/j.1349-7006.1989.tb02290.x; Vesselinovitch S D, 1982, Carcinog Compr Surv, V7, P127; VESSELINOVITCH SD, 1985, CANCER RES, V45, P910; VESSELINOVITCH SD, 1983, CANCER RES, V43, P4253; WARD JM, 1979, J NATL CANCER I, V63, P849, DOI 10.1093/jnci/63.3.849; WISEMAN RW, 1986, P NATL ACAD SCI USA, V83, P5825, DOI 10.1073/pnas.83.16.5825; YOU M, 1989, P NATL ACAD SCI USA, V86, P3070, DOI 10.1073/pnas.86.9.3070	43	66	66	0	4	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1991	6	2					333	338						6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ134	2000226				2022-12-25	WOS:A1991FZ13400021
J	SEGERS, A; MUYLDERMANS, S; WYNS, L				SEGERS, A; MUYLDERMANS, S; WYNS, L			THE INTERACTION OF HISTONE H5 AND ITS GLOBULAR DOMAIN WITH CORE PARTICLES, DEPLETED CHROMATOSOMES, POLYNUCLEOSOMES, AND A DNA DECAMER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGHER-ORDER STRUCTURE; NUCLEAR MAGNETIC-RESONANCE; COOPERATIVE BINDING; LINKER HISTONES; H-1 VARIANTS; CHROMATIN; NUCLEOSOME; PROTEIN	Certain features of linker histone behavior were analyzed using a precipitation and a nitrocellulose filter binding assay. Chromatosomes, depleted of the linker histones, present one unique binding site to the globular domain of histone H5 (GH5) which involves the two 10-base pair DNA ends of the chromatosome. Additional binding to lower affinity sites is intrinsically different and results in aggregation as does all binding to core particles. These findings, as well as the binding study on a synthetic DNA decamer, lend support to earlier hypotheses of more than one DNA binding site on the globular domain. Our studies provide a deeper insight into the long standing question of H5/nucleosome stoichiometry. A salt dependence analysis of GH5 binding to H5-depleted chromatosomes indicates that GH5 displaces a number of ions similar to the total H1 linker histone, suggesting a delocalized binding of the carboxyl- and amino-terminal tails.			SEGERS, A (corresponding author), VRIJE UNIV BRUSSELS,INST MOLEK BIOL,PAARDENST 65,B-1640 RHODE ST GENESE,BELGIUM.		Muyldermans, Serge V/C-6418-2016; Muyldermans, Serge/AAC-7374-2019	Muyldermans, Serge V/0000-0002-3678-3575; Muyldermans, Serge/0000-0002-3678-3575				ALI Z, 1987, J BIOL CHEM, V262, P12989; ALLAN J, 1981, J CELL BIOL, V90, P279, DOI 10.1083/jcb.90.2.279; ALLAN J, 1980, NATURE, V288, P675, DOI 10.1038/288675a0; AVILES FJ, 1978, EUR J BIOCHEM, V88, P363, DOI 10.1111/j.1432-1033.1978.tb12457.x; BATES DL, 1981, NUCLEIC ACIDS RES, V9, P5883, DOI 10.1093/nar/9.22.5883; BRADBURY EM, 1975, EUR J BIOCHEM, V57, P521, DOI 10.1111/j.1432-1033.1975.tb02327.x; BUTLER PJG, 1980, J MOL BIOL, V140, P505, DOI 10.1016/0022-2836(80)90268-5; CLARK DJ, 1990, J MOL BIOL, V211, P883, DOI 10.1016/0022-2836(90)90081-V; CLARK DJ, 1988, EUR J BIOCHEM, V178, P225, DOI 10.1111/j.1432-1033.1988.tb14447.x; CLARK DJ, 1986, J MOL BIOL, V187, P569, DOI 10.1016/0022-2836(86)90335-9; CLARK DJ, 1988, EMBO J, V7, P69, DOI 10.1002/j.1460-2075.1988.tb02784.x; CLORE GM, 1987, EMBO J, V6, P1833, DOI 10.1002/j.1460-2075.1987.tb02438.x; CRANEROBINSON C, 1989, PROTEIN ENG, V2, P577, DOI 10.1093/protein/2.8.577; DEHASETH P L, 1978, Biochemistry, V17, P1612, DOI 10.1021/bi00602a006; DEPETROCELLIS L, 1986, EUR J BIOCHEM, V156, P143; GLAZER AN, 1975, CHEM MODIFICATIONS P, P71; GRAZIANO V, 1990, J MOL BIOL, V212, P253, DOI 10.1016/0022-2836(90)90122-3; GRAZIANO V, 1988, J MOL BIOL, V203, P997, DOI 10.1016/0022-2836(88)90124-6; HOFMANN KW, 1980, INT J BIOL MACROMOL, V2, P25, DOI 10.1016/0141-8130(80)90006-9; IGOKEMENES T, 1982, ANNU REV BIOCHEM, V51, P89, DOI 10.1146/annurev.bi.51.070182.000513; JIN YJ, 1986, J BIOL CHEM, V261, P5805; KLINGHOLZ R, 1982, J BIOL CHEM, V257, P3101; LIBERTINI LJ, 1988, BIOPOLYMERS, V27, P1459, DOI 10.1002/bip.360270911; MANIATIS T, 1982, MOL CLONING LABORATO, P113; MANNING GS, 1978, Q REV BIOPHYS, V11, P179, DOI 10.1017/S0033583500002031; MURRAY K, 1968, BIOCHEM J, V107, P207, DOI 10.1042/bj1070207; MUYLDERMANS S, 1980, NUCLEIC ACIDS RES, V8, P731; NELSON PP, 1979, J BIOL CHEM, V254, P1751; PENNINGS S, 1989, MOL BIOL REP, V13, P191, DOI 10.1007/BF00788170; SIMPSON RT, 1978, BIOCHEMISTRY-US, V17, P5524, DOI 10.1021/bi00618a030; SUN JM, 1989, SCIENCE, V245, P68, DOI 10.1126/science.2740916; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; THOMAS JO, 1986, EMBO J, V5, P3531, DOI 10.1002/j.1460-2075.1986.tb04679.x; WATANABE F, 1989, FEBS LETT, V249, P147, DOI 10.1016/0014-5793(89)80612-X; WATANABE F, 1986, NUCLEIC ACIDS RES, V14, P3573, DOI 10.1093/nar/14.8.3573; WIDOM J, 1986, J MOL BIOL, V190, P411, DOI 10.1016/0022-2836(86)90012-4; WRIGHT JM, 1987, EUR J BIOCHEM, V168, P281, DOI 10.1111/j.1432-1033.1987.tb13418.x; ZARBOCK J, 1986, P NATL ACAD SCI USA, V83, P7628, DOI 10.1073/pnas.83.20.7628	38	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1502	1508						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1988433				2022-12-25	WOS:A1991EU49700026
J	SPAARGAREN, M; DEFIZE, LHK; BOONSTRA, J; DELAAT, SW				SPAARGAREN, M; DEFIZE, LHK; BOONSTRA, J; DELAAT, SW			ANTIBODY-INDUCED DIMERIZATION ACTIVATES THE EPIDERMAL GROWTH-FACTOR RECEPTOR TYROSINE KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY RECEPTORS; ATP-BINDING-SITE; EGF-RECEPTOR; MONOCLONAL-ANTIBODIES; SELF-PHOSPHORYLATION; SIGNAL TRANSDUCTION; POINT MUTATION; CROSS-LINKING; CELL-PROLIFERATION; PROTEIN-KINASE	The relationship between epidermal growth factor receptor (EGF-R) protein tyrosine kinase activation and ligand-induced receptor dimerization was investigated using several bivalent anti-EGF-R antibodies directed against various receptor epitopes. In A431 membrane preparations and permeabilized cells, all antibodies were able to activate the EGF-R tyrosine kinase, as measured by EGF-R autophosphorylation and phosphorylation of other substrates on tyrosine residues. EGF-R tyrosine kinase activation correlated strongly with the induction of EGF-R dimerization. (i) Both processes specifically occurred in a narrow antibody concentration range; (ii) both processes required the presence of detergent; and (iii) both processes depended on antibody bivalence since monovalent Fab fragments were inactive yet regained full activity after cross-linking by a second bivalent antibody. These data demonstrate that antibody bivalence is essential and sufficient for EGF-R activation and that activation occurs regardless of the EGF-R epitope recognized. Finally, EGF-R dimerization was shown not to depend on receptor autophosphorylation since it still occurred in the absence of ATP. Also, partial inhibition of the tyrosine kinase activity by the specific EGF-R tyrosine kinase inhibitor tyrphostin AG 213 did not affect formation of EGF-R dimers. Taken together these results demonstrate that induction of EGF-R dimerization is sufficient and in case of antibody action, essential, for activation of the EGF-R tyrosine kinase and thus provide strong support for an intermolecular mechanism of EGF-R tyrosine kinase activation.	STATE UNIV UTRECHT,DEPT MOLEC CELL BIOL,3584 CH UTRECHT,NETHERLANDS	Utrecht University	SPAARGAREN, M (corresponding author), NETHERLANDS INST DEV BIOL,HUBRECHT LAB,UPPSALALAAN 8,3584 CT UTRECHT,NETHERLANDS.		Spaargaren, Marcel/AAU-1298-2021	Spaargaren, Marcel/0000-0002-3135-5109				BASU A, 1989, MOL CELL BIOL, V9, P671, DOI 10.1128/MCB.9.2.671; BASU M, 1986, J BIOL CHEM, V261, P2879; BELLOT F, 1990, J CELL BIOL, V110, P491, DOI 10.1083/jcb.110.2.491; BERTICS PJ, 1985, J BIOL CHEM, V260, P4642; BISHAYEE S, 1989, J BIOL CHEM, V264, P11699; BISWAS R, 1985, BIOCHEMISTRY-US, V24, P3795, DOI 10.1021/bi00335a056; BONISCHNETZLER M, 1987, P NATL ACAD SCI USA, V84, P7832, DOI 10.1073/pnas.84.22.7832; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; CHEN WS, 1987, NATURE, V328, P820, DOI 10.1038/328820a0; COCHET C, 1988, J BIOL CHEM, V263, P3290; COHEN S, 1982, J BIOL CHEM, V257, P1523; DEFIZE LHK, 1988, J CELL BIOL, V107, P939, DOI 10.1083/jcb.107.3.939; DEFIZE LHK, 1989, J CELL BIOL, V109, P2495, DOI 10.1083/jcb.109.5.2495; DEFIZE LHK, 1986, EMBO J, V5, P1187, DOI 10.1002/j.1460-2075.1986.tb04345.x; DEFIZE LHK, 1987, CELL DIFFER DEV, V20, P87, DOI 10.1016/0045-6039(87)90423-4; DEFIZE LHK, 1988, THESIS U UTRECHT; FANGER BO, 1989, FASEB J, V3, P71, DOI 10.1096/fasebj.3.1.2783412; FANGER BO, 1986, BIOCHEMISTRY-US, V25, P6414, DOI 10.1021/bi00369a011; FAVA RA, 1984, J BIOL CHEM, V259, P2636; GILL GN, 1987, MOL CELL ENDOCRINOL, V51, P169, DOI 10.1016/0303-7207(87)90027-X; GILL GN, 1984, J BIOL CHEM, V259, P7755; GLENNEY JR, 1988, CELL, V52, P675, DOI 10.1016/0092-8674(88)90405-9; GREENFIELD C, 1989, EMBO J, V8, P4115, DOI 10.1002/j.1460-2075.1989.tb08596.x; GUIGNI TD, 1985, J BIOL CHEM, V260, P15081; HAMMACHER A, 1989, EMBO J, V8, P2489, DOI 10.1002/j.1460-2075.1989.tb08385.x; HELDIN CH, 1989, J BIOL CHEM, V264, P8905; HONEGGER AM, 1989, P NATL ACAD SCI USA, V86, P925, DOI 10.1073/pnas.86.3.925; HONEGGER AM, 1987, MOL CELL BIOL, V7, P4568, DOI 10.1128/MCB.7.12.4568; HONEGGER AM, 1987, CELL, V51, P199, DOI 10.1016/0092-8674(87)90147-4; HONEGGER AM, 1990, MOL CELL BIOL, V10, P4035, DOI 10.1128/MCB.10.8.4035; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; KASHLES O, 1988, P NATL ACAD SCI USA, V85, P9567, DOI 10.1073/pnas.85.24.9567; KOLAND JG, 1988, J BIOL CHEM, V263, P2230; LIVNEH E, 1986, J BIOL CHEM, V261, P2490; LYALL RM, 1989, J BIOL CHEM, V264, P14503; MARGOLIS B, 1990, MOL CELL BIOL, V10, P435, DOI 10.1128/MCB.10.2.435; MOOLENAAR WH, 1988, EMBO J, V7, P707, DOI 10.1002/j.1460-2075.1988.tb02866.x; NORTHWOOD IC, 1988, J BIOL CHEM, V263, P7450; OBRIEN RM, 1987, EMBO J, V6, P4003, DOI 10.1002/j.1460-2075.1987.tb02743.x; PEPINSKY RB, 1986, NATURE, V321, P81, DOI 10.1038/321081a0; PRYWES R, 1986, EMBO J, V5, P2179, DOI 10.1002/j.1460-2075.1986.tb04482.x; SCHLESSINGER J, 1988, TRENDS BIOCHEM SCI, V13, P443, DOI 10.1016/0968-0004(88)90219-8; SCHLESSINGER J, 1986, J CELL BIOL, V103, P2067, DOI 10.1083/jcb.103.6.2067; SCHREIBER AB, 1981, P NATL ACAD SCI-BIOL, V78, P7535, DOI 10.1073/pnas.78.12.7535; SCHREIBER AB, 1983, J BIOL CHEM, V258, P846; SPAARGAREN M, 1990, BIOCHEM BIOPH RES CO, V171, P882, DOI 10.1016/0006-291X(90)91228-K; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WEBER W, 1984, J BIOL CHEM, V259, P4631; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; YAISH P, 1988, SCIENCE, V242, P933, DOI 10.1126/science.3263702; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; YARDEN Y, 1990, P NATL ACAD SCI USA, V87, P2569, DOI 10.1073/pnas.87.7.2569; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034	54	92	104	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1733	1739						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1988447				2022-12-25	WOS:A1991EU49700060
J	CASERO, RA; CELANO, P; ERVIN, SJ; APPLEGREN, NB; WIEST, L; PEGG, AE				CASERO, RA; CELANO, P; ERVIN, SJ; APPLEGREN, NB; WIEST, L; PEGG, AE			ISOLATION AND CHARACTERIZATION OF A CDNA CLONE THAT CODES FOR HUMAN SPERMIDINE SPERMINE N1-ACETYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-ADENOSYLMETHIONINE DECARBOXYLASE; CELL LUNG-CARCINOMA; ORNITHINE DECARBOXYLASE; MESSENGER-RNAS; BIS(ETHYL)POLYAMINE ANALOGS; POLYAMINE ACETYLATION; LINE NCI-H157; DIFLUOROMETHYLORNITHINE; SEQUENCES; GROWTH	Spermidine/spermine N1-acetyltransferase (Spd/Spm acetyltransferase) is the rate-limiting enzyme in the catabolism of polyamines. This enzyme is highly inducible by several stimuli, including the natural polyamines and their structural analogues. To investigate the underlying mechanism responsible for the control of this enzyme a cDNA which codes for an active human Spd/Spm acetyltransferase has been isolated from a random primed cDNA library constructed from mRNA of a polyamine analogue treated large cell lung carcinoma line, NCI H157. The 972-base pair cDNA was identified using a 32-fold degenerate, 20-base oligomer probe to a 7-amino acid polypeptide sequence derived from the purified protein. The cDNA has a 513-base open reading frame that codes for a protein of 171 amino acids with a predicted molecular weight of 20,023. In vitro translation studies demonstrated the protein product of this cDNA to be a biologically active enzyme. The cDNA recognizes a 1.5-kilobase transcript in human cells which is highly induced in the human large cell lung carcinoma NCI H157 line following treatment with the polyamine analogue. The unusually high expression of Spd/Spm acetyltransferase mRNA by the NCI H157 cells in response to treatment does not appear to be a result of an amplification of the Spd/Spm acetyltransferase gene.	PENN STATE UNIV,MILTON S HERSHEY MED CTR,DEPT CELLULAR & MOLEC PHYSIOL,HERSHEY,PA 17033; PENN STATE UNIV,MILTON S HERSHEY MED CTR,DEPT PHARMACOL,HERSHEY,PA 17033	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	CASERO, RA (corresponding author), JOHNS HOPKINS UNIV,SCH MED,JOHNS HOPKINS ONCOL CTR LABS,424 N BOND ST,BALTIMORE,MD 21205, USA.			Casero, Robert/0000-0001-5653-3306	NCI NIH HHS [CA37606, CA51068, CA51085] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA051068, R01CA051085, U01CA037606] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BERGER FG, 1984, J BIOL CHEM, V259, P7941; BERGERON RJ, 1988, J MED CHEM, V31, P1183, DOI 10.1021/jm00401a019; BERGERON RJ, 1984, J ORG CHEM, V49, P2997, DOI 10.1021/jo00190a028; BERGERON RJ, 1982, SYNTHESIS-STUTTGART, V39, P689; CASERO RA, 1989, CANCER RES, V49, P639; CASERO RA, 1990, BIOCHEM J, V270, P615, DOI 10.1042/bj2700615; CASERO RA, 1986, BIOCHEM BIOPH RES CO, V134, P572, DOI 10.1016/S0006-291X(86)80458-2; CASERO RA, 1989, CANCER RES, V49, P3829; CASERO RA, 1987, CANCER RES, V47, P3964; CELANO P, 1989, J BIOL CHEM, V264, P8922; CELANO P, 1988, J BIOL CHEM, V263, P5491; DELLARAGIONE F, 1982, BIOCHEMISTRY-US, V21, P6152, DOI 10.1021/bi00267a020; DELLARAGIONE F, 1983, BIOCHEM J, V213, P701, DOI 10.1042/bj2130701; DENSTMAN SC, 1987, BIOCHEM BIOPH RES CO, V149, P194, DOI 10.1016/0006-291X(87)91623-8; ERWIN BG, 1986, BIOCHEM J, V238, P581, DOI 10.1042/bj2380581; FULLER DJM, 1990, BIOCHEM J, V267, P601, DOI 10.1042/bj2670601; GHODA L, 1989, SCIENCE, V243, P1493, DOI 10.1126/science.2928784; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; GUPTA M, 1985, J BIOL CHEM, V260, P2941; JACOBS KA, 1988, NUCLEIC ACIDS RES, V16, P4637, DOI 10.1093/nar/16.10.4637; KAHANA C, 1985, P NATL ACAD SCI USA, V82, P1673, DOI 10.1073/pnas.82.6.1673; KAMEJI T, 1987, J BIOL CHEM, V262, P2427; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; LIBBY PR, 1989, BIOCHEM PHARMACOL, V38, P1435, DOI 10.1016/0006-2952(89)90182-2; LUK GD, 1981, P NATL ACAD SCI-BIOL, V78, P2355, DOI 10.1073/pnas.78.4.2355; MAMONT PS, 1978, BIOCHEM BIOPH RES CO, V81, P58, DOI 10.1016/0006-291X(78)91630-3; MATSUI I, 1981, J BIOL CHEM, V256, P2454; OKAYAMA H, 1989, METHOD ENZYMOL, V154, P3; PAJUNEN A, 1988, J BIOL CHEM, V263, P17040; PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249; PEGG AE, 1988, J BIOL CHEM, V263, P11008; PEGG AE, 1988, CANCER RES, V48, P759; PEGG AE, 1990, BIOCHEM J, V267, P331, DOI 10.1042/bj2670331; PEGG AE, 1989, J BIOL CHEM, V264, P11744; PERSSON L, 1984, J BIOL CHEM, V259, P2364; PORTER CW, 1987, BIOCHEM J, V242, P433, DOI 10.1042/bj2420433; PORTER CW, 1990, IN PRESS ANTICANCER; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; SANGER F, 1978, FEBS LETT, V87, P107, DOI 10.1016/0014-5793(78)80145-8; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SEILER N, 1987, CAN J PHYSIOL PHARM, V65, P2024, DOI 10.1139/y87-317; SHINKI T, 1989, EUR J BIOCHEM, V183, P285, DOI 10.1111/j.1432-1033.1989.tb14926.x; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STANLEY BA, 1989, J BIOL CHEM, V264, P21073; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201	47	109	113	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					810	814						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985966				2022-12-25	WOS:A1991ET17700024
J	LEVIN, EG; SANTELL, L				LEVIN, EG; SANTELL, L			THROMBIN-INDUCED AND HISTAMINE-INDUCED SIGNAL TRANSDUCTION IN HUMAN ENDOTHELIAL-CELLS - STIMULATION AND AGONIST-DEPENDENT DESENSITIZATION OF PROTEIN-PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTOR; PLASMINOGEN-ACTIVATOR RELEASE; KINASE-C; PROSTACYCLIN PRODUCTION; CYTOSOLIC CALCIUM; MESSENGER-RNA; BRADYKININ; OCCUPANCY; BINDING; DIACYLGLYCEROLS	Treatment of human endothelial cells with thrombin, histamine, or dioctanoylglycerol (DiC8), a synthetic diacylglycerol, resulted in the rapid and transient phosphorylation of a M(r) = 29,000 protein (P29) in a dose-dependent manner. Various tumor promoters also promoted P29 phosphorylation while the adenylate cyclase activator, forskolin, did not. The level of phosphorylation with all three agonists was similar (2.5-4-fold), and analysis of P29 by two-dimensional gel electrophoresis revealed identical patterns in each case. Receptor specificity was demonstrated for the histamine-stimulated changes; pyrilamine (10(-6) M; H1) but not cimetidine (10(-4); H2) blocked the response. The thrombin effect was active site-dependent. Phosphorylation induced by thrombin and histamine occurred within 1 min, peaked between 5 and 10 min, and returned to control levels by 1 h. DiC8-induced phosphorylation occurred more slowly but was also reduced by 1 h while phorbol ester treatment prolonged phosphorylation for at least 4 h. Treatment of these cells with thrombin or histamine for 1 h desensitized P29 to further phosphorylation by the homologous agonist although secondary phosphorylation could occur with heterologous compounds. However, if the primary agonist was removed following the onset of a desensitized state, secondary phosphorylation of P29 could be stimulated by the same compound. These same results were observed with two other phosphoproteins M(r) = 18,000 (P18) and 80,000 (P80) which became more highly phosphorylated in response to thrombin treatment and with histamine/thrombin-stimulated prostaglandin I2 production. In contrast, homologous down-regulation of P29 phosphorylation was not observed with DiC8-treated cells, and the decline in phosphorylated P29 was associated with the loss of functional DiC8. The protein kinase inhibitors staurosporine and H-7 blocked P18 and P80 phosphorylation by thrombin but had no effect on P29 phosphorylation by histamine, thrombin, or DiC8 suggesting distinct pathways leading to the phosphorylation of these different proteins. These data suggest that multiple and independent thrombin/histamine-induced events are susceptible to receptor occupancy-dependent homologous down-regulation.			LEVIN, EG (corresponding author), SCRIPPS RES INST, DEPT MOLEC & EXPTL MED, LA JOLLA, CA 92037 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030244, R01HL040435] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL40435, HL30244] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AWBREY BJ, 1979, J BIOL CHEM, V254, P4092; BAENZIGER NL, 1981, CELL, V24, P915, DOI 10.1016/0092-8674(81)90117-3; BARTHA K, 1989, BIOCHEM J, V263, P149, DOI 10.1042/bj2630149; BENOVIC JL, 1987, J BIOL CHEM, V262, P9026; BENOVIC JL, 1985, J BIOL CHEM, V260, P7094; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; BLACKSHEAR PJ, 1985, J BIOL CHEM, V260, P3304; BOUVIER M, 1987, J BIOL CHEM, V262, P3106; CHRETIEN P, 1988, J CELL PHYSIOL, V137, P157, DOI 10.1002/jcp.1041370119; CONN PM, 1985, BIOCHEM BIOPH RES CO, V126, P532, DOI 10.1016/0006-291X(85)90638-2; DARBON JM, 1986, J BIOL CHEM, V261, P8002; DAVIS RJ, 1985, J BIOL CHEM, V260, P1562; DEMOLLE D, 1988, J BIOL CHEM, V263, P18459; EXTON JH, 1985, J CLIN INVEST, V75, P1753, DOI 10.1172/JCI111886; GOLIGORSKY MS, 1989, J BIOL CHEM, V264, P16771; ISSANDOU M, 1989, BIOCHEM BIOPH RES CO, V163, P201, DOI 10.1016/0006-291X(89)92121-9; JAFFE EA, 1987, J BIOL CHEM, V262, P8557; KAUR P, 1988, FEBS LETT, V241, P6, DOI 10.1016/0014-5793(88)81019-6; KORCHAK HM, 1988, J BIOL CHEM, V263, P11098; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEFKOWITZ RJ, 1988, J BIOL CHEM, V263, P4993; LEVIN EG, 1989, J BIOL CHEM, V264, P16030; LEVIN EG, 1988, J BIOL CHEM, V263, P9360; LEVIN EG, 1984, J CLIN INVEST, V74, P1988, DOI 10.1172/JCI111620; LEW VL, 1982, NATURE, V298, P478, DOI 10.1038/298478a0; LOLLAR P, 1980, J BIOL CHEM, V255, P279; MARINO MW, 1989, P NATL ACAD SCI USA, V86, P8417, DOI 10.1073/pnas.86.21.8417; MATSUI T, 1986, CANCER RES, V46, P583; MAYOR F, 1987, J BIOL CHEM, V262, P6468; MCINTYRE TM, 1985, J CLIN INVEST, V76, P271, DOI 10.1172/JCI111957; MITSUHASHI T, 1988, J BIOL CHEM, V263, P8790; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; RITTENHOUSESIMMONS S, 1979, J CLIN INVEST, V63, P580, DOI 10.1172/JCI109339; ROSOFF PM, 1988, CELL, V54, P73, DOI 10.1016/0092-8674(88)90181-X; ROTROSEN D, 1986, J CELL BIOL, V103, P2379, DOI 10.1083/jcb.103.6.2379; SKLAR LA, 1985, J BIOL CHEM, V260, P1468; TAMAOKI K, 1988, BIOCHEM BIOPH RES CO, V135, P397; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0	38	40	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					174	181						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985891				2022-12-25	WOS:A1991EQ33900028
J	TANOUE, A; ENDO, F; MATSUDA, I				TANOUE, A; ENDO, F; MATSUDA, I			STRUCTURAL ORGANIZATION OF THE GENE FOR HUMAN PROLIDASE (PEPTIDASE-D) AND DEMONSTRATION OF A PARTIAL GENE DELETION IN A PATIENT WITH PROLIDASE DEFICIENCY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									KUMAMOTO UNIV, SCH MED, DEPT PEDIAT, 1-1-1 HONJO, KUMAMOTO 860, JAPAN	Kumamoto University								AGARWAL KL, 1981, J BIOL CHEM, V256, P1023; BERK AJ, 1977, CELL, V12, P721, DOI 10.1016/0092-8674(77)90272-0; BLAKE C, 1983, NATURE, V306, P535, DOI 10.1038/306535a0; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DILELLA AG, 1986, BIOCHEMISTRY-US, V25, P743, DOI 10.1021/bi00352a001; ENDO F, 1988, CLIN CHIM ACTA, V176, P143, DOI 10.1016/0009-8981(88)90201-X; ENDO F, 1987, J INHERIT METAB DIS, V10, P305, DOI 10.1007/BF01800088; ENDO F, 1989, J BIOL CHEM, V264, P4476; ENDO F, 1990, J CLIN INVEST, V85, P162, DOI 10.1172/JCI114407; ENDO F, 1987, PEDIATR RES, V22, P627, DOI 10.1203/00006450-198712000-00002; ENDO F, 1982, PEDIATR RES, V16, P227, DOI 10.1203/00006450-198203000-00013; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GITSCHIER J, 1984, NATURE, V312, P326, DOI 10.1038/312326a0; HATA A, 1988, J BIOCHEM-TOKYO, V103, P302, DOI 10.1093/oxfordjournals.jbchem.a122265; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; INDO Y, 1987, J CLIN INVEST, V80, P63, DOI 10.1172/JCI113064; ISHII S, 1985, P NATL ACAD SCI USA, V82, P4920, DOI 10.1073/pnas.82.15.4920; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KIM SH, 1986, NUCLEIC ACIDS RES, V14, P3103, DOI 10.1093/nar/14.7.3103; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LEWIN B, 1983, GENES, P174; Maniatis T., 1982, MOL CLONING; MARTINI G, 1986, EMBO J, V5, P1849, DOI 10.1002/j.1460-2075.1986.tb04436.x; MATSUURA S, 1989, J BIOL CHEM, V264, P10148; MELTON DW, 1984, P NATL ACAD SCI-BIOL, V81, P2147, DOI 10.1073/pnas.81.7.2147; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; OBRIEN T, 1983, ANN HUM GENET, V47, P117, DOI 10.1111/j.1469-1809.1983.tb00978.x; OGATA A, 1981, ARCH DERMATOL, V117, P689, DOI 10.1001/archderm.117.11.689; Phang JM, 1989, METABOLIC BASIS INHE, P577; REYNOLDS GA, 1984, CELL, V38, P275, DOI 10.1016/0092-8674(84)90549-X; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEINO S, 1989, P NATL ACAD SCI USA, V86, P114, DOI 10.1073/pnas.86.1.114; SINGERSAM J, 1984, GENE, V32, P409, DOI 10.1016/0378-1119(84)90016-7; SJOSTROM H, 1974, BIOCHIM BIOPHYS ACTA, V359, P177, DOI 10.1016/0005-2795(74)90141-X; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TAKIGUCHI M, 1988, NUCLEIC ACIDS RES, V16, P8789, DOI 10.1093/nar/16.18.8789; VALERIO D, 1985, EMBO J, V4, P437, DOI 10.1002/j.1460-2075.1985.tb03648.x; VANOMMEN GJ, 1983, NUCLEIC ACIDS RES, V11, P2273; WERTMAN KF, 1986, GENE, V49, P253, DOI 10.1016/0378-1119(86)90286-6; WILKS A, 1981, GENE, V16, P249, DOI 10.1016/0378-1119(81)90081-0; WYMAN AR, 1985, P NATL ACAD SCI USA, V82, P2880, DOI 10.1073/pnas.82.9.2880; YOSHIMOTO T, 1983, J BIOCHEM, V94, P1889, DOI 10.1093/oxfordjournals.jbchem.a134542	47	52	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	1990	265	19					11306	11311						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL655	1972707				2022-12-25	WOS:A1990DL65500080
J	CHEN, YN; MICKLEY, LA; SCHWARTZ, AM; ACTON, EM; HWANG, J; FOJO, AT				CHEN, YN; MICKLEY, LA; SCHWARTZ, AM; ACTON, EM; HWANG, J; FOJO, AT			CHARACTERIZATION OF ADRIAMYCIN-RESISTANT HUMAN BREAST-CANCER CELLS WHICH DISPLAY OVEREXPRESSION OF A NOVEL RESISTANCE-RELATED MEMBRANE-PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									NCI, MED BRANCH, BETHESDA, MD 20892 USA; NCI, DIV CANC TREATMENT, DRUG SYNTH & CHEM BRANCH, BETHESDA, MD 20892 USA; GEORGE WASHINGTON UNIV, MED CTR, WASHINGTON, DC 20037 USA; ACAD SINICA, INST MOL BIOL, TAIPEI 22517, TAIWAN	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); George Washington University; Academia Sinica - Taiwan								ANDOH T, 1987, P NATL ACAD SCI USA, V84, P5565, DOI 10.1073/pnas.84.16.5565; BATIST G, 1986, J BIOL CHEM, V261, P5544; BHALLA K, 1985, CANCER RES, V45, P3657; BLITHE DL, 1982, J BIOL CHEM, V257, P7135; BODLEY AL, 1988, MECHANISMS DRUG RESI, P277; BROGGINI M, 1983, EUR J CANCER CLIN ON, V19, P419, DOI 10.1016/0277-5379(83)90141-4; Chen G.L, 1986, ANNU REP MED CHEM, V21, P257, DOI [10.1016/S0065-7743(08)61134-3, DOI 10.1016/S0065-7743(08)61134-3]; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CORNWELL MM, 1986, P NATL ACAD SCI USA, V83, P3847, DOI 10.1073/pnas.83.11.3847; CORNWELL MM, 1987, J BIOL CHEM, V262, P2166; DEFFIE AM, 1988, CANCER RES, V48, P3595; EGORIN MJ, 1980, CANCER RES, V40, P4669; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; FOJO A, 1985, CANCER RES, V45, P3002; FOJO AT, 1987, P NATL ACAD SCI USA, V84, P265, DOI 10.1073/pnas.84.1.265; GARMAN D, 1982, BIOCHEM BIOPH RES CO, V105, P157, DOI 10.1016/S0006-291X(82)80025-9; GIAVAZZI R, 1983, CANCER RES, V43, P2216; GLISSON BS, 1987, NATL CANCER I MONOGR, V4, P89; GOTTESMAN MM, 1988, J BIOL CHEM, V263, P12163; HALLIGAN BD, 1985, J BIOL CHEM, V260, P2475; HAMADA H, 1988, CANCER RES, V48, P7082; HARKER WG, 1985, CANCER RES, V45, P4091; HWANG JL, 1987, J CELL PHYSIOL, V133, P127, DOI 10.1002/jcp.1041330116; HWANG JL, 1989, CANCER RES, V49, P958; INABA M, 1979, CANCER RES, V39, P2200; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; KARTNER N, 1983, CANCER RES, V43, P4413; KJELDSEN E, 1988, J BIOL CHEM, V263, P3912; KOHN K W, 1987, NCI (National Cancer Institute) Monographs, P61; LING V, 1975, CAN J GENET CYTOL, V17, P503, DOI 10.1139/g75-064; MARKOVITS J, 1987, CANCER RES, V47, P2050; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MUHAMMED H, 1983, BIOCHIM BIOPHYS ACTA, V722, P43, DOI 10.1016/0005-2728(83)90155-X; NELSON WG, 1987, CANCER RES, V47, P3246; PETERSON C, 1978, CANCER RES, V38, P4645; POMMIER Y, 1987, NATL CANCER I MONOGR, V4, P83; POTMESIL M, 1987, NATL CANCER I MONOGR, V4, P105; RICHERT N, 1985, P NATL ACAD SCI USA, V82, P2330, DOI 10.1073/pnas.82.8.2330; RIEHM H, 1971, CANCER RES, V31, P409; ROBERS KE, 1983, CANCER RES, V43, P2741; RONINSON IB, 1983, NUCLEIC ACIDS RES, V11, P5413, DOI 10.1093/nar/11.16.5413; ROWE TC, 1986, CANCER RES, V46, P2021; ROY SN, 1985, CANCER RES, V45, P3856; SCUDDER SA, 1988, J NATL CANCER I, V80, P1294, DOI 10.1093/jnci/80.16.1294; SHEN J, 1987, P NATL ACAD SCI USA, V84, P3278, DOI 10.1073/pnas.84.10.3278; SIKIC BI, 1985, SCIENCE, V228, P1544, DOI 10.1126/science.4012308; SINHA BK, 1987, BIOCHEMISTRY-US, V26, P3776, DOI 10.1021/bi00387a006; STREETER DG, 1986, CANCER CHEMOTH PHARM, V16, P247, DOI 10.1007/BF00293986; SULLIVAN DM, 1987, NATL CANCER I MONOGR, V4, P73; TEWEY KM, 1984, SCIENCE, V226, P466, DOI 10.1126/science.6093249; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRENT JM, 1988, MECHANISMS DRUG RESI, P259; TRITTON TR, 1982, SCIENCE, V217, P248, DOI 10.1126/science.7089561; TSURUO T, 1982, CANCER RES, V42, P4730; TSURUO T, 1984, CANCER RES, V44, P4303; WHEELER C, 1982, BIOCHEM PHARMACOL, V31, P2691, DOI 10.1016/0006-2952(82)90723-7; WILLINGHAM MC, 1986, CANCER RES, V46, P5941; ZENEBERGH A, 1982, CANCER CHEMOTH PHARM, V8, P243	58	199	216	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	1990	265	17					10073	10080						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH141	1972154				2022-12-25	WOS:A1990DH14100078
J	PALACIN, M; WERNER, A; BIBER, J; MURER, H				PALACIN, M; WERNER, A; BIBER, J; MURER, H			EXPRESSION OF RAT-LIVER CANALICULAR SULFATE CARRIER IN XENOPUS-LAEVIS OOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV ZURICH,INST PHYSIOL,WINTERTHURERSTR 190,CH-8057 ZURICH,SWITZERLAND; UNIV ZURICH,INST PHYSIOL,CH-8057 ZURICH,SWITZERLAND	University of Zurich; University of Zurich				Palacin, Manuel/0000-0002-8670-293X				CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; HEDIGER MA, 1987, P NATL ACAD SCI USA, V84, P2634, DOI 10.1073/pnas.84.9.2634; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; HUGENTOBLER G, 1986, AM J PHYSIOL, V251, pG656, DOI 10.1152/ajpgi.1986.251.5.G656; MEIER PJ, 1987, AM J PHYSIOL, V253, pG461, DOI 10.1152/ajpgi.1987.253.4.G461; MEIER PJ, 1988, SEMIN LIVER DIS, V8, P293, DOI 10.1055/s-2008-1040551	6	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1990	265	13					7142	7144						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB307	1970568				2022-12-25	WOS:A1990DB30700011
J	TOMODA, H; IGARASHI, K; CYONG, JC; OMURA, S				TOMODA, H; IGARASHI, K; CYONG, JC; OMURA, S			EVIDENCE FOR AN ESSENTIAL ROLE OF LONG-CHAIN ACYL-COA SYNTHETASE IN ANIMAL-CELL PROLIFERATION - INHIBITION OF LONG-CHAIN ACYL-COA SYNTHETASE BY TRIACSINS CAUSED INHIBITION OF RAJI CELL-PROLIFERATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A SYNTHETASE; MICROSOMAL PALMITOYL-COENZYME; RAT-LIVER; FATTY ACYLATION; PURIFICATION; PROTEINS; GLYCOPROTEIN; TRANSPORT	Triacsins A, B, C, and D are new inhibitors of long chain acyl-CoA synthetase (EC 6.2.1.3) and possess different inhibitory potencies against the enzyme (Tomoda, H., Igarashi, K., and Omura, S. (1987) Biochim. Biophys. Acta 921, 595-598). Acyl-CoA synthetase activity in the membrane fraction of Raji cells was also inhibited by triacsins. The same hierarchy of inhibitory potency as that against the enzyme from other sources, triacsin C > triacsin A >> triacsin D greater-than-or-equal-to triacsin B, was observed. When Raji cells were cultivated in the presence of triacsins, cell proliferation was inhibited in a dose-dependent fashion. The drug concentrations required for 50% inhibition of cell growth at day 2 were calculated to be 1.8-mu-M for triacsin A, >> 20-mu-M for triacsin B, 1.0-mu-M for triacsin C, and >> 15-mu-M for triacsin D, demonstrating a hierarchy for inhibitory potency of triacsins similar to that against the acyl-CoA synthetase activity. To understand the role of long chain acyl-CoA synthetase in animal cells, the effect of triacsins on the lipid metabolism of Raji cells was studied. When intact Raji cells were incubated with [C-14]oleate in the presence of individual triacsins, the incorporation of [C-14]oleate into each of the lipid fractions such as phosphatidylcholine, phosphatidylethanolamine, and triacylglycerol was inhibited to an analogous extent. A common hierarchy, triacsin C > triacsin A >> triacsin D > triacsin B, was shown for the inhibition in each synthesis of the three lipids, which was identical with that for acyl-CoA synthetase. These findings indicate that the inhibition of acyl-CoA synthetase is well correlated with the inhibition of lipid synthesis. Taken together, the data strongly suggest that the inhibition of acyl-CoA synthetase by triacsins leads to the inhibition of lipid synthesis and eventually to the inhibition of proliferation of Raji cells.	KITASATO UNIV,KITASATO INST,ORIENTAL MED RES CTR,MINATO KU,TOKYO 108,JAPAN; KITASATO UNIV,SCH PHARMACEUT SCI,MINATO KU,TOKYO 108,JAPAN	Kitasato University; Kitasato University	TOMODA, H (corresponding author), KITASATO UNIV,BIOL FUNCT RES CTR,MINATO KU,TOKYO 108,JAPAN.							BARTANA J, 1973, BIOCHEM J, V131, P443, DOI 10.1042/bj1310443; BARTANA J, 1971, BIOCHEM J, V122, P353, DOI 10.1042/bj1220353; BERG T, 1972, EXP CELL RES, V72, P571, DOI 10.1016/0014-4827(72)90034-1; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; GLICK BS, 1987, NATURE, V326, P309, DOI 10.1038/326309a0; HARTMAN EJ, 1989, PROSTAGLANDINS, V37, P655, DOI 10.1016/0090-6980(89)90103-2; LAPOSATA M, 1985, J BIOL CHEM, V260, P1016; LYNEN F, 1969, METHOD ENZYMOL, V14, P17; MACK D, 1987, J BIOL CHEM, V262, P4297; NEUFELD EJ, 1984, J BIOL CHEM, V259, P1986; OMURA S, 1986, J ANTIBIOT, V39, P1211, DOI 10.7164/antibiotics.39.1211; PFANNER N, 1989, CELL, V59, P95, DOI 10.1016/0092-8674(89)90872-6; PHILIPP DP, 1979, J BIOL CHEM, V254, P776; POWELL GL, 1985, FED PROC, V44, P81; PULVERTAFT RJV, 1964, LANCET, V1, P238; RAETZ CRH, 1990, J BIOL CHEM, V265, P1235; ROCK CO, 1985, BIOCH LIPIDS MEMBRAN, P75; SCHULTZ AM, 1988, ANNU REV CELL BIOL, V4, P611, DOI 10.1146/annurev.cb.04.110188.003143; SEFTON BM, 1987, J CELL BIOL, V104, P1449, DOI 10.1083/jcb.104.6.1449; SLOMIANY A, 1984, J BIOL CHEM, V259, P3304; TANAKA T, 1979, EUR J BIOCHEM, V98, P165, DOI 10.1111/j.1432-1033.1979.tb13173.x; TOMODA H, 1987, BIOCHIM BIOPHYS ACTA, V921, P595; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; WAKIL SJ, 1983, ENZYMES, P3; WILCOX CA, 1987, BIOCHEMISTRY-US, V26, P1029, DOI 10.1021/bi00378a008; WILSON DB, 1982, J BIOL CHEM, V257, P3510	27	108	113	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4214	4219						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999415				2022-12-25	WOS:A1991FA69400033
J	GIACHELLI, CM; MAJESKY, MW; SCHWARTZ, SM				GIACHELLI, CM; MAJESKY, MW; SCHWARTZ, SM			DEVELOPMENTALLY REGULATED CYTOCHROME-P-450IA1 EXPRESSION IN CULTURED RAT VASCULAR SMOOTH-MUSCLE CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; PROTEIN-SYNTHESIS; ATHEROSCLEROSIS; SEQUENCE; 3-METHYLCHOLANTHRENE; MONOOXYGENASE; GROWTH; AORTA	We have examined the expression of cytochrome P-450IA1 (CypIa1) in cultured rat arterial smooth muscle cells (SMC). We report here that newborn (pup) aortic and adult carotid neointimal SMC express 10- 20-fold higher steady-state levels of CypIa1 mRNA compared with identically treated SMC derived from adult aorta or uninjured carotid media, respectively. Nuclear transcription experiments suggest that the difference in basal expression of CypIa1 reflects differences in transcription rates of the gene in these two cell types. Treatment of adult aortic SMC with cycloheximide dramatically elevated CypIa1 mRNA levels and had little effect on the amount of this mRNA in pup SMC. That the cycloheximide effect in adult SMC was due to enhanced transcription of the CypIa1 gene was demonstrated by 1) the ability of actinomycin D to completely block the cycloheximide-induced increase in steady-state mRNA levels, and 2) the increased transcription rate of the CypIa1 gene in cycloheximide-treated adult nuclei determined via nuclear transcription assays. Treatment of either cell type with beta-naphthoflavone increased CypIa1 mRNA levels to a similar extent, suggesting that the differential response to cycloheximide was specific and not a general lack of pup SMC to respond to transcriptional inducers of the CypIa1 gene. Our data suggest that a labile repressor of the CypIa1 gene is present in cultured adult aortic SMC and is absent, inactive, or at a greatly reduced level in cultured pup SMC.			GIACHELLI, CM (corresponding author), UNIV WASHINGTON,DEPT PATHOL,SJ-60,SEATTLE,WA 98195, USA.				NHLBI NIH HHS [HL-07312, HL-03174] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABRAHAM NG, 1985, HYPERTENSION, V7, P899, DOI 10.1161/01.HYP.7.6.899; ALBERT RE, 1977, CANCER RES, V37, P2232; BENDITT EP, 1973, P NATL ACAD SCI USA, V70, P1753, DOI 10.1073/pnas.70.6.1753; BOND JA, 1981, J TOXICOL ENV HEALTH, V7, P327, DOI 10.1080/15287398109529983; BOND JA, 1979, LIFE SCI, V25, P425, DOI 10.1016/0024-3205(79)90574-5; CARROLL SL, 1988, MOL CELL BIOL, V8, P241, DOI 10.1128/MCB.8.1.241; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CRESTEIL T, 1987, ARCH BIOCHEM BIOPHYS, V253, P233, DOI 10.1016/0003-9861(87)90656-4; FAGAN JB, 1986, ARCH BIOCHEM BIOPHYS, V244, P261, DOI 10.1016/0003-9861(86)90116-5; FUJISAWASEHARA A, 1987, NUCLEIC ACIDS RES, V15, P4179, DOI 10.1093/nar/15.10.4179; GIACHELLI CM, 1989, J BIOL CHEM, V264, P7046; GONZALEZ FJ, 1985, NUCLEIC ACIDS RES, V13, P7269, DOI 10.1093/nar/13.20.7269; GONZALEZ FJ, 1984, MOL PHARMACOL, V26, P117; GORDON D, 1986, CIRC RES, V59, P633, DOI 10.1161/01.RES.59.6.633; GOWN AM, 1985, J CELL BIOL, V100, P807, DOI 10.1083/jcb.100.3.807; GUENGERICH FP, 1985, CRC CR REV TOXICOL, V14, P259, DOI 10.3109/10408448509037460; HINES RN, 1988, CARCINOGENESIS, V9, P1599, DOI 10.1093/carcin/9.9.1599; ISRAEL DI, 1985, J BIOL CHEM, V260, P5648; JAISWAL AK, 1985, SCIENCE, V228, P80, DOI 10.1126/science.3838385; JONES PBC, 1985, SCIENCE, V227, P1499, DOI 10.1126/science.3856321; JUCHAU MR, 1976, P NATL ACAD SCI USA, V73, P3723, DOI 10.1073/pnas.73.10.3723; KIMURA S, 1987, Journal of Experimental Pathology (New York), V3, P61; KOCHER O, 1985, CIRC RES, V56, P829, DOI 10.1161/01.RES.56.6.829; KUROO M, 1989, J BIOL CHEM, V264, P18272; MAJESKY MW, 1985, P NATL ACAD SCI USA, V82, P3450, DOI 10.1073/pnas.82.10.3450; MAJESKY MW, 1983, CARCINOGENESIS, V4, P647, DOI 10.1093/carcin/4.6.647; MAJESKY MW, 1988, P NATL ACAD SCI USA, V85, P1524, DOI 10.1073/pnas.85.5.1524; MAYO KE, 1981, J BIOL CHEM, V256, P2621; MCKNIGHT GS, 1979, J BIOL CHEM, V254, P9050; MCLEMORE TL, 1989, J NATL CANCER I, V81, P1787, DOI 10.1093/jnci/81.23.1787; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.biochem.56.1.945; OWENS GK, 1986, J BIOL CHEM, V261, P3373; PAIGEN B, 1985, CANCER RES, V45, P3850; PAIGEN B, 1986, CANCER RES, V46, P3321; REVIS NW, 1984, TOXICOLOGY, V32, P215, DOI 10.1016/0300-483X(84)90075-1; RINGOLD GM, 1984, P NATL ACAD SCI-BIOL, V81, P3964, DOI 10.1073/pnas.81.13.3964; RUSHMORE TH, 1990, P NATL ACAD SCI USA, V87, P3826, DOI 10.1073/pnas.87.10.3826; SCHLESINGER MJ, 1986, J CELL BIOL, V103, P321, DOI 10.1083/jcb.103.2.321; SCHWARTZ SM, 1986, CIRC RES, V58, P427, DOI 10.1161/01.RES.58.4.427; SCHWARTZ SM, 1990, AM J PATHOL, V136, P1417; SCHWARZBAUER JE, 1983, CELL, V35, P421, DOI 10.1016/0092-8674(83)90175-7; SEIFERT RA, 1984, NATURE, V311, P669, DOI 10.1038/311669a0; SERABJITSINGH CJ, 1985, MOL PHARMACOL, V28, P72; STIMAC E, 1987, J CELL PHYSIOL, V133, P590, DOI 10.1002/jcp.1041330323; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; TURCOTTE B, 1985, NUCLEIC ACIDS RES, V13, P2387, DOI 10.1093/nar/13.7.2387; VLASUK GP, 1982, BIOCHEMISTRY-US, V21, P789, DOI 10.1021/bi00533a033; WALKER LN, 1986, P NATL ACAD SCI USA, V83, P7311, DOI 10.1073/pnas.83.19.7311; WEBSTER KA, 1988, NATURE, V332, P553, DOI 10.1038/332553a0; YABUSAKI Y, 1984, NUCLEIC ACIDS RES, V12, P2929, DOI 10.1093/nar/12.6.2929	50	65	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3981	3986						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995646				2022-12-25	WOS:A1991EY68200094
J	YAMASHITA, T; SHIMIZU, T; OGATA, E				YAMASHITA, T; SHIMIZU, T; OGATA, E			ACTIVIN-A ERYTHROID-DIFFERENTIATION FACTOR INDUCES THROMBOXANE-A2 SYNTHETIC ACTIVITY IN MURINE ERYTHROLEUKEMIA-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH FACTOR-BETA; FOLLICLE-STIMULATING-HORMONE; ARACHIDONIC-ACID METABOLISM; PROSTAGLANDIN-H SYNTHASE; FSH-RELEASING PROTEIN; DENOVO SYNTHESIS; HUMAN-PLATELETS; HL-60 CELLS; LINE THP-1; FACTOR EDF	Activin A, a protein homologous to transforming growth factor-beta, was shown to induce hemoglobin synthesis in murine erythroleukemia (MEL) cells and was also termed erythroid differentiation factor (EDF) (Eto, Y., Tsuji, T., Takezawa, M., Takano, S., Yokogawa, Y., and Shibai, H. (1987) Biochem. Biophys. Res. Commun. 142, 1095-1103). We found that activin A/EDF also induced thromboxane (TX) A2 synthetic activity in these cells. Synthesis of TXA2 from arachidonic acid is catalyzed by cyclooxygenase and TX synthase. Activin A/EDF induced the latter TX synthase activity, whereas the cyclooxygenase activity was constitutively expressed. The induction of this enzyme activity was inhibited by cycloheximide, suggesting that activin A/EDF induced de novo protein synthesis of TX synthase. Furthermore, we studied the relationship between the induction of TXA2 synthetic activity and erythroid differentiation in MEL cells, since the former is not an erythroid phenotype. We found 1) that the two responses to activin A/EDF were distinctly affected by the initial cell density; 2) that the dose-response curves for activin A/EDF were similar (ED50 = approximately 100 pM), whereas the time course of induction of TXA2 synthetic activity was much faster; and 3) that other erythroid differentiation inducers of MEL cells, namely dimethyl sulfoxide and hexamethylene bisacetamide, had little or no effect on TXA2 synthesis. These results indicate that activin A/EDF induces TXA2 synthetic activity independently of erythroid differentiation.	UNIV TOKYO, FAC MED, DEPT PHYSIOL CHEM & NUTR, BUNKYO KU, TOKYO 112, JAPAN	University of Tokyo	YAMASHITA, T (corresponding author), UNIV TOKYO, FAC MED, DEPT INTERNAL MED 3, 3-28-6 MEJIRODAI, BUNKYO KU, TOKYO 112, JAPAN.							BROXMEYER HE, 1988, P NATL ACAD SCI USA, V85, P9052, DOI 10.1073/pnas.85.23.9052; BURSTEIN SA, 1985, J CELL PHYSIOL, V122, P159, DOI 10.1002/jcp.1041220124; CHEIFETZ S, 1987, CELL, V48, P409, DOI 10.1016/0092-8674(87)90192-9; CHEIFETZ S, 1988, J BIOL CHEM, V263, P17225; DIAZ A, 1989, J BIOL CHEM, V264, P11554; ETO Y, 1987, BIOCHEM BIOPH RES CO, V142, P1095, DOI 10.1016/0006-291X(87)91528-2; FRASIERSCOTT K, 1988, J CLIN INVEST, V82, P1877, DOI 10.1172/JCI113805; GOERIG M, 1987, J CLIN INVEST, V79, P903, DOI 10.1172/JCI112900; GOERIG M, 1988, J BIOL CHEM, V263, P19384; GOODMAN LV, 1989, J BIOL CHEM, V264, P5241; GRAFF G, 1982, METHOD ENZYMOL, V86, P376; HABENICHT AJR, 1985, J CLIN INVEST, V75, P1381, DOI 10.1172/JCI111839; HAMBERG M, 1974, P NATL ACAD SCI USA, V71, P3400, DOI 10.1073/pnas.71.9.3400; HAURAND M, 1985, J BIOL CHEM, V260, P5059; HINO M, 1989, J BIOL CHEM, V264, P10309; HONDA A, 1986, BIOCHIM BIOPHYS ACTA, V877, P423, DOI 10.1016/0005-2760(86)90208-0; IKAWA Y, 1976, BIBL HAEMATOL, V43, P37; JACKSON CW, 1973, BLOOD, V42, P413, DOI 10.1182/blood.V42.3.413.413; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; KONDO S, 1989, BIOCHEM BIOPH RES CO, V161, P1267, DOI 10.1016/0006-291X(89)91379-X; LI CY, 1973, J HISTOCHEM CYTOCHEM, V21, P1; LING N, 1986, BIOCHEM BIOPH RES CO, V138, P1129, DOI 10.1016/S0006-291X(86)80400-4; MARKS PA, 1978, ANNU REV BIOCHEM, V47, P419, DOI 10.1146/annurev.bi.47.070178.002223; MEUNIER H, 1988, P NATL ACAD SCI USA, V85, P247, DOI 10.1073/pnas.85.1.247; MILLER JL, 1982, BIOCHEM BIOPH RES CO, V107, P752, DOI 10.1016/0006-291X(82)91555-8; MONCADA S, 1978, PHARMACOL REV, V30, P293; MURATA M, 1988, P NATL ACAD SCI USA, V85, P2434, DOI 10.1073/pnas.85.8.2434; NAITO J, 1983, EUR J PHARMACOL, V91, P41, DOI 10.1016/0014-2999(83)90359-X; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.biochem.56.1.945; ORKIN SH, 1975, P NATL ACAD SCI USA, V72, P98, DOI 10.1073/pnas.72.1.98; PAWLOWSKI NA, 1983, J EXP MED, V158, P393, DOI 10.1084/jem.158.2.393; RAZ A, 1988, J BIOL CHEM, V263, P3022; SCHWALL R, 1989, ENDOCRINOLOGY, V125, P1420, DOI 10.1210/endo-125-3-1420; SEGARINI PR, 1987, J BIOL CHEM, V262, P14655; SERHAN CN, 1988, INT J IMMUNOPATH PH, V1, P73; SHEN RF, 1986, J BIOL CHEM, V261, P1585; SHEN RF, 1986, J BIOL CHEM, V261, P1592; SHIMIZU T, 1990, J NEUROCHEM, V55, P1, DOI 10.1111/j.1471-4159.1990.tb08813.x; SHIMIZU T, 1981, ARCH BIOCHEM BIOPHYS, V206, P271, DOI 10.1016/0003-9861(81)90091-6; SHIOZAKI M, 1989, BIOCHEM BIOPH RES CO, V165, P1155, DOI 10.1016/0006-291X(89)92723-X; SMITH WL, 1989, BIOCHEM J, V259, P315, DOI 10.1042/bj2590315; TAKAHASHI S, 1990, BIOCHEM BIOPH RES CO, V167, P654, DOI 10.1016/0006-291X(90)92075-B; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; TSUJI T, 1988, BIOTECHNOL BIOENG, V31, P675, DOI 10.1002/bit.260310708; VALE W, 1986, NATURE, V321, P776, DOI 10.1038/321776a0; YAMASHITA T, 1990, CANCER RES, V50, P3182; YING SY, 1988, ENDOCR REV, V9, P267, DOI 10.1210/edrv-9-2-267; YOKOTA K, 1986, J BIOL CHEM, V261, P5410; YU J, 1989, BLOOD, V73, P952; YU J, 1987, NATURE, V330, P765, DOI 10.1038/330765a0	50	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3888	3892						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995639				2022-12-25	WOS:A1991EY68200081
J	DONALDSON, RW; HAGEDORN, CH; COHEN, S				DONALDSON, RW; HAGEDORN, CH; COHEN, S			EPIDERMAL GROWTH-FACTOR OR OKADAIC ACID STIMULATES PHOSPHORYLATION OF EUKARYOTIC INITIATION FACTOR-4F	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAP-BINDING-PROTEIN; MESSENGER-RNA; CELLS; TRANSLATION; ACTIVATION; INSULIN; INVITRO; KINASES; EIF-4F	Eukaryotic initiation factor 4F, a multi-protein mRNA cap binding complex, was isolated by m7GTP-Sepharose affinity chromatography from human mammary epithelial cells (184A1N4) incubated with [P-32] orthophosphate. Treatment of cells with epidermal growth factor resulted in enhanced phosphorylation of both p28 (eIF-4E) and p220 subunits. The identities of the p28 and p220 subunits were confirmed by immunoprecipitation. The phosphorylation was both rapid and sustained in duration; p28 attained maximal levels (2-3-fold) within 30 min of treatment and remained elevated for at least 2 h, while p220 reached one-half maximal levels by 30 min, and maximal levels (3-4-fold) by 2 h of treatment. Two phosphorylated isoforms of p28 and multiple phosphorylated forms of p220 were detected by two-dimensional isoelectric focusing/sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Phosphoamino acid analysis of 6 N HCl hydrolyzates of p28 and p220 isolated from epidermal growth factor-treated and control cells indicated that serine is the predominant phosphorylated amino acid in both instances. In no case was phosphotyrosine observed. Pretreatment of cells with 1-mu-M okadaic acid resulted in the hyperphosphorylation of both p28 and p220 subunits. These results suggest that mitogenic growth factors and cellular serine/threonine phosphatases (pp1 and/or pp2A) serve essential roles in regulating phosphorylation levels of eukaryotic initiation factor 4F and support the concept that translational control is a component of the signal transduction mechanisms involved in growth regulation.	VANDERBILT UNIV,MED CTR,SCH MED,DEPT BIOCHEM,NASHVILLE,TN 37232; VANDERBILT UNIV,MED CTR,SCH MED,DEPT CELL BIOL,NASHVILLE,TN 37232; VET ADM MED CTR,NASHVILLE,TN 37232	Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA)					NCI NIH HHS [5-T32-CA09582] Funding Source: Medline; NICHD NIH HHS [5-RO1-HD00700] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD000700] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009582] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AHN NG, 1990, J BIOL CHEM, V265, P11487; BONNEAU AM, 1987, J BIOL CHEM, V262, P11134; BRAVO R, 1984, 2 DIMENSIONAL GEL EL, P3; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; CLARK R, 1988, CANCER RES, V48, P4689; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; COHEN S, 1968, BIOCHIM BIOPHYS ACTA, V166, P427, DOI 10.1016/0005-2787(68)90231-1; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; CZECH MP, 1988, J BIOL CHEM, V263, P11017; DUNCAN R, 1987, J BIOL CHEM, V262, P380; ETCHISON D, 1990, J BIOL CHEM, V265, P7492; GRIFO JA, 1983, J BIOL CHEM, V258, P5804; HAAS D, 1989, 1989 M TRANSL CONTR, P79; HERSHEY JWB, 1989, J BIOL CHEM, V264, P20823; HIREMATH LS, 1985, J BIOL CHEM, V260, P7843; HIREMATH LS, 1989, J BIOL CHEM, V264, P1132; HOOBER JK, 1967, BIOCHIM BIOPHYS ACTA, V138, P357, DOI 10.1016/0005-2787(67)90496-0; Jagus R, 1981, Prog Nucleic Acid Res Mol Biol, V25, P127, DOI 10.1016/S0079-6603(08)60484-5; JOSHIBARVE S, 1990, J BIOL CHEM, V265, P2979; KASPAR RL, 1990, J BIOL CHEM, V265, P3619; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; MARINO MW, 1989, P NATL ACAD SCI USA, V86, P8417, DOI 10.1073/pnas.86.21.8417; MCMULLIN EL, 1988, BIOCHEM BIOPH RES CO, V153, P340, DOI 10.1016/S0006-291X(88)81228-2; MCMULLIN EL, 1988, BIOCHEM BIOPH RES CO, V153, P925; MORGAN MA, 1980, BIOCHEMISTRY-US, V19, P5960, DOI 10.1021/bi00567a003; MORLEY SJ, 1989, J BIOL CHEM, V264, P2401; MORLEY SJ, 1990, J BIOL CHEM, V265, P10611; NOVAKHOFER I, 1985, J BIOL CHEM, V260, P314; RAY BK, 1985, J BIOL CHEM, V260, P7651; RAY BK, 1986, J BIOL CHEM, V261, P1466; RHOADS RE, 1988, TRENDS BIOCHEM SCI, V13, P52, DOI 10.1016/0968-0004(88)90028-X; RYCHLIK W, 1987, J BIOL CHEM, V262, P10434; RYCHLIK W, 1986, J BIOL CHEM, V261, P71; SAVAGE CR, 1972, J BIOL CHEM, V247, P7609; SONNENBERG N, 1978, P NATL ACAD SCI USA, V75, P4843; THOMAS G, 1982, CELL, V30, P235, DOI 10.1016/0092-8674(82)90029-0; TUAZON PT, 1989, J BIOL CHEM, V264, P2773; ULRICH A, 1990, CELL, V61, P203; VALVERIUS EM, 1989, MOL ENDOCRINOL, V3, P201; WEBB NR, 1984, BIOCHEMISTRY-US, V23, P177, DOI 10.1021/bi00297a001; WEIEL JE, 1990, ADV 2ND MESSENGERS P, P182	42	64	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3162	3166						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993687				2022-12-25	WOS:A1991EX60000074
J	SHEFER, S; NGUYEN, LB; SALEN, G; NESS, GC; TINT, GS; BATTA, AK; HAUSER, S; RANI, I				SHEFER, S; NGUYEN, LB; SALEN, G; NESS, GC; TINT, GS; BATTA, AK; HAUSER, S; RANI, I			REGULATION OF CHOLESTEROL 7-ALPHA-HYDROXYLASE BY HEPATIC 7-ALPHA-HYDROXYLATED BILE-ACID FLUX AND NEWLY SYNTHESIZED CHOLESTEROL SUPPLY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							7 ALPHA-HYDROXYLASE; COA REDUCTASE; PHOSPHORYLATION-DEPHOSPHORYLATION; FEEDBACK-REGULATION; SALT SYNTHESIS; RAT; 7-ALPHA-HYDROXYLASE; MODULATION; CYTOCHROME-P-450; TAUROCHOLATE	We measured hepatic cholesterol 7-alpha-hydroxylase activity, mass, and catalytic efficiency (activity/unit mass) in bile fistula rats infused intraduodenally with taurocholate and its 7-beta-hydroxy epimer, tauroursocholate, with or without mevalonolactone to supply newly synthesized cholesterol. Enzyme activity was measured by an isotope incorporation assay and enzyme mass by densitometric scanning of immunoblots using rabbit anti-rat liver cholesterol 7-alpha-hydroxylase antisera. Cholesterol 7-alpha-hydroxylase activity increased 6-fold, enzyme mass 34%, and catalytic efficiency 5-fold after interruption of the enterohepatic circulation for 48 h. When taurocholate was infused to the bile acid-depleted animals at a rate equivalent to the hepatic bile acid flux (27-mu-mol/100-g rat/h), cholesterol 7-alpha-hydroxylase activity and enzyme mass declined 60 and 61%, respectively. Tauroursocholate did not significantly decrease cholesterol 7-alpha-hydroxylase activity, mass and catalytic efficiency. The administration of mevalonolactone, which is converted to cholesterol, modestly increased cholesterol 7-alpha-hydroxylase activity and enzyme mass in the bile acid-depleted rats. However, when taurocholate was infused together with mevalonolactone, cholesterol 7-alpha-hydroxylase activity and catalytic efficiency were markedly depressed while enzyme mass did not change as compared with bile acid-depleted rats. These results show that (a) hepatic bile acid depletion increases bile acid synthesis mainly by activating cholesterol 7-alpha-hydroxylase with only a small rise in enzyme mass, (b) replacement with taurocholate for 24 h decreases both cholesterol 7-alpha-hydroxylase activity and mass proportionally, (c) when cholesterol is available (mevalonolactone supplementation), the infusion of taurocholate results in the formation of a catalytically less active cholesterol 7-alpha-hydroxylase, and (d) tauroursocholate, the 7-beta-hydroxy epimer of taurocholate, does not inhibit cholesterol 7-alpha-hydroxylase. Thus, bile acid synthesis is modulated by the catalytic efficiency and mass of cholesterol 7-alpha-hydroxylase. The enterohepatic flux of 7-alpha-hydroxylated bile acids and the formation of hepatic cholesterol apparently control cholesterol 7-alpha-hydroxylase by different mechanisms.	UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,SAMMY DAVIS JR NATL LIVER INST,NEWARK,NJ 07103; UNIV S FLORIDA,COLL MED,DEPT BIOCHEM & MOLEC BIOL,TAMPA,FL 33612; VET ADM MED CTR,E ORANGE,NJ 07019	Rutgers State University New Brunswick; Rutgers State University Medical Center; State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA)	SHEFER, S (corresponding author), UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,DEPT MED,MSB H-534,185 S ORANGE AVE,NEWARK,NJ 07103, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL017818, R37HL017818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026756, R37DK026756, R01DK018707] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 17818] Funding Source: Medline; NIDDK NIH HHS [DK 26756, DK 18707] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERGLUND L, 1986, ACTA CHEM SCAND B, V40, P457, DOI 10.3891/acta.chem.scand.40b-0457; CHIANG JYL, 1990, J BIOL CHEM, V265, P3889; DAVIS RA, 1988, J LIPID RES, V29, P202; DUANE WC, 1988, J LIPID RES, V29, P212; ELDREDGE ER, 1989, BIOCHEM J, V262, P91, DOI 10.1042/bj2620091; JELINEK DF, 1990, J BIOL CHEM, V265, P8190; KUIPERS F, 1985, GASTROENTEROLOGY, V88, P403, DOI 10.1016/0016-5085(85)90499-8; LI YC, 1990, J BIOL CHEM, V265, P12012; LIDSTROMOLSSON B, 1985, FEBS LETT, V189, P124, DOI 10.1016/0014-5793(85)80855-3; NGUYEN LB, 1990, J BIOL CHEM, V265, P4541; NOSHIRO M, 1989, FEBS LETT, V257, P97, DOI 10.1016/0014-5793(89)81795-8; PRIES JM, 1983, J LIPID RES, V24, P141; SANGHVI A, 1981, BIOCHEM BIOPH RES CO, V103, P886, DOI 10.1016/0006-291X(81)90893-7; SHEFER S, 1969, J LIPID RES, V10, P646; SHEFER S, 1990, J CLIN INVEST, V85, P1191, DOI 10.1172/JCI114552; SHEFER S, 1973, J LIPID RES, V14, P573; SHEFER S, 1986, CHOLESTEROL 7 ALPHA, P43; STANGE EF, 1988, HEPATOLOGY, V8, P879, DOI 10.1002/hep.1840080429; TANG PM, 1986, BIOCHEM BIOPH RES CO, V134, P797, DOI 10.1016/S0006-291X(86)80491-0; TSERNG KY, 1977, J LIPID RES, V18, P404; WAXMAN DJ, 1986, ARCH BIOCHEM BIOPHYS, V247, P335, DOI 10.1016/0003-9861(86)90592-8; WAYNE WD, 1983, BIOSTATISTICS F ANAL, P112; WEIS EE, 1978, J LIPID RES, V19, P856	23	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2693	2696						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993648				2022-12-25	WOS:A1991EX60000004
J	ASTERMARK, J; STENFLO, J				ASTERMARK, J; STENFLO, J			THE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS OF FACTOR-IX - EFFECT ON BLOOD-CLOTTING AND ENDOTHELIAL-CELL BINDING OF A FRAGMENT CONTAINING THE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS LINKED TO THE GAMMA-CARBOXYGLUTAMIC ACID REGION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-HYDROXYASPARTIC ACID; COAGULATION FACTOR-IX; PLASMA THROMBOPLASTIN ANTECEDENT; RUSSELLS VIPER VENOM; FACTOR-X; CALCIUM-BINDING; CHRISTMAS FACTOR; FACTOR-VIII; PROTEIN-C; PHOSPHOLIPID-BINDING	The binding of factor IX to cultured bovine endothelial cells was characterized using isolated domains of bovine factor IX. An NH2-terminal fragment that consists of the gamma-carboxyglutamic acid (Gla) region linked to the two epidermal growth factor (EGF)-like domains bound to the endothelial cells with the same affinity as intact factor IX, indicating that the serine protease part of factor IX is not involved in binding. This fragment also inhibited the factor IXa-beta'-induced clotting of plasma at a concentration that would suggest a competition for phospholipid binding sites. However, after proteolytic removal of the Gla region from the fragment, the two EGF-like domains inhibited clotting almost as effectively, suggesting a direct interaction between this part of the molecule and the cofactor, factor VIIIa. Using affinity-purified Fab fragments against the Gla region, the EGF-like domains, and the serine protease part, it was observed that the serine protease part of the molecule undergoes a large conformational change upon activation, whereas the Gla region and the EGF-like domains appear to be unaffected. All three classes of Fab fragments were equally efficient as inhibitors of the factor IXa-beta'-induced clotting reaction. Part of factor Va and factor VIIIa have significant sequence homology to a lectin. We therefore investigated the effect on in vitro clotting of the recently identified unique disaccharide Xyl-alpha-1-3Glc, that is O-linked to a serine residue in the NH2-terminal EGF-like domain of human factor IX (Hase, S., Nishimura, H., Kawabata, S.-I., Iwanaga, S., and Ikenaka, T. (1990) J. Biol. Chem. 265, 1858-1861). However, no effect on blood clotting was observed in the assay system used. Our results are compatible with a model in which the serine protease part provides the specificity of the binding of factor IXa to factor VIIIa-phospholipid, but that the EGF-like domain(s) also contributes to the interaction of the enzyme with its cofactor.	UNIV LUND,MALMO GEN HOSP,DEPT CLIN CHEM,S-21401 MALMO,SWEDEN	Lund University								ASTERMARK J, 1991, J BIOL CHEM, V266, P2430; BAJAJ SP, 1985, J BIOL CHEM, V260, P1574; CHASE T, 1969, BIOCHEMISTRY-US, V13, P1014; DERIAN CK, 1989, J BIOL CHEM, V264, P6615; FALKE P, 1989, PHARMACOL TOXICOL, V64, P173, DOI 10.1111/j.1600-0773.1989.tb00624.x; FUJIKAWA K, 1974, BIOCHEMISTRY-US, V13, P4508, DOI 10.1021/bi00719a006; FUJIKAWA K, 1973, BIOCHEMISTRY-US, V12, P4938, DOI 10.1021/bi00748a019; GREEN PM, 1989, EMBO J, V8, P1067, DOI 10.1002/j.1460-2075.1989.tb03474.x; HANDFORD PA, 1990, EMBO J, V9, P475, DOI 10.1002/j.1460-2075.1990.tb08133.x; HARLOW E, 1988, ANTIBODIES LABORATOR, P627; HASE S, 1990, J BIOL CHEM, V265, P1858; HASE S, 1988, J BIOCHEM-TOKYO, V104, P867, DOI 10.1093/oxfordjournals.jbchem.a122571; HEIMARK RL, 1983, BIOCHEM BIOPH RES CO, V111, P723, DOI 10.1016/0006-291X(83)90365-0; HUANG LH, 1989, BIOCHEM BIOPH RES CO, V160, P133, DOI 10.1016/0006-291X(89)91631-8; HURSH DA, 1987, SCIENCE, V237, P1487, DOI 10.1126/science.3498216; KANE WH, 1988, BLOOD, V71, P539; KISIEL W, 1976, BIOCHEMISTRY-US, V15, P4901, DOI 10.1021/bi00667a023; LIEBMAN HA, 1987, J BIOL CHEM, V262, P7605; LIN SW, 1990, J BIOL CHEM, V265, P144; LINDQUIST PA, 1978, J BIOL CHEM, V253, P1902; LOLLAR P, 1984, ARCH BIOCHEM BIOPHYS, V233, P438, DOI 10.1016/0003-9861(84)90465-X; LUNDBLAD A, 1973, BIOCHEMISTRY-US, V12, P306, DOI 10.1021/bi00726a020; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MCCORD DM, 1990, J BIOL CHEM, V265, P10250; MORITA T, 1985, BIOCHEM BIOPH RES CO, V130, P841, DOI 10.1016/0006-291X(85)90493-0; MORITA T, 1984, J BIOL CHEM, V259, P5698; NISHIMURA H, 1989, J BIOL CHEM, V264, P20320; OHLIN AK, 1987, J BIOL CHEM, V262, P13798; OHLIN AK, 1988, J BIOL CHEM, V263, P7411; PERSSON E, 1989, J BIOL CHEM, V264, P16897; PERSSON E, 1991, J BIOL CHEM, V266, P2444; PERSSON E, 1991, J BIOL CHEM, V266, P2453; REES DJG, 1988, EMBO J, V7, P2053, DOI 10.1002/j.1460-2075.1988.tb03045.x; RIMON S, 1987, J BIOL CHEM, V262, P6023; RYAN J, 1989, J BIOL CHEM, V264, P20283; SCHWALBE RA, 1989, J BIOL CHEM, V264, P20288; STERN DM, 1983, P NATL ACAD SCI-BIOL, V80, P4119, DOI 10.1073/pnas.80.13.4119; STERN DM, 1985, J BIOL CHEM, V260, P6717; SUGO T, 1985, J BIOL CHEM, V260, P453; THOMPSON AR, 1986, BLOOD, V67, P565; THOMPSON AR, 1978, BIOCHEMISTRY-US, V17, P4304, DOI 10.1021/bi00613a030; VASSIN H, 1987, EMBO J, V6, P3431, DOI 10.1002/j.1460-2075.1987.tb02666.x; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6	43	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2438	2443						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989995				2022-12-25	WOS:A1991EV51500065
J	HOLZMAN, TF; EGAN, DA; EDALJI, R; SIMMER, RL; HELFRICH, R; TAYLOR, A; BURRES, NS				HOLZMAN, TF; EGAN, DA; EDALJI, R; SIMMER, RL; HELFRICH, R; TAYLOR, A; BURRES, NS			PRELIMINARY CHARACTERIZATION OF A CLONED NEUTRAL ISOELECTRIC FORM OF THE HUMAN PEPTIDYL PROLYL ISOMERASE CYCLOPHILIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS-TRANS-ISOMERASE; A-BINDING-PROTEIN; CYCLOSPORIN-A; CATALYSIS; SEQUENCE	We report the cloning of a neutral isoelectric form of the human peptidyl prolyl isomerase, cyclophilin, its expression in escherichia coli, and its purification and comparison to bovine thymus cyclophilin. The cloned protein exhibited a pI of approximately 7.8 and formed a simple 1:1 complex with cyclosporin A. This cloned form had a pI similar to that observed for the neutral isoform (pI approximately 7.4) of human splenocyte cyclophilin. The bovine thymus proteins exhibited anomalous behavior on CM-cellulose chromatography but were resolved into alkaline (pI approximately 9.3) isoforms and a new neutral (pI approximately 7.8) isoform by isoelectric focusing gel electrophoresis and ultimately into at least four discrete isoforms by capillary electrophoresis. For cyclosporin A binding we observe a K(d) of approximately 160 nM for an electrophoretically heterogeneous preparation of the natural bovine protein and approximately 360 nM for the more homogeneous preparation of the cloned human neutral isoform. Stopped-flow measurements of the activation energies for peptidyl-prolyl isomerase activity indicate the recombinant human protein has an activation enthalpy of 3.67 kcal/mol and an activation entropy of -47.3 cal/K-mol for cis --> trans isomerization.	ABBOTT LABS,DEPT MOLEC BIOL,ABBOTT PK,IL 60064; ABBOTT LABS,DEPT PROT BIOCHEM,ABBOTT PK,IL 60064; ABBOTT LABS,DEPT CORP MOLEC BIOL,ABBOTT PK,IL 60064; ABBOTT LABS,DIV PHARMACEUT PROD,DEPT ANTI INFECT RES,PHARMACEUT DISCOVERY,ABBOTT PK,IL 60064	Abbott Laboratories; Abbott Laboratories; Abbott Laboratories; Abbott Laboratories								AGARWAL RP, 1987, CLIN CHEM, V33, P481; BACHINGER HP, 1987, J BIOL CHEM, V262, P17144; DALGARNO DC, 1986, BIOCHEMISTRY-US, V25, P6778, DOI 10.1021/bi00370a008; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; DEBOER HA, 1983, P NATL ACAD SCI-BIOL, V80, P21; DERANLEA.DA, 1969, J AM CHEM SOC, V91, P4050, DOI 10.1021/ja01043a005; DERANLEAU DA, 1969, J AM CHEM SOC, V91, P4044, DOI 10.1021/ja01043a004; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DEYL Z, 1989, J LIQ CHROMATOGR, V12, P2515; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; FALOONA F, 1987, METHOD ENZYMOL, V155, P335; FARNSWORTH CC, 1990, SCIENCE, V247, P320, DOI 10.1126/science.2296721; FESIK SW, 1990, SCIENCE, V250, P1406, DOI 10.1126/science.2255910; FISCHER G, 1985, BIOCHIM BIOPHYS ACTA, V828, P39, DOI 10.1016/0167-4838(85)90006-8; FISCHER G, 1989, FEBS LETT, V250, P267, DOI 10.1016/0014-5793(89)80735-5; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; GORDON MJ, 1988, SCIENCE, V242, P224, DOI 10.1126/science.242.4876.224; HAENDLER B, 1987, EMBO J, V6, P947, DOI 10.1002/j.1460-2075.1987.tb04843.x; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; HARDING MW, 1986, J BIOL CHEM, V261, P8547; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P1684, DOI 10.1021/bi00459a003; HEALD SL, 1990, BIOCHEMISTRY-US, V29, P4466, DOI 10.1021/bi00470a029; LANG K, 1988, NATURE, V331, P453, DOI 10.1038/331453a0; LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0; LIU J, 1990, P NATL ACAD SCI USA, V87, P4028, DOI 10.1073/pnas.87.11.4028; LIU J, 1990, P NATL ACAD SCI USA, V87, P2304, DOI 10.1073/pnas.87.6.2304; Maniatis T., 1982, MOL CLONING; McFarland J, 1907, J AMER MED ASSOC, V49, P1176; RILLING HC, 1990, SCIENCE, V247, P318, DOI 10.1126/science.2296720; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Schreier, 1986, PROG CLIN BIOCH MED, V3, P157; STILLER CR, 1984, PROGR TRANSPLANTATIO, V1, P11; TAKAHASHI N, 1989, NATURE, V337, P473, DOI 10.1038/337473a0; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WENGER RM, 1985, ANGEW CHEM INT EDIT, V24, P77, DOI 10.1002/anie.198500773	36	35	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2474	2479						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989998				2022-12-25	WOS:A1991EV51500070
J	BUJALOWSKI, W; LOHMAN, TM				BUJALOWSKI, W; LOHMAN, TM			MONOMER-TETRAMER EQUILIBRIUM OF THE ESCHERICHIA-COLI SSB-1 MUTANT SINGLE-STRAND BINDING-PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID UNWINDING PROTEIN; DNA-BINDING; DEOXYRIBONUCLEIC-ACID; OLIGONUCLEOTIDE INTERACTIONS; SOLVENT DENATURATION; NUCLEIC-ACIDS; RECA-PROTEIN; COMPLEXES; GENE; REPLICATION	The Escherichia coli single strand binding (SSB) protein is an essential protein required for DNA replication and involved in recombination and a number of repair processes. It is a stable homotetramer in solution; however the ssb-1 mutation (His-55 to Tyr) destabilizes the tetramer with respect to monomers and this defect seems to explain the observed phenotype (Williams, K. R., Murphy, J. B., and Chase, J. W. (1989) J. Biol. Chem. 259, 11804-11811). We report a quantitative study of the SSB-1 monomer-tetramer equilibrium in vitro as a function of temperature, pH, NaCl, MgCl2, urea, and guanidine hydrochloride concentrations. The self-assembly equilibrium was monitored by the increase in intrinsic protein fluorescence anisotrophy accompanying the formation of the tetramer. The experimental isotherms indicate that SSB-1 dimers are not highly populated at equilibrium, hence the formation of the tetramer is well-described as a one-step association of four monomers. At 25-degrees-C, pH 8.1, the monomer concentration for 50% tetramer dissociation is (M(T)1/2 = 0.87-mu-M, corresponding to a monomer-tetramer equilibrium constant, K(T) = 3 +/- 1 x 10(18) M-3. The tetramerization constant, K(T), is highly dependent upon temperature and pH, with DELTA-H(O) = -51 +/- 7 kcal/mol (pH 8.1) and DELTA-H(O) = -37 +/- 5 kcal/mol (pH 6.9). There is no effect of NaCl on the monomer-tetramer association in the range from 0.20 to 1.0 M; however, MgCl2 decreases the stability of the SSB-1 tetramer. In the presence of high concentrations of the single-stranded oligonucleotide, dT(pT)15, the tetramerization constant is slightly increased indicating that binding of the oligonucleotide to the SSB-1 monomer promotes the assembly process, although not dramatically. The large negative DELTA-H(O) that is associated with formation of the tetramer provides a likely explanation for the temperature sensitivity of the ssb-1 mutation.	TEXAS A&M UNIV SYST,DEPT BIOCHEM & BIOPHYS,COLLEGE STN,TX 77843	Texas A&M University System; Texas A&M University College Station					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030498] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM030498] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERTS B, 1970, NATURE, V277, P1313; BALUCH J, 1980, J BACTERIOL, V144, P489, DOI 10.1128/JB.144.2.489-498.1980; BANDYOPADHYAY PK, 1978, BIOCHEMISTRY-US, V17, P4078, DOI 10.1021/bi00612a032; BUJALOWSKI W, 1987, BIOCHEMISTRY-US, V26, P3099, DOI 10.1021/bi00385a023; BUJALOWSKI W, 1989, J MOL BIOL, V207, P269, DOI 10.1016/0022-2836(89)90455-5; BUJALOWSKI W, 1988, J BIOL CHEM, V263, P4629; BUJALOWSKI W, 1989, J MOL BIOL, V207, P249, DOI 10.1016/0022-2836(89)90454-3; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P7799, DOI 10.1021/bi00372a003; BUJALOWSKI W, 1989, Biophysical Journal, V55, p526A; BUJALOWSKI W, 1990, IN PRESS J MOL BIOL; BUJALOWSKI W, 1987, J MOL BIOL, V195, P895; CARROLL RB, 1975, J MOL BIOL, V91, P275, DOI 10.1016/0022-2836(75)90380-0; CASASSA EF, 1964, ADV PROTEIN CHEM, V19, P287, DOI 10.1016/S0065-3233(08)60191-6; CHASE JW, 1986, ANNU REV BIOCHEM, V55, P103, DOI 10.1146/annurev.biochem.55.1.103; CHASE JW, 1983, J MOL BIOL, V164, P193, DOI 10.1016/0022-2836(83)90075-X; CHASE JW, 1984, J BIOL CHEM, V259, P805; CHRYSOGELOS S, 1982, P NATL ACAD SCI-BIOL, V79, P5803, DOI 10.1073/pnas.79.19.5803; ELLERTON NF, 1969, BIOPOLYMERS, V8, P767, DOI 10.1002/bip.1969.360080607; GLASSBERG J, 1979, J BACTERIOL, V140, P14, DOI 10.1128/JB.140.1.14-19.1979; GRIFFITH JD, 1984, COLD SPRING HARB SYM, V49, P553, DOI 10.1101/SQB.1984.049.01.062; Jablonski A, 1935, Z PHYS, V96, P236, DOI 10.1007/BF01341525; Jablonski A., 1960, B ACAD POL SCI SET S, V8, P259; KRAUSS G, 1981, BIOCHEMISTRY-US, V20, P5346, DOI 10.1021/bi00521a040; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; LAKOWICZ JR, 1980, BIOPHYS J, V32, P591, DOI 10.1016/S0006-3495(80)84992-7; LIEBERMAN HB, 1983, MOL GEN GENET, V190, P92, DOI 10.1007/BF00330329; LOHMAN TM, 1988, BIOCHEMISTRY-US, V27, P2260, DOI 10.1021/bi00407a002; LOHMAN TM, 1986, J MOL BIOL, V187, P603, DOI 10.1016/0022-2836(86)90338-4; LOHMAN TM, 1988, TRENDS BIOCHEM SCI, V13, P250; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; LOHMAN TM, 1986, BIOCHEMISTRY-US, V25, P21, DOI 10.1021/bi00349a004; Lohman TM., 1990, BIOL NONSPECIFIC DNA, P131; LOW RL, 1982, J BIOL CHEM, V257, P6242; MEYER RR, 1982, MUTAT RES, V94, P299, DOI 10.1016/0027-5107(82)90293-7; MEYER RR, 1982, J BACTERIOL, V150, P433, DOI 10.1128/JB.150.1.433-435.1982; MEYER RR, 1980, J BIOL CHEM, V255, P2897; MEYER RR, 1979, P NATL ACAD SCI USA, V76, P1702, DOI 10.1073/pnas.76.4.1702; MOLINEUX IJ, 1975, J MOL BIOL, V98, P811, DOI 10.1016/S0022-2836(75)80012-X; MOLINEUX IJ, 1974, J BIOL CHEM, V249, P6090; OVERMAN LB, 1988, BIOCHEMISTRY-US, V27, P456, DOI 10.1021/bi00401a067; Pace C N, 1986, Methods Enzymol, V131, P266; PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034; PERRINO FW, 1988, J BIOL CHEM, V263, P11833; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; ROYER CA, 1986, BIOCHEMISTRY-US, V25, P8308, DOI 10.1021/bi00373a027; RUBEN SM, 1988, P NATL ACAD SCI USA, V85, P3767, DOI 10.1073/pnas.85.11.3767; RUYECHAN WT, 1975, BIOCHEMISTRY-US, V14, P5529, DOI 10.1021/bi00696a023; SANCAR A, 1981, P NATL ACAD SCI-BIOL, V78, P4274, DOI 10.1073/pnas.78.7.4274; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SCHELLMAN JA, 1978, BIOPOLYMERS, V17, P1305, DOI 10.1002/bip.1978.360170515; SCHELLMAN JA, 1987, BIOPOLYMERS, V26, P549, DOI 10.1002/bip.360260408; SIGAL N, 1972, P NATL ACAD SCI USA, V69, P3537, DOI 10.1073/pnas.69.12.3537; Stern O, 1919, PHYS Z, V20, P183; VALES LD, 1980, J BACTERIOL, V143, P887, DOI 10.1128/JB.143.2.887-896.1980; WEBER G, 1952, BIOCHEM J, V51, P145, DOI 10.1042/bj0510145; WEINER JH, 1975, J BIOL CHEM, V250, P1972; WELTMAN JK, 1967, BIOCHEMISTRY-US, V6, P1437, DOI 10.1021/bi00857a028; WHITTIER RF, 1981, MOL GEN GENET, V183, P341, DOI 10.1007/BF00270638; WILLIAMS KR, 1984, J BIOL CHEM, V259, P1804; WILLIAMS KR, 1980, P NATL ACAD SCI-BIOL, V77, P4614, DOI 10.1073/pnas.77.8.4614; XU GJ, 1982, P NATL ACAD SCI-BIOL, V79, P5268, DOI 10.1073/pnas.79.17.5268	61	66	66	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1616	1626						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1988441				2022-12-25	WOS:A1991EU49700042
J	OKAMOTO, T; ASANO, T; HARADA, S; OGATA, E; NISHIMOTO, I				OKAMOTO, T; ASANO, T; HARADA, S; OGATA, E; NISHIMOTO, I			REGULATION OF TRANSMEMBRANE SIGNAL TRANSDUCTION OF INSULIN-LIKE GROWTH FACTOR-II BY COMPETENCE TYPE GROWTH-FACTORS OR VIRAL RAS P21	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEIN; BALB/C 3T3 CELLS; ISLET-ACTIVATING PROTEIN; PERTUSSIS-TOXIN; ACETYLCHOLINE-RECEPTOR; CALCIUM INFLUX; IGF RECEPTOR; PURIFICATION; CLONING; GENE	In BALB/c 3T3 cells pretreated with platelet-derived growth factor (PDGF) and epidermal growth factor (EGF) (primed-competent cells), insulin-like growth factors I and II (IGF-I and IGF-II) bind to their own receptors (IGF-IR and IGF-IIR) and stimulate calcium influx and DNA synthesis by a mechanism involving a 40-kDa pertussis toxin substrate. In contrast, these IGFs do not act on unprimed quiescent cells. In this study, the 40-kDa pertussis toxin substrate was identified as G(i-2-alpha) using anti-G protein antibodies. We analyzed the quality of signal transduction from IGF-II to G(i-2-alpha). There was no difference in the amount of G(i-2-alpha) between quiescent and primed-competent cells, and both of these cells had similar K(d) values and numbers of IGF-II-binding sites. Whereas IGF-II did not alter pertussis toxin-catalyzed ADP-ribosylation of G(i-2-alpha) in quiescent cells, IGF-II reduced the pertussis toxin substrate activity by 35-50% via the IGF-IIR in primed-competent cells. The action of IGF-II lasted for up to 3 h when IGF-II was present in the medium, and it disappeared when IGF-II was removed. These results suggest that the signaling pathway triggered by IGF-II is uncoupled between the IGF-IIR and G(i-2-alpha) in quiescent cells and that PDGF and EGF restore the IGF-IIR-G(i-2) coupling. This study also indicates that low concentrations of IGF-I reduce the pertussis toxin substrate activity of G(i-2-alpha) in primed-competent cells in a time course slower than that of IGF-II, but not at all in quiescent cells. However, both of these cells had similar K(d) values and numbers of IGF-I binding sites. Therefore, the IGF-I signaling pathway may also be uncoupled between the IGF-IR and G(i-2-alpha) in quiescent cells and restored by PDGF and EGF. In BALB/c 3T3 cells transfected with temperature-sensitive Kirsten sarcoma virus bearing the v-Ki-ras gene (ts cells), a 40-kDa pertussis toxin substrate was also identified as G(i-2-alpha). In nonpermissive ts cells, IGF-II was without effect on the pertussis toxin substrate activity of G(i-2-alpha) or on calcium influx. In contrast, in permissive ts cells expressing transforming v-ras p21, IGF-II reduced the pertussis toxin substrate activity of G(i-2-alpha) and proportionally stimulated calcium influx. There was no difference in IGF-II binding or in the amount of G(i-2-alpha) between nonpermissive and permissive ts cells. Furthermore, in nonpermissive ts cells pretreated with PDGF and EGF, IGF-II modifed G(i-2-alpha) and stimulated calcium influx. Therefore, v-ras p21 activation acted on the IGF-IIR-G(i-2) linkage in a manner similar to the action of PDGF and EGF. We postulate that (i) uncoupling between the IGF-IIR and G(i-2) is one major mechanism that precludes quiescent cells from responding to IGF-II via calcium influx, and (ii) the combination of PDGF and EGF or the activation of v-ras p21 commonly regulates the IGF-II-triggered calcium signaling pathway by restoring receptor-G protein coupling.	UNIV TOKYO,SCH MED,DEPT INTERNAL MED 4,LIFE SCI LAB,TOKYO 112,JAPAN; AICHI PREFECTURAL COLONY,INST DEV RES,KASUGAI,AICHI 48003,JAPAN	University of Tokyo								ASANO T, 1989, BIOCHEMISTRY-US, V28, P4749, DOI 10.1021/bi00437a035; BATEMAN JF, 1981, P NATL ACAD SCI-BIOL, V78, P6028, DOI 10.1073/pnas.78.10.6028; BLANCHARD MM, 1988, MOL CELL ENDOCRINOL, V56, P235, DOI 10.1016/0303-7207(88)90066-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; FISCHER HD, 1982, J BIOL CHEM, V257, P9938; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GOLDMAN D, 1987, CELL, V48, P965, DOI 10.1016/0092-8674(87)90705-7; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HASEGAWASASAKI H, 1985, BIOCHEM J, V232, P99, DOI 10.1042/bj2320099; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KATADA T, 1987, FEBS LETT, V213, P353, DOI 10.1016/0014-5793(87)81521-1; KOBILKA BK, 1987, SCIENCE, V238, P650, DOI 10.1126/science.2823383; KOJIMA I, 1988, BIOCHEM BIOPH RES CO, V154, P9, DOI 10.1016/0006-291X(88)90642-0; KOJIMA I, 1988, J BIOL CHEM, V263, P16561; KUBO T, 1986, NATURE, V323, P411, DOI 10.1038/323411a0; MATSUNAGA H, 1988, AM J PHYSIOL, V255, pC442, DOI 10.1152/ajpcell.1988.255.4.C442; MOLLOY CJ, 1989, NATURE, V342, P711, DOI 10.1038/342711a0; MORISHITA R, 1990, BIOCHEM BIOPH RES CO, V172, P249, DOI 10.1016/S0006-291X(05)80201-3; MORISHITA R, 1989, BIOCHEM BIOPH RES CO, V161, P1280, DOI 10.1016/0006-291X(89)91381-8; MORISHITA R, 1988, EUR J BIOCHEM, V174, P87, DOI 10.1111/j.1432-1033.1988.tb14066.x; MURAYAMA Y, 1990, J BIOL CHEM, V265, P17456; NISHIMOTO I, 1987, BIOCHEM BIOPH RES CO, V142, P275, DOI 10.1016/0006-291X(87)90481-5; NISHIMOTO I, 1989, J BIOL CHEM, V264, P14029; NISHIMOTO I, 1987, J BIOL CHEM, V262, P12120; OINUMA M, 1986, FEBS LETT, V207, P28, DOI 10.1016/0014-5793(86)80007-2; OKAMOTO T, 1990, CELL, V62, P709, DOI 10.1016/0092-8674(90)90116-V; OVCHINNIKOV YA, 1982, FEBS LETT, V148, P179, DOI 10.1016/0014-5793(82)80805-3; RECHLER MM, 1985, ANNU REV PHYSIOL, V47, P425; ROSENFELD RG, 1986, BIOCHEM BIOPH RES CO, V138, P304, DOI 10.1016/0006-291X(86)90280-9; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; STILES CD, 1979, P NATL ACAD SCI USA, V76, P1279, DOI 10.1073/pnas.76.3.1279; TALLY M, 1987, BIOCHEM BIOPH RES CO, V148, P811, DOI 10.1016/0006-291X(87)90948-X; TONG PY, 1988, J BIOL CHEM, V263, P2585	34	34	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1085	1091						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985936				2022-12-25	WOS:A1991ET17700065
J	GERSHMAN, LC; SELDEN, LA; ESTES, JE				GERSHMAN, LC; SELDEN, LA; ESTES, JE			HIGH-AFFINITY DIVALENT-CATION EXCHANGE ON ACTIN - ASSOCIATION RATE MEASUREMENTS SUPPORT THE SIMPLE COMPETITIVE MODEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MG2+-INDUCED CONFORMATIONAL CHANGE; MONOMERIC ACTIN; METAL-ION; BINDING; ATP; SITES; POLYMERIZATION; KINETICS; CA-2+; MG-2+	Each actin molecule has one high affinity site which binds a divalent cation. It has been proposed that an isomerization of the actin molecule is involved in divalent cation exchange at this site ("isomerization model," Frieden, C. (1982) J Biol. Chem. 257, 2882-2886); we have maintained that exchange is by a simple competitive mechanism (Estes, J. E., Selden, L. A., and Gershman, L.C. (1987) J. Biol. Chem. 262, 4952-4957). Here, using fluorescent-labeled actin, we measure the apparent rate constant for exchange (k(app)) as a function of the ratio of free Ca2+ and Mg2+ concentrations, ([Ca]/[Mg]), and show that both models are consistent with the data. The major parameter controlling this relationship in the simple competitive exchange model, the ratio of the association rate constants for Ca2+ and Mg2+ to actin (k(ca)/k(Mg)), is found to have a value of about 90. We have verified this parameter by direct measurements of k(Ca) and k(Mg), finding that k(Ca) = 1.9 X 10(7) M-1 S-1 and k(Mg) = 2.3 X 10(5) M-1 S-1, consistent with the characteristics of the Ca2+ and Mg2+ aquo ions. The corresponding parameter derived from the isomerization model is not verifiable. We conclude that high affinity divalent action exchange on actin proceeds by a simple competitive mechanism.	VET ADM MED CTR,RES SERV,ALBANY,NY 12208; VET ADM MED CTR,MED SERV,ALBANY,NY 12208; UNION UNIV,DEPT PHYSIOL & CELL BIOL,ALBANY,NY 12208; UNION UNIV,DEPT CELL BIOL,ALBANY,NY 12208	US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Union College; Union College					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032007] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM-32007] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSSON T, 1980, CALCIUM BINDING PROT, P293; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARLIER MF, 1986, J BIOL CHEM, V261, P785; CARLIER MF, 1986, J BIOL CHEM, V261, P778; DETMERS P, 1981, J BIOL CHEM, V256, P99; DIEBLER H, 1969, Pure and Applied Chemistry, V20, P93, DOI 10.1351/pac196920010093; ESTES JE, 1987, J BIOL CHEM, V262, P4952; FRIEDEN C, 1985, BIOCHEMISTRY-US, V24, P4192, DOI 10.1021/bi00336a056; FRIEDEN C, 1982, J BIOL CHEM, V257, P2882; GERSHMAN LC, 1986, BIOCHEM BIOPH RES CO, V135, P607, DOI 10.1016/0006-291X(86)90036-7; GERSHMAN LC, 1988, BIOPHYS J, V53, P573; KONNO K, 1985, P NATL ACAD SCI USA, V82, P7904, DOI 10.1073/pnas.82.23.7904; MCCAMMON JA, 1987, DYNAMICS PROTEINS NU, P29; NOWAK E, 1988, BIOCHEMISTRY-US, V27, P1785, DOI 10.1021/bi00405a060; POTTER JD, 1980, CALCIUM BINDING PROT, P279; REID SS, 1990, BIOCHEMISTRY-US, V29, P6025, DOI 10.1021/bi00477a021; SELDEN LA, 1989, J BIOL CHEM, V264, P9271; SELDEN LA, 1986, J MUSCLE RES CELL M, V7, P215, DOI 10.1007/BF01753554; SELDEN LA, 1987, FEBS LETT, V217, P89, DOI 10.1016/0014-5793(87)81249-8; Szent-Gy_orgyi A., 1951, CHEM MUSCULAR CONTRA, V2nd; TOBACMAN LS, 1987, BIOCHEMISTRY-US, V26, P492, DOI 10.1021/bi00376a022; VALENTINRANC C, 1989, J BIOL CHEM, V264, P20871; ZIMMERLE CT, 1988, BIOCHEMISTRY-US, V27, P7759, DOI 10.1021/bi00420a026; ZIMMERLE CT, 1987, BIOCHEMISTRY-US, V26, P6545, DOI 10.1021/bi00394a039	24	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					76	82						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985925				2022-12-25	WOS:A1991EQ33900014
J	SCHNETKAMP, PPM; SZERENCSEI, RT				SCHNETKAMP, PPM; SZERENCSEI, RT			EFFECT OF POTASSIUM-IONS AND MEMBRANE-POTENTIAL ON THE NA-CA-K EXCHANGER IN ISOLATED INTACT BOVINE ROD OUTER SEGMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGE; PLASMA-MEMBRANE; LIGHT ADAPTATION; SALAMANDER RODS; OPTICAL PROBE; PHOTORECEPTORS; FLUXES; PERMEABILITIES; PURIFICATION; SELECTIVITY	Two recent studies reported that Na-Ca exchange in the outer segments of tiger salamander rod photoreceptors (Cervetto, L., Lagnado, L., Perry, R.J., Robinson, D.W., and McNaughton, P.A. (1989) Nature 337, 740-743) and of bovine rod photoreceptors (Schnetkamp, P.P.M., Basu, D.K., and Szerencsei, R.T. (1989) Am. J. Physiol. 257, C153-157) requires and transports K+ in a 4Na/(1Ca+1K) stoichiometry. In this study, we have examined the effects of K+ ions and membrane potential on the kinetics of Na-Ca and Ca-Ca exchange in rod outer segments isolated from bovine retinas. The objective was to establish the ion selectivity and voltage dependence of the different cation binding sites on the Na-Ca-K exchange protein. Potassium ions activated Na-Ca exchange when present on the Ca2+ side, although the extent of activation decreased with decreasing Na+ concentration. Potassium ions inhibited Na-Ca exchange when present on the Na+ side; inhibition arose from competition between Na+ and K+ for a common single cation-binding site. Activation of Na-Ca exchange by K+ displayed a different ion selectivity than that observed for inhibition of Na-Ca exchange by K+. The results are interpreted in terms of a three-site model for the rod Na-Ca-K exchanger. The rate of forward Na-Ca exchange decreased by 1.75-fold for a 60 mV depolarization of the plasma membrane but only at lower Na+ concentrations. The rate of Ca-Ca exchange was not affected by changes in membrane potential.			SCHNETKAMP, PPM (corresponding author), UNIV CALGARY,HLTH SCI CTR,DEPT MED BIOCHEM,3330 HOSP DR NW,CALGARY T2N 4N1,ALBERTA,CANADA.							CERVETTO L, 1989, NATURE, V337, P740, DOI 10.1038/337740a0; COOK NJ, 1988, J BIOL CHEM, V263, P11382; DAEMEN FJM, 1973, BIOCHIM BIOPHYS ACTA, V300, P255, DOI 10.1016/0304-4157(73)90006-3; Dixon M., 1964, ENZYMES, V2nd; EISNER DA, 1985, AM J PHYSIOL, V248, pC189, DOI 10.1152/ajpcell.1985.248.3.C189; GOLD GH, 1986, P NATL ACAD SCI USA, V83, P1150, DOI 10.1073/pnas.83.4.1150; HILGEMANN DW, 1988, PROG BIOPHYS MOL BIO, V51, P1, DOI 10.1016/0079-6107(88)90009-0; HODGKIN AL, 1985, J PHYSIOL-LONDON, V358, P447, DOI 10.1113/jphysiol.1985.sp015561; HODGKIN AL, 1987, J PHYSIOL-LONDON, V391, P371, DOI 10.1113/jphysiol.1987.sp016743; HODGKIN AL, 1987, J PHYSIOL-LONDON, V391, P347, DOI 10.1113/jphysiol.1987.sp016742; KAUPP UB, 1982, CELL CALCIUM, V3, P83, DOI 10.1016/0143-4160(82)90008-2; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; LAGNADO L, 1988, P NATL ACAD SCI USA, V85, P4548, DOI 10.1073/pnas.85.12.4548; LAUGER P, 1987, J MEMBRANE BIOL, V99, P1, DOI 10.1007/BF01870617; MATTHEWS HR, 1988, NATURE, V334, P67, DOI 10.1038/334067a0; MCNAUGHTON PA, 1986, NATURE, V322, P261, DOI 10.1038/322261a0; MILLER DL, 1987, J GEN PHYSIOL, V90, P397, DOI 10.1085/jgp.90.3.397; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; NICOL GD, 1989, J GEN PHYSIOL, V94, P233, DOI 10.1085/jgp.94.2.233; NICOLL DA, 1989, J BIOL CHEM, V264, P16207; RATTO GM, 1988, J NEUROSCI, V8, P3240; REEVES JP, 1985, CURR TOP MEMBR TRANS, V25, P77; SCHNETKAMP PPM, 1980, BIOCHIM BIOPHYS ACTA, V598, P66, DOI 10.1016/0005-2736(80)90266-7; SCHNETKAMP PPM, 1985, J MEMBRANE BIOL, V88, P263, DOI 10.1007/BF01871090; SCHNETKAMP PPM, 1985, BIOCHEMISTRY-US, V24, P723, DOI 10.1021/bi00324a028; SCHNETKAMP PPM, 1985, J MEMBRANE BIOL, V88, P249, DOI 10.1007/BF01871089; SCHNETKAMP PPM, 1989, AM J PHYSIOL, V257, pC153, DOI 10.1152/ajpcell.1989.257.1.C153; SCHNETKAMP PPM, 1986, J PHYSIOL-LONDON, V373, P25, DOI 10.1113/jphysiol.1986.sp016033; SCHNETKAMP PPM, 1988, BIOPHYS J, V53, pA389; SCHNETKAMP PPM, 1987, J GEN PHYSIOL, V89, P481, DOI 10.1085/jgp.89.3.481; SCHNETKAMP PPM, 1979, BIOCHIM BIOPHYS ACTA, V554, P441, DOI 10.1016/0005-2736(79)90383-3; SCHNETKAMP PPM, 1979, BIOCHIM BIOPHYS ACTA, V552, P379, DOI 10.1016/0005-2736(79)90182-2; SCHNETKAMP PPM, 1990, IN PRESS PROGR BIOPH; SLAUGHTER RS, 1983, J BIOL CHEM, V258, P3183; YAU KW, 1985, NATURE, V313, P579, DOI 10.1038/313579a0; YAU KW, 1984, NATURE, V311, P661, DOI 10.1038/311661a0	36	36	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					189	197						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985892				2022-12-25	WOS:A1991EQ33900030
J	SIMENTAL, JA; SAR, M; LANE, MV; FRENCH, FS; WILSON, EM				SIMENTAL, JA; SAR, M; LANE, MV; FRENCH, FS; WILSON, EM			TRANSCRIPTIONAL ACTIVATION AND NUCLEAR TARGETING SIGNALS OF THE HUMAN ANDROGEN RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHICKEN PROGESTERONE-RECEPTOR; HUMAN GLUCOCORTICOID RECEPTOR; COMPLEMENTARY DEOXYRIBONUCLEIC-ACID; THYROID-HORMONE RECEPTOR; HUMAN ESTROGEN-RECEPTOR; STEROID BINDING DOMAIN; FUNCTIONAL DOMAINS; DNA-BINDING; MONOCLONAL-ANTIBODIES; IMMUNOCYTOCHEMICAL LOCALIZATION	The androgen receptor (AR) is a signal-transducing protein required for sexual differentiation, development, and expression of the male phenotype. A series of human AR deletion mutants were created either by site-directed mutagenesis using restriction enzyme digestion, the polymerase chain reaction, or, for a series of unidirectional NH2-terminal deletions, exonuclease III digestion. Receptor mutants were expressed in monkey kidney COS cells as truncated AR proteins between 20 and 107 kDa as revealed on immunoblots, where wild type AR was a doublet of 114 and 108 kDa. Subcellular localization by immunocytochemical staining demonstrated androgen-dependent nuclear uptake of AR from a perinuclear region of the cytoplasm. A nuclear targeting signal similar in sequence and position to the glucocorticoid receptor and homologous to the SV40 large T antigen was required for androgen-induced nuclear uptake of wild type AR. AR mutants lacking the NH2-terminal and/or steroid binding domains were constitutively nuclear with reduced transcriptional activity. Transcriptional activation by wild type AR was androgen-dependent in cotransfection studies of CV1 cells using the chloramphenicol acetyltransferase reporter gene linked to the mouse mammary tumor virus promoter. Deletion mutagenesis revealed within the NH2-terminal region a domain required for full transcriptional activity and within the steroid binding domain, an inhibitory function, deletion of which yielded a constitutively active receptor. Inhibition of wild type AR by coexpression with an inactive NH2-terminal fragment suggested competition for nuclear factors required for transcriptional regulation. These studies demonstrate a concerted interplay among the domains of the AR protein in regulating gene transcription.	UNIV N CAROLINA,REPROD BIOL LABS,CB 7500 MACNIDER BLDG,CHAPEL HILL,NC 27599; UNIV N CAROLINA,DEPT PEDIAT,CHAPEL HILL,NC 27599; UNIV N CAROLINA,DEPT CELL BIOL & ANAT,CHAPEL HILL,NC 27599; UNIV N CAROLINA,DEPT BIOCHEM,CHAPEL HILL,NC 27599	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill					NICHD NIH HHS [P30-HD18968, HD16910] Funding Source: Medline; NINDS NIH HHS [NS17479] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD018968, R37HD016910, R01HD016910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017479] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; BOCQUEL MT, 1989, NUCLEIC ACIDS RES, V17, P2581, DOI 10.1093/nar/17.7.2581; BURGLIN TR, 1987, EMBO J, V6, P2617, DOI 10.1002/j.1460-2075.1987.tb02552.x; CARSON MA, 1987, MOL ENDOCRINOL, V1, P791, DOI 10.1210/mend-1-11-791; CARSONJURICA MA, 1990, MOL ENDOCRINOL, V11, P201; DANG CV, 1988, MOL CELL BIOL, V8, P4048, DOI 10.1128/MCB.8.10.4048; DANIELSEN M, 1987, MOL ENDOCRINOL, V1, P816, DOI 10.1210/mend-1-11-816; DANIELSEN M, 1986, EMBO J, V5, P2513, DOI 10.1002/j.1460-2075.1986.tb04529.x; DANIELSEN M, 1989, CELL, V57, P1131, DOI 10.1016/0092-8674(89)90050-0; DINGWALL C, 1986, ANNU REV CELL BIOL, V2, P367, DOI 10.1146/annurev.cellbio.2.1.367; DOBSON ADW, 1989, J BIOL CHEM, V264, P4207; ELASHRYSTOWERS D, 1988, CANCER RES, V48, P6462; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FAWELL SE, 1990, CELL, V60, P983; FREEDMAN LP, 1989, SCIENCE, V245, P298, DOI 10.1126/science.2473529; FRNECH FS, 1990, IN PRESS RECENT PROG; GEHRING U, 1985, FEBS LETT, V179, P138, DOI 10.1016/0014-5793(85)80208-8; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; GODOWSKI PJ, 1988, SCIENCE, V241, P812, DOI 10.1126/science.3043662; GREEN S, 1986, COLD SPRING HARB SYM, V51, P751, DOI 10.1101/SQB.1986.051.01.088; GREEN S, 1986, NATURE, V324, P615, DOI 10.1038/324615a0; GREEN S, 1988, EMBO J, V7, P3037, DOI 10.1002/j.1460-2075.1988.tb03168.x; GRONEMEYER H, 1987, EMBO J, V6, P3985, DOI 10.1002/j.1460-2075.1987.tb02741.x; GUIOCHONMANTEL A, 1989, CELL, V57, P1147, DOI 10.1016/0092-8674(89)90052-4; HARD T, 1990, SCIENCE, V249, P157, DOI 10.1126/science.2115209; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Higuchi R., 1989, PCR TECHNOLOGY, P61; HOLLENBERG SM, 1987, CELL, V49, P39, DOI 10.1016/0092-8674(87)90753-7; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; HOPE IA, 1988, NATURE, V333, P635, DOI 10.1038/333635a0; HUGHES MR, 1988, SCIENCE, V242, P1702, DOI 10.1126/science.2849209; HUNT T, 1989, CELL, V59, P949, DOI 10.1016/0092-8674(89)90747-2; HUSMANN DA, 1990, ENDOCRINOLOGY, V126, P2359, DOI 10.1210/endo-126-5-2359; JONES DH, 1990, BIOTECHNIQUES, V8, P178; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KING WJ, 1984, NATURE, V307, P745, DOI 10.1038/307745a0; KOZAK M, 1984, NATURE, V308, P241, DOI 10.1038/308241a0; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; LEA OA, 1979, J BIOL CHEM, V254, P6196; LEES JA, 1989, NUCLEIC ACIDS RES, V17, P5477, DOI 10.1093/nar/17.14.5477; LUBAHN DB, 1989, P NATL ACAD SCI USA, V86, P9534, DOI 10.1073/pnas.86.23.9534; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; LUBAHN DB, 1988, SCIENCE, V240, P327, DOI 10.1126/science.3353727; MCDONNELL DP, 1989, MOL ENDOCRINOL, V3, P635, DOI 10.1210/mend-3-4-635; MIESFELD R, 1987, SCIENCE, V236, P423, DOI 10.1126/science.3563519; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MORELAND RB, 1987, MOL CELL BIOL, V5, P2569; ORO AE, 1988, CELL, V55, P1109, DOI 10.1016/0092-8674(88)90255-3; PERROTAPPLANAT M, 1985, ENDOCRINOLOGY, V116, P1473, DOI 10.1210/endo-116-4-1473; PICARD D, 1990, CELL REGUL, V1, P291, DOI 10.1091/mbc.1.3.291; PICARD D, 1988, CELL, V54, P1073, DOI 10.1016/0092-8674(88)90122-5; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; PRATT WB, 1988, J BIOL CHEM, V263, P267; QUARMBY VE, 1990, MOL ENDOCRINOL, V4, P1399, DOI 10.1210/mend-4-9-1399; QUIGLEY CA, 1990, 72ND ANN M END SOC A, P223; RUNDLETT SE, 1990, MOL ENDOCRINOL, V4, P708, DOI 10.1210/mend-4-5-708; SAR M, 1985, TECHNIQUES IMMUNOCYT, V3, P43; SCHENA M, 1989, GENE DEV, V3, P1590, DOI 10.1101/gad.3.10.1590; STRAHLE U, 1989, NATURE, V339, P629, DOI 10.1038/339629a0; STRAHLE U, 1988, EMBO J, V7, P3389, DOI 10.1002/j.1460-2075.1988.tb03212.x; TAN JA, 1988, MOL ENDOCRINOL, V2, P1276, DOI 10.1210/mend-2-12-1276; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; TORA L, 1988, NATURE, V333, P185, DOI 10.1038/333185a0; TSAI SY, 1988, CELL, V55, P361, DOI 10.1016/0092-8674(88)90059-1; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; WELSHONS WV, 1984, NATURE, V307, P747, DOI 10.1038/307747a0; WIKSTROM AC, 1987, ENDOCRINOLOGY, V120, P1232, DOI 10.1210/endo-120-4-1232; WILDEMAN AG, 1989, P NATL ACAD SCI USA, V86, P2123, DOI 10.1073/pnas.86.7.2123; WILSON EM, 1976, J BIOL CHEM, V251, P5620; WILSON EM, 1979, J BIOL CHEM, V254, P6310; WILSON EM, 1986, J BIOL CHEM, V261, P6501; WRANGE O, 1989, J BIOL CHEM, V264, P5253; YAMAMOTO KR, 1974, P NATL ACAD SCI USA, V71, P3901, DOI 10.1073/pnas.71.10.3901; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; YARBROUGH WG, 1990, J BIOL CHEM, V265, P8893	79	538	559	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					510	518						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985913				2022-12-25	WOS:A1991EQ33900076
J	CORVERA, S; CAPOCASALE, RJ				CORVERA, S; CAPOCASALE, RJ			ENHANCED PHOSPHORYLATION OF A COATED VESICLE POLYPEPTIDE IN RESPONSE TO INSULIN STIMULATION OF RAT ADIPOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV MASSACHUSETTS, SCH MED, DEPT CELL BIOL, WORCESTER, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	CORVERA, S (corresponding author), UNIV MASSACHUSETTS, SCH MED, PROGRAM MOLEC MED, WORCESTER, MA 01655 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040330] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-40330] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHLE S, 1986, EMBO J, V5, P3143, DOI 10.1002/j.1460-2075.1986.tb04621.x; AHLE S, 1988, EMBO J, V7, P919, DOI 10.1002/j.1460-2075.1988.tb02897.x; BARZVI D, 1988, J BIOL CHEM, V263, P4408; BARZVI D, 1986, J BIOL CHEM, V261, P9614; BRODSKY FM, 1988, SCIENCE, V242, P1396, DOI 10.1126/science.2904698; CAMPBELL C, 1984, BIOCHEMISTRY-US, V23, P4420, DOI 10.1021/bi00314a028; CANTOURNET B, 1987, FEBS LETT, V220, P143, DOI 10.1016/0014-5793(87)80892-X; CORVERA S, 1990, J BIOL CHEM, V265, P2413; CORVERA S, 1989, J BIOL CHEM, V264, P12568; CORVERA S, 1989, J BIOL CHEM, V264, P10133; CZECH MP, 1988, J BIOL CHEM, V263, P11017; DAVIS RJ, 1986, J BIOL CHEM, V261, P8708; GLICKMAN JN, 1989, EMBO J, V8, P1041, DOI 10.1002/j.1460-2075.1989.tb03471.x; GOUD B, 1985, J CELL BIOL, V100, P521, DOI 10.1083/jcb.100.2.521; HANSON VG, 1990, J NEUROCHEM, V54, P46, DOI 10.1111/j.1471-4159.1990.tb13281.x; IACOPETTA BJ, 1988, CELL, V54, P485, DOI 10.1016/0092-8674(88)90069-4; KEDERSHA NL, 1986, J CELL BIOL, V103, P699, DOI 10.1083/jcb.103.3.699; KEEN JH, 1986, J CELL BIOL, V102, P1325, DOI 10.1083/jcb.102.4.1325; KEEN JH, 1987, J CELL BIOL, V105, P1989, DOI 10.1083/jcb.105.5.1989; KEEN JH, 1979, CELL, V16, P303, DOI 10.1016/0092-8674(79)90007-2; KLARLUND JK, 1988, J BIOL CHEM, V263, P15872; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARSHALL S, 1981, J BIOL CHEM, V256, P1464; MARTINPEREZ J, 1989, J CELL BIOL, V109, P577, DOI 10.1083/jcb.109.2.577; MAYORGA LS, 1989, METHOD CELL BIOL, V31, P179; MOORE MS, 1987, SCIENCE, V236, P558, DOI 10.1126/science.2883727; OKA Y, 1986, J BIOL CHEM, V261, P9090; PAULOIN A, 1986, PROG BRAIN RES, V69, P259; PEARSE BMF, 1982, P NATL ACAD SCI-BIOL, V79, P451, DOI 10.1073/pnas.79.2.451; PEARSE BMF, 1987, ANNU REV BIOPHYS BIO, V16, P49, DOI 10.1146/annurev.bb.16.060187.000405; PUCCI DL, 1983, J BIOL CHEM, V258, P2907; RAMAKRISHNA S, 1979, J BIOL CHEM, V254, P9232; ROBINSON MS, 1986, J CELL BIOL, V102, P48, DOI 10.1083/jcb.102.1.48; ROBINSON MS, 1987, J CELL BIOL, V104, P887, DOI 10.1083/jcb.104.4.887; RODBELL M, 1964, J BIOL CHEM, V239, P375; SALZMAN NH, 1989, J CELL BIOL, V109, P2097, DOI 10.1083/jcb.109.5.2097; SCHOOK WJ, 1985, P NATL ACAD SCI USA, V82, P8039, DOI 10.1073/pnas.82.23.8039; SMITH CJ, 1980, P NATL ACAD SCI-BIOL, V77, P2641, DOI 10.1073/pnas.77.5.2641; SOMMERCORN J, 1987, P NATL ACAD SCI USA, V84, P8834, DOI 10.1073/pnas.84.24.8834; TANNER LI, 1987, J BIOL CHEM, V262, P8975; WARDZALA LJ, 1984, J BIOL CHEM, V259, P8378; WITTERS LA, 1983, J BIOL CHEM, V258, P5643	42	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	1990	265	26					15963	15969						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY964	1975592				2022-12-25	WOS:A1990DY96400094
J	TYAGI, SC				TYAGI, SC			REVERSIBLE INHIBITION OF NEUTROPHIL ELASTASE BY THIOL-MODIFIED ALPHA-1 PROTEASE INHIBITOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALPHA-1-PROTEINASE INHIBITOR; HUMAN ALPHA-1-ANTITRYPSIN; REACTIVE SITE; KINETICS; BINDING; INACTIVATION; METHIONINE; SEQUENCE; RESIDUES; PLASMA	We have modified the single cysteine residue of alpha-1-protease inhibitor (alpha-1-PI) with HgCl2, methylmethane thiosulfonate, oxidized glutathione (GSSG), and N-(1-anilinonaphthyl-4)maleimide (ANM). Whereas native alpha-1-PI combines rapidly and quasi-irreversibly with neutrophil elastase, the thiol-modified alpha-1-PI derivatives are dissociable reversible competitive inhibitors of the enzyme, with values of K(i) in the range of 6-7 nM. Removal of the thiol modifications restores the rapid irreversible mode of inhibition. Once native alpha-1-PI has combined with neutrophil elastase, the enzyme-inhibitor complex retains a reactive thiol group, but the two proteins can no longer be dissociated by subsequent reaction with ANM, even after exposure to sodium dodecyl sulfate-polyacrylamide gel electrophoresis. From kinetic measurements of fluorescence, ANM-modified alpha-1-PI combines with neutrophil elastase via an apparent bimolecular process with a second order rate constant on the order of 10(5) M-1 S-1. We estimate a dissociation rate constant on the order of 10(-3) s-1. The emission of ANM-modified alpha-1-PI is increased in intensity and blue shifted from the maximum in ANM-modified cysteine, consistent with a predominantly nonpolar environment. Association with neutrophil elastase results in an additional blue shift with further increase in intensity, consistent with a further decrease in polarity of the environment of the cysteine. Modification with methylmethane thiosulfonate or GSSG results in a small decrease in quantum yield and a red shift in the tryptophan emission spectrum of the modified inhibitor, suggestive of increased polarity of the environment of at least 1 of the 2 tryptophan residues in alpha-1-PI. These changes are reversed by dithiothreitol and are consistent with a conformational change which transforms the inhibitory activity from a rapid, irreversible mode in the native alpha-1-PI to a dissociable competitive mode in the mixed disulfide derivatives.			TYAGI, SC (corresponding author), SUNY STONY BROOK, DEPT BIOCHEM & CELL BIOL, STONY BROOK, NY 11794 USA.				NHLBI NIH HHS [HL-14262] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL014262, R37HL014262] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAUGH RJ, 1976, BIOCHEMISTRY-US, V15, P836, DOI 10.1021/bi00649a017; Bieth J., 1974, BAYER S, P463; BIETH JG, 1986, BIOL EXTRACELLULAR M, P217; BOCK SC, 1986, BIOCHEMISTRY-US, V25, P4292, DOI 10.1021/bi00363a018; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI 10.1111/j.1751-1097.1973.tb06422.x; BUSBY TF, 1977, ARCH BIOCHEM BIOPHYS, V184, P267, DOI 10.1016/0003-9861(77)90350-2; BUSBY TF, 1976, ARCH BIOCHEM BIOPHYS, V177, P552, DOI 10.1016/0003-9861(76)90466-5; CARP H, 1980, J CLIN INVEST, V66, P987, DOI 10.1172/JCI109968; CARRELL R, 1985, TRENDS BIOCHEM SCI, V10, P20, DOI 10.1016/0968-0004(85)90011-8; CARRELL RW, 1980, BIOCHEM BIOPH RES CO, V93, P399, DOI 10.1016/0006-291X(80)91090-6; CARRELL RW, 1982, NATURE, V298, P329, DOI 10.1038/298329a0; CARRELL RW, 1981, FEBS LETT, V135, P301, DOI 10.1016/0014-5793(81)80805-8; CHANDRA T, 1983, BIOCHEMISTRY-US, V22, P5055, DOI 10.1021/bi00291a001; CLARK RA, 1981, J BIOL CHEM, V256, P3348; COHEN AB, 1973, J BIOL CHEM, V248, P7055; EMPIE MW, 1982, BIOCHEMISTRY-US, V21, P2274, DOI 10.1021/bi00539a002; FESTE A, 1981, J BIOL CHEM, V256, P6374; FRETZ JC, 1978, BIOCHIM BIOPHYS ACTA, V537, P226, DOI 10.1016/0005-2795(78)90506-8; GREEN NM, 1953, BIOCHEM J, V54, P347, DOI 10.1042/bj0540347; HASINOFF BB, 1971, CAN J BIOCHEM CELL B, V49, P742, DOI 10.1139/o71-105; HEIMBURGER N, 1971, 1ST P INT RES C PROT, P1; HENDERSON PJ, 1972, BIOCHEM J, V127, P321, DOI 10.1042/bj1270321; JANOFF A, 1985, ANNU REV MED, V36, P207; JENCKS WP, 1969, CATALYSIS CHEM ENZYM, P564; JEPPSSON JO, 1978, EUR J BIOCHEM, V83, P143, DOI 10.1111/j.1432-1033.1978.tb12078.x; JOHNSON D, 1978, J BIOL CHEM, V253, P7142; JOHNSON D, 1979, J BIOL CHEM, V254, P4022; JOHNSON D, 1975, PROTIDES BIOL FLUIDS, V23, P35; KANAOKA Y, 1973, BIOCHIM BIOPHYS ACTA, V317, P563, DOI 10.1016/0005-2795(73)90253-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAURELL CB, 1975, EUR J BIOCHEM, V57, P107, DOI 10.1111/j.1432-1033.1975.tb02281.x; Laurell CB, 1979, CHEM PHYSL HUMAN PLA, P329; LAURELL CB, 1976, LA RICERCA CLIN L S3, V6, P57; LIJNEN HR, 1987, EUR J BIOCHEM, V166, P565, DOI 10.1111/j.1432-1033.1987.tb13551.x; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; Lundblad R.L, 1984, CHEM REAGENTS PROTEI, VI; NAKAJIMA K, 1979, J BIOL CHEM, V254, P4027; NALIN CM, 1983, J BIOL CHEM, V258, P3376; PADRINES M, 1989, AM REV RESPIR DIS, V139, P783, DOI 10.1164/ajrccm/139.3.783; PARKER CA, 1960, ANALYST, V85, P587, DOI 10.1039/an9608500587; PENEFSKY HS, 1977, J BIOL CHEM, V252, P2891; SANDBORG RR, 1988, LAB INVEST, V59, P300; SILVERMAN R, 1988, MECHANISM BASED ENZY, V1, P22; SILVERSTEIN RM, 1975, ANAL BIOCHEM, V63, P281, DOI 10.1016/0003-2697(75)90219-5; TEALE FWJ, 1957, BIOCHEM J, V65, P476, DOI 10.1042/bj0650476; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; TRAVIS J, 1988, AM J MED, V84, P37	48	25	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					5279	5285						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002060				2022-12-25	WOS:A1991FC21700087
J	STUMP, DG; LLOYD, RS; CHYTIL, F				STUMP, DG; LLOYD, RS; CHYTIL, F			SITE-DIRECTED MUTAGENESIS OF RAT CELLULAR RETINOL-BINDING PROTEIN - ALTERATION IN BINDING-SPECIFICITY RESULTING FROM MUTATION OF GLUTAMINE-108 TO ARGININE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; ESCHERICHIA-COLI; MESSENGER-RNA; RECEPTOR; IDENTIFICATION; PURIFICATION; TISSUE; LIVER; DNA; EXPRESSION	Cellular retinol-binding protein (CRBP) is a retinol-specific binding protein. A rat cDNA clone of CRBP was expressed in Escherichia coli. In order to determine amino acid residues in CRBP which may be important for the binding of all-trans-retinol, comparative model-building studies were performed in which strong sequence similarities were identified between CRBP and several other binding proteins. Based on this analysis, specific amino acids were predicted to be important in retinol binding, and these predictions were tested using the technique of site-directed mutagenesis to subtly alter the protein's structure and function. Specifically, site-directed mutagenesis was performed to alter the Gln-108 to Arg-108 (Q108R). Making use of fluorescence, Q108R was found to have a 3-fold lower affinity for all-trans-retinol, and the fine structure of the excitation spectrum of the Q108R.all-trans-retinol complex was also different than for the wild type.all-trans-retinol complex. The mutant bound 13-cis-retinol with an excitation spectrum identical to wild type bound to 13-cis-retinol, but with only one-half of the fluorescence intensity. In competition binding experiments, the Q108R mutant was found to have similar binding affinities for all-trans-retinol, all-trans-retinoic acid, 13-cis-retinoic acid, and retinal, while wild type CRBP was only able to bind to all-trans-retinol. Thus, altering a single amino acid in CRBP (Gln-108 to Arg-108) caused a significant change in the ligand binding specificity of the protein.			STUMP, DG (corresponding author), VANDERBILT UNIV,MED CTR,SCH MED,DEPT BIOCHEM,NASHVILLE,TN 37232, USA.			Lloyd, R. Stephen/0000-0001-7273-372X	NICHD NIH HHS [HD-09195, HD-07043] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD009195] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BASHOR MM, 1973, P NATL ACAD SCI USA, V70, P3483, DOI 10.1073/pnas.70.12.3483; BASS NM, 1985, J BIOL CHEM, V260, P1432; BENBROOK D, 1988, NATURE, V333, P669, DOI 10.1038/333669a0; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BERNLOHR DA, 1984, P NATL ACAD SCI-BIOL, V81, P5468, DOI 10.1073/pnas.81.17.5468; BOHEMR FD, 1987, J BIOL CHEM, V262, P15137; BRAND N, 1988, NATURE, V332, P850, DOI 10.1038/332850a0; CHYTIL F, 1984, RETINOIDS, V2, P89; COHEN SN, 1972, P NATL ACAD SCI USA, V69, P2110, DOI 10.1073/pnas.69.8.2110; FUTTERMAN S, 1977, J BIOL CHEM, V252, P3267; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; GORDON JI, 1983, J BIOL CHEM, V258, P3356; HEUCKEROTH RO, 1987, J BIOL CHEM, V262, P9709; HUNT CR, 1986, P NATL ACAD SCI USA, V83, P3786, DOI 10.1073/pnas.83.11.3786; ISHAQUE A, 1982, J BIOL CHEM, V257, P592; JONES TA, 1988, EMBO J, V7, P1597, DOI 10.1002/j.1460-2075.1988.tb02985.x; KRUST A, 1989, P NATL ACAD SCI USA, V86, P5310, DOI 10.1073/pnas.86.14.5310; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVIN MS, 1988, J BIOL CHEM, V263, P17715; MACDONALD PN, 1987, J BIOL CHEM, V262, P10550; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; Moore T., 1967, VITAMINS, V1, P245; ONG DE, 1975, J BIOL CHEM, V250, P6113; ONG DE, 1984, J BIOL CHEM, V259, P1476; ONG DE, 1978, J BIOL CHEM, V253, P828; ONG DE, 1982, NATURE, V257, P13385; SACCHETTINI JC, 1989, J MOL BIOL, V208, P327, DOI 10.1016/0022-2836(89)90392-6; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANI BP, 1974, BIOCHEM BIOPH RES CO, V61, P1276, DOI 10.1016/S0006-291X(74)80422-5; SHERMAN DR, 1987, P NATL ACAD SCI USA, V84, P3209, DOI 10.1073/pnas.84.10.3209; STUMP DG, 1988, BIOCHEMISTRY-US, V27, P1839, DOI 10.1021/bi00406a007; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WALZ DA, 1988, J BIOL CHEM, V263, P14189; ZELENT A, 1989, NATURE, V339, P714, DOI 10.1038/339714a0; ZOLLER MJ, 1983, METHOD ENZYMOL, V100, P468	35	40	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4622	4630						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999437				2022-12-25	WOS:A1991FA69400092
J	ARFMAN, N; VANBEEUMEN, J; DEVRIES, GE; HARDER, W; DIJKHUIZEN, L				ARFMAN, N; VANBEEUMEN, J; DEVRIES, GE; HARDER, W; DIJKHUIZEN, L			PURIFICATION AND CHARACTERIZATION OF AN ACTIVATOR PROTEIN FOR METHANOL DEHYDROGENASE FROM THERMOTOLERANT BACILLUS SPP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KEY ENZYME; METABOLISM; OXIDATION; STRAINS; PQQ	All thermotolerant methanol-utilizing Bacillus spp. investigated by us possess a NAD-dependent methanol dehydrogenase (MDH) activity which is stimulated by a protein present in the soluble fraction of Bacillus sp. C1 cells. This activator protein was purified to homogeneity from Bacillus sp. C1 cells grown at a low dilution rate in a methanol-limited chemostat culture. The native activator protein (M(r) = 50,000) is a dimer of M(r) = 27,000 subunits. The N-terminal amino acid sequence revealed no significant similarity with any published sequences. Stimulation of MDH activity by the activator protein required the presence of Mg2+ ions. Plots of specific MDH activity versus activator protein concentration revealed Michaelis-Menten type kinetics. In the presence of activator protein, MDH displayed biphasic kinetics (v versus substrate concentration) toward C1-C4 primary alcohols and NAD. The data suggest that in the presence of activator protein plus Mg2+ ions, MDH possesses a high affinity active site for alcohols and NAD, in addition to an activator- and Mg2+-independent low affinity active site. The activation mechanism remains to be elucidated.	STATE UNIV GHENT,MICROBIOL & MICROBIAL GENET LAB,B-9000 GHENT,BELGIUM	Ghent University	ARFMAN, N (corresponding author), STATE UNIV GRONINGEN,DEPT MICROBIOL,9751 NN HAREN,NETHERLANDS.		Dijkhuizen, Lubbert/E-9454-2014; Dijkhuizen, Lubbert/K-3539-2019	Dijkhuizen, Lubbert/0000-0003-2312-7162				ALAWADHI N, 1988, APPL MICROBIOL BIOT, V29, P485, DOI 10.1007/BF00269073; ANTHONY C, 1986, ADV MICROB PHYSIOL, V27, P113, DOI 10.1016/S0065-2911(08)60305-7; Anthony C., 1982, BIOCH METHYLOTROPHS; ARFMAN N, 1989, ARCH MICROBIOL, V152, P280, DOI 10.1007/BF00409664; BASTIDE A, 1989, J GEN MICROBIOL, V135, P2869; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branden C.-I., 1975, ENZYMES, V11, P103; DEVRIES GE, 1986, FEMS MICROBIOL LETT, V39, P235, DOI 10.1016/0378-1097(86)90448-9; DIJKHUIZEN L, 1988, FEMS MICROBIOL LETT, V52, P209; DIJKSTRA M, 1988, FEBS LETT, V227, P198, DOI 10.1016/0014-5793(88)80898-6; DUINE JA, 1986, FEMS MICROBIOL LETT, V32, P165; DUINE JA, 1984, FEBS LETT, V168, P217, DOI 10.1016/0014-5793(84)80249-5; HILLMER P, 1974, BIOCHIM BIOPHYS ACTA, V334, P12, DOI 10.1016/0005-2744(74)90146-6; KATO N, 1974, J FERMENT TECHNOL, V52, P917; KATO N, 1988, AGR BIOL CHEM TOKYO, V52, P2659, DOI 10.1080/00021369.1988.10869105; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVERING PR, 1981, ARCH MICROBIOL, V129, P72, DOI 10.1007/BF00417184; NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416; NEAL JL, 1972, J THEOR BIOL, V35, P113, DOI 10.1016/0022-5193(72)90196-8; SHEEHAN MC, 1988, BIOCHEM J, V252, P661, DOI 10.1042/bj2520661; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; Sund H., 1963, ENZYMES, V7, P25; VONCK J, 1991, J BIOL CHEM, V266, P3949	24	31	35	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3955	3960						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995643				2022-12-25	WOS:A1991EY68200090
J	VANLAAR, JH; BERREVOETS, CA; TRAPMAN, J; ZEGERS, ND; BRINKMANN, AO				VANLAAR, JH; BERREVOETS, CA; TRAPMAN, J; ZEGERS, ND; BRINKMANN, AO			HORMONE-DEPENDENT ANDROGEN RECEPTOR PHOSPHORYLATION IS ACCOMPANIED BY RECEPTOR TRANSFORMATION IN HUMAN LYMPH-NODE CARCINOMA OF THE PROSTATE CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AVIAN PROGESTERONE-RECEPTOR; BREAST-CANCER-CELLS; GLUCOCORTICOID RECEPTORS; ESTROGEN-RECEPTOR; FUNCTIONAL DOMAINS; DOWN-REGULATION; NUCLEAR; BINDING; SITES; DEPHOSPHORYLATION	Phosphorylation of the androgen receptor was investigated in the absence of hormone as well as during and after transformation of the receptor to the tight nuclear binding form. Human prostate tumor cells (LNCaP) were labeled for 4 h with [P-32]orthophosphate in the presence or absence of steroid. Subsequently, androgen receptors were immunoprecipitated either from total cell lysates or from nuclear extracts using a specific monoclonal antibody. The immunoprecipitated receptor preparations were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, Western blotting, using a polyclonal antiserum, and autoradiography. It was observed that the androgen receptor is already phosphorylated in the absence of hormone, but undergoes a hormone-induced additional phosphorylation. After administration of 10 nM R1881, a 1.8-fold increase in phosphorylation over nonstimulated control cells was reached. Moreover, the amount of nuclear extractable androgen receptor was increased; the acquisition of tight nuclear binding capacity was accompanied by hormone-induced receptor phosphorylation.	ERASMUS UNIV,FAC MED,DEPT BIOCHEM 2,POB 1738,3000 DR ROTTERDAM,NETHERLANDS; ORG APPL SCI RES,DEPT IMMUNOL,MED BIOL LAB,RIJSWIJK,NETHERLANDS; ERASMUS UNIV,FAC MED,DEPT PATHOL,3000 DR ROTTERDAM,NETHERLANDS	Erasmus University Rotterdam; Netherlands Organization Applied Science Research; Erasmus University Rotterdam								AURICCHIO F, 1984, J STEROID BIOCHEM, V20, P31, DOI 10.1016/0022-4731(84)90185-7; AURICCHIO F, 1987, EMBO J, V6, P2293; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; CAMPEN CA, 1986, ENDOCRINOLOGY, V119, P1454, DOI 10.1210/endo-119-4-1454; CHANG CS, 1988, SCIENCE, V240, P324, DOI 10.1126/science.3353726; DALMAN FC, 1988, J BIOL CHEM, V263, P12259; DOUGHERTY JJ, 1984, J BIOL CHEM, V259, P8004; ECKERT RL, 1984, ENDOCRINOLOGY, V114, P629, DOI 10.1210/endo-114-2-629; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; GOLSTEYN EJ, 1989, PROSTATE, V14, P91, DOI 10.1002/pros.2990140203; HOECK W, 1989, J BIOL CHEM, V264, P14396; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; HOUSLEY PR, 1983, J BIOL CHEM, V258, P4630; HUSMANN DA, 1990, ENDOCRINOLOGY, V126, P2359, DOI 10.1210/endo-126-5-2359; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUBAHN DB, 1988, SCIENCE, V240, P327, DOI 10.1126/science.3353727; MCINTYRE WR, 1985, J BIOL CHEM, V260, P418; MIGLIACCIO A, 1989, MOL ENDOCRINOL, V3, P1061, DOI 10.1210/mend-3-7-1061; MIGLIACCIO A, 1986, EMBO J, V5, P2867, DOI 10.1002/j.1460-2075.1986.tb04581.x; MULLICK A, 1986, J BIOL CHEM, V261, P3236; NARDULLI AM, 1986, ENDOCRINOLOGY, V119, P2038, DOI 10.1210/endo-119-5-2038; NIELSEN CJ, 1977, P NATL ACAD SCI USA, V74, P1398, DOI 10.1073/pnas.74.4.1398; ORTI E, 1989, J BIOL CHEM, V264, P9728; PERROTAPPLANAT M, 1985, ENDOCRINOLOGY, V116, P1473, DOI 10.1210/endo-116-4-1473; PIKE JW, 1985, BIOCHEM BIOPH RES CO, V131, P378, DOI 10.1016/0006-291X(85)91813-3; PURI RK, 1984, J STEROID BIOCHEM, V20, P23, DOI 10.1016/0022-4731(84)90184-5; ROSSINI GP, 1982, BIOCHEM J, V208, P383, DOI 10.1042/bj2080383; SANDO JJ, 1979, J BIOL CHEM, V254, P4772; SHERIDAN PL, 1988, MOL ENDOCRINOL, V2, P1329, DOI 10.1210/mend-2-12-1329; SHERIDAN PL, 1989, J BIOL CHEM, V264, P6520; SMITH LI, 1989, BIOCHEMISTRY-US, V28, P4490, DOI 10.1021/bi00436a055; SULLIVAN WP, 1988, J BIOL CHEM, V263, P14717; TRAPMAN J, 1988, BIOCHEM BIOPH RES CO, V153, P241, DOI 10.1016/S0006-291X(88)81214-2; VANLAAR JH, 1990, BIOCHEM BIOPH RES CO, V166, P193, DOI 10.1016/0006-291X(90)91930-Q; VANLAAR JH, 1989, MOL CELL ENDOCRINOL, V67, P29, DOI 10.1016/0303-7207(89)90227-X; VELDSCHOLTE J, 1990, BIOCHIM BIOPHYS ACTA, V1052, P187, DOI 10.1016/0167-4889(90)90075-O; WELSHONS WV, 1984, NATURE, V307, P747, DOI 10.1038/307747a0	37	73	73	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3734	3738						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995627				2022-12-25	WOS:A1991EY68200060
J	HARA, H; YOKOYAMA, S				HARA, H; YOKOYAMA, S			INTERACTION OF FREE APOLIPOPROTEINS WITH MACROPHAGES - FORMATION OF HIGH-DENSITY LIPOPROTEIN-LIKE LIPOPROTEINS AND REDUCTION OF CELLULAR CHOLESTEROL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-SKIN FIBROBLASTS; PERIPHERAL LYMPH LIPOPROTEINS; BETA-ELECTROPHORETIC MOBILITY; LIPID-PROTEIN INTERACTIONS; SMOOTH-MUSCLE CELLS; A-I; HUMAN-PLASMA; FOAM CELLS; FLUID LIPOPROTEINS; RECEPTOR ACTIVITY	Mouse peritoneal macrophages, loaded with cholesteryl ester by incubating with acetylated human low density lipoprotein containing [H-3]cholesteryl oleate, were exposed to purified human apolipoproteins (apo) A-I, A-II, C-III, or E in aqueous solutions. Unesterified cholesterol was released into the medium in the presence of apoA-I, -A-II, or -E, accompanied by the decrease in intracellular cholesteryl ester. ApoC-III had no such effects. Apparent K(m) values of the cholesterol release were estimated as 0.11, 0.14, and 0.24-mu-M, and V(max) values 35, 11, and 14-mu-g of cholesterol/mg of cell protein/6 h, for apoA-I, -A-II, and -E, respectively. The products formed with apoA-I, -A-II, or -E in the media were analyzed by density gradient ultracentrifugation when the cells were preloaded with [H-3]cholesteryl oleate-acetylated low density lipoproteins and [H-3]choline. Free [H-3]cholesterol, [H-3]phosphatidylcholine, and [H-3]sphingomyelin were detected coincidentally as a symmetric peak at the density of 1.1 in each case. In the complex of lipids and apoA-I or apoA-II, the weight ratios of apolipoprotein/cholesterol/phosphatidylcholine/sphingomyelin/lysophosphatidylcholine were estimated as 2.2:1:0.6:0.2:0.07 and 4.0:1:0.5:0.3:0.07, respectively. Both of the products formed with apoA-I and -A-II migrated slower than plasma high density lipoprotein in electrophoresis on agarose gel. Because the K(m) values are as low as 1:340-400, 1:140-160, and 1:6-8 of plasma concentrations of apoA-I, -A-II, and -E, respectively, the results have physiological relevance for a function of the free apolipoproteins in interstitial fluid to form high density lipoprotein and to reduce cellular cholesterol.	UNIV ALBERTA,DEPT MED,LIPID & LIPOPROT RES GRP,EDMONTON T6G 2S2,ALBERTA,CANADA	University of Alberta								AMES BN, 1960, J BIOL CHEM, V235, P769; ARVIDSON GA, 1968, EUR J BIOCHEM, V4, P478, DOI 10.1111/j.1432-1033.1968.tb00237.x; ASSMANN G, 1977, J CLIN INVEST, V59, P565, DOI 10.1172/JCI108672; AVIRAM M, 1989, J LIPID RES, V30, P65; BASU SK, 1982, J BIOL CHEM, V257, P9788; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; BISGAIER CL, 1985, J LIPID RES, V26, P11; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BROWN MS, 1975, J CLIN INVEST, V55, P783, DOI 10.1172/JCI107989; BROWN MS, 1980, J BIOL CHEM, V255, P9344; BROWN MS, 1979, J CELL BIOL, V82, P597, DOI 10.1083/jcb.82.3.597; CASTRO GR, 1988, BIOCHEMISTRY-US, V27, P25, DOI 10.1021/bi00401a005; DANIELS RJ, 1981, J BIOL CHEM, V256, P4978; DAS HK, 1985, J BIOL CHEM, V260, P6240; DORY L, 1983, P NATL ACAD SCI-BIOL, V80, P3489, DOI 10.1073/pnas.80.11.3489; EDELSON PJ, 1976, IN VITRO METHODS CEL, P333; EISENBERG S, 1984, J LIPID RES, V25, P1017; FITCH WM, 1977, GENETICS, V86, P623; GERRITY RG, 1981, AM J PATHOL, V103, P191; GERRITY RG, 1981, AM J PATHOL, V103, P181; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; HAVEL RJ, 1980, J CLIN INVEST, V66, P1351, DOI 10.1172/JCI109988; HO YK, 1980, J LIPID RES, V21, P391; INNERARITY TL, 1979, J BIOL CHEM, V254, P4186; ISHIDA BY, 1987, J LIPID RES, V28, P778; JOHNSON WJ, 1988, J BIOL CHEM, V263, P14099; JONAS A, 1986, METHOD ENZYMOL, V128, P553; KARLIN JB, 1987, J BIOL CHEM, V262, P12557; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; KUNITAKE ST, 1985, J LIPID RES, V26, P549; LAGGNER P, 1979, BIOCHEMISTRY-US, V18, P164, DOI 10.1021/bi00568a025; LEFEVRE M, 1988, J LIPID RES, V29, P1139; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASSEY JB, 1979, J BIOL CHEM, V254, P9359; MASSEY JB, 1981, BIOCHEMISTRY-US, V20, P1575, DOI 10.1021/bi00509a026; MCGOOKEY DJ, 1983, J CELL BIOL, V97, P1156, DOI 10.1083/jcb.97.4.1156; MENDEL CM, 1988, J LIPID RES, V29, P1171; NEARY RH, 1987, CLIN CHEM, V33, P1163; NISHIKAWA O, 1986, J BIOCHEM, V99, P295, DOI 10.1093/oxfordjournals.jbchem.a135473; ORAM JF, 1983, J CLIN INVEST, V72, P1611, DOI 10.1172/JCI111120; ORAM JF, 1981, J BIOL CHEM, V256, P8348; PITTMAN RC, 1987, J BIOL CHEM, V262, P2435; POMERANTZ KB, 1990, BIOCHEMISTRY-US, V29, P1892, DOI 10.1021/bi00459a033; POWNALL HJ, 1981, J BIOL CHEM, V256, P9849; REICHL D, 1973, CLIN SCI MOL MED, V45, P313, DOI 10.1042/cs0450313; REICHL D, 1989, BIOCHIM BIOPHYS ACTA, V1006, P246, DOI 10.1016/0005-2760(89)90203-8; REICHL D, 1985, J LIPID RES, V26, P1399; SCHONFELD G, 1974, J CLIN INVEST, V54, P236, DOI 10.1172/JCI107758; SEGREST JP, 1974, FEBS LETT, V38, P247, DOI 10.1016/0014-5793(74)80064-5; SLOOP CH, 1987, J LIPID RES, V28, P225; SLOOP CH, 1983, J LIPID RES, V24, P1429; SLOTTE JP, 1987, J BIOL CHEM, V262, P12904; STEIN O, 1976, BIOCHIM BIOPHYS ACTA, V431, P347, DOI 10.1016/0005-2760(76)90155-7; STEIN O, 1979, BIOCHIM BIOPHYS ACTA, V574, P495, DOI 10.1016/0005-2760(79)90246-7; STEIN O, 1973, BIOCHIM BIOPHYS ACTA, V326, P232, DOI 10.1016/0005-2760(73)90249-X; STEIN O, 1986, BIOCHIM BIOPHYS ACTA, V878, P7, DOI 10.1016/0005-2760(86)90337-1; TABAS I, 1984, J BIOL CHEM, V259, P3897; TAJIMA S, 1983, J BIOL CHEM, V258, P73; YOKOYAMA S, 1982, J BIOCHEM, V91, P1267, DOI 10.1093/oxfordjournals.jbchem.a133811; YOKOYAMA S, 1984, J BIOCHEM, V96, P871, DOI 10.1093/oxfordjournals.jbchem.a134905; YOKOYAMA S, 1985, J BIOL CHEM, V260, P6375	61	307	310	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3080	3086						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993681				2022-12-25	WOS:A1991EX60000063
J	LEE, YM; LEIBY, KR; ALLAR, J; PARIS, K; LERCH, B; OKARMA, TB				LEE, YM; LEIBY, KR; ALLAR, J; PARIS, K; LERCH, B; OKARMA, TB			PRIMARY STRUCTURE OF BOVINE CONGLUTININ, A MEMBER OF THE C-TYPE ANIMAL LECTIN FAMILY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; HUMAN ASIALOGLYCOPROTEIN RECEPTOR; CARBOHYDRATE-RECOGNITION DOMAINS; PULMONARY SURFACTANT APOPROTEIN; CARTILAGE PROTEOGLYCAN; CDNA; PROTEIN; HOMOLOGY; MANNOSE; MEMBRANE	We report the complete amino acid sequence of bovine conglutinin obtained by structural characterization of peptides derived from the protein by various chemical and enzymatic fragmentations methods. The protein consists of 351 amino acid residues including 55 apparent Gly-X-Y repeats with two interruptions. This 171-residue-long collagenous domain separates a short noncollagenous NH2-terminal region of 25 residues from the 155-residue-long globular COOH terminus revealing the structural relation of conglutinin with mannose-binding proteins, pulmonary surfactant-associated proteins, and a complement component C1q. Eight hydroxylysine residues were found in the collagenous domain. All of these hydroxylysine residues which occupy a Y position in a Gly-X-Y triplet are possible glycosylation sites since no phenylthiohydantoin amino acid was identified in automated Edman degradation cycles corresponding to these sites. The noncollagenous COOH domain of conglutinin, on the other hand, contains a carbohydrate recognition domain which shares substantial sequence homology with C-type animal lectins. Conglutinin has the greatest sequence similarity with mannose-binding proteins and pulmonary surfactant-associated proteins.			LEE, YM (corresponding author), APPL IMMUNE SCI INC, 200 CONSTITUT DR, MENLO PK, CA 94025 USA.							BENSON B, 1985, P NATL ACAD SCI USA, V82, P6379, DOI 10.1073/pnas.82.19.6379; BERG JM, 1988, P NATL ACAD SCI USA, V85, P99, DOI 10.1073/pnas.85.1.99; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; BOGGARAM V, 1988, J BIOL CHEM, V263, P2939; BROWN RH, 1974, BIOCHEM J, V137, P93, DOI 10.1042/bj1370093; BUTLER WT, 1966, J BIOL CHEM, V241, P3882; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; DAVIS AE, 1984, BIOCHEMISTRY-US, V23, P2139, DOI 10.1021/bi00305a006; Dickerson R., 1975, ENZYMES, V11, P397; DOEGE K, 1986, J BIOL CHEM, V261, P8108; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; DRICKAMER K, 1986, J BIOL CHEM, V261, P6878; EISENBERG RA, 1977, J IMMUNOL, V118, P1428; EZEKOWITZ RAB, 1988, J EXP MED, V167, P1034, DOI 10.1084/jem.167.3.1034; FLOROS J, 1986, J BIOL CHEM, V261, P9029; FUHLENDORFF J, 1987, BIOCHEMISTRY-US, V26, P6757, DOI 10.1021/bi00395a027; GASCUEL O, 1988, COMPUT APPL BIOSCI, V4, P357; GIGA Y, 1987, J BIOL CHEM, V262, P6197; HIRANI S, 1985, J IMMUNOL, V134, P1105; HOFMANN H, 1984, J MOL BIOL, V172, P325, DOI 10.1016/S0022-2836(84)80029-7; IKUTA K, 1987, P NATL ACAD SCI USA, V84, P819, DOI 10.1073/pnas.84.3.819; LACHMANN PJ, 1968, J IMMUNOL, V100, P691; LACHMANN PJ, 1965, CIBA F S, V22, P242; LINACOTT WD, 1978, J IMMUNOL, V121, P658; LOVELESS RW, 1989, BIOCHEM J, V258, P109, DOI 10.1042/bj2580109; MAYNE R, 1987, STRUCTURE FUNCTION C, P43; MIZUOCHI T, 1989, J BIOL CHEM, V264, P13834; MOORE S, 1963, METHOD ENZYMOL, V6, P819, DOI 10.1016/0076-6879(63)06257-1; REID KB, 1976, BIOCHEM J, V155, P12; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SANO K, 1987, BIOCHEM BIOPH RES CO, V144, P367, DOI 10.1016/S0006-291X(87)80519-3; SPIESS M, 1985, P NATL ACAD SCI USA, V82, P6465, DOI 10.1073/pnas.82.19.6465; SPIESS M, 1985, J BIOL CHEM, V260, P1979; SPIRO RG, 1967, J BIOL CHEM, V242, P4813; STOOLMAN LM, 1989, CELL, V56, P907, DOI 10.1016/0092-8674(89)90620-X; STRANG CJ, 1986, BIOCHEM J, V234, P381, DOI 10.1042/bj2340381; TAKAHASHI H, 1985, J BIOL CHEM, V260, P2228; TARR GE, 1983, P NATL ACAD SCI-BIOL, V80, P6552, DOI 10.1073/pnas.80.21.6552; YOUNG NM, 1987, BIOCHEM BIOPH RES CO, V143, P645, DOI 10.1016/0006-291X(87)91402-1; 1990, SWISS RPROT DATA BAS	40	76	79	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2715	2723						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993651				2022-12-25	WOS:A1991EX60000010
J	MILES, MF; DIAZ, JE; DEGUZMAN, VS				MILES, MF; DIAZ, JE; DEGUZMAN, VS			MECHANISMS OF NEURONAL ADAPTATION TO ETHANOL - ETHANOL INDUCES HSC70 GENE-TRANSCRIPTION IN NG108-15 NEUROBLASTOMA X GLIOMA-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK; STRESS PROTEINS; MESSENGER-RNA; ANTIGEN EXPRESSION; UNCOATING ATPASE; BRAIN MEMBRANES; RECEPTORS; HEPATOCYTES; LYMPHOCYTES; WITHDRAWAL	The mechanisms underlying neuronal adaptation to ethanol are poorly understood but appear to involve alterations in cellular membrane structure and/or function. Using a two-dimensional gel analysis, we have recently identified Hsc70 as an ethanol-responsive gene (Miles, M. F. (1989) Neurology 39, (Suppl. 1), 425). HSC70 is a constitutive member of the 70-kDa stress protein family which plays an important role in protein trafficking and coated vesicle processing. Thus, modulation of Hsc70 by ethanol could produce widespread changes in cellular membrane functioning. Here, we report a detailed study on the regulation of Hsc70 by ethanol in NG108-15 neuroblastoma x glioma cells. Northern and Western blot analyses showed that ethanol concentrations observed in actively drinking alcoholics caused an induction of Hsc70 mRNA and protein. Increases in Hsc70 mRNA were seen as early as 4 h after exposure to ethanol. In comparison with ethanol, propanol and butanol caused proportionally greater increases in Hsc70 mRNA. This is consistent with known anesthetic and intoxicating potencies of these aliphatic alcohols and suggested that lipophilicity, rather than an osmotic effect, was critical for ethanol induction of Hsc70. Induction of Hsc70 mRNA by ethanol resulted, at least in part, from increased Hsc70 gene transcription as determined by nuclear runoff studies. Stable transfection analysis revealed an ethanol-responsiveness cis-acting element in the proximal 2500 base pairs of the Hsc70 promoter. Regulation of Hsc70 by 50-200 mM ethanol appeared to be a specific change in expression of an ethanol-responsive gene rather than a typical stress protein response since no induction of the highly inducible stress protein, Hsp70, was seen at these ethanol concentrations. These results suggest that ethanol-induced changes in Hsc70 transcription may be important for neuronal adaptation to ethanol and the development of tolerance and dependence in alcoholics.	ERNEST GALLO CLIN & RES CTR,SAN FRANCISCO,CA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	MILES, MF (corresponding author), UNIV CALIF SAN FRANCISCO,SAN FRANCISCO GEN HOSP,SCH MED,DEPT NEUROL,BLDG 1,RM 101,SAN FRANCISCO,CA 94110, USA.				NIAAA NIH HHS [AA0018, AA07750] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R29AA007750, R01AA007750] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; CASEY CA, 1987, J BIOL CHEM, V262, P2704; CASEY CA, 1989, ALCOHOL CLIN EXP RES, V13, P258, DOI 10.1111/j.1530-0277.1989.tb00323.x; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; CHAPPELL TG, 1986, CELL, V45, P3, DOI 10.1016/0092-8674(86)90532-5; CHARNESS ME, 1986, J BIOL CHEM, V261, P3164; CHARNESS ME, 1988, BIOCHEM BIOPH RES CO, V155, P138, DOI 10.1016/S0006-291X(88)81060-X; CHARNESS ME, 1989, NEW ENGL J MED, V321, P442, DOI 10.1056/NEJM198908173210706; CHARNESS ME, 1983, SCIENCE, V222, P1426; CHIN JH, 1977, SCIENCE, V196, P684, DOI 10.1126/science.193186; CHIN JH, 1977, MOL PHARMACOL, V13, P435; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; CHOBERT MN, 1988, J HEPATOL, V6, P85, DOI 10.1016/S0168-8278(88)80466-5; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FREUND G, 1988, ALCOHOL CLIN EXP RES, V12, P630, DOI 10.1111/j.1530-0277.1988.tb00255.x; GOLDSTEI.DB, 1971, SCIENCE, V172, P288, DOI 10.1126/science.172.3980.288; GOLDSTEIN DB, 1973, J PHARMACOL EXP THER, V186, P1; GOLDSTEIN DB, 1983, PHARM ALCOHOL, P48; GORDON AS, 1986, P NATL ACAD SCI USA, V83, P2105, DOI 10.1073/pnas.83.7.2105; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; HENDERSON GI, 1989, J CLIN INVEST, V84, P1287, DOI 10.1172/JCI114296; HUNT C, 1985, P NATL ACAD SCI USA, V82, P6455, DOI 10.1073/pnas.82.19.6455; KINGSTON RE, 1987, CURRENT PROTOCOLS MO; KOLBER MA, 1988, ALCOHOL CLIN EXP RES, V12, P820, DOI 10.1111/j.1530-0277.1988.tb01353.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAIMINS LA, 1982, P NATL ACAD SCI-BIOL, V79, P6453, DOI 10.1073/pnas.79.21.6453; LI GC, 1983, J CELL PHYSIOL, V115, P116, DOI 10.1002/jcp.1041150203; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYON RC, 1981, J PHARMACOL EXP THER, V218, P669; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; MESSING RO, 1986, P NATL ACAD SCI USA, V83, P2105; MILES M F, 1989, Neurology, V39, P425; MILES MF, 1981, J BIOL CHEM, V256, P2545; MOCHLYROSEN D, 1988, NATURE, V333, P848, DOI 10.1038/333848a0; NAGY LE, 1990, J BIOL CHEM, V265, P1946; NAGY LE, 1988, P NATL ACAD SCI USA, V85, P6973, DOI 10.1073/pnas.85.18.6973; OMALLEY K, 1985, MOL CELL BIOL, V5, P3476, DOI 10.1128/MCB.5.12.3476; PARENT LJ, 1987, FASEB J, V1, P469, DOI 10.1096/fasebj.1.6.3678702; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; RICHELSON E, 1986, J PHARMACOL EXP THER, V239, P687; RODENHISER DI, 1986, CAN J GENET CYTOL, V28, P1115, DOI 10.1139/g86-155; RUBIN E, 1982, FED PROC, V41, P2465; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; SINGER DS, 1989, ALCOHOL CLIN EXP RES, V13, P480, DOI 10.1111/j.1530-0277.1989.tb00360.x; SORGER PK, 1987, EMBO J, V6, P993, DOI 10.1002/j.1460-2075.1987.tb04850.x; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; TABAKOFF B, 1979, LIFE SCI, V25, P2173, DOI 10.1016/0024-3205(79)90089-4; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WALSH KH, 1989, J LAB CLIN MED, V114, P563; WATOWICH SS, 1988, MOL CELL BIOL, V8, P393, DOI 10.1128/MCB.8.1.393; WELCH WJ, 1983, J BIOL CHEM, V258, P7102; WELCH WJ, 1986, J CELL BIOL, V103, P2035, DOI 10.1083/jcb.103.5.2035; WELCH WJ, 1987, IMMUNOBIOLOGY PROTEI, P287	56	82	84	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2409	2414						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989992				2022-12-25	WOS:A1991EV51500061
J	DARWISH, H; KRISINGER, J; FURLOW, JD; SMITH, C; MURDOCH, FE; DELUCA, HF				DARWISH, H; KRISINGER, J; FURLOW, JD; SMITH, C; MURDOCH, FE; DELUCA, HF			AN ESTROGEN-RESPONSIVE ELEMENT MEDIATES THE TRANSCRIPTIONAL REGULATION OF CALBINDIN D-9K GENE IN RAT UTERUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEIN; 1ST INTRON; EUKARYOTIC PROMOTERS; NUCLEOTIDE-SEQUENCE; OSTEOCALCIN GENE; MESSENGER-RNA; YOLK-SAC; VITAMIN; RECEPTORS; 1,25-DIHYDROXYVITAMIN-D3	The rat calbindin (molecular mass 9 kDa) gene sequence revealed the presence of an imperfect palindromic estrogen-responsive-like element (ERE) located at position +51 from the transcriptional initiation site. This element has the sequence AGGTCAGGGTGATCT which differs by one nucleotide from the vitellogenin ERE palindromic sequence AGGTCACTGTGACCT. The activity of this element to induce transcription in response to estrogen and the ability to bind estrogen receptor was investigated. This sequence confers estrogen-dependent transcriptional activity when cloned upstream from the tkp-CAT construct in pBLCAT2 plasmid and transfected into T47D cells, similar to the vitellogenin gene ERE activity but to a lesser extent. This element binds to the estrogen receptor in vitro as assessed by gel retardation assay similar to the vitellogenin gene ERE. No such binding was detected when a mutant sequence AGATCACTGTGATCT was used. The specificity of the complex was confirmed using polyclonal antibodies, ER712 raised against the estrogen receptor. Futhermore, competition assays showed that both sequences were able to compete for binding to the estrogen receptor. The in vivo transcriptional regulation of the calbindin D-9K gene by estrogen was also investigated in the rat. Female animals maintained on a vitamin D-sufficient or a vitamin D-deficient diet were ovariectomized, housed for 3 weeks, and then injected with 17-beta-estradiol (0.5-mu-g/kg body weight/day). Slot blot analysis of total RNA showed a marked increased in calbindin D-9K mRNA levels in the uterus but not in the intestine by 26 and 50 h post-injection. These results demonstrate that the calbindin D-9K gene is transcriptionally regulated by estrogen in the uterus mediated by an estrogen-responsive element identified in the gene.	UNIV WISCONSIN,COLL AGR & LIFE SCI,DEPT BIOCHEM,420 HENRY MALL,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison				MURDOCH, FERN/0000-0001-5724-9681	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK014881] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-14881] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ausubel FM, 1987, CURRENT PROTOCOLS MO, V1-5; BAILLY A, 1980, J BIOL CHEM, V255, P2729; BALMAIN N, 1986, HISTOCHEMISTRY, V84, P161, DOI 10.1007/BF00499828; BORNSTEIN P, 1988, J BIOL CHEM, V263, P1603; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN M, 1990, J BIOL CHEM, V265, P11238; BRUNS ME, 1988, ENDOCRINOLOGY, V122, P2371, DOI 10.1210/endo-122-6-2371; BRUNS ME, 1986, J BIOL CHEM, V261, P7485; BUCKLEY M, 1980, ARCH BIOCHEM BIOPHYS, V202, P235, DOI 10.1016/0003-9861(80)90425-7; BURCH JBE, 1988, MOL CELL BIOL, V8, P1123, DOI 10.1128/MCB.8.3.1123; CHRISTAKOS S, 1989, ENDOCR REV, V10, P3, DOI 10.1210/edrv-10-1-3; DARWISH HM, 1987, P NATL ACAD SCI USA, V84, P6108, DOI 10.1073/pnas.84.17.6108; DELORME AC, 1983, J BIOL CHEM, V258, P1878; DELORME AC, 1983, PLACENTA, V4, P263, DOI 10.1016/S0143-4004(83)80005-8; DELORME AC, 1983, ENDOCRINOLOGY, V113, P1340, DOI 10.1210/endo-113-4-1340; DEMAY MB, 1990, P NATL ACAD SCI USA, V87, P369, DOI 10.1073/pnas.87.1.369; DRESCHER D, 1971, BIOCHEMISTRY-US, V10, P2302; DUPERT JM, 1987, J BIOL CHEM, V262, P16553; FURLOW D, 1989, 71ST ANN M END SOC S, P159; GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025; KALLFELZ FA, 1967, P SOC EXP BIOL MED, V125, P54, DOI 10.3181/00379727-125-32011; KERNER SA, 1989, P NATL ACAD SCI USA, V86, P4455, DOI 10.1073/pnas.86.12.4455; KESSLER MA, 1986, ARCH BIOCHEM BIOPHYS, V251, P403, DOI 10.1016/0003-9861(86)90346-2; KLEINHITPASS L, 1989, MOL CELL BIOL, V9, P43, DOI 10.1128/MCB.9.1.43; KLOCK G, 1987, NATURE, V329, P734, DOI 10.1038/329734a0; KRESSINGER RH, 1976, ANN REV BIOCH, V45, P239; KRISINGER J, 1988, P NATL ACAD SCI USA, V85, P8988, DOI 10.1073/pnas.85.23.8988; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; LEVY J, 1984, J ENDOCRINOL, V100, P265, DOI 10.1677/joe.0.1000265; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MACMANUS JP, 1986, BIOCHEM J, V235, P585, DOI 10.1042/bj2350585; MARTINEZ E, 1987, EMBO J, V6, P3719, DOI 10.1002/j.1460-2075.1987.tb02706.x; MATHIEU CL, 1989, ENDOCRINOLOGY, V125, P2745, DOI 10.1210/endo-125-5-2745; MAURER RA, 1987, MOL CELL BIOL, V7, P4247, DOI 10.1128/MCB.7.12.4247; MEYER ME, 1989, CELL, V57, P433, DOI 10.1016/0092-8674(89)90918-5; MOORE DD, 1985, P NATL ACAD SCI USA, V82, P699, DOI 10.1073/pnas.82.3.699; MORRISON NA, 1989, SCIENCE, V246, P1158, DOI 10.1126/science.2588000; PERRET C, 1985, EUR J BIOCHEM, V150, P211, DOI 10.1111/j.1432-1033.1985.tb09009.x; PERRET C, 1988, EUR J BIOCHEM, V172, P43, DOI 10.1111/j.1432-1033.1988.tb13853.x; PROST E, 1986, GENE, V45, P107, DOI 10.1016/0378-1119(86)90138-1; ROSSOUW CMS, 1987, J BIOL CHEM, V262, P15151; SHAPIRO D, 1982, CRC CR REV BIOCH MOL, V12, P187, DOI 10.3109/10409238209108706; SINGH H, 1986, NATURE, V319, P154, DOI 10.1038/319154a0; SUDA T, 1970, J NUTR, V100, P1049, DOI 10.1093/jn/100.9.1049; WALKER P, 1984, NUCLEIC ACIDS RES, V12, P8611, DOI 10.1093/nar/12.22.8611; WALTERS MR, 1983, J STEROID BIOCHEM, V19, P913, DOI 10.1016/0022-4731(83)90034-1; WAREMBOURG M, 1987, CELL TISSUE RES, V247, P51, DOI 10.1007/BF00216546; WASSERMAN RH, 1985, CALCIUM CELL FUNCTIO, P175; WILLIAMS D, 1974, BIOCHEMISTRY-US, V13, P5537, DOI 10.1021/bi00724a013	49	114	114	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					551	558						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985915				2022-12-25	WOS:A1991EQ33900081
J	POE, M; BLAKE, JT; BOULTON, DA; GAMMON, M; SIGAL, NH; WU, JK; ZWEERINK, HJ				POE, M; BLAKE, JT; BOULTON, DA; GAMMON, M; SIGAL, NH; WU, JK; ZWEERINK, HJ			HUMAN CYTOTOXIC LYMPHOCYTE GRANZYME-B - ITS PURIFICATION FROM GRANULES AND THE CHARACTERIZATION OF SUBSTRATE AND INHIBITOR SPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTO-TOXIC LYMPHOCYTES; ACIDIC CYTOPLASMIC GRANULES; SERINE ESTERASE GENE; T-CELL GRANULES; MEDIATED CYTOLYSIS; CATHEPSIN-D; KILLER CELLS; CHROMOSOMAL ASSIGNMENT; PROTEINASE-INHIBITORS; FUNCTIONAL-PROPERTIES	Granzyme B has been purified to homogeneity from the granules of a human cytolytic lymphocyte line, Q31, in an enzymatically active form by a three-step procedure. Q31 granzyme B hydrolyzed N-alpha-t-butyloxycarbonyl-L-alanyl-L-alanyl-L-aspartyl (Boc-Ala-Ala-Asp) thiobenzyl ester with a k(cat) of 11 +/- 5 mol/s/mol enzyme and catalytic efficiency k(cat)/K(m) of 76,000 +/- 44,000 M-1 S-1. The hydrolysis of Boc-Ala-Ala-Asp thiobenzyl ester by crude Q31 percoll fractions paralleled the tryptase activity for granule-containing fractions, which showed that granzyme B was associated with granules. When chromatographed on Sephacryl S-300, Q31 granzyme B eluted in two broad bands corresponding to dimer and monomer, both of which electrophoresed at 35 kDA in reducing NaDodSO4 polyacrylamide, and both of which showed a lag phase in assays. The lag phase in assays could be extended with 0.03 mM pepstatin. Upon elution from ion-exchange chromatography Q31 granzyme B electrophoresed at 32 kDa in reducing NaDodSO4 polyacrylamide and did not have a lag phase in assays. The amino-terminal sequence of the 32-kDa Q31 granzyme B was identical to four other human cytotoxic T-lymphocyte granzymes B in 18 of 18 positions sequenced. Purified Q31 granzyme B had a preference for substrates with Glu or Asp as the residue amino-terminal to the scissile bond; little or no activity was noted with oligopeptide substrates for trypsin-like, chymotrypsin-like, and elastase-like proteases. Human plasma alpha-1-protease inhibitor, human plasma alpha-2-protease macroglobulin, soybean and lima-bean trypsin inhibitors, bovine aprotinin, phosphoramidon, and chymostatin inhibited Q31 granzyme B. The inhibition by alpha-1-protease inhibitor was rapid enough to be of physiological significance.			POE, M (corresponding author), MERCK SHARP & DOHME LTD, RAHWAY, NJ 07065 USA.							AOYAGI T, 1971, J ANTIBIOT, V24, P687, DOI 10.7164/antibiotics.24.687; BARRETT AJ, 1986, RES MONOG CELL TISSU, V12, P515; BENDER ML, 1965, ANNU REV BIOCHEM, V34, P49, DOI 10.1146/annurev.bi.34.070165.000405; BERKE G, 1989, IMMUNOL LETT, V20, P169, DOI 10.1016/0165-2478(89)90075-8; BIDDISON WE, 1984, J EXP MED, V159, P783, DOI 10.1084/jem.159.3.783; BIETH JG, 1984, BIOCHEM MED METAB B, V32, P387, DOI 10.1016/0006-2944(84)90046-2; BIETH JG, 1980, CLIN RES PROC, V16, P183; BLEACKLEY RC, 1988, FEBS LETT, V234, P153, DOI 10.1016/0014-5793(88)81323-1; CAPUTO A, 1988, J BIOL CHEM, V263, P6363; CEROTTINI JC, 1987, ANN INST PASTEUR IMM, V138, P289, DOI 10.1016/S0769-2625(87)80080-6; CHANG TW, 1980, J IMMUNOL, V124, P1028; CLAUSBRUCH U C V, 1988, Biological Chemistry Hoppe-Seyler, V369, P683; DAHLMANN B, 1985, BIOCHEM J, V228, P161, DOI 10.1042/bj2280161; Drapeau G R, 1976, Methods Enzymol, V45, P469; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FRUTH U, 1987, EUR J IMMUNOL, V17, P1625, DOI 10.1002/eji.1830171116; GARCIASANZ JA, 1988, IMMUNOLOGY, V64, P129; GERSHENFELD HK, 1988, P NATL ACAD SCI USA, V85, P1184, DOI 10.1073/pnas.85.4.1184; GERSHENFELD HK, 1986, SCIENCE, V232, P854, DOI 10.1126/science.2422755; GOETZL EJ, 1989, IMMUNOLOGY, V66, P554; HAMEED A, 1988, J IMMUNOL, V141, P3142; HENDRICK JP, 1989, P NATL ACAD SCI USA, V86, P4056, DOI 10.1073/pnas.86.11.4056; HENKART PA, 1987, J IMMUNOL, V139, P2398; HENKART PA, 1985, ANNU REV IMMUNOL, V3, P31, DOI 10.1146/annurev.iy.03.040185.000335; HENKART PA, 1986, J IMMUNOL, V137, P2611; HUDIG D, 1989, MOL IMMUNOL, V26, P793, DOI 10.1016/0161-5890(89)90040-0; HUDIG D, 1987, BIOCHEM BIOPH RES CO, V149, P882, DOI 10.1016/0006-291X(87)90490-6; IRVINE GB, 1983, BIOCHEM J, V211, P237, DOI 10.1042/bj2110237; ISHIKAWA I, 1977, BIOCHIM BIOPHYS ACTA, V480, P228, DOI 10.1016/0005-2744(77)90336-9; JENNE D, 1988, P NATL ACAD SCI USA, V85, P4814, DOI 10.1073/pnas.85.13.4814; JENNE DE, 1989, BIOCHEMISTRY-US, V28, P7953, DOI 10.1021/bi00445a060; JOAG S, 1989, J CELL BIOCHEM, V39, P239, DOI 10.1002/jcb.240390304; KAM CM, 1990, IN PRESS BIOCHEMISTR; KHAVARI P, 1987, YALE J BIOL MED, V60, P409; KLEIN JL, 1989, GENOMICS, V5, P110, DOI 10.1016/0888-7543(89)90093-1; KNIGHT CG, 1976, BIOCHEM J, V155, P117, DOI 10.1042/bj1550117; KRAHENBUHL O, 1988, J IMMUNOL, V141, P3471; KRAMER MD, 1987, IMMUNOL TODAY, V8, P140, DOI 10.1016/0167-5699(87)90141-1; LOBE CG, 1989, NUCLEIC ACIDS RES, V17, P5765, DOI 10.1093/nar/17.14.5765; LOBE CG, 1986, SCIENCE, V232, P858, DOI 10.1126/science.3518058; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P558, DOI 10.1016/0167-4838(83)90273-X; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P539, DOI 10.1016/0167-4838(83)90272-8; MANYAK CL, 1989, J IMMUNOL, V142, P3707; MASSON D, 1986, EMBO J, V5, P1595, DOI 10.1002/j.1460-2075.1986.tb04401.x; MASSON D, 1987, CELL, V49, P679, DOI 10.1016/0092-8674(87)90544-7; MURPHY MEP, 1988, PROTEINS, V4, P190, DOI 10.1002/prot.340040306; NABHOLZ M, 1989, IMMUNOL LETT, V20, P179, DOI 10.1016/0165-2478(89)90076-X; OSTERGAARD HL, 1989, J IMMUNOL, V143, P2120; PASTERNACK MS, 1986, NATURE, V322, P740, DOI 10.1038/322740a0; PASTERNACK MS, 1985, NATURE, V314, P743, DOI 10.1038/314743a0; PETERS PJ, 1989, EUR J IMMUNOL, V19, P1469, DOI 10.1002/eji.1830190819; PODACK ER, 1985, IMMUNOL TODAY, V6, P21, DOI 10.1016/0167-5699(85)90164-1; PODACK ER, 1984, J EXP MED, V160, P695, DOI 10.1084/jem.160.3.695; POE M, 1988, J BIOL CHEM, V263, P13215; POE M, 1972, BIOCHEMISTRY-US, V11, P1023, DOI 10.1021/bi00756a012; POE M, 1978, J BIOL CHEM, V253, P4499; POE M, 1984, J BIOL CHEM, V259, P8358; REDELMAN D, 1980, J IMMUNOL, V124, P870; REDMOND MJ, 1987, J IMMUNOL, V139, P3184; RICH DH, 1986, PROTEINASE INHIBITOR, P179; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHMID J, 1987, J IMMUNOL, V139, P250; SIMON MM, 1986, EMBO J, V5, P3267, DOI 10.1002/j.1460-2075.1986.tb04638.x; TAKAYAMA H, 1987, J IMMUNOL, V138, P566; TRAPANI JA, 1988, P NATL ACAD SCI USA, V85, P6924, DOI 10.1073/pnas.85.18.6924; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; TSCHOPP J, 1988, BIOCHEMISTRY-US, V27, P2641, DOI 10.1021/bi00408a001; UMEZAWA H, 1982, ANNU REV MICROBIOL, V36, P75, DOI 10.1146/annurev.mi.36.100182.000451; VANDERSLICE P, 1989, BIOCHEMISTRY-US, V28, P4148, DOI 10.1021/bi00436a004; VANNOORT JM, 1989, J BIOL CHEM, V264, P14159; WEBER K, 1969, J BIOL CHEM, V244, P4406; WILDE CG, 1990, J BIOL CHEM, V265, P2038; WILK S, 1983, J NEUROCHEM, V40, P842, DOI 10.1111/j.1471-4159.1983.tb08056.x; YOUNG JD, 1986, CELL, V46, P641, DOI 10.1016/0092-8674(86)90336-3; YOUNG JDE, 1986, CELL, V47, P183, DOI 10.1016/0092-8674(86)90441-1; YOUNG JDE, 1989, PHYSIOL REV, V69, P250, DOI 10.1152/physrev.1989.69.1.250	77	184	190	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					98	103						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985927				2022-12-25	WOS:A1991EQ33900017
J	KAY, MMB				KAY, MMB			MOLECULAR MAPPING OF HUMAN BAND-3 ANION TRANSPORT REGIONS USING SYNTHETIC PEPTIDES	FASEB JOURNAL			English	Note						AGING; BAND-3; LYSINE; ANTIIDIOTYPIC ANTIBODIES; ARGININE	SITE-DIRECTED MUTAGENESIS; SENESCENT SOMATIC-CELLS; IGG-BINDING ANTIGEN; ERYTHROCYTE-MEMBRANE; XENOPUS-LAEVIS; PROTEIN; LOCALIZATION; MECHANISM; RESIDUES; REMOVAL	Band 3 is a ubiquitous membrane transport protein found in Golgi, mitochondrial, nuclear, and cell membranes. It is the most heavily used anion transport system in the body because it is responsible for CO2 exchange in all tissues and organs and for acid-base balance. The anion transport regions are mapped along the band 3 molecule using synthetic peptides (pep) from extracellular regions of band 3 and/or suspected anion transport regions. Assays include anion transport/inhibition and immunoblotting with anti-idiotypic antibodies to a transport inhibitor. Results indicate that anion binding/transport regions of band 3 reside within residues 549-594, (588-594 being the most active) and 804-839 (822-839 being the most active), and 869-883. Pep-COOH (residues 812-827), which is part of senescent cell antigen, is an anion binding site with most of the activity localized to residues 813-818 (the six amino acids on the amino side of pep-COOH). The stilbene disulfonate inhibitors of transport bind to peptide 812-830, and possibly peptides 788-805 and 800-818, as determined with anti-idiotypic antibodies. Residues 538-554, which have been reported to be a transport segment of band 3, do not bind sulfate. Band 3 external loops containing residues 539-553 and 812-830, and internal segments containing residues 588-594 and 869-883, are in close spacial proximity in the membrane. The contribution of lysine and/or arginine to anion transport is examined by synthesizing peptides in which glycines or arginines are substituted for lysines or arginines. Lysines can contribute to anion binding but are not required.			KAY, MMB (corresponding author), UNIV ARIZONA,ARIZONA HLTH SCI CTR,DEPT MICROBIOL & IMMUNOL,TUCSON,AZ 85724, USA.							BARTEL D, 1989, EMBO J, V8, P3601, DOI 10.1002/j.1460-2075.1989.tb08533.x; BARTEL D, 1989, BIOCHIM BIOPHYS ACTA, V985, P355, DOI 10.1016/0005-2736(89)90427-6; BJERRUM PJ, 1983, J GEN PHYSIOL, V81, P453, DOI 10.1085/jgp.81.4.453; BOSMAN G, 1990, IN PRESS GERONTOLOGY; BOSMAN GJCGM, 1988, BLOOD CELLS, V14, P19; ELGAVISH A, 1985, J CELL PHYSIOL, V125, P243, DOI 10.1002/jcp.1041250211; GARCIA AM, 1989, J BIOL CHEM, V264, P19607; JENNINGS ML, 1989, ANNU REV BIOPHYS BIO, V18, P397, DOI 10.1146/annurev.bb.18.060189.002145; JENNINGS ML, 1987, J BIOL CHEM, V262, P1691; JENNINGS ML, 1979, BIOCHIM BIOPHYS ACTA, V554, P498, DOI 10.1016/0005-2736(79)90387-0; JENNINGS ML, 1989, ANION TRANSPORT PROT, V3, P59; KAWANO Y, 1988, J BIOL CHEM, V263, P8232; KAY MMB, 1985, P NATL ACAD SCI USA, V82, P1731, DOI 10.1073/pnas.82.6.1731; KAY MMB, 1984, P NATL ACAD SCI-BIOL, V81, P5753, DOI 10.1073/pnas.81.18.5753; KAY MMB, 1978, J SUPRAMOL STR CELL, V9, P555, DOI 10.1002/jss.400090409; KAY MMB, 1981, NATURE, V289, P491, DOI 10.1038/289491a0; KAY MMB, 1975, P NATL ACAD SCI USA, V72, P3521, DOI 10.1073/pnas.72.9.3521; KAY MMB, 1990, BRAIN RES BULL, V24, P105, DOI 10.1016/0361-9230(90)90293-9; KAY MMB, 1989, P NATL ACAD SCI USA, V86, P5834, DOI 10.1073/pnas.86.15.5834; KAY MMB, 1988, P NATL ACAD SCI USA, V85, P492, DOI 10.1073/pnas.85.2.492; KAY MMB, 1986, P NATL ACAD SCI USA, V83, P2463, DOI 10.1073/pnas.83.8.2463; KAY MMB, 1988, METHODS HEMATOLOGY R, P135; Kay MMB., 1986, RED CELL ANTIGENS AN, P35; KAY MMB, 1990, IN PRESS P NATL ACAD; KAY MMB, 1990, IN PRESS GERONTOLOGY; KAY MMB, 1990, IN PRESS P NATL ACAD, V3; KAY MMB, 1988, ANTIIDIOTYPES RECEPT, P231; MORGAN M, 1985, EMBO J, V4, P1927, DOI 10.1002/j.1460-2075.1985.tb03872.x; PIMPLIKAR SW, 1986, J BIOL CHEM, V261, P9770; TANNER MJA, 1988, BIOCHEM J, V256, P703, DOI 10.1042/bj2560703; ZAKI L, 1983, BIOCHEM BIOPH RES CO, V110, P616, DOI 10.1016/0006-291X(83)91194-4	31	28	28	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998	0892-6638			FASEB J	Faseb J.	JAN	1991	5	1					109	115		10.1096/fasebj.5.1.1991578	http://dx.doi.org/10.1096/fasebj.5.1.1991578			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ET609	1991578				2022-12-25	WOS:A1991ET60900023
J	KIM, HC; LEWIS, MS; GORMAN, JJ; PARK, SC; GIRARD, JE; FOLK, JE; CHUNG, SI				KIM, HC; LEWIS, MS; GORMAN, JJ; PARK, SC; GIRARD, JE; FOLK, JE; CHUNG, SI			PROTRANSGLUTAMINASE-E FROM GUINEA-PIG SKIN - ISOLATION AND PARTIAL CHARACTERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									NIDR,CELLULAR DEV & ONCOL LAB,BLDG 30,RM 211,9000 ROCKVILLE PIKE,BETHESDA,MD 20892; NIH,NATL CTR RES RESOURCES,BETHESDA,MD 20892; SEOUL NATL UNIV,COLL MED,DEPT BIOCHEM,SEOUL 110,SOUTH KOREA; AMERICAN UNIV,DEPT CHEM,WASHINGTON,DC 20016; CSIRO,AUSTRALIAN ANIM HLTH LAB,GEELONG,VIC 3220,AUSTRALIA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; Seoul National University (SNU); American University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)								ABERNETHY JL, 1977, J BIOL CHEM, V252, P1837; ANDO Y, 1990, ARCH DERMATOL RES, V282, P65, DOI 10.1007/BF00505647; ANDO Y, 1988, ARCH DERMATOL RES, V280, P380, DOI 10.1007/BF00426618; BETTELHEIM FR, 1952, BIOCHIM BIOPHYS ACTA, V9, P578, DOI 10.1016/0006-3002(52)90213-8; BUXMAN MM, 1976, BIOCHIM BIOPHYS ACTA, V452, P356, DOI 10.1016/0005-2744(76)90185-6; EDMAN P, 1967, EUR J BIOCHEM, V1, P80, DOI 10.1111/j.1432-1033.1967.tb00047.x; Folk J E, 1977, Adv Protein Chem, V31, P1, DOI 10.1016/S0065-3233(08)60217-X; FOLK JE, 1985, METHOD ENZYMOL, V113, P358; FOLK JE, 1966, J BIOL CHEM, V241, P5518; GORMAN JJ, 1987, ANAL BIOCHEM, V160, P376, DOI 10.1016/0003-2697(87)90064-9; GORMAN JJ, 1987, EUR J BIOCHEM, V168, P169, DOI 10.1111/j.1432-1033.1987.tb13401.x; HAWKES R, 1982, ANAL BIOCHEM, V119, P142, DOI 10.1016/0003-2697(82)90677-7; HEWICK RM, 1981, J BIOL CHEM, V256, P7990; Hurn B A, 1980, Methods Enzymol, V70, P104; ICHINOSE A, 1986, BIOCHEMISTRY-US, V25, P6900, DOI 10.1021/bi00370a025; KIM HJ, 1989, J INVEST DERMATOL, V92, P458; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LICHTI U, 1989, J INVEST DERMATOL, V92, P471; LICHTI U, 1985, J BIOL CHEM, V260, P1422; MARTINET N, 1988, J BIOL CHEM, V263, P4236; MARTINET N, 1990, BIOCHEM J, V27, P305; MICHEL S, 1988, J INVEST DERMATOL, V90, P472, DOI 10.1111/1523-1747.ep12460922; NEGI M, 1985, J INVEST DERMATOL, V85, P75, DOI 10.1111/1523-1747.ep12275357; Neurath H., 1975, PROTEASES BIOL CONTR, P51; OGAWA H, 1976, J BIOL CHEM, V251, P7281; PARK SC, 1988, J CELL BIOL, V107, P783; PLISHKER MF, 1978, ARCH BIOCHEM BIOPHYS, V191, P49, DOI 10.1016/0003-9861(78)90066-8; RICE RH, 1977, CELL, V11, P417, DOI 10.1016/0092-8674(77)90059-9; RODBARD D, 1976, METHODS PROTEIN SEPA, V2, P145; SCHERAGA HA, 1977, CHEM BIOL THROMBIN, P145; SIMON M, 1985, CELL, V40, P677, DOI 10.1016/0092-8674(85)90216-8; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Svedberg T, 1940, THE ULTRACENTRIFUGE; THACHER SM, 1985, CELL, V40, P685, DOI 10.1016/0092-8674(85)90217-X; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350	35	112	114	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1990	265	35					21971	21978						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM456	1979327				2022-12-25	WOS:A1990EM45600090
J	VUOLTEENAHO, R; CHOW, LT; TRYGGVASON, K				VUOLTEENAHO, R; CHOW, LT; TRYGGVASON, K			STRUCTURE OF THE HUMAN LAMININ-B1 CHAIN GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV OULU,DEPT BIOCHEM,SF-90570 OULU,FINLAND; UNIV ROCHESTER,SCH MED & DENT,DEPT BIOCHEM,ROCHESTER,NY 14642	Finland National Institute for Health & Welfare; University of Oulu; University of Rochester	VUOLTEENAHO, R (corresponding author), UNIV OULU,BIOCTR,SF-90570 OULU,FINLAND.				PHS HHS [36200] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ausubel FM, 1989, CURRENT PROTOCOLS MO, V1-3; BAKER CC, 1979, CELL, V18, P569, DOI 10.1016/0092-8674(79)90073-4; BOOTHANDFORD RP, 1987, J BIOL CHEM, V262, P12475; BRABANT M, 1988, P NATL ACAD SCI USA, V85, P2200, DOI 10.1073/pnas.85.7.2200; CHOW LT, 1979, J MOL BIOL, V134, P265, DOI 10.1016/0022-2836(79)90036-6; CORNBROOKS CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3850, DOI 10.1073/pnas.80.12.3850; DYNAN WS, 1983, CELL, V32, P669, DOI 10.1016/0092-8674(83)90053-3; ENGEL J, 1981, J MOL BIOL, V150, P97, DOI 10.1016/0022-2836(81)90326-0; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FRENETTE GP, 1989, J BIOL CHEM, V264, P3078; GHOSH PK, 1978, J MOL BIOL, V126, P813, DOI 10.1016/0022-2836(78)90022-0; GILBERT W, 1981, SCIENCE, V214, P1305, DOI 10.1126/science.7313687; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; HUHTALA P, 1990, J BIOL CHEM, V265, P11077; HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0; IKONEN J, 1989, NUCLEIC ACIDS RES, V17, P473; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; JAT P, 1982, NUCLEIC ACIDS RES, V10, P871, DOI 10.1093/nar/10.3.871; KLEINMAN HK, 1987, DEV BIOL, V122, P373, DOI 10.1016/0012-1606(87)90302-2; KRETZ KA, 1989, NUCLEIC ACIDS RES, V17, P5684; LOPATA MA, 1983, CELL, V32, P713, DOI 10.1016/0092-8674(83)90057-0; Maniatis T., 1982, MOL CLONING; MONTELL DJ, 1989, J CELL BIOL, V109, P2441, DOI 10.1083/jcb.109.5.2441; MONTELL DJ, 1988, CELL, V53, P463, DOI 10.1016/0092-8674(88)90166-3; OLSEN D, 1989, LAB INVEST, V60, P772; PETERS BP, 1985, J BIOL CHEM, V260, P4732; PIKKARAINEN T, 1989, NUCLEIC ACIDS RES, V17, P4424, DOI 10.1093/nar/17.11.4424; PIKKARAINEN T, 1987, J BIOL CHEM, V262, P10454; PIKKARAINEN T, 1988, J BIOL CHEM, V263, P6751; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASAKI M, 1987, J BIOL CHEM, V262, P17111; SASAKI M, 1987, P NATL ACAD SCI USA, V84, P935, DOI 10.1073/pnas.84.4.935; SASAKI M, 1988, J BIOL CHEM, V263, P16536; SINGERSAM J, 1984, GENE, V32, P409, DOI 10.1016/0378-1119(84)90016-7; SOININEN R, 1986, P NATL ACAD SCI USA, V83, P1568, DOI 10.1073/pnas.83.6.1568; SOININEN R, 1988, J BIOL CHEM, V263, P17217; SOININEN R, 1989, J BIOL CHEM, V264, P13565; TIMPL R, 1979, J BIOL CHEM, V254, P9933; TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x; VASIOS GW, 1989, P NATL ACAD SCI USA, V86, P9099, DOI 10.1073/pnas.86.23.9099; YAMADA Y, 1980, CELL, V22, P887, DOI 10.1016/0092-8674(80)90565-6	42	47	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1990	265	26					15611	15616						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY964	1975589				2022-12-25	WOS:A1990DY96400044
J	HORIKOSHI, N; SEKIMIZU, K; NATORI, S				HORIKOSHI, N; SEKIMIZU, K; NATORI, S			SITE-DIRECTED MUTAGENESIS OF ARGININE-246, GLUTAMIC-ACID 247, AND HISTIDINE-248 IN THE EUKARYOTIC TRANSCRIPTION FACTOR-S-II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV TOKYO,FAC PHARMACEUT SCI,BUNKYO KU,TOKYO 113,JAPAN	University of Tokyo								HAMAMOTO Y, 1988, BIOCHEM BIOPH RES CO, V155, P1346, DOI 10.1016/S0006-291X(88)81289-0; HIRAI H, 1988, FEBS LETT, V238, P119, DOI 10.1016/0014-5793(88)80239-4; HIRASHIMA S, 1989, BIOCHEM BIOPH RES CO, V160, P1093, DOI 10.1016/S0006-291X(89)80115-9; HIRASHIMA S, 1988, J BIOL CHEM, V263, P3858; HORIKOSHI M, 1985, J BIOL CHEM, V260, P5739; HORIKOSHI M, 1984, J BIOL CHEM, V259, P608; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Miles E W, 1977, Methods Enzymol, V47, P431; MURAKAMI Y, 1989, APPL MICROBIOL BIOT, V30, P619; NATORI S, 1982, MOL CELL BIOCHEM, V46, P173; RAPPAPORT J, 1987, J BIOL CHEM, V262, P5227; REINBERG D, 1987, J BIOL CHEM, V262, P3331; REINES D, 1989, J BIOL CHEM, V264, P10799; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEKIMIZU K, 1983, J BIOCHEM-TOKYO, V93, P1523, DOI 10.1093/oxfordjournals.jbchem.a134290; SEKIMIZU K, 1985, BIOCHEM BIOPH RES CO, V127, P956, DOI 10.1016/S0006-291X(85)80037-1; SEKIMIZU K, 1979, BIOCHEMISTRY-US, V18, P1582, DOI 10.1021/bi00575a031; SEKIMIZU K, 1981, BIOCHEMISTRY-US, V20, P2286, DOI 10.1021/bi00511a033; TOOHEY MG, 1989, GENE DEV, V3, P265, DOI 10.1101/gad.3.3.265; UENO K, 1979, NATURE, V277, P145, DOI 10.1038/277145a0; VOLWERK JJ, 1974, BIOCHEMISTRY-US, V13, P1446, DOI 10.1021/bi00704a020	21	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 15	1990	265	20					11854	11857						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN233	1973165				2022-12-25	WOS:A1990DN23300068
J	KOSKINEN, P; LEHVASLAIHO, H; MACDONALDBRAVO, H; ALITALO, K; BRAVO, R				KOSKINEN, P; LEHVASLAIHO, H; MACDONALDBRAVO, H; ALITALO, K; BRAVO, R			SIMILAR EARLY GENE RESPONSES TO LIGAND-ACTIVATED EGFR AND NEU TYROSINE KINASES IN NIH3T3 CELLS	ONCOGENE			English	Note									UNIV HELSINKI,DEPT PATHOL,SF-00290 HELSINKI 29,FINLAND; EUROPEAN MOLEC BIOL LAB,W-6900 HEIDELBERG,GERMANY	University of Helsinki; European Molecular Biology Laboratory (EMBL)	KOSKINEN, P (corresponding author), UNIV HELSINKI,DEPT UROL,CANC BIOL LAB,HAARTMANINK 3,SF-00290 HELSINKI 29,FINLAND.		Koskinen, Päivi J/G-8939-2014; Alitalo, Kari K/J-5013-2014	Alitalo, Kari K/0000-0002-7331-0902				ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; BARGMANN CI, 1988, P NATL ACAD SCI USA, V85, P5394, DOI 10.1073/pnas.85.15.5394; BARGMANN CI, 1988, ONCOGENE HDB, P107; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GULLICK WJ, 1987, INT J CANCER, V40, P246, DOI 10.1002/ijc.2910400221; KOKAI Y, 1989, CELL, V58, P287, DOI 10.1016/0092-8674(89)90843-X; LEE J, 1989, EMBO J, V8, P167, DOI 10.1002/j.1460-2075.1989.tb03361.x; Lehtola L, 1989, GROWTH FACTORS, V1, DOI 10.3109/08977198909000256; LEHVASLAIHO H, 1989, EMBO J, V8, P159, DOI 10.1002/j.1460-2075.1989.tb03360.x; LIN AH, 1988, MOL CELL BIOL, V8, P5052, DOI 10.1128/MCB.8.11.5052; PANDIELLA A, 1989, ONCOGENE, V4, P1299; RYSECK RP, 1989, EMBO J, V8, P3327, DOI 10.1002/j.1460-2075.1989.tb08494.x; SISTONEN L, 1989, J CELL BIOL, V109, P1911, DOI 10.1083/jcb.109.5.1911; VELU TJ, 1987, SCIENCE, V238, P1408, DOI 10.1126/science.3500513; ZULLO JN, 1988, MOL CELL BIOL, V8, P5080, DOI 10.1128/MCB.8.12.5080	16	14	16	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	APR	1990	5	4					615	618						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DB853	1970155				2022-12-25	WOS:A1990DB85300024
J	SPURLINO, JC; LU, GY; QUIOCHO, FA				SPURLINO, JC; LU, GY; QUIOCHO, FA			THE 2.3-A RESOLUTION STRUCTURE OF THE MALTOSE-BINDING OR MALTODEXTRIN-BINDING PROTEIN, A PRIMARY RECEPTOR OF BACTERIAL ACTIVE-TRANSPORT AND CHEMOTAXIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GALACTOSE CHEMORECEPTOR PROTEIN; ESCHERICHIA-COLI; MEMBRANE-COMPONENTS; SALMONELLA-TYPHIMURIUM; CYTOPLASMIC MEMBRANE; SUGAR-BINDING; PERIPLASMIC RECEPTOR; SIGNAL-TRANSDUCER; MALE MUTATIONS; SITE	The three-dimensional structure of the maltose- or maltodextrin-binding protein (M(r) = 40,622) with bound maltose has been obtained by crystallographic analysis at 2.8-angstrom resolution. The structure, which has been partially refined at 2.3 angstrom, is ellipsoidal with overall dimensions of 30 x 40 x 65 angstrom and divided into two distinct globular domains by a deep groove. Although each domain is built from two peptide segments from the amino- and carboxyl-terminal halves, both domains exhibit similar supersecondary structure, consisting of a central beta-pleated sheet flanked on both sides with two or three parallel alpha-helices. The groove, which has a depth of 18 angstrom and a base of about 9 x 18 angstrom, contains the maltodextrin-binding site. We have previously observed the same general features in the well-refined structures of six other periplasmic receptors with specificities for L-arabinose, D-galactose/D-glucose, sulfate, phosphate, leucine/isoleucine/valine, and leucine. The bound maltose is buried in the groove and almost completely inaccessible to the bulk solvent. The groove is heavily populated by polar and aromatic groups many of which are involved in extensive hydrogen-bonding and van der Waals interactions with the maltose. All the disaccharide hydroxyl groups, which form a peripheral polar surface approximately in the plane of the sugar rings, are tied in a total of 11 direct hydrogen bonds with six charged side chains, one Trp side chain, and one peptide backbone NH, and five indirect hydrogen bonds via water molecules. The maltose is wedged between four aromatic side chains. The resulting stacking of these aromatic residues on the faces of the glucosyl units provides a majority of the van der Waals contacts in the complex. The nonreducing glucosyl unit of the maltose is involved in approximately twice as many hydrogen bonds and van der Waals contacts as the glucosyl unit at the reducing end. The binding protein-maltose complex shows the best example of the extensive use of polar and aromatic residues in binding oligosaccharides. The tertiary structure of the maltodextrin-binding protein, along with the results of genetic studies by a number of investigators, has also enabled us for the first time to map the different regions on the surface of the protein involved in the interactions with the membrane-bound protein components necessary for transport of and chemotaxis toward maltodextrins. These sites permit distinction of the "open cleft" (without bound sugar) and closed (with bound sugar) conformations of the binding protein by the chemotactic signal transducer with which the maltodextrin-binding protein interacts. While a similar mechanism of molecular recognition is operational for the transport system, the membrane transport components interact with sites on the binding protein that are distinct from the ones for chemotaxis.	BAYLOR UNIV, DEPT BIOCHEM & STRUCT BIOL, HOUSTON, TX 77030 USA; RICE UNIV, DEPT BIOCHEM, HOUSTON, TX 77251 USA	Baylor University; Rice University	SPURLINO, JC (corresponding author), HOWARD HUGHES MED INST, 1 BAYLOR PLAZA, HOUSTON, TX 77030 USA.							AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; BAVOIL P, 1980, J BIOL CHEM, V255, P8366; BLOW DM, 1961, ACTA CRYSTALLOGR, V14, P1195, DOI 10.1107/S0365110X61003454; Blundell T.L., 1976, PROTEIN CRYSTALLOGRA; BRASS JM, 1985, J BACTERIOL, V161, P720, DOI 10.1128/JB.161.2.720-726.1985; DASSA E, 1985, EMBO J, V4, P2287, DOI 10.1002/j.1460-2075.1985.tb03928.x; DUPLAY P, 1987, J MOL BIOL, V194, P663, DOI 10.1016/0022-2836(87)90243-9; DUPLAY P, 1984, J BIOL CHEM, V259, P606; FALKE JJ, 1987, SCIENCE, V237, P1596, DOI 10.1126/science.2820061; FERENCI T, 1978, FEBS LETT, V94, P213, DOI 10.1016/0014-5793(78)80940-5; FINKELSHTEIN AV, 1975, DOKL AKAD NAUK SSSR+, V223, P744; FROSHAUER S, 1984, J BIOL CHEM, V259, P896; FURLONG CE, 1987, ESCHERICHIA COLI SAL, P768; GILLILAND GL, 1981, J MOL BIOL, V146, P341, DOI 10.1016/0022-2836(81)90392-2; GILSON E, 1982, J BIOL CHEM, V257, P9915; GILSON E, 1988, EMBO J, V7, P3971, DOI 10.1002/j.1460-2075.1988.tb03284.x; Hammes G.G., 1970, ENZYMES, V2, P67; HAZELBAUER GL, 1971, NATURE-NEW BIOL, V230, P101, DOI 10.1038/newbio230101a0; HAZELBAUER GL, 1975, J BACTERIOL, V122, P206, DOI 10.1128/JB.122.1.206-214.1975; HENDRICKSON WA, 1980, COMPUTING CRYSTALLOG; HIGGINS CF, 1986, NATURE, V323, P448, DOI 10.1038/323448a0; HIGGINS CF, 1985, EMBO J, V4, P1033, DOI 10.1002/j.1460-2075.1985.tb03735.x; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; JACOBSON BL, 1988, J MOL BIOL, V204, P783, DOI 10.1016/0022-2836(88)90369-5; JOHNSON LN, 1988, CURR TOP MICROBIOL, V139, P81; KOSSMANN M, 1988, J BACTERIOL, V170, P4516, DOI 10.1128/jb.170.10.4516-4521.1988; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LEVITT M, 1988, J MOL BIOL, V201, P751, DOI 10.1016/0022-2836(88)90471-8; LUECKE H, 1990, NATURE, V347, P402, DOI 10.1038/347402a0; LUNIN VY, 1985, ACTA CRYSTALLOGR A, V41, P166, DOI 10.1107/S0108767385000332; Macnab R. M., 1987, ESCHERICHIA COLI SAL, V1, P732; MANSON MD, 1986, J BACTERIOL, V165, P34, DOI 10.1128/jb.165.1.34-40.1986; MAO B, 1982, J BIOL CHEM, V257, P1131; MARTINEAU P, 1990, J MOL BIOL, V214, P337, DOI 10.1016/0022-2836(90)90165-I; MILLER DM, 1980, J BIOL CHEM, V255, P2465; NEU HC, 1965, J BIOL CHEM, V240, P3685; NEWCOMER ME, 1981, J BIOL CHEM, V256, P3218; PARKINSON JS, 1983, J BACTERIOL, V155, P265, DOI 10.1128/JB.155.1.265-274.1983; PFLUGRATH JW, 1988, J MOL BIOL, V200, P163, DOI 10.1016/0022-2836(88)90341-5; PFLUGRATH JW, 1985, NATURE, V314, P257, DOI 10.1038/314257a0; PFLUGRATH JW, 1984, COMPUTATIONAL CRYSTA, P404; PODJARNY AD, 1987, ANNU REV BIOPHYS BIO, V16, P351; PRIESTLE JP, 1988, J APPL CRYSTALLOGR, V21, P572, DOI 10.1107/S0021889888005746; PTITSYN OB, 1983, BIOPOLYMERS, V22, P15, DOI 10.1002/bip.360220105; QUIOCHO FA, 1979, J MOL BIOL, V133, P181, DOI 10.1016/0022-2836(79)90256-0; QUIOCHO FA, 1990, PHILOS T R SOC B, V326, P341, DOI 10.1098/rstb.1990.0016; QUIOCHO FA, 1989, PURE APPL CHEM, V61, P1293, DOI 10.1351/pac198961071293; QUIOCHO FA, 1986, ANNU REV BIOCHEM, V55, P287, DOI 10.1146/annurev.bi.55.070186.001443; QUIOCHO FA, 1989, NATURE, V340, P404, DOI 10.1038/340404a0; QUIOCHO FA, 1977, J BIOL CHEM, V252, P5142; QUIOCHO FA, 1984, NATURE, V310, P381, DOI 10.1038/310381a0; RODSETH LE, 1990, J MOL BIOL, V213, P607, DOI 10.1016/S0022-2836(05)80246-3; ROSSMANN MG, 1977, J MOL BIOL, V109, P99, DOI 10.1016/S0022-2836(77)80048-X; SACK JS, 1989, J MOL BIOL, V206, P171, DOI 10.1016/0022-2836(89)90531-7; SACK JS, 1989, J MOL BIOL, V206, P193, DOI 10.1016/0022-2836(89)90532-9; SAENGER W, 1983, BIOCHEM SOC T, V11, P136, DOI 10.1042/bst0110136; SAPER MA, 1983, J BIOL CHEM, V258, P1057; SCHEVITZ RW, 1981, ACTA CRYSTALLOGR A, V37, P669, DOI 10.1107/S0567739481001526; SHUMAN HA, 1982, J BIOL CHEM, V257, P5455; SHUMAN HA, 1981, J BIOL CHEM, V256, P560; Smoluchowski M., 1917, Z PHYS CHEM, V92, P129, DOI [10.1515/zpch-1918-9209, DOI 10.1515/ZPCH-1918-9209]; SPURLINO JC, 1988, THESIS RICE U HOUSTO; STOCK AM, 1989, NATURE, V337, P745, DOI 10.1038/337745a0; SZMELCMAN S, 1976, EUR J BIOCHEM, V65, P13, DOI 10.1111/j.1432-1033.1976.tb10383.x; TAKUSAGAWA F, 1978, ACTA CRYSTALLOGR B, V34, P213, DOI 10.1107/S0567740878002630; THIEME R, 1986, EUR J BIOCHEM, V160, P83, DOI 10.1111/j.1432-1033.1986.tb09943.x; TOLLEY SP, 1988, J MOL BIOL, V204, P493, DOI 10.1016/0022-2836(88)90591-8; TREPTOW NA, 1985, J BACTERIOL, V163, P654, DOI 10.1128/JB.163.2.654-660.1985; TREPTOW NA, 1988, J MOL BIOL, V202, P809, DOI 10.1016/0022-2836(88)90560-8; VYAS MN, 1989, J BIOL CHEM, V264, P20817; VYAS NK, 1991, J BIOL CHEM, V266, P5226; VYAS NK, 1983, P NATL ACAD SCI-BIOL, V80, P1792, DOI 10.1073/pnas.80.7.1792; VYAS NK, 1988, SCIENCE, V242, P1290, DOI 10.1126/science.3057628; VYAS NK, 1987, NATURE, V327, P635, DOI 10.1038/327635a0	74	489	503	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					5202	5219						18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002054				2022-12-25	WOS:A1991FC21700077
J	DEWAARD, P; KOOREVAAR, A; KAMERLING, JP; VLIEGENTHART, JFG				DEWAARD, P; KOOREVAAR, A; KAMERLING, JP; VLIEGENTHART, JFG			STRUCTURE DETERMINATION BY H-1-NMR SPECTROSCOPY OF (SULFATED) SIALYLATED N-LINKED CARBOHYDRATE CHAINS RELEASED FROM PORCINE THYROGLOBULIN BY PEPTIDE-N4-(N-ACETYL-BETA-GLUCOSAMINYL)ASPARAGINE AMIDASE-F	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CHORIONIC-GONADOTROPIN; D-GALACTOSYL RESIDUES; ACETYLLACTOSAMINE TYPE; HEN OVOMUCIN; SIALIC-ACID; OLIGOSACCHARIDES; GLYCOPROTEINS; IDENTIFICATION; GLYCOPEPTIDES; H-1-NMR	The N-linked carbohydrate chains of porcine thyroglobulin were released by peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase-F (PNGase-F). The resulting oligosaccharides were fractionated by a combination of fast protein liquid chromatography and high performance liquid chromatography and analyzed by 500-MHz H-1 NMR spectroscopy. The major acidic compounds are mono- and disialylated, fucosylated diantennary compounds terminated with alpha-(2-6)-linked sialic acid on the Man-alpha(1-3) branch. The Man-alpha(1-6) branch shows a large heterogeneity. It can be terminated with Man-4', GlcNAc-5' or Gal-6', whereas the Gal-6' residue may be extended with Gal-alpha(1-3), NeuAc-alpha(2-3), or Sia-alpha(2-6). In the major structures 8% of alpha(2-6)-linked sialic acid was found as NeuGc instead of NeuAc. The main compounds have sulfated homologues bearing a sulfate group (6-20%) at C-3 of Gal-6' or at C-6 of GlcNAc-5 as follows. [GRAPHICS]			DEWAARD, P (corresponding author), STATE UNIV UTRECHT,BIJVOET CTR,DEPT BIOORGAN CHEM,POB 80075,3508 TB UTRECHT,NETHERLANDS.							BAENZIGER JU, 1988, BIOCHIM BIOPHYS ACTA, V947, P287, DOI 10.1016/0304-4157(88)90012-3; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BAX A, 1985, J MAGN RESON, V63, P207, DOI 10.1016/0022-2364(85)90171-4; BRAULKE T, 1987, BIOCHEM BIOPH RES CO, V143, P178, DOI 10.1016/0006-291X(87)90647-4; CAPON C, 1989, EUR J BIOCHEM, V182, P139, DOI 10.1111/j.1432-1033.1989.tb14810.x; CONTRERAS RR, 1988, CARBOHYD RES, V179, P411; DAMM JBL, 1988, GLYCOCONJUGATE J, V5, P221, DOI 10.1007/BF01049083; DAMM JBL, 1990, EUR J BIOCHEM, V189, P175, DOI 10.1111/j.1432-1033.1990.tb15474.x; DAMM JBL, 1989, RECL TRAV CHIM PAY B, V108, P351; DAMM JBL, 1987, GLYCOCONJUGATE J, V4, P129, DOI 10.1007/BF01049451; DAMM JBL, 1989, EUR J BIOCHEM, V180, P101, DOI 10.1111/j.1432-1033.1989.tb14620.x; DEWAARD P, 1989, J BIOL CHEM, V264, P12141; DORLAND L, 1984, BIOCHEM BIOPH RES CO, V122, P859, DOI 10.1016/S0006-291X(84)80113-8; Ernst RR, 1966, ADV MAGN RESON, V2, P1; FREEZE HH, 1986, BIOCHEM BIOPH RES CO, V140, P967, DOI 10.1016/0006-291X(86)90730-8; FREEZE HH, 1986, J BIOL CHEM, V261, P127; FUKUDA M, 1971, BIOCHEM J, V123, P407, DOI 10.1042/bj1230407; FUKUDA M, 1971, BIOCHEM J, V123, P415, DOI 10.1042/bj1230415; GERWIG GJ, 1989, J BIOL CHEM, V264, P1027; HARRIS MJ, 1970, CARBOHYD RES, V15, P57, DOI 10.1016/S0008-6215(00)80294-3; HERNANDEZ LM, 1989, J BIOL CHEM, V264, P13648; HOUNSELL EF, 1986, EUR J BIOCHEM, V157, P375, DOI 10.1111/j.1432-1033.1986.tb09679.x; JOZIASSE DH, 1989, J BIOL CHEM, V264, P14290; JOZIASSE DH, 1987, J BIOL CHEM, V262, P2025; KAMERLING JP, 1988, FEBS LETT, V241, P246, DOI 10.1016/0014-5793(88)81070-6; KATO Y, 1989, J BIOL CHEM, V264, P3364; KESSLER H, 1986, J MAGN RESON, V70, P106, DOI 10.1016/0022-2364(86)90366-5; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; MAAS AAM, 1985, 3RD EUR S CARB GREN, P20; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; MALTHIERY Y, 1989, BIOCHIMIE, V71, P195, DOI 10.1016/0300-9084(89)90057-6; MONSIGNY M, 1988, ANAL BIOCHEM, V175, P525, DOI 10.1016/0003-2697(88)90578-7; NAGAI K, 1989, J BIOL CHEM, V264, P16229; RONIN C, 1986, J BIOL CHEM, V261, P7287; ROUX L, 1988, J BIOL CHEM, V263, P8879; SPIRO MJ, 1988, ENDOCRINOLOGY, V123, P56; SPIRO RG, 1984, J BIOL CHEM, V259, P9858; SPIRO RG, 1988, J BIOL CHEM, V263, P14351; SPIRO RG, 1965, J BIOL CHEM, V240, P997; STRECKER G, 1989, CARBOHYD RES, V185, P1, DOI 10.1016/0008-6215(89)84016-9; STRECKER G, 1987, GLYCOCONJUGATE J, V4, P329, DOI 10.1007/BF01048366; SUGAHARA K, 1988, J BIOL CHEM, V263, P10168; TSUJI T, 1981, BIOCHEM J, V195, P691, DOI 10.1042/bj1950691; VANKUIK JA, 1987, EUR J BIOCHEM, V169, P399; VANKUIK JA, 1987, FEBS LETT, V221, P150, DOI 10.1016/0014-5793(87)80370-8; VLIEGENTHART JFG, 1983, ADV CARBOHYD CHEM BI, V41, P209, DOI 10.1016/S0065-2318(08)60059-1; YAMAMOTO K, 1981, BIOCHEM J, V195, P701, DOI 10.1042/bj1950701; YAMASHITA K, 1983, J BIOL CHEM, V258, P4144	48	112	114	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4237	4243						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999416				2022-12-25	WOS:A1991FA69400036
J	SAFER, D; ELZINGA, M; NACHMIAS, VT				SAFER, D; ELZINGA, M; NACHMIAS, VT			THYMOSIN-BETA-4 AND FX, AN ACTIN-SEQUESTERING PEPTIDE, ARE INDISTINGUISHABLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							AMINO-ACID-SEQUENCE; RABBIT SKELETAL-MUSCLE; PROFILIN; TROPOMYOSIN; PROTEINS; GELSOLIN; COMPLEX; HORMONE; TISSUES; MYOSIN	At least 50% of the actin in resting human platelets is unpolymerized, and the bulk of this unpolymerized actin is complexed with a recently identified acidic, heat-stable 5-kDa peptide, named "Fx." Purified Fx binds stoichiometrically to muscle G-actin, forming a complex identifiable by nondenaturing polyacrylamide gel electrophoresis. Formation of the complex inhibits salt-induced polymerization of G-actin. Here we report that Fx is indistinguishable from thymosin-beta-4, an acidic, heat-stable 5-kDa peptide first isolated from calf thymus and thought to be a thymic hormone. The complete amino acid sequence of Fx was determined and was found to be identical with that of thymosin-beta-4. Authentic thymosin-beta-4 is functionally equivalent to Fx, forming a 1:1 complex with actin monomers and inhibiting polymerization. The widespread distribution and high intracellular concentration of thymosin-beta-4 (Fx) strongly suggest that it plays a significant role in regulating actin polymerization in many cell types.	INST BASIC RES DEV DISABIL,NEUROBIOCHEM LAB,STATEN ISL,NY 10314		SAFER, D (corresponding author), UNIV PENN,SCH MED,DEPT ANAT,PHILADELPHIA,PA 19104, USA.							ABIKO T, 1989, CHEM PHARM BULL, V37, P2467; BAMBURG JR, 1987, J CELL BIOL, V105, P2817, DOI 10.1083/jcb.105.6.2817; BAXEVANIS CN, 1987, IMMUNOPHARMACOLOGY, V13, P133, DOI 10.1016/0162-3109(87)90050-6; ELZINGA M, 1973, P NATL ACAD SCI USA, V70, P2687, DOI 10.1073/pnas.70.9.2687; ERICKSONVIITANEN S, 1983, ARCH BIOCHEM BIOPHYS, V221, P570, DOI 10.1016/0003-9861(83)90177-7; GOMEZMARQUEZ J, 1989, J IMMUNOL, V143, P2740; GOODALL GJ, 1983, ARCH BIOCHEM BIOPHYS, V221, P598, DOI 10.1016/0003-9861(83)90182-0; HANNAPPEL E, 1987, J CHROMATOGR, V397, P279, DOI 10.1016/S0021-9673(01)85010-X; HANNAPPEL E, 1986, ANAL BIOCHEM, V156, P390, DOI 10.1016/0003-2697(86)90270-8; HARRIS HE, 1978, FEBS LETT, V90, P84, DOI 10.1016/0014-5793(78)80303-2; KURTH MC, 1984, J BIOL CHEM, V259, P7473; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHRER SS, 1972, BIOCHEMISTRY-US, V11, P1211, DOI 10.1021/bi00757a015; LEWIS WG, 1983, FEBS LETT, V156, P269, DOI 10.1016/0014-5793(83)80511-0; LIND SE, 1987, J CELL BIOL, V105, P833, DOI 10.1083/jcb.105.2.833; LOW TLK, 1981, P NATL ACAD SCI-BIOL, V78, P1162, DOI 10.1073/pnas.78.2.1162; MARKEY F, 1978, FEBS LETT, V88, P75, DOI 10.1016/0014-5793(78)80610-3; NACHMIAS VT, 1988, ADV CELL BIOL, V2, P181; NISHIDA E, 1985, BIOCHEMISTRY-US, V24, P1160, DOI 10.1021/bi00326a015; NOEGEL A, 1987, FEBS LETT, V221, P391, DOI 10.1016/0014-5793(87)80962-6; REBAR RW, 1981, SCIENCE, V214, P669, DOI 10.1126/science.7027442; SAFER D, 1990, P NATL ACAD SCI USA, V87, P2536, DOI 10.1073/pnas.87.7.2536; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SOUTHWICK FS, 1990, J CELL BIOL, V110, P1965, DOI 10.1083/jcb.110.6.1965; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; STREHLER EE, 1986, J MOL BIOL, V190, P291, DOI 10.1016/0022-2836(86)90003-3; TZEHOVAL E, 1989, IMMUNOPHARMACOLOGY, V18, P107, DOI 10.1016/0162-3109(89)90063-5; VANDEKERCKHOVE J, 1990, J BIOL CHEM, V265, P12801; WANG LL, 1981, CELL, V25, P637, DOI 10.1016/0092-8674(81)90171-9; WELLNER D, 1990, P NATL ACAD SCI USA, V87, P1947, DOI 10.1073/pnas.87.5.1947	31	327	345	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4029	4032						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999398				2022-12-25	WOS:A1991FA69400002
J	LEONI, J; GHISO, J; GONI, F; FRANGIONE, B				LEONI, J; GHISO, J; GONI, F; FRANGIONE, B			THE PRIMARY STRUCTURE OF THE FAB FRAGMENT OF PROTEIN KAU, A MONOCLONAL IMMUNOGLOBULIN-M COLD AGGLUTININ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-IDIOTYPIC SPECIFICITY; HUMAN IGMK AUTOANTIBODIES; VARIABLE REGION GENES; AMINO-ACID SEQUENCE; HEAVY-CHAIN; RHEUMATOID FACTORS; I SPECIFICITIES; LIGHT-CHAINS; ANTI-I; SIMILARITIES	The complete amino acid sequence of the Fab fragment of protein KAU, a human monoclonal cold agglutinin (IgM(k)) with anti-I activity, was determined. The light chain (L-chain) consists of 215 residues; the variable (V)L region belongs to the Hum/Kv325/K(IIIb) sub-subgroup that is preferentially selected in human IgM autoimmune response. The joining (J) region is encoded by the J(k4) gene, and the constant region (C)L domain expresses the km3 allotypic marker. The Fd fragment contains 232 amino acids, and 120 of them comprise the variable domain. The V(H) region corresponds to the V(H)IV subgroup and is closely related to the V(H)IV 2.1 gene isolated from genomic DNA expressed in peripheral blood of a healthy Caucasian. The complementary-determining region 1 has a unique amino acid (Asp) at position 31, and the complementary-determining region 3 codified by the diversity segment (D) gene, shows poor homology with other known D sequences. The joining segment with two unusual substitutions at the D-J junction is encoded by the J(H4) gene. Thus, cold agglutinin KAU is an IgM, V(kIIb)-J(k4)-Km3; V(H)IV-J(H4)-C-mu.	NYU MED CTR,DEPT PATHOL,UH 427,550 1ST AVE,NEW YORK,NY 10016	New York University					NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR002594, R37AR002594] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR 02594] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BARNES JL, 1990, ARTHRITIS RHEUM-US, V33, P1710, DOI 10.1002/art.1780331115; BERMAN JE, 1988, EMBO J, V7, P727, DOI 10.1002/j.1460-2075.1988.tb02869.x; CHEN PP, 1990, MOLECULAR ASPECTS OF AUTOIMMUNITY, P41; CHEN PP, 1987, J IMMUNOL, V139, P1727; CHEN PP, 1987, J EXP MED, V166, P1900, DOI 10.1084/jem.166.6.1900; CHILDS R, 1975, NATURE, V255, P562, DOI 10.1038/255562a0; EVANS SW, 1983, MOL IMMUNOL, V20, P1127, DOI 10.1016/0161-5890(83)90122-0; GERGELY J, 1973, VOX SANG, V24, P432, DOI 10.1111/j.1423-0410.1973.tb03484.x; GONI F, 1985, J IMMUNOL, V135, P4073; GONI FR, 1990, MOLECULAR ASPECTS OF AUTOIMMUNITY, P29; GONI FR, 1989, J IMMUNOL, V142, P3158; Hayashi R, 1977, Methods Enzymol, V47, P84; HIETER PA, 1982, J BIOL CHEM, V257, P1516; ICHIHARA Y, 1988, EMBO J, V7, P4141, DOI 10.1002/j.1460-2075.1988.tb03309.x; KABAT EA, 1987, SEQUENCES PROTEINS I, P41; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEDFORD DK, 1983, J IMMUNOL, V131, P1322; LEE KH, 1987, J MOL BIOL, V195, P761, DOI 10.1016/0022-2836(87)90482-7; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; PLAUT A G, 1970, Proceedings of the National Academy of Sciences of the United States of America, V65, P318, DOI 10.1073/pnas.65.2.318; PODELL DN, 1978, BIOCHEM BIOPH RES CO, V81, P176, DOI 10.1016/0006-291X(78)91646-7; PONSESTEL B, 1984, J EXP MED, V160, P893, DOI 10.1084/jem.160.3.893; PUTNAM FW, 1973, SCIENCE, V182, P287, DOI 10.1126/science.182.4109.287; RAVETCH JV, 1981, CELL, V27, P583, DOI 10.1016/0092-8674(81)90400-1; Roelcke D, 1989, Transfus Med Rev, V3, P140, DOI 10.1016/S0887-7963(89)70075-4; SANZ I, 1989, EMBO J, V8, P3741, DOI 10.1002/j.1460-2075.1989.tb08550.x; SILBERSTEIN LE, 1986, BLOOD, V67, P1705; SILBERSTEIN LE, 1989, J EXP MED, V169, P1631, DOI 10.1084/jem.169.5.1631; SILVERMAN GJ, 1988, J EXP MED, V168, P2361, DOI 10.1084/jem.168.6.2361; SILVERMAN GJ, 1990, EUR J IMMUNOL, V20, P351, DOI 10.1002/eji.1830200218; SILVERMAN GJ, 1988, J CLIN INVEST, V82, P469, DOI 10.1172/JCI113620; SMITH I, 1953, NATURE, V171, P43, DOI 10.1038/171043a0; SPATZ LA, 1990, J IMMUNOL, V144, P2821; STEVENSON FK, 1989, BRIT J HAEMATOL, V72, P9, DOI 10.1111/j.1365-2141.1989.tb07643.x; WATANABE S, 1973, H-S Z PHYSIOL CHEM, V354, P1505; WORD JC, 1989, INT IMMUNOL, V3, P296	36	35	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2836	2842						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993660				2022-12-25	WOS:A1991EX60000029
J	JAHN, D; MICHELSEN, U; SOLL, D				JAHN, D; MICHELSEN, U; SOLL, D			2 GLUTAMYL-TRANSFER RNA REDUCTASE ACTIVITIES IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA-AMINOLEVULINIC-ACID; ENZYMATIC CONVERSION; SOLUBLE EXTRACTS; CHLOROPHYLL BIOSYNTHESIS; SYNTHESIZING ENZYMES; CHLORELLA-VULGARIS; GREENING BARLEY; CHLAMYDOMONAS; PURIFICATION; SYNTHETASE	delta-Aminolevulinic acid (ALA) is the first committed precursor for tetrapyrrole biosynthesis. ALA formation in Escherichia coli occurs in a tRNA-dependent three-step conversion from glutamate. Glu-tRNA reductase is the key enzyme in this pathway. E. coli K12 contains two Glu-tRNA reductase activities which differ in their molecular weights. Here we describe the purification of one of these enzymes. Four different chromatographic separations yielded a nearly homogeneous protein. Its apparent molecular mass under denaturing (sodium dodecyl sulfate-polyacrylamide gel electrophoresis) and nondenaturing conditions (rate zonal sedimentation and gel filtration) is 85,000 +/- 5,000 Da. This indicates a monomeric structure for the active enzyme. Gel filtration and glycerol gradient centrifugation indicate that the other activity has a molecular mass of 45,000 +/- 5,000 Da. In the presence of NADPH both enzyme activities converted E. coli Glu-tRNA2(Glu) to glutamate 1-semialdehyde. Addition of GTP or hemin did not affect the reductase activity. Both enzymes display sequence-specific recognition of tRNA; E. coli Glu-tRNA2(Glu) is a good substrate while the Chlamydomonas reinhardtii, Bacillus subtilis, and Synechocystis Glu-tRNA(Glu) species are poorly recognized.	YALE UNIV, DEPT MOLEC BIOPHYS & BIOCHEM, POB 6666, NEW HAVEN, CT 06511 USA	Yale University				Jahn, Dieter/0000-0002-4064-9205				AVISSAR YJ, 1989, ARCH MICROBIOL, V151, P513, DOI 10.1007/BF00454867; AVISSAR YJ, 1989, J BACTERIOL, V171, P2919, DOI 10.1128/jb.171.6.2919-2924.1989; AVISSAR YJ, 1990, J BACTERIOL, V172, P1656, DOI 10.1128/jb.172.3.1656-1659.1990; Beale S. I., 1990, BIOSYNTHESIS HEME CH, P287; BEALE SI, 1975, P NATL ACAD SCI USA, V72, P2719, DOI 10.1073/pnas.72.7.2719; BRETON R, 1986, J BIOL CHEM, V261, P610; CHEN MW, 1990, J BIOL CHEM, V265, P4054; CHEN MW, 1990, J BIOL CHEM, V265, P4058; ELLIOTT T, 1989, MOL GEN GENET, V216, P303, DOI 10.1007/BF00334369; FRIEDMANN HC, 1986, FEBS LETT, V207, P84, DOI 10.1016/0014-5793(86)80017-5; HOOBER JK, 1988, CARLSBERG RES COMMUN, V53, P363; HOUEN G, 1983, CARLSBERG RES COMMUN, V48, P567, DOI 10.1007/BF02907558; HOUGHTON JD, 1989, CARLSBERG RES COMMUN, V54, P131, DOI 10.1007/BF02907183; HUANG DD, 1986, J BIOL CHEM, V261, P3451; HUANG DD, 1984, SCIENCE, V225, P1482, DOI 10.1126/science.6206568; JAHN D, 1990, J BIOL CHEM, V265, P8059; JAHN D, 1991, J BIOL CHEM, V266, P161; Jordan PM, 1990, BIOSYNTHESIS HEME CH, P55; KANNANGARA CG, 1988, TRENDS BIOCHEM SCI, V13, P139; KANNANGARA CG, 1990, MOL BIOL PLASTIDS MI, V7; KIKUCHI G, 1958, J BIOL CHEM, V233, P1214; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPOINTE J, 1972, J BIOL CHEM, V247, P4966; LAPOINTE J, 1985, METHOD ENZYMOL, V113, P42; LI JM, 1989, J BACTERIOL, V171, P2547, DOI 10.1128/jb.171.5.2547-2552.1989; LI LM, 1989, GENE, V82, P209; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; MAU YH, 1987, ARCH BIOCHEM BIOPHYS, V255, P75, DOI 10.1016/0003-9861(87)90295-5; MAY BK, 1986, CURR TOP CELL REGUL, V28, P233; MAYER SM, 1987, J BIOL CHEM, V262, P12541; ONEILL GP, 1989, FEMS MICROBIOL LETT, V60, P255; ONEILL GP, 1988, J BACTERIOL, V170, P3810, DOI 10.1128/jb.170.9.3810-3816.1988; PETERSON D, 1988, PLANT MOL BIOL, V11, P293, DOI 10.1007/BF00027386; POWELL KA, 1973, ENZYME, V16, P65, DOI 10.1159/000459363; RIEBLE S, 1988, J BIOL CHEM, V263, P8864; SASARMAN A, 1968, J BACTERIOL, V96, P1882; SCHNEEGURT MA, 1986, PLANT PHYSIOL, V81, P965, DOI 10.1104/pp.81.4.965; SCHON A, 1986, NATURE, V322, P281, DOI 10.1038/322281a0; SHEMIN D, 1953, J AM CHEM SOC, V75, P4873, DOI 10.1021/ja01115a546; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; VERKAMP E, 1989, J BACTERIOL, V171, P4728, DOI 10.1128/jb.171.9.4728-4735.1989; WALDSCHMIDT R, 1988, J BIOL CHEM, V263, P13350; WANG WY, 1984, PLANT PHYSIOL, V74, P569, DOI 10.1104/pp.74.3.569; WEINSTEIN JD, 1986, PLANT PHYSIOL, V82, P1096, DOI 10.1104/pp.82.4.1096; WEINSTEIN JD, 1985, ARCH BIOCHEM BIOPHYS, V239, P87, DOI 10.1016/0003-9861(85)90814-8; WEINSTEIN JD, 1985, ARCH BIOCHEM BIOPHYS, V237, P454, DOI 10.1016/0003-9861(85)90299-1; WULFF DL, 1967, J BACTERIOL, V93, P1473, DOI 10.1128/JB.93.4.1473-1474.1967	47	54	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2542	2548						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1990004				2022-12-25	WOS:A1991EV51500081
J	BISCHOFF, FZ; STRONG, LC; YIM, SO; PRATT, DR; SICILIANO, MJ; GIOVANELLA, BC; TAINSKY, MA				BISCHOFF, FZ; STRONG, LC; YIM, SO; PRATT, DR; SICILIANO, MJ; GIOVANELLA, BC; TAINSKY, MA			TUMORIGENIC TRANSFORMATION OF SPONTANEOUSLY IMMORTALIZED FIBROBLASTS FROM PATIENTS WITH A FAMILIAL CANCER SYNDROME	ONCOGENE			English	Article							DIPLOID HUMAN-FIBROBLASTS; ANCHORAGE-INDEPENDENT GROWTH; MALIGNANT TRANSFORMATION; SKIN FIBROBLASTS; MORPHOLOGICAL TRANSFORMATION; RAS ONCOGENE; HUMAN-CELLS; DNA; TRANSFECTION; EXPRESSION	Immortal cell lines arose spontaneously during in vitro culture of initially normal fibroblasts, MDAH041 and MDAH087, from patients with Li-Fraumeni familial cancer syndrome. Fibroblasts from a control donor, MDAH170, maintained a normal morphology and senesced at 31 population doublings. The immortal fibroblasts have several properties of transformed cells. In addition to having acquired an altered morphology and chromosomal anomalies, MDAH041 and MDAH087 have escaped from senescence, growing beyond 300 and 100 population doublings (pd), respectively. As early as 50 pd, these cells can be transformed by an activated H-ras oncogene to form tumors in nude mice. However, MDAH041 immortal cells were resistant to tumorigenic transformation by transfection with the v-abl oncogene.	UNIV TEXAS,MD ANDERSON CANC CTR,DEPT TUMOR BIOL,HOUSTON,TX 77030; UNIV TEXAS,MD ANDERSON CANC CTR,DEPT PEDIAT,HOUSTON,TX 77030; ST JOSEPHS HOSP,STEHLIN FDN CANC RES,CANC RES LAB,HOUSTON,TX 77003; UNIV TEXAS,MD ANDERSON CANC CTR,DEPT MOLEC GENET,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center				Tainsky, Michael/0000-0002-0261-831X	NCI NIH HHS [CA 09299, CA 34936, CA 42810] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009299, P01CA034936, R01CA042810] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BENEDICT WF, 1984, CANCER RES, V44, P3471; BERG P, 1982, MOL APPL GENET, V1, P327; BISCHOFF FZ, 1990, CANCER RES, V50, P7979; CHEN S, 1989, P NATL ACAD SCI USA, V86, P2008, DOI 10.1073/pnas.86.6.2008; GUMERLOCK PH, 1989, ANAL BIOCHEM, V180, P158, DOI 10.1016/0003-2697(89)90105-X; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; HURLIN PJ, 1989, P NATL ACAD SCI USA, V86, P187, DOI 10.1073/pnas.86.1.187; HURLIN PJ, 1987, CANCER RES, V47, P5752; HUSCHTSCHA LI, 1986, PROC R SOC SER B-BIO, V229, P1, DOI 10.1098/rspb.1986.0070; KNUDSON AG, 1972, J NATL CANCER I, V48, P313; LI FP, 1969, J NATL CANCER I, V43, P1365; LITTLE JB, 1987, CANCER RES, V47, P4229; MAYNE LV, 1986, EXP CELL RES, V162, P530, DOI 10.1016/0014-4827(86)90356-3; MCCORMICK JJ, 1988, MUTAT RES, V199, P273; MORGAN TL, 1986, IN VITRO CELL DEV B, V22, P317, DOI 10.1007/BF02623404; RULEY HE, 1984, CANCER CELL, V2, P481; SAGER R, 1983, P NATL ACAD SCI-BIOL, V80, P7601, DOI 10.1073/pnas.80.24.7601; SANTOS E, 1982, NATURE, V298, P343, DOI 10.1038/298343a0; SILINSKAS KC, 1981, CANCER RES, V41, P1620; SRINIVASAN A, 1981, P NATL ACAD SCI-BIOL, V78, P2077, DOI 10.1073/pnas.78.4.2077; STRONG LC, 1987, JNCI-J NATL CANCER I, V79, P1213; SUTHERLAND BM, 1980, CANCER RES, V40, P1934; WILLIAMS WR, 1985, FAM CANCER, P151; WILSON DM, 1989, CARCINOGENESIS, V10, P635, DOI 10.1093/carcin/10.4.635; WILSON DM, 1990, CANCER RES, V50, P5587; ZIMMERMAN RJ, 1983, CANCER RES, V43, P2183	27	50	50	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1991	6	2					183	186						4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ134	2000218				2022-12-25	WOS:A1991FZ13400001
J	GIESEN, PLA; WILLEMS, GM; HERMENS, WT				GIESEN, PLA; WILLEMS, GM; HERMENS, WT			PRODUCTION OF THROMBIN BY THE PROTHROMBINASE COMPLEX IS REGULATED BY MEMBRANE-MEDIATED TRANSPORT OF PROTHROMBIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							FACTOR-X; PHOSPHOLIPID-BILAYERS; BOVINE PROTHROMBIN; BLOOD-COAGULATION; STUART FACTOR; FACTOR-VA; BINDING; ADSORPTION; ACTIVATION; PHOSPHATIDYLSERINE	Production of thrombin by phospholipid-bound prothrombinase complexes has been described as being regulated by the prothrombin concentration in the buffer (free-substrate model) as well as by the concentration of prothrombin adsorbed to the phospholipid surface (bound-substrate model). We studied simultaneous adsorption and conversion of prothrombin on planar bilayers consisting of 20% dioleoylphosphatidylserine and 80% dioleoylphosphatidylcholine. A transport limitation in the conversion of prothrombin was prevented by using a very low (0.3 fmol cm-2) amount of prothrombinase on the bilayer. The Michaelis and catalytic constants thus found were K(m) = 5.8 +/- 0.7 nM and k(cat) = 33 +/- 1 s-1 (mean +/- S.D.). The apparent bimolecular rate constant k(cat)/K(m) = 5.7 x 10(9) M-1 S-1 exceeds the theoretically maximal value for the free-substrate model. In contrast, k(cat)/K(m) is within the range expected for a diffusion-controlled bound-substrate model. A similar mechanism for prothrombin conversion in suspensions of phospholipid vesicles would imply increasing k(cat)/K(m) values for increasing vesicle diameter. This prediction was tested and a 3-fold increase in k(cat)/K(m) values was indeed found for vesicles 60-80 nm in diameter compared to vesicles of 20-30 nm diameter. It is concluded that thrombin production is dependent on protein fluxes rather than on protein concentrations.	STATE UNIV LIMBURG,CTR BIOMED,CARDIOVASC RES INST MAASTRICHT,POB 616,6200 MD MAASTRICHT,NETHERLANDS	Maastricht University								Adam G., 1968, STRUCTURAL CHEM MOL, P198; Bottcher CJF, 1961, ANAL CHIM ACTA, V24, P203; Clegg R. M., 1985, PROGR PROTEIN LIPID, P173; COMFURIUS P, 1977, BIOCHIM BIOPHYS ACTA, V488, P36, DOI 10.1016/0005-2760(77)90120-5; CORSEL JW, 1986, J COLLOID INTERF SCI, V111, P544, DOI 10.1016/0021-9797(86)90058-5; CUYPERS PA, 1983, J BIOL CHEM, V258, P2426; DEKRUIJFF B, 1975, BIOCHIM BIOPHYS ACTA, V406, P6, DOI 10.1016/0005-2736(75)90038-3; FERSHT A, 1985, ENZYME STRUCTURE MEC, P201; FORMAN SD, 1986, P NATL ACAD SCI USA, V83, P4675, DOI 10.1073/pnas.83.13.4675; FUJIKAWA K, 1972, BIOCHEMISTRY-US, V11, P4892, DOI 10.1021/bi00776a003; FUJIKAWA K, 1972, BIOCHEMISTRY-US, V11, P4882, DOI 10.1021/bi00776a002; HEMKER HC, 1967, NATURE, V215, P248, DOI 10.1038/215248a0; HEMKER HC, 1983, HDB SYNTHETIC SUBSTR, P75; HERMENS W, 1988, COAGULATION LIPIDS, P73; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; JACKSON CM, 1980, ANNU REV BIOCHEM, V49, P765, DOI 10.1146/annurev.bi.49.070180.004001; JOBIN F, 1967, BIOCHEM J, V102, P666, DOI 10.1042/bj1020666; KOP JMM, 1984, J BIOL CHEM, V259, P3993; KOP JMM, 1989, J COLLOID INTERF SCI, V133, P369, DOI 10.1016/S0021-9797(89)80045-1; LINDHOUT T, 1982, BIOCHEMISTRY-US, V21, P5494, DOI 10.1021/bi00265a018; NELSESTUEN GL, 1981, BIOCHEMISTRY-US, V20, P351, DOI 10.1021/bi00505a019; NELSESTUEN GL, 1977, BIOCHEMISTRY-US, V16, P4164, DOI 10.1021/bi00638a005; NESHEIM ME, 1981, J BIOL CHEM, V256, P9874; OWEN WG, 1974, J BIOL CHEM, V249, P594; PUSEY ML, 1983, BIOCHEM BIOPH RES CO, V114, P526, DOI 10.1016/0006-291X(83)90812-4; SMITH RL, 1973, J BIOL CHEM, V248, P2418; Smoluchowski M., 1917, Z PHYS CHEM, V92, P129, DOI [10.1515/zpch-1918-9209, DOI 10.1515/ZPCH-1918-9209]; TAMM LK, 1988, BIOCHEMISTRY-US, V27, P1450, DOI 10.1021/bi00405a009; VANRIJN JLML, 1984, BIOCHEMISTRY-US, V23, P4557, DOI 10.1021/bi00315a008; WEI GJ, 1982, BIOCHEMISTRY-US, V21, P1949, DOI 10.1021/bi00537a039	30	69	70	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1379	1382						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1988426				2022-12-25	WOS:A1991EU49700007
J	HIROSE, M; YAMASHITA, H				HIROSE, M; YAMASHITA, H			PARTIALLY FOLDED STATE OF THE DISULFIDE-REDUCED N-TERMINAL HALF-MOLECULE OF OVOTRANSFERRIN AS A RENATURATION INTERMEDIATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC TRYPSIN-INHIBITOR; IMMUNOGLOBULIN LIGHT CHAIN; MOLTEN-GLOBULE STATE; CONFORMATIONAL STABILITY; CIRCULAR-DICHROISM; CONSTANT FRAGMENT; ALPHA-LACTALBUMIN; BONDS; RIBONUCLEASE-T1; PROTEINS	A previous report (Hirose, M., Akuta, T., and Takahashi, N. (1989) J. Biol. Chem. 264, 16867-16872) has shown that for the efficient oxidative refolding of disulfide-reduced ovotransferrin, a preincubation under reduced conditions at a low temperature is essential. To study the renaturation pathway, the disulfide-reduced N-terminal half-molecule of ovotransferrin was analyzed by CD spectrum. The reduced protein was found to take, at low temperatures, a partially folded conformation that can be distinguished from both the native and denatured states. The folded protein was in a metastable state with DELTA-G(D) value of 2.2-2.8 kcal/mol at 6-degrees-C. The conformation was variable depending on temperature conditions; its stability was decreased at a lower temperature (1.0-1.2 kcal/mol at 0-degrees-C). Subsequent reoxidization at 6-degrees-C by oxidized glutathione led efficiently the reduced protein to the correctly renatured form having the iron-binding capacity, indicating that the partially folded state is the immediate precursor to subsequent oxidative refolding.			HIROSE, M (corresponding author), KYOTO UNIV,FOOD SCI RES INST,UJI,KYOTO 611,JAPAN.			Hirose, Masaaki/0000-0003-2672-4384				ACHARYA AS, 1980, J BIOL CHEM, V255, P1905; ALOBEIDI AM, 1988, J BIOL CHEM, V263, P8642; ANDERSON BF, 1989, J MOL BIOL, V209, P711, DOI 10.1016/0022-2836(89)90602-5; BAILEY S, 1988, BIOCHEMISTRY-US, V27, P5804, DOI 10.1021/bi00415a061; BREMS DN, 1990, J BIOL CHEM, V265, P5504; Creighton T E, 1986, Methods Enzymol, V131, P83; CREIGHTON TE, 1977, J MOL BIOL, V113, P275, DOI 10.1016/0022-2836(77)90142-5; CREIGHTON TE, 1984, J MOL BIOL, V179, P497, DOI 10.1016/0022-2836(84)90077-9; CREIGHTON TE, 1977, J MOL BIOL, V113, P329, DOI 10.1016/0022-2836(77)90145-0; CREIGHTON TE, 1977, J MOL BIOL, V113, P295, DOI 10.1016/0022-2836(77)90143-7; DOLGIKH DA, 1981, FEBS LETT, V136, P311, DOI 10.1016/0014-5793(81)80642-4; GALAT A, 1981, BIOCHEMISTRY-US, V20, P594, DOI 10.1021/bi00506a023; GOTO Y, 1981, J MOL BIOL, V146, P321, DOI 10.1016/0022-2836(81)90391-0; GOTO Y, 1990, P NATL ACAD SCI USA, V87, P573, DOI 10.1073/pnas.87.2.573; GOTO Y, 1989, BIOCHEMISTRY-US, V28, P945, DOI 10.1021/bi00429a004; GOTO Y, 1979, J BIOCHEM-TOKYO, V86, P1433, DOI 10.1093/oxfordjournals.jbchem.a132661; HIROSE M, 1989, J BIOL CHEM, V264, P16867; HIROSE M, 1988, ANAL BIOCHEM, V168, P193, DOI 10.1016/0003-2697(88)90028-0; KOSEN PA, 1983, BIOCHEMISTRY-US, V22, P2433, DOI 10.1021/bi00279a020; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; KUWAJIMA K, 1989, J MOL BIOL, V206, P547, DOI 10.1016/0022-2836(89)90500-7; OE H, 1988, J BIOCHEM-TOKYO, V103, P1066, DOI 10.1093/oxfordjournals.jbchem.a122381; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; OOBATAKE M, 1979, J BIOCHEM-TOKYO, V86, P65; PACE CN, 1986, J MOL BIOL, V188, P477, DOI 10.1016/0022-2836(86)90169-5; PACE CN, 1988, J BIOL CHEM, V263, P11820; PTITSYN OB, 1990, FEBS LETT, V262, P20, DOI 10.1016/0014-5793(90)80143-7; SHORTLE D, 1989, ARCH BIOCHEM BIOPHYS, V272, P103, DOI 10.1016/0003-9861(89)90200-2; Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; WALZ FG, 1990, J BIOL CHEM, V265, P7127; WILLIAMS J, 1982, TRENDS BIOCHEM SCI, V7, P394, DOI 10.1016/0968-0004(82)90183-9; WILLIAMS J, 1982, EUR J BIOCHEM, V122, P297, DOI 10.1111/j.1432-1033.1982.tb05880.x	33	20	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1463	1468						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1988430				2022-12-25	WOS:A1991EU49700020
J	LEDERKREMER, GZ; LODISH, HF				LEDERKREMER, GZ; LODISH, HF			AN ALTERNATIVELY SPLICED MINIEXON ALTERS THE SUBCELLULAR FATE OF THE HUMAN ASIALOGLYCOPROTEIN RECEPTOR H2 SUBUNIT - ENDOPLASMIC-RETICULUM RETENTION AND DEGRADATION OR CELL-SURFACE EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Two types of cDNAs encoding the H2 subunit of the human asialoglycoprotein receptor had been cloned, differing only by the presence (H2a) or absence (H2b) of a segment of 15 base pairs (bp), encoding five amino acids (Glu-Gly-His-Arg-Gly) immediately carboxyl-terminal (exoplasmic) to the single membrane-spanning segment. We have cloned and sequenced this region of the H2 gene and showed that the two H2 forms are alternatively spliced variants differing in the presence of a 15-bp miniexon. Both H2 messenger RNAs were found in HepG2 cells, H2b accounting for about 92% of the H2 mRNAs. When expressed in NIH 3T3 cells without the H1 receptor subunit, the two-variant polypeptides exhibit different subcellular fates. H2a is completely retained in and degraded in the endoplasmic reticulum or a related pre-Golgi compartment. In contrast a substantial amount of H2b is processed by Golgi enzymes and reaches the cell surface. Thus, the sole difference determining the subcellular localization of the two forms if the five-amino acid insert in H2a. When a virion-packaged retroviral vector containing H2a cDNA infected 3T3 cells, 70% of the resulting clones expressed H2b and 30% H2a. Thus the 15-bp H2a miniexon can be spliced out, at least during the retrovirus life cycle.	WHITEHEAD INST BIOMED RES, 9 CAMBRIDGE CTR, CAMBRIDGE, MA 02142 USA; MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)				Lederkremer, Gerardo/0000-0002-9857-7152	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035012] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-35012] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMARA JF, 1989, J CELL BIOL, V109, P3315, DOI 10.1083/jcb.109.6.3315; ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; AUSUBEL FM, 1987, CURRENTS PROTOCOLS M, P471; BISCHOFF J, 1988, J CELL BIOL, V106, P1067, DOI 10.1083/jcb.106.4.1067; BISCHOFF J, 1987, J BIOL CHEM, V262, P11825; BONIFACINO JS, 1990, SCIENCE, V247, P79, DOI 10.1126/science.2294595; BREITFELD PP, 1985, INT REV CYTOL, V97, P47, DOI 10.1016/S0074-7696(08)62348-7; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; DEITCHER DL, 1986, J CELL BIOL, V102, P911, DOI 10.1083/jcb.102.3.911; GETHING MJ, 1986, CELL, V46, P939, DOI 10.1016/0092-8674(86)90076-0; HENIS YI, 1990, J CELL BIOL, V111, P1409, DOI 10.1083/jcb.111.4.1409; JACOB M, 1989, NUCLEIC ACIDS RES, V17, P2159, DOI 10.1093/nar/17.6.2159; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; LEUNG JO, 1985, J BIOL CHEM, V260, P2523; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; LODISH HF, 1988, J BIOL CHEM, V263, P2107; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MCPHAUL M, 1987, MOL CELL BIOL, V7, P1841, DOI 10.1128/MCB.7.5.1841; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; ROSE JK, 1988, ANNU REV CELL BIOL, V4, P257, DOI 10.1146/annurev.cellbio.4.1.257; RUSKIN B, 1984, CELL, V38, P317, DOI 10.1016/0092-8674(84)90553-1; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHMID SR, 1988, J BIOL CHEM, V263, P16886; SHIA MA, 1989, P NATL ACAD SCI USA, V86, P1158, DOI 10.1073/pnas.86.4.1158; SPIESS M, 1985, P NATL ACAD SCI USA, V82, P6465, DOI 10.1073/pnas.82.19.6465; SPIESS M, 1985, J BIOL CHEM, V260, P1979; SPIESS M, 1986, CELL, V44, P177, DOI 10.1016/0092-8674(86)90496-4; THOMPSON JA, 1987, BIOCHEMISTRY-US, V26, P743, DOI 10.1021/bi00377a014; VARMUS HE, 1982, SCIENCE, V216, P812, DOI 10.1126/science.6177038; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WEIL D, 1988, J BIOL CHEM, V263, P8561; WIERINGA B, 1984, CELL, V37, P915, DOI 10.1016/0092-8674(84)90426-4	32	51	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1237	1244						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985943				2022-12-25	WOS:A1991ET17700085
J	LEFKOWITH, JB; ROGERS, M; LENNARTZ, MR; BROWN, EJ				LEFKOWITH, JB; ROGERS, M; LENNARTZ, MR; BROWN, EJ			ESSENTIAL FATTY-ACID DEFICIENCY IMPAIRS MACROPHAGE SPREADING AND ADHERENCE - ROLE OF ARACHIDONATE IN CELL-ADHESION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN KINASE-C; CALCIUM-INDEPENDENT ACTIVATION; EICOSAPENTAENOIC ACID; EXPERIMENTAL GLOMERULONEPHRITIS; POTASSIUM CHANNELS; ENDOTHELIAL-CELLS; MICE; RESIDENT; INJURY; RABBIT	Dietary polyunsaturated fatty acid manipulation exerts a strikingly protective effect in models of tissue inflammation and injury. A critical element of this effect appears to revolve around leukocyte trafficking but underlying mechanisms are ill understood. In the current study it was observed that essential fatty acid (EFA) deficiency markedly impaired the capacity of resident macrophages to spread and adhere. This effect was not a simple function of the alteration of membrane fatty acid composition. Elicited EFA-deficient macrophages were equally adherent to elicited control cells, despite the fact that they were equally EFA-deficient relative to resident EFA-deficient cells. With respect to the mechanism underlying defective macrophage adherence in EFA deficiency, no change in the expression of cell surface adherence molecules (Fc receptor, Mac-1, or LFA-1) was noted with the deficiency state. Also, an adherence defect could not be induced in normal cells pharmacologically with cyclooxygenase blockade, lipoxygenase blockade, or a platelet-activating factor receptor antagonist. In contrast, phospholipase inhibition was able to induce a spreading and adherence defect in resident macrophages similar to that seen with EFA deficiency. Using several phospholipase inhibitors, a correlation between phospholipase inhibition and impairment of adherence was observed. Adding back exogenous fatty acids to cells after phospholipase inhibition demonstrated that normal adherence was reconstituted with arachidonate. This alteration in macrophage spreading and adherence with EFA deficiency may be an important component of the anti-inflammatory effect of dietary polyunsaturated fatty acid manipulation. Additionally, these results suggest that arachidonate may be an intracellular mediator of leukocyte adherence.	WASHINGTON UNIV,SCH MED,DEPT PHARMACOL,ST LOUIS,MO 63110	Washington University (WUSTL)	LEFKOWITH, JB (corresponding author), WASHINGTON UNIV,SCH MED,DEPT MED,DIV RHEUMATOL,BOX 8045,660 S EUCLID AVE,ST LOUIS,MO 63110, USA.				NIAID NIH HHS [AI-27547] Funding Source: Medline; NIDDK NIH HHS [DK-37879] Funding Source: Medline; NIGMS NIH HHS [GM-38330] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038330] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; CONFORTI G, 1990, J BIOL CHEM, V265, P4011; CREUTZ CE, 1981, J CELL BIOL, V91, P247, DOI 10.1083/jcb.91.1.247; DIAMOND JR, 1989, AM J PHYSIOL, V257, pF798, DOI 10.1152/ajprenal.1989.257.5.F798; DISE CA, 1982, J BIOL CHEM, V257, P4701; EVANS JF, 1985, J BIOL CHEM, V260, P966; FREED MS, 1989, PROSTAGLANDINS, V38, P33, DOI 10.1016/0090-6980(89)90014-2; GIMBRONE MA, 1984, J CLIN INVEST, V74, P1552, DOI 10.1172/JCI111570; HARRIS KPG, 1990, J CLIN INVEST, V86, P1115, DOI 10.1172/JCI114816; HOLDSWORTH SR, 1981, J CLIN INVEST, V68, P686, DOI 10.1172/JCI110304; HOOVER RL, 1984, P NATL ACAD SCI-BIOL, V81, P2191, DOI 10.1073/pnas.81.7.2191; HURD ER, 1981, J CLIN INVEST, V67, P476, DOI 10.1172/JCI110056; IRVINE RF, 1982, BIOCHEM J, V204, P3, DOI 10.1042/bj2040003; KELLEY VE, 1985, J IMMUNOL, V134, P1914; KIM D, 1989, SCIENCE, V244, P1174, DOI 10.1126/science.2727703; KLUCIS E, 1987, BIOCHEM BIOPH RES CO, V147, P1041, DOI 10.1016/S0006-291X(87)80175-4; LACY PE, 1986, CLIN CHEM, V32, pB76; LEE TH, 1984, J BIOL CHEM, V259, P2383; LEFKOWITH J, 1990, J EXP MED, V171, P729, DOI 10.1084/jem.171.3.729; LEFKOWITH JB, 1985, J BIOL CHEM, V260, P5736; LEFKOWITH JB, 1987, J BIOL CHEM, V262, P6668; LEFKOWITH JB, 1988, J IMMUNOL, V140, P228; LEFKOWITH JB, 1987, J CLIN INVEST, V80, P947, DOI 10.1172/JCI113187; LEFKOWITH JB, 1990, J IMMUNOL, V145, P1523; LENNARTZ MR, 1990, J CELL BIOL, V109, P211; LESLIE CA, 1985, J EXP MED, V162, P1336, DOI 10.1084/jem.162.4.1336; LISTER MD, 1989, J BIOL CHEM, V264, P8520; LOMBARDO D, 1985, J BIOL CHEM, V260, P7234; MAHONEY EM, 1980, J BIOL CHEM, V255, P4910; MEERS P, 1988, BIOCHEMISTRY-US, V27, P6784, DOI 10.1021/bi00418a021; MORGANROTH ML, 1989, AM J PHYSIOL, V257, pH1192, DOI 10.1152/ajpheart.1989.257.4.H1192; MURAKAMI K, 1985, FEBS LETT, V192, P189, DOI 10.1016/0014-5793(85)80105-8; NAOR Z, 1988, MOL ENDOCRINOL, V2, P1043, DOI 10.1210/mend-2-11-1043; ORDWAY RW, 1989, SCIENCE, V244, P1176, DOI 10.1126/science.2471269; PRICKETT JD, 1981, J CLIN INVEST, V68, P556, DOI 10.1172/JCI110288; RAMESHA CS, 1986, J BIOL CHEM, V261, P7592; ROBERTS MF, 1977, J BIOL CHEM, V252, P2405; ROSEN H, 1987, J EXP MED, V166, P1685, DOI 10.1084/jem.166.6.1685; ROVIN BH, 1990, J IMMUNOL, V145, P1238; SCHREINER GF, 1978, J EXP MED, V147, P369, DOI 10.1084/jem.147.2.369; SCHREINER GF, 1989, J IMMUNOL, V143, P3192; SEKIGUCHI K, 1987, BIOCHEM BIOPH RES CO, V145, P797, DOI 10.1016/0006-291X(87)91035-7; SPAETHE SM, 1988, J PHARMACOL EXP THER, V245, P1088; SPERLING RI, 1987, J IMMUNOL, V139, P4186; THOMPSON JA, 1987, BIOCHEMISTRY-US, V26, P743, DOI 10.1021/bi00377a014; TONNESEN MG, 1989, J CLIN INVEST, V83, P637, DOI 10.1172/JCI113928; TRIPP CS, 1986, P NATL ACAD SCI USA, V83, P9655, DOI 10.1073/pnas.83.24.9655; VALONE FH, 1908, AM J PATHOL, V113, P85; WIGHTMAN PD, 1981, BIOCHEM J, V195, P427, DOI 10.1042/bj1950427; WRIGHT JR, 1988, P NATL ACAD SCI USA, V85, P6137, DOI 10.1073/pnas.85.16.6137; ZIMMERMAN GA, 1988, J CLIN INVEST, V81, P531, DOI 10.1172/JCI113351	51	41	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1071	1076						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985935				2022-12-25	WOS:A1991ET17700063
J	DAHLMANWRIGHT, K; SILTALAROOS, H; CARLSTEDTDUKE, J; GUSTAFSSON, JA				DAHLMANWRIGHT, K; SILTALAROOS, H; CARLSTEDTDUKE, J; GUSTAFSSON, JA			PROTEIN-PROTEIN INTERACTIONS FACILITATE DNA-BINDING BY THE GLUCOCORTICOID RECEPTOR DNA-BINDING DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									KAROLINSKA INST,HUDDINGE UNIV HOSP,CTR BIOTECHNOL,S-14186 HUDDINGE,SWEDEN	Karolinska Institutet	DAHLMANWRIGHT, K (corresponding author), KAROLINSKA INST,HUDDINGE UNIV HOSP,DEPT MED NUTR,F60,S-14186 HUDDINGE,SWEDEN.							BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; CARLSTEDTDUKE J, 1989, STEROID THYROID HORM, P93; DAHLMAN K, 1989, J BIOL CHEM, V264, P804; DANG CV, 1989, NATURE, V337, P664, DOI 10.1038/337664a0; ERIKSSON P, 1990, J BIOL CHEM, V265, P3535; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FRANKEL AD, 1988, SCIENCE, V240, P70, DOI 10.1126/science.2832944; FREEDMAN LP, 1988, NATURE, V334, P543, DOI 10.1038/334543a0; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GREEN S, 1987, NATURE, V325, P75, DOI 10.1038/325075a0; GREEN S, 1988, TRENDS GENET, V4, P309, DOI 10.1016/0168-9525(88)90108-4; HARD T, 1990, BIOCHEMISTRY-US, V29, P5358; JANTZEN HM, 1987, CELL, V49, P29, DOI 10.1016/0092-8674(87)90752-5; KLOCK G, 1987, NATURE, V329, P734, DOI 10.1038/329734a0; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; SASSONECORSI P, 1988, NATURE, V336, P692, DOI 10.1038/336692a0; TSAI SY, 1988, CELL, V55, P361, DOI 10.1016/0092-8674(88)90059-1; WRANGE O, 1989, J BIOL CHEM, V264, P5253; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209	22	113	113	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1990	265	23					14030	14035						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DU275	1974254				2022-12-25	WOS:A1990DU27500095
J	HAYCOCK, JW				HAYCOCK, JW			PHOSPHORYLATION OF TYROSINE-HYDROXYLASE INSITU AT SERINE-8, SERINE-19, SERINE-31, AND SERINE-40	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											HAYCOCK, JW (corresponding author), LOUISIANA STATE UNIV,MED CTR,DEPT BIOCHEM & MOLEC BIOL,NEW ORLEANS,LA 70112, USA.				NINDS NIH HHS [NS25134] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025134, R29NS025134] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBERT KA, 1984, P NATL ACAD SCI-BIOL, V81, P7713, DOI 10.1073/pnas.81.24.7713; ASE K, 1988, FEBS LETT, V236, P396, DOI 10.1016/0014-5793(88)80064-4; ATKINSON J, 1987, J NEUROCHEM, V49, P1241, DOI 10.1111/j.1471-4159.1987.tb10016.x; Braun R K, 1989, Proc West Pharmacol Soc, V32, P15; BROWNE CA, 1982, ANAL BIOCHEM, V124, P201, DOI 10.1016/0003-2697(82)90238-X; CAHILL AL, 1989, NEUROSCIENCE, V30, P811, DOI 10.1016/0306-4522(89)90172-3; CAHILL AL, 1987, BIOCHIM BIOPHYS ACTA, V930, P454, DOI 10.1016/0167-4889(87)90019-X; CAMPBELL DG, 1986, J BIOL CHEM, V261, P489; COOPER DR, 1989, BIOCHEM BIOPH RES CO, V161, P327, DOI 10.1016/0006-291X(89)91600-8; CREMINS J, 1986, J CELL BIOL, V103, P887, DOI 10.1083/jcb.103.3.887; D'MELLO SR, 1988, J NEUROSCI RES, V19, P440, DOI 10.1002/jnr.490190408; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; EIPPER BA, 1982, J BIOL CHEM, V257, P4907; FAUQUET M, 1988, J NEUROCHEM, V50, P142, DOI 10.1111/j.1471-4159.1988.tb13241.x; GEORGE RJ, 1989, J NEUROCHEM, V52, P274, DOI 10.1111/j.1471-4159.1989.tb10928.x; GREENE LA, 1984, J NEUROCHEM, V42, P1728, DOI 10.1111/j.1471-4159.1984.tb12764.x; GREENE LA, 1987, METHOD ENZYMOL, V147, P207; Greene LA., 1982, ADV CELL NEUROBIOL, V3, P373, DOI [10.1016/B978-0-12-008303-9.50016-5, DOI 10.1016/B978-0-12-008303-9.50016-5]; GRIFFITH LC, 1988, J BIOL CHEM, V263, P9542; GRIMA B, 1987, NATURE, V326, P707, DOI 10.1038/326707a0; HAAVIK J, 1989, FEBS LETT, V251, P36, DOI 10.1016/0014-5793(89)81424-3; HALEGOUA S, 1980, CELL, V22, P571, DOI 10.1016/0092-8674(80)90367-0; HAYCOCK D A, 1988, Society for Neuroscience Abstracts, V14, P1093; HAYCOCK J W, 1989, Society for Neuroscience Abstracts, V15, P1312; HAYCOCK JW, 1989, ANAL BIOCHEM, V181, P259, DOI 10.1016/0003-2697(89)90240-6; HAYCOCK JW, 1987, BRAIN RES BULL, V19, P619, DOI 10.1016/0361-9230(87)90046-3; HAYCOCK JW, 1982, J BIOL CHEM, V257, P1369; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; HOUSE C, 1987, J BIOL CHEM, V262, P772; HUANG FL, 1989, J BIOL CHEM, V264, P4238; INGEBRITSEN TS, 1983, EUR J BIOCHEM, V132, P297, DOI 10.1111/j.1432-1033.1983.tb07362.x; JOH TH, 1978, P NATL ACAD SCI USA, V75, P4744, DOI 10.1073/pnas.75.10.4744; KAUFMAN S, 1985, FOLATES PTERINS, V2, P251; KISHIMOTO A, 1985, J BIOL CHEM, V260, P2492; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE KY, 1985, MOL PHARMACOL, V28, P220; MALHOTRA R K, 1989, Society for Neuroscience Abstracts, V15, P1228; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MCTIGUE M, 1985, J BIOL CHEM, V260, P9047; ROSKOSKI R, 1987, J NEUROCHEM, V48, P840, DOI 10.1111/j.1471-4159.1987.tb05593.x; ROWLAND EA, 1987, J BIOL CHEM, V262, P7504; SAADAT S, 1988, J NEUROCHEM, V51, P572, DOI 10.1111/j.1471-4159.1988.tb01077.x; SEELEY PJ, 1984, J CELL BIOL, V98, P417, DOI 10.1083/jcb.98.2.417; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; TACHIKAWA E, 1987, J NEUROCHEM, V48, P1366, DOI 10.1111/j.1471-4159.1987.tb05673.x; TACHIKAWA E, 1986, MOL PHARMACOL, V30, P476; TARR GE, 1987, PROTEIN PEPTIDE SEQU, P35; VULLIET PR, 1984, J BIOL CHEM, V259, P3680; VULLIET PR, 1980, P NATL ACAD SCI-BIOL, V77, P92, DOI 10.1073/pnas.77.1.92; VULLIET PR, 1985, FEBS LETT, V182, P335, DOI 10.1016/0014-5793(85)80328-8; VULLIET PR, 1989, J BIOL CHEM, V264, P16292; WANG YH, 1988, ANAL BIOCHEM, V174, P537, DOI 10.1016/0003-2697(88)90053-X; WAYMIRE JC, 1988, J BIOL CHEM, V263, P12439; YAMAUCHI T, 1978, BIOCHEM BIOPH RES CO, V82, P514, DOI 10.1016/0006-291X(78)90904-X; YAMAUCHI T, 1981, BIOCHEM BIOPH RES CO, V100, P807, DOI 10.1016/S0006-291X(81)80246-X; YANAGIHARA N, 1984, MOL PHARMACOL, V26, P141; ZIGMOND RE, 1989, ANNU REV NEUROSCI, V12, P415, DOI 10.1146/annurev.ne.12.030189.002215	57	212	213	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 15	1990	265	20					11682	11691						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN233	1973163				2022-12-25	WOS:A1990DN23300042
J	JAHN, D; KIM, YC; ISHINO, Y; CHEN, MW; SOLL, D				JAHN, D; KIM, YC; ISHINO, Y; CHEN, MW; SOLL, D			PURIFICATION AND FUNCTIONAL-CHARACTERIZATION OF THE GLU-TRANSFER RNAGLN AMIDOTRANSFERASE FROM CHLAMYDOMONAS-REINHARDTII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									YALE UNIV,DEPT MOLEC BIOPHYS & BIOCHEM,POB 6666,NEW HAVEN,CT 06511	Yale University				Jahn, Dieter/0000-0002-4064-9205; Ishino, Yoshizumi/0000-0001-9419-0826				BUCHANAN JM, 1973, ADV ENZYMOL RAMB, V39, P91; CHEN MW, 1990, J BIOL CHEM, V265, P4054; CHEN MW, 1990, J BIOL CHEM, V265, P4058; DEUTSCHER MP, 1967, J BIOL CHEM, V242, P1123; GUPTA R, 1984, J BIOL CHEM, V259, P9461; HARTMAN SC, 1963, J BIOL CHEM, V238, P3030; KASEMAN DS, 1985, METHOD ENZYMOL, V113, P305; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPOINTE J, 1986, J BACTERIOL, V165, P88, DOI 10.1128/jb.165.1.88-93.1986; LAZZARINI RA, 1964, BIOCHEMISTRY-US, V3, P1445, DOI 10.1021/bi00898a009; LIPMANN F, 1945, J BIOL CHEM, V159, P21; MARTIN NC, 1978, BIOCHEMISTRY-US, V17, P1628, DOI 10.1021/bi00602a008; MEI B, 1989, J BIOL CHEM, V264, P16613; MEISTER A, 1985, METHOD ENZYMOL, V113, P327; MESSENGER LJ, 1979, J BIOL CHEM, V254, P3382; Neher R., 1963, J CHROMATOGR, V12, P329; PATEL N, 1977, ARCH BIOCHEM BIOPHYS, V178, P652, DOI 10.1016/0003-9861(77)90237-5; PERONA J, 1989, SCIENCE, V246, P1135; PETERSON D, 1988, PLANT MOL BIOL, V11, P293, DOI 10.1007/BF00027386; Prusiner S, 1973, ENZYMES GLUTAMINE ME; RAVEL JM, 1965, J BIOL CHEM, V240, P432; ROE B, 1973, BIOCHIM BIOPHYS ACTA, V319, P25, DOI 10.1016/0005-2787(73)90037-3; ROULD MA, 1989, SCIENCE, V246, P1152; SCHIMMEL PR, 1979, ANNU REV BIOCHEM, V48, P601, DOI 10.1146/annurev.bi.48.070179.003125; SCHON A, 1988, BIOCHIMIE, V70, P391, DOI 10.1016/0300-9084(88)90212-X; SCHON A, 1988, NATURE, V331, P187, DOI 10.1038/331187a0; SRIVASTAVA DK, 1986, SCIENCE, V234, P1081, DOI 10.1126/science.3775377; STRAUCH MA, 1988, J BACTERIOL, V170, P916, DOI 10.1128/jb.170.2.916-920.1988; TSO JY, 1982, J BIOL CHEM, V257, P3532; WALDSCHMIDT R, 1988, J BIOL CHEM, V263, P13350; WENG M, 1987, J BACTERIOL, V169, P3023, DOI 10.1128/jb.169.7.3023-3028.1987; WHITE BN, 1971, CAN J BIOCHEM, V50, P601; WILCOX M, 1969, EUR J BIOCHEM, V11, P405, DOI 10.1111/j.1432-1033.1969.tb00788.x; WILCOX M, 1968, P NATL ACAD SCI USA, V61, P229, DOI 10.1073/pnas.61.1.229; ZALKIN H, 1977, J BIOL CHEM, V252, P5431; ZALKIN H, 1985, METHOD ENZYMOL, V113, P263	36	44	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 15	1990	265	14					8059	8064						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DC835	1970821				2022-12-25	WOS:A1990DC83500056
J	GETTINS, P; CREWS, BC				GETTINS, P; CREWS, BC			SE-77 NMR CHARACTERIZATION OF SE-77-LABELED OVINE ERYTHROCYTE GLUTATHIONE-PEROXIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PLASMA; PURIFICATION; LIVER; HYDROPEROXIDE; DISTINCT; FORMS	Lambs, maintained on a selenium-deficient diet supplemented with 94 atom % Na2(27)SeO3, have been used as a source of Se-77-enriched erythrocyte glutathione peroxidase. After 5 months on this diet, the percentage of selenium in the enzyme derived from the supplement had reached 88%. From each monthly bleeding of two sheep, approximately 20 mg of Se-77-enriched glutathione peroxidase could be isolated in pure form. Although attempts to observe Se-77 NMR signals from the native enzyme labeled with 6,6'-[Se-77]diselenobis-(3-nitrobenzoic acid) failed, due to the low solubility of the enzyme, two Se-77 resonances were observed after unfolding the enzyme with 8 M urea and reaction with iodoacetamide. These resonances, at 195 and 377 ppm, were from the selenoether alkylamide derivative and from protein cross-linked selenide sulfide species, respectively. Relaxation time measurements on the selenoether at 4.7 and 9.4 teslas enabled an estimate of the chemical shift anisotropy to be made. A value of less-than-or-equal-to 262 ppm was determined. Reduction of the denatured selenide sulfide species with dithiothreitol gave an observable Se-77 resonance from the Se- moiety at pH 8 and from SeH at pH 4.2. The chemical form of the selenocysteine residue in the resting state enzyme most consistent with formation of the acetamide derivative and the selenide sulfide is Se- or SeH. From the magnitudes of the estimated chemical shift anisotropies, it is predicted that direct observation of selenium in the native enzyme will be feasible if the enzyme concentration can be increased to 0.25 mM tetrameric glutathione peroxidase.	VANDERBILT UNIV,MED CTR,SCH MED,CTR MOLEC TOXICOL,NASHVILLE,TN 37232	Vanderbilt University	GETTINS, P (corresponding author), VANDERBILT UNIV,MED CTR,SCH MED,DEPT BIOCHEM,NASHVILLE,TN 37232, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039509] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM39509] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akerboom T P, 1981, Methods Enzymol, V77, P373; AWASTHI YC, 1975, J BIOL CHEM, V250, P5144; BELL JG, 1984, BIOCHIM BIOPHYS ACTA, V795, P91, DOI 10.1016/0005-2760(84)90108-5; CHAUDIERE J, 1983, ARCH BIOCHEM BIOPHYS, V226, P448, DOI 10.1016/0003-9861(83)90314-4; CHRISTOP.BO, 1969, BIOCHIM BIOPHYS ACTA, V176, P463, DOI 10.1016/0005-2760(69)90213-6; DICKSON RC, 1969, ARCH BIOCHEM BIOPHYS, V130, P547, DOI 10.1016/0003-9861(69)90068-X; DOWD D, 1988, MAGN RESON CHEM, V26, P1, DOI 10.1002/mrc.1260260102; EPP O, 1983, EUR J BIOCHEM, V133, P51, DOI 10.1111/j.1432-1033.1983.tb07429.x; FLOHE L, 1971, KLIN WOCHENSCHR, V49, P669, DOI 10.1007/BF01487101; FLOHE L, 1971, H-S Z PHYSIOL CHEM, V352, P159, DOI 10.1515/bchm2.1971.352.1.159; FLOHE L, 1979, CIBA F S, V65, P95; FORSTROM JW, 1979, J BIOL CHEM, V254, P2888; FORSTROM JW, 1979, ARCH BIOCHEM BIOPHYS, V193, P51, DOI 10.1016/0003-9861(79)90007-9; FORWARD R, 1985, J CHROMATOGR, V330, P383, DOI 10.1016/S0021-9673(01)81999-3; GANTHER HE, 1984, METHOD ENZYMOL, V107, P593; GETTINS P, 1991, J BIOL CHEM, V266, P3422; KIMURA K, 1983, J MAGN RESON, V52, P13, DOI 10.1016/0022-2364(83)90252-4; KRAUS RJ, 1980, BIOCHIM BIOPHYS ACTA, V615, P19, DOI 10.1016/0005-2744(80)90004-2; KUWAJIMA K, 1990, BIOCHEMISTRY-US, V29, P8240, DOI 10.1021/bi00488a007; LUTHRA NP, 1981, ANAL BIOCHEM, V117, P94, DOI 10.1016/0003-2697(81)90697-7; LUTHRA NP, 1982, J BIOL CHEM, V257, P1142; MADDIPATI KR, 1987, J BIOL CHEM, V262, P17398; NAKAMURA W, 1974, BIOCHIM BIOPHYS ACTA, V358, P251, DOI 10.1016/0005-2744(74)90455-0; ODOM JD, 1979, J AM CHEM SOC, V101, P5815, DOI 10.1021/ja00513a058; READ R, 1990, J BIOL CHEM, V265, P17899; TAKAHASHI K, 1987, ARCH BIOCHEM BIOPHYS, V256, P677, DOI 10.1016/0003-9861(87)90624-2; TOSSELL JA, 1988, J MAGN RESON, V80, P39, DOI 10.1016/0022-2364(88)90055-8; URSINI F, 1985, BIOCHIM BIOPHYS ACTA, V839, P62, DOI 10.1016/0304-4165(85)90182-5; YANG JG, 1987, J BIOL CHEM, V262, P13372	29	34	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4804	4809						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002027				2022-12-25	WOS:A1991FC21700023
J	LINCKE, CR; SMIT, JJM; VANDERVELDEKOERTS, T; BORST, P				LINCKE, CR; SMIT, JJM; VANDERVELDEKOERTS, T; BORST, P			STRUCTURE OF THE HUMAN MDR3 GENE AND PHYSICAL MAPPING OF THE HUMAN MDR LOCUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-GLYCOPROTEIN GENE; MULTIDRUG-RESISTANCE GENE; BACTERIAL TRANSPORT PROTEINS; GEL-ELECTROPHORESIS; COMPLEMENTARY-DNA; SPLICE JUNCTIONS; DRUG-RESISTANCE; MOUSE CELLS; SEQUENCE; EXPRESSION	Two genes, MDR1 and MDR3, constitute the human P-glycoprotein gene family. To examine the evolutionary relationship between the three known classes of mammalian P-glycoprotein genes, we have cloned the MDR3 gene and compared its structure with that of the human MDR1 and the mouse mdr1 (mdr1b) genes analyzed by other groups. The MDR3 gene contains 28 exons and 27 of these contain coding sequences for the two homologous halves of the protein that correlate with functional domains. This structure is virtually identical to that of the human MDR1 gene and the mouse mdr1 (mdr1b) gene, indicating that the exon/intron structure was fixed before the duplication events that generated different classes of P-glycoproteins, but after the P-glycoproteins diverged from related genes, like the cystic fibrosis transmembrane conductance regulator (CFTR) gene, which has an entirely different exon/intron structure. The four alternatively spliced transcripts of the MDR3 gene arise from alternative splicing of exons 23 and 26. Our analysis of DNA clones covering about 120 kilobases (kb) of the human MDR locus, including the entire MDR3 gene (74 kb) and the intergenic region between both genes (34 kb), combined with pulsed-field gel electrophoresis data shows that the human MDR locus covers about 230 kb. In contrast to the mouse mdr genes, both human genes are transcribed in the same direction (MDR3 located downstream of MDR1). The CpG-rich sequences marking the 5' ends of both genes are hypomethylated to different extents in different cell lines. Hypomethylation roughly correlates with transcriptional activity.	NETHERLANDS CANC INST, DIV MOLEC BIOL, PLESMANLAAN 121, 1066 CX AMSTERDAM, NETHERLANDS; UNIV AMSTERDAM, BIOCHEM LAB, AMSTERDAM, NETHERLANDS	Netherlands Cancer Institute; University of Amsterdam								ALITALO K, 1983, P NATL ACAD SCI-BIOL, V80, P1707, DOI 10.1073/pnas.80.6.1707; BAAS F, 1988, FEBS LETT, V229, P329, DOI 10.1016/0014-5793(88)81150-5; BAAS F, 1990, CANCER RES, V50, P5392; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BROWN WRA, 1986, NATURE, V322, P477, DOI 10.1038/322477a0; CALLEN DF, 1987, HUM GENET, V77, P142, DOI 10.1007/BF00272381; CHEN CJ, 1990, J BIOL CHEM, V265, P506; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; CHIN JE, 1989, MOL CELL BIOL, V9, P3808, DOI 10.1128/MCB.9.9.3808; CHOI K, 1988, CELL, V53, P519, DOI 10.1016/0092-8674(88)90568-5; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; CRAIK CS, 1984, J BIOL CHEM, V259, P4255; CRAIK CS, 1983, SCIENCE, V220, P1125, DOI 10.1126/science.6344214; CROOP JM, 1989, MOL CELL BIOL, V9, P1346, DOI 10.1128/MCB.9.3.1346; CROOP JM, 1988, J CLIN INVEST, V81, P1303, DOI 10.1172/JCI113455; DEVAULT A, 1990, MOL CELL BIOL, V10, P1652, DOI 10.1128/MCB.10.4.1652; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; ENDICOTT JA, 1989, ANNU REV BIOCHEM, V58, P137, DOI 10.1146/annurev.bi.58.070189.001033; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FOOTE SJ, 1989, CELL, V57, P921, DOI 10.1016/0092-8674(89)90330-9; GOTTESMAN MM, 1988, J BIOL CHEM, V263, P12163; GROS P, 1986, CELL, V47, P371, DOI 10.1016/0092-8674(86)90594-5; GROS P, 1986, NATURE, V323, P728, DOI 10.1038/323728a0; GROS P, 1988, MOL CELL BIOL, V8, P2770, DOI 10.1128/MCB.8.7.2770; HERWEIJER H, 1990, JNCI-J NATL CANCER I, V82, P1133, DOI 10.1093/jnci/82.13.1133; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; HSU SIH, 1989, J BIOL CHEM, V264, P12053; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; KOHARA Y, 1987, CELL, V50, P495, DOI 10.1016/0092-8674(87)90503-4; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; LINCKE CR, 1990, CANCER RES, V50, P1779; LOCKSHIN A, 1985, CANCER RES, V45, P345; Maniatis T., 1982, MOL CLONING; MARTINSSON T, 1987, CYTOGENET CELL GENET, V45, P99, DOI 10.1159/000132437; MCGRATH JP, 1989, NATURE, V340, P400, DOI 10.1038/340400a0; MEESE E, 1989, GENOMICS, V5, P371, DOI 10.1016/0888-7543(89)90073-6; NG WF, 1989, MOL CELL BIOL, V9, P1224, DOI 10.1128/MCB.9.3.1224; NYCE J, 1989, CANCER RES, V49, P5829; OUELLETTE M, 1990, EMBO J, V9, P1027, DOI 10.1002/j.1460-2075.1990.tb08206.x; RAYMOND M, 1990, MOL CELL BIOL, V10, P1642, DOI 10.1128/MCB.10.4.1642; RAYMOND M, 1989, P NATL ACAD SCI USA, V86, P6488, DOI 10.1073/pnas.86.17.6488; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROGAN AM, 1984, SCIENCE, V224, P994, DOI 10.1126/science.6372095; RONINSON IB, 1986, P NATL ACAD SCI USA, V83, P4538, DOI 10.1073/pnas.83.12.4538; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHARP PA, 1981, CELL, V23, P643, DOI 10.1016/0092-8674(81)90425-6; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; UEDA K, 1987, J BIOL CHEM, V262, P17432; VANDERBLIEK AM, 1987, EMBO J, V6, P3325, DOI 10.1002/j.1460-2075.1987.tb02653.x; VANDERBLIEK AM, 1988, GENE, V71, P401, DOI 10.1016/0378-1119(88)90057-1; VANDERBLIEK AM, 1989, ADV CANCER RES, V52, P165; VANDERBLIEK AM, 1988, CANCER RES, V48, P5927; VANDERBLIEK AM, 1986, MOL CELL BIOL, V6, P1671, DOI 10.1128/MCB.6.5.1671	58	112	118	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					5303	5310						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002063				2022-12-25	WOS:A1991FC21700091
J	ROY, S; PABORSKY, LR; VEHAR, GA				ROY, S; PABORSKY, LR; VEHAR, GA			SELF-ASSOCIATION OF TISSUE FACTOR AS REVEALED BY CHEMICAL CROSS-LINKING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							HUMAN FACTOR-VII; HUMAN FACTOR-V; BLOOD-COAGULATION; CELL-LINE; MEMBRANE-IMPERMEANT; EXTRINSIC PATHWAY; BINDING; CDNA; INITIATION; MONOCYTES	The possible self-association of tissue factor molecules was investigated by treating cells expressing tissue factor with bifunctional cross-linking agents. The two reagents chosen were 3,3'-dithiobis(sulfosuccinimidylpropionate) and sulfosuccinimidyl 2-(p-azidosalicylamido)ethyl-1,3'-dithiopropionate, both of which are membrane-impermeable and thiol-cleavable. A human bladder carcinoma cell line, J82, and a transfected human kidney cell line expressing high amounts of recombinant tissue factor were used in these studies. Exposure of the intact cells to the cross-linking reagents was found to result in the formation of multimeric tissue factor-containing complexes, the extent of which appeared to be dependent upon the amount of tissue factor expressed by the cell. The self-association of tissue factor was prevented in a variant tissue factor molecule harboring a non-homologous transmembrane domain.	GENENTECH INC, DEPT CARDIOVASC RES, 460 POINT SAN BRUNO BLVD, SAN FRANCISCO, CA 94080 USA	Roche Holding; Genentech			Roy, Soumitra/B-9113-2008					BACH R, 1986, BIOCHEMISTRY-US, V25, P4007, DOI 10.1021/bi00362a005; BACH R, 1988, BIOCHEMISTRY-US, V27, P4227, DOI 10.1021/bi00412a004; BACH RR, 1988, CRC CR REV BIOCH MOL, V23, P339, DOI 10.3109/10409238809082548; BLOEM LJ, 1989, J CELL PHYSIOL, V139, P418, DOI 10.1002/jcp.1041390226; BROZE GJ, 1982, J CLIN INVEST, V70, P526, DOI 10.1172/JCI110644; CLEVELAND DW, 1983, METHOD ENZYMOL, V96, P223; DAS M, 1979, ANNU REV BIOPHYS BIO, V8, P165, DOI 10.1146/annurev.bb.08.060179.001121; DRAKE TA, 1989, J CELL BIOL, V109, P389, DOI 10.1083/jcb.109.1.389; FAIR DS, 1987, J BIOL CHEM, V262, P11692; HARTZELL S, 1989, MOL CELL BIOL, V9, P2567, DOI 10.1128/MCB.9.6.2567; JENNY RJ, 1987, P NATL ACAD SCI USA, V84, P4846, DOI 10.1073/pnas.84.14.4846; KANE WH, 1986, P NATL ACAD SCI USA, V83, P6800, DOI 10.1073/pnas.83.18.6800; LEE WT, 1985, J IMMUNOL, V134, P518; MASON AJ, 1989, MOL ENDOCRINOL, V3, P1352, DOI 10.1210/mend-3-9-1352; MUESING MA, 1985, NATURE, V313, P450, DOI 10.1038/313450a0; OBRIEN DP, 1988, J CLIN INVEST, V82, P206, DOI 10.1172/JCI113571; OSTERUD B, 1977, P NATL ACAD SCI USA, V74, P5260, DOI 10.1073/pnas.74.12.5260; PABORSKY LR, 1990, PROTEIN ENG, V3, P547, DOI 10.1093/protein/3.6.547; PABORSKY LR, 1989, BIOCHEMISTRY-US, V28, P8072, DOI 10.1021/bi00446a016; PLOPLIS VA, 1987, J BIOL CHEM, V262, P9503; RODGERS GM, 1984, BLOOD, V63, P434; SAKAI T, 1989, J BIOL CHEM, V264, P9980; SHEPHARD EG, 1988, ANAL BIOCHEM, V168, P306, DOI 10.1016/0003-2697(88)90323-5; STAROS JV, 1982, BIOCHEMISTRY-US, V21, P3950, DOI 10.1021/bi00260a008; STAROS JV, 1989, METHOD ENZYMOL, V172, P609; STERNBERG MJE, 1989, NATURE, V339, P587, DOI 10.1038/339587a0; TOOLE JJ, 1984, NATURE, V312, P342, DOI 10.1038/312342a0; VEHAR GA, 1984, NATURE, V312, P337, DOI 10.1038/312337a0	28	43	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4665	4668						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002014				2022-12-25	WOS:A1991FC21700002
J	RUNDLE, SJ; ZIELINSKI, RE				RUNDLE, SJ; ZIELINSKI, RE			ORGANIZATION AND EXPRESSION OF 2 TANDEMLY ORIENTED GENES ENCODING RIBULOSEBISPHOSPHATE CARBOXYLASE OXYGENASE ACTIVASE IN BARLEY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION INITIATION SITE; HORDEUM-VULGARE-L; RUBISCO ACTIVASE; ARABIDOPSIS-THALIANA; MESSENGER-RNA; BINDING PROTEIN; SEQUENCES; CHLOROPHYLL; CALMODULIN; PROMOTERS	We have isolated and structurally characterized genomic DNA and cDNA sequences encoding ribulose-1,5-bisphosphate carboxylase/oxygenase (Rbu-P2 carboxylase) activase from barley (Hordeum vulgare L.). Three Rbu-P2 carboxylase activase (Rca) polypeptides are encoded in the barley genome by two closely linked, tandemly oriented nuclear genes (RcaA and RcaB); cDNAs encoding each of the three Rbu-P2 carboxylase activase polypeptides were isolated from cDNA libraries of barley leaf mRNA. RcaA produces two mRNAs, which encode polypeptides of 42 and 46 kDa, by an alternative splicing mechanism identical to that previously reported for spinach and Arabidopsis Rca genes (Werneke, J. M., Chatfield, J. M., and Ogren, W. L. (1989) Plant Cell 1, 815-825). RcaB is transcribed to produce a single mRNA, which encodes a mature peptide of 42 kDa. Genomic Southern blots indicate that RcaA and RcaB represent the entire Rbu-P2 carboxylase activase gene family in barley. The genes share 80% nucleotide sequence identity, and the 42-kDa polypeptides encoded by RcaA and RcaB share 87% amino acid sequence identity. Coding regions of the two barley Rca genes are separated by 1 kilobase pair of flanking DNA. DNA sequence motifs similar to those thought to control light-regulated gene expression in other nuclear-encoded plastid polypeptide genes are found at the 5' end of both barley Rca genes. Probes specific to three mRNAs were used to determine the relative contribution each species makes to the total Rca mRNA pool.	UNIV ILLINOIS,DEPT PLANT BIOL,289 MORRILL HALL,505 S GOODWIN AVE,URBANA,IL 61801	University of Illinois System; University of Illinois Urbana-Champaign				Zielinski, Ray/0000-0003-0324-7407				BROWN JWS, 1986, NUCLEIC ACIDS RES, V14, P9549, DOI 10.1093/nar/14.24.9549; CAMPBELL WH, 1990, PLANT PHYSIOL, V92, P1, DOI 10.1104/pp.92.1.1; CASHMORE AR, 1984, P NATL ACAD SCI-BIOL, V81, P2960, DOI 10.1073/pnas.81.10.2960; DATTA N, 1989, PLANT CELL, V1, P1069, DOI 10.1105/tpc.1.11.1069; ELLIS JG, 1987, EMBO J, V6, P3203, DOI 10.1002/j.1460-2075.1987.tb02636.x; ERICKSON AH, 1983, METHOD ENZYMOL, V96, P38; GIULIANO G, 1988, P NATL ACAD SCI USA, V85, P7089, DOI 10.1073/pnas.85.19.7089; GRENE PJ, 1988, EMBO J, V17, P4035; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HANLEY BA, 1988, NUCLEIC ACIDS RES, V16, P7159, DOI 10.1093/nar/16.14.7159; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HODGSON CP, 1987, NUCLEIC ACIDS RES, V15, P6295, DOI 10.1093/nar/15.15.6295; KEITH B, 1986, EMBO J, V5, P2419, DOI 10.1002/j.1460-2075.1986.tb04516.x; KRIEG PA, 1987, METHOD ENZYMOL, V155, P397; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAM E, 1990, SCIENCE, V248, P471, DOI 10.1126/science.2330508; LING V, 1989, PLANT PHYSIOL, V90, P714, DOI 10.1104/pp.90.2.714; LORIMER GH, 1980, BIOCHEMISTRY-US, V19, P5321, DOI 10.1021/bi00564a027; Maxam A M, 1980, Methods Enzymol, V65, P499; MITRA A, 1989, PLANT MOL BIOL, V12, P169, DOI 10.1007/BF00020502; MULLET JE, 1985, PLANT MOL BIOL, V4, P39, DOI 10.1007/BF02498714; MURRAY MG, 1984, GENE, V30, P237, DOI 10.1016/0378-1119(84)90126-4; SALVUCCI ME, 1987, PLANT PHYSIOL, V84, P381; SALVUCCI ME, 1985, PHOTOSYNTH RES, V7, P191; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHULER MA, 1988, METHODS PLANT MOL, P39; SOMERVILLE CR, 1982, PLANT PHYSIOL, V70, P381, DOI 10.1104/pp.70.2.381; STREUSAND VJ, 1987, PLANT PHYSIOL, V85, P152, DOI 10.1104/pp.85.1.152; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WALKER P, 1984, NUCLEIC ACIDS RES, V12, P8611, DOI 10.1093/nar/12.22.8611; WERNEKE JM, 1989, PLANT CELL, V1, P815, DOI 10.1105/tpc.1.8.815; WERNEKE JM, 1989, NUCLEIC ACIDS RES, V17, P2871, DOI 10.1093/nar/17.7.2871; WERNEKE JM, 1988, PLANT PHYSIOL, V87, P917, DOI 10.1104/pp.87.4.917; WERNEKE JM, 1988, P NATL ACAD SCI USA, V85, P787, DOI 10.1073/pnas.85.3.787; ZIELINSKI RE, 1987, PLANT PHYSIOL, V84, P937, DOI 10.1104/pp.84.3.937; ZIELINSKI RE, 1989, PLANT PHYSIOL, V90, P516, DOI 10.1104/pp.90.2.516	37	76	89	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4677	4685						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002016				2022-12-25	WOS:A1991FC21700005
J	MCCREA, PD; GUMBINER, BM				MCCREA, PD; GUMBINER, BM			PURIFICATION OF A 92-KDA CYTOPLASMIC PROTEIN TIGHTLY ASSOCIATED WITH THE CELL-CELL ADHESION MOLECULE E-CADHERIN (UVOMORULIN) - CHARACTERIZATION AND EXTRACTABILITY OF THE PROTEIN COMPLEX FROM THE CELL CYTOSTRUCTURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERCELLULAR ADHERENS JUNCTIONS; POLYACRYLAMIDE GELS; EPITHELIAL-CELLS; 135-KD RECEPTOR; A-CAM; ANKYRIN; FODRIN; EXPRESSION; MODULATION; EMBRYOS	The transmembrane epithelial cell-cell adhesion protein E-cadherin (uvomorulin) associates via its cytoplasmic domain with three or more proteins whose structure and function are not yet established. The associated proteins, also termed catenins (Ozawa, M., Baribault, H., and Kemler, R. (1989) EMBO J. 8, 1711-1717), are of interest because they may form a link to the cytoskeleton, and/or regulate E-cadherin function. In this report immunoprecipitates of E-cadherin complexes, isolated from Xenopus laevis A6 and Madin-Darby canine kidney cell monolayers, were stringently washed to leave a single very tightly associated protein of approximately 92 kDa. We report on the 92-kDa protein's association with E-cadherin in the presence of various perturbants, its preferential dissociation from the immune complex upon exposure to mixed detergent micelles containing sodium dodecyl sulfate, and its preparative purification to homogeneity. We have additionally found that E-cadherin and its associated proteins may be easily and quantitatively extracted from both subconfluent and fully confluent cells by a variety of mild nonionic detergents made up in isotonic buffers. In contrast, such extractions at short times left most of the cytoskeletal protein fodrin in the insoluble pellet fraction. Western blots of immunoprecipitated E-cadherin complexes failed to detect the presence of fodrin, or that of the cytoskeletal proteins adducin, alpha-actinin, and vinculin. If the E-cadherin-associated protein complex interacts with known proteins of the cell cytoskeleton, such interactions are labile and/or transient.	UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	MCCREA, PD (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT PHARMACOL,SAN FRANCISCO,CA 94143, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM037432, F32GM013060, R01GM037432] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM37432, 5-F32-GM-13060] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOLLER K, 1985, J CELL BIOL, V100, P327, DOI 10.1083/jcb.100.1.327; CAMPBELL AM, 1984, MONOCLONAL ANTIBODY, P1; CHOI YS, 1989, J CELL BIOL, V108, P2449, DOI 10.1083/jcb.108.6.2449; CHOI YS, 1990, J CELL BIOL, V110, P1575, DOI 10.1083/jcb.110.5.1575; DAVIS J, 1989, J BIOL CHEM, V264, P6417; GUMBINER B, 1988, TRENDS BIOCHEM SCI, V13, P75, DOI 10.1016/0968-0004(88)90040-0; GUMBINER B, 1988, J CELL BIOL, V107, P1575, DOI 10.1083/jcb.107.4.1575; GUMBINER B, 1986, J CELL BIOL, V102, P457, DOI 10.1083/jcb.102.2.457; HIRANO S, 1987, J CELL BIOL, V105, P2501, DOI 10.1083/jcb.105.6.2501; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P227; JAFFE SH, 1990, P NATL ACAD SCI USA, V87, P3589, DOI 10.1073/pnas.87.9.3589; Kemler R, 1989, CURR OPIN CELL BIOL, V1, P892, DOI 10.1016/0955-0674(89)90055-0; MEZA I, 1980, J CELL BIOL, V87, P746, DOI 10.1083/jcb.87.3.746; MORROW JS, 1989, J CELL BIOL, V108, P455, DOI 10.1083/jcb.108.2.455; NAGAFUCHI A, 1988, EMBO J, V7, P3679, DOI 10.1002/j.1460-2075.1988.tb03249.x; NAGAFUCHI A, 1989, CELL REGUL, V1, P37, DOI 10.1091/mbc.1.1.37; NELSON WJ, 1987, J CELL BIOL, V104, P1527, DOI 10.1083/jcb.104.6.1527; NELSON WJ, 1990, J CELL BIOL, V110, P349, DOI 10.1083/jcb.110.2.349; NELSON WJ, 1989, J CELL BIOL, V108, P893, DOI 10.1083/jcb.108.3.893; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; PEYRIERAS N, 1985, P NATL ACAD SCI USA, V82, P8067, DOI 10.1073/pnas.82.23.8067; PEYRIERAS N, 1983, P NATL ACAD SCI-BIOL, V80, P6274, DOI 10.1073/pnas.80.20.6274; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; VESTWEBER D, 1984, CELL DIFFER DEV, V15, P269, DOI 10.1016/0045-6039(84)90084-8; VESTWEBER D, 1987, DEV BIOL, V124, P451, DOI 10.1016/0012-1606(87)90498-2; VOLBERG T, 1986, J CELL BIOL, V102, P1832, DOI 10.1083/jcb.102.5.1832; VOLK T, 1986, J CELL BIOL, V103, P1451, DOI 10.1083/jcb.103.4.1451; VOLK T, 1986, J CELL BIOL, V103, P1441, DOI 10.1083/jcb.103.4.1441; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WINKEL GK, 1990, DEV BIOL, V138, P1, DOI 10.1016/0012-1606(90)90171-E; [No title captured]	33	187	190	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4514	4520						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999432				2022-12-25	WOS:A1991FA69400077
J	YAMAGUCHI, N; MAYNE, R; NINOMIYA, Y				YAMAGUCHI, N; MAYNE, R; NINOMIYA, Y			THE ALPHA-1(VIII) COLLAGEN GENE IS HOMOLOGOUS TO THE ALPHA-1(X) COLLAGEN GENE AND CONTAINS A LARGE EXON ENCODING THE ENTIRE TRIPLE HELICAL AND CARBOXYL-TERMINAL NON-TRIPLE HELICAL DOMAINS OF THE ALPHA-1(VIII) POLYPEPTIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORNEAL ENDOTHELIAL-CELLS; SHORT-CHAIN COLLAGEN; VIII COLLAGEN; X COLLAGEN; BIOSYNTHETIC PRECURSOR; CULTURE; MEMBRANE; SEQUENCES; PROMOTER; RNA	We recently cloned and sequenced alpha-1(VIII) collagen cDNAs and demonstrated that type VIII collagen is a short-chain collagen that contains both triple helical and carboxyl-terminal non-triple helical domains similar to those of type X collagen (Yamaguchi, N., Benya, P., van der Rest, M., and Ninomiya, Y. (1989) J. Biol. Chem. 264, 16022-16029). We report here on the structural organization of the gene encoding the rabbit alpha-1(VIII) collagen chain. The alpha-1(VIII) gene contains four exons, whose sizes are 69, 120, 331, and 2278 base pairs. The first and second exons encode only 5'-untranslated sequences, whereas the third exon codes for a very short (3 nucleotides) stretch of 5'-untranslated sequence, the signal peptide, and almost the entire amino-terminal non-triple helical (NC2) domain (109(1/3) codons). Interestingly, the last exon encodes the rest of the translated region, including 7(2/3) codons of the NC2 domains, the complete triple helical domain (COL1, 454 amino acid residues), the entire carboxyl-terminal non-triple helical domain (NC1, 173 amino acid residues), and the 3'-untranslated region. This exon-intron structure is in stark contrast to the multi-exon structure of the fibrillar collagen (types I, II, III, V, and XI) genes, but it is remarkably similar to that of the type X collagen gene (LuValle, P., Ninomiya, Y., Rosenblum, N. D., and Olsen, B. R. (1988) J. Biol. Chem. 263, 18278-18385). The data suggest that the alpha-1(VIII) and the alpha-1(X) genes belong to the same subclass within the collagen family and that they arose from a common evolutionary precursor.	HARVARD UNIV,SCH MED,DEPT ANAT & CELLULAR BIOL,BOSTON,MA 02115; UNIV ALABAMA,DEPT CELL BIOL,BIRMINGHAM,AL 35294	Harvard University; Harvard Medical School; University of Alabama System; University of Alabama Birmingham					NEI NIH HHS [EY07334] Funding Source: Medline; NIAMS NIH HHS [AR32984, AR30481] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY007334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR030481, R01AR030481] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALITALO K, 1983, J BIOL CHEM, V258, P2653; BENYA P D, 1980, Renal Physiology, V3, P30; BOEDTKER H, 1985, ANN NY ACAD SCI, V460, P85, DOI 10.1111/j.1749-6632.1985.tb51159.x; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHU ML, 1987, EUR J BIOCHEM, V168, P309, DOI 10.1111/j.1432-1033.1987.tb13422.x; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KAPOOR R, 1986, BIOCHEMISTRY-US, V25, P3930, DOI 10.1021/bi00361a029; KAPOOR R, 1988, J CELL BIOL, V107, P721, DOI 10.1083/jcb.107.2.721; KAY EP, 1982, J BIOL CHEM, V257, P7116; KITTELBERGER R, 1990, CONNECT TISSUE RES, V24, P303, DOI 10.3109/03008209009152157; KOHNO K, 1985, J BIOL CHEM, V260, P4441; LUVALLE P, 1988, J BIOL CHEM, V263, P18378; Maniatis T., 1982, MOL CLONING; MYERS JC, 1983, J BIOL CHEM, V258, P128; NINOMIYA Y, 1986, J BIOL CHEM, V261, P5041; NINOMIYA Y, 1990, EXTRACELLULAR MATRIX, P79; NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9; OLSEN BR, 1985, ANN NY ACAD SCI, V460, P141, DOI 10.1111/j.1749-6632.1985.tb51162.x; OVERBEEK PA, 1981, BIOCHIM BIOPHYS ACTA, V656, P195, DOI 10.1016/0005-2787(81)90087-3; PERBAL B, 1984, PRACTICAL GUIDE MOL; RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8; SAGE H, 1984, LAB INVEST, V50, P219; SAGE H, 1980, BIOCHEMISTRY-US, V19, P5747, DOI 10.1021/bi00566a013; Sage H, 1987, STRUCTURE FUNCTION C, P173; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAWADA H, 1990, J CELL BIOL, V110, P219, DOI 10.1083/jcb.110.1.219; SCHMID TM, 1984, J ULTRASTRUCT RES, V86, P1286; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; VASIOS GW, 1986, THESIS RUTGERS MED S; VUORIO E, 1990, ANNU REV BIOCHEM, V59, P837, DOI 10.1146/annurev.bi.59.070190.004201; YAMAGUCHI N, 1989, J BIOL CHEM, V264, P16022	34	51	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4508	4513						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999431				2022-12-25	WOS:A1991FA69400076
J	VANSCHAFTINGEN, E; DAVIES, DR				VANSCHAFTINGEN, E; DAVIES, DR			FRUCTOSE ADMINISTRATION STIMULATES GLUCOSE PHOSPHORYLATION IN THE LIVERS OF ANESTHETIZED RATS	FASEB JOURNAL			English	Note						GLUCOKINASE; FRUCTOSE; FRUCTOSE 1-PHOSPHATE; GLUCOSE PHOSPHORYLATION	CARBOHYDRATE-METABOLISM; HEPATOCYTES; GLYCOGEN; GLUCOKINASE	A method allowing one to measure the rate of glucose phosphorylation in the livers of anesthetized rats is described. Upon injection of [2-H-3]glucose into the portal vein, about 90% of the radioactivity remained in the liver for approximately 30 s. The proportion of radioactivity accounted for by tritiated water increased linearly at a rate of about 5%/min in control animals. Fructose injected into the penile vein stimulated this rate of up to 2.2- and 2.7-fold in fed and overnight starved rats respectively, a maximal effect being observed at a dose of 50 mg/kg under both conditions. Fructose was also active when administered by intragastric infusion. The ketose caused increases in the concentration of fructose 1-phosphate, which reached values known to relieve the inhibition exerted on glucokinase by its regulatory protein.	CATHOLIC UNIV LOUVAIN,B-1200 BRUSSELS,BELGIUM; INT INST CELLULAR & MOLEC PATHOL,PHYSIOL CHEM LAB,B-1200 BRUSSELS,BELGIUM	Universite Catholique Louvain			Van+Schaftingen, Emile/AAF-5532-2020	Van Schaftingen, Emile/0000-0002-6199-7647	NIDDK NIH HHS [DK 9235] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAUR H, 1977, EUR J BIOCHEM, V74, P397, DOI 10.1111/j.1432-1033.1977.tb11404.x; Bergmeyer H. U., 1974, METHOD ENZYMAT AN, V3, P1196; BONTEMPS F, 1978, BIOCHEM J, V174, P603, DOI 10.1042/bj1740603; CLARK DG, 1979, BIOCHEM J, V184, P501, DOI 10.1042/bj1840501; DAVIES DR, 1990, IN PRESS EUR J BIOCH; GORESKY CA, 1974, J CLIN INVEST, V53, P634, DOI 10.1172/JCI107598; HUE L, 1972, EUR J BIOCHEM, V29, P268, DOI 10.1111/j.1432-1033.1972.tb01984.x; HUE L, 1975, BIOCHEM J, V152, P105, DOI 10.1042/bj1520105; Hue L, 1981, Adv Enzymol Relat Areas Mol Biol, V52, P247; KATZ J, 1978, J BIOL CHEM, V253, P4530; KATZ J, 1975, EUR J BIOCHEM, V60, P91, DOI 10.1111/j.1432-1033.1975.tb20979.x; Katz J, 1976, Curr Top Cell Regul, V10, P237; MALAISSE WJ, 1990, EUR J BIOCHEM, V190, P539, DOI 10.1111/j.1432-1033.1990.tb15607.x; MURATOGLU M, 1986, BIOCHEM J, V233, P245, DOI 10.1042/bj2330245; PARDRIDGE WM, 1975, AM J PHYSIOL, V228, P1155; SATO T, 1987, CIRC SHOCK, V21, P31; SHALLENBERGER R S, 1974, P67; TOPPING DL, 1971, NUTR METAB, V13, P331; VANDERCAMMEN A, 1990, EUR J BIOCHEM, V191, P483, DOI 10.1111/j.1432-1033.1990.tb19147.x; VANHOOF F, 1972, BIOCHIMIE, V54, P745, DOI 10.1016/S0300-9084(72)80177-9; VANSCHAFTINGEN E, 1989, EUR J BIOCHEM, V179, P173; VANSCHAFTINGEN E, 1987, ADV ENZYMOL RAMB, V59, P315; VANSCHAFTINGEN E, 1980, BIOCHEM J, V192, P263, DOI 10.1042/bj1920263; VANSCHAFTINGEN E, 1989, EUR J BIOCHEM, V179, P179; WILLIAMS TF, 1968, AM J PHYSIOL, V215, P1200, DOI 10.1152/ajplegacy.1968.215.5.1200; WOLLENBERGER A, 1960, PFLUG ARCH GES PHYS, V270, P399, DOI 10.1007/BF00362995; ZALITIS J, 1967, BIOCHEM J, V102, P753, DOI 10.1042/bj1020753	27	34	34	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998	0892-6638			FASEB J	Faseb J.	MAR 1	1991	5	3					326	330		10.1096/fasebj.5.3.2001793	http://dx.doi.org/10.1096/fasebj.5.3.2001793			5	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FC556	2001793				2022-12-25	WOS:A1991FC55600011
J	BERK, JL; FRANZBLAU, C; GOLDSTEIN, RH				BERK, JL; FRANZBLAU, C; GOLDSTEIN, RH			RECOMBINANT INTERLEUKIN-1-BETA INHIBITS ELASTIN FORMATION BY A NEONATAL RAT LUNG FIBROBLAST SUBTYPE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALVEOLAR MACROPHAGES; SMOOTH-MUSCLE CELLS; MESSENGER-RNA LEVELS; GROWTH FACTOR-BETA; PULMONARY FIBROBLASTS; POLYACRYLAMIDE GELS; COLLAGEN-SYNTHESIS; INTERSTITIAL CELL; FACTOR-I; EMPHYSEMA	The effect of recombinant interleukin-1-beta (rIL-1-beta) on elastin accumulation by lipid-laden interstitial cells (LIC) derived from neonatal rat lung was examined. The LIC, a fibroblast subtype, synthesized large amounts of elastin which was deposited into the extracellular matrix. This elastin was alkali-resistant and had an amino acid composition typical of adult rat elastin. Treatment of lipid-laden interstitial cell cultures with rIL-1-beta at 100 pg/ml caused a dramatic decrease in elastin accumulation as assessed by hot alkali treatment and transmission electron micrographs of the cell cultures. Tropoelastin formation was selectively decreased by rIL-1-beat relative to other proteins. Steady state levels of elastin mRNA were slightly decreased by rIL-1-beta at 5 pg/ml and markedly decreased by rIL-1-beta at 50 pg/ml or greater. The addition of indomethacin had no effect on rIL-1-beta-induced decreases in elastin mRNA levels. Inhibiting protein synthesis with cycloheximide blocked the effect of rIL-1-beta on elastin mRNA levels. The level of alpha-1(I) collagen mRNA was decreased by rIL-1-beta, but only at concentrations higher than that needed to induce a decrease in elastin mRNA. These data indicate that rIL-1-beta decreased steady state levels for elastin mRNA and elastin accumulation and can selectively regulate the accumulation of elastin and collagen.	BOSTON UNIV, SCH MED, DEPT BIOCHEM, BOSTON, MA 02118 USA; VET ADM MED CTR JAMAICA PLAIN, BOSTON, MA 02130 USA	Boston University	BERK, JL (corresponding author), BOSTON UNIV, SCH MED, CTR PULM, BOSTON, MA 02118 USA.			Franzblau, Carl/0000-0001-9248-6324; Berk, John/0000-0002-1768-2373	NHLBI NIH HHS [HL-19717, HL-39865] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039865, P01HL019717] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKAHOSHI T, 1988, J CLIN INVEST, V82, P1219, DOI 10.1172/JCI113719; AREND WP, 1989, J IMMUNOL, V143, P118; BADESCH DB, 1989, BIOCHEM BIOPH RES CO, V160, P382, DOI 10.1016/0006-291X(89)91667-7; BARONE LM, 1988, BIOCHEMISTRY-US, V27, P3175, DOI 10.1021/bi00409a008; BASHIR MM, 1989, J BIOL CHEM, V264, P8887; BERNAUDIN JF, 1988, J IMMUNOL, V140, P3822; BHATNAGAR R, 1986, BIOCHEM INT, V13, P709; BIRD TA, 1987, J IMMUNOL, V139, P92; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; BRODY JS, 1983, AM REV RESPIR DIS, V127, P763; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CAMPAGNONE R, 1987, LAB INVEST, V56, P224; CANALIS E, 1986, ENDOCRINOLOGY, V118, P74, DOI 10.1210/endo-118-1-74; CHIN J, 1987, J EXP MED, V165, P70, DOI 10.1084/jem.165.1.70; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; CONCA W, 1989, J CLIN INVEST, V83, P1753, DOI 10.1172/JCI114077; DINARELLO CA, 1988, FASEB J, V2, P108, DOI 10.1096/fasebj.2.2.3277884; EDEN E, 1986, AM REV RESPIR DIS, V133, P455; FINE A, 1989, J BIOL CHEM, V264, P16988; FOSTER J, 1987, COLLAGEN REL RES, V7, P161; FRANZBLAU C, 1989, J BIOL CHEM, V264, P15115; FUKUDA Y, 1989, HUM PATHOL, V20, P652, DOI 10.1016/0046-8177(89)90152-4; GENOVESE C, 1984, BIOCHEMISTRY-US, V23, P6210, DOI 10.1021/bi00320a049; GOLDRING MB, 1987, J BIOL CHEM, V262, P16724; JANOFF A, 1983, CHEST, V83, pS54, DOI 10.1378/chest.83.5.54S; JONES DT, 1987, J BIOL CHEM, V262, P14241; KAHARI VM, 1990, J BIOL CHEM, V265, P9485; KUHN C, 1976, LAB INVEST, V34, P372; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANSING AI, 1952, ANAT RECORD, V114, P555, DOI 10.1002/ar.1091140404; LIU JM, 1988, BIOCHEM BIOPH RES CO, V154, P895, DOI 10.1016/0006-291X(88)90224-0; LUCEY EC, 1980, AM REV RESPIR DIS, V121, P83; MAKSVYTIS HJ, 1981, LAB INVEST, V45, P248; MAKSVYTIS HJ, 1984, J CELL PHYSIOL, V118, P113, DOI 10.1002/jcp.1041180203; MECHAM RP, 1984, J BIOL CHEM, V259, P2414; MIZEL SB, 1987, J IMMUNOL, V138, P2906; MORRIS SM, 1981, ANAT RECORD, V201, P523, DOI 10.1002/ar.1092010309; MUEGGE K, 1989, SCIENCE, V246, P249, DOI 10.1126/science.2799385; POSTLETHWAITE AE, 1989, J CLIN INVEST, V83, P629, DOI 10.1172/JCI113927; RAZ A, 1988, J BIOL CHEM, V263, P3022; RICH CB, 1989, ARCH BIOCHEM BIOPHYS, V268, P551, DOI 10.1016/0003-9861(89)90322-6; SENIOR RM, 1984, J CELL BIOL, V99, P870, DOI 10.1083/jcb.99.3.870; SENIOR RM, 1977, AM REV RESPIR DIS, V116, P469, DOI 10.1164/arrd.1977.116.3.469; SENIOR RM, 1989, AM REV RESPIR DIS, V139, P1251, DOI 10.1164/ajrccm/139.5.1251; SNIDER GL, 1986, AM REV RESPIR DIS, V133, P149, DOI 10.1164/arrd.1986.133.1.149; STONE PJ, 1982, J CLIN INVEST, V69, P920, DOI 10.1172/JCI110531; TAKIMOTO M, 1989, J BIOL CHEM, V264, P8992; THOMAS PS, 1983, METHOD ENZYMOL, V100, P255; VACCARO C, 1978, ANAT REC, V192, P467, DOI 10.1002/ar.1091920402; ZUCALI JR, 1986, J CLIN INVEST, V77, P1857, DOI 10.1172/JCI112512	51	58	58	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3192	3197						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993692				2022-12-25	WOS:A1991EX60000079
J	CHEN, HM; CONSIDINE, KB; LIAO, WSL				CHEN, HM; CONSIDINE, KB; LIAO, WSL			INTERLEUKIN-6 RESPONSIVENESS AND CELL-SPECIFIC EXPRESSION OF THE RAT KININOGEN GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHASE PLASMA-PROTEINS; TUMOR NECROSIS FACTOR; RECOMBINANT HUMAN INTERLEUKIN-6; HEPATOCYTE-STIMULATING FACTOR; HIGH MOLECULAR-WEIGHT; T-KININOGEN; PROGESTERONE INDUCTION; DNA; TRANSCRIPTION; INFLAMMATION	The serum concentration of rat T1 kininogen increases 20-30-fold in response to acute inflammation, an induced hepatic synthesis regulated primarily at the transcriptional level. To analyze the cis-regulatory elements responsible for the induced transcription, we fused a 1.6-kilobase segment of the rat T1 kininogen promoter to a reporter gene, chloramphenicol acetyltransferase (CAT). The resultant chimeric DNA was transfected into cultured cells. In transient transfection assays, this 5'-flanking sequence was sufficient to confer cell-specific expression: CAT activity was readily detectable when the construct was transfected into liver-derived cells, but it was not detectable in nonliver cells. Furthermore, when liver cells (Hep3B) transfected with this construct were treated with conditioned medium prepared from activated mixed lymphocyte cultures or with recombinant interleukin-6 (IL-6), a 5-fold increase in CAT activity was detected. Addition of dexamethasone to the conditioned medium or to IL-6 showed synergistic effects and resulted in a 10-fold increase in CAT activity. In contrast, when IL-1 was used with IL-6, induction of CAT activity was inhibited. Deletion analyses revealed two regions important for tissue-specific and induced regulation of T1 kininogen: sequences proximal to base pair -73 conferred enhanced expression in liver-derived cells and a distal region that conferred responsiveness to conditioned medium, recombinant IL-6, and dexamethasone. This responsive element had properties of an inducible transcriptional enhancer, and it was functional in both liver and nonliver cells when placed immediately upstream of a thymidine kinase promoter.	UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT BIOCHEM & MOLEC BIOL,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center					NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR038858, R01AR038858] Funding Source: NIH RePORTER; NCRR NIH HHS [RR5511] Funding Source: Medline; NIAMS NIH HHS [AR38858] Funding Source: Medline; NICHD NIH HHS [HD07325] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDERSON KP, 1989, GENE, V81, P119, DOI 10.1016/0378-1119(89)90342-9; ANDERSON KP, 1989, NUCLEIC ACIDS RES, V17, P2835, DOI 10.1093/nar/17.7.2835; ANDUS T, 1988, EUR J BIOCHEM, V173, P287, DOI 10.1111/j.1432-1033.1988.tb13997.x; ANDUS T, 1988, EUR J IMMUNOL, V18, P739, DOI 10.1002/eji.1830180513; BAUER J, 1989, FEBS LETT, V249, P27, DOI 10.1016/0014-5793(89)80008-0; BAUMANN H, 1989, J BIOL CHEM, V264, P8046; BAUMANN H, 1987, J BIOL CHEM, V262, P9756; BAUMANN H, 1988, J BIOL CHEM, V263, P17390; BIRCH HE, 1986, J BIOL CHEM, V261, P8077; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CATO ACB, 1986, EMBO J, V5, P2237, DOI 10.1002/j.1460-2075.1986.tb04490.x; CONTENT J, 1982, P NATL ACAD SCI-BIOL, V79, P2768, DOI 10.1073/pnas.79.9.2768; DALE TC, 1989, EMBO J, V8, P831, DOI 10.1002/j.1460-2075.1989.tb03444.x; DARLINGTON GJ, 1986, J CELL BIOL, V103, P787, DOI 10.1083/jcb.103.3.787; FEY GH, 1987, MOL BIOL MED, V4, P323; FUNG WP, 1987, J BIOL CHEM, V262, P9298; GANTER U, 1989, EMBO J, V8, P3773, DOI 10.1002/j.1460-2075.1989.tb08554.x; GAULDIE J, 1989, ANN NY ACAD SCI, V557, P46; GAULDIE J, 1987, P NATL ACAD SCI USA, V84, P7251, DOI 10.1073/pnas.84.20.7251; GEIGER T, 1988, EUR J IMMUNOL, V18, P717, DOI 10.1002/eji.1830180510; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HATTORI M, 1990, P NATL ACAD SCI USA, V87, P2364, DOI 10.1073/pnas.87.6.2364; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; HUANG JH, 1990, MOL CELL BIOL, V10, P3619, DOI 10.1128/MCB.10.7.3619; KAGEYAMA R, 1985, J BIOL CHEM, V260, P2060; KAGEYAMA R, 1987, J BIOL CHEM, V262, P2345; KAWAI S, 1984, MOL CELL BIOL, V4, P1172, DOI 10.1128/MCB.4.6.1172; KITAGAWA H, 1987, J BIOL CHEM, V262, P2190; KITAMURA N, 1983, NATURE, V305, P545, DOI 10.1038/305545a0; KLEINHITPASS L, 1988, NUCLEIC ACIDS RES, V16, P647, DOI 10.1093/nar/16.2.647; KOJ A, 1989, ANN NY ACAD SCI, V557, P1; KOJ A, 1974, STRUCTURE FUNCTION P, V1, P73; KUSHNER I, 1982, ANN NY ACAD SCI, V389, P39, DOI 10.1111/j.1749-6632.1982.tb22124.x; LIAO WSL, 1989, MOL CELL BIOL, V9, P2779, DOI 10.1128/MCB.9.7.2779; MAIZEL AL, 1981, J IMMUNOL, V127, P1058; MAJELLO B, 1990, EMBO J, V9, P457, DOI 10.1002/j.1460-2075.1990.tb08131.x; Maniatis T., 1982, MOL CLONING; MARINKOVIC S, 1990, MOL CELL BIOL, V10, P1573, DOI 10.1128/MCB.10.4.1573; MORRONE G, 1988, J BIOL CHEM, V263, P12554; OLIVIERO S, 1989, EMBO J, V8, P1145, DOI 10.1002/j.1460-2075.1989.tb03485.x; PARKER BA, 1979, J VIROL, V31, P360, DOI 10.1128/JVI.31.2.360-369.1979; POLI V, 1989, P NATL ACAD SCI USA, V86, P8202, DOI 10.1073/pnas.86.21.8202; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STRAHLE U, 1987, P NATL ACAD SCI USA, V84, P7871, DOI 10.1073/pnas.84.22.7871; TAKAGAKI Y, 1985, J BIOL CHEM, V260, P8601; URGAN J, 1979, J BIOL CHEM, V254, P10565; VANDAMME J, 1987, J EXP MED, V165, P914, DOI 10.1084/jem.165.3.914	49	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2946	2952						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993668				2022-12-25	WOS:A1991EX60000045
J	SASSANFAR, M; DOSANJH, MK; ESSIGMANN, JM; SAMSON, L				SASSANFAR, M; DOSANJH, MK; ESSIGMANN, JM; SAMSON, L			RELATIVE EFFICIENCIES OF THE BACTERIAL, YEAST, AND HUMAN DNA METHYLTRANSFERASES FOR THE REPAIR OF O6-METHYLGUANINE AND O4-METHYLTHYMINE - SUGGESTIVE EVIDENCE FOR O4-METHYLTHYMINE REPAIR BY EUKARYOTIC METHYLTRANSFERASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADA REGULATORY PROTEIN; ESCHERICHIA-COLI; ALKYLATING-AGENTS; ADAPTIVE RESPONSE; TRANSCRIPTIONAL REGULATOR; METHYL PHOSPHOTRIESTERS; MOLECULAR-CLONING; GENE-PRODUCT; POLYMERASE-I; O-6-METHYLGUANINE	The suicidal inactivation mechanism of DNA repair methyltransferases (MTases) was exploited to measure the relative efficiencies with which the Escherichia coli, human, and Saccharomyces cerevisiae DNA MTases repair O6-methylguanine (O6MeG) and O4-methylthymine (O4MeT), two of the DNA lesions produced by mutagenic and carcinogenic alkylating agents. Using chemically synthesized double-stranded 25-base pair oligodeoxynucleotides containing a single O6MeG or a single O4MeT, the concentration of O6MeG or O4MeT substrate that produced 50% inactivation (IC50) was determined for each of four MTases. The E. coli ogt gene product had a relatively high affinity for the O6MeG substrate (IC50 8.1 nM) but had an even higher affinity for the O4MeT substrate (IC50 3nM). By contrast, the E. coli Ada MTase displayed a striking preference for O6MeG (IC50 1.25 nM) as compared to O4MeT (IC50 27.5 nM). Both the human and the yeast DNA MTases were efficiently inactivated upon incubation with the O6MeG-containing oligomer (IC50 values of 1.5 and 1.3 nM, respectively). Surprisingly, the human and yeast MTases were also inactivated by the O4MeT-containing oligomer albeit at IC50 values of 29.5 and 44 nM, respectively. This result suggests that O4MeT lesions can be recognized in this substrate by eukaryotic DNA MTases but the exact biochemical mechanism of methyltransferase inactivation remains to be determined.	HARVARD UNIV,SCH PUBL HLTH,TOXICOL LAB,BOSTON,MA 02115; MIT,DEPT CHEM,CAMBRIDGE,MA 02139; MIT,WHITAKER COLL HLTH SCI & TECHNOL,CAMBRIDGE,MA 02139	Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)				Dosanjh, Manjit/0000-0003-1378-349X	NATIONAL CANCER INSTITUTE [R35CA052127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES003926] Funding Source: NIH RePORTER; NCI NIH HHS [CA52127] Funding Source: Medline; NIEHS NIH HHS [ES03926] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		[Anonymous], 1985, DNA REPAIR; BECKER RA, 1985, CARCINOGENESIS, V6, P313, DOI 10.1093/carcin/6.2.313; BOITEUX S, 1984, EMBO J, V3, P2569, DOI 10.1002/j.1460-2075.1984.tb02175.x; BOULDEN AM, 1987, J BIOSCIENCE, V11, P215, DOI 10.1007/BF02704671; BRENT TP, 1985, PHARMACOL THERAPEUT, V31, P121, DOI 10.1016/0163-7258(85)90040-3; BRENT TP, 1988, P NATL ACAD SCI USA, V85, P1759, DOI 10.1073/pnas.85.6.1759; DOLAN ME, 1988, MUTAT RES, V193, P131, DOI 10.1016/0167-8817(88)90043-0; DOSANJH MK, 1990, BIOCHEMISTRY-US, V29, P4698, DOI 10.1021/bi00471a026; EADIE JS, 1984, NATURE, V308, P201, DOI 10.1038/308201a0; ELLIS KS, 1989, P NATL ACAD SCI USA, V86, P862; EVENSEN G, 1982, NATURE, V296, P773, DOI 10.1038/296773a0; Gait M. J, 1984, OLIGONUCLEOTIDE SYNT; GRAVES RJ, 1989, CARCINOGENESIS, V10, P661, DOI 10.1093/carcin/10.4.661; HAYAKAWA H, 1990, J MOL BIOL, V213, P739, DOI 10.1016/S0022-2836(05)80260-8; KARRAN P, 1979, NATURE, V280, P76, DOI 10.1038/280076a0; KATAOKA H, 1985, MOL GEN GENET, V198, P263, DOI 10.1007/BF00383004; KOIKE G, 1990, J BIOL CHEM, V265, P14754; KUZMICH S, 1983, NUCLEIC ACIDS RES, V11, P3393, DOI 10.1093/nar/11.10.3393; LINDAHL T, 1982, EMBO J, V1, P1359, DOI 10.1002/j.1460-2075.1982.tb01323.x; LINDAHL T, 1988, ANNU REV BIOCHEM, V57, P133, DOI 10.1146/annurev.bi.57.070188.001025; LOECHLER EL, 1984, P NATL ACAD SCI-BIOL, V81, P6271, DOI 10.1073/pnas.81.20.6271; MARGISON GP, 1985, CARCINOGENESIS, V6, P1699, DOI 10.1093/carcin/6.12.1699; MARGISON GP, 1985, NUCLEIC ACIDS RES, V13, P1939, DOI 10.1093/nar/13.6.1939; MCCARTHY TV, 1985, NUCLEIC ACIDS RES, V13, P2683, DOI 10.1093/nar/13.8.2683; MCCARTHY TV, 1984, EMBO J, V3, P545, DOI 10.1002/j.1460-2075.1984.tb01844.x; NAKABEPPU Y, 1986, P NATL ACAD SCI USA, V83, P6297, DOI 10.1073/pnas.83.17.6297; OLSSON M, 1980, J BIOL CHEM, V255, P569; PFEIFER GP, 1985, J BIOL CHEM, V260, P3787; POTTER PM, 1987, NUCLEIC ACIDS RES, V15, P9177, DOI 10.1093/nar/15.22.9177; PRESTON BD, 1986, P NATL ACAD SCI USA, V83, P8501, DOI 10.1073/pnas.83.22.8501; REBECK GW, 1989, J BACTERIOL, V171, P4563, DOI 10.1128/jb.171.9.4563-4568.1989; REBECK GW, 1988, P NATL ACAD SCI USA, V85, P3039, DOI 10.1073/pnas.85.9.3039; RICHARDSON FC, 1985, CARCINOGENESIS, V6, P625, DOI 10.1093/carcin/6.4.625; RICHARDSON KK, 1987, P NATL ACAD SCI USA, V84, P344, DOI 10.1073/pnas.84.2.344; RYDBERG B, 1990, J BIOL CHEM, V265, P9563; SAFFHILL R, 1985, BIOCHIM BIOPHYS ACTA, V823, P111, DOI 10.1016/0304-419X(85)90009-5; SAMSON L, 1988, EMBO J, V7, P2261, DOI 10.1002/j.1460-2075.1988.tb03066.x; SAMSON L, 1977, NATURE, V267, P281, DOI 10.1038/267281a0; SASSANFAR M, 1990, J BIOL CHEM, V265, P20; SCICCHITANO D, 1986, CARCINOGENESIS, V8, P1383; SEDGWICK B, 1983, MOL GEN GENET, V191, P466, DOI 10.1007/BF00425764; SEDGWICK B, 1988, J BIOL CHEM, V263, P4430; SINGER B, 1983, P NATL ACAD SCI-BIOL, V80, P4884, DOI 10.1073/pnas.80.16.4884; SINGER B, 1989, P NATL ACAD SCI USA, V86, P8271, DOI 10.1073/pnas.86.21.8271; SINHA ND, 1984, NUCLEIC ACIDS RES, V12, P4539, DOI 10.1093/nar/12.11.4539; TAKANO K, 1988, J MOL BIOL, V201, P261, DOI 10.1016/0022-2836(88)90137-4; TANO K, 1990, P NATL ACAD SCI USA, V87, P686, DOI 10.1073/pnas.87.2.686; TEO I, 1984, EMBO J, V3, P2151, DOI 10.1002/j.1460-2075.1984.tb02105.x; TEO I, 1986, CELL, V45, P315, DOI 10.1016/0092-8674(86)90396-X; TEO IA, 1987, MUTAT RES, V153, P123; TOPAL MD, 1986, J BIOL CHEM, V261, P9879; WEINFELD M, 1985, NUCLEIC ACIDS RES, V13, P7067, DOI 10.1093/nar/13.19.7067; WILKINSON MC, 1989, NUCLEIC ACIDS RES, V17, P8475, DOI 10.1093/nar/17.21.8475; YOSHIKAI T, 1988, J BIOL CHEM, V263, P19174	54	110	111	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2767	2771						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1993655				2022-12-25	WOS:A1991EX60000018
J	LU, M; GUO, Q; STUDIER, FW; KALLENBACH, NR				LU, M; GUO, Q; STUDIER, FW; KALLENBACH, NR			RESOLUTION OF BRANCHED DNA SUBSTRATES BY T7 ENDONUCLEASE-I AND ITS INHIBITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOLLIDAY JUNCTION ANALOGS; GENETIC-RECOMBINATION; GENE-49-CONTROLLED ENDONUCLEASE; SACCHAROMYCES-CEREVISIAE; GENE-3 ENDONUCLEASE; T4-HEAD MATURATION; CRUCIFORM DNA; VII CLEAVES; BACTERIOPHAGE-T7; PURIFICATION	Endonuclease I is a multipurpose enzyme implicated in the breakdown of host DNA, packaging of phage DNA, and recombination during the lytic cycle of bacteriophage T7. We investigate here some aspects of the substate requirements for its activity in resolving branched intermediates similar to Holliday junctions (Holliday, R. (1964) Genet. Res. 5, 282-304) that arise in recombination. The enzyme is able to resolve branched substrates containing very short duplex arms: 4 base pairs suffice. It cleaves 5' to the branch, with a distinct preference for the non-crossover strands in Holliday-like model junctions. Ligands that interact strongly with the branch site can inhibit the enzyme, with K(I) values in the 10-50-mu-M range.	NYU, DEPT CHEM, NEW YORK, NY 10003 USA; BROOKHAVEN NATL LAB, DEPT BIOL, UPTON, NY 11973 USA	New York University; United States Department of Energy (DOE); Brookhaven National Laboratory					NCI NIH HHS [CA-24101] Funding Source: Medline; NIGMS NIH HHS [GM-29554] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA024101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029554, R01GM029554] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BROKER TR, 1971, J MOL BIOL, V60, P131, DOI 10.1016/0022-2836(71)90453-0; CARUTHERS MH, 1982, CHEM ENZYMATIC SYNTH, P71; CENTER MS, 1970, J BIOL CHEM, V245, P6285; CHEN JH, 1988, BIOCHEMISTRY-US, V27, P6032, DOI 10.1021/bi00416a031; CHURCHILL MEA, 1988, P NATL ACAD SCI USA, V85, P4653, DOI 10.1073/pnas.85.13.4653; COOPER JP, 1987, J MOL BIOL, V198, P711, DOI 10.1016/0022-2836(87)90212-9; COOPER JP, 1989, P NATL ACAD SCI USA, V86, P7336, DOI 10.1073/pnas.86.19.7336; DEMASSY B, 1987, J MOL BIOL, V193, P359, DOI 10.1016/0022-2836(87)90224-5; DEMASSY B, 1984, COLD SPRING HARB SYM, V49, P715, DOI 10.1101/SQB.1984.049.01.081; DICKIE P, 1988, J MOL BIOL, V201, P19, DOI 10.1016/0022-2836(88)90435-4; DICKIE P, 1987, J BIOL CHEM, V262, P14826; DRESSLER D, 1982, ANNU REV BIOCHEM, V51, P727, DOI 10.1146/annurev.bi.51.070182.003455; DUCKETT DR, 1988, CELL, V55, P79, DOI 10.1016/0092-8674(88)90011-6; GUO Q, 1990, BIOCHEMISTRY-US, V29, P570, DOI 10.1021/bi00454a034; GUO Q, 1989, BIOCHEMISTRY-US, V28, P2355, DOI 10.1021/bi00432a001; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; JENSCH F, 1986, EMBO J, V5, P181, DOI 10.1002/j.1460-2075.1986.tb04194.x; KEMPER B, 1981, EUR J BIOCHEM, V115, P123; KEMPER B, 1984, COLD SPRING HARB SYM, V49, P815, DOI 10.1101/SQB.1984.049.01.092; KERR C, 1975, VIROLOGY, V65, P281, DOI 10.1016/0042-6822(75)90031-8; LILLEY DMJ, 1984, CELL, V36, P413, DOI 10.1016/0092-8674(84)90234-4; LOW KB, 1988, RECOMBINATION GENETI; LU M, 1990, J BIOL CHEM, V265, P16778; LU M, 1990, BIOCHEMISTRY-US, V29, P1614, DOI 10.1021/bi00458a037; LU M, 1990, BIOCHEMISTRY-US, V29, P3407, DOI 10.1021/bi00465a038; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MESELSON MS, 1975, P NATL ACAD SCI USA, V72, P358, DOI 10.1073/pnas.72.1.358; MIZUUCHI K, 1982, CELL, V29, P357, DOI 10.1016/0092-8674(82)90152-0; MUELLER JE, 1988, P NATL ACAD SCI USA, V85, P9441, DOI 10.1073/pnas.85.24.9441; MUELLER JE, 1990, J BIOL CHEM, V265, P13918; MURCHIE AIH, 1989, NATURE, V341, P763, DOI 10.1038/341763a0; PASTERNA.RF, 1973, INORG CHEM, V12, P2606, DOI 10.1021/ic50129a023; POWLING A, 1974, MOL GEN GENET, V134, P173, DOI 10.1007/BF00268418; SADOWSKI PD, 1971, J BIOL CHEM, V246, P200; SIGAL N, 1972, J MOL BIOL, V71, P789, DOI 10.1016/S0022-2836(72)80039-1; SYMINGTON LS, 1985, P NATL ACAD SCI USA, V82, P7247, DOI 10.1073/pnas.82.21.7247; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; TAYLOR AF, 1990, J MOL BIOL, V211, P117, DOI 10.1016/0022-2836(90)90015-E; TSUJIMOTO Y, 1978, J MOL BIOL, V125, P255, DOI 10.1016/0022-2836(78)90402-3; WEST SC, 1985, P NATL ACAD SCI USA, V82, P6445, DOI 10.1073/pnas.82.19.6445	40	16	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2531	2536						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1990002				2022-12-25	WOS:A1991EV51500079
J	POSTBEITTENMILLER, D; JAWORSKI, JG; OHLROGGE, JB				POSTBEITTENMILLER, D; JAWORSKI, JG; OHLROGGE, JB			INVIVO POOLS OF FREE AND ACYLATED ACYL CARRIER PROTEINS IN SPINACH - EVIDENCE FOR SITES OF REGULATION OF FATTY-ACID BIOSYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA CARBOXYLASE; MOLECULAR-PROPERTIES; ESCHERICHIA-COLI; OLERACEA LEAVES; COENZYME-A; PURIFICATION; SYNTHASE; CHLOROPLASTS; SYNTHETASE; EXPRESSION	In order to examine potential regulatory steps in plant fatty acid biosynthesis, we have developed procedures for the analysis of the major acyl-acyl carrier protein (ACP) intermediates of this pathway. These techniques have been used to separate and identify acyl-ACPs with chain configurations ranging from 2:0 to 18:1 and to determine the relative in vivo concentrations of acyl-ACPs in spinach leaf and developing seed. In both leaf and seed as much as 60% of the total ACPs were nonesterified (free), with the remaining proportion consisting of acyl-ACP intermediates leading to the formation of palmitate, stearate, and oleate. In spinach leaf the proportions of the various acyl groups esterified to each ACP isoform were indistinguishable, indicating that these isoforms are utilized similarly in de novo fatty acid biosynthesis in vivo. However, the acyl group distribution pattern of seed ACP-II differed significantly from that of leaf ACP-II. The malonyl-ACP levels were less than the 4:0-ACP and 6:0-ACP levels in leaf, and in contrast, the malonyl-ACP-II levels in seed were approximately 3-fold higher than the 4:0-ACP-II and 6:0-ACP-II levels. In addition, the ratio of oleoyl-ACP-II (18:1) to stearoyl-ACP-II (18:0) was higher in seed than in leaf. These data suggest that the differences in acyl-ACP patterns reflect a tissue/organ-specific difference rather than an isoform-specific difference. In extracts prepared from leaf samples collected in the dark, the levels of acetyl-ACPs were approximately 5-fold higher compared to samples collected in the light. The levels of free ACPs showed an inverse response, increasing in the light and decreasing in the dark. Notably there was no concomitant increase in the malonyl-ACP levels. The most likely explanation for the major increase in acetyl-ACP levels in the dark is that light/dark control over the rate of fatty acid biosynthesis occurs at the reaction catalyzed by acetyl-CoA carboxylase.	MIAMI UNIV,DEPT CHEM,OXFORD,OH 45056	University System of Ohio; Miami University	POSTBEITTENMILLER, D (corresponding author), MICHIGAN STATE UNIV,DEPT BOT & PLANT PATHOL,E LANSING,MI 48824, USA.		Jaworski, Jan/N-2255-2014	Jaworski, Jan/0000-0003-3309-4915				ALBERTS AW, 1972, J BIOL CHEM, V247, P3190; BATTEY JF, 1990, PLANTA, V180, P352, DOI 10.1007/BF00198786; BEREMAND PD, 1987, ARCH BIOCHEM BIOPHYS, V256, P90, DOI 10.1016/0003-9861(87)90428-0; BROWSE J, 1981, BIOCHEM J, V196, P347, DOI 10.1042/bj1960347; CRONAN JE, 1981, P NATL ACAD SCI-BIOL, V78, P5440, DOI 10.1073/pnas.78.9.5440; CRONAN JE, 1982, J BIOL CHEM, V257, P5013; EASTWELL KC, 1983, PLANT PHYSIOL, V72, P50, DOI 10.1104/pp.72.1.50; ELHUSSEIN SA, 1988, BIOCHEM J, V252, P39, DOI 10.1042/bj2520039; GUERRA DJ, 1988, J BIOL CHEM, V263, P4386; GUERRA DJ, 1986, PLANT PHYSIOL, V82, P448, DOI 10.1104/pp.82.2.448; HARWOOD JL, 1988, ANNU REV PLANT PHYS, V39, P101, DOI 10.1146/annurev.arplant.39.1.101; HOJ PB, 1984, CARLSBERG RES COMMUN, V49, P483, DOI 10.1007/BF02904401; JACKOWSKI S, 1989, J BIOL CHEM, V264, P7624; JACKOWSKI S, 1987, J BIOL CHEM, V262, P7927; JAWORSKI JG, 1989, PLANT PHYSIOL, V90, P41, DOI 10.1104/pp.90.1.41; KIM KH, 1989, FASEB J, V3, P2250, DOI 10.1096/fasebj.3.11.2570725; LAKINTHOMAS PL, 1986, J BIOL CHEM, V261, P4785; LAW MY, 1983, BIOCHEM J, V210, P899, DOI 10.1042/bj2100899; MANCHA M, 1981, PHYTOCHEMISTRY, V20, P2139, DOI 10.1016/0031-9422(81)80101-X; NIKOLAU BJ, 1984, ARCH BIOCHEM BIOPHYS, V228, P86, DOI 10.1016/0003-9861(84)90049-3; OHLROGGE JB, 1979, P NATL ACAD SCI USA, V76, P1194, DOI 10.1073/pnas.76.3.1194; POSTBEITTENMILLER MA, 1989, PLANT CELL, V1, P889, DOI 10.1105/tpc.1.9.889; Rock C O, 1981, Methods Enzymol, V71 Pt C, P341; ROCK CO, 1981, J BIOL CHEM, V256, P2669; Rolleston FS, 1972, CURRENT TOPICS CELLU, V5, P47; SHIMAKATA T, 1983, J BIOL CHEM, V258, P3592; SHIMAKATA T, 1983, ARCH BIOCHEM BIOPHYS, V220, P39, DOI 10.1016/0003-9861(83)90384-3; SINGH SS, 1986, LIPIDS, V21, P143, DOI 10.1007/BF02534436; SOLL J, 1982, FEBS LETT, V146, P189, DOI 10.1016/0014-5793(82)80732-1; STAPLETON SR, 1984, BIOCHIM BIOPHYS ACTA, V794, P240, DOI 10.1016/0005-2760(84)90151-6; WILLIAMS.IP, 1966, J BIOL CHEM, V241, P2326	31	191	202	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1858	1865						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1988450				2022-12-25	WOS:A1991EU49700075
J	GREVATT, PC; DONAHUE, JM; BHANOT, OS				GREVATT, PC; DONAHUE, JM; BHANOT, OS			THE ROLE OF N3-ETHYLDEOXYTHYMIDINE IN MUTAGENESIS AND CYTOTOXICITY BY ETHYLATING AGENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; ESCHERICHIA-COLI; N-NITROSOUREA; TRANSVERSION MUTATIONS; BASE SUBSTITUTION; ALKYLATING-AGENTS; NEU ONCOGENE; POLYMERASE-I; SITE; ETHYLNITROSOUREA	The significance of DNA ethylation at the central hydrogen-bonding site (N3) of thymine was investigated using an in vitro DNA replication system. The system utilized a primed template in which the 3'-end of the primer is eight nucleotides away from N3-ethyldeoxythymidine (N3-Et-dT), present at template position 26 from the 3'-end. The 34-nucleotide template corresponds to a specific DNA sequences at gene G of bacteriophage phi-X174. DNA synthesis products were quantitated by electrophoretic separation and autoradiography. At 10-mu-M dNTP and 0.5 mM Mn2+ N3-Et-dT blocked DNA synthesis by Escherichia coli polymerase I (Klenow fragment): 60% after incorporating a nucleotide opposite N3-Et-dT (incorporation-dependent blocked product) and 39% 3' to N3-Et-dT. DNA replication past the lesion (post-lesion synthesis) was negligible. Post-lesion synthesis increased using higher concentrations of dNTP, reaching 68% at 200-mu-M dNTP. DNA sequencing revealed that dA was incorporated opposite N3-Et-dT in the incorporation-dependent blocked product. In the post-lesion synthesis product, dT was exclusively incorporated opposite N3-Et-dT. Formation of the N3-Et-dT.dA base pair at the replication fork terminated DNA synthesis, while the N3-Et-dT.dT base pair formed at the 3'-end of the growing chain was extended, leading to an A.T-->T.A transversion mutation. The results suggest a dual role for the N3-Et-dT lesion, contributing in part to the cytotoxicity and mutagenicity of ethylating agents. These studies provide a basis for understanding the activation of oncogene neu by A.T-->T.A transversion mutation in rat neuroblastomas induced by N-ethyl-N-nitrosourea.	NYU MED CTR,DEPT ENVIRONM MED,NEW YORK,NY 10016	New York University					NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007081, P30ES000260] Funding Source: NIH RePORTER; NIEHS NIH HHS [2T 32 ES 07081, ES 00260] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BASU AK, 1988, CHEM RES TOXICOL, V1, P1, DOI 10.1021/tx00001a001; BERANEK DT, 1980, CARCINOGENESIS, V1, P595, DOI 10.1093/carcin/1.7.595; BHANOT OS, 1979, J BIOL CHEM, V254, P2684; BHANOT OS, 1986, P NATL ACAD SCI USA, V83, P7348, DOI 10.1073/pnas.83.19.7348; BHANOT OS, 1990, IN PRESS BIOCHEMISTR; CLARK JM, 1987, J MOL BIOL, V198, P123, DOI 10.1016/0022-2836(87)90462-1; CUOTO L, 1989, J BACTERIOL, V171, P4170; DAS SK, 1983, BIOCHEM BIOPH RES CO, V114, P458, DOI 10.1016/0006-291X(83)90802-1; DRINKWATER NR, 1980, BIOCHEMISTRY-US, V19, P5087, DOI 10.1021/bi00563a023; ECKERT KA, 1987, MUTAT RES, V178, P1, DOI 10.1016/0027-5107(87)90079-0; ECKERT KA, 1988, MOL CARCINOGEN, V1, P50, DOI 10.1002/mc.2940010111; ECKERT KA, 1989, CARCINOGENESIS, V10, P2261, DOI 10.1093/carcin/10.12.2261; ELDEIRY WS, 1988, BIOCHEMISTRY-US, V27, P546, DOI 10.1021/bi00402a007; ENGLUND PT, 1969, J BIOL CHEM, V244, P3038; EVENSEN G, 1982, NATURE, V296, P773, DOI 10.1038/296773a0; FOSTER PL, 1985, J BACTERIOL, V163, P213, DOI 10.1128/JB.163.1.213-220.1985; GREVATT P, 1990, Proceedings of the American Association for Cancer Research Annual Meeting, V31, P100; HEVRONI D, 1988, P NATL ACAD SCI USA, V85, P5046, DOI 10.1073/pnas.85.14.5046; HUFF AC, 1987, J BIOL CHEM, V262, P12843; KUNKEL TA, 1988, J BIOL CHEM, V263, P14784; KUNKEL TA, 1986, J BIOL CHEM, V261, P160; LAWLEY PD, 1963, BIOCHEM J, V89, P127, DOI 10.1042/bj0890127; LEWIS SE, 1985, P NATL ACAD SCI USA, V82, P5829, DOI 10.1073/pnas.82.17.5829; LINDAHL T, 1988, ANNU REV BIOCHEM, V57, P133, DOI 10.1146/annurev.bi.57.070188.001025; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; LIVNEH Z, 1986, J BIOL CHEM, V261, P9526; LOEB LA, 1982, ANNU REV BIOCHEM, V52, P429; LOECHLER EL, 1984, P NATL ACAD SCI-BIOL, V81, P6271, DOI 10.1073/pnas.81.20.6271; MAXAM AM, 1980, METHOD ENZYMOL, V65, P497; MCCARTHY TV, 1984, EMBO J, V3, P545, DOI 10.1002/j.1460-2075.1984.tb01844.x; MENDELMAN LV, 1989, J BIOL CHEM, V264, P14415; MILLER JH, 1983, ANNU REV GENET, V17, P215, DOI 10.1146/annurev.ge.17.120183.001243; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; PERANTONI AO, 1987, P NATL ACAD SCI USA, V84, P6317, DOI 10.1073/pnas.84.17.6317; POPP RA, 1983, GENETICS, V105, P157; PRESTON BD, 1986, P NATL ACAD SCI USA, V83, P8501, DOI 10.1073/pnas.83.22.8501; SAFFHILL R, 1985, CHEM-BIOL INTERACT, V53, P121, DOI 10.1016/S0009-2797(85)80090-9; SAFFHILL R, 1985, BIOCHIM BIOPHYS ACTA, V823, P111, DOI 10.1016/0304-419X(85)90009-5; SINGER B, 1983, P NATL ACAD SCI-BIOL, V80, P4884, DOI 10.1073/pnas.80.16.4884; SINGER B, 1986, CANCER RES, V46, P4879; Singer B., 1983, MOL BIOL MUTAGENS CA; STOWERS SJ, 1988, CARCINOGENESIS, V9, P271, DOI 10.1093/carcin/9.2.271; STRAUSS B, 1982, BIOCHIMIE, V64, P829, DOI 10.1016/S0300-9084(82)80138-7; STRAUSS BS, 1985, CANCER SURV, V4, P493; TAKESHITA M, 1987, J BIOL CHEM, V262, P10171; VOLKIN E, 1983, BIOCHIM BIOPHYS ACTA, V755, P217, DOI 10.1016/0304-4165(83)90206-4; WALKER GC, 1984, MICROBIOL REV, V48, P60, DOI 10.1128/MMBR.48.1.60-93.1984; WITKIN EM, 1976, BACTERIOL REV, V40, P869, DOI 10.1128/MMBR.40.4.869-907.1976; ZIELENSKA M, 1988, ENVIRON MOL MUTAGEN, V11, P473, DOI 10.1002/em.2850110408	50	46	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1269	1275						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985945				2022-12-25	WOS:A1991ET17700090
J	BEAUMONT, A; LEMOUAL, H; BOILEAU, G; CRINE, P; ROQUES, BP				BEAUMONT, A; LEMOUAL, H; BOILEAU, G; CRINE, P; ROQUES, BP			EVIDENCE THAT BOTH ARGININE-102 AND ARGININE-747 ARE INVOLVED IN SUBSTRATE BINDING TO NEUTRAL ENDOPEPTIDASE (EC-3.4.24.11)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOTENSIN-CONVERTING ENZYME; 24.11 ENKEPHALINASE; ACTIVE-SITE; CARBOXYPEPTIDASE-A; LEUKEMIA ANTIGEN; COS-1 CELLS; THERMOLYSIN; KIDNEY; METALLOENDOPEPTIDASE; PURIFICATION	Neutral endopeptidase (EC 3.4.24.11, NEP) is a Zn-metallopeptidase involved in the degradation of biologically active peptides, notably the enkephalins and atrial natriuretic peptide. Recently, the structure of the active site of this enzyme has been probed by site-directed mutagenesis, and 4 amino acid residues have been identified, namely 2 histidines (His583 and His587), which act as zinc-binding ligands, a glutamate (Glu584) involved in catalysis, and an arginine residue (Arg102), suggested to participate in substrate binding. Site-directed mutagenesis has now been used to investigate the role of 4 other arginine residues (Arg408, Arg409, Arg659, and Arg747) that have been proposed as possible active site residues and to further analyze the role of Arg102. In each case, the arginine was replaced with a methionine, and both enzymatic activity and the IC50 values of several NEP inhibitors were measured for the mutated enzymes and compared to wild-type enzyme. The results suggest that 2 arginines, Arg102 and Arg747, could both be important for substrate and inhibitor binding. Arg747 seems to be positioned to interact with the carbonyl amide group of the P1' residue and can be modified when the enzyme is treated with the arginine-specific reagents phenylglyoxal and butanedione. Arg102 could be positioned to interact with the free carboxyl group of a P2' residue in some substrates and inhibitors and can be modified by phenylglyoxal but not by butanedione. The results could explain the dual dipeptidylcarboxypeptidase and endopeptidase nature of NEP.	CNRS,UA 498,INSERM,U266,DEPT CHIM ORGAN,4 AVE OBSERV,F-75270 PARIS 06,FRANCE; UNIV MONTREAL,DEPT BIOCHIM,MONTREAL H3C 3J7,QUEBEC,CANADA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montreal								AUBRY M, 1987, BIOCHEM CELL BIOL, V65, P398, DOI 10.1139/o87-050; BATEMAN RC, 1987, BIOCHEMISTRY-US, V26, P4237, DOI 10.1021/bi00388a009; BATEMAN RC, 1989, J BIOL CHEM, V264, P6151; BEAUMONT A, 1986, BIOCHEM BIOPH RES CO, V139, P733, DOI 10.1016/S0006-291X(86)80052-3; BENCHETRIT T, 1988, BIOCHEMISTRY-US, V27, P592, DOI 10.1021/bi00402a014; BOWES MA, 1986, BIOCHEM J, V236, P801, DOI 10.1042/bj2360801; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHRISTIANSON DW, 1985, P NATL ACAD SCI USA, V82, P6840, DOI 10.1073/pnas.82.20.6840; CONNELLY JC, 1985, P NATL ACAD SCI USA, V82, P8737, DOI 10.1073/pnas.82.24.8737; DANIELSEN EM, 1980, BIOCHEM J, V191, P645, DOI 10.1042/bj1910645; DEVAULT A, 1988, J BIOL CHEM, V263, P4033; DEVAULT A, 1988, FEBS LETT, V231, P54, DOI 10.1016/0014-5793(88)80701-4; DEVAULT A, 1987, EMBO J, V6, P1317, DOI 10.1002/j.1460-2075.1987.tb02370.x; FEHRENTZ JA, 1983, SYNTHESIS-STUTTGART, P676; FERSHT AR, 1985, NATURE, V314, P235, DOI 10.1038/314235a0; FLORENTIN D, 1984, ANAL BIOCHEM, V141, P62, DOI 10.1016/0003-2697(84)90425-1; FOURNIEZALUSKI MC, 1982, LIFE SCI, V31, P2947, DOI 10.1016/0024-3205(82)90060-1; FOURNIEZALUSKI MC, 1984, EUR J BIOCHEM, V139, P267, DOI 10.1111/j.1432-1033.1984.tb08003.x; FOURNIEZALUSKI MC, 1979, BIOCHEM BIOPH RES CO, V91, P130, DOI 10.1016/0006-291X(79)90593-X; FOURNIEZALUSKI MC, 1980, PEPTIDES, P476; GEE NS, 1985, BIOCHEM J, V228, P119, DOI 10.1042/bj2280119; HOLDEN HM, 1987, BIOCHEMISTRY-US, V26, P8542, DOI 10.1021/bi00400a008; HOLMES MA, 1982, J MOL BIOL, V160, P623, DOI 10.1016/0022-2836(82)90319-9; HORNE VA, 1990, GESELLSCHAFT DTSCH C, P5; JACKSON DG, 1986, J BIOL CHEM, V261, P8649; JOHNSON AR, 1985, AM REV RESPIR DIS, V132, P564; JONGENEEL CV, 1989, FEBS LETT, V242, P211, DOI 10.1016/0014-5793(89)80471-5; KENNY AJ, 1988, FEBS LETT, V232, P1, DOI 10.1016/0014-5793(88)80375-2; KERR MA, 1974, BIOCHEM J, V137, P489, DOI 10.1042/bj1370489; KESTER WR, 1977, J BIOL CHEM, V252, P7704; LEMAY G, 1989, J BIOL CHEM, V264, P15620; LETARTE M, 1988, J EXP MED, V168, P1247, DOI 10.1084/jem.168.4.1247; MALFROY B, 1982, BIOCHEM BIOPH RES CO, V106, P276, DOI 10.1016/0006-291X(82)91106-8; MALFROY B, 1978, NATURE, V276, P523, DOI 10.1038/276523a0; MATSAS R, 1983, P NATL ACAD SCI-BIOL, V80, P3111, DOI 10.1073/pnas.80.10.3111; RIORDAN JF, 1979, MOL CELL BIOCHEM, V26, P71; RODREICK SL, 1989, BIOCHEMISTRY-US, V28, P1493; Roques B P, 1986, NIDA Res Monogr, V70, P128; ROQUES BP, 1990, TRENDS PHARMACOL SCI, V11, P245; ROQUES BP, 1980, NATURE, V288, P286, DOI 10.1038/288286a0; ROQUES BP, 1983, P NATL ACAD SCI-BIOL, V80, P3178, DOI 10.1073/pnas.80.11.3178; SHIPP MA, 1989, P NATL ACAD SCI USA, V86, P297, DOI 10.1073/pnas.86.1.297; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8764; Thorsett E. D., 1987, NEUROPEPTIDES THEIR, P229; TURNER AJ, 1987, NEUROPEPTIDES THEIR, P181; VOGEL Z, 1977, FEBS LETT, V80, P332, DOI 10.1016/0014-5793(77)80469-9; [No title captured]	47	69	72	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					214	220						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985894				2022-12-25	WOS:A1991EQ33900033
J	JAHN, D; CHEN, MW; SOLL, D				JAHN, D; CHEN, MW; SOLL, D			PURIFICATION AND FUNCTIONAL-CHARACTERIZATION OF GLUTAMATE-1-SEMIALDEHYDE AMINOTRANSFERASE FROM CHLAMYDOMONAS-REINHARDTII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREENING BARLEY LEAVES; GLUTAMATE 1-SEMIALDEHYDE AMINOTRANSFERASE; DELTA-AMINOLEVULINATE BIOSYNTHESIS; TRANSFER-RNA; CHLOROPHYLL BIOSYNTHESIS; ACID; ENZYMES; GABACULINE; MECHANISM; INHIBITION	The formation of delta-aminolevulinic acid, the first committed precursor of chlorophyll biosynthesis, occurs in the chloroplast of plants and algae by the C5-pathway, a three-step, tRNA-dependent transformation of glutamate. Previously, we reported the purification and characterization of the first two enzyme of this pathway, glutamyl-tRNA synthetase and Glu-tRNA reductase from the green alga Chlamydomonas reinhardtii (Chen, M., Jahn, D., O'Neill, G.P., and Soll, D. (1990) J. Biol. Chem. 25, 4058-4063). Here we present the purification of the third enzyme of the pathway, the glutamate-1-semialdehyde aminotransferase from C. reinhardtii. The enzyme was purified from the membrane fraction of a whole cell extract employing four different chromatographic separations. The apparent molecular mass of the protein was approximately 43,000 Da as analyzed by denaturing sodium dodecyl sulfate-polyacrylamide gel electrophoresis, by nondenaturing rate zonal sedimentation on glycerol gradients, and by gel filtration. By these criteria, the enzyme in its active form is a monomer of 43,000 Da. In the presence of pyridoxal 5'-phosphate, purified glutamate-1-semialdehyde aminotransferase converts synthetic glutamate 1-semialdehyde to delta-aminolevulinic acid. The enzyme is inhibited by gabaculine and aminooxyacetate, both typical inhibitors of aminotransferases. The purified glutamate-1-semialdehyde aminotransferase successfully reconstitutes the whole C5-pathway in vitro from glutamate in the presence of purified glutamyl-tRNA synthetase, glutamyl-tRNA reductase, Mg2+, ATP, NADPH, tRNA, and pyridoxal 5'-phosphate.	YALE UNIV, DEPT MOLEC BIOPHYS & BIOCHEM, NEW HAVEN, CT 06511 USA	Yale University				Jahn, Dieter/0000-0002-4064-9205				Beale S. I., 1990, BIOSYNTHESIS HEME CH, P287; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREU V, 1988, BIOCHIM BIOPHYS ACTA, V967, P135, DOI 10.1016/0304-4165(88)90002-5; BRUYANT P, 1987, CARLSBERG RES COMMUN, V52, P99, DOI 10.1007/BF02910432; CASTELFRANCO PA, 1983, ANNU REV PLANT PHYS, V34, P241, DOI 10.1146/annurev.pp.34.060183.001325; CHEN MW, 1990, J BIOL CHEM, V265, P4054; CHEN MW, 1990, J BIOL CHEM, V265, P4058; Christen P, 1985, TRANSAMINASES; GATEHOUSE PW, 1967, J BIOL CHEM, V242, P2319; Givan CV, 1980, BIOCH PLANTS, P329; GOUGH SP, 1989, CARLSBERG RES COMMUN, V54, P99, DOI 10.1007/BF02908302; GRIMM B, 1989, CARLSBERG RES COMMUN, V54, P67, DOI 10.1007/BF02907586; HOOBER JK, 1988, CARLSBERG RES COMMUN, V53, P11, DOI 10.1007/BF02908411; HOUEN G, 1983, CARLSBERG RES COMMUN, V48, P567, DOI 10.1007/BF02907558; HOUGHTON JD, 1989, CARLSBERG RES COMMUN, V54, P131, DOI 10.1007/BF02907183; HUANG DD, 1986, MOL GEN GENET, V205, P217, DOI 10.1007/BF00430430; HUANG DD, 1986, J BIOL CHEM, V261, P3451; IRELAND RJ, 1985, TRANSAMINASES, P376; JAHN D, 1990, J BIOL CHEM, V265, P8059; JENKINS WT, 1985, TRANSAMINASES, P365; Jordan PM, 1990, BIOSYNTHESIS HEME CH, P55; KANNANGARA CG, 1988, TRENDS BIOCHEM SCI, V13, P139; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI JM, 1989, J BACTERIOL, V171, P2547, DOI 10.1128/jb.171.5.2547-2552.1989; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; MAU YH, 1987, ARCH BIOCHEM BIOPHYS, V255, P75, DOI 10.1016/0003-9861(87)90295-5; MAU YHL, 1988, PLANT PHYSIOL, V86, P793, DOI 10.1104/pp.86.3.793; MAUZERALL D, 1956, J BIOL CHEM, V219, P435; MIFLIN BJ, 1977, ANNU REV PLANT PHYS, V28, P299, DOI 10.1146/annurev.pp.28.060177.001503; OZOLS J, 1990, METHOD ENZYMOL, V182, P225; RANDO RR, 1977, BIOCHEMISTRY-US, V16, P4604, DOI 10.1021/bi00640a012; RATINAUD MH, 1983, EUR J BIOCHEM, V135, P471, DOI 10.1111/j.1432-1033.1983.tb07675.x; SCHON A, 1986, NATURE, V322, P281, DOI 10.1038/322281a0; SCHON A, 1988, NATURE, V331, P187, DOI 10.1038/331187a0; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SOPER TS, 1982, J BIOL CHEM, V257, P3930; SOPER TS, 1985, TRANSAMINASES, P266; WALDSCHMIDT R, 1988, J BIOL CHEM, V263, P13350; WANG WY, 1981, CARLSBERG RES COMMUN, V46, P243, DOI 10.1007/BF02906501; WANG WY, 1984, PLANT PHYSIOL, V74, P569, DOI 10.1104/pp.74.3.569; WEINSTEIN JD, 1985, ARCH BIOCHEM BIOPHYS, V237, P454, DOI 10.1016/0003-9861(85)90299-1	42	40	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					161	167						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985889				2022-12-25	WOS:A1991EQ33900026
J	STUMPO, DJ; BLACKSHEAR, PJ				STUMPO, DJ; BLACKSHEAR, PJ			CELLULAR EXPRESSION OF MUTANT INSULIN-RECEPTORS INTERFERES WITH THE RAPID TRANSCRIPTIONAL RESPONSE TO BOTH INSULIN AND INSULIN-LIKE GROWTH FACTOR-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT HEPATOMA-CELLS; PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; COOH-TERMINAL TRUNCATION; MESSENGER-RNA; KINASE-ACTIVITY; PROTEIN-KINASE; PRIMARY CULTURES; PHOSPHORYLATION; BINDING; ACCUMULATION	We examined the expression of the proto-oncogene c-fos and the early growth response gene, Egr-1, in Rat 1 fibroblasts expressing high levels of normal or mutated human insulin receptors (McClain, D. A., Maegawa, H., Lee, J., Dull, T.J., Ullrich, A., and Olefsky, J.M. (1987) J. Biol. Chem. 262, 14663-14671). In cells expressing large numbers of normal human insulin receptors (HIRc-B cells), insulin (greater-than-or-equal-to 0.7 nM) stimulated the rapid accumulation of mRNAs for both genes. This response was blunted, but not lost, in cells expressing large numbers of human insulin receptors missing 43 amino acids at the carboxyl terminus of the beta-subunit. In contrast, the insulin response was completely absent in cells expressing large numbers of receptors that contained a mutation at the ATP-binding site that destroyed intrinsic protein tyrosine kinase activity (A/K 1018-B cells). this mutation also suppressed the modest transcriptional response to insulin that occurred in the parental Rat 1 cells. The transcriptional response to serum was normal in the A/K 1018-B cells, even after protein kinase C depletion; however, the response to insulin-like growth factor I was essentially lost. These studies suggest that overexpression of a kinase-deficient insulin receptor can suppress the transcriptional response to both insulin and insulin-like growth factor I that is ordinarily transduced through endogenous insulin and insulin-like growth factor I receptors, respectively. Competition for shared substrates of these related receptor kinases is a potential mechanism for this effect.	DUKE UNIV,MED CTR,HOWARD HUGHES MED INST LABS,BOX 3897,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT MED,DIV ENDOCRINOL METAB & GENET,DIABET & METAB SECT,DURHAM,NC 27710	Duke University; Duke University			Blackshear, Perry J./C-6206-2019	Blackshear, Perry J./0000-0002-9561-8529				ALEXANDER M, 1985, J BIOL CHEM, V260, P1978; ALEXANDER M, 1986, MECHANISMS INSULIN A, V7, P395; ANDREONE TL, 1982, J BIOL CHEM, V257, P35; BERGERON JJM, 1985, ANNU REV PHYSIOL, V47, P383; BLACKSHEAR PJ, 1987, MOL ENDOCRINOL, V1, P44, DOI 10.1210/mend-1-1-44; BLACKSHEAR PJ, 1985, J BIOL CHEM, V260, P3304; BOLANDER FF, 1981, P NATL ACAD SCI-BIOL, V78, P5682, DOI 10.1073/pnas.78.9.5682; CHOU CK, 1987, J BIOL CHEM, V262, P1842; CIMBALA MA, 1982, J BIOL CHEM, V257, P7629; DANI C, 1986, MECHANISMS INSULIN A, V7, P383; EBINA Y, 1987, P NATL ACAD SCI USA, V84, P704, DOI 10.1073/pnas.84.3.704; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; EVANS MI, 1984, ENDOCRINOLOGY, V115, P368, DOI 10.1210/endo-115-1-368; FLAIM KE, 1985, AM J PHYSIOL, V249, pE447, DOI 10.1152/ajpendo.1985.249.5.E447; FREYCHET P, 1971, P NATL ACAD SCI USA, V68, P1833, DOI 10.1073/pnas.68.8.1833; GRANNER D, 1983, NATURE, V305, P549, DOI 10.1038/305549a0; HOVIS JG, 1986, J BIOL CHEM, V261, P380; KAHN CR, 1978, P NATL ACAD SCI USA, V75, P4209, DOI 10.1073/pnas.75.9.4209; KASUGA M, 1982, SCIENCE, V215, P185, DOI 10.1126/science.7031900; MAEGAWA H, 1988, J BIOL CHEM, V263, P12629; MAEGAWA H, 1988, J BIOL CHEM, V263, P8912; MCCLAIN DA, 1987, J BIOL CHEM, V262, P14663; MCCLAIN DA, 1988, J BIOL CHEM, V263, P8904; MCCLAIN DA, 1990, J BIOL CHEM, V265, P1678; MESSINA JL, 1985, BIOCHEM BIOPH RES CO, V133, P1168, DOI 10.1016/0006-291X(85)91259-8; MESSINA JL, 1985, J BIOL CHEM, V260, P6418; RECHLER MM, 1985, ANNU REV PHYSIOL, V47, P425; ROSEN OM, 1983, P NATL ACAD SCI-BIOL, V80, P3237, DOI 10.1073/pnas.80.11.3237; ROSEN OM, 1987, SCIENCE, V237, P1452, DOI 10.1126/science.2442814; SASAKI K, 1984, J BIOL CHEM, V259, P5242; SCHREIBER AB, 1983, J BIOL CHEM, V258, P846; STUMPO DJ, 1986, P NATL ACAD SCI USA, V83, P9453, DOI 10.1073/pnas.83.24.9453; STUMPO DJ, 1984, EUR J BIOCHEM, V144, P497, DOI 10.1111/j.1432-1033.1984.tb08493.x; SUKHATME VP, 1987, ONCOGENE RES, V1, P343; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; TAUB R, 1987, J BIOL CHEM, V262, P10893; THIES RS, 1989, J BIOL CHEM, V264, P12820; YOOWARREN H, 1981, J BIOL CHEM, V256, P224	38	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					455	460						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985910				2022-12-25	WOS:A1991EQ33900066
J	KOHNO, K; SATO, S; UCHIUMI, T; TAKANO, H; KATO, S; KUWANO, M				KOHNO, K; SATO, S; UCHIUMI, T; TAKANO, H; KATO, S; KUWANO, M			TISSUE-SPECIFIC ENHANCER OF THE HUMAN MULTIDRUG-RESISTANCE (MDR1) GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									SAGAMI CHEM RES CTR,SAGAMIHARA,KANAGAWA 229,JAPAN		KOHNO, K (corresponding author), OITA MED SCH,DEPT BIOCHEM,OITA 87956,JAPAN.							AKIYAMA SI, 1985, SOMAT CELL MOLEC GEN, V11, P117, DOI 10.1007/BF01534700; BATES SE, 1989, MOL CELL BIOL, V9, P4337, DOI 10.1128/MCB.9.10.4337; BIEDLER JL, 1970, CANCER RES, V30, P1174; BRADLEY G, 1988, BIOCHIM BIOPHYS ACTA, V948, P87, DOI 10.1016/0304-419X(88)90006-6; BURT RK, 1988, J NATL CANCER I, V80, P1383, DOI 10.1093/jnci/80.17.1383; CORNWELL MM, 1986, J BIOL CHEM, V261, P7921; CROOP JM, 1989, MOL CELL BIOL, V9, P1346, DOI 10.1128/MCB.9.3.1346; FOJO AT, 1987, P NATL ACAD SCI USA, V84, P265, DOI 10.1073/pnas.84.1.265; FUJISAWASEHARA A, 1988, P NATL ACAD SCI USA, V85, P5859, DOI 10.1073/pnas.85.16.5859; FUJISAWASEHARA A, 1987, NUCLEIC ACIDS RES, V15, P4179, DOI 10.1093/nar/15.10.4179; GOLDSTEIN LJ, 1989, J NATL CANCER I, V81, P116, DOI 10.1093/jnci/81.2.116; GONZALEZ FJ, 1985, J BIOL CHEM, V260, P5040; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; KARTNER N, 1983, SCIENCE, V221, P1285, DOI 10.1126/science.6137059; KOHNO K, 1988, BIOCHEM BIOPH RES CO, V154, P483, DOI 10.1016/0006-291X(88)90712-7; KOHNO K, 1989, BIOCHEM BIOPH RES CO, V165, P1415, DOI 10.1016/0006-291X(89)92761-7; KOHNO K, 1985, J BIOL CHEM, V260, P4441; KOHNO K, 1988, JPN J CANCER RES, V80, P475; LING V, 1974, J CELL PHYSIOL, V83, P103, DOI 10.1002/jcp.1040830114; LOPATA MA, 1984, NUCLEIC ACIDS RES, V12, P5707, DOI 10.1093/nar/12.14.5707; MA DDF, 1987, LANCET, V1, P135; MERMOD N, 1988, NATURE, V332, P557, DOI 10.1038/332557a0; MICKLEY LA, 1989, J BIOL CHEM, V264, P18031; NAKAGAWARA A, 1990, CANCER RES, V50, P3043; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCOTTO KW, 1986, SCIENCE, V232, P751, DOI 10.1126/science.2421411; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SOGAWA K, 1986, P NATL ACAD SCI USA, V83, P8044, DOI 10.1073/pnas.83.21.8044; SUGIMOTO Y, 1987, MOL CELL BIOL, V7, P4549, DOI 10.1128/MCB.7.12.4549; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; UEDA K, 1987, J BIOL CHEM, V262, P17432; WINGENDER E, 1988, NUCLEIC ACIDS RES, V16, P1879, DOI 10.1093/nar/16.5.1879; YOSHIMURA A, 1989, J BIOL CHEM, V264, P16282	35	71	71	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1990	265	32					19690	19696						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ188	1978833				2022-12-25	WOS:A1990EJ18800051
J	BROSS, P; ENGST, S; STRAUSS, AW; KELLY, DP; RASCHED, I; GHISLA, S				BROSS, P; ENGST, S; STRAUSS, AW; KELLY, DP; RASCHED, I; GHISLA, S			CHARACTERIZATION OF WILD-TYPE AND AN ACTIVE-SITE MUTANT OF HUMAN MEDIUM CHAIN ACYL-COA DEHYDROGENASE AFTER EXPRESSION IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note									WASHINGTON UNIV,SCH MED,DEPT BIOCHEM & MOLEC BIOPHYS,ST LOUIS,MO 63110	Washington University (WUSTL)	BROSS, P (corresponding author), UNIV CONSTANCE,FAC BIOL,POB 5560,W-7750 CONSTANCE,GERMANY.		Bross, Peter/B-7219-2013; Kelly, Daniel/ABG-2056-2021	Bross, Peter/0000-0001-9526-8525; 				BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; FENDRICH G, 1982, BIOCHEMISTRY-US, V21, P6685, DOI 10.1021/bi00269a011; FINOCCHIARO G, 1987, J BIOL CHEM, V262, P7982; GHISLA S, 1990, IN PRESS NEW TRENDS; HORII T, 1980, P NATL ACAD SCI-BIOL, V77, P313, DOI 10.1073/pnas.77.1.313; IKEDA Y, 1986, PEDIATR RES, V20, P843, DOI 10.1203/00006450-198609000-00007; KELLY DP, 1987, P NATL ACAD SCI USA, V84, P4068, DOI 10.1073/pnas.84.12.4068; KIM JJP, 1988, P NATL ACAD SCI USA, V85, P6677, DOI 10.1073/pnas.85.18.6677; Maniatis T., 1982, MOL CLONING; MASSEY V, 1974, ANN NY ACAD SCI, V227, P446, DOI 10.1111/j.1749-6632.1974.tb14407.x; MATSUBARA Y, 1989, J BIOL CHEM, V264, P16321; MATSUBARA Y, 1987, J BIOL CHEM, V262, P10104; POHL B, 1986, EUR J BIOCHEM, V160, P109, DOI 10.1111/j.1432-1033.1986.tb09946.x; POWELL PJ, 1988, BIOCHEMISTRY-US, V27, P8022, DOI 10.1021/bi00421a008; POWELL PJ, 1987, BIOCHEMISTRY-US, V26, P3704, DOI 10.1021/bi00386a066; RINALDO P, 1988, NEW ENGL J MED, V319, P1308, DOI 10.1056/NEJM198811173192003; SOBERON X, 1980, GENE, V9, P287, DOI 10.1016/0378-1119(90)90328-O; STRAUSS AW, 1990, FATTY ACID OXIDATION, P609; THORPE C, 1979, BIOCHEMISTRY-US, V18, P331, DOI 10.1021/bi00569a016; VIANEYLIAUD C, 1987, J INHERIT METAB DIS, V10, P159, DOI 10.1007/BF01812855; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WENZ A, 1981, J BIOL CHEM, V256, P9809; WILLIAMSON G, 1982, J BIOL CHEM, V257, P4314; ZOLLER MJ, 1983, METHOD ENZYMOL, V100, P468	24	83	83	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1990	265	13					7116	7119						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DB307	1970566				2022-12-25	WOS:A1990DB30700007
J	BAKER, BJ; DOTZLAF, JE; YEH, WK				BAKER, BJ; DOTZLAF, JE; YEH, WK			DEACETOXYCEPHALOSPORIN-C HYDROXYLASE OF STREPTOMYCES-CLAVULIGERUS - PURIFICATION, CHARACTERIZATION, BIFUNCTIONALITY, AND EVOLUTIONARY IMPLICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOPENICILLIN-N SYNTHETASE; ESCHERICHIA-COLI; CEPHALOSPORIUM-ACREMONIUM; INITIAL CHARACTERIZATION; PENICILLIN BIOSYNTHESIS; SEQUENCE DETERMINATION; ASPERGILLUS-NIDULANS; EXPRESSION; CLONING; ENZYME	Deacetoxycephalosporin C hydroxylase from cell-free extracts of Streptomyces clavuligerus was stabilized partially and purified to near homogeneity by three anion-exchange chromatographies, ammonium sulfate fractionation, and two gel filtrations. The hydroxylase was a monomer with a M(r) of 35,000-38,000. Alpha-Ketoglutarate, ferrous iron, and molecular oxygen were required for the enzyme activity. The hydroxylase was optimally active between pH 7.0 and 7.4 in a 3-(N-morpholino)propanesulfonic acid buffer and at 29-degrees-C. It was stimulated by a reducing agent, particularly dithiothreitol or reduced glutathione, and ATP. The requirement for ferrous ion was specific, and at least one sulfhydryl group was apparently essential for the enzymatic hydroxylation. The K(m) values of the hydroxylase for deacetoxycephalosporin C and alpha-ketoglutarate were 59 and 10-mu-M, respectively, and the K(a) for ferrous ion was 20-mu-M. In addition to its known hydroxylation of deacetoxycephalosporin C to deacetylcephalosporin C, the hydroxylase catalyzed effectively an analogous hydroxylation of 3-exomethylenecephalosporin C to deacetoxycephalosporin C. Surprisingly, the hydroxylase also mediated slightly a novel ring-expansion of penicillin N to deacetoxycephalosporin C. The substrate specificity of the hydroxylase is overlapping with but distinguishable from that of deacetoxycephalosporin C synthase, the enzyme which normally mediates the ring-expansion reaction (Dotzlaf, J. E., and Yeh, W. K. (1989) J. Biol. Chem. 264, 10219-10227). Furthermore, the hydroxylase exhibited an extensive sequence similarity to the synthase. Thus, the two enzymes catalyzing the consecutive reactions for cephamycin C biosynthesis in S. clavuligerus represent apparent products from a divergent evolution.	ELI LILLY & CO,LILLY RES LAB,LILLY CORP CTR,DIV ELI LILLY & CO,INDIANAPOLIS,IN 46285	Eli Lilly			Baker, Bradley/P-5047-2016	Baker, Bradley/0000-0003-4652-5585				BALDWIN JE, 1987, J CHEM SOC CHEM COMM, P1556, DOI 10.1039/c39870001556; BALDWIN JE, 1987, BIOCHEM J, V245, P831, DOI 10.1042/bj2450831; BLACKSHEAR PJ, 1984, METHOD ENZYMOL, V104, P237; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CANTWELL CA, 1990, CURR GENET, V17, P213, DOI 10.1007/BF00312612; CARR LG, 1986, GENE, V48, P257, DOI 10.1016/0378-1119(86)90084-3; Cleland W. W, 1970, ENZYMES, V2, P1; CORTES J, 1987, J GEN MICROBIOL, V133, P3165; DOTZLAF JE, 1987, J BACTERIOL, V169, P1611, DOI 10.1128/jb.169.4.1611-1618.1987; DOTZLAF JE, 1989, J BIOL CHEM, V264, P10219; HOLLANDER IJ, 1984, SCIENCE, V224, P610, DOI 10.1126/science.6546810; HOROWITZ N. H., 1965, P15; INGOLIA TD, 1989, MED RES REV, V9, P245, DOI 10.1002/med.2610090206; JENSEN SE, 1986, CAN J MICROBIOL, V32, P953, DOI 10.1139/m86-176; JENSEN SE, 1985, J ANTIBIOT, V38, P263, DOI 10.7164/antibiotics.38.263; KOMATSU K, 1988, Patent No. 74488; KOVACEVIC S, 1989, J BACTERIOL, V171, P754, DOI 10.1128/jb.171.2.754-760.1989; KOVACEVIC S, 1990, J BACTERIOL, V172, P3952, DOI 10.1128/jb.172.7.3952-3958.1990; KOVACEVIC S, 1991, J BACTERIOL, V173, P398, DOI 10.1128/jb.173.1.398-400.1991; LAIZ L, 1990, J GEN MICROBIOL, V136, P663, DOI 10.1099/00221287-136-4-663; LESKIW BK, 1988, GENE, V62, P187, DOI 10.1016/0378-1119(88)90557-4; MARCHALONIS JJ, 1971, COMP BIOCHEM PHYSIOL, V38, P609, DOI 10.1016/0305-0491(71)90316-6; NAGARAJAN R, 1971, J AM CHEM SOC, V93, P2308, DOI 10.1021/ja00738a035; PANG CP, 1984, BIOCHEM J, V222, P789, DOI 10.1042/bj2220789; QUEENER SW, 1990, ANTIMICROB AGENTS CH, V34, P943, DOI 10.1128/AAC.34.6.943; RAMOS FR, 1985, ANTIMICROB AGENTS CH, V27, P380, DOI 10.1128/AAC.27.3.380; ROLLINS MJ, 1988, CAN J MICROBIOL, V34, P1196, DOI 10.1139/m88-210; SAMSON SM, 1985, NATURE, V318, P191, DOI 10.1038/318191a0; SAMSON SM, 1987, BIO-TECHNOL, V5, P1207, DOI 10.1038/nbt1187-1207; SKATRUD PL, 1989, BIO-TECHNOL, V7, P477, DOI 10.1038/nbt0589-477; SPORTSMAN JR, 1985, J IMMUNOL, V135, P158; USUI S, 1989, BIOCHIM BIOPHYS ACTA, V999, P78, DOI 10.1016/0167-4838(89)90033-2; VANLIEMPT H, 1989, J BIOL CHEM, V264, P3680; WEIGEL BJ, 1988, J BACTERIOL, V170, P3817, DOI 10.1128/jb.170.9.3817-3826.1988; YEH WK, 1978, J BIOL CHEM, V253, P4920; YEH WK, 1991, IN PRESS ANN NY ACAD	36	35	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					5087	5093						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002049				2022-12-25	WOS:A1991FC21700062
J	MCILROY, BK; WALTERS, JD; BLACKSHEAR, PJ; JOHNSON, JD				MCILROY, BK; WALTERS, JD; BLACKSHEAR, PJ; JOHNSON, JD			PHOSPHORYLATION-DEPENDENT BINDING OF A SYNTHETIC MARCKS PEPTIDE TO CALMODULIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PROMINENT CELLULAR SUBSTRATE; BRAIN SYNAPTOSOMES; PHORBOL ESTERS; LIGHT CHAIN; PURIFICATION; ASSAY; PHOSPHATASE; CHICKEN; CALCIUM	A 25-amino acid peptide, containing the four protein kinase C (PKC) phosphorylation sites and the calmodulin (CaM) binding domain of the myristoylated alanine-rich C kinase substrate (MARCKS) protein, has been synthesized and used to determine the effects of phosphorylation on its binding and regulation of CaM. PKC phosphorylation of this peptide (3.0 mol of P(i)/mol of peptide) produced a 200-fold decrease in its affinity for CaM. PKC phosphorylation of the peptide resulted in its dissociation from CaM over a time course that paralleled the phosphorylation of 1 mol of serine/mol of peptide. The peptide inhibited CaM's binding to myosin light chain kinase and CaM's stimulation of phosphodiesterase and calcineurin. PKC phosphorylation of the peptide resulted in a rapid release of bound CaM, allowing its subsequent binding to myosin light chain kinase (t1/2 = 1.6 min), stimulation of phosphodiesterase (t1/2 = 1.2 min) and calcineurin (t1/2 = 1.7 min). Partially purified MARCKS protein produced a similar inhibition of CaM-phosphodiesterase which was reversed by PKC phosphorylation. PKC phosphorylation of the peptide occurred primarily at serine 8 and serine 12, and phosphorylation of serine 12 regulated peptide affinity for CaM. Thus, PKC phosphorylation of the peptide and the MARCKS protein results in the rapid release of CaM and the subsequent activation of CaM-dependent enzymes. This process might allow for interplay between PKC and CaM-dependent signal transduction pathways.	OHIO STATE UNIV,COLL MED,DEPT MED BIOCHEM,5170 GRAVES HALL,333 W 10TH AVE,COLUMBUS,OH 43210; OHIO STATE UNIV,COLL MED,COLL DENT,COLUMBUS,OH 43210; HOWARD HUGHES MED INST LABS,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT MED,DIV ENDOCRINOL METAB & GENET,DIABET & METAB SECT,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT BIOCHEM,DURHAM,NC 27710	Ohio State University; Ohio State University; Duke University; Duke University			Blackshear, Perry J./C-6206-2019	Blackshear, Perry J./0000-0002-9561-8529	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033727] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE00188] Funding Source: Medline; NIDDK NIH HHS [DK33727] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALBERT KA, 1987, P NATL ACAD SCI USA, V84, P7046, DOI 10.1073/pnas.84.20.7046; ALEXANDER KA, 1987, J BIOL CHEM, V262, P6108; ALEXANDER KA, 1988, J BIOL CHEM, V263, P7544; ANTHONY FA, 1986, ANAL BIOCHEM, V155, P103, DOI 10.1016/0003-2697(86)90232-0; APEL ED, 1990, BIOCHEMISTRY-US, V29, P2330, DOI 10.1021/bi00461a017; BLACKSHEAR PJ, 1986, J BIOL CHEM, V261, P1459; GIRARD PR, 1990, J NEUROCHEM, V54, P300, DOI 10.1111/j.1471-4159.1990.tb13315.x; GRAFF JM, 1989, J BIOL CHEM, V264, P21818; GRAFF JM, 1989, J BIOL CHEM, V264, P11912; HUANG KP, 1986, BIOCHEM BIOPH RES CO, V139, P320, DOI 10.1016/S0006-291X(86)80116-4; JOHNSON JD, 1980, J BIOL CHEM, V255, P9635; JOHNSON JD, 1986, MED RES REV, V6, P341, DOI 10.1002/med.2610060304; JOHNSON JD, 1983, BIOCHEM J, V211, P473, DOI 10.1042/bj2110473; JOHNSON JD, 1987, ANAL BIOCHEM, V162, P291, DOI 10.1016/0003-2697(87)90039-X; KENNELLY PJ, 1987, J BIOL CHEM, V262, P11958; Klee CB, 1985, CONTROL MANIPULATION, P131; LINDEN DJ, 1989, BRAIN RES REV, V14, P279, DOI 10.1016/0165-0173(89)90004-0; LIU YC, 1990, TRENDS PHARMACOL SCI, V11, P107; MEANS AR, 1982, PHYSIOL REV, V62, P1, DOI 10.1152/physrev.1982.62.1.1; MILLS JS, 1988, BIOCHEMISTRY-US, V27, P991, DOI 10.1021/bi00403a023; Neidel J.E., 1986, PHOSPHOINOSITIDES RE, P47; NICHOLS RA, 1987, J NEUROCHEM, V48, P615, DOI 10.1111/j.1471-4159.1987.tb04137.x; NISHIZUKA Y, 1984, SCIENCE, V225, P1365, DOI 10.1126/science.6147898; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; PATELJ, 1987, J BIOL CHEM, V262, P16686; RASSMUSSEN CD, 1989, EMBO J, V8, P73; RODRIGUEZPENA A, 1986, BIOCHEM BIOPH RES CO, V140, P379, DOI 10.1016/0006-291X(86)91101-0; SAITOH T, 1986, BRAIN RES, V379, P196, DOI 10.1016/0006-8993(86)90277-5; SHARMA RK, 1983, METHOD ENZYMOL, V102, P210; STUMPO DJ, 1989, P NATL ACAD SCI USA, V86, P4012, DOI 10.1073/pnas.86.11.4012; THELEN M, 1990, P NATL ACAD SCI USA, V87, P5603, DOI 10.1073/pnas.87.15.5603; TOKUMITSU H, 1989, BIOCHEM BIOPH RES CO, V163, P581, DOI 10.1016/0006-291X(89)92177-3; TRIFARO JM, 1989, NEUROSCIENCE, V29, P1, DOI 10.1016/0306-4522(89)90327-8; TSUKUDA M, 1988, BIOCHEM BIOPH RES CO, V155, P1387, DOI 10.1016/S0006-291X(88)81295-6; TUCKER RW, 1989, J CELL BIOCHEM, V39, P139, DOI 10.1002/jcb.240390206; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; WALTERS JD, 1990, J BIOL CHEM, V265, P4223; WOODGETT JR, 1987, CELL MEMBRANES METHO, V3, P215; WU WCS, 1982, P NATL ACAD SCI-BIOL, V79, P5249, DOI 10.1073/pnas.79.17.5249; YOSHIDA M, 1986, J BIOCHEM-TOKYO, V99, P1027, DOI 10.1093/oxfordjournals.jbchem.a135566	40	137	137	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4959	4964						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	2002042				2022-12-25	WOS:A1991FC21700045
J	BRYANT, C; HUBBARD, L; MCELROY, WD				BRYANT, C; HUBBARD, L; MCELROY, WD			CLONING, NUCLEOTIDE-SEQUENCE, AND EXPRESSION OF THE NITROREDUCTASE GENE FROM ENTEROBACTER-CLOACAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; NITROFURAN REDUCTASES; 1-NITROPYRENE; PROTEINS; NITROCELLULOSE; ANTIBODY; PROBES; DNA	The "classical" nitroreductases of enteric bacteria are flavoproteins which catalyze the reduction of a variety of nitroaromatic compounds to metabolites which are highly toxic, mutagenic, or carcinogenic. The gene for the nitroreductase Enterobacter cloacae has now been cloned using an antibody specific to this protein. The nucleotide sequence of the structural gene and flanking regions are reported. Sequence analysis indicates that this gene belongs to a gene family of flavoproteins which have not been previously described. Analysis of the 5'-untranslated region reveals the presence of putative regulatory elements which may be involved in the modulation of the expression of this enzyme. The cloned gene was placed under the control of a T7 promoter for overexpression of the protein in Escherichia coli. The expressed recombinant protein was purified to homogeneity and exhibited physical, spectral, and catalytic properties identical to the protein isolated from E. cloacae.			BRYANT, C (corresponding author), UNIV CALIF SAN DIEGO,DEPT CHEM,M-001,LA JOLLA,CA 92093, USA.							BRYANT C, 1991, J BIOL CHEM, V266, P4119; BRYANT DW, 1981, CAN J MICROBIOL, V27, P81, DOI 10.1139/m81-013; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; COHEN SM, 1978, NITROFURANS CHEM MET, P171; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOI T, 1983, CHEM PHARM BULL, V31, P1105; HARTTER DR, 1985, TOXICITY NITROAROMAT, P1; HEFLICH RH, 1985, MUTAT RES, V149, P25, DOI 10.1016/0027-5107(85)90005-3; HOOPES BC, 1987, ESCHERICHIA COLI SAL, V2, P1231; HORIE S, 1982, J BIOCHEM, V92, P661, DOI 10.1093/oxfordjournals.jbchem.a133977; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; KINOUCHI T, 1983, APPL ENVIRON MICROB, V46, P596, DOI 10.1128/AEM.46.3.596-604.1983; KULIOPULOS N, 1967, P NATL ACAD SCI USA, V84, P8893; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEARY JJ, 1983, P NATL ACAD SCI-BIOL, V80, P4045, DOI 10.1073/pnas.80.13.4045; MIRSALIS JC, 1982, NATURE, V295, P322, DOI 10.1038/295322a0; NARAI N, 1984, J PHARMACOBIO-DYNAM, V7, P407; ROSENBERG M, 1979, ANNU REV GENET, V13, P319, DOI 10.1146/annurev.ge.13.120179.001535; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TATSUMI K, 1982, J PHARMACOBIO-DYNAM, V5, P423; VANCE WA, 1984, ENVIRON MUTAGEN, V6, P797, DOI 10.1002/em.2860060607; WATANABE M, 1990, NUCLEIC ACIDS RES, V18, P1059, DOI 10.1093/nar/18.4.1059; WHEELER LA, 1975, J PHARMACOL EXP THER, V194, P135; WIERENGA RK, 1985, BIOCHEMISTRY-US, V24, P1346, DOI 10.1021/bi00327a012; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194	26	70	78	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4126	4130						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999406				2022-12-25	WOS:A1991FA69400019
J	MURPHY, JE; PLEASURE, IT; PUSZKIN, S; PRASAD, K; KEEN, JH				MURPHY, JE; PLEASURE, IT; PUSZKIN, S; PRASAD, K; KEEN, JH			CLATHRIN ASSEMBLY PROTEIN AP-3 - THE IDENTITY OF THE 155K PROTEIN, AP-180, AND NP185 AND DEMONSTRATION OF A CLATHRIN BINDING DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COATED VESICLE PROTEINS; POLYACRYLAMIDE-GEL ELECTROPHORESIS; MONOCLONAL-ANTIBODIES; MOLECULAR-CLONING; PLASMA-MEMBRANE; IDENTIFICATION; PURIFICATION; POLYPEPTIDES; PHOSPHORYLATION; RECEPTORS	Three independently isolated clathrin-associated proteins have been reported that have molecular weights of approximately 155,000-185,000 on sodium dodecyl sulfate-polyacrylamide gel electrophoresis: the 155K protein (Keen, J. H., and Black, M. M. (1986) J. Cell Biol. 102, 1325-1333), AP 180 (Ahle, S., and Ungewickell, E. (1986) EMBO J. 5, 3143-3149), and NP185 (Kohtz, D. S., and Puszkin, S. (1988) J. Biol. Chem. 263, 7418-7425). Using two-dimensional isoelectric focusing polyacrylamide gel electrophoresis and one- and two-dimensional immunoblots with two different monoclonal antibodies, we show that these three proteins are identical. The term AP-3 is used to denote this protein. A preliminary analysis of the domain structure of AP-3 was done by controlled proteolysis. Trypsin treatment of AP-3 yields two distinct classes of products. The larger fragments obtained (100,000-135,000 apparent M(r)) are acidic and behave anomalously on gel electrophoresis, yielding aberrantly high M(r) and exhibiting poor dye binding; these characteristics are shared with intact AP-3. Trypsin also generates a smaller neutral species of almost-equal-to 30,000 Da which migrates appropriately on sodium dodecyl sulfate-gel electrophoresis, binds dye comparatively strongly, and behaves as a monomeric globular species in solution. In addition, this species, which is also released by a variety of other proteases, binds specifically and reversibly to clathrin-Sepharose, identifying it as a clathrin recognition domain.	CUNY MT SINAI SCH MED,DEPT PATHOL,NEW YORK,NY 10029; TEMPLE UNIV,HLTH SCI CTR,SCH MED,DEPT BIOCHEM,PHILADELPHIA,PA 19140	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	MURPHY, JE (corresponding author), TEMPLE UNIV,HLTH SCI CTR,SCH MED,FELS INST CANC RES & MOLEC BIOL,PHILADELPHIA,PA 19140, USA.				NIGMS NIH HHS [GM-28526] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028526] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHLE S, 1989, J BIOL CHEM, V264, P20089; AHLE S, 1986, EMBO J, V5, P3143, DOI 10.1002/j.1460-2075.1986.tb04621.x; AHLE S, 1988, EMBO J, V7, P919, DOI 10.1002/j.1460-2075.1988.tb02897.x; BARZVI D, 1988, J BIOL CHEM, V263, P4408; BLACK MM, 1984, BRAIN RES, V295, P255, DOI 10.1016/0006-8993(84)90974-0; BRODSKY FM, 1988, SCIENCE, V242, P1396, DOI 10.1126/science.2904698; BRYAN J, 1989, J MUSCLE RES CELL M, V10, P95, DOI 10.1007/BF01739964; DAHMS NM, 1989, J BIOL CHEM, V264, P12115; EARNSHAW WC, 1987, J CELL BIOL, V104, P817, DOI 10.1083/jcb.104.4.817; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; HEUSER JE, 1988, J CELL BIOL, V107, P877, DOI 10.1083/jcb.107.3.877; JACKSON AP, 1987, NATURE, V326, P154, DOI 10.1038/326154a0; KEEN JH, 1986, J CELL BIOL, V103, pA54; KEEN JH, 1986, J CELL BIOL, V102, P1325, DOI 10.1083/jcb.102.4.1325; KEEN JH, 1990, ANNU REV BIOCHEM, V59, P415, DOI 10.1146/annurev.biochem.59.1.415; KEEN JH, 1989, BIOCHEM BIOPH RES CO, V158, P17, DOI 10.1016/S0006-291X(89)80170-6; KEEN JH, 1987, J CELL BIOL, V105, P1989, DOI 10.1083/jcb.105.5.1989; KEEN JH, 1985, ENDOCYTOSIS, P85; KIRCHHAUSEN T, 1987, P NATL ACAD SCI USA, V84, P8805, DOI 10.1073/pnas.84.24.8805; KOHTZ DS, 1988, J BIOL CHEM, V263, P7418; LEE VMY, 1987, J NEUROSCI, V7, P3474; MORRIS SA, 1990, J BIOL CHEM, V265, P3354; MORRIS SA, 1989, CURR OPINION CELL BI, V1, P688; PEARSE BMF, 1984, EMBO J, V3, P1951, DOI 10.1002/j.1460-2075.1984.tb02075.x; PEARSE BMF, 1988, EMBO J, V7, P3331, DOI 10.1002/j.1460-2075.1988.tb03204.x; PENG I, 1985, BRAIN RES, V361, P200, DOI 10.1016/0006-8993(85)91290-9; PONNAMBALAM S, 1990, J BIOL CHEM, V265, P4814; PRASAD K, 1988, BIOCHEMISTRY-US, V27, P6098, DOI 10.1021/bi00416a040; ROBINSON MS, 1989, J CELL BIOL, V108, P833, DOI 10.1083/jcb.108.3.833; ROBINSON MS, 1987, J CELL BIOL, V104, P887, DOI 10.1083/jcb.104.4.887; TAKANO E, 1988, BIOCHEMISTRY-US, V27, P1964, DOI 10.1021/bi00406a024; UNGEWICKELL E, 1989, ANAL BIOCHEM, V179, P352, DOI 10.1016/0003-2697(89)90143-7; VIGERS GPA, 1986, EMBO J, V5, P2079, DOI 10.1002/j.1460-2075.1986.tb04469.x; ZAREMBA S, 1983, J CELL BIOL, V97, P1339, DOI 10.1083/jcb.97.5.1339; ZAREMBA S, 1985, J CELL BIOCHEM, V28, P47, DOI 10.1002/jcb.240280108	35	73	73	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4401	4408						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1999423				2022-12-25	WOS:A1991FA69400060
J	QIAN, Z; DREWES, LR				QIAN, Z; DREWES, LR			CROSS-TALK BETWEEN RECEPTOR-REGULATED PHOSPHOLIPASE-D AND PHOSPHOLIPASE-C IN BRAIN	FASEB JOURNAL			English	Note						RECEPTOR; PHOSPHOLIPASE-D; PHOSPHOLIPASE-C; SYNAPTOSOME; PHOSPHATIDYLCHOLINE	LIVER PLASMA-MEMBRANES; PHOSPHATIDIC-ACID; RAT-BRAIN; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; DIACYLGLYCEROL FORMATION; INOSITOL TRISPHOSPHATE; GUANINE-NUCLEOTIDE; GROWTH-FACTOR; STIMULATION; HEPATOCYTES	Because receptors, G proteins, and phospholipases all exist within a membrane lipid environment, it is not unreasonable to assume that an enzyme capable of changing the lipid environment can affect the coupling relationship among these signal transducing components. Our previous study showed that a muscarinic acetylcholine receptor regulates phosphatidylcholine phospholipase D via a G protein in brain. We demonstrate here that phosphatidylinositol phospholipase C and phosphatidylcholine phospholipase D are simultaneously activated within 15 s by muscarine in the presence of 1-mu-M GTP-gamma-S. More important, inhibition of phospholipase D by zinc attenuated carbamylcholine-induced activation of phospholipase C by 30%. Our additional evidence strongly indicates that the receptor-regulated phospholipase D plays an important modulatory role in agonist-stimulated phosphatidylinositol breakdown. This modulatory effect may be achieved by changing the membrane microenvironment in which phospholipase C and phosphoinositol lipids reside, consequently amplifying the inositol phospholipid signaling process. Our results lead us to postulate that the potential interaction between two different signaling pathways may provide a cell with intracellular coordination and enable the cell to achieve functional responses.	UNIV MINNESOTA,SCH MED,DEPT BIOCHEM & MOLEC BIOL,DULUTH,MN 55812	University of Minnesota System; University of Minnesota Duluth			Drewes, Lester R/X-9794-2018	Drewes, Lester R/0000-0002-7440-0387				AGWU DE, 1989, J BIOL CHEM, V264, P1405; AUGERT G, 1989, J BIOL CHEM, V264, P21689; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; BILLAH MM, 1989, J BIOL CHEM, V264, P9069; BOCCKINO SB, 1987, J BIOL CHEM, V262, P15309; CABOT MC, 1988, BIOCHIM BIOPHYS ACTA, V959, P46, DOI 10.1016/0005-2760(88)90148-8; CLARO E, 1989, J BIOL CHEM, V264, P18288; COCKCROFT S, 1985, NATURE, V314, P534, DOI 10.1038/314534a0; DOWNES CP, 1982, CELL CALCIUM, V3, P413, DOI 10.1016/0143-4160(82)90027-6; EXTON JH, 1990, J BIOL CHEM, V265, P1; IRVINE RF, 1979, EUR J BIOCHEM, V99, P525, DOI 10.1111/j.1432-1033.1979.tb13284.x; JACKOWSKI S, 1989, ARCH BIOCHEM BIOPHYS, V268, P516, DOI 10.1016/0003-9861(89)90318-4; JACOBSON MD, 1985, J NEUROCHEM, V44, P465, DOI 10.1111/j.1471-4159.1985.tb05437.x; MAJERUS PW, 1984, CELL, V37, P701, DOI 10.1016/0092-8674(84)90405-7; MICHELL RH, 1975, BIOCHIM BIOPHYS ACTA, V415, P81, DOI 10.1016/0304-4157(75)90017-9; MOOLENAAR WH, 1986, NATURE, V323, P171, DOI 10.1038/323171a0; QIAN Z, 1990, J NEUROCHEM, V54, P1632, DOI 10.1111/j.1471-4159.1990.tb01215.x; QIAN Z, 1990, J BIOL CHEM, V265, P3607; QIAN Z, 1989, J BIOL CHEM, V264, P21720; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; SMITH CD, 1986, SCIENCE, V232, P97, DOI 10.1126/science.3006254; TAKI T, 1979, J BIOL CHEM, V254, P9761; TAYLOR SJ, 1987, BIOCHEM J, V248, P791, DOI 10.1042/bj2480791; UHING RJ, 1986, J BIOL CHEM, V261, P2140; WALLACE MA, 1985, J BIOL CHEM, V260, P9527; WILSON DB, 1984, J BIOL CHEM, V259, P1718; WRIGHT TM, 1988, J BIOL CHEM, V263, P9374	28	40	40	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998	0892-6638			FASEB J	Faseb J.	MAR 1	1991	5	3					315	319		10.1096/fasebj.5.3.2001791	http://dx.doi.org/10.1096/fasebj.5.3.2001791			5	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FC556	2001791				2022-12-25	WOS:A1991FC55600009
J	SAHA, AK; CRANS, DC; POPE, MT; SIMONE, CM; GLEW, RH				SAHA, AK; CRANS, DC; POPE, MT; SIMONE, CM; GLEW, RH			INHIBITION OF HUMAN SEMINAL FLUID AND LEISHMANIA-DONOVANI PHOSPHATASES BY MOLYBDATE HETEROPOLYANIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATIC ACID-PHOSPHATASE; SURFACE-MEMBRANE; NEUTROPHIL; PHOSPHATIDYLINOSITOL; PURIFICATION; VANADIUM(V); HYDROLYSIS; CATALYZES; VANADATE; ANALOGS	Inhibition of a tartrate-resistant acid phosphatase (ACP) from Leishmania donovani and the tartrate-sensitive ACP from human seminal fluid (prostatic ACP) was examined using a series of 13 molybdate-containing heteropolyanions. The heteropolyanions were divided into four groups based on the number of molybdenum atoms they contain: Group I, Mo4; Group II, Mo6-8; Group III, Mo12; Group IV, Mo18. Two of the four groups, those consisting of compounds that contain either an Mo4 unit or an Mo18 unit with a heteroatom in the central cavity, were potent inhibitors and exhibited the highest degree of selectivity against the leishmanial and seminal fluid ACPs. The inhibition of prostatic ACP by complex E2 could be completely reversed by dialysis. Little inhibition of the acid phosphatase, beta-glucuronidase, or alpha-mannosidase from human spleen was observed with complexes B' and E2. For the seminal fluid phosphatase, the K(i) values obtained with arsenate and vanadate depended markedly on pH, suggesting that, unlike most other phosphatases, the conformation of the inhibitor binding site on human seminal fluid ACP is pH-dependent. Results of competition experiments performed with various inhibitor pairs indicated that complex D2 binds to the active site of prostatic ACP while complex M binds at some site on the enzyme that affects the active site. Binding of complex M also modifies the affinity of the enzyme for other inhibitors such as vanadate. The potency of several heteropolyanion complexes and their selective inhibition of pathophysiologically significant acid phosphatases indicate that these compounds may have value as tools for study of the structure and function of this class of enzyme and perhaps in the therapy of human disease.	UNIV NEW MEXICO,SCH MED,DEPT BIOCHEM,ALBUQUERQUE,NM 87131; COLORADO STATE UNIV,DEPT CHEM,FT COLLINS,CO 80523; GEORGETOWN UNIV,DEPT CHEM,WASHINGTON,DC 20057	University of New Mexico; Colorado State University; Georgetown University			Crans, Debbie C./L-3895-2018	Crans, Debbie C./0000-0001-7792-3450	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040525, R29GM040525] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 18945] Funding Source: Medline; NIGMS NIH HHS [GM 40525] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cleland W W, 1979, Methods Enzymol, V63, P103; CRANS DC, 1989, BIOCHEM BIOPH RES CO, V165, P246, DOI 10.1016/0006-291X(89)91061-9; CRANS DC, 1989, J AM CHEM SOC, V111, P7597, DOI 10.1021/ja00201a049; CRANS DC, 1988, INORG CHEM, V27, P1797, DOI 10.1021/ic00283a025; CRANS DC, 1990, J AM CHEM SOC, V112, P427, DOI 10.1021/ja00157a063; CRANS DC, 1990, J AM CHEM SOC, V112, P2901, DOI 10.1021/ja00164a009; GLEW RH, 1982, COMP BIOCHEM PHYS B, V72, P581, DOI 10.1016/0305-0491(82)90510-7; GOTTLIEB M, 1981, SCIENCE, V212, P939, DOI 10.1126/science.7233189; Gresser M. J., 1987, ADV PROTEIN PHOSPHAT, V4, P35; LIN MF, 1986, BIOCHEM J, V235, P351, DOI 10.1042/bj2350351; MUKHOPADHYAY NK, 1989, CLIN CHIM ACTA, V182, P31, DOI 10.1016/0009-8981(89)90147-2; NOMIYA K, 1987, POLYHEDRON, V6, P213, DOI 10.1016/S0277-5387(00)80791-3; PETERS SP, 1975, CLIN CHIM ACTA, V60, P391, DOI 10.1016/0009-8981(75)90083-2; REMALEY AT, 1985, J BIOL CHEM, V260, P880; REMALEY AT, 1984, J BIOL CHEM, V259, P1173; REMALEY AT, 1985, EXP PARASITOL, V60, P331, DOI 10.1016/0014-4894(85)90039-6; ROBINSON DB, 1980, J BIOL CHEM, V255, P5864; SAHA AK, 1985, J CLIN MICROBIOL, V22, P329, DOI 10.1128/JCM.22.3.329-332.1985; SAHA AK, 1988, ARCH BIOCHEM BIOPHYS, V265, P94, DOI 10.1016/0003-9861(88)90375-X; SAHA AK, 1989, J BACTERIOL, V171, P5103, DOI 10.1128/jb.171.9.5103-5110.1989; SAHA AK, 1985, ARCH BIOCHEM BIOPHYS, V43, P150; SAHA AK, 1990, FASEB J, V4, P3130; SEGEL JH, 1975, ENZYME KINETICS, P227; STANKIEWICZ PJ, 1988, BIOCHEMISTRY-US, V27, P206, DOI 10.1021/bi00401a031; TRACEY AS, 1988, J AM CHEM SOC, V110, P5869, DOI 10.1021/ja00225a044; VANETTEN RL, 1977, BIOCHIM BIOPHYS ACTA, V484, P386, DOI 10.1016/0005-2744(77)90094-8; YONETANI T, 1964, ARCH BIOCHEM BIOPHYS, V106, P243, DOI 10.1016/0003-9861(64)90184-5	28	28	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3511	3517						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1995614				2022-12-25	WOS:A1991EY68200029
J	MULLMANN, TJ; SIEGEL, MI; EGAN, RW; BILLAH, MM				MULLMANN, TJ; SIEGEL, MI; EGAN, RW; BILLAH, MM			SPHINGOSINE INHIBITS PHOSPHATIDATE PHOSPHOHYDROLASE IN HUMAN NEUTROPHILS BY A PROTEIN KINASE-C-INDEPENDENT MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							LONG-CHAIN BASES; PHOSPHOLIPASE-D; PITUITARY-CELLS; PHORBOL ESTERS; PHOSPHATIDYLCHOLINE; HYDROLYSIS; METABOLISM; BREAKDOWN; SECRETION; PLATELETS	Human neutrophils have been labeled in 1-O-alkylphosphatidylcholine with H-3 in both the alkyl chain and the choline moiety. Upon stimulation of these labeled cells with formyl-Met-Leu-Phe, C5a, or phorbol 12-myristate 13-acetate, phospholipase D is activated to produce 1-O-[H-3]alkylphosphatidic acid ([H-3]alkyl-PA and [H-3]choline. The [H-3]alkyl-PA is then dephosphorylated by phosphatidate phosphohydrolase (PPH) to produce 1-O-[H-3]alkyldiglyceride ([H-3]alkyl-DG). Sphingosine, a sphingoid base known to inhibit protein kinase C (PKC), causes a dose-dependent inhibition of [H-3]alkyl-DG formation. This inhibition is accompanied by increased accumulation of [H-3]alkyl-PA without alterations in ]H-3[choline formation. Studies using various other sphingoid bases demonstrate that a long hydrocarbon chain and an amino group are required for the inhibition of DG formation. These results suggest that sphingoid bases inhibit PPH activity without altering phospholipase D activation and that they exhibit a similar structure-activity relationship for both PPH and PKC. K252a, a PKC inhibitor which acts by competing for ATP binding sites, does not inhibit the formation of [H-3]alkyl-DG, [H-3]alkyl-PA, or [H-3]choline at a concentration (3-mu-M) that completely blocks phorbol 12-myristate 13-acetate-induced protein phosphorylation. Moreover, in neutrophil homogenates, sphingosine but not octylamine, inhibits PPH activity in a dose-dependent manner. Thus sphingosine inhibits PPH activity by a PKC-independent mechanism, raising the possibility that sphingoid bases may play a role in regulating PPH-mediated lipid metabolism in stimulated cells.			MULLMANN, TJ (corresponding author), SCHERING PLOUGH CORP,DEPT ALLERGY & IMMUNOL,BLOOMFIELD,NJ 07003, USA.							ANTHES JC, 1989, BIOCHEM BIOPH RES CO, V163, P657, DOI 10.1016/0006-291X(89)92187-6; BILLAH MM, 1989, J BIOL CHEM, V264, P9069; BILLAH MM, 1989, J BIOL CHEM, V264, P17069; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRINDLEY DN, 1984, PROG LIPID RES, V23, P115, DOI 10.1016/0163-7827(84)90001-8; HALL M, 1985, FEBS LETT, V179, P351, DOI 10.1016/0014-5793(85)80549-4; HANNUN YA, 1986, J BIOL CHEM, V261, P2604; HANNUN YA, 1987, SCIENCE, V235, P670, DOI 10.1126/science.3101176; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; KOLESNICK RN, 1987, J BIOL CHEM, V262, P16759; LAVIE Y, 1990, J BIOL CHEM, V265, P3868; MARTIN TW, 1988, BIOCHIM BIOPHYS ACTA, V962, P282, DOI 10.1016/0005-2760(88)90258-5; MOOLENAAR WH, 1986, NATURE, V323, P171, DOI 10.1038/323171a0; MULLMANN TJ, 1990, J IMMUNOL, V144, P1901; MULLMANN TJ, 1990, BIOCHEM BIOPH RES CO, V170, P1197, DOI 10.1016/0006-291X(90)90520-W; MURAYAMA T, 1987, J BIOL CHEM, V262, P5522; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; RIDER LG, 1988, J IMMUNOL, V140, P200; SLIFE CW, 1989, J BIOL CHEM, V264, P10371; WALTON PA, 1985, ANAL BIOCHEM, V151, P479, DOI 10.1016/0003-2697(85)90208-8; WILSON E, 1987, ARCH BIOCHEM BIOPHYS, V259, P204, DOI 10.1016/0003-9861(87)90487-5; WILSON E, 1988, J BIOL CHEM, V263, P9304; WILSON E, 1986, J BIOL CHEM, V261, P2616; WINICOV I, 1988, J BIOL CHEM, V263, P12179; YAMADA K, 1987, BIOCHEM BIOPH RES CO, V144, P35, DOI 10.1016/S0006-291X(87)80471-0; YAVIN E, 1976, J BIOL CHEM, V251, P1392; YU CL, 1988, CELL, V52, P63, DOI 10.1016/0092-8674(88)90531-4; ZHANG H, 1990, J BIOL CHEM, V265, P76	29	106	107	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2013	2016						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989967				2022-12-25	WOS:A1991EV51500003
J	PERSSON, E; BJORK, I; STENFLO, J				PERSSON, E; BJORK, I; STENFLO, J			PROTEIN STRUCTURAL REQUIREMENTS FOR CA2+ BINDING TO THE LIGHT CHAIN OF FACTOR-X - STUDIES USING ISOLATED INTACT FRAGMENTS CONTAINING THE GAMMA-CARBOXYGLUTAMIC ACID REGION AND OR THE EPIDERMAL GROWTH FACTOR-LIKE DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-HYDROXYASPARTIC ACID; BLOOD-COAGULATION FACTOR; BOVINE FACTOR-X; K-DEPENDENT PROTEINS; FACTOR-IX; CALCIUM-BINDING; PROTHROMBIN FRAGMENT-1; PHOSPHOLIPID BINDING; MONOCLONAL-ANTIBODY; THROMBIN BINDING	Coagulation factor X is a multidomain proenzyme of a serine protease. Calcium ions bind to the vitamin K-dependent gamma-carboxyglutamic acid (Gla) residues and to a site in the NH2-terminal of two epidermal growth factor (EGF)-like domains. To study structure-function relationships in the NH2-terminal part of factor X and to determine the structure of isolated domains, we have developed methods that allow the subsequent isolation of the first or both EGF-like domains with or without an attached Gla domain from controlled proteolytic digests of the protein. The Ca2+ -induced changes of the intrinsic protein fluorescence were measured to elucidate whether the isolated fragments retain their native conformation. Changes in the fluorescence caused by Ca2+ binding were found to result from perturbations of the environment of the Trp residue in position 41. calcium ion binding to the Gla-containing region linked to the NH2-terminal EGF-like domain was identical with that to intact factor X, indicating a native orientation of the ligand binding groups in the fragment. In contrast, the isolated Gla peptide had a lower affinity for Ca2+, suggesting that the NH2-terminal EGF-like domain serves as a scaffold for the folding of the Gla region. Similarly, the presence of the Gla region was found to increase the affinity of the Gla-independent site in the first EGF-like domain for Ca2+. The metal ion-induced resistance against chymotryptic cleavage COOH-terminal of Tyr-44 in intact factor X is similar in the isolated fragment that contains the Gla region linked to one EGF-like domain, indicating a native conformation of the fragment in the presence of Ca2+. Furthermore, the Gla-independent metal ion binding site binds Ca2+ but does not appear to bind Mg2+.	UNIV LUND,MALMO GEN HOSP,DEPT CLIN CHEM,S-21401 MALMO,SWEDEN; SWEDISH UNIV AGR SCI,CTR BIOMED,DEPT VET MED CHEM,S-75123 UPPSALA,SWEDEN	Lund University; Swedish University of Agricultural Sciences				Persson, Egon/0000-0003-3005-4926				APPELLA E, 1987, J BIOL CHEM, V262, P4437; ASTERMARK J, 1991, J BIOL CHEM, V266, P2430; ASTERMARK J, 1991, J BIOL CHEM, V266, P2438; BAJAJ SP, 1982, J BIOL CHEM, V257, P3726; CHURCH WR, 1989, J BIOL CHEM, V264, P17882; DAVIS LM, 1987, BLOOD, V69, P140; DIXON HBF, 1968, BIOCHEM J, V109, P312, DOI 10.1042/bj1090312; DRAKENBERG T, 1983, P NATL ACAD SCI-BIOL, V80, P1802, DOI 10.1073/pnas.80.7.1802; ENFIELD DL, 1980, BIOCHEMISTRY-US, V19, P659, DOI 10.1021/bi00545a009; FERNLUND P, 1983, J BIOL CHEM, V258, P2509; FERNLUND P, 1980, VITAMIN K METABOLISM, P166; FUNG MR, 1985, P NATL ACAD SCI USA, V82, P3591, DOI 10.1073/pnas.82.11.3591; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; GREEN PM, 1989, EMBO J, V8, P1067, DOI 10.1002/j.1460-2075.1989.tb03474.x; HANDFORD PA, 1990, EMBO J, V9, P475, DOI 10.1002/j.1460-2075.1990.tb08133.x; HUANG LH, 1989, BIOCHEM BIOPH RES CO, V160, P133, DOI 10.1016/0006-291X(89)91631-8; JACKSON CM, 1972, BIOCHEMISTRY-US, V11, P4873, DOI 10.1021/bi00776a001; JOHNSON AE, 1983, J BIOL CHEM, V258, P5554; KEYT B, 1982, J BIOL CHEM, V257, P8687; KUROSAWA S, 1988, J BIOL CHEM, V263, P5993; LEYTUS SP, 1986, BIOCHEMISTRY-US, V25, P5098, DOI 10.1021/bi00366a018; LINSE S, 1988, NATURE, V335, P651, DOI 10.1038/335651a0; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MCCORD DM, 1990, J BIOL CHEM, V265, P10250; MCMULLEN BA, 1983, BIOCHEMISTRY-US, V22, P2875, DOI 10.1021/bi00281a016; MCMULLEN BA, 1983, BIOCHEM BIOPH RES CO, V115, P8, DOI 10.1016/0006-291X(83)90961-0; MORITA T, 1986, J BIOL CHEM, V261, P4015; MORITA T, 1984, J BIOL CHEM, V259, P5698; MORITA T, 1980, VITAMIN K METABOLISM, P124; NELSESTUEN GL, 1976, J BIOL CHEM, V251, P5648; NELSESTUEN GL, 1981, BIOCHEMISTRY-US, V20, P351, DOI 10.1021/bi00505a019; OHLIN AK, 1987, J BIOL CHEM, V262, P13798; OHLIN AK, 1990, BIOCHEMISTRY-US, V29, P644; ORTHNER CL, 1989, J BIOL CHEM, V264, P18781; PERSSON E, 1989, J BIOL CHEM, V264, P16897; POLLOCK JS, 1988, J BIOL CHEM, V263, P14216; PRENDERGAST FG, 1977, J BIOL CHEM, V252, P840; REES DJG, 1988, EMBO J, V7, P2053, DOI 10.1002/j.1460-2075.1988.tb03045.x; RYAN J, 1989, J BIOL CHEM, V264, P20283; SCHWALBE RA, 1989, J BIOL CHEM, V264, P20288; SELANDER M, 1990, BIOCHEMISTRY-US, V29, P85111; SKOGEN WF, 1983, BIOCHEM BIOPH RES CO, V111, P14, DOI 10.1016/S0006-291X(83)80110-7; SORIANOGARCIA M, 1989, BIOCHEMISTRY-US, V28, P6805, DOI 10.1021/bi00443a004; STEARNS DJ, 1988, J BIOL CHEM, V263, P826; STENFLO J, 1976, J BIOL CHEM, V251, P355; STENFLO J, 1977, ANNU REV BIOCHEM, V46, P157, DOI 10.1146/annurev.bi.46.070177.001105; SUGO T, 1984, J BIOL CHEM, V259, P5705; SUZUKI K, 1989, J BIOL CHEM, V264, P4872; TITANI K, 1975, P NATL ACAD SCI USA, V72, P3082, DOI 10.1073/pnas.72.8.3082; WAKABAYASHI K, 1986, J BIOL CHEM, V261, P1097	50	73	73	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2444	2452						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989996				2022-12-25	WOS:A1991EV51500066
J	VANBERKEL, TJC; DERIJKE, YB; KRUIJT, JK				VANBERKEL, TJC; DERIJKE, YB; KRUIJT, JK			DIFFERENT FATE INVIVO OF OXIDATIVELY MODIFIED LOW-DENSITY-LIPOPROTEIN AND ACETYLATED LOW-DENSITY-LIPOPROTEIN IN RATS - RECOGNITION BY VARIOUS SCAVENGER RECEPTORS ON KUPFFER AND ENDOTHELIAL LIVER-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HERITABLE HYPERLIPIDEMIC RABBIT; BOVINE SERUM-ALBUMIN; BINDING-SITE; FAMILIAL HYPERCHOLESTEROLEMIA; CHOLESTEROL DEPOSITION; PLASMA-LIPOPROTEINS; PARENCHYMAL-CELLS; METABOLISM; DEGRADATION; MACROPHAGES	Human low density lipoprotein was oxidized (Ox-LDL) by exposure to 5-mu-M Cu2+ and its fate in vivo was compared to acetylated low density lipoprotein (Ac-LDL). Ox-LDL, when injected into rats, is rapidly removed from the blood circulation by the liver, similarly as Ac-LDL. A separation of rat liver cells into parenchymal, endothelial, and Kupffer cells at 10 min after injection of Ox-LDL or Ac-LDL indicated that the Kupffer cell uptake of Ox-LDL is 6.8-fold higher than for Ac-LDL, leading to Kupffer cells as the main liver site for Ox-LDL uptake. In vitro studies with isolated liver cells indicated that saturable high affinity sites for Ox-LDL were present on both endothelial and Kupffer cells, whereby the capacity of Kupffer cells to degrade Ox-LDL is 6-fold higher than for endothelial cells. Competition studies showed that unlabeled Ox-LDL competed as efficiently (90%) as unlabeled Ac-LDL with the cell association and degradation of I-125-labeled Ac-LDL by endothelial and Kupffer cells. However, unlabeled Ac-LDL competed only partially (20-30%) with the cell association and degradation of I-125-labeled Ox-LDL by Kupffer cells, while unlabeled Ox-LDL or polyinosinic acid competed for 70-80%. It is concluded that the liver contains, in addition to the scavenger (Ac-LDL) receptor which interacts efficiently with both Ac-LDL and Ox-LDL and which is concentrated on endothelial cells an additional specific Ox-LDL receptor which is highly concentrated on Kupffer cells. In vivo the specific Ox-LDL recognition site on Kupffer cells will form the major protection system against the occurrence of the atherogenic Ox-LDL particles in the blood.			VANBERKEL, TJC (corresponding author), LEIDEN STATE UNIV,CTR BIOPHARMACEUT SCI,DIV BIOPHARMACEUT,SYLVIUS LAB,POB 9503,2312 AV LEIDEN,NETHERLANDS.		de Rijke, Yolanda/AAQ-5497-2020; Van Berkel, Theo/ABD-7677-2021					ARAI H, 1989, BIOCHEM BIOPH RES CO, V159, P1375, DOI 10.1016/0006-291X(89)92262-6; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; BIERMAN EL, 1974, CIRC RES, V35, P136, DOI 10.1161/01.RES.35.1.136; BILHEIMER DW, 1972, BIOCHIM BIOPHYS ACTA, V260, P212, DOI 10.1016/0005-2760(72)90034-3; BLOMHOFF R, 1984, J BIOL CHEM, V259, P8898; BROWN MS, 1980, J SUPRAMOL STR CELL, V13, P67, DOI 10.1002/jss.400130107; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; CAREW TE, 1987, P NATL ACAD SCI USA, V84, P7725, DOI 10.1073/pnas.84.21.7725; DRESEL HA, 1987, EMBO J, V6, P319, DOI 10.1002/j.1460-2075.1987.tb04757.x; FOGELMAN AM, 1980, P NATL ACAD SCI-BIOL, V77, P2214, DOI 10.1073/pnas.77.4.2214; FURUNO K, 1982, J BIOCHEM-TOKYO, V91, P1485, DOI 10.1093/oxfordjournals.jbchem.a133840; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; HARKES L, 1983, FEBS LETT, V154, P75, DOI 10.1016/0014-5793(83)80878-3; HORIUCHI S, 1985, J BIOL CHEM, V259, P53; KITA T, 1987, P NATL ACAD SCI USA, V84, P5928, DOI 10.1073/pnas.84.16.5928; MAHLEY RW, 1979, J CLIN INVEST, V64, P743, DOI 10.1172/JCI109518; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; MCFARLANE AS, 1958, NATURE, V182, P53, DOI 10.1038/182053a0; MOREL DW, 1983, J LIPID RES, V24, P1070; NAGELKERKE JF, 1983, J BIOL CHEM, V258, P2221; NAGELKERKE JF, 1984, ARTERIOSCLEROSIS, V4, P256, DOI 10.1161/01.ATV.4.3.256; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; OTTNAD E, 1988, BIOCHEM J, V253, P835, DOI 10.1042/bj2530835; PALINSKI W, 1989, P NATL ACAD SCI USA, V86, P1372, DOI 10.1073/pnas.86.4.1372; PARTHASARATHY S, 1985, P NATL ACAD SCI USA, V82, P3000, DOI 10.1073/pnas.82.9.3000; PITAS RE, 1985, J CELL BIOL, V100, P103, DOI 10.1083/jcb.100.1.103; REDGRAVE TG, 1975, ANAL BIOCHEM, V65, P42, DOI 10.1016/0003-2697(75)90488-1; SPARROW CP, 1989, J BIOL CHEM, V264, P2599; Steinberg D., 1988, ATHEROSCLER REV, V18, P1; STEINBRECHER UP, 1987, ARTERIOSCLEROSIS, V7, P135, DOI 10.1161/01.ATV.7.2.135; TOLLESHAUG H, 1979, BIOCHEM PHARMACOL, V28, P2919, DOI 10.1016/0006-2952(79)90586-0; VANBERKEL TJC, 1985, J BIOL CHEM, V260, P2203; VANBERKEL TJC, 1978, BIOCHIM BIOPHYS ACTA, V530, P299, DOI 10.1016/0005-2760(78)90015-2; VANBERKEL TJC, 1982, BIOCHEM J, V208, P493, DOI 10.1042/bj2080493; VANBERKEL TJC, 1985, J BIOL CHEM, V260, P2694	35	252	259	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2282	2289						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1989982				2022-12-25	WOS:A1991EV51500043
J	GARCIA, A; LAMONTAGNE, K; REAVIS, D; STOBERGRASSER, U; LIPSICK, JS				GARCIA, A; LAMONTAGNE, K; REAVIS, D; STOBERGRASSER, U; LIPSICK, JS			DETERMINANTS OF SEQUENCE-SPECIFIC DNA-BINDING BY P48V-MYB	ONCOGENE			English	Article							V-MYB ONCOGENE; AVIAN-MYELOBLASTOSIS VIRUS; AMINO-TERMINAL REGION; ENCODED PROTEIN DETECT; C-MYB; NUCLEOTIDE-SEQUENCE; TRANS-ACTIVATION; GENE-EXPRESSION; LEUKEMIA-VIRUS; ZEA-MAYS	The v-myb oncogene of the avian myeloblastosis virus encodes a nuclear protein, p48v-myb, which binds to DNA in a sequence-specific manner. We have used wild type and mutant forms of this protein expressed in E. coli to study the protein and DNA determinants for sequence-specific DNA-binding. We have shown that only the highly conserved domain at the amino terminus of p48v-myb is required for sequence-specific DNA-binding. However, neither of the tandem 50 amino acid repeats present in this domain is alone sufficient for such binding. We have also demonstrated that p48v-myb can recognize a single consensus myb binding site and appears to interact with DNA as a protein monomer. In addition, we have shown that sequence-specific binding by p48v-myb requires nucleotides which flank the previously reported PyAAC(T)/(G)G consensus.	SUNY STONY BROOK,SCH MED,DEPT MICROBIOL,STONY BROOK,NY 11794	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook					NATIONAL CANCER INSTITUTE [P01CA028146, R01CA043592, K04CA001457] Funding Source: NIH RePORTER; NCI NIH HHS [K04 CA-01457, R01 CA-43592, P01 CA-28146] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BADING H, 1987, ONCOGENE, V1, P395; BENDER TP, 1986, P NATL ACAD SCI USA, V83, P3204, DOI 10.1073/pnas.83.10.3204; BEUG H, 1987, GENE DEV, V1, P277, DOI 10.1101/gad.1.3.277; BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; BOYLE WJ, 1984, P NATL ACAD SCI-BIOL, V81, P4265, DOI 10.1073/pnas.81.14.4265; BOYLE WJ, 1986, P NATL ACAD SCI USA, V83, P4685, DOI 10.1073/pnas.83.13.4685; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLARKE MF, 1988, MOL CELL BIOL, V8, P884, DOI 10.1128/MCB.8.2.884; DUPREY SP, 1985, P NATL ACAD SCI USA, V82, P6937, DOI 10.1073/pnas.82.20.6937; DURBAN EM, 1981, J VIROL, V37, P488, DOI 10.1128/JVI.37.1.488-492.1981; EVAN GI, 1984, MOL CELL BIOL, V4, P2843, DOI 10.1128/MCB.4.12.2843; GERONDAKIS S, 1986, MOL CELL BIOL, V6, P3677, DOI 10.1128/MCB.6.11.3677; GONDA TJ, 1985, EMBO J, V4, P2003, DOI 10.1002/j.1460-2075.1985.tb03884.x; HOPE IA, 1987, EMBO J, V6, P2781, DOI 10.1002/j.1460-2075.1987.tb02573.x; HOWE KM, 1990, EMBO J, V9, P161, DOI 10.1002/j.1460-2075.1990.tb08092.x; IBANEZ CE, 1988, J VIROL, V62, P1981, DOI 10.1128/JVI.62.6.1981-1988.1988; IBANEZ CE, 1988, J VIROL, V62, P4398, DOI 10.1128/JVI.62.11.4398-4402.1988; IBANEZ CE, 1990, MOL CELL BIOL, V10, P2285, DOI 10.1128/MCB.10.5.2285; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; KATZEN AL, 1985, CELL, V41, P449, DOI 10.1016/S0092-8674(85)80018-0; KLEMPNAUER KH, 1984, CELL, V37, P537, DOI 10.1016/0092-8674(84)90384-2; KLEMPNAUER KH, 1987, EMBO J, V6, P2719, DOI 10.1002/j.1460-2075.1987.tb02565.x; KLEMPNAUER KH, 1986, EMBO J, V5, P1903, DOI 10.1002/j.1460-2075.1986.tb04443.x; KLEMPNAUER KH, 1989, GENE DEV, V3, P1582, DOI 10.1101/gad.3.10.1582; LANE T, 1990, MOL CELL BIOL, V10, P2591, DOI 10.1128/MCB.10.6.2591; Lipsick J S, 1986, Gene Amplif Anal, V4, P73; LIPSICK JS, 1986, J VIROL, V59, P267, DOI 10.1128/JVI.59.2.267-275.1986; MAJELLO B, 1986, P NATL ACAD SCI USA, V83, P9636, DOI 10.1073/pnas.83.24.9636; MAROCCO A, 1989, MOL GEN GENET, V216, P183, DOI 10.1007/BF00334354; MCMAHON J, 1988, ONCOGENE, V3, P717; MEIJER L, 1989, EMBO J, V8, P2275, DOI 10.1002/j.1460-2075.1989.tb08353.x; MOSCOVICI C, 1981, VIROLOGY, V113, P765, DOI 10.1016/0042-6822(81)90205-1; NESS SA, 1989, CELL, V59, P1115, DOI 10.1016/0092-8674(89)90767-8; NISHINA Y, 1989, NUCLEIC ACIDS RES, V17, P107, DOI 10.1093/nar/17.1.107; PAZARES J, 1987, EMBO J, V6, P3553, DOI 10.1002/j.1460-2075.1987.tb02684.x; RADKE K, 1982, CELL, V31, P643, DOI 10.1016/0092-8674(82)90320-8; RALSTON R, 1983, NATURE, V306, P803, DOI 10.1038/306803a0; ROSSON D, 1986, NATURE, V319, P604, DOI 10.1038/319604a0; SLAMON DJ, 1986, SCIENCE, V233, P347, DOI 10.1126/science.3014652; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TICEBALDWIN K, 1989, SCIENCE, V246, P931, DOI 10.1126/science.2683089; WESTIN EH, 1982, P NATL ACAD SCI-BIOL, V79, P2194, DOI 10.1073/pnas.79.7.2194; WESTON K, 1989, CELL, V58, P85, DOI 10.1016/0092-8674(89)90405-4	43	46	47	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	FEB	1991	6	2					265	273						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ134	2000220				2022-12-25	WOS:A1991FZ13400012
J	VISVADER, J; BEGLEY, CG; ADAMS, JM				VISVADER, J; BEGLEY, CG; ADAMS, JM			DIFFERENTIAL EXPRESSION OF THE LYL, SCL AND E2A HELIX-LOOP-HELIX GENES WITHIN THE HEMATOPOIETIC SYSTEM	ONCOGENE			English	Article							T-CELL LEUKEMIA; DNA-BINDING MOTIF; CHROMOSOMAL TRANSLOCATION; DROSOPHILA-MELANOGASTER; TRANSCRIPTION FACTOR; HEMATOPOIETIC-CELLS; ENHANCER BINDING; MESSENGER-RNA; PROTEIN; MYC	The helix-loop-helix genes LYL, SCL and E2A are associated with chromosome translocations found in human lymphoid leukemias. To establish their hematopoietic expression patterns, we have isolated murine LYL and SCL cDNA clones and investigated the expression of all three genes by Northern blot analysis of 58 murine hemopoietic cell lines and tissues. The nucleotide sequences of LYL cDNA clones revealed alternative 5' untranslated sequences and differential splicing within the 5' portion of the coding region that may produce a LYL polypeptide lacking an N-terminal segment. The LYL gene was expressed in most myeloid, erythroid and B lymphocyte cell lines and displayed two alternative size classes of transcripts, the smaller size class (1.5-1.8 kb) being typical of the erythroid lineage and the larger class (2.0-2.3 kb) of the B cell lineage. These two size classes were found to differ in the 5' untranslated region. Thus, expression of the LYL gene appears to be differentially regulated in different hemopoietic cell types. In contrast, the E2A gene was expressed throughout the hemopoietic compartment as a single dominant transcript (3.5 kb). SCL expression was restricted to erythroid, mast and early myeloid cell lines, and the level of SCL transcripts (3.0 and 4.7 kb species) increased markedly during DMSO-induced differentiation of erythroleukemia cells. Hence the SCL gene product may be an important regulatory factor for the erythroid lineage. The low or undetectable expression of both SCL and LYL in most T lymphoid cell sources is consistent with the view that the translocations of these genes in human T cell leukemias alter their normal regulation and may thereby contribute to neoplasia.			VISVADER, J (corresponding author), ROYAL MELBOURNE HOSP, WALTER & ELIZA HALL INST MED RES, PARKVILLE, VIC 3050, AUSTRALIA.		Adams, Jerry M/E-1199-2013	Adams, Jerry/0000-0002-4360-8628	NATIONAL CANCER INSTITUTE [R01CA012421] Funding Source: NIH RePORTER; NCI NIH HHS [CA12421] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ANDERSSON J, 1972, EUR J IMMUNOL, V2, P349, DOI 10.1002/eji.1830020410; ANDRE C, 1989, ONCOGENE, V4, P1047; BECKMANN H, 1990, GENE DEV, V4, P167, DOI 10.1101/gad.4.2.167; BEGLEY CG, 1989, P NATL ACAD SCI USA, V86, P2031, DOI 10.1073/pnas.86.6.2031; BEGLEY CG, 1989, P NATL ACAD SCI USA, V86, P10128, DOI 10.1073/pnas.86.24.10128; BERNARD O, 1990, GENE CHROMOSOME CANC, V1, P194, DOI 10.1002/gcc.2870010303; CAUDY M, 1988, CELL, V55, P1061, DOI 10.1016/0092-8674(88)90250-4; CHEN Q, 1990, EMBO J, V9, P415, DOI 10.1002/j.1460-2075.1990.tb08126.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CORY S, 1986, ADV CANCER RES, V47, P189, DOI 10.1016/S0065-230X(08)60200-6; CULVENOR JG, 1981, J IMMUNOL, V126, P1974; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DUBE SK, 1975, P NATL ACAD SCI USA, V72, P1863, DOI 10.1073/pnas.72.5.1863; ELEFANTY AG, 1990, EMBO J, V9, P1069, DOI 10.1002/j.1460-2075.1990.tb08212.x; FINGER LR, 1989, P NATL ACAD SCI USA, V86, P5039, DOI 10.1073/pnas.86.13.5039; GONDA TJ, 1982, MOL CELL BIOL, V2, P617, DOI 10.1128/MCB.2.6.617; HAMILTON JA, 1988, BLOOD, V71, P1574; HARRIS AW, 1988, CURR TOP MICROBIOL, V141, P82; HENTHORN P, 1990, SCIENCE, V247, P467, DOI 10.1126/science.2105528; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; Kelso A, 1989, GROWTH FACTORS, V1, P165, DOI 10.3109/08977198909029126; Kinashi T, 1989, INT IMMUNOL, V1, P11, DOI 10.1093/intimm/1.1.11; KLAMBT C, 1989, EMBO J, V8, P203, DOI 10.1002/j.1460-2075.1989.tb03365.x; KLINKEN SP, 1988, CELL, V53, P857, DOI 10.1016/S0092-8674(88)90309-1; KONGSUWAN K, 1988, EMBO J, V7, P2131, DOI 10.1002/j.1460-2075.1988.tb03052.x; MARTIN DIK, 1989, NATURE, V338, P435, DOI 10.1038/338435a0; MARTIN DIK, 1990, NATURE, V344, P444, DOI 10.1038/344444a0; MELLENTIN JD, 1989, SCIENCE, V246, P379, DOI 10.1126/science.2799390; MELLENTIN JD, 1989, CELL, V58, P77, DOI 10.1016/0092-8674(89)90404-2; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; PERKINS A, 1990, IN PRESS P NATL ACAD; ROMEO PH, 1990, NATURE, V344, P447, DOI 10.1038/344447a0; RUSHLOW CA, 1989, EMBO J, V8, P3095, DOI 10.1002/j.1460-2075.1989.tb08461.x; SETO M, 1988, EMBO J, V7, P123, DOI 10.1002/j.1460-2075.1988.tb02791.x; STRASSER A, 1990, IN PRESS NATURE; THISSE B, 1988, EMBO J, V7, P2175, DOI 10.1002/j.1460-2075.1988.tb03056.x; VILLARES R, 1987, CELL, V50, P415, DOI 10.1016/0092-8674(87)90495-8	41	158	160	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB	1991	6	2					187	194						8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ134	2000219				2022-12-25	WOS:A1991FZ13400002
J	KRISINGER, J; STROM, M; DARWISH, HD; PERLMAN, K; SMITH, C; DELUCA, HF				KRISINGER, J; STROM, M; DARWISH, HD; PERLMAN, K; SMITH, C; DELUCA, HF			INDUCTION OF CALBINDIN-D 9K MESSENGER-RNA BUT NOT CALCIUM-TRANSPORT IN RAT INTESTINE BY 1,25-DIHYDROXYVITAMIN-D3 24-HOMOLOGS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN GENE; VITAMIN-D; DIETARY CALCIUM; LEUKEMIA CELLS; DIFFERENTIATION; HL-60; 1-ALPHA,25-DIHYDROXYVITAMIN-D3; MECHANISMS; EXPRESSION	The function and precise mechanism of regulation of calbindin-D 9k in intestine is largely unknown. It is suggested that this calcium binding protein is involved in active intestinal calcium transport and that its expression is mainly mediated by 1,25-dihydroxyvitamin D3. We examined the effect of two side chain modified analogs of 1,25-dihydroxyvitamin D3 as compared to 1,25-dihydroxyvitamin D3 itself on the regualtion of the calbindin-D 9k at the mRNA level and on intestinal calcium transport in the rat. DELTA-22-24,24-dihomo-1,25-dihydroxyvitamin D3 at a single dose of 500, 1,000, and 2,000 pmol caused > 7.0-fold increase in calbindin-D 9k mRNA without stimulating intestinal calcium transport. A 10,000-pmol dose of DELTA-22-24,24,24-trihomo-1,25-dihydroxyvitamin D3 caused a 7.6-fold increase in calbindin-D 9k mRNA without significantly increasing intestinal absorption of calcium. In contrast, 1,25-dihydroxyvitamin D3 caused a parallel increase in calbindin-D 9k mRNA and intestinal absorption of calcium. Thus, calbindin 9k is not by itself responsible for 1,25-dihydroxyvitamin D3-mediated increase in intestinal absorption of calcium.	UNIV WISCONSIN,COLL AGR & LIFE SCI,DEPT BIOCHEM,420 HENRY MALL,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK014881] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-14881] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BRUNS ME, 1987, ENDOCRINOLOGY, V121, P278, DOI 10.1210/endo-121-1-278; BUCKLEY M, 1980, ARCH BIOCHEM BIOPHYS, V202, P235, DOI 10.1016/0003-9861(80)90425-7; CHERTOW BS, 1983, ENDOCRINOLOGY, V113, P1511, DOI 10.1210/endo-113-4-1511; CLEMENS TL, 1989, ENDOCRINOLOGY, V124, P1582, DOI 10.1210/endo-124-3-1582; DELUCA HF, 1983, ANNU REV BIOCHEM, V52, P411, DOI 10.1146/annurev.bi.52.070183.002211; DUPRET JM, 1987, J BIOL CHEM, V262, P16553; GILSIN V, 1974, BIOCHEMISTRY-US, V13, P2633; HALLORAN BP, 1981, ARCH BIOCHEM BIOPHYS, V208, P477, DOI 10.1016/0003-9861(81)90534-8; HARMEYER J, 1969, ARCH BIOCHEM BIOPHYS, V133, P247, DOI 10.1016/0003-9861(69)90452-4; HONMA Y, 1983, P NATL ACAD SCI-BIOL, V80, P201, DOI 10.1073/pnas.80.1.201; JACKOB M, 1987, PEDIATR RES, V22, P518; KESSLER MA, 1986, ARCH BIOCHEM BIOPHYS, V251, P403, DOI 10.1016/0003-9861(86)90346-2; KRISINGER J, 1988, P NATL ACAD SCI USA, V85, P8988, DOI 10.1073/pnas.85.23.8988; Maniatis T., 1982, MOL CLONING; MARTIN DL, 1969, AM J PHYSIOL, V216, P1351, DOI 10.1152/ajplegacy.1969.216.6.1351; OSTREM VK, 1987, P NATL ACAD SCI USA, V84, P2610, DOI 10.1073/pnas.84.9.2610; OSTREM VK, 1987, J BIOL CHEM, V262, P14164; PERLMAN K, 1990, BIOCHEMISTRY-US, V29, P190, DOI 10.1021/bi00453a026; PERRET C, 1985, EUR J BIOCHEM, V150, P211, DOI 10.1111/j.1432-1033.1985.tb09009.x; SILVER J, 1985, P NATL ACAD SCI USA, V82, P4270, DOI 10.1073/pnas.82.12.4270; SMITH EL, 1986, J INVEST DERMATOL, V86, P709, DOI 10.1111/1523-1747.ep12276343; SOMMERVILLE BA, 1985, HORM METAB RES, V17, P78, DOI 10.1055/s-2007-1013456; SUDA T, 1970, J NUTR, V100, P1049, DOI 10.1093/jn/100.9.1049; TANAKA H, 1982, BIOCHEM J, V204, P713, DOI 10.1042/bj2040713	24	54	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1910	1913						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1988453				2022-12-25	WOS:A1991EU49700082
J	HATAKEYAMA, K; INOUE, Y; HARADA, T; KAGAMIYAMA, H				HATAKEYAMA, K; INOUE, Y; HARADA, T; KAGAMIYAMA, H			CLONING AND SEQUENCING OF CDNA-ENCODING RAT GTP CYCLOHYDROLASE-I - THE 1ST ENZYME OF THE TETRAHYDROBIOPTERIN BIOSYNTHETIC-PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SEQUENCE; DIHYDROFOLATE-REDUCTASE; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; THYMIDYLATE SYNTHASE; CRYSTAL-STRUCTURES; NUCLEIC-ACID; DNA-SEQUENCE; COFACTOR; CELLS	A full-length cDNA clone for GTP cyclohydrolase I, the first enzyme of the tetrahydrobiopterin biosynthetic pathway, was isolated and characterized. Synthetic oligonucleotides, constructed according to selected amino acid sequences of purified GTP cyclohydrolase I, were used to screen a rat liver cDNA library. Four clones were isolated, and the length of the longest cDNA insert was 1024 base pairs. The identity of the cDNA was confirmed by amino acid sequence data for eight fragments obtained by lysyl endopeptidase digestion of the purified protein. The coding region encoded a protein of 241 amino acid residues, but the NH2 terminus of the protein contained 11 additional amino acid residues not present in the purified protein. RNA blot analysis showed a single mRNA species of 1.2 kilobases in rat liver. A characteristic feature of the deduced amino acid sequence of GTP cyclohydrolase I was the presence of sequences similar to those proposed for the phosphorylation sites for casein kinase II and growth-associated histone H1 kinase. Furthermore, significant similarity was found to the highly conserved sequences of dihydrofolate reductases, which are known to be involved in the binding of the pterin group of dihydrofolate to the reductases. This region in GTP cyclohydrolase I may be assigned to the binding site of tetrahydrobiopterin, one of the inhibitors of this enzyme.	OSAKA MED COLL,DEPT MED CHEM,2-7 DAIGAKUMACHI,TAKATSUKI,OSAKA 569,JAPAN	Osaka Medical College								AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; BELLAHSENE Z, 1984, BIOCHEM J, V217, P59, DOI 10.1042/bj2170059; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BEVERLEY SM, 1986, P NATL ACAD SCI USA, V83, P2584, DOI 10.1073/pnas.83.8.2584; BOLIN JT, 1982, J BIOL CHEM, V257, P13650; CARROLL D, 1989, J BIOL CHEM, V264, P7345; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CROUSE GF, 1982, J BIOL CHEM, V257, P7887; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; FLING ME, 1988, GENE, V63, P165, DOI 10.1016/0378-1119(88)90522-7; GLEISNER JM, 1974, P NATL ACAD SCI USA, V71, P3001, DOI 10.1073/pnas.71.8.3001; GRUMONT R, 1986, P NATL ACAD SCI USA, V83, P5387, DOI 10.1073/pnas.83.15.5387; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HATAKEYAMA K, 1989, J BIOL CHEM, V264, P21660; KAUFMAN S, 1967, J BIOL CHEM, V242, P3934; KAUFMAN S, 1967, ANNU REV BIOCHEM, V36, P171, DOI 10.1146/annurev.bi.36.070167.001131; KETTLER R, 1974, NATURE, V249, P476, DOI 10.1038/249476a0; KLICKSTEIN LB, 1987, CURRENT PROTOCOLS MO; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KUHARA S, 1984, NUCLEIC ACIDS RES, V12, P89, DOI 10.1093/nar/12.1Part1.89; KWON NS, 1989, J BIOL CHEM, V264, P20496; Langan T A, 1978, Methods Cell Biol, V19, P127; LATHE R, 1985, J MOL BIOL, V183, P1, DOI 10.1016/0022-2836(85)90276-1; LEVINE RA, 1981, SCIENCE, V214, P919, DOI 10.1126/science.6117945; Maniatis T., 1982, MOL CLONING; MARIN O, 1986, EUR J BIOCHEM, V160, P239, DOI 10.1111/j.1432-1033.1986.tb09962.x; MASTERS JN, 1983, GENE, V21, P59, DOI 10.1016/0378-1119(83)90147-6; MATTHEWS DA, 1985, J BIOL CHEM, V260, P381; MCGEOCH DJ, 1986, NUCLEIC ACIDS RES, V14, P1727, DOI 10.1093/nar/14.4.1727; MILSTIEN S, 1989, J BIOL CHEM, V264, P8066; NICHOL CA, 1985, ANNU REV BIOCHEM, V54, P729, DOI 10.1146/annurev.biochem.54.1.729; OEFNER C, 1988, EUR J BIOCHEM, V174, P377, DOI 10.1111/j.1432-1033.1988.tb14108.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHOEDON G, 1987, EUR J BIOCHEM, V166, P303, DOI 10.1111/j.1432-1033.1987.tb13515.x; SHEN R, 1988, BIOCHIM BIOPHYS ACTA, V965, P9, DOI 10.1016/0304-4165(88)90144-4; SMITH DR, 1980, NUCLEIC ACIDS RES, V8, P2255, DOI 10.1093/nar/8.10.2255; STAMMERS DK, 1987, FEBS LETT, V218, P178, DOI 10.1016/0014-5793(87)81042-6; TANAKA K, 1989, P NATL ACAD SCI USA, V86, P5864, DOI 10.1073/pnas.86.15.5864; TAYEH MA, 1989, J BIOL CHEM, V264, P19654; TIETZ A, 1964, J BIOL CHEM, V239, P4081; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; VIVEROS OH, 1981, SCIENCE, V213, P349, DOI 10.1126/science.7017928; WERNER ER, 1989, BIOCHEM J, V262, P861, DOI 10.1042/bj2620861; WILBUR WJ, 1983, P NATL ACAD SCI-BIOL, V80, P726, DOI 10.1073/pnas.80.3.726; WOODFORD TA, 1986, J BIOL CHEM, V261, P4669	47	94	97	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					765	769						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985963				2022-12-25	WOS:A1991ET17700017
J	HOOGEWERF, AJ; BENSADOUN, A				HOOGEWERF, AJ; BENSADOUN, A			OCCURRENCE OF SULFATE IN AN ASPARAGINE-LINKED COMPLEX OLIGOSACCHARIDE OF CHICKEN ADIPOSE LIPOPROTEIN-LIPASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DICTYOSTELIUM-DISCOIDEUM; STRUCTURAL-ANALYSIS; ENDOTHELIAL-CELLS; MAMMALIAN-CELLS; GLYCOPROTEINS; ADIPOCYTES; SECRETION; MEMBRANE; PROTEINS; GLYCOSYLATION	After adipocytes were labeled with Na2[35SO4], immunoadsorbed with immobilized antilipoprotein lipase, and subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and fluorography, a labeled band was identified at 59,700 daltons, the molecular mass of chicken lipoprotein lipase (LPL). Excess unlabeled LPL prevented the immunoadsorption of this labeled species, hence the labeled species was determined to be LPL. Digestion of LPL with endo-beta-N-acetylglucosaminidase H (Endo H) caused a shift in mobility of LPL in SDS-PAGE with no loss of radioactivity, whereas digestion with glycopeptidase F resulted in removal of 99% of the radioactivity. Adipocytes cultured with Trans-S-35-label(TM) and tunicamycin produced an LPL species of 52,000 daltons, but tunicamycin abolished the incorporation of 35SO4 into LPL. This established that 35SO4 was incorporated into an N-linked oligosaccharide of LPL. Endo H digestion of pulse-chase labeled LPL revealed the presence of two complex and one high mannose-type N-linked oligosaccharides. A single 35SO4-labeled tryptic peptide was isolated by reverse phase chromatography. The amino acid sequence of the peptide established that the 35SO4 oligosaccharide is conjugated at Asn-45. Behavior of the 35SO4-labeled oligosaccharide on concanavalin A-agarose, sequential exoglycosidase digestion, and chemical analysis of the 35SO4 oligosaccharide confirms that this moiety is of the complex type. Sequential exoglycosidase digestion, thin layer chromatography of the released monosaccharides, and the use of glycosylation inhibitors established that the sulfated sugar is a core N-acetylglucosamine (GlcNAc). The data show that chicken LPL contains two complex and one high mannose N-linked oligosaccharides and that 35SO4 is incorporated into LPL on a GlcNAc residue of a complex oligosaccharide located at Asn-45.	CORNELL UNIV,DIV NUTR SCI,ITHACA,NY 14853; CORNELL UNIV,DIV BIOL SCI,ITHACA,NY 14853	Cornell University; Cornell University					NHLBI NIH HHS [HL-14990] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL014990] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AMRI EZ, 1986, BIOCHIM BIOPHYS ACTA, V875, P334, DOI 10.1016/0005-2760(86)90184-0; ASHWELL G, 1974, ADV ENZYMOL RAMB, V41, P99; BENGTSSON G, 1980, BIOCHEM J, V189, P625, DOI 10.1042/bj1890625; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BURKE B, 1984, EMBO J, V3, P551, DOI 10.1002/j.1460-2075.1984.tb01845.x; CHAJEKSHAUL T, 1985, BIOCHIM BIOPHYS ACTA, V875, P123; Chaplin M.F., 1986, MASS SPECTROM, P1; CHAPLIN MF, 1982, ANAL BIOCHEM, V123, P336, DOI 10.1016/0003-2697(82)90455-9; CHENG CF, 1981, J BIOL CHEM, V256, P2893; CHEUNG AH, 1979, ANAL BIOCHEM, V94, P346, DOI 10.1016/0003-2697(79)90371-3; CISAR LA, 1989, J BIOL CHEM, V264, P1767; CLADARAS MH, 1984, J BIOL CHEM, V259, P4165; COOPER DA, 1989, BIOCHIM BIOPHYS ACTA, V1008, P92, DOI 10.1016/0167-4781(89)90174-7; CRYER A, 1981, INT J BIOCHEM, V13, P525, DOI 10.1016/0020-711X(81)90177-4; CUPP M, 1987, J BIOL CHEM, V262, P6383; DOOLITTLE MH, 1990, J BIOL CHEM, V265, P4570; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; FREEZE HH, 1986, J BIOL CHEM, V261, P127; FREEZE HH, 1983, J BIOL CHEM, V258, P4874; GREEN ED, 1988, J BIOL CHEM, V263, P25; HUBBARD SC, 1988, J BIOL CHEM, V263, P19303; HUNKAPILLER MW, 1983, SCIENCE, V219, P650, DOI 10.1126/science.6687410; JACKSON RL, 1983, ENZYMES, V16, P141; KOMPIANG IP, 1976, J LIPID RES, V17, P498; KREESE H, 1981, J BIOL CHEM, V256, P12926; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LLOYD AG, 1961, BIOCHEM J, V83, P455; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MASUNO H, 1990, J BIOL CHEM, V265, P1628; MIZUOCHI T, 1984, J BIOCHEM-TOKYO, V95, P1209, DOI 10.1093/oxfordjournals.jbchem.a134711; OLIVECRONA T, 1987, J BIOL CHEM, V262, P10748; ONG JM, 1989, J BIOL CHEM, V264, P3177; PEYRIERAS N, 1983, EMBO J, V2, P823, DOI 10.1002/j.1460-2075.1983.tb01509.x; REES DA, 1963, BIOCHEM J, V88, P343, DOI 10.1042/bj0880343; ROUX L, 1988, J BIOL CHEM, V263, P8879; SEMB H, 1989, J BIOL CHEM, V264, P4195; SEMENKOVICH CF, 1989, J BIOL CHEM, V264, P9030; SEMENKOVICH CF, 1990, J BIOL CHEM, V265, P5429; SHIMADA K, 1981, J CLIN INVEST, V68, P995, DOI 10.1172/JCI110354; SIMPSON DL, 1976, BIOCHEMISTRY-US, V15, P5449, DOI 10.1021/bi00670a005; SORBO B, 1987, METHOD ENZYMOL, V143, P3; SPIRO RG, 1988, J BIOL CHEM, V263, P14351; SUNDBLAD G, 1988, J BIOL CHEM, V263, P8897; VANNIER C, 1989, J BIOL CHEM, V264, P13206; VARKI A, 1983, J BIOL CHEM, V258, P2808; WANGIVERSON P, 1980, ATHEROSCLEROSIS, V5, P375	47	24	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1048	1057						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985932				2022-12-25	WOS:A1991ET17700060
J	KUMAR, A; BLUMENTHAL, DK; FAIR, DS				KUMAR, A; BLUMENTHAL, DK; FAIR, DS			IDENTIFICATION OF MOLECULAR SITES ON FACTOR-VII WHICH MEDIATE ITS ASSEMBLY AND FUNCTION IN THE EXTRINSIC PATHWAY ACTIVATION COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN FACTOR-X; BLOOD-COAGULATION; TISSUE FACTOR; FACTOR-IX; PLASMA; CHROMATOGRAPHY; INITIATION; THROMBIN; SEQUENCE; PROTEINS	Factor VII-VIIa, in association with tissue factor, participates in the complex which initiates blood coagulation through the extrinsic pathway. To identify functional domains on factor VII which mediate the activation of factor X, 16 synthetic peptides corresponding to 55% of the primary structure were assayed for their ability to inhibit factor VII function. Factor Xa formation was inhibited by eight of the peptides in a dose-dependent manner. Kinetic analyses indicated noncompetitive inhibition of factor X activation by seven of these peptides. Peptide-(347-361) inhibited factor Xa cleavage of a chromogenic substrate by a competitive mechanism and was excluded from further analysis in this study. Among the seven inhibitory peptides which have the ability to prevent the factor VIIa-tissue factor-mediated conversion of factor X to factor Xa, peptide-(285-305) was most inhibitory, with a K(i) value of 2.4-mu-M. The K(i) values were in the range of 42-65-mu-M for peptides-(44-50), -(194-214), -(208-229), and -(376-390). The least inhibitory peptides were at positions 170-178 and 330-340, with a K(i) value > 200-mu-M. Polyclonal antibodies were raised against four of these peptides; and when antisera were assayed by a solid-phase radioimmunoassay, they bound not only to their respective immunizing peptides, but also to factor VII. The Fab fragments of specific IgG preparations, affinity-purified on a factor VII-agarose column, inhibited the rate of factor X activation in a dose-dependent manner. Six of the seven inhibitory peptides represent amino acid sequences within the heavy chain of factor VII, and the remaining one corresponds to a sequence within the light chain. The corresponding regions in the x-ray crystal structure of chymotrypsin represented by the six heavy chain inhibitory peptides are found to be located in three distinct regions, one region located spatially distal to the active site and the other two regions located relatively closer to the active site and the substrate-binding pocket. The results suggest that at least three specific regions in the heavy chain and one region in the light chain of factor VII mediate its interaction with the factor X activation complex.			KUMAR, A (corresponding author), UNIV TEXAS,CTR HLTH,DEPT BIOCHEM,TYLER,TX 75710, USA.			Blumenthal, Donald/0000-0002-8614-1167	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL037770] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 37770] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BACH RR, 1988, CRC CR REV BIOCH MOL, V23, P339, DOI 10.3109/10409238809082548; BAJAJ SP, 1981, J BIOL CHEM, V256, P253; BERZOFSKY JA, 1985, SCIENCE, V229, P932, DOI 10.1126/science.2410982; BROZE GJ, 1980, J BIOL CHEM, V255, P1242; CHATTOPADHYAY A, 1989, J BIOL CHEM, V264, P11035; DAYSON HJ, 1988, ANNU REV BIOPHYS BIO, V17, P305; FAIR DS, 1983, BLOOD, V62, P784; FAIR DS, 1979, J CLIN INVEST, V64, P884, DOI 10.1172/JCI109554; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; FURIE B, 1982, J BIOL CHEM, V257, P3875; GARCIA MS, 1989, BIOCHEMISTRY-US, V28, P6805; GLASS DB, 1983, METHOD ENZYMOL, V99, P119; HAGEN FS, 1986, P NATL ACAD SCI USA, V83, P2412, DOI 10.1073/pnas.83.8.2412; Hartley BS, 1971, ENZYMES, V3, P323; Hewett-Emmett D, 1981, Ann N Y Acad Sci, V370, P511, DOI 10.1111/j.1749-6632.1981.tb29759.x; JACKSON CM, 1984, PROG HEMOST THROMB, V7, P55; JACKSON CM, 1980, ANNU REV BIOCHEM, V49, P765, DOI 10.1146/annurev.bi.49.070180.004001; KATAYAMA K, 1979, P NATL ACAD SCI USA, V76, P4990, DOI 10.1073/pnas.76.10.4990; KISIEL W, 1976, BIOCHEMISTRY-US, V15, P4901, DOI 10.1021/bi00667a023; MARCH SC, 1974, ANAL BIOCHEM, V60, P149, DOI 10.1016/0003-2697(74)90139-0; Marlar R A, 1981, Ann N Y Acad Sci, V370, P325, DOI 10.1111/j.1749-6632.1981.tb29745.x; MATTHEWS BW, 1967, NATURE, V214, P653; MORRISSEY JH, 1988, THROMB RES, V50, P481, DOI 10.1016/0049-3848(88)90197-1; NEMERSON Y, 1980, CRC CR REV BIOCH MOL, V9, P45, DOI 10.3109/10409238009105472; OSTERUD B, 1977, P NATL ACAD SCI USA, V74, P5260, DOI 10.1073/pnas.74.12.5260; PARK CH, 1986, BIOCHEMISTRY-US, V25, P3977, DOI 10.1021/bi00362a001; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; RADCLIFFE R, 1975, J BIOL CHEM, V250, P388; RAO LVM, 1988, P NATL ACAD SCI USA, V85, P6687, DOI 10.1073/pnas.85.18.6687; RAO LVM, 1990, BLOOD, V75, P1069; SELIGSOHN U, 1979, J CLIN INVEST, V64, P1056, DOI 10.1172/JCI109543; SIGLER PB, 1968, J MOL BIOL, V35, P143, DOI 10.1016/S0022-2836(68)80043-9; STEITZ TA, 1969, J MOL BIOL, V46, P337, DOI 10.1016/0022-2836(69)90426-4; WELLING GW, 1985, FEBS LETT, V188, P215, DOI 10.1016/0014-5793(85)80374-4; WILLIAMS EB, 1989, J BIOL CHEM, V264, P7536; ZUR M, 1982, J BIOL CHEM, V257, P5623	36	44	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					915	921						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985971				2022-12-25	WOS:A1991ET17700039
J	NANDURI, J; DENNIS, JE; ROSENBERRY, TL; MAHMOUD, AAF; TARTAKOFF, AM				NANDURI, J; DENNIS, JE; ROSENBERRY, TL; MAHMOUD, AAF; TARTAKOFF, AM			GLYCOCALYX OF BODIES VERSUS TAILS OF SCHISTOSOMA-MANSONI CERCARIAE LECTIN-BINDING, SIZE, CHARGE, AND ELECTRON-MICROSCOPIC CHARACTERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-MEMBRANE MATURATION; GLYCOPROTEINS; ULTRASTRUCTURE; OLIGOSACCHARIDES; TRANSFORMATION; COMPLEMENT; ACID	Infection with Schistosoma mansoni is initiated by penetration of the intact skin of the mammalian host with the head but not the tail of the parasite cercariae. The surface of cercariae is covered by a 1-2-micron thick carbohydrate-rich glycocalyx (gx). Furthermore, the transformation of cercariae to schistosomula (the next parasitic stage in the mammalian host) is associated with loss of gx from the bodies. To understand the role of gx in the host-parasite relationship, we have characterized the gx of both bodies and tails of S. mansoni cercariae. A fluorescent fucose-specific lectin-stained bodies and not tails of the organism. Moreover, when an enriched preparation of gx obtained by extraction with 40% aqueous phenol and exclusion from Sepharose CL-6B was subjected to affinity chromatography on insolubilized Lotus lectin, which binds fucose-containing glycans, only body gx was retained. Body gx is smaller and less negatively charged than tail gx. Electron microscopy showed that gx from bodies and tails is composed of 25-40-nm particles and fibrillar material. Carbohydrate composition of gx of bodies and tails indicate that fucose and glucose are major components, respectively. beta-Elimination experiments indicate that the linkage sugar is N-acetylgalactosamine in both cases. Upon treatment with alkaline borohydride, nearly 90% of gx of both bodies and tails was recovered as two glycan chains: I and II (M(r) approximately 10,500 and 5,600, respectively). Glycan I was in both cases more negatively charged than glycan II. Fucose is the predominant sugar in glycan I of the bodies while glycan I of tails is mainly composed of glucose. The gx was resistant to several proteases. This resistance and the abundance of carbohydrate in gx may be of biological importance for survival of cercariae. The substantial differences observed between the gx of bodies and tails may provide the basis for understanding the mechanism of selective release of body gx during transformation.	CASE WESTERN RESERVE UNIV, DEPT BIOL, CLEVELAND, OH 44106 USA; CASE WESTERN RESERVE UNIV, DEPT PHARMACOL, CLEVELAND, OH 44106 USA; CASE WESTERN RESERVE UNIV, INST PATHOL, CLEVELAND, OH 44106 USA; CASE WESTERN RESERVE UNIV HOSP, CLEVELAND, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital	NANDURI, J (corresponding author), CASE WESTERN RESERVE UNIV, DEPT MED, DIV GEOG MED, CLEVELAND, OH 44106 USA.		Mahmoud, Azza Ahmed/S-1502-2016		NCRR NIH HHS [1-P41-RR05351-01] Funding Source: Medline; NIAID NIH HHS [AI 15351] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI015351] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BENNETT HS, 1963, J HISTOCHEM CYTOCHEM, V11, P14, DOI 10.1177/11.1.14; BIERMANN CJ, 1988, ADV CARBOHYD CHEM BI, V46, P251, DOI 10.1016/S0065-2318(08)60168-7; BOCTOR FN, 1979, J IMMUNOL, V122, P39; CARLSON DM, 1968, J BIOL CHEM, V243, P616; CAULFIELD JP, 1988, EXP PARASITOL, V65, P10, DOI 10.1016/0014-4894(88)90102-6; CAULFIELD JP, 1987, J PARASITOL, V73, P514, DOI 10.2307/3282129; COLLEY DG, 1974, EXP PARASITOL, V35, P44, DOI 10.1016/0014-4894(74)90005-8; CONSTANTOPOULOS G, 1969, ANAL BIOCHEM, V31, P59, DOI 10.1016/0003-2697(69)90241-3; CUMMINGS RD, 1989, METHOD CELL BIOL, V32, P141; DALTON JP, 1987, EXP PARASITOL, V63, P215, DOI 10.1016/0014-4894(87)90164-0; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; FAWCETT DW, 1965, J HISTOCHEM CYTOCHEM, V13, P75, DOI 10.1177/13.2.75; GAHMBERG CG, 1977, J BIOL CHEM, V252, P5888; HOCKLEY D J, 1973, International Journal for Parasitology, V3, P13, DOI 10.1016/0020-7519(73)90004-0; ITO S, 1969, FED PROC, V28, P12; LUMSDEN RD, 1972, J PARASITOL, V58, P229, DOI 10.2307/3278076; LUMSDEN RD, 1975, EXP PARASITOL, V37, P267, DOI 10.1016/0014-4894(75)90078-8; MARIKOVSKY M, 1988, J IMMUNOL, V141, P273; MARKWELL M, 1972, ANAL BIOCHEM, V25, P464; Martuinez-Palomo A., 1970, INT REV CYTOL, V29, P29; MCDIARMID SS, 1984, MOL BIOCHEM PARASIT, V10, P33, DOI 10.1016/0166-6851(84)90016-1; MURRELL KD, 1978, EXP PARASITOL, V46, P247, DOI 10.1016/0014-4894(78)90138-8; NYAME K, 1987, J BIOL CHEM, V262, P7990; NYAME K, 1988, J PARASITOL, V74, P562, DOI 10.2307/3282171; PAULSSON M, 1987, BIOCHEM J, V245, P763, DOI 10.1042/bj2450763; PEARCE EJ, 1989, J IMMUNOL, V142, P979; RAMALHOPINTO FJ, 1974, EXP PARASITOL, V36, P360, DOI 10.1016/0014-4894(74)90076-9; SAMUELSON JC, 1986, INFECT IMMUN, V51, P181, DOI 10.1128/IAI.51.1.181-186.1986; SAMUELSON JC, 1985, J CELL BIOL, V100, P1423, DOI 10.1083/jcb.100.5.1423; SHEEHAN JK, 1990, BIOCHEM J, V265, P169, DOI 10.1042/bj2650169; SHOGREN RL, 1987, CARBOHYD RES, V160, P317; SIMPSON AJG, 1983, MOL BIOCHEM PARASIT, V8, P191, DOI 10.1016/0166-6851(83)90009-9; SMITHERS SR, 1965, PARASITOLOGY, V55, P695, DOI 10.1017/S0031182000086248; Stirewalt M.A., 1974, Advances Parasit, V12, P115, DOI 10.1016/S0065-308X(08)60388-7; STIREWALT MA, 1983, EXP PARASITOL, V56, P358, DOI 10.1016/0014-4894(83)90081-4; THREADGOLD LT, 1976, EXP PARASITOL, V39, P119, DOI 10.1016/0014-4894(76)90019-9; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; WIEST PM, 1989, AM J TROP MED HYG, V41, P70, DOI 10.4269/ajtmh.1989.41.70; WIEST PM, 1988, P NATL ACAD SCI USA, V85, P3825, DOI 10.1073/pnas.85.11.3825; WIGHTMAN BC, 1986, BIOCHEM J, V235, P469, DOI 10.1042/bj2350469; WOODWARD HD, 1987, BIOCHEMISTRY-US, V26, P5315, DOI 10.1021/bi00391a015; YORK WS, 1986, METHOD ENZYMOL, V118, P3	42	35	36	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1341	1347						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1985952				2022-12-25	WOS:A1991ET17700100
J	KERRIGAN, LA; CROSTON, GE; LIRA, LM; KADONAGA, JT				KERRIGAN, LA; CROSTON, GE; LIRA, LM; KADONAGA, JT			SEQUENCE-SPECIFIC TRANSCRIPTIONAL ANTIREPRESSION OF THE DROSOPHILA-KRUPPEL GENE BY THE GAGA FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-II TRANSCRIPTION; INVITRO TRANSCRIPTION; PROMOTER; BINDING; GAP; PROTEINS; EMBRYO; EXPRESSION; HUNCHBACK; EXTRACTS	We have analyzed the proximal promoter of the Drosophila Kruppel (Kr) gene. A 44-base pair fragment containing the RNA start sites contains significant promoter activity, and this minimal promoter is flanked both upstream and downstream by binding sites for the GAGA factor. The GAGA factor is the predominant sequence-specific DNA binding factor that interacts with the Kr promoter region, and the purified protein activates Kr transcription in vitro. However, strong transcriptional activation of Kr as well as of Ultrabithorax, another GAGA factor-responsive gene, requires the presence of a DNA binding transcriptional repressor. The GAGA factor is able to relieve this repression in a binding site-dependent manner, and, thus, these data suggest that the GAGA factor functions as an antirepressor, rather than an activator, of the Kr gene.	UNIV CALIF SAN DIEGO,DEPT MOLEC GENET,LA JOLLA,CA 92093	University of California System; University of California San Diego	KERRIGAN, LA (corresponding author), UNIV CALIF SAN DIEGO,DEPT BIOL B022,LA JOLLA,CA 92093, USA.				NIGMS NIH HHS [GM 41249] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKAM M, 1987, DEVELOPMENT, V101, P1; BERGER SL, 1990, CELL, V61, P1199, DOI 10.1016/0092-8674(90)90684-7; BIGGIN MD, 1988, CELL, V53, P699, DOI 10.1016/0092-8674(88)90088-8; BIGGIN MD, 1989, TRENDS GENET, V5, P377, DOI 10.1016/0168-9525(89)90173-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHALIFOUR LE, 1987, GENE DEV, V1, P1096, DOI 10.1101/gad.1.10.1096; CHASMAN DI, 1989, MOL CELL BIOL, V9, P4746, DOI 10.1128/MCB.9.11.4746; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; GAUL U, 1987, TRENDS GENET, V3, P127, DOI 10.1016/0168-9525(87)90202-2; GERMOND JE, 1975, P NATL ACAD SCI USA, V72, P1843, DOI 10.1073/pnas.72.5.1843; GILMOUR DS, 1989, SCIENCE, V245, P1487, DOI 10.1126/science.2781290; HEIERMANN R, 1985, NUCLEIC ACIDS RES, V13, P2709, DOI 10.1093/nar/13.8.2709; HOCH M, 1990, EMBO J, V9, P2587, DOI 10.1002/j.1460-2075.1990.tb07440.x; HOEY T, 1990, CELL, V61, P1179, DOI 10.1016/0092-8674(90)90682-5; HULTMARK D, 1986, CELL, V44, P429, DOI 10.1016/0092-8674(86)90464-2; INGHAM PW, 1988, NATURE, V335, P25, DOI 10.1038/335025a0; KADONAGA JT, 1990, J BIOL CHEM, V265, P2624; KELLEHER RJ, 1990, CELL, V61, P1209, DOI 10.1016/0092-8674(90)90685-8; KNIPPLE DC, 1985, NATURE, V317, P40, DOI 10.1038/317040a0; LIN YS, 1988, CELL, V54, P659, DOI 10.1016/S0092-8674(88)80010-2; MARTINEZSALAS E, 1989, GENE DEV, V3, P1493, DOI 10.1101/gad.3.10.1493; MARTINEZSALAS E, 1988, GENE DEV, V2, P1115, DOI 10.1101/gad.2.9.1115; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; PANKRATZ MJ, 1989, NATURE, V341, P337, DOI 10.1038/341337a0; PERKINS KK, 1988, GENE DEV, V2, P1615, DOI 10.1101/gad.2.12a.1615; PETERSON MG, 1990, SCIENCE, V248, P1625, DOI 10.1126/science.2363050; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; ROSENBERG UB, 1986, NATURE, V319, P336, DOI 10.1038/319336a0; SALTZMAN AG, 1989, FASEB J, V3, P1723, DOI 10.1096/fasebj.3.6.2649403; SCOTT MP, 1987, CELL, V51, P689, DOI 10.1016/0092-8674(87)90092-4; SOELLER WC, 1988, GENE DEV, V2, P68, DOI 10.1101/gad.2.1.68; STANOJEVIC D, 1989, NATURE, V341, P331, DOI 10.1038/341331a0; THUMMEL CS, 1989, GENE DEV, V3, P782, DOI 10.1101/gad.3.6.782; TREISMAN J, 1989, NATURE, V341, P335, DOI 10.1038/341335a0; WAMPLER SL, 1990, IN PRESS J BIOL CHEM; WORKMAN JL, 1988, CELL, V55, P211, DOI 10.1016/0092-8674(88)90044-X; WORKMAN JL, 1987, CELL, V51, P613, DOI 10.1016/0092-8674(87)90130-9	38	95	96	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					574	582						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1985916				2022-12-25	WOS:A1991EQ33900084
J	PUNYAMMALEE, B; CRABEEL, M; DELANNOY, C; PERBAL, B; GLANSDORFF, N				PUNYAMMALEE, B; CRABEEL, M; DELANNOY, C; PERBAL, B; GLANSDORFF, N			2 C-MYB PROTEINS DIFFERING BY THEIR AMINOTERMINI EXHIBIT DIFFERENT TRANSCRIPTIONAL TRANSACTIVATION ACTIVITIES - YEAST REPORTER-EFFECTOR SYSTEM	ONCOGENE			English	Article							AVIAN-MYELOBLASTOSIS VIRUS; DNA-BINDING ACTIVITY; GENE V-MYB; NUCLEOTIDE-SEQUENCE; PROTO-ONCOGENE; SACCHAROMYCES-CEREVISIAE; TRANSFORMING GENE; MESSENGER-RNA; CHICKEN DNA; PLASMACYTOID LYMPHOSARCOMAS	We assayed in the yeast S. cerevisiae the transcriptional transactivation activity of the c-myb products encoded by a normal thymus cDNA and of an aminoterminally truncated version of it (minus 58 amino acids) corresponding to the cDNAs isolated from lymphoma and leukemia cells from different origins. Both proto-oncogene products were expressed under the control of the galactose inducible GAL10 promoter. The reporter system used to monitor the transactivation potential of the myb products consisted of a CYCl-lacZ gene fusion in which the UAS(cyc) signals were replaced by one or multiple copies of the myb recognition element (mRE). As shown by Northern blot analyses and by primer extension experiments both c-myb products increase the level of beta-galactosidase transcription. Interestingly, the c-myb product corresponding to lymphoma cDNAs stimulates transcription four to five times more efficiently than does the normal thymic c-myb product.	VRIJE UNIV BRUSSELS,COOVI,CERIA,RES INST,1 E GRYSONLAAN,B-1070 BRUSSELS,BELGIUM; UNIV PARIS 06,F-75230 PARIS 05,FRANCE; CTR UNIV ORSAY,INST CURIE,F-91405 ORSAY,FRANCE	Vrije Universiteit Brussel; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay								BADING H, 1987, ONCOGENE, V1, P395; BALUDA MA, 1983, FOLIA BIOL-PRAGUE, V29, P18; BENDER TP, 1986, P NATL ACAD SCI USA, V83, P3204, DOI 10.1073/pnas.83.10.3204; BERGMAN DG, 1980, J VIROL, V40, P450; BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; BOYLE WJ, 1985, MOL CELL BIOL, V5, P3017, DOI 10.1128/MCB.5.11.3017; BOYLE WJ, 1986, P NATL ACAD SCI USA, V83, P4685, DOI 10.1073/pnas.83.13.4685; Broach J. R., 1983, EXPT MANIPULATION GE, P83; CHEN JH, 1980, J VIROL, V36, P162, DOI 10.1128/JVI.36.1.162-170.1980; CLARKE MF, 1988, MOL CELL BIOL, V8, P884, DOI 10.1128/MCB.8.2.884; GERONDAKIS S, 1986, MOL CELL BIOL, V6, P3677, DOI 10.1128/MCB.6.11.3677; GEWIRTZ AM, 1988, SCIENCE, V242, P1303, DOI 10.1126/science.2461588; GONDA TJ, 1987, J VIROL, V61, P2754, DOI 10.1128/JVI.61.9.2754-2763.1987; GONDA TJ, 1982, MOL CELL BIOL, V2, P617, DOI 10.1128/MCB.2.6.617; GONDA TJ, 1985, EMBO J, V4, P2003, DOI 10.1002/j.1460-2075.1985.tb03884.x; GUARENTE L, 1981, P NATL ACAD SCI-BIOL, V78, P2199, DOI 10.1073/pnas.78.4.2199; HAHN S, 1985, P NATL ACAD SCI USA, V82, P8562, DOI 10.1073/pnas.82.24.8562; HAMILTON R, 1987, NUCLEIC ACIDS RES, V15, P3581, DOI 10.1093/nar/15.8.3581; HENTZE MW, 1987, P NATL ACAD SCI USA, V84, P6730, DOI 10.1073/pnas.84.19.6730; HOPE IA, 1986, CELL, V46, P885, DOI 10.1016/0092-8674(86)90070-X; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KANTER MR, 1988, J VIROL, V62, P1423, DOI 10.1128/JVI.62.4.1423-1432.1988; KATZEN AL, 1985, CELL, V41, P449, DOI 10.1016/S0092-8674(85)80018-0; KLEMPNAUER KH, 1984, CELL, V37, P537, DOI 10.1016/0092-8674(84)90384-2; KLEMPNAUER KH, 1988, ONCOGENE, V2, P545; KLEMPNAUER KH, 1982, CELL, V31, P453, DOI 10.1016/0092-8674(82)90138-6; KLEMPNAUER KH, 1986, EMBO J, V5, P1903, DOI 10.1002/j.1460-2075.1986.tb04443.x; KLEMPNAUER KH, 1983, CELL, V33, P345, DOI 10.1016/0092-8674(83)90416-6; KLEMPNAUER KH, 1986, MOL CELL BIOL, V6, P62, DOI 10.1128/MCB.6.1.62; KRUYS VI, 1988, GENE, V72, P191, DOI 10.1016/0378-1119(88)90144-8; LAVU S, 1986, NUCLEIC ACIDS RES, V14, P5309, DOI 10.1093/nar/14.13.5309; MA J, 1987, CELL, V51, P13; MAJELLO B, 1986, P NATL ACAD SCI USA, V83, P9636, DOI 10.1073/pnas.83.24.9636; MCMAHON J, 1988, ONCOGENE, V3, P717; MCNEIL JB, 1985, MOL CELL BIOL, V5, P3545, DOI 10.1128/MCB.5.12.3545; Miller J.H., 1972, EXPT MOL GENETICS; MOELLING K, 1985, CELL, V40, P983, DOI 10.1016/0092-8674(85)90358-7; MUSHINSKI JF, 1983, SCIENCE, V220, P795, DOI 10.1126/science.6687762; NAKAGOSHI H, 1989, NUCLEIC ACIDS RES, V17, P7315, DOI 10.1093/nar/17.18.7315; NAKAMAYE KL, 1986, NUCLEIC ACIDS RES, V14, P9679, DOI 10.1093/nar/14.24.9679; NISHINA Y, 1989, NUCLEIC ACIDS RES, V17, P107, DOI 10.1093/nar/17.1.107; PELLICI PG, 1986, SCIENCE, V224, P1117; PERBAL B, 1983, J VIROL, V45, P925, DOI 10.1128/JVI.45.3.925-940.1983; PERBAL B, 1982, J VIROL, V44, P586, DOI 10.1128/JVI.44.2.586-594.1982; PERBAL B, 1982, J VIROL, V41, P250, DOI 10.1128/JVI.41.1.250-257.1982; Perbal B., 1988, PRACTICAL GUIDE MOL; RAMOS F, 1979, EUR J BIOCHEM, V94, P409, DOI 10.1111/j.1432-1033.1979.tb12908.x; RAMSAY RG, 1989, ONCOGENE RES, V4, P259; ROSSON D, 1986, NATURE, V319, P604, DOI 10.1038/319604a0; ROUSSEL M, 1979, NATURE, V281, P452, DOI 10.1038/281452a0; SAKURA H, 1989, P NATL ACAD SCI USA, V86, P5758, DOI 10.1073/pnas.86.15.5758; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHENONG GLC, 1984, SCIENCE, V226, P1077, DOI 10.1126/science.6093260; SHENONG GLC, 1986, MOL CELL BIOL, V6, P380, DOI 10.1128/MCB.6.2.380; SPRAGUE J, 1983, J VIROL, V45, P773, DOI 10.1128/JVI.45.2.773-781.1983; SSAMBROOK J, 1988, MOL CLONING LABORATO; STRICKLAND S, 1988, SCIENCE, V241, P680, DOI 10.1126/science.2456615; TODOKORO K, 1988, P NATL ACAD SCI USA, V85, P8900, DOI 10.1073/pnas.85.23.8900; WEINSTEIN Y, 1986, P NATL ACAD SCI USA, V83, P5010, DOI 10.1073/pnas.83.14.5010; WEINSTEIN Y, 1987, J VIROL, V61, P2339, DOI 10.1128/JVI.61.7.2339-2343.1987; WESTIN EH, 1982, P NATL ACAD SCI-BIOL, V79, P2194, DOI 10.1073/pnas.79.7.2194; WESTON K, 1989, CELL, V58, P85, DOI 10.1016/0092-8674(89)90405-4; YOKOTA J, 1986, SCIENCE, V231, P261, DOI 10.1126/science.3941898	63	13	13	0	0	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0950-9232			ONCOGENE	Oncogene	JAN	1991	6	1					11	19						9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EY039	1992438				2022-12-25	WOS:A1991EY03900002
